PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Raspelli, E; Cassani, C; Chiroli, E; Fraschini, R				Raspelli, Erica; Cassani, Corinne; Chiroli, Elena; Fraschini, Roberta			Budding Yeast Swe1 Is Involved in the Control of Mitotic Spindle Elongation and Is Regulated by Cdc14 Phosphatase during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclin-dependent Kinase (Cdk); Mitosis; Mitotic Spindle; Phosphorylation; Yeast	MORPHOGENESIS CHECKPOINT; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHORYLATION; PROTEIN-KINASE; POLO KINASE; CELL-CYCLE; ANAPHASE; DEGRADATION; EXIT; WEE1	Background: Timely mitotic spindle elongation ensures correct chromosome segregation, which is crucial for genetic stability. Results: The protein kinase Swe1 contributes to restraining anaphase progression and is regulated by the protein phosphatase Cdc14. Conclusion: Swe1 plays a role in the control of mitotic spindle elongation. Significance: Swe1 regulation by Cdc14 allows proper coordination of spindle elongation with mitotic progression. Cyclin-dependent kinase (Cdk1) activity is required for mitotic entry, and this event is restrained by an inhibitory phosphorylation of the catalytic subunit Cdc28 on a conserved tyrosine (Tyr(19)). This modification is brought about by the protein kinase Swe1 that inhibits Cdk1 activation thus blocking mitotic entry. Swe1 levels are regulated during the cell cycle, and they decrease during G(2)/M concomitantly to Cdk1 activation, which drives entry into mitosis. However, after mitotic entry, a pool of Swe1 persists, and we collected evidence that it is involved in controlling mitotic spindle elongation. We also describe that the protein phosphatase Cdc14 is implicated in Swe1 regulation; in fact, we observed that Swe1 dephosphorylation in vivo depends on Cdc14 that, in turn, is able to control its subcellular localization. In addition we show that the lack of Swe1 causes premature mitotic spindle elongation and that high levels of Swe1 block mitotic spindle elongation, indicating that Swe1 inhibits this process. Importantly, these effects are not dependent upon the role of in Cdk1 inhibition. These data fit into a model in which Cdc14 binds and inhibits Swe1 to allow timely mitotic spindle elongation.	[Raspelli, Erica; Cassani, Corinne; Fraschini, Roberta] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy; [Chiroli, Elena] FIRC, Inst Mol Oncol, IFOM, I-20139 Milan, Italy	University of Milano-Bicocca; IFOM - FIRC Institute of Molecular Oncology	Fraschini, R (corresponding author), Univ Milano Bicocca, Dipt Biotecnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	roberta.fraschini@unimib.it	fraschini, roberta/G-5680-2015	Raspelli, Erica/0000-0002-0937-0521; Chiroli, Elena/0000-0001-8668-0657	Fondazione Buzzati-Traverso; Fondazione Confalonieri; Fondazione Veronesi	Fondazione Buzzati-Traverso; Fondazione Confalonieri; Fondazione Veronesi(Fondazione Umberto Veronesi)	Supported by a fellowship from Fondazione Buzzati-Traverso.; Supported by a fellowship from Fondazione Confalonieri.; Supported by a Young Investigator Programme 2013 fellowship from Fondazione Veronesi.	AMON A, 1992, NATURE, V355, P368, DOI 10.1038/355368a0; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Bembenek J, 2005, CELL CYCLE, V4, P961, DOI 10.4161/cc.4.7.1798; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; de Gramont A, 2005, TRENDS BIOCHEM SCI, V30, P559, DOI 10.1016/j.tibs.2005.08.008; Fraschini R, 2006, J CELL BIOL, V172, P335, DOI 10.1083/jcb.200507162; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Garcia K, 2009, CURR BIOL, V19, P1670, DOI 10.1016/j.cub.2009.08.013; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keaton MA, 2006, CURR OPIN MICROBIOL, V9, P540, DOI 10.1016/j.mib.2006.10.004; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; King K, 2013, MOL BIOL CELL, V24, P914, DOI 10.1091/mbc.E12-11-0812; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Maniatis T., 1992, MOL CLONING LAB MANU; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; McMillan JN, 1999, MOL CELL BIOL, V19, P5981; McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487; Merlini L, 2012, PLOS GENET, V8, P531, DOI 10.1371/journal.pgen.1002670; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Raspelli E, 2011, MOL BIOL CELL, V22, P2185, DOI 10.1091/mbc.E11-02-0127; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687	43	10	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					1	12		10.1074/jbc.M114.590984	http://dx.doi.org/10.1074/jbc.M114.590984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406317	Green Published, hybrid			2022-12-26	WOS:000347231200001
J	Hleap, JS; Blouin, C				Hleap, Jose Sergio; Blouin, Christian			Inferring Meaningful Communities from Topology-Constrained Correlation Networks	PLOS ONE			English	Article							AMYLASE; CONSISTENCY; SELECTION; EVOLUTION; DATABASE; MODEL	Community structure detection is an important tool in graph analysis. This can be done, among other ways, by solving for the partition set which optimizes the modularity scores Q. Here it is shown that topological constraints in correlation graphs induce over-fragmentation of community structures. A refinement step to this optimization based on Linear Discriminant Analysis (LDA) and a statistical test for significance is proposed. In structured simulation constrained by topology, this novel approach performs better than the optimization of modularity alone. This method was also tested with two empirical datasets: the Roll-Call voting in the 110th US Senate constrained by geographic adjacency, and a biological dataset of 135 protein structures constrained by inter-residue contacts. The former dataset showed sub-structures in the communities that revealed a regional bias in the votes which transcend party affiliations. This is an interesting pattern given that the 110th Legislature was assumed to be a highly polarized government. The alpha-amylase catalytic domain dataset (biological dataset) was analyzed with and without topological constraints (inter-residue contacts). The results without topological constraints showed differences with the topology constrained one, but the LDA filtering did not change the outcome of the latter. This suggests that the LDA filtering is a robust way to solve the possible over-fragmentation when present, and that this method will not affect the results where there is no evidence of over-fragmentation.	[Hleap, Jose Sergio; Blouin, Christian] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Blouin, Christian] Dalhousie Univ, Dept Comp Sci, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Hleap, JS (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	jshleap@dal.ca		Hleap, Jose Sergio/0000-0003-2602-5276; Blouin, Christian/0000-0002-4434-4142	NSERC [120504858]; Departamento Administrativo de Ciencia y Tecnologia - Colciencias (Colombia) through the CALDAS scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Departamento Administrativo de Ciencia y Tecnologia - Colciencias (Colombia) through the CALDAS scholarship	This study was funded by NSERC through the grant No. 120504858. This work was partially supported by The Departamento Administrativo de Ciencia y Tecnologia - Colciencias (Colombia) through the CALDAS scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben Ali M, 2006, BIOCHEM J, V394, P51, DOI 10.1042/BJ20050726; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Burt RS, 2013, ANNU REV PSYCHOL, V64, P527, DOI 10.1146/annurev-psych-113011-143828; Cho WKT, 2010, J POLIT, V72, P124, DOI 10.1017/S002238160999051X; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Diestel R., 2012, GRADUATE TEXTS MATH, V173; Dobra A, 2004, J MULTIVARIATE ANAL, V90, P196, DOI 10.1016/j.jmva.2004.02.009; FARBER GK, 1993, CURR OPIN STRUC BIOL, V3, P409, DOI 10.1016/S0959-440X(05)80114-9; Fidelak J, 2010, EUR BIOPHYS J BIOPHY, V39, P1503, DOI 10.1007/s00249-010-0608-9; Fort J, 2007, J BIOL CHEM, V282, P31444, DOI 10.1074/jbc.M704524200; Fortunato S., 2012, COMPUT COMPLEX THEOR, P490, DOI [10.1007/978-1-4614-1800-9_33, DOI 10.1007/978-1-4614-1800-9_33]; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Gorman SP, 2000, TELECOMMUN POLICY, V24, P113, DOI 10.1016/S0308-5961(00)00005-7; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Hleap Jose S., 2013, 5th International Conference on Bioinformatics and Computational Biology (BICOB-2013). Proceedings, P153; Hleap JS, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-20; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Jacob L., 2009, P 26 ANN INT C MACH, P26, DOI DOI 10.1145/1553374.1553431; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Keskin M, 2011, PHYSICA A, V390, P719, DOI 10.1016/j.physa.2010.10.041; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; Muller-Linow M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-44; Mukherjee S, 2011, BIOINFORMATICS, V27, P994, DOI 10.1093/bioinformatics/btr070; Murdoch D, 2013, ELLIPSE FUNCTIONS DR; Navia AF, 2010, ECOL MODEL, V221, P2918, DOI 10.1016/j.ecolmodel.2010.09.006; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Onnela JP, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036104; Rao C. R., 2009, LINEAR STAT INFERENC, V22; Reichardt J, 2009, UNDERST COMPLEX SYST, P147, DOI 10.1007/978-3-540-92267-4_7; Reichardt J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015102; Stanford NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079195; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Venables WN., 2002, MODERN APPL STAT S 4; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zhao P, 2006, J MACH LEARN RES, V7, P2541	49	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113438	10.1371/journal.pone.0113438	http://dx.doi.org/10.1371/journal.pone.0113438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409022	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200123
J	Kristensen, SL; Galloe, AM; Thuesen, L; Kelbaek, H; Thayssen, P; Havndrup, O; Hansen, PR; Bligaard, N; Saunamaki, K; Junker, A; Aaroe, J; Abildgaard, U; Jeppesen, JL				Kristensen, Soren Lund; Galloe, Anders M.; Thuesen, Leif; Kelbaek, Henning; Thayssen, Per; Havndrup, Ole; Hansen, Peter Riis; Bligaard, Niels; Saunamaki, Kari; Junker, Anders; Aaroe, Jens; Abildgaard, Ulrik; Jeppesen, Jorgen L.			Stent Thrombosis is the Primary Cause of ST-Segment Elevation Myocardial Infarction following Coronary Stent Implantation: A Five Year Follow-Up of the SORT OUT II Study	PLOS ONE			English	Article							SIROLIMUS-ELUTING STENTS; HIGH-RISK PATIENTS; CLINICAL-PRACTICE; INTERVENTION; TRIAL; PREDICTORS; COHORT	Background: The widespread use of coronary stents has exposed a growing population to the risk of stent thrombosis, but the importance in terms of risk of ST-segment elevation myocardial infarctions (STEMIs) remains unclear. Methods: We studied five years follow-up data for 2,098 all-comer patients treated with coronary stents in the randomized SORT OUT II trial (mean age 63.6 yrs. 74.8% men). Patients who following stent implantation were readmitted with STEMI were included and each patient was categorized ranging from definite-to ruled-out stent thrombosis according to the Academic Research Consortium definitions. Multivariate logistic regression was performed on selected covariates to assess odds ratios (ORs) for definite stent thrombosis. Results: 85 patients (4.1%), mean age 62.7 years, 77.1% men, were admitted with a total of 96 STEMIs, of whom 60 (62.5%) had definite stent thrombosis. Notably, definite stent thrombosis was more frequent in female than male STEMI patients (81.8% vs. 56.8%, p=0.09), and in very late STEMIs (p=0.06). Female sex (OR 3.53 [1.01-12.59]) and clopidogrel (OR 4.43 [1.03-19.01]) was associated with increased for definite stent thrombosis, whereas age, time since stent implantation, use of statins, initial PCI urgency (STEMI [primary PCI], NSTEMI/unstable angina [subacute PCI] or stable angina [elective PCI]), and glucose-lowering agents did not seem to influence risk of stent thrombosis. Conclusion: In a contemporary cohort of coronary stented patients, stent thrombosis was evident in more than 60% of subsequent STEMIs.	[Kristensen, Soren Lund; Galloe, Anders M.; Havndrup, Ole] Univ Copenhagen, Hosp Roskilde, Dept Cardiol, Roskilde, Denmark; [Kristensen, Soren Lund; Hansen, Peter Riis; Abildgaard, Ulrik] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Thuesen, Leif] Aarhus Univ, Hosp Herning, Dept Med, Herning, Denmark; [Kelbaek, Henning; Saunamaki, Kari] Copenhagen Univ Hosp, Rigshosp, Ctr Heart, Copenhagen, Denmark; [Thayssen, Per; Junker, Anders] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Bligaard, Niels] Univ Copenhagen, Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Aaroe, Jens] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Jeppesen, Jorgen L.] Univ Copenhagen, Glostrup Hosp, Dept Med, Glostrup, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital; Aalborg University; Aalborg University Hospital; University of Copenhagen	Kristensen, SL (corresponding author), Univ Copenhagen, Hosp Roskilde, Dept Cardiol, Roskilde, Denmark.	slk@heart.dk	Kristensen, Søren Lund/J-5267-2019; Hansen, Peter Riis/AAR-7659-2020	Kristensen, Søren Lund/0000-0002-9759-7397; Saunamaki, Kari/0000-0001-5953-5243	Boston Scientific; Cordis; Johnson & Johnson company	Boston Scientific(Boston Scientific); Cordis; Johnson & Johnson company(Johnson & JohnsonJohnson & Johnson USA)	Boston Scientific and Cordis, a Johnson & Johnson company, supported the completion of the primary SORT OUT II study and event detection for a follow-up period of five years. They had no role in the design of the current substudy and did not provide support for its completion.	Bligaard N, 2014, SCAND CARDIOVASC J, V48, P148, DOI 10.3109/14017431.2014.883461; Brodie BR, 2012, J AM COLL CARDIOL, V60, P1989, DOI 10.1016/j.jacc.2012.07.043; Chechi T, 2008, J AM COLL CARDIOL, V51, P2396, DOI 10.1016/j.jacc.2008.01.070; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; D'Ascenzo F, 2012, INT J CARDIOL, V2, P575; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Ergelen M, 2010, AM HEART J, V159, P672, DOI 10.1016/j.ahj.2009.12.032; Galloe AM, 2008, JAMA-J AM MED ASSOC, V299, P409, DOI 10.1001/jama.299.4.409; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Li J, 2013, EUR HEART J, V34, P1375, DOI 10.1093/eurheartj/eht005; Lindhardsen J, 2012, ANN RHEUM DIS, V71, P1496, DOI 10.1136/annrheumdis-2011-200806; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Parodi G, 2009, AM J CARDIOL, V103, P913, DOI 10.1016/j.amjcard.2008.12.006; Riley RF, 2011, CIRC-CARDIOVASC QUAL, V4, P193, DOI 10.1161/CIRCOUTCOMES.110.958744; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055	18	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113399	10.1371/journal.pone.0113399	http://dx.doi.org/10.1371/journal.pone.0113399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409336	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200110
J	Spence, S; Delve, J; Stamp, E; Matthews, JNS; White, M; Adamson, AJ				Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; Matthews, John N. S.; White, Martin; Adamson, Ashley J.			Did School Food and Nutrient-Based Standards in England Impact on 11-12Y Olds Nutrient Intake at Lunchtime and in Total Diet? Repeat Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDREN; OBESITY; CHILDHOOD; PREVALENCE; ADULTHOOD; QUALITY; WEIGHTS; LUNCHES; TRENDS	Introduction: In September 2009, middle and secondary schools in England were required to comply with food and nutrient-based standards for school food. We examined the impact of this policy change on children's lunchtime and total dietary intake. Methods: We undertook repeat cross-sectional surveys in six Northumberland middle schools in 1999-2000 and 2009-10. Dietary data were collected from 11-12 y olds (n = 298 in 1999-2000; n = 215 in 2009-10). Children completed two consecutive 3-day food diaries, each followed by an interview. Linear mixed effect models examined the effect of year, lunch type and level of socio-economic deprivation on children's mean total dietary intake. Results: We found both before and after the introduction of the food and nutrient-based standards children consuming a school lunch, had a lower per cent energy from saturated fat (20.5%; p = 0.02), and a lower intake of sodium (-143 mg; p = 0.02), and calcium (-81 mg; p = 0.001) in their total diet, compared with children consuming a home-packed lunch. We found no evidence that lunch type was associated with mean energy, or absolute amounts of NSP, vitamin C and iron intake. There was marginal evidence of an association between lunch type and percent energy NMES (p = 0.06). In 1999-2000, children consuming a school lunch had a higher per cent energy from fat in their total diet compared with children consuming a home-packed lunch (2.8%), whereas by 2009-10, they had slightly less (-0.2%) (year by lunch type interaction p<0.001; change in mean differences -3%). Conclusions: We found limited evidence of an impact of the school food and nutrient-based standards on total diet among 11-12 year olds. Such policies may need to be supported by additional measures, including guidance on individual food choice, and the development of wider supportive environments in school and beyond the school gates.	[Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; White, Martin; Adamson, Ashley J.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; White, Martin; Adamson, Ashley J.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Matthews, John N. S.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [White, Martin; Adamson, Ashley J.] UKCRC Ctr Translat Res Publ Hlth, Fuse, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Adamson, AJ (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	ashley.adamson@ncl.ac.uk		White, Martin/0000-0002-1861-6757; Spence, Suzanne/0000-0002-7089-7197; Adamson, Ashley/0000-0003-3735-2846	Department of Health (DH) Policy Research Programme; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under UKCRC; National Institute of Health Research as an NIHR; Economic and Social Research Council [ES/G007462/1, ES/G007470/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MR/K02325X/1B, MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001] Funding Source: researchfish; ESRC [ES/G007470/1, ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI	Department of Health (DH) Policy Research Programme; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under UKCRC; National Institute of Health Research as an NIHR; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken as part of the research programme of the Public Health Research Consortium (PHRC). The Public Health Research Consortium is funded by the Department of Health (DH) Policy Research Programme. The views expressed in this publication are those of the authors and not necessarily those of DH. Information about the wider programme of the PHRC is available from http://phrc.lshtm.ac.uk/. The funders had no role in the study design, data collection or analysis, interpretation of findings, writing of, or the decision to submit for publication. All authors had access to data, and take responsibility for the integrity of the data and the accuracy of the data analysis. MW is director and AJA is associate director of Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UKCRC, is gratefully acknowledged. AJA is funded by the National Institute of Health Research as an NIHR Research Professor. Opinions expressed are not necessarily those of the funders.	Adamson A, 2011, PROCESS IMPACT CHANG; Adamson AJ, 1996, J HUM NUTR DIET, V9, P55, DOI 10.1046/j.1365-277X.1996.00441.x; Adamson AJ, 1992, BR J NUTR, V68, P543; Bates B, 2011, NATL DIET NUTR SURVE; Bates B, 2008, NAT DIET NUTR SURV H; Bates CJ, 2000, NATL DIET NUTR SURVE; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Craigie AM, 2009, OBESITY FACTS, V2, P150, DOI 10.1159/000218092; Department of Health, 1991, DIET REF VAL FOOD EN; Department of Health, 2005, CHOOS BETT DIET FOOD; Department of Health, 2004, CHOOS HLTH MAK HLTH; Evans CEL, 2010, BRIT J NUTR, V104, P474, DOI 10.1017/S0007114510001601; Fletcher A, 2014, SOCIOLOGY, V48, P500, DOI 10.1177/0038038513500102; Fletcher ES, 2004, BRIT J NUTR, V92, P321, DOI 10.1079/BJN20041199; Food Standards Agency, 2002, MCCANCE WIDD COMP FO; Foster E., 2010, YOUNG PERSONS FOOD A; Fung C, 2013, PREV MED, V57, P934, DOI 10.1016/j.ypmed.2013.07.016; Golley R, 2011, PUBLIC HEALTH NUTR, V14, P271, DOI 10.1017/S1368980010002120; HACKETT AF, 1984, ANN HUM BIOL, V11, P545, DOI 10.1080/03014468400007461; HACKETT AF, 1983, HUM NUTR-APPL NUTR, V37, P293; HACKETT AF, 1985, HUM NUTR-APPL NUTR, V39A, P167; HACKETT AF, 1984, BRIT J NUTR, V51, P67, DOI 10.1079/BJN19840010; Haroun D, 2011, PUBLIC HEALTH NUTR, V14, P209, DOI 10.1017/S1368980010002132; Harrison F, 2013, PUBLIC HEALTH NUTR, V16, P1132, DOI 10.1017/S1368980011002321; Hur I., 2011, ICAN: Infant, Child & Adolescent Nutrition, V3, P70; Kitchen S, 2013, SCH FOOD HEAD TEACH; Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169; Nelson M, 2011, STAT REL TAK SCH LUN; Pearce J, 2013, J HUM NUTR DIET, V26, P553, DOI 10.1111/jhn.12067; Pearce J, 2013, PUBLIC HEALTH NUTR, V16, P1126, DOI 10.1017/S1368980012003928; Pearce J, 2011, PUBLIC HEALTH NUTR, V14, P1507, DOI 10.1017/S1368980010003605; Pockett RD, 2011, CURR MED RES OPIN, V27, P777, DOI 10.1185/03007995.2011.555757; Prynne CJ, 2013, PUBLIC HEALTH NUTR, V16, P1118, DOI 10.1017/S1368980011002205; Rees GA, 2008, J HUM NUTR DIET, V21, P420, DOI 10.1111/j.1365-277X.2008.00885.x; Rogers IS, 2007, EUR J CLIN NUTR, V61, P856, DOI 10.1038/sj.ejcn.1602592; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Ruag-Gunn AJ, 2007, PUBLIC HEALTH NUTR, V10, P354, DOI 10.1017/S1368980007249729; School Food Trust, GUID INTR GOV FOOD B; Spence S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078298; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; Stead M, 2011, SOC SCI MED, V72, P1131, DOI 10.1016/j.socscimed.2010.12.029; Stevens L, 2011, SECONDARY SCH FOOD S; Stevens L, 2013, PUBLIC HEALTH NUTR, V16, P1037, DOI 10.1017/S1368980013000852; Taylor JP, 2012, PUBLIC HEALTH NUTR, V15, P2259, DOI 10.1017/S1368980012000699; The Health and Social Care Information Centre, 2012, NAT CHILD MEAS PROGR; Wills W, 2005, HEALTH EDUC RES, V20, P458, DOI 10.1093/her/cyg132	48	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112648	10.1371/journal.pone.0112648	http://dx.doi.org/10.1371/journal.pone.0112648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409298	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200030
J	Korotkova, N; Nauheimer, L; Ter-Voskanyan, H; Allgaier, M; Borsch, T				Korotkova, Nadja; Nauheimer, Lars; Ter-Voskanyan, Hasmik; Allgaier, Martin; Borsch, Thomas			Variability among the Most Rapidly Evolving Plastid Genomic Regions is Lineage-Specific: Implications of Pairwise Genome Comparisons in Pyrus (Rosaceae) and Other Angiosperms for Marker Choice	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; COMPLETE NUCLEOTIDE-SEQUENCES; GROUP-II INTRONS; PHYLOGENETIC UTILITY; HYPERVARIABLE REGIONS; SUBSECTION OENOTHERA; MOLECULAR EVOLUTION; DNA-SEQUENCES; IDENTIFICATION; GENES	Plastid genomes exhibit different levels of variability in their sequences, depending on the respective kinds of genomic regions. Genes are usually more conserved while noncoding introns and spacers evolve at a faster pace. While a set of about thirty maximum variable noncoding genomic regions has been suggested to provide universally promising phylogenetic markers throughout angiosperms, applications often require several regions to be sequenced for many individuals. Our project aims to illuminate evolutionary relationships and species-limits in the genus Pyrus (Rosaceae)-a typical case with very low genetic distances between taxa. In this study, we have sequenced the plastid genome of Pyrus spinosa and aligned it to the already available P. pyrifolia sequence. The overall p-distance of the two Pyrus genomes was 0.00145. The intergenic spacers between ndhC-trnV, trnR-atpA, ndhF-rpl32, psbM-trnD, and trnQ-rps16 were the most variable regions, also comprising the highest total numbers of substitutions, indels and inversions (potentially informative characters). Our comparative analysis of further plastid genome pairs with similar low p-distances from Oenothera (representing another rosid), Olea (asterids) and Cymbidium (monocots) showed in each case a different ranking of genomic regions in terms of variability and potentially informative characters. Only two intergenic spacers (ndhF-rpl32 and trnK-rps16) were consistently found among the 30 top-ranked regions. We have mapped the occurrence of substitutions and microstructural mutations in the four genome pairs. High AT content in specific sequence elements seems to foster frequent mutations. We conclude that the variability among the fastest evolving plastid genomic regions is lineage-specific and thus cannot be precisely predicted across angiosperms. The often lineage-specific occurrence of stem-loop elements in the sequences of introns and spacers also governs lineage-specific mutations. Sequencing whole plastid genomes to find markers for evolutionary analyses is therefore particularly useful when overall genetic distances are low.	[Korotkova, Nadja; Nauheimer, Lars; Borsch, Thomas] Free Univ Berlin, Inst Biol Bot Systemat Bot & Pflanzengeog, Berlin, Germany; [Korotkova, Nadja; Nauheimer, Lars; Borsch, Thomas] DCPS, Berlin, Germany; [Korotkova, Nadja; Ter-Voskanyan, Hasmik; Borsch, Thomas] Bot Garten & Bot Museum Berlin Dahlem, Berlin, Germany; [Ter-Voskanyan, Hasmik] Natl Acad Sci Republ Armenia, Inst Bot, Yerevan, Armenia; [Allgaier, Martin] Berlin Ctr Genom Biodivers Res BeGenDiv, Berlin, Germany	Free University of Berlin; National Academy of Sciences of Armenia; Institute of Botany after A.L. Takhtajyan - NAS RA	Borsch, T (corresponding author), Free Univ Berlin, Inst Biol Bot Systemat Bot & Pflanzengeog, Berlin, Germany.	t.borsch@bgbm.org	Korotkova, Nadja/ABD-2326-2021; Monaghan, Michael T/A-2589-2009	Korotkova, Nadja/0000-0003-0106-3209; Monaghan, Michael T/0000-0001-6200-2376	VolkswagenStiftung [AZ85021]	VolkswagenStiftung(Volkswagen)	The study was carried out as part of the project "Developing tools for conserving the plant diversity of the Transcaucasus" funded by VolkswagenStiftung (http://www.volkswagenstiftung.de/nc/en.html), grant number AZ85021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, MOL ECOL RESOUR, V13, P929, DOI 10.1111/1755-0998.12128; Akopian JA, 2007, FL RAST RASTITEL RES, V16, P15; Barniske AM, 2012, J SYST EVOL, V50, P85, DOI 10.1111/j.1759-6831.2012.00181.x; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Borsch T, 2007, INT J PLANT SCI, V168, P639, DOI 10.1086/513476; Borsch T, 2009, PLANT SYST EVOL, V282, P169, DOI 10.1007/s00606-009-0210-8; Campagna Mary L., 1998, Transactions of the Illinois State Academy of Science, V91, P1; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Cuizhi G, 2003, PYRUS FLORA CHINA EF, P173; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Erixon P, 2008, MOL PHYLOGENET EVOL, V48, P313, DOI 10.1016/j.ympev.2008.04.015; Fedorov AA, 1954, DEREVA KUSTARNIKI SS, P378; Fior S, 2013, NEW PHYTOL, V198, P579, DOI 10.1111/nph.12163; Gargano D, 2012, GENET RESOUR CROP EV, V59, P419, DOI 10.1007/s10722-011-9692-7; Goodson BE, 2006, TAXON, V55, P671, DOI 10.2307/25065643; Greiner S, 2008, MOL BIOL EVOL, V25, P2019, DOI 10.1093/molbev/msn149; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jheng CF, 2012, PLANT SCI, V190, P62, DOI 10.1016/j.plantsci.2012.04.001; Kallersjo M, 1998, PLANT SYST EVOL, V213, P259, DOI 10.1007/BF00985205; Katayama H, 2003, THEOR APPL GENET, V106, P303, DOI 10.1007/s00122-002-1003-4; Katayama H, 2012, TREE GENET GENOMES, V8, P313, DOI 10.1007/s11295-011-0442-y; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kelchner SA, 2002, AM J BOT, V89, P1651, DOI 10.3732/ajb.89.10.1651; Korotkova N, 2011, AM J BOT, V98, P1549, DOI 10.3732/ajb.1000502; Korotkova N, 2009, PLANT SYST EVOL, V282, P201, DOI 10.1007/s00606-008-0099-7; Krzywinski MI, 2009, GENOME RES; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068518; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kurtto A, 2009, ROSACEAE PRO PARTE M; Lee C, 2004, MOL PHYLOGENET EVOL, V31, P894, DOI 10.1016/j.ympev.2003.10.009; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Lo EYY, 2012, MOL PHYLOGENET EVOL, V63, P230, DOI 10.1016/j.ympev.2011.10.005; Lohne C, 2007, BOT J LINN SOC, V154, P141, DOI 10.1111/j.1095-8339.2007.00659.x; Lohne C, 2005, MOL BIOL EVOL, V22, P317, DOI 10.1093/molbev/msi019; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Muller J., 2005, PHYDE PHYLOGENETIC D; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; PYLE AM, 2006, RNA WORLD, P449; Quandt D, 2004, MONOG SYST BOTAN, V98, P13; Quandt D, 2003, PLANT BIOLOGY, V5, P400, DOI 10.1055/s-2003-42715; Sarkinen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082266; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sang T, 1997, MOL BIOL EVOL, V14, P994, DOI 10.1093/oxfordjournals.molbev.a025716; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Storchova H, 2007, PLANT SYST EVOL, V268, P235, DOI 10.1007/s00606-007-0582-6; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Terakami S, 2012, TREE GENET GENOMES, V8, P841, DOI 10.1007/s11295-012-0469-8; Tesfaye K, 2007, GENOME, V50, P1112, DOI 10.1139/G07-088; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Wicke S, 2014, MOL BIOL EVOL, V31, P529, DOI 10.1093/molbev/mst261; Wuyun T, 2013, TREE GENET GENOMES, V9, P167, DOI 10.1007/s11295-012-0544-1; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu Q, 2012, PLOS ONE, V7; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]	68	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112998	10.1371/journal.pone.0112998	http://dx.doi.org/10.1371/journal.pone.0112998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405773	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300069
J	Li, L; Tan, YH; Chen, XH; Xu, ZF; Yang, SY; Ren, FG; Guo, HX; Wang, XJ; Chen, Y; Li, GX; Wang, HW				Li, Li; Tan, Yanhong; Chen, Xiuhua; Xu, Zhifang; Yang, Siyao; Ren, Fanggang; Guo, Haixiu; Wang, Xiaojuan; Chen, Yi; Li, Guoxia; Wang, Hongwei			MDM4 Overexpressed in Acute Myeloid Leukemia Patients with Complex Karyotype and Wild-Type TP53	PLOS ONE			English	Article							POOR-PROGNOSIS; CELL-LINES; CYTOGENETIC ABNORMALITIES; MONOSOMAL KARYOTYPE; SPINDLE CHECKPOINT; P53 MUTATION; HUMAN CANCER; GENE; EXPRESSION; PROTEIN	Acute myeloid leukemia patients with complex karyotype (CK-AML) account for approximately 10-15% of adult AML cases, and are often associated with a poor prognosis. Except for about 70% of CK-AML patients with biallelic inactivation of TP53, the leukemogenic mechanism in the nearly 30% of CK-AML patients with wild-type TP53 has remained elusive. In this study, 15 cases with complex karyotype and wild-type TP53 were screened out of 140 de novo AML patients and the expression levels of MDM4, a main negative regulator of p53-signaling pathway, were detected. We ruled out mutations in genes associated with a poor prognosis of CK-AML, including RUNX1 or FLT3-ITD. The mRNA expression levels of the full-length of MDM4 (MDM4FL) and short isoform MDM4 (MDM4S) were elevated in CK-AML relative to normal karyotype AML (NK-AML) patients. We also explored the impact of MDM4 overexpression on the cell cycle, cell proliferation and the spindle checkpoint of HepG2 cells, which is a human cancer cell line with normal MDM4 and TP53 expression. The mitotic index and the expression of p21, BubR1 and Securin were all reduced following Nocodazole treatment. Moreover, karyotype analysis showed that MDM4 overexpression might lead to aneuploidy or polyploidy. These results suggest that MDM4 overexpression is related to CK-AML with wild-type TP53 and might play a pathogenic role by inhibiting p53-signal pathway.	[Li, Li; Tan, Yanhong; Chen, Xiuhua; Xu, Zhifang; Yang, Siyao; Ren, Fanggang; Wang, Xiaojuan; Chen, Yi; Li, Guoxia; Wang, Hongwei] Shanxi Med Univ, Dept Hematol, Hosp 2, Taiyuan, Shanxi, Peoples R China; [Li, Li; Guo, Haixiu] Shanxi Med Univ, Dept Biol, Sch Basic Med, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University	Wang, HW (corresponding author), Shanxi Med Univ, Dept Hematol, Hosp 2, Taiyuan, Shanxi, Peoples R China.	wanghw68@hotmail.com			Natural Science Fund of China [81241014]; Natural Science Fund of Shanxi Province [2014011039-2]; University of Shanxi Science and Technology Development Project [20121004]; Shanxi Medical Innovation Fund [C01201006]; Foundation for phD scientific research of Shanxi Medical University [03201309]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shanxi Province(Natural Science Foundation of Shanxi Province); University of Shanxi Science and Technology Development Project; Shanxi Medical Innovation Fund; Foundation for phD scientific research of Shanxi Medical University	This study was supported by Natural Science Fund (81241014) of China, Natural Science Fund (2014011039-2) of Shanxi Province, University of Shanxi Science and Technology Development Project (20121004), Shanxi Medical Innovation Fund (C01201006), and Foundation for phD scientific research of Shanxi Medical University (03201309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek KH, 2003, J LEUKOCYTE BIOL, V73, P850, DOI 10.1189/jlb.1202607; Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Bista M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037518; Bowen D, 2009, LEUKEMIA, V23, P203, DOI 10.1038/leu.2008.173; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; DANOVA M, 1990, LEUKEMIA RES, V14, P417, DOI 10.1016/0145-2126(90)90027-7; Gogolin S, 2013, CANCER LETT, V331, P35, DOI 10.1016/j.canlet.2012.11.028; Greif PA, 2012, HAEMATOL-HEMATOL J, V97, P1909, DOI 10.3324/haematol.2012.064667; Haferlach C, 2008, LEUKEMIA, V22, P1539, DOI 10.1038/leu.2008.143; Harutyunyan A, 2011, NEW ENGL J MED, V364, P488, DOI 10.1056/NEJMc1012718; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Ikawa-Yoshida A, 2013, CANCER MED-US, V2, P447, DOI 10.1002/cam4.101; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Karess RE, 2013, INT REV CEL MOL BIO, V306, P223, DOI 10.1016/B978-0-12-407694-5.00006-7; Kim S, 2011, SEMIN CELL DEV BIOL, V22, P551, DOI 10.1016/j.semcdb.2011.03.008; Lenos K, 2012, CANCER RES, V72, P4074, DOI 10.1158/0008-5472.CAN-12-0215; Liu L, 2012, CANCER SCI, V103, P2056, DOI 10.1111/cas.12008; LUBBERT M, 1988, J EXP MED, V167, P873, DOI 10.1084/jem.167.3.873; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Pei DS, 2012, ONCOTARGET, V3, P228; Perrot A, 2011, BLOOD, V118, P679, DOI 10.1182/blood-2010-09-307264; Rallapalli R, 2003, J CELL BIOCHEM, V89, P563, DOI 10.1002/jcb.10535; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Yurlova L, 2014, J BIOMOL SCREEN, V19, P516, DOI 10.1177/1087057113518067; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zhi L, 2011, OLIGONUCLEOTIDES, V21, P21, DOI 10.1089/oli.2010.0254	32	18	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113088	10.1371/journal.pone.0113088	http://dx.doi.org/10.1371/journal.pone.0113088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405759	gold, Green Submitted, Green Published			2022-12-26	WOS:000347121300076
J	Silveira, LCL; Saito, CA; da Silva, M; Kremers, J; Bowmaker, JK; Lee, BB				Silveira, Luiz Carlos L.; Saito, Cezar A.; da Silva Filho, Manoel; Kremers, Jan; Bowmaker, James K.; Lee, Barry B.			Alouatta Trichromatic Color Vision: Cone Spectra and Physiological Responses Studied with Microspectrophotometry and Single Unit Retinal Electrophysiology	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; NEW-WORLD MONKEY; MACAQUE GANGLION-CELLS; CONTRAST GAIN-CONTROL; VISUAL RESPONSES; PRIMATE RETINA; EVOLUTION; SENSITIVITY; FRUGIVORY; GENES	The howler monkeys (Alouatta sp.) are the only New World primates to exhibit routine trichromacy. Both males and females have three cone photopigments. However, in contrast to Old World monkeys, Alouatta has a locus control region upstream of each opsin gene on the X-chromosome and this might influence the retinal organization underlying its color vision. Postmortem microspectrophotometry (MSP) was performed on the retinae of two male Alouatta to obtain rod and cone spectral sensitivities. The MSP data were consistent with only a single opsin being expressed in each cone and electrophysiological data were consistent with this primate expressing full trichromacy. To study the physiological organization of the retina underlying Alouatta trichromacy, we recorded from retinal ganglion cells of the same animals used for MSP measurements with a variety of achromatic and chromatic stimulus protocols. We found MC cells and PC cells in the Alouatta retina with similar properties to those previously found in the retina of other trichromatic primates. MC cells showed strong phasic responses to luminance changes and little response to chromatic pulses. PC cells showed strong tonic response to chromatic changes and small tonic response to luminance changes. Responses to other stimulus protocols (flicker photometry; changing the relative phase of red and green modulated lights; temporal modulation transfer functions) were also similar to those recorded in other trichromatic primates. MC cells also showed a pronounced frequency double response to chromatic modulation, and with luminance modulation response saturation accompanied by a phase advance between 10-20 Hz, characteristic of a contrast gain mechanism. This indicates a very similar retinal organization to Old-World monkeys. Cone-specific opsin expression in the presence of a locus control region for each opsin may call into question the hypothesis that this region exclusively controls opsin expression.	[Silveira, Luiz Carlos L.; Saito, Cezar A.; da Silva Filho, Manoel] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Silveira, Luiz Carlos L.] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [Kremers, Jan] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Bowmaker, James K.] UCL, Inst Ophthalmol, Div Visual Sci, London, England; [Lee, Barry B.] SUNY Coll Optometry, New York, NY 10036 USA; [Lee, Barry B.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Universidade Federal do Para; Universidade Federal do Para; University of Erlangen Nuremberg; University of London; University College London; State University of New York (SUNY) System; SUNY Optometry; Max Planck Society	Silveira, LCL (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	luiz@ufpa.br	Kremers, Jan/X-3125-2019; da Silva Filho, Manoel/C-6684-2013; Saito, Cézar/Q-5274-2019	Kremers, Jan/0000-0002-9293-7380; Saito, Cézar/0000-0002-4931-1884	CNPq-PRONEX / FAPESPA / UFPA / FADESP [2268]; CNPq-PRONEX / FAPESPA [316799/2009]; FINEP IBN Net [1723]; Hertie Foundation	CNPq-PRONEX / FAPESPA / UFPA / FADESP; CNPq-PRONEX / FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP IBN Net(Financiadora de Inovacao e Pesquisa (Finep)); Hertie Foundation	This research was supported by the following grants: CNPq-PRONEX / FAPESPA / UFPA / FADESP #2268; CNPq-PRONEX / FAPESPA #316799/2009; FINEP IBN Net #1723. LCLS is a CNPq research fellow. JK was supported by the Hertie Foundation. The authors would like to thank Dr. Jose Augusto Pereira Carneiro Muniz of the Centro Nacional de Primatas (Ananindeua, Para, Brazil) for provision of animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AC, 2008, VISUAL NEUROSCI, V25, P243, DOI 10.1017/S0952523808080292; BENARDETE EA, 1992, VISUAL NEUROSCI, V8, P483, DOI 10.1017/S0952523800004995; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; BOWMAKER JK, 1991, J EXP BIOL, V156, P1; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Chan TL, 2001, J COMP NEUROL, V437, P219, DOI 10.1002/cne.1280; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; de Athaide LM, 2009, 20 INT COL VIS SOC I, P85; Dulai KS, 1999, GENOME RES, V9, P629; Fleagle JG, 1988, PRIMATE ADAPTATION E; Franco ECS, 2000, BRAIN BEHAV EVOLUT, V56, P276, DOI 10.1159/000047211; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hashemi-Nezhad M, 2008, VISION RES, V48, P2604, DOI 10.1016/j.visres.2008.02.017; Hunt DM, 1998, VISION RES, V38, P3299, DOI 10.1016/S0042-6989(97)00443-4; IBBOTSON RE, 1992, P ROY SOC B-BIOL SCI, V247, P145, DOI 10.1098/rspb.1992.0021; Jacobs GH, 2007, INT J PRIMATOL, V28, P729, DOI 10.1007/s10764-007-9168-y; Jacobs GH, 1996, NATURE, V382, P156, DOI 10.1038/382156a0; JACOBS GH, 1965, NATURE, V206, P487, DOI 10.1038/206487a0; Judd D. B., 1951, TECHNICAL COMMITTEE, P1; Kainz PM, 1998, VISION RES, V38, P3315, DOI 10.1016/S0042-6989(98)00078-9; Goulart PRK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062255; Kremers J, 1997, VISION RES, V37, P2171, DOI 10.1016/S0042-6989(97)00041-2; Kremers J, 2000, J OPT SOC AM A, V17, P517, DOI 10.1364/JOSAA.17.000517; Kremers J, 1997, VISION RES, V37, P2649, DOI 10.1016/S0042-6989(97)00090-4; Kremers Jan, 1999, P123; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; LEE BB, 1989, J PHYSIOL-LONDON, V414, P223, DOI 10.1113/jphysiol.1989.sp017685; LEE BB, 1989, J PHYSIOL-LONDON, V414, P245, DOI 10.1113/jphysiol.1989.sp017686; Lee BB, 2000, J PHYSIOL-LONDON, V528, P573, DOI 10.1111/j.1469-7793.2000.00573.x; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; LIEBMAN PA, 1964, J OPT SOC AM, V54, P1451, DOI 10.1364/JOSA.54.001451; LINDSEY DT, 1986, J OPT SOC AM A, V3, P921, DOI 10.1364/JOSAA.3.000921; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; Lucas PW, 1998, FOLIA PRIMATOL, V69, P139, DOI 10.1159/000021576; Martin PR, 2011, J PHYSIOL-LONDON, V589, P2795, DOI 10.1113/jphysiol.2010.194076; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; Matsushita Y, 2014, INT J PRIMATOL, V35, P71, DOI 10.1007/s10764-013-9705-9; Mollon J.D., 1989, FARBE, V35, P139; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; MOLLON JD, 1991, EVOLUTION EYE VISUAL, P306; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Polyak S., 1957, VERTEBRATE VISUAL SY; Regan BC, 1998, VISION RES, V38, P3321, DOI 10.1016/S0042-6989(97)00462-8; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Saito CA, 2004, ARVO ABSTR INV OPHTH, V45; Saito CA, 2005, ARVO ABSTR INV OPHTH, V46; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Silveira LCD, 2004, METH NE FRO NEUROSCI, P29; Silveira LCL, 1999, VISUAL NEUROSCI, V16, P333, DOI 10.1017/S0952523899162138; SILVEIRA LCL, 1989, VISION RES, V29, P1471, DOI 10.1016/0042-6989(89)90131-4; Silveira LCL, 1998, VISION RES, V38, P3329, DOI 10.1016/S0042-6989(97)00335-0; Silveira LCL, 2005, PRIMATE VISUAL SYSTEM: A COMPARATIVE APPROACH, P127; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; SMITH VC, 1992, J PHYSIOL-LONDON, V458, P191, DOI 10.1113/jphysiol.1992.sp019413; SNODDERLY DM, 1979, BEHAV SIGNIFICANCE C, P238; Solomon SG, 1999, J PHYSIOL-LONDON, V517, P907, DOI 10.1111/j.1469-7793.1999.0907s.x; Solomon SG, 2005, J NEUROSCI, V25, P4527, DOI 10.1523/JNEUROSCI.3921-04.2005; Stoner KE, 2005, AM J PRIMATOL, V67, P399, DOI 10.1002/ajp.20195; Szmajda BA, 2005, VISUAL NEUROSCI, V22, P395, DOI 10.1017/S0952523805224021; Usrey WM, 2000, J PHYSIOL-LONDON, V523, P755, DOI 10.1111/j.1469-7793.2000.00755.x; White AJR, 1998, J NEUROPHYSIOL, V80, P2063, DOI 10.1152/jn.1998.80.4.2063; White AJR, 2001, J PHYSIOL-LONDON, V533, P519, DOI 10.1111/j.1469-7793.2001.0519a.x; YEH T, 1995, J OPT SOC AM A, V12, P456, DOI 10.1364/JOSAA.12.000456; Yeh TY, 1995, J NEUROSCI, V15, P7892	68	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113321	10.1371/journal.pone.0113321	http://dx.doi.org/10.1371/journal.pone.0113321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405863	Green Published, gold			2022-12-26	WOS:000347121300105
J	Wang, Y; Nizkorodov, A; Riemenschneider, K; Lee, CSD; Olivares-Navarrete, R; Schwartz, Z; Boyan, BD				Wang, Yun; Nizkorodov, Alexandr; Riemenschneider, Kelsie; Lee, Christopher S. D.; Olivares-Navarrete, Rene; Schwartz, Zvi; Boyan, Barbara D.			Impaired Bone Formation in Pdia3 Deficient Mice	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; GROWTH-PLATE CHONDROCYTES; PROTEIN-KINASE-C; KNOCKOUT MICE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; FRACTURE REPAIR; OSTEOBLASTS; CELLS; CAVEOLIN-1	1 alpha,25-dihydroxyvitamin D-3 [1 alpha,25(OH)(2)D-3] is crucial for normal skeletal development and bone homeostasis. Protein disulfide isomerase family A, member 3 (PDIA3) mediates 1 alpha,25(OH)(2)D-3 initiated-rapid membrane signaling in several cell types. To understand its role in regulating skeletal development, we generated Pdia3-deficient mice and examined the physiologic consequence of Pdia3-disruption in embryos and Pdia3(+/-) heterozygotes at different ages. No mice homozygous for the Pdia3-deletion were found at birth nor were there embryos after E12.5, indicating that targeted disruption of the Pdia3 gene resulted in early embryonic lethality. Pdia3-deficiency also resulted in skeletal manifestations as revealed by mu CT analysis of the tibias. In comparison to wild type mice, Pdia3 heterozygous mice displayed expanded growth plates associated with decreased tether formation. Histomorphometry also showed that the hypertrophic zone in Pdia3(+/-) mice was more cellular than seen in wild type growth plates. Metaphyseal trabecular bone in Pdia3(+/-) mice exhibited an age-dependent phenotype with lower BV/TV and trabecular numbers, which was most pronounced at 15 weeks of age. Bone marrow cells from Pdia3(+/-) mice exhibited impaired osteoblastic differentiation, based on reduced expression of osteoblast markers and mineral deposition compared to cells from wild type animals. Collectively, our findings provide in vivo evidence that PDIA3 is essential for normal skeletal development. The fact that the Pdia3(+/-) heterozygous mice share a similar growth plate and bone phenotype to nVdr knockout mice, suggests that PDIA3-mediated rapid membrane signaling might be an alternative mechanism responsible for 1 alpha,25(OH)(2)D-3's actions in regulating skeletal development.	[Wang, Yun; Nizkorodov, Alexandr; Riemenschneider, Kelsie; Lee, Christopher S. D.; Boyan, Barbara D.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Olivares-Navarrete, Rene; Schwartz, Zvi; Boyan, Barbara D.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA	University System of Georgia; Georgia Institute of Technology; Virginia Commonwealth University	Boyan, BD (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	bboyan@vcu.edu		Olivares-Navarrete, Rene/0000-0003-1232-9164	Price Gilbert, Jr. Foundation	Price Gilbert, Jr. Foundation	This study was funded by the Price Gilbert, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyay A, 2012, PEDIATR HEMAT ONCOL, V29, P691, DOI 10.3109/08880018.2012.727064; Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Baron Roland, 2007, Curr Osteoporos Rep, V5, P73; Boyan BD, 2006, J BONE MINER RES, V21, P1637, DOI 10.1359/JBMR.060713; Boyan BD, 2012, STEROIDS, V77, P892, DOI 10.1016/j.steroids.2012.04.018; Boyan BD, 1999, STEROIDS, V64, P129, DOI 10.1016/S0039-128X(98)00099-3; Boyan BD, 2003, J CELL BIOCHEM, V90, P1207, DOI 10.1002/jcb.10716; Brameld JM, 1998, P NUTR SOC, V57, P207, DOI 10.1079/PNS19980033; Chen JX, 2010, J BIOL CHEM, V285, P37041, DOI 10.1074/jbc.M110.157115; Chen J, 2009, CALCIFIED TISSUE INT, V85, P134, DOI 10.1007/s00223-009-9259-1; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Doroudi M, 2014, BBA-MOL CELL RES, V1843, P2365, DOI 10.1016/j.bbamcr.2014.06.006; Doroudi M, 2012, J STEROID BIOCHEM, V132, P48, DOI 10.1016/j.jsbmb.2012.03.001; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; JORGENSEN PH, 1991, BONE, V12, P353, DOI 10.1016/8756-3282(91)90022-B; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Kinney MA, 2012, INTEGR BIOL-UK, V4, P641, DOI 10.1039/c2ib00165a; Lee CSD, 2011, BONE, V49, P419, DOI 10.1016/j.bone.2011.05.004; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; MARTENS M, 1981, ARCH ORTHOP TRAUM SU, V98, P113, DOI 10.1007/BF00460798; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Nemere I, 2004, P NATL ACAD SCI USA, V101, P7392, DOI 10.1073/pnas.0402207101; Nemere I, 2010, J BIOL CHEM, V285, P31859, DOI 10.1074/jbc.M110.116954; Nemere K, 2005, STEROIDS, V70, P455, DOI 10.1016/j.steroids.2005.02.005; Nolan RL, 2006, J BIOCHEM BIOPH METH, V68, P127, DOI 10.1016/j.jbbm.2006.04.002; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Olivares-Navarrete R, 2012, STEM CELLS DEV, V21, P1726, DOI 10.1089/scd.2011.0411; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Schwartz Z, 2002, ENDOCRINOLOGY, V143, P2775, DOI 10.1210/en.143.7.2775; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Simpson RU, 2007, J STEROID BIOCHEM, V103, P521, DOI 10.1016/j.jsbmb.2006.12.098; Sooy K, 2005, J CELL BIOCHEM, V94, P81, DOI 10.1002/jcb.20313; St-Arnaud R, 2011, MOL CELL ENDOCRINOL, V347, P48, DOI 10.1016/j.mce.2011.05.018; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Vertino AM, 2005, J BIOL CHEM, V280, P14130, DOI 10.1074/jbc.M410720200; Wang Y, 2010, J STEROID BIOCHEM, V121, P257, DOI 10.1016/j.jsbmb.2010.05.004; Wilson JL, 2013, BIOTECHNOL BIOENG; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	41	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112708	10.1371/journal.pone.0112708	http://dx.doi.org/10.1371/journal.pone.0112708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405762	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300048
J	Cook, GJ; Caudell, DL; Elford, HL; Pardee, TS				Cook, Guerry J.; Caudell, David L.; Elford, Howard L.; Pardee, Timothy S.			The Efficacy of the Ribonucleotide Reductase Inhibitor Didox in Preclinical Models of AML	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; PROGNOSTIC-FACTORS; DOSE CYTARABINE; CELLS; HYDROXYUREA; EXPRESSION; APOPTOSIS; CANCER; ACID; CHEMOTHERAPY	Acute Myeloid Leukemia (AML) is an aggressive malignancy which leads to marrow failure, and ultimately death. There is a desperate need for new therapeutics for these patients. Ribonucleotide reductase (RR) is the rate limiting enzyme in DNA synthesis. Didox (3,4-Dihydroxybenzohydroxamic acid) is a novel RR inhibitor noted to be more potent than hydroxyurea. In this report we detail the activity and toxicity of Didox in preclinical models of AML. RR was present in all AML cell lines and primary patient samples tested. Didox was active against all human and murine AML lines tested with IC50 values in the low micromolar range (mean IC50 37 mu M [range 25.89-52.70 mu M]). It was active against primary patient samples at concentrations that did not affect normal hematopoietic stem cells (HSCs). Didox exposure resulted in DNA damage and p53 induction culminating in apoptosis. In syngeneic, therapy-resistant AML models, single agent Didox treatment resulted in a significant reduction in leukemia burden and a survival benefit. Didox was well tolerated, as marrow from treated animals was morphologically indistinguishable from controls. Didox exposure at levels that impaired leukemia growth did not inhibit normal HSC engraftment. In summary, Didox was well tolerated and effective against preclinical models of AML.	[Cook, Guerry J.; Pardee, Timothy S.] Wake Forest Univ Hlth Sci, Dept Internal Med, Sect Hematol & Oncol, Winston Salem, NC 27103 USA; [Caudell, David L.] Wake Forest Univ Hlth Sci, Dept Pathol, Comparat Med Sect, Winston Salem, NC USA; [Elford, Howard L.] Mol Hlth, Richmond, VA USA; [Pardee, Timothy S.] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University	Pardee, TS (corresponding author), Wake Forest Univ Hlth Sci, Dept Internal Med, Sect Hematol & Oncol, Winston Salem, NC 27103 USA.	tspardee@wakehealth.edu		Pardee, Timothy/0000-0002-1186-6948	Doug Coley Foundation for Leukemia Research; Frances P. Tutwiler Fund; National Cancer Institute [P30CA012197, 1K08CA169809-01]; NATIONAL CANCER INSTITUTE [P30CA012197, K08CA169809] Funding Source: NIH RePORTER	Doug Coley Foundation for Leukemia Research; Frances P. Tutwiler Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Doug Coley Foundation for Leukemia Research, the Frances P. Tutwiler Fund, and the National Cancer Institute (award P30CA012197, 1K08CA169809-01; TSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimiuwu J, 2012, BLOOD, V119, P5229, DOI 10.1182/blood-2011-11-382226; Alibhai SMH, 2009, CANCER, V115, P2903, DOI 10.1002/cncr.24373; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Cory JG, 1989, INHIBITORS RIBONUCLE, Vix; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; ELFORD HL, 1979, CANCER RES, V39, P844; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Farag SS, 2006, BLOOD, V108, P63, DOI 10.1182/blood-2005-11-4354; Ferrara F, 2004, HAEMATOLOGICA, V89, P998; Gallaugher LD, 2009, COMPARATIVE MED, V59, P567; Garrido SM, 2001, EXP HEMATOL, V29, P448, DOI 10.1016/S0301-472X(01)00612-9; Gilliland D Gary, 2004, Hematology Am Soc Hematol Educ Program, P80; Grusch M, 2001, EXP HEMATOL, V29, P623, DOI 10.1016/S0301-472X(01)00624-5; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Horvath Z, 2004, CANCER CHEMOTH PHARM, V54, P139, DOI 10.1007/s00280-004-0795-0; Howlader N, 2011, SEER CANC STAT REV 1; Inayat MS, 2010, J INFLAMM-LOND, V7; KANTARJIAN HM, 1988, J CLIN ONCOL, V6, P232, DOI 10.1200/JCO.1988.6.2.232; Kaul DK, 2006, MICROCIRCULATION, V13, P489, DOI 10.1080/10739680600778456; Klisovic RB, 2008, CLIN CANCER RES, V14, P3889, DOI 10.1158/1078-0432.CCR-08-0109; Longo DL, 2012, HARRISONS PRINCIPLES; Macanas-Pirard P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037203; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Matsusaka S, 2007, CHEMOTHERAPY, V53, P36, DOI 10.1159/000098249; Mayhew CN, 1999, STEM CELLS, V17, P345, DOI 10.1002/stem.170345; Mayhew CN, 2002, ANTIVIR RES, V56, P167, DOI 10.1016/S0166-3542(02)00108-0; Nakano Y, 2000, EUR J HAEMATOL, V65, P23, DOI 10.1034/j.1600-0609.2000.90138.x; Okamura H, 2003, ACTA CYTOL, V47, P209, DOI 10.1159/000326506; Pardee TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043185; Raje N, 2006, BRIT J HAEMATOL, V135, P52, DOI 10.1111/j.1365-2141.2006.06261.x; Rollig C, 2010, BLOOD, V116, P971, DOI 10.1182/blood-2010-01-267302; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; Shankar DB, 2007, BLOOD, V109, P3400, DOI 10.1182/blood-2006-06-029579; TAKEDA E, 1981, LIFE SCI, V28, P1007, DOI 10.1016/0024-3205(81)90746-3; VEALE D, 1988, BRIT J CANCER, V58, P70, DOI 10.1038/bjc.1988.164; Wang LM, 2012, CHINESE MED J-PEKING, V125, P2151, DOI 10.3760/cma.j.issn.0366-6999.2012.12.013; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112619	10.1371/journal.pone.0112619	http://dx.doi.org/10.1371/journal.pone.0112619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402485	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700058
J	Li, JJ; Wei, F; Chen, JG; Yu, YW; Gu, HY; Jiang, R; Wu, XL; Sun, Q				Li, Jing-Jie; Wei, Fang; Chen, Ju-Gang; Yu, Yan-Wei; Gu, Hong-Yue; Jiang, Rui; Wu, Xiu-Li; Sun, Qian			Assessment of Atrial Fibrillation and Vulnerability in Patients with Wolff-Parkinson-White Syndrome Using Two-Dimensional Speckle Tracking Echocardiography	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL CHARACTERISTICS; ACCESSORY PATHWAY; CATHETER ABLATION; RISK; TACHYCARDIA; MECHANISMS; MORTALITY; IMPACT	Purpose: The aim was to assess atrial fibrillation (AF) and vulnerability in Wolff-Parkinson-White (WPW) syndrome patients using two-dimensional speckle tracking echocardiography (2D-STE). Methods: All patients were examined via transthoracic echocardiography and 2D-STE in order to assess atrial function 7 days before and 10 days after RF catheter ablation. A postoperative 3-month follow-up was performed via outpatient visit or telephone calls. Results: Results showed significant differences in both body mass index (BMI) and supraventricular tachycardia (SVT) duration between WPW patients and DAVNP patients (both P<0.05). Echocardiography revealed that the maximum left atrial volume (LAV(max)) and the left ventricular mass index (LVMI) in diastole increased noticeably in patients with WPW compared to patients with DAVNP both before and after ablation (all P<0.05). Before ablation, there were obvious differences in the levels of SRs, SRe, and SRa from the 4-chamber view (LA) in the WPW patients group compared with patients in the DAVNP group (all P<0.05). In the AF group, there were significant differences in the levels of systolic strain rate (SRs), early diastolic strain rate (SRe), and late diastolic strain rate (SRa) from the 4-chamber view (LA) both before and after ablation (all P<0.05). In the non-AF group, there were decreased SRe levels from the 4-chamber view (LA/RA) pre-ablation compared to post-ablation (all P<0.05). Conclusion: Our findings provide convincing evidence that WPW syndrome may result in increased atrial vulnerability and contribute to the development of AF. Further, RF catheter ablation of AAV pathway can potentially improve atrial function in WPW syndrome patients. Two-dimensional speckle tracking echocardiography imaging in WPW patients would be necessary in the evaluation and improvement of the overall function of RF catheter ablation in a long-term follow-up period.	[Li, Jing-Jie; Chen, Ju-Gang; Yu, Yan-Wei; Gu, Hong-Yue; Jiang, Rui; Wu, Xiu-Li; Sun, Qian] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Peoples R China; [Wei, Fang] Taiyuan Iron & Steel Co, Gen Hosp, Dept Cardiol, Taiyuan, Peoples R China	Harbin Medical University	Gu, HY (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Peoples R China.	guhongyue218@126.com			Natural Science Foundation of Heilongjiang Province [D201285]; Post-doctoral research starting capital of Heilongjiang Province [LBH-Q12035]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Post-doctoral research starting capital of Heilongjiang Province	This study was funded by Natural Science Foundation of Heilongjiang Province No. (D201285) and Post-doctoral research starting capital of Heilongjiang Province No.(LBH-Q12035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhoon B, 2010, PHYSIOL RES, V59, P1, DOI 10.33549/physiolres.931651; Ball J, 2013, INT J CARDIOL, V167, P1807, DOI 10.1016/j.ijcard.2012.12.093; Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002; Cai QJ, 2012, INT J CARDIOVAS IMAG, V28, P725, DOI 10.1007/s10554-011-9880-8; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Centurion OA, 2008, EUROPACE, V10, P292, DOI 10.1093/europace/eun031; Christophersen IE, 2013, CIRC-ARRHYTHMIA ELEC, V6, P10, DOI 10.1161/CIRCEP.112.971580; de Veire NRV, 2008, HEART, V94, P1065, DOI [10.1136/hrt.2007.120758, 10.1136/hrt.2006.099424corr1]; DELLABELLA P, 1991, J AM COLL CARDIOL, V17, P1352, DOI 10.1016/S0735-1097(10)80146-9; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Emkanjoo Z, 2010, INT J CARDIOL, V142, P196, DOI 10.1016/j.ijcard.2008.11.114; Erdem Alim, 2010, Indian Pacing Electrophysiol J, V10, P195; Cianciulli TF, 2010, WORLD J CARDIOL, V2, P163, DOI 10.4330/wjc.v2.i7.163; Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Hogarth AJ, 2013, J HUM HYPERTENS, V27, P707, DOI 10.1038/jhh.2013.75; Huang YC, 2013, J CARDIOVASC ELECTR, V24, P1306, DOI 10.1111/jce.12177; Katritsis DG, 2013, EUROPACE, V15, P779, DOI 10.1093/europace/eus374; Kim HK, 2007, J AM SOC ECHOCARDIOG, V20, P45, DOI 10.1016/j.echo.2006.07.007; Kroesen Michiel, 2012, J Pediatr Pharmacol Ther, V17, P93, DOI 10.5863/1551-6776-17.1.93; Lalani SR, 2009, J MED GENET, V46, P168, DOI 10.1136/jmg.2008.061002; Li CH, 2011, J CARDIOVASC ELECTR, V22, P274, DOI 10.1111/j.1540-8167.2010.01906.x; Lim PB, 2011, J CARDIOVASC ELECTR, V22, P638, DOI 10.1111/j.1540-8167.2010.01992.x; Liu XP, 2010, J CARDIOVASC ELECTR, V21, P1024, DOI 10.1111/j.1540-8167.2010.01746.x; Lubitz SA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P291, DOI 10.1161/CIRCEP.110.942441; Mah DY, 2013, PACE, V36, P1117, DOI 10.1111/pace.12144; Mase M, 2012, AM J PHYSIOL-HEART C, V303, pH1219, DOI 10.1152/ajpheart.00228.2012; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Oakes RS, 2009, CIRCULATION, V119, P1758, DOI 10.1161/CIRCULATIONAHA.108.811877; Obeyesekere M, 2012, CIRCULATION, V125, P659, DOI 10.1161/CIRCULATIONAHA.111.085159; Oddsson H, 2002, EUROPACE, V4, P201, DOI 10.1053/eupc.2002.0223; Pappone C, 2012, CIRCULATION, V125, P661, DOI 10.1161/CIRCULATIONAHA.111.065722; Patel Sandeep M, 2011, Indian Pacing Electrophysiol J, V11, P43; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Pinho-Gomes AC, 2013, ANTIOXID REDOX SIGNA; Rentschler S, 2011, J CLIN INVEST, V121, P525, DOI 10.1172/JCI44470; Roberts JD, 2010, J AM COLL CARDIOL, V55, P705, DOI 10.1016/j.jacc.2009.12.005; Rosner MH, 1999, AM J EMERG MED, V17, P705, DOI 10.1016/S0735-6757(99)90167-5; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Takahashi K, 2013, J ELECTROCARDIOL, V46, P663, DOI 10.1016/j.jelectrocard.2013.01.007	40	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e108315	10.1371/journal.pone.0108315	http://dx.doi.org/10.1371/journal.pone.0108315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397668	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500001
J	Wannhoff, A; Muller, OJ; Friedrich, K; Rupp, C; Kloters-Plachky, P; Leopold, Y; Brune, M; Senner, M; Weiss, KH; Stremmel, W; Schemmer, P; Katus, HA; Gotthardt, DN				Wannhoff, Andreas; Mueller, Oliver J.; Friedrich, Kilian; Rupp, Christian; Kloeters-Plachky, Petra; Leopold, Yvonne; Brune, Maik; Senner, Mirja; Weiss, Karl-Heinz; Stremmel, Wolfgang; Schemmer, Peter; Katus, Hugo A.; Gotthardt, Daniel N.			Effects of Increased Von Willebrand Factor Levels on Primary Hemostasis in Thrombocytopenic Patients with Liver Cirrhosis	PLOS ONE			English	Article							PLATELET-FUNCTION ANALYZER; BLEEDING-TIME; DISEASE; DESMOPRESSIN; PFA-100(TM); THROMBOSIS; ADHESION; MARKER; RISK	In patients with liver cirrhosis procoagulant and anticoagulant changes occur simultaneously. During primary hemostasis, platelets adhere to subendothelial structures, via von Willebrand factor (vWF). We aimed to investigate the influence of vWF on primary hemostasis in patients with liver cirrhosis. Therefore we assessed in-vitro bleeding time as marker of primary hemostasis in cirrhotic patients, measuring the Platelet Function Analyzer (PFA-100) closure times with collagen and epinephrine (Col-Epi, upper limit of normal <= 165 s) or collagen and ADP (Col-ADP, upper limit of normal <= 118 s). If Col-Epi and Col-ADP were prolonged, the PFA-100 was considered to be pathological. Effects of vWF on primary hemostasis in thrombocytopenic patients were analyzed and plasma vWF levels were modified by adding recombinant vWF or anti-vWF antibody. Of the 72 included cirrhotic patients, 32 (44.4%) showed a pathological result for the PFA-100. They had mean closure times (+/- SD) of 180 +/- 62 s with Col-Epi and 160 +/- 70 s with Col-ADP. Multivariate analysis revealed that hematocrit (P = 0.027) and vWF-antigen levels (P = 0.010) are the predictors of a pathological PFA-100 test in cirrhotic patients. In 21.4% of cirrhotic patients with platelet count >= 150/nL and hematocrit >= 27.0%, pathological PFA-100 results were found. In thrombocytopenic (<150/nL) patients with cirrhosis, normal PFA-100 results were associated with higher vWF-antigen levels (462.3 +/- 235.9% vs. 338.7 +/- 151.6%, P = 0.021). These results were confirmed by multivariate analysis in these patients as well as by adding recombinant vWF or polyclonal anti-vWF antibody that significantly shortened or prolonged closure times, respectively. In conclusion, primary hemostasis is impaired in cirrhotic patients. The effect of reduced platelet count in cirrhotic patients can at least be partly compensated by increased vWF levels. Recombinant vWF could be an alternative to platelet transfusions in the future.	[Wannhoff, Andreas; Friedrich, Kilian; Rupp, Christian; Kloeters-Plachky, Petra; Leopold, Yvonne; Senner, Mirja; Weiss, Karl-Heinz; Stremmel, Wolfgang; Gotthardt, Daniel N.] Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Germany; [Mueller, Oliver J.; Katus, Hugo A.] Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany; [Brune, Maik] Univ Heidelberg Hosp, Dept Internal Med & Clin Chem 1, Heidelberg, Germany; [Schemmer, Peter] Univ Heidelberg Hosp, Dept Gen & Transplant Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Gotthardt, DN (corresponding author), Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Germany.	Daniel_Gotthardt@med.uni-heidelberg.de	Müller, Oliver/AAA-4399-2021; Müller, Oliver J./H-4739-2016; Rupp, Christian/E-7652-2019; Weiss, Karl Heinz/AAA-9117-2022	Müller, Oliver/0000-0001-8223-2638; Rupp, Christian/0000-0003-2808-9230; Stremmel, Wolfgang/0000-0002-8545-1753	Dekanat der Medizinischen Fakultat Heidelberg (Medical faculty Heidelberg); Deutsche Forschungsgemeinschaft (German Research Foundation)	Dekanat der Medizinischen Fakultat Heidelberg (Medical faculty Heidelberg); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	AW received a grant from the Dekanat der Medizinischen Fakultat Heidelberg (Medical faculty Heidelberg). DNG was supported by a grant from Deutsche Forschungsgemeinschaft (German Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitrano L, 2004, J HEPATOL, V40, P736, DOI 10.1016/j.jhep.2004.01.001; BURROUGHS AK, 1985, BRIT MED J, V291, P1377, DOI 10.1136/bmj.291.6506.1377; Buyukasik Y, 2002, BLOOD COAGUL FIBRIN, V13, P349, DOI 10.1097/00001721-200206000-00011; Escolar G, 1999, HAEMATOLOGICA, V84, P614; Ferlitsch M, 2012, HEPATOLOGY, V56, P1439, DOI 10.1002/hep.25806; Ferro D, 1996, HEPATOLOGY, V23, P1377, DOI 10.1053/jhep.1996.v23.pm0008675154; Giannini EG, 2008, CURR OPIN HEMATOL, V15, P473, DOI 10.1097/MOH.0b013e32830a9746; Harrison P, 1999, BLOOD COAGUL FIBRIN, V10, P25, DOI 10.1097/00001721-199901000-00004; Haubelt H, 2005, BRIT J HAEMATOL, V130, P759, DOI 10.1111/j.1365-2141.2005.05680.x; Hollestellel MJ, 2004, THROMB HAEMOSTASIS, V91, P267, DOI 10.1160/TH03-05-0310; Horvatits T, 2014, J HEPATOL; KUNDU SK, 1995, SEMIN THROMB HEMOST, V21, P106; La Mura V, 2011, GUT, V60, P1133, DOI 10.1136/gut.2010.235689; LAFFI G, 1992, GASTROENTEROLOGY, V103, P641, DOI 10.1016/0016-5085(92)90859-W; LAFFI G, 1993, GASTROENTEROLOGY, V105, P148, DOI 10.1016/0016-5085(93)90020-D; LAFFI G, 1986, GASTROENTEROLOGY, V90, P274, DOI 10.1016/0016-5085(86)90921-2; Lenting PJ, 2012, J THROMB HAEMOST, V10, P2428, DOI 10.1111/jth.12008; Levy GG, 2005, BLOOD, V106, P11, DOI 10.1182/blood-2004-10-4097; Lisman T, 2006, HEPATOLOGY, V44, P53, DOI 10.1002/hep.21231; Lisman T, 2010, BLOOD, V116, P878, DOI 10.1182/blood-2010-02-261891; Lisman T, 2010, SEMIN THROMB HEMOST, V36, P170, DOI 10.1055/s-0030-1251501; Mammen EF, 1998, SEMIN THROMB HEMOST, V24, P195, DOI 10.1055/s-2007-995840; MANNUCCI PM, 1986, BLOOD, V67, P1148; Mannucci PM, 1998, ARTERIOSCL THROM VAS, V18, P1359, DOI 10.1161/01.ATV.18.9.1359; Mannucci PM, 2001, BLOOD, V98, P2730, DOI 10.1182/blood.V98.9.2730; Pihusch R, 2002, J HEPATOL, V37, P548, DOI 10.1016/S0168-8278(02)00239-8; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; Saner FH, 2013, DIGESTION, V88, P135, DOI 10.1159/000354400; Sogaard KK, 2009, AM J GASTROENTEROL, V104, P96, DOI 10.1038/ajg.2008.34; Tripodi A, 2006, HEPATOLOGY, V44, P440, DOI 10.1002/hep.21266; Tripodi Armando, 2013, Hepatology, V58, P1177, DOI 10.1002/hep.26502; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Da Rocha ECV, 2009, CLIN GASTROENTEROL H, V7, P988, DOI 10.1016/j.cgh.2009.04.019; Violi F, 2011, J HEPATOL, V55, P1415, DOI 10.1016/j.jhep.2011.06.008; Zupan IP, 2003, AM J KIDNEY DIS, V42, P746, DOI 10.1016/S0272-6386(03)00913-2	35	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112583	10.1371/journal.pone.0112583	http://dx.doi.org/10.1371/journal.pone.0112583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397410	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500063
J	Kuznetsov, NA; Faleev, NG; Kuznetsova, AA; Morozova, EA; Revtovich, SV; Anufrieva, NV; Nikulin, AD; Fedorova, OS; Demidkina, TV				Kuznetsov, Nikita A.; Faleev, Nicolai G.; Kuznetsova, Alexandra A.; Morozova, Elena A.; Revtovich, Svetlana V.; Anufrieva, Natalya V.; Nikulin, Alexei D.; Fedorova, Olga S.; Demidkina, Tatyana V.			Pre-steady-state Kinetic and Structural Analysis of Interaction of Methionine gamma-Lyase from Citrobacter freundii with Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Enzyme Structure; Pre-steady-state Kinetics; Pyridoxal Phosphate; Substrate Specificity; Methionine -Lyase; Structure of Pyridoxal 5-Phosphate-Cycloserine Derivative	FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE; CRYSTAL-STRUCTURES; THERAPEUTIC APPLICATIONS; CONFORMATIONAL DYNAMICS; ACID AMINOTRANSFERASE; MERCAPTOMETHANE-LYASE; PSEUDOMONAS-PUTIDA; REACTION-MECHANISM; METHYL MERCAPTAN; ENZYME	Methionine gamma-lyase (MGL) catalyzes the gamma-elimination of l-methionine and its derivatives as well as the beta-elimination of l-cysteine and its analogs. These reactions yield alpha-keto acids and thiols. The mechanism of chemical conversion of amino acids includes numerous reaction intermediates. The detailed analysis of MGL interaction with glycine, l-alanine, l-norvaline, and l-cycloserine was performed by pre-steady-state stopped-flow kinetics. The structure of side chains of the amino acids is important both for their binding with enzyme and for the stability of the external aldimine and ketimine intermediates. X-ray structure of the MGLl-cycloserine complex has been solved at 1.6 angstrom resolution. The structure models the ketimine intermediate of physiological reaction. The results elucidate the mechanisms of the intermediate interconversion at the stages of external aldimine and ketimine formation.	[Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Fedorova, Olga S.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia; [Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Fedorova, Olga S.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia; [Faleev, Nicolai G.] Russian Acad Sci, Nesmeyanov Inst Organoelement Cpds, Moscow 119991, Russia; [Morozova, Elena A.; Revtovich, Svetlana V.; Anufrieva, Natalya V.; Demidkina, Tatyana V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Nikulin, Alexei D.] Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences	Fedorova, OS (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia.	fedorova@niboch.nsc.ru; tvd@eimb.ru	Fedorova, Olga/ABE-6637-2020; Kuznetsov, Nikita A/F-3245-2011; Fedorova, Olga S./E-1291-2013; Demidkina, Tatyana/AAD-9427-2019; Nikulin, Alexey/B-8226-2011; Kuznetsov, Nikita/CAA-3889-2022; Kuznetsov, Nikita/AFU-9897-2022; Anufrieva, Natalya V/B-5794-2016; Kuznetsova, Aleksandra A/G-5119-2013; Morozova, Elena/B-5849-2016; Revtovich, Svetlana V/F-9646-2015	Fedorova, Olga/0000-0002-4001-7187; Kuznetsov, Nikita A/0000-0002-4016-198X; Fedorova, Olga S./0000-0002-4001-7187; Nikulin, Alexey/0000-0001-5391-6184; Kuznetsov, Nikita/0000-0002-4016-198X; Kuznetsov, Nikita/0000-0002-4016-198X; Anufrieva, Natalya V/0000-0002-6611-8840; Morozova, Elena/0000-0003-2922-2793; Revtovich, Svetlana V/0000-0003-1594-9334; Kuznetsova, Aleksandra/0000-0002-9805-7050	Russian Academy of Sciences Program [6.11]; Russian Foundation for Basic Researches [14-04-00349]; Russian Scientific Foundation [14-14-00063]; Russian Federation for State Support of the Leading Scientific Schools [SS-2064.2014.4, SS-1205.2014.4]; Russian Ministry of Education and Science [SP-4012.2013.4]	Russian Academy of Sciences Program(Russian Academy of Sciences); Russian Foundation for Basic Researches(Russian Foundation for Basic Research (RFBR)); Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Federation for State Support of the Leading Scientific Schools; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Academy of Sciences Program "Molecular & Cell Biology" (6.11), Russian Foundation for Basic Researches Grant 14-04-00349, Russian Scientific Foundation Grant 14-14-00063, President of the Russian Federation for State Support of the Leading Scientific Schools Grants SS-2064.2014.4 and SS-1205.2014.4, and Russian Ministry of Education and Science Grant SP-4012.2013.4.	BRZOVIC P, 1990, BIOCHEMISTRY-US, V29, P442, DOI 10.1021/bi00454a020; BUTTERWORTH PJ, 1972, BIOCHIM BIOPHYS ACTA, V289, P251, DOI 10.1016/0005-2744(72)90074-5; DAVIS L, 1971, ADV ENZYMOL, V35, P33; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; El-Sayed AS, 2010, APPL MICROBIOL BIOT, V86, P445, DOI 10.1007/s00253-009-2303-2; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedemann TE, 1943, J BIOL CHEM, V147, P415; Fukamachi H, 2005, BIOCHEM BIOPH RES CO, V331, P127, DOI 10.1016/j.bbrc.2005.03.139; Hoffman R M, 1997, Hum Cell, V10, P69; ITO S, 1976, J BIOCHEM-TOKYO, V79, P1263, DOI 10.1093/oxfordjournals.jbchem.a131180; JOHNSON GF, 1970, J BIOL CHEM, V245, P5560; KOCHETKOV NK, 1959, DOKLADY AKAD NAYK SS, V129, P1132; Koulikova VV, 2011, AMINO ACIDS, V41, P1247, DOI 10.1007/s00726-010-0802-1; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; KREIS W, 1973, CANCER RES, V33, P1862; Kudou D, 2007, J BIOCHEM, V141, P535, DOI 10.1093/jb/mvm055; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuznetsov NA, 2012, DNA REPAIR, V11, P884, DOI 10.1016/j.dnarep.2012.08.004; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Kuznetsov NA, 2009, BIOCHEMISTRY-US, V48, P11335, DOI 10.1021/bi901100b; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOCKWOOD BC, 1991, BIOCHEM J, V279, P675, DOI 10.1042/bj2790675; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malashkevich VN, 1999, J MOL BIOL, V294, P193, DOI 10.1006/jmbi.1999.3254; Mamaeva DV, 2005, ACTA CRYSTALLOGR F, V61, P546, DOI 10.1107/S1744309105015447; Manukhov IV, 2005, J BACTERIOL, V187, P3889, DOI 10.1128/JB.187.11.3889-3893.2005; Morozova EA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1272, DOI 10.1134/S0006297910100093; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAKAYAMA T, 1984, AGR BIOL CHEM TOKYO, V48, P2367, DOI 10.1080/00021369.1984.10866502; Nikulin A, 2008, ACTA CRYSTALLOGR D, V64, P211, DOI 10.1107/S0907444907065390; Olson GT, 1998, J AM CHEM SOC, V120, P2256, DOI 10.1021/ja972907b; Peisach D, 1998, J AM CHEM SOC, V120, P2268, DOI 10.1021/ja973353f; Rebeille F, 2006, P NATL ACAD SCI USA, V103, P15687, DOI 10.1073/pnas.0606195103; Revtovich SV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P564, DOI 10.1134/S0006297911050063; Revtovich SV, 2014, BIOCHIMIE, V101, P161, DOI 10.1016/j.biochi.2014.01.007; Ronda L, 2011, BBA-PROTEINS PROTEOM, V1814, P834, DOI 10.1016/j.bbapap.2010.06.017; Sato D, 2009, IUBMB LIFE, V61, P1019, DOI 10.1002/iub.255; SHALTIEL S, 1970, BIOCHEM BIOPH RES CO, V41, P594, DOI 10.1016/0006-291X(70)90054-9; Steegborn C, 2001, J MOL BIOL, V311, P789, DOI 10.1006/jmbi.2001.4880; Tan YY, 2010, ANTICANCER RES, V30, P1041; TANAKA H, 1977, BIOCHEMISTRY-US, V16, P100, DOI 10.1021/bi00620a016; TANAKA H, 1985, ENZYME MICROB TECH, V7, P530, DOI 10.1016/0141-0229(85)90094-8; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshimura M, 2000, INFECT IMMUN, V68, P6912, DOI 10.1128/IAI.68.12.6912-6916.2000	45	15	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					671	681		10.1074/jbc.M114.586511	http://dx.doi.org/10.1074/jbc.M114.586511			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398880	hybrid, Green Published			2022-12-26	WOS:000347231200057
J	Gomes, L; Fernando, S; Fernando, RH; Wickramasinghe, N; Shyamali, NLA; Ogg, GS; Malavige, GN				Gomes, Laksiri; Fernando, Samitha; Fernando, Randika Heshan; Wickramasinghe, Nilanka; Shyamali, Narangoda Liyanage Ajantha; Ogg, Graham S.; Malavige, Gathsaurie Neelika			Sphingosine 1-Phosphate in Acute Dengue Infection	PLOS ONE			English	Article							INFLUENZA-VIRUS INFECTION; RECEPTOR AGONIST THERAPY; HUMAN ENDOTHELIAL-CELLS; HEMORRHAGIC-FEVER; CYTOKINE STORM; T-CELLS; PERMEABILITY; PROTECTION; ANTIBODIES; RESPONSES	Background: Vascular leak is the hallmark of severe dengue infections and leads to complications such as shock and multi-organ failure. Although many mediators have been implicated in the vascular leak in dengue, the role of sphingosine 1 phosphate (S1P) has not been investigated. Metholodology/Principal findings: As S1P has been shown to be important in barrier integrity, we assessed the S1P levels in 28 patients with acute dengue and 12 healthy individuals. The S1P levels were significantly lower in patients with acute dengue (p = 0.002) and the levels in patients with grade IV dengue haemorrhagic fever (DHF) were significantly lower than those with dengue fever (p = 0.005). We then investigated the kinetics of S1P levels throughout the course of the illness in another 32 patients in serum samples obtained twice a day. We found that S1P levels were low throughout the course of illness and S1P levels were <0.5 mu M in 12/23 patients with DHF when compared to 1/9 with DF. Conclusions/Significance: As S1P has shown to be important in the endothelial barrier integrity and increases transendothelial resistance, low levels of S1P in acute dengue infection are likely to contribute to increased vascular permeability.	[Gomes, Laksiri; Fernando, Samitha; Fernando, Randika Heshan; Wickramasinghe, Nilanka; Malavige, Gathsaurie Neelika] Univ Sri Jayawardanapura, Fac Med Sci, Dept Microbiol, Ctr Dengue Res, Gangodawila, Sri Lanka; [Shyamali, Narangoda Liyanage Ajantha] Oxford NIHR Biomed Res Ctr, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Shyamali, Narangoda Liyanage Ajantha] Univ Oxford, Oxford, England; [Ogg, Graham S.; Malavige, Gathsaurie Neelika] Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England	University Sri Jayewardenepura; University of Oxford; University of Oxford; University of Oxford	Malavige, GN (corresponding author), Univ Sri Jayawardanapura, Fac Med Sci, Dept Microbiol, Ctr Dengue Res, Gangodawila, Sri Lanka.	gathsaurie.malavige@ndm.ox.ac.uk	Malavige, Gathsaurie/J-5483-2015	Malavige, Gathsaurie/0000-0001-9201-0449; Fernando, Bentotage/0000-0002-5613-5807; Ogg, Graham/0000-0002-3097-045X	Centre for Dengue Research, University of Sri Jayawardenapura; Medical Research Council, UK; MRC [MC_UU_12010/5] Funding Source: UKRI; Medical Research Council [MC_UU_12010/5] Funding Source: researchfish	Centre for Dengue Research, University of Sri Jayawardenapura; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to the Centre for Dengue Research, University of Sri Jayawardenapura and the Medical Research Council, UK for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appanna R, 2012, AM J TROP MED HYG, V87, P936, DOI 10.4269/ajtmh.2012.11-0606; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brasier AR, 2012, AM J TROP MED HYG, V86, P341, DOI 10.4269/ajtmh.2012.11-0469; Darwish I, 2013, VIRULENCE, V4, P572, DOI 10.4161/viru.25740; Dewi BE, 2008, J GEN VIROL, V89, P642, DOI 10.1099/vir.0.83356-0; Dong T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001192; Finney CAM, 2011, MOL MED, V17, P717, DOI 10.2119/molmed.2010.00214; Jayaratne S D, 2012, BMC Res Notes, V5, P645, DOI 10.1186/1756-0500-5-645; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261; Lundblad C, 2013, ACTA ANAESTH SCAND, V57, P713, DOI 10.1111/aas.12130; Malavige GN, 2013, J CLIN VIROL, V58, P605, DOI 10.1016/j.jcv.2013.10.023; Malavige GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050387; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Ntranos A, 2014, J NEUROIMMUNOL, V270, P13, DOI 10.1016/j.jneuroim.2014.03.007; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sang CT, 1998, CLIN DIAGN LAB IMMUN, V5, P7, DOI 10.1128/CDLI.5.1.7-10.1998; Schaphorst KL, 2003, AM J PHYSIOL-LUNG C, V285, pL258, DOI 10.1152/ajplung.00311.2002; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Srikiatkhachorn A, 2007, J VIROL, V81, P1592, DOI 10.1128/JVI.01642-06; Srikiatkhachorn A, 2014, ANTIVIR RES, V109, P160, DOI 10.1016/j.antiviral.2014.07.005; Teijaro JR, 2014, VIROLOGY, V452, P152, DOI 10.1016/j.virol.2014.01.003; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; Walsh KB, 2014, J VIROL, V88, P6281, DOI 10.1128/JVI.00464-14; Walsh KB, 2011, IMMUNOL RES, V51, P15, DOI 10.1007/s12026-011-8240-z; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wei HY, 2003, J GEN VIROL, V84, P3095, DOI 10.1099/vir.0.19308-0; Whitehorn J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001716; Who, 2011, COMP GUID PREV CONTR; World Health Organization, 2009, DENG GUID DIAGN PREV	33	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113394	10.1371/journal.pone.0113394	http://dx.doi.org/10.1371/journal.pone.0113394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409037	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200108
J	Kang, MY; Kim, HR				Kang, Mo-Yeol; Kim, Hyoung-Ryoul			Association between Voluntary/Involuntary Job Loss and the Development of Stroke or Cardiovascular Disease: A Prospective Study of Middle-Aged to Older Workers in a Rapidly Developing Asian Country	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; RETIREMENT SURVEY; MENTAL-HEALTH; ALCOHOL-CONSUMPTION; FOLLOW-UP; UNEMPLOYMENT; RISK; MORTALITY; GENDER; HOSPITALIZATION	Background: The aim of this research was to investigate the association between job loss and the development of stroke or cardiovascular disease among middle-aged to older individuals in Korea. We also examined how this relationship was modified by gender and the nature of the job loss. Methods: This study used samples from the first-to fourth-wave datasets from the Korean Longitudinal Study of Aging (KLoSA), which were collected in 2006, 2008, 2010, and 2012. The study collected data from a total of 10,254 subjects aged >= 45 years at baseline. After applying exclusion criteria, the final sample size for analysis consisted of 4,000 individuals. Information about employment status, development of stroke or cardiovascular disease, and covariates (age, income level, and behavioral factors) was obtained. Cox proportional hazards models were used to evaluate the association between voluntary/involuntary job loss and the development of stroke or cardiovascular disease. We performed these analyses separately according to disease, gender, and the nature of the job loss. Results: Involuntary job loss significantly increased the risk of stroke or cardiovascular disease among males (adjusted hazard ratio [HR] = 3.560, 95% confidence interval [CI] = 2.055-6.168). Voluntary retirement also increased the risk of cardiovascular disease or stroke among males (adjusted HR = 2.879, 95% CI = 1.533-5.409). Job loss was more closely associated with stroke than with cardiovascular disease (stroke, adjusted HR = 6.208, 95% CI = 2.417-15.943; cardiovascular disease, adjusted HR = 2.768, 95% CI = 1.402-5.465). Conclusion: Our findings suggest that both voluntary retirement and involuntary job loss increase the risk for stroke or cardiovascular disease in middle-aged to older individuals, especially males.	[Kang, Mo-Yeol] Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Ulsan, South Korea; [Kang, Mo-Yeol] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Hyoung-Ryoul] Catholic Univ Korea, Coll Med, Dept Occupat & Environm Med, Seoul, South Korea	Seoul National University (SNU); Catholic University of Korea	Kim, HR (corresponding author), Catholic Univ Korea, Coll Med, Dept Occupat & Environm Med, Seoul, South Korea.	cyclor@catholic.ac.kr						Artazcoz L, 2004, AM J PUBLIC HEALTH, V94, P82, DOI 10.2105/AJPH.94.1.82; Bolton KL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-77; BRACKBILL RM, 1995, BRIT MED J, V310, P568, DOI 10.1136/bmj.310.6979.568; Broman CL, 1995, AM J COMMUN PSYCHOL, V23, P813, DOI 10.1007/BF02507017; Browning M, 2012, J HEALTH ECON, V31, P599, DOI 10.1016/j.jhealeco.2012.03.001; BUNN AR, 1979, AM J PUBLIC HEALTH, V69, P772, DOI 10.2105/AJPH.69.8.772; Buxton JW, 2005, SOC PSYCH PSYCH EPID, V40, P99, DOI 10.1007/s00127-005-0866-5; Dupre ME, 2012, ARCH INTERN MED, V172, P1731, DOI 10.1001/2013.jamainternmed.447; Ekerdt DJ, 2000, RES AGING, V22, P3, DOI 10.1177/0164027500221001; Eliason M, 2009, SOC SCI MED, V68, P1396, DOI 10.1016/j.socscimed.2009.01.021; ENSMINGER ME, 1988, SOC SCI MED, V27, P239, DOI 10.1016/0277-9536(88)90127-X; Falba T, 2005, ADDICTION, V100, P1330, DOI 10.1111/j.1360-0443.2005.01150.x; FRANKS PJ, 1991, J EPIDEMIOL COMMUN H, V45, P16, DOI 10.1136/jech.45.1.16; Gallo WT, 2006, INT ARCH OCC ENV HEA, V80, P109, DOI 10.1007/s00420-006-0108-5; Gallo WT, 2000, J GERONTOL B-PSYCHOL, V55, pS131, DOI 10.1093/geronb/55.3.S131; Gallo WT, 2004, AM J IND MED, V45, P408, DOI 10.1002/ajim.20004; Gallo WT, 2001, J GERONTOL B-PSYCHOL, V56, pS3, DOI 10.1093/geronb/56.1.S3; Garcy AM, 2012, SOC SCI MED, V74, P1911, DOI 10.1016/j.socscimed.2012.01.034; IVERSEN L, 1986, SOC SCI MED, V22, P107, DOI 10.1016/0277-9536(86)90314-X; Kim JE, 2002, J GERONTOL B-PSYCHOL, V57, pP212, DOI 10.1093/geronb/57.3.P212; Kornerup H, 2010, EUR J CARDIOV PREV R, V17, P113, DOI 10.1097/HJR.0b013e3283359c18; Lundin A, 2014, OCCUPATIONAL ENV MED; Mandal B, 2007, RETIREMENT MENTA JUN; Marshall VW, 2001, RES AGING, V23, P379, DOI 10.1177/0164027501234001; Moon JR, 2012, SOC SCI MED, V75, P526, DOI 10.1016/j.socscimed.2012.04.004; OECD (Organisation for Economic Co-operation and Development), STATEXTRACTS LABR FO; Olesen K, 2014, INT J EPIDEMIOL, V43, P160, DOI 10.1093/ije/dyt260; Park S, 2012, J PREVENTIVE MED PUB, V45, P188, DOI DOI 10.3961/JPMPH.2012.45.3.188; SALOKANGAS RKR, 1991, PSYCHOTHER PSYCHOSOM, V55, P100, DOI 10.1159/000288415; Statistics Korea, 2011, STAT ELD; Stephens M, 2004, REV ECON STAT, V86, P253, DOI 10.1162/003465304323023796; van Rijn R., 2013, OCCUPATIONAL ENV MED; Westerlund H., 2010, BMJ, V341; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; YEUNG WJJ, 1998, J FAMILY EC ISSUES, V0019	35	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113495	10.1371/journal.pone.0113495	http://dx.doi.org/10.1371/journal.pone.0113495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409032	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200128
J	Santos, BA; Tabarelli, M; Melo, FPL; Camargo, JLC; Andrade, A; Laurance, SG; Laurance, WF				Santos, Braulio A.; Tabarelli, Marcelo; Melo, Felipe P. L.; Camargo, Jose L. C.; Andrade, Ana; Laurance, Susan G.; Laurance, William F.			Phylogenetic Impoverishment of Amazonian Tree Communities in an Experimentally Fragmented Forest Landscape	PLOS ONE			English	Article							ATLANTIC FOREST; NONRANDOM EXTINCTION; DIVERSITY; FIRE; CONSERVATION; PHYLOCOM; ECOLOGY; HISTORY; EROSION; STAND	Amazonian rainforests sustain some of the richest tree communities on Earth, but their ecological and evolutionary responses to human threats remain poorly known. We used one of the largest experimental datasets currently available on tree dynamics in fragmented tropical forests and a recent phylogeny of angiosperms to test whether tree communities have lost phylogenetic diversity since their isolation about two decades previously. Our findings revealed an overall trend toward phylogenetic impoverishment across the experimentally fragmented landscape, irrespective of whether tree communities were in 1-ha, 10-ha, or 100-ha forest fragments, near forest edges, or in continuous forest. The magnitude of the phylogenetic diversity loss was low (< 2% relative to before-fragmentation values) but widespread throughout the study landscape, occurring in 32 of 40 1-ha plots. Consistent with this loss in phylogenetic diversity, we observed a significant decrease of 50% in phylogenetic dispersion since forest isolation, irrespective of plot location. Analyses based on tree genera that have significantly increased (28 genera) or declined (31 genera) in abundance and basal area in the landscape revealed that increasing genera are more phylogenetically related than decreasing ones. Also, the loss of phylogenetic diversity was greater in tree communities where increasing genera proliferated and decreasing genera reduced their importance values, suggesting that this taxonomic replacement is partially underlying the phylogenetic impoverishment at the landscape scale. This finding has clear implications for the current debate about the role human-modified landscapes play in sustaining biodiversity persistence and key ecosystem services, such as carbon storage. Although the generalization of our findings to other fragmented tropical forests is uncertain, it could negatively affect ecosystem productivity and stability and have broader impacts on coevolved organisms.	[Santos, Braulio A.] Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58051900 Joao Pessoa, Paraiba, Brazil; [Tabarelli, Marcelo; Melo, Felipe P. L.] Univ Fed Pernambuco, Dept Bot, BR-50670901 Recife, PE, Brazil; [Camargo, Jose L. C.; Andrade, Ana] Natl Inst Amazonian Res INPA, Biol Dynam Forest Fragment Project, BR-69011970 Manaus, Amazonas, Brazil; [Laurance, Susan G.; Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia; [Laurance, Susan G.; Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia	Universidade Federal da Paraiba; Universidade Federal de Pernambuco; Institute Nacional de Pesquisas da Amazonia; James Cook University; James Cook University	Santos, BA (corresponding author), Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58051900 Joao Pessoa, Paraiba, Brazil.	braulio@dse.ufpb.br	Tabarelli, Marcelo/F-1088-2010; Laurance, William F/B-2709-2012; Laurance, Susan/G-6021-2011; Melo, Felipe P.L./B-7720-2008; Santos, Bráulio A./M-2582-2013; Camargo, José Luís C/C-3137-2015	Tabarelli, Marcelo/0000-0001-7573-7216; Laurance, William F/0000-0003-4430-9408; Laurance, Susan/0000-0002-2831-2933; Melo, Felipe P.L./0000-0002-1271-3214; Santos, Bráulio A./0000-0001-6046-4024; Campana Camargo, Jose Luis/0000-0003-0370-9878	Instituto Nacional de Pesquisas da Amazonia (INPA); Smithsonian Institution; US National Science Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); NASA-LBA program; US-AID; Blue Moon Fund; Marisla Foundation; CNPq; Mellon Foundation	Instituto Nacional de Pesquisas da Amazonia (INPA); Smithsonian Institution(Smithsonian Institution); US National Science Foundation(National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NASA-LBA program(National Aeronautics & Space Administration (NASA)); US-AID(United States Agency for International Development (USAID)); Blue Moon Fund; Marisla Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Mellon Foundation	The Instituto Nacional de Pesquisas da Amazonia (INPA), Smithsonian Institution, US National Science Foundation, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), NASA-LBA program, US-AID, Mellon Foundation, Blue Moon Fund, and Marisla Foundation generously supported the Biological Dynamics of Forest Fragment Project. BAS, FPLM and MT are thankful to CNPq for postdoctoral fellowship and research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Arroyo-Rodriguez V, 2012, J ECOL, V100, P702, DOI 10.1111/j.1365-2745.2011.01952.x; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Barlow J, 2012, BIOL CONSERV, V151, P45, DOI 10.1016/j.biocon.2011.10.013; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bouroncle C, 2011, BIOTROPICA, V43, P562, DOI 10.1111/j.1744-7429.2011.00750.x; Briant G, 2010, BIOL CONSERV, V143, P2763, DOI 10.1016/j.biocon.2010.07.024; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cadotte MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019363; Cavender-Bares J, 2012, ECOLOGY, V93, pS1, DOI 10.1890/12-0092.1; Cavender-Bares J, 2012, ECOLOGY, V93, pS52, DOI 10.1890/11-0502.1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Cianciaruso MV, 2012, PERSPECT PLANT ECOL, V14, P205, DOI 10.1016/j.ppees.2011.11.004; D'Angelo SA, 2004, J TROP ECOL, V20, P243, DOI 10.1017/S0266467403001032; Gastauer M, 2013, ECOL INFORM, V15, P85, DOI 10.1016/j.ecoinf.2013.03.005; Grafen A., 2002, MODERN STAT LIFE SCI; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Hernandez-Ruedas MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098931; Laurance SGW, 2010, BIOTROPICA, V42, P429, DOI 10.1111/j.1744-7429.2009.00611.x; Susan GWL, 2009, J VEG SCI, V20, P323, DOI 10.1111/j.1654-1103.2009.01044.x; Laurance WF, 2004, NATURE, V428, P171, DOI 10.1038/nature02383; LAURANCE WF, 2006, EMERGING THREATS TRO; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lessard JP, 2009, ECOLOGY, V90, P2664, DOI 10.1890/09-0503.1; Letcher SG, 2012, PERSPECT PLANT ECOL, V14, P79, DOI 10.1016/j.ppees.2011.09.005; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Lopes AV, 2009, BIOL CONSERV, V142, P1154, DOI 10.1016/j.biocon.2009.01.007; Magurran A.E., 2004, MEASURING BIOL DIVER; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Michalski F, 2007, BIOTROPICA, V39, P691, DOI 10.1111/j.1744-7429.2007.00318.x; Norden N, 2012, ECOLOGY, V93, pS70, DOI 10.1890/10-2179.1; Oliveira MA, 2008, FOREST ECOL MANAG, V256, P1910, DOI 10.1016/j.foreco.2008.07.014; Pausas JG, 2010, BIOSCIENCE, V60, P614, DOI 10.1525/bio.2010.60.8.7; Piperno DR, 1996, QUATERNARY RES, V45, P202, DOI 10.1006/qres.1996.0020; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Ros M, 2012, DIVERS DISTRIB, V18, P377, DOI 10.1111/j.1472-4642.2011.00834.x; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Santos GGA, 2012, BIOTROPICA, V44, P771, DOI 10.1111/j.1744-7429.2012.00882.x; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Tabarelli M, 2010, CONSERV BIOL, V24, P1654, DOI 10.1111/j.1523-1739.2010.01529.x; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Verdu M, 2007, J ECOL, V95, P1316, DOI 10.1111/j.1365-2745.2007.01300.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Youssef NH, 2012, APPL ENVIRON MICROB, V78, P1332, DOI 10.1128/AEM.07420-11	58	29	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113109	10.1371/journal.pone.0113109	http://dx.doi.org/10.1371/journal.pone.0113109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409011	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200068
J	Wijemanne, P; Moxley, RA				Wijemanne, Prageeth; Moxley, Rodney A.			Glucose Significantly Enhances Enterotoxigenic Escherichia coli Adherence to Intestinal Epithelial Cells through Its Effects on Heat-Labile Enterotoxin Production	PLOS ONE			English	Article							STIMULATES PROLIFERATION; SECRETORY PATHWAY; VIRULENCE GENES; WEANED PIGS; YOUNG-PIGS; DISEASE; PREVALENCE; REPRESSION; VISCOSITY; VESICLES	The present study tested whether exposure of enterotoxigenic Escherichia coli (ETEC) to glucose at different concentrations in the media results in increased bacterial adherence to host cells through increased heat-labile enterotoxin (LT) production, thereby suggesting the effects are physiological. Porcine-origin ETEC strains grown in Casamino acid yeast extract medium containing different concentrations of glucose were washed and inoculated onto IPEC-J2 porcine intestinal epithelial cells to test for effects on adherence and host cell cAMP concentrations. Consistent with previous studies, all LT+ strains had higher ETEC adherence to IPEC-J2 cells than did LT- strains. Adherence of the LT- but not the LT+ strains was increased by pre-incubating the IPEC-J2 cells with LT and decreased by co-incubation with GM1 ganglioside in a dose-dependent manner (P<0.05). To determine whether the glucose concentration of the cell culture media has an effect on adherence, IPEC-J2 cells were inoculated with LT+ or LT- strains in cell culture media containing a final glucose concentration of 0, 0.25, 0.5, 1.0 or 2.0%, and incubated for 4 h. Only media containing 0.25% glucose resulted in increased adherence and cAMP levels, and this was limited to IPEC-J2 cells inoculated with LT+ strains. This study supports the hypothesis that glucose, at a concentration optimal for LT expression, enhances bacterial adherence through the promotion of LT production. Hence, these results establish the physiological relevance of the effects of glucose on LT production and provide a basis for how glucose intake may influence the severity of ETEC infection.	[Wijemanne, Prageeth; Moxley, Rodney A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Moxley, RA (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA.	rmoxley1@unl.edu		Moxley, Rodney/0000-0002-5377-7716	United States Department of Agriculture [NC-1202, NEB-39-167]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture, Multi-State Project NC-1202, NEB-39-167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflen KP, 2006, INFECT IMMUN, V74, P869; Argenzio R. A., 2004, Dukes' physiology of domestic animals, P405; BAYLEY HS, 1970, J ANIM SCI, V30, P394, DOI 10.2527/jas1970.303394x; Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; Bodero MD, 2009, INFECT IMMUN, V77, P791, DOI 10.1128/IAI.00928-08; BUSQUE P, 1995, MICROBIOL-SGM, V141, P1621, DOI 10.1099/13500872-141-7-1621; CHEN TM, 1985, INFECT IMMUN, V47, P5, DOI 10.1128/IAI.47.1.5-10.1985; Dorsey FC, 2006, CELL MICROBIOL, V8, P1516, DOI 10.1111/j.1462-5822.2006.00736.x; Erume J, 2008, INFECT IMMUN, V76, P3141, DOI 10.1128/IAI.01743-07; Erume J, 2013, VET MICROBIOL, V161, P315, DOI 10.1016/j.vetmic.2012.07.048; Fekete PZ, 2013, VET MICROBIOL, V164, P330, DOI 10.1016/j.vetmic.2013.02.019; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; GILLIGAN PH, 1979, INFECT IMMUN, V23, P99, DOI 10.1128/IAI.23.1.99-107.1979; Hegde A, 2009, INDIAN J MED MICROBI, V27, P325, DOI 10.4103/0255-0857.55446; HOHMANN A, 1975, INFECT IMMUN, V12, P866, DOI 10.1128/IAI.12.4.866-880.1975; Hopwood DE, 2002, BRIT J NUTR, V88, P523, DOI 10.1079/BJN2002694; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Johnson AM, 2009, J BACTERIOL, V191, P178, DOI 10.1128/JB.00822-08; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; KUNKEL SL, 1979, INFECT IMMUN, V23, P652, DOI 10.1128/IAI.23.3.652-659.1979; McDonald DE, 2001, BRIT J NUTR, V86, P487, DOI 10.1079/BJN2001416; Moxley RA, 1998, INFECT IMMUN, V66, P5031, DOI 10.1128/IAI.66.10.5031-5035.1998; Mudrak B, 2010, TOXINS, V2, P1445, DOI 10.3390/toxins2061445; MUNDELL DH, 1976, INFECT IMMUN, V14, P383, DOI 10.1128/IAI.14.2.383-388.1976; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; PICKEN RN, 1983, INFECT IMMUN, V42, P269, DOI 10.1128/IAI.42.1.269-275.1983; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; SMITH HW, 1968, J MED MICROBIOL, V1, P45, DOI 10.1099/00222615-1-1-45; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; Walker RI, 2007, VACCINE, V25, P2545, DOI 10.1016/j.vaccine.2006.12.028; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018	33	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113230	10.1371/journal.pone.0113230	http://dx.doi.org/10.1371/journal.pone.0113230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409235	Green Published, gold			2022-12-26	WOS:000345533200079
J	Hatton, SN; Lagopoulos, J; Hermens, DF; Hickie, IB; Scott, E; Bennett, MR				Hatton, Sean N.; Lagopoulos, Jim; Hermens, Daniel F.; Hickie, Ian B.; Scott, Elizabeth; Bennett, Maxwell R.			Short Association Fibres of the Insula-Temporoparietal Junction in Early Psychosis: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							AUDITORY VERBAL HALLUCINATIONS; SUPERFICIAL WHITE-MATTER; HOMO-SAPIENS PAYS; BRAIN IMAGES; YOUNG-PEOPLE; SCHIZOPHRENIA; MRI; NEUROANATOMY; LANGUAGE; ABNORMALITIES	Evidence shows that there are reductions in gray matter volume (GMV) and changes in long association white matter fibres within the left insula-temporoparietal junction (TPJ) during the early stages of psychotic disorders but less is known about short association fibres (sAFs). In this study we sought to characterise the changes in sAFs and associated volumetric changes of the left insula-TPJ during the early stages of psychosis. Magnetic resonance imaging was obtained from a sample of young people with psychosis (n = 42) and healthy controls (n = 45), and cortical parcellations of the left insula-TPJ were used as seeding masks to reconstruct 13 sAFs. Compared to healthy counterparts, the psychosis group showed significant reductions in fractional anisotropy (FA) in the sAFs connecting the superior (STG) and middle temporal gyri (MTG) and as well as reduced GMV within the inferior temporal gyrus and increased white matter volume (WMV) within Heschl's gyrus (HG). Furthermore, adolescent-onset psychosis subjects (onset 18 year or earlier) showed FA reductions in the STG-HG sAF when compared to adult-onset subjects, but this was not associated with changes in GMV nor WMV of the STG or HG. These findings suggest that during the early stages of psychosis, changes in sAFs and associated cortical GMV and WMV appear to occur independently, however age of onset of a psychotic syndrome/disorder influences the pattern of neuroanatomical abnormalities.	[Hatton, Sean N.; Lagopoulos, Jim; Hermens, Daniel F.; Hickie, Ian B.; Scott, Elizabeth; Bennett, Maxwell R.] Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia	University of Sydney	Hatton, SN (corresponding author), Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia.	sean.hatton@sydney.edu.au	Hatton, Sean/U-5993-2019; Hatton, Sean/ABF-2549-2020; Hickie, Ian B/K-8975-2015	Hickie, Ian B/0000-0001-8832-9895; Hermens, Daniel/0000-0002-8570-2663; Hatton, Sean/0000-0002-9149-8726	National Health & Medical Research Council funding sources: Program Grant [566529]; Centres of Clinical Research Excellence Grant [264611]; Australia Fellowship [464914]; Clinical Research Fellowship [402864]; Australian Postgraduate Award; NSW Health, Mental Health and Drug Alcohol Office; NHMRC Australia Fellowship; National Health and Medical Research Council Australia Fellowship [464914]	National Health & Medical Research Council funding sources: Program Grant; Centres of Clinical Research Excellence Grant; Australia Fellowship; Clinical Research Fellowship; Australian Postgraduate Award(Australian Government); NSW Health, Mental Health and Drug Alcohol Office; NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the following National Health & Medical Research Council funding sources: Program Grant (No. 566529), Centres of Clinical Research Excellence Grant (No. 264611), Australia Fellowship (No. 464914) and Clinical Research Fellowship (No. 402864). Sean Hatton is supported by an Australian Postgraduate Award (APA). Dr Daniel Hermens is currently supported by a grant from the NSW Health, Mental Health and Drug & Alcohol Office as well as an NHMRC Australia Fellowship (awarded to Professor Hickie). Professor Ian B Hickie is supported by a National Health and Medical Research Council Australia Fellowship (No. 464914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2012, SCHIZOPHRENIA BULL, V38, P695, DOI 10.1093/schbul/sbs066; American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Chance SA, 2008, BRAIN, V131, P3178, DOI 10.1093/brain/awn211; Crow TJ, 2008, SCHIZOPHR RES, V102, P31, DOI 10.1016/j.schres.2008.03.010; Crow TJ, 2000, BRAIN RES REV, V31, P118, DOI 10.1016/S0165-0173(99)00029-6; Crow TJ, 1997, SCHIZOPHR RES, V28, P127, DOI 10.1016/S0920-9964(97)00110-2; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hatton SN, 2013, INT J BIPOLAR DISORD, V1, DOI 10.1186/2194-7511-1-3; Hatton SN, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-45; Hatton SN, 2014, J PSYCHIATR NEUROSCI, V39; Hubl D, 2010, NEUROPSYCHOBIOLOGY, V61, P1, DOI 10.1159/000258637; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kuroki N, 2006, AM J PSYCHIAT, V163, P2103, DOI 10.1176/appi.ajp.163.12.2103; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meynert T, 1869, S STRICKER HDB LEHRE; Modinos G, 2013, CORTEX, V49, P1046, DOI 10.1016/j.cortex.2012.01.009; Nazeri A, 2013, NEUROPSYCHOPHARMACOL, V38, P1954, DOI 10.1038/npp.2013.93; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Phillips OR, 2011, BIOL PSYCHIAT, V70, P680, DOI 10.1016/j.biopsych.2011.03.039; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Scott EM, 2013, J AFFECT DISORDERS, V144, P208, DOI 10.1016/j.jad.2012.06.031; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; Smiley JF, 2012, SCHIZOPHR RES, V136, P43, DOI 10.1016/j.schres.2012.01.006; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Tozer DJ, 2012, NEUROIMAGE, V59, P3094, DOI 10.1016/j.neuroimage.2011.10.088; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D., 2001, WECHSLER TEST ADULT; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yushkevich PA, 2009, NEUROIMAGE, V45, pS99, DOI 10.1016/j.neuroimage.2008.10.051; Zhang FF, 2014, SCHIZOPHR RES, V159, P31, DOI 10.1016/j.schres.2014.07.050; Zhang H, 2007, LECT NOTES COMPUT SC, V4792, P211; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang SW, 2011, NEUROIMAGE, V54, P974, DOI 10.1016/j.neuroimage.2010.09.008; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112842	10.1371/journal.pone.0112842	http://dx.doi.org/10.1371/journal.pone.0112842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405994	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300057
J	Vetreno, RP; Broadwater, M; Liu, W; Spear, LP; Crews, FT				Vetreno, Ryan P.; Broadwater, Margaret; Liu, Wen; Spear, Linda P.; Crews, Fulton T.			Adolescent, but Not Adult, Binge Ethanol Exposure Leads to Persistent Global Reductions of Choline Acetyltransferase Expressing Neurons in Brain	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; EFFERENT CONNECTIONS; PARADOXICAL SLEEP; DOPAMINE RELEASE; MEDIAL HABENULA; NUCLEUS; LESIONS; DRINKING; NICOTINE; RAT	During the adolescent transition from childhood to adulthood, notable maturational changes occur in brain neurotransmitter systems. The cholinergic system is composed of several distinct nuclei that exert neuromodulatory control over cognition, arousal, and reward. Binge drinking and alcohol abuse are common during this stage, which might alter the developmental trajectory of this system leading to long-term changes in adult neurobiology. In Experiment 1, adolescent intermittent ethanol (AIE; 5.0 g/kg, i.g., 2-day on/2-day off from postnatal day [P] 25 to P55) treatment led to persistent, global reductions of choline acetyltransferase (ChAT) expression. Administration of the Toll-like receptor 4 agonist lipopolysaccharide to young adult rats (P70) produced a reduction in ChAT+ IR that mimicked AIE. To determine if the binge ethanol-induced ChAT decline was unique to the adolescent, Experiment 2 examined ChAT+ IR in the basal forebrain following adolescent (P28-P48) and adult (P70-P90) binge ethanol exposure. Twenty-five days later, ChAT expression was reduced in adolescent, but not adult, binge ethanol-exposed animals. In Experiment 3, expression of ChAT and vesicular acetylcholine transporter expression was found to be significantly reduced in the alcoholic basal forebrain relative to moderate drinking controls. Together, these data suggest that adolescent binge ethanol decreases adult ChAT expression, possibly through neuroimmune mechanisms, which might impact adult cognition, arousal, or reward sensitivity.	[Vetreno, Ryan P.; Liu, Wen; Crews, Fulton T.] Univ N Carolina, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Broadwater, Margaret; Spear, Linda P.] SUNY Binghamton, Dept Psychol, Ctr Dev & Behav Neurosci, Binghamton, NY 13902 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Vetreno, RP (corresponding author), Univ N Carolina, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA.	rvetreno@email.unc.edu	Crews, Fulton/T-1181-2019	Crews, Fulton/0000-0003-2393-4976	National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse [AA019767, AA11605, AA007573, AA021040, AA018026]; Neurobiology of Adolescent Drinking in Adulthood (NADIA) [AA020023, AA020024, AA020022]; Bowles Center for Alcohol Studies; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA021040, U01AA019972, T32AA007573, P60AA011605, U24AA020022, P50AA011605, R01AA018026, U01AA020023, U54AA019767, U24AA020024] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Neurobiology of Adolescent Drinking in Adulthood (NADIA); Bowles Center for Alcohol Studies; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by the National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse (AA019767, AA11605, AA007573, AA021040, and AA018026), the Neurobiology of Adolescent Drinking in Adulthood (NADIA [AA020023, AA020024, and AA020022]), and the Bowles Center for Alcohol Studies. The NIH, NIAAA, NADIA, and Bowles Center for Alcohol Studies had no further role in the study design, collection, analysis, and interpretation of data, writing of the report, or decision to submit the article for publication.	ARENDT T, 1989, NEUROSCIENCE, V33, P435, DOI 10.1016/0306-4522(89)90397-7; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Bah TM, 2010, SLEEP, V33, P1703, DOI 10.1093/sleep/33.12.1703; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Benarroch EE, 2013, NEUROLOGY, V80, P1148, DOI 10.1212/WNL.0b013e3182886a76; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Broadwater M, 2013, BEHAV BRAIN RES, V256, P10, DOI 10.1016/j.bbr.2013.08.013; Cabrera SM, 2006, BEHAV NEUROSCI, V120, P298, DOI 10.1037/0735-7044.120.2.298; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Carlson J, 2000, NEUROPHARMACOLOGY, V39, P2792, DOI 10.1016/S0028-3908(00)00141-6; Carlson J, 2001, BRAIN RES, V906, P127, DOI 10.1016/S0006-8993(01)02570-7; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Criado JR, 2008, ALCOHOL, V42, P631, DOI 10.1016/j.alcohol.2008.08.001; De Rosa E, 2004, NEURON, V41, P825, DOI 10.1016/S0896-6273(04)00080-7; Dedova I, 2009, INT J MOL SCI, V10, P366, DOI 10.3390/ijms10010366; Ehlers CL, 2011, NEUROSCIENCE, V199, P333, DOI 10.1016/j.neuroscience.2011.10.011; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Guerri C, 2010, ALCOHOL, V44, P15, DOI 10.1016/j.alcohol.2009.10.003; Guo KH, 2010, NEUROCHEM INT, V56, P694, DOI 10.1016/j.neuint.2010.02.005; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hingson R, 2001, PEDIATRICS, V108, P872, DOI 10.1542/peds.108.4.872; Johnston L., 2009, MONITORING FUTURE NA, VI; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; Knox D, 2006, BEHAV NEUROSCI, V120, P307, DOI 10.1037/0735-7044.120.2.307; Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017; LEVEY AI, 1983, J NEUROSCI, V3, P1; Ma M, 2012, J NEUROSCI, V32, P10105, DOI 10.1523/JNEUROSCI.0058-12.2012; MCMILLIAN M, 1995, BIOCHEM BIOPH RES CO, V215, P572, DOI 10.1006/bbrc.1995.2503; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Oda Y, 2000, HISTOL HISTOPATHOL, V15, P825, DOI 10.14670/HH-15.825; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; POTTHOFF AD, 1983, PHARMACOL BIOCHEM BE, V18, P489, DOI 10.1016/0091-3057(83)90269-1; Power AE, 2002, BEHAV BRAIN RES, V134, P307, DOI 10.1016/S0166-4328(02)00046-3; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Roehrs T, 2001, SLEEP MED REV, V5, P287, DOI 10.1053/smrv.2001.0162; Rupp CI, 2003, ALCOHOL CLIN EXP RES, V27, P432, DOI 10.1097/01.ALC.0000057945.57330.2C; Sher KJ, 1999, DEV PSYCHOPATHOL, V11, P933, DOI 10.1017/S0954579499002394; Silveri MM, 1998, ALCOHOL CLIN EXP RES, V22, P670, DOI 10.1111/j.1530-0277.1998.tb04310.x; Slotkin TA, 2008, BRAIN RES BULL, V76, P522, DOI 10.1016/j.brainresbull.2008.03.001; Smith HR, 2005, NEUROSCIENCE, V132, P261, DOI 10.1016/j.neuroscience.2004.12.037; Spear LP, 2011, DEV COGN NEUROS-NETH, V1, P390, DOI 10.1016/j.dcn.2011.08.001; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Szutowicz A, 2006, METAB BRAIN DIS, V21, P149, DOI 10.1007/s11011-006-9007-4; Unal CT, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00021; Usunoff KG, 2007, BRAIN RES, V1133, P87, DOI 10.1016/j.brainres.2006.11.073; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Vetreno RP, 2013, NEUROBIOL DIS, V59, P52, DOI 10.1016/j.nbd.2013.07.002; WEBSTER HH, 1988, BRAIN RES, V458, P285, DOI 10.1016/0006-8993(88)90471-4; Windle M, 2008, PEDIATRICS, V121, pS273, DOI 10.1542/peds.2007-2243C; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	58	68	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113421	10.1371/journal.pone.0113421	http://dx.doi.org/10.1371/journal.pone.0113421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405505	Green Published, gold			2022-12-26	WOS:000347121300116
J	Xiang, L; Kong, W; Su, JT; Liang, J; Zhang, GY; Xie, LP; Zhang, RQ				Xiang, Liang; Kong, Wei; Su, Jingtan; Liang, Jian; Zhang, Guiyou; Xie, Liping; Zhang, Rongqing			Amorphous Calcium Carbonate Precipitation by Cellular Biomineralization in Mantle Cell Cultures of Pinctada fucata	PLOS ONE			English	Article							MATRIX PROTEIN SECRETION; PEARL OYSTER; PRECURSOR PHASE; SHELL FORMATION; MOLLUSK; TISSUE; NACRE; ARAGONITE; ABALONE; LAYER	The growth of molluscan shell crystals is generally thought to be initiated from the extrapallial fluid by matrix proteins, however, the cellular mechanisms of shell formation pathway remain unknown. Here, we first report amorphous calcium carbonate (ACC) precipitation by cellular biomineralization in primary mantle cell cultures of Pinctada fucata. Through real-time PCR and western blot analyses, we demonstrate that mantle cells retain the ability to synthesize and secrete ACCBP, Pif80 and nacrein in vitro. In addition, the cells also maintained high levels of alkaline phosphatase and carbonic anhydrase activity, enzymes responsible for shell formation. On the basis of polarized light microscopy and scanning electron microscopy, we observed intracellular crystals production by mantle cells in vitro. Fourier transform infrared spectroscopy and X-ray diffraction analyses revealed the crystals to be ACC, and de novo biomineralization was confirmed by following the incorporation of Sr into calcium carbonate. Our results demonstrate the ability of mantle cells to perform fundamental biomineralization processes via amorphous calcium carbonate, and these cells may be directly involved in pearl oyster shell formation.	[Xiang, Liang; Kong, Wei; Su, Jingtan; Liang, Jian; Zhang, Guiyou; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xiang, Liang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Lab Reprod Hlth, Shenzhen, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, U0831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090002110055]; Independent Research Projects of Tsinghua University [20111080964]; National Key Scientific and Technological Project [2011ZX08011]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Research Projects of Tsinghua University; National Key Scientific and Technological Project	This work was supported by the National Basic Research Program of China Grant 2010CB126405, http://www.973.gov.cn/English/Index.aspx, the National High Technology Research and Development Program of China 2010AA09Z405, http://www.most.gov.cn/eng/index.htm, the National Natural Science Foundation of China Grants 31172382 and U0831001 (Joint Fund with Guangdong) http://www.nsfc.gov.cn/Portal0/default124.htm, the Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20090002110055, and Independent Research Projects of Tsinghua University Grant 20111080964, and National Key Scientific and Technological Project 2011ZX08011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Auzoux-Bordenave S, 2010, J STRUCT BIOL, V171, P277, DOI 10.1016/j.jsb.2010.05.012; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Beniash E, 1999, J STRUCT BIOL, V125, P50, DOI 10.1006/jsbi.1998.4081; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Checa AG, 2005, BIOMATERIALS, V26, P1071, DOI 10.1016/j.biomaterials.2004.04.007; Collin R, 1998, J MORPHOL, V235, P77, DOI 10.1002/(SICI)1097-4687(199801)235:1<77::AID-JMOR6>3.0.CO;2-L; Domart-Coulon IJ, 2001, P NATL ACAD SCI USA, V98, P11885, DOI 10.1073/pnas.211439698; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fang Z, 2008, MAR BIOL, V153, P745, DOI 10.1007/s00227-007-0851-5; Gardner LD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-455; Gaume B, 2011, MAR BIOL, V158, P341, DOI 10.1007/s00227-010-1562-x; Gong NP, 2008, CELL TISSUE RES, V333, P493, DOI 10.1007/s00441-008-0609-5; Gong NP, 2008, MAR BIOTECHNOL, V10, P457, DOI 10.1007/s10126-008-9081-1; Hasse B, 2000, CHEM-EUR J, V6, P3679, DOI 10.1002/1521-3765(20001016)6:20<3679::AID-CHEM3679>3.0.CO;2-#; Inoue N, 2011, MAR BIOTECHNOL, V13, P48, DOI 10.1007/s10126-010-9267-1; Jacob DE, 2008, GEOCHIM COSMOCHIM AC, V72, P5401, DOI 10.1016/j.gca.2008.08.019; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Koga N, 1998, THERMOCHIM ACTA, V318, P239, DOI 10.1016/S0040-6031(98)00348-7; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; McDougall C, 2011, CELLS TISSUES ORGANS, V194, P103, DOI 10.1159/000324213; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Nassif N, 2005, P NATL ACAD SCI USA, V102, P12653, DOI 10.1073/pnas.0502577102; Natoli A, 2010, MICRON, V41, P359, DOI 10.1016/j.micron.2010.01.002; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; Poncet JM, 2000, MAR BIOTECHNOL, V2, P387; Rinkevich B, 2005, MAR BIOTECHNOL, V7, P429, DOI 10.1007/s10126-004-0108-y; Rousseau M, 2003, COMP BIOCHEM PHYS A, V135, P271, DOI 10.1016/S1095-6433(03)00070-9; Sud D, 2001, TISSUE CELL, V33, P154, DOI 10.1054/tice.2000.0166; Suja CP, 2007, AQUACULTURE, V271, P516, DOI 10.1016/j.aquaculture.2007.04.086; Suja CP, 2005, TISSUE CELL, V37, P1, DOI 10.1016/j.tice.2004.08.002; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Wang XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066522; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; Yan ZG, 2011, ACTA OCEANOL SIN, V30, P87, DOI 10.1007/s13131-011-0094-7; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	43	38	39	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113150	10.1371/journal.pone.0113150	http://dx.doi.org/10.1371/journal.pone.0113150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405357	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300087
J	Eggert, T; Medina-Echeverz, J; Kapanadze, T; Kruhlak, MJ; Korangy, F; Greten, TF				Eggert, Tobias; Medina-Echeverz, Jose; Kapanadze, Tamar; Kruhlak, Michael J.; Korangy, Firouzeh; Greten, Tim F.			Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSE; T-CELLS; MECHANISMS; DIFFERENTIATION; RECRUITMENT; APOPTOSIS; ACCUMULATION; INFLAMMATION; GENERATION	Subcutaneous tumors induce the accumulation of myeloid derived suppressor cells (MDSC) not only in blood and spleens, but also in livers of these animals. Unexpectedly, we observed a moderate increase in serum transaminases in mice with EL4 subcutaneous tumors, which prompted us to study the relationship of hepatic MDSC accumulation and liver injury. MDSC were the predominant immune cell population expanding in livers of all subcutaneous tumor models investigated (RIL175, B16, EL4, CT26 and BNL), while liver injury was only observed in EL4 and B16 tumor-bearing mice. Elimination of hepatic MDSC in EL4 tumor-bearing mice using low dose 5-fluorouracil (5-FU) treatment reversed transaminase elevation and adoptive transfer of hepatic MDSC from B16 tumor-bearing mice caused transaminase elevation indicating a direct MDSC mediated effect. Surprisingly, hepatic MDSC from B16 tumor-bearing mice partially lost their damage-inducing potency when transferred into mice bearing non damage-inducing RIL175 tumors. Furthermore, MDSC expansion and MDSC-mediated liver injury further increased with growing tumor burden and was associated with different cytokines including GM-CSF, VEGF, interleukin-6, CCL2 and KC, depending on the tumor model used. In contrast to previous findings, which have implicated MDSC only in protection from T cell-mediated hepatitis, we show that tumor-induced hepatic MDSC themselves can cause moderate liver damage.	[Eggert, Tobias; Medina-Echeverz, Jose; Kapanadze, Tamar; Korangy, Firouzeh; Greten, Tim F.] NCI, Gastrointestinal Malignancy Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kapanadze, Tamar] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Greten, TF (corresponding author), NCI, Gastrointestinal Malignancy Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	tim.greten@nih.gov	Greten, Tim F/B-3127-2015	Greten, Tim F/0000-0002-0806-2535	National Institutes of Health intramural research program; NATIONAL CANCER INSTITUTE [ZIABC011345] Funding Source: NIH RePORTER	National Institutes of Health intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The underlying research reported in the study was funded by the National Institutes of Health intramural research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Black D, 2007, BIOCHIMIE, V89, P1464, DOI 10.1016/j.biochi.2007.09.001; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Cheng LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017631; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Conrad E, 2014, HEPATOLOGY, V59, P1555, DOI 10.1002/hep.26915; Corazza Nadia, 2009, Semin Immunopathol, V31, P267, DOI 10.1007/s00281-009-0168-1; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Drozdzik M, 2000, J HEPATOL, V32, P279, DOI 10.1016/S0168-8278(00)80073-2; Eksteen B, 2007, SEMIN LIVER DIS, V27, P351, DOI 10.1055/s-2007-991512; Faubion WA, 1999, HEPATOLOGY, V29, P1, DOI 10.1002/hep.510290101; FIDLER IJ, 1975, CANCER RES, V35, P218; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GORER PA, 1959, CANCER RES, V19, P824; GRISWOLD DP, 1975, CANCER, V36, P2441, DOI 10.1002/1097-0142(197512)36:6<2441::AID-CNCR2820360627>3.0.CO;2-P; Hori Y, 2000, SURGERY, V127, P641, DOI 10.1067/msy.2000.105499; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647; Jaeschke H, 2006, LIVER INT, V26, P912, DOI 10.1111/j.1478-3231.2006.01327.x; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Kapanadze T, 2013, J HEPATOL, V59, P1007, DOI 10.1016/j.jhep.2013.06.010; Kaplowitz N, 2002, SEMIN LIVER DIS, V22, P137, DOI 10.1055/s-2002-30100; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Ma C, 2012, J LEUKOCYTE BIOL, V92, P1199, DOI 10.1189/jlb.0212059; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; NELSON SD, 1990, SEMIN LIVER DIS, V10, P267, DOI 10.1055/s-2008-1040482; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Sarra M, 2013, HEPATOLOGY, V58, P1436, DOI 10.1002/hep.26446; Schrum LW, 2001, AM J PHYSIOL-GASTR L, V280, pG139, DOI 10.1152/ajpgi.2001.280.1.G139; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shima Y, 1999, HEPATOLOGY, V30, P1215, DOI 10.1002/hep.510300503; Terabe M, 2003, J EXP MED, V198, P1741, DOI 10.1084/jem.20022227; Teufelhofer O, 2005, CARCINOGENESIS, V26, P319, DOI 10.1093/carcin/bgh320; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zuo DM, 2013, HEPATOLOGY, V57, P228, DOI 10.1002/hep.25983	57	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112717	10.1371/journal.pone.0112717	http://dx.doi.org/10.1371/journal.pone.0112717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401795	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700065
J	Sousa, MC; Mendes, R; Alvarez, I; Vaz, N; Gomez-Gesteira, M; Dias, JM				Sousa, Magda Catarina; Mendes, Renato; Alvarez, Ines; Vaz, Nuno; Gomez-Gesteira, Moncho; Dias, Joao Miguel			Unusual Circulation Patterns of the Rias Baixas Induced by Minho Freshwater Intrusion (NW of the Iberian Peninsula)	PLOS ONE			English	Article							GALICIAN RIAS; ESTUARINE-PLUME; NORTH-ATLANTIC; RIVER PLUME; SPAIN; HYDROGRAPHY; VARIABILITY; SALINITY; DYNAMICS; SYSTEM	The Minho River, situated 30 km south of the Rias Baixas, is the most important freshwater source flowing into the Western Galician coast (NW of the Iberian Peninsula). The buoyancy generated by the Minho estuarine plume can reverse the normal circulation pattern inside the Rias Baixas affecting the exchange between the Rias and the ocean, changing the input of nutrients. Nevertheless, this inversion of the circulation patterns is not a well-monitored phenomenon. The only published results based on in situ data related to the presence of the Minho River plume inside the Rias de Vigo and Pontevedra correspond to an event measured on spring 1998. In this case unexpectedly higher inflow surface current velocities were found at the Ria de Pontevedra, located further away from Minho River. Thus, the main aim of this study is to research the main factors inducing this unusual pattern on the circulation of the Rias de Vigo and Pontevedra. A numerical model implementation of MOHID previously developed, calibrated, and validated for this coastal area was used. Several scenarios were performed in order to explain the individual effect of the Minho River, rivers discharging into each Rias, and estuarine morphology changes. According to the model results, the Minho River discharge is a key factor in the establishment of the negative circulation, while small rivers inside the Rias slightly attenuate this circulation. The negative circulation was stronger in Ria de Pontevedra independently of the distance of this coastal system from the Minho River mouth, showing that morphologic estuarine features are the main factor justifying the different local circulation patterns.	[Sousa, Magda Catarina; Mendes, Renato; Alvarez, Ines; Vaz, Nuno; Dias, Joao Miguel] Univ Aveiro, Dept Fis, CESAM, P-3800 Aveiro, Portugal; [Alvarez, Ines; Gomez-Gesteira, Moncho] Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain	Universidade de Aveiro; Universidade de Vigo	Dias, JM (corresponding author), Univ Aveiro, Dept Fis, CESAM, Campus Santiago, P-3800 Aveiro, Portugal.	joao.dias@ua.pt	Mendes, Renato/D-5952-2015; Mendes, Renato/AAW-8775-2021; Vaz, Nuno AF/F-5552-2010; Gesteira, Moncho Gomez/R-9431-2019; Alvarez, Ines/F-9482-2016; Dias, João Miguel/F-3292-2010; Sousa, Magda C/L-7665-2014; Vaz, Nuno/GXH-8216-2022	Mendes, Renato/0000-0002-2964-9757; Mendes, Renato/0000-0002-2964-9757; Vaz, Nuno AF/0000-0002-8484-6948; Gesteira, Moncho Gomez/0000-0002-0661-9731; Alvarez, Ines/0000-0002-3837-1742; Dias, João Miguel/0000-0002-7613-6241; Sousa, Magda C/0000-0003-2575-3263; 	Portuguese Science Foundation (FCT) [SFRH/BD/79555/2011]; Ramon y Cajal program; Ciencia program; FCT; European Union (COMPETE) [Pest (C/MAR/LA0017/2013)]; European Union (QREN) [Pest (C/MAR/LA0017/2013)]; European Union (FEDER) [Pest (C/MAR/LA0017/2013)]; Xunta de Galicia [GR2013-001]; European Regional Development Fund (FEDER) [EM2013/003]; Galician Internal Basin Paleoclimatic Sedimentary Archives: Transport, Provenances, Hydrology and reliability [GALINCLIMARCH - CGL2010-16688/BTE]; Fundação para a Ciência e a Tecnologia [Incentivo/MAR/LA0017/2013] Funding Source: FCT	Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Ramon y Cajal program(Spanish Government); Ciencia program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union (COMPETE); European Union (QREN); European Union (FEDER)(European Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Regional Development Fund (FEDER)(European Commission); Galician Internal Basin Paleoclimatic Sedimentary Archives: Transport, Provenances, Hydrology and reliability; Fundação para a Ciência e a Tecnologia	RM has been supported by the Portuguese Science Foundation (FCT) through a doctoral grant (SFRH/BD/79555/2011). IA and NV are supported by the Ramon y Cajal and Ciencia 2008 programs, respectively. This work has been supported by FCT and by the European Union (COMPETE, QREN, FEDER) in the frame of the research project Pest (C/MAR/LA0017/2013) and partially supported by Xunta de Galicia under projects "Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas: Grupos de Referencia Competitiva" (GR2013-001) co-funded by European Regional Development Fund (FEDER), EM2013/003, and "Galician Internal Basin Paleoclimatic Sedimentary Archives: Transport, Provenances, Hydrology and reliability (GALINCLIMARCH - CGL2010-16688/BTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez F, 2010, J EXP MAR BIOL ECOL, V382, P96, DOI 10.1016/j.jembe.2009.11.008; Alvarez I, 2006, J MARINE SYST, V60, P144, DOI 10.1016/j.jmarsys.2005.12.005; Alvarez I, 2005, J GEOPHYS RES-OCEANS, V110; Antonov J. I., 2010, WORLD OCEAN ATLAS 20, V2; Banas NS, 2004, J PHYS OCEANOGR, V34, P2413, DOI 10.1175/JPO2637.1; Chapra SC, 1997, SURFACE WATER QUALIT; Choi BJ, 2007, J PHYS OCEANOGR, V37, P1878, DOI 10.1175/JPO3081.1; Das A, 2012, ESTUAR COAST SHELF S, V111, P17, DOI 10.1016/j.ecss.2012.06.005; deCastro M, 2004, ESTUAR COAST SHELF S, V60, P301, DOI 10.1016/j.ecss.2004.01.006; deCastro M, 2006, ESTUAR COAST SHELF S, V70, P52, DOI 10.1016/j.ecss.2006.05.035; Garcia-Berdeal I, 2002, J GEOPHYS RES-OCEANS, V107; Genio L, 2008, J SEA RES, V59, P133, DOI 10.1016/j.seares.2007.09.001; Hickey BM, 2002, J GEOPHYS RES-OCEANS, V107; Jurisa JT, 2012, OCEAN DYNAM, V62, P771, DOI 10.1007/s10236-012-0527-7; Lee J, 2012, CONT SHELF RES, V41, P77, DOI 10.1016/j.csr.2012.04.006; Locarnini R. A., 2010, WORLD OCEAN ATLAS 20, V1; Lyard F, 2006, OCEAN DYNAM, V56, P394, DOI 10.1007/s10236-006-0086-x; Marques WC, 2009, CONT SHELF RES, V29, P556, DOI 10.1016/j.csr.2008.09.022; Monteiro PMS, 1999, ESTUAR COAST SHELF S, V49, P877, DOI 10.1006/ecss.1999.0550; MOURINO C, 1982, INVEST PESQ, V46, P459; NONN H, 1966, THESIS U STRASBOURG; PREGO R, 1992, ESTUAR COAST SHELF S, V34, P603, DOI 10.1016/S0272-7714(05)80065-4; Prego R, 2001, J GEOPHYS RES-OCEANS, V106, P19845, DOI 10.1029/2000JC000775; Rio-Barja FX, 1996, RIOS AUGAS GALICIA; RIOS AF, 1992, DEEP-SEA RES, V39, P645, DOI 10.1016/0198-0149(92)90093-9; Sordo I, 2001, ESTUAR COAST SHELF S, V53, P787, DOI 10.1006/ecss.2000.0788; Sousa MC, 2014, CONT SHELF RES, V85, P30, DOI 10.1016/j.csr.2014.06.004; Sousa MC, 2013, J COASTAL RES, P2059, DOI 10.2112/SI65-348.1; TENORE KR, 1995, J GEOPHYS RES-OCEANS, V100, P10943, DOI 10.1029/95JC00529; Valentim JM, 2013, ESTUAR COAST SHELF S, V130, P138, DOI 10.1016/j.ecss.2013.04.005; Varela RA, 2005, J MARINE SYST, V54, P97, DOI 10.1016/j.jmarsys.2004.07.006; Vaz N, 2014, J MARINE SYSTEMS, DOI [10.1016/j.jmarsys.2014.1005.1022, DOI 10.1016/J.JMARSYS.2014.1005.1022]; Warrick JA, 2011, CONT SHELF RES, V31, P85, DOI 10.1016/j.csr.2010.11.007; WONG KC, 1994, J GEOPHYS RES-OCEANS, V99, P12683, DOI 10.1029/94JC00569; WOOSTER WS, 1976, J MAR RES, V34, P131	35	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112587	10.1371/journal.pone.0112587	http://dx.doi.org/10.1371/journal.pone.0112587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402444	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700055
J	Taoka, M; Ishikawa, D; Nobe, Y; Ishikawa, H; Yamauchi, Y; Terukina, G; Nakayama, H; Hirota, K; Takahashi, N; Isobe, T				Taoka, Masato; Ishikawa, Daisuke; Nobe, Yuko; Ishikawa, Hideaki; Yamauchi, Yoshio; Terukina, Goro; Nakayama, Hiroshi; Hirota, Kouji; Takahashi, Nobuhiro; Isobe, Toshiaki			RNA Cytidine Acetyltransferase of Small-Subunit Ribosomal RNA: Identification of Acetylation Sites and the Responsible Acetyltransferase in Fission Yeast, Schizosaccharomyces pombe	PLOS ONE			English	Article							NUCLEOLAR PROTEIN; GENE; CLONING; NAT10; SEQUENCE; DATABASE	The eukaryotic small-subunit (SSU) ribosomal RNA (rRNA) has two evolutionarily conserved acetylcytidines. However, the acetylation sites and the acetyltransferase responsible for the acetylation have not been identified. We performed a comprehensive MS-based analysis covering the entire sequence of the fission yeast, Schizosaccharomyces pombe, SSU rRNA and identified two acetylcytidines at positions 1297 and 1815 in the 3' half of the rRNA. To identify the enzyme responsible for the cytidine acetylation, we searched for an S. pombe gene homologous to TmcA, a bacterial tRNA N-acetyltransferase, and found one potential candidate, Nat10. A temperature-sensitive strain of Nat10 with a mutation in the Walker A type ATP-binding motif abolished the cytidine acetylation in SSU rRNA, and the wild-type Nat10 supplemented to this strain recovered the acetylation, providing evidence that Nat10 is necessary for acetylation of SSU rRNA. The Nat10 mutant strain showed a slow-growth phenotype and was defective in forming the SSU rRNA from the precursor RNA, suggesting that cytidine acetylation is necessary for ribosome assembly.	[Taoka, Masato; Ishikawa, Daisuke; Nobe, Yuko; Yamauchi, Yoshio; Terukina, Goro; Hirota, Kouji; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Tokyo 158, Japan; [Taoka, Masato; Nobe, Yuko; Ishikawa, Hideaki; Yamauchi, Yoshio; Terukina, Goro; Nakayama, Hiroshi; Takahashi, Nobuhiro; Isobe, Toshiaki] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Ishikawa, Hideaki; Takahashi, Nobuhiro] Tokyo Univ Agr & Technol, United Grad Sch Agr, Dept Biotechnol, Tokyo, Japan; [Nakayama, Hiroshi] RIKEN Adv Sci Inst, Biomol Characterizat Team, Saitama, Japan	Tokyo Metropolitan University; Japan Science & Technology Agency (JST); Tokyo University of Agriculture & Technology; RIKEN	Taoka, M (corresponding author), Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Tokyo 158, Japan.	mango@tmu.ac.jp; isobe-toshiaki@tmu.ac.jp	Ishikawa, Hideaki/J-2217-2016; Isobe, Toshiaki/Q-9279-2017; TAKAHASHI, Nobuhiro/G-1129-2013	Ishikawa, Hideaki/0000-0002-2989-8411; Taoka, Masato/0000-0001-5554-4951	Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency	Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency	This work was supported by Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BRUENGER E, 1993, FASEB J, V7, P196, DOI 10.1096/fasebj.7.1.8422966; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chimnaronk S, 2009, EMBO J, V28, P1362, DOI 10.1038/emboj.2009.69; Duveau F, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001230; ELDER RT, 1983, P NATL ACAD SCI-BIOL, V80, P2432, DOI 10.1073/pnas.80.9.2432; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; Gutz H, 1974, SCHIZOSACCHAROMYCES; Hirota K, 2001, GENES CELLS, V6, P201, DOI 10.1046/j.1365-2443.2001.00415.x; Ikeuchi Y, 2008, EMBO J, V27, P2194, DOI 10.1038/emboj.2008.154; Ito S, 2014, J BIOL CHEM, V289, P26201, DOI 10.1074/jbc.M114.593996; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Kalis AK, 2010, GENETICS, V185, P523, DOI 10.1534/genetics.110.116038; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Konstantinidis TC, 2006, BIOCHEMISTRY-US, V45, P3525, DOI 10.1021/bi052505d; Larrieu D, 2014, SCIENCE, V344, P527, DOI 10.1126/science.1252651; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Liu HJ, 2007, MOL CELL BIOCHEM, V300, P249, DOI 10.1007/s11010-006-9390-5; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MCCARROLL R, 1983, BIOCHEMISTRY-US, V22, P5858, DOI 10.1021/bi00294a027; NAKAI C, 1994, FEBS LETT, V339, P67, DOI 10.1016/0014-5793(94)80386-2; Nakayama H, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp099; Noon KR, 1998, J BACTERIOL, V180, P2883, DOI 10.1128/JB.180.11.2883-2888.1998; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; Sambrook J., 2001, MOL CLONING LAB MANU; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Sherman F., 1986, METHODS YEAST GENETI; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Swaminathan S, 2006, MOL BIOL CELL, V17, P1472, DOI 10.1091/mbc.e05-07-0632; Taoka M, 2010, ANAL CHEM, V82, P7795, DOI 10.1021/ac101623j; Taoka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp732; THOMAS G, 1978, J BIOL CHEM, V253, P1101; Voigts-Hoffmann F, 2012, CURR OPIN STRUC BIOL, V22, P768, DOI 10.1016/j.sbi.2012.07.010; Wilson DN, 2012, COLD SPRING HARB PER, V4; Yamauchi Y, 2013, J CHROMATOGR A, V1312, P87, DOI 10.1016/j.chroma.2013.09.021; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445	40	15	17	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112156	10.1371/journal.pone.0112156	http://dx.doi.org/10.1371/journal.pone.0112156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402480	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700031
J	Loghmanpour, NA; Druzdzel, MJ; Antaki, JF				Loghmanpour, Natasha A.; Druzdzel, Marek J.; Antaki, James F.			Cardiac Health Risk Stratification System (CHRiSS): A Bayesian-Based Decision Support System for Left Ventricular Assist Device (LVAD) Therapy	PLOS ONE			English	Article							DESTINATION THERAPY; PATIENT SELECTION; MODEL; NETWORK; PROGNOSIS; SURVIVAL; FAILURE; CANCER; SCORE; TREE	This study investigated the use of Bayesian Networks (BNs) for left ventricular assist device (LVAD) therapy; a treatment for end-stage heart failure that has been steadily growing in popularity over the past decade. Despite this growth, the number of LVAD implants performed annually remains a small fraction of the estimated population of patients who might benefit from this treatment. We believe that this demonstrates a need for an accurate stratification tool that can help identify LVAD candidates at the most appropriate point in the course of their disease. We derived BNs to predict mortality at five endpoints utilizing the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database: containing over 12,000 total enrolled patients from 153 hospital sites, collected since 2006 to the present day, and consisting of approximately 230 pre-implant clinical variables. Synthetic minority oversampling technique (SMOTE) was employed to address the uneven proportion of patients with negative outcomes and to improve the performance of the models. The resulting accuracy and area under the ROC curve (%) for predicted mortality were 30 day: 94.9 and 92.5; 90 day: 84.2 and 73.9; 6 month: 78.2 and 70.6; 1 year: 73.1 and 70.6; and 2 years: 71.4 and 70.8. To foster the translation of these models to clinical practice, they have been incorporated into a web-based application, the Cardiac Health Risk Stratification System (CHRiSS). As clinical experience with LVAD therapy continues to grow, and additional data is collected, we aim to continually update these BN models to improve their accuracy and maintain their relevance. Ongoing work also aims to extend the BN models to predict the risk of adverse events post-LVAD implant as additional factors for consideration in decision making.	[Loghmanpour, Natasha A.; Antaki, James F.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Druzdzel, Marek J.] Univ Pittsburgh, Sch Informat Sci, Decis Syst Lab, Pittsburgh, PA USA; [Druzdzel, Marek J.] Bialystok Tech Univ, Fac Comp Sci, Bialystok, Poland	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Bialystok University of Technology	Antaki, JF (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	antaki@cmu.edu	Druzdzel, Marek J/AAR-9653-2020; Antaki, James/S-3051-2016; Antaki, James Francis/AAC-5331-2020	Druzdzel, Marek J/0000-0002-7598-2286; Antaki, James/0000-0002-5430-7353; Antaki, James Francis/0000-0002-5430-7353	National Institutes of Health grants [1R41 HL120428-01, 1R01HL086918, U01HL101066-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL120428, R01HL086918, U01HL101066] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by the 1R41 HL120428-01, 1R01HL086918, and U01HL101066-01 National Institutes of Health grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin RM, 2010, ARCH PATHOL LAB MED, V134, P744, DOI 10.1043/1543-2165-134.5.744; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Brahnam S, 2011, INTELLIGENT DECISION; Cao CG, 1998, INT J MED INFORM, V51, P13, DOI 10.1016/S1386-5056(98)00085-9; Charitos T, 2009, EXPERT SYST APPL, V36, P1249, DOI 10.1016/j.eswa.2007.11.065; Chawla N. V., 2011, ARXIV11061813; Cooper Gregory F., 1991, UNCERTAINTY ARTIFICI, V1991, P86, DOI DOI 10.1016/B978-1-55860-203-8.50015-2; Cowger J, 2013, J AM COLL CARDIOL, V61, P313, DOI 10.1016/j.jacc.2012.09.055; Diez FJ, 1997, ARTIF INTELL MED, V10, P59, DOI 10.1016/S0933-3657(97)00384-9; Druzdzel MJ, 1999, J AM MED INFORM ASSN, P1206; Eom JH, 2008, EXPERT SYST APPL, V34, P2465, DOI 10.1016/j.eswa.2007.04.015; Faller H, 2005, PSYCHOTHER PSYCH MED, V55, P200, DOI 10.1055/s-2004-834597; FDA, 2010, OUTL KEY DIFF MED DE; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Heckerman D, 1998, TUTORIAL LEARNING BA; Hoot Nathan, 2005, AMIA Annu Symp Proc, P345; Ibrahim J. G., 2005, BAYESIAN SURVIVAL AN; Kanwar M, 2013, J AM COLL CARDIOLOGY, V61; Koller D., 1996, OPTIMAL FEATURE SELE; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972; Lietz K, 2008, SEMIN THORAC CARDIOV, V20, P225, DOI 10.1053/j.semtcvs.2008.08.004; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Loghmanpour NA, 2013, J HEART LUNG TRANSPL, V32, pS232, DOI 10.1016/j.healun.2013.01.593; Lucas P, 2001, P EUNITE WORKSH INT, P73; Miller LW, 2011, CIRCULATION, V123, P1552, DOI 10.1161/CIRCULATIONAHA.110.958991; Musen M.A., 2014, BIOMEDICAL INFORM, P643, DOI [10.1007/978-1-4471-4474-8_22, DOI 10.1007/978-1-4471-4474-8_22, DOI 10.1007/978-1-4471-4474-822]; Onioeko ADM, 2014, 13 INT C ART INT SOF; Onisko A, 2002, ADV SOFT COMP, V17, P351; Onisko A, 2013, ARTIF INTELL MED, V57, P197, DOI 10.1016/j.artmed.2013.01.004; Parameters NH, 2009, LABORATORY VALUES; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Peura JL, 2012, CIRCULATION, V126, P2648, DOI 10.1161/CIR.0b013e3182769a54; Rose EA, 1999, ANN THORAC SURG, V67, P723, DOI 10.1016/S0003-4975(99)00042-9; Sadeghi S, 2006, INT J MED INFORM, V75, P403, DOI 10.1016/j.ijmedinf.2005.07.028; Santelices LC, 2010, ANN THORAC SURG, V90, P713, DOI 10.1016/j.athoracsur.2010.03.073; Stewart GC, 2011, CIRCULATION, V123, P1559, DOI 10.1161/CIRCULATIONAHA.110.982512; Teuteberg JJ, 2012, J AM COLL CARDIOL, V60, P44, DOI 10.1016/j.jacc.2012.02.032; Wang Y, 2010, MACH LEARN APPL ICML, P293; Wang YJ, 2012, IEEE T INF TECHNOL B, V16, P383, DOI 10.1109/TITB.2012.2187458; Wang YJ, 2012, J HEART LUNG TRANSPL, V31, P140, DOI 10.1016/j.healun.2011.11.003; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Witten I. H., 2005, DATA MINING PRACTICA	43	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111264	10.1371/journal.pone.0111264	http://dx.doi.org/10.1371/journal.pone.0111264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397576	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500014
J	Virel, A; Faergemann, E; Oradd, G; Stromberg, I				Virel, Ana; Faergemann, Erik; Oradd, Greger; Stromberg, Ingrid			Magnetic Resonance Imaging (MRI) to Study Striatal Iron Accumulation in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							BRAIN IRON; IN-VIVO; NEURODEGENERATIVE DISORDERS; SUBSTANTIA-NIGRA; 6-HYDROXYDOPAMINE; METABOLISM; FERRITIN; LESIONS; IMMUNOHISTOCHEMISTRY; DEGENERATION	Abnormal accumulation of iron is observed in neurodegenerative disorders. In Parkinson's disease, an excess of iron has been demonstrated in different structures of the basal ganglia and is suggested to be involved in the pathogenesis of the disease. Using the 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease, the edematous effect of 6-OHDA and its relation with striatal iron accumulation was examined utilizing in vivo magnetic resonance imaging (MRI). The results revealed that in comparison with control animals, injection of 6-OHDA into the rat striatum provoked an edematous process, visible in T2-weighted images that was accompanied by an accumulation of iron clearly detectable in T2*-weighted images. Furthermore, Prussian blue staining to detect iron in sectioned brains confirmed the existence of accumulated iron in the areas of T2* hypointensities. The presence of ED1-positive microglia in the lesioned striatum overlapped with this accumulation of iron, indicating areas of toxicity and loss of dopamine nerve fibers. Correlation analyses demonstrated a direct relation between the hyperintensities caused by the edema and the hypointensities caused by the accumulation of iron.	[Virel, Ana; Faergemann, Erik; Stromberg, Ingrid] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Oradd, Greger] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Umea University	Virel, A (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	ana.virel@umu.se			Swedish brain foundation (Hjarnfonden); Swedish Research Council [09917]; Lars Hiertas Minne foundation; Ahlen foundation; Umea University Medical Faculty Foundations	Swedish brain foundation (Hjarnfonden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lars Hiertas Minne foundation; Ahlen foundation; Umea University Medical Faculty Foundations	This work was supported by grants from the Swedish brain foundation (Hjarnfonden), Swedish Research Council grant number 09917, Lars Hiertas Minne, Ahlen foundations, and Umea University Medical Faculty Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LJ, 2011, PROG CARDIOVASC DIS, V54, P287, DOI 10.1016/j.pcad.2011.07.004; Batista-Nascimento L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/128647; Berg D, 2006, MOVEMENT DISORD, V21, P1299, DOI 10.1002/mds.21020; Brass Steven D, 2006, Top Magn Reson Imaging, V17, P31, DOI 10.1097/01.rmr.0000245459.82782.e4; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Carvey PM, 2005, EUR J NEUROSCI, V22, P1158, DOI 10.1111/j.1460-9568.2005.04281.x; Cozzi A, 2010, NEUROBIOL DIS, V37, P77, DOI 10.1016/j.nbd.2009.09.009; Dexter DT, 2011, J NEURAL TRANSM, V118, P223, DOI 10.1007/s00702-010-0531-3; Dhawan JK, 1998, BRAIN RES BULL, V45, P333, DOI 10.1016/S0361-9230(97)00404-8; Double KL, 1998, J NEUROCHEM, V70, P2492; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HALL S, 1992, J NEUROL SCI, V113, P198, DOI 10.1016/0022-510X(92)90247-I; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hare D, 2009, METALLOMICS, V1, P53, DOI 10.1039/b816188g; Hare DJ, 2014, CHEM SCI, V5, P2160, DOI 10.1039/c3sc53461h; He Y, 1999, FREE RADICAL RES, V31, P103, DOI 10.1080/10715769900301611; HILL JM, 1985, P NATL ACAD SCI USA, V82, P4553, DOI 10.1073/pnas.82.13.4553; JELLINGER K, 1990, J NEURAL TRANSM-PARK, V2, P327, DOI 10.1007/BF02252926; Jiang H, 2010, CELL RES, V20, P345, DOI 10.1038/cr.2010.20; Ke Y, 2003, LANCET NEUROL, V2, P246, DOI 10.1016/S1474-4422(03)00353-3; Kondoh T, 2005, EXP NEUROL, V192, P194, DOI 10.1016/j.expneurol.2004.12.016; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Kwan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035241; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Li WJ, 2011, NEUROTOX RES, V19, P435, DOI 10.1007/s12640-010-9187-x; Lv ZY, 2011, J NEURAL TRANSM, V118, P361, DOI 10.1007/s00702-010-0434-3; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Mounsey Ross B, 2012, Int J Cell Biol, V2012, P983245, DOI 10.1155/2012/983245; Nunez MT, 2012, BIOMETALS, V25, P761, DOI 10.1007/s10534-012-9523-0; Ohta E, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/197438; Ortega R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000925; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Rossi M, 2013, CLIN IMAG, V37, P631, DOI 10.1016/j.clinimag.2013.02.001; Rouault TA, 2001, PEDIATR NEUROL, V25, P130, DOI 10.1016/S0887-8994(01)00260-0; SACHS C, 1975, BIOCHEM PHARMACOL, V24, P1, DOI 10.1016/0006-2952(75)90304-4; Sadrzadeh S M Hossein, 2004, Am J Clin Pathol, V121 Suppl, pS64; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; Schenck JF, 2003, J NEUROL SCI, V207, P99, DOI 10.1016/S0022-510X(02)00431-8; Schipper HM, 2012, BBA-MOL BASIS DIS, V1822, P350, DOI 10.1016/j.bbadis.2011.06.016; SCHMIDTKASTNER R, 1993, J NEUROSCI METH, V46, P121, DOI 10.1016/0165-0270(93)90147-J; Soria G, 2011, EUR J NEUROSCI, V33, P1551, DOI 10.1111/j.1460-9568.2011.07639.x; Stankiewicz J, 2007, NEUROTHERAPEUTICS, V4, P371, DOI 10.1016/j.nurt.2007.05.006; STROMBERG I, 1986, BRAIN RES BULL, V17, P225, DOI 10.1016/0361-9230(86)90119-X; Tarohda T, 2005, ANAL BIOANAL CHEM, V383, P224, DOI 10.1007/s00216-005-3423-x; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Van Camp N, 2010, MAGN RESON MATER PHY, V23, P65, DOI 10.1007/s10334-010-0198-7; Wachter B, 2012, BEHAV BRAIN RES, V232, P148, DOI 10.1016/j.bbr.2012.04.005; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Wang J, 2004, NEUROCHEM RES, V29, P2239, DOI 10.1007/s11064-004-7031-5; Wood JC, 2011, HEMATOL-AM SOC HEMAT, P443, DOI 10.1182/asheducation-2011.1.443; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036	53	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112941	10.1371/journal.pone.0112941	http://dx.doi.org/10.1371/journal.pone.0112941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398088	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500115
J	Martin, L; Gardner, LB				Martin, L.; Gardner, L. B.			Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; PROMOTES TUMOR-GROWTH; GENE-EXPRESSION; OXIDATIVE STRESS; CELL-SURVIVAL; CANCER-CELLS; IN-VIVO; METABOLISM; AUTOPHAGY	SLC7A11 encodes a subunit of the xCT cystine/glutamate amino-acid transport system and has a critical role in the generation of glutathione and the protection of cells from oxidative stress. Expression of SLC7A11 promotes tumorigenesis and chemotherapy resistance, but while SLC7A11 has been previously noted to be upregulated in hypoxic cells, its regulation has not been fully delineated. We have recently shown that nonsense-mediated RNA decay (NMD) is inhibited by cellular stresses generated by the tumor microenvironment, including hypoxia, and augments tumorigenesis. Here we demonstrate that the inhibition of NMD by various cellular stresses leads to the stabilization and upregulation of SLC7A11 mRNA and protein. The inhibition of NMD and upregulation of SLC7A11 augments intracellular cystine transport and increases intracellular levels of cysteine and glutathione. Accordingly, the inhibition of NMD protects cells against oxidative stress via SLC7A11 upregulation. Together our studies identify a mechanism for the dynamic regulation of SLC7A11, through the stress-inhibited regulation of NMD, and add to the growing evidence that the inhibition of NMD is an adaptive response.	[Martin, L.; Gardner, L. B.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Gardner, L. B.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Gardner, L. B.] NYU, Sch Med, NYU Perlmutter Canc Ctr, New York, NY 10016 USA	New York University; New York University; New York University	Gardner, LB (corresponding author), NYU, Sch Med, Div Hematol & Med Oncol, 550 First Ave,Smilow 1204, New York, NY 10016 USA.	Lawrence.gardner@nyumc.org		Gardner, Lawrence/0000-0003-0191-0172	NYU Cancer Institute;  [RO1DK081641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081641] Funding Source: NIH RePORTER	NYU Cancer Institute; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by RO1DK081641 (to LBG), a generous gift from Mr Arthur Levine and Ms Diane Lederman and the NYU Cancer Institute. LBG was the Saul Farber Associate Professor of Medicine.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; BANNAI S, 1986, J BIOL CHEM, V261, P2256; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chen RS, 2009, ONCOGENE, V28, P599, DOI 10.1038/onc.2008.414; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Fernandez PC, 1999, BIOL CHEM, V380, P1383, DOI 10.1515/BC.1999.178; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gardner LB, 2008, CELL CYCLE, V7, P1916, DOI 10.4161/cc.7.13.6203; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Huang CC, 2010, BIOCHEM J, V429, P215, DOI 10.1042/BJ20100286; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; JANSSEN YMW, 1993, LAB INVEST, V69, P261; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Martin L, 2010, J BIOL CHEM, V285, P31944, DOI 10.1074/jbc.M110.153148; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Ogunrinu TA, 2010, J BIOL CHEM, V285, P37716, DOI 10.1074/jbc.M110.161190; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Tomi M, 2002, INVEST OPHTH VIS SCI, V43, P774; Wang D, 2011, J BIOL CHEM, V286, P40038, DOI 10.1074/jbc.M111.266361; Wang D, 2011, MOL CELL BIOL, V31, P3670, DOI 10.1128/MCB.05704-11; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wengrod J, 2013, MOL CELL BIOL, V33, P2128, DOI 10.1128/MCB.00174-13; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	42	35	39	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4211	4218		10.1038/onc.2014.352	http://dx.doi.org/10.1038/onc.2014.352			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	25399695	Green Accepted			2022-12-26	WOS:000359199800007
J	Chernoivanenko, IS; Matveeva, EA; Gelfand, VI; Goldman, RD; Minin, AA				Chernoivanenko, Ivan S.; Matveeva, Elena A.; Gelfand, Vladimir I.; Goldman, Robert D.; Minin, Alexander A.			Mitochondrial membrane potential is regulated by vimentin intermediate filaments	FASEB JOURNAL			English	Article						cytoskeleton; mitochondrial respiratory chain; rho 0 cells	DEPENDENT ANION CHANNEL; AXONAL-TRANSPORT; DESMIN CYTOSKELETON; BRAIN MITOCHONDRIA; IN-SITU; CELLS; DYSFUNCTION; DISEASE; PROTEINS; FIBROBLASTS	This study demonstrates that the association of mitochondria with vimentin intermediate filaments (VIFs) measurably increases their membrane potential. This increase is detected by quantitatively comparing the fluorescence intensity of mitochondria stained with the membrane potential-sensitive dye tetramethylrhodamine-ethyl ester (TMRE) in murine vimentin-null fibroblasts with that in the same cells expressing human vimentin (similar to 35% rise). When vimentin expression is silenced by small hairpin RNA(shRNA) to reduce vimentin by 90%, the fluorescence intensity of mitochondria decreases by 20%. The increase in membrane potential is caused by specific interactions between a subdomain of the non-alpha-helical N terminus (residues 40 to 93) of vimentin and mitochondria. In rho 0 cells lacking mitochondrial DNA (mtDNA) and consequently missing several key proteins in the mitochondrial respiratory chain (rho(0) cells), the membrane potential generated by an alternative anaerobic process is insensitive to the interactions between mitochondria and VIF. The results of our studies show that the close association between mitochondria and VIF is important both for determining their position in cells and their physiologic activity.	[Chernoivanenko, Ivan S.; Matveeva, Elena A.; Minin, Alexander A.] Russian Acad Sci, Inst Prot Res, Cell Biol Grp, Moscow 119988, Russia; [Gelfand, Vladimir I.; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Russian Academy of Sciences; Northwestern University; Feinberg School of Medicine	Minin, AA (corresponding author), Russian Acad Sci, Inst Prot Res, Cell Biol Grp, Str Vavilova 34,Room 113, Moscow 119988, Russia.	alexminin@gmail.com	Zerkalenkova, Elena/U-2515-2018; Gelfand, Vladimir I/D-2545-2013; Gelfand, Vladimir/M-1974-2019; Minin, Alexander/K-5340-2015	Zerkalenkova, Elena/0000-0001-9634-5828; Gelfand, Vladimir I/0000-0002-6361-2798; Gelfand, Vladimir/0000-0002-6361-2798; 	Russian Foundation for Basic Research [06-04-48452-a, 10-04-00414-a, 13-04-00931-a]; U.S. National Institutes of Health [P01-GM096971]; Russian Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM096971] Funding Source: NIH RePORTER	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Academy of Sciences(Russian Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Dr. R. Evans for the cell lines, Natalia Minina for excellent technical assistance, and Dr. P. Chumakov for several useful advices. This work was funded by the Russian Academy of Sciences and Russian Foundation for Basic Research (Grants 06-04-48452-a, 10-04-00414-a, and 13-04-00931-a; to A.A.M.); and the U.S. National Institutes of Health (Grant P01-GM096971; to V.I.G. and R.D.G.).	Allen R, 2002, FEBS LETT, V514, P347, DOI 10.1016/S0014-5793(02)02433-X; Avsyuk AY, 1997, DOKL AKAD NAUK+, V357, P130; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brownlees J, 2002, HUM MOL GENET, V11, P2837, DOI 10.1093/hmg/11.23.2837; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chernoivanenko I. S., 2010, MEMBR CELL BIOL B SA, V5, P21; DeFlora S, 1997, MUTAGENESIS, V12, P431, DOI 10.1093/mutage/12.6.431; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Holwell TA, 1997, J CELL SCI, V110, P1947; Jarrett SG, 2010, OPHTHALMIC RES, V44, P179, DOI 10.1159/000316480; Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kumemura H, 2008, BIOCHEM BIOPH RES CO, V367, P33, DOI 10.1016/j.bbrc.2007.12.116; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETERRIER JF, 1994, MICROSC RES TECHNIQ, V27, P233, DOI 10.1002/jemt.1070270305; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Minin AA, 2006, J CELL SCI, V119, P659, DOI 10.1242/jcs.02762; Monge C, 2008, MOL CELL BIOCHEM, V318, P147, DOI 10.1007/s11010-008-9865-7; Nekrasova OE, 2011, MOL BIOL CELL, V22, P2282, DOI 10.1091/mbc.E10-09-0766; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Perez-Olle R, 2005, J NEUROCHEM, V93, P861, DOI 10.1111/j.1471-4159.2005.03095.x; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Rocha M, 2010, CURR MED CHEM, V17, P3827, DOI 10.2174/092986710793205444; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Sorokin PA, 2011, ACTA ICHTHYOL PISCAT, V41, P95, DOI 10.3750/AIP2011.41.2.04; Tolstonog GV, 2001, DNA CELL BIOL, V20, P509, DOI 10.1089/104454901317094945; Uttam J, 1996, P NATL ACAD SCI USA, V93, P9079, DOI 10.1073/pnas.93.17.9079; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147	47	56	57	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					820	827		10.1096/fj.14-259903	http://dx.doi.org/10.1096/fj.14-259903			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25404709	Green Published			2022-12-26	WOS:000350633000009
J	Crowe, AM; Stogios, PJ; Casabon, I; Evdokimova, E; Savchenko, A; Eltis, LD				Crowe, Adam M.; Stogios, Peter J.; Casabon, Israel; Evdokimova, Elena; Savchenko, Alexei; Eltis, Lindsay D.			Structural and Functional Characterization of a Ketosteroid Transcriptional Regulator of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETR FAMILY; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; SIDE-CHAIN; DEGRADATION; CATABOLISM; REPRESSOR; BINDING; CONSERVATION; SMEGMATIS; PROTEINS	Catabolism of host cholesterol is critical to the virulence of Mycobacterium tuberculosis and is a potential target for novel therapeutics. KstR2, a TetR family repressor (TFR), regulates the expression of 15 genes encoding enzymes that catabolize the last half of the cholesterol molecule, represented by 3a alpha-H-4 alpha(3'-propanoate)-7a beta -methylhexahydro-1,5-indane-dione (HIP). Binding of KstR2 to its operator sequences is relieved upon binding of HIP-CoA. A 1.6-angstrom resolution crystal structure of the KstR2(Mtb)center dot HIP-CoA complex reveals that the KstR2(Mtb) dimer accommodates two molecules of HIP-CoA. Each ligand binds in an elongated cleft spanning the dimerization interface such that the HIP and CoA moieties interact with different KstR2(Mtb) protomers. In isothermal titration calorimetry studies, the dimer bound 2 eq of HIP-CoA with high affinity (K-d = 80 +/- 10 n(M)) but bound neither HIP nor CoASH. Substitution of Arg-162 or Trp-166, residues that interact, respectively, with the diphosphate and HIP moieties of HIP-CoA, dramatically decreased the affinity of KstR2(Mtb) for HIP-CoA but not for its operator sequence. The variant of R162M that decreased the affinity for HIP-CoA (Delta Delta G = 13 kJ mol(-1)) is consistent with the loss of three hydrogen bonds as indicated in the structural data. A 24-bp operator sequence bound two dimers of KstR2. Structural comparisons with a ligand-free rhodococcal homologue and a DNA-bound homologue suggest that HIP-CoA induces conformational changes of the DNA-binding domains of the dimer that preclude their proper positioning in the major groove of DNA. The results provide insight into KstR2-mediated regulation of expression of steroid catabolic genes and the determinants of ligand binding in TFRs.	[Crowe, Adam M.; Eltis, Lindsay D.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Casabon, Israel; Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Stogios, Peter J.; Evdokimova, Elena; Savchenko, Alexei] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Evdokimova, Elena; Savchenko, Alexei] Argonne Natl Lab, MCSG, Argonne, IL 60439 USA	University of British Columbia; University of British Columbia; University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory	Savchenko, A (corresponding author), Univ Toronto, 200 Coll St,Rm 420B, Toronto, ON M5S 3E5, Canada.	alexei.savchenko@utoronto.ca; leltis@mail.ubc.ca	Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158; Stogios, Peter/0000-0001-8663-1425; Crowe, Adam/0000-0002-5487-2520	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Hiroshi Otani is thanked for critical comments. Members of the Structural Biology Center at Argonne National Laboratory assisted with conducting data collection and structure determination experiments. Veronica Yim provided technical assistance. The structure of KstR2<INF>Mtb</INF> was determined by the Midwest Centre for Structural Genomics as target APC111849. Argonne National Laboratory is operated by University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Agari Y, 2011, MICROBIOL-SGM, V157, P1589, DOI 10.1099/mic.0.048017-0; Anand S, 2012, FEBS J, V279, P3214, DOI 10.1111/j.1742-4658.2012.08707.x; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Barrientos A, 2015, ENVIRON MICROBIOL, V17, P47, DOI 10.1111/1462-2920.12395; Bhukya H, 2014, NUCLEIC ACIDS RES, V42, P10122, DOI 10.1093/nar/gku587; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; Capyk JK, 2011, J BIOL CHEM, V286, P40717, DOI 10.1074/jbc.M111.289975; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Casabon I, 2014, J BACTERIOL, V196, P579, DOI 10.1128/JB.01012-13; Casabon I, 2013, MOL MICROBIOL, V89, P1201, DOI 10.1111/mmi.12340; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujihashi M, 2014, PROTEINS, V82, P1301, DOI 10.1002/prot.24496; Garcia-Fernandez E, 2014, J BIOL CHEM, V289, P17576, DOI 10.1074/jbc.M113.545715; HILLEN W, 1982, J BIOL CHEM, V257, P6605; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horinouchi M, 2012, J STEROID BIOCHEM, V129, P4, DOI 10.1016/j.jsbmb.2010.10.008; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEE SS, 1967, BIOCHEMISTRY-US, V6, P1395, DOI 10.1021/bi00857a023; Luengo JM, 2001, MOL MICROBIOL, V39, P1434, DOI 10.1046/j.1365-2958.2001.02344.x; Mehrotra P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004265; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mohn WW, 2012, J BACTERIOL, V194, P6712, DOI 10.1128/JB.01169-12; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Sambrook J., 2001, MOL CLONING LAB MANU; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Tonthat NK, 2013, P NATL ACAD SCI USA, V110, P10586, DOI 10.1073/pnas.1221036110; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang SF, 2013, J BIOL CHEM, V288, P23687, DOI 10.1074/jbc.M113.468694; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062	46	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					872	882		10.1074/jbc.M114.607481	http://dx.doi.org/10.1074/jbc.M114.607481			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406313	hybrid, Green Published			2022-12-26	WOS:000347778200017
J	Dureja, C; Mahajan, S; Raychaudhuri, S				Dureja, Chetna; Mahajan, Sakshi; Raychaudhuri, Saumya			Phylogenetic Distribution and Prevalence of Genes Encoding Class I Integrons and CTX-M-15 Extended-Spectrum beta-Lactamases in Escherichia coli Isolates from Healthy Humans in Chandigarh, India	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE GENES; ANTIBIOTIC-RESISTANCE; FLUOROQUINOLONE RESISTANCE; RISK-FACTORS; COMMENSAL; ENTEROBACTERIACEAE; KLEBSIELLA; STRAINS; DISSEMINATION; ASSOCIATION	Escherichia coli is generally considered as a commensal inhabitant of gastrointestinal tract of humans and animals. The aim of this study was to gain insight on the distribution of phylotypes and presence of genes encoding integrons, extended beta-lactamases and resistance to other antimicrobials in the commensal E. coli isolates from healthy adults in Chandigarh, India. PCR and DNA sequencing were used for phylogenetic classification, detections of integrase genes, gene cassettes within the integron and extended beta-lactamases. The genetic structure of E. coli revealed a non-uniform distribution of isolates among the seven phylogenetic groups with significant representation of group A. Integron-encoded integrases were detected in 25 isolates with class 1 integron-encoded int/1 integrase being in the majority (22 isolates). The gene cassettes identified were those for trimethoprim, streptomycin, spectinomycin and streptothricin. The dfrA12-orfF-aadA2 was the most commonly found gene cassette in int/1 positive isolates. Phenotypic assay for screening the potential ESBL producers suggested 16 isolates to be ESBL producers. PCR detection using gene-specific primers showed that 15 out of these 16 ESBL-producing E. coli harboured the bla(CTX-M-15) gene. Furthermore, molecular studies helped in characterizing the genes responsible for tetracycline, chloramphenicol and sulphonamides resistance. Collectively, our study outlines the intra-species phylogenetic structure and highlights the prevalence of class 1 integron and bla(CTX-M-15) in commensal E. coli isolates of healthy adults in Chandigarh, India. Our findings further reinforce the relevance of commensal E. coli strains on the growing burden of antimicrobial resistance.	[Dureja, Chetna; Mahajan, Sakshi; Raychaudhuri, Saumya] CSIR, Inst Microbial Technol, Div Mol Biol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raychaudhuri, S (corresponding author), CSIR, Inst Microbial Technol, Div Mol Biol, Chandigarh 160036, India.	saumya@rocketmail.com	Raychaudhuri, Saumya/AFL-0368-2022		CSIR Network project Human Microbiom [HUM-CSIR-BSC-0119A]	CSIR Network project Human Microbiom	CSIR Network project Human Microbiome (HUM-CSIR-BSC-0119A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes P, 2007, ANTIMICROB AGENTS CH, V51, P1545, DOI 10.1128/AAC.01275-06; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Bailey JK, 2010, J CLIN MICROBIOL, V48, P3455, DOI 10.1128/JCM.00760-10; Ben Nasr A, 2013, ANTIMICROB AGENTS CH, V57, P4089, DOI 10.1128/AAC.00536-13; Blahna MT, 2006, J ANTIMICROB CHEMOTH, V57, P666, DOI 10.1093/jac/dkl020; Blake DP, 2003, J APPL MICROBIOL, V95, P428, DOI 10.1046/j.1365-2672.2003.01988.x; Bryan A, 2004, APPL ENVIRON MICROB, V70, P2503, DOI 10.1128/AEM.70.4.2503-2507.2004; Cao V, 2002, ANTIMICROB AGENTS CH, V46, P3739, DOI 10.1128/AAC.46.12.3739-3743.2002; Chang CY, 2011, J MED MICROBIOL, V60, P197, DOI 10.1099/jmm.0.022517-0; Chang LL, 2004, J ANTIMICROB CHEMOTH, V53, P518, DOI 10.1093/jac/dkh094; Ciccozzi M, 2013, NEW MICROBIOL, V36, P385; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUS S, V32; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Gundogdu A, 2011, J MED MICROBIOL, V60, P1633, DOI 10.1099/jmm.0.034140-0; Jemima SA, 2008, INDIAN J MED RES, V128, P313; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Jouini A, 2010, J CHEMOTHERAPY, V22, P318, DOI 10.1179/joc.2010.22.5.318; Kang HY, 2005, J ANTIMICROB CHEMOTH, V55, P639, DOI 10.1093/jac/dki076; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Katsandri A, 2008, J CHEMOTHERAPY, V20, P452, DOI 10.1179/joc.2008.20.4.452; Lautenbach E, 2001, CLIN INFECT DIS, V33, P1288, DOI 10.1086/322667; Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49, DOI 10.1086/341078; Li B, 2010, APPL ENVIRON MICROB, V76, P6698, DOI 10.1128/AEM.00707-10; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Muzaheed, 2008, J ANTIMICROB CHEMOTH, V61, P1393, DOI 10.1093/jac/dkn109; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P2720, DOI 10.1128/AAC.00026-07; Pitout JDD, 2007, ANTIMICROB AGENTS CH, V51, P1281, DOI 10.1128/AAC.01377-06; Raghunath D, 2008, J BIOSCIENCES, V33, P593, DOI 10.1007/s12038-008-0077-9; Rakotonirina HC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-85; Rao PNS, 2008, INDIAN J PATHOL MICR, V51, P497, DOI 10.4103/0377-4929.43739; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Seidman JC, 2009, EPIDEMIOL INFECT, V137, P879, DOI 10.1017/S0950268808001519; Skurnik D, 2005, ANTIMICROB AGENTS CH, V49, P3062, DOI 10.1128/AAC.49.7.3062-3065.2005; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; van Essen-Zandbergen A, 2007, J ANTIMICROB CHEMOTH, V59, P746, DOI 10.1093/jac/dkl549; Wilkerson C, 2004, ANTIMICROB AGENTS CH, V48, P1066, DOI 10.1128/AAC.48.3.1066-1067.2004; Yu HS, 2003, J CLIN MICROBIOL, V41, P5429, DOI 10.1128/JCM.41.12.5429-5433.2003	43	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112551	10.1371/journal.pone.0112551	http://dx.doi.org/10.1371/journal.pone.0112551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409321	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200025
J	Gangisetty, O; Bekdash, R; Maglakelidze, G; Sarkar, DK				Gangisetty, Omkaram; Bekdash, Rola; Maglakelidze, George; Sarkar, Dipak K.			Fetal Alcohol Exposure Alters Proopiomelanocortin Gene Expression and Hypothalamic-Pituitary-Adrenal Axis Function via Increasing MeCP2 Expression in the Hypothalamus	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; ASSOCIATION; STRESS; NEURONS; COMPLEX; SYSTEM; FAMILY	Proopiomelanocortin (POMC) is a precursor gene of the neuropeptide beta-endorphin in the hypothalamus and is known to regulate various physiological functions including stress response. Several recent reports showed that fetal alcohol exposure programs the hypothalamus to produce lower levels of POMC gene transcripts and to elevate the hypothalamic-pituitary-adrenal (HPA) axis response to stressful stimuli. We investigated the role of methyl CpG binding protein (MeCP2) in the effects of prenatal ethanol on POMC gene expression and hypothalamic-pituitary-adrenal (HPA) axis function. Pregnant Sprague Dawley rats were fed between GD 7 and 21 with a liquid diet containing 6.7% alcohol, pair-fed with isocaloric liquid diet, or fed ad libitum with rat chow, and their male offsprings were used at 60 days after birth in this study. Fetal alcohol exposure reduced the level of POMC mRNA, but increased the level of DNA methylation of this gene in the arcuate nucleus (ARC) of the hypothalamus where the POMC neuronal cell bodies are located. Fetal alcohol exposed rats showed a significant increase in MeCP2 protein levels in POMC cells, MeCP2 gene transcript levels as well as increased MeCP2 protein binding on the POMC promoter in the arcuate nucleus. Lentiviral delivery of MeCP2 shRNA into the third ventricle efficiently reduced MeCP2 expression and prevented the effect of prenatal ethanol on POMC gene expression in the arcuate nucleus. MeCP2-shRNA treatment also normalized the prenatal ethanol-induced increase in corticotropin releasing hormone (CRH) gene expression in the hypothalamus and elevated plasma adrenocorticotrophic hormone (ACTH) and corticosterone hormone responses to lipopolysaccharide (LPS) challenge. These results suggest that fetal alcohol programming of POMC gene may involve recruitment of MeCP2 on to the methylated promoter of the POMC gene to suppress POMC transcript levels and contribute to HPA axis dysregulation.	[Gangisetty, Omkaram; Bekdash, Rola; Maglakelidze, George; Sarkar, Dipak K.] Rutgers State Univ, Dept Anim Sci, Endocrine Program, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Sarkar, DK (corresponding author), Rutgers State Univ, Dept Anim Sci, Endocrine Program, New Brunswick, NJ 08903 USA.	sarkar@aesop.rutgers.edu	Sarkar, Dipak K/O-7942-2017	Sarkar, Dipak K/0000-0003-3237-9871; Gangisetty, Omkaram/0000-0001-6280-0642	National Institutes of Health [R37AA08757]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA008757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a National Institutes of Health Grant R37AA08757 to DS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjona A, 2006, ALCOHOL CLIN EXP RES, V30, P1039, DOI 10.1111/j.1530-0277.2006.00117.x; Baker M, 2005, DIABETES, V54, P2492, DOI 10.2337/diabetes.54.8.2492; Ballestar E, 2005, HUM GENET, V116, P91, DOI 10.1007/s00439-004-1200-0; Bekdash RA, 2013, ALCOHOL CLIN EXP RES, V37, P1133, DOI 10.1111/acer.12082; Bernal AJ, 2010, BIRTH DEFECTS RES A, V88, P938, DOI 10.1002/bdra.20685; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boyadjieva NI, 2009, ALCOHOL CLIN EXP RES, V33, P931, DOI 10.1111/j.1530-0277.2009.00911.x; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Govorko D, 2012, BIOL PSYCHIAT, V72, P378, DOI 10.1016/j.biopsych.2012.04.006; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Itoh M, 2007, J NEUROPATH EXP NEUR, V66, P117, DOI 10.1097/nen.0b013e3180302078; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kelley ML, 2010, AM J ORTHOPSYCHIAT, V80, P204, DOI 10.1111/j.1939-0025.2010.01024.x; Latino-Martel P, 2010, CANCER EPIDEM BIOMAR, V19, P1238, DOI 10.1158/1055-9965.EPI-09-1110; LISSONI P, 1987, BRIT J CANCER, V56, P834, DOI 10.1038/bjc.1987.300; Liu YL, 2009, EPIGENETICS-US, V4, P500, DOI 10.4161/epi.4.7.9925; Lopez-Serra L, 2008, ONCOGENE, V27, P3556, DOI 10.1038/sj.onc.1211022; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; MILLER MW, 1992, BRAIN RES, V595, P17, DOI 10.1016/0006-8993(92)91447-M; Mountjoy KG, 2010, BIOCHEM J, V428, P305, DOI 10.1042/BJ20091957; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Newell-Price J, 2003, J ENDOCRINOL, V177, P365, DOI 10.1677/joe.0.1770365; Newell-Price J, 2001, MOL ENDOCRINOL, V15, P338, DOI 10.1210/me.15.2.338; Plagemann A, 1999, J NEUROENDOCRINOL, V11, P541; PLOTSKY PM, 1991, J NEUROENDOCRINOL, V3, P1, DOI 10.1111/j.1365-2826.1991.tb00231.x; Raffin-Sanson ML, 2003, EUR J ENDOCRINOL, V149, P79, DOI 10.1530/eje.0.1490079; Rizzato C, 2011, J DERMATOL SCI, V63, P47, DOI 10.1016/j.jdermsci.2011.03.006; Sarkar DK, 2007, ENDOCRINOLOGY, V148, P2828, DOI 10.1210/en.2006-1606; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Smart JL, 2007, ENDOCRINOLOGY, V148, P647, DOI 10.1210/en.2006-0990; Sutton BS, 2005, OBES RES, V13, P1491, DOI 10.1038/oby.2005.180; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wynne O., 2013, HDB PSYCHONEUROIMMUN, P198; Xuei XL, 2007, AM J MED GENET B, V144B, P877, DOI 10.1002/ajmg.b.30531; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	46	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113228	10.1371/journal.pone.0113228	http://dx.doi.org/10.1371/journal.pone.0113228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409090	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200078
J	Wu, XQ; He, LS; Chen, FJ; He, XE; Cai, Y; Zhang, GP; Yi, Q; He, MX; Luo, JD				Wu, Xiaoqian; He, Lishan; Chen, Fajiang; He, Xiaoen; Cai, Yi; Zhang, Guiping; Yi, Quan; He, Meixiang; Luo, Jiandong			Impaired Autophagy Contributes to Adverse Cardiac Remodeling in Acute Myocardial Infarction	PLOS ONE			English	Article							NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-KINASE; HEART-FAILURE; CARDIOMYOCYTE DEATH; INFLAMMATION; INHIBITION; MODEL; PHOSPHORYLATION; DEGRADATION	Objective: Autophagy is activated in ischemic heart diseases, but its dynamics and functional roles remain unclear and controversial. In this study, we investigated the dynamics and role of autophagy and the mechanism(s), if any, during postinfarction cardiac remodeling. Methods and results: Acute myocardial infarction (AMI) was induced by ligating left anterior descending (LAD) coronary artery. Autophagy was found to be induced sharply 12-24 hours after surgery by testing LC3 modification and Electron microscopy. P62 degradation in the infarct border zone was increased from day 0.5 to day 3, and however, decreased from day 5 until day 21 after LAD ligation. These results indicated that autophagy was induced in the acute phase of AMI, and however, impaired in the latter phase of AMI. To investigate the significance of the impaired autophagy in the latter phase of AMI, we treated the mice with Rapamycin (an autophagy enhancer, 2.0 mg/kg/day) or 3-methyladenine (3MA, an autophagy inhibitor, 15 mg/kg/day) one day after LAD ligation until the end of experiment. The results showed that Rapamycin attenuated, while 3MA exacerbated, postinfarction cardiac remodeling and dysfunction respectively. In addition, Rapamycin protected the H9C2 cells against oxygen glucose deprivation in vitro. Specifically, we found that Rapamycin attenuated NF kappa B activation after LAD ligation. And the inflammatory response in the acute stage of AMI was significantly restrained with Rapamycin treatment. In vitro, inhibition of NF kappa B restored autophagy in a negative reflex. Conclusion: Sustained myocardial ischemia impairs cardiomyocyte autophagy, which is an essential mechanism that protects against adverse cardiac remodeling. Augmenting autophagy could be a therapeutic strategy for acute myocardial infarction.	[Wu, Xiaoqian; He, Lishan; Chen, Fajiang; He, Xiaoen; Cai, Yi; Zhang, Guiping; Yi, Quan; He, Meixiang; Luo, Jiandong] Guangzhou Med Univ, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Zhang, Guiping; Luo, Jiandong] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Guangzhou Key Lab Cardiovasc Dis, Guangzhou, Guangdong, Peoples R China; [Zhang, Guiping; Luo, Jiandong] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Wu, XQ (corresponding author), Guangzhou Med Univ, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	wuxiaoqian@gzhmu.edu.cn; luojiandong@gzhmu.edu.cn	Wu, X/I-7859-2019	wu, xiaoqian/0000-0002-4441-5772	National Natural Science Foundation of China [81001436, 81173062]; Education Administration Research Foundation of Guangzhou City [10A018G, 10A157]; Department of Education of Guangdong province [Yq2013134]; Science and Information Technology of Guangzhou [12C22021631]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Administration Research Foundation of Guangzhou City; Department of Education of Guangdong province(National Natural Science Foundation of Guangdong Province); Science and Information Technology of Guangzhou	This study was supported by grants from the National Natural Science Foundation of China (grant No. 81001436 to Dr. X Wu and grant No. 81173062 to Dr. J Luo), the Education Administration Research Foundation of Guangzhou City (grant No. 10A018G and 10A157 to Dr. X Wu), outstanding young scientist training program by Department of Education of Guangdong province (grant No. Yq2013134 to Dr. X Wu), and Science and Information Technology of Guangzhou (grant No. 12C22021631 to Dr. J Luo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Carmignac V, 2011, HUM MOL GENET, V20, P4891, DOI 10.1093/hmg/ddr427; Chen J, 2013, CIRCULATION, V128, P2577, DOI 10.1161/CIRCULATIONAHA.113.003668; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Hausleiter J, 2004, CIRCULATION, V110, P790, DOI 10.1161/01.CIR.0000138935.17503.35; Jundt F, 2005, BLOOD, V106, P1801, DOI 10.1182/blood-2004-11-4513; Kanamori H, 2011, CARDIOVASC RES, V91, P330, DOI 10.1093/cvr/cvr073; Kanamori H, 2011, AM J PHYSIOL-HEART C, V300, pH2261, DOI 10.1152/ajpheart.01056.2010; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mauriello A, 2005, J AM COLL CARDIOL, V45, P1585, DOI 10.1016/j.jacc.2005.01.054; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sala-Mercado JA, 2010, CIRCULATION, V122, pS179, DOI 10.1161/CIRCULATIONAHA.109.928242; Shan K, 1997, CURR OPIN CARDIOL, V12, P218, DOI 10.1097/00001573-199705000-00002; Shibata Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2068; Shinde AV, 2013, J MOL CELL CARDIOL; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Takemura G, 2006, AUTOPHAGY, V2, P212, DOI 10.4161/auto.2608; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060087; WEISMAN HF, 1988, CIRCULATION, V78, P186, DOI 10.1161/01.CIR.78.1.186; Wu XQ, 2013, MOL MED REP, V8, P1824, DOI 10.3892/mmr.2013.1708; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Xiao Q, 2012, CARDIOVASC RES, V95, P507, DOI 10.1093/cvr/cvs216; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhang HN, 2012, J CARDIOVASC PHARM, V60, P33, DOI 10.1097/FJC.0b013e3182567fef; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	42	105	116	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112891	10.1371/journal.pone.0112891	http://dx.doi.org/10.1371/journal.pone.0112891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409294	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200045
J	Zengin, G; Uysal, A; Gunes, E; Aktumsek, A				Zengin, Gokhan; Uysal, Ahmet; Gunes, Erdogan; Aktumsek, Abdurrahman			Survey of Phytochemical Composition and Biological Effects of Three Extracts from a Wild Plant (Cotoneaster nummularia Fisch et Mey.): A Potential Source for Functional Food Ingredients and Drug Formulations	PLOS ONE			English	Article							TOTAL PHENOLIC CONTENT; ANTIOXIDANT ACTIVITY; FERULIC ACID; MEDICINAL-PLANTS; AQUEOUS EXTRACTS; ESSENTIAL OIL; IN-VITRO; L.; INHIBITORS; ANTICHOLINESTERASE	This study was focused on the analysis of the phenolic content, antioxidant, antibacterial, anti-cholinesterase, anti-tyrosinase, anti-amylase and anti-glucosidase activity of three solvent extracts from Cotoneaster nummularia. Moreover, water extract was tested in terms of mutagenic/anti-mutagenic effects. The antioxidant activities of these extracts were evaluated by DPPH, ABTS, O-2, metal chelating, phosphomolybdenum, beta-carotene/linoleic acid, ferric and cupric reducing power assays. Enzyme inhibitory activities were also examined with colorimetric methods. Generally, methanol and water extracts exhibited excellent biological activities. These extracts were rich in phenolic and flavonoid content. Furthermore, Cotoneaster extracts indicated appreciable antibacterial properties against human pathogen strains. HPLC analysis showed that ferulic acid, chlorogenic acid, (-) - epicatechin and (+)-catechin were the major phenolics in extracts tested. These data offer that these extracts from C. nummularia may be considered as a potential source of biological agents for developing functional foods or drug formulations.	[Zengin, Gokhan; Gunes, Erdogan; Aktumsek, Abdurrahman] Selcuk Univ, Fac Sci, Dept Biol, Konya, Turkey; [Uysal, Ahmet] Selcuk Univ, Vocat Sch Hlth Serv, Konya, Turkey	Selcuk University; Selcuk University	Uysal, A (corresponding author), Selcuk Univ, Vocat Sch Hlth Serv, Konya, Turkey.	ahuysal@selcuk.edu.tr	Zengin, Gokhan/K-9393-2015; Uysal, Ahmet/V-7909-2017; Zengin, Gokhan/GLS-8806-2022	Zengin, Gokhan/0000-0001-6548-7823; Uysal, Ahmet/0000-0002-9297-4050; Zengin, Gokhan/0000-0001-6548-7823				Adebiyi AO, 2009, PHARM BIOL, V47, P320, DOI 10.1080/13880200902748460; Aksoy L, 2013, SAUDI J BIOL SCI, V20, P235, DOI 10.1016/j.sjbs.2013.02.003; Aktumsek A, 2013, FOOD CHEM TOXICOL, V55, P290, DOI 10.1016/j.fct.2013.01.018; Apak R, 2006, INT J FOOD SCI NUTR, V57, P292, DOI 10.1080/09637480600798132; Berk S, 2011, AFR J BIOTECHNOL, V10, P8902; Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244; BUENING MK, 1981, CANCER RES, V41, P67; Cakilcioglu U, 2011, J ETHNOPHARMACOL, V137, P469, DOI 10.1016/j.jep.2011.05.046; Caponio F, 1999, FOOD CHEM, V64, P203, DOI 10.1016/S0308-8146(98)00146-0; Chakrabarti R, 2002, CURR SCI INDIA, V83, P1533; Chandini SK, 2008, FOOD CHEM, V107, P707, DOI 10.1016/j.foodchem.2007.08.081; Dalar A, 2013, IND CROP PROD, V44, P383, DOI 10.1016/j.indcrop.2012.11.037; Dasgupta N, 2004, FOOD CHEM, V88, P219, DOI 10.1016/j.foodchem.2004.01.036; DEAN BJ, 1985, MUTAT RES, V153, P57, DOI 10.1016/0165-1110(85)90005-3; EDENHARDER R, 1993, MUTAT RES, V287, P261, DOI 10.1016/0027-5107(93)90019-C; Eldeen IMS, 2005, J ETHNOPHARMACOL, V102, P457, DOI 10.1016/j.jep.2005.08.049; Erdogan-Orhan I, 2010, J SERB CHEM SOC, V75, P1491, DOI 10.2298/JSC100322115E; Fang L, 2008, BIOORG MED CHEM LETT, V18, P2905, DOI 10.1016/j.bmcl.2008.03.073; Gallegos-Tintore S, 2011, J SCI FOOD AGR, V91, P1618, DOI 10.1002/jsfa.4357; Ranilla LG, 2010, BIORESOURCE TECHNOL, V101, P4676, DOI 10.1016/j.biortech.2010.01.093; Goze I, 2009, J MED PLANTS RES, V3, P246; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Horn RC, 2003, MUTAGENESIS, V18, P113, DOI 10.1093/mutage/18.2.113; Jang HD, 2007, FOOD CHEM, V103, P749, DOI 10.1016/j.foodchem.2006.09.026; Javanmardi J, 2003, FOOD CHEM, V83, P547, DOI 10.1016/S0308-8146(03)00151-1; KAPPUS H, 1986, BIOCHEM PHARMACOL, V35, P1, DOI 10.1016/0006-2952(86)90544-7; Karioti A, 2007, BIOORGAN MED CHEM, V15, P2708, DOI 10.1016/j.bmc.2007.01.035; Khan S, 2009, J ASIAN NAT PROD RES, V11, P44, DOI 10.1080/10286020802435745; Kinghorn AD, 2004, PLANTA MED, V70, P691, DOI 10.1055/s-2004-827198; Koc ZE, 2013, EXCLI J, V12, P396; Leonti M, 2012, GENET RESOUR CROP EV, V59, P1295, DOI 10.1007/s10722-012-9894-7; Mamiya T, 2008, NEUROSCI LETT, V430, P115, DOI 10.1016/j.neulet.2007.10.029; Manian R, 2008, FOOD CHEM, V107, P1000, DOI 10.1016/j.foodchem.2007.09.008; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Matthews VA, 1972, FLORA TURKEY E AEGEA, V4; Mitscher LA, 1996, MUTAT RES-FUND MOL M, V350, P143, DOI 10.1016/0027-5107(95)00099-2; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Nazir A, 2010, NAT SCI, V8, P57; Negi PS, 2003, FOOD CHEM, V80, P393, DOI 10.1016/S0308-8146(02)00279-0; Okombi S, 2006, BIOORG MED CHEM LETT, V16, P2252, DOI 10.1016/j.bmcl.2006.01.022; Oksana S., 2012, Journal of Medicinal Plants Research, V6, P2526; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Ozgen U, 2012, TURK J BIOL, V36, P93, DOI 10.3906/biy-1009-124; Pandey MR, 2007, OUR NAT, V4, P69; PARKE DV, 1991, CAN J PHYSIOL PHARM, V69, P537, DOI 10.1139/y91-081; Polat R, 2013, J ETHNOPHARMACOL, V148, P951, DOI 10.1016/j.jep.2013.05.050; Priya Darsini DT, 2013, FREE RADICAL ANTIOXI, V3, P62, DOI DOI 10.1016/J.FRA.2013.08.001; Rajaei A, 2010, FOOD CHEM TOXICOL, V48, P107, DOI 10.1016/j.fct.2009.09.023; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Roy S, 2013, ENDOCRINE, V44, P369, DOI 10.1007/s12020-012-9868-8; Saija A, 2000, INT J PHARM, V199, P39, DOI 10.1016/S0378-5173(00)00358-6; Sarikurkcu C, 2012, SPECTROSC LETT, V45, P352, DOI 10.1080/00387010.2012.666701; Sarikurkcu C, 2011, AFR J BIOTECHNOL, V10, P831; Shahwar D, 2010, J MED PLANTS RES, V4, P260; Skotti E, 2014, IND CROP PROD, V53, P46, DOI 10.1016/j.indcrop.2013.12.013; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Suhaj M, 2006, J FOOD COMPOS ANAL, V19, P531, DOI 10.1016/j.jfca.2004.11.005; Vladimir-Knezevic S, 2014, MOLECULES, V19, P767, DOI 10.3390/molecules19010767; Zengin G, 2014, IND CROP PROD, V53, P244, DOI 10.1016/j.indcrop.2013.12.043	61	89	89	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113527	10.1371/journal.pone.0113527	http://dx.doi.org/10.1371/journal.pone.0113527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409171	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200134
J	Chen, HY; Yamagishi, J; Kishino, H				Chen, Hungyen; Yamagishi, Junko; Kishino, Hirohisa			Bayesian Inference of Baseline Fertility and Treatment Effects via a Crop Yield-Fertility Model	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; SOIL FERTILITY; AGRICULTURAL SUSTAINABILITY; CARBON SEQUESTRATION; DAIRY MANURE; WORLD FOOD; TILLAGE; QUALITY; MANAGEMENT; NITROGEN	To effectively manage soil fertility, knowledge is needed of how a crop uses nutrients from fertilizer applied to the soil. Soil quality is a combination of biological, chemical and physical properties and is hard to assess directly because of collective and multiple functional effects. In this paper, we focus on the application of these concepts to agriculture. We define the baseline fertility of soil as the level of fertility that a crop can acquire for growth from the soil. With this strict definition, we propose a new crop yield-fertility model that enables quantification of the process of improving baseline fertility and the effects of treatments solely from the time series of crop yields. The model was modified from Michaelis-Menten kinetics and measured the additional effects of the treatments given the baseline fertility. Using more than 30 years of experimental data, we used the Bayesian framework to estimate the improvements in baseline fertility and the effects of fertilizer and farmyard manure (FYM) on maize (Zea mays), barley (Hordeum vulgare), and soybean (Glycine max) yields. Fertilizer contributed the most to the barley yield and FYM contributed the most to the soybean yield among the three crops. The baseline fertility of the subsurface soil was very low for maize and barley prior to fertilization. In contrast, the baseline fertility in this soil approximated half-saturated fertility for the soybean crop. The long-term soil fertility was increased by adding FYM, but the effect of FYM addition was reduced by the addition of fertilizer. Our results provide evidence that longterm soil fertility under continuous farming was maintained, or increased, by the application of natural nutrients compared with the application of synthetic fertilizer.	[Chen, Hungyen; Kishino, Hirohisa] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yamagishi, Junko] Univ Tokyo, Inst Sustainable Agroecosyst Serv, Tokyo, Japan	University of Tokyo; University of Tokyo	Kishino, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	kishino@lbm.ab.a.u-tokyo.ac.jp	Kishino, Hirohisa/U-9311-2019	CHEN, Hungyen/0000-0003-3693-9354	Ministry of Education, Science and Culture (MEXT) [59440009]; Japan Society for the Promotion of Science (JSPS) [25280006]	Ministry of Education, Science and Culture (MEXT); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Grant-in-Aid for Scientific Research (grant number 59440009, PI: Wataru Sunohara) by the Ministry of Education, Science and Culture (MEXT, http://www.mext.go.jp) supported the initial phase (1984-1987) of the long-term fertilizer experiment. The University Farm continued the experiment until 2010 by the regular budget supplied by the University of Tokyo. This work was supported by Grants-in-Aid for Scientific Research (grant number 25280006) by the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/) to H. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N, 1999, P NATL ACAD SCI USA, V96, P5908, DOI 10.1073/pnas.96.11.5908; Alteri MA, 2002, AGR ECOSYST ENVIRON, V93, P1, DOI 10.1016/S0167-8809(02)00085-3; Altieri MA, 2003, SOIL TILL RES, V72, P203, DOI 10.1016/S0167-1987(03)00089-8; Aref S, 1998, ADV AGRON, V62, P153; Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098; Canali S, 2004, BIOL FERT SOILS, V40, P206, DOI 10.1007/s00374-004-0759-x; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Clark MS, 1998, AGRON J, V90, P662, DOI 10.2134/agronj1998.00021962009000050016x; Cong RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095142; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Denef K, 2004, SOIL SCI SOC AM J, V68, P1935, DOI 10.2136/sssaj2004.1935; Deng JM, 2012, P NATL ACAD SCI USA, V109, P15823, DOI 10.1073/pnas.1210955109; DRURY CF, 1995, CAN J PLANT SCI, V75, P355, DOI 10.4141/cjps95-060; Fan RQ, 2012, CAN J SOIL SCI, V92, P463, DOI 10.4141/CJSS2010-020; Fan TL, 2008, J PLANT NUTR SOIL SC, V171, P448, DOI 10.1002/jpln.200625192; Glover JD, 2012, NATURE, V489, P359, DOI 10.1038/489359a; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; HOLDREN JP, 1974, AM SCI, V62, P282; Huang S, 2010, GEODERMA, V154, P364, DOI 10.1016/j.geoderma.2009.11.009; International Benchmark Sites Network for Agrotechnology Transfer, 1993, IBSNAT DEC; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; JENKINSON DS, 1991, AGRON J, V83, P2, DOI 10.2134/agronj1991.00021962008300010008x; Khan AUH, 2007, BIORESOURCE TECHNOL, V98, P1972, DOI 10.1016/j.biortech.2006.07.041; Korschens M, 2013, ARCH AGRON SOIL SCI, V59, P1017, DOI 10.1080/03650340.2012.704548; [李菊梅 Li Jumei], 2005, [植物营养与肥料学报, Plant nutrition and fertitizer science], V11, P51; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Malhi SS, 2007, SOIL TILL RES, V96, P269, DOI 10.1016/j.still.2007.06.011; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McCown RL, 1996, AGR SYST, V50, P255, DOI 10.1016/0308-521X(94)00055-V; MERCIK S, 1985, PLANT SOIL, V83, P151, DOI 10.1007/BF02182725; Michaelis L, 1913, BIOCHEM Z, V49, P333; Min DH, 2003, COMMUN SOIL SCI PLAN, V34, P781, DOI 10.1081/CSS-120018975; MYERS RJK, 1984, FERT RES, V5, P95, DOI 10.1007/BF01049494; Neupane RP, 2001, AGR ECOSYST ENVIRON, V84, P157, DOI 10.1016/S0167-8809(00)00203-6; PEOPLES MB, 1995, PLANT SOIL, V174, P3, DOI 10.1007/BF00032239; Poulton PR, 1996, CAN J PLANT SCI, V76, P559, DOI 10.4141/cjps96-103; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasmussen PE, 1998, SCIENCE, V282, P893, DOI 10.1126/science.282.5390.893; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Shen J, 2004, FIELD CROP RES, V86, P225, DOI 10.1016/j.fcr.2003.08.013; SPIECKER H, 1995, PLANT SOIL, V168, P555, DOI 10.1007/BF00029368; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vanlauwe B, 2005, PLANT SOIL, V273, P337, DOI 10.1007/s11104-005-0194-2; Watson CA, 2002, SOIL USE MANAGE, V18, P264, DOI 10.1079/SUM2002127; Watson CA, 2002, SOIL USE MANAGE, V18, P239, DOI 10.1079/SUM2002131; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Yadvinder-Singh, 2004, SOIL SCI SOC AM J, V68, P854; Yanni YG, 2010, PLANT SOIL, V336, P129, DOI 10.1007/s11104-010-0454-7; Zhang H, 2009, J AGR SCI-CAMBRIDGE, V147, P31, DOI 10.1017/S0021859608008265; Zhu P, 2007, J PLANT NUTR SOIL SC, V170, P219, DOI 10.1002/jpln.200620635	56	5	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112785	10.1371/journal.pone.0112785	http://dx.doi.org/10.1371/journal.pone.0112785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405353	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300052
J	Miller, CR; Lee, KH; Wichman, HA; Ytreberg, FM				Miller, Craig R.; Lee, Kuo Hao; Wichman, Holly A.; Ytreberg, F. Marty			Changing Folding and Binding Stability in a Viral Coat Protein: A Comparison between Substitutions Accessible through Mutation and Those Fixed by Natural Selection	PLOS ONE			English	Article							EXPERIMENTAL EVOLUTION; FORCE-FIELD; WEB SERVER; THERMODYNAMICS; PREDICTION; SEQUENCE; PHI-X174; VIRUS; BACTERIOPHAGE-PHI-X174; AGGREGATION	Previous studies have shown that most random amino acid substitutions destabilize protein folding (i.e. increase the folding free energy). No analogous studies have been carried out for protein-protein binding. Here we use a structure-based model of the major coat protein in a simple virus, bacteriophage phi X174, to estimate the free energy of folding of a single coat protein and binding of five coat proteins within a pentameric unit. We confirm and extend previous work in finding that most accessible substitutions destabilize both protein folding and protein-protein binding. We compare the pool of accessible substitutions with those observed among the phi X174-like wild phage and in experimental evolution with phi X174. We find that observed substitutions have smaller effects on stability than expected by chance. An analysis of adaptations at high temperatures suggests that selection favors either substitutions with no effect on stability or those that simultaneously stabilize protein folding and slightly destabilize protein binding. We speculate that these mutations might involve adjusting the rate of capsid assembly. At normal laboratory temperature there is little evidence of directional selection. Finally, we show that cumulative changes in stability are highly variable; sometimes they are well beyond the bounds of single substitution changes and sometimes they are not. The variation leads us to conclude that phenotype selection acts on more than just stability. Instances of larger cumulative stability change (never via a single substitution despite their availability) lead us to conclude that selection views stability at a local, not a global, level.	[Miller, Craig R.; Wichman, Holly A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Miller, Craig R.] Univ Idaho, Dept Math, Moscow, ID 83843 USA; [Miller, Craig R.; Lee, Kuo Hao; Wichman, Holly A.; Ytreberg, F. Marty] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Lee, Kuo Hao] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Kansas State University; Idaho; University of Idaho	Ytreberg, FM (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.	ytreberg@uidaho.edu	Miller, Craig/GWQ-5012-2022; Lee, Kuo Hao/H-9929-2019		National Institutes of Health [P20-RR016448-07S1, R01-GM076040, R21-GM083827]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076040, R21GM083827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KHL and FMY were supported by grant P20-RR016448-07S1 from the National Institutes of Health. CRM and HAW were supported by grant number R01-GM076040 from the National Institutes of Health. Computational resources were provided in part by grant R21-GM083827 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2007, GENETICS, V175, P255, DOI 10.1534/genetics.106.061754; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060401; Brown CJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-66; Bull JJ, 2000, MOL BIOL EVOL, V17, P942, DOI 10.1093/oxfordjournals.molbev.a026375; Bull JJ, 1997, GENETICS, V147, P1497; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cherwa JE, 2011, J MOL BIOL, V412, P387, DOI 10.1016/j.jmb.2011.07.070; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Crill WD, 2000, GENETICS, V154, P27; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dokland T, 1999, J MOL BIOL, V288, P595, DOI 10.1006/jmbi.1999.2699; Dokland T, 1998, ACTA CRYSTALLOGR D, V54, P878, DOI 10.1107/S0907444998002467; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; Gromiha MM, 2007, BIOCHEM SOC T, V35, P1569, DOI 10.1042/BST0351569; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Jha BK, 2004, J BIOL CHEM, V279, P23061, DOI 10.1074/jbc.M310676200; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Kronenberg ZN, 2010, ASYMMETRICAL ADAPTIO; Lee KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025640; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; MCKENNA R, 1992, ACTA CRYSTALLOGR B, V48, P499, DOI 10.1107/S0108768192001344; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; Pace CN, 1998, J MOL BIOL, V279, P271, DOI 10.1006/jmbi.1998.1760; Pace CN, 2001, J MOL BIOL, V312, P393, DOI 10.1006/jmbi.2001.4956; Pepin KM, 2008, INFECT GENET EVOL, V8, P825, DOI 10.1016/j.meegid.2008.08.008; Pepin KM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-85; Rain MW, 2001, MOL EVOLUTION 2 VIRU; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wichman HA, 2005, GENETICS, V170, P19, DOI 10.1534/genetics.104.034488; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wichman HA, 2000, PHILOS T R SOC B, V355, P1677, DOI 10.1098/rstb.2000.0731; Wichman HA, 2010, PHILOS T R SOC B, V365, P2495, DOI 10.1098/rstb.2010.0053; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	51	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112988	10.1371/journal.pone.0112988	http://dx.doi.org/10.1371/journal.pone.0112988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405628	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300068
J	Priyadarsini, S; Hjortdal, J; Sarker-Nag, A; Sejersen, H; Asara, JM; Karamichos, D				Priyadarsini, Shrestha; Hjortdal, Jesper; Sarker-Nag, Akhee; Sejersen, Henrik; Asara, John M.; Karamichos, Dimitrios			Gross Cystic Disease Fluid Protein-15/Prolactin-Inducible Protein as a Biomarker for Keratoconus Disease	PLOS ONE			English	Article							PROLACTIN-INDUCIBLE PROTEIN; HUMAN SEMINAL PLASMA; CORNEAL ALDEHYDE DEHYDROGENASE; IN-VITRO MODEL; OXIDATIVE STRESS; ZINC ALPHA-2-GLYCOPROTEIN; PATHOLOGICAL CORNEAS; COLLAGEN MATRICES; GENE-EXPRESSION; CELLS	Keratoconus (KC) is a bilateral degenerative disease of the cornea characterized by corneal bulging, stromal thinning, and scarring. The etiology of the disease is unknown. In this study, we identified a new biomarker for KC that is present in vivo and in vitro. In vivo, tear samples were collected from age-matched controls with no eye disease (n = 36) and KC diagnosed subjects (n = 17). Samples were processed for proteomics using LC-MS/MS. In vitro, cells were isolated from controls (Human Corneal Fibroblasts-HCF) and KC subjects (Human Keratoconus Cells-HKC) and stimulated with a Vitamin C (VitC) derivative for 4 weeks, and with one of the three transforming growth factor-beta (TGF-beta) isoforms. Samples were analyzed using realtime PCR and Western Blots. By using proteomics analysis, the Gross cystic disease fluid protein-15 (GCDFP-15) or prolactin-inducible protein (PIP) was found to be the best independent biomarker able to discriminate between KC and controls. The intensity of GCDFP-15/PIP was significantly higher in healthy subjects compared to KC-diagnosed. Similar findings were seen in vitro, using a 3D culture model. All three TGF-b isoforms significantly down-regulated the expression of GCDFP-15/PIP. Zinc-alpha-2-glycoprotein (AZGP1), a protein that binds to PIP, was identified by proteomics and cell culture to be highly regulated. In this study by different complementary techniques we confirmed the potential role of GCDFP-15/PIP as a novel biomarker for KC disease. It is likely that exploring the GCDFP-15/PIP-AZGP1 interactions will help better understand the mechanism of KC disease.	[Priyadarsini, Shrestha; Sarker-Nag, Akhee; Karamichos, Dimitrios] Univ Oklahoma, Dean McGee Eye Inst, Oklahoma City, OK 73106 USA; [Hjortdal, Jesper; Sejersen, Henrik] Aarhus Univ Hosp, Dept Ophthalmol, Aarhus C, Denmark; [Asara, John M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Signal Transduct,Mass Spectrometry Core, Boston, MA 02215 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Aarhus University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Karamichos, D (corresponding author), Univ Oklahoma, Dean McGee Eye Inst, Oklahoma City, OK 73106 USA.	dimitrios-karamichos@ouhsc.edu	karamichos, dimitrios/D-9651-2015		National Eye Institute [R01-EY023568]; Dana-Farber/Harvard Cancer Center [5P30CA006516];  [2P01CA120964]; NATIONAL CANCER INSTITUTE [P30CA006516, P01CA120964] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023568] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Dana-Farber/Harvard Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by the following: 1) R01-EY023568, National Eye Institute, http://www.nei.nih.gov (D.K.); 2) 2P01CA120964 (J.M.A.); and 3) 5P30CA006516 Dana-Farber/Harvard Cancer Center Support Grant (J.M.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarran C, 1997, Cont Lens Anterior Eye, V20, P129, DOI 10.1016/S1367-0484(97)80011-2; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; AUTIERO M, 1995, EUR J IMMUNOL, V25, P1461, DOI 10.1002/eji.1830250550; Behndig A, 2001, INVEST OPHTH VIS SCI, V42, P2293; Brizzi MF, 2002, DIABETES, V51, P3311, DOI 10.2337/diabetes.51.11.3311; Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306; Cabassi A, 2013, CURR OPIN CLIN NUTR, V16, P267, DOI 10.1097/MCO.0b013e32835f816c; Caputo E, 2003, BIOCHEMISTRY-US, V42, P6169, DOI 10.1021/bi034038a; Chung EH, 1999, INVEST OPHTH VIS SCI, V40, P1952; Daxer A, 1997, INVEST OPHTH VIS SCI, V38, P121; Espandar L, 2010, MIDDLE EAST AFR J OP, V17, P15, DOI 10.4103/0974-9233.61212; Fodor M, 2013, EYE CONTACT LENS, V39, P147, DOI 10.1097/ICL.0b013e318273b35f; Gallo A, 2013, J GENET SYNDR GENE T, V4; GONDHOWIARDJO TD, 1993, CORNEA, V12, P146, DOI 10.1097/00003226-199303000-00010; GONDHOWIARDJO TD, 1993, CORNEA, V12, P310, DOI 10.1097/00003226-199307000-00006; HAAGENSEN DE, 1990, ANN NY ACAD SCI, V586, P161, DOI 10.1111/j.1749-6632.1990.tb17804.x; Hassan MI, 2008, J SEP SCI, V31, P2318, DOI 10.1002/jssc.200700686; Hassan MI, 2008, MOL CANCER RES, V6, P892, DOI 10.1158/1541-7786.MCR-07-2195; Hassan MI, 2008, J MOL BIOL, V384, P663, DOI 10.1016/j.jmb.2008.09.072; Hayes S, 2007, EXP EYE RES, V84, P423, DOI 10.1016/j.exer.2006.10.014; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Karamichos D, 2014, EXP EYE RES; Karamichos D, 2013, INVEST OPHTH VIS SCI, V54, P6612, DOI 10.1167/iovs.13-12861; Karamichos D, 2012, J FUNCT BIOMATER, V3, P760, DOI 10.3390/jfb3040760; Karamichos D, 2011, J FUNCT BIOMATER, V2, P213, DOI 10.3390/jfb2030213; Karamichos D, 2007, INVEST OPHTH VIS SCI, V48, P5030, DOI 10.1167/iovs.07-0443; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Karamichos D, 2009, CELL MOTIL CYTOSKEL, V66, P1, DOI 10.1002/cm.20326; Kenney M. Cristina, 2000, CLAO Journal, V26, P10; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; Kim A, 2010, INVEST OPHTH VIS SCI, V51, P864, DOI 10.1167/iovs.09-4200; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Levy DE, 2000, ONCOGENE, V19, P2505, DOI 10.1038/sj.onc.1203480; MAGUIRE LJ, 1989, AM J OPHTHALMOL, V108, P107, DOI 10.1016/0002-9394(89)90001-9; Meek KM, 2005, INVEST OPHTH VIS SCI, V46, P1948, DOI 10.1167/iovs.04-1253; Mirels L, 1998, J HISTOCHEM CYTOCHEM, V46, P1061, DOI 10.1177/002215549804600910; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; MURPHY LC, 1987, J BIOL CHEM, V262, P15236; Parris TZ, 2014, INT J CANCER, V134, P1617, DOI 10.1002/ijc.28497; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Radner W, 1998, OPHTHALMIC RES, V30, P327, DOI 10.1159/000055492; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; Sawaguchi S, 1998, ARCH OPHTHALMOL-CHIC, V116, P62, DOI 10.1001/archopht.116.1.62; Sharma M, 2006, AM J OPHTHALMOL, V141, P891, DOI 10.1016/j.ajo.2005.12.027; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Sporl E, 2000, OPHTHALMOLOGE, V97, P203, DOI 10.1007/s003470050515; Udar N, 2009, CORNEA, V28, P902, DOI 10.1097/ICO.0b013e3181983a0c; UEYAMA H, 1991, BIOCHEM BIOPH RES CO, V177, P696, DOI 10.1016/0006-291X(91)91844-3; UEYAMA H, 1994, J BIOCHEM, V116, P677, DOI 10.1093/oxfordjournals.jbchem.a124579; Webhofer C, 2013, J PSYCHIATR RES, V47, P289, DOI 10.1016/j.jpsychires.2012.11.003; Wentz-Hunter K, 2001, MOL MED, V7, P470, DOI 10.1007/BF03401852; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	54	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113310	10.1371/journal.pone.0113310	http://dx.doi.org/10.1371/journal.pone.0113310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405607	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300103
J	Wang, ZJ; Chen, R; Wang, SH; Zhong, J; Wu, MN; Zhao, J; Duan, JC; Zhuo, ML; An, TT; Wang, YY; Bai, H; Wang, J				Wang, Zhijie; Chen, Rui; Wang, Shuhang; Zhong, Jia; Wu, Meina; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; An, Tongtong; Wang, Yuyan; Bai, Hua; Wang, Jie			Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; FACTOR RECEPTOR MUTATIONS; LUNG-CANCER PATIENTS; ACQUIRED-RESISTANCE; NONINVASIVE DETECTION; 1ST-LINE TREATMENT; OPEN-LABEL; GEFITINIB; ERLOTINIB; CHEMOTHERAPY	Background: Among advanced non-small cell lung cancer (NSCLC) patients with an acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI), about 50% carry the T790M mutation, but this frequency in EGFR-TKI-naive patients and dynamic change during therapy remains unclear. This study investigated the quantification and dynamic change of T790M mutation in plasma cell-free DNA (cf-DNA) of advanced NSCLC patients to assess the clinical outcomes of EGFR-TKI therapy. Materials and Methods: We retrospectively investigated 135 patients with advanced NSCLC who obtained progression-free survival (PFS) after EGFR-TKI for.6 months for their EGFR sensitive mutations and T790M mutation in matched pre-and post-TKI plasma samples, using denaturing high-performance liquid chromatography (DHPLC), amplification refractory mutation system (ARMS), and digital-PCR (D-PCR). Real-time PCR was performed to measure c-MET amplification. Results: Detection limit of D-PCR in assessing the T790M mutation was approximately 0.03%. D-PCR identified higher frequency of T790M than ARMS in pre-TKI (31.3% vs. 5.5%) and post-TKI (43.0% vs. 25.2%) plasma samples. Patients with pre-TKI T790M showed inferior PFS (8.9 vs. 12.1 months, p = 0.007) and overall survival (OS, 19.3 vs. 31.9 months, p = 0.001) compared with those without T790M. In patients harboring EGFR sensitive mutation, high quantities of pre-TKI T790M predicted poorer PFS (p = 0.001) on EGFR-TKI than low ones. Moreover, patients who experienced increased quantity of T790M during EGFR-TKI treatment showed superior PFS and OS compared with those with decreased changes (p = 0.044 and p = 0.015, respectively). Conclusion: Qualitative and quantitative T790M in plasma cf-DNA by D-PCR provided a non-invasive and sensitive assay to predict EGFR-TKI prognosis.	[Bai, Hua] Beijing Canc Hosp, Minist Educ, Key Lab Carcinogenesis & Translat Res, Dept Thorac Med Oncol, Beijing, Peoples R China; Beijing Inst Canc Res, Beijing, Peoples R China	Peking University	Bai, H (corresponding author), Beijing Canc Hosp, Minist Educ, Key Lab Carcinogenesis & Translat Res, Dept Thorac Med Oncol, Beijing, Peoples R China.	baihuahb@sina.com; zlhuxi@163.com	Duan, Jianchun/AAM-5765-2020	zhuo, minglei/0000-0003-2489-7791	National Natural Science Foundation Distinguished Young Scholars [81025012]; National Natural Science Foundation Key Program [81330062]; Education Ministry Innovative Research Team Program [IRT13003]; Peking University-Tsinghua University Joint Center; Wujieping Medicine Foundation [320.6750.1361, 320.6750.12192]	National Natural Science Foundation Distinguished Young Scholars; National Natural Science Foundation Key Program; Education Ministry Innovative Research Team Program; Peking University-Tsinghua University Joint Center; Wujieping Medicine Foundation	This work was supported by the National Natural Science Foundation Distinguished Young Scholars (81025012); the National Natural Science Foundation Key Program (81330062); Education Ministry Innovative Research Team Program (IRT13003); Peking University-Tsinghua University Joint Center for Life Sciences Clinical Investigator; and Wujieping Medicine Foundation (320.6750.1361 and 320.6750.12192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CANCER DISCOV, V3, pOF9, DOI [10.1158/2159-8290.CD-ND2013-025, DOI 10.1158/2159-8290.CD-ND2013-025]; Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; CHMIELECKI J, 2009, AACR 100 ANN M DENV; Day E, 2013, METHODS, V59, P101, DOI 10.1016/j.ymeth.2012.08.001; Hata A, 2013, CANCER-AM CANCER SOC, V119, P4325, DOI 10.1002/cncr.28364; Huang Z, 2012, THORAC CANCER, V3, P334, DOI 10.1111/j.1759-7714.2012.00133.x; Kimura H, 2007, BRIT J CANCER, V97, P778, DOI 10.1038/sj.bjc.6603949; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Liu SV, 2014, EXPERT OPIN EMERG DR, V19, P51, DOI 10.1517/14728214.2014.873403; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok T, 2013, J CLIN ONCOL, V31; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Ranson M, 2013, AZD9291 IRREVERSIBLE; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Wakelee HA, 2013, SERIAL MONITORING PL; Wang J, 2010, CLIN CHEM, V56, P623, DOI 10.1373/clinchem.2009.134973; Wang SH, 2010, CLIN CANCER RES, V16, P1324, DOI 10.1158/1078-0432.CCR-09-2672; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Yang JC, 2013, ACTIVITY AFATINIB UN; Ye X, 2013, J THORAC ONCOL, V8, P1118, DOI 10.1097/JTO.0b013e31829f691f; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	34	15	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e110780	10.1371/journal.pone.0110780	http://dx.doi.org/10.1371/journal.pone.0110780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405807	Green Submitted, gold, Green Published			2022-12-26	WOS:000347121300007
J	Hornseth, ML; Walpole, AA; Walton, LR; Bowman, J; Ray, JC; Fortin, MJ; Murray, DL				Hornseth, Megan L.; Walpole, Aaron A.; Walton, Lyle R.; Bowman, Jeff; Ray, Justina C.; Fortin, Marie-Josee; Murray, Dennis L.			Habitat Loss, Not Fragmentation, Drives Occurrence Patterns of Canada Lynx at the Southern Range Periphery	PLOS ONE			English	Article							SNOWSHOE HARE POPULATION; GENETIC DIVERSITY; ABUNDANCE; CONNECTIVITY; CONSERVATION; SELECTION; THRESHOLDS; MODELS; FOREST; MAINE	Peripheral populations often experience more extreme environmental conditions than those in the centre of a species' range. Such extreme conditions include habitat loss, defined as a reduction in the amount of suitable habitat, as well as habitat fragmentation, which involves the breaking apart of habitat independent of habitat loss. The 'threshold hypothesis' predicts that organisms will be more affected by habitat fragmentation when the amount of habitat on the landscape is scarce (i.e., less than 30%) than when habitat is abundant, implying that habitat fragmentation may compound habitat loss through changes in patch size and configuration. Alternatively, the 'flexibility hypothesis' predicts that individuals may respond to increased habitat disturbance by altering their selection patterns and thereby reducing sensitivity to habitat loss and fragmentation. While the range of Canada lynx (Lynx canadensis) has contracted during recent decades, the relative importance of habitat loss and habitat fragmentation on this phenomenon is poorly understood. We used a habitat suitability model for lynx to identify suitable land cover in Ontario, and contrasted occupancy patterns across landscapes differing in cover, to test the 'threshold hypothesis' and 'flexibility hypothesis'. When suitable land cover was widely available, lynx avoided areas with less than 30% habitat and were unaffected by habitat fragmentation. However, on landscapes with minimal suitable land cover, lynx occurrence was not related to either habitat loss or habitat fragmentation, indicating support for the 'flexibility hypothesis'. We conclude that lynx are broadly affected by habitat loss, and not specifically by habitat fragmentation, although occurrence patterns are flexible and dependent on landscape condition. We suggest that lynx may alter their habitat selection patterns depending on local conditions, thereby reducing their sensitivity to anthropogenically-driven habitat alteration.	[Hornseth, Megan L.] Trent Univ, Peterborough, ON K9J 7B8, Canada; [Walpole, Aaron A.; Bowman, Jeff] Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON, Canada; [Walton, Lyle R.] Ontario Minist Nat Resources, Reg Operat Div, South Porcupine, ON, Canada; [Ray, Justina C.] Wildlife Conservat Soc Canada, Toronto, ON, Canada; [Fortin, Marie-Josee] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Murray, Dennis L.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada	Trent University; Ministry of Natural Resources & Forestry; Ministry of Natural Resources & Forestry; University of Toronto; Trent University	Hornseth, ML (corresponding author), Lakehead Univ, Ontario Minist Nat Resources & Forestry, Ctr Northern Forest Ecol Res, Thunder Bay, ON P7B 5E1, Canada.	mhornseth@gmail.com	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Hornseth, Megan/0000-0002-9596-0316	Panthera Foundation; Ontario Ministry of Natural Resources North East Science and Information Section; Strategic Natural Sciences and Engineering Research grant; Natural Sciences and Engineering Research Industrial Postgraduate Scholarship; Wildlife Conservation Society Canada	Panthera Foundation; Ontario Ministry of Natural Resources North East Science and Information Section; Strategic Natural Sciences and Engineering Research grant; Natural Sciences and Engineering Research Industrial Postgraduate Scholarship; Wildlife Conservation Society Canada	This study was funded by the Wildlife Conservation Society Kaplan Awards Program (now the Panthera Foundation, given to MLH), the Ontario Ministry of Natural Resources North East Science and Information Section, a Strategic Natural Sciences and Engineering Research grant to DLM, and a Natural Sciences and Engineering Research Industrial Postgraduate Scholarship with the Wildlife Conservation Society Canada to Megan Hornseth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard-Duchene A, 2014, FOREST ECOL MANAG, V313, P17, DOI 10.1016/j.foreco.2013.10.046; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Aubry Keith B., 2000, P373; Barnagaud JY, 2011, GLOBAL ECOL BIOGEOGR, V20, P630, DOI 10.1111/j.1466-8238.2010.00629.x; Bayne EM, 2008, CAN J ZOOL, V86, P1189, DOI 10.1139/Z08-099; Bonn A, 2001, ECOGRAPHY, V24, P483, DOI 10.1034/j.1600-0587.2001.d01-204.x; Burdett CL, 2007, J MAMMAL, V88, P457, DOI 10.1644/06-MAMM-A-181R.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Cheng E, 2014, MOL ECOL, V23, P2929, DOI 10.1111/mec.12790; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2002, J WILDLIFE MANAGE, V61, P603; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; Fuller AK, 2007, J WILDLIFE MANAGE, V71, P1980, DOI 10.2193/2006-288; Gaston K. J., 2003, STRUCTURE DYNAMICS G, P266; Girvetz EH, 2008, LANDSCAPE URBAN PLAN, V86, P205, DOI 10.1016/j.landurbplan.2008.02.007; Girvetz EH, 2007, LANDSCAPE ECOL, V22, P1131, DOI 10.1007/s10980-007-9104-8; GRANT MC, 1978, EVOLUTION, V32, P822, DOI [10.2307/2407497, 10.1111/j.1558-5646.1978.tb04637.x]; Holloway GL, 2004, HABITAT RELATIONSHIP; Holt RD, 2008, ISR J ECOL EVOL, V54, P295, DOI 10.1560/IJEE.54.3-4.295; Homyack JA, 2006, WILDLIFE SOC B, V34, P74, DOI 10.2193/0091-7648(2006)34[74:QDOSHI]2.0.CO;2; Hoving CL, 2005, J WILDLIFE MANAGE, V69, P739, DOI 10.2193/0022-541X(2005)069[0739:BPOCLO]2.0.CO;2; Jaeger JAG, 2000, LANDSCAPE ECOL, V15, P115, DOI 10.1023/A:1008129329289; Koen EL, 2014, ECOGRAPHY, V37, P754, DOI 10.1111/j.1600-0587.2013.00629.x; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lewis CW, 2011, J MAMMAL, V92, P561, DOI 10.1644/10-MAMM-A-095.1; LITVAITIS JA, 1985, J WILDLIFE MANAGE, V49, P866, DOI 10.2307/3801359; Maxie AJ, 2010, FOREST CHRON, V86, P77, DOI 10.5558/tfc86077-1; Mowat G, 2003, CAN J ZOOL, V81, P1736, DOI 10.1139/Z03-174; Mowat Garth, 2000, P265; Murray DL, 2008, J WILDLIFE MANAGE, V72, P1463, DOI 10.2193/2007-389; Murray DL, 2000, CAN J ZOOL, V78, P1207, DOI 10.1139/cjz-78-7-1207; MURRAY DL, 1994, CAN J ZOOL, V72, P1444, DOI 10.1139/z94-191; OMNR, 2011, ANN REP FOR MAN 2009; Peers MJL, 2014, GLOBAL CHANGE BIOL, V20, P1126, DOI 10.1111/gcb.12469; Peers MJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051488; Perera AH, 2000, SPATIAL PATTERNS MAN, P74; Poole KG, 2003, CAN FIELD NAT, V117, P360, DOI 10.22621/cfn.v117i3.738; Radford JQ, 2004, BIOL CONSERV, V117, P375, DOI 10.1016/j.biocon.2003.08.002; Reunanen P., 2004, Ecological Bulletins, V51, P277; Roth JD, 2007, ECOLOGY, V88, P2736, DOI 10.1890/07-0147.1; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Steury TD, 2004, BIOL CONSERV, V117, P127, DOI 10.1016/S0006-3207(03)00287-8; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Swihart RK, 2006, DIVERS DISTRIB, V12, P277, DOI 10.1111/j.1366-9516.2006.00242.x; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Vashon JH, 2008, J WILDLIFE MANAGE, V72, P1479, DOI 10.2193/2007-462; Walpole AA, 2012, LANDSCAPE ECOL, V27, P761, DOI 10.1007/s10980-012-9728-1; Wirsing AJ, 2002, CAN J ZOOL, V80, P169, DOI 10.1139/Z01-214; Yackulic CB, 2011, P NATL ACAD SCI USA, V108, P4024, DOI 10.1073/pnas.1015097108	55	13	13	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113511	10.1371/journal.pone.0113511	http://dx.doi.org/10.1371/journal.pone.0113511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401737	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700139
J	Lane, T; Osmand, T; Marr, A; Shade, SB; Dunkle, K; Sandfort, T; Struthers, H; Kegeles, S; McIntyre, JA				Lane, Tim; Osmand, Thomas; Marr, Alexander; Shade, Starley B.; Dunkle, Kristin; Sandfort, Theodorus; Struthers, Helen; Kegeles, Susan; McIntyre, James A.			The Mpumalanga Men's Study (MPMS): Results of a Baseline Biological and Behavioral HIV Surveillance Survey in Two MSM Communities in South Africa	PLOS ONE			English	Article							SEXUAL RISK BEHAVIOR; YOUNG GAY; MPOWERMENT PROJECT; BISEXUAL MEN; CAPE-TOWN; BLACK-MEN; INFECTION; PREVALENCE; PREVENTION; CARE	The Mpumalanga Men's Study (MPMS) is the assessment of the Project Boithato HIV prevention intervention for South African MSM. Boithato aims to increase consistent condom use, regular testing for HIV-negative MSM, and linkage to care for HIV-positive MSM. The MPMS baseline examined HIV prevalence and associated risk behaviors, and testing, care, and treatment behaviors among MSM in Gert Sibande and Ehlanzeni districts in Mpumalanga province, South Africa in order to effectively target intervention activities. We recruited 307 MSM in Gert Sibande and 298 in Ehlanzeni through respondentdriven sampling (RDS) between September 2012-March 2013. RDS-adjusted HIV prevalence estimates are 28.3% (95% CI 21.1%-35.3%) in Gert Sibande, and 13.7% (95% CI 9.1%-19.6%) in Ehlanzeni. Prevalence is significantly higher among MSM over age 25 [ 57.8% (95% CI 43.1%-72.9%) vs. 17.9% (95% CI 10.6%-23.9%), P < 0.001 in Gert Sibande; 34.5% (95% CI 20.5%-56.0%) vs. 9.1% (95% CI 4.6%-13.9%), P < 0.001 in Ehlanzeni]. In Gert Sibande, prevalence is higher among self-identified gay and transgender MSM vs. other MSM [39.3% (95% CI, 28.3%-47.9%), P < 0.01], inconsistent condom users [38.1% (18.1%64.2%), P < 0.05], those with a current regular male partner [35.0% (27.1%-46.4%), P < 0.05], and those with lifetime experience of intimate partner violence with men [40.4%, (95% CI 28.9%-50.9%), P < 0.05]. Prevalence of previous HIV testing was 65.8% (95% CI 58.8%-74.0%) in Gert Sibande, and 69.3% (95% CI 61.9%-76.8%) in Ehlanzeni. Regular HIV testing was uncommon [(34.6%, (95% CI 27.9%-41.4%) in Gert Sibande; 31.0% (95% CI 24.9%-37.8%) in Ehlanzeni]. Among HIV-positive participants, few knew their status (28.1% in Gert Sibande and 14.5% in Ehlanzeni), or were appropriately linked to care (18.2% and 11.3%, respectively), or taking antiretroviral therapy (13.6% and 9.6% respectively). MPMS results demonstrate the importance of implementing interventions for MSM to increase consistent condom use, regular HIV testing, and linkage and engagement in care for HIV-infected MSM.	[Lane, Tim; Osmand, Thomas; Marr, Alexander; Shade, Starley B.; Kegeles, Susan] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Dunkle, Kristin] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Sandfort, Theodorus] Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY USA; [Struthers, Helen; McIntyre, James A.] Anova Hlth Inst, Johannesburg, South Africa; [Struthers, Helen] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [McIntyre, James A.] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	University of California System; University of California San Francisco; Emory University; Rollins School Public Health; Columbia University; University of Cape Town; University of Cape Town	Lane, T (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	Tim.Lane@ucsf.edu	Harding, Richard/G-9729-2012; Dunkle, Kristin/AAU-5488-2020; Sandfort, Theo/D-1796-2011	Dunkle, Kristin/0000-0003-3071-5544; Sandfort, Theo/0000-0002-4986-1739	National Institute of Allergy and Infectious Disease (NIAID) [R01AI089292]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520, P30MH062246] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Allergy and Infectious Disease (NIAID) R01AI089292. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Arnold MP, 2012, AIDS BEHAV; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Baral SD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18768; Beyrer C, 2006, HIV EPIDEMIOLOGY UPD; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Dahoma M, 2011, AIDS BEHAV, V15, P186, DOI 10.1007/s10461-009-9646-7; Hays RB, 2003, AM J COMMUN PSYCHOL, V31, P301, DOI 10.1023/A:1023966905973; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Imrie J, 2013, AIDS BEHAV, V17, pS70, DOI 10.1007/s10461-012-0356-1; Johnson CA, 2007, MAP HIV AIDS PROGRAM; Johnston LG, 2008, AIDS BEHAV, V12, P294, DOI 10.1007/s10461-007-9300-1; Kegeles SM, 1999, AIDS, V13, P1753, DOI 10.1097/00002030-199909100-00020; Kegeles SM, 1996, AM J PUBLIC HEALTH, V86, P1129, DOI 10.2105/AJPH.86.8_Pt_1.1129; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Knox J, 2013, AIDS BEHAV, V17, P350, DOI 10.1007/s10461-012-0337-4; Knox J, 2010, PSYCHOL HEALTH MED, V15, P660, DOI 10.1080/13548506.2010.507772; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Merrigan M, 2011, SEX TRANSM INFECT, V87, P65, DOI 10.1136/sti.2008.034991; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Millett GA, 2012, LANCET, V380, P411, DOI 10.1016/S0140-6736(12)60722-3; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; Park JN, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18752; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Rispel LC, 2011, J PUBLIC HEALTH POL, V32, pS137, DOI 10.1057/jphp.2011.29; Rispel LC, 2011, JAIDS-J ACQ IMM DEF, V57, P69, DOI 10.1097/QAI.0b013e318211b40a; Salganik M, 2004, SOCIOLOGICA IN PRESS; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; South African National AIDS Council, 2011, NAT STRAT PLAN HIV S, P2012; South African National Department of Health, 2011, 2011 NAT ANT SENT HI; Statistics South Africa, 2011, STAT PLAC; Stephenson R, 2013, AIDS BEHAV, V17, pS43, DOI 10.1007/s10461-012-0293-z; Stephenson R, 2012, AIDS CARE, V24, P529, DOI 10.1080/09540121.2011.617413; Vu L, 2013, JAIDS-J ACQ IMM DEF, V63, P221, DOI 10.1097/QAI.0b013e31828a3e60; World Health Organization, 2014, POL BRIEF CONS GUID	44	48	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111063	10.1371/journal.pone.0111063	http://dx.doi.org/10.1371/journal.pone.0111063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25401785	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700012
J	Janardhan, SV; Marks, R; Gajewski, TF				Janardhan, Sujit V.; Marks, Reinhard; Gajewski, Thomas F.			Primary Murine CD4(+) T Cells Fail to Acquire the Ability to Produce Effector Cytokines When Active Ras Is Present during Th1/Th2 Differentiation	PLOS ONE			English	Article							ERYTHROID-DIFFERENTIATION; DNA METHYLTRANSFERASE; TRANSCRIPTION FACTOR; ANTIGEN RECEPTOR; GENE-EXPRESSION; ERK ACTIVATION; SELECTION; PATHWAY; ANERGY; SOS1	Constitutive Ras signaling has been shown to augment IL-2 production, reverse anergy, and functionally replace many aspects of CD28 co-stimulation in CD4(+) T cells. These data raise the possibility that introduction of active Ras into primary T cells might result in improved functionality in pathologic situations of T cell dysfunction, such as cancer or chronic viral infection. To test the biologic effects of active Ras in primary T cells, CD4(+) T cells from Coxsackie-Adenovirus Receptor Transgenic mice were transduced with an adenovirus encoding active Ras. As expected, active Ras augmented IL-2 production in naive CD4(+) T cells. However, when cells were cultured for 4 days under conditions to promote effector cell differentiation, active Ras inhibited the ability of CD4(+) T cells to acquire a Th1 or Th2 effector cytokine profile. This differentiation defect was not due to deficient STAT4 or STAT6 activation by IL-12 or IL-4, respectively, nor was it associated with deficient induction of T-bet and GATA-3 expression. Impaired effector cytokine production in active Ras-transduced cells was associated with deficient demethylation of the IL-4 gene locus. Our results indicate that, despite augmenting acute activation of naive T cells, constitutive Ras signaling inhibits the ability of CD4(+) T cells to properly differentiate into Th1/Th2 effector cytokine-producing cells, in part by interfering with epigenetic modification of effector gene loci. Alternative strategies to potentiate Ras pathway signaling in T cells in a more regulated fashion should be considered as a therapeutic approach to improve immune responses in vivo.	[Janardhan, Sujit V.; Marks, Reinhard; Gajewski, Thomas F.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Gajewski, Thomas F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Gajewski, TF (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu			National Institutes of Health [R21 AI59818, R01 CA118153]; NATIONAL CANCER INSTITUTE [R01CA118153] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R21 AI59818 and R01 CA118153 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Crespo P, 2000, CELL MOL LIFE SCI, V57, P1613, DOI 10.1007/PL00000645; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Deng C, 1998, BIOL CHEM, V379, P1113, DOI 10.1515/bchm.1998.379.8-9.1113; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Farrar JD, 2002, J CLIN INVEST, V109, P431, DOI 10.1172/JCI200215093; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; GUERRERO I, 1984, SCIENCE, V225, P1159, DOI 10.1126/science.6474169; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Iborra S, 2013, J EXP MED, V210, P1463, DOI 10.1084/jem.20112495; Janardhan SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024931; Kang CD, 1999, EXP MOL MED, V31, P76, DOI 10.1038/emm.1999.13; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Kortum RL, 2013, J IMMUNOL, V190, P147, DOI 10.4049/jimmunol.1201458; Kortum RL, 2011, P NATL ACAD SCI USA, V108, P12407, DOI 10.1073/pnas.1104295108; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Marks RE, 2003, BIOCHEM BIOPH RES CO, V312, P691, DOI 10.1016/j.bbrc.2003.10.168; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Omidvar N, 2006, MOL CELL BIOL, V26, P3966, DOI 10.1128/MCB.26.10.3966-3975.2006; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; Poltorak M, 2014, EUR J IMMUNOL, V44, P1535, DOI 10.1002/eji.201344046; Prasad A, 2009, P NATL ACAD SCI USA, V106, P528, DOI 10.1073/pnas.0805981105; ROULEAU J, 1995, J BIOL CHEM, V270, P1595, DOI 10.1074/jbc.270.4.1595; Rouquette-Jazdanian AK, 2012, MOL CELL, V48, P298, DOI 10.1016/j.molcel.2012.08.011; SEDER RA, 1994, J ALLERGY CLIN IMMUN, V94, P1195, DOI 10.1016/0091-6749(94)90332-8; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Wang XZ, 2000, J VIROL, V74, P11296, DOI 10.1128/JVI.74.23.11296-11303.2000; Warnecke N, 2012, EMBO REP, V13, P386, DOI 10.1038/embor.2012.17; Zaker F, 1997, LEUKEMIA RES, V21, P635, DOI 10.1016/S0145-2126(97)00022-2; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	51	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112831	10.1371/journal.pone.0112831	http://dx.doi.org/10.1371/journal.pone.0112831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397617	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558500097
J	Perkins, TL; Clements, K; Baas, JH; Jago, CF; Jones, DL; Malham, SK; McDonald, JE				Perkins, Tracy L.; Clements, Katie; Baas, Jaco H.; Jago, Colin F.; Jones, Davey L.; Malham, Shelagh K.; McDonald, James E.			Sediment Composition Influences Spatial Variation in the Abundance of Human Pathogen Indicator Bacteria within an Estuarine Environment	PLOS ONE			English	Article							WATERBORNE ESCHERICHIA-COLI; FECAL-COLIFORMS; CAMPYLOBACTER-JEJUNI; MICROBIAL PATHOGENS; ENTERIC BACTERIA; VIBRIO-CHOLERAE; MARINE WATERS; SURVIVAL; TEMPERATURE; QUALITY	Faecal contamination of estuarine and coastal waters can pose a risk to human health, particularly in areas used for shellfish production or recreation. Routine microbiological water quality testing highlights areas of faecal indicator bacteria (FIB) contamination within the water column, but fails to consider the abundance of FIB in sediments, which under certain hydrodynamic conditions can become resuspended. Sediments can enhance the survival of FIB in estuarine environments, but the influence of sediment composition on the ecology and abundance of FIB is poorly understood. To determine the relationship between sediment composition (grain size and organic matter) and the abundance of pathogen indicator bacteria (PIB), sediments were collected from four transverse transects of the Conwy estuary, UK. The abundance of culturable Escherichia coli, total coliforms, enterococci, Campylobacter, Salmonella and Vibrio spp. in sediments was determined in relation to sediment grain size, organic matter content, salinity, depth and temperature. Sediments that contained higher proportions of silt and/or clay and associated organic matter content showed significant positive correlations with the abundance of PIB. Furthermore, the abundance of each bacterial group was positively correlated with the presence of all other groups enumerated. Campylobacter spp. were not isolated from estuarine sediments. Comparisons of the number of culturable E. coli, total coliforms and Vibrio spp. in sediments and the water column revealed that their abundance was 281, 433 and 58-fold greater in sediments (colony forming units (CFU)/100 g) when compared with the water column (CFU/100 ml), respectively. These data provide important insights into sediment compositions that promote the abundance of PIB in estuarine environments, with important implications for the modelling and prediction of public health risk based on sediment resuspension and transport.	[Perkins, Tracy L.; McDonald, James E.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Clements, Katie; Baas, Jaco H.; Jago, Colin F.; Malham, Shelagh K.] Bangor Univ, Sch Ocean Sci, Bangor, Gwynedd, Wales; [Jones, Davey L.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Malham, Shelagh K.] Bangor Univ, Ctr Appl Marine Sci, Bangor, Gwynedd, Wales	Bangor University; Bangor University; Bangor University; Bangor University	McDonald, JE (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	j.mcdonald@bangor.ac.uk	Jones, Davey L/C-7411-2011; jones, davey/AAN-5606-2020; Jones, Davey/AAD-6037-2020; Malham, Shelagh K/O-9054-2014	Jones, Davey L/0000-0002-1482-4209; Jones, Davey/0000-0002-1482-4209; McDonald, James/0000-0002-6328-3752	Knowledge Economy Skills Scholarship (KESS); European Social Fund (ESF) through the European Union's Convergence program; Natural Environment Research Council consortium grant under the Macronutrient Cycles Research Programme [NE/J011908/1]; Natural Environment Research Council [NE/J011908/1] Funding Source: researchfish; NERC [NE/J011908/1] Funding Source: UKRI	Knowledge Economy Skills Scholarship (KESS); European Social Fund (ESF) through the European Union's Convergence program; Natural Environment Research Council consortium grant under the Macronutrient Cycles Research Programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by a Knowledge Economy Skills Scholarship (KESS), part-funded by the European Social Fund (ESF) through the European Union's Convergence program administered by the Welsh Government in association with Dwr Cymru Cyf/Welsh Water Ltd. (http://www.higherskillswales.co.uk/kess/index.php.en?menu = 0&catid = 0), and a Natural Environment Research Council consortium grant under the Macronutrient Cycles Research Programme (NE/J011908/1) (http://www.nerc.ac.uk/research/funded/programmes/macronutrient/#xcollapse3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO JL, 1993, WATER RES, V27, P1559, DOI 10.1016/0043-1354(93)90100-V; An YJ, 2002, ENVIRON POLLUT, V120, P771, DOI 10.1016/S0269-7491(02)00173-2; Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005; Bakr W. M. K., 2011, The Journal of American Science, V7, P663; Barcina I, 1997, FEMS MICROBIOL ECOL, V23, P1, DOI 10.1111/j.1574-6941.1997.tb00385.x; Berthe T, 2008, MAR POLLUT BULL, V57, P59, DOI 10.1016/j.marpolbul.2007.10.013; Bordalo AA, 2002, J APPL MICROBIOL, V93, P864, DOI 10.1046/j.1365-2672.2002.01760.x; BURTON GA, 1987, APPL ENVIRON MICROB, V53, P633, DOI 10.1128/AEM.53.4.633-638.1987; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Carrero-Colon M, 2011, FECAL BACTERIA, P23; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cox AM, 2012, APPL ENVIRON MICROB, V78, P2996, DOI 10.1128/AEM.07519-11; Craig DL, 2004, J APPL MICROBIOL, V96, P922, DOI 10.1111/j.1365-2672.2004.02243.x; Danovaro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007006; Davies CM, 2000, J APPL MICROBIOL, V89, P349, DOI 10.1046/j.1365-2672.2000.01118.x; DAVIES CM, 1991, J APPL BACTERIOL, V70, P265, DOI 10.1111/j.1365-2672.1991.tb02935.x; DAVIES CM, 1995, APPL ENVIRON MICROB, V61, P1888, DOI 10.1128/AEM.61.5.1888-1896.1995; Davies-Colley RJ, 1999, WATER RES, V33, P1220, DOI 10.1016/S0043-1354(98)00321-2; Droppo IG, 2009, ENVIRON SCI TECHNOL, V43, P1737, DOI 10.1021/es802321w; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Edge TA, 2011, FECAL BACTERIA, P241; EVISON LM, 1988, WATER SCI TECHNOL, V20, P309, DOI 10.2166/wst.1988.0300; FAUST MA, 1975, APPL MICROBIOL, V30, P800, DOI 10.1128/AEM.30.5.800-806.1975; Figueras MJ, 1997, MAR POLLUT BULL, V34, P148, DOI 10.1016/S0025-326X(97)00107-0; Garzio-Hadzick A, 2010, WATER RES, V44, P2753, DOI 10.1016/j.watres.2010.02.011; GERBA CP, 1976, APPL ENVIRON MICROB, V32, P114, DOI 10.1128/AEM.32.1.114-120.1976; GESAMP, 2001, GESAMP REP STUD, V70, P19; GRIMES DJ, 1975, APPL MICROBIOL, V29, P109, DOI 10.1128/AEM.29.1.109-111.1975; Haller L, 2009, WATER AIR SOIL POLL, V203, P217, DOI 10.1007/s11270-009-0005-0; Hong HC, 2010, J ENVIRON SCI-CHINA, V22, P663, DOI 10.1016/S1001-0742(09)60160-1; Howell JM, 1996, J ENVIRON QUAL, V25, P1216, DOI 10.2134/jeq1996.00472425002500060007x; Ishii S, 2007, ENVIRON SCI TECHNOL, V41, P2203, DOI 10.1021/es0623156; JONES GE, 1964, J BACTERIOL, V87, P483, DOI 10.1128/JB.87.3.483-499.1964; KORHONEN LK, 1991, J APPL BACTERIOL, V71, P379, DOI 10.1111/j.1365-2672.1991.tb03804.x; Levin RE, 2007, FOOD BIOTECHNOL, V21, P271, DOI 10.1080/08905430701536565; Malham SK, 2014, ENVIRON SCI-PROC IMP, V16, P2145, DOI [10.1039/c4em00031e, 10.1039/C4EM00031E]; MARINO RP, 1991, WATER RES, V25, P1089, DOI 10.1016/0043-1354(91)90202-2; Obiri-Danso K, 2000, WATER RES, V34, P519, DOI 10.1016/S0043-1354(99)00146-3; Okpokwasili GC, 1996, ENVIRON TOXIC WATER, V11, P77; Oliver LR, 2008, HYDROBIOLOGIA, V606, P117, DOI 10.1007/s10750-008-9339-7; Polo F, 1998, FEMS MICROBIOL LETT, V160, P253, DOI 10.1016/S0378-1097(98)00040-8; POMMEPUY M, 1992, WATER SCI TECHNOL, V25, P93, DOI 10.2166/wst.1992.0341; Pote J, 2009, J ENVIRON SCI, V21, P62, DOI 10.1016/S1001-0742(09)60012-7; Power ML, 2005, ENVIRON MICROBIOL, V7, P631, DOI 10.1111/j.1462-2920.2005.00729.x; Quilliam RS, 2011, J WATER HEALTH, V9, P734, DOI 10.2166/wh.2011.057; Roper MM, 1974, MICROB ECOL, V1, P1, DOI 10.1007/BF02512375; Shuval Hillel, 2003, Journal of Water and Health, V1, P53; SINGLETON FL, 1982, APPL ENVIRON MICROB, V44, P1047, DOI 10.1128/AEM.44.5.1047-1058.1982; SINTON LW, 1994, APPL ENVIRON MICROB, V60, P2040, DOI 10.1128/AEM.60.6.2040-2048.1994; Straub TM, 2003, J MICROBIOL METH, V53, P185, DOI 10.1016/S0167-7012(03)00023-X; Thorn CE, 2011, ANAEROBE, V17, P330, DOI 10.1016/j.anaerobe.2011.04.021; Thorns CJ, 2000, REV SCI TECH OIE, V19, P226, DOI 10.20506/rst.19.1.1219; Topp E, 2009, BIORESOURCE TECHNOL, V100, P5395, DOI 10.1016/j.biortech.2008.11.001; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	55	55	60	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112951	10.1371/journal.pone.0112951	http://dx.doi.org/10.1371/journal.pone.0112951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397595	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558500118
J	Tognetti, R; Lombardi, F; Lasserre, B; Cherubini, P; Marchetti, M				Tognetti, Roberto; Lombardi, Fabio; Lasserre, Bruno; Cherubini, Paolo; Marchetti, Marco			Tree-Ring Stable Isotopes Reveal Twentieth-Century Increases in Water-Use Efficiency of Fagus sylvatica and Nothofagus spp. in Italian and Chilean Mountains	PLOS ONE			English	Article							LONG-TERM TRENDS; CARBON-DIOXIDE; CLIMATE-CHANGE; QUERCUS-PUBESCENS; CENTRAL APENNINES; BEECH FOREST; GROWTH; DELTA-C-13; DROUGHT; L.	Changes in intrinsic water use efficiency (iWUE) were investigated in Fagus sylvatica and Nothofagus spp. over the last century. We combined dendrochronological methods with dual-isotope analysis to investigate whether atmospheric changes enhanced iWUE of Fagus and Nothofagus and tree growth (basal area increment, BAI) along latitudinal gradients in Italy and Chile. Post-maturation phases of the trees presented different patterns in delta C-13, Delta C-13, delta O-18, Ci (internal CO2 concentration), iWUE, and BAI. A continuous enhancement in isotope-derived iWUE was observed throughout the twentieth century, which was common to all sites and related to changes in Ca (ambient CO2 concentration) and secondarily to increases in temperature. In contrast to other studies, we observed a general increasing trend of BAI, with the exception of F. sylvatica in Aspromonte. Both iWUE and BAI were uncoupled with the estimated drought index, which is in agreement with the absence of enduring decline in tree growth. In general, delta C-13 and delta O-18 showed a weak relationship, suggesting the major influence of photosynthetic rate on Ci and delta C-13, and the minor contribution of the regulation of stomatal conductance to iWUE. The substantial warming observed during the twentieth century did not result in a clear pattern of increased drought stress along these latitudinal transects, because of the variability in temporal trends of precipitation and in specific responses of populations.	[Tognetti, Roberto; Lombardi, Fabio; Lasserre, Bruno; Marchetti, Marco] Univ Molise, Dipartimento Biosci & Terr, Pesche, Italy; [Tognetti, Roberto] Edmund Mach Fdn, EFI Project Ctr Mt Forests MOUNTFOR, San Michele All Adige, Italy; [Cherubini, Paolo] WSL Swiss Fed Inst Forest Snow & Landscape Res, Birmensdorf, Switzerland	University of Molise; Fondazione Edmund Mach; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Tognetti, R (corresponding author), Univ Molise, Dipartimento Biosci & Terr, Pesche, Italy.	tognetti@unimol.it	Cherubini, Paolo/N-9702-2013; Tognetti, Roberto/C-4962-2008; Cherubini, Paolo/AAC-3121-2021; lasserre, bruno/G-1409-2011; Marchetti, Marco/D-9277-2012	Cherubini, Paolo/0000-0002-9809-250X; Tognetti, Roberto/0000-0002-7771-6176; Cherubini, Paolo/0000-0002-9809-250X; lasserre, bruno/0000-0003-1150-8064; Marchetti, Marco/0000-0002-5275-5769; Lombardi, Fabio/0000-0003-3517-5890	MIUR, Italy; FIRB, MIUR, Italy	MIUR, Italy(Ministry of Education, Universities and Research (MIUR)); FIRB, MIUR, Italy(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	Financial support was provided by the project "Ciclo del carbonio ed altri gas serra in ecosistemi forestali, naturali ed artificiali dell'America Latina: analisi preliminare, studio di fattibilita e comparazione con ecosistemi italiani'' (Internationalization 2008, MIUR, Italy) and "Sviluppo di modelli innovativi per il monitoraggio multiscala degli indicatori di servizi ecosistemici nelle foreste Mediterranee'' (FIRB 2012, MIUR, Italy) - http://www.istruzione.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, TRENDS PLANT SCI, V17, P693, DOI 10.1016/j.tplants.2012.09.006; Anderson W. T., 2005, Dendrochronologia, V23, P1, DOI 10.1016/j.dendro.2005.07.006; Andreu-Hayles L, 2011, GLOBAL CHANGE BIOL, V17, P2095, DOI 10.1111/j.1365-2486.2010.02373.x; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Barbour MM, 2007, FUNCT PLANT BIOL, V34, P83, DOI 10.1071/FP06228; Barbour MM, 2002, PLANT CELL ENVIRON, V25, P1483, DOI 10.1046/j.0016-8025.2002.00931.x; Barnard HR, 2012, TREE PHYSIOL, V32, P1183, DOI 10.1093/treephys/tps078; Bascietto M, 2004, CAN J FOREST RES, V34, P481, DOI 10.1139/X03-214; Battipaglia G, 2008, PALAEOGEOGR PALAEOCL, V261, P193, DOI 10.1016/j.palaeo.2008.01.020; Borella S, 1998, J GEOPHYS RES-ATMOS, V103, P19519, DOI 10.1029/98JD01169; BORGHETTI M, 1993, FUNCT ECOL, V7, P713, DOI 10.2307/2390193; Linares JC, 2012, GLOBAL CHANGE BIOL, V18, P1000, DOI 10.1111/j.1365-2486.2011.02566.x; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cook E., 1990, METHODS DENDROCHRONO, P104, DOI 10.1007/978-94-015-7879-0; Cullen LE, 2001, J ECOL, V89, P1061, DOI 10.1111/j.1365-2745.2001.00628.x; Cullen LE, 2008, TREE PHYSIOL, V28, P1525, DOI 10.1093/treephys/28.10.1525; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Daniels LD, 2004, ECOLOGY, V85, P1284, DOI 10.1890/03-0092; Di Filippo A, 2012, GLOBAL CHANGE BIOL, V18, P960, DOI 10.1111/j.1365-2486.2011.02617.x; Dittmar C, 2003, FOREST ECOL MANAG, V173, P63, DOI 10.1016/S0378-1127(01)00816-7; Douville H, 2013, NAT CLIM CHANGE, V3, P59, DOI [10.1038/nclimate1632, 10.1038/NCLIMATE1632]; Duquesnay A, 1998, PLANT CELL ENVIRON, V21, P565, DOI 10.1046/j.1365-3040.1998.00304.x; Eilmann B, 2012, TREE PHYSIOL, V32, P178, DOI 10.1093/treephys/tps004; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Feng XH, 1999, GEOCHIM COSMOCHIM AC, V63, P1891, DOI 10.1016/S0016-7037(99)00088-5; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; FRANCEY RJ, 1982, NATURE, V297, P28, DOI 10.1038/297028a0; Fritts H. C., 1976, TREE RINGS CLIMATE; Gagen M, 2011, GLOBAL CHANGE BIOL, V17, P1064, DOI 10.1111/j.1365-2486.2010.02273.x; Gessler A, 2014, TREE PHYSL IN PRESS; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Grams TEE, 2007, PLANT CELL ENVIRON, V30, P1023, DOI 10.1111/j.1365-3040.2007.01696.x; Granda E, 2014, OECOLOGIA, V174, P307, DOI 10.1007/s00442-013-2742-4; Grossiord C, 2014, P NATL ACAD SCI USA, V111, P14812, DOI 10.1073/pnas.1411970111; GUTIERREZ E, 1988, ACTA OECOL-OEC PLANT, V9, P301; Hardtle W, 2013, ECOSYSTEMS, V16, P1413, DOI 10.1007/s10021-013-9692-x; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; HARGREAVES GH, 1982, J IRR DRAIN DIV-ASCE, V108, P225; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hietz P, 2005, TREE PHYSIOL, V25, P745, DOI 10.1093/treephys/25.6.745; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Holtmeier FK, 2005, GLOBAL ECOL BIOGEOGR, V14, P395, DOI 10.1111/j.1466-822x.2005.00168.x; Kaennel M, 1995, MULTILINGUAL GLOSSAR; Keitel C, 2006, PLANT CELL ENVIRON, V29, P1492, DOI 10.1111/j.1365-3040.2006.01520.x; Kendall MG, 1976, RANK CORRELATION MET; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Kress A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003613; Lara A, 2005, J BIOGEOGR, V32, P879, DOI 10.1111/j.1365-2699.2005.01191.x; Lara A, 2001, CAN J FOREST RES, V31, P925, DOI 10.1139/cjfr-31-6-925; LEAVITT SW, 1986, ECOLOGY, V67, P1002, DOI 10.2307/1939823; Li JB, 2008, GLOBAL CHANGE BIOL, V14, P2096, DOI 10.1111/j.1365-2486.2008.01603.x; Linares JC, 2009, OECOLOGIA, V161, P611, DOI 10.1007/s00442-009-1409-7; Loader NJ, 1997, CHEM GEOL, V136, P313, DOI 10.1016/S0009-2541(96)00133-7; Lombardi F, 2008, ECOSYSTEMS, V11, P882, DOI 10.1007/s10021-008-9167-7; Lombardi F, 2011, AUSTRAL ECOL, V36, P329, DOI 10.1111/j.1442-9993.2010.02154.x; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Marchetti M, 2010, PLANT BIOSYST, V144, P130, DOI 10.1080/11263500903560470; Marshall JD, 1996, OECOLOGIA, V105, P13, DOI 10.1007/BF00328786; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; McMahon SM, 2010, P NATL ACAD SCI USA, V107, P3611, DOI 10.1073/pnas.0912376107; Nock CA, 2011, GLOBAL CHANGE BIOL, V17, P1049, DOI 10.1111/j.1365-2486.2010.02222.x; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Osmond C. B., 1980, PHYSL PROCESSES PLAN, DOI 10.1007/978-3-642-67637-6; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Piovesan G, 2005, ACTA OECOL, V27, P197, DOI 10.1016/j.actao.2005.01.001; Piovesan G, 2008, GLOBAL CHANGE BIOL, V14, P1265, DOI 10.1111/j.1365-2486.2008.01570.x; Premoli AC, 2007, AUSTRAL ECOL, V32, P515, DOI 10.1111/j.1442-9993.2007.01720.x; Richardson SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058878; Rigling A, 2013, GLOBAL CHANGE BIOL, V19, P229, DOI 10.1111/gcb.12038; Ripullone F, 2009, IFOREST, V2, P59, DOI 10.3832/ifor0491-002; Roden JS, 2012, TREE PHYSIOL, V32, P490, DOI 10.1093/treephys/tps019; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Saurer M, 1997, PLANT CELL ENVIRON, V20, P1543, DOI 10.1046/j.1365-3040.1997.d01-53.x; Scartazza A, 2013, TREE PHYSIOL, V33, P730, DOI 10.1093/treephys/tpt045; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; Schollaen K, 2013, QUATERNARY SCI REV, V73, P170, DOI 10.1016/j.quascirev.2013.05.018; Silva LCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053089; Silva LCR, 2013, GLOBAL ECOL BIOGEOGR, V22, P83, DOI 10.1111/j.1466-8238.2012.00783.x; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Silva LCR, 2009, GLOBAL CHANGE BIOL, V15, P2387, DOI 10.1111/j.1365-2486.2009.01859.x; Song X, 2014, PLANT CELL IN PRESS; Srur AM, 2008, REV CHIL HIST NAT, V81, P239; Suarez ML, 2004, J ECOL, V92, P954, DOI 10.1111/j.1365-2745.2004.00941.x; Switsur R., 1998, STABLE ISOTOPES INTE, P303; Tognetti R, 1999, TREE PHYSIOL, V19, P261; Tognetti R, 1998, ENVIRON EXP BOT, V39, P233, DOI 10.1016/S0098-8472(98)00013-6; Tognetti R, 1998, TREES-STRUCT FUNCT, V12, P326, DOI 10.1007/s004680050158; TOGNETTI R, 1995, TREES-STRUCT FUNCT, V9, P348, DOI 10.1007/BF00202499; TOGNETTI R, 1994, TREE PHYSIOL, V14, P751, DOI 10.1093/treephys/14.7-8-9.751; Tognetti R, 2012, TREES-STRUCT FUNCT, V26, P1805, DOI 10.1007/s00468-012-0749-9; Villalba R, 2003, CLIMATIC CHANGE, V59, P177, DOI 10.1023/A:1024452701153; Villalba R, 1997, CLIMATIC CHANGE, V36, P425, DOI 10.1023/A:1005366317996; Villalba R, 2012, NAT GEOSCI, V5, P793, DOI [10.1038/NGEO1613, 10.1038/ngeo1613]; Weber P, 2013, TREES-STRUCT FUNCT, V27, P171, DOI 10.1007/s00468-012-0786-4	101	49	49	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113136	10.1371/journal.pone.0113136	http://dx.doi.org/10.1371/journal.pone.0113136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398040	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500135
J	Johnson, JS; Reeder, DM; McMichael, JW; Meierhofer, MB; Stern, DWF; Lumadue, SS; Sigler, LE; Winters, HD; Vodzak, ME; Kurta, A; Kath, JA; Field, KA				Johnson, Joseph S.; Reeder, DeeAnn M.; McMichael, James W., III; Meierhofer, Melissa B.; Stern, Daniel W. F.; Lumadue, Shayne S.; Sigler, Lauren E.; Winters, Harrison D.; Vodzak, Megan E.; Kurta, Allen; Kath, Joseph A.; Field, Kenneth A.			Host, Pathogen, and Environmental Characteristics Predict White-Nose Syndrome Mortality in Captive Little Brown Myotis (Myotis lucifugus)	PLOS ONE			English	Article							MAMMALIAN HIBERNATION; ENERGY AVAILABILITY; EMERGING DISEASE; METABOLIC-RATE; BATS; DESTRUCTANS; GEOMYCES; POPULATIONS; RESPONSES; AROUSALS	An estimated 5.7 million or more bats died in North America between 2006 and 2012 due to infection with the fungus Pseudogymnoascus destructans (Pd) that causes white-nose syndrome (WNS) during hibernation. The behavioral and physiological changes associated with hibernation leave bats vulnerable to WNS, but the persistence of bats within the contaminated regions of North America suggests that survival might vary predictably among individuals or in relation to environmental conditions. To investigate variables influencing WNS mortality, we conducted a captive study of 147 little brown myotis (Myotis lucifugus) inoculated with 0, 500, 5 000, 50 000, or 500 000 Pd conidia and hibernated for five months at either 4 or 10 degrees C. We found that female bats were significantly more likely to survive hibernation, as were bats hibernated at 4 degrees C, and bats with greater body condition at the start of hibernation. Although all bats inoculated with Pd exhibited shorter torpor bouts compared to controls, a characteristic of WNS, only bats inoculated with 500 conidia had significantly lower survival odds compared to controls. These data show that host and environmental characteristics are significant predictors of WNS mortality, and that exposure to up to 500 conidia is sufficient to cause a fatal infection. These results also illustrate a need to quantify dynamics of Pd exposure in free-ranging bats, as dynamics of WNS produced in captive studies inoculating bats with several hundred thousand conidia may differ from those in the wild.	[Johnson, Joseph S.; Reeder, DeeAnn M.; McMichael, James W., III; Meierhofer, Melissa B.; Stern, Daniel W. F.; Lumadue, Shayne S.; Sigler, Lauren E.; Winters, Harrison D.; Vodzak, Megan E.; Field, Kenneth A.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Kurta, Allen] Eastern Michigan Univ, Dept Biol, Ypsilanti, MI 48197 USA; [Kath, Joseph A.] Illinois Dept Nat Resources, Springfield, IL USA	Bucknell University; Eastern Michigan University	Field, KA (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	kfield@bucknell.edu	Meierhofer, Melissa/AAS-3473-2021	Meierhofer, Melissa/0000-0003-2384-1999; Field, Kenneth/0000-0001-7417-4386; Reeder, DeeAnn/0000-0001-8651-2012	United States Fish and Wildlife Service [F12AP01210]; Woodtiger Foundation	United States Fish and Wildlife Service(US Fish & Wildlife Service); Woodtiger Foundation	Funding for this project was provided by the United States Fish and Wildlife Service grant F12AP01210 (DMR and KAF) and the Woodtiger Foundation (DMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blehert DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002779; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Brock Fenton M. B., 1970, Contr. Life Sci. Div. R. Ont. Mus., V77, P1; Brownlee-Bouboulis SA, 2013, J WILDLIFE DIS, V49, P850, DOI 10.7589/2012-10-242; BUCHANAN GD, 1987, AM J ANAT, V178, P335, DOI 10.1002/aja.1001780405; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chitarra GS, 2004, APPL ENVIRON MICROB, V70, P2823, DOI 10.1128/AEM.70.5.2823-2829.2004; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Dixon MD, 2011, J MAMMAL, V92, P1343, DOI 10.1644/10-MAMM-A-426.1; Dunbar MB, 2010, J COMP PHYSIOL B, V180, P885, DOI 10.1007/s00360-010-0457-y; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; GUSTAFSON AW, 1976, BIOL REPROD, V15, P9, DOI 10.1093/biolreprod/15.1.9; Herrero-Garcia E, 2011, FUNGAL BIOL-UK, V115, P393, DOI 10.1016/j.funbio.2011.02.005; HOLM S, 1979, SCAND J STAT, V6, P65; Humphrey SR, 1976, POPULATION ECOLOGY L; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Jonasson KA, 2012, J EXP BIOL, V215, P2141, DOI 10.1242/jeb.066514; Jonasson KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021061; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Luis AD, 2006, FUNCT ECOL, V20, P471, DOI 10.1111/j.1365-2435.2006.01119.x; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Moore MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058976; Muller LK, 2013, MYCOLOGIA, V105, P253, DOI 10.3852/12-242; Norquay KJO, 2013, J MAMMAL, V94, P506, DOI 10.1644/12-MAMM-A-065.1; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reeder DeeAnn M., 2013, P413; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; SPEAKMAN JR, 1986, J ZOOL, V210, P515; Storey KR, 2010, TOP CURR GENET, V21, P227, DOI 10.1007/978-3-642-12422-8_13; THOMAS DW, 1992, PHYSIOL ZOOL, V65, P443, DOI 10.1086/physzool.65.2.30158262; THOMAS DW, 1990, J EXP BIOL, V149, P395; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Turner Gregory G., 2011, Bat Research News, V52, P13; TWENTE JW, 1985, CAN J ZOOL, V63, P2955, DOI 10.1139/z85-443; van der Plank J.E., 1963, PLANT DIS, P1; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076	52	31	31	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112502	10.1371/journal.pone.0112502	http://dx.doi.org/10.1371/journal.pone.0112502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409028	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200023
J	Nassour, H; Dubreuil, JD				Nassour, Hassan; Dubreuil, J. Daniel			Escherichia coli STb Enterotoxin Dislodges Claudin-1 from Epithelial Tight Junctions	PLOS ONE			English	Article							HEAT-STABLE ENTEROTOXIN; PROTEIN-KINASE-C; BARRIER FUNCTION; BIOCHEMICAL-CHARACTERIZATION; LABILE ENTEROTOXIN; COLORECTAL-CANCER; T84 CELLS; TOXIN; PHOSPHORYLATION; PERMEABILITY	Enterotoxigenic Escherichia coli produce various heat-labile and heat-stable enterotoxins. STb is a low molecular weight heat-resistant toxin responsible for diarrhea in farm animals, mainly young pigs. A previous study demonstrated that cells having internalized STb toxin induce epithelial barrier dysfunction through changes in tight junction (TJ) proteins. These modifications contribute probably to the diarrhea observed. To gain insight into the mechanism of increased intestinal permeability following STb exposure we treated human colon cells (T84) with purified STb toxin after which cells were harvested and proteins extracted. Using a 1% Nonidet P-40-containing solution we investigated the distribution of claudin-1, a major structural and functional TJ protein responsible for the epithelium impermeability, between membrane (NP40-insoluble) and the cytoplasmic (NP-40 soluble) location. Using immunoblot and confocal microscopy, we observed that treatment of T84 cell monolayers with STb induced redistribution of claudin-1. After 24 h, cells grown in Ca++-free medium treated with STb showed about 40% more claudin-1 in the cytoplasm compare to the control. Switching from Ca++-free to Ca++-enriched medium (1.8 mM) increased the dislodgement rate of claudin-1 as comparable quantitative delocalization was observed after only 6 h. Medium supplemented with the same concentration of Mg++ or Zn++ did not affect the dislodgement rate compared to the Ca++-free medium. Using anti-phosphoserine and anti-phosphothreonine antibodies, we observed that the loss of membrane claudin-1 was accompanied by dephosphorylation of this TJ protein. Overall, our findings showed an important redistribution of claudin-1 in cells treated with STb toxin. The loss of phosphorylated TJ membrane claudin-1 is likely to be involved in the increased permeability observed. The mechanisms by which these changes are brought about remain to be elucidated.	[Nassour, Hassan; Dubreuil, J. Daniel] Univ Montreal, Fac Vet Med, GREMIP, Montreal, PQ, Canada	Universite de Montreal	Dubreuil, JD (corresponding author), Univ Montreal, Fac Vet Med, GREMIP, Montreal, PQ, Canada.	daniel.dubreuil@umontreal.ca	Dubreuil, Jean-Daniel/A-5929-2015		Natural Sciences and Engineering Council of Canada (NSERC) [139070]	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Council of Canada (NSERC) Discovery Grant (139070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1993, CURR OPIN CELL BIOL, V5, P772, DOI 10.1016/0955-0674(93)90024-K; Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Aono S, 2008, EXP CELL RES, V314, P3326, DOI 10.1016/j.yexcr.2008.08.012; ARRIAGA YL, 1995, INFECT IMMUN, V63, P4715, DOI 10.1128/IAI.63.12.4715-4720.1995; Balkovetz DF, 2003, MICROBES INFECT, V5, P613, DOI 10.1016/S1286-4579(03)00089-3; Banan A, 2005, J PHARMACOL EXP THER, V313, P962, DOI 10.1124/jpet.104.083428; Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Chao KL, 1997, INFECT IMMUN, V65, P3209, DOI 10.1128/IAI.65.8.3209-3217.1997; D'Souza T, 2007, EXP CELL RES, V313, P3364, DOI 10.1016/j.yexcr.2007.06.026; de Oliveira SS, 2005, FEBS LETT, V579, P6179, DOI 10.1016/j.febslet.2005.09.091; de Sousa CP, 2001, INT J MED MICROBIOL, V291, P15, DOI 10.1078/1438-4221-00097; DREYFUS LA, 1993, P NATL ACAD SCI USA, V90, P3202, DOI 10.1073/pnas.90.8.3202; Dubreuil JD, 2008, FEMS MICROBIOL LETT, V278, P137, DOI 10.1111/j.1574-6968.2007.00967.x; Erume J, 2013, VET MICROBIOL, V161, P315, DOI 10.1016/j.vetmic.2012.07.048; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fleckenstein JM, 2010, MICROBES INFECT, V12, P89, DOI 10.1016/j.micinf.2009.10.002; Fujibe M, 2004, EXP CELL RES, V295, P36, DOI 10.1016/j.yexcr.2003.12.014; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Harville BA, 1996, PEPTIDES, V17, P363, DOI 10.1016/0196-9781(96)00033-2; HARVILLE BA, 1995, INFECT IMMUN, V63, P745, DOI 10.1128/IAI.63.3.745-750.1995; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kreisberg RB, 2011, AM J TROP MED HYG, V84, P451, DOI 10.4269/ajtmh.2011.10-0445; Krug SM, 2009, BIOPHYS J, V97, P2202, DOI 10.1016/j.bpj.2009.08.003; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Labrie V, 2001, MICROBIOL-SGM, V147, P3141, DOI 10.1099/00221287-147-11-3141; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041041; Mukiza CN, 2013, INFECT IMMUN, V81, P2819, DOI 10.1128/IAI.00455-13; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nakashima R, 2013, VET IMMUNOL IMMUNOP, V152, P78, DOI 10.1016/j.vetimm.2012.09.026; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; Philpott DJ, 1996, AM J PHYSIOL-GASTR L, V270, pG634, DOI 10.1152/ajpgi.1996.270.4.G634; Philpott DJ, 1998, INFECT IMMUN, V66, P1680, DOI 10.1128/IAI.66.4.1680-1687.1998; Puthenedam M, 2007, CELL BIOL INT, V31, P836, DOI 10.1016/j.cellbi.2007.01.036; Ricardo R., 2008, J VIS EXP; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Rousset E, 1998, INFECT IMMUN, V66, P5650, DOI 10.1128/IAI.66.12.5650-5658.1998; Roxas JL, 2010, LAB INVEST, V90, P1152, DOI 10.1038/labinvest.2010.91; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Savarino SJ, 1996, J INFECT DIS, V173, P1019, DOI 10.1093/infdis/173.4.1019; Schmidt E, 2007, FEBS LETT, V581, P2974, DOI 10.1016/j.febslet.2007.05.051; Simonovic I, 2001, INFECT IMMUN, V69, P5679, DOI 10.1128/IAI.69.9.5679-5688.2001; Sjo A, 2003, BIOSCIENCE REP, V23, P87, DOI 10.1023/A:1025524323842; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; STEVENSON BR, 1988, MOL CELL BIOCHEM, V83, P129; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Suzuki H, 2012, ANN NY ACAD SCI, V1258, P65, DOI 10.1111/j.1749-6632.2012.06503.x; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Syed HC, 2012, MICROB PATHOGENESIS, V53, P147, DOI 10.1016/j.micpath.2012.06.003; Toriano R, 2001, AM J PHYSIOL-GASTR L, V281, pG816, DOI 10.1152/ajpgi.2001.281.3.G816; Turner SM, 2006, FEMS MICROBIOL LETT, V263, P10, DOI 10.1111/j.1574-6968.2006.00401.x; Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004; VISWESWARIAH SS, 1992, MICROB PATHOGENESIS, V12, P209, DOI 10.1016/0882-4010(92)90055-S; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05	58	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113273	10.1371/journal.pone.0113273	http://dx.doi.org/10.1371/journal.pone.0113273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409315	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200090
J	Sugimoto, H; Konno, S; Nomoto, N; Nakazora, H; Murata, M; Kitazono, H; Imamura, T; Inoue, M; Sasaki, M; Fuse, A; Hagiwara, W; Kobayashi, M; Fujioka, T				Sugimoto, Hideki; Konno, Shingo; Nomoto, Nobuatsu; Nakazora, Hiroshi; Murata, Mayumi; Kitazono, Hisao; Imamura, Tomomi; Inoue, Masashi; Sasaki, Miyuki; Fuse, Akihisa; Hagiwara, Wataru; Kobayashi, Mari; Fujioka, Toshiki			The Long-Term Effects of Pitavastatin on Blood Lipids and Platelet Activation Markers in Stroke Patients: Impact of the Homocysteine Level	PLOS ONE			English	Article							ATHEROSCLEROSIS; JAPANESE; STATINS; CELLS; RISK	To examine the impact of the plasma homocysteine level on the anti-atherosclerotic effects of pitavastatin treatment, we retrospectively examined 59 patients who had a history of stroke and had been prescribed pitavastatin for the treatment of dyslipidemia at the Neurology department of Toho University Ohashi Medical Center Hospital. The patients were classified into two groups according to their homocysteine levels. Carotid artery plaque progression was determined before and after pitavastatin treatment. Plasma levels of high-sensitivity C-reactive protein, platelet molecular markers, and von Willebrand factor were measured. Pitavastatin treatment had beneficial effects on the lipid profiles of these patients and slowed atherosclerosis progression. These effects were observed in both the high and low homocysteine groups. Proactive lipid intervention using pitavastatin may inhibit the progression of atherosclerosis and contribute to secondary prevention of stroke in high-risk patients. We conclude that this statin could inhibit progression at any stage of disease and should therefore be proactively administered to these patient groups, regardless of disease severity.	[Sugimoto, Hideki; Konno, Shingo; Nomoto, Nobuatsu; Nakazora, Hiroshi; Murata, Mayumi; Kitazono, Hisao; Imamura, Tomomi; Inoue, Masashi; Sasaki, Miyuki; Fuse, Akihisa; Hagiwara, Wataru; Kobayashi, Mari; Fujioka, Toshiki] Toho Univ Ohashi, Dept Internal Med, Div Neurol, Tokyo, Japan	Toho University	Sugimoto, H (corresponding author), Toho Univ Ohashi, Dept Internal Med, Div Neurol, Tokyo, Japan.	sugi-h@oha.toho-u.ac.jp						Adachi H, 2002, STROKE, V33, P2177, DOI 10.1161/01.STR.0000026861.18199.89; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Bogdanski P, 2012, CLIN CHEM LAB MED, V50, P1107, DOI 10.1515/cclm-2011-0856; CEJKA J, 1982, CLIN CHEM, V28, P1356; Cui RZ, 2008, ATHEROSCLEROSIS, V198, P412, DOI 10.1016/j.atherosclerosis.2007.09.029; Iso H, 2004, CIRCULATION, V109, P2766, DOI 10.1161/01.CIR.0000131942.77635.2D; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Koshiyama H, 2008, J ATHEROSCLER THROMB, V15, P345, DOI 10.5551/jat.E581; Lee M, 2010, STROKE, V41, P1205, DOI 10.1161/STROKEAHA.109.573410; Li H, 2002, CIRCULATION, V105, P1037, DOI 10.1161/hc0902.104713; Lin CP, 2008, EUR J CLIN INVEST, V38, P106, DOI 10.1111/j.1365-2362.2007.01911.x; Maeda K, 2005, ATHEROSCLEROSIS, V181, P87, DOI 10.1016/j.atherosclerosis.2004.12.044; Milionis HJ, 2003, J CLIN PHARMACOL, V43, P825, DOI 10.1177/0091270003255920	13	2	2	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113766	10.1371/journal.pone.0113766	http://dx.doi.org/10.1371/journal.pone.0113766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409188	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200154
J	Kerfahi, D; Tripathi, BM; Lee, J; Edwards, DP; Adams, JM				Kerfahi, Dorsaf; Tripathi, Binu M.; Lee, Junghoon; Edwards, David P.; Adams, Jonathan M.			The Impact of Selective-Logging and Forest Clearance for Oil Palm on Fungal Communities in Borneo	PLOS ONE			English	Article							SOIL BACTERIAL COMMUNITIES; HUMID TROPICAL FORESTS; RAIN-FOREST; ECTOMYCORRHIZAL FUNGI; AGRICULTURAL LAND; SOUTHEAST-ASIA; LOGGED FORESTS; BETA-DIVERSITY; SPOROCARP DNA; BIODIVERSITY	Tropical forests are being rapidly altered by logging, and cleared for agriculture. Understanding the effects of these land use changes on soil fungi, which play vital roles in the soil ecosystem functioning and services, is a major conservation frontier. Using 454-pyrosequencing of the ITS1 region of extracted soil DNA, we compared communities of soil fungi between unlogged, once-logged, and twice-logged rainforest, and areas cleared for oil palm, in Sabah, Malaysia. Overall fungal community composition differed significantly between forest and oil palm plantation. The OTU richness and Chao 1 were higher in forest, compared to oil palm plantation. As a proportion of total reads, Basidiomycota were more abundant in forest soil, compared to oil palm plantation soil. The turnover of fungal OTUs across space, true beta-diversity, was also higher in forest than oil palm plantation. Ectomycorrhizal (EcM) fungal abundance was significantly different between land uses, with highest relative abundance (out of total fungal reads) observed in unlogged forest soil, lower abundance in logged forest, and lowest in oil palm. In their entirety, these results indicate a pervasive effect of conversion to oil palm on fungal community structure. Such wholesale changes in fungal communities might impact the long-term sustainability of oil palm agriculture. Logging also has more subtle long term effects, on relative abundance of EcM fungi, which might affect tree recruitment and nutrient cycling. However, in general the logged forest retains most of the diversity and community composition of unlogged forest.	[Kerfahi, Dorsaf; Tripathi, Binu M.; Adams, Jonathan M.] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Kerfahi, Dorsaf; Lee, Junghoon] Seoul Natl Univ, Interdisciplinary Program Bioengn, Sch Chem & Biol Engn, Seoul, South Korea; [Edwards, David P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Seoul National University (SNU); Seoul National University (SNU); University of Sheffield	Edwards, DP (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	david.edwards@sheffield.ac.uk; foundinkualalumpur@yahoo.com	Edwards, David/AAC-5091-2019; Tripathi, Binu M/J-3075-2015	Edwards, David/0000-0001-8562-3853; Tripathi, Binu M/0000-0002-7848-0206; Adams, Jonathan/0000-0001-7954-8332	National Research Foundation grant, Ministry of Education, Science and Technology, South Korea [NRF-2013-031400]	National Research Foundation grant, Ministry of Education, Science and Technology, South Korea	This project was funded by a National Research Foundation grant (NRF-2013-031400), Ministry of Education, Science and Technology, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2010, GLOBAL FOREST RESOUR; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Ba AM, 2012, MYCORRHIZA, V22, P1, DOI 10.1007/s00572-011-0415-x; Baraloto C, 2012, J APPL ECOL, V49, P861, DOI 10.1111/j.1365-2664.2012.02164.x; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Blaser J., 2011, INT TROP TIMBER ORG, V38; Brearley FQ, 2012, BIOTROPICA, V44, P637, DOI 10.1111/j.1744-7429.2012.00862.x; Bridge PD, 2009, FUNGAL ECOL, V2, P66, DOI 10.1016/j.funeco.2008.10.008; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Cleary DFR, 2007, ECOL APPL, V17, P1184, DOI 10.1890/05-0878; CORNEJO FH, 1994, OIKOS, V70, P183, DOI 10.2307/3545629; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; Edwards FA, 2014, ANIM CONSERV, V17, P163, DOI 10.1111/acv.12074; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geml J, 2010, NEW PHYTOL, V187, P494, DOI 10.1111/j.1469-8137.2010.03283.x; Geml J, 2009, MOL ECOL, V18, P2213, DOI 10.1111/j.1365-294X.2009.04192.x; Ghazoul J, 2002, BIODIVERS CONSERV, V11, P521, DOI 10.1023/A:1014812701423; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Hamer KC, 2003, J APPL ECOL, V40, P150, DOI 10.1046/j.1365-2664.2003.00783.x; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Haug I, 2005, NEW PHYTOL, V165, P923, DOI 10.1111/j.1469-8137.2004.01284.x; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kuramae EE, 2013, FEMS MICROBIOL ECOL, V84, P519, DOI 10.1111/1574-6941.12080; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lee-Cruz L, 2013, APPL ENVIRON MICROB, V79, P7290, DOI 10.1128/AEM.02541-13; Liedloff A. C., 1999, MANTEL NONPARAMETRIC; Lupatini M, 2013, WORLD J MICROB BIOT, V29, P223, DOI 10.1007/s11274-012-1174-3; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martin F, 2011, NEW PHYTOL, V190, P818, DOI 10.1111/j.1469-8137.2011.03688.x; McGrath DA, 2001, ECOSYSTEMS, V4, P625, DOI 10.1007/s10021-001-0033-0; McGuire KL, 2014, MICROBIAL ECOL; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Moyersoen B, 2001, NEW PHYTOL, V150, P591, DOI 10.1046/j.1469-8137.2001.00125.x; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Natarajan K, 2005, CURR SCI INDIA, V88, P1893; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Oros-Sichler M, 2006, J MICROBIOL METH, V65, P63, DOI 10.1016/j.mimet.2005.06.014; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Piesse J, 2009, FOOD POLICY, V34, P119, DOI 10.1016/j.foodpol.2009.01.001; Ramage BS, 2013, CONSERV BIOL, V27, P364, DOI 10.1111/cobi.12004; Riviere T, 2007, MYCORRHIZA, V17, P415, DOI 10.1007/s00572-007-0117-6; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Smith ME, 2011, NEW PHYTOL, V192, P699, DOI 10.1111/j.1469-8137.2011.03844.x; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Whitmore TC, 1990, INTRO TROPICAL RAIN; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Woodcock P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060756; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Wu TH, 2007, SOIL BIOL BIOCHEM, V39, P1139, DOI 10.1016/j.soilbio.2006.11.024; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500	69	34	35	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111525	10.1371/journal.pone.0111525	http://dx.doi.org/10.1371/journal.pone.0111525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405609	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300012
J	Sun, Q; Tarnberg, M; Zhao, LB; Lundborg, CS; Song, YY; Grape, M; Nilsson, M; Tomson, G; Nilsson, LE				Sun, Qiang; Tarnberg, Maria; Zhao, Lingbo; Lundborg, Cecilia Stalsby; Song, Yanyan; Grape, Malin; Nilsson, Maud; Tomson, Goran; Nilsson, Lennart E.			Varying High Levels of Faecal Carriage of Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in Rural Villages in Shandong, China: Implications for Global Health	PLOS ONE			English	Article							ESCHERICHIA-COLI; RISK-FACTORS; ANTIBIOTIC-RESISTANCE; NONHOSPITALIZED PATIENTS; WESTERN CHINA; PREVALENCE; COMMUNITY; EPIDEMIOLOGY; PERSISTENCE; INFECTIONS	Antibiotic resistance is considered a major threat to global health and is affected by many factors, of which antibiotic use is probably one of the more important. Other factors include hygiene, crowding and travel. The rapid resistance spread in Gram-negative bacteria, in particular extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae (ESBL-E), is a global challenge, leading to increased mortality, morbidity and health systems costs worldwide. Knowledge about resistance in commensal flora is limited, including in China. Our aim was to establish the faecal carriage rates of ESBL-E and find its association with known and suspected risk factors in rural residents of all ages in three socio-economically different counties in the Shandong Province, China. Faecal samples and risk-factor information (questionnaire) were collected in 2012. ESBL-E carriage was screened using ChromID ESBL agar. Risk factors were analysed using standard statistical methods. Data from 1000 individuals from three counties and in total 18 villages showed a high and varying level of ESBL-E carriage. Overall, 42% were ESBL-E carriers. At county level the carriage rates were 49%, 45% and 31%, respectively, and when comparing individual villages (n = 18) the rate varied from 22% to 64%. The high level of ESBL-E carriage among rural residents in China is an indication of an exploding global challenge in the years to come as resistance spreads among bacteria and travels around the world with the movement of people and freight. A high carriage rate of ESBL-E increases the risk of infection with multi-resistant bacteria, and thus the need for usage of last resort antibiotics, such as carbapenems and colistin, in the treatment of common infections.	[Sun, Qiang; Zhao, Lingbo] Shandong Univ, Ctr Hlth Management & Policy, Key Lab Hlth Econ & Policy Res, Minist Hlth, Jinan, Shandong, Peoples R China; [Tarnberg, Maria; Nilsson, Maud; Nilsson, Lennart E.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lundborg, Cecilia Stalsby; Tomson, Goran] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, Sweden; [Song, Yanyan] Shandong Univ, Sch Publ Hlth, Jinan, Shandong, Peoples R China; [Grape, Malin] Publ Hlth Agcy Sweden, Antibiot & Infect Control Unit, Solna, Sweden; [Tomson, Goran] Karolinska Inst, MMC, Dept Learning Informat Management Eth, Stockholm, Sweden	Shandong University; Linkoping University; Karolinska Institutet; Shandong University; Public Health Agency of Sweden; Karolinska Institutet	Sun, Q (corresponding author), Shandong Univ, Ctr Hlth Management & Policy, Key Lab Hlth Econ & Policy Res, Minist Hlth, Jinan, Shandong, Peoples R China.	qiangs@sdu.edu.ch		Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Tomson, Goran/0000-0001-9222-3604	National Nature Science Foundation of China [71073098]; Swedish International Development Cooperation Agency [2010-001861]; Swedish Research Council [2013-46520-109134-94]; China Medical Board [11-068]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish International Development Cooperation Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); China Medical Board	This work was supported by the National Nature Science Foundation of China (71073098); the Swedish International Development Cooperation Agency (2010-001861); The Swedish Research Council (2013-46520-109134-94); and China Medical Board (11-068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean DC, 2005, J ANTIMICROB CHEMOTH, V56, P962, DOI 10.1093/jac/dki332; Calbo E, 2006, J ANTIMICROB CHEMOTH, V57, P780, DOI 10.1093/jac/dkl035; Cars O, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1438; Coast J, 2003, DRUG DISCOV TODAY, V8, P1, DOI 10.1016/S1359-6446(02)02542-4; Colodner R, 2004, EUR J CLIN MICROBIOL, V23, P163, DOI 10.1007/s10096-003-1084-2; Dong LF, 2011, FAM PRACT, V28, P63, DOI 10.1093/fampra/cmq077; Doumith M, 2012, J ANTIMICROB CHEMOTH, V67, P878, DOI 10.1093/jac/dkr553; Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0; Ghidan A, 2008, ACTA MICROBIOL IMM H, V55, P409, DOI 10.1556/AMicr.55.2008.4.5; Health and Family Planning Commission of Shandong Province, 2013, SHAND HLTH STAT YB; Heddini A, 2009, LANCET, V373, P30, DOI 10.1016/S0140-6736(08)61956-X; Hu YY, 2013, APPL ENVIRON MICROB, V79, P5988, DOI 10.1128/AEM.01740-13; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Li B, 2011, SCAND J INFECT DIS, V43, P170, DOI 10.3109/00365548.2010.538856; Lim SK, 2006, MICROB DRUG RESIST, V12, P136, DOI 10.1089/mdr.2006.12.136; Lo WU, 2010, J INFECTION, V60, P286, DOI 10.1016/j.jinf.2010.02.002; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Nordberg P., 2005, International Journal of Risk & Safety in Medicine, V17, P117; Rahman EMA, 2011, J INVEST MED, V59, P1284, DOI 10.2130/JIM.0b013e318238748e; Rodriguez-Bano J, 2004, J CLIN MICROBIOL, V42, P1089, DOI 10.1128/JCM.42.3.1089-1094.2004; Rodriguez-Bano J, 2008, J ANTIMICROB CHEMOTH, V62, P1142, DOI 10.1093/jac/dkn293; Stromdahl H, 2011, EUR J CLIN MICROBIOL, V30, P1159, DOI 10.1007/s10096-011-1202-5; Sundqvist M, 2010, J ANTIMICROB CHEMOTH, V65, P350, DOI 10.1093/jac/dkp387; Tian GB, 2012, J MED MICROBIOL, V61, P233, DOI 10.1099/jmm.0.036806-0; Tian SF, 2008, CAN J MICROBIOL, V54, P781, DOI 10.1139/w08-059; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; Yezli S, 2012, INT J ANTIMICROB AG, V40, P389, DOI 10.1016/j.ijantimicag.2012.07.009; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	28	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113121	10.1371/journal.pone.0113121	http://dx.doi.org/10.1371/journal.pone.0113121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405340	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300080
J	Clark, SJ; Houle, B				Clark, Samuel J.; Houle, Brian			Validation, Replication, and Sensitivity Testing of Heckman-Type Selection Models to Adjust Estimates of HIV Prevalence	PLOS ONE			English	Article							BIAS	A recent study using Heckman-type selection models to adjust for non-response in the Zambia 2007 Demographic and Health Survey (DHS) found a large correction in HIV prevalence for males. We aim to validate this finding, replicate the adjustment approach in other DHSs, apply the adjustment approach in an external empirical context, and assess the robustness of the technique to different adjustment approaches. We used 6 DHSs, and an HIV prevalence study from rural South Africa to validate and replicate the adjustment approach. We also developed an alternative, systematic model of selection processes and applied it to all surveys. We decomposed corrections from both approaches into rate change and age-structure change components. We are able to reproduce the adjustment approach for the 2007 Zambia DHS and derive results comparable with the original findings. We are able to replicate applying the approach in several other DHSs. The approach also yields reasonable adjustments for a survey in rural South Africa. The technique is relatively robust to how the adjustment approach is specified. The Heckman selection model is a useful tool for assessing the possibility and extent of selection bias in HIV prevalence estimates from sample surveys.	[Clark, Samuel J.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Clark, Samuel J.; Houle, Brian] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Clark, Samuel J.; Houle, Brian] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Houle, Brian] Australian Natl Univ, Australian Demog & Social Res Inst, Canberra, ACT, Australia	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; University of Witwatersrand; Australian National University	Houle, B (corresponding author), Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA.	brian.houle@anu.edu.au	Clark, Samuel J/A-8419-2009	Clark, Samuel J/0000-0002-4929-6231; Houle, Brian/0000-0003-2157-3118	USAID, through the MEASURE DHS project; University of Colorado Population Center - Eunice Shriver National Institute of Child Health and Human Development [NICHD R21 HD051146]; 'Partnership for Social Science AIDS Research in South Africa's Era of ART Rollout' from the National Institute on Aging (NIA) [R24AG032112]; National Institute of Child Health and Human Development (NICHD) [K01 HD057246]; William and Flora Hewlett Foundation [2006-8377, 2009-4069]; Wellcome Trust; Anglo American Chairmans Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD057246, R24HD042828, R01HD054511, R01HD070936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R24AG032112] Funding Source: NIH RePORTER	USAID, through the MEASURE DHS project(United States Agency for International Development (USAID)); University of Colorado Population Center - Eunice Shriver National Institute of Child Health and Human Development; 'Partnership for Social Science AIDS Research in South Africa's Era of ART Rollout' from the National Institute on Aging (NIA); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); William and Flora Hewlett Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Anglo American Chairmans Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially supported by USAID, through the MEASURE DHS project, and received funding and administrative support from the University of Colorado Population Center, which is funded by the Eunice Shriver National Institute of Child Health and Human Development (grant NICHD R21 HD051146). The survey study at the Agincourt Health and Demographic Surveillance Site was supported by grant R24AG032112 'Partnership for Social Science AIDS Research in South Africa's Era of ART Rollout' from the National Institute on Aging (NIA). Samuel Clark was partially supported by grant K01 HD057246 from the National Institute of Child Health and Human Development (NICHD). The Agincourt site received partial support from the William and Flora Hewlett Foundation Grants 2006-8377 and 2009-4069, the Wellcome Trust and the Anglo American Chairmans Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2011, EPIDEMIOLOGY, V22, P27, DOI 10.1097/EDE.0b013e3181ffa201; Bushway S, 2007, J QUANT CRIMINOL, V23, P151, DOI 10.1007/s10940-007-9024-4; Central Statistical Office Ministry of Health Tropical Diseases Research Centre University of Zambia, 2009, ZAMB DEM HLTH SURV 2; DUBIN JA, 1989, SOCIOL METHOD RES, V18, P360, DOI 10.1177/0049124189018002006; Floyd S, 2013, AIDS, V27, P233, DOI 10.1097/QAD.0b013e32835848ab; Geneletti S, 2011, EPIDEMIOLOGY, V22, P36, DOI 10.1097/EDE.0b013e3182003276; Gomez-Olive FX, 2013, AIDS CARE, P1; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hogan DR, 2012, SEX TRANSM INFECT, V88, pI17, DOI 10.1136/sextrans-2012-050636; Janssens W, 2009, 13298 AMST I INT DEV; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Ministry of Health and Social Welfare (MOHSW) [Lesotho] and ICF Macro, 2010, LES DEM HLTH SURV 20; MoHSW, 2005, LES DEM HLTH SURV 20; Preston S., 2000, DEMOGRAPHY MEASURING; Reniers G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-163; Vella F, 1998, J HUM RESOUR, V33, P127, DOI 10.2307/146317; WINSHIP C, 1992, ANNU REV SOCIOL, V18, P327, DOI 10.1146/annurev.so.18.080192.001551	18	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112563	10.1371/journal.pone.0112563	http://dx.doi.org/10.1371/journal.pone.0112563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402333	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700054
J	Giron-Martinez, A; Perez-Rial, S; Terron-Exposito, R; Diaz-Gil, JJ; Gonzalez-Mangado, N; Peces-Barba, G				Giron-Martinez, Alvaro; Perez-Rial, Sandra; Terron-Exposito, Raul; Jose Diaz-Gil, Juan; Gonzalez-Mangado, Nicolas; Peces-Barba, German			Proliferative Activity of Liver Growth Factor is Associated with an Improvement of Cigarette Smoke-Induced Emphysema in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SPONTANEOUSLY HYPERTENSIVE-RATS; NEURAL STEM-CELLS; OXIDATIVE STRESS; IN-VIVO; II CELL; LUNG; REPAIR; KERATINOCYTE; EXPRESSION	Cigarette smoke (CS)-induced emphysema is a major component of chronic obstructive pulmonary disease (COPD). COPD treatment is based on the administration of bronchodilators and corticosteroids to control symptoms and exacerbations, however, to date, there are no effective therapies to reverse disease progression. Liver growth factor (LGF) is an albumin-bilirubin complex with mitogenic properties, whose therapeutic effects have previously been reported in a model of emphysema and several rodent models of human disease. To approach the therapeutic effect of LGF in a model of previously established emphysema, morphometric and lung function parameters, matrix metalloproteinase (MMP) activity and the expression of several markers, such as VEGF, PCNA, 3NT and Nrf2, were assessed in air-exposed and CS-exposed C57BL/6J male mice with and without intraperitoneal (i.p.) injection of LGF. CS-exposed mice presented a significant enlargement of alveolar spaces, higher alveolar internal area and loss of lung function that correlated with higher MMP activity, higher expression of 3NT and lower expression of VEGF. CS-exposed mice injected with LGF, showed an amelioration of emphysema and improved lung function, which correlated with lower MMP activity and 3NT expression and higher levels of VEGF, PCNA and Nrf2. Taken together, this study suggests that LGF administration ameliorates CS-induced emphysema, highlights the ability of LGF to promote alveolar cell proliferation and may be a promising strategy to revert COPD progression.	[Giron-Martinez, Alvaro; Perez-Rial, Sandra; Terron-Exposito, Raul; Jose Diaz-Gil, Juan; Gonzalez-Mangado, Nicolas; Peces-Barba, German] UAM, CIBERES, FJD, IIS,Resp Res Grp, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Fundacion Jimenez Diaz	Giron-Martinez, A (corresponding author), UAM, CIBERES, FJD, IIS,Resp Res Grp, Madrid, Spain.	agiron@fjd.es	Rial, Sandra Pérez/C-6809-2019	Rial, Sandra Pérez/0000-0002-7349-7682	Ministry of Science and Innovation of Spain [SAF2008-05412-C02-02]; Spanish Society of Pneumology and Thoracic Surgery (SEPAR) [139]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Society of Pneumology and Thoracic Surgery (SEPAR)	This work was funded by the Ministry of Science and Innovation of Spain (SAF2008-05412-C02-02) and the Spanish Society of Pneumology and Thoracic Surgery (SEPAR-#139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshiba K, 2003, AM J RESP CELL MOL, V28, P555, DOI 10.1165/rcmb.2002-0090OC; Barreiro E, 2012, RESP PHYSIOL NEUROBI, V182, P9, DOI 10.1016/j.resp.2012.02.001; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Conde MV, 2011, AM J PHYSIOL-HEART C, V301, pH1153, DOI 10.1152/ajpheart.00886.2010; Condezo-Hoyos L, 2012, J HYPERTENS, V30, P1185, DOI 10.1097/HJH.0b013e328353824b; Condezo-Hoyos L, 2009, FREE RADICAL BIO MED, V46, P656, DOI 10.1016/j.freeradbiomed.2008.12.002; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Diab KJ, 2010, AM J RESP CRIT CARE, V181, P344, DOI 10.1164/rccm.200906-0826OC; Diaz-Gil JJ, 2003, J HEPATOL, V38, P598, DOI 10.1016/S0168-8278(03)00030-8; Diaz-Gil JJ, 2009, HISTOL HISTOPATHOL, V24, P473, DOI 10.14670/HH-24.473; DIAZGIL JJ, 1986, BIOCHEM J, V235, P49, DOI 10.1042/bj2350049; DIAZGIL JJ, 1987, BIOCHEM J, V243, P443, DOI 10.1042/bj2430443; DIAZGIL JJ, 1988, HEPATOLOGY, V8, P484, DOI 10.1002/hep.1840080308; Driscoll B, 2000, AM J PHYSIOL-LUNG C, V279, pL1191, DOI 10.1152/ajplung.2000.279.6.L1191; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Finlay GA, 1997, THORAX, V52, P502, DOI 10.1136/thx.52.6.502; Foronjy RF, 2006, AM J RESP CRIT CARE, V173, P623, DOI 10.1164/rccm.200506-850OC; Fujita M, 2004, THORAX, V59, P224, DOI 10.1136/thx.2003.010785; GIL JJD, 1994, GROWTH REGULAT, V4, P113; Gonzalo-Gobernado R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067771; Gonzalo-Gobernado R, 2009, J HISTOCHEM CYTOCHEM, V57, P491, DOI 10.1369/jhc.2009.952275; Gosker HR, 2009, AM J RESP CELL MOL, V40, P710, DOI 10.1165/rcmb.2008-0312OC; Huang ZP, 2012, J BIOL CHEM, V287, P18091, DOI 10.1074/jbc.M111.313163; Ichinose M, 2000, AM J RESP CRIT CARE, V162, P701, DOI 10.1164/ajrccm.162.2.9908132; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kyriazis A, 2010, IEEE T BIO-MED ENG, V57, P1745, DOI 10.1109/TBME.2010.2042596; Lee J, 2006, AM J PHYSIOL-LUNG C, V290, pL685, DOI 10.1152/ajplung.00020.2005; Liu C, 2003, AM J PHYSIOL-LUNG C, V285, pL1246, DOI 10.1152/ajplung.00443.2002; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Martinez-Galan L, 2010, ARCH BRONCONEUMOL, V46, P20, DOI 10.1016/j.arbres.2009.10.006; MARTINHIDALGO A, 2007, FEBS J S1, V274, P296; Massaro GD, 1997, NAT MED, V3, P675, DOI 10.1038/nm0697-675; Molet S, 2005, INFLAMM RES, V54, P31, DOI 10.1007/s00011-004-1319-4; Morissette Mathieu C, 2009, Int J Chron Obstruct Pulmon Dis, V4, P19; Muyal JP, 2013, LUNG, V191, P147, DOI 10.1007/s00408-012-9438-0; PANOS RJ, 1995, J CLIN INVEST, V96, P2026, DOI 10.1172/JCI118250; Perez-Crespo M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-21; Perez-Rial S, 2014, AM J PHYSL LUNG CELL; Perez-Rial S, 2011, MOL IMAGING, V10, P398, DOI 10.2310/7290.2011.00010; Plantier L, 2007, AM J PHYSIOL-LUNG C, V293, pL1230, DOI 10.1152/ajplung.00460.2006; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003; Reimers D, 2006, J HISTOCHEM CYTOCHEM, V54, P457, DOI 10.1369/jhc.5A6805.2005; Reimers D, 2012, CURR STEM CELL RES T, V7, P15, DOI 10.2174/157488812798483421; Rubio ML, 2000, EUR RESPIR J, V15, P505, DOI 10.1034/j.1399-3003.2000.15.13.x; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Shigemura N, 2005, CIRCULATION, V111, P1407, DOI 10.1161/01.CIR.0000158433.89103.85; Somoza B, 2006, CARDIOVASC RES, V69, P764, DOI 10.1016/j.cardiores.2005.08.021; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tetley Teresa D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P607, DOI 10.2174/156801005774912824; van der Vliet A, 1999, AM J RESP CRIT CARE, V160, P1; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001	58	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112995	10.1371/journal.pone.0112995	http://dx.doi.org/10.1371/journal.pone.0112995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401951	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700090
J	Hahn, ME; McArthur, AG; Karchner, SI; Franks, DG; Jenny, MJ; Timme-Laragy, AR; Stegeman, JJ; Woodin, BR; Cipriano, MJ; Linney, E				Hahn, Mark E.; McArthur, Andrew G.; Karchner, Sibel I.; Franks, Diana G.; Jenny, Matthew J.; Timme-Laragy, Alicia R.; Stegeman, John J.; Woodin, Bruce R.; Cipriano, Michael J.; Linney, Elwood			The Transcriptional Response to Oxidative Stress during Vertebrate Development: Effects of tert-Butylhydroquinone and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin	PLOS ONE			English	Article							ELEMENT SIGNALING PATHWAY; GENE-EXPRESSION PROFILES; ZEBRAFISH DANIO-RERIO; DNA-DAMAGE; MELANOCYTE DIFFERENTIATION; ANTIOXIDANT RESPONSES; TRANSGENIC ZEBRAFISH; LIFE STAGES; NRF2; GLUTATHIONE	Oxidative stress is an important mechanism of chemical toxicity, contributing to teratogenesis and to cardiovascular and neurodegenerative diseases. Developing animals may be especially sensitive to chemicals causing oxidative stress. The developmental expression and inducibility of anti-oxidant defenses through activation of NF-E2-related factor 2 (NRF2) affect susceptibility to oxidants, but the embryonic response to oxidants is not well understood. To assess the response to chemically mediated oxidative stress and how it may vary during development, zebrafish embryos, eleutheroembryos, or larvae at 1, 2, 3, 4, 5, and 6 days post fertilization (dpf) were exposed to DMSO (0.1%), tert-butylhydroquinone (tBHQ; 10 mu M) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 2 nM) for 6 hr. Transcript abundance was assessed by real-time qRT-PCR and microarray. qRT-PCR showed strong (4- to 5-fold) induction of gstp1 by tBHQ as early as 1 dpf. tBHQ also induced gclc (2 dpf), but not sod1, nqo1, or cyp1a. TCDD induced cyp1a but none of the other genes. Microarray analysis showed that 1477 probes were significantly different among the DMSO-, tBHQ-, and TCDD-treated eleutheroembryos at 4 dpf. There was substantial overlap between genes induced in developing zebrafish and a set of marker genes induced by oxidative stress in mammals. Genes induced by tBHQ in 4-dpf zebrafish included those involved in glutathione synthesis and utilization, signal transduction, and DNA damage/stress response. The strong induction of hsp70 determined by microarray was confirmed by qRT-PCR and by use of transgenic zebrafish expressing enhanced green fluorescent protein (EGFP) under control of the hsp70 promoter. Genes strongly down-regulated by tBHQ included mitfa, providing a molecular explanation for the loss of pigmentation in tBHQ-exposed embryos. These data show that zebrafish embryos are responsive to oxidative stress as early as 1 dpf, that responsiveness varies with development in a gene-specific manner, and that the oxidative stress response is substantially conserved in vertebrate animals.	[Hahn, Mark E.; Karchner, Sibel I.; Franks, Diana G.; Jenny, Matthew J.; Timme-Laragy, Alicia R.; Stegeman, John J.; Woodin, Bruce R.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [McArthur, Andrew G.; Cipriano, Michael J.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Linney, Elwood] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole; Duke University	Hahn, ME (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mhahn@whoi.edu	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082; McArthur, Andrew/0000-0002-1142-3063; Jenny, Matthew/0000-0002-1834-2629; Stegeman, John/0000-0001-8204-5357; Timme-Laragy, Alicia/0000-0002-8835-5038; Cipriano, Michael/0000-0001-8163-8812	National Institutes of Health [R01ES016366, R01ES006272, R01ES015912, F32ES017585]; Andrew W. Mellon Foundation Endowed Fund for Innovative Research; Walter A. and Hope Noyes Smith endowed chair; Marine Biological Laboratory's Program in Global Infectious Disease - Ellison Medical Foundation; WHOI (Woods Hole Oceanographic Institution) Postdoctoral Scholar award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381, R01ES016366, F32ES017585, R01ES006272, R01ES015912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Andrew W. Mellon Foundation Endowed Fund for Innovative Research; Walter A. and Hope Noyes Smith endowed chair; Marine Biological Laboratory's Program in Global Infectious Disease - Ellison Medical Foundation; WHOI (Woods Hole Oceanographic Institution) Postdoctoral Scholar award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by National Institutes of Health grants R01ES016366 (MEH), R01ES006272 (MEH), R01ES015912 (JJS), and F32ES017585 (ART-L), the Andrew W. Mellon Foundation Endowed Fund for Innovative Research, a WHOI (Woods Hole Oceanographic Institution) Postdoctoral Scholar award, and the Walter A. and Hope Noyes Smith endowed chair (MEH). AGM and MJC were supported in part by the Marine Biological Laboratory's Program in Global Infectious Disease, funded by the Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The U.S. Government is authorized to produce and distribute reprints for governmental purposes notwithstanding any copyright notation that may appear hereon.	Agyeman AS, 2012, BREAST CANCER RES TR, V132, P175, DOI 10.1007/s10549-011-1536-9; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Alexeyenko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010465; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Blechinger SR, 2002, ENVIRON HEALTH PERSP, V110, P1041, DOI 10.1289/ehp.021101041; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; Carney SA, 2006, MOL PHARMACOL, V70, P549, DOI 10.1124/mol.106.025304; Carvan MJ, 2000, ARCH BIOCHEM BIOPHYS, V376, P320, DOI 10.1006/abbi.2000.1727; Carvan MJ, 2001, SCI TOTAL ENVIRON, V274, P183, DOI 10.1016/S0048-9697(01)00742-2; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; Dalton TP, 2004, FREE RADICAL BIO MED, V37, P1511, DOI 10.1016/j.freeradbiomed.2004.06.040; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; Dennery PA, 2004, ANTIOXID REDOX SIGN, V6, P147, DOI 10.1089/152308604771978453; Dennery Phyllis A., 2007, Birth Defects Research, V81, P155, DOI 10.1002/bdrc.20098; Di Giulio Richard T., 2008, P273, DOI 10.1201/9780203647295.ch6; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Dobbin K, 2003, J NATL CANCER I, V95, P1362, DOI 10.1093/jnci/djg049; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Evans BR, 2005, ARCH BIOCHEM BIOPHYS, V441, P151, DOI 10.1016/j.abb.2005.07.008; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Fang LH, 2012, FREE RADICAL BIO MED, V53, P1411, DOI 10.1016/j.freeradbiomed.2012.08.004; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fletcher N, 2005, TOXICOL APPL PHARM, V207, P1, DOI 10.1016/j.taap.2004.12.003; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Gharavi N, 2005, DRUG METAB DISPOS, V33, P365, DOI 10.1124/dmd.104.002253; Goering W, 2008, CYTOGENET GENOME RES, V121, P88, DOI 10.1159/000125833; Goldstone HMH, 2006, DRUG METAB REV, V38, P261, DOI 10.1080/03602530600570099; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Guan CP, 2008, EXP DERMATOL, V17, P1059, DOI 10.1111/j.1600-0625.2008.00752.x; Hahn M. E., 2014, TOXICOL SCI TOXICOLO, P52; Hahn ME, 2008, MAR ENVIRON RES, V66, P138; Hahn ME, 2007, TOXICOL SCI TOXICO S, V96, P326; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Hansen Jason M., 2006, Birth Defects Research, V78, P293, DOI 10.1002/bdrc.20085; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hayes KR, 2005, CHEM RES TOXICOL, V18, P403, DOI 10.1021/tx0496690; Hernandez-Garcia D, 2010, FREE RADICAL BIO MED, V49, P130, DOI 10.1016/j.freeradbiomed.2010.03.020; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hong HK, 2001, GENESIS, V29, P163, DOI 10.1002/gene.1020; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ishibashi M, 1997, FREE RADICAL BIO MED, V22, P447, DOI 10.1016/S0891-5849(96)00338-3; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Kelly SA, 1998, ENVIRON HEALTH PERSP, V106, P375, DOI 10.2307/3434064; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kingo K, 2008, J DERMATOL SCI, V52, P39, DOI 10.1016/j.jdermsci.2008.03.013; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Konwinski RR, 2004, TOXICOL LETT, V153, P343, DOI 10.1016/j.toxlet.2004.06.006; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; Kusik BW, 2008, MAR BIOTECHNOL, V10, P750, DOI 10.1007/s10126-008-9113-x; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li J, 2005, PHYSIOL GENOMICS, V21, P43, DOI 10.1152/physiolgenomics.00214.2004; Li L, 2008, J BIOL CHEM, V283, P3248, DOI 10.1074/jbc.M708702200; Lister JA, 2001, DEV BIOL, V237, P333, DOI 10.1006/dbio.2001.0379; Lister JA, 1999, DEVELOPMENT, V126, P3757; Loeken MR, 2006, J SOC GYNECOL INVEST, V13, P2, DOI 10.1016/j.jsgi.2005.09.007; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Manga P, 2006, AM J PATHOL, V169, P1652, DOI 10.2353/ajpath.2006.050769; Mellgren EM, 2004, DEV GENES EVOL, V214, P493, DOI 10.1007/s00427-004-0428-y; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Nakajima H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026884; Nakamichi N, 2005, J NEUROCHEM, V93, P84, DOI 10.1111/j.1471-4159.2005.02999.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; National Research Council/National Academy of Sciences, 2000, SCI FRONT DEV TOX RI; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Ornoy A, 2007, REPROD TOXICOL, V24, P31, DOI 10.1016/j.reprotox.2007.04.004; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Planchart A, 2010, CHEM RES TOXICOL, V23, P480, DOI 10.1021/tx9003165; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Pruess Manuela, 2005, In Silico Biology, V5, P179; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reichard John F., 2005, Dose-Response, V3, P306, DOI 10.2203/dose-response.003.03.003; Reimers MJ, 2006, NEUROTOXICOL TERATOL, V28, P497, DOI 10.1016/j.ntt.2006.05.007; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Rizzo AM, 2007, COMP BIOCHEM PHYS B, V146, P94, DOI 10.1016/j.cbpb.2006.09.009; Rojas E, 2000, MUTAT RES-FUND MOL M, V447, P305, DOI 10.1016/S0027-5107(99)00191-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schreiber TD, 2006, DRUG METAB DISPOS, V34, P1096, DOI 10.1124/dmd.106.009662; Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004; Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230309774; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; Sun YV, 2004, NUCLEIC ACIDS RES, V32, P4512, DOI 10.1093/nar/gkh782; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Teraoka Hiroki, 2003, Congenital Anomalies, V43, P123, DOI 10.1111/j.1741-4520.2003.tb01036.x; Timme-Laragy AR, 2013, FREE RADICAL BIO MED, V65, P89, DOI 10.1016/j.freeradbiomed.2013.06.011; Timme-Laragy AR, 2012, J BIOL CHEM, V287, P4609, DOI 10.1074/jbc.M111.260125; Timme-Laragy AR, 2009, TOXICOL SCI, V109, P217, DOI 10.1093/toxsci/kfp038; Tsujita T, 2011, GENES CELLS, V16, P46, DOI 10.1111/j.1365-2443.2010.01466.x; Usenko CY, 2008, TOXICOL APPL PHARM, V229, P44, DOI 10.1016/j.taap.2007.12.030; Voelker D, 2007, AQUAT TOXICOL, V81, P355, DOI 10.1016/j.aquatox.2006.12.013; Wang L, 2013, TOXICOL APPL PHARM, V266, P177, DOI 10.1016/j.taap.2012.11.010; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wells Peter G, 2005, Toxicol Appl Pharmacol, V207, P354, DOI 10.1016/j.taap.2005.01.061; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Wells PG, 1996, CRIT REV BIOCHEM MOL, V31, P1, DOI 10.3109/10409239609110574; Wells PG, 1997, MUTAT RES-FUND MOL M, V396, P65, DOI 10.1016/S0027-5107(97)00175-9; Williams LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079574; WOLTERING DM, 1984, AQUAT TOXICOL, V5, P1, DOI 10.1016/0166-445X(84)90028-6; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yildirim M, 2004, J EUR ACAD DERMATOL, V18, P683, DOI 10.1111/j.1468-3083.2004.01080.x; Yokoi H, 2009, DEV BIOL, V329, P1, DOI 10.1016/j.ydbio.2009.01.002; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200; Zhang XL, 2004, KIDNEY INT, V65, P798, DOI 10.1111/j.1523-1755.2004.00454.x; Zhang Y, 2011, CHEM BIOL, V18, P1355, DOI 10.1016/j.chembiol.2011.09.008; Zhu XS, 2007, ENVIRON TOXICOL CHEM, V26, P976, DOI 10.1897/06-583.1	137	38	39	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113158	10.1371/journal.pone.0113158	http://dx.doi.org/10.1371/journal.pone.0113158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402455	gold, Green Published			2022-12-26	WOS:000345158700120
J	Okland, AL; Nylund, A; Overgard, AC; Blindheim, S; Watanabe, K; Grotmol, S; Arnesen, CE; Plarre, H				Okland, Arnfinn Lodden; Nylund, Are; Overgard, Aina-Cathrine; Blindheim, Steffen; Watanabe, Kuninori; Grotmol, Sindre; Arnesen, Carl-Erik; Plarre, Heidrun			Genomic Characterization and Phylogenetic Position of Two New Species in Rhabdoviridae Infecting the Parasitic Copepod, Salmon Louse (Lepeophtheirus salmonis)	PLOS ONE			English	Article							VIRAL DISEASES; BLUE-CRAB; MOLECULAR CHARACTERIZATION; CARCINUS-MEDITERRANEUS; TAXONOMIC POSITION; HISTORIC EMERGENCE; GLYCOPROTEIN GENE; SHRIMP PATHOGENS; SPRING VIREMIA; VIRUS	Several new viruses have emerged during farming of salmonids in the North Atlantic causing large losses to the industry. Still the blood feeding copepod parasite, Lepeophtheirus salmonis, remains the major challenge for the industry. Histological examinations of this parasite have revealed the presence of several virus-like particles including some with morphologies similar to rhabdoviruses. This study is the first description of the genome and target tissues of two new species of rhabdoviruses associated with pathology in the salmon louse. Salmon lice were collected at different Atlantic salmon (Salmo salar) farming sites on the west coast of Norway and prepared for histology, transmission electron microscopy and Illumina sequencing of the complete RNA extracted from these lice. The nearly complete genomes, around 11 600 nucleotides encoding the five typical rhabdovirus genes N, P, M, G and L, of two new species were obtained. The genome sequences, the putative protein sequences, and predicted transcription strategies for the two viruses are presented. Phylogenetic analyses of the putative N and L proteins indicated closest similarity to the Sigmavirus/Dimarhabdoviruses cluster, however, the genomes of both new viruses are significantly diverged with no close affinity to any of the existing rhabdovirus genera. In situ hybridization, targeting the N protein genes, showed that the viruses were present in the same glandular tissues as the observed rhabdovirus-like particles. Both viruses were present in all developmental stages of the salmon louse, and associated with necrosis of glandular tissues in adult lice. As the two viruses were present in eggs and free-living planktonic stages of the salmon louse vertical, transmission of the viruses are suggested. The tissues of the lice host, Atlantic salmon, with the exception of skin at the attachment site for the salmon louse chalimi stages, were negative for these two viruses.	[Okland, Arnfinn Lodden; Nylund, Are; Blindheim, Steffen; Watanabe, Kuninori; Grotmol, Sindre; Plarre, Heidrun] Univ Bergen, Dept Biol, N-5020 Bergen, Norway; [Overgard, Aina-Cathrine] Inst Marine Res, SLRC, N-5817 Bergen, Norway; [Grotmol, Sindre] Univ Bergen, Dept Biol, SLRC, N-5020 Bergen, Norway; [Arnesen, Carl-Erik] Firda Sjofarmer AS, N-5966 Eivindvik, Norway	University of Bergen; Institute of Marine Research - Norway; University of Bergen	Nylund, A (corresponding author), Univ Bergen, Dept Biol, N-5020 Bergen, Norway.	are.nylund@bio.uib.no	Grotmol, Sindre/AAB-8316-2020	Overgard, Aina-Cathrine/0000-0002-7789-5581				Adair B. M., 1986, Bulletin of the European Association of Fish Pathologists, V6, P85; AHNE W, 1985, J FISH DIS, V8, P241, DOI 10.1111/j.1365-2761.1985.tb01220.x; Behringer DC, 2011, DIS AQUAT ORGAN, V94, P153, DOI 10.3354/dao02326; BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x; Bonami JR, 2011, J INVERTEBR PATHOL, V106, P6, DOI 10.1016/j.jip.2010.09.009; Bonami JR, 2011, J INVERTEBR PATHOL, V106, P131, DOI 10.1016/j.jip.2010.09.007; Borzym E, 2014, J FISH DIS, V37, P423, DOI 10.1111/jfd.12119; Bourhy H, 2005, J GEN VIROL, V86, P2849, DOI 10.1099/vir.0.81128-0; Chen HL, 2009, ARCH VIROL, V154, P1489, DOI 10.1007/s00705-009-0455-0; Cherian SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030315; Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026; CRYSLER JG, 1990, J GEN VIROL, V71, P2191, DOI 10.1099/0022-1317-71-9-2191; Dalvin S, 2013, J NAT HIST, V47, P889, DOI 10.1080/00222933.2012.738830; Devold M, 2000, DIS AQUAT ORGAN, V40, P9, DOI 10.3354/dao040009; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Galinier R, 2012, VIRUS RES, V166, P1, DOI 10.1016/j.virusres.2012.02.020; Ghedin E, 2013, J GEN VIROL, V94, P2609, DOI 10.1099/vir.0.055939-0; Gubala A, 2011, J GEN VIROL, V92, P2160, DOI 10.1099/vir.0.026120-0; Gubala A, 2010, VIROLOGY, V399, P98, DOI 10.1016/j.virol.2009.12.013; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Heuch PA, 2005, AQUACULTURE, V246, P79, DOI 10.1016/j.aquaculture.2004.12.027; Hoffmann B, 2002, VIRUS RES, V84, P89, DOI 10.1016/S0168-1702(01)00441-5; JAHROMI SS, 1977, J GEN VIROL, V36, P485, DOI 10.1099/0022-1317-36-3-485; Jakob E, 2011, DIS AQUAT ORGAN, V97, P155, DOI 10.3354/dao02414; Johansson T, 2001, VIRUS RES, V80, P11, DOI 10.1016/S0168-1702(01)00323-9; Johnson MC, 1999, VIRUS RES, V64, P95, DOI 10.1016/S0168-1702(99)00071-4; JOHNSON PT, 1980, J INVERTEBR PATHOL, V35, P90, DOI 10.1016/0022-2011(80)90089-0; JOHNSON PT, 1978, MAR FISH REV, V40, P13; JOHNSON PT, 1984, HELGOLANDER MEERESUN, V37, P65, DOI 10.1007/BF01989296; Karlsbakk E, 2013, AQUACULTURE, V412, P41, DOI 10.1016/j.aquaculture.2013.07.007; King A. M. Q, 2012, VIRUS TAXONOMY; Koski P., 1992, Bulletin of the European Association of Fish Pathologists, V12, P177; Krkosek M, 2012, P R SOC B; LANNAN CN, 1984, IN VITRO CELL DEV B, V20, P671, DOI 10.1007/BF02618871; Lightner DV, 2012, J INVERTEBR PATHOL, V110, P174, DOI 10.1016/j.jip.2012.03.006; Lightner DV, 2011, J INVERTEBR PATHOL, V106, P110, DOI 10.1016/j.jip.2010.09.012; Longdon B, 2010, P ROY SOC B-BIOL SCI, V277, P35, DOI 10.1098/rspb.2009.1472; Longshaw M, 2011, J INVERTEBR PATHOL, V106, P54, DOI 10.1016/j.jip.2010.09.013; LU Y, 1994, DIS AQUAT ORGAN, V19, P187, DOI 10.3354/dao019187; MARI J, 1988, J GEN VIROL, V69, P561, DOI 10.1099/0022-1317-69-3-561; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Munro J, 2007, AQUAC RES, V38, P893, DOI 10.1111/j.1365-2109.2007.01735.x; Nylund A., 1993, P367; Nylund A., 1991, Bulletin of the European Association of Fish Pathologists, V11, P213; NYLUND A, 1992, J CRUSTACEAN BIOL, V12, P423, DOI 10.2307/1549036; Oelckers K, 2014, AQUACULTURE, V420, P126, DOI 10.1016/j.aquaculture.2013.10.016; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Overstreet RM, 2009, INTEGR COMP BIOL, V49, P127, DOI 10.1093/icb/icp033; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PAPPALARDO R, 1986, J INVERTEBR PATHOL, V47, P361, DOI 10.1016/0022-2011(86)90107-2; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; Quan PL, 2010, VIRUS RES, V147, P17, DOI 10.1016/j.virusres.2009.09.013; Rodriguez LL, 2012, RHABDOVIRUSES MOL TA; Schoeler GB, 2001, ANN TROP MED PARASIT, V95, P755, DOI 10.1080/0003498012011118; Skern-Mauritzen R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-32; Steigen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066840; Stentiford GD, 2009, AQUACULTURE, V291, P1, DOI 10.1016/j.aquaculture.2009.02.042; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TORDO N, 1986, NUCLEIC ACIDS RES, V14, P2671, DOI 10.1093/nar/14.6.2671; Torkarz R, 2014, VIROL J, V11, P26; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Trosse C, 2014, COMP BIOCHEM PHYS B, V170, P1, DOI 10.1016/j.cbpb.2013.12.006; Vasilakis N, 2013, VIROLOGY, V444, P80, DOI 10.1016/j.virol.2013.05.035; Vasilakis N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-69; Vega-Heredia S, 2012, TRANSBOUND EMERG DIS, V59, P95, DOI 10.1111/j.1865-1682.2011.01249.x; Vogt G, 1996, J INVERTEBR PATHOL, V68, P239, DOI 10.1006/jipa.1996.0091; Walker PJ, 2011, VIRUS RES, V162, P110, DOI 10.1016/j.virusres.2011.09.004; WALKER PJ, 1994, J GEN VIROL, V75, P1889, DOI 10.1099/0022-1317-75-8-1889; Walker PJ, VET RES, V51, P51; YUDIN AI, 1979, J INVERTEBR PATHOL, V33, P133, DOI 10.1016/0022-2011(79)90146-0; Zeng WW, 2014, ARCH VIROL, V159, P2469, DOI 10.1007/s00705-014-2061-z; Zhu RL, 2011, VIRUS RES, V155, P495, DOI 10.1016/j.virusres.2010.12.006	74	16	16	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112517	10.1371/journal.pone.0112517	http://dx.doi.org/10.1371/journal.pone.0112517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402203	Green Published, Green Accepted, gold			2022-12-26	WOS:000345158700053
J	Wahab, T; Birdsell, DN; Hjertqvist, M; Mitchell, CL; Wagner, DM; Keim, PS; Hedenstrom, I; Lofdahl, S				Wahab, Tara; Birdsell, Dawn N.; Hjertqvist, Marika; Mitchell, Cedar L.; Wagner, David M.; Keim, Paul S.; Hedenstrom, Ingela; Lofdahl, Sven			Insights to Genetic Characterization Tools for Epidemiological Tracking of Francisella tularensis in Sweden	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; MULTIPLE-LOCUS; UNITED-STATES; TULAREMIA; PHYLOGEOGRAPHY; HOLARCTICA; STRAINS; GENOME	Tularaemia, caused by the bacterium Francisella tularensis, is endemic in Sweden and is poorly understood. The aim of this study was to evaluate the effectiveness of three different genetic typing systems to link a genetic type to the source and place of tularemia infection in Sweden. Canonical single nucleotide polymorphisms (canSNPs), MLVA including five variable number of tandem repeat loci and PmeI-PFGE were tested on 127 F. tularensis positive specimens collected from Swedish case-patients. All three typing methods identified two major genetic groups with near-perfect agreement. Higher genetic resolution was obtained with canSNP and MLVA compared to PFGE; F. tularensis samples were first assigned into ten phylogroups based on canSNPs followed by 33 unique MLVA types. Phylogroups were geographically analysed to reveal complex phylogeographic patterns in Sweden. The extensive phylogenetic diversity found within individual counties posed a challenge to linking specific genetic types with specific geographic locations. Despite this, a single phylogroup (B.22), defined by a SNP marker specific to a lone Swedish sequenced strain, did link genetic type with a likely geographic place. This result suggests that SNP markers, highly specific to a particular reference genome, may be found most frequently among samples recovered from the same location where the reference genome originated. This insight compels us to consider whole-genome sequencing (WGS) as the appropriate tool for effectively linking specific genetic type to geography. Comparing the WGS of an unknown sample to WGS databases of archived Swedish strains maximizes the likelihood of revealing those rare geographically informative SNPs.	[Wahab, Tara; Hjertqvist, Marika; Hedenstrom, Ingela; Lofdahl, Sven] Publ Hlth Agcy Sweden, Dept Microbiol, Stockholm, Sweden; [Birdsell, Dawn N.; Mitchell, Cedar L.; Wagner, David M.; Keim, Paul S.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA	Public Health Agency of Sweden; Northern Arizona University	Wahab, T (corresponding author), Publ Hlth Agcy Sweden, Dept Microbiol, Stockholm, Sweden.	tara.wahab@folkhalsomyndigheten.se		Wagner, David/0000-0003-2684-6007	Swedish Emergency Management Agency; US Department of Homeland Security Science and Technology Directorate [HSHQDC-10-C-00139]	Swedish Emergency Management Agency; US Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS))	This work was supported by grants from the Swedish Emergency Management Agency and by the US Department of Homeland Security Science and Technology Directorate via award HSHQDC-10-C-00139. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Carvalho DDB, 2012, INT J COMPUT ASS RAD, V7, P207, DOI 10.1007/s11548-011-0633-x; Chanturia G, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-139; Del Blanco NG, 2002, J CLIN MICROBIOL, V40, P2964, DOI 10.1128/JCM.40.8.2964-2972.2002; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Farlow J, 2001, J CLIN MICROBIOL, V39, P3186, DOI 10.1128/JCM.39.9.3186-3192.2001; Gyuranecz M, 2012, EMERG INFECT DIS, V18, P290, DOI 10.3201/eid1802.111305; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Karlsson E, 2013, ENVIRON MICROBIOL, V15, P634, DOI 10.1111/1462-2920.12052; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Larsson P, 2007, EMERG INFECT DIS, V13, P1725, DOI 10.3201/eid1311.070603; MORNER T, 1983, NORD VET MED, V35, P82; Padeshki PI, 2010, EPIDEMIOL INFECT, V138, P376, DOI 10.1017/S0950268809990513; Payne L, 2005, EMERG INFECT DIS, V11, P1440, DOI 10.3201/eid1109.041189; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Weir B.S., 1990, GENETIC DATA ANAL ME	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112167	10.1371/journal.pone.0112167	http://dx.doi.org/10.1371/journal.pone.0112167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401326	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700033
J	Agis, H; Collins, A; Taut, AD; Jin, QM; Kruger, L; Gorlach, C; Giannobile, WV				Agis, Hermann; Collins, Amy; Taut, Andrei D.; Jin, Qiming; Kruger, Laura; Goerlach, Christoph; Giannobile, William V.			Cell Population Kinetics of Collagen Scaffolds in Ex Vivo Oral Wound Repair	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; GINGIVAL FIBROBLASTS; TGF-BETA; IN-VITRO; MATRICELLULAR PROTEIN; EXTRACELLULAR-MATRIX; VOLUME AUGMENTATION; STEM-CELLS; MEMBRANES; REGENERATION	Biodegradable collagen scaffolds are used clinically for oral soft tissue augmentation to support wound healing. This study sought to provide a novel ex vivo model for analyzing healing kinetics and gene expression of primary human gingival fibroblasts (hGF) within collagen scaffolds. Sponge type and gel type scaffolds with and without platelet-derived growth factor-BB (PDGF) were assessed in an hGF containing matrix. Morphology was evaluated with scanning electron microscopy, and hGF metabolic activity using MTT. We quantitated the population kinetics within the scaffolds based on cell density and distance from the scaffold border of DiI-labled hGFs over a two-week observation period. Gene expression was evaluated with gene array and qPCR. The sponge type scaffolds showed a porous morphology. Absolute cell number and distance was higher in sponge type scaffolds when compared to gel type scaffolds, in particular during the first week of observation. PDGF incorporated scaffolds increased cell numbers, distance, and formazan formation in the MTT assay. Gene expression dynamics revealed the induction of key genes associated with the generation of oral tissue. DKK1, CYR61, CTGF, TGFBR1 levels were increased and integrin ITGA2 levels were decreased in the sponge type scaffolds compared to the gel type scaffold. The results suggest that this novel model of oral wound healing provides insights into population kinetics and gene expression dynamics of biodegradable scaffolds.	[Agis, Hermann; Collins, Amy; Taut, Andrei D.; Kruger, Laura; Giannobile, William V.] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Agis, Hermann] Med Univ Vienna, Dept Conservat Dent & Periodontol, Vienna, Austria; [Agis, Hermann] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Jin, Qiming] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Goerlach, Christoph] Geistlich Pharma AG, Wolhusen, Switzerland; [Giannobile, William V.] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Medical University of Vienna; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Giannobile, WV (corresponding author), Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA.	wgiannob@umich.edu	Agis, Hermann/O-4596-2016	Agis, Hermann/0000-0001-9509-1555; Giannobile, William/0000-0002-7102-9746	Geistlich Pharma AG (Wolhusen, Switzerland); Austrian Science Fund (FWF) [J3379-B19]	Geistlich Pharma AG (Wolhusen, Switzerland); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by Geistlich Pharma AG (www.geistlich-pharma.com, Wolhusen, Switzerland). Christoph Gorlach is employed by Geistlich Pharma AG. The authors confirm that the funder provided support in the form of salary for Christoph Gorlach, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Hermann Agis received the Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF, fwf.ac.at): J3379-B19. The Austrian Science Fund had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Akman AC, 2010, J BIOMED MATER RES A, V92A, P953, DOI 10.1002/jbm.a.32428; Anusaksathien O, 2003, TISSUE ENG, V9, P745, DOI 10.1089/107632703768247421; Behring J, 2008, ODONTOLOGY, V96, P1, DOI 10.1007/s10266-008-0087-y; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Black SA, 2008, J BIOL CHEM, V283, P10835, DOI 10.1074/jbc.M710363200; Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215; Crowston JG, 2006, INVEST OPHTH VIS SCI, V47, P946, DOI 10.1167/iovs.05-1048; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Ehashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085132; Froelich K, 2013, CELLS TISSUES ORGANS, V197, P384, DOI 10.1159/000346714; Ghanaati S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015010; Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Gruber R, 2004, PLATELETS, V15, P29, DOI 10.1080/09537100310001643999; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; Heng ECK, 2006, J CELL BIOCHEM, V98, P409, DOI 10.1002/jcb.20810; Herford AS, 2012, INT J ORAL MAX IMPL, V27, P1351; IRWIN CR, 1994, J PERIODONTAL RES, V29, P309, DOI 10.1111/j.1600-0765.1994.tb01227.x; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kabashima K, 2010, AM J PATHOL, V176, P721, DOI 10.2353/ajpath.2010.090454; Kim HN, 2012, BIOMATERIALS, V33, P8782, DOI 10.1016/j.biomaterials.2012.08.038; Kinikoglu B, 2009, BIOMATERIALS, V30, P6418, DOI 10.1016/j.biomaterials.2009.08.010; Kobayashi K, 2010, BIOMATERIALS, V31, P4855, DOI 10.1016/j.biomaterials.2010.02.027; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Martin MM, 2007, AM J PHYSIOL-LUNG C, V293, pL790, DOI 10.1152/ajplung.00099.2007; Marx G, 2008, J BIOMED MATER RES B, V84B, P571, DOI 10.1002/jbm.b.30905; Mathes SH, 2010, BIOTECHNOL BIOENG, V107, P1029, DOI 10.1002/bit.22893; MINABE M, 1989, J PERIODONTOL, V60, P35, DOI 10.1902/jop.1989.60.1.35; Mio T, 1996, IN VITRO CELL DEV-AN, V32, P427; Mumford JH, 2001, J PERIODONTOL, V72, P331, DOI 10.1902/jop.2001.72.3.331; OCCLESTON NL, 1994, INVEST OPHTH VIS SCI, V35, P3681; Ohshima M, 2010, J DENT RES, V89, P1315, DOI 10.1177/0022034510378423; Orsini M, 2004, J PERIODONTOL, V75, P470, DOI 10.1902/jop.2004.75.3.470; Ravindran S, 2010, TISSUE ENG PT A, V16, P327, DOI [10.1089/ten.tea.2009.0110, 10.1089/ten.TEA.2009.0110]; Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x; Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x; San Martin S, 2013, J TISSUE ENG REGEN M, V7, P10, DOI 10.1002/term.490; Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x; Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5; Schor S L, 1996, Oral Dis, V2, P155; Simion M, 2012, INT J PERIODONT REST, V32, P273; Stalling SS, 2009, ACTA BIOMATER, V5, P1911, DOI 10.1016/j.actbio.2009.02.020; Stoecklin-Wasmer C, 2013, J DENT RES, V92, P773, DOI 10.1177/0022034513496428; Thoma DS, 2011, J CLIN PERIODONTOL, V38, P1063, DOI 10.1111/j.1600-051X.2011.01786.x; Thoma DS, 2010, J CLIN PERIODONTOL, V37, P659, DOI 10.1111/j.1600-051X.2010.01581.x; Thoma DS, 2009, CLIN ORAL IMPLAN RES, V20, P146, DOI 10.1111/j.1600-0501.2009.01784.x; Wang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056330; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Yamaguchi Y, 2008, FASEB J, V22, P1009, DOI 10.1096/fj.07-9475com; Zhang XJ, 2009, BIOMATERIALS, V30, P2666, DOI 10.1016/j.biomaterials.2009.01.018	52	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112680	10.1371/journal.pone.0112680	http://dx.doi.org/10.1371/journal.pone.0112680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397671	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500077
J	Kumari, P; Sahal, D; Chauhan, VS				Kumari, Pinky; Sahal, Dinkar; Chauhan, Virander S.			Dendrimeric Template of Plasmodium falciparum Histidine Rich Protein II Repeat Motifs Bearing Asp -> Asn Mutation Exhibits Heme Binding and beta-Hematin Formation	PLOS ONE			English	Article							HYDROGEN-BOND ACCEPTORS; ANION-PI INTERACTIONS; MALARIA PIGMENT; AROMATIC RINGS; X-RAY; PEPTIDES; CONFORMATION	Plasmodium falciparum (Pf) employs a crucial PfHRPII catalyzed reaction that converts toxic heme into hemozoin. Understanding heme polymerization mechanism is the first step for rational design of new drugs, targeting this pathway. Heme binding and hemozoin formation have been ascribed to PfHRPII aspartate carboxylate-heme metal ionic interactions. To investigate, if this ionic interaction is indeed pivotal, we examined the comparative heme binding and beta-hematin forming abilities of a wild type dendrimeric peptide BNT1 {harboring the native sequence motif of PfHRPII (AHHAHHAADA)} versus a mutant dendrimeric peptide BNTM {in which ionic Aspartate residues have been replaced by the neutral Asparaginyl residues (AHHAHHAANA)}. UV and IR data reported here reveal that at pH 5, both BNT1 and BNTM exhibit comparable heme binding as well as beta-hematin forming abilities, thus questioning the role of PfHRPII aspartate carboxylate-heme metal ionic interactions in heme binding and beta-hematin formation. Based on our data and information in the literature we suggest the possible role of weak dispersive interactions like N-H center dot center dot center dot pi and lone-pair center dot center dot center dot pi in heme binding and hemozoin formation.	[Kumari, Pinky; Sahal, Dinkar; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, Malaria Res Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sahal, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Res Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	dinkar@icgeb.res.in; virander@icgeb.res.in	SAHAL, DINKAR/GYD-7570-2022; Chauhan, Virander S./K-5276-2019		Malaria Core Fund, ICGEB, New Delhi; University Grants Commission, New Delhi, India [10-2(5)/2005(i)-E.U.II]	Malaria Core Fund, ICGEB, New Delhi; University Grants Commission, New Delhi, India(University Grants Commission, India)	This study was supported by Malaria Core Fund, ICGEB, New Delhi. Pinky Kumari got financial assistance from University Grants Commission, New Delhi, India in the form of "CSIR-UGC Research Fellowship, Award No - F.No. 10-2(5)/2005(i)-E.U.II". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breman JG, 2001, AM J TROP MED HYG, V64, P1; Choi CYH, 1999, BIOCHEMISTRY-US, V38, P16916, DOI 10.1021/bi991665k; Dauster I, 2008, PHYS CHEM CHEM PHYS, V10, P2827, DOI 10.1039/b717823a; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; EGLI M, 1995, P NATL ACAD SCI USA, V92, P180, DOI 10.1073/pnas.92.1.180; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Frontera A, 2005, CHEM-EUR J, V11, P6560, DOI 10.1002/chem.200500783; Gallivan JP, 1999, ORG LETT, V1, P103, DOI 10.1021/ol990577p; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Li Y, 2003, BIOORG MED CHEM LETT, V13, P3261, DOI 10.1016/S0960-894X(03)00662-0; Lynn A, 1999, FEBS LETT, V459, P267, DOI 10.1016/S0014-5793(99)01260-0; MORGAN WT, 1985, BIOCHEMISTRY-US, V24, P1496, DOI 10.1021/bi00327a031; Niles JC, 2009, P NATL ACAD SCI USA, V106, P13266, DOI 10.1073/pnas.0906370106; Ottiger P, 2009, J PHYS CHEM B, V113, P2937, DOI 10.1021/jp8110474; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pandey AV, 1999, J PHARMACEUT BIOMED, V20, P203, DOI 10.1016/S0731-7085(99)00021-7; PANTON LJ, 1989, MOL BIOCHEM PARASIT, V35, P149, DOI 10.1016/0166-6851(89)90117-5; PERUTZ MF, 1986, J AM CHEM SOC, V108, P1064, DOI 10.1021/ja00265a036; Sarkhel S, 2003, J AM CHEM SOC, V125, P8998, DOI 10.1021/ja0357801; Schneider EL, 2005, BIOCHEMISTRY-US, V44, P979, DOI 10.1021/bi048570p; Schottel BL, 2006, J AM CHEM SOC, V128, P5895, DOI 10.1021/ja0606273; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Sullivan DJ, 2002, INT J PARASITOL, V32, P1645, DOI 10.1016/S0020-7519(02)00193-5; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; Tilley L, 2001, INFEC DIS S, P87; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; Ziegler J, 1999, J AM CHEM SOC, V121, P2395, DOI 10.1021/ja983220+	31	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112087	10.1371/journal.pone.0112087	http://dx.doi.org/10.1371/journal.pone.0112087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398028	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558500031
J	Lejeune, M; Moreau, F; Chadee, K				Lejeune, Manigandan; Moreau, France; Chadee, Kris			Loss of EP2 Receptor Subtype in Colonic Cells Compromise Epithelial Barrier Integrity by Altering Claudin-4	PLOS ONE			English	Article							TIGHT JUNCTION; PROSTANOID RECEPTORS; DISEASE-ACTIVITY; EXPRESSION; CANCER; PERMEABILITY; INFLAMMATION; EICOSANOIDS; INTESTINE; COMPLEX	Prostaglandin E-2 (PGE(2)) is a bioactive lipid mediator that exerts its biological function through interaction with four different subtypes of E-Prostanoid receptor namely EP1, EP2, EP3 and EP4. It has been known that EP2 receptor is differentially over-expressed in the epithelia of inflamed human colonic mucosa. However, the significance of the differential expression in altering epithelial barrier function is not known. In this study, we used Caco-2 cells expressing EP2 receptor, either high (EP2S) or low (EP2A), as a model epithelia and determined the barrier function of these cell monolayers by measuring the trans epithelial resistance (TER). Basal TER of EP2A (but not EP2S) monolayer was significantly lower suggesting a loss of colonic epithelial barrier integrity. In comparison, the TER of wild type Caco-2 was decreased in response to an EP2 receptor specific antagonist (AH-6809) indicating an important role for EP2 receptor in the maintenance of epithelial barrier function. The decrease TER in EP2A monolayer corresponded with a significant loss of the tight junction (TJ) protein claudin-4 without affecting other major TJ proteins. Similarly, EP2 receptor antagonism/siRNA based silencing significantly decreased claudin-4 expression in EP2S cells. Surprisingly, alteration in claudin-4 was not transcriptionally regulated in EP2A cells but rather undergoes increased proteosomal degradation. Moreover, among the TER compromising cytokines examined (IL-8, IL-1 beta, TNF-alpha, IFN-gamma) only IFN-gamma was significantly up regulated in EP2A cells. However, IFN-gamma did not significantly decreased claudin-4 expression in Caco-2 cells indicating no role for IFN-gamma in degrading claudin-4. We conclude that differential down-regulation of EP2 receptor play a major role in compromising colonic epithelial barrier function by selectively increasing proteosomal degradation of claudin-4.	[Lejeune, Manigandan; Moreau, France; Chadee, Kris] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Calgary	Chadee, K (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	kchadee@ucalgary.ca	Lejeune, Manigandan/AAI-9474-2021		Canadian Institute for Health Research; Crohn's and Colitis Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Canada	This work was supported by the Canadian Institute for Health Research (KC); Crohn's and Colitis Canada (KC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENSTEDT O, 1994, J GASTROEN HEPATOL, V9, P539, DOI 10.1111/j.1440-1746.1994.tb01557.x; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Atay S, 2000, PROSTAG OTH LIPID M, V61, P105, DOI 10.1016/S0090-6980(00)00067-8; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Buret AG, 2002, PARASITOLOGY, V125, P11, DOI 10.1017/S0031182002001853; Cosme R, 2000, HUM IMMUNOL, V61, P684, DOI 10.1016/S0198-8859(00)00131-2; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Dey I, 2009, BRIT J PHARMACOL, V156, P475, DOI 10.1111/j.1476-5381.2008.00056.x; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Houchen CW, 2003, AM J PHYSIOL-GASTR L, V284, pG490, DOI 10.1152/ajpgi.00240.2002; Jang TJ, 2004, GUT, V53, P27, DOI 10.1136/gut.53.1.27; Krause W, 2000, PROSTAG OTH LIPID M, V61, P145, DOI 10.1016/S0090-6980(00)00069-1; Leroy A, 2000, FASEB J, V14, P1139, DOI 10.1096/fasebj.14.9.1139; Moeser AJ, 2004, GASTROENTEROLOGY, V127, P802, DOI 10.1053/j.gastro.2004.06.004; Mohajer B, 2000, PROSTAG OTH LIPID M, V61, P125, DOI 10.1016/S0090-6980(00)00068-X; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nava P, 2004, J CELL SCI, V117, P5509, DOI 10.1242/jcs.01425; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; RAMPTON DS, 1980, GUT, V21, P591, DOI 10.1136/gut.21.7.591; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Shoji Y, 2004, GUT, V53, P1151, DOI 10.1136/gut.2003.028787; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Takafuji V, 2000, PROSTAG LEUKOTR ESS, V63, P223, DOI 10.1054/plef.2000.0144; Takafuji VA, 2002, PROSTAG LEUKOTR ESS, V66, P71, DOI 10.1054/plef.2001.0299; Tanaka MN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-63; Thanabalasuriar A, 2010, CELL MICROBIOL, V12, P31, DOI 10.1111/j.1462-5822.2009.01376.x; Tsuji S, 1996, PROSTAG LEUKOTR ESS, V55, P179, DOI 10.1016/S0952-3278(96)90095-2; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113270	10.1371/journal.pone.0113270	http://dx.doi.org/10.1371/journal.pone.0113270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396731	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500145
J	Miao, Y; Wang, L; Zhang, XP; Xu, XH; Jiang, GY; Fan, CF; Liu, Y; Lin, XY; Yu, JH; Zhang, Y; Wang, EH				Miao, Yuan; Wang, Liang; Zhang, Xiupeng; Xu, Xiaohan; Jiang, Guiyang; Fan, Chuifeng; Liu, Yang; Lin, Xuyong; Yu, Juanhan; Zhang, Yong; Wang, Enhua			Promoter Methylation-Mediated Silencing of beta-Catenin Enhances Invasiveness of Non-Small Cell Lung Cancer and Predicts Adverse Prognosis	PLOS ONE			English	Article							E-CADHERIN; MICROSATELLITE INSTABILITY; DNA METHYLATION; POOR-PROGNOSIS; BREAST-CANCER; EXPRESSION; GENES; HYPERMETHYLATION; CARCINOMA; SUPPRESSION	beta-Catenin plays dual role in adhesion complex formation and the Wnt signaling pathway. Although beta-catenin expression appears to be upregulated and Wnt signaling pathway is activated in the majority of cancers, its expression level seems to be lost in non-small cell lung cancer (NSCLC). We previously reported that the promoter of beta-catenin was hypermethylated in two NSCLC cell lines. In the current study, we expanded our analysis for the methylation status of beta-catenin promoter region and its protein expression in seven NSCLC cell lines and a series of 143 cases of primary human lung cancer with adjacent non-neoplastic tissues. Quantitative methylation specific PCR (qMSP) analysis showed methylation of beta-catenin promoter region in five NSCLC cell lines, with increased beta-catenin protein levels upon 5'-Aza-2'-deoxycytidine (5-aza-dC) treatment. The methylation status in SPC (methylated) and A549 (unmethylated) was confirmed by bisulfite sequencing PCR. 5-Aza-dC treatment inhibited invasiveness of SPC but not A549. Immunofluorescence analysis showed membranous bcatenin expression was lost in SPC and could be re-established by 5-aza-dC, while Wnt3a treatment led to nuclear translocation of b-catenin in both SPC and A549. Dual-luciferase assays indicated that 5-aza-dC treatment caused no significant increase in Wnt signaling activity compared with Wnt3a treatment. The effect of demethylation agent in SPC can be reversed by beta-catenin depletion but not E-cadherin depletion which indicated that the methylation mediated beta-catenin silencing might enhance NSCLC invasion and metastasis in an E-cadherin independent manner. Subsequent immunohistochemistry results further confirmed that beta-catenin promoter hypermethylation correlated with loss of immunoreactive protein expression, positive lymph node metastasis, high TNM stage and poor prognosis. The present study implicates beta-catenin promoter hypermethylation in the mechanism of epigenetic changes underlying NSCLC metastasis and progression, thus indicating the potential of beta-catenin as a novel epigenetic target for the treatment of NSCLC patients.	[Miao, Yuan; Wang, Liang; Zhang, Xiupeng; Jiang, Guiyang; Fan, Chuifeng; Liu, Yang; Lin, Xuyong; Yu, Juanhan; Zhang, Yong; Wang, Enhua] China Med Univ, Dept Pathol, Hosp 1, Shenyang, Peoples R China; [Miao, Yuan; Wang, Liang; Zhang, Xiupeng; Jiang, Guiyang; Fan, Chuifeng; Liu, Yang; Lin, Xuyong; Yu, Juanhan; Zhang, Yong; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Xu, Xiaohan] China Med Univ, Year Program Med 96K 7, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, EH (corresponding author), China Med Univ, Dept Pathol, Hosp 1, Shenyang, Peoples R China.	wangeh@hotmail.com	Wang, Liang/AAM-2378-2021; Miao, Yuan/AAG-9754-2021	Wang, Liang/0000-0003-4015-9385; 	National Natural Science Foundation of China [81000942, 30900562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81000942 to Yuan Miao and No. 30900562 to Yang Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Cho YH, 2012, BREAST CANCER RES TR, V131, P197, DOI 10.1007/s10549-011-1712-y; Ebert MPA, 2003, J CLIN ONCOL, V21, P1708, DOI 10.1200/JCO.2003.10.017; Fu YJ, 2011, INT J CANCER, V129, P1541, DOI 10.1002/ijc.26102; Goldstraw P, 2011, SURG ONCOL CLIN N AM, V20, P655, DOI 10.1016/j.soc.2011.07.005; Hugh TJ, 1999, INT J CANCER, V82, P504, DOI 10.1002/(SICI)1097-0215(19990812)82:4<504::AID-IJC6>3.0.CO;2-6; Kase S, 2000, CLIN CANCER RES, V6, P4789; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Kwon MJ, 2013, HUM PATHOL, V44, P1722, DOI 10.1016/j.humpath.2013.03.004; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087537; Mareel M, 1996, J CELL BIOCHEM, V61, P524; Miao Y, 2013, PATHOL ONCOL RES, V19, P281, DOI 10.1007/s12253-012-9580-2; Miao Y, 2012, FOLIA HISTOCHEM CYTO, V50, P392, DOI [10.5603/FHC.2012.0053, 10.5603/11957]; Mirabelli-Primdahl L, 1999, CANCER RES, V59, P3346; Nakata S, 2006, CANCER-AM CANCER SOC, V106, P2190, DOI 10.1002/cncr.21870; Pirinen RT, 2001, J CLIN PATHOL, V54, P391, DOI 10.1136/jcp.54.5.391; Retera JMAM, 1998, J CLIN PATHOL, V51, P891, DOI 10.1136/jcp.51.12.891; Russo AL, 2005, CLIN CANCER RES, V11, P2466, DOI 10.1158/1078-0432.CCR-04-1962; Salon Caroline, 2005, Future Oncol, V1, P649, DOI 10.2217/14796694.1.5.649; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Takahashi Y, 2008, INT J CANCER, V123, P2315, DOI 10.1002/ijc.23812; Travis WD., 2004, TRAVIS WB WHO CLASSI; Travis WD, 2011, CLIN CHEST MED, V32, P669, DOI 10.1016/j.ccm.2011.08.005; Tsou JA, 2002, ONCOGENE, V21, P5450, DOI 10.1038/sj.onc.1205605; Vaissiere T, 2009, CANCER RES, V69, P243, DOI 10.1158/0008-5472.CAN-08-2489; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Yanagawa N, 2003, CANCER SCI, V94, P589, DOI 10.1111/j.1349-7006.2003.tb01487.x; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	32	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112258	10.1371/journal.pone.0112258	http://dx.doi.org/10.1371/journal.pone.0112258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396757	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500041
J	Wu, WC; Liu, CH; Wang, NK; Chen, KJ; Chen, TL; Hwang, YS; Liao, PJ; Li, LM; Lai, CC				Wu, Wei-Chi; Liu, Chi-Hsien; Wang, Nan-Kai; Chen, Kwan-Jen; Chen, Tun-Lu; Hwang, Yih-Shiou; Liao, Pei-Ju; Li, Lien-Min; Lai, Chi-Chun			Lens Subluxation after Plasmin and SF6 Injections in Rabbit Eyes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ENZYME-ASSISTED VITRECTOMY; POSTERIOR VITREOUS DETACHMENT; DIABETIC MACULAR EDEMA; RETINAL VEIN OCCLUSION; PHARMACOLOGICAL VITREOLYSIS; EXTRACELLULAR-MATRIX; STAGE-5 RETINOPATHY; CILIARY ZONULE; PREMATURITY	Purpose: To investigate the rate of lens subluxation following plasmin and/or SF6 injections in eyes, and whether a subsequent elevated level of vascular endothelial growth factor (VEGF) and vitreous tap would aggravate subluxation. Methods: Four groups of rabbits were used. Group 1 received an intravitreal injection (IVI) of plasmin and SF6 in the right eye; group 2 received an IVI of plasmin in the right eye; group 3 received an IVI of SF6 in the right eye; and group 4 received an IVI of balanced salt solution in the right eye. After treatment, IVIs of VEGF were given and vitreous tap was performed three times, followed by clinical observation of lens subluxation and scanning electronic microscope evaluation of the zonular fibers. Results: After IVIs of plasmin and SF6, and VEGF and vitreous tap had been performed one to three times, lens subluxation was noted in 0%, 43%, 71%, 71%, and 86% of the eyes in group 1. After IVIs of plasmin, VEGF, and vitreous tap had been performed one to three times, lens subluxation was noted in 11%, 22%, 44%, 44%, and 67% of the eyes in group 2. The eyes in group 3 and 4 did not show signs of lens subluxation after VEGF IVIs and vitreous tap. Histology confirmed zonular fiber damage in the eyes treated with plasmin. Conclusions: The incidence of lens subluxation increased following plasmin injections in the eyes, and this was aggravated by the subsequent high VEGF level in the eyes and vitreous tapping. Zonular fibers were disrupted following plasmin treatment. These effects should be kept in mind when using plasmin enzymes in patients with vitreoretinal abnormalities.	[Wu, Wei-Chi; Wang, Nan-Kai; Chen, Kwan-Jen; Chen, Tun-Lu; Hwang, Yih-Shiou; Li, Lien-Min; Lai, Chi-Chun] Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan; [Wu, Wei-Chi; Wang, Nan-Kai; Chen, Kwan-Jen; Chen, Tun-Lu; Hwang, Yih-Shiou; Lai, Chi-Chun] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Liu, Chi-Hsien] Chang Gung Univ, Grad Inst Biochem & Biomed Engn, Taoyuan, Taiwan; [Liao, Pei-Ju] Oriental Inst Technol, Dept Hlth Care Adm, New Taipei City, Taiwan; [Liao, Pei-Ju] Natl Taiwan Univ, Dept Business Adm, Taipei 10764, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Asia Eastern University of Science & Technology; National Taiwan University	Wu, WC (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan.	weichi666@gmail.com	Wang, Nan-Kai/D-6608-2011; Wang, Nan-Kai/AAO-6559-2020	Wang, Nan-Kai/0000-0002-6277-9879; Wang, Nan-Kai/0000-0002-6277-9879; Lai, Chi-Chun/0000-0001-9547-7212; Chen, Kuan-Jen/0000-0002-4994-8391	National Science Council, Taipei, Taiwan [NSC101-2314-B-182A-055-MY3]; Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPG3A0391, CMRPG3A0392]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital)	This study was supported by grants from the National Science Council, Taipei, Taiwan (NSC101-2314-B-182A-055-MY3) and Chang Gung Memorial Hospital, Taoyuan, Taiwan (CMRPG3A0391 and CMRPG3A0392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Boyd SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P1644; CHAN FL, 1995, HISTOCHEM CELL BIOL, V104, P369, DOI 10.1007/BF01458131; Costagliola C, 2013, EXP EYE RES, V110, P50, DOI 10.1016/j.exer.2013.02.004; Diaz-Llopis M, 2009, J OCUL PHARMACOL TH, V25, P379, DOI 10.1089/jop.2008.0118; Dureau P, 2008, CURR OPIN OPHTHALMOL, V19, P27, DOI 10.1097/ICU.0b013e3282f29f01; GOLDFISCHER S, 1985, TISSUE CELL, V17, P441, DOI 10.1016/0040-8166(85)90023-0; Henderson M, 1996, J HISTOCHEM CYTOCHEM, V44, P1389, DOI 10.1177/44.12.8985131; Hermel M, 2006, GRAEF ARCH CLIN EXP, V244, P996, DOI 10.1007/s00417-005-0159-4; HIKICHI T, 1995, RETINA-J RET VIT DIS, V15, P29, DOI 10.1097/00006982-199515010-00006; Hoffman RS, 2013, J CATARACT REFR SURG, V39, P1904, DOI 10.1016/j.jcrs.2013.09.005; Joshi MM, 2006, RETINA-J RET VIT DIS, V26, pS38, DOI 10.1097/01.iae.0000244287.63757.5a; Kim BT, 2013, OPHTHAL SURG LAS IM, V44, P334, DOI 10.3928/23258160-20130715-05; Kliche S, 2001, IUBMB LIFE, V52, P61, DOI 10.1080/15216540252774784; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P506; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; LIOTTA LA, 1981, CANCER RES, V41, P4629; MACHEMER R, 1985, OPHTHALMOLOGY, V92, P1000; MAGENIS RE, 1991, GENOMICS, V11, P346, DOI 10.1016/0888-7543(91)90142-2; Margherio AR, 1998, OPHTHALMOLOGY, V105, P1617, DOI 10.1016/S0161-6420(98)99027-3; MARSHALL GE, 1992, INVEST OPHTH VIS SCI, V33, P2546; NASRALLAH FP, 1988, OPHTHALMOLOGY, V95, P1335; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Peer J, 1996, BRIT J OPHTHALMOL, V80, P241, DOI 10.1136/bjo.80.3.241; Proksch JW, 2008, J OCUL PHARMACOL TH, V24, P320, DOI 10.1089/jop.2007.0120; Quiram PA, 2007, RETINA-J RET VIT DIS, V27, P1090, DOI 10.1097/IAE.0b013e3180654229; RAVIOLA G, 1971, INVEST OPHTH VISUAL, V10, P851; Rezende FA, 2014, AM J OPHTHA IN PRESS; Robison CD, 2009, AM J OPHTHALMOL, V148, P79, DOI 10.1016/j.ajo.2009.01.014; RUSSELL SR, 1991, INVEST OPHTH VIS SCI, V32, P1986; Sato T, 2009, OPHTHALMOLOGY, V116, P2165, DOI 10.1016/j.ophtha.2009.04.026; Sato T, 2009, OPHTHALMOLOGY, V116, P1599, DOI 10.1016/j.ophtha.2008.12.023; SCHEPENS CL, 1984, SURV OPHTHALMOL, V28, P499, DOI 10.1016/0039-6257(84)90232-7; Sebag J, 2007, GRAEF ARCH CLIN EXP, V245, P576, DOI 10.1007/s00417-006-0394-3; Sounni NE, 2004, J BIOL CHEM, V279, P13564, DOI 10.1074/jbc.M307688200; Stalmans P, 2012, NEW ENGL J MED, V367, P606, DOI 10.1056/NEJMoa1110823; TAGAWA H, 1986, OPHTHALMOLOGY, V93, P596; Trese MT, 2000, OPHTHALMOLOGY, V107, P1607, DOI 10.1016/S0161-6420(00)00210-4; Tsukahara Y, 2007, AM J OPHTHALMOL, V144, P139, DOI 10.1016/j.ajo.2007.03.020; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; VERSTRAETEN TC, 1993, ARCH OPHTHALMOL-CHIC, V111, P849, DOI 10.1001/archopht.1993.01090060139038; Wang FH, 2004, INVEST OPHTH VIS SCI, V45, P3286, DOI 10.1167/iovs.04-0026; Wang ZL, 2009, RETINA-J RET VIT DIS, V29, P269, DOI 10.1097/IAE.0b013e3181923ff0; Wij WC, 2007, RETINA-J RET VIT DIS, V27, P1079, DOI 10.1097/IAE.0b013e31806196d0; Williams JG, 2001, OPHTHALMOLOGY, V108, P1902, DOI 10.1016/S0161-6420(01)00720-5; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Wu WC, 2008, RETINA-J RET VIT DIS, V28, pS75, DOI 10.1097/IAE.0b013e318158ea0e; Wu WC, 2007, AM J OPHTHALMOL, V144, P668, DOI 10.1016/j.ajo.2007.07.027; Wu WC, 2012, MOL VIS, V18, P2361; Wu WC, 2010, INVEST OPHTH VIS SCI, V51, P3701, DOI 10.1167/iovs.09-4425	51	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112957	10.1371/journal.pone.0112957	http://dx.doi.org/10.1371/journal.pone.0112957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397749	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500119
J	Katsuyama, E; Miyamoto, H; Kobayashi, T; Sato, Y; Hao, W; Kanagawa, H; Fujie, A; Tando, T; Watanabe, R; Morita, M; Miyamoto, K; Niki, Y; Morioka, H; Matsumoto, M; Toyama, Y; Miyamoto, T				Katsuyama, Eri; Miyamoto, Hiroya; Kobayashi, Tami; Sato, Yuiko; Hao, Wu; Kanagawa, Hiroya; Fujie, Atsuhiro; Tando, Toshimi; Watanabe, Ryuichi; Morita, Mayu; Miyamoto, Kana; Niki, Yasuo; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi			Interleukin-1 Receptor-associated Kinase-4 (IRAK4) Promotes Inflammatory Osteolysis by Activating Osteoclasts and Inhibiting Formation of Foreign Body Giant Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE POLARIZATION; DC-STAMP; FUSION; BISPHOSPHONATES; OSTEOPETROSIS; OSTEONECROSIS; CHEMOKINES; PLASTICITY; FRACTURES; RESPONSES	Formation of foreign body giant cells (FBGCs) occurs following implantation of medical devices such as artificial joints and is implicated in implant failure associated with inflammation or microbial infection. Two major macrophage subpopulations, M1 and M2, play different roles in inflammation and wound healing, respectively. Therefore, M1/M2 polarization is crucial for the development of various inflammation-related diseases. Here, we show that FBGCs do not resorb bone but rather express M2 macrophage-like wound healing and inflammation-terminating molecules in vitro. We also found that FBGC formation was significantly inhibited by inflammatory cytokines or infection mimetics in vitro. Interleukin-1 receptor-associated kinase-4 (IRAK4) deficiency did not alter osteoclast formation in vitro, and IRAK4-deficient mice showed normal bone mineral density in vivo. However, IRAK4-deficient mice were protected from excessive osteoclastogenesis induced by IL-1 beta in vitro or by LPS, an infection mimetic of Gram-negative bacteria, in vivo. Furthermore, IRAK4 deficiency restored FBGC formation and expression of M2 macrophage markers inhibited by inflammatory cytokines in vitro or by LPS in vivo. Our results demonstrate that osteoclasts and FBGCs are reciprocally regulated and identify IRAK4 as a potential therapeutic target to inhibit stimulated osteoclastogenesis and rescue inhibited FBGC formation under inflammatory and infectious conditions without altering physiological bone resorption.	[Katsuyama, Eri; Miyamoto, Hiroya; Kobayashi, Tami; Sato, Yuiko; Hao, Wu; Kanagawa, Hiroya; Fujie, Atsuhiro; Tando, Toshimi; Watanabe, Ryuichi; Miyamoto, Kana; Niki, Yasuo; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Kobayashi, Tami; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Yuiko] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Morita, Mayu] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Keio University; Keio University; Keio University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	hao, wu/HDM-1705-2022	NIKI, YASUO/0000-0002-0197-5171				Amano S, 1996, J IMMUNOL, V156, P1931; Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; ARONSON M, 1962, NATURE, V193, P399, DOI 10.1038/193399a0; Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Biteman B, 2007, FASEB J, V21, P2257, DOI 10.1096/fj.06-7918com; Borromeo GL, 2014, J BONE MINER RES, V29, P1363, DOI 10.1002/jbmr.2179; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; Edwards BJ, 2013, J BONE JOINT SURG AM, V95A, P297, DOI 10.2106/JBJS.K.01181; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Hoshi H, 2012, J BONE MINER RES, V27, P2015, DOI 10.1002/jbmr.1634; Iglesias JE, 2015, GERODONTOLOGY, V32, P169, DOI 10.1111/ger.12093; Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035; Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221; Khan AA, 2009, J RHEUMATOL, V36, P478, DOI 10.3899/jrheum.080759; Khan UA, 2014, J CELL BIOCHEM, V115, P1290, DOI 10.1002/jcb.24781; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lin T, 2012, OSTEOPOROSIS INT, V23, P1823, DOI 10.1007/s00198-011-1797-5; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P869, DOI 10.1001/jama.283.7.869; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto T, 2000, BLOOD, V96, P4335, DOI 10.1182/blood.V96.13.4335.h8004335_4335_4343; Miyauchi Y, 2012, J BIOL CHEM, V287, P28508, DOI 10.1074/jbc.M112.356634; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakanishi-Matsui M, 2013, BIOCHEM BIOPH RES CO, V440, P611, DOI 10.1016/j.bbrc.2013.09.109; NAWROTH PP, 1986, J EXP MED, V163, P1363, DOI 10.1084/jem.163.6.1363; Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599; Okada Y, 2000, J CLIN INVEST, V105, P823, DOI 10.1172/JCI8195; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Rao AJ, 2013, J BIOMED MATER RES A, V101, P1925, DOI 10.1002/jbm.a.34486; Rao AJ, 2012, ACTA BIOMATER, V8, P2815, DOI 10.1016/j.actbio.2012.03.042; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837; Suratwala SJ, 2008, J BONE JOINT SURG AM, V90A, P2189, DOI 10.2106/JBJS.G.00409; Suzuki N, 2006, SCIENCE, V311, P1927, DOI 10.1126/science.1124256; Suzuki N, 2003, J IMMUNOL, V171, P6065, DOI 10.4049/jimmunol.171.11.6065; Suzuki N, 2003, J IMMUNOL, V170, P4031, DOI 10.4049/jimmunol.170.8.4031; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124; TANG LP, 1995, AM J CLIN PATHOL, V103, P466; Uderhardt S, 2012, J MOL MED, V90, P1247, DOI 10.1007/s00109-012-0954-4; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803; Whyte MP, 2008, J BONE MINER RES, V23, P1698, DOI [10.1359/jbmr.080511, 10.1359/JBMR.080511]; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yang SY, 2007, J ORTHOP RES, V25, P603, DOI 10.1002/jor.20342; ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205	58	23	24	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					716	726		10.1074/jbc.M114.568360	http://dx.doi.org/10.1074/jbc.M114.568360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25404736	Green Published, hybrid			2022-12-26	WOS:000347778200003
J	Terakawa, MS; Yagi, H; Adachi, M; Lee, YH; Goto, Y				Terakawa, Mayu S.; Yagi, Hisashi; Adachi, Masayuki; Lee, Young-Ho; Goto, Yuji			Small Liposomes Accelerate the Fibrillation of Amyloid beta (1-40)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; A-BETA; MEMBRANE DISRUPTION; LIPID-MEMBRANES; PROTEIN; FIBRILS; PEPTIDE; AGGREGATION; MECHANISM	The deposition of amyloid beta (A beta) peptides is a pathological hallmark of Alzheimer disease. A beta peptides were previously considered to interact specifically with ganglioside-containing membranes. Several studies have suggested that A beta peptides also bind to phosphatidylcholine membranes, which lead to deformation of membranes and fibrillation of A beta. Moreover, the role of membrane curvature, one type of deformation produced by binding of proteins to a membrane, in the binding and fibrillation of A beta remains unclear. To clearly understand the relationship between the binding, consequent membrane deformation, and fibrillation of A beta, we examined the amyloid fibrillation of A beta-(1-40) in the presence of liposomes of various sizes. Membrane curvature increased with a decrease in the size of the liposomes. We used liposomes made of 1,2-dioleoyl-sn-glycero-3-phosphocholine to eliminate electrostatic effects. The results obtained showed that liposomes of smaller sizes (<= 50 nm) significantly accelerated the nucleation step, thereby shortening the lag time of fibrillation. On the other hand, liposomes of larger sizes decreased the amount of fibrils but did not notably affect the lag time. The morphologies of fibrils, which were monitored by total internal reflection fluorescence microscopy, atomic force microscopy, and transmission electron microscopy, revealed that the length of A beta -(1-40) fibrils became shorter and the amount of amorphous aggregates became larger as liposomes increased in size. These results suggest that the curvature of membranes coupled with an increase in water-accessible hydrophobic regions is important for binding and concentrating A beta monomers, leading to amyloid nucleation. Furthermore, amyloid fibrillation on membranes may compete with non-productive binding to produce amorphous aggregates.	[Terakawa, Mayu S.; Yagi, Hisashi; Adachi, Masayuki; Lee, Young-Ho; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp			Ministry of Education, Science, Sports, and Culture, Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25870407, 13J03790] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Science, Sports, and Culture, Japan, a grant-in-aid for scientific research (to Y. G.), and a grantin-aid for the Japan Society for the Promotion of Science Fellows (to M. S. T.). We acknowledge financial support from Takeda Science Foundation (to H. Y.).	Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; [Anonymous], 2010, INT J ALZHEIMERS DIS; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, METHOD ENZYMOL, V413, P91, DOI 10.1016/S0076-6879(06)13005-0; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bokvist M, 2007, J AM CHEM SOC, V129, P14848, DOI 10.1021/ja076059o; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chauhan A, 2000, NEUROCHEM RES, V25, P423, DOI 10.1023/A:1007509608440; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HALVERSON K, 1990, BIOCHEMISTRY-US, V29, P2639, DOI 10.1021/bi00463a003; Hamada T, 2010, J PHYS CHEM LETT, V1, P170, DOI 10.1021/jz900106z; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; KREMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932, DOI 10.1021/bi00636a033; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Morita M, 2012, SOFT MATTER, V8, P2816, DOI 10.1039/c2sm07185a; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Pannuzzo M, 2013, PHYS CHEM CHEM PHYS, V15, P8940, DOI 10.1039/c3cp44539a; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Qu L, 2009, J COMP NEUROL, V514, P343, DOI 10.1002/cne.22007; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Sasahara K, 2012, BIOCHEMISTRY-US, V51, P6908, DOI 10.1021/bi300542g; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Shimanouchi T, 2011, COLLOID SURFACE B, V88, P221, DOI 10.1016/j.colsurfb.2011.06.036; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Sun Y, 2010, BIOPHYS J, V99, P544, DOI 10.1016/j.bpj.2010.04.045; Tomas S, 2010, NAT CHEM, V2, P1077, DOI 10.1038/NCHEM.892; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Yagi H, 2013, BBA-PROTEINS PROTEOM, V1834, P2480, DOI 10.1016/j.bbapap.2013.08.013; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	63	61	62	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					815	826		10.1074/jbc.M114.592527	http://dx.doi.org/10.1074/jbc.M114.592527			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406316	hybrid, Green Published			2022-12-26	WOS:000347778200012
J	Manohar, M; Khan, H; Sirohi, VK; Das, V; Agarwal, A; Pandey, A; Siddiqui, WA; Dwivedi, A				Manohar, Murli; Khan, Huma; Sirohi, Vijay Kumar; Das, Vinita; Agarwal, Anjoo; Pandey, Amita; Siddiqui, Waseem Ahmad; Dwivedi, Anila			Alteration in Endometrial Proteins during Early- and Mid- Secretory Phases of the Cycle in Women with Unexplained Infertility	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; DIFFERENTIALLY EXPRESSED PROTEINS; PROTEOMIC ANALYSIS; SUPEROXIDE-DISMUTASE; GENE-EXPRESSION; IMPLANTATION FAILURE; EMBRYO IMPLANTATION; UTERINE ENDOMETRIUM; MENSTRUAL-CYCLE; IDENTIFICATION	Background: Compromised receptivity of the endometrium is a major cause of unexplained infertility, implantation failure and subclinical pregnancy loss. In order to investigate the changes in endometrial protein profile as a cause of unexplained infertility, the current study was undertaken to analyze the differentially expressed proteins of endometrium from early-secretory (LH+2) to mid-secretory phase (LH+7), in women with unexplained infertility. Methods: 2-D gel electrophoresis was performed to analyze the proteomic changes between early-(n = 8) and mid-secretory (n = 8) phase endometrium of women with unexplained infertility. The differentially expressed protein spots were identified by LC-MS analysis and validated by immunoblotting and immuno-histochemical analysis in early-(n = 4) and mid-secretory (n = 4) phase endometrium of infertile women. Validated proteins were also analyzed in early-(n = 4) and mid-secretory (n = 4) phase endometrium of fertile women. Results: Nine proteins were found to be differentially expressed between early-and mid-secretory phases of endometrium of infertile women. The expression of Ras-related protein Rap-1b, Protein disulfide isomerase A3, Apolipoprotein-A1 (Apo-A1), Cofilin-1 and RAN GTP-binding nuclear protein (Ran) were found to be significantly increased, whereas, Tubulin polymerization promoting protein family member 3, Superoxide dismutase [Cu-Zn], Sorcin, and Proteasome subunit alpha type-5 were significantly decreased in mid-secretory phase endometrium of infertile women as compared to early-secretory phase endometrium of infertile women. Validation of 4 proteins viz. Sorcin, Cofilin-1, Apo-A1 and Ran were performed in separate endometrial biopsy samples from infertile women. The up-regulated expression of Sorcin and down-regulated expression of Cofilin-1 and Apolipoprotein-A1, were observed in mid-secretory phase as compared to early-secretory phase in case of fertile women. Conclusions: De-regulation of the expression of Sorcin, Cofilin-1, Apo-A1 and Ran, during early-to mid-secretory phase may have physiological significance and it may be one of the causes for altered differentiation and/or maturation of endometrium, in women with unexplained infertility.	[Manohar, Murli; Sirohi, Vijay Kumar; Dwivedi, Anila] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Khan, Huma; Das, Vinita; Agarwal, Anjoo; Pandey, Amita] King Georges Med Univ, Dept Obstet & Gynaecol, Lucknow, Uttar Pradesh, India; [Manohar, Murli; Siddiqui, Waseem Ahmad] Jamia Hamdard, Dept Biochem, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University; Jamia Hamdard University	Dwivedi, A (corresponding author), CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	anila.dwivedi@rediffmail.com	AGARWAL, Anjoo/AAC-4411-2021; Manohar, Murli/R-8619-2018	AGARWAL, Anjoo/0000-0002-4616-177X; Siddiqui, Waseem/0000-0001-8727-866X	Ministry of Health and Family Welfare; Indian Council of Medical Research, Government of India; Council of Scientific and Industrial Research, New Delhi	Ministry of Health and Family Welfare; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Funding was provided by Ministry of Health and Family Welfare, and Indian Council of Medical Research, Government of India. One of the authors (MM) is thankful to Council of Scientific and Industrial Research, New Delhi for award of Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Altmae S, 2010, MOL HUM REPROD, V16, P178, DOI 10.1093/molehr/gap102; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Awasthi S, 2007, ACTA PHYSIOL, V189, P47, DOI 10.1111/j.1748-1716.2006.01638.x; Bao L, 2006, MOL ENDOCRINOL, V20, P3240, DOI 10.1210/me.2006-0296; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernassola F, 2010, CELL DEATH DIFFER, V17, P1, DOI 10.1038/cdd.2009.189; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; Bringans S, 2008, RAPID COMMUN MASS SP, V22, P3450, DOI 10.1002/rcm.3752; Brosens JJ, 2010, MOL HUM REPROD, V16, P273, DOI 10.1093/molehr/gap108; Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037; Carla B, 2005, CURRENT PHARM DESIGN, V11, P2075; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Chen JIC, 2009, J PROTEOME RES, V8, P2032, DOI 10.1021/pr801024g; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Crespo P, 2000, CELL MOL LIFE SCI, V57, P1613, DOI 10.1007/PL00000645; DeSouza L, 2005, PROTEOMICS, V5, P270, DOI 10.1002/pmic.200400920; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Dicker L, 2010, MOL CELL PROTEOMICS, V9, P2704, DOI 10.1074/mcp.M110.002774; Dominguez F, 2009, HUM REPROD, V24, P2607, DOI 10.1093/humrep/dep230; Edi-Osagie ECO, 2004, FERTIL STERIL, V82, P1379, DOI 10.1016/j.fertnstert.2004.04.046; Ferenczy A, 2008, GLOB LIB WOMENS MED, DOI [10.3843/GLOWM.10293, DOI 10.3843/GLOWM.10293]; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Frohlich T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-171; GRAHAM RA, 1990, BRIT MED J, V300, P1428, DOI 10.1136/bmj.300.6737.1428; Gundisch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060638; Hannan NJ, 2010, J PROTEOME RES, V9, P6256, DOI 10.1021/pr1004828; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Ho YS, 1998, J BIOL CHEM, V273, P7765, DOI 10.1074/jbc.273.13.7765; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Kokawa K, 1996, J CLIN ENDOCR METAB, V81, P4144, DOI 10.1210/jc.81.11.4144; LESSEY BA, 1995, FERTIL STERIL, V63, P535, DOI 10.1016/S0015-0282(16)57422-6; Li J, 2011, FERTIL STERIL, V95, P1161, DOI 10.1016/j.fertnstert.2010.09.033; Makker A, 2009, FERTIL STERIL, V91, P2298, DOI 10.1016/j.fertnstert.2008.04.018; Matsuzaki S, 2005, FERTIL STERIL, V84, P1180, DOI 10.1016/j.fertnstert.2005.04.041; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; MEYERS MB, 1987, BIOCHEM PHARMACOL, V36, P2373, DOI 10.1016/0006-2952(87)90606-X; MEYERS MB, 1995, J BIOL CHEM, V270, P26411, DOI 10.1074/jbc.270.44.26411; Morris K, 2011, REPROD SCI, V18, P1014, DOI 10.1177/1933719111401663; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Orsi NM, 2001, MOL REPROD DEV, V59, P44, DOI 10.1002/mrd.1006; Patel S, 2007, NEUROTOXICOL TERATOL, V29, P578, DOI 10.1016/j.ntt.2007.04.002; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rai P, 2010, PROTEOM CLIN APPL, V4, P48, DOI 10.1002/prca.200900094; Rashid NA, 2011, AM J REPROD IMMUNOL, V66, P23, DOI 10.1111/j.1600-0897.2011.01048.x; Ray A, 2012, REPROD BIOMED ONLINE, V24, P591, DOI 10.1016/j.rbmo.2012.02.021; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; Scotchie JG, 2009, REPROD SCI, V16, P883, DOI 10.1177/1933719109337165; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Sinha A, 2009, CLIN CHIM ACTA, V400, P14, DOI 10.1016/j.cca.2008.09.026; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sugino N, 1996, HUM REPROD, V11, P1073; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tuli L, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-13; Van Lenten BJ, 2009, CURR ATHEROSCLER REP, V11, P52, DOI 10.1007/s11883-009-0008-8; Williamson BL, 2006, MOL CELL PROTEOMICS, V5, P337, DOI 10.1074/mcp.M500210-MCP200; Wu YP, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-38; Xu YL, 2010, HUM REPROD, V25, P2480, DOI 10.1093/humrep/deq197; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zhuang HQ, 2013, PROTEOMICS, V13, P2398, DOI 10.1002/pmic.201300017	62	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111687	10.1371/journal.pone.0111687	http://dx.doi.org/10.1371/journal.pone.0111687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405865	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300014
J	Cameron, EG; Robinson, PR				Cameron, Evan G.; Robinson, Phyllis R.			beta-Arrestin-Dependent Deactivation of Mouse Melanopsin	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; PROTEIN-COUPLED RECEPTORS; VISUAL ARRESTIN; 7-TRANSMEMBRANE RECEPTORS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; LIGHT; RHODOPSIN; BINDING; ENDOCYTOSIS	In mammals, the expression of the unusual visual pigment, melanopsin, is restricted to a small subset of intrinsically photosensitive retinal ganglion cells (ipRGCs), whose signaling regulate numerous non-visual functions including sleep, circadian photoentrainment and pupillary constriction. IpRGCs exhibit attenuated electrical responses following sequential and prolonged light exposures indicative of an adaptational response. The molecular mechanisms underlying deactivation and adaptation in ipRGCs however, have yet to be fully elucidated. The role of melanopsin phosphorylation and beta-arrestin binding in this adaptive process is suggested by the phosphorylation-dependent reduction of melanopsin signaling in vitro and the ubiquitous expression of beta-arrestin in the retina. These observations, along with the conspicuous absence of visual arrestin in ipRGCs, suggest that a beta-arrestin terminates melanopsin signaling. Here, we describe a light-and phosphorylation-dependent reduction in melanopsin signaling mediated by both beta-arrestin 1 and beta-arrestin 2. Using an in vitro calcium imaging assay, we demonstrate that increasing the cellular concentration of beta-arrestin 1 and beta-arrestin 2 significantly increases the rate of deactivation of light-activated melanopsin in HEK293 cells. Furthermore, we show that this response is dependent on melanopsin carboxyl-tail phosphorylation. Crosslinking and co-immunoprecipitation experiments confirm beta-arrestin 1 and beta-arrestin 2 bind to melanopsin in a light-and phosphorylation-dependent manner. These data are further supported by proximity ligation assays (PLA), which demonstrate a melanopsin/beta-arrestin interaction in HEK293 cells and ipRGCs. Together, these results suggest that melanopsin signaling is terminated in a light-and phosphorylation-dependent manner through the binding of a beta-arrestin within the retina.	[Cameron, Evan G.; Robinson, Phyllis R.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	Robinson, PR (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	probinso@umbc.edu			National Institute of Health [RO1EY019053, NIH/NIGMS T32GM066706]; NATIONAL EYE INSTITUTE [R01EY019053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by PRR, National Institute of Health RO1EY019053, EGC, National Institute of Health training grant NIH/NIGMS T32GM066706. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blasic JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045387; Blasic JR, 2012, CELL MOL LIFE SCI, V69, P1551, DOI 10.1007/s00018-011-0891-3; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; Do MTH, 2013, P NATL ACAD SCI USA, V110, P7470, DOI 10.1073/pnas.1304039110; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Giesbers ME, 2008, PHOTOCHEM PHOTOBIOL; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leuchowius K., 2011, CURR PROTOC CYTOM, V56, P9, DOI [10.1002/0471142956.cy0936s56, DOI 10.1002/0471142956.CY0936S56]; Lucas RJ, 2013, CURR BIOL, V23, pR125, DOI 10.1016/j.cub.2012.12.029; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Pal K, 2013, J BIOL CHEM, V288, P3265, DOI 10.1074/jbc.M112.400234; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sand A, 2012, PROG RETIN EYE RES, V31, P287, DOI 10.1016/j.preteyeres.2012.03.003; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Xue YK, 2010, CLIM DYNAM, V35, P1, DOI 10.1007/s00382-010-0831-1; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999	45	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113138	10.1371/journal.pone.0113138	http://dx.doi.org/10.1371/journal.pone.0113138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401926	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700116
J	Lai, CK; Moon, Y; Kuchenbauer, F; Starzcynowski, DT; Argiropoulos, B; Yung, E; Beer, P; Schwarzer, A; Sharma, A; Park, G; Leung, M; Lin, G; Vollett, S; Fung, S; Eaves, CJ; Karsan, A; Weng, AP; Humphries, RK; Heuser, M				Lai, Courteney K.; Moon, Yeonsook; Kuchenbauer, Florian; Starzcynowski, Daniel T.; Argiropoulos, Bob; Yung, Eric; Beer, Philip; Schwarzer, Adrian; Sharma, Amit; Park, Gyeongsin; Leung, Malina; Lin, Grace; Vollett, Sarah; Fung, Stephen; Eaves, Connie J.; Karsan, Aly; Weng, Andrew P.; Humphries, R. Keith; Heuser, Michael			Cell Fate Decisions in Malignant Hematopoiesis: Leukemia Phenotype Is Determined by Distinct Functional Domains of the MN1 Oncogene	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; STEM-CELLS; FUSION GENE; MUTATIONS; OVEREXPRESSION; IDENTIFICATION; REVEALS; CANCER; MODEL	Extensive molecular profiling of leukemias and preleukemic diseases has revealed that distinct clinical entities, like acute myeloid (AML) and T-lymphoblastic leukemia (T-ALL), share similar pathogenetic mutations. It is not well understood how the cell of origin, accompanying mutations, extracellular signals or structural differences in a mutated gene determine the phenotypic identity of leukemias. We dissected the functional aspects of different protein regions of the MN1 oncogene and their effect on the leukemic phenotype, building on the ability of MN1 to induce leukemia without accompanying mutations. We found that the most C-terminal region of MN1 was required to block myeloid differentiation at an early stage, and deletion of an extended C-terminal region resulted in loss of myeloid identity and cell differentiation along the T-cell lineage in vivo. Megakaryocytic/erythroid lineage differentiation was blocked by the N-terminal region. In addition, the N-terminus was required for proliferation and leukemogenesis in vitro and in vivo through upregulation of HoxA9, HoxA10 and Meis2. Our results provide evidence that a single oncogene can modulate cellular identity of leukemic cells based on its active gene regions. It is therefore likely that different mutations in the same oncogene may impact cell fate decisions and phenotypic appearance of malignant diseases.	[Lai, Courteney K.; Yung, Eric; Beer, Philip; Leung, Malina; Lin, Grace; Vollett, Sarah; Fung, Stephen; Eaves, Connie J.; Weng, Andrew P.; Humphries, R. Keith] BC Canc Agcy Res Ctr, Terry Fox Lab, Vancouver, BC, Canada; [Lai, Courteney K.; Eaves, Connie J.; Humphries, R. Keith] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada; [Moon, Yeonsook] Inha Univ, Sch Med, Dept Lab Med, Inchon, South Korea; [Kuchenbauer, Florian] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Kuchenbauer, Florian] Univ Hosp Ulm, Ctr Comprehens Canc, Inst Expt Canc Res, Ulm, Germany; [Starzcynowski, Daniel T.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Argiropoulos, Bob] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Schwarzer, Adrian; Sharma, Amit] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Park, Gyeongsin] Catholic Univ Korea, Dept Hosp Pathol, Seoul, South Korea; [Karsan, Aly] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Karsan, Aly; Weng, Andrew P.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Heuser, Michael] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany	University of British Columbia; Inha University; Ulm University; Ulm University; Cincinnati Children's Hospital Medical Center; University of Calgary; Hannover Medical School; Catholic University of Korea; British Columbia Cancer Agency; University of British Columbia; Hannover Medical School	Humphries, RK (corresponding author), BC Canc Agcy Res Ctr, Terry Fox Lab, Vancouver, BC, Canada.	khumphri@bccrc.ca	Schwarzer, Adrian/AAA-2571-2022; Karsan, Aly/K-2067-2015; Heuser, Michael/S-2363-2017	Heuser, Michael/0000-0001-5318-9044; Eaves, Connie/0000-0002-3452-1926; Humphries, Richard/0000-0003-0540-7005; Schwarzer, Adrian/0000-0001-5684-2280; Beer, Philip/0000-0003-3056-5419; Kuchenbauer, Florian/0000-0002-9820-3409; Yung, Eric/0000-0002-7328-7204	Terry Fox Foundation, Canada [18006, 122869]; Cancer Research Society, Canada; Stem Cell Network of Canada; Deutsche Krebshilfe e.V [109003, 110284, 110292, 111267]; Deutsche-Jose-Carreras Leukamie-Stiftung e.V [DJCLS H09/1f, R 10/22, R13/14]; H. W. & J. Hector Stiftung [M 47.1]; German Federal Ministry of Education and Research [01EO0802 (IFB-Tx)]; DFG [HE 5240/4-1, HE 5240/5-1]; Canadian Institute of Health Research; University of British Columbia; BC Cancer Agency; Deutsche Krebshilfe [109420]; European Hematology Association [2010/04]; Deutsche Forschungsgemeinschaft [D.3955, SFB 1074]; Kay Kendall Leukaemia Fund; BC Cancer Studentship from the BC Cancer Agency	Terry Fox Foundation, Canada; Cancer Research Society, Canada; Stem Cell Network of Canada; Deutsche Krebshilfe e.V(Deutsche Krebshilfe); Deutsche-Jose-Carreras Leukamie-Stiftung e.V; H. W. & J. Hector Stiftung; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia; BC Cancer Agency; Deutsche Krebshilfe(Deutsche Krebshilfe); European Hematology Association; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kay Kendall Leukaemia Fund; BC Cancer Studentship from the BC Cancer Agency	This study was supported by grants from the Terry Fox Foundation, Canada (http://www.terryfox.org/TerryFox/The_Terry_Fox_Foundation.html) (grant Nos. 18006 and 122869), the Cancer Research Society, Canada (http://www.crs-src.ca/), the Stem Cell Network of Canada (http://www.stemcellnetwork.ca/index.php?page = funding-opportunities), Deutsche Krebshilfe e.V (grant No. 109003, 110284, 110292, and 111267) (http://www.krebshilfe.de/metanavigation/english.html), grant No. DJCLS H09/1f, R 10/22, and R13/14 from the Deutsche-Jose-Carreras Leukamie-Stiftung e.V (http://www.carreras-stiftung.de/); grant No. M 47.1 from the H. W. & J. Hector Stiftung (http://www.hector-stiftung.de/), the German Federal Ministry of Education and Research grant 01EO0802 (IFB-Tx) (http://www.bmbf.de/en/14580.php), and DFG grants HE 5240/4-1, HE 5240/5-1 (http://www.dfg.de/en/research_funding/programmes/individual/research_grants/). CKL was supported by studentships from the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html#), the University of British Columbia (https://www.grad.ubc.ca/awards/four-year-doctoral-fellowship-4yf), and the BC Cancer Agency (http://www.bccancer.bc.ca/default.htm). FK was supported by grants from Deutsche Krebshilfe grant 109420 (Max-Eder program) (http://www.krebshilfe.de/metanavigation/english.html); fellowship 2010/04 by the European Hematology Association (http://www.ehaweb.org/career/career-development-grants/eha-research-fellowships-and-the-jose-carreras-foundation-eha-young-investigator-fellowship/); and by the Deutsche Forschungsgemeinschaft (grant D.3955 (SFB 1074)) (http://www.dfg.de/en/research_funding/programmes/individual/). PB was supported by an intermediate fellowship from the Kay Kendall Leukaemia Fund (http://www.kklf.org.uk/intermediate.html). GL was supported by a BC Cancer Studentship from the BC Cancer Agency (http://www.bccancer.bc.ca/default.htm). SV was supported by a studentship from the Stem Cell Network of Canada (http://www.stemcellnetwork.ca/index.php?page = co-op-award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Bruce MA, 2013, OPT EXPRESS, V21, P4766, DOI 10.1364/OE.21.004766; BUIJS A, 1995, ONCOGENE, V10, P1511; Burnett AK, 2010, BLOOD, V115, P948, DOI 10.1182/blood-2009-08-236588; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Funnell APW, 2012, MOL CELL BIOL, V32, P3281, DOI 10.1128/MCB.00173-12; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilliland DG, 2001, CURR OPIN HEMATOL, V8, P189, DOI 10.1097/00062752-200107000-00001; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gurevich RM, 2004, BLOOD, V104, P1127, DOI 10.1182/blood-2003-10-3550; Haferlach C, 2012, GENE CHROMOSOME CANC, V51, P257, DOI 10.1002/gcc.20950; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Heuser M, 2011, CANCER CELL, V20, P39, DOI 10.1016/j.ccr.2011.06.020; Heuser M, 2009, BLOOD, V114, P3983, DOI 10.1182/blood-2009-06-227603; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Horton SJ, 2013, LEUKEMIA, V27, P1116, DOI 10.1038/leu.2012.343; Jacobs-Helber SM, 2004, BLOOD, V104, P696, DOI 10.1182/blood-2003-05-1754; Kalra IS, 2011, BRIT J HAEMATOL, V154, P248, DOI 10.1111/j.1365-2141.2011.08710.x; Kandilci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061706; Kandilci A, 2009, BLOOD, V114, P1596, DOI 10.1182/blood-2009-02-205443; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kawagoe H, 2005, BLOOD, V106, P4278, DOI 10.1182/blood-2005-04-1674; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Langer C, 2009, J CLIN ONCOL, V27, P3198, DOI 10.1200/JCO.2008.20.6110; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liu T, 2010, LEUKEMIA, V24, P601, DOI 10.1038/leu.2009.272; Marini MG, 2010, BRIT J HAEMATOL, V149, P748, DOI 10.1111/j.1365-2141.2010.08130.x; Meester-Smoor MA, 2007, J MOL ENDOCRINOL, V38, P113, DOI 10.1677/jme.1.02110; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Neumann M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.49; Neumann M, 2013, BLOOD, V121, P4749, DOI 10.1182/blood-2012-11-465138; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191; Schwind S, 2011, BLOOD, V118, P4188, DOI 10.1182/blood-2011-06-357764; Sharma A YH, 2014, LEUKEMIA; Smyth G, 2005, LIMMA LINEAR MODELS; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Wely KHM, 2003, ONCOGENE, V22, P699, DOI 10.1038/sj.onc.1206124; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020	51	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112671	10.1371/journal.pone.0112671	http://dx.doi.org/10.1371/journal.pone.0112671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401736	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700062
J	Lasley-Rasher, RS; Kramer, AM; Burdett-Coutts, V; Yen, J				Lasley-Rasher, Rachel S.; Kramer, Andrew M.; Burdett-Coutts, Victoria; Yen, Jeannette			Assessing the In Situ Fertilization Status of Two Marine Copepod Species, Temora longicornis and Eurytemora herdmani; How Common Are Unfertilized Eggs in Nature?	PLOS ONE			English	Article							REPRODUCTIVE-BIOLOGY; CALANOID COPEPODS; HATCHING SUCCESS; PELAGIC COPEPOD; FOOD LIMITATION; POPULATION-DYNAMICS; OITHONA-DAVISAE; MATING SUCCESS; PREDATION RISK; ACARTIA-CLAUSI	We utilized an egg staining technique to measure the in situ fertilization success of two marine copepod species, Temora longicornis and Eurytemora herdmani from May to October 2008 in coastal Maine and correlated fertilization success with environmental conditions in their habitat. T. longicornis is a free spawning species that releases eggs into the ambient seawater after mating. In contrast, E. herdmani carries eggs in an egg sac until they hatch. The proportion of fertilized eggs within E. herdmani egg sacs was significantly higher than the freely spawned clutches of T. longicornis. This may be a result of the asymmetrical costs associated with carrying vs. spawning unfertilized eggs. T. longicornis frequently laid both fertilized and unfertilized eggs within their clutch. T. longicornis fertilization was negatively associated with chlorophyll concentration and positively associated with population density in their local habitat. The fertilization status of E. herdmani egg sacs was high throughout the season, but the proportion of ovigerous females was negatively associated with an interaction between predators and the proportion of females in the population. This study emphasizes that, in addition to population level processes, community and ecosystem level processes strongly influence the fertilization success and subsequent productivity of copepods.	[Lasley-Rasher, Rachel S.; Yen, Jeannette] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kramer, Andrew M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Burdett-Coutts, Victoria] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada	University System of Georgia; Georgia Institute of Technology; University System of Georgia; University of Georgia; Memorial University Newfoundland	Lasley-Rasher, RS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	rachel.lasleyrasher@maine.edu	Kramer, Andrew/C-5495-2008	Kramer, Andrew/0000-0002-9031-6580	National Science Foundation Integrated Graduate Education and Research Traineeship grant (Division of Graduate Education) [0114400]; Directorate For Geosciences [1226209] Funding Source: National Science Foundation	National Science Foundation Integrated Graduate Education and Research Traineeship grant (Division of Graduate Education); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation Integrated Graduate Education and Research Traineeship grant (Division of Graduate Education-0114400), http://www.nsf.gov/, RLR. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ban SH, 1997, MAR ECOL PROG SER, V157, P287, DOI 10.3354/meps157287; Belmonte G, 2007, J PLANKTON RES, V29, pI39, DOI 10.1093/plankt/fbl064; Boyer S, 2013, ESTUAR COAST SHELF S, V117, P125, DOI 10.1016/j.ecss.2012.11.006; Brugnano C, 2009, MAR BIOL, V156, P331, DOI 10.1007/s00227-008-1086-9; Castellani C, 2003, J PLANKTON RES, V25, P527, DOI 10.1093/plankt/25.5.527; Ceballos S, 2014, J PLANKTON RES, V36, P736, DOI 10.1093/plankt/fbu021; Ceballos S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018870; Choi KH, 2008, LIMNOL OCEANOGR, V53, P1656, DOI 10.4319/lo.2008.53.4.1656; Choi KH, 2009, MAR ECOL PROG SER, V377, P183, DOI 10.3354/meps07819; Crawley MJ, 2005, STAT INTRO USING R; Dagg MJ, 2003, DEEP-SEA RES PT II, V50, P675, DOI 10.1016/S0967-0645(02)00590-8; Devreker D, 2005, J EXP MAR BIOL ECOL, V318, P145, DOI [10.1016/j.jembe.2004.12.011, 10.1016/j.jembre.2004.12.011]; Devreker D, 2009, J EXP MAR BIOL ECOL, V368, P113, DOI 10.1016/j.jembe.2008.10.015; DURBIN EG, 1983, LIMNOL OCEANOGR, V28, P1199, DOI 10.4319/lo.1983.28.6.1199; Dutz J, 2012, MAR ECOL PROG SER, V462, P51, DOI 10.3354/meps09830; GERRITSEN J, 1980, AM NAT, V115, P718, DOI 10.1086/283594; Goetze E, 2008, MAR ECOL PROG SER, V370, P185, DOI 10.3354/meps07616; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Heuschele J, 2014, MAR BIOL, V161, P1653, DOI 10.1007/s00227-014-2449-z; Holste L, 2009, MAR BIOL, V156, P527, DOI DOI 10.1007/s00227-008-1101-1; HOPKINS CCE, 1982, J EXP MAR BIOL ECOL, V60, P91, DOI 10.1016/0022-0981(81)90183-0; HUNTLEY ME, 1992, AM NAT, V140, P201, DOI 10.1086/285410; Ianora A, 1999, LIMNOL OCEANOGR, V44, P147, DOI 10.4319/lo.1999.44.1.0147; IANORA A, 1993, LIMNOL OCEANOGR, V38, P1615, DOI 10.4319/lo.1993.38.8.1615; IANORA A, 1989, MAR BIOL, V101, P187, DOI 10.1007/BF00391457; IANORA A, 1995, MAR BIOL, V121, P533, DOI 10.1007/BF00349463; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; JACOBY CA, 1983, MAR BIOL, V76, P77, DOI 10.1007/BF00393058; Jonasdottir SH, 2002, MAR BIOL, V140, P1195, DOI 10.1007/s00227-002-0782-0; Kimmerer WJ, 2005, ESTUARIES, V28, P541, DOI 10.1007/BF02696065; Kiorboe T, 2006, OECOLOGIA, V148, P40, DOI 10.1007/s00442-005-0346-3; KIORBOE T, 1990, MAR ECOL PROG SER, V59, P19, DOI 10.3354/meps059019; KIORBOE T, 1994, J PLANKTON RES, V16, P1353, DOI 10.1093/plankt/16.10.1353; Kiorboe T, 2007, LIMNOL OCEANOGR, V52, P1511, DOI 10.4319/lo.2007.52.4.1511; Kramer AM, 2008, ECOLOGY, V89, P2760, DOI 10.1890/07-1505.1; Lasley-Rasher RS, 2012, LIMNOL OCEANOGR, V57, P433, DOI 10.4319/lo.2012.57.2.0433; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Maier G, 2000, J PLANKTON RES, V22, P1977, DOI 10.1093/plankt/22.10.1977; Marcus NH, 1996, HYDROBIOLOGIA, V320, P141, DOI 10.1007/BF00016815; Mauchline J, 1998, ADV MAR BIOL, V33, P1; McAlice C, 1977, PRELIMINARY OCEANOGR; Moore PJ, 2007, AM NAT, V169, P311, DOI 10.1086/510687; Niehoff B, 2004, J EXP MAR BIOL ECOL, V307, P237, DOI 10.1016/j.jembe.2004.02.006; Ohtsuka S, 2001, HYDROBIOLOGIA, V453, P441, DOI 10.1023/A:1013162605809; Parsons T.R., 1984, MANUAL BIOL CHEM MET; PETERSON WT, 1994, LIMNOL OCEANOGR, V39, P1594, DOI 10.4319/lo.1994.39.7.1594; RUNGE JA, 1988, HYDROBIOLOGIA, V167, P61, DOI 10.1007/BF00026294; Seuront L, 2006, J PLANKTON RES, V28, P805, DOI 10.1093/plankt/fbl012; Sichlau MH, 2011, MAR ECOL PROG SER, V442, P123, DOI 10.3354/meps09402; Tang KW, 2005, J EXP MAR BIOL ECOL, V318, P85, DOI 10.1016/j.jembe.2004.12.004; Team RCD, 2011, R LANG ENV STAT COMP; Thompson BP, 2006, THESIS U MAINE; Thum RA, 2007, OIKOS, V116, P759, DOI 10.1111/j.2007.0030-1299.15782.x; UNESCO, 1994, IOC MAN GUID, V29; UYE S, 1995, MAR ECOL PROG SER, V118, P121, DOI 10.3354/meps118121; UYE SI, 1982, J EXP MAR BIOL ECOL, V57, P55, DOI 10.1016/0022-0981(82)90144-7; Wesche A, 2007, MAR BIOL, V151, P1309, DOI 10.1007/s00227-006-0560-5; WILLIAMSON CE, 1986, LIMNOL OCEANOGR, V31, P393, DOI 10.4319/lo.1986.31.2.0393; Zirbel MJ, 2007, LIMNOL OCEANOGR-METH, V5, P106, DOI 10.4319/lom.2007.5.106	62	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112920	10.1371/journal.pone.0112920	http://dx.doi.org/10.1371/journal.pone.0112920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397669	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500112
J	Liang, TM; Yang, C; Li, P; Liu, C; Guo, L				Liang, Tingming; Yang, Chen; Li, Ping; Liu, Chang; Guo, Li			Genetic Analysis of Loop Sequences in the Let-7 Gene Family Reveal a Relationship between Loop Evolution and Multiple IsomiRs	PLOS ONE			English	Article							NUCLEOTIDES CONTROL; MICRORNA; RECOGNITION; REPERTOIRE; EXPRESSION; MOUSE	While mature miRNAs have been widely studied, the terminal loop sequences are rarely examined despite regulating both primary and mature miRNA functions. Herein, we attempted to understand the evolutionary pattern of loop sequences by analyzing loops in the let-7 gene family. Compared to the stable miRNA length distributions seen in most metazoans, higher metazoan species exhibit a longer length distribution. Examination of these loop sequence length distributions, in addition to phylogenetic tree construction, implicated loop sequences as the main evolutionary drivers in miRNA genes. Moreover, loops from relevant clustered miRNA gene families showed varying length distributions and higher levels of nucleotide divergence, even between homologous pre-miRNA loops. Furthermore, we found that specific nucleotides were dominantly distributed in the 5' and 3' terminal loop ends, which may contribute to the relatively precise cleavage that leads to a stable isomiR expression profile. Overall, this study provides further insight into miRNA processing and maturation and further enriches our understanding of miRNA biogenesis.	[Liang, Tingming; Yang, Chen; Li, Ping; Liu, Chang] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Guo, Li] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Medical University	Guo, L (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China.	gl8008@163.com	Liang, Tingming/ACL-6141-2022		National Basic Research Program of China (973 Program) [2012CB947600, 2013CB911600]; National Natural Science Foundation of China [31171137, 31271261, 31401009, 61301251]; Program for New Century Excellent Talents in University by the Chinese Ministry of Education [NCET-11- 0990]; Program for the Top Young Talents by the Organization Department of the CPC Central Committee; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Research Fund for the Doctoral Program of Higher Education of China [20133234120009]; National Natural Science Foundation of Jiangsu [BK20130885]; Natural Science Foundation of the Jiangsu Higher Education Institutions [12KJB360001, 13KJB330003]; NSFC [J1103507]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Chinese Ministry of Education; Program for the Top Young Talents by the Organization Department of the CPC Central Committee; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of Jiangsu; Natural Science Foundation of the Jiangsu Higher Education Institutions; NSFC(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program) (No. 2012CB947600 and 2013CB911600), the National Natural Science Foundation of China (No. 31171137, 31271261, 31401009 and 61301251), the Program for New Century Excellent Talents in University by the Chinese Ministry of Education (No. NCET-11- 0990), the Program for the Top Young Talents by the Organization Department of the CPC Central Committee, the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University), the Research Fund for the Doctoral Program of Higher Education of China (No. 20133234120009), the National Natural Science Foundation of Jiangsu (No. BK20130885), the Natural Science Foundation of the Jiangsu Higher Education Institutions (No. 12KJB360001 and 13KJB330003), NSFC for Talents Training in Basic Science (J1103507), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Guo L, 2013, MICRORNA NONCODING R, P127; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Guo L, 2012, MOL BIOL REP, V39, P2031, DOI 10.1007/s11033-011-0950-8; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Guo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007944; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hinton Tracey M, 2008, J RNAi Gene Silencing, V4, P295; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Schopman NCT, 2010, ANTIVIR RES, V86, P204, DOI 10.1016/j.antiviral.2010.02.320; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Vlassov AV, 2007, OLIGONUCLEOTIDES, V17, P223, DOI 10.1089/oli.2006.0069; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yue SB, 2011, RNA BIOL, V8, P1115, DOI 10.4161/rna.8.6.17626; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	43	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113042	10.1371/journal.pone.0113042	http://dx.doi.org/10.1371/journal.pone.0113042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397967	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500127
J	Qin, JL; Ying, WW; Cheng, XD; Wu, XD; Lu, BJ; Liang, Y; Wang, XY; Wan, XY; Xie, X; Lu, WG				Qin, Jiale; Ying, Weiwen; Cheng, Xiaodong; Wu, Xiaodong; Lu, Bingjian; Liang, Yun; Wang, Xinyu; Wan, Xiaoyun; Xie, Xing; Lu, Weiguo			A Well-Circumscribed Border with Peripheral Doppler Signal in Sonographic Image Distinguishes Epithelioid Trophoblastic Tumor from Other Gestational Trophoblastic Neoplasms	PLOS ONE			English	Article							PLACENTAL SITE; DISEASE; MANAGEMENT; DIAGNOSIS; PATHOLOGY; LESIONS	As epithelioid trophoblastic tumor (ETT) shares similar clinical features with other gestational trophoblastic neoplasms (GTNs), it is likely to be clinically misdiagnosed and subsequently treated in an improper way. This study aimed to identify the sonographic features of ETT that are distinct from other GTNs, including placental site trophoblastic tumor (PSTT) and invasive mole/choriocarcinoma (IM/CC). Here, we retrospectively analyzed ultrasound images of 12 patients with ETT in comparison with those of 21 patients with PSTT and 24 patients with IM/CC. The results showed that maximal diameter and hemodynamic parameters were not significantly different among ETT, PSTT and IM/CC (P>0.05). However, a well-circumscribed border with hypoechogenic halo was identified in the gray-scale sonogram in all 12 cases of ETT, while only in 1 out of 21 cases of PSTT and 1 out of 16 cases of IM/CC (P<0.001 for ETT vs. PSTT or IM/CC). Moreover, a peripheral pattern of Doppler signals was observed in 11 out of 12 ETT lesions, showing relatively more Doppler signal spots around the tumor border than within the boundary, while a non-peripheral pattern of Doppler signals in all 21 PSTT cases and 14 out of 16 IM/CC cases: with minimal, moderate or remarkable signal spots within the tumor, but not along the tumor (P, 0.001 for ETT vs. PSTT or IM/CC). These distinct sonographic features of ETT correlated with histopathologic observations, such as expansive growth pattern and vascular morphology. Thus, we draw the conclusions that the well-circumscribed border with peripheral Doppler signal may serve as a reliable sonographic feature to discriminate ETT from other types of GTNs. With further validation in a larger patient set in our ongoing multi-center study, this finding will be potentially developed into a non-invasive pre-operative GTN subtyping method for ETT.	[Qin, Jiale] Zhejiang Univ, Sch Med, Womens Hosp, Dept Ultrasound, Hangzhou, Zhejiang, Peoples R China; [Ying, Weiwen] Zhejiang Univ, Sch Med, Womens Hosp, Dept Womens Hlth, Hangzhou, Zhejiang, Peoples R China; [Cheng, Xiaodong; Wu, Xiaodong; Wang, Xinyu; Wan, Xiaoyun; Xie, Xing; Lu, Weiguo] Zhejiang Univ, Sch Med, Womens Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Lu, Bingjian; Liang, Yun] Zhejiang Univ, Sch Med, Womens Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Lu, WG (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China.	lwg@hzcnc.com	Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	Population and Family Planning Commission of Zhejiang Province, China [JSW2012-A019]; Education Bureau of Zhejiang Province, China [Y200909401]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Health Bureau of Zhejiang Province, China; Zhejiang University international collaboration funding for postgraduate	Population and Family Planning Commission of Zhejiang Province, China; Education Bureau of Zhejiang Province, China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Health Bureau of Zhejiang Province, China; Zhejiang University international collaboration funding for postgraduate	This work was funded by: 1 Grant numbers: JSW2012-A019, Institution: Population and Family Planning Commission of Zhejiang Province, China, The author funded: JQ. 2 Grant numbers: Y200909401, URLs:www.zjedu.gov.cn/upload/col31/20100224092329.xls, Institution: Education Bureau of Zhejiang Province, China, The author funded: JQ. 3 Grant name: Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, URLs:www.zjwst.gov.cn/./-1/1401231329189903539.doc, Institution: Health Bureau of Zhejiang Province, China, The author funded: WL. 4 Grant name: Zhejiang University international collaboration funding for postgraduate(2013), URLs:http://grs.zju.edu.cn/News/html/grs/pygcjgl/gpcg/gpcg_tz/2013-07-09/270-20130709095525.html, The author funded: JQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SD, 2006, CLIN RADIOL, V61, P301, DOI 10.1016/j.crad.2005.12.003; Berkowitz RS, 2009, NEW ENGL J MED, V360, P1639, DOI 10.1056/NEJMcp0900696; Genest DR, 2003, WHO CLASSIFICATION T, P250; Horn LC, 2004, PATHOLOGE, V25, P281, DOI 10.1007/s00292-004-0702-9; Hui P, 2013, EPITHELIOID TROPHOBL, P105; Kani KK, 2012, CURR PROBL DIAGN RAD, V41, P1, DOI 10.1067/j.cpradiol.2011.06.002; Kohorn EI, 2001, INT J GYNECOL CANCER, V11, P73, DOI 10.1046/j.1525-1438.2001.011001073.x; Leone FPG, 2010, ULTRASOUND OBST GYN, V35, P103, DOI 10.1002/uog.7487; Luiza John W, 2014, Gynecol Oncol Case Rep, V7, P13, DOI 10.1016/j.gynor.2013.11.001; Lurain JR, 2011, AM J OBSTET GYNECOL, V204, P11, DOI 10.1016/j.ajog.2010.06.072; Lurain JR, 2010, AM J OBSTET GYNECOL, V203, P531, DOI 10.1016/j.ajog.2010.06.073; Moutte A, 2013, GYNECOL ONCOL, V128, P568, DOI 10.1016/j.ygyno.2012.11.010; Okumura M, 2010, ULTRASOUND OBST GYN, V36, P249, DOI 10.1002/uog.7560; Palmer JE, 2008, J REPROD MED, V53, P465; Shih IM, 2007, ANN DIAGN PATHOL, V11, P228, DOI 10.1016/j.anndiagpath.2007.04.001; Shih IM, 2001, INT J GYNECOL PATHOL, V20, P31, DOI 10.1097/00004347-200101000-00004; Shih IM, 1998, AM J SURG PATHOL, V22, P1393, DOI 10.1097/00000478-199811000-00010; Shih IM, 2004, AM J SURG PATHOL, V28, P1177, DOI 10.1097/01.pas.0000130325.66448.a1; Sung WJ, 2013, KOREAN J PATHOL, V47, P67, DOI 10.4132/KoreanJPathol.2013.47.1.67; Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x; Zhang XF, 2013, INT J GYNECOL CANCER, V23, P1334, DOI 10.1097/IGC.0b013e31829ea023	21	15	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112618	10.1371/journal.pone.0112618	http://dx.doi.org/10.1371/journal.pone.0112618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396428	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500068
J	Lee, S; Zhang, CG; Liu, XD				Lee, Schuyler; Zhang, Conggang; Liu, Xuedong			Role of Glucose Metabolism and ATP in Maintaining PINK1 Levels during Parkin-mediated Mitochondrial Damage Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOPHAGY; PROTEASOME; GENE; DEGRADATION; RECRUITMENT; ACTIVATION; MECHANISMS; MUTATIONS; NEURONS; OCCURS	Mutations in several genes, including PINK1 and Parkin, are known to cause autosomal recessive cases of Parkinson disease in humans. These genes operate in the same pathway and play a crucial role in mitochondrial dynamics and maintenance. PINK1 is required to recruit Parkin to mitochondria and initiate mitophagy upon mitochondrial depolarization. In this study, we show that PINK1-dependent Parkin mitochondrial recruitment in response to global mitochondrial damage by carbonyl cyanide m-chlorophenylhydrazine (CCCP) requires active glucose metabolism. Parkin accumulation on mitochondria and subsequent Parkin-dependent mitophagy is abrogated in glucose-free medium or in the presence of 2-deoxy-D-glucose upon CCCP treatment. The defects in Parkin recruitment correlate with intracellular ATP levels and can be attributed to suppression of PINK1 up-regulation in response to mitochondria depolarization. Low levels of ATP appear to prevent PINK1 translation instead of affecting PINK1 mRNA expression or reducing its stability. Consistent with a requirement of ATP for elevated PINK1 levels and Parkin mitochondrial recruitment, local or individual mitochondrial damage via photoirradiation does not affect Parkin recruitment to damaged mitochondria as long as a pool of functional mitochondria is present in the photoirradiated cells even in glucose-free or 2-deoxy-D-glucose-treated conditions. Thus, our data identify ATP as a key regulator for Parkin mitochondrial translocation and sustaining elevated PINK1 levels during mitophagy. PINK1 functions as an AND gate and a metabolic sensor coupling biogenetics of cells and stress signals to mitochondria dynamics.	[Lee, Schuyler; Zhang, Conggang; Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, JSCBB, 3415 Colorado Ave, Boulder, CO 80303 USA.	Xuedong.Liu@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019; , tanglang/AAD-3372-2020	LIU, XUEDONG/0000-0001-7209-4964	National Institutes of Health [CA107098, S10 RR026680]; Butch Award of University of Colorado; Cancer League of Colorado; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Butch Award of University of Colorado; Cancer League of Colorado; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107098 (to X. L.) and S10 RR026680 (to ImageXpress MicroXL). This work was also supported by the Butch Award of University of Colorado and a grant from the Cancer League of Colorado (to X. L.).	AGGARWAL BB, 1978, BIOCHIM BIOPHYS ACTA, V502, P367, DOI 10.1016/0005-2728(78)90057-9; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ihrlund LS, 2008, MOL ONCOL, V2, P94, DOI 10.1016/j.molonc.2008.01.003; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McCoy MK, 2014, HUM MOL GENET, V23, P145, DOI 10.1093/hmg/ddt407; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Peng XY, 2005, J BIOL CHEM, V280, P13148, DOI 10.1074/jbc.M410838200; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rogaeva E, 2004, ARCH NEUROL-CHICAGO, V61, P1898, DOI 10.1001/archneur.61.12.1898; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Vadlakonda L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00165; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang JY, 2011, AUTOPHAGY, V7, P1230, DOI 10.4161/auto.7.10.16626; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang C., 2014, CELL RES IN PRESS; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014	49	31	31	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					904	917		10.1074/jbc.M114.606798	http://dx.doi.org/10.1074/jbc.M114.606798			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25404737	hybrid, Green Published			2022-12-26	WOS:000347778200025
J	Cheng, L; Shi, SB; Li, Q; Chen, JF; Zhang, H; Lu, YH				Cheng, Lei; Shi, Shengbao; Li, Qiang; Chen, Jianfa; Zhang, Hui; Lu, Yahai			Progressive Degradation of Crude Oil n-Alkanes Coupled to Methane Production under Mesophilic and Thermophilic Conditions	PLOS ONE			English	Article							METHANOGENIC ARCHAEAL COMMUNITY; SP NOV.; GEN. NOV.; PRODUCTION WATER; ANAEROBIC BIODEGRADATION; SMITHELLA-PROPIONICA; PETROLEUM RESERVOIR; REDUCING BACTERIUM; SP. NOV.; HYDROCARBONS	Although methanogenic degradation of hydrocarbons has become a well-known process, little is known about which crude oil tend to be degraded at different temperatures and how the microbial community is responded. In this study, we assessed the methanogenic crude oil degradation capacity of oily sludge microbes enriched from the Shengli oilfield under mesophilic and thermophilic conditions. The microbial communities were investigated by terminal restriction fragment length polymorphism (T-RFLP) analysis of 16S rRNA genes combined with cloning and sequencing. Enrichment incubation demonstrated the microbial oxidation of crude oil coupled to methane production at 35 and 55 degrees C, which generated 3.7 +/- 0.3 and 2.8 +/- 0.3 mmol of methane per gram oil, respectively. Gas chromatography-mass spectrometry (GC-MS) analysis revealed that crude oil n-alkanes were obviously degraded, and high molecular weight n-alkanes were preferentially removed over relatively shorter-chain n-alkanes. Phylogenetic analysis revealed the concurrence of acetoclastic Methanosaeta and hydrogenotrophic methanogens but different methanogenic community structures under the two temperature conditions. Candidate divisions of JS1 and WWE 1, Proteobacteria (mainly consisting of Syntrophaceae, Desulfobacteraceae and Syntrophorhabdus) and Firmicutes (mainly consisting of Desulfotomaculum) were supposed to be involved with n-alkane degradation in the mesophilic conditions. By contrast, the different bacterial phylotypes affiliated with Caldisericales, "Shengli Cluster'' and Synergistetes dominated the thermophilic consortium, which was most likely to be associated with thermophilic crude oil degradation. This study revealed that the oily sludge in Shengli oilfield harbors diverse uncultured microbes with great potential in methanogenic crude oil degradation over a wide temperature range, which extend our previous understanding of methanogenic degradation of crude oil alkanes.	[Cheng, Lei; Lu, Yahai] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Cheng, Lei; Li, Qiang; Zhang, Hui] Minist Agr, Key Lab Dev & Applicat Rural Renewable Energy, Biogas Inst, Chengdu 610041, Peoples R China; [Shi, Shengbao; Chen, Jianfa] China Univ Petr, State Key Lab Petr Resources & Prospecting, Beijing 102200, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Biogas Institute of Ministry of Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; China University of Petroleum	Lu, YH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	yhlu@cau.edu.cn	Lu, Yahai/A-5030-2013	Lu, Yahai/0000-0002-1702-9868	National Nature Science Foundation of Science [40973059, 30900049]; National High Technology Research and Development Program of China [2013aa064401]; Sichuan Projects of International Cooperation and Exchanges [2013HH0018]; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2013ZL001]	National Nature Science Foundation of Science; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Sichuan Projects of International Cooperation and Exchanges; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China	This work was financially supported by National Nature Science Foundation of Science (40973059, 30900049), National High Technology Research and Development Program of China (2013aa064401), Sichuan Projects of International Cooperation and Exchanges (2013HH0018) and Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China (2013ZL001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CM, 2013, GEOCHIM COSMOCHIM AC, V109, P162, DOI 10.1016/j.gca.2013.01.031; ATLAS RM, 1975, APPL MICROBIOL, V30, P396, DOI 10.1128/AEM.30.3.396-403.1975; Bekins B.A., 2005, ENV GEOSCI, V12, P139, DOI DOI 10.1306/EG.11160404036; Berdugo-Clavijo C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00197; Caldwell ME, 1998, ENVIRON SCI TECHNOL, V32, P2191, DOI 10.1021/es9801083; Callaghan AV, 2012, ENVIRON MICROBIOL, V14, P101, DOI 10.1111/j.1462-2920.2011.02516.x; Callaghan AV, 2010, ENVIRON SCI TECHNOL, V44, P7287, DOI 10.1021/es1002023; Callaghan AV, 2013, FRONTIERS MICROBIOLO, V4; Callaghan AV, 2012, CURRENT OPINION BIOT; Chen CL, 2004, MICROBIOL-SGM, V150, P3429, DOI 10.1099/mic.0.27193-0; Cheng L, 2013, FEMS MICROBIOL ECOL, V85, P568, DOI 10.1111/1574-6941.12141; Cheng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066784; Cheng L, 2013, FEMS MICROBIOL ECOL, V83, P757, DOI 10.1111/1574-6941.12031; Cheng L, 2011, APPL ENVIRON MICROB, V77, P5212, DOI 10.1128/AEM.00210-11; Chin KJ, 1999, APPL ENVIRON MICROB, V65, P2341; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cravo-Laureau C, 2004, INT J SYST EVOL MICR, V54, P1639, DOI 10.1099/ijs.0.63104-0; Cravo-Laureau C, 2004, INT J SYST EVOL MICR, V54, P77, DOI 10.1099/ijs.0.02717-0; de Bok FAM, 2001, APPL ENVIRON MICROB, V67, P1800, DOI 10.1128/AEM.67.4.1800-1804.2001; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolfing J, 2008, ISME J, V2, P442, DOI 10.1038/ismej.2007.111; Drake HL, 2004, RES MICROBIOL, V155, P422, DOI 10.1016/j.resmic.2004.03.003; Embree M, 2014, ISME J, V8, P757, DOI 10.1038/ismej.2013.187; Ficker M, 1999, APPL ENVIRON MICROB, V65, P5576; Galperin Y, 2008, ENVIRON FORENSICS, V9, P117, DOI 10.1080/15275920802115324; Gieg LM, 2008, APPL ENVIRON MICROB, V74, P3022, DOI 10.1128/AEM.00119-08; Gieg LM, 2014, CURR OPIN BIOTECH, V27, P21, DOI 10.1016/j.copbio.2013.09.002; Gieg LM, 2010, ENVIRON MICROBIOL, V12, P3074, DOI 10.1111/j.1462-2920.2010.02282.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gray ND, 2011, ENVIRON MICROBIOL, V13, P2957, DOI 10.1111/j.1462-2920.2011.02570.x; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hasinger M, 2012, J BIOTECHNOL, V157, P490, DOI 10.1016/j.jbiotec.2011.09.027; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Hostettler FD, 2007, ENVIRON FORENSICS, V8, P139, DOI 10.1080/15275920601180685; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Jones DM, 2008, NATURE, V451, P176, DOI 10.1038/nature06484; Kunapuli U, 2007, ISME J, V1, P643, DOI 10.1038/ismej.2007.73; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu YT, 1999, INT J SYST BACTERIOL, V49, P545, DOI 10.1099/00207713-49-2-545; Lykidis A, 2011, ISME J, V5, P122, DOI 10.1038/ismej.2010.125; Mbadinga SM, 2012, APPL MICROBIOL BIOT, V96, P531, DOI 10.1007/s00253-011-3828-8; Meckenstock RU, 2011, CURR OPIN BIOTECH, V22, P406, DOI 10.1016/j.copbio.2011.02.009; Mori K, 2009, INT J SYST EVOL MICR, V59, P2894, DOI 10.1099/ijs.0.010033-0; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Peng JJ, 2008, APPL ENVIRON MICROB, V74, P2894, DOI 10.1128/AEM.00070-08; Peters K. E., 1993, BIOMARKER GUIDE INTE; Pham VD, 2009, ENVIRON MICROBIOL, V11, P176, DOI 10.1111/j.1462-2920.2008.01751.x; Qiu YL, 2008, APPL ENVIRON MICROB, V74, P2051, DOI 10.1128/AEM.02378-07; Rabus R, 1999, ENVIRON MICROBIOL, V1, P145; RAINEY FA, 1993, INT J SYST BACTERIOL, V43, P857, DOI 10.1099/00207713-43-4-857; Rees GN, 1997, INT J SYST BACTERIOL, V47, P150, DOI 10.1099/00207713-47-1-150; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Sasaki K, 2011, J BIOSCIENC IN PRESS; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siddique T, 2006, ENVIRON SCI TECHNOL, V40, P5459, DOI 10.1021/es060993m; Siddique T, 2012, ENVIRON SCI TECHNOL, V46, P9802, DOI 10.1021/es302202c; Siddique T, 2011, ENVIRON SCI TECHNOL, V45, P5892, DOI 10.1021/es200649t; Sousa DZ, 2007, INT J SYST EVOL MICR, V57, P609, DOI 10.1099/ijs.0.64734-0; Stahl DA, 1991, DEV APPL NUCL ACID P, P205; SVETLICHNY VA, 1991, SYST APPL MICROBIOL, V14, P254, DOI 10.1016/S0723-2020(11)80377-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan B, 2014, ISME J; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Townsend GT, 2003, ENVIRON SCI TECHNOL, V37, P5213, DOI 10.1021/es0264495; Wang LY, 2011, INT BIODETER BIODEGR, V65, P444, DOI 10.1016/j.ibiod.2010.12.010; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Widdel F., 2010, HDB HYDROCARBON LIPI, P1997, DOI [10.1007/978-3-540-77587-4_146, DOI 10.1007/978-3-540-77587-4_146]; Widdel F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P1028, DOI 10.1007/0-387-30742-7_33; Zedelius J, 2011, ENV MICROBIOL REP, V3, P125, DOI 10.1111/j.1758-2229.2010.00198.x; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777; Zhou L, 2012, ECOTOXICOLOGY, V21, P1680, DOI 10.1007/s10646-012-0949-5	72	51	53	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113253	10.1371/journal.pone.0113253	http://dx.doi.org/10.1371/journal.pone.0113253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409013	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200083
J	Nah, GSS; Tay, BH; Brenner, S; Osato, M; Venkatesh, B				Nah, Giselle Sek Suan; Tay, Boon-Hui; Brenner, Sydney; Osato, Motomi; Venkatesh, Byrappa			Characterization of the Runx Gene Family in a Jawless Vertebrate, the Japanese Lamprey (Lethenteron japonicum)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PEBP2; WHOLE-GENOME DUPLICATION; TUMOR-SUPPRESSOR RUNX3; DNA-BINDING ACTIVITY; GASTRIC-CANCER; BONE-FORMATION; ANCESTRAL VERTEBRATE; CELL-PROLIFERATION; ADAPTIVE IMMUNITY; FUGU GENOME	The cyclostomes (jawless vertebrates), comprising lampreys and hagfishes, are the sister group of jawed vertebrates (gnathostomes) and are hence an important group for the study of vertebrate evolution. In mammals, three Runx genes, Runx1, Runx2 and Runx3, encode transcription factors that are essential for cell proliferation and differentiation in major developmental pathways such as haematopoiesis, skeletogenesis and neurogenesis and are frequently associated with diseases. We describe here the characterization of Runx gene family members from a cyclostome, the Japanese lamprey (Lethenteron japonicum). The Japanese lamprey contains three Runx genes, RunxA, RunxB, and RunxC. However, phylogenetic and synteny analyses suggest that they are not one-to-one orthologs of gnathostome Runx1, Runx2 and Runx3. The major protein domains and motifs found in gnathostome Runx proteins are highly conserved in the lamprey Runx proteins. Although all gnathostome Runx genes each contain two alternative promoters, P1 (distal) and P2 (proximal), only lamprey RunxB possesses the alternative promoters; lamprey RunxA and RunxC contain only P2 and P1 promoter, respectively. Furthermore, the three lamprey Runx genes give rise to fewer alternative isoforms than the three gnathostome Runx genes. The promoters of the lamprey Runx genes lack the tandem Runx-binding motifs that are highly conserved among the P1 promoters of gnathostome Runx1, Runx2 and Runx3 genes; instead these promoters contain dispersed single Runx-binding motifs. The 39UTR of lamprey RunxB contains binding sites for miR-27 and miR-130b/301ab, which are conserved in mammalian Runx1 and Runx3, respectively. Overall, the Runx genes in lamprey seem to have experienced a different evolutionary trajectory from that of gnathostome Runx genes which are highly conserved all the way from cartilaginous fishes to mammals.	[Nah, Giselle Sek Suan; Tay, Boon-Hui; Brenner, Sydney; Osato, Motomi; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Brenner, Sydney] Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa 9040495, Japan; [Osato, Motomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Osato, Motomi] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Okinawa Institute of Science & Technology Graduate University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore	Osato, M (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.	csimo@nus.edu.sg; mcbbv@imcb.a-star.edu.sg	Osato, Motomi/N-5056-2014	Osato, Motomi/0000-0003-3982-9054; Venkatesh, Byrappa/0000-0003-3620-0277	Biomedical Research Council of A*STAR, Singapore	Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	Biomedical Research Council of A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 1997, J BIOL CHEM, V272, P14497, DOI 10.1074/jbc.272.23.14497; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Bee T, 2010, BLOOD, V115, P3042, DOI 10.1182/blood-2009-08-238626; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cattell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022474; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fujioka M, 1996, GENES CELLS, V1, P741, DOI 10.1111/j.1365-2443.1996.tb00014.x; Glusman G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-43; Golling G, 1996, MOL CELL BIOL, V16, P932; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Huang GH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000206; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Javed A, 2000, J CELL SCI, V113, P2221; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kagoshima H, 1996, J BIOL CHEM, V271, P33074, DOI 10.1074/jbc.271.51.33074; Kalev-Zylinska ML, 2003, DEV DYNAM, V228, P323, DOI 10.1002/dvdy.10388; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kaneto S, 2011, J EXP ZOOL PART B, V316B, P409, DOI 10.1002/jez.b.21411; Kasahara M, 2014, ADV IMMUNOL, V122, P59, DOI 10.1016/B978-0-12-800267-4.00002-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Camacho C, 2014, J CELL PHYSL; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Nah GSS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093816; Nam S, 2002, MOL CELL BIOL, V22, P547, DOI 10.1128/MCB.22.2.547-554.2002; Ng CEL, 2007, GENE, V399, P162, DOI 10.1016/j.gene.2007.05.014; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Ohno SI, 2008, INT IMMUNOL, V20, P71, DOI 10.1093/intimm/dxm120; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2005, CRIT REV EUKAR GENE, V15, P217, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.40; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park BY, 2010, GENE EXPR PATTERNS, V10, P159, DOI 10.1016/j.gep.2010.04.004; Park ES, 2012, MOL CELL ENDOCRINOL, V362, P165, DOI 10.1016/j.mce.2012.06.005; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Robertson AJ, 2002, MECH DEVELOP, V117, P327, DOI 10.1016/S0925-4773(02)00201-0; Rossetti S, 2013, INT J MOL SCI, V14, P1566, DOI 10.3390/ijms14011566; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Sullivan JC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-228; Sun JJ, 2012, CURR BIOL, V22, P862, DOI 10.1016/j.cub.2012.03.059; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Van de Peer Y, 2010, NAT REV GENET, V11, DOI 10.1038/nrg2600-c2; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wang M, 2013, J GASTROENTEROL, V48, P1023, DOI 10.1007/s00535-012-0733-6; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Woolf E, 2007, DEV BIOL, V303, P703, DOI 10.1016/j.ydbio.2006.12.005; Xu Y, 2013, FEBS LETT, V587, P3166, DOI 10.1016/j.febslet.2013.05.069; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zhang YH, 2004, J BIOL CHEM, V279, P53116, DOI 10.1074/jbc.M405502200	75	17	18	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113445	10.1371/journal.pone.0113445	http://dx.doi.org/10.1371/journal.pone.0113445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405766	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300118
J	Liu, TF; Qu, H; Luo, CL; Li, XW; Shu, DM; Lund, MS; Su, GS				Liu, Tianfei; Qu, Hao; Luo, Chenglong; Li, Xuewei; Shu, Dingming; Lund, Mogens Sando; Su, Guosheng			Genomic Selection for the Improvement of Antibody Response to Newcastle Disease and Avian Influenza Virus in Chickens	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; ESTIMATED BREEDING VALUES; LAYING HENS; CROSSBRED PERFORMANCE; HOLSTEIN POPULATION; NORDIC HOLSTEIN; MAREKS-DISEASE; BODY-WEIGHT; RESISTANCE; TRAITS	Newcastle disease (ND) and avian influenza (AI) are the most feared diseases in the poultry industry worldwide. They can cause flock mortality up to 100%, resulting in a catastrophic economic loss. This is the first study to investigate the feasibility of genomic selection for antibody response to Newcastle disease virus (Ab-NDV) and antibody response to Avian Influenza virus (Ab-AIV) in chickens. The data were collected from a crossbred population. Breeding values for Ab-NDV and Ab-AIV were estimated using a pedigree-based best linear unbiased prediction model (BLUP) and a genomic best linear unbiased prediction model (GBLUP). Single-trait and multiple-trait analyses were implemented. According to the analysis using the pedigree-based model, the heritability for Ab-NDV estimated from the single-trait and multiple-trait models was 0.478 and 0.487, respectively. The heritability for Ab-AIV estimated from the two models was 0.301 and 0.291, respectively. The estimated genetic correlation between the two traits was 0.438. A four-fold cross-validation was used to assess the accuracy of the estimated breeding values (EBV) in the two validation scenarios. In the family sample scenario each half-sib family is randomly allocated to one of four subsets and in the random sample scenario the individuals are randomly divided into four subsets. In the family sample scenario, compared with the pedigree-based model, the accuracy of the genomic prediction increased from 0.086 to 0.237 for Ab-NDV and from 0.080 to 0.347 for Ab-AIV. In the random sample scenario, the accuracy was improved from 0.389 to 0.427 for Ab-NDV and from 0.281 to 0.367 for Ab-AIV. The multiple-trait GBLUP model led to a slightly higher accuracy of genomic prediction for both traits. These results indicate that genomic selection for antibody response to ND and AI in chickens is promising.	[Liu, Tianfei; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Peoples R China; [Liu, Tianfei; Qu, Hao; Luo, Chenglong; Shu, Dingming] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China; [Liu, Tianfei; Lund, Mogens Sando; Su, Guosheng] Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Tjele, Denmark; [Liu, Tianfei; Qu, Hao; Luo, Chenglong; Shu, Dingming] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China	Sichuan Agricultural University; Guangdong Academy of Agricultural Sciences; Aarhus University	Li, XW (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Peoples R China.	lixuewei9125@126.com; shudm@263.net; Guosheng.Su@agrsci.dk	Lund, Mogens S/I-4321-2016; Liu, Tianfei/X-9848-2019	Liu, Tianfei/0000-0003-1835-9807	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAD28B03]; Key Technology Research and Development Program of Guangdong Emerging Strategic Industries [2012A020800005]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Key Technology Research and Development Program of Guangdong Emerging Strategic Industries	This work was supported by grants from the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (grant no. 2011BAD28B03, http://www.most.gov.cn/) and Key Technology Research and Development Program of Guangdong Emerging Strategic Industries (grant no. 2012A020800005, http://www.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneha MMK, 2012, RES VET SCI, V93, P1512, DOI 10.1016/j.rvsc.2012.03.004; Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; ALEXANDER DJ, 1995, J COMP PATHOL, V112, P105, DOI 10.1016/S0021-9975(05)80054-4; Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; Biscarini F, 2010, ANIM GENET, V41, P26, DOI 10.1111/j.1365-2052.2009.01960.x; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Calus MPL, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-26; Capua I, 2009, POULTRY SCI, V88, P842, DOI 10.3382/ps.2008-00289; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; Fulton JE, 2013, AVIAN DIS, V57, P519, DOI 10.1637/10408-100212-Reg.1; Gao H, 2013, J DAIRY SCI, V96, P4678, DOI 10.3168/jds.2012-6406; GAVORA JS, 1974, POULTRY SCI, V53, P889, DOI 10.3382/ps.0530889; Gavora S., 1983, ANIMAL BLOOD GROUPS, V14, P159; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; GROSS WG, 1980, POULTRY SCI, V59, P205, DOI 10.3382/ps.0590205; Guo G, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-30; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Jaworek B, 1978, GENET SEL EVOL, V10, P1; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Kapell DNRG, 2012, POULTRY SCI, V91, P3032, DOI 10.3382/ps.2012-02578; Legarra A, 2011, POULTRY SCI, V90, P731, DOI 10.3382/ps.2010-01260; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Lund M. S., 2009, BMC P S1, V3, pS1, DOI DOI 10.1186/1753-6561-3-S1-S1; Luo CL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-42; Madsen P, 2010, P 9 WORLD C GEN APPL; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENETICS SELECTION E, V41, P35; Meuwissen T, 2013, ANNU REV ANIM BIOSCI, V1, P221, DOI 10.1146/annurev-animal-031412-103705; MOYER SE, 1962, POULTRY SCI, V41, P1374, DOI 10.3382/ps.0411374; Newman S, 2002, J ANIM SCI, V80, P1801; Ostersen T, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-38; PINARD MH, 1992, J ANIM SCI, V70, P2986, DOI 10.2527/1992.70102986x; Saatchi M, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-40; SACCO RE, 1994, AVIAN DIS, V38, P33, DOI 10.2307/1591833; Sanchez JP, 2008, J ANIM SCI, V86, P267, DOI 10.2527/jas.2007-0064; Sartore S, 2010, POULTRY SCI, V89, P1115, DOI 10.3382/ps.2009-00556; Sheng ZY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-151; Sironi Laura, 2011, BMC Proc, V5 Suppl 4, pS25, DOI 10.1186/1753-6561-5-S4-S25; Su G, 2012, J DAIRY SCI, V95, P4657, DOI 10.3168/jds.2012-5379; Su G, 2010, J DAIRY SCI, V93, P1175, DOI 10.3168/jds.2009-2192; Tsuruta S, 2011, J DAIRY SCI, V94, P4198, DOI 10.3168/jds.2011-4256; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang Y, 2012, POULTRY SCI, V91, P3019, DOI 10.3382/ps.2012-02471; WEI M, 1995, J ANIM SCI, V73, P2220; WILSON LL, 1971, J HERED, V62, P123, DOI 10.1093/oxfordjournals.jhered.a108138; Wolc A, 2013, POULTRY SCI, V92, P2270, DOI 10.3382/ps.2013-03085; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-23; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457	53	12	15	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112685	10.1371/journal.pone.0112685	http://dx.doi.org/10.1371/journal.pone.0112685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401767	gold, Green Submitted, Green Published			2022-12-26	WOS:000345158700064
J	Zhang, BP; Liu, B; Zhang, H; Wang, JZ				Zhang, Baoping; Liu, Bin; Zhang, Hong; Wang, Jizeng			Erythrocyte Stiffness during Morphological Remodeling Induced by Carbon Ion Radiation	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BLOOD-CELL MEMBRANE; BONE-MARROW-CELLS; PERIPHERAL-BLOOD; MECHANICAL-PROPERTIES; VISCOELASTIC PROPERTIES; HEMATOPOIETIC SYNDROME; LARGE-DEFORMATION; BODY IRRADIATION; ELASTIC-MODULI	The adverse effect induced by carbon ion radiation (CIR) is still an unavoidable hazard to the treatment object. Thus, evaluation of its adverse effects on the body is a critical problem with respect to radiation therapy. We aimed to investigate the change between the configuration and mechanical properties of erythrocytes induced by radiation and found differences in both the configuration and the mechanical properties with involving in morphological remodeling process. Syrian hamsters were subjected to whole-body irradiation with carbon ion beams (1, 2, 4, and 6 Gy) or X-rays (2, 4, 6, and 12 Gy) for 3, 14 and 28 days. Erythrocytes in peripheral blood and bone marrow were collected for cytomorphological analysis. The mechanical properties of the erythrocytes were determined using atomic force microscopy, and the expression of the cytoskeletal protein spectrin-alpha 1 was analyzed via western blotting. The results showed that dynamic changes were evident in erythrocytes exposed to different doses of carbon ion beams compared with X-rays and the control (0 Gy). The magnitude of impairment of the cell number and cellular morphology manifested the subtle variation according to the irradiation dose. In particular, the differences in the size, shape and mechanical properties of the erythrocytes were well exhibited. Furthermore, immunoblot data showed that the expression of the cytoskeletal protein spectrin-alpha 1 was changed after irradiation, and there was a common pattern among its substantive characteristics in the irradiated group. Based on these findings, the present study concluded that CIR could induce a change in mechanical properties during morphological remodeling of erythrocytes. According to the unique characteristics of the biomechanical categories, we deduce that changes in cytomorphology and mechanical properties can be measured to evaluate the adverse effects generated by tumor radiotherapy. Additionally, for the first time, the current study provides a new strategy for enhancing the assessment of the curative effects and safety of clinical radiotherapy, as well as reducing adverse effects.	[Zhang, Baoping; Wang, Jizeng] Lanzhou Univ, Sch Civil Engn & Mech, Lanzhou 730000, Peoples R China; [Zhang, Baoping; Wang, Jizeng] Lanzhou Univ, Minist Educ China, Key Lab Mech Disaster & Environm Western China, Lanzhou 730000, Peoples R China; [Zhang, Baoping; Liu, Bin; Wang, Jizeng] Lanzhou Univ, Inst Biomech & Med Engn, Lanzhou 730000, Peoples R China; [Liu, Bin; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Ministry of Education, China; Lanzhou University; Chinese Academy of Sciences; Institute of Modern Physics, CAS	Wang, JZ (corresponding author), Lanzhou Univ, Sch Civil Engn & Mech, Lanzhou 730000, Peoples R China.	jizengwangibme@gmail.com	Wang, Jizeng/A-2706-2008	Wang, Jizeng/0000-0002-8383-5868	National Natural Science Foundation of China [11032006, 11072094, 11121202]; PhD Program Foundation of the Ministry of Education of China [20100211110022]; New Century Excellent Talents in University [NCET-10-0445]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PhD Program Foundation of the Ministry of Education of China(Ministry of Education, China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Natural Science Foundation of China (grants No. 11032006, No. 11072094, and No. 11121202), the PhD Program Foundation of the Ministry of Education of China (grant No. 20100211110022), and New Century Excellent Talents in University (program No. NCET-10-0445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin R, 2012, CYTOSKELETON, V69, P101, DOI 10.1002/cm.21001; Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6; An X, 2010, TRANSFUS CLIN BIOL, V17, P197, DOI 10.1016/j.tracli.2010.06.009; Baines AJ, 2010, TRANSFUS CLIN BIOL, V17, P95, DOI 10.1016/j.tracli.2010.06.008; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Bao YZ, 2012, MUTAT RES-GEN TOX EN, V743, P67, DOI 10.1016/j.mrgentox.2011.12.025; Blanc L, 2010, BIOCHEMISTRY-US, V49, P4516, DOI 10.1021/bi1003684; Boey SK, 1998, BIOPHYS J, V75, P1573, DOI 10.1016/S0006-3495(98)74075-5; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Buys AV, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-25; Callan-Jones A, 2012, BIOPHYS J, V103, P2475, DOI 10.1016/j.bpj.2012.11.008; Cardamone L, 2011, P NATL ACAD SCI USA, V108, P13978, DOI 10.1073/pnas.1100549108; Carl P, 2008, PFLUG ARCH EUR J PHY, V457, P551, DOI 10.1007/s00424-008-0524-3; Chan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054902; Coates PJ, 2004, MUTAT RES-FUND MOL M, V568, P5, DOI 10.1016/j.mrfmmm.2004.06.042; Corre I, 2010, MUTAT RES-REV MUTAT, V704, P61, DOI 10.1016/j.mrrev.2010.01.014; Daniels G, 2007, VOX SANG, V93, P331, DOI 10.1111/j.1423-0410.2007.00970.x; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; De Nunzio C, 2012, EUR UROL, V61, P560, DOI 10.1016/j.eururo.2011.11.013; de Oliveira M, 2010, ANN BIOMED ENG, V38, P2956, DOI 10.1007/s10439-010-0040-4; Debaugnies F, 2011, CLIN CHEM LAB MED, V49, P485, DOI 10.1515/CCLM.2011.066; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Discher DE, 2001, CELL MOL BIOL LETT, V6, P593; Discher DE, 1998, BIOPHYS J, V75, P1584, DOI 10.1016/S0006-3495(98)74076-7; Dubreuil RR, 2006, J MEMBRANE BIOL, V211, P151, DOI 10.1007/s00232-006-0863-y; Fedosov DA, 2010, COMPUT METHOD APPL M, V199, P1937, DOI 10.1016/j.cma.2010.02.001; Foretz M, 2011, FASEB J, V25, P337, DOI 10.1096/fj.10-169383; Franke RP, 2013, CLIN HEMORHEOL MICRO, V54, P273, DOI 10.3233/CH-131733; Garaj-Vrhovac V, 2011, INT J HYG ENVIR HEAL, V214, P59, DOI 10.1016/j.ijheh.2010.08.003; Gavara N, 2012, NAT NANOTECHNOL, V7, P733, DOI [10.1038/NNANO.2012.163, 10.1038/nnano.2012.163]; Ghorai A, 2014, SCIENTIFICA, V2014, DOI DOI 10.1155/2014/438030; Ghosh S, 2011, MUTAT RES-FUND MOL M, V716, P10, DOI 10.1016/j.mrfmmm.2011.07.015; Grande T, 2006, INT J RADIAT ONCOL, V64, P612, DOI 10.1016/j.ijrobp.2005.09.036; Guo SL, 2006, BIOMACROMOLECULES, V7, P1630, DOI 10.1021/bm0600724; Haghparast SMA, 2013, J BIOSCI BIOENG, V116, P380, DOI 10.1016/j.jbiosc.2013.03.003; Hansen JC, 1996, BIOPHYS J, V70, P146, DOI 10.1016/S0006-3495(96)79556-5; Heinrich V, 2001, BIOPHYS J, V81, P1452, DOI 10.1016/S0006-3495(01)75800-6; Hu SW, 2011, HEALTH PHYS, V101, P67, DOI 10.1097/HP.0b013e31820dba65; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kabaso D, 2010, BIOPHYS J, V99, P808, DOI 10.1016/j.bpj.2010.04.067; Katira P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.028103; Ketene AN, 2012, NANOMED-NANOTECHNOL, V8, P93, DOI 10.1016/j.nano.2011.05.012; Ketene AN, 2011, AFM STUDY OVARIAN CE; Kim Y, 2011, MED BIOL ENG COMPUT, V49, P453, DOI 10.1007/s11517-010-0730-y; Koshino I, 2012, J BIOL CHEM, V287, P35244, DOI 10.1074/jbc.M111.305441; Kozlova EK, 2013, MICRON, V44, P218, DOI 10.1016/j.micron.2012.06.012; Kulkarni S, 2010, CURR DRUG TARGETS, V11, P1375, DOI 10.2174/1389450111009011375; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kuriakose S, 2013, SOFT MATTER, V9, P4284, DOI 10.1039/c3sm27683j; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Lara P. C., 2013, CANC LETT; Lekka M, 2005, BIORHEOLOGY, V42, P307; Li J, 2007, P NATL ACAD SCI USA, V104, P4937, DOI 10.1073/pnas.0700257104; Li M, 2012, SCI CHINA LIFE SCI, V55, P968, DOI 10.1007/s11427-012-4399-3; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Li QF, 2014, INT J RADIAT BIOL, V90, P36, DOI 10.3109/09553002.2014.847294; Li W, 2004, EXP HEMATOL, V32, P1088, DOI 10.1016/j.exphem.2004.07.015; Li XJ, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0389; Liesveld JL, 2014, HEMATOPOIETIC SYSTEM, P623, DOI DOI 10.1007/978-3-540-75863-1; Lim CT, 2011, THEOR APPL MECH LETT, V1, DOI 10.1063/2.1101400; LIN S, 1977, J BIOL CHEM, V252, P5464; Liu F, 2003, CELL BIOCHEM BIOPHYS, V38, P251, DOI 10.1385/CBB:38:3:251; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Ludwig T, 2008, PFLUG ARCH EUR J PHY, V456, P29, DOI 10.1007/s00424-007-0398-9; Ma XF, 2011, MUTAT RES-FUND MOL M, V716, P20, DOI 10.1016/j.mrfmmm.2011.07.016; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Machnicka B, 2013, BIOCHIM BIOPHYS ACTA, V1838, P620; Maciaszek JL, 2011, J BIOMECH, V44, P657, DOI 10.1016/j.jbiomech.2010.11.008; Manda K, 2014, MUTAT RES REV MUTAT; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; Matsunaga A, 2010, CANCER-AM CANCER SOC, V116, P3740, DOI 10.1002/cncr.25134; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Moroni M, 2014, INT J RADIAT BIOL, V90, P363, DOI 10.3109/09553002.2014.892226; Moroni M, 2011, RADIAT RES, V176, P89, DOI 10.1667/RR2481.1; Mukherjee D, 2013, INT J RADIAT BIOL, V89, P139, DOI 10.3109/09553002.2013.741280; Muravyov AV, 2013, CLIN HEMORHEOL MICRO, V53, P45, DOI 10.3233/CH-2012-1575; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Nikkhah M, 2010, BIOMATERIALS, V31, P4552, DOI 10.1016/j.biomaterials.2010.02.034; Nomura T, 2008, MUTAT RES-GEN TOX EN, V657, P68, DOI 10.1016/j.mrgentox.2008.08.006; Pan CQ, 2012, CELL SIGNAL, V24, P2143, DOI 10.1016/j.cellsig.2012.06.002; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Peng ZL, 2013, P NATL ACAD SCI USA, V110, P13356, DOI 10.1073/pnas.1311827110; Peslak SA, 2011, EXP HEMATOL, V39, P434, DOI 10.1016/j.exphem.2011.01.010; Picas L, 2013, ACS NANO, V7, P1054, DOI 10.1021/nn303824j; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Rojas-Aguirre Y, 2012, BBA-BIOMEMBRANES, V1818, P738, DOI 10.1016/j.bbamem.2011.11.026; Salomao M, 2006, P NATL ACAD SCI USA, V103, P643, DOI 10.1073/pnas.0507661103; Samanta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028169; SCHMIDT CF, 1993, SCIENCE, V259, P952, DOI 10.1126/science.8438153; SHEETZ MP, 1980, J BIOL CHEM, V255, P9955; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061170; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Sonmez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076579; Stewart MP, 2012, NAT PROTOC, V7, P143, DOI 10.1038/nprot.2011.434; STREY H, 1995, BIOPHYS J, V69, P478, DOI 10.1016/S0006-3495(95)79921-0; Strobl JS, 2010, BIOMATERIALS, V31, P7043, DOI 10.1016/j.biomaterials.2010.05.023; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Suzuki Y, 2008, J RADIAT RES, V49, P473, DOI 10.1269/jrr.07107; Svelc T, 2012, CELL MOL BIOL LETT, V17, P217, DOI 10.2478/s11658-012-0005-8; Svetina S, 2004, BIOELECTROCHEMISTRY, V62, P107, DOI 10.1016/j.bioelechem.2003.08.002; Swihart AH, 2001, J MICROSC-OXFORD, V204, P212, DOI 10.1046/j.1365-2818.2001.00960.x; Szarama KB, 2012, DEVELOPMENT, V139, P2187, DOI 10.1242/dev.073734; Takeuchi M, 1998, BIOPHYS J, V74, P2171, DOI 10.1016/S0006-3495(98)77926-3; Umegaki K, 2001, FREE RADICAL BIO MED, V31, P1066, DOI 10.1016/S0891-5849(01)00689-X; Wang CS, 2013, INT J RADIAT BIOL, V89, P132, DOI 10.3109/09553002.2013.734947; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Weng HB, 2014, BBA-BIOMEMBRANES, V1838, P185, DOI 10.1016/j.bbamem.2013.09.014; Xu H, 2012, CANCER BIOTHER RADIO, V27, P113, DOI 10.1089/cbr.2011.1037; Zhang R, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2958268; Zhu Q, 2008, BIOPHYS J, V94, P2529, DOI 10.1529/biophysj.107.119438; Zhu Q, 2007, BIOPHYS J, V93, P386, DOI 10.1529/biophysj.106.094383; Zou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073499; Zuk A, 2011, INT J NANOMED, V6, P249, DOI 10.2147/IJN.S15802	118	14	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112624	10.1371/journal.pone.0112624	http://dx.doi.org/10.1371/journal.pone.0112624			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401336	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700059
J	Cabrera, S; Sanchez, E; Requena, T; Martinez-Bueno, M; Benitez, J; Perez, N; Trinidad, G; Soto-Varela, A; Santos-Perez, S; Martin-Sanz, E; Fraile, J; Perez, P; Alarcon-Riquelme, ME; Batuecas, A; Espinosa-Sanchez, JM; Aran, I; Lopez-Escamez, JA				Cabrera, Sonia; Sanchez, Elena; Requena, Teresa; Martinez-Bueno, Manuel; Benitez, Jesus; Perez, Nicolas; Trinidad, Gabriel; Soto-Varela, Andres; Santos-Perez, Sofia; Martin-Sanz, Eduardo; Fraile, Jesus; Perez, Paz; Alarcon-Riquelme, Marta E.; Batuecas, Angel; Espinosa-Sanchez, Juan M.; Aran, Ismael; Lopez-Escamez, Jose A.			Intronic Variants in the NFKB1 Gene May Influence Hearing Forecast in Patients with Unilateral Sensorineural Hearing Loss in Meniere's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; KAPPA-B; PROGRESSION; DATABASE; INNATE; REGION; COMMON	Meniere's disease is an episodic vestibular syndrome associated with sensorineural hearing loss (SNHL) and tinnitus. Patients with MD have an elevated prevalence of several autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis and psoriasis), which suggests a shared autoimmune background. Functional variants of several genes involved in the NF-kB pathway, such as REL, TNFAIP3, NFKB1 and TNIP1, have been associated with two or more immune-mediated diseases and allelic variations in the TLR10 gene may influence bilateral affectation and clinical course in MD. We have genotyped 716 cases of MD and 1628 controls by using the ImmunoChip, a high-density genotyping array containing 186 autoimmune loci, to explore the association of immune system related-loci with sporadic MD. Although no single nucleotide polymorphism (SNP) reached a genome-wide significant association (p<10(-8)), we selected allelic variants in the NF-kB pathway for further analyses to evaluate the impact of these SNPs in the clinical outcome of MD in our cohort. None of the selected SNPs increased susceptibility for MD in patients with uni or bilateral SNHL. However, two potential regulatory variants in the NFKB1 gene (rs3774937 and rs4648011) were associated with a faster hearing loss progression in patients with unilateral SNHL. So, individuals with unilateral MD carrying the C allele in rs3774937 or G allele in rs4648011 had a shorter mean time to reach hearing stage 3 (>40 dB HL) (log-rank test, corrected p values were p = 0.009 for rs3774937 and p = 0.003 for rs4648011, respectively). No variants influenced hearing in bilateral MD. Our data support that the allelic variants rs3774937 and rs4648011 can modify hearing outcome in patients with MD and unilateral SNHL.	[Cabrera, Sonia; Requena, Teresa; Espinosa-Sanchez, Juan M.; Lopez-Escamez, Jose A.] Pfizer Univ Granada Junta Andalucia GENYO, Ctr Genom & Invest Oncol, Dept Genom Med, Otol & Neurotol Grp CTS495, Granada, Spain; [Sanchez, Elena] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Martinez-Bueno, Manuel; Alarcon-Riquelme, Marta E.] Pfizer Univ Granada Junta Andalucia GENYO, Ctr Genom & Invest Oncol, Dept Genom Med, Grp Genet Complex Dis, Granada, Spain; [Benitez, Jesus] Hosp Univ Gran Canaria Dr Negrin, Dept Otolaryngol, Las Palmas Gran Canaria, Spain; [Perez, Nicolas] Univ Navarra Clin, Dept Otolaryngol, Pamplona, Spain; [Trinidad, Gabriel] Complejo Hosp Badajoz, Dept Otorhinolaryngol, Div Otoneurol, Badajoz, Spain; [Soto-Varela, Andres; Santos-Perez, Sofia] Complexo Hosp Univ, Dept Otorhinolaryngol, Div Otoneurol, Santiago De Compostela, Spain; [Martin-Sanz, Eduardo] Hosp Univ Getafe, Dept Otolaryngol, Getafe, Spain; [Fraile, Jesus] Hosp Miguel Servet, Dept Otolaryngol, Zaragoza, Spain; [Perez, Paz] Hosp Cabuenes, Dept Otorhinolaryngol, Gijon, Spain; [Batuecas, Angel] Hosp Univ Salamanca, Dept Otolaryngol, Salamanca, Spain; [Espinosa-Sanchez, Juan M.] Hosp San Agustin, Dept Otorhinolaryngol, Jaen, Spain; [Aran, Ismael] Complexo Hosp Pontevedra, Dept Otolaryngol, Pontevedra, Spain; [Lopez-Escamez, Jose A.] Hosp Poniente, Dept Otolaryngol, El Ejido, Almeria, Spain	Pfizer; University of Granada; Icahn School of Medicine at Mount Sinai; Pfizer; University of Granada; University of Navarra; Hospital Universitario de Getafe; Miguel Servet University Hospital; Hospital de Cabuenes; University of Salamanca; Hospital San Agustin; Complexo Hospitalario Universitario de Pontevedra	Lopez-Escamez, JA (corresponding author), Pfizer Univ Granada Junta Andalucia GENYO, Ctr Genom & Invest Oncol, Dept Genom Med, Otol & Neurotol Grp CTS495, Granada, Spain.	antonio.lopezescamez@genyo.es	Espinosa-Sanchez, Juan M./AAV-8380-2021; Pérez Vázquez, Paz/F-8759-2013; Alarcón-Riquelme, Marta E./ABF-8163-2020; Sanchez, Elena/AAC-1985-2021; Sanchez, Elena/B-4140-2017; Caletrio, Angel Batuecas/AAC-3333-2019; TRINIDAD-RUIZ, GABRIEL/X-8071-2019; RUIZ, GABRIEL GTR TRINIDAD/H-6501-2017; Perez, Paz/H-7366-2017; Martin-Sanz, Eduardo/N-5814-2014; Perez, Nicolas/A-7850-2015; Soto-Varela, Andrés/H-6489-2019; Lopez-Escamez, Jose Antonio/D-6642-2018	Espinosa-Sanchez, Juan M./0000-0001-8436-5629; Pérez Vázquez, Paz/0000-0002-4383-9151; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Sanchez, Elena/0000-0002-7041-5485; Caletrio, Angel Batuecas/0000-0003-2613-670X; TRINIDAD-RUIZ, GABRIEL/0000-0002-6917-4928; RUIZ, GABRIEL GTR TRINIDAD/0000-0002-6917-4928; Perez, Paz/0000-0002-4383-9151; Martin-Sanz, Eduardo/0000-0003-1175-3844; Perez, Nicolas/0000-0002-1192-5901; Soto-Varela, Andrés/0000-0001-6763-329X; Lopez-Escamez, Jose Antonio/0000-0002-8583-1430; Requena, Teresa/0000-0001-8355-6028; Martinez Bueno, Manuel/0000-0002-4333-4487	Instituto de Salud Carlos III; FEDER Funds from the EU; COST Action BM1306 TINNET	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER Funds from the EU; COST Action BM1306 TINNET(European Cooperation in Science and Technology (COST))	This project was funded by Research Grants PI09/00920 and PI13/1242 from Instituto de Salud Carlos III by FEDER Funds from the EU. The authors also acknowledge the COST Action BM1306 TINNET which supports part of their networking activities (http://tinnet.tinnitusresearch.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2009, NEUROSCIENCE, V160, P530, DOI 10.1016/j.neuroscience.2009.02.073; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bowes J, 2011, ANN RHEUM DIS, V70, P164, DOI [10.1136/ard.2011.150102.1, DOI 10.1136/ARD.2011.150102.1]; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Campbell CA, 2010, AM J MED GENET A, V152A, P67, DOI 10.1002/ajmg.a.33114; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Clemmens C, 2012, OTOL NEUROTOL, V33, P1266, DOI 10.1097/MAO.0b013e31826426b9; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Gazquez I, 2013, EUR ARCH OTO-RHINO-L, V270, P1521, DOI 10.1007/s00405-012-2268-0; Gazquez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026759; Gazquez I, 2012, OTOL NEUROTOL, V33, P223, DOI 10.1097/MAO.0b013e31824296c8; Greco A, 2012, AUTOIMMUN REV, V11, P731, DOI 10.1016/j.autrev.2012.01.004; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hietikko E, 2012, INT J AUDIOL, V51, P841, DOI 10.3109/14992027.2012.705900; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XN, 2012, J ALLERGY CLIN IMMUN, V130, P861, DOI 10.1016/j.jaci.2012.04.041; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Lopez-Escamez JA, 2007, OTOL NEUROTOL, V28, P891; Lopez-Escamez JA, 2010, LARYNGOSCOPE, V120, P103, DOI 10.1002/lary.20650; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pathak S, 2011, J IMMUNOL, V186, P1870, DOI 10.4049/jimmunol.1002275; Platt M, 2014, OTOLARYNG HEAD NECK, V150, P460, DOI 10.1177/0194599813514725; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Requena T, 2013, IMMUNOGENETICS, V65, P345, DOI 10.1007/s00251-013-0683-z; Ricano-Ponce I, 2013, ANNU REV GENOM HUM G, V14, P325, DOI 10.1146/annurev-genom-091212-153450; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Svrakic M, 2012, ARCH OTOLARYNGOL, V138, P1052, DOI 10.1001/2013.jamaoto.76; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tyrrell JS, 2014, EAR HEARING, V35, pE162, DOI 10.1097/AUD.0000000000000041; Waldner H, 2009, AUTOIMMUN REV, V8, P400, DOI 10.1016/j.autrev.2008.12.019; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Xia K, 2012, BIOINFORMATICS, V28, P451, DOI 10.1093/bioinformatics/btr678; Zhao RJ, 2013, INT IMMUNOPHARMACOL, V17, P658, DOI 10.1016/j.intimp.2013.08.012; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235	46	22	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112171	10.1371/journal.pone.0112171	http://dx.doi.org/10.1371/journal.pone.0112171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397881	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500037
J	Fayaz, SM; Kumar, VSS; Rajanikant, KG				Fayaz, Shaik M.; Kumar, Valsala S. Suvanish; Rajanikant, Krishnamurthy G.			Finding Needles in a Haystack: Application of Network Analysis and Target Enrichment Studies for the Identification of Potential Anti-Diabetic Phytochemicals	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; P38 MAPK INHIBITION; NF-KAPPA-B; ALDOSE REDUCTASE; GALLIC ACID; INSULIN-RESISTANCE; MEDICINAL-PLANTS; XANTHINE-OXIDASE; OXIDATIVE STRESS; ALPHA-AMYLASE	Diabetes mellitus is a debilitating metabolic disorder and remains a significant threat to public health. Herbal medicines have been proven to be effective anti-diabetic agents compared to synthetic drugs in terms of side effects. However, the complexity in their chemical constituents and mechanism of action, hinder the effort to discover novel anti-diabetic drugs. Hence, understanding the biological and chemical basis of pharmacological action of phytochemicals is essential for the discovery of potential anti-diabetic drugs. Identifying important active compounds, their protein targets and the pathways involved in diabetes would serve this purpose. In this context, the present study was aimed at exploring the mechanism of action of anti-diabetic plants phytochemicals through network and chemical-based approaches. This study also involves a focused and constructive strategy for preparing new effective anti-diabetic formulations. Further, a protocol for target enrichment was proposed, to identify novel protein targets for important active compounds. Therefore, the successive use of network analysis combined with target enrichment studies would accelerate the discovery of potential anti-diabetic phytochemicals.	[Fayaz, Shaik M.; Kumar, Valsala S. Suvanish; Rajanikant, Krishnamurthy G.] Natl Inst Technol Calicut, Sch Biotechnol, Calicut 673601, Kerala, India	National Institute of Technology (NIT System); National Institute of Technology Calicut	Rajanikant, KG (corresponding author), Natl Inst Technol Calicut, Sch Biotechnol, Calicut 673601, Kerala, India.	rajanikant@nitc.ac.in	G.K, Rajanikant/H-3275-2019; S.M., Fayaz/P-6103-2015	S.M., Fayaz/0000-0002-1212-7952; KUMAR, SUVANISH/0000-0001-9033-0422; , Rajanikant/0000-0001-9754-997X	Kerala State Council for Science, Technology and Environment, Kerala Biotechnology Commission, Government of Kerala, Thiruvananthapuram, India [1051/2013/KSCSTE]	Kerala State Council for Science, Technology and Environment, Kerala Biotechnology Commission, Government of Kerala, Thiruvananthapuram, India	This work was supported by the Kerala State Council for Science, Technology and Environment, Kerala Biotechnology Commission, Government of Kerala, Thiruvananthapuram, India (Grant number: 1051/2013/KSCSTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amin ZM, 2006, BRIT J NUTR, V96, P660, DOI 10.1079/BJN20061849; Alqahtani A, 2013, CURR MED CHEM, V20, P908; Alvarado-Vasquez N, 2003, COMP BIOCHEM PHYS C, V134, P521, DOI 10.1016/S1532-0456(03)00046-2; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Awazu M, 1999, J AM SOC NEPHROL, V10, P738; Ayyanar Muniappan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P240, DOI 10.1016/S2221-1691(12)60050-1; Babu PA, 2006, BIOINFORMATION, V1, P130, DOI 10.6026/97320630001130; Baker DJ, 2005, DIABETES, V54, P2453, DOI 10.2337/diabetes.54.8.2453; Bhatia H, 2014, J ETHNOPHARMACOL, V151, P1005, DOI 10.1016/j.jep.2013.12.017; BISCHOFF H, 1995, CLIN INVEST MED, V18, P303; Bjerre M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-658; Bravard A, 2011, AM J PHYSIOL-ENDOC M, V300, pE581, DOI 10.1152/ajpendo.00455.2010; Cheriyan J, 2011, CIRCULATION, V123, P515, DOI 10.1161/CIRCULATIONAHA.110.971986; Chethan S, 2008, BIOORGAN MED CHEM, V16, P10085, DOI 10.1016/j.bmc.2008.10.003; CHOWDHURY AR, 2002, MED SCI MONITOR, V8, P254; Davalli AM, 2012, ACTA DIABETOL, V49, P167, DOI 10.1007/s00592-011-0364-z; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; de Melo CL, 2009, J AGR FOOD CHEM, V57, P8776, DOI 10.1021/jf900768w; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Dhanbal SP, 2004, INDIAN J PHARM EDUC, V8, P163; Drel VR, 2008, INT J MOL MED, V21, P667; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Gupta O. P., 2003, INT J DIABETES DEV C, V23, P37; Hachmeister Jorge E., 2003, Yale Journal of Biology and Medicine, V76, P81; He H, 2013, J AGR FOOD CHEM, V61, P8110, DOI 10.1021/jf4019323; He L, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep095; Hodgkinson AD, 2001, KIDNEY INT, V60, P211, DOI 10.1046/j.1523-1755.2001.00788.x; Holscher C, 2014, ALZHEIMERS DEMENT, V10, pS33, DOI 10.1016/j.jalz.2013.12.006; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Hwang EY, 2008, FEBS LETT, V582, P3793, DOI 10.1016/j.febslet.2008.10.010; Jangra Meenu, 2011, International Journal of Green Pharmacy, V5, P266, DOI 10.4103/0973-8258.94345; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Jung M, 2006, CURR MED CHEM, V13, P1203, DOI 10.2174/092986706776360860; Kapoor, 2000, HDB AYURVEDIC MED PL; Kharjul A, 2012, INT J PHARM SCI RES, V3, P4913, DOI 10.13040/IJPSR.0975-8232.3(12).4913-18; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; Lakshmi CM, 2003, SCI BASIS AYURVEDIC; Lim S, 2012, J CELL BIOCHEM, V113, P3436, DOI 10.1002/jcb.24220; Lima MMS, 2014, CNS NEUROL DISORD-DR, V13, P418, DOI 10.2174/18715273113126660155; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu IM, 2007, LIFE SCI, V81, P1479, DOI 10.1016/j.lfs.2007.08.045; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Liu Zhenqi, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P38; Madlener S, 2007, CANCER LETT, V245, P156, DOI 10.1016/j.canlet.2006.01.001; Mathew M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086804; Medicherla S, 2009, DIABET METAB SYND OB, V2, P91; Medikayala S, 2011, AM J PHYSIOL-CELL PH, V300, pC338, DOI 10.1152/ajpcell.00248.2010; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Melzig MF, 2007, WIEN MED WOCHENSCHR, V157, P320, DOI 10.1007/s10354-007-0433-7; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Modak M, 2007, J CLIN BIOCHEM NUTR, V40, P163, DOI 10.3164/jcbn.40.163; Mukherjee PK, 2006, J ETHNOPHARMACOL, V106, P1, DOI 10.1016/j.jep.2006.03.021; Nair SB, 2013, COMB CHEM HIGH T SCR, V16, P449; Nair SB, 2012, COMPUT BIOL MED, V42, P697, DOI 10.1016/j.compbiomed.2012.04.001; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1; Ozcan F, 2012, CLIN EXP MED, V12, P265, DOI 10.1007/s10238-011-0167-0; Padberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085082; Paek JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/679463; Palanisamy Bhuvaneswari, 2012, International Journal of Green Pharmacy, V6, P330; Pan MH, 2008, MOL NUTR FOOD RES, V52, P1467, DOI 10.1002/mnfr.200700515; Pandey KB, 2009, Z NATURFORSCH C, V64, P626; Pari L, 2003, BRAZ J MED BIOL RES, V36, P861, DOI 10.1590/S0100-879X2003000700006; Pari L, 2000, PHYTOTHER RES, V14, P136, DOI 10.1002/(SICI)1099-1573(200003)14:2&lt;136::AID-PTR607&gt;3.0.CO;2-K; Patel JR, 2011, J ETHNOPHARMACOL, V138, P286, DOI 10.1016/j.jep.2011.09.040; Patel SS, 2011, PHARMACOGN RES, V3, P239, DOI 10.4103/0974-8490.89743; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Prajapati H, 2012, CHEM BIOL INTERFACE, V2, P38; Prakasam A, 2003, POL J PHARMACOL, V55, P43; Punithavathi VR, 2011, J BIOCHEM MOL TOXIC, V25, P68, DOI 10.1002/jbt.20360; Punithavathi VR, 2011, EUR J PHARMACOL, V650, P465, DOI 10.1016/j.ejphar.2010.08.059; Purves T, 2001, FASEB J, V15, P2508, DOI 10.1096/fj.01-0253hyp; Raina, 1989, INDIAN DRUGS, V26, P199; Rajesh M, 2009, J CELL MOL MED, V13, P2330, DOI 10.1111/j.1582-4934.2008.00564.x; Ramkumar KM, 2014, HUM EXP TOXICOL, V33, P638, DOI 10.1177/0960327113504792; Reddy SV, 2005, PHYTOTHER RES, V19, P277, DOI 10.1002/ptr.1491; Sankeshi V, 2013, J ETHNOPHARMACOL, V149, P215, DOI 10.1016/j.jep.2013.06.025; Santhosh Kumari K. S., 1993, Indian Journal of Experimental Biology, V31, P595; Santiago JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083940; Saxena A, 2004, J ALTERN COMPLEM MED, V10, P369, DOI 10.1089/107555304323062365; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SOCHOR M, 1986, BIOCHEM J, V234, P573, DOI 10.1042/bj2340573; Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36; Steinkamp-Fenske K, 2007, J PHARMACOL EXP THER, V322, P836, DOI 10.1124/jpet.107.123356; Sudha P, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-5; Talukder FZ, 2012, DRUG DISCOV THER, V6, P298, DOI 10.5582/ddt.2012.v6.6.298; Tapola N, 2005, NUTR METAB CARDIOVAS, V15, P255, DOI 10.1016/j.numecd.2004.09.003; Tayade PM, 2011, PHARM ONLINE, V1, P282; Teli MK, 2012, MOL DIVERS, V16, P193, DOI 10.1007/s11030-011-9338-x; Tiwari S, 2012, INT J PHARM SCI RES, V3, P3354, DOI 10.13040/IJPSR.0975-8232.3(9).3354-61; Todorov IN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P962, DOI 10.1134/S000629790909003X; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007; Tzeng TF, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/neq017; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	107	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112911	10.1371/journal.pone.0112911	http://dx.doi.org/10.1371/journal.pone.0112911			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396726	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500110
J	Hu, XW; Wu, YP; Ding, XY; Zhang, R; Wang, YR; Baskin, JM; Baskin, CC				Hu, Xiao Wen; Wu, Yan Pei; Ding, Xing Yu; Zhang, Rui; Wang, Yan Rong; Baskin, Jerry M.; Baskin, Carol C.			Seed Dormancy, Seedling Establishment and Dynamics of the Soil Seed Bank of Stipa bungeana (Poaceae) on the Loess Plateau of Northwestern China	PLOS ONE			English	Article							AFTER-RIPENING TIME; ABSCISIC-ACID; GERMINATION; TEMPERATURE; BREAKING; MECHANISMS; EMERGENCE; RELEASE; ECOLOGY; GREEN	Studying seed dormancy and its consequent effect can provide important information for vegetation restoration and management. The present study investigated seed dormancy, seedling emergence and seed survival in the soil seed bank of Stipa bungeana, a grass species used in restoration of degraded land on the Loess Plateau in northwest China. Dormancy of fresh seeds was determined by incubation of seeds over a range of temperatures in both light and dark. Seed germination was evaluated after mechanical removal of palea and lemma (hulls), chemical scarification and dry storage. Fresh and one-year-stored seeds were sown in the field, and seedling emergence was monitored weekly for 8 weeks. Furthermore, seeds were buried at different soil depths, and then retrieved every 1 or 2 months to determine seed dormancy and seed viability in the laboratory. Fresh seeds (caryopses enclosed by palea and lemma) had non-deep physiological dormancy. Removal of palea and lemma, chemical scarification, dry storage (afterripening), gibberellin (GA(3)) and potassium nitrate (KNO3) significantly improved germination. Dormancy was completely released by removal of the hulls, but seeds on which hulls were put back to their original position germinated to only 46%. Pretreatment of seeds with a 30% NaOH solution for 60 min increased germination from 25% to 82%. Speed of seedling emergence from fresh seeds was significantly lower than that of seeds stored for 1 year. However, final percentage of seedling emergence did not differ significantly for seeds sown at depths of 0 and 1 cm. Most fresh seeds of S. bungeana buried in the field in early July either had germinated or lost viability by September. All seeds buried at a depth of 5 cm had lost viability after 5 months, whereas 12% and 4% seeds of those sown on the soil surface were viable after 5 and 12 months, respectively.	[Hu, Xiao Wen; Wu, Yan Pei; Ding, Xing Yu; Zhang, Rui; Wang, Yan Rong] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730020, Peoples R China; [Baskin, Jerry M.; Baskin, Carol C.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA; [Baskin, Carol C.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA	Lanzhou University; University of Kentucky; University of Kentucky	Hu, XW (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730020, Peoples R China.	huxw@lzu.edu.cn; yrwang@lzu.edu.cn			Program for Changjiang Scholars and Innovative Research Team in University [IRT13019]; National Key Technology Research and Development Program [2011BAD17B02]; Gansu Provincial Key Grant Project [1203FKDA035]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology Research and Development Program(National Key Technology R&D Program); Gansu Provincial Key Grant Project	This study was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT13019), the National Key Technology Research and Development Program (2011BAD17B02) and the Gansu Provincial Key Grant Project (1203FKDA035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins SW, 2002, EUPHYTICA, V126, P13, DOI 10.1023/A:1019623706427; ALBALADEJO J, 1996, SOIL DEGRADATION DES, P265; [Anonymous], 2012, SEED SCI TECHNOL S, V27; Bair NB, 2006, SEED SCI RES, V16, P17, DOI 10.1079/SSR2005237; Baskin CC, 2006, SEED SCI RES, V16, P165, DOI 10.1079/SSR2006247; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Baskin Carol C., 1998, P30, DOI 10.1017/CBO9780511525445.004; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; Benech-Arnold RL, 1999, SEED SCI RES, V9, P39, DOI 10.1017/S0960258599000045; Brady NC, 2008, NATURE PROPERTIES SO, V14; Cheng J, 2010, AFR J BIOTECHNOL, V9, P6733; ELLIS RH, 1983, SEED SCI TECHNOL, V11, P77; Fenner M., 2005, ECOLOGY SEEDS; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Footitt S, 2011, P NATL ACAD SCI USA, V108, P20236, DOI 10.1073/pnas.1116325108; Francis D.F., 1990, SOIL DEGRADATION REH, P87; FULBRIGHT TE, 1983, J RANGE MANAGE, V36, P390, DOI 10.2307/3898496; Gasque M, 2003, PLANT ECOL, V168, P279, DOI 10.1023/A:1024471827734; Gianinetti A, 2007, J EXP BOT, V58, P3449, DOI 10.1093/jxb/erm198; Graeber K, 2012, PLANT CELL ENVIRON, V35, P1769, DOI 10.1111/j.1365-3040.2012.02542.x; GUTTERMAN Y, 1980, EXPERIENTIA, V36, P662, DOI 10.1007/BF01970124; Gutterman Y, 1996, J ARID ENVIRON, V33, P337, DOI 10.1006/jare.1996.0069; Gutterman Yitzchak, 2002, P1; He XQ, 2011, THESIS LANZHOU U LAN; He Xue-qing, 2010, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V30, P120; Hou JW, 2009, THESIS LANZHOU U LAN; Hu XW, 2013, ECOL RES, V28, P801, DOI 10.1007/s11284-013-1063-8; Hu XW, 2012, PLANT GROWTH REGUL, V67, P199, DOI 10.1007/s10725-012-9677-3; Huang ZY, 2004, AUST J BOT, V52, P519, DOI 10.1071/BT03149; Jin Y, 1997, ACTA AGRESTIA SINICA, V5, P93; Koller D, 1969, Symp Soc Exp Biol, V23, P449; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; LAVIE D, 1974, NATURE, V249, P388, DOI 10.1038/249388a0; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Liu K, 2011, AM J BOT, V98, P12, DOI 10.3732/ajb.1000043; Ma HY, 2008, J ARID ENVIRON, V72, P573, DOI 10.1016/j.jaridenv.2007.06.013; Ma HY, 2010, J PLANT ECOL, V3, P269, DOI 10.1093/jpe/rtp035; Mensching HG, 1986, DESERTIFICATION EURO, P3; Morgan RPC, 1990, SOIL DEGRADATION REH, P69; PONS TL, 1989, ANN BOT-LONDON, V63, P139, DOI 10.1093/oxfordjournals.aob.a087716; POPAY AI, 1970, J ECOL, V58, P123, DOI 10.2307/2258172; Probert R. J., 2000, Seeds: the ecology of regeneration in plant communities, P261, DOI 10.1079/9780851994321.0261; ROBERTS EH, 1962, J EXP BOT, V13, P75, DOI 10.1093/jxb/13.1.75; SIMPSON GM, 1990, SEED DORMANCY GRASS; Steadman KJ, 2003, FUNCT PLANT BIOL, V30, P345, DOI 10.1071/FP02175; THANOS CA, 1991, ANN BOT-LONDON, V68, P469, DOI 10.1093/oxfordjournals.aob.a088280; Wang N, 2011, SEED SCI RES, V21, P295, DOI 10.1017/S0960258511000195; [王彦荣 Wang Yanrong], 2004, [生态学报, Acta Ecologica Sinica], V24, P402; Zhang FC, 2003, CAN J BOT, V81, P375, DOI [10.1139/B03-035, 10.1139/b03-035]; [赵凌平 ZHAO Lingping], 2008, [水土保持通报, Bulletin of Soil and Water Conservation], V28, P60; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; [周芝琴 Zhou Zhiqin], 2013, [草业科学, Pratacultural Science], V30, P218; Zhu YJ, 2007, FLORA, V202, P249, DOI 10.1016/j.flora.2006.05.006	54	14	14	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112579	10.1371/journal.pone.0112579	http://dx.doi.org/10.1371/journal.pone.0112579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396423	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500061
J	Hussain, Z; Katas, H; Amin, MCIM; Kumolosasi, E				Hussain, Zahid; Katas, Haliza; Amin, Mohd Cairul Iqbal Mohd; Kumolosasi, Endang			Efficient Immuno-Modulation of T-H1/T-H2 Biomarkers in 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis: Nanocarrier-Mediated Transcutaneous Co-Delivery of Anti-Inflammatory and Antioxidant Drugs	PLOS ONE			English	Article							SKIN PENETRATION ENHANCEMENT; EX-VIVO; IN-VIVO; NANOPARTICLES; CHITOSAN; PERMEATION; ACCUMULATION; SUPPRESSION; LESIONS; ACID	The present study was conducted with the aim to investigate the immuno-modulatory and histological stabilization effects of nanocarrier-based transcutaneous co-delivery of hydrocortisone (HC) and hydroxytyrosol (HT). In this investigation, the clinical and pharmacological efficacies of nanoparticle (NP)-based formulation to alleviate 2,4-dinitrofluorobenzene (DNFB)-induced atopic dermatitis (AD) was explored by using an NC/Nga mouse model. Ex vivo visual examination of AD induction in experimental mice indicated remarkable control of NP-based formulations in reducing pathological severity of AD-like skin lesions. Therapeutic effectiveness of NP-based formulations was also evaluated by comparing skin thickness of AD-induced NP-treated mice (456 +/- 627 mm) with that of atopic mice (916 +/- 37 mm). Analysis of the immuno-spectrum of AD also revealed the dominance of NP-based formulations in restraining immunoglobulin-E (IgE), histamine, prostaglandin-E-2 (PGE(2)), vascular endothelial growth factor-alpha (VEGF-alpha), and T-helper cells (T-H1/T-H2) producing cytokines in serum and skin biopsies of tested mice. These anti-AD data were further supported by histological findings that revealed alleviated pathological features, including collagen fiber deposition, fibroblasts infiltration, and fragmentation of elastic fibers in experimental mice. Thus, NP-mediated transcutaneous co-delivery of HC and HT can be considered as a promising therapy for managing immunological and histological spectra associated with AD.	[Hussain, Zahid; Katas, Haliza; Amin, Mohd Cairul Iqbal Mohd; Kumolosasi, Endang] Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia	Katas, H (corresponding author), Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Malaysia.	haliz12@hotmail.com	KATAS, HALIZA/I-6417-2016; HUSSAIN, ZAHID/AAX-8822-2020; Hussain, Zahid/HGU-8912-2022; Hussain, Za hid/AAD-8892-2020	KATAS, HALIZA/0000-0001-7249-1628; Hussain, Zahid/0000-0003-4989-6496; Hussain, Za hid/0000-0002-6978-3133	UKM Arus Perdana grant [AP-2013-002]	UKM Arus Perdana grant	This work was supported by the UKM Arus Perdana grant (AP-2013-002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abramovits W, 2005, J AM ACAD DERMATOL, V53, pS86, DOI 10.1016/j.jaad.2005.04.034; Almeida IF, 2006, INT J PHARMACEUT, V327, P73, DOI 10.1016/j.ijpharm.2006.07.036; Alomar A, 2004, BRIT J DERMATOL, V151, P3, DOI 10.1111/j.1365-2133.2004.06269.x; Biruss B, 2006, EUR J PHARM BIOPHARM, V62, P210, DOI 10.1016/j.ejpb.2005.08.004; Clausen AE, 2001, EUR J PHARM BIOPHARM, V51, P25, DOI 10.1016/S0939-6411(00)00130-2; Contreras MD, 2002, INT J PHARMACEUT, V234, P149, DOI 10.1016/S0378-5173(01)00954-1; COUVREUR P, 1995, EUR J PHARM BIOPHARM, V41, P2; El-Hefian EA, 2010, TURK J CHEM, V34, P47, DOI 10.3906/kim-0901-38; Fang YP, 2009, EUR J PHARM BIOPHARM, V73, P391, DOI 10.1016/j.ejpb.2009.07.011; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Godwin DA, 2002, EUR J PHARM BIOPHARM, V53, P23, DOI 10.1016/S0939-6411(01)00215-6; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Hussain Z, 2013, INT J PHARMACEUT, V444, P109, DOI 10.1016/j.ijpharm.2013.01.024; Hussain Z, 2013, J PHARM SCI-US, V102, P1063, DOI 10.1002/jps.23446; Izidoro DR, 2008, LWT-FOOD SCI TECHNOL, V41, P1018, DOI 10.1016/j.lwt.2007.07.009; Jenning V, 2000, EUR J PHARM BIOPHARM, V49, P211, DOI 10.1016/S0939-6411(99)00075-2; Jung MK, 2010, J INVEST DERMATOL, V130, P1459, DOI 10.1038/jid.2009.401; Kang MJ, 2010, INT J PHARMACEUT, V402, P198, DOI 10.1016/j.ijpharm.2010.09.030; Kuchler S, 2009, EUR J PHARM BIOPHARM, V71, P243, DOI 10.1016/j.ejpb.2008.08.019; Lademann J, 2007, EUR J PHARM BIOPHARM, V66, P159, DOI 10.1016/j.ejpb.2006.10.019; Lee HS, 2006, BRIT J DERMATOL, V155, P33, DOI 10.1111/j.1365-2133.2006.07303.x; Leung DYM, 2000, J ALLERGY CLIN IMMUN, V105, P860, DOI 10.1067/mai.2000.106484; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Lippacher A, 2001, INT J PHARM, V214, P9, DOI 10.1016/S0378-5173(00)00623-2; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Mei ZN, 2005, DRUG DEV IND PHARM, V31, P161, DOI 10.1081/DDC-200047791; Moser K, 2001, EUR J PHARM BIOPHARM, V52, P103, DOI 10.1016/S0939-6411(01)00166-7; Papadimitriou S, 2008, CARBOHYD POLYM, V73, P44, DOI 10.1016/j.carbpol.2007.11.007; Park EJ, 2007, J INVEST DERMATOL, V127, P1154, DOI 10.1038/sj.jid.5700658; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Sammeta SM, 2010, J CONTROL RELEASE, V142, P361, DOI 10.1016/j.jconrel.2009.10.036; Schoepe S, 2006, EXP DERMATOL, V15, P406, DOI 10.1111/j.0906-6705.2006.00435.x; Senyigit T, 2009, INT J PHARMACEUT, V380, P155, DOI 10.1016/j.ijpharm.2009.07.018; Shu XZ, 2002, EUR J PHARM BIOPHARM, V54, P235, DOI 10.1016/S0939-6411(02)00052-8; Suda N, 2002, IMMUNOL LETT, V79, P177; Tomimori Y, 2005, J INVEST DERMATOL, V124, P119, DOI 10.1111/j.0022-202X.2004.23516.x; Trotta M, 2002, INT J PHARM, V241, P319, DOI 10.1016/S0378-5173(02)00266-1; Wu HL, 2001, INT J PHARM, V220, P63, DOI 10.1016/S0378-5173(01)00671-8; Wuthrich B, 2007, ANN AGR ENV MED, V14, P195; Zhang Y, 2006, ARCH DERMATOL RES, V297, P425, DOI 10.1007/s00403-006-0641-9; Zoller NN, 2008, TOXICOL IN VITRO, V22, P747, DOI 10.1016/j.tiv.2007.11.022	41	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113143	10.1371/journal.pone.0113143	http://dx.doi.org/10.1371/journal.pone.0113143			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396426	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500137
J	Luo, YQ; Ma, XJ; Shen, Y; Hao, YP; Hu, YQ; Xiao, YF; Bao, YQ; Jia, WP				Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Xiao, Yunfeng; Bao, Yuqian; Jia, Weiping			Positive Relationship between Serum Low-Density Lipoprotein Cholesterol Levels and Visceral Fat in a Chinese Nondiabetic Population	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; ABDOMINAL OBESITY; RISK-FACTOR; METABOLIC SYNDROME; APOLIPOPROTEIN-B; LIPIDS; ASSOCIATION; EVENTS	Background: It has been reported that obesity and serum low-density lipoprotein cholesterol (LDL-c) are important risk factors of cardiovascular disease (CVD). It is recognized that regionalized adiposity has different cardiovascular risk, visceral versus subcutaneous, is a better predictor of CVD. However, the relationship between regionalized adiposity and LDL-c is unclear. The present study was designed to investigate the relationship between visceral fat accumulation and serum LDL-c levels in a Chinese cohort. Methods: A total of 1 538 subjects (539 men, 999 women; 20-75 years old) with normal glucose tolerance and blood pressure were recruited. All subjects underwent magnetic resonance imaging to quantify visceral fat area (VFA) and subcutaneous fat area. Serum LDL-c levels were detected by direct assay method. Results: Overweight/obese subjects (body mass index (BMI) >= 25 kg/m(2)) had significantly higher serum LDL-c levels than the lean subjects (BMI <25 kg/m(2)) (P<0.01). An increasing trend in serum LDL-c levels was found to accompany the increase in VFA (P for trend <0.01). Within the same BMI category, subjects with abdominal obesity (VFA >= 80 cm(2)) had significantly higher LDL-c levels than those without abdominal obesity (VFA <80 cm(2)) (P<0.05). Multiple stepwise regression analysis showed that increased VFA was an independent risk factor for elevated LDL-c levels, not only in the entire study population (Standard beta = 0.138; P<0.01), but also when the study population was subdivided into men, premenopausal and postmenopausal women (Standard beta = 0.117, 0.145, 0.090 respectively for men, premenopausal women, postmenopausal women; all P<0.01). Conclusions: VFA was positively correlated with serum LDL-c levels in a nondiabetic Chinese population with normal blood pressure.	[Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China; [Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China; [Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Key Clin Ctr Metab Dis, Shanghai 200233, Peoples R China; [Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Diabet Inst, Shanghai 200233, Peoples R China; [Luo, Yuqi; Ma, Xiaojing; Shen, Yun; Hao, Yaping; Hu, Yaqin; Bao, Yuqian; Jia, Weiping] Shanghai Key Lab Diabet Mellitus, Shanghai 200233, Peoples R China; [Xiao, Yunfeng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bao, YQ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China.	byq522@163.com	, zz/AAG-3515-2020	Shen, Yun/0000-0002-9850-122X; Hu, Yaqin/0000-0003-0637-4209	973 Program of China [2013CB530606]; National Key Technology R&D Program of China [2012BAI02B03]; Project of National Natural Science Foundation of China [81100563]; Key Project of Science and Technology of Shanghai [13XD1403000]; Shanghai Health and Family Planning Commission [2013ZYJB1001]	973 Program of China(National Basic Research Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai; Shanghai Health and Family Planning Commission	Funded by 973 Program of China (2013CB530606), National Key Technology R&D Program of China (2012BAI02B03), Project of National Natural Science Foundation of China (81100563), Key Project of Science and Technology of Shanghai (13XD1403000), and grant from Shanghai Health and Family Planning Commission (2013ZYJB1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bao YQ, 2013, J CLIN ENDOCR METAB, V98, P345, DOI 10.1210/jc.2012-2906; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Bjorntorp P, 1988, Acta Med Scand Suppl, V723, P121; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; GOFMAN JW, 1950, SCIENCE, V111, P166, DOI 10.1126/science.111.2877.166; Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438; Klopfenstein BJ, 2012, BRIT J RADIOL, V85, pE826, DOI 10.1259/bjr/57987644; LEMIEUX S, 1995, ATHEROSCLEROSIS, V118, P155, DOI 10.1016/0021-9150(95)05603-T; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Onat A, 2013, EUR J CLIN INVEST, V43, P1129, DOI 10.1111/eci.12150; Peleska J, 2002, ST HEAL T, V90, P268; Pelletier-Beaumont E, 2012, ATHEROSCLEROSIS, V221, P577, DOI 10.1016/j.atherosclerosis.2012.01.023; Robinson JG, 2009, J AM COLL CARDIOL, V55, P42, DOI 10.1016/j.jacc.2009.07.056; Sadeghi M, 2013, J RES MED SCI, V18, P326; Sadeghi M, 2013, ARCH IRAN MED, V16, P149, DOI 013163/AIM.006; Sharma S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-10; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Soeki T, 1999, JPN CIRC J, V63, P976, DOI 10.1253/jcj.63.976; Wang Y, 2012, INT J OBESITY, V36, P1203, DOI 10.1038/ijo.2011.222; World Health Organization, 1999, DIAGN CLASS DIAB M 1; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904	28	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112715	10.1371/journal.pone.0112715	http://dx.doi.org/10.1371/journal.pone.0112715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398089	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500080
J	Sato, R; Maekawa, M; Genma, R; Shirai, K; Ohki, S; Morita, H; Suda, T; Watanabe, H				Sato, Ryosuke; Maekawa, Masato; Genma, Rieko; Shirai, Kenji; Ohki, Shigeru; Morita, Hiroshi; Suda, Takafumi; Watanabe, Hiroshi			Final Height and Cardiometabolic Outcomes in Young Adults with Very Low Birth Weight (< 1500 g)	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; PLASMA-GLUCOSE; SHORT STATURE; RISK-FACTORS; GROWTH; AGE; LENGTH; HEART; OSTEOPOROSIS	Objective: Individuals with very low birth weight (VLBW; <1500 g) are known to be predisposed to both short final height and cardiometabolic disorders. However, associations between final height and cardiometabolic outcomes including glucose metabolism in VLBW individuals in young adulthood are not fully investigated. Methods: We investigated glucose metabolism and other cardiometabolic outcomes such as lipid profiles, blood pressure, renal function, urinary albumin, and thyroid function in young adults with VLBW born between 1980 and 1990. Short stature was defined as a final height <10th percentile. Glucose intolerance [diabetes, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG)] was determined using 75-g oral glucose tolerance tests. Associations between final height and cardiometabolic outcomes were examined using logistic or multiple linear regression. Results: A total of 628 VLBW individuals were screened and 111 young adults with VLBW (19-30 years) participated in the study. Of the participants, 40 subjects (36%) had short stature with a final height <10th percentile. Eight subjects (7.2%) had glucose intolerance (1, diabetes; 6, IGT; 1, IFG). Short stature was correlated with glucose intolerance (odds ratio 11.1; 95% CI 1.92, 99.7; P = 0.006). Final height was inversely associated with the homeostatic model assessment (HOMA) of insulin resistance, HOMA-beta, insulinogenic index, and total/LDL-cholesterol. The associations of final height with insulin sensitivity and lipid profiles remained after adjustment for target height and age at puberty onset. Conclusions: Shorter final height was associated with less favorable metabolic profiles in young adults with VLBW, and may be partly mediated by reduced insulin sensitivity. These associations were independent of target height or age at puberty onset.	[Sato, Ryosuke; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med 2, Hamamatsu, Shizuoka 4313192, Japan; [Sato, Ryosuke; Genma, Rieko] Seirei Hamamatsu Gen Hosp, Dept Endocrinol & Metab, Hamamatsu, Shizuoka, Japan; [Maekawa, Masato] Hamamatsu Univ Sch Med, Dept Lab Med, Hamamatsu, Shizuoka 4313192, Japan; [Shirai, Kenji; Ohki, Shigeru] Seirei Hamamatsu Gen Hosp, Dept Neonatol, Hamamatsu, Shizuoka, Japan; [Watanabe, Hiroshi] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Sato, R (corresponding author), Pharmaceut & Med Devices Agcy, Tokyo, Japan.	sato-ryosuke@pmda.go.jp		Maekawa, Masato/0000-0001-9710-5324	Japan Society for the Promotion of Science [24390144]; Ministry of Health, Labour and Welfare in Japan [H23-Cardiovascular disease, Diabetes-011]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This study was partly supported by grants from the Japan Society for the Promotion of Science (24390144) and from the Ministry of Health, Labour and Welfare in Japan (H23-Cardiovascular disease and Diabetes-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2008, DIABETES CARE, V31, P1650, DOI 10.2337/dc08-0225; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Asao K, 2006, DIABETES CARE, V29, P1632, DOI 10.2337/dc05-1997; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Eichenwald EC, 2008, NEW ENGL J MED, V358, P1700, DOI 10.1056/NEJMra0707601; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Field DJ, 2008, BMJ-BRIT MED J, V336, P1221, DOI 10.1136/bmj.39555.670718.BE; Gavin JR, 1997, DIABETES CARE, V20, P1183; He QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094385; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Johnston LW, 2013, DIABETES CARE, V36, P3599, DOI 10.2337/dc13-0254; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Kindblom JM, 2006, DIABETES, V55, P3047, DOI 10.2337/db06-0192; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Leger J, 1997, BRIT MED J, V315, P341; Lettre G, 2011, HUM GENET, V129, P465, DOI 10.1007/s00439-011-0969-x; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Liu J, 2009, DIABETES CARE, V32, P739, DOI 10.2337/dc08-1547; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ministry of Health Labour and Welfare Japan, 2007, NAT HLTH NUTR SURV J; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; OGATA T, 1990, JPN J PAEDIAT, V94, P1535; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Qiu CS, 2013, J CLIN ENDOCR METAB, V98, P1612, DOI 10.1210/jc.2012-2919; Radetti G, 2004, J CLIN ENDOCR METAB, V89, P6320, DOI 10.1210/jc.2003-032185; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Sato R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000327; Smits MM, 2012, DIABETOLOGIA, V55, P1679, DOI 10.1007/s00125-012-2500-x; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Taylor PN, 2013, J CLIN ENDOCR METAB, V98, P3562, DOI 10.1210/jc.2013-1315; The study group of the Health Ministry in Japan, 1994, FET GROWTH CURV JAP; Walsh JP, 2010, J CLIN ENDOCR METAB, V95, P1095, DOI 10.1210/jc.2009-1977; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Widen E, 2012, DIABETES CARE, V35, P850, DOI 10.2337/dc11-1365	40	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112286	10.1371/journal.pone.0112286	http://dx.doi.org/10.1371/journal.pone.0112286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397968	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500044
J	Tvrdonova, V; Rokic, MB; Stojilkovic, SS; Zemkova, H				Tvrdonova, Vendula; Rokic, Milos B.; Stojilkovic, Stanko S.; Zemkova, Hana			Identification of Functionally Important Residues of the Rat P2X4 Receptor by Alanine Scanning Mutagenesis of the Dorsal Fin and Left Flipper Domains	PLOS ONE			English	Article							HUMAN P2X(1) RECEPTORS; GATED ION CHANNELS; ATP-BINDING-SITE; AGONIST BINDING; TRANSMEMBRANE SEGMENTS; CATION PERMEABILITY; KINASE-C; ACTIVATION; DESENSITIZATION; IVERMECTIN	Crystallization of the zebrafish P2X4 receptor in both open and closed states revealed conformational differences in the ectodomain structures, including the dorsal fin and left flipper domains. Here, we focused on the role of these domains in receptor activation, responsiveness to orthosteric ATP analogue agonists, and desensitization. Alanine scanning mutagenesis of the R203-L214 (dorsal fin) and the D280-N293 (left flipper) sequences of the rat P2X4 receptor showed that ATP potency/efficacy was reduced in 15 out of 26 alanine mutants. The R203A, N204A, and N293A mutants were essentially non-functional, but receptor function was restored by ivermectin, an allosteric modulator. The I205A, T210A, L214A, P290A, G291A, and Y292A mutants exhibited significant changes in the responsiveness to orthosteric analog agonists 2-(methylthio) adenosine 5'-triphosphate, adenosine 5'-(gamma-thio) triphosphate, 2'(3'-O-(4-benzoylbenzoyl) adenosine 5'-triphosphate, and alpha,beta-methyleneadenosine 5'-triphosphate. In contrast, the responsiveness of L206A, N208A, D280A, T281A, R282A, and H286A mutants to analog agonists was comparable to that of the wild type receptor. Among these mutants, D280A, T281A, R282A, H286A, G291A, and Y292A also exhibited increased time-constant of the desensitizing current response. These experiments, together with homology modeling, indicate that residues located in the upper part of the dorsal fin and left flipper domains, relative to distance from the channel pore, contribute to the organization of the ATP binding pocket and to the initiation of signal transmission towards residues in the lower part of both domains. The R203 and N204 residues, deeply buried in the protein, may integrate the output signal from these two domains towards the gate. In addition, the left flipper residues predominantly account for the control of transition of channels from an open to a desensitized state.	[Tvrdonova, Vendula; Rokic, Milos B.; Zemkova, Hana] Acad Sci Czech Republic, Inst Physiol, Dept Cellular & Mol Neuroendocrinol, Prague, Czech Republic; [Tvrdonova, Vendula] Charles Univ Prague, Fac Sci, Dept Anim Physiol, Prague, Czech Republic; [Rokic, Milos B.; Stojilkovic, Stanko S.] NICHHD, Sect Cellular Signaling, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Zemkova, H (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Cellular & Mol Neuroendocrinol, Prague, Czech Republic.	zemkova@biomed.cas.cz	Stillerova (Tvrdonova), Vendula/G-3060-2014; Zemkova, Hana/C-1844-2012; ROKIC, MILOS/O-7204-2014	Stillerova (Tvrdonova), Vendula/0000-0001-5295-2837; Zemkova, Hana/0000-0001-5219-8563; ROKIC, MILOS/0000-0002-9148-2716	Grant Agency of the Czech Republic [P304/12/G069]; Centrum of Biomedicine Research [CZ.1.07/2.3.00/30.0025]; "BIOCEV'' project; Biotechnology and Biomedicine Centre of the Academy of Sciences; Grant Agency of Charles University in Prague [3446/2011]; Academy of Sciences of the Czech Republic [RVO 67985823]; Intramural Research Program of the NICHD, NIH; Charles University in Vestec from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000195] Funding Source: NIH RePORTER	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Centrum of Biomedicine Research; "BIOCEV'' project; Biotechnology and Biomedicine Centre of the Academy of Sciences; Grant Agency of Charles University in Prague; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Intramural Research Program of the NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Charles University in Vestec from the European Regional Development Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Grant Agency of the Czech Republic (P304/12/G069), the Centrum of Biomedicine Research (CZ.1.07/2.3.00/30.0025), the "BIOCEV'' project with the Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec (CZ.1.05/1.1.00/02.0109) from the European Regional Development Fund, the Grant Agency of Charles University in Prague (3446/2011), the Academy of Sciences of the Czech Republic (Research Project No. RVO 67985823, and the Intramural Research Program of the NICHD, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; Carugo O, 1999, PROTEIN ENG, V12, P1021, DOI 10.1093/protein/12.12.1021; Coddou C, 2003, J BIOL CHEM, V278, P36777, DOI 10.1074/jbc.M305177200; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Coddou C, 2011, REV NEUROSCIENCE, V22, P335, DOI 10.1515/RNS.2011.014; Collo G, 1996, J NEUROSCI, V16, P2495; Digby HR, 2005, J NEUROCHEM, V95, P1746, DOI 10.1111/j.1471-4159.2005.03494.x; Du J, 2012, P NATL ACAD SCI USA, V109, P4140, DOI 10.1073/pnas.1119546109; Egan TM, 1998, J NEUROSCI, V18, P2350; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Fabbretti E, 2004, J BIOL CHEM, V279, P53109, DOI 10.1074/jbc.M409772200; Friday SC, 2008, J NEUROCHEM, V105, P1264, DOI 10.1111/j.1471-4159.2008.05228.x; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Jelinkova I, 2008, PFLUG ARCH EUR J PHY, V456, P939, DOI 10.1007/s00424-008-0450-4; Jelinkova I, 2006, BIOCHEM BIOPH RES CO, V349, P619, DOI 10.1016/j.bbrc.2006.08.084; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Kowalski M, 2014, BRIT J PHARMACOL, V171, P5093, DOI 10.1111/bph.12830; Le KT, 1998, J NEUROSCI, V18, P7152; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; Lorinczi E, 2012, P NATL ACAD SCI USA, V109, P11396, DOI 10.1073/pnas.1118759109; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Petrenko N, 2011, BIOCHEMISTRY-US, V50, P8427, DOI 10.1021/bi200812u; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Roberts JA, 2006, J NEUROCHEM, V96, P843, DOI 10.1111/j.1471-4159.2005.03593.x; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Rokic MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059411; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Stanchev D, 2006, NEUROSCI LETT, V393, P78, DOI 10.1016/j.neulet.2005.09.045; Toulme E, 2006, MOL PHARMACOL, V69, P576, DOI 10.1124/mol.105.018812; Wirkner K, 2005, J NEUROSCI, V25, P7734, DOI 10.1523/JNEUROSCI.2028-05.2005; Xiong KM, 2004, NEUROSCI LETT, V365, P195, DOI 10.1016/j.neulet.2004.04.078; Xu J, 2014, J GEN PHYSIOL, V144, P79, DOI 10.1085/jgp.201411169; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Yan ZH, 2006, J BIOL CHEM, V281, P32649, DOI 10.1074/jbc.M512791200; Zemkova H, 2004, J NEUROSCI, V24, P6968, DOI 10.1523/JNEUROSCI.1471-04.2004; Zemkova H., 2014, PFLUGERS ARCH; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x; Zhang LM, 2014, BIOCHEMISTRY-US, V53, P3012, DOI 10.1021/bi401711n; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	60	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112902	10.1371/journal.pone.0112902	http://dx.doi.org/10.1371/journal.pone.0112902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398027	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500107
J	Wong, CKM; Liang, J; Chan, ML; Chan, YH; Chan, L; Wan, KY; Ng, MS; Chan, DCC; Wong, SYS; Wong, MCS				Wong, Carmen K. M.; Liang, Jun; Chan, Man L.; Chan, Yin H.; Chan, Laam; Wan, Kwong Y.; Ng, Ming S.; Chan, Dicken C. C.; Wong, Samuel Y. S.; Wong, Martin C. S.			Prevalence and Psychosocial Correlates of Depressive Symptoms in Urban Chinese Women during Midlife	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; MAJOR DEPRESSION; HONG-KONG; MENOPAUSAL TRANSITION; GENDER-DIFFERENCES; LIFE EVENTS; HEALTH; POPULATION; ONSET; SEX	Objective: Depression is common in women with much research focusing on hormonal changes and menopausal symptoms but with little exploration of psychosocial problems in midlife. This study investigates the prevalence of clinically relevant depressive symptoms in midlife Chinese women and its association with psychosocial factors. Methods: A cross-sectional, community-based household survey of women aged 45 to 64 years of age was conducted in Hong Kong from September 2010 to March 2011. The structured questionnaire included demographic data, educational status, marital status and household income, as well as perceived current stressful events and significant life events in the past 12 months. Information on clinically relevant depressive symptoms was measured by the validated chinese Patient Health Questionnaire (PHQ-9). Results: A total of 402 participants were recruited in the study period. Of the 393 women who completed the questionnaire, the prevalence of clinically relevant depressive symptoms (PHQ-9 score >= 10) was 11.0%. In multiple regression analysis, being single/divorced/separated/widowed, having an educational level of primary school level or below, having multiple chronic diseases, loss of hobby or loss of close social support in the past 12 months in midlife were associated with clinically relevant depressive symptoms. Conclusions: Correlates of clinically relevant depressive symptoms in midlife Chinese women can be used to identify those at increased risk and potentiate further studies to explore early psychosocial and community interventions.	[Wong, Carmen K. M.; Chan, Dicken C. C.; Wong, Samuel Y. S.; Wong, Martin C. S.] Chinese Univ Hong Kong, Div Family Med & Primary Hlth Care, JC Sch Publ Hlth & Primary Care, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Liang, Jun; Chan, Man L.; Chan, Yin H.; Chan, Laam; Wan, Kwong Y.; Ng, Ming S.] Tuen Mun Hosp, Hong Kong Primary Care Res Network, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Tuen Mun Hospital	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Div Family Med & Primary Hlth Care, JC Sch Publ Hlth & Primary Care, Prince Wales Hosp, 4-F,Sch Publ Hlth Bldg, Shatin, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wong, Martin/L-4568-2014; WONG, Samuel Yeung Shan/D-7311-2013	Wong, Martin/0000-0001-7706-9370; WONG, Samuel Yeung Shan/0000-0003-0934-6385				Angst J, 1997, J AFFECT DISORDERS, V45, P31, DOI 10.1016/S0165-0327(97)00057-8; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bracke P, 2000, SOC SCI MED, V51, P51, DOI 10.1016/S0277-9536(99)00432-3; Bromberger JT, 2007, J AFFECT DISORDERS, V103, P267, DOI 10.1016/j.jad.2007.01.034; Bromberger JT, 2004, AM J PUBLIC HEALTH, V94, P1378, DOI 10.2105/AJPH.94.8.1378; Buist-Bouwman MA, 2005, ACTA PSYCHIAT SCAND, V111, P436, DOI 10.1111/j.1600-0447.2005.00513.x; Census and Statistics Department, 2011, CENS 2011; Cheng C., 2007, J ESTHET RESTOR DENT, V29, P381, DOI [DOI 10.1016/J.JAD.2013.07.014, 10.1016/j.jad.2013.07.014]; Chi I, 2005, AM J GERIAT PSYCHIAT, V13, P409, DOI 10.1176/appi.ajgp.13.5.409; Chou KL, 2005, INT J GERIATR PSYCH, V20, P41, DOI 10.1002/gps.1246; Cohen LS, 2006, ARCH GEN PSYCHIAT, V63, P385, DOI 10.1001/archpsyc.63.4.385; Coiro MJ, 2001, WOMEN HEALTH, V32, P1, DOI 10.1300/J013v32n01_01; Department of Health, 2010, ANN REP 2009 2010; Eaton WW, 2001, J HEALTH SOC BEHAV, V42, P277, DOI 10.2307/3090215; Elliott M, 2001, WOMEN HEALTH, V33, P163; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Ho SC, 2003, MATURITAS, V44, P149, DOI 10.1016/S0378-5122(02)00325-0; KENDLER KS, 1993, AM J PSYCHIAT, V150, P1139; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; KESSLER RC, 1994, J AFFECT DISORDERS, V30, P15, DOI 10.1016/0165-0327(94)90147-3; KESSLER RC, 1981, AM SOCIOL REV, V46, P443, DOI 10.2307/2095263; Kessler RC, 1997, ANNU REV PSYCHOL, P48191; Krause N., 1999, HDB SOCIOLOGY MENTAL, P183, DOI [10.1007/0-387-36223-1_10, DOI 10.1007/0-387-36223-1_10]; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LAU EMC, 1995, J EPIDEMIOL COMMUN H, V49, P492, DOI 10.1136/jech.49.5.492; Levav I, 2002, ISRAEL J PSYCHIAT, V39, P50; Liu JZ, 2007, MATURITAS, V58, P359, DOI 10.1016/j.maturitas.2007.09.007; Loh FH, 2005, MATURITAS, V52, P169, DOI 10.1016/j.maturitas.2004.11.004; Mirowsky J, 2017, SOCIAL CAUSES PSYCHO; Nazroo JY, 1997, PSYCHOL MED, V27, P9, DOI 10.1017/S0033291796004187; O'Campo P, 2004, SOC SCI MED, V58, P585, DOI 10.1016/S0277-9536(03)00230-2; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Shim RS, 2011, J AM BOARD FAM MED, V24, P33, DOI 10.3122/jabfm.2011.01.100121; Simonsick EM, 1995, NIH PUB, V95-4009; Simpson HB, 1997, ARCH GEN PSYCHIAT, V54, P633; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; TURNER RJ, 1989, J NERV MENT DIS, V177, P443, DOI 10.1097/00005053-198908000-00001; Wong SYS, 2006, J AFFECT DISORDERS, V92, P215, DOI 10.1016/j.jad.2006.01.027; WOO J, 1994, ACTA PSYCHIAT SCAND, V89, P8, DOI 10.1111/j.1600-0447.1994.tb01478.x	39	42	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e110877	10.1371/journal.pone.0110877	http://dx.doi.org/10.1371/journal.pone.0110877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25398009	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500010
J	Yang, JP; Wei, F; Schafer, C; Wong, DTW				Yang, Jieping; Wei, Fang; Schafer, Christopher; Wong, David T. W.			Detection of Tumor Cell-Specific mRNA and Protein in Exosome-Like Microvesicles from Blood and Saliva	PLOS ONE			English	Article							BIOMARKERS; CANCER; CARCINOMA; VESICLES; IDENTIFICATION; MUTATIONS; MICRORNAS; MELANOMA; RELEASE; PLASMA	The discovery of disease-specific biomarkers in oral fluids has revealed a new dimension in molecular diagnostics. Recent studies have reported the mechanistic involvement of tumor cells derived mediators, such as exosomes, in the development of saliva-based mRNA biomarkers. To further our understanding of the origins of disease-induced salivary biomarkers, we here evaluated the hypothesis that tumor-shed secretory lipidic vesicles called exosome-like microvesicles (ELMs) that serve as protective carriers of tissue-specific information, mRNAs, and proteins, throughout the vasculature and bodily fluids. RNA content was analyzed in cell free-saliva and ELM-enriched fractions of saliva. Our data confirmed that the majority of extracellular RNAs (exRNAs) in saliva were encapsulated within ELMs. Nude mice implanted with human lung cancer H460 cells expressing hCD63-GFP were used to follow the circulation of tumor cell specific protein and mRNA in the form of ELMs in vivo. We were able to identify human GAPDH mRNA in ELMs of blood and saliva of tumor bearing mice using nested RT-qPCR. ELMs positive for hCD63-GFP were detected in the saliva and blood of tumor bearing mice as well as using electric field-induced release and measurement (EFIRM). Altogether, our results demonstrate that ELMs carry tumor cell-specific mRNA and protein from blood to saliva in a xenografted mouse model of human lung cancer. These results therefore strengthen the link between distal tumor progression and the biomarker discovery of saliva through the ELMs.	[Yang, Jieping; Wei, Fang; Schafer, Christopher; Wong, David T. W.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Wong, DTW (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	dtww@ucla.edu			Ruth L. Kirschstein National Research Service Award [T32-DE07296]; National Institute of Dental and Craniofacial Research/National Institutes of Health [UO1-DE017790, RO1-DE15970]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000124]; California Tobacco-Related Diseases Research Program (TRDRP) [20PT-0032, 21RT-0112]; DoD [LS110207]; Univerity of California, Los Angeles School of Dentistry [441901-69749-FWEI-FY11DR]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015970, T32DE007296, U01DE017790] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); California Tobacco-Related Diseases Research Program (TRDRP); DoD(United States Department of Defense); Univerity of California, Los Angeles School of Dentistry; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by a Ruth L. Kirschstein National Research Service Award (grant T32-DE07296) and the National Institute of Dental and Craniofacial Research/National Institutes of Health (grants UO1-DE017790 and RO1-DE15970). The project described was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (grant UL1TR000124). It was also supported by the California Tobacco-Related Diseases Research Program (TRDRP) 20PT-0032, 21RT-0112 and also DoD grant LS110207. Support was also received from a Faculty Seed Grant from the Univerity of California, Los Angeles School of Dentistry (grant 441901-69749-FWEI-FY11DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; BLAND J, 2008, ALTERN THER HEALTH M, V14, P18; Bossuyt PMM, 2011, JAMA-J AM MED ASSOC, V305, P2229, DOI 10.1001/jama.2011.729; Brinkmann O, 2011, ADV CLIN CHEM, V55, P21, DOI 10.1016/B978-0-12-387042-1.00002-2; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; De la Pena H, 2009, J IMMUNOL METHODS, V344, P121, DOI 10.1016/j.jim.2009.03.011; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dimov I, 2009, THESCIENTIFICWORLDJO, V9, P1107, DOI 10.1100/tsw.2009.128; Farrell JJ, 2012, GUT, V61, P582, DOI 10.1136/gutjnl-2011-300784; Frangogiannis NG, 2012, TRANSL RES, V159, P197, DOI 10.1016/j.trsl.2012.01.023; Gao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005875; Gray RD, 2010, CHEST, V137, P635, DOI 10.1378/chest.09-1047; Hess C, 1999, J IMMUNOL, V163, P4564; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hu S, 2011, PROTEOMICS, V11, P1499, DOI 10.1002/pmic.201000206; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kraus-Berthier L, 2000, CLIN CANCER RES, V6, P297; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lau C, 2013, J BIOL CHEM; Lee YH, 2012, J MOL MED, V90, P427, DOI 10.1007/s00109-011-0829-0; Lee YH, 2011, CLIN CHEM, V57, P1295, DOI 10.1373/clinchem.2010.159210; Lee YH, 2009, AM J DENT, V22, P241; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Nonaka D, 2005, CANCER RES, V65, P1207, DOI 10.1158/0008-5472.CAN-04-3461; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Park NJ, 2006, CLIN CHEM, V52, P988, DOI 10.1373/clinchem.2005.063206; Petty TL, 2000, CANCER, V89, P2461; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Sharma S, 2010, ACS NANO, V4, P1921, DOI 10.1021/nn901824n; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Taylor DD, 2002, GYNECOL ONCOL, V84, P443, DOI 10.1006/gyno.2001.6551; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Wei F, 2013, BIOSENS BIOELECTRON, V44, P115, DOI 10.1016/j.bios.2012.12.046; Wei F, 2009, CLIN CANCER RES, V15, P4446, DOI 10.1158/1078-0432.CCR-09-0050; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yang C, 2011, CLIN DEV IMMUNOL, V2011, P11, DOI DOI 10.1155/2011/842849; Zhang L, 2012, CELL MOL LIFE SCI, V69, P3341, DOI 10.1007/s00018-012-1027-0; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09	64	75	81	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e110641	10.1371/journal.pone.0110641	http://dx.doi.org/10.1371/journal.pone.0110641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397880	Green Published, gold			2022-12-26	WOS:000345558500009
J	Zhang, X; Li, F; Zhang, L; Zhao, ZH; Norback, D				Zhang, Xin; Li, Fan; Zhang, Li; Zhao, Zhuohui; Norback, Dan			A Longitudinal Study of Sick Building Syndrome (SBS) among Pupils in Relation to SO2, NO2, O-3 and PM10 in Schools in China	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; INDOOR AIR-POLLUTION; SYMPTOMS; HEALTH; PREVALENCE; ASSOCIATIONS; VENTILATION; ENVIRONMENT; OUTDOOR; QUALITY	There are fewer longitudinal studies from China on symptoms as described for the sick building syndrome (SBS). Here, we performed a two-year prospective study and investigated associations between environmental parameters such as room temperature, relative air humidity (RH), carbon dioxide (CO2), nitrogen dioxide (NO2), sulphur dioxide (SO2), ozone (O-3), particulate matter (PM10), and health outcomes including prevalence, incidence and remission of SBS symptoms in junior high schools in Taiyuan, China. Totally 2134 pupils participated at baseline, and 1325 stayed in the same classrooms during the study period (2010-2012). The prevalence of mucosal symptoms, general symptoms and symptoms improved when away from school (school-related symptoms) was 22.7%, 20.4% and 39.2%, respectively, at baseline, and the prevalence increased during follow-up (P<0.001). At baseline, both indoor and outdoor SO2 were found positively associated with prevalence of school-related symptoms. Indoor O-3 was shown to be positively associated with prevalence of skin symptoms. At follow-up, indoor PM10 was found to be positively associated with new onset of skin, mucosal and general symptoms. CO2 and RH were positively associated with new onset of mucosal, general and school-related symptoms. Outdoor SO2 was positively associated with new onset of skin symptoms, while outdoor NO2 was positively associated with new onset of skin, general and mucosal symptoms. Outdoor PM10 was found to be positively associated with new onset of skin, general and mucosal symptoms as well as school-related symptoms. In conclusion, symptoms as described for SBS were commonly found in school children in Taiyuan City, China, and increased during the two-year follow-up period. Environmental pollution, including PM10, SO2 and NO2, could increase the prevalence and incidence of SBS and decrease the remission rate. Moreover, parental asthma and allergy (heredity) and pollen or pet allergy (atopy) can be risk factors for SBS.	[Zhang, Xin; Li, Fan; Zhang, Li] Shanxi Univ, Inst Environm Sci, Taiyuan, Peoples R China; [Zhao, Zhuohui] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Norback, Dan] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden	Shanxi University; Fudan University; Uppsala University	Zhao, ZH (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China.	zhzhao@fudan.edu.cn		Norback, Dan/0000-0002-5174-6668	Swedish Research Council [348-2011-7402]; National Natural Science Foundation of China [21207083]; Natural Science Foundation of Shanxi Province of China [2013021033-1]; Shanxi Scholarship Council of China [2012-005]; Taiyuan Environmental Protection Agency for Environmental Sciences and Technology [201218]	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province of China(Natural Science Foundation of Shanxi Province); Shanxi Scholarship Council of China; Taiyuan Environmental Protection Agency for Environmental Sciences and Technology	This study was supported by grants from the Swedish Research Council (348-2011-7402), the National Natural Science Foundation of China (21207083), Natural Science Foundation of Shanxi Province of China (2013021033-1), a research project supported by Shanxi Scholarship Council of China (2012-005), and Taiyuan Environmental Protection Agency for Environmental Sciences and Technology (201218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman M, 2000, INDOOR AIR, V10, P57, DOI 10.1034/j.1600-0668.2000.010001057.x; APTER A, 1994, J ALLERGY CLIN IMMUN, V94, P277, DOI 10.1016/0091-6749(94)90087-6; ASHRAE, 1989, 621989 ASHRAE; Bjornsson E, 1998, INT J TUBERC LUNG D, V2, P1023; Cai GH, 2011, PEDIAT ALLERG IMM-UK, V22, P290, DOI 10.1111/j.1399-3038.2010.01127.x; CAMPBELL GW, 1994, ATMOS ENVIRON, V28, P477, DOI 10.1016/1352-2310(94)90125-2; Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x; Ferm M, 1998, ATMOS ENVIRON, V32, P1377, DOI 10.1016/S1352-2310(97)00170-2; Fox A, 2005, J ENVIRON MONITOR, V7, P450, DOI 10.1039/b418038k; Guo P, 2013, INT J ENV RES PUB HE, V10, P1489, DOI 10.3390/ijerph10041489; Hwang BF, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-23; Lee SC, 2000, CHEMOSPHERE, V41, P109, DOI 10.1016/S0045-6535(99)00396-3; Mendell MJ, 2005, INDOOR AIR, V15, P27, DOI 10.1111/j.1600-0668.2004.00320.x; Mengersen K, 2011, INDOOR AIR, V21, P25, DOI 10.1111/j.1600-0668.2010.00679.x; Meyer HW, 2004, INDOOR AIR, V14, P65, DOI 10.1046/j.1600-0668.2003.00213.x; Mi YH, 2006, INDOOR AIR, V16, P454, DOI 10.1111/j.1600-0668.2006.00439.x; Morales-Suarez-Varela M, 2013, IRAN J ALLERGY ASTHM, V12, P220; Norback D, 2008, INDOOR AIR, V18, P293, DOI 10.1111/j.1600-0668.2008.00530.x; NORBACK D, 1990, BRIT J IND MED, V47, P733; NORBACK D, 1991, BRIT J IND MED, V48, P451; Norback D, 2009, CURR OPIN ALLERGY CL, V9, P55, DOI 10.1097/ACI.0b013e32831f8f08; Oeder S, 2012, INDOOR AIR, V22, P148, DOI 10.1111/j.1600-0668.2011.00743.x; Oeder S, 2012, AM J RESP CELL MOL, V47, P575, DOI 10.1165/rcmb.2012-0139OC; Penard-Morand C, 2005, CLIN EXP ALLERGY, V35, P1279, DOI 10.1111/j.1365-2222.2005.02336.x; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Reinikainen LM, 2003, INDOOR AIR, V13, P344, DOI 10.1111/j.1600-0668.2003.00155.x; Reinikainen LM, 2001, ARCH ENVIRON HEALTH, V56, P365, DOI 10.1080/00039890109604469; Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Sahlberg B, 2013, SCI TOTAL ENVIRON, V444, P433, DOI 10.1016/j.scitotenv.2012.10.114; Saijo Yasuaki, 2009, Environmental Health and Preventive Medicine, V14, P26, DOI 10.1007/s12199-008-0052-y; Saijo Yasuaki, 2010, Environmental Health and Preventive Medicine, V15, P276, DOI 10.1007/s12199-010-0139-0; Salo PM, 2009, J ALLERGY CLIN IMMUN, V124, P185, DOI 10.1016/j.jaci.2009.05.012; Satish U, 2012, ENVIRON HEALTH PERSP, V120, P1671, DOI 10.1289/ehp.1104789; Simoni M, 2010, EUR RESPIR J, V35, P742, DOI 10.1183/09031936.00016309; SKOV P, 1992, ANN NY ACAD SCI, V641, P17, DOI 10.1111/j.1749-6632.1992.tb16528.x; SOINE L, 1995, SOC WORK HEALTH CARE, V20, P51, DOI 10.1300/J010v20n03_04; Sun YX, 2013, BUILD ENVIRON, V68, P134, DOI 10.1016/j.buildenv.2013.06.010; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; Syazwan AI, 2013, THER CLIN RISK MANAG, V9, DOI 10.2147/TCRM.S39136; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072385; WHO, 2009, GUID IND AIR QUAL DA; WHO, 1983, IND AIR POLL EXP HLT; WHO, 2005, AIR QUAL GUID GLOB U; Zhang JF, 2002, ENVIRON HEALTH PERSP, V110, P961, DOI 10.1289/ehp.02110961; Zhang X, 2011, INDOOR AIR, V21, P462, DOI 10.1111/j.1600-0668.2011.00726.x; Zhang X, 2012, SCI TOTAL ENVIRON, V430, P75, DOI 10.1016/j.scitotenv.2012.04.040	46	30	30	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112933	10.1371/journal.pone.0112933	http://dx.doi.org/10.1371/journal.pone.0112933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398002	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558500114
J	Venkatraman, G; Benesch, MGK; Tang, XY; Dewald, J; McMullen, TPW; Brindley, DN				Venkatraman, Ganesh; Benesch, Matthew G. K.; Tang, Xiaoyun; Dewald, Jay; McMullen, Todd P. W.; Brindley, David N.			Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment	FASEB JOURNAL			English	Article						autotaxin; autotaxin inhibitors; breast cancer; chemoresistance; doxorubicin	TRANSCRIPTION FACTOR NRF2; PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; HUMAN NEUROBLASTOMA-CELLS; BREAST-CANCER; ANTIOXIDANT RESPONSE; MULTIDRUG-RESISTANCE; ACID RECEPTOR; HEPATOCELLULAR CANCER; HEME OXYGENASE-1; AUTOTAXIN ENPP2	The present work elucidates novel mechanisms for lysophosphatidate (LPA)-induced chemoresistance using human breast, lung, liver, and thyroid cancer cells. LPA (0.5-10 mu M) increased Nrf2 transcription factor stability and nuclear localization by <= 5-fold. This involved lysophosphatidate type 1 (LPA(1)) receptors as identified with 1 mu M wls-31 (LPA(1/2) receptor agonist) and blocking this effect with 20 mu M Ki16425 (LPA(1-3) antagonist, K-i = 0.34 mu M). Knockdown of LPA(1) by 50% to 60% with siRNA decreased Nrf2 stability and expressing LPA1, but not LPA(2/3), in human HepG2 cells increased Nrf2 stabilization. LPA-induced Nrf2 expression increased transcription of multidrug-resistant transporters and antioxidant genes by 2- to 4-fold through the antioxidant response element. This protected cells from doxorubicin-induced death. This pathway was verified in vivo by orthotopic injection of 20,000 mouse 4T1 breast cancer cells into syngeneic mice. Blocking LPA production with 10 mg/kg per d ONO-8430506 (competitive autotaxin inhibitor, IC90 = 100 nM) decreased expression of Nrf2, multidrug-resistant transporters, and antioxidant genes in breast tumors by <= 90%. Combining 4 mg/kg doxorubicin every third day with ONO-8430506 synergistically decreased tumor growth and metastasis to lungs and liver by >70%, whereas doxorubicin alone had no significant effect. This study provides the first evidence that LPA increases antioxidant gene and multidrug-resistant transporter expression. Blocking this aspect of LPA signaling provides a novel strategy for improving chemotherapy.	[Venkatraman, Ganesh; Benesch, Matthew G. K.; Tang, Xiaoyun; Dewald, Jay; Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada; [McMullen, Todd P. W.] Univ Alberta, Dept Surg, WC Mackenzie Hlth Sci Ctr, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, 357 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca	Benesch, Matthew/GRF-0677-2022	Benesch, Matthew/0000-0002-1326-684X	Canadian Breast Cancer Foundation (CBCF); Canadian Institutes of Health Research (CIHR); Alberta Cancer Foundation; Alberta Innovates-Health Solutions (AIHS); Vanier Canada Graduate Scholarship from the government of Canada; Killam Trust award; CIHR; AIHS; CBCF; Women and Children's Health Research Institute of the University of Alberta; Ono Pharmaceuticals	Canadian Breast Cancer Foundation (CBCF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Alberta Innovates-Health Solutions (AIHS); Vanier Canada Graduate Scholarship from the government of Canada; Killam Trust award; CIHR(Canadian Institutes of Health Research (CIHR)); AIHS; CBCF; Women and Children's Health Research Institute of the University of Alberta(University of Alberta); Ono Pharmaceuticals	The authors thank W. Santos for the gift of wls-31, and R. Wolf and Cancer Research UK for supplying AREc32 cells. The work was supported by grants to D.N.B. from the Canadian Breast Cancer Foundation (CBCF), Canadian Institutes of Health Research (CIHR), with the Alberta Cancer Foundation. G.V. received a graduate studentship from Alberta Innovates-Health Solutions (AIHS). M.G.K.B. received a Vanier Canada Graduate Scholarship from the government of Canada, a Killam Trust award, and MD/PhD studentships from CIHR and AIHS. X.T. held a research fellowship from CBCF and received a salary from the Women and Children's Health Research Institute of the University of Alberta. We thank the core microscopy, flow cytometry, and histology facilities at the University of Alberta for help with analyses. The authors declare the following conflicts of interest: D.N.B. and T.P.W.M. received consulting fees from Ono Pharmaceuticals. The remaining authors declare no conflicts of interest.	An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Bhave SR, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00236; Bidard FC, 2008, CLIN CANCER RES, V14, P3306, DOI 10.1158/1078-0432.CCR-07-4749; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Braun S, 2000, J CLIN ONCOL, V18, P80, DOI 10.1200/JCO.2000.18.1.80; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cooper AB, 2007, J GASTROINTEST SURG, V11, P1628, DOI 10.1007/s11605-007-0322-9; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Euer N, 2002, ANTICANCER RES, V22, P733; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gaetano CG, 2009, MOL CARCINOGEN, V48, P801, DOI 10.1002/mc.20524; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Harrison EM, 2006, FEBS J, V273, P2345, DOI 10.1111/j.1742-4658.2006.05224.x; Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086; Hooks SB, 2001, J BIOL CHEM, V276, P4611, DOI 10.1074/jbc.M007782200; Hozumi H, 2013, LAB INVEST, V93, P508, DOI 10.1038/labinvest.2013.45; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Ji LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063404; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kehlen A, 2001, CLIN EXP IMMUNOL, V123, P147, DOI 10.1046/j.1365-2249.2001.01432.x; Krech T, 2012, CANCER LETT, V315, P153, DOI 10.1016/j.canlet.2011.09.038; Kwo P, 2007, J GASTROINTEST SURG, V11, P1634; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Lau A, 2013, ANTIOXID REDOX SIGN, V18, P91, DOI 10.1089/ars.2012.4754; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lohoff M, 1998, J CLIN INVEST, V101, P703, DOI 10.1172/JCI824; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Pilquil C, 2006, J BIOL CHEM, V281, P38418, DOI 10.1074/jbc.M601670200; Popnikolov NK, 2012, TUMOR BIOL, V33, P2237, DOI 10.1007/s13277-012-0485-1; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rojo AI, 2008, J NEUROCHEM, V105, P192, DOI 10.1111/j.1471-4159.2007.05124.x; Saga H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093230; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Samadi N, 2009, ONCOGENE, V28, P1028, DOI 10.1038/onc.2008.442; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; Shida D, 2003, CANCER RES, V63, P1706; Shim GS, 2009, FREE RADICAL BIO MED, V47, P1619, DOI 10.1016/j.freeradbiomed.2009.09.006; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Singh A, 2010, MOL CANCER THER, V9, P2365, DOI 10.1158/1535-7163.MCT-10-0108; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Su SC, 2013, CLIN CANCER RES, V19, P6461, DOI 10.1158/1078-0432.CCR-13-1284; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302	75	62	65	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					772	785		10.1096/fj.14-262659	http://dx.doi.org/10.1096/fj.14-262659			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25398768				2022-12-26	WOS:000350633000005
J	Zhang, ML; Zhu, B; Davie, J				Zhang, Meiling; Zhu, Bo; Davie, Judith			Alternative Splicing of MEF2C pre-mRNA Controls Its Activity in Normal Myogenesis and Promotes Tumorigenicity in Rhabdomyosarcoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Histone Deacetylase (HDAC); Myogenesis; Rhabdomyosarcoma (RMS); Tumor Cell Biology; Tumor Immunology; MEF2C; SRPK3	MYOCYTE ENHANCER FACTOR-2; TUMOR ALVEOLAR RHABDOMYOSARCOMA; SKELETAL-MUSCLE DIFFERENTIATION; HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MADS-BOX; HISTONE DEACETYLASES; FACTOR 2C; ACTIVATION	Background: MEF2C is an important regulator of many developmental programs. Results: Alternative splicing of the exon of MEF2C regulates myogenesis. Loss of SRPK3 in rhabdomyosarcoma cells inhibits this splicing and blocks differentiation. Conclusion: MEF2C2 promotes myogenesis, and restoration of MEF2C2 in rhabdomyosarcoma cells inhibits growth. Significance: Defining the function and deregulation of MEF2C2 enhances the understanding of normal myogenesis and RMS tumorigenesis. Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Many cellular disruptions contribute to the progression of this pediatric cancer, including aberrant alternative splicing. The MEF2 family of transcription factors regulates many developmental programs, including myogenesis. MEF2 gene transcripts are subject to alternate splicing to generate protein isoforms with divergent functions. We found that MEF2C1 was the ubiquitously expressed isoform that exhibited no myogenic activity and that MEF2C2, the muscle-specific MEF2C isoform, was required for efficient differentiation. We showed that exon in MEF2C was aberrantly alternatively spliced in RMS cells, with the ratio of 2/1 highly down-regulated in RMS cells compared with normal myoblasts. Compared with MEF2C2, MEF2C1 interacted more strongly with and recruited HDAC5 to myogenic gene promoters to repress muscle-specific genes. Overexpression of the MEF2C2 isoform in RMS cells increased myogenic activity and promoted differentiation in RMS cells. We also identified a serine protein kinase, SRPK3, that was down-regulated in RMS cells and found that expression of SRPK3 promoted the splicing of the MEF2C2 isoform and induced differentiation. Restoration of either MEF2C2 or SPRK3 inhibited both proliferation and anchorage-independent growth of RMS cells. Together, our findings indicate that the alternative splicing of MEF2C plays an important role in normal myogenesis and RMS development. An improved understanding of alternative splicing events in RMS cells will potentially reveal novel therapeutic targets for RMS treatment.	[Davie, Judith] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; So Illinois Univ, Simmons Canc Inst, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Davie, J (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, 229 Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.	jdavie@siumed.edu			NIAMS/National Institutes of Health [RAR 060017A]; American Cancer Society, Illinois Division [159609]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR060017] Funding Source: NIH RePORTER	NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Cancer Society, Illinois Division(American Cancer Society); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by NIAMS/National Institutes of Health Grant RAR 060017A. This work was also supported by Grant 159609 from the American Cancer Society, Illinois Division (to J. D.).	Ab Hakim NH, 2010, GENES CELLS, V15, P255, DOI 10.1111/j.1365-2443.2009.01378.x; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bachinski LL, 2010, MUSCLE NERVE, V42, P856, DOI 10.1002/mus.21789; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chen SL, 2000, GENE DEV, V14, P1209; D'Andrea M, 2006, J CELL PHYSIOL, V207, P379, DOI 10.1002/jcp.20585; Das S, 2014, MOL CANCER RES, V12, P1195, DOI 10.1158/1541-7786.MCR-14-0131; Davie JK, 2007, DEV BIOL, V311, P650, DOI 10.1016/j.ydbio.2007.08.014; Dodou E, 1997, MOL CELL BIOL, V17, P1848, DOI 10.1128/MCB.17.4.1848; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Du SY, 2005, INT J CANCER, V115, P85, DOI 10.1002/ijc.20844; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Infantino V, 2013, GENE, V531, P355, DOI 10.1016/j.gene.2013.08.044; Jacob AG, 2013, NEOPLASIA, V15, P1049, DOI 10.1593/neo.13286; Kablar B, 2000, HISTOL HISTOPATHOL, V15, P649, DOI 10.14670/HH-15.649; Kalsotra A, 2014, CELL REP, V6, P336, DOI 10.1016/j.celrep.2013.12.025; Kasukawa Y, 2002, J BONE MINER RES, V17, P1579, DOI 10.1359/jbmr.2002.17.9.1579; Keller C, 2013, FEBS J, V280, P4323, DOI 10.1111/febs.12421; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; MacQuarrie KL, 2013, MOL CELL BIOL, V33, P773, DOI 10.1128/MCB.00916-12; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Nadruz W, 2003, CIRC RES, V92, P243, DOI 10.1161/01.RES.0000053184.94618.97; Nakagawa O, 2005, GENE DEV, V19, P2066, DOI 10.1101/gad.1338705; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sartori F, 2006, CANCER, V106, P1766, DOI 10.1002/cncr.21772; Sebastian S, 2013, GENE DEV, V27, P1247, DOI 10.1101/gad.215400.113; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang ML, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-150; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004; Zhu B, 2014, INT J CANCER, V135, P785, DOI 10.1002/ijc.28721	54	43	43	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					310	324		10.1074/jbc.M114.606277	http://dx.doi.org/10.1074/jbc.M114.606277			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404735	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000347231200028
J	Bosse, JT; Soares-Bazzolli, DM; Li, YW; Wren, BW; Tucker, AW; Maskell, DJ; Rycroft, AN; Langford, PR				Bosse, Janine T.; Soares-Bazzolli, Denise M.; Li, Yanwen; Wren, Brendan W.; Tucker, Alexander W.; Maskell, Duncan J.; Rycroft, Andrew N.; Langford, Paul R.		BRaDP1T Consortium	The Generation of Successive Unmarked Mutations and Chromosomal Insertion of Heterologous Genes in Actinobacillus pleuropneumoniae Using Natural Transformation	PLOS ONE			English	Article							SUCROSE SENSITIVITY MARKER; BIOFILM FORMATION; HAEMOPHILUS-INFLUENZAE; GENOME SEQUENCE; UREASE ACTIVITY; COMPETENCE; INFECTION; VIRULENCE; PASTEURELLACEAE; DELETION	We have developed a simple method of generating scarless, unmarked mutations in Actinobacillus pleuropneumoniae by exploiting the ability of this bacterium to undergo natural transformation, and with no need to introduce plasmids encoding recombinases or resolvases. This method involves two successive rounds of natural transformation using linear DNA: the first introduces a cassette carrying cat (which allows selection by chloramphenicol) and sacB (which allows counter-selection using sucrose) flanked by sequences to either side of the target gene; the second transformation utilises the flanking sequences ligated directly to each other in order to remove the cat-sacB cassette. In order to ensure efficient uptake of the target DNA during transformation, A. pleuropneumoniae uptake sequences are added into the constructs used in both rounds of transformation. This method can be used to generate multiple successive deletions and can also be used to introduce targeted point mutations or insertions of heterologous genes into the A. pleuropneumoniae chromosome for development of live attenuated vaccine strains. So far, we have applied this method to highly transformable isolates of serovars 8 (MIDG2331), which is the most prevalent in the UK, and 15 (HS143). By screening clinical isolates of other serovars, it should be possible to identify other amenable strains.	[Bosse, Janine T.; Soares-Bazzolli, Denise M.; Li, Yanwen; Langford, Paul R.] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London, England; [Soares-Bazzolli, Denise M.] Univ Fed Vicosa, Lab Genet Mol Microorganismos, Dept Microbiol, DMB,BIOAGRO, Vicosa, MG, Brazil; [Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Tucker, Alexander W.; Maskell, Duncan J.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Rycroft, Andrew N.] Royal Vet Coll, Dept Pathol & Pathogen Biol, Hatfield, Herts, England	Imperial College London; Universidade Federal de Vicosa; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of London; University of London Royal Veterinary College	Bosse, JT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Paediat Sect, St Marys Campus, London, England.	j.bosse@imperial.ac.uk	Langford, Paul/AAU-4189-2020; Chaudhuri, Roy/E-3774-2014	Langford, Paul/0000-0002-6368-4724; Chaudhuri, Roy/0000-0001-5037-2695; Tucker, Alexander William/0000-0003-0062-0843; Maglennon, Gareth/0000-0001-9783-7269; Bosse, Janine/0000-0002-8491-4779	Biotechnology and Biological Sciences Research Council [BB/G020744/1, BB/G019177/1, BB/G019274/1, BB/G018553/1]; UK Department for Environment, Food and Rural Affairs; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [PDE 201840/2011-1]; BBSRC Imperial-Brazil partnering award [BB/K021109/1]; Zoetis; BBSRC [BB/G020744/1, BB/G018553/1, BB/G019274/1, BB/K021109/1, BB/G019177/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K021109/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC Imperial-Brazil partnering award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Longer and Larger (LoLa) grant from the Biotechnology and Biological Sciences Research Council (grant numbers BB/G020744/1, BB/G019177/1, BB/G019274/1 and BB/G018553/1), the UK Department for Environment, Food and Rural Affairs, and Zoetis (formerly Pfizer Animal Health) awarded to the Bacterial Respiratory Diseases of Pigs-1 Technology (BRaDP1T) consortium, a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant number PDE 201840/2011-1) awarded to DMSB, and a BBSRC Imperial-Brazil partnering award (BB/K021109/1) awarded to PRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali T, 2008, INFECT IMMUN, V76, P5608, DOI 10.1128/IAI.00085-08; Baltes N, 2005, INFECT IMMUN, V73, P4614, DOI 10.1128/IAI.73.8.4614-4619.2005; Baltes N, 2004, VET MICROBIOL, V102, P67, DOI 10.1016/j.vetmic.2004.05.002; Baltes N, 2003, FEMS MICROBIOL LETT, V220, P41, DOI 10.1016/S0378-1097(03)00064-8; Baltes N, 2003, INFECT IMMUN, V71, P6784, DOI 10.1128/IAI.71.12.6784-6792.2003; Baltes N, 2001, INFECT IMMUN, V69, P472, DOI 10.1128/IAI.69.1.472-478.2001; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Bosse JT, 2010, J BACTERIOL, V192, P2414, DOI 10.1128/JB.01513-09; Bosse JT, 2009, APPL ENVIRON MICROB, V75, P6124, DOI 10.1128/AEM.00809-09; Bosse JT, 2009, FEMS MICROBIOL LETT, V298, P124, DOI 10.1111/j.1574-6968.2009.01706.x; Bosse JT, 2004, FEMS MICROBIOL LETT, V233, P277, DOI 10.1111/j.1574-6968.2004.tb09492.x; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bosse JT, 2001, J BACTERIOL, V183, P1242, DOI 10.1128/JB.183.4.1242-1247.2001; Buettner FFR, 2008, VET MICROBIOL, V127, P106, DOI 10.1016/j.vetmic.2007.08.005; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; Foote SJ, 2008, J BACTERIOL, V190, P1495, DOI 10.1128/JB.01845-07; Fung WWM, 2006, J CLIN MICROBIOL, V44, P4222, DOI 10.1128/JCM.01376-06; Gottschalk M, 2006, DIS SWINE, P563; INZANA TJ, 1993, INFECT IMMUN, V61, P1682, DOI 10.1128/IAI.61.5.1682-1686.1993; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Jacobsen I, 2005, INFECT IMMUN, V73, P3740, DOI 10.1128/IAI.73.6.3740-3744.2005; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; JANSEN R, 1995, INFECT IMMUN, V63, P27, DOI 10.1128/IAI.63.1.27-37.1995; Jones RM, 2003, APPL ENVIRON MICROB, V69, P5627, DOI 10.1128/AEM.69.9.5627-5635.2003; Li G, 2012, J BACTERIOL, V194, P6606, DOI 10.1128/JB.01650-12; Lin LW, 2007, FEMS MICROBIOL LETT, V274, P55, DOI 10.1111/j.1574-6968.2007.00813.x; Maas A, 2006, VACCINE, V24, P7226, DOI 10.1016/j.vaccine.2006.06.047; Maas A, 2006, INFECT IMMUN, V74, P4124, DOI 10.1128/IAI.00133-06; Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x; Mullen LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003991; O'Neill C, 2010, VET REC, V167, P661, DOI 10.1136/vr.c5106; Oswald W, 1999, FEMS MICROBIOL LETT, V179, P153, DOI 10.1111/j.1574-6968.1999.tb08721.x; Ramjeet Mahendrasingh, 2008, Animal Health Research Reviews, V9, P25, DOI 10.1017/S1466252307001338; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Tonpitak W, 2002, INFECT IMMUN, V70, P7120, DOI 10.1128/IAI.70.12.7120-7125.2002; Tonpitak W, 2000, INFECT IMMUN, V68, P1164, DOI 10.1128/IAI.68.3.1164-1170.2000; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10; Zhan BJ, 2010, J BACTERIOL, V192, P5846, DOI 10.1128/JB.00867-10	39	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111252	10.1371/journal.pone.0111252	http://dx.doi.org/10.1371/journal.pone.0111252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409017	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200003
J	Yin, ZW; Li, LZ				Yin, Zi-Wei; Li, Li-Zhen			Description of Bryantinus gen. n. from Sarawak, and New Distributional Records for Cerochusa cilioceps in Thailand (Coleoptera: Staphylinidae: Pselaphinae)	PLOS ONE			English	Article							BORNEO	A new genus and species of the subtribe Batrisina from western Sarawak, Bryantinus matangus gen. et sp. n., is described, illustrated, and compared with related taxa. In addition, examination of a small series of batrisine material from Thailand revealed a new country record for Cerochusa cilioceps Yin & Nomura, which was previously known only from the island of Hainan in southern China.	[Yin, Zi-Wei; Li, Li-Zhen] Shanghai Normal Univ, Coll Life & Environm Sci, Dept Biol, Shanghai, Peoples R China	Shanghai Normal University	Li, LZ (corresponding author), Shanghai Normal Univ, Coll Life & Environm Sci, Dept Biol, Shanghai, Peoples R China.	pselaphinae@gmail.com			National Science Foundation of China [31172134]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (No. 31172134). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutel RG, 2005, COLEOPTERA BEETLES V, V1, P35, DOI [10.1515/9783110904550, DOI 10.1515/9783110904550]; Chandler D.S., 1990, P1175; Chandler D.S., 2001, MEMOIRS ENTOMOLOGY I, V15, P1; Chandler DS, 2000, GUIA ILLUSTRADA GENE, P49; Chandler DS, 1997, AGR HDB, V529-31; Jeannel R, 1962, BIOL AMERIQUE AUSTRA, P295; Kurbatov S, 2007, RUSSIAN ENTOMOLOGICA, V16, P275; Lobl I., 1973, Revue Suisse de Zoologie, V80, P151; LOBL I, 1975, Revue Suisse de Zoologie, V82, P563; LOBL I, 1979, REV SUISSE ZOOL, V86, P285; Lobl I., 2004, CATALOGUE PALAEARCTI, V2; Newton AF, 1995, BIOL PHYLOGENY CLASS, V1, P219; Nomura S., 2003, Serangga, V8, P55; Nomura S, 2000, TAXONOMICAL STUDIES; Nomura S, 2008, INSECT INVENTORY PRO, P253; Nomura Shuhei, 2013, Japanese Journal of Systematic Entomology, V19, P233; Nomura Shuhei, 2005, Serangga, V10, P1; Nomura Shuhei, 2008, Memoirs of the National Science Museum (Tokyo), P13; Park O., 1942, NW U STUDIES BIOL SC, V1, P1, DOI [10.5962/bhl.title.6838, DOI 10.5962/BHL.TITLE.6838]; PARK ORLANDO, 1952, CHICAGO ACAD SCI SPEC PUBL, V9, P1; Raffray A., 1894, REV ENTOMOLOGIE, V13, P197; Raffray A, 1890, REV ENTOMOLOGIE, V9, P1; Thomas, 2000, AM BEETLES, P272, DOI DOI 10.5860/CHOICE.38-5558; Yin ZW, 2012, ZOOTAXA, P62; Yin ZW, 2014, REV SUISSE ZOOL, V121, P11; Yin ZW, 2013, ZOOTAXA, V3718, P477, DOI 10.11646/zootaxa.3718.5.4	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113474	10.1371/journal.pone.0113474	http://dx.doi.org/10.1371/journal.pone.0113474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409318	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200125
J	Chen, MX; Wu, LD; Wu, F; Wittert, GA; Norman, RJ; Robker, RL; Heilbronn, LK				Chen, Miaoxin; Wu, Linda; Wu, Fang; Wittert, Gary A.; Norman, Robert J.; Robker, Rebecca L.; Heilbronn, Leonie K.			Impaired Glucose Metabolism in Response to High Fat Diet in Female Mice Conceived by In Vitro Fertilization (IVF) or Ovarian Stimulation Alone	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; BIRTH-WEIGHT; CHILDREN BORN; PREIMPLANTATION PERIOD; SECRETORY DYSFUNCTION; ASSISTED REPRODUCTION; VASCULAR DYSFUNCTION; INSULIN-RESISTANCE; EMBRYO DEVELOPMENT; ENERGY-METABOLISM	Individuals conceived by in vitro fertilization (IVF) may be at increased risk of cardio-metabolic disorders. We recently reported that IVF conceived male mice displayed impaired glucose metabolism at normal and high body weights. In this study, we examined glucose metabolism in mature female C57BL/6J mice that were conceived by natural conception (NC), by ovarian stimulation (OS) or by IVF following chow or high-fat diet (HFD) for 8 weeks. By design, litter size was comparable between groups, but interestingly the birth weight of IVF and OS females was lower than NC females (p <= 0.001). Mature IVF female mice displayed increased fasting glucose as compared to NC and OS mice, irrespective of diet. Mature IVF and OS mice were also more susceptible to the metabolic consequences of high fat diet as compared with NC females, with impaired glucose tolerance (p <= 0.01), whereas peripheral insulin resistance and increased hepatic expression of gluconeogenic genes Ppargc1 alpha, Pck1 and G6pc was observed in IVF mice only (p<0.05). This study suggests that ovarian stimulation alone and IVF program distinct metabolic effects in females, but that high fat diet may be required to unmask these effects. This study adds to the growing body of literature that assisted reproduction procedures may increase the risk of developing type 2 diabetes in an obesity prone environment.	[Chen, Miaoxin; Wu, Linda; Norman, Robert J.; Robker, Rebecca L.; Heilbronn, Leonie K.] Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Chen, Miaoxin] Guiyang Med Coll, Affiliated Hosp, Dept Obstet & Gynaecol, Guiyang 550004, Peoples R China; [Chen, Miaoxin; Wu, Fang; Wittert, Gary A.; Heilbronn, Leonie K.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia; [Wu, Fang] Guiyang Med Coll, Affiliated Hosp, Dept Emergency, Guiyang 550004, Peoples R China	Robinson Research Institute; University of Adelaide; Guizhou Medical University; University of Adelaide; Guizhou Medical University	Heilbronn, LK (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia.	leonie.heilbronn@adelaide.edu.au	wittert, gary/AAE-2398-2019; Norman, Robert J/A-1155-2007; Heilbronn, Leonie/H-1874-2013	Norman, Robert J/0000-0002-3118-3896; Robker, Rebecca/0000-0002-1538-4604; Heilbronn, Leonie/0000-0003-2106-7303; Wittert, Gary/0000-0001-6818-6065	ARC Future Fellowship [FT120100027]	ARC Future Fellowship(Australian Research Council)	This work and LH was supported by ARC Future Fellowship FT120100027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Aiken CEM, 2008, REPROD BIOMED ONLINE, V17, P806, DOI 10.1016/S1472-6483(10)60409-9; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; Bermejo-Alvarez P, 2011, REPRODUCTION, V141, P563, DOI 10.1530/REP-10-0482; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Ceelen M, 2007, J CLIN ENDOCR METAB, V92, P3417, DOI 10.1210/jc.2006-2896; Ceelen M, 2009, HUM REPROD, V24, P2788, DOI 10.1093/humrep/dep273; Chen M, 2012, J DIABETES RES CLIN, V1, P16, DOI [DOI 10.7243/2050-0866-1-16, 10.7243/2050-0866-1-16]; Chen MX, 2014, DIABETES, V63, P3189, DOI 10.2337/db14-0103; Chen MX, 2011, CURR DIABETES REV, V7, P426, DOI 10.2174/157339911797579151; Crescenzo R, 2003, DIABETES, V52, P1090, DOI 10.2337/diabetes.52.5.1090; D'Angelo DV, 2011, FERTIL STERIL, V96, P314, DOI 10.1016/j.fertnstert.2011.05.073; Donjacour A, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113134; Edwards LJ, 2002, AM J PHYSIOL-REG I, V283, pR669, DOI 10.1152/ajpregu.00736.2001; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Ertzeid G, 2001, HUM REPROD, V16, P221, DOI 10.1093/humrep/16.2.221; ERTZEID G, 1992, J REPROD FERTIL, V96, P649, DOI 10.1530/jrf.0.0960649; Feuer SK, 2014, ENDOCRINOLOGY, V155, P1956, DOI 10.1210/en.2013-2081; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; Gardner DS, 2004, HYPERTENSION, V43, P1290, DOI 10.1161/01.HYP.0000126991.67203.7b; Gaudoin M, 2003, AM J OBSTET GYNECOL, V188, P611, DOI 10.1067/mob.2003.5; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Kelley RL, 2006, AM J PHYSIOL-ENDOC M, V291, pE761, DOI 10.1152/ajpendo.00079.2006; Klemetti R, 2010, FERTIL STERIL, V93, P1157, DOI 10.1016/j.fertnstert.2008.12.025; Kwong WY, 2007, MOL REPROD DEV, V74, P48, DOI 10.1002/mrd.20606; Kwong WY, 2000, DEVELOPMENT, V127, P4195; La Bastide-Van Gemert S, 2014, HUM REPROD, V29, P510, DOI 10.1093/humrep/det448; Le F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106070; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MITTWOCH U, 1993, HUM REPROD, V8, P1550, DOI 10.1093/oxfordjournals.humrep.a137889; Nagy A., 2003, MANIPULATING MOUSE E; Ombelet W, 2006, HUM REPROD, V21, P1025, DOI 10.1093/humrep/dei419; Ong KK, 2004, EUR J ENDOCRINOL, V151, pU131, DOI 10.1530/eje.0.151U131; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Pelinck MJ, 2010, REPROD BIOMED ONLINE, V21, P245, DOI 10.1016/j.rbmo.2010.04.024; Pelkonen S, 2010, HUM REPROD, V25, P914, DOI 10.1093/humrep/dep477; Pinborg A, 2013, HUM REPROD UPDATE, V19, P87, DOI 10.1093/humupd/dms044; Pinborg A, 2010, FERTIL STERIL, V94, P1320, DOI 10.1016/j.fertnstert.2009.05.091; Rexhaj E, 2013, J CLIN INVEST, V123, P5052, DOI 10.1172/JCI68943; Sakka SD, 2010, FERTIL STERIL, V94, P1693, DOI 10.1016/j.fertnstert.2009.09.049; Santos MA, 2010, REPRODUCTION, V139, P23, DOI 10.1530/REP-09-0187; Scherrer U, 2012, CIRCULATION, V125, P1890, DOI 10.1161/CIRCULATIONAHA.111.071183; Scott KA, 2010, BIOL REPROD, V83, P220, DOI 10.1095/biolreprod.109.082826; Van der Auwera I, 2001, HUM REPROD, V16, P1237, DOI 10.1093/humrep/16.6.1237; Van der Auwera I, 1999, HUM REPROD, V14, P2570, DOI 10.1093/humrep/14.10.2570; Wander PL, 2013, DIABETES CARE, V36, P289, DOI 10.2337/dc12-0198; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Wu LDL, 2012, MOL ENDOCRINOL, V26, P562, DOI 10.1210/me.2011-1362; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	62	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113155	10.1371/journal.pone.0113155	http://dx.doi.org/10.1371/journal.pone.0113155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405530	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300088
J	Kravchenko-Balasha, N; Simon, S; Levine, RD; Remacle, F; Exman, I				Kravchenko-Balasha, Nataly; Simon, Simcha; Levine, R. D.; Remacle, F.; Exman, Iaakov			Computational Surprisal Analysis Speeds-Up Genomic Characterization of Cancer Processes	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; INFORMATION; EXPRESSION	Surprisal analysis is increasingly being applied for the examination of transcription levels in cellular processes, towards revealing inner network structures and predicting response. But to achieve its full potential, surprisal analysis should be integrated into a wider range computational tool. The purposes of this paper are to combine surprisal analysis with other important computation procedures, such as easy manipulation of the analysis results - e.g. to choose desirable result subsets for further inspection -, retrieval and comparison with relevant datasets from public databases, and flexible graphical displays for heuristic thinking. The whole set of computation procedures integrated into a single practical tool is what we call Computational Surprisal Analysis. This combined kind of analysis should facilitate significantly quantitative understanding of different cellular processes for researchers, including applications in proteomics and metabolomics. Beyond that, our vision is that Computational Surprisal Analysis has the potential to reach the status of a routine method of analysis for practitioners. The resolving power of Computational Surprisal Analysis is here demonstrated by its application to a variety of cellular cancer process transcription datasets, ours and from the literature. The results provide a compact biological picture of the thermodynamic significance of the leading gene expression phenotypes in every stage of the disease. For each transcript we characterize both its inherent steady state weight, its correlation with the other transcripts and its variation due to the disease. We present a dedicated website to facilitate the analysis for researchers and practitioners.	[Kravchenko-Balasha, Nataly] CALTECH, Div Chem, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA; [Simon, Simcha; Exman, Iaakov] Azrieli, Jerusalem Coll Engn, Software Engn Dept, Jerusalem, Israel; [Levine, R. D.; Remacle, F.] Hebrew Univ Jerusalem, Inst Chem, Jerusalem, Israel; [Levine, R. D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Remacle, F.] Univ Liege, Dept Chim, Liege, Belgium	California Institute of Technology; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Liege	Exman, I (corresponding author), Azrieli, Jerusalem Coll Engn, Software Engn Dept, Jerusalem, Israel.	iaakov@jce.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479; Remacle, Francoise/0000-0001-7434-5245	EMBO postdoctoral fellowship; European Commission FP7 Future and Emerging Technologies- Open Project BAMBI [618024]	EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); European Commission FP7 Future and Emerging Technologies- Open Project BAMBI	This work was supported by an EMBO postdoctoral fellowship to N.K.B. and European Commission FP7 Future and Emerging Technologies- Open Project BAMBI 618024 (to FR and RDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057748; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Exman I, 2013, ICSOFT 2012 COMMUNIC, V411, P203, DOI DOI 10.1007/978-3-642-45404-2_; Exman I, 2012, COMPUTATIONAL SURPRI; Facciotti MT, 2013, P NATL ACAD SCI USA, V110, P19181, DOI 10.1073/pnas.1317876110; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gamma E., 1994, DESIGN PATTERNS ELEM; Gross A, 2013, BIOCHEMISTRY-US, V52, P1641, DOI 10.1021/bi3016982; Kravchenko-Balasha N, 2012, P NATL ACAD SCI USA, V109, P4702, DOI 10.1073/pnas.1200790109; Kravchenko-Balasha N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-42; Kravchenko-Balasha N, 2011, MOL BIOSYST, V7, P1501, DOI 10.1039/c0mb00284d; Kravchenko-Balasha N, 2009, J BIOL CHEM, V284, P11717, DOI 10.1074/jbc.M900217200; Laidler KJ, 1996, PURE APPL CHEM, V68, P149, DOI 10.1351/pac199668010149; LEVINE RD, 1978, ANNU REV PHYS CHEM, V29, P59, DOI 10.1146/annurev.pc.29.100178.000423; LEVINE RD, 1974, ACCOUNTS CHEM RES, V7, P393, DOI 10.1021/ar50084a001; LEVINE RD, 1980, J PHYS A-MATH GEN, V13, P91, DOI 10.1088/0305-4470/13/1/011; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880; Minner S, 2012, CANCER-AM CANCER SOC, V118, P1268, DOI 10.1002/cncr.26436; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Remacle F, 2010, P NATL ACAD SCI USA, V107, P10324, DOI 10.1073/pnas.1005283107; Simon S, 2012, THESIS JERUSALEM COL; Stickel JS, 2009, CANCER IMMUNOL IMMUN, V58, P1407, DOI 10.1007/s00262-008-0655-6; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Walther MM, 1998, J UROLOGY, V159, P718, DOI 10.1016/S0022-5347(01)63709-1; Weisstein EW, 2013, SINGULAR VALUE DECOM; Zadran S, 2013, P NATL ACAD SCI US	27	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e108549	10.1371/journal.pone.0108549	http://dx.doi.org/10.1371/journal.pone.0108549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405334	Green Published, gold, Green Accepted			2022-12-26	WOS:000347121300003
J	Yang, H; Ye, EL; Si, GX; Chen, LM; Cai, LQ; Ye, CF; Zhang, C; Lu, XM				Yang, Hong; Ye, Enling; Si, Guangxin; Chen, Liangmiao; Cai, Lingqiao; Ye, Chengfu; Zhang, Chi; Lu, Xuemian			Adiponectin Gene Polymorphism rs2241766 T/G Is Associated with Response to Pioglitazone Treatment in Type 2 Diabetic Patients from Southern China	PLOS ONE			English	Article							IRANIAN POPULATION RELATION; INSULIN-RESISTANCE; OBESITY	Introduction: Insulin sensitizing drugs such as pioglitazone are not uniformly treatment effective among individual type 2 diabetic patients. Here, the relationship of pioglitazone efficacy to single nucleotide polymorphisms (SNP) of the adiponectin gene, a critical gene directly regulated by the drug, was examined in a cohort of Chinese Han type 2 diabetic patients. Methods: Eighty type 2 diabetic patients were treated with pioglitazone (15 mg/day) for 12 weeks without interruption of their current therapeutic regimen. Fasting plasma glucose, fasting insulin, homeostasis model assessment for insulin resistance (HOMA-IR), and glycated hemoglobin (HbA1c%) were collected both prior to and following pioglitazone treatment. Response to pioglitazone was defined as a decrease of at least 15% in HbA1c% levels. Three regions of the adiponectin gene containing SNPs (promoter, intron 2 and exon 2, and exon 3) were amplified and sequenced to determine genotype. Results: Serum adiponectin levels were significantly increased (p<0.001) whereas fasting plasma glucose, fasting insulin, HOMA-IR, and HbA1c% values were significantly decreased relative to baseline measurements (p<0.001). Response of patients with TG and TT genotypes at rs2241766 (exon2; 52.9% vs. 12.7%, respectively p = 0.001) was statistically significant relative to all other patients. Amongst rs2241766 TG and TT patients, the mean decrease in HbA1c% levels was greater where the genotype was TG (1.15 +/- 0.80 vs. 0.52 +/- 0.64, p = 0.001). Conclusions: The adiponectin gene polymorphism rs2241766 T/G is associated with pioglitazone efficacy in type 2 diabetic patients, and status of the polymorphism may be an important clinical factor to consider prior to pioglitazone treatment.	[Yang, Hong; Ye, Enling; Chen, Liangmiao; Cai, Lingqiao; Ye, Chengfu; Lu, Xuemian] Wenzhou Med Univ, Dept Endocrinol, Hosp 3, Ruian, Zhejiang, Peoples R China; [Yang, Hong; Ye, Enling; Chen, Liangmiao; Cai, Lingqiao; Ye, Chengfu; Zhang, Chi; Lu, Xuemian] Wenzhou Med Univ, Affiliated Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian Ctr, Wenzhou, Peoples R China; [Si, Guangxin] Shangdong Jining 1 Peoples Hosp, Dept Endocrinol, Jining, Shangdong, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Lu, XM (corresponding author), Wenzhou Med Univ, Dept Endocrinol, Hosp 3, Ruian, Zhejiang, Peoples R China.	lu89118@medmail.com.cn	Cai, Lu/AAG-9920-2019		Wenzhou Science and Technology Plan [Y20080007]	Wenzhou Science and Technology Plan	This study was supported by a research grant from the Wenzhou Science and Technology Plan (Y20080007, to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji Vijayam, 2013, Indian J Endocrinol Metab, V17, P709, DOI 10.4103/2230-8210.113766; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bin Alwi Z, 2005, MALAYS J MED SCI, V12, P4; Bouatia-Naji N, 2006, DIABETES, V55, P545, DOI 10.2337/diabetes.55.02.06.db05-0971; Daien CI, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/386148; Derosa G, 2007, VASC HEALTH RISK MAN, V3, P665; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; Hasani-Ranjbar S, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-14; Hayes DF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-37; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Li Z, 2008, DIABETES OBES METAB, V10, P794, DOI 10.1111/j.1463-1326.2008.00905.x; Menzaghi C, 2002, DIABETES, V51, P2306, DOI 10.2337/diabetes.51.7.2306; Namvaran F, 2012, MOL BIOL REP, V39, P5511, DOI 10.1007/s11033-011-1354-5; Namvaran F, 2011, EUR J PHARMACOL, V671, P1, DOI 10.1016/j.ejphar.2011.09.158; Perez A, 2009, CURR MED RES OPIN, V25, P2915, DOI 10.1185/03007990903350011; Schwarz PEH, 2006, DIABETES CARE, V29, P1645, DOI 10.2337/dc05-2123; Subbaramaiah K, 2012, CANCER PREV RES, V5, P1183, DOI 10.1158/1940-6207.CAPR-12-0201; Takahashi M, 2000, INT J OBESITY, V24, P861, DOI 10.1038/sj.ijo.0801244; Yang WS, 2007, AM J CLIN NUTR, V86, P509, DOI 10.1093/ajcn/86.2.509; Ye EL, 2014, LIFE SCI, V98, P55, DOI 10.1016/j.lfs.2013.12.232	20	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112480	10.1371/journal.pone.0112480	http://dx.doi.org/10.1371/journal.pone.0112480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405601	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300033
J	Garde, A; Dehkordi, P; Karlen, W; Wensley, D; Ansermino, JM; Dumont, GA				Garde, Ainara; Dehkordi, Parastoo; Karlen, Walter; Wensley, David; Ansermino, J. Mark; Dumont, Guy A.			Development of a Screening Tool for Sleep Disordered Breathing in Children Using the Phone Oximeter (TM)	PLOS ONE			English	Article							BLOOD-OXYGEN SATURATION; PULSE-RATE VARIABILITY; APNEA; ADENOTONSILLECTOMY; POLYSOMNOGRAPHY; OXIMETRY; DIAGNOSIS; OUTCOMES; SIGNAL; HOME	Background: Sleep disordered breathing (SDB) can lead to daytime sleepiness, growth failure and developmental delay in children. Polysomnography (PSG), the gold standard to diagnose SDB, is a highly resource-intensive test, confined to the sleep laboratory. Aim: To combine the blood oxygen saturation (SpO(2)) characterization and cardiac modulation, quantified by pulse rate variability (PRV), to identify children with SDB using the Phone Oximeter, a device integrating a pulse oximeter with a smartphone. Methods: Following ethics approval and informed consent, 160 children referred to British Columbia Children's Hospital for overnight PSG were recruited. A second pulse oximeter sensor applied to the finger adjacent to the one used for standard alongside the PSG. Results: We studied 146 children through the analysis of the SpO(2) pattern, and PRV as an estimate of heart rate variability calculated from the PPG. SpO(2) variability and SpO(2) spectral power at low frequency, was significantly higher in children with SDB due to the modulation provoked by airway obstruction during sleep (p-value <0:01). PRV analysis reflected a significant augmentation of sympathetic activity provoked by intermittent hypoxia in SDB children. A linear classifier was trained with the most discriminating features to identify children with SDB. The classifier was validated with internal and external cross-validation, providing a high negative predictive value (92.6%) and a good balance between sensitivity (88.4%) and specificity (83.6%). Combining SpO(2) and PRV analysis improved the classification performance, providing an area under the receiver operating characteristic curve of 88%, beyond the 82% achieved using SpO(2) analysis alone. Conclusions: These results demonstrate that the implementation of this algorithm in the Phone Oximeter will provide an improved portable, at-home screening tool, with the capability of monitoring patients over multiple nights.	[Garde, Ainara; Dehkordi, Parastoo; Karlen, Walter; Ansermino, J. Mark; Dumont, Guy A.] Univ British Columbia, Elect & Comp Engn Med Grp, Vancouver, BC V5Z 1M9, Canada; [Garde, Ainara; Dehkordi, Parastoo; Karlen, Walter; Wensley, David; Ansermino, J. Mark; Dumont, Guy A.] BC Childrens Hosp, Vancouver, BC, Canada; [Ansermino, J. Mark] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wensley, David] Univ British Columbia, Div Crit Care, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of British Columbia	Garde, A (corresponding author), Univ British Columbia, Elect & Comp Engn Med Grp, Vancouver, BC V5Z 1M9, Canada.	ainara.garde@cw.bc.ca	Karlen, Walter/C-6290-2008; Garde, Ainara/J-9442-2017; Karlen, Walter/AAN-9397-2020	Karlen, Walter/0000-0001-8643-3074; Garde, Ainara/0000-0002-9503-6908; Karlen, Walter/0000-0001-8643-3074; Ansermino, J Mark/0000-0001-8427-2035; Dumont, Guy/0000-0003-2048-4391; Wensley, David/0000-0001-7228-4274	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research through the Collaborative Health Research Projects program [NSERC-CHRP 395100-11]; Child and Family Research Institute at the University of British Columbia through a Postdoctoral Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research through the Collaborative Health Research Projects program(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute at the University of British Columbia through a Postdoctoral Fellowship	This work was supported in part by The Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca), the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) through the Collaborative Health Research Projects program (NSERC-CHRP 395100-11), and the Child and Family Research Institute at the University of British Columbia through a Postdoctoral Fellowship (www.cfri.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarez D, 2006, PHYSIOL MEAS, V27, P399, DOI 10.1088/0967-3334/27/4/006; Alvarez D, 2007, ARTIF INTELL MED, V41, P13, DOI 10.1016/j.artmed.2007.06.002; Alvarez D, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500202; Alvarez D, 2010, IEEE T BIO-MED ENG, V57, P2816, DOI 10.1109/TBME.2010.2056924; BERGER RD, 1986, IEEE T BIO-MED ENG, V33, P900, DOI 10.1109/TBME.1986.325789; Bhattacharjee R, 2010, AM J RESP CRIT CARE, V182, P676, DOI 10.1164/rccm.200912-1930OC; Chervin RD, 1999, ANN INTERN MED, V130, P496, DOI 10.7326/0003-4819-130-6-199903160-00006; Chouchou F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086434; Chung F, 2012, ANESTH ANALG, V114, P993, DOI 10.1213/ANE.0b013e318248f4f5; de Chazal P, 2009, PHILOS T R SOC A, V367, P369, DOI 10.1098/rsta.2008.0156; Dehkordi P, 2013, COMPUTING C IN PRESS; Dehkordi P, 2013, IEEE ENG MED BIO, P6563, DOI 10.1109/EMBC.2013.6611059; Deutsch PA, 2006, J CLIN SLEEP MED, V2, P145; Garde A, 2014, IEEE ENG MED BIO, P2257; Garde A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086427; Garde A, 2013, IEEE ENG MED BIO, P2531, DOI 10.1109/EMBC.2013.6610055; Garde A, 2010, IEEE T BIO-MED ENG, V57, P1964, DOI 10.1109/TBME.2010.2044176; Gil E, 2010, PHYSIOL MEAS, V31, P1271, DOI 10.1088/0967-3334/31/9/015; Gil E, 2010, IEEE T BIO-MED ENG, V57, P1079, DOI 10.1109/TBME.2009.2037734; Gil E, 2009, IEEE T BIO-MED ENG, V56, P1005, DOI 10.1109/TBME.2008.2009340; Heneghan C, 2008, SLEEP, V31, P1432; Horwood L, 2014, JAMA OTOLARYNGO 0522; Huang YS, 2014, SLEEP, V37, P71, DOI 10.5665/sleep.3310; Hudson J, 2012, ANAESTHESIA, V67, P957, DOI 10.1111/j.1365-2044.2012.07196.x; Iber C, 2007, AASM MANUAL SCORING; Johnson EO, 2006, SLEEP, V29, P1135, DOI 10.1093/sleep/29.9.1135; Kang KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078666; Karlen W, 2012, PHYSIOL MEAS, V33, P1617, DOI 10.1088/0967-3334/33/10/1617; Karlen W, 2011, HEALTHINF 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P433; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lazaro J, 2014, IEEE J BIOMED HEALTH, V18, P240, DOI 10.1109/JBHI.2013.2267096; Marcus CL, 2013, NEW ENGL J MED, V368, P2366, DOI 10.1056/NEJMoa1215881; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; Marcus CL, 2002, PEDIATRICS, V109, P704; Medical Services Commission of British Columbia, 2013, RESPIROLOGY; Montesano M, 2010, SLEEP, V33, P1349, DOI 10.1093/sleep/33.10.1349; Nixon GM, 2004, PEDIATRICS, V113, pE19, DOI 10.1542/peds.113.1.e19; Petersen CL, 2013, SENSORS-BASEL, V13, P16882, DOI 10.3390/s131216882; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; Sinha D, 2010, INDIAN J MED RES, V131, P311; Stats BC, 2014, 2013 SUBPROVINCIAL P; Wildhaber JH, 2007, SWISS MED WKLY, V137, P689, DOI 2007/49/smw-11986; Zhao J, 2011, EUR J PEDIATR, V170, P1097, DOI 10.1007/s00431-011-1409-6	44	89	90	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112959	10.1371/journal.pone.0112959	http://dx.doi.org/10.1371/journal.pone.0112959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401696	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700086
J	Li, JL; Li, N; Li, FC; Zou, T; Yu, SX; Wang, YC; Qin, S; Wang, GY				Li, Jialin; Li, Nan; Li, Fuchao; Zou, Tao; Yu, Shuxian; Wang, Yinchu; Qin, Song; Wang, Guangyi			Spatial Diversity of Bacterioplankton Communities in Surface Water of Northern South China Sea	PLOS ONE			English	Article							PHYTOPLANKTON GROWTH; NUTRIENT LIMITATION; MICROBIAL DIVERSITY; MARINE-SEDIMENTS; ABUNDANCE; COASTAL; ASSEMBLAGES; POPULATION; LIBRARIES; SUMMER	The South China Sea is one of the largest marginal seas, with relatively frequent passage of eddies and featuring distinct spatial variation in the western tropical Pacific Ocean. Here, we report a phylogenetic study of bacterial community structures in surface seawater of the northern South China Sea (nSCS). Samples collected from 31 sites across large environmental gradients were used to construct clone libraries and yielded 2,443 sequences grouped into 170 OTUs. Phylogenetic analysis revealed 23 bacterial classes with major components alpha-, beta- and gamma-Proteobacteria, as well as Cyanobacteria. At class and genus taxon levels, community structure of coastal waters was distinctively different from that of deep-sea waters and displayed a higher diversity index. Redundancy analyses revealed that bacterial community structures displayed a significant correlation with the water depth of individual sampling sites. Members of alpha-Proteobacteria were the principal component contributing to the differences of the clone libraries. Furthermore, the bacterial communities exhibited heterogeneity within zones of upwelling and anticyclonic eddies. Our results suggested that surface bacterial communities in nSCS had two-level patterns of spatial distribution structured by ecological types (coastal VS. oceanic zones) and mesoscale physical processes, and also provided evidence for bacterial phylogenetic phyla shaped by ecological preferences.	[Li, Jialin; Li, Nan; Yu, Shuxian; Wang, Yinchu; Qin, Song] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Biol & Bioresource Utilizat, Yantai, Peoples R China; [Li, Fuchao] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zou, Tao] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Peoples R China; [Yu, Shuxian; Wang, Yinchu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Guangyi] Tianjin Univ, Sch Environm Sci & Engn, Tianjin Univ Ctr Marine Environm Ecol, Tianjin 300072, Peoples R China; [Wang, Guangyi] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tianjin University; University of Hawaii System; University of Hawaii Manoa	Qin, S (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Biol & Bioresource Utilizat, Yantai, Peoples R China.	sqin@yic.ac.cn; gywang@tju.edu.cn		Li, Nan/0000-0003-1782-6610; li, jia lin/0000-0003-1663-2259	National Natural Science Foundation of China [41106100]; CAS/SAFEA International Partnership Program for Creative Research Teams "Representative environmental processes and resources effects in coastal zone''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams "Representative environmental processes and resources effects in coastal zone''	This research work was financially supported by grants from the National Natural Science Foundation of China 41106100 and the CAS/SAFEA International Partnership Program for Creative Research Teams "Representative environmental processes and resources effects in coastal zone''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2013, ISME J, V7, P256, DOI 10.1038/ismej.2012.108; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Bowman JP, 2005, MICROB ECOL, V49, P451, DOI 10.1007/s00248-004-0070-2; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Cai HY, 2008, MICROB ECOL, V56, P751, DOI 10.1007/s00248-008-9394-7; Chen CTA, 2001, MAR CHEM, V75, P281, DOI 10.1016/S0304-4203(01)00041-X; Chen YLL, 2004, CONT SHELF RES, V24, P527, DOI 10.1016/j.csr.2003.12.006; Copley J, 2002, NATURE, V415, P572, DOI 10.1038/415572a; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; Dang HY, 2013, APPL ENVIRON MICROB, V79, P121, DOI 10.1128/AEM.01889-12; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrier M, 2002, J APPL MICROBIOL, V92, P706, DOI 10.1046/j.1365-2672.2002.01576.x; Ghiglione JF, 2012, P NATL ACAD SCI USA, V109, P17633, DOI 10.1073/pnas.1208160109; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hu J., 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; ISHIDA Y, 1986, MAR ECOL PROG SER, V30, P197, DOI 10.3354/meps030197; Jiang HC, 2007, GEOMICROBIOL J, V24, P505, DOI 10.1080/01490450701572473; Kan J, 2008, AQUAT MICROB ECOL, V51, P55, DOI 10.3354/ame01177; Lai XT, 2007, ISME J, V1, P756, DOI 10.1038/ismej.2007.51; Lee K, 2011, ENERG ENVIRON SCI, V4, P1133, DOI 10.1039/c0ee00663g; Li L, 2014, CHINESE SCI BULL, V59, P981, DOI 10.1007/s11434-013-0106-4; Liu FF, 2013, J MARINE SYST, V123, P33, DOI 10.1016/j.jmarsys.2013.04.005; [刘恒彪 Liu Hengbiao], 2011, [光学学报, Acta Optica Sinica], V31, P133; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lydell C, 2004, MICROB ECOL, V48, P263, DOI 10.1007/s00248-003-1068-x; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Morton B, 2001, MAR POLLUT BULL, V42, P1236, DOI 10.1016/S0025-326X(01)00240-5; Ning X, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002365; Ning XR, 2005, MAR ECOL PROG SER, V293, P17, DOI 10.3354/meps293017; North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pinhassi J, 2006, AQUAT MICROB ECOL, V44, P241, DOI 10.3354/ame044241; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seymour JR, 2012, ENV MICROBIOL REP, V4, P548, DOI 10.1111/j.1758-2229.2012.00362.x; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Song H, 2012, J APPL MICROBIOL, V112, P79, DOI 10.1111/j.1365-2672.2011.05187.x; Urakawa H, 2010, APPL ENVIRON MICROB, V76, P2129, DOI 10.1128/AEM.02692-09; Wang GH, 2010, ACTA OCEANOL SIN, V29, P98, DOI 10.1007/s13131-010-0054-7; Wang J, 2010, INT J SYST EVOL MICR, V60, P985, DOI 10.1099/ijs.0.013862-0; Wang SF, 2008, HYDROBIOLOGIA, V596, P79, DOI 10.1007/s10750-007-9059-4; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xu J, 2008, DEEP-SEA RES PT I, V55, P1330, DOI 10.1016/j.dsr.2008.05.007; Yin KD, 2001, MAR ECOL PROG SER, V221, P17, DOI 10.3354/meps221017; Yin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055148; Yuan XC, 2011, CONT SHELF RES, V31, P1214, DOI 10.1016/j.csr.2011.04.012; Zehr J.P., 2011, MICROBE MAG, V6, P169, DOI [10.1128/microbe.6.169.1, DOI 10.1128/MICROBE.6.169.1]; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	56	11	16	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113014	10.1371/journal.pone.0113014	http://dx.doi.org/10.1371/journal.pone.0113014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402458	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700094
J	Porcellato, I; Brachelente, C; Guelfi, G; Reginato, A; Sforna, M; Bongiovanni, L; Mechelli, L				Porcellato, Ilaria; Brachelente, Chiara; Guelfi, Gabriella; Reginato, Alice; Sforna, Monica; Bongiovanni, Laura; Mechelli, Luca			A Retrospective Investigation on Canine Papillomavirus 1 (CPV1) in Oral Oncogenesis Reveals Dogs Are Not a Suitable Animal Model for High-Risk HPV-Induced Oral Cancer	PLOS ONE			English	Article							INFERIOR MESENTERIC PLEXUS; MALE GERM-CELLS; SPERM MOTILITY; IN-VITRO; ISOFLURANE ANESTHESIA; MAMMALIAN SPERMATOZOA; HAMSTER SPERMATOZOA; ACROSOME REACTION; HUMAN TESTIS; CATECHOLAMINES	CPV1 (also called COPV) is a papillomavirus responsible for oral papillomatosis in young dogs. The involvement of this viral type in oral oncogenesis has been hypothesized in oral squamous cell carcinomas (SCCs), but has never been investigated in other neoplastic and hyperplastic oral lesions of dogs. Aim of this study was to investigate the presence of CPV1 in different neoplastic and hyperplastic lesions in order to assess its role in canine oral oncogenesis; according to the results obtained, a second aim of the study was to define if the dog can be considered a valid animal model for oral high risk HPV-induced tumors. Eighty-eight formalin-fixed, paraffin-embedded (FFPE) canine oral lesions including 78 oral tumors (papillomas, SCCs, melanomas, ameloblastomas, oral adenocarcinomas) and 10 hyperplastic lesions (gingival hyperplasia) were investigated with immunohistochemistry for the presence of papillomavirus L1 protein and with Real-Time PCR for CPV1 DNA. RT-PCR for RNA was performed on selected samples. All viral papillomas tested were positive for immunohistochemistry and Real-time PCR. In 3/33 (10%) SCCs, viral DNA was demonstrated but no viral RNA could be found. No positivity was observed both with immunohistochemistry and Real-Time PCR in the other hyperplastic and neoplastic lesions of the oral cavity of dogs. Even though the finding of CPV1 DNA in few SCCs in face of a negative immunohistochemistry could support the hypothesis of an abortive infection in the development of these lesions, the absence of viral RNA points out that CPV1 more likely represents an innocent bystander in SCC oncogenesis. The study demonstrates a strong association between CPV1 and oral viral papillomas whereas viral contribution to the pathogenesis of other oral lesions seems unlikely. Moreover, it suggests that a canine model of CPV1 infection for HPV-induced oncogenesis could be inappropriate.	[Porcellato, Ilaria; Brachelente, Chiara; Guelfi, Gabriella; Reginato, Alice; Sforna, Monica; Mechelli, Luca] Univ Perugia, Dept Vet Med, I-06100 Perugia, Italy; [Bongiovanni, Laura] Univ Teramo, Fac Vet Med, Teramo, Italy	University of Perugia; University of Teramo	Porcellato, I (corresponding author), Univ Perugia, Dept Vet Med, I-06100 Perugia, Italy.	ilariaporcellato@yahoo.it	Porcellato, Ilaria/J-2228-2018; Guelfi, Gabriella/AAE-6081-2019; Bongiovanni, Laura/R-4056-2019	Porcellato, Ilaria/0000-0003-2882-6739; Guelfi, Gabriella/0000-0003-3695-9275; 				Adeoya-Osiguwa SA, 2007, HUM REPROD, V22, P756, DOI 10.1093/humrep/del454; Adeoya-Osiguwa SA, 2006, HUM REPROD, V21, P1555, DOI 10.1093/humrep/del016; Ayala I, 2012, RES VET SCI, V93, P103, DOI 10.1016/j.rvsc.2011.05.013; Bae SE, 2001, REPRODUCTION, V122, P275, DOI 10.1530/reprod/122.2.275; BAVISTER BD, 1979, J REPROD FERTIL, V56, P507, DOI 10.1530/jrf.0.0560507; BILLUPS KL, 1990, J UROLOGY, V143, P625, DOI 10.1016/S0022-5347(17)40043-7; BILLUPS KL, 1990, FERTIL STERIL, V53, P1076; BONISCH H, 1980, PHARMACOLOGY, V21, P93, DOI 10.1159/000137422; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAUD M, 1983, PHARMACOL RES COMMUN, V15, P923, DOI 10.1016/S0031-6989(83)80022-8; CORNETT LE, 1979, BIOL REPROD, V20, P925, DOI 10.1095/biolreprod20.4.925; CORNETT LE, 1978, P NATL ACAD SCI USA, V75, P4954, DOI 10.1073/pnas.75.10.4954; Cortes-Gutierrez EI, 2008, THERIOGENOLOGY, V69, P1022, DOI 10.1016/j.theriogenology.2008.02.002; Davidoff MS, 2005, HISTOCHEM CELL BIOL, V124, P313, DOI 10.1007/s00418-005-0024-x; Fait G, 2001, ANDROLOGIA, V33, P347, DOI 10.1046/j.1439-0272.2001.00461.x; Frungieri MB, 2000, NEUROENDOCRINOLOGY, V71, P43, DOI 10.1159/000054519; Gil AG, 2005, VET REC, V157, P589; Gil AG, 2007, LAB ANIM-UK, V41, P411, DOI 10.1258/002367707782314274; HELM G, 1982, BIOL REPROD, V26, P553, DOI 10.1095/biolreprod26.4.553; KHATCHADOURIAN C, 1987, HUM REPROD, V2, P1; Kotwica G, 2003, THERIOGENOLOGY, V60, P953, DOI 10.1016/S0093-691X(03)00086-4; LINDAHL PE, 1981, EXPERIENTIA, V37, P860, DOI 10.1007/BF01985681; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; Mayerhofer A, 1999, J ANDROL, V20, P341; Mayerhofer A, 1996, BIOL REPROD, V55, P509, DOI 10.1095/biolreprod55.3.509; MEIZEL S, 1980, BIOL REPROD, V22, P211, DOI 10.1095/biolreprod22.2.211; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Otth C, 2007, J CELL BIOCHEM, V100, P141, DOI 10.1002/jcb.21037; Oz M, 2010, J NEUROCHEM, V114, P1019, DOI 10.1111/j.1471-4159.2010.06828.x; Ramirez AR, 2009, BIOL REPROD, V80, P753, DOI 10.1095/biolreprod.108.070961; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Villarroel-Espindola F, 2013, J CELL BIOCHEM, V114, P1653, DOI 10.1002/jcb.24507; Way AL, 2002, J ANDROL, V23, P352; Wu XH, 1999, GENE, V233, P163, DOI 10.1016/S0378-1119(99)00143-2	34	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112833	10.1371/journal.pone.0112833	http://dx.doi.org/10.1371/journal.pone.0112833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401953	Green Submitted, gold, Green Published			2022-12-26	WOS:000345158700078
J	Shen, YC; Wen, ZJ; Wang, N; Zheng, Z; Liu, K; Xia, X; Gu, Q; Shi, YY; Xu, X				Shen, Yinchen; Wen, Zujia; Wang, Ning; Zheng, Zhi; Liu, Kun; Xia, Xin; Gu, Qing; Shi, Yongyong; Xu, Xun			Investigation of Variants in UCP2 in Chinese Type 2 Diabetes and Diabetic Retinopathy	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 GENE; RETINAL MITOCHONDRIA; POLYMORPHISMS; RISK; ASSOCIATION; PROMOTER; PREVALENCE; POPULATION; EXPRESSION; CAUCASIANS	Purpose: The aim of this study was to investigate variants in UCP2 genes in type 2 diabetes mellitus (DM) and diabetic retinopathy (DR) in Chinese population. Materials and Methods: We conducted a single nucleotide polymorphism-based and haplotype-based case-control study between the variants of UCP2 and DM and between the variants of UCP2 and DR in 479 Chinese patients with type 2 DM and 479 control subjects without DM. Two SNPs (rs660339 and rs659366) were selected as genetic markers. Results: The risk allele C at UCP2 rs660339 was closely associated with DM in Chinese population. There was significant difference in rs660339 between DM and controls (P = 0.0016; OR [95% CI] = 1.37 (1.14-1.65)). Subjects who were homozygous of the C allele were more likely to develop DM. The frequency of C allele was higher in DM (58%) than in control (51%). But this locus didn't have a definite effect on the onset of non-proliferative diabetic retinopathy (NPDR) (P = 0.44; OR [95% CI] = 0.80 (0.56-1.14)) and proliferative diabetic retinopathy (PDR) (P = 1.00; OR [95% CI] = 0.99 (0.74-1.34)) comparing to subjects with DM without retinopathy (DWR), respectively. Moreover, the UCP2 rs659366 polymorphism showed no significant difference between DM and control (P = 0.66; OR [95% CI] = 1.10 (0.91-1.32)). However, there was a significant difference between PDR and DWR (P = 0.016; OR [95% CI] = 0.66 (0.49-0.90)), but there was no difference between NPDR and DWR (P = 1.00; OR [95% CI] = 0.96 (0.67-1.37)). Participants who carried the G allele at rs659366 were more likely to develop PDR. For the haplotype, C-A was present more frequently in DM than in control (16% vs 7%), indicating that it was risky, and T-A was present less in DM than in control (29% vs 35%). Haplotype frequencies in DR and DWR showed no significant difference (P = 0.068). Conclusion: It was indicated that UCP2 may be implicated in the pathogenesis of type 2 DM and DR in Chinese population.	[Shen, Yinchen; Wang, Ning; Zheng, Zhi; Liu, Kun; Xia, Xin; Gu, Qing; Xu, Xun] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai Key Lab Fundus Dis, Shanghai 200030, Peoples R China; [Wen, Zujia; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, N (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai Key Lab Fundus Dis, Shanghai 200030, Peoples R China.	drwangning@126.com	Shi, Yongyong/GSO-1627-2022	Shi, Yongyong/0000-0003-1710-1505	National Natural Science Foundation of China [81100679, 81273424]; Major Basic Research Development Program of China (973 Program) [2011CB707500]; Shanghai Guide Fund for Medical Projects [124119a9600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Shanghai Guide Fund for Medical Projects	This work was sponsored by grants from the National Natural Science Foundation of China (No. 81100679; No. 81273424), Major Basic Research Development Program of China (973 Program) (No. 2011CB707500) and Shanghai Guide Fund for Medical Projects (No. 124119a9600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2000, J NUTR, V130, P711, DOI 10.1093/jn/130.4.711; Bulotta A, 2005, J CLIN ENDOCR METAB, V90, P1176, DOI 10.1210/jc.2004-1072; Cilensek I, 2012, DIS MARKERS, V32, P93, DOI [10.1155/2012/675628, 10.3233/DMA-2011-0863]; Crispim D, 2010, CLIN ENDOCRINOL, V72, P612, DOI 10.1111/j.1365-2265.2009.03684.x; D'Adamo M, 2004, DIABETES, V53, P1905, DOI 10.2337/diabetes.53.7.1905; de Souza BM, 2012, EXP EYE RES, V94, P49, DOI 10.1016/j.exer.2011.11.004; de Souza BM, 2011, ARQ BRAS ENDOCRINOL, V55, P239, DOI 10.1590/S0004-27302011000400001; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Gioli-Pereira L, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-40; He Y, 2014, INT J MOL MED, V33, P1275, DOI 10.3892/ijmm.2014.1676; Heidari J, 2010, ARCH IRAN MED, V13, P384, DOI 010135/AIM.004; Hsu YH, 2008, DIABETES, V57, P1101, DOI 10.2337/db07-1269; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Lee HJ, 2008, CLIN CHIM ACTA, V398, P27, DOI 10.1016/j.cca.2008.07.029; Liew G, 2008, INT OPHTHALMOL CLIN, V49, P35; Lindholm E, 2004, J DIABETES COMPLICAT, V18, P103, DOI 10.1016/S1056-8727(03)00019-9; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oktavianthi S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-41; Petrovic D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/540416; Piconi L, 2003, CLIN CHEM LAB MED, V41, P1144, DOI 10.1515/CCLM.2003.177; Qin LJ, 2013, GENET MOL RES, V12, P3324, DOI 10.4238/2013.September.3.9; Rudofsky G, 2006, DIABETES CARE, V29, P89, DOI 10.2337/diacare.29.01.06.dc05-0757; Rudofsky G, 2007, HORM METAB RES, V39, P306, DOI 10.1055/s-2007-973816; Santos JM, 2012, FREE RADICAL BIO MED, V53, P1729, DOI 10.1016/j.freeradbiomed.2012.08.588; Sasahara M, 2004, DIABETES, V53, P482, DOI 10.2337/diabetes.53.2.482; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Threatt J, 2013, AM J MED SCI, V345, P266, DOI 10.1097/MAJ.0b013e31828aa6fb; Vimaleswaran KS, 2011, DIABETES TECHNOL THE, V13, P19, DOI 10.1089/dia.2010.0091; Xu K, 2011, DIABETOLOGIA, V54, P2315, DOI 10.1007/s00125-011-2245-y; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yu XH, 2005, CLIN CHEM, V51, P1451, DOI 10.1373/clinchem.2004.044859	36	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112670	10.1371/journal.pone.0112670	http://dx.doi.org/10.1371/journal.pone.0112670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396419	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500074
J	Tsai, MS; Lin, YC; Sun, CK; Huang, SC; Lee, PH; Kao, YH				Tsai, Ming-Shian; Lin, Yu-Chun; Sun, Cheuk-Kwan; Huang, Shih-Che; Lee, Po-Huang; Kao, Ying-Hsien			Up-Regulation of Nerve Growth Factor in Cholestatic Livers and Its Hepatoprotective Role against Oxidative Stress	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; HEPATIC STELLATE CELLS; PC12 CELLS; HEPATOCELLULAR-CARCINOMA; PARACRINE REGULATION; SYMPATHETIC NEURONS; GASTRIC PERFORATION; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; FACTOR EXPRESSION	The role of nerve growth factor (NGF) in liver injury induced by bile duct ligation (BDL) remains elusive. This study aimed to investigate the relationship between inflammation and hepatic NGF expression, to explore the possible upstream molecules up-regulating NGF, and to determine whether NGF could protect hepatocytes from oxidative liver injury. Biochemical and molecular detection showed that NGF was up-regulated in cholestatic livers and plasma, and well correlated with systemic and hepatic inflammation. Conversely, systemic immunosuppression reduced serum NGF levels and resulted in higher mortality in BDL-treated mice. Immunohistochemistry showed that the up-regulated NGF was mainly localized in parenchymal hepatocytes. In vitro mechanistic study further demonstrated that TGF-beta 1 up-regulated NGF expression in clone-9 and primary rat hepatocytes. Exogenous NGF supplementation and endogenous NGF overexpression effectively protected hepatocytes against TGF-beta 1- and oxidative stress-induced cell death in vitro, along with reduced formation of oxidative adducted proteins modified by 4-HNE and 8-OHdG. TUNEL staining confirmed the involvement of anti-apoptosis in the NGF-exhibited hepatoprotection. Moreover, NGF potently induced Akt phosphorylation and increased Bcl-2 to Bax ratios, whereas these molecular alterations by NGF were only seen in the H2O2-, but not TGF-beta 1-treated hepatocytes. In conclusion, NGF exhibits anti-oxidative and hepatoprotective effects and is suggested to be therapeutically applicable in treating cholestatic liver diseases.	[Tsai, Ming-Shian; Lee, Po-Huang] E DA Hosp, Dept Surg, Kaohsiung, Taiwan; [Tsai, Ming-Shian] I Shou Univ, Sch Med Postbaccalaureate, Kaohsiung, Taiwan; [Lin, Yu-Chun; Huang, Shih-Che; Kao, Ying-Hsien] E DA Hosp, Dept Med Res, Kaohsiung, Taiwan; [Sun, Cheuk-Kwan] E DA Hosp, Dept Med Educ, Kaohsiung, Taiwan; [Lee, Po-Huang] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10764, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; E-Da Hospital; National Taiwan University; National Taiwan University Hospital	Lee, PH (corresponding author), E DA Hosp, Dept Surg, Kaohsiung, Taiwan.	pohuang1115@ntu.edu.tw; danyhkao@gmail.com	Sun, Cheuk-Kwan/K-5723-2012; Kao, Ying-Hsien/H-4134-2019	LEE, PO-HUANG/0000-0001-5831-035X; Sun, Cheuk-Kwan/0000-0002-2524-9684; Kao, Ying-Hsien/0000-0001-7803-9384	EDA Hospital [EDAHP-100004, EDAHT-100021]	EDA Hospital	This study was supported in part by grants from EDA Hospital (EDAHP-100004 to MST and EDAHT-100021 to YHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assimakopoulos SF, 2008, REDOX REP, V13, P179, DOI 10.1179/135100008X308902; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Cao GF, 2011, BIOCHEM BIOPH RES CO, V414, P499, DOI 10.1016/j.bbrc.2011.09.094; Chiba T, 2004, ONCOLOGY-BASEL, V66, P481, DOI 10.1159/000079503; COSGAYA JM, 1995, J NEUROCHEM, V65, P2484; Czaja MJ, 2002, ANTIOXID REDOX SIGN, V4, P759, DOI 10.1089/152308602760598909; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Gigliozzi A, 2004, GASTROENTEROLOGY, V127, P1198, DOI 10.1053/j.gastro.2004.06.023; Guerios SD, 2008, AM J PHYSIOL-REG I, V295, pR111, DOI 10.1152/ajpregu.00728.2007; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Haas SL, 2009, GROWTH FACTORS, V27, P289, DOI 10.1080/08977190903132273; Herrera B, 2004, J CELL PHYSIOL, V201, P385, DOI 10.1002/jcp.20078; Hofmann AF, 2002, LIVER, V22, P14, DOI 10.1034/j.1600-0676.2002.00002.x; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Kao YH, 2010, J HEPATOL, V52, P96, DOI 10.1016/j.jhep.2009.10.002; Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701; Kirschner PB, 1996, BRAIN RES, V713, P178, DOI 10.1016/0006-8993(95)01513-2; Kishibe K, 2002, GASTROENTEROLOGY, V122, P1978, DOI 10.1053/gast.2002.33581; Li JF, 2013, MOL MED REP, V8, P813, DOI 10.3892/mmr.2013.1590; Lin N, 2009, LIFE SCI, V85, P291, DOI 10.1016/j.lfs.2009.06.007; Lindholm D, 1990, Neuroreport, V1, P9; Liu JW, 2007, PHARMACOL REP, V59, P573; Ljubuncic P, 2000, GUT, V47, P710, DOI 10.1136/gut.47.5.710; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Lu J, 2010, BRAIN PATHOL, V20, P952, DOI 10.1111/j.1750-3639.2010.00397.x; Marin JJG, 2013, FREE RADICAL BIO MED, V61, P218, DOI 10.1016/j.freeradbiomed.2013.04.002; Maroto R, 1997, J NEUROCHEM, V69, P514; Nair P, 2000, CELL DEATH DIFFER, V7, P207, DOI 10.1038/sj.cdd.4400628; Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4; Ohkubo T, 2002, J HEPATOL, V36, P210, DOI 10.1016/S0168-8278(01)00258-6; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x; SAMPATH D, 1994, J NEUROCHEM, V62, P2476; Satoh T, 1996, J BIOCHEM-TOKYO, V120, P540; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Suzuki K, 2008, GASTROENTEROLOGY, V135, P270, DOI 10.1053/j.gastro.2008.03.075; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Tsai MS, 2011, J SURG RES, V171, P205, DOI 10.1016/j.jss.2010.01.021; Tsai MS, 2010, SHOCK, V33, P170, DOI 10.1097/SHK.0b013e3181ab9ee0; Valdovinos-Flores C, 2013, FREE RADICAL RES, V47, P404, DOI 10.3109/10715762.2013.783210; Xu LB, 2010, WORLD J SURG, V34, P1039, DOI 10.1007/s00268-010-0417-4; Yongchaitrakul T, 2007, EUR J ORAL SCI, V115, P57, DOI 10.1111/j.1600-0722.2007.00420.x	44	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112113	10.1371/journal.pone.0112113	http://dx.doi.org/10.1371/journal.pone.0112113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397406	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500035
J	Park, H; Han, SS; Sako, Y; Pack, CG				Park, Hweon; Han, Sung-Sik; Sako, Yasushi; Pack, Chan-Gi			Dynamic and unique nucleolar microenvironment revealed by fluorescence correlation spectroscopy	FASEB JOURNAL			English	Article						nucleolar organization; diffusion coefficient; crowding effect; ATP depletion; actinomycin D	LIVING CELL-NUCLEI; CHROMATIN; MOBILITY; DIFFUSION; PROTEINS; LAMIN; ORGANIZATION; RNA; SUBCOMPARTMENTS; ACCESSIBILITY	Organization and functions of the nucleolus is maintained by mobilities and interactions of nucleolar factors. Because the nucleolus is a densely packed structure, molecular crowding effects determined by the molecular concentrations and mobilities in the nucleolus should also be important for regulating nucleolar organization and functions. However, such molecular property of nucleolar organization is not fully understood. To understand the biophysical property of nucleolar organization, the diffusional behaviors of inert green fluorescent protein (GFP) oligomers with or without nuclear localization signals (NLSs) were analyzed under various conditions by fluorescence correlation spectroscopy. Our result demonstrates that the mobility of GFPs inside the nucleolus and the nucleoplasm can be represented by single free diffusion under normal conditions, even though the mobility in the nucleolus is considerably slower than that in the chromatin region. Moreover, the free diffusion of GFPs is found to be significantly size-and NLS-dependent only in the nucleolus. Interestingly, themobility in the nucleolus is highly sensitive to ATP depletion, as well as actinomycin D (ActD) treatment. In contrast, the ultra-structure of the nucleolus was not significantly changed by ATP depletion but was changed by ActD treatment. These results suggest that the nucleolus behaves similarly to an open aqueous-phase medium with an increased molecular crowding effect that depends on both energy and transcription.	[Park, Hweon; Han, Sung-Sik] Korea Univ, Dept Life Sci, Seoul 136701, South Korea; [Sako, Yasushi] RIKEN, Cellular Informat Lab, Wako, Saitama, Japan; [Pack, Chan-Gi] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea	Korea University; RIKEN; University of Ulsan; Asan Medical Center	Han, SS (corresponding author), Korea Univ, Dept Life Sci, 145 Anam Ro, Seoul 136701, South Korea.	shan@korea.ac.kr; changipack@amc.seoul.kr	Sako, Yasushi/B-3253-2015	Sako, Yasushi/0000-0002-5707-5455	Fund for Seeds of Collaborative Research from RIKEN, Japan [29100]	Fund for Seeds of Collaborative Research from RIKEN, Japan	The authors thank Hiromi Sato (RIKEN, Wako) for technical assistance provided with the gene sequencing and cloning. C.G.P. was partly supported by the FY2012 Fund for Seeds of Collaborative Research from RIKEN (29100), Japan.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Banerjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083410; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Cardoso MC, 2012, CURR OPIN CELL BIOL, V24, P79, DOI 10.1016/j.ceb.2011.12.009; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Delloye-Bourgeois C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002456; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Finch RA, 1996, BIOCHEM BIOPH RES CO, V222, P553, DOI 10.1006/bbrc.1996.0782; Gorisch S, 2005, HISTOCHEM CELL BIOL, V123, P217, DOI 10.1007/s00418-005-0752-y; Grunwald D, 2008, BIOPHYS J, V94, P2847, DOI 10.1529/biophysj.107.115014; Grummt I, 2013, CHROMOSOMA, V122, P487, DOI 10.1007/s00412-013-0430-0; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Hayashi K, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13136-6; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Jacob MD, 2013, MOL BIOL CELL, V24, P2943, DOI 10.1091/mbc.E13-04-0223; Kiesslich T, 2003, J BIOCHEM BIOPH METH, V57, P247, DOI 10.1016/S0165-022X(03)00102-7; LEBEL S, 1987, J CELL BIOL, V105, P1099, DOI 10.1083/jcb.105.3.1099; Lee KE, 2009, J ELECTRON MICROSC, V58, P305, DOI 10.1093/jmicro/dfp019; Lide D.R., 2000, HDB CHEM PHYS, V81st; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Martin C, 2009, J CELL SCI, V122, P1551, DOI 10.1242/jcs.046284; Martin RM, 2010, FASEB J, V24, P1066, DOI 10.1096/fj.08-128959; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Pack C, 2006, BIOPHYS J, V91, P3921, DOI 10.1529/biophysj.106.079467; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Trinkle-Mulcahy L, 2007, SCIENCE, V318, P1402, DOI 10.1126/science.1142033; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; van Steensel B, 2011, EMBO J, V30, P1885, DOI 10.1038/emboj.2011.135; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wachsmuth M, 2008, BBA-MOL CELL RES, V1783, P2061, DOI 10.1016/j.bbamcr.2008.07.022; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871	49	12	12	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					837	848		10.1096/fj.14-254110	http://dx.doi.org/10.1096/fj.14-254110			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25404711				2022-12-26	WOS:000350633000011
J	Claverie, T; Wainwright, PC				Claverie, Thomas; Wainwright, Peter C.			A Morphospace for Reef Fishes: Elongation Is the Dominant Axis of Body Shape Evolution	PLOS ONE			English	Article							MORPHOLOGICAL DIVERSITY; TELEOST FISHES; TRADE-OFFS; DIVERSIFICATION; PERFORMANCE; FORM; DISPARITY; MECHANICS; RADIATION; EXAMPLE	Tropical reef fishes are widely regarded as being perhaps the most morphologically diverse vertebrate assemblage on earth, yet much remains to be discovered about the scope and patterns of this diversity. We created a morphospace of 2,939 species spanning 56 families of tropical Indo-Pacific reef fishes and established the primary axes of body shape variation, the phylogenetic consistency of these patterns, and whether dominant patterns of shape change can be accomplished by diverse underlying changes. Principal component analysis showed a major axis of shape variation that contrasts deepbodied species with slender, elongate forms. Furthermore, using custom methods to compare the elongation vector (axis that maximizes elongation deformation) and the main vector of shape variation (first principal component) for each family in the morphospace, we showed that two thirds of the families diversify along an axis of body elongation. Finally, a comparative analysis using a principal coordinate analysis based on the angles among first principal component vectors of each family shape showed that families accomplish changes in elongation with a wide range of underlying modifications. Some groups such as Pomacentridae and Lethrinidae undergo decreases in body depth with proportional increases in all body regions, while other families show disproportionate changes in the length of the head (e.g., Labridae), the trunk or caudal region in all combinations (e.g., Pempheridae and Pinguipedidae). In conclusion, we found that evolutionary changes in body shape along an axis of elongation dominates diversification in reef fishes. Changes in shape on this axis are thought to have immediate implications for swimming performance, defense from gape limited predators, suction feeding performance and access to some highly specialized habitats. The morphological modifications that underlie changes in elongation are highly diverse, suggesting a role for a range of developmental processes and functional consequences.	[Claverie, Thomas] CUFR Mayotte, F-97660 Dembeni, France; [Wainwright, Peter C.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Claverie, T (corresponding author), CUFR Mayotte, Route Natl 3, F-97660 Dembeni, France.	tclaverie@gmail.com	Claverie, Thomas/D-3544-2018	Claverie, Thomas/0000-0002-6258-4991	NSF [IOS 0924489, DEB 1061981]; Direct For Biological Sciences [1061981] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0924489] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the NSF grants IOS 0924489 and DEB 1061981 to PCW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Medrano R, 2013, ANIM BIOL, V63, P217, DOI 10.1163/15707563-00002407; Alfa MJ, 2009, BMC INFECT DIS, V9, DOI [10.1186/1471-2334-9-56, 10.1186/1471-2148-9-255]; [Anonymous], 2020, CATALOG FISHES; Bergmann PJ, 2012, EVOLUTION, V66, P1044, DOI 10.1111/j.1558-5646.2011.01491.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brainerd EL, 1998, COPEIA, P971, DOI 10.2307/1447344; Broughton R, 2013, PLOS CURRENTS TREE L, DOI [10.1371/currents.tol.1353ba26640df26640ccaee26675bb26165c26648c26288, DOI 10.1371/CURRENTS.TOL.1353BA26640DF26640CCAEE26675BB26165C26648C26288]; Carroll AM, 2004, J EXP BIOL, V207, P3873, DOI 10.1242/jeb.01227; Claverie T, 2013, EVOLUTION, V67, P3191, DOI 10.1111/evo.12185; Collar DC, 2006, EVOLUTION, V60, P2575; Collar DC, 2013, ZOOLOGY, V116, P246, DOI 10.1016/j.zool.2013.03.001; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Dornburg A, 2011, EVOLUTION, V65, P1912, DOI 10.1111/j.1558-5646.2011.01275.x; Ellerby DJ, 2011, EVOL BIOL, V38, P422, DOI 10.1007/s11692-011-9130-y; Frederich B, 2013, AM NAT, V181, P94, DOI 10.1086/668599; Frederich B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-82; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Gerry SP, 2012, PHYSIOL BIOCHEM ZOOL, V85, P694, DOI 10.1086/667593; Holzman R, 2012, J EXP BIOL, V215, P1, DOI 10.1242/jeb.057851; Hulsey CD, 2002, P ROY SOC B-BIOL SCI, V269, P317, DOI 10.1098/rspb.2001.1874; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kazancioglu E, 2009, P ROY SOC B-BIOL SCI, V276, P3439, DOI 10.1098/rspb.2009.0876; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Kusche H, 2014, ECOL EVOL, V4, P1127, DOI 10.1002/ece3.1015; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Legendre P., 2012, NUMERICAL ECOLOGY; Liem KF., 2001, FUNCTIONAL ANATOMY V; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Marcus Leslie F., 2000, Hystrix, V11, P27; Mehta RS, 2010, INTEGR COMP BIOL, V50, P1091, DOI 10.1093/icb/icq075; Miller TL, 2007, MOL PHYLOGENET EVOL, V44, P450, DOI 10.1016/j.ympev.2006.10.029; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Near TJ, 2013, P NATL ACAD SCI USA, P1; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Oufiero CE, 2012, J EXP BIOL, V215, P3845, DOI 10.1242/jeb.074849; Polly PD, 2001, BEYOND HETEROCHRONY, P305; Price SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0321; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Price SA, 2013, EVOLUTION, V67, P417, DOI 10.1111/j.1558-5646.2012.01773.x; R Core Team, 2020, R LANG ENV STAT COMP; Reece JS, 2013, BIOL J LINN SOC, V109, P861, DOI 10.1111/bij.12098; Rohlf F.J., 2003, TPSSMALL; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2005, TPSDIG2 DIGITIZE LAN; Sallan LC, 2012, P ROY SOC B-BIOL SCI, V279, P2025, DOI 10.1098/rspb.2011.2454; Santini F, 2013, J EVOLUTION BIOL, V26, P1003, DOI 10.1111/jeb.12112; Smith WL, 2005, LIMITS RELATIONSHIPS; Smith WL, 2007, COPEIA, P35, DOI 10.1643/0045-8511(2007)7[35:CTPNWT]2.0.CO;2; Thacker CE, 2011, SYST BIODIVERS, V9, P329, DOI 10.1080/14772000.2011.629011; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Wainwright P, 2007, INTEGR COMP BIOL, V47, P96, DOI 10.1093/icb/icm032; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Ward AB, 2007, BIOL J LINN SOC, V90, P97, DOI 10.1111/j.1095-8312.2007.00714.x; Ward AB, 2014, ZOOLOGY, V117, P70, DOI 10.1016/j.zool.2013.10.006; WEBB PW, 1984, AM ZOOL, V24, P107; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Wiens JJ, 2001, EVOLUTION, V55, P2303; Yamada T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-145; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	62	99	99	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112732	10.1371/journal.pone.0112732	http://dx.doi.org/10.1371/journal.pone.0112732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409027	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200038
J	Hill, G; Headon, D; Harris, ZI; Huttner, K; Limesand, KH				Hill, Grace; Headon, Denis; Harris, Zoey I.; Huttner, Kenneth; Limesand, Kirsten H.			Pharmacological Activation of the EDA/EDAR Signaling Pathway Restores Salivary Gland Function following Radiation-Induced Damage	PLOS ONE			English	Article							ADENOVIRAL-MEDIATED TRANSFER; SUBMANDIBULAR-GLAND; AQUAPORIN-1 CDNA; FLUID SECRETION; ACINAR-CELLS; ECTODYSPLASIN; PROLIFERATION; APOPTOSIS; HYPOFUNCTION; IRRADIATION	Radiotherapy of head and neck cancers often results in collateral damage to adjacent salivary glands associated with clinically significant hyposalivation and xerostomia. Due to the reduced capacity of salivary glands to regenerate, hyposalivation is treated by substitution with artificial saliva, rather than through functional restoration of the glands. During embryogenesis, the ectodysplasin/ectodysplasin receptor (EDA/EDAR) signaling pathway is a critical element in the development and growth of salivary glands. We have assessed the effects of pharmacological activation of this pathway in a mouse model of radiation-induced salivary gland dysfunction. We report that post-irradiation administration of an EDAR-agonist monoclonal antibody (mAbEDAR1) normalizes function of radiation damaged adult salivary glands as determined by stimulated salivary flow rates. In addition, salivary gland structure and homeostasis is restored to pre-irradiation levels. These results suggest that transient activation of pathways involved in salivary gland development could facilitate regeneration and restoration of function following damage.	[Hill, Grace; Harris, Zoey I.; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA; [Headon, Denis] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Headon, Denis] Univ Edinburgh, Royal Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Huttner, Kenneth] Edimer Pharmaceut Inc, Cambridge, MA USA	University of Arizona; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Limesand, KH (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	limesank@u.arizona.edu			National Institutes of Health Research Grant [RO1DE018888]; Edimer Pharmaceuticals; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018888] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221657] Funding Source: researchfish; BBSRC [BBS/E/D/20221657] Funding Source: UKRI	National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edimer Pharmaceuticals; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the National Institutes of Health Research Grant RO1DE018888 to GH and KHL. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by Edimer Pharmaceuticals to GH, DH, KH, and KHL. http://edimerpharma.com/. This funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila JL, 2009, INT J RADIAT ONCOL, V73, P523, DOI 10.1016/j.ijrobp.2008.09.036; Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; Beech N, 2014, AUST DENT J, V59, P20, DOI 10.1111/adj.12134; Boraks George, 2008, Braz. Dent. J., V19, P73, DOI 10.1590/S0103-64402008000100013; Bralic M, 2005, ACTA MED OKAYAMA, V59, P153; Burlage FR, 2009, RADIOTHER ONCOL, V90, P253, DOI 10.1016/j.radonc.2008.11.011; Cannon DM, 2013, HEAD NECK, V10; Carpenter GH, 2007, ACTA PHYSIOL, V189, P241, DOI 10.1111/j.1365-201X.2006.01662.x; Chang SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007591; Cotroneo E, 2008, CELL TISSUE RES, V332, P227, DOI 10.1007/s00441-008-0588-6; Cotroneo E, 2010, DIFFERENTIATION, V79, P120, DOI 10.1016/j.diff.2009.11.005; Delporte C, 1997, P NATL ACAD SCI USA, V94, P3268, DOI 10.1073/pnas.94.7.3268; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; HAND AR, 1988, J ORAL PATHOL MED, V17, P279, DOI 10.1111/j.1600-0714.1988.tb01537.x; Jaskoll T, 2003, ANAT REC PART A, V271A, P322, DOI 10.1002/ar.a.10045; Kowalczyk C, 2011, J BIOL CHEM, V286, P30769, DOI 10.1074/jbc.M111.267997; Kowalczyk-Quintas C, 2014, CYTOKINE GROWTH F R, V25, P195, DOI 10.1016/j.cytogfr.2014.01.004; Limesand KH, 2006, MOL CELL BIOL, V26, P8840, DOI 10.1128/MCB.01846-05; Limesand KH, 2010, INT J RADIAT ONCOL, V78, P579, DOI 10.1016/j.ijrobp.2010.03.035; Limesand KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004663; Lin AL, 2001, ARCH ORAL BIOL, V46, P1085, DOI 10.1016/S0003-9969(01)00063-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombaert IMA, 2011, ORAL DIS, V17, P445, DOI 10.1111/j.1601-0825.2010.01783.x; Lombaert IMA, 2008, STEM CELLS, V26, P2595, DOI 10.1634/stemcells.2007-1034; MAKKONEN TA, 1986, ORAL SURG ORAL MED O, V62, P270, DOI 10.1016/0030-4220(86)90007-1; Martin KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051363; Mitchell GC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.28; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Morgan-Bathke M, 2013, J DENT RES, V92, P911, DOI 10.1177/0022034513499350; Morgan-Bathke M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05206; Muhvic-Urek M, 2006, PHYSIOL RES, V55, P89, DOI 10.33549/physiolres.930739; National Cancer Institute, 2014, SEER STAT FACT SHEET; Sagowski C, 2003, EUR ARCH OTO-RHINO-L, V260, P513, DOI 10.1007/s00405-003-0631-x; SODICOFF M, 1974, RADIAT RES, V58, P196, DOI 10.2307/3573932; TURNER RJ, 1993, ANN NY ACAD SCI, V694, P24, DOI 10.1111/j.1749-6632.1993.tb18339.x; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Voutilainen M, 2012, P NATL ACAD SCI USA, V109, P5744, DOI 10.1073/pnas.1110627109; Wells KL, 2011, DEV BIOL, V349, P137, DOI 10.1016/j.ydbio.2010.10.012; Wells KL, 2010, DEV DYNAM, V239, P2674, DOI 10.1002/dvdy.22406	40	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112840	10.1371/journal.pone.0112840	http://dx.doi.org/10.1371/journal.pone.0112840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409170	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200044
J	Lu, HK; Gray, LR; Wightman, F; Ellenberg, P; Khoury, G; Cheng, WJ; Mota, TM; Wesselingh, S; Gorry, PR; Cameron, PU; Churchill, MJ; Lewin, SR				Lu, Hao K.; Gray, Lachlan R.; Wightman, Fiona; Ellenberg, Paula; Khoury, Gabriela; Cheng, Wan-Jung; Mota, Talia M.; Wesselingh, Steve; Gorry, Paul R.; Cameron, Paul U.; Churchill, Melissa J.; Lewin, Sharon R.			Ex Vivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; TRANSCRIPTIONAL ACTIVITY; LATENT RESERVOIR; P-TEFB; EXPRESSION; ACTIVATION; PROMOTER; REPLICATION; INCREASE	Histone deacetylase inhibitors (HDACi) can induce human immunodeficiency virus (HIV) transcription from the HIV long terminal repeat (LTR). However, ex vivo and in vivo responses to HDACi are variable and the activity of HDACi in cells other than T-cells have not been well characterised. Here, we developed a novel assay to determine the activity of HDACi on patient-derived HIV LTRs in different cell types. HIV LTRs from integrated virus were amplified using triple-nested Alu-PCR from total memory CD4(+) T-cells (CD45RO+) isolated from HIV-infected patients prior to and following suppressive antiretroviral therapy. NL4-3 or patient-derived HIV LTRs were cloned into the chromatin forming episomal vector pCEP4, and the effect of HDACi investigated in the astrocyte and epithelial cell lines SVG and HeLa, respectively. There were no significant differences in the sequence of the HIV LTRs isolated from CD4(+) T-cells prior to and after 18 months of combination antiretroviral therapy (cART). We found that in both cell lines, the HDACi panobinostat, trichostatin A, vorinostat and entinostat activated patient-derived HIV LTRs to similar levels seen with NL4-3 and all patient derived isolates had similar sensitivity to maximum HDACi stimulation. We observed a marked difference in the maximum fold induction of luciferase by HDACi in HeLa and SVG, suggesting that the effect of HDACi may be influenced by the cellular environment. Finally, we observed significant synergy in activation of the LTR with vorinostat and the viral protein Tat. Together, our results suggest that the LTR sequence of integrated virus is not a major determinant of a functional response to an HDACi.	[Lu, Hao K.; Gray, Lachlan R.; Wightman, Fiona; Ellenberg, Paula; Khoury, Gabriela; Mota, Talia M.; Gorry, Paul R.; Cameron, Paul U.; Lewin, Sharon R.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lu, Hao K.; Gray, Lachlan R.; Wightman, Fiona; Ellenberg, Paula; Khoury, Gabriela; Cheng, Wan-Jung; Mota, Talia M.; Wesselingh, Steve; Gorry, Paul R.; Cameron, Paul U.; Churchill, Melissa J.; Lewin, Sharon R.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Mota, Talia M.; Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Wesselingh, Steve] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Cameron, Paul U.; Lewin, Sharon R.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Churchill, Melissa J.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Churchill, Melissa J.] Monash Univ, Dept Med, Clayton, Vic, Australia; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst, Melbourne, Vic, Australia	Monash University; Burnet Institute; University of Melbourne; South Australian Health & Medical Research Institute (SAHMRI); Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; University of Melbourne	Lewin, SR (corresponding author), Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia.	sharon.lewin@unimelb.edu.au	Ellenberg, paula/AAW-5460-2021; Khoury, Gabriela/AAD-1524-2019; Lewin, Sharon/Z-3297-2019	Khoury, Gabriela/0000-0002-6616-3932; Lewin, Sharon Ruth/0000-0002-0330-8241; Cameron, Paul Urquhart/0000-0002-1906-6945; Lu, Hao/0000-0002-3940-3283; Mota, Talia/0000-0002-8925-0158; Ellenberg, Paula/0000-0002-7622-9106; Wightman, Fiona/0000-0003-1203-1325; Gray, Lachlan/0000-0002-9894-1049; Churchill, Melissa/0000-0001-5510-7954	Australian National Health and Medical Research Council (NHMRC) [1009533, 1051093]; National Institutes of Health, USA [NIMH100594]; Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE) [U19AI096109]; Australian Research Council Future Fellowship (FT2); NHMRC Early Career Fellowship [GNT0606967]; NHMRC Dora Lush biomedical post-graduate scholarship [579719]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE); Australian Research Council Future Fellowship (FT2)(Australian Research Council); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Dora Lush biomedical post-graduate scholarship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant 1009533 and 1051093; the National Institutes of Health, USA (NIMH100594) and the Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE; U19AI096109). S. R. L. is an NHMRC senior practitioner fellow. P. R. G is supported by an Australian Research Council Future Fellowship (FT2). L. R. G was supported by a NHMRC Early Career Fellowship (GNT0606967). G. K. is a recipient of an NHMRC Dora Lush biomedical post-graduate scholarship (579719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Barboric M, 2010, NAT STRUCT MOL BIOL, V17, P928, DOI 10.1038/nsmb0810-928; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bouchat S, 2012, AIDS, V26, P1473, DOI 10.1097/QAD.0b013e32835535f5; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Burnett JC, 2010, J VIROL, V84, P5958, DOI 10.1128/JVI.00161-10; Cillo AR, 2014, P NATL ACAD SCI US; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Einav Y, 2003, MOL CANCER THER, V2, P1121; Elliott JH, 2014, PLOS PATHOG IN PRESS; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gray LR, 2013, AIDS RES HUM RETROV, V29, P365, DOI [10.1089/aid.2012.0138, 10.1089/AID.2012.0138]; He MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067186; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hodin TL, 2013, J VIROL, V87, P13020, DOI 10.1128/JVI.01606-13; KAMINE J, 1993, J VIROL, V67, P6828, DOI 10.1128/JVI.67.11.6828-6834.1993; Kato TA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-116; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077595; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Marelli-Berg FM, 2012, IMMUNOLOGY, V136, P363, DOI 10.1111/j.1365-2567.2012.03583.x; Ramakrishnan R, 2014, AIDS RES HUM RETROVI; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P993, DOI 10.4161/hv.23800; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Shan L, 2014, J ANTIMICROB CHEMOTH, V69, P28, DOI 10.1093/jac/dkt338; Shehu-Xhilaga M, 2009, AIDS, V23, P2047, DOI 10.1097/QAD.0b013e328330342c; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wightman F, 2013, AIDS, V27, P2853, DOI 10.1097/QAD.0000000000000067; Wightman F, 2012, IMMUNOL CELL BIOL, V90, P47, DOI 10.1038/icb.2011.95; Wightman F, 2010, J INFECT DIS, V202, P1738, DOI 10.1086/656721; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; ZEICHNER SL, 1991, J VIROL, V65, P2436, DOI 10.1128/JVI.65.5.2436-2444.1991; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113341	10.1371/journal.pone.0113341	http://dx.doi.org/10.1371/journal.pone.0113341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409334	Green Published, gold			2022-12-26	WOS:000345533200100
J	Takaesu, Y; Komada, Y; Asaoka, S; Kagimura, T; Inoue, Y				Takaesu, Yoshikazu; Komada, Yoko; Asaoka, Shoichi; Kagimura, Tatsuo; Inoue, Yuichi			Factors Associated with Long-Term Use of Hypnotics among Patients with Chronic Insomnia	PLOS ONE			English	Article							SLEEP FOUNDATION SURVEY; PSYCHOLOGICAL TREATMENT; QUALITY INDEX; UNITED-STATES; OLDER-ADULTS; RISK-FACTOR; DEPRESSION; METAANALYSIS; EFFICACY; THERAPY	This study investigated factors associated with long-term use of benzodiazepines (BZDs) or benzodiazepine receptor agonists (BzRAs) as hypnotics in patients with chronic insomnia. Consecutive patients (n = 140) with chronic insomnia were enrolled in this study (68 men and 72 women; mean age, 53.8 +/- 10.8 years). All patients filled out a self-assessment questionnaire asking clinical descriptive variables at the baseline of the treatment period; patients received the usual dose of a single type of BZD or BzRA. The Pittsburgh Sleep Quality Index (PSQI) and the Zung Self-Rating Depression Scale were self-assessed at the baseline, and the former was re-evaluated at the time of cessation of medication or at the end of the 6-month treatment period. The PSQI included the following sub-items: evaluating sleep quality (C1), sleep latency (C2), sleep duration (C3), habitual sleep efficiency (C4), frequency of sleep disturbance (C5), use of sleeping medication (C6), and daytime dysfunction (C7). Among the patients, 54.6% needed to continue hypnotics for a 6-month treatment period. Logistic regression analysis revealed that, among descriptive variables, only the PSQI score appeared as a significant factor associated with long-term use {odds ratio (OR) = 2.8, 95% confidence interval (CI) = 2.0-4.0}. The receiver operating curve (ROC) analysis identified that the cut-off PSQI total score at the baseline for predicting long-term use was estimated at 13.5 points (area under the curve = 0.86, 95% CI = 0.8-0.92). Among the sub-items of PSQI, the increases in C1: (OR = 8.4, 95% CI = 2.4-30.0), C3: (OR = 3.6, 95% CI = 1.1-11.5), C4: (OR = 11.1, 95% CI = 3.6-33.9), and C6: (OR = 3.4, 95% CI = 1.9-6.2) scores were associated with long-term use. This study revealed that a high PSQI score at the baseline, particularly in the sub-items relating to sleep maintenance disturbance, is predictive of long-term hypnotic treatment. Our results imply the limitation of the effectiveness of hypnotic treatment alone for chronic insomnia.	[Takaesu, Yoshikazu; Inoue, Yuichi] Tokyo Med Univ, Dept Psychiat, Shinjuku Ku, Tokyo 1600023, Japan; [Komada, Yoko; Asaoka, Shoichi; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Shinjuku Ku, Tokyo 1600023, Japan; [Komada, Yoko; Inoue, Yuichi] Japan Somnol Ctr, Neuropsychiat Res Inst, Shibuya Ku, Tokyo 1510053, Japan; [Kagimura, Tatsuo] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan	Tokyo Medical University; Tokyo Medical University; Institute for Biomedical Research & Innovation (IBRI)	Takaesu, Y (corresponding author), Tokyo Med Univ, Dept Psychiat, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	esu-yosh@tokyo-med.ac.jp	Komada, Yoko/AAN-8342-2021	Komada, Yoko/0000-0002-0884-1555	Nippon Boehringer Ingelheim; Takeda Pharmaceutical; Mitsubishi Tanabe Pharma; Astellas Pharma; Shionogi; Sanofi-Aventis	Nippon Boehringer Ingelheim(Boehringer Ingelheim); Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd); Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Astellas Pharma(Astellas Pharmaceuticals); Shionogi; Sanofi-Aventis(Sanofi-Aventis)	Yuichi Inoue has received clinically pertinent fees, lecture fees, and research funding from Nippon Boehringer Ingelheim, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma, Astellas Pharma, Shionogi, and Sanofi-Aventis. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALLAIN H, 1991, SLEEP, V14, P408, DOI 10.1093/sleep/14.5.408; Ancoli-Israel S, 1999, SLEEP, V22, pS347; [Anonymous], 2005, NIH Consens State Sci Statements, V22, P1; Baillargeon L, 2003, CAN MED ASSOC J, V169, P1015; Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Dundar Y, 2004, HUM PSYCHOPHARM CLIN, V19, P305, DOI 10.1002/hup.594; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kim K, 2000, SLEEP, V23, P41; Lader M, 2014, BRIT J CLIN PHARMACO, V77, P295, DOI 10.1111/j.1365-2125.2012.04418.x; Lader MH, 1999, EUR NEUROPSYCHOPHARM, V9, P399; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Morgan K, 2003, J PSYCHOSOM RES, V54, P21, DOI 10.1016/S0022-3999(02)00569-X; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Morin CM, 2004, AM J PSYCHIAT, V161, P332, DOI 10.1176/appi.ajp.161.2.332; Ohayon MM, 1996, CAN J PSYCHIAT, V41, P457, DOI 10.1177/070674379604100711; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; RICKELS K, 1983, JAMA-J AM MED ASSOC, V250, P767, DOI 10.1001/jama.250.6.767; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Roane BM, 2008, SLEEP, V31, P1351; Roehrs T, 1996, PSYCHOPHARMACOLOGY, V127, P150, DOI 10.1007/BF02805988; Rosenberg Russell P, 2006, Ann Clin Psychiatry, V18, P49, DOI 10.1080/10401230500464711; Roth T, 1999, SLEEP, V22, pS354; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Shapiro DE, 1999, STAT METHODS MED RES, V8, P113, DOI 10.1177/096228029900800203; Soeffing JP, 2008, SLEEP MED, V9, P165, DOI 10.1016/j.sleep.2007.02.009; Soldatos CR, 1999, INT CLIN PSYCHOPHARM, V14, P287; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stepanski EJ, 2003, SLEEP MED REV, V7, P215, DOI 10.1053/smrv.2001.0246; Suka M, 2003, J OCCUP HEALTH, V45, P344, DOI 10.1539/joh.45.344; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Wade AG, 2007, CURR MED RES OPIN, V23, P2597, DOI 10.1185/030079907X233098; Zammit GK, 1999, SLEEP, V22, pS379; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	35	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113753	10.1371/journal.pone.0113753	http://dx.doi.org/10.1371/journal.pone.0113753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409018	Green Published, gold			2022-12-26	WOS:000345533200153
J	Turek, M; Bringmann, H				Turek, Michal; Bringmann, Henrik			Gene Expression Changes of Caenorhabditis elegans Larvae during Molting and Sleep-Like Lethargus	PLOS ONE			English	Article							WAKEFULNESS; BEHAVIOR; QUIESCENCE; CIRCUIT; NEURON; BRAIN; CUT-1	During their development, Caenorhabditis elegans larvae go through four developmental stages. At the end of each larval stage, nematodes molt. They synthesize a new cuticle and shed the old cuticle. During the molt, larvae display a sleep-like behavior that is called lethargus. We wanted to determine how gene expression changes during the C. elegans molting cycle. We performed transcriptional profiling of C. elegans by selecting larvae displaying either sleep-like behavior during the molt or wake behavior during the intermolt to identify genes that oscillate with the molting-cycle. We found that expression changed during the molt and we identified 520 genes that oscillated with the molting cycle. 138 of these genes were not previously reported to oscillate. The majority of genes that had oscillating expression levels appear to be involved in molting, indicating that the majority of transcriptional changes serve to resynthesize the cuticle. Identification of genes that control sleep-like behavior during lethargus is difficult but may be possible by looking at genes that are expressed in neurons. 22 of the oscillating genes were expressed in neurons. One of these genes, the dopamine transporter gene dat-1, was previously shown in mammals and in C. elegans to control sleep. Taken together, we provide a dataset of genes that oscillate with the molting and sleep-wake cycle, which will be useful to investigate molting and possibly also sleep-like behavior during lethargus.	[Turek, Michal; Bringmann, Henrik] Max Planck Inst Biophys Chem, Max Planck Res Grp Sleep & Wake, D-37077 Gottingen, Germany	Max Planck Society	Bringmann, H (corresponding author), Max Planck Inst Biophys Chem, Max Planck Res Grp Sleep & Wake, D-37077 Gottingen, Germany.	Henrik.Bringmann@mpibpc.mpg.de	Turek, Michał/AAT-3216-2021; Turek, Michał/H-3528-2016	Turek, Michał/0000-0002-4637-5700	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; BRENNER S, 1974, GENETICS, V77, P71; Bringmann H, 2011, J NEUROSCI METH, V201, P78, DOI 10.1016/j.jneumeth.2011.07.013; Brooks DR, 2003, J BIOL CHEM, V278, P52340, DOI 10.1074/jbc.M308858200; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Cho JY, 2014, CELL, V156, P249, DOI 10.1016/j.cell.2013.11.036; Choi S, 2013, NEURON, V78, P869, DOI 10.1016/j.neuron.2013.04.002; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2005, J NEUROCHEM, V94, P1411, DOI 10.1111/j.1471-4159.2005.03291.x; Davis MW, 2004, DEVELOPMENT, V131, P6001, DOI 10.1242/dev.01454; Driver RJ, 2013, CURR BIOL, V23, P501, DOI 10.1016/j.cub.2013.02.009; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwanir S, 2013, SLEEP, V36, P385, DOI 10.5665/sleep.2456; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Jones S, 2008, J NEUROCHEM, V105, P46, DOI 10.1111/j.1471-4159.2007.05089.x; Kim DH, 2013, NAT GENET, V45, P1337, DOI 10.1038/ng.2763; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mackiewicz M, 2009, TRENDS MOL MED, V15, P79, DOI 10.1016/j.molmed.2008.12.002; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Muriel JM, 2003, DEV BIOL, V260, P339, DOI 10.1016/S0012-1606(03)00237-9; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Page A.P., 2007, CUTICLE, P1; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; Schwarz A, 2013, PLOS ONE, V8; Schwarz Juliane, 2012, Worm, V1, P12, DOI 10.4161/worm.19499; Schwarz J, 2011, CURR BIOL, V21, pR983, DOI 10.1016/j.cub.2011.10.046; SEBASTIANO M, 1991, DEV BIOL, V146, P519, DOI 10.1016/0012-1606(91)90253-Y; Singh K, 2014, SLEEP, V37, P1439, DOI 10.5665/sleep.3990; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Turek M, 2013, CURR BIOL, V23, P2215, DOI 10.1016/j.cub.2013.09.028; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001	41	18	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113269	10.1371/journal.pone.0113269	http://dx.doi.org/10.1371/journal.pone.0113269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409030	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200088
J	Chen, YX; Zhang, W; Wang, WM; Yu, XL; Wang, YM; Zhang, MJ; Chen, N				Chen, Yong-Xi; Zhang, Wen; Wang, Wei-Ming; Yu, Xia-Lian; Wang, Yi-Mei; Zhang, Min-Jun; Chen, Nan			Role of Moesin in Renal Fibrosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GLYCATION END-PRODUCTS; ERM PROTEINS; INTERSTITIAL FIBROSIS; ACTIN-BINDING; CELL CORTEX; EZRIN; EXPRESSION; EMT; PHOSPHORYLATION	Background: Renal fibrosis is the final common pathway of chronic kidney disease (CKD). Moesin is a member of Ezrin/Radixin/Moesin (ERM) protein family but its role in renal fibrosis is not clear. Method: Human proximal tubular cells (HK-2) were stimulated with or without TGF-beta 1. Moesin and downstream target genes were examined by real-time PCR and western blot. Phosphorylation of moesin and related signaling pathway was investigated as well. Rat model of unilateral ureteral obstruction (UUO) was established and renal moesin was examined by immunohistochemistry. Moesin in HK-2 cells were knocked down by siRNA and change of downstream genes in transfected HK-2 cells was studied. All animal experiments were reviewed and approved by the Ethics Committee for animal care of Ruijin Hospital. Result: HK-2 cells stimulated with TGF-beta 1 showed up-regulated level of alpha-SMA and down-regulated level of E-Cadherin as well as elevated mRNA and protein level of moesin. In rat model of UUO, renal moesin expression increased in accordance with severity of tubulointerestital fibrosis in the kidneys with ureteral ligation while the contralateral kidneys were normal. Further study showed that TGF-beta 1 could induce phosphorylation of moesin which depended on Erk signaling pathway and Erk inhibitor PD98059 could block moesin phosphorylation. Effects of TGF-beta 1 on moesin phosphorylation was prior to its activation to total moesin. RNA silencing studies showed that knocking down of moesin could attenuate decrease of E-Cadherin induced by TGF-beta 1. Conclusion: We find that moesin might be involved in renal fibrosis and its effects could be related to interacting with E-Cadherin.	[Chen, Yong-Xi; Zhang, Wen; Wang, Wei-Ming; Yu, Xia-Lian; Wang, Yi-Mei; Chen, Nan] Shanghai Jiao Tong Univ, Dept Nephrol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Min-Jun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Anim Expt & Res Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, N (corresponding author), Shanghai Jiao Tong Univ, Dept Nephrol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	chen-nan@medmail.com.cn			National Natural Science Foundation [81000285, 81470041]; Leading Academic Discipline Project of Shanghai Health Bureau [05III001]; Shanghai Leading Academic Discipline Project [T0201]; National Basic Research Program of China 973 [2012CB517600, 2012CB517604]; Shanghai Scientific Committee [10411965900, 08dz1900502]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Leading Academic Discipline Project of Shanghai Health Bureau; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Basic Research Program of China 973(National Basic Research Program of China); Shanghai Scientific Committee	This study was supported by grants from National Natural Science Foundation (No. 81000285, No. 81470041), a grant from the Leading Academic Discipline Project of Shanghai Health Bureau (No. 05III001), a grant from the Shanghai Leading Academic Discipline Project (No. T0201), a grant from National Basic Research Program of China 973 (No. 2012CB517600, No. 2012CB517604) and grant from Shanghai Scientific Committee (No. 10411965900, No. 08dz1900502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach LA, 2005, ANN NY ACAD SCI, V1043, P609, DOI 10.1196/annals.1338.069; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chen YX, 2010, AM J NEPHROL, V31, P24, DOI 10.1159/000253865; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Delle H, 2012, J AM SOC NEPHROL, V23, P37, DOI 10.1681/ASN.2011010046; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Hao L, 2010, TOXICON, V55, P1378, DOI 10.1016/j.toxicon.2010.02.015; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khwaja A, 2007, KIDNEY INT, V72, P1316, DOI 10.1038/sj.ki.5002489; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McRobert EA, 2003, J BIOL CHEM, V278, P25783, DOI 10.1074/jbc.M210433200; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Tokunou M, 2000, LAB INVEST, V80, P1643, DOI 10.1038/labinvest.3780174; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang AH, 2007, AM J PHYSIOL-RENAL, V293, pF723, DOI 10.1152/ajprenal.00480.2006	39	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112936	10.1371/journal.pone.0112936	http://dx.doi.org/10.1371/journal.pone.0112936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406076	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300065
J	Duan, JL; Yin, J; Wu, MM; Liao, P; Deng, D; Liu, G; Wen, QQ; Wang, YF; Qiu, W; Liu, Y; Wu, XL; Ren, WK; Tan, B; Chen, MH; Xiao, H; Wu, L; Li, TJ; Nyachoti, CM; Adeola, O; Yin, YL				Duan, Jielin; Yin, Jie; Wu, Miaomiao; Liao, Peng; Deng, Dun; Liu, Gang; Wen, Qingqi; Wang, Yongfei; Qiu, Wei; Liu, Yan; Wu, Xingli; Ren, Wenkai; Tan, Bie; Chen, Minghong; Xiao, Hao; Wu, Li; Li, Tiejun; Nyachoti, Charles M.; Adeola, Olayiwola; Yin, Yulong			Dietary Glutamate Supplementation Ameliorates Mycotoxin-Induced Abnormalities in the Intestinal Structure and Expression of Amino Acid Transporters in Young Pigs	PLOS ONE			English	Article							PORTAL-DRAINED VISCERA; L-ARGININE; N-CARBAMYLGLUTAMATE; GROWTH-PERFORMANCE; OXIDATIVE STRESS; DEOXYNIVALENOL DON; HEPATIC EXPRESSION; GENE-EXPRESSION; L-PROLINE; METABOLISM	The purpose of this study was to investigate the hypothesis that dietary supplementation with glutamic acid has beneficial effects on growth performance, antioxidant system, intestinal morphology, serum amino acid profile and the gene expression of intestinal amino acid transporters in growing swine fed mold-contaminated feed. Fifteen pigs (LandracexLarge White) with a mean body weight (BW) of 55 kg were randomly divided into control group (basal feed), mycotoxin group (contaminated feed) and glutamate group (2% glutamate+ contaminated feed). Compared with control group, mold-contaminated feed decreased average daily gain (ADG) and increased feed conversion rate (FCR). Meanwhile, fed mold-contaminated feed impaired anti-oxidative system and intestinal morphology, as well as modified the serum amino acid profile in growing pigs. However, supplementation with glutamate exhibited potential positive effects on growth performance of pigs fed mold-contaminated feed, ameliorated the imbalance antioxidant system and abnormalities of intestinal structure caused by mycotoxins. In addition, dietary glutamate supplementation to some extent restored changed serum amino acid profile caused by mold-contaminated feed. In conclusion, glutamic acid may be act as a nutritional regulating factor to ameliorate the adverse effects induced by mycotoxins.	[Duan, Jielin; Yin, Jie; Wu, Miaomiao; Liao, Peng; Deng, Dun; Liu, Gang; Liu, Yan; Wu, Xingli; Ren, Wenkai; Tan, Bie; Xiao, Hao; Wu, Li; Li, Tiejun; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr,Minist Agr, Key Lab Agroecol Proc Subtrop Reg,Hunan Prov Engn, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Changsha 410125, Hunan, Peoples R China; [Wen, Qingqi; Wang, Yongfei] Fujian Aonong Biotechnol Corp, Dept Anim Nutr, Xiamen 361007, Fujian, Peoples R China; [Qiu, Wei] Twins Grp Co Ltd, Ctr Res & Dev, Nanchang 330096, Jiangxi, Peoples R China; [Chen, Minghong] Hunan New Wellful Co LTD, Changsha 410001, Hunan, Peoples R China; [Nyachoti, Charles M.] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Adeola, Olayiwola] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Yin, Yulong] Southwest Collaborat Innovat Ctr Swine Qual & Saf, Chengdu, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Ministry of Agriculture & Rural Affairs; University of Manitoba; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liao, P (corresponding author), Chinese Acad Sci, Inst Subtrop Agr,Minist Agr, Key Lab Agroecol Proc Subtrop Reg,Hunan Prov Engn, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Changsha 410125, Hunan, Peoples R China.	liaopeng@isa.ac.cn; Tjli@isa.ac.cn; yinyulong@isa.ac.cn	YIN, Jie/H-3578-2019; Liao, Peng/N-7270-2017; Liu, Gang/G-5283-2017	YIN, Jie/0000-0003-1852-1042; Liao, Peng/0000-0001-5740-7272; Liu, Gang/0000-0002-9475-5134	National Natural Science Foundation of China [31110103909, 31330075, 31272463]; Hunan Provincial Natural Science Foundation of China [12JJ2014, 13JJ2034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	The present work was supported by grants from the National Natural Science Foundation of China (31110103909, 31330075, 31272463), and the Hunan Provincial Natural Science Foundation of China (No. 12JJ2014, 13JJ2034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas HK, 2013, TOXICON, V74, P68, DOI 10.1016/j.toxicon.2013.07.026; Akiba Y, 2009, AM J PHYSIOL-GASTR L, V297, pG781, DOI 10.1152/ajpgi.90605.2008; Andretta I, 2012, ANIMAL, V6, P1476, DOI 10.1017/S1751731111002278; [Anonymous], [No title captured]; Awad WA, 2005, POULTRY SCI, V84, P928, DOI 10.1093/ps/84.6.928; Beardall J, 1994, Mycotoxin Res, V10, P21, DOI 10.1007/BF03192248; Becker Christiane, 2011, Mycotoxin Res, V27, P287, DOI 10.1007/s12550-011-0106-7; Belokrylov G A, 1999, Biull Eksp Biol Med, V128, P419; Bergen WG, 2009, J NUTR, V139, P821, DOI 10.3945/jn.109.104497; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Boutry C, 2012, AMINO ACIDS, V43, P1485, DOI 10.1007/s00726-012-1221-2; Burkhardt Britta, 2009, Mycotoxin Res, V25, P149, DOI 10.1007/s12550-009-0022-2; Chen G, 2014, AMINO ACIDS, V46, P245, DOI 10.1007/s00726-013-1615-9; Chen S, 2014, AMINO ACIDS, V46, P2365, DOI 10.1007/s00726-014-1789-9; Coppock RW, 2009, TOXICOL IND HEALTH, V25, P637, DOI 10.1177/0748233709348263; Danicke S, 2012, FOOD CHEM TOXICOL, V50, P979, DOI 10.1016/j.fct.2011.12.024; Dietrich B, 2012, ANIMAL, V6, P278, DOI 10.1017/S1751731111001601; Feng YJ, 2012, ANN NY ACAD SCI, V1258, P71, DOI 10.1111/j.1749-6632.2012.06572.x; Feng ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084533; Fleck SC, 2012, TOXICOL LETT, V214, P27, DOI 10.1016/j.toxlet.2012.08.003; Geng MM, 2011, AMINO ACIDS, V40, P1513, DOI 10.1007/s00726-010-0761-6; Grenier B, 2013, TOXINS, V5, P396, DOI 10.3390/toxins5020396; He LQ, 2013, AMINO ACIDS, V45, P383, DOI 10.1007/s00726-013-1514-0; He QH, 2011, J PROTEOME RES, V10, P5214, DOI 10.1021/pr200688u; Hou YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060374; Janeczko MJ, 2007, J NUTR, V137, P2384, DOI 10.1093/jn/137.11.2384; Kang P, 2014, ASIAN AUSTRAL J ANIM, V27, P1150, DOI 10.5713/ajas.2013.13828; Kong XF, 2012, J NUTR BIOCHEM, V23, P1178, DOI 10.1016/j.jnutbio.2011.06.012; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Liu XD, 2012, AMINO ACIDS, V42, P2111, DOI 10.1007/s00726-011-0948-5; Liu YL, 2011, BRIT POULTRY SCI, V52, P255, DOI 10.1080/00071668.2011.559453; Makun Hussaini Anthony, 2011, Mycotoxin Res, V27, P97, DOI 10.1007/s12550-010-0080-5; Mankeviciene A, 2014, FOOD ADDIT CONTAM A, V31, P132, DOI 10.1080/19440049.2013.861614; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P1715, DOI 10.1073/pnas.87.5.1715; Meloche JL, 1995, P SOC EXP BIOL MED, V210, P260, DOI 10.3181/00379727-210-43947; Mezes M, 2010, ACTA VET HUNG, V58, P1, DOI 10.1556/AVet.58.2010.1.1; Modra H, 2013, NEUROENDOCRINOL LETT, V34, P84; Nakamura H, 2013, AM J PHYSIOL-ENDOC M, V304, pE100, DOI 10.1152/ajpendo.00331.2012; Ren WK, 2014, AMINO ACIDS, V46, P2403, DOI 10.1007/s00726-014-1793-0; Ren WK, 2014, J NUTR, V144, P988, DOI 10.3945/jn.114.192120; Ren WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088335; Ren WK, 2013, VACCINE, V31, P367, DOI 10.1016/j.vaccine.2012.10.107; Riedijk MA, 2007, PEDIATR RES, V62, P468, DOI 10.1203/PDR.0b013e31813cbeba; Ruan Z, 2014, AMINO ACIDS, V46, P2219, DOI 10.1007/s00726-014-1762-7; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Soleimany F, 2011, FOOD ADDIT CONTAM A, V28, P494, DOI 10.1080/19440049.2010.551547; Stoll B, 1999, AM J PHYSIOL-ENDOC M, V277, pE168, DOI 10.1152/ajpendo.1999.277.1.E168; Tan BE, 2012, FRONT BIOSCI-LANDMRK, V17, P2237, DOI 10.2741/4047; Tan B, 2012, AMINO ACIDS, V43, P2481, DOI 10.1007/s00726-012-1328-5; Tan B, 2011, J NUTR BIOCHEM, V22, P441, DOI 10.1016/j.jnutbio.2010.03.012; Tan B, 2010, AMINO ACIDS, V38, P1227, DOI 10.1007/s00726-009-0334-8; Tan B, 2009, AMINO ACIDS, V37, P323, DOI 10.1007/s00726-008-0155-1; Tan B, 2009, AMINO ACIDS, V37, P169, DOI 10.1007/s00726-008-0148-0; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Wu GY, 2007, LIVEST SCI, V112, P8, DOI 10.1016/j.livsci.2007.07.003; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Wu GY, 2013, AMINO ACIDS, V44, P1107, DOI 10.1007/s00726-012-1444-2; Wu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069502; Wu X, 2012, J ANIM SCI, V90, P337, DOI 10.2527/jas.53752; Wu X, 2012, ANIM REPROD SCI, V132, P187, DOI 10.1016/j.anireprosci.2012.05.002; Wu X, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-63; Wu X, 2010, AMINO ACIDS, V39, P831, DOI 10.1007/s00726-010-0538-y; Xiao H, 2013, J ANIM SCI, V91, P4772, DOI 10.2527/jas.2013-6426; Xin W, 2013, BIOL TRACE ELEM RES, V153, P191, DOI 10.1007/s12011-013-9668-x; Yang HS, 2013, J ANIM SCI, V91, P2740, DOI 10.2527/jas.2012-5795; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Yao K, 2012, AMINO ACIDS, V42, P2491, DOI 10.1007/s00726-011-1060-6; Yao Kang, 2011, Front Biosci (Schol Ed), V3, P286; Yao K, 2011, BRIT J NUTR, V105, P703, DOI 10.1017/S000711451000365X; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin J, 2013, J FOOD AGRIC ENVIRON, V11, P132; Yin YL, 2010, J FOOD AGRIC ENVIRON, V8, P447; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Yunus AW, 2012, POULTRY SCI, V91, P852, DOI 10.3382/ps.2011-01903; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2	77	44	48	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112357	10.1371/journal.pone.0112357	http://dx.doi.org/10.1371/journal.pone.0112357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405987	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300029
J	Heinonen, JPM; Palmer, SCF; Redpath, SM; Travis, JMJ				Heinonen, Johannes P. M.; Palmer, Stephen C. F.; Redpath, Steve M.; Travis, Justin M. J.			Modelling Hen Harrier Dynamics to Inform Human-Wildlife Conflict Resolution: A Spatially-Realistic, Individual-Based Approach	PLOS ONE			English	Article							CIRCUS-CYANEUS; SENSITIVITY-ANALYSIS; RED GROUSE; MANAGEMENT; BEHAVIOR; PREDATORS; RESPONSES; SELECTION; PROTOCOL; ECOLOGY	Individual-based models have gained popularity in ecology, and enable simultaneous incorporation of spatial explicitness and population dynamic processes to understand spatio-temporal patterns of populations. We introduce an individual-based model for understanding and predicting spatial hen harrier (Circus cyaneus) population dynamics in Great Britain. The model uses a landscape with habitat, prey and game management indices. The hen harrier population was initialised according to empirical census estimates for 1988/89 and simulated until 2030, and predictions for 1998, 2004 and 2010 were compared to empirical census estimates for respective years. The model produced a good qualitative match to overall trends between 1989 and 2010. Parameter explorations revealed relatively high elasticity in particular to demographic parameters such as juvenile male mortality. This highlights the need for robust parameter estimates from empirical research. There are clearly challenges for replication of real-world population trends, but this model provides a useful tool for increasing understanding of drivers of hen harrier dynamics and focusing research efforts in order to inform conflict management decisions.	[Heinonen, Johannes P. M.; Palmer, Stephen C. F.; Redpath, Steve M.; Travis, Justin M. J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen	Heinonen, JPM (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	j.heinonen@abdn.ac.uk	Palmer, Steve/GSE-1103-2022; Travis, Justin/B-8571-2014; Redpath, Stephen/B-4640-2012	Travis, Justin/0000-0002-5785-4272; Redpath, Stephen/0000-0001-5399-9477	College of Life Sciences and Medicine of the University	College of Life Sciences and Medicine of the University	Johannes Heinonen has been funded by a scholarship from the College of Life Sciences and Medicine of the University of Aberdeen during the work leading to this manuscript. The funder had no role in study design, simulation data generation and analysis, decision to publish, or preparation of the manuscript.	Aben J, 2014, J APPL ECOL, V51, P693, DOI 10.1111/1365-2664.12224; An L, 2012, ECOL MODEL, V229, P25, DOI 10.1016/j.ecolmodel.2011.07.010; Anderson BJ, 2009, BIOL CONSERV, V142, P488, DOI 10.1016/j.biocon.2008.10.036; Arroyo B, 2009, BIOL CONSERV, V142, P586, DOI 10.1016/j.biocon.2008.11.013; Arroyo B, 2014, BIRD STUDY, V61, P48, DOI 10.1080/00063657.2013.874976; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Bennett VJ, 2011, ECOL MODEL, V222, P2770, DOI 10.1016/j.ecolmodel.2011.04.025; Bennett VJ, 2009, ECOL COMPLEX, V6, P113, DOI 10.1016/j.ecocom.2008.08.002; Bousquet F, 2004, ECOL MODEL, V176, P313, DOI 10.1016/j.ecolmodel.2004.01.011; Bunnefeld N, 2011, TRENDS ECOL EVOL, V26, P441, DOI 10.1016/j.tree.2011.05.003; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Cortes-Avizanda A, 2014, ECOLOGY, V95, P1799, DOI 10.1890/13-0574.1; de Almeida SJ, 2010, ENVIRON MODELL SOFTW, V25, P1490, DOI 10.1016/j.envsoft.2010.04.021; Etheridge B, 1997, J APPL ECOL, V34, P1081, DOI 10.2307/2405296; Fielding A, 2011, 441 JNCC; Filatova T, 2013, ENVIRON MODELL SOFTW, V45, P1, DOI 10.1016/j.envsoft.2013.03.017; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hayhow DB, 2013, BIRD STUDY, V60, P446, DOI 10.1080/00063657.2013.839621; Jeltsch F, 1997, P ROY SOC B-BIOL SCI, V264, P495, DOI 10.1098/rspb.1997.0071; Jordan F, 2011, ECOL COMPLEX, V8, P357, DOI 10.1016/j.ecocom.2011.07.006; Le Hay G, 2001, ENVIRON MANAGE, V27, P451; Lovegrove R., 2007, SILENT FIELDS LONG D; MacDonald D, 2009, KEY TOPICS CONSERVAT; McCaffery RM, 2014, BIOL CONSERV, V170, P169, DOI 10.1016/j.biocon.2013.12.013; Merkle JA, 2011, J WILDLIFE MANAGE, V75, P1121, DOI 10.1002/jwmg.153; New LF, 2011, J APPL ECOL, V48, P1187, DOI 10.1111/j.1365-2664.2011.02013.x; Parry HR, 2013, ENVIRON MODELL SOFTW, V45, P104, DOI 10.1016/j.envsoft.2012.08.006; PICOZZI N, 1984, IBIS, V126, P356, DOI 10.1111/j.1474-919X.1984.tb00256.x; Potts GR, 1998, IBIS, V140, P76, DOI 10.1111/j.1474-919X.1998.tb04544.x; Redpath S, 1998, BIRD STUDY, V45, P51, DOI 10.1080/00063659809461077; Redpath SM, 1999, J ANIM ECOL, V68, P879, DOI 10.1046/j.1365-2656.1999.00340.x; Risely K., 2009, 537 BTO; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Sharrock J.T.R., 1976, ATLAS BREEDING BIRDS; Sim IMW, 2007, BIRD STUDY, V54, P256, DOI 10.1080/00063650709461482; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Thirgood S, 2008, J APPL ECOL, V45, P1550, DOI 10.1111/j.1365-2664.2008.01519.x; Thirgood SJ, 2000, P ROY SOC B-BIOL SCI, V267, P651, DOI 10.1098/rspb.2000.1051; Tourenq C, 2001, J APPL ECOL, V38, P170, DOI 10.1046/j.1365-2664.2001.00581.x; Travis JMJ, 2011, METHODS ECOL EVOL, V2, P477, DOI 10.1111/j.2041-210X.2011.00104.x; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Valbuena D, 2010, J ENVIRON MANAGE, V91, P2615, DOI 10.1016/j.jenvman.2010.07.041; Valbuena D, 2010, LANDSCAPE ECOL, V25, P185, DOI 10.1007/s10980-009-9380-6; White RM, 2009, LAND USE POLICY, V26, P242, DOI 10.1016/j.landusepol.2008.03.005; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 2005, CONSERV BIOL SER, V9, P388; Woodroffe R., 2005, CONSERV BIOL; [No title captured]	52	5	5	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112492	10.1371/journal.pone.0112492	http://dx.doi.org/10.1371/journal.pone.0112492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405860	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300035
J	Iachini, T; Coello, Y; Frassinetti, F; Ruggiero, G				Iachini, Tina; Coello, Yann; Frassinetti, Francesca; Ruggiero, Gennaro			Body Space in Social Interactions: A Comparison of Reaching and Comfort Distance in Immersive Virtual Reality	PLOS ONE			English	Article							PERSONAL-SPACE; SEX	Background: Do peripersonal space for acting on objects and interpersonal space for interacting with con-specifics share common mechanisms and reflect the social valence of stimuli? To answer this question, we investigated whether these spaces refer to a similar or different physical distance. Methodology: Participants provided reachability-distance (for potential action) and comfort-distance (for social processing) judgments towards human and non-human virtual stimuli while standing still (passive) or walking toward stimuli (active). Principal Findings: Comfort-distance was larger than other conditions when participants were passive, but reachability and comfort distances were similar when participants were active. Both spaces were modulated by the social valence of stimuli (reduction with virtual females vs males, expansion with cylinder vs robot) and the gender of participants. Conclusions: These findings reveal that peripersonal reaching and interpersonal comfort spaces share a common motor nature and are sensitive, at different degrees, to social modulation. Therefore, social processing seems embodied and grounded in the body acting in space.	[Iachini, Tina; Ruggiero, Gennaro] Univ Naples 2, Lab Cognit Sci & Immers Virtual Real, Dept Psychol, Caserta, Italy; [Coello, Yann] Univ Lille, Res Unit Cognit & Affect Sci, Dept Psychol, Lille, France; [Frassinetti, Francesca] Univ Bologna, Dept Psychol, Bologna, Italy	Universita della Campania Vanvitelli; Universite de Lille - ISITE; Universite de Lille; University of Bologna	Iachini, T (corresponding author), Univ Naples 2, Lab Cognit Sci & Immers Virtual Real, Dept Psychol, Caserta, Italy.	santa.iachini@unina2.it	FRASSINETTI, FRANCESCA/ABI-1533-2020; Frassinetti, Francesca/K-1474-2016; Iachini, Tina/E-1268-2014	FRASSINETTI, FRANCESCA/0000-0001-6810-2861; Frassinetti, Francesca/0000-0001-6810-2861; Iachini, Tina/0000-0001-8405-8768; Ruggiero, Gennaro/0000-0002-3940-6740	Ministry of Research (program "Investments for the Future''); National Research Agency [ANR-11-EQPX-0023]; European funds; Second University of Naples funds	Ministry of Research (program "Investments for the Future''); National Research Agency(French National Research Agency (ANR)); European funds; Second University of Naples funds	This work was supported by a grant from the Ministry of Research (program "Investments for the Future'') and managed by the National Research Agency under the reference ANR-11-EQPX-0023, as well as by European funds through the program FEDER SCV-IrDIVE. The work was also supported by Second University of Naples funds to TI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello J. R., 1987, HDB ENV PSYCHOL; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bartolo A, 2009, P 14 INT C FUNCT MAP; Bell P. A., 2005, ENV PSYCHOL; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Brozzoli C, 2013, CURR BIOL, V23, P1764, DOI 10.1016/j.cub.2013.07.004; BYRNE D, 1971, J APPL SOC PSYCHOL, V1, P137; Cardellicchio P, 2011, NEUROPSYCHOLOGIA, V49, P1369, DOI 10.1016/j.neuropsychologia.2011.01.021; Cardinali L., 2011, TOOL USE CAUSAL COGN; Coello Y, 2012, COGN PROCESS, V13, pS131, DOI 10.1007/s10339-012-0470-z; Coello Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002862; Delevoye-Turrell Y., 2010, PERCEPTION ACTION CO; Delevoye-Turrell Y, 2011, SOC PSYCHOL-GERMANY, V42, P193, DOI 10.1027/1864-9335/a000063; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; FISHER JD, 1975, J PERS SOC PSYCHOL, V32, P15, DOI 10.1037/h0076837; Gabbard C, 2007, J MOTOR BEHAV, V39, P242, DOI 10.3200/JMBR.39.4.242-246; Gallese V, 2009, PSYCHOL RES-PSYCH FO, V73, P486, DOI 10.1007/s00426-009-0232-4; Gessaroli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074959; GOGEL WC, 1976, PERCEPT PSYCHOPHYS, V20, P419, DOI 10.3758/BF03208276; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Iachini T, 2011, J MENTAL IMAGERY, V35, P1; Iachini T, 2012, APPL COGNITIVE PSYCH, V26, P757, DOI 10.1002/acp.2856; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Lourenco SF, 2011, COGNITION, V119, P448, DOI 10.1016/j.cognition.2011.02.009; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PATTERSON ML, 1976, PSYCHOL REV, V83, P235, DOI 10.1037/0033-295X.83.3.235; Quesque F, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00014; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Ruggiero G, 2014, NEUROPSYCHOLOGY, V28, P147, DOI 10.1037/neu0000009; Ruotolo F, 2013, ENVIRON IMPACT ASSES, V41, P10, DOI 10.1016/j.eiar.2013.01.007; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Sommer R, 2002, HDB ENV PSYCHOL, V1937, P647; Tajadura-Jimenez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026083; Takayama L, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5495, DOI 10.1109/IROS.2009.5354145; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043; Uzzell D, 2006, BRIT J SOC PSYCHOL, V45, P579, DOI 10.1348/014466605X58384	45	99	101	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111511	10.1371/journal.pone.0111511	http://dx.doi.org/10.1371/journal.pone.0111511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405344	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300010
J	Moschetti, R; Celauro, E; Cruciani, F; Caizzi, R; Dimitri, P				Moschetti, Roberta; Celauro, Emanuele; Cruciani, Fulvio; Caizzi, Ruggiero; Dimitri, Patrizio			On the Evolution of Yeti, a Drosophila melanogaster Heterochromatin Gene	PLOS ONE			English	Article							CENTRIC HETEROCHROMATIN; CENTROMERIC HETEROCHROMATIN; CHROMOSOME HETEROCHROMATIN; CYTOGENETIC ANALYSIS; HYBRIDIZATION; SEQUENCE; ELEMENTS; LOCI; DNA	Constitutive heterochromatin is a ubiquitous and still unveiled component of eukaryotic genomes, within which it comprises large portions. Although constitutive heterochromatin is generally considered to be transcriptionally silent, it contains a significant variety of sequences that are expressed, among which about 300 single-copy coding genes have been identified by genetic and genomic analyses in the last decades. Here, we report the results of the evolutionary analysis of Yeti, an essential gene of Drosophila melanogaster located in the deep pericentromeric region of chromosome 2R. By FISH, we showed that Yeti maintains a heterochromatin location in both D. simulans and D. sechellia species, closely related to D. melanogaster, while in the more distant species e. g., D. pseudoobscura and D. virilis, it is found within euchromatin, in the syntenic chromosome Muller C, that corresponds to the 2R arm of D. melanogaster chromosome 2. Thus, over evolutionary time, Yeti has been resident on the same chromosomal element, but it progressively moved closer to the pericentric regions. Moreover, in silico reconstruction of the Yeti gene structure in 19 Drosophila species and in 5 non-drosophilid dipterans shows a rather stable organization during evolution. Accordingly, by PCR analysis and sequencing, we found that the single intron of Yeti does not undergo major intraspecies or interspecies size changes, unlike the introns of other essential Drosophila heterochromatin genes, such as light and Dbp80. This implicates diverse evolutionary forces in shaping the structural organization of genes found within heterochromatin. Finally, the results of d(S) - d(N) tests show that Yeti is under negative selection both in heterochromatin and euchromatin, and indicate that the change in genomic location did not affected significantly the molecular evolution of the gene. Together, the results of this work contribute to our understanding of the evolutionary dynamics of constitutive heterochromatin in the genomes of higher eukaryotes.	[Moschetti, Roberta; Caizzi, Ruggiero] Univ Bari, Dipartimento Biol, Bari, Italy; [Celauro, Emanuele; Cruciani, Fulvio; Dimitri, Patrizio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Celauro, Emanuele; Cruciani, Fulvio; Dimitri, Patrizio] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Universita degli Studi di Bari Aldo Moro; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Dimitri, P (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	patrizio.dimitri@uniroma1.it	Celauro, Emanuele/N-4228-2016	Celauro, Emanuele/0000-0002-0781-5873; Caizzi, Ruggiero/0000-0002-4360-2808; Cruciani, Fulvio/0000-0002-6900-024X; Moschetti, Roberta/0000-0003-3035-1090	Ministero dell'Universita e della Ricerca-Miur; Istituto Pasteur-Fondazione Cenci-Bolognetti; Fondazione Roma terzo settore	Ministero dell'Universita e della Ricerca-Miur(Ministry of Education, Universities and Research (MIUR)); Istituto Pasteur-Fondazione Cenci-Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Fondazione Roma terzo settore(Fondazione Roma)	This research was supported by grants from Ministero dell'Universita e della Ricerca-Miur (Prin 2008), Istituto Pasteur-Fondazione Cenci-Bolognetti and Fondazione Roma terzo settore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Berghella L, 1996, GENETICS, V144, P117; BRIZUELA BJ, 1994, GENETICS, V137, P803; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Cenci G, 2003, GENET RES, V81, P15, DOI 10.1017/S0016672302006018; Coulthard AB, 2010, GENETICS, V185, P479, DOI 10.1534/genetics.110.117259; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; DEVLIN RH, 1990, GENETICS, V125, P129; DIMITRI P, 1991, GENETICS, V127, P553; Dimitri P, 2004, METH MOL B, V260, P29, DOI 10.1385/1-59259-755-6:029; Dimitri P, 2003, GENETICA, V117, P209, DOI 10.1023/A:1022996112742; Dimitri P, 2003, MOL BIOL EVOL, V20, P503, DOI 10.1093/molbev/msg048; Dimitri P, 2009, CHROMOSOMA, V118, P419, DOI 10.1007/s00412-009-0211-y; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Fitzpatrick KA, 2005, GENOME, V48, P571, DOI 10.1139/G05-025; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; He B, 2012, GENOME RES, V22, P2507, DOI 10.1101/gr.137406.112; Heitz E, 1928, JAHRB WISS BOT, V69, P762; HILLIKER AJ, 1976, GENETICS, V83, P765; Hoskins RA, 2002, GENOME BIOL, V3; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Iwashita S, 2003, MOL BIOL EVOL, V20, P1556, DOI 10.1093/molbev/msg168; John B, 1988, HETEROCHROMATIN MOL, P1; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Koryakov DE, 2002, GENETICS, V160, P509; MARCHANT GE, 1988, GENETICS, V120, P519; Marygold SJ, 2005, GENETICS, V169, P683, DOI 10.1534/genetics.104.034124; Messina G, 2014, J CELL SCI, V127, P2577, DOI 10.1242/jcs.150243; MORITZ KB, 1976, NATURE, V259, P55, DOI 10.1038/259055a0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pardue ML, 2007, ANNU REV CELL DEV BI, V23, P1, DOI 10.1146/annurev.cellbio.23.090506.123459; Pardue ML, 1986, DROSOPHILA PRACTICAL, P111; Peterson DG, 1998, GENOME, V41, P346, DOI 10.1139/gen-41-3-346; Rossi F, 2007, GENETICS, V175, P595, DOI 10.1534/genetics.106.065441; Schaeffer SW, 2008, GENETICS, V179, P1601, DOI 10.1534/genetics.107.086074; Schulze SR, 2006, GENETICS, V173, P1433, DOI 10.1534/genetics.106.056069; Schulze SR, 2005, GENETICS, V169, P2165, DOI 10.1534/genetics.103.023341; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Villasante A, 2007, CELL CYCLE, V6, P2872, DOI 10.4161/cc.6.23.5047; Waterhouse RM, 2011, NUCLEIC ACIDS RES, V39, pD283, DOI 10.1093/nar/gkq930; WILLIAMS SM, 1992, TRENDS GENET, V8, P335, DOI 10.1016/0168-9525(92)90277-B; Yasuhara JC, 2005, P NATL ACAD SCI USA, V102, P10958, DOI 10.1073/pnas.0503424102; ZHANG P, 1995, GENETICS, V139, P659	46	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113010	10.1371/journal.pone.0113010	http://dx.doi.org/10.1371/journal.pone.0113010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405891	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300070
J	Rudick, CN; Taylor, AK; Yaggie, RE; Schaeffer, AJ; Klumpp, DJ				Rudick, Charles N.; Taylor, Aisha K.; Yaggie, Ryan E.; Schaeffer, Anthony J.; Klumpp, David J.			Asymptomatic Bacteriuria Escherichia coli Are Live Biotherapeutics for UTI	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; RANDOMIZED CONTROLLED-TRIAL; CROSS-TALK; PREVENTION; BLADDER; PLACEBO; EVASION; INTERFERENCE; INDUCTION; WOMEN	Urinary tract infections (UTI) account for approximately 8 million clinic visits annually with symptoms that include acute pelvic pain, dysuria, and irritative voiding. Empiric UTI management with antimicrobials is complicated by increasing antimicrobial resistance among uropathogens, but live biotherapeutics products (LBPs), such as asymptomatic bacteriuria (ASB) strains of E. coli, offer the potential to circumvent antimicrobial resistance. Here we evaluated ASB E. coli as LBPs, relative to ciprofloxacin, for efficacy against infection and visceral pain in a murine UTI model. Visceral pain was quantified as tactile allodynia of the pelvic region in response to mechanical stimulation with von Frey filaments. Whereas ciprofloxacin promoted clearance of uropathogenic E. coli (UPEC), it did not reduce pelvic tactile allodynia, a measure of visceral pain. In contrast, ASB E. coli administered intravesically or intravaginally provided comparable reduction of allodynia similar to intravesical lidocaine. Moreover, ASB E. coli were similarly effective against UTI allodynia induced by Proteus mirabilis, Enterococccus faecalis and Klebsiella pneumoniae. Therefore, ASB E. coli have anti- infective activity comparable to the current standard of care yet also provide superior analgesia. These studies suggest that ASB E. coli represent novel LBPs for UTI symptoms.	[Rudick, Charles N.; Taylor, Aisha K.; Yaggie, Ryan E.; Schaeffer, Anthony J.; Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Klumpp, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	d-klumpp@northwestern.edu			National Institute of Diabetes and Digestive and Kidney Diseases;  [R01 DK042648];  [U01 DK8234201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK082342, R01DK042648] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were funded by the National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov/Pages/default.aspx). Funding was through awards R01 DK042648 and U01 DK8234201 to D.J.K. and A.J.S. Award U01 DK8234201 is within the Multi-Disciplinary Approaches to Chronic Pelvic Pain Research Network (MAPP, www.mappnetwork.org). This work was approved for publication by the MAPP Publications Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON P, 1991, INFECT IMMUN, V59, P2915, DOI 10.1128/IAI.59.9.2915-2921.1991; Bergsten G, 2007, CELL MICROBIOL, V9, P1766, DOI 10.1111/j.1462-5822.2007.00912.x; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Bleidorn J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-30; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; Czaja Christopher A, 2007, Infect Dis Obstet Gynecol, V2007, P35387, DOI 10.1155/2007/35387; Darouiche RO, 2011, UROLOGY, V78, P341, DOI 10.1016/j.urology.2011.03.062; Darouiche RO, 2005, CLIN INFECT DIS, V41, P1531, DOI 10.1086/497272; Ferry SA, 2004, SCAND J INFECT DIS, V36, P296, DOI 10.1080/00365540410019642; Fiore C, 2010, REGULATORY CONSIDERA; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Hang L, 2000, J INFECT DIS, V182, P1738, DOI 10.1086/317599; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; HOPKINS WJ, 1995, J INFECT DIS, V171, P462, DOI 10.1093/infdis/171.2.462; Hull R, 2000, J UROLOGY, V163, P872, DOI 10.1016/S0022-5347(05)67823-8; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Klemm P, 2007, INFECT IMMUN, V75, P3688, DOI 10.1128/IAI.01730-06; Klumpp DJ, 2006, INFECT IMMUN, V74, P5106, DOI 10.1128/IAI.00376-06; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; LINDBERG U, 1975, ACTA PAEDIATR SCAND, V64, P718, DOI 10.1111/j.1651-2227.1975.tb03910.x; Looft T, 2012, GUT MICROBES, V3, P463, DOI 10.4161/gmic.21288; Malykhina AP, 2012, NEUROUROL URODYNAM, V31, P352, DOI 10.1002/nau.21228; McMahon SB, 1978, J PHYSL, V275; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Naber KG, 2011, INT J ANTIMICROB AG, V38, P21, DOI 10.1016/j.ijantimicag.2011.09.003; Nelson C, 1999, VITAL HLTH STAT, V13; OLD DC, 1970, J BACTERIOL, V103, P447, DOI 10.1128/JB.103.2.447-456.1970; Parsons CL, 2006, EXPERT OPIN PHARMACO, V7, P411, DOI 10.1517/14656566.7.4.411; Pezzone MA, 2005, GASTROENTEROLOGY, V128, P1953, DOI 10.1053/j.gastro.2005.03.008; Reid G, 2006, WORLD J UROL, V24, P28, DOI 10.1007/s00345-005-0043-1; Rudick CN, 2007, AM J PHYSIOL-REG I, V293, pR1191, DOI 10.1152/ajpregu.00411.2007; Rudick CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041273; Rudick CN, 2010, J INFECT DIS, V201, P1240, DOI 10.1086/651275; Schaeffer AJ, 2012, CAMPBELL WALSH UROLO, P223; Stapleton A, 2003, INFECT DIS CLIN N AM, V17, P457, DOI 10.1016/S0891-5520(03)00010-2; Stewardson AJ, 2011, CURR OPIN PHARMACOL, V11, P446, DOI 10.1016/j.coph.2011.06.011; Sunden F, 2010, J UROLOGY, V184, P179, DOI 10.1016/j.juro.2010.03.024; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Wise BL, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.05.027	45	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e109321	10.1371/journal.pone.0109321	http://dx.doi.org/10.1371/journal.pone.0109321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405579	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300005
J	Cohen, SS; Park, YY; Signorello, LB; Patel, AV; Boggs, DA; Kolonel, LN; Kitahara, CM; Knutsen, SF; Gillanders, E; Monroe, KR; de Gonzalez, AB; Bethea, TN; Black, A; Fraser, G; Gapstur, S; Hartge, P; Matthews, CE; Park, SY; Purdue, MP; Singh, P; Harvey, C; Blot, WJ; Palmer, JR				Cohen, Sarah S.; Park, Yikyung; Signorello, Lisa B.; Patel, Alpa V.; Boggs, Deborah A.; Kolonel, Laurence N.; Kitahara, Cari M.; Knutsen, Synnove F.; Gillanders, Elizabeth; Monroe, Kristine R.; de Gonzalez, Amy Berrington; Bethea, Traci N.; Black, Amanda; Fraser, Gary; Gapstur, Susan; Hartge, Patricia; Matthews, Charles E.; Park, Song-Yi; Purdue, Mark P.; Singh, Pramil; Harvey, Chinonye; Blot, William J.; Palmer, Julie R.			A Pooled Analysis of Body Mass Index and Mortality among African Americans	PLOS ONE			English	Article							SELF-REPORTED HEIGHT; UNITED-STATES; US ADULTS; PROSPECTIVE COHORT; OBESITY; WEIGHT; ASSOCIATION; OVERWEIGHT; WHITE; WOMEN	Pooled analyses among whites and East Asians have demonstrated positive associations between all-cause mortality and body mass index (BMI), but studies of African Americans have yielded less consistent results. We examined the association between BMI and all-cause mortality in a sample of African Americans pooled from seven prospective cohort studies: NIH-AARP, 1995-2009; Adventist Health Study 2, 2002-2008; Black Women's Health Study, 1995-2009; Cancer Prevention Study II, 1982-2008; Multiethnic Cohort Study, 1993-2007; Prostate, Lung, Colorectal and Ovarian Screening Trial, 1993-2009; Southern Community Cohort Study, 2002-2009. 239,526 African Americans (including 100,175 never smokers without baseline heart disease, stroke, or cancer), age 30-104 (mean 52) and 71% female, were followed up to 26.5 years (mean 11.7). Hazard ratios (HR) and 95% confidence intervals (CI) for mortality were derived from multivariate Cox proportional hazards models. Among healthy, never smokers (11,386 deaths), HRs (CI) for BMI 25-27.4, 27.5-29.9, 30-34.9, 35-39.9, 40-49.9, and 50-60 kg/m(2) were 1.02 (0.92-1.12), 1.06 (0.95-1.18), 1.32 (1.18-1.47), 1.54 (1.29-1.83), 1.93 (1.46-2.56), and 1.93 (0.80-4.69), respectively among men and 1.06 (0.99-1.15), 1.15 (1.06-1.25), 1.24 (1.15-1.34), 1.58 (1.43-1.74), 1.80 (1.60-2.02), and 2.31 (1.74-3.07) respectively among women (reference category 22.5-24.9). HRs were highest among those with the highest educational attainment, longest follow-up, and for cardiovascular disease mortality. Obesity was associated with a higher risk of mortality in African Americans, similar to that observed in pooled analyses of whites and East Asians. This study provides compelling evidence to support public health efforts to prevent excess weight gain and obesity in African Americans.	[Cohen, Sarah S.; Blot, William J.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Cohen, Sarah S.] EpidStat Inst, Ann Arbor, MI USA; [Park, Yikyung; Kitahara, Cari M.; de Gonzalez, Amy Berrington; Black, Amanda; Hartge, Patricia; Matthews, Charles E.; Purdue, Mark P.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Signorello, Lisa B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Patel, Alpa V.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Boggs, Deborah A.; Bethea, Traci N.; Palmer, Julie R.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Kolonel, Laurence N.; Park, Song-Yi] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Knutsen, Synnove F.; Fraser, Gary] Loma Linda Univ, Sch Publ Hlth, Ctr Nutr Hlth Lifestyle & Dis Prevent, Loma Linda, CA 92350 USA; [Gillanders, Elizabeth] NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; [Monroe, Kristine R.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Singh, Pramil] Loma Linda Univ, Sch Publ Hlth, Ctr Hlth Res, Loma Linda, CA 92350 USA; [Harvey, Chinonye] NCI, Epidemiol & Genom Res Program, NIH, Bethesda, MD 20892 USA; [Blot, William J.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN 37235 USA; [Blot, William J.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; American Cancer Society; Boston University; Cancer Research Center of Hawaii; University of Hawaii System; Loma Linda University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; Loma Linda University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University	Cohen, SS (corresponding author), Int Epidemiol Inst, Rockville, MD 20850 USA.	sarah@epidstat.com	Purdue, Mark P/C-9228-2016; Kitahara, Cari M/R-8267-2016; de gonzalez, amy berrington/L-7017-2017; matthews, Charles e/E-8073-2015	Purdue, Mark P/0000-0003-1177-3108; Kitahara, Cari M/0000-0001-6416-4432; de gonzalez, amy berrington/0000-0002-7332-8387; matthews, Charles e/0000-0001-8037-3103; Park, Yikyung/0000-0002-6281-489X; Singh, Pramil/0000-0002-9820-2887; Cohen, Sarah/0000-0003-0421-1983; Bethea, Traci/0000-0003-3205-2078	National Cancer Institute's (NCI) Intramural Research Program, Division of Cancer Epidemiology and Genetics (DCEG); Epidemiology and Genomics Research Program, Division of Cancer Control and Populations Sciences; Intramural Research Program of the National Cancer Institute, National Institutes of Health; National Cancer Institute [R01 CA94594, R01 CA058420, R37 CA54281, R01 CA092447, 3R01 CA092447-08S1]; American Cancer Society; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA094594, R01CA058420, ZIACP010196, R37CA054281, R01CA092447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092986] Funding Source: NIH RePORTER	National Cancer Institute's (NCI) Intramural Research Program, Division of Cancer Epidemiology and Genetics (DCEG); Epidemiology and Genomics Research Program, Division of Cancer Control and Populations Sciences; Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This pooled analysis was supported by the National Cancer Institute's (NCI) Intramural Research Program, Division of Cancer Epidemiology and Genetics (DCEG) and the Epidemiology and Genomics Research Program, Division of Cancer Control and Populations Sciences. The NIH-AARP study is supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The Adventist Health Study 2 is funded by grant R01 CA94594 from the National Cancer Institute. The Black Women's Health Study is funded by grant R01 CA058420 from the National Cancer Institute. The Cancer Prevention Study II Nutrition Cohort is supported by the American Cancer Society. The authors thank all of the men and women in the Cancer Prevention Study II Nutrition Cohort for their many years of dedicated participation in the study. The Multiethnic Cohort Study (MEC) is funded by grant R37 CA54281 from the National Cancer Institute. The PLCO is supported by contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health. The PLCO investigators thank the Screening Center investigators and staff of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, Mr. Tom Riley and staff, Information Management Services, Inc., Ms. Barbara O'Brien and staff, Westat, Inc. Most importantly, we acknowledge the study participants for their contributions to making this study possible. The Southern Community Cohort Study (SCCS) is funded by grant R01 CA092447 from the National Cancer Institute including special allocations from the American Recovery and Reinvestment Act (3R01 CA092447-08S1). The funding sources for this study did not participate in the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, or the decision to submit the manuscript for publication.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Craig BM, 2009, MATERN CHILD HLTH J, V13, P489, DOI 10.1007/s10995-008-0384-7; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Doubeni CA, 2012, AM J PUBLIC HEALTH, V102, P680, DOI 10.2105/AJPH.2011.300158; DurazoArvizu R, 1997, ANN EPIDEMIOL, V7, P383, DOI 10.1016/S1047-2797(97)00044-6; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Keith SW, 2011, INT J OBESITY, V35, P401, DOI 10.1038/ijo.2010.148; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Park SY, 2012, EUR J EPIDEMIOL, V27, P489, DOI 10.1007/s10654-012-9695-5; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; SORLIE PD, 1995, AM J PUBLIC HEALTH, V85, P949, DOI 10.2105/AJPH.85.7.949; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	23	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111980	10.1371/journal.pone.0111980	http://dx.doi.org/10.1371/journal.pone.0111980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25401742	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700023
J	Dakshinamoorthy, G; von Gegerfelt, A; Andersen, H; Lewis, M; Kalyanasundaram, R				Dakshinamoorthy, Gajalakshmi; von Gegerfelt, Agneta; Andersen, Hanne; Lewis, Mark; Kalyanasundaram, Ramaswamy			Evaluation of a Multivalent Vaccine against Lymphatic Filariasis in Rhesus macaque Model	PLOS ONE			English	Article							BRUGIA-MALAYI; BANCROFTIAN FILARIASIS; CYTOKINE RESPONSES; IMMUNOGLOBULIN-G; IMMUNE-RESPONSE; INFECTION; MONKEYS; ALBENDAZOLE; ELIMINATION; INDUCTION	Lymphatic filariasis affects 120 million people worldwide and another 1.2 billion people are at risk of acquiring the infection. Chemotherapy with mass drug administration is substantially reducing the incidence of the infection. Nevertheless, an effective vaccine is needed to prevent the infection and eradicate the disease. Previously we reported that a multivalent fusion protein vaccine (rBmHAT) composed of small heat shock proteins 12.6 (HSP12.6), abundant larval transcript-2 (ALT-2) and large extracellular domain of tetraspanin (TSP LEL) could confer >95% protection against the challenge infection with Brugia malayi infective larvae (L3) in mouse and gerbil models. In this study we evaluated the immunogenicity and efficacy of rBmHAT fusion protein vaccine in a rhesus macaque model. Our results show that rBmHAT is highly immunogenic in rhesus macaques. All the vaccinated monkeys developed significant titers of antigen-specific IgG antibodies against each of the component antigens (16,000 for rBmHSP12.6), (24,000 for rBmALT-2) and (16,000 for rBmTSP-LEL). An in vitro antibody dependent cellular cytotoxicity (ADCC) assay performed using the sera samples from vaccinated monkeys showed that the anti-rBmHAT antibodies are functional with 35% killing of B. malayi L3s. Vaccinated monkeys also had antigen responding cells in the peripheral blood. Vaccine-induced protection was determined after challenging the monkeys with 500 B. malayi L3. Following challenge infection, 3 out of 5 vaccinated macaques failed to develop the infection. These three protected macaques had high titers of IgG1 antibodies and their PBMC secreted significantly high levels of IFN-gamma in response to the vaccine antigens. The two vaccinated macaques that picked the infection had slightly low titers of antibodies and their PBMC secreted high levels of IL-10. Based on these findings we conclude that the rBmHAT vaccine is highly immunogenic and safe and can confer significant protection against challenge infections in rhesus macaques.	[Dakshinamoorthy, Gajalakshmi; Kalyanasundaram, Ramaswamy] Univ Illinois Coll Med Rockford, Dept Biomed Sci, Rockford, IL 61101 USA; [von Gegerfelt, Agneta; Andersen, Hanne; Lewis, Mark] Bioqual Inc, Rockville, MD USA	BIOQUAL Inc.	Kalyanasundaram, R (corresponding author), Univ Illinois Coll Med Rockford, Dept Biomed Sci, Rockford, IL 61101 USA.	ramswamy@uic.edu		Elyard, Hanne/0000-0003-1103-9608	PIPB by the Division of Microbial and Infectious Diseases [HHSN27220100006I/HHSN2720003]; NIH RO1 grant [AI064745]; Bioqual Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064745, R01AI064745] Funding Source: NIH RePORTER	PIPB by the Division of Microbial and Infectious Diseases; NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bioqual Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for these studies was provided through PIPB by the Division of Microbial and Infectious Diseases contract number HHSN27220100006I/HHSN2720003 to Bioqual, and additional funding was from NIH RO1 grant AI064745 to RK. Bioqual Inc. provided support in the form of salaries for authors AVG, HA, and ML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad G, 2011, J INFECT DIS, V204, P1437, DOI 10.1093/infdis/jir545; Anand SB, 2007, PARASITOL RES, V101, P981, DOI 10.1007/s00436-007-0571-2; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; CRANDELL RB, 1983, ACTA TROP, V40, P53; Critchley J, 2005, TROP MED INT HEALTH, V10, P818, DOI 10.1111/j.1365-3156.2005.01458.x; Dakshinamoorthy G, 2013, VACCINE, V32, P19, DOI 10.1016/j.vaccine.2013.10.083; Dakshinamoorthy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077394; Dakshinamoorthy G, 2013, VACCINE, V31, P1616, DOI 10.1016/j.vaccine.2012.09.055; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; DAY KP, 1991, PARASITOL TODAY, V7, P341, DOI 10.1016/0169-4758(91)90215-A; deAlmeida AB, 1996, J INFECT DIS, V173, P1453, DOI 10.1093/infdis/173.6.1453; ELBIHARI S, 1971, J PARASITOL, V57, P1170, DOI 10.2307/3277959; Farid HA, 2005, AM J TROP MED HYG, V73, P108, DOI 10.4269/ajtmh.2005.73.108; FOLSE DS, 1988, LYMPHOLOGY, V21, P244; Gardner MB, 2008, ILAR J, V49, P220, DOI 10.1093/ilar.49.2.220; Giambartolomei GH, 1998, EXP PARASITOL, V90, P77, DOI 10.1006/expr.1998.4312; Gnanasekar M, 2004, INFECT IMMUN, V72, P4707, DOI 10.1128/IAI.72.8.4707-4715.2004; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Jin Bo-Ra, 2013, Immune Netw, V13, P10, DOI 10.4110/in.2013.13.1.10; Joseph SK, 2013, VACCINE, V31, P3320, DOI 10.1016/j.vaccine.2013.05.077; LIU JY, 1989, J TROP MED HYG, V92, P93; MAHANTY S, 1995, PARASITE IMMUNOL, V17, P385, DOI 10.1111/j.1365-3024.1995.tb00906.x; Mahanty S, 1996, EXP PARASITOL, V84, P282, DOI 10.1006/expr.1996.0114; MAIZELS RM, 1995, PARASITOL TODAY, V11, P50, DOI 10.1016/0169-4758(95)80116-2; Maizels RM, 1999, IMMUNOL REV, V171, P125, DOI 10.1111/j.1600-065X.1999.tb01345.x; Mishra K, 2005, ACTA TROP, V93, P233, DOI 10.1016/j.actatropica.2005.01.001; Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374; Parish CR, 2009, CURR PROTOC IMMUNOL; PEARLMAN E, 1993, J IMMUNOL, V151, P4857; PEARLMAN E, 1993, EXP PARASITOL, V76, P200, DOI 10.1006/expr.1993.1023; Rao RU, 2006, J CLIN MICROBIOL, V44, P3887, DOI 10.1128/JCM.00969-06; Shearer MH, 1999, CLIN DIAGN LAB IMMUN, V6, P953, DOI 10.1128/CDLI.6.6.953-958.1999; Shedlock DJ, 2009, NAT REV IMMUNOL, V9, P717, DOI 10.1038/nri2636; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; TURNER P, 1993, TROP MED PARASITOL, V44, P45; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457; WONG M M, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P265; WONG MM, 1969, B WORLD HEALTH ORGAN, V40, P493	38	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112982	10.1371/journal.pone.0112982	http://dx.doi.org/10.1371/journal.pone.0112982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401783	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700089
J	Mattioli, S; Farioli, A; Legittimo, P; Miligi, L; Benvenuti, A; Ranucci, A; Salvan, A; Rondelli, R; Magnani, C				Mattioli, Stefano; Farioli, Andrea; Legittimo, Patrizia; Miligi, Lucia; Benvenuti, Alessandra; Ranucci, Alessandra; Salvan, Alberto; Rondelli, Roberto; Magnani, Corrado		SETIL Study Grp	Tobacco Smoke and Risk of Childhood Acute Non-Lymphocytic Leukemia: Findings from the SETIL Study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MARGINAL STRUCTURAL MODELS; IN-UTERO; EXPOSURE; CANCER; PREGNANCY; ETIOLOGY	Background: Parental smoking and exposure of the mother or the child to environmental tobacco smoke (ETS) as risk factors for Acute non-Lymphocytic Leukemia (AnLL) were investigated. Methods: Incident cases of childhood AnLL were enrolled in 14 Italian Regions during 1998-2001. We estimated odds ratios (OR) and 95% confidence intervals (95% CI) conducting logistic regression models including 82 cases of AnLL and 1,044 controls. Inverse probability weighting was applied adjusting for: age; sex; provenience; birth order; birth weight; breastfeeding; parental educational level age, birth year, and occupational exposure to benzene. Results: Paternal smoke in the conception period was associated with AnLL (OR for >= 11 cigarettes/day = 1.79, 95% CI 1.01-3.15; P trend 0.05). An apparent effect modification by maternal age was identified: only children of mothers aged below 30 presented increased risks. We found weak statistical evidence of an association of AnLL with maternal exposure to ETS (OR for exposure. 3 hours/day = 1.85, 95% CI 0.97-3.52; P trend 0.07). No association was observed between AnLL and either maternal smoking during pregnancy or child exposure to ETS. Conclusions: This study is consistent with the hypothesis that paternal smoke is associated with AnLL. We observed statistical evidence of an association between maternal exposure to ETS and AnLL, but believe bias might have inflated our estimates.	[Mattioli, Stefano; Farioli, Andrea] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy; [Legittimo, Patrizia] S Orsola Malpighi Univ Hosp, Unit Occupat Med, Bologna, Italy; [Legittimo, Patrizia; Miligi, Lucia; Benvenuti, Alessandra] ISPO Canc Prevent & Res Inst, Occupat & Environm Epidemiol Unit, Florence, Italy; [Ranucci, Alessandra; Magnani, Corrado] CPO Piemonte, Dept Translat Med, Canc Epidemiol Unit, Novara, Italy; [Salvan, Alberto] CNR, IASI, Rome, Italy; [Rondelli, Roberto] St Orsola Marcello Malpighi Hosp, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; Consiglio Nazionale delle Ricerche (CNR); IRCCS Azienda Ospedaliero-Universitaria di Bologna	Mattioli, S (corresponding author), Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy.	s.mattioli@unibo.it	LAGORIO, Susanna/I-5033-2012; Lagorio, Susanna/AAL-8389-2021; Michelozzi, Paola/J-8608-2016; Farioli, Andrea/K-9256-2016; Kirchmayer, Ursula/L-7847-2016; Forastiere, Francesco/J-9067-2016	LAGORIO, Susanna/0000-0001-8883-8745; Lagorio, Susanna/0000-0001-8883-8745; Michelozzi, Paola/0000-0002-1646-2555; Farioli, Andrea/0000-0003-2001-2140; chiavarini, manuela/0000-0002-3551-7486; Kirchmayer, Ursula/0000-0001-7732-0166; Forastiere, Francesco/0000-0002-9162-5684; Miligi, Lucia/0000-0002-8223-485X; Mattioli, Stefano/0000-0002-9639-7430	AIRC (Italian Association on Research on Cancer); MIUR (Ministry for Instruction, University and Research, PRIN Program); Ministry of Health (Ricerca Sanitaria Finalizzata Program); Ministry of Labour and Welfare; Associazione Neuroblastoma; Piemonte Region (Ricerca Sanitaria Finalizzata Regione Piemonte Program); Liguria Region; Comitato per la vita "Daniele Chianelli"-Associazione per la Ricerca e la Cura delle Leucemie, Linfomi e Tumori di Adulti e Bambini, (Perugia)	AIRC (Italian Association on Research on Cancer)(Fondazione AIRC per la ricerca sul cancro); MIUR (Ministry for Instruction, University and Research, PRIN Program)(Ministry of Education, Universities and Research (MIUR)); Ministry of Health (Ricerca Sanitaria Finalizzata Program); Ministry of Labour and Welfare; Associazione Neuroblastoma; Piemonte Region (Ricerca Sanitaria Finalizzata Regione Piemonte Program); Liguria Region(Regione Liguria); Comitato per la vita "Daniele Chianelli"-Associazione per la Ricerca e la Cura delle Leucemie, Linfomi e Tumori di Adulti e Bambini, (Perugia)	The SETIL study was financially supported by research grants received by AIRC (Italian Association on Research on Cancer), MIUR (Ministry for Instruction, University and Research, PRIN Program), Ministry of Health (Ricerca Sanitaria Finalizzata Program), Ministry of Labour and Welfare, Associazione Neuroblastoma, Piemonte Region (Ricerca Sanitaria Finalizzata Regione Piemonte Program), Liguria Region, Comitato per la vita "Daniele Chianelli"-Associazione per la Ricerca e la Cura delle Leucemie, Linfomi e Tumori di Adulti e Bambini, (Perugia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRTUM Working Group, 2008, Epidemiol Prev, V32, P5; AIRTUM Working Group, 2008, EPIDEMIOL PREV S2, V32, P5; AIRTUM Working Group, 2008, EPIDEMIOL PREV, V32, P16; Badaloni C, 2013, OCCUP ENVIRON MED, V70, P876, DOI 10.1136/oemed-2013-101604; Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Boffetta P, 2000, ENVIRON HEALTH PERSP, V108, P73, DOI 10.2307/3454298; Chang Jeffrey S., 2009, V472, P103, DOI 10.1007/978-1-60327-492-0_5; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Farioli A, 2014, CANCER CAUSE CONTROL, V25, P683, DOI 10.1007/s10552-014-0371-9; Greaves M, 2005, EARLY HUM DEV, V81, P123, DOI 10.1016/j.earlhumdev.2004.10.004; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; GREAVES MF, 1993, LEUKEMIA, V7, P349; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Lee KM, 2009, LEUKEMIA RES, V33, P250, DOI 10.1016/j.leukres.2008.06.031; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mansson R, 2007, AM J EPIDEMIOL, V166, P332, DOI 10.1093/aje/kwm069; Menezo YJ, 2006, REPROD BIOMED ONLINE, V12, P616, DOI 10.1016/S1472-6483(10)61188-1; Metayer C, 2013, CANCER EPIDEMIOL, V37, P336, DOI 10.1016/j.canep.2012.12.011; Miligi L, 2013, OCCUP ENVIRON MED, V70, P648, DOI 10.1136/oemed-2012-100951; Milne E, 2012, AM J EPIDEMIOL, V175, P43, DOI 10.1093/aje/kwr275; Post A, 2008, PAEDIATR PERINAT EP, V22, P155, DOI 10.1111/j.1365-3016.2007.00917.x; Pui CH, 2006, CHILDHOOD LEUKEMIAS, 2ND EDITION, P1, DOI 10.1017/CBO9780511471001; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sasco AJ, 1999, HUM EXP TOXICOL, V18, P192, DOI 10.1191/096032799678839905; Schnatter AR, 2005, CHEM-BIOL INTERACT, V153, P9, DOI 10.1016/j.cbi.2005.03.039; Tchernis R, 2005, STAT MED, V24, P2197, DOI 10.1002/sim.2095; TREDANIEL J, 1994, PAEDIATR PERINAT EP, V8, P233, DOI 10.1111/j.1365-3016.1994.tb00455.x; WHO-IARC, 2009, IARC MON EV CARC R E, V100	29	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111028	10.1371/journal.pone.0111028	http://dx.doi.org/10.1371/journal.pone.0111028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401754	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700011
J	Park, YJ; Koh, J; Gauna, AE; Chen, SU; Cha, SH				Park, Yun-Jong; Koh, Jin; Gauna, Adrienne E.; Chen, Sixue; Cha, Seunghee			Identification of Regulatory Factors for Mesenchymal Stem Cell-Derived Salivary Epithelial Cells in a Co-Culture System	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN ADIPOSE-TISSUE; STATISTICAL-MODEL; TCF3 REPRESSION; TRANSCRIPTION; ACINAR; GENE; TRANSDIFFERENTIATION; DIFFERENTIATION; PANCREAS	Patients with Sjogren's syndrome or head and neck cancer patients who have undergone radiation therapy suffer from severe dry mouth (xerostomia) due to salivary exocrine cell death. Regeneration of the salivary glands requires a better understanding of regulatory mechanisms by which stem cells differentiate into exocrine cells. In our study, bone marrow-derived mesenchymal stem cells were co-cultured with primary salivary epithelial cells from C57BL/6 mice. Co-cultured bone marrow-derived mesenchymal stem cells clearly resembled salivary epithelial cells, as confirmed by strong expression of salivary gland epithelial cell-specific markers, such as alpha-amylase, muscarinic type 3 receptor, aquaporin-5, and cytokeratin 19. To identify regulatory factors involved in this differentiation, transdifferentiated mesenchymal stem cells were analyzed temporarily by two-dimensional-gel-electrophoresis, which detected 58 protein spots (>1.5 fold change, p < 0.05) that were further categorized into 12 temporal expression patterns. Of those proteins only induced in differentiated mesenchymal stem cells, ankryin-repeat-domain-containing-protein 56, high-mobility-group-protein 20B, and transcription factor E2a were selected as putative regulatory factors for mesenchymal stem cell transdifferentiation based on putative roles in salivary gland development. Induction of these molecules was confirmed by RT-PCR and western blotting on separate sets of co-cultured mesenchymal stem cells. In conclusion, our study is the first to identify differentially expressed proteins that are implicated in mesenchymal stem cell differentiation into salivary gland epithelial cells. Further investigation to elucidate regulatory roles of these three transcription factors in mesenchymal stem cell reprogramming will provide a critical foundation for a novel cell-based regenerative therapy for patients with xerostomia.	[Park, Yun-Jong; Gauna, Adrienne E.; Cha, Seunghee] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32611 USA; [Koh, Jin; Chen, Sixue] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Chen, Sixue] Univ Florida, UF Genet Inst, Dept Biol, Gainesville, FL USA; [Chen, Sixue] Univ Florida, Genet Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cha, SH (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32611 USA.	scha@dental.ufl.edu		Williams, Adrienne/0000-0003-0247-1175	National Institutes of Health/National Institute of Dental and Craniofacial Research [DE019644]; NIH/National Center for Advancing Translational Sciences Clinical and Translational Science Awards [UL1 TR000064, TL1 TR000066]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, TL1TR000066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990, R01DE019644] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/National Center for Advancing Translational Sciences Clinical and Translational Science Awards; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding from National Institutes of Health/National Institute of Dental and Craniofacial Research grant DE019644 (SC) and in part by the NIH/National Center for Advancing Translational Sciences Clinical and Translational Science Awards grant UL1 TR000064 and TL1 TR000066 (AEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2000, CELL GROWTH DIFFER, V11, P137; Atlasi Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003424; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; Bullard T, 2008, DEV BIOL, V320, P72, DOI 10.1016/j.ydbio.2008.04.018; Chien KR, 2008, NATURE, V453, P302, DOI 10.1038/nature07037; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; de Almeida Patricia Del Vigna, 2008, J Contemp Dent Pract, V9, P72; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; El-Badri NS, 2006, STEM CELLS DEV, V15, P473, DOI 10.1089/scd.2006.15.473; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Johnson CL, 2004, MECH DEVELOP, V121, P261, DOI 10.1016/j.mod.2004.01.003; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071167; Lim JY, 2013, ORAL ONCOL, V49, P136, DOI 10.1016/j.oraloncology.2012.08.010; Lin CY, 2011, J DENT RES, V90, P341, DOI 10.1177/0022034510386374; Lin CY, 2007, J FORMOS MED ASSOC, V106, P1, DOI 10.1016/S0929-6646(09)60209-6; Lin CY, 2013, J FORMOS MED ASSOC, V112, P713, DOI 10.1016/j.jfma.2012.08.006; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Maria OM, 2011, STEM CELLS DEV, V20, P959, DOI 10.1089/scd.2010.0214; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pringle S, 2011, JOVE-J VIS EXP, DOI 10.3791/2484; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rabilloud T, 2009, MASS SPECTROM REV, V28, P816, DOI 10.1002/mas.20204; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Ravanpay AC, 2008, J NEUROSCI RES, V86, P1472, DOI 10.1002/jnr.21615; Rotter N, 2008, STEM CELLS DEV, V17, P509, DOI 10.1089/scd.2007.0180; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; SOMMER L, 1991, CELL, V67, P987, DOI 10.1016/0092-8674(91)90371-5; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Sumoy L, 2000, CYTOGENET CELL GENET, V88, P62, DOI 10.1159/000015486; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Voulgarelis M, 2010, NAT REV RHEUMATOL, V6, P529, DOI 10.1038/nrrheum.2010.118; WOLFF A, 1991, ORAL SURG ORAL MED O, V71, P569, DOI 10.1016/0030-4220(91)90364-I; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Xu JJ, 2012, BLOOD, V120, P3142, DOI 10.1182/blood-2011-11-391144; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Yoshida S, 2001, DEV BIOL, V240, P517, DOI 10.1006/dbio.2001.0473; Zhao Y, 2006, MOL ENDOCRINOL, V20, P2187, DOI 10.1210/me.2005-0214; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zurita M, 2008, NEUROSCI RES, V60, P275, DOI 10.1016/j.neures.2007.11.006	50	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112158	10.1371/journal.pone.0112158	http://dx.doi.org/10.1371/journal.pone.0112158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402494	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700032
J	Pitts, TM; Newton, TP; Bradshaw-Pierce, EL; Addison, R; Arcaroli, JJ; Klauck, PJ; Bagby, SM; Hyatt, SL; Purkey, A; Tentler, JJ; Tan, AC; Messersmith, WA; Eckhardt, SG; Leong, S				Pitts, Todd M.; Newton, Timothy P.; Bradshaw-Pierce, Erica L.; Addison, Rebecca; Arcaroli, John J.; Klauck, Peter J.; Bagby, Stacey M.; Hyatt, Stephanie L.; Purkey, Alicia; Tentler, John J.; Tan, Aik Choon; Messersmith, Wells A.; Eckhardt, S. Gail; Leong, Stephen			Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer	PLOS ONE			English	Article							PREVIOUSLY TREATED PATIENTS; ORAL MEK INHIBITOR; SMALL-CELL LUNG; BREAST-CANCER; PHASE-I; TUBEROUS SCLEROSIS; ANTITUMOR-ACTIVITY; SIGNALING PATHWAY; CARCINOMA-CELLS; COLON-CANCER	Background: The activation of the MAPK and PI3K/AKT/mTOR pathways is implicated in the majority of cancers. Activating mutations in both of these pathways has been described in colorectal cancer (CRC), thus indicating their potential as therapeutic targets. This study evaluated the combination of a PI3K/mTOR inhibitor (PF-04691502/PF-502) in combination with a MEK inhibitor (PD-0325901/PD-901) in CRC cell lines and patient-derived CRC tumor xenograft models (PDTX). Materials and Methods: The anti-proliferative effects of PF-502 and PD-901 were assessed as single agents and in combination against a panel of CRC cell lines with various molecular backgrounds. Synergy was evaluated using the Bliss Additivity method. In selected cell lines, we investigated the combination effects on downstream effectors by immunoblotting. The combination was then evaluated in several fully genetically annotated CRC PDTX models. Results: The in vitro experiments demonstrated a wide range of IC50 values for both agents against a cell line panel. The combination of PF-502 and PD-901 demonstrated synergistic anti-proliferative activity with Bliss values in the additive range. As expected, p-AKT and p-ERK were downregulated by PF-502 and PD-901, respectively. In PDTX models, following a 30-day exposure to PF-502, PD-901 or the combination, the combination demonstrated enhanced reduction in tumor growth as compared to either single agent regardless of KRAS or PI3K mutational status. Conclusions: The combination of a PI3K/mTOR and a MEK inhibitor demonstrated enhanced anti-proliferative effects against CRC cell lines and PDTX models.	[Pitts, Todd M.; Newton, Timothy P.; Addison, Rebecca; Arcaroli, John J.; Klauck, Peter J.; Bagby, Stacey M.; Hyatt, Stephanie L.; Purkey, Alicia; Tentler, John J.; Tan, Aik Choon; Messersmith, Wells A.; Eckhardt, S. Gail; Leong, Stephen] Univ Colorado, Sch Med, Div Med Oncol, Aurora, CO 80045 USA; [Bradshaw-Pierce, Erica L.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA; [Pitts, Todd M.; Bradshaw-Pierce, Erica L.; Arcaroli, John J.; Tentler, John J.; Tan, Aik Choon; Messersmith, Wells A.; Eckhardt, S. Gail; Leong, Stephen] Univ Colorado, Ctr Canc, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Pitts, TM (corresponding author), Univ Colorado, Sch Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA.	Todd.Pitts@ucdenver.edu	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369; Purkey, Alicia/0000-0002-1865-1421	Pfizer Inc; University of Colorado Cancer Center [P30 CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Pfizer Inc(Pfizer); University of Colorado Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Pfizer Inc and University of Colorado Cancer Center Grant P30 CA046934. The funders had a minor role in study design and decision to publish. The funders had no role in data collection and analysis, or preparation of the manuscript.	Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Bennouna J, 2011, INVEST NEW DRUG, V29, P1021, DOI 10.1007/s10637-010-9392-8; Boasberg PD, 2011, CANCER CHEMOTH PHARM, V68, P547, DOI 10.1007/s00280-011-1620-1; Britten C WZ, 2012, MULTIARM PHASE 1 DOS; Britten CD, 2014, INVEST NEW DRUG, V32, P510, DOI 10.1007/s10637-013-0062-5; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Cheng HM, 2013, BIOORG MED CHEM LETT, V23, P2787, DOI 10.1016/j.bmcl.2013.02.020; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dienstmann R, 2012, MOL CANCER THER, V11, P2062, DOI 10.1158/1535-7163.MCT-12-0290; Fasolo A, 2011, EXPERT OPIN INV DRUG, V20, P381, DOI 10.1517/13543784.2011.541154; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; Henderson YC, 2010, MOL CANCER THER, V9, P1968, DOI 10.1158/1535-7163.MCT-10-0062; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Johansson CH, 2014, PHARMACOL THERAPEUT, V142, P176, DOI 10.1016/j.pharmthera.2013.11.011; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; LoRusso P, 2012, J CLIN ONCOL, V2566; LoRusso PM, 2010, CLIN CANCER RES, V16, P1924, DOI 10.1158/1078-0432.CCR-09-1883; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mao ML, 2013, CLIN CANCER RES, V19, P657, DOI 10.1158/1078-0432.CCR-11-1446; Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683; MORIKAWA K, 1988, CANCER RES, V48, P6863; Mueller H, 2000, INT J CANCER, V89, P384, DOI 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nandan MO, 2011, CURR COLORECT CANC R, V7, P113, DOI 10.1007/s11888-011-0086-1; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pitts TM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00035; Pitts TM, 2010, CLIN CANCER RES, V16, P3193, DOI 10.1158/1078-0432.CCR-09-3191; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roper J, 2014, CANC LETT; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sheppard KE, 2013, EUR J CANCER, V49, P3936, DOI 10.1016/j.ejca.2013.08.007; Suk Heist R, 2013, J CLIN ONCOL, V2530; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Towers M, 1967, S Afr Med J, V41, P181; Valentino JD, 2014, CLIN CANCER RES, V20, P1212, DOI 10.1158/1078-0432.CCR-13-1897; Yu M, 2012, THER ADV GASTROENTER, V5, P319, DOI 10.1177/1756283X12448456; Yuan J, 2011, MOL CANCER THER, V10, P2189, DOI 10.1158/1535-7163.MCT-11-0185; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhou HY, 2012, CHIN J CANCER, V31, P8, DOI 10.5732/cjc.011.10281; Zitzmann K, 2010, CANCER LETT, V295, P100, DOI 10.1016/j.canlet.2010.02.018	51	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113037	10.1371/journal.pone.0113037	http://dx.doi.org/10.1371/journal.pone.0113037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401499	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700098
J	Robertson, ED; Wasylyk, C; Ye, T; Jung, AC; Wasylyk, B				Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Jung, Alain C.; Wasylyk, Bohdan			The Oncogenic MicroRNA Hsa-miR-155-5p Targets the Transcription Factor ELK3 and Links It to the Hypoxia Response	PLOS ONE			English	Article							COMPLEX FACTOR NET; GENE-EXPRESSION; UP-REGULATION; CLIP-SEQ; MIR-155; CANCER; INHIBITION; PROLIFERATION; MIGRATION; STARBASE	The molecular response to hypoxia is a critical cellular process implicated in cancer, and a target for drug development. The activity of the major player, HIF1 alpha, is regulated at different levels by various factors, including the transcription factor ELK3. The molecular mechanisms of this intimate connection remain largely unknown. Whilst investigating global ELK3-chromatin interactions, we uncovered an unexpected connection that involves the microRNA hsa-miR-155-5p, a hypoxia-inducible oncomir that targets HIF1 alpha. One of the ELK3 chromatin binding sites, detected by Chromatin Immuno-Precipitation Sequencing (ChIP-seq) of normal Human Umbilical Vein Endothelial Cells (HUVEC), is located at the transcription start site of the MIR155HG genes that expresses hsa-miR-155-5p. We confirmed that ELK3 binds to this promoter by ChIP and quantitative polymerase chain reaction (QPCR). We showed that ELK3 and hsa-miR-155-5p form a double-negative regulatory loop, in that ELK3 depletion induced hsa-miR-155-5p expression and hsa-miR-155-5p expression decreased ELK3 expression at the RNA level through a conserved target sequence in its 3'-UTR. We further showed that the activities of hsa-miR-155-5p and ELK3 are functionally linked. Pathway analysis indicates that both factors are implicated in related processes, including cancer and angiogenesis. Hsa-miR-155-5p expression and ELK3 depletion have similar effects on expression of known ELK3 target genes, and on in-vitro angiogenesis and wound closure. Bioinformatic analysis of cancer RNA-seq data shows that hsa-miR-155-5p and ELK3 expression are significantly anti-correlated, as would be expected from hsa-miR-155-5p targeting ELK3 RNA. Finally, hypoxia (0% oxygen) down-regulates ELK3 mRNA in a microRNA and hsa-miR-155-5p dependent manner. These results tie ELK3 into the hypoxia response pathway through an oncogenic microRNA and into a circuit implicated in the dynamics of the hypoxic response. This crosstalk could be important for the development of new treatments for a range of pathologies.	[Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Wasylyk, Bohdan] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Wasylyk, Bohdan] CNRS, UMR7104, Illkirch Graffenstaden, France; [Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Wasylyk, Bohdan] INSERM, U964, Illkirch Graffenstaden, France; [Robertson, E. Douglas; Wasylyk, Christine; Ye, Tao; Wasylyk, Bohdan] Univ Strasbourg, Illkirch Graffenstaden, France; [Jung, Alain C.] Univ Strasbourg, Ctr Reg Lutte Canc Paul Strauss, Lab Biol Tumorale, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UNICANCER; Centre Paul Strauss	Wasylyk, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.	boh@igbmc.fr	Jung, Alain/X-5384-2019; Jung, Alain/AAC-6598-2019; Wasylyk, Bohdan/ABG-6778-2020	Jung, Alain/0000-0002-4049-4151; Wasylyk, Bohdan/0000-0002-1718-1237	Institut National du Cancer (INCa; HypoNet) [PLBIO2010]; Association pour la Recherche sur le Cancer; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg (UdS); Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer	Institut National du Cancer (INCa; HypoNet)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg (UdS); Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer(General Electric)	The authors are thankful for financial support from the Institut National du Cancer (INCa; HypoNet, PLBIO2010), the Association pour la Recherche sur le Cancer, the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite de Strasbourg (UdS) and the Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi A, 2001, EMBO J, V20, P5139, DOI 10.1093/emboj/20.18.5139; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Buchwalter G, 2005, MOL CELL BIOL, V25, P10853, DOI 10.1128/MCB.25.24.10853-10862.2005; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chen ZL, 2014, J CELL PHYSIOL, V229, P545, DOI 10.1002/jcp.24492; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Czyzyk-Krzeska MF, 2014, ONCOGENE, V33, P677, DOI 10.1038/onc.2013.26; Dai Y, 2012, PLACENTA, V33, P824, DOI 10.1016/j.placenta.2012.07.012; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Ferrajoli A, 2013, BLOOD, V122, P1891, DOI 10.1182/blood-2013-01-478222; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; Goda N, 2012, INT J HEMATOL, V95, P457, DOI 10.1007/s12185-012-1069-y; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gross C, 2008, ONCOGENE, V27, P1333, DOI 10.1038/sj.onc.1210736; Gross C, 2007, MOL CELL BIOL, V27, P4133, DOI 10.1128/MCB.01867-06; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Higgs Gadareth, 2013, J Clin Bioinforma, V3, P17, DOI 10.1186/2043-9113-3-17; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kong W, 2014, ONCOGENE, V33, P679, DOI 10.1038/onc.2012.636; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liao WL, 2014, BIOMARKERS GENOMIC M; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; Mucaj V, 2012, INT J HEMATOL, V95, P464, DOI 10.1007/s12185-012-1070-5; O'Geen H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-689; Oda Y, 2012, TOXICOL APPL PHARM, V260, P222, DOI 10.1016/j.taap.2012.02.012; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; Serchov T, 2010, J BIOL CHEM, V285, P21223, DOI 10.1074/jbc.M110.121723; Shen GM, 2013, ACTA PHARMACOL SIN, V34, P336, DOI 10.1038/aps.2012.195; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; van Beijnum JR, 2008, EXP CELL RES, V314, P264, DOI 10.1016/j.yexcr.2007.08.013; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; WILLIAMS RL, 1988, CELL, V52, P121; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zheng H, 2003, GENE DEV, V17, P2283, DOI 10.1101/gad.272503	47	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113050	10.1371/journal.pone.0113050	http://dx.doi.org/10.1371/journal.pone.0113050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401928	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700102
J	Sparding, N; Slotved, HC; Nicolaisen, GM; Giese, SB; Elmlund, J; Steenhard, NR				Sparding, Nadja; Slotved, Hans-Christian; Nicolaisen, Gert M.; Giese, Steen B.; Elmlund, Jon; Steenhard, Nina R.			Development of an ELISA for Evaluation of Swab Recovery Efficiencies of Bovine Serum Albumin	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; BACILLUS-ANTHRACIS SPORES; FLOCKED NYLON SWABS; SENSITIVE ELISA; SURFACES; VACCINES; PROTOCOL; BSA	After a potential biological incident the sampling strategy and sample analysis are crucial for the outcome of the investigation and identification. In this study, we have developed a simple sandwich ELISA based on commercial components to quantify BSA (used as a surrogate for ricin) with a detection range of 1.32-80 ng/mL. We used the ELISA to evaluate different protein swabbing procedures (swabbing techniques and after-swabbing treatments) for two swab types: a cotton gauze swab and a flocked nylon swab. The optimal swabbing procedure for each swab type was used to obtain recovery efficiencies from different surface materials. The surface recoveries using the optimal swabbing procedure ranged from 0-60% and were significantly higher from nonporous surfaces compared to porous surfaces. In conclusion, this study presents a swabbing procedure evaluation and a simple BSA ELISA based on commercial components, which are easy to perform in a laboratory with basic facilities. The data indicate that different swabbing procedures were optimal for each of the tested swab types, and the particular swab preference depends on the surface material to be swabbed.	[Sparding, Nadja; Slotved, Hans-Christian; Nicolaisen, Gert M.; Giese, Steen B.; Elmlund, Jon; Steenhard, Nina R.] Statens Serum Inst, Ctr Biosecur & Biopreparedness, DK-2300 Copenhagen, Denmark; [Slotved, Hans-Christian] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut	Sparding, N (corresponding author), Statens Serum Inst, Ctr Biosecur & Biopreparedness, DK-2300 Copenhagen, Denmark.	nasp@ssi.dk	Slotved, Hans-Christian/H-7476-2019	Slotved, Hans-Christian/0000-0002-7294-4911				Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Dalmaso Giblerto, 2008, PDA J Pharm Sci Technol, V62, P191; Frawley DA, 2008, J FORENSIC SCI, V53, P1102, DOI 10.1111/j.1556-4029.2008.00811.x; Gage JC, 2011, ACTA CYTOL, V55, P364, DOI 10.1159/000329488; Hedin G, 2010, J HOSP INFECT, V75, P314, DOI 10.1016/j.jhin.2010.02.027; Hodges LR, 2006, APPL ENVIRON MICROB, V72, P4429, DOI 10.1128/AEM.02923-05; Hodges LR, 2010, J MICROBIOL METH, V81, P141, DOI 10.1016/j.mimet.2010.02.010; Khamehchian S, 2008, HUM VACCINES, V4, P375, DOI 10.4161/hv.4.5.6009; Lean MH, 2004, P 2 JOINT C POINT DE; Mirsky AE, 1936, P NATL ACAD SCI USA, V22, P439, DOI 10.1073/pnas.22.7.439; Probst A, 2011, APPL ENVIRON MICROB, V77, P1628, DOI 10.1128/AEM.02037-10; Rastogi VK, 2002, ASSESSMENT ENV BENIG; Rose L, 2004, EMERG INFECT DIS, V10, P1023, DOI 10.3201/eid1006.030716; Steinitz M, 2000, ANAL BIOCHEM, V282, P232, DOI 10.1006/abio.2000.4602; TERAVEST AR, 1987, J BIOL STAND, V15, P245, DOI 10.1016/0092-1157(87)90027-8; WANG J, 1994, TOHOKU J EXP MED, V172, P345, DOI 10.1620/tjem.172.345; Zhang K, 2010, HUM VACCINES, V6, P652, DOI 10.4161/hv.6.8.11935; Zhang XM, 2011, BIOSENS BIOELECTRON, V26, P3958, DOI 10.1016/j.bios.2011.02.050	18	1	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112876	10.1371/journal.pone.0112876	http://dx.doi.org/10.1371/journal.pone.0112876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402464	gold, Green Published			2022-12-26	WOS:000345158700081
J	Wang, XN; Ye, P; Cao, RH; Yang, X; Xiao, WK; Zhang, Y; Bai, YY; Wu, HM				Wang, Xiaona; Ye, Ping; Cao, Ruihua; Yang, Xu; Xiao, Wenkai; Zhang, Yun; Bai, Yongyi; Wu, Hongmei			The Association of Homocysteine with Metabolic Syndrome in a Community-Dwelling Population: Homocysteine Might Be Concomitant with Metabolic Syndrome	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; PLASMA HOMOCYSTEINE; ARTERIAL STIFFNESS; SERUM; HYPERHOMOCYSTEINEMIA; INSULIN; RISK; STRESS	Objective: Elevated plasma total homocysteine (tHcy) and metabolic syndrome (MetS) are both associated with cardiovascular disease, but the association between tHcy and MetS is not well characterized. The aim of this study was to determine the relationship between tHcy and MetS. Methods: To further estimate the time-dependent association of tHcy and MetS, we analyzed the tHcy level and MetS in 1499 subjects from a 4.8-year longitudinal study in Beijing, People's Republic of China. Results: In multiple linear regression analysis, baseline tHcy levels associated with age, BMI, SBP, DBP, LDL-C and Cr independently over 4.8-years follow-up; age, BMI, SBP, DBP and Cr were found to be associated with tHcy levels independently at the end of follow-up. Logistic regression analysis showed that there was no association between the baseline tHcy level and MetS over the 4.8-year follow-up (odds ratio (OR), 1.32; 95% confidence interval (CI), 0.79-2.19; P = 0.282); rather, there was an association only with hypertension as a MetS component (OR, 1.53; 95% CI, 1.06-2.21; P = 0.024). tHcy levels were associated with MetS at both cross-sectional baseline (OR, 1.38; 95% CI, 1.02-1.88; P = 0.038) and cross-sectional follow-up (OR, 1.60; 95% CI, 1.02-2.50; P = 0.041). The tHcy levels of MetS subjects were higher than those of non-MetS subjects at both cross-sectional baseline (19.35 +/- 7.92 mu mol/L vs. 17.45 +/- 6.70 mu mol/L, respectively; P = 0.001) and cross-sectional follow-up (18.95 +/- 7.15 mu mol/L vs. 17.11 +/- 5.98 mu mol/L, respectively; P = 0.02). Conclusion: The tHcy level was not predictive of the incidence of MetS; however, it may be a risk factor for hypertension as a MetS component. Furthermore, tHcy levels were associated with MetS at cross-sectional baseline and follow-up, which suggests that a higher level of tHcy might be concomitant with MetS.	[Wang, Xiaona; Ye, Ping; Cao, Ruihua; Yang, Xu; Xiao, Wenkai; Zhang, Yun; Bai, Yongyi; Wu, Hongmei] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Ye, P (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	yeping301@sina.com	Wang, Dapeng/HGD-4818-2022		National Nature Science Foundation of China [81270941]; Key National Basic Research Program of China [2012CB517503, 2013CB530804]; Key Science and Technology Foundation of China [2012ZX09303004-002]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Basic Research Program of China(National Basic Research Program of China); Key Science and Technology Foundation of China	This research is supported by the grant from the National Nature Science Foundation of China (81270941), the Key National Basic Research Program of China (2012CB517503, 2013CB530804) and the Key Science and Technology Foundation of China (2012ZX09303004-002) to Dr. Ping Ye. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bai YY, 2011, ATHEROSCLEROSIS, V218, P493, DOI 10.1016/j.atherosclerosis.2011.06.035; Bjorck J, 2006, METABOLISM, V55, P1007, DOI 10.1016/j.metabol.2006.03.010; Bravo E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-60; Budak N, 2009, METAB SYNDR RELAT D, V7, P357, DOI 10.1089/met.2008.0037; Feng Sheng-qiang, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P256; Fonseca V, 2000, METABOLISM, V49, P736, DOI 10.1053/meta.2000.6256; Garcin J. -M., 2006, Metabolic Syndrome and Related Disorders, V4, P185, DOI 10.1089/met.2006.4.185; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guven A, 2005, HEART VESSELS, V20, P290, DOI 10.1007/s00380-004-0822-4; Hajer GR, 2007, HEART, V93, P216, DOI 10.1136/hrt.2006.093971; Hao L, 2007, J NUTR, V137, P407, DOI 10.1093/jn/137.2.407; Jacques PF, 1999, AM J CLIN NUTR, V69, P482; Kanani PM, 1999, CIRCULATION, V100, P1161, DOI 10.1161/01.CIR.100.11.1161; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lu Yan-hui, 2006, Zhonghua Yi Xue Za Zhi, V86, P386; Malinow MR, 1996, ATHEROSCLEROSIS, V126, P27, DOI 10.1016/0021-9150(96)05890-X; Meigs JB, 2001, DIABETES CARE, V24, P1403, DOI 10.2337/diacare.24.8.1403; Must A, 2003, J NUTR, V133, P2643, DOI 10.1093/jn/133.8.2643; Nabipour I, 2009, J ENDOCRINOL INVEST, V32, P406, DOI 10.1007/BF03346476; Oda E, 2012, ACTA DIABETOL, V49, P89, DOI 10.1007/s00592-011-0309-6; Rhee EJ, 2007, ENDOCR J, V54, P995, DOI 10.1507/endocrj.K07E-018; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Soonthornpun Supamai, 2007, Journal of the Medical Association of Thailand, V90, P1506; Tayama J, 2006, HYPERTENS RES, V29, P403, DOI 10.1291/hypres.29.403; UELAND PM, 1993, CLIN CHEM, V39, P1764; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yakub M, 2010, J NUTR, V140, P1261, DOI 10.3945/jn.109.120477	30	11	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113148	10.1371/journal.pone.0113148	http://dx.doi.org/10.1371/journal.pone.0113148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401978	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700117
J	Xi, T; Schreurs, R; Heerink, WJ; Berge, SJ; Maal, TJJ				Xi, Tong; Schreurs, Ruud; Heerink, Wout J.; Berge, Stefaan J.; Maal, Thomas J. J.			A Novel Region-Growing Based Semi-Automatic Segmentation Protocol for Three-Dimensional Condylar Reconstruction Using Cone Beam Computed Tomography (CBCT)	PLOS ONE			English	Article							RESORPTION; ACCURACY; OSTEOTOMIES; ADVANCEMENT	Objective: To present and validate a semi-automatic segmentation protocol to enable an accurate 3D reconstruction of the mandibular condyles using cone beam computed tomography (CBCT). Materials and Methods: Approval from the regional medical ethics review board was obtained for this study. Bilateral mandibular condyles in ten CBCT datasets of patients were segmented using the currently proposed semi-automatic segmentation protocol. This segmentation protocol combined 3D region-growing and local thresholding algorithms. The segmentation of a total of twenty condyles was performed by two observers. The Dice-coefficient and distance map calculations were used to evaluate the accuracy and reproducibility of the segmented and 3D rendered condyles. Results: The mean inter-observer Dice-coefficient was 0.98 (range [0.95-0.99]). An average 90th percentile distance of 0.32 mm was found, indicating an excellent inter-observer similarity of the segmented and 3D rendered condyles. No systematic errors were observed in the currently proposed segmentation protocol. Conclusion: The novel semi-automated segmentation protocol is an accurate and reproducible tool to segment and render condyles in 3D. The implementation of this protocol in the clinical practice allows the CBCT to be used as an imaging modality for the quantitative analysis of condylar morphology.	[Xi, Tong; Schreurs, Ruud; Berge, Stefaan J.; Maal, Thomas J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Heerink, Wout J.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	Radboud University Nijmegen; University of Groningen	Xi, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands.	Tong.Xi@radboudumc.nl	Maal, Thomas JJ/L-4497-2015; Berge, Stefaan/AAP-3708-2020; Xi, Tong/P-6268-2015; Bergé, S.J./H-8011-2014; Schreurs, Ruud/P-6769-2015	Maal, Thomas JJ/0000-0002-1702-4733; Xi, Tong/0000-0002-9142-9253; Schreurs, Ruud/0000-0003-2429-2071; Heerink, Wouter/0000-0002-5629-1359	Netherlands Organization for Scientific Research [017.005.006]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by a Mozaiek grant (project number 017.005.006) from the Netherlands Organization for Scientific Research, granted to TX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Jiwanasha Manish, 2013, J Contemp Dent Pract, V14, P153; Borstlap WA, 2004, INT J ORAL MAX SURG, V33, P649, DOI 10.1016/j.ijom.2004.01.018; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; Engelbrecht WP, 2013, CLIN ORAL INVESTIGAT; Fourie Z, 2012, EUR J RADIOL, V81, pE524, DOI 10.1016/j.ejrad.2011.06.001; Honey OB, 2007, AM J ORTHOD DENTOFAC, V132, P429, DOI 10.1016/j.ajodo.2005.10.032; Hoppenreijs TJM, 1998, INT J ORAL MAX SURG, V27, P81, DOI 10.1016/S0901-5027(98)80301-9; Katsumata A, 2007, ORAL SURG ORAL MED O, V104, P829, DOI 10.1016/j.tripleo.2006.12.005; Kobayashi T, 2012, BRIT J ORAL MAX SURG, V50, P176, DOI 10.1016/j.bjoms.2011.02.006; Ludlow JB, 2007, ORAL SURG ORAL MED O, V103, P534, DOI 10.1016/j.tripleo.2006.04.008; Paniagua B, 2011, COMPUT MED IMAG GRAP, V35, P345, DOI 10.1016/j.compmedimag.2010.11.012; Paniagua B, 2011, INT J COMPUT ASS RAD, V6, P617, DOI 10.1007/s11548-010-0539-z; Park SB, 2011, J ORAL MAXILLOFACIAL; Scarfe William C, 2008, Dent Clin North Am, V52, P707, DOI 10.1016/j.cden.2008.05.005; Schlueter B, 2008, ANGLE ORTHOD, V78, P880, DOI 10.2319/072007-339.1; Shafi MI, 2013, INT J ORAL MAXILLOFA; Xi T, 2013, INT J ORAL MAX SURG, V42, P1023, DOI 10.1016/j.ijom.2013.01.016; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	18	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111126	10.1371/journal.pone.0111126	http://dx.doi.org/10.1371/journal.pone.0111126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401954	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700013
J	Ishikawa, A; Okuno, S				Ishikawa, Akira; Okuno, Sin-ichiro			Fine Mapping and Candidate Gene Search of Quantitative Trait Loci for Growth and Obesity Using Mouse Intersubspecific Subcongenic Intercrosses and Exome Sequencing	PLOS ONE			English	Article							POSTNATAL-GROWTH; BODY-WEIGHT; FAT; RECEPTOR; REVEALS; QTL; INFLAMMATION; EXPRESSION; PHENOTYPES; VARIANTS	Although growth and body composition traits are quantitative traits of medical and agricultural importance, the genetic and molecular basis of those traits remains elusive. Our previous genome-wide quantitative trait locus (QTL) analyses in an intersubspecific backcross population between C57BL/6JJcl (B6) and wild Mus musculus castaneus mice revealed a major growth QTL (named Pbwg1) on a proximal region of mouse chromosome 2. Using the B6. Cg-Pbwg1 intersubspecific congenic strain created, we revealed 12 closely linked QTLs for body weight and body composition traits on an approximately 44.1-Mb wild-derived congenic region. In this study, we narrowed down genomic regions harboring three (Pbwg1.12, Pbwg1.3 and Pbwg1.5) of the 12 linked QTLs and searched for possible candidate genes for the QTLs. By phenotypic analyses of F-2 intercross populations between B6 and each of four B6. Cg-Pbwg1 subcongenic strains with overlapping and non-overlapping introgressed regions, we physically defined Pbwg1.12 affecting body weight to a 3.8-Mb interval (61.5-65.3 Mb) on chromosome 2. We fine-mapped Pbwg1.3 for body length to an 8.0-Mb interval (57.3-65.3) and Pbwg1.5 for abdominal white fat weight to a 2.1-Mb interval (59.4-61.5). The wild-derived allele at Pbwg1.12 and Pbwg1.3 uniquely increased body weight and length despite the fact that the wild mouse has a smaller body size than that of B6, whereas it decreased fat weight at Pbwg1.5. Exome sequencing and candidate gene prioritization suggested that Gcg and Grb14 are putative candidate genes for Pbwg1.12 and that Ly75 and Itgb6 are putative candidate genes for Pbwg1.5. These genes had nonsynonymous SNPs, but the SNPs were predicted to be not harmful to protein functions. These results provide information helpful to identify wild-derived quantitative trait genes causing enhanced growth and resistance to obesity.	[Ishikawa, Akira; Okuno, Sin-ichiro] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Nagoya, Aichi 4648601, Japan	Nagoya University	Ishikawa, A (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Nagoya, Aichi 4648601, Japan.	ishikawa@agr.nagoya-u.ac.jp	Ishikawa, Akira/I-6856-2014	Ishikawa, Akira/0000-0002-8275-4230	Japan Society for the Promotion of Science to A Ishikawa	Japan Society for the Promotion of Science to A Ishikawa(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science to A Ishikawa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Baeza E, 2013, ANIMAL, V7, P965, DOI 10.1017/S1751731113000153; Cariou B, 2004, FRONT BIOSCI-LANDMRK, V9, P1626, DOI 10.2741/1228; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cheverud JM, 2008, P NATL ACAD SCI USA, V105, P4253, DOI 10.1073/pnas.0706562105; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Darvasi A, 1997, MAMM GENOME, V8, P163, DOI 10.1007/s003359900382; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; Drinkwater NR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002975; Eisen EJ, 2005, MOUSE IN ANIMAL GENETICS AND BREEDING RESEARCH, P1, DOI 10.1142/9781860947162; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fall T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001474; Farber CR, 2007, MAMM GENOME, V18, P635, DOI 10.1007/s00335-007-9046-0; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hayashi Y, 2011, DIABETES OBES METAB, V13, P151, DOI 10.1111/j.1463-1326.2011.01456.x; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921; Ishikawa A, 2000, MAMM GENOME, V11, P824, DOI 10.1007/s003350010145; Ishikawa A, 2005, GENET RES, V85, P127, DOI 10.1017/S001667230500738X; Ishikawa A, 2004, GENES GENET SYST, V79, P27, DOI 10.1266/ggs.79.27; Ishikawa A, 2007, MAMM GENOME, V18, P229, DOI 10.1007/s00335-007-9009-5; Ishikawa A, 2009, J HERED, V100, P501, DOI 10.1093/jhered/esp004; Jarvis JP, 2005, J LIPID RES, V46, P1692, DOI 10.1194/jlr.M500073-JLR200; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mighiu PI, 2013, NAT MED, V19, P766, DOI 10.1038/nm.3115; Mollah MBR, 2011, MAMM GENOME, V22, P282, DOI 10.1007/s00335-011-9323-9; Mollah MBR, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-84; Mollah MBR, 2013, ANIM SCI J, V84, P296, DOI 10.1111/asj.12004; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Partridge CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-99; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Robins Diane M, 2005, Novartis Found Symp, V268, P42; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yogosawa S, 2013, DIABETES, V62, P115, DOI 10.2337/db12-0295	44	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113233	10.1371/journal.pone.0113233	http://dx.doi.org/10.1371/journal.pone.0113233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398139	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500143
J	Lin, YH; Deng, KH; Sun, YX; Zeng, DZ; Liu, WY; Kong, XW; Singh, A				Lin, Yuanhua; Deng, Kuanhai; Sun, Yongxing; Zeng, Dezhi; Liu, Wanying; Kong, Xiangwei; Singh, Ambrish			Burst Strength of Tubing and Casing Based on Twin Shear Unified Strength Theory	PLOS ONE			English	Article							PREDICTION; PRESSURE	The internal pressure strength of tubing and casing often cannot satisfy the design requirements in high pressure, high temperature and high H2S gas wells. Also, the practical safety coefficient of some wells is lower than the design standard according to the current API 5C3 standard, which brings some perplexity to the design. The ISO 10400: 2007 provides the model which can calculate the burst strength of tubing and casing better than API 5C3 standard, but the calculation accuracy is not desirable because about 50 percent predictive values are remarkably higher than real burst values. So, for the sake of improving strength design of tubing and casing, this paper deduces the plastic limit pressure of tubing and casing under internal pressure by applying the twin shear unified strength theory. According to the research of the influence rule of yield-to-tensile strength ratio and mechanical properties on the burst strength of tubing and casing, the more precise calculation model of tubing-casing's burst strength has been established with material hardening and intermediate principal stress. Numerical and experimental comparisons show that the new burst strength model is much closer to the real burst values than that of other models. The research results provide an important reference to optimize the tubing and casing design of deep and ultra-deep wells.	[Lin, Yuanhua; Deng, Kuanhai] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu 610500, Sichuan, Peoples R China; [Sun, Yongxing; Zeng, Dezhi; Kong, Xiangwei; Singh, Ambrish] Southwest Petr Univ, CNPC Key Lab Tubular Goods Engn, Chengdu 610500, Sichuan, Peoples R China; [Liu, Wanying] Sichuan Univ, Sch Mat Sci & Engn, Chengdu 610000, Sichuan, Peoples R China	Southwest Petroleum University; Southwest Petroleum University; Sichuan University	Lin, YH (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu 610500, Sichuan, Peoples R China.	yhlin28@163.com		Singh, Ambrish/0000-0002-9652-7717	National Natural Science Foundation of China [51274170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 51274170) to LYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen JA, 2007, J PETROL SCI ENG, V56, P232, DOI 10.1016/j.petrol.2006.09.005; American National Standards Institute, 1984, MAN DET REM STRENGHT; Committee on Standardization of Tubular Goods, 1994, B FORM CALC CAS TUB; [冯剑军 Feng Jianjun], 2004, [固体力学学报, Acta Mechanica Solida Sinica], V25, P208; Gao DL, 2004, J PETROL SCI ENG, V41, P183, DOI 10.1016/S0920-4105(03)00152-9; Hasan S, 2012, INT J PRES VES PIP, V89, P48, DOI 10.1016/j.ijpvp.2011.09.005; ISO Technical Committees, 2007, PETR NAT GAS IND FOR; Jianan W, 1980, METALLOGRAPHY HEAT T; Kamaya M, 2008, INT J PRES VES PIP, V85, P628, DOI 10.1016/j.ijpvp.2007.11.005; Kiefner JF., 1989, PR3805 BATT MEM I; Klever FJ, 1992, 7029 SPE; Law M, 2007, INT J PRES VES PIP, V84, P487, DOI 10.1016/j.ijpvp.2007.04.002; Lee YK, 1996, INT J PLASTICITY, V12, P1179, DOI 10.1016/S0749-6419(96)00047-2; Lin W, 2010, THESIS SW PETROLEUM; Mao-hong Y.U., 2004, UNIFIED STRENGTH THE; Maohong Y, 1997, CHINA CIVIL ENG J, V30, P182; Nadai A, 1931, PLASCITY; Paslay PR, 1998, 48327 SPE; STEWART G., 1998, 48329 SPE; Stewart G, 1998, 48330 SPE; Tallin AG, 1998, 48320 SPE; Wang LZ, 2011, INT J MECH SCI, V53, P348, DOI 10.1016/j.ijmecsci.2011.02.004; Xiankui Z, 2005, J PRESSURE VESSEL TE, V127, P436; Yongxing S, 2009, PETROLEUM DRILLING T, V37, P35; Yongxing S, 2008, THESIS SW PETROLEUM; Yuanhua L, 2013, J PRESSURE VESSEL TE, V135; Zhang SH, 2014, J CENT SOUTH UNIV, V21, P460, DOI 10.1007/s11771-014-1960-1; [赵均海 Zhao Junhai], 2013, [石油学报, Acta Petrolei Sinica], V34, P969; Zhilun X., 2006, ELASTICITY MECH	29	11	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111426	10.1371/journal.pone.0111426	http://dx.doi.org/10.1371/journal.pone.0111426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397886	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500016
J	Lovrics, A; Gao, Y; Juhasz, B; Bock, I; Byrne, HM; Dinnyes, A; Kovacs, KA				Lovrics, Anna; Gao, Yu; Juhasz, Bianka; Bock, Istvan; Byrne, Helen M.; Dinnyes, Andras; Kovacs, Krisztian A.			Boolean Modelling Reveals New Regulatory Connections between Transcription Factors Orchestrating the Development of the Ventral Spinal Cord	PLOS ONE			English	Article							PROGENITOR-CELL IDENTITY; NEURONAL FATE; MOTOR-NEURON; ARABIDOPSIS-THALIANA; SUBTYPE IDENTITY; GENETIC-CONTROL; NKX2.2; DIFFERENTIATION; SPECIFICATION; DETERMINES	We have assembled a network of cell-fate determining transcription factors that play a key role in the specification of the ventral neuronal subtypes of the spinal cord on the basis of published transcriptional interactions. Asynchronous Boolean modelling of the network was used to compare simulation results with reported experimental observations. Such comparison highlighted the need to include additional regulatory connections in order to obtain the fixed point attractors of the model associated with the five known progenitor cell types located in the ventral spinal cord. The revised gene regulatory network reproduced previously observed cell state switches between progenitor cells observed in knock-out animal models or in experiments where the transcription factors were overexpressed. Furthermore the network predicted the inhibition of Irx3 by Nkx2.2 and this prediction was tested experimentally. Our results provide evidence for the existence of an as yet undescribed inhibitory connection which could potentially have significance beyond the ventral spinal cord. The work presented in this paper demonstrates the strength of Boolean modelling for identifying gene regulatory networks.	[Lovrics, Anna; Gao, Yu; Juhasz, Bianka; Bock, Istvan; Dinnyes, Andras; Kovacs, Krisztian A.] Biotalentum Ltd, Godollo, Hungary; [Bock, Istvan; Dinnyes, Andras] Szent Istvan Univ, Mol Anim Biotechnol Lab, Godollo, Hungary; [Byrne, Helen M.] Univ Oxford, Oxford Ctr Collaborat Appl Math, Math Inst, Oxford, England; [Dinnyes, Andras] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Kovacs, Krisztian A.] IST Austria, Klosterneuburg, Austria	BioTalentum Ltd; Hungarian University of Agriculture & Life Sciences; University of Oxford; Utrecht University; Institute of Science & Technology - Austria	Lovrics, A (corresponding author), Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary.	anna.lovrics@gmail.com	; Dinnyes, Andras/D-5131-2013	Gao, Yu/0000-0001-5090-8250; Byrne, Helen/0000-0003-1771-5910; Dinnyes, Andras/0000-0003-3791-2583; Bock, Istvan/0000-0001-9178-4506; Kovacs, Krisztian/0000-0001-6251-1007	IDPbyNMR; PluriSys; InduStem; RESOLVE; EpiHealth; Stem-Cam; EC Seventh Framework Programme [PITN-GA-2010-264257, HEALTH-F4-2009-223485, PIAP-GA-2008-230675, FP7-HEALTH-F4-2008-202047, HEALTH-2012-F2-278418, PIAP-GA-2009-251186, PIAPP-GA-2011-286264]; Research Centre of Excellence [8526-5/2014/TUDPOL]; King Abdullah University of Science and Technology (KAUST) [KUK-C1-013-04]; IST FELLOWSHIP under REA grant [P IST EU01, 291734]; Biotalentum Ltd	IDPbyNMR; PluriSys; InduStem; RESOLVE; EpiHealth; Stem-Cam; EC Seventh Framework Programme(European Commission); Research Centre of Excellence; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); IST FELLOWSHIP under REA grant; Biotalentum Ltd	This publication was based on work supported in part by IDPbyNMR, PluriSys, InduStem, RESOLVE, EpiHealth, Stem-Cam, ANISTEM (grant agreement numbers PITN-GA-2010-264257, HEALTH-F4-2009-223485, PIAP-GA-2008-230675, FP7-HEALTH-F4-2008-202047, HEALTH-2012-F2-278418, PIAP-GA-2009-251186, PIAPP-GA-2011-286264) projects funded by the EC Seventh Framework Programme, Research Centre of Excellence, 8526-5/2014/TUDPOL, Award No. KUK-C1-013-04, made by King Abdullah University of Science and Technology (KAUST) and the IST FELLOWSHIP awarded to Krisztian A Kovacs (Project: P IST EU01 under REA grant agreement no 291734). Al, YG, BJ and KK were affiliated to Biotalentum Ltd. IB and AD are still affiliated to Biotalentum Ltd, and received salary from them to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Anderson KR, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-65; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Boykin ER, 2010, MOL BIOSYST, V6, P1993, DOI 10.1039/c0mb00006j; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; Cheng XR, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0574; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Cohen M, 2013, CURR OPIN GENET DEV, V23, P423, DOI 10.1016/j.gde.2013.04.003; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Giacomantonio CE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000936; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Harvey I, 1997, FROM ANIM ANIMAT, P67; Hill JT, 2010, MOL ENDOCRINOL, V24, P381, DOI 10.1210/me.2009-0360; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kobayashi D, 2002, DEVELOPMENT, V129, P83; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nishi Y, 2009, BBA-GENE REGUL MECH, V1789, P299, DOI 10.1016/j.bbagrm.2009.01.002; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Oosterveen T, 2012, DEV CELL, V23, P1006, DOI 10.1016/j.devcel.2012.09.015; Panovska-Griffiths J, 2013, J R SOC INTERFACE, V10; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Peter IS, 2012, P NATL ACAD SCI US; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Ribes V, 2010, GENE DEV, V24, P1186, DOI 10.1101/gad.559910; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Sanchez-Corrales YE, 2010, J THEOR BIOL, V264, P971, DOI 10.1016/j.jtbi.2010.03.006; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Todd KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031176; Tozer S, 2013, DEVELOPMENT, V140, P1467, DOI 10.1242/dev.090118; Ulloa F, 2010, DEV DYNAM, V239, P69, DOI 10.1002/dvdy.22058; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wittmann DM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000569; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	55	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111430	10.1371/journal.pone.0111430	http://dx.doi.org/10.1371/journal.pone.0111430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398016	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500017
J	Yamaoka, M; Maeda, N; Takayama, Y; Sekimoto, R; Tsushima, Y; Matsuda, K; Mori, T; Inoue, K; Nishizawa, H; Tominaga, M; Funahashi, T; Shimomura, I				Yamaoka, Masaya; Maeda, Norikazu; Takayama, Yasunori; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Mori, Takuya; Inoue, Kana; Nishizawa, Hitoshi; Tominaga, Makoto; Funahashi, Tohru; Shimomura, Iichiro			Adipose Hypothermia in Obesity and Its Association with Period Homolog 1, Insulin Sensitivity, and Inflammation in Fat	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; PROTEIN-KINASE-A; METABOLIC SYNDROME; CIRCADIAN CLOCK; FEEDBACK LOOP; MICE; TISSUE; THERMOGENESIS; CELLS; CALPROTECTIN	Visceral fat adiposity plays an important role in the development of metabolic syndrome. We reported previously the impact of human visceral fat adiposity on gene expression profile of peripheral blood cells. Genes related to circadian rhythm were highly associated with visceral fat area and period homolog 1 (PER1) showed the most significant negative correlation with visceral fat area. However, regulation of adipose Per1 remains poorly understood. The present study was designed to understand the regulation of Per1 in adipose tissues. Adipose Per1 mRNA levels of ob/ob mice were markedly low at 25 and 35 weeks of age. The levels of other core clock genes of white adipose tissues were also low in ob/ob mice at 25 and 35 weeks of age. Per1 mRNA was mainly expressed in the mature adipocyte fraction (MAF) and it was significantly low in MAF of ob/ob mice. To examine the possible mechanisms, 3T3-L1 adipocytes were treated with H2O2, tumor necrosis factor-alpha (TNF-alpha), S100A8, and lipopolysaccharide (LPS). However, no significant changes in Per1 mRNA level were observed by these agents. Exposure of cultured 3T3-L1 adipocytes to low temperature (33 degrees C) decreased Per1 and catalase, and increased monocyte chemoattractant protein-1 (Mcp-1) mRNA levels. Hypothermia also worsened insulin-mediated Akt phosphorylation in 3T3-L1 adipocytes. Finally, telemetric analysis showed low temperature of adipose tissues in ob/ob mice. In obesity, adipose hypothermia seems to accelerate adipocyte dysfunction.	[Yamaoka, Masaya; Maeda, Norikazu; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Mori, Takuya; Inoue, Kana; Nishizawa, Hitoshi; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan; [Takayama, Yasunori; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka 5650871, Japan	Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Osaka University	Maeda, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp			Takeda Science Foundation; Japan Diabetes Foundation; Suzuken Memorial Foundation;  [22590979];  [24390238];  [22126008]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Diabetes Foundation; Suzuken Memorial Foundation; ; ; 	This work was supported in part by a Grants-in-Aid for Scientific Research (C) no. 22590979 (to NM), a Grants-in-Aid for Scientific Research (B) no. 24390238 (to IS), a Grants-in-Aid for Scientific Research on Innovative Areas no. 22126008 (to TF), Takeda Science Foundation (to NM), Japan Diabetes Foundation (to NM), and Suzuken Memorial Foundation (to NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Becerril S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010962; Burioka N, 2008, EUR RESPIR J, V32, P105, DOI 10.1183/09031936.00138207; Burioka N, 2005, CHRONOBIOL INT, V22, P585, DOI 10.1081/CBI-200062416; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; de Weerd L, 2011, CLIN PLAST SURG, V38, P277, DOI 10.1016/j.cps.2011.03.013; Du GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072044; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Funahashi T, 2007, ANN MED, V39, P482, DOI 10.1080/07853890701491026; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gilbert MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017051; Gimble JM, 2011, NAT REV ENDOCRINOL, V7, P98, DOI 10.1038/nrendo.2010.214; Gorbach AM, 2008, J SURG RES, V149, P310, DOI 10.1016/j.jss.2008.02.007; Hiuge-Shimizu A, 2011, ARTERIOSCL THROM VAS, V31, P792, DOI 10.1161/ATVBAHA.110.221747; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Huang W, 2012, J LIPID RES, V53, P368, DOI 10.1194/jlr.M019687; Husse J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052983; Inoue K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087661; Jurgens HS, 2006, PHYSIOL GENOMICS, V25, P234, DOI 10.1152/physiolgenomics.00252.2005; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Merla A, 2008, INT J IMMUNOPATH PH, V21, P679, DOI 10.1177/039463200802100322; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076199; Morioka N, 2010, J PHARMACOL SCI, V113, P234, DOI 10.1254/jphs.10031FP; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ring Francis, 2010, J Diabetes Sci Technol, V4, P857; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; Sugimoto T, 2011, NEUROSCIENCE, V185, P1, DOI 10.1016/j.neuroscience.2011.04.024; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Xi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036453; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; Yamaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047377; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yoo HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096432; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112813	10.1371/journal.pone.0112813	http://dx.doi.org/10.1371/journal.pone.0112813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397888	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500092
J	Tan, Z; Xie, N; Banerjee, S; Cui, HC; Fu, MG; Thannickal, VJ; Liu, G				Tan, Zheng; Xie, Na; Banerjee, Sami; Cui, Huachun; Fu, Mingui; Thannickal, Victor J.; Liu, Gang			The Monocarboxylate Transporter 4 Is Required for Glycolytic Reprogramming and Inflammatory Response in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycolysis; Inflammation; Lipopolysaccharide (LPS); Macrophage; Toll-like Receptor (TLR); MCT4	TOLL-LIKE RECEPTOR; PATTERN-RECOGNITION RECEPTORS; LACTIC-ACID; EFFECTOR FUNCTION; LACTATE; METABOLISM; HYPOXIA; ACTIVATION; CANCER; CELLS	Background: Glycolysis has an important role in inflammation. Results: MCT4 is up-regulated in inflammatorily activated macrophages and required for innate immune response. Conclusion: MCT4 up-regulation represents a positive feedback mechanism in inflammation. Significance: Delineation of the role of MCT4 provides further insight into the regulation of inflammation by glycolysis. There has been fast growing evidence showing that glycolysis plays a critical role in the activation of immune cells. Enhanced glycolysis leads to increased formation of intracellular lactate that is exported to the extracellular environment by monocarboxylate transporter 4 (MCT4). Although the biological activities of extracellular lactate have been well studied, it is less understood how the lactate export is regulated or whether lactate export affects glycolysis during inflammatory activation. In this study, we found that MCT4 is up-regulated by TLR2 and TLR4, but not TLR3 agonists in a variety of macrophages. The increased expression of MCT4 was mediated by MYD88 in a NF-B-dependent manner. Furthermore, we found that MCT4 is required for macrophage activation upon TLR2 and TLR4 stimulations, as evidenced by attenuated expression of proinflammatory mediators in macrophages with MCT4 knockdown. Mechanistically, we found that MCT4 knockdown leads to enhanced intracellular accumulation of lactate and decreased glycolysis in LPS-treated macrophages. We found that LPS-induced expression of key glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 is diminished in macrophages with MCT4 knockdown. Our data suggest that MCT4 up-regulation represents a positive feedback mechanism in macrophages to maintain a high glycolytic rate that is essential to a fully activated inflammatory response.	[Tan, Zheng; Xie, Na; Banerjee, Sami; Cui, Huachun; Thannickal, Victor J.; Liu, Gang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Tan, Zheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Immunol, Wuhan 430030, Peoples R China; [Fu, Mingui] Univ Missouri, Dept Basic Med Sci, Kansas City, MO 64108 USA	University of Alabama System; University of Alabama Birmingham; Huazhong University of Science & Technology; University of Missouri System; University of Missouri Kansas City	Liu, G (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Dept Med, 901 19th St So,BMR II 233, Birmingham, AL 35294 USA.	gliu@uab.edu		, Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X	National Institutes of Health [HL105473, HL076206, HL114470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470, R01HL105473, R01HL076206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL105473 and HL076206 (to G. L.) and HL114470 (to V.J.T.).	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Banerjee S, 2013, J IMMUNOL, V190, P6542, DOI 10.4049/jimmunol.1202496; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hoque R, 2014, GASTROENTEROLOGY, V146, P1763, DOI 10.1053/j.gastro.2014.03.014; Jeannin P, 2008, CURR OPIN IMMUNOL, V20, P530, DOI 10.1016/j.coi.2008.04.013; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lim KS, 2014, ONCOGENE, V33, P4433, DOI 10.1038/onc.2013.390; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Samuvel DJ, 2009, J IMMUNOL, V182, P2476, DOI 10.4049/jimmunol.0802059; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Shime H, 2008, J IMMUNOL, V180, P7175, DOI 10.4049/jimmunol.180.11.7175; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Yoshimura A, 1999, J IMMUNOL, V163, P1	51	101	102	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					46	55		10.1074/jbc.M114.603589	http://dx.doi.org/10.1074/jbc.M114.603589			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406319	Green Published, hybrid			2022-12-26	WOS:000347231200005
J	Lane, JM; Doyle, JR; Fortin, JP; Kopin, AS; Ordovas, JM				Lane, Jacqueline M.; Doyle, Jamie R.; Fortin, Jean-Philippe; Kopin, Alan S.; Ordovas, Jose M.			Development of an OP9 Derived Cell Line as a Robust Model to Rapidly Study Adipocyte Differentiation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; 3T3-L1 CELLS; PPAR-GAMMA; STEM-CELLS; ADIPOSE; ADIPOGENESIS; PU.1; RISK; MICRORNAS	One hallmark of obesity is adipocyte hypertrophy and hyperplasia. To gain novel insights into adipose biology and therapeutics, there is a pressing need for a robust, rapid, and informative cell model of adipocyte differentiation for potential RNAi and drug screens. Current models are prohibitive for drug and RNAi screens due to a slow differentiation time course and resistance to transfection. We asked if we could create a rapid, robust model of adipogenesis to potentially enable rapid functional and obesity therapeutic screens. We generated the clonal population OP9-K, which differentiates rapidly and reproducibly, and displays classic adipocyte morphology: rounded cell shape, lipid accumulation, and coalescence of lipids into a large droplet. We further validate the OP9-K cells as an adipocyte model system by microarray analysis of the differentiating transcriptome. OP9-K differentiates via known adipogenic pathways, involving the transcriptional activation and repression of common adipose markers Plin1, Gata2, C/Ebp alpha and C/Ebp beta and biological pathways, such as lipid metabolism, PPAR gamma signaling, and osteogenesis. We implemented a method to quantify lipid accumulation using automated microscopy and tested the ability of our model to detect alterations in lipid accumulation by reducing levels of the known master adipogenic regulator Ppar gamma. We further utilized our model to query the effects of a novel obesity therapeutic target, the transcription factor SPI1. We determine that reduction in levels of Spi1 leads to an increase in lipid accumulation. We demonstrate rapid, robust differentiation and efficient transfectability of the OP9-K cell model of adipogenesis. Together with our microscopy based lipid accumulation assay, adipogenesis assays can be achieved in just four days' time. The results of this study can contribute to the development of rapid screens with the potential to deepen our understanding of adipose biology and efficiently test obesity therapeutics.	[Lane, Jacqueline M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Lane, Jacqueline M.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Lane, Jacqueline M.; Ordovas, Jose M.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Doyle, Jamie R.; Fortin, Jean-Philippe; Kopin, Alan S.] Tufts Med Ctr, Mol Cardiol Res Inst, Mol Pharmacol Res Ctr, Boston, MA 02111 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Tufts University; United States Department of Agriculture (USDA); Tufts Medical Center	Lane, JM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	lane@chgr.mgh.harvard.edu	Ordovas, Jose/B-8727-2013	Ordovas, Jose/0000-0002-7581-5680	U.S. Department of Agriculture [58-1950-0-014]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work supported by the U.S. Department of Agriculture, under agreement No. 58-1950-0-014. Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge A, 2013, CYTOTHERAPY, V15, P89, DOI 10.1016/j.jcyt.2012.07.001; Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Bray GA., 2014, HDB OBESITY EPIDEMIO; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chen HC, 2002, J LIPID RES, V43, P986; Chen L, 2013, CELL BIOL INT, V37, P533, DOI 10.1002/cbin.10063; Chung NJ, 2010, ASSAY DRUG DEV TECHN, V8, P286, DOI 10.1089/adt.2009.0262; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; Di Iorgi N, 2008, J CLIN ENDOCR METAB, V93, P2281, DOI 10.1210/jc.2007-2691; Doran AC, 2008, CIRC RES, V103, P624, DOI 10.1161/CIRCRESAHA.108.175893; Dragunow M, 2007, J BIOMOL SCREEN, V12, P999, DOI 10.1177/1087057107306502; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gade Wayne, 2010, Clin Lab Sci, V23, P39; Gasparri F, 2009, EXPERT OPIN DRUG DIS, V4, P643, DOI 10.1517/17460440902992870; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Han YY, 2013, J STEROID BIOCHEM, V133, P129, DOI 10.1016/j.jsbmb.2012.09.005; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kamstra JH, 2014, ENVIRON SCI TECHNOL, V48, P4110, DOI 10.1021/es405524b; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lin LG, 2012, AM J PHYSIOL-ENDOC M, V302, pE1550, DOI 10.1152/ajpendo.00462.2011; Ling HY, 2013, BIOCHEM CELL BIOL, V91, P195, DOI 10.1139/bcb-2012-0053; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Menssen A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-461; Morganstein DL, 2008, J LIPID RES, V49, P679, DOI 10.1194/jlr.D700029-JLR200; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Pang WJ, 2013, J CELL BIOCHEM, V114, P2500, DOI 10.1002/jcb.24595; Peng YD, 2014, CELL SIGNAL, V26, P1888, DOI 10.1016/j.cellsig.2014.05.006; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Prokesch A, 2009, CURR MED CHEM, V16, P2952, DOI 10.2174/092986709788803132; Puri V, 2007, J LIPID RES, V48, P465, DOI 10.1194/jlr.D600033-JLR200; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Shimada T, 2007, BIOCHEM BIOPH RES CO, V363, P355, DOI 10.1016/j.bbrc.2007.08.167; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Sohle J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031193; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Suwa A, 2011, ENDOCRINE, V40, P56, DOI 10.1007/s12020-011-9455-4; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tong Q, 2001, Rev Endocr Metab Disord, V2, P349, DOI 10.1023/A:1011863414321; Wang F, 2008, AM J PHYSIOL-CELL PH, V295, pC213, DOI 10.1152/ajpcell.00422.2007; Wei P, 2005, J BIOCHEM, V138, P399, DOI 10.1093/jb/mvi136; Welter JF, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/806525; WING RR, 1992, AM J CLIN NUTR, V55, P1086, DOI 10.1093/ajcn/55.6.1086; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Yaskin J, 2009, POPUL HEALTH MANAG, V12, P305, DOI 10.1089/pop.2008.0049; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005	61	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112123	10.1371/journal.pone.0112123	http://dx.doi.org/10.1371/journal.pone.0112123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409310	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200015
J	Wang, CZ; Pahk, JB; Balaban, CD; Miller, MC; Wood, AR; Vipperman, JS				Wang, Chenzhi; Pahk, Jae Bum; Balaban, Carey D.; Miller, Mark C.; Wood, Adam R.; Vipperman, Jeffrey S.			Computational Study of Human Head Response to Primary Blast Waves of Five Levels from Three Directions	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PATHOLOGY; EXPOSURE	Human exposure to blast waves without any fragment impacts can still result in primary blast-induced traumatic brain injury (bTBI). To investigate the mechanical response of human brain to primary blast waves and to identify the injury mechanisms of bTBI, a three-dimensional finite element head model consisting of the scalp, skull, cerebrospinal fluid, nasal cavity, and brain was developed from the imaging data set of a human female. The finite element head model was partially validated and was subjected to the blast waves of five blast intensities from the anterior, right lateral, and posterior directions at a stand-off distance of one meter from the detonation center. Simulation results show that the blast wave directly transmits into the head and causes a pressure wave propagating through the brain tissue. Intracranial pressure (ICP) is predicted to have the highest magnitude from a posterior blast wave in comparison with a blast wave from any of the other two directions with same blast intensity. The brain model predicts higher positive pressure at the site proximal to blast wave than that at the distal site. The intracranial pressure wave invariably travels into the posterior fossa and vertebral column, causing high pressures in these regions. The severities of cerebral contusions at different cerebral locations are estimated using an ICP based injury criterion. Von Mises stress prevails in the cortex with a much higher magnitude than in the internal parenchyma. According to an axonal injury criterion based on von Mises stress, axonal injury is not predicted to be a cause of primary brain injury from blasts.	[Wang, Chenzhi; Miller, Mark C.; Wood, Adam R.; Vipperman, Jeffrey S.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA; [Pahk, Jae Bum] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Balaban, Carey D.] Univ Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vipperman, JS (corresponding author), Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA.	jsv@pitt.edu	Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Vipperman, Jeffrey/0000-0001-5585-954X	University of Pittsburgh; National Science Foundation (NSF); NSF [1130289]; National Institute of Biomedical Imaging and BioEngineering	University of Pittsburgh(University of Pittsburgh); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); National Institute of Biomedical Imaging and BioEngineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors gratefully acknowledge the University of Pittsburgh and National Science Foundation (NSF) for the funding support. This material is based upon work supported by the NSF under Grant No. 1130289. Thanks are also expressed for the MRI data obtained from The International Consortium for Brain Mapping (ICBM 2011). The ICBM project (Principal Investigator John Mazziotta, M.D, University of California, Los Angeles) is supported by the National Institute of Biomedical Imaging and BioEngineering. ICBM is the result of efforts of co-investigators from UCLA, Montreal Neurologic Institute, University of Texas at San Antonio, and the Institute of Medicine, Juelich/Heinrich Heine University - Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cooper PW., 1996, EXPLOSIVES ENG; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Friedlander FG, 1976, WAVE EQUATION CURVED; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hoffer ME, 2013, PSYCHIAT ANN, V43, P318, DOI 10.3928/00485713-20130703-06; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Lee E., 1973, JWL EQUATION STATE C, DOI [10.2172/4479737, DOI 10.2172/4479737]; Lee EL., 1968, ADIABATIC EXPANSION; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Nahum A, 1977, 21 STAPP CAR CRASH C, DOI [10.4271/770922, DOI 10.4271/770922]; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rogers G. F. C., 1980, THERMODYNAMIC TRANSP; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wang C, 2011, P IMECE 2011; Wang C, 2012, P IMECE 2012; Ward C., 1980, SAE TECHNICAL PAPER; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	42	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113264	10.1371/journal.pone.0113264	http://dx.doi.org/10.1371/journal.pone.0113264			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409326	gold, Green Published, Green Accepted			2022-12-26	WOS:000345533200085
J	Chow, IT; Yang, JB; Gates, TJ; James, EA; Mai, DT; Greenbaum, C; Kwok, WW				Chow, I-Ting; Yang, Junbao; Gates, Theresa J.; James, Eddie A.; Mai, Duy T.; Greenbaum, Carla; Kwok, William W.			Assessment of CD4+T Cell Responses to Glutamic Acid Decarboxylase 65 Using DQ8 Tetramers Reveals a Pathogenic Role of GAD65 121-140 and GAD65 250-266 in T1D Development	PLOS ONE			English	Article							CD4(+) T-CELLS; TYPE-1 DIABETES RISK; EPITOPES; SUSCEPTIBILITY; AUTOANTIGEN; HAPLOTYPES; GENOTYPES; COMPLEX; MICE	Susceptibility to type 1 diabetes (T1D) is strongly associated with MHC class II molecules, particularly HLA-DQ8 (DQ8: DQA1* 03: 01/DQB1* 03: 02). Monitoring T1D-specific T cell responses to DQ8-restricted epitopes may be key to understanding the immunopathology of the disease. In this study, we examined DQ8-restricted T cell responses to glutamic acid decarboxylase 65 (GAD65) using DQ8 tetramers. We demonstrated that GAD65(121-140) and GAD65(250-266) elicited responses from DQ8+ subjects. Circulating CD4+ T cells specific for these epitopes were detected significantly more often in T1D patients than in healthy individuals after in vitro expansion. T cell clones specific for GAD65(121-140) and GAD65(250)-(266) carried a Th1-dominant phenotype, with some of the GAD65(121)-(140)-specific T cell clones producing IL-17. GAD65(250)-(266)-specific CD4+ T cells could also be detected by direct ex vivo staining. Analysis of unmanipulated peripheral blood mononuclear cells (PBMCs) revealed that GAD65250-266-specific T cells could be found in both healthy and diabetic individuals but the frequencies of specific T cells were higher in subjects with type 1 diabetes. Taken together, our results suggest a proinflammatory role for T cells specific for DQ8-restricted GAD65121-140 and GAD65250-266 epitopes and implicate their possible contribution to the progression of T1D.	[Chow, I-Ting; Yang, Junbao; Gates, Theresa J.; James, Eddie A.; Mai, Duy T.; Greenbaum, Carla; Kwok, William W.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Kwok, William W.] Univ Washington, Dept Med, Seattle, WA USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Kwok, WW (corresponding author), Benaroya Res Inst Virginia Mason, Seattle, WA USA.	bkwok@benaroyaresearch.org	James, Eddie/V-4929-2019	James, Eddie/0000-0002-7217-5729	National Institutes of Health [DP3 DK097653]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, DP3DK097653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by JDRF center funding for Translational Research at BRI and DP3 DK097653 grant from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Bingley PJ, 2010, J CLIN ENDOCR METAB, V95, P25, DOI 10.1210/jc.2009-1365; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Herman AE, 1999, J IMMUNOL, V163, P6275; Ide A, 2003, REV ENDOCR METAB DIS, V4, P243, DOI 10.1023/A:1025100328425; Kwok WW, 1996, J IMMUNOL, V156, P2171; Liu JL, 1999, DIABETES, V48, P469, DOI 10.2337/diabetes.48.3.469; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; Narendran P, 2005, QJM-INT J MED, V98, P547, DOI 10.1093/qjmed/hci088; Novak EJ, 2001, J IMMUNOL, V166, P6665, DOI 10.4049/jimmunol.166.11.6665; Oling V, 2005, J AUTOIMMUN, V25, P235, DOI 10.1016/j.jaut.2005.09.018; Oling V, 2012, CELL IMMUNOL, V273, P133, DOI 10.1016/j.cellimm.2011.12.008; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Scriba TJ, 2005, J IMMUNOL, V175, P6334, DOI 10.4049/jimmunol.175.10.6334; Thomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; Wen L, 1998, J CLIN INVEST, V102, P947, DOI 10.1172/JCI2723; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Yang JB, 2004, HUM IMMUNOL, V65, P692, DOI 10.1016/j.humimm.2004.04.001; Yang JB, 2013, IMMUNOLOGY, V138, P269, DOI 10.1111/imm.12034; Yoshida K, 2010, J CLIN INVEST, V120, P1578, DOI 10.1172/JCI41502	30	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112882	10.1371/journal.pone.0112882	http://dx.doi.org/10.1371/journal.pone.0112882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405480	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300060
J	Delesque-Touchard, N; Pendaries, C; Volle-Challier, C; Millet, L; Salel, V; Herve, C; Pflieger, AM; Berthou-Soulie, L; Prades, C; Sorg, T; Herbert, JM; Savi, P; Bono, F				Delesque-Touchard, Nathalie; Pendaries, Caroline; Volle-Challier, Cecile; Millet, Laurence; Salel, Veronique; Herve, Caroline; Pflieger, Anne-Marie; Berthou-Soulie, Laurence; Prades, Catherine; Sorg, Tania; Herbert, Jean-Marc; Savi, Pierre; Bono, Francoise			Regulator of G-Protein Signaling 18 Controls Both Platelet Generation and Function	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACTIVATED PLATELETS; RGS PROTEINS; MEGAKARYOCYTE DIFFERENTIATION; DRUG DISCOVERY; MEGAKARYOPOIESIS; TARGETS; LINEAGE; MICE; EXPRESSION	RGS18 is a myeloerythroid lineage-specific regulator of G-protein signaling, highly expressed in megakaryocytes (MKs) and platelets. In the present study, we describe the first generation of a RGS18 knockout mouse model (RGS18-/-). Interesting phenotypic differences between RGS18-/- and wild-type (WT) mice were identified, and show that RGS18 plays a significant role in both platelet generation and function. RGS18 deficiency produced a gain of function phenotype in platelets. In resting platelets, the level of CD62P expression was increased in RGS18-/- mice. This increase correlated with a higher level of plasmatic serotonin concentration. RGS18-/- platelets displayed a higher sensitivity to activation in vitro. RGS18 deficiency markedly increased thrombus formation in vivo. In addition, RGS18-/- mice presented a mild thrombocytopenia, accompanied with a marked deficit in MK number in the bone marrow. Analysis of MK maturation in vitro and in vivo revealed a defective megakaryopoiesis in RGS18-/- mice, with a lower bone marrow content of only the most committed MK precursors. Finally, RGS18 deficiency was correlated to a defect of platelet recovery in vivo under acute conditions of thrombocytopenia. Thus, we highlight a role for RGS18 in platelet generation and function, and provide additional insights into the physiology of RGS18.	[Delesque-Touchard, Nathalie; Pendaries, Caroline; Volle-Challier, Cecile; Millet, Laurence; Salel, Veronique; Herve, Caroline; Pflieger, Anne-Marie; Herbert, Jean-Marc; Savi, Pierre; Bono, Francoise] Sanofi, Toulouse, France; [Berthou-Soulie, Laurence; Prades, Catherine] Sanofi, SCP Biol, Vitry Sur Seine, France; [Sorg, Tania] MCI, Dept Sci Operat PhenoPro, Strasbourg, France	Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Delesque-Touchard, N (corresponding author), Sanofi, Toulouse, France.	nathalie.delesque-touchard@sanofi.com			Sanofi	Sanofi(Sanofi-Aventis)	In addition, the authors received no specific funding for this work. Sanofi provided support in the form of salaries for authors ND-T, C. Pendaries, CV-C, LM, VS, CH, A-MP, LB-S, C. Prades, J-MH, PS and FB. Sanofi had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Berthebaud M, 2005, BLOOD, V106, P2962, DOI 10.1182/blood-2005-02-0526; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Davis RE, 1997, EXP HEMATOL, V25, P638; DEJANA E, 1979, THROMB RES, V15, P191, DOI 10.1016/0049-3848(79)90064-1; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Esbenshade T, 2005, G PROTEIN COUPLED RE, P15; Gagnon AW, 2002, CELL SIGNAL, V14, P595, DOI 10.1016/S0898-6568(02)00012-8; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Gegenbauer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080251; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Gobbi G, 2003, BRIT J HAEMATOL, V121, P892, DOI 10.1046/j.1365-2141.2003.04369.x; Grillet N, 2005, MOL CELL BIOL, V25, P4221, DOI 10.1128/MCB.25.10.4221-4228.2005; Kaur K, 2011, METHODS MOL BIOL, V756, P75, DOI 10.1007/978-1-61779-160-4_4; Kim SD, 2006, PLATELETS, V17, P493, DOI 10.1080/09537100600758123; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kirito K, 2002, BLOOD, V99, P3220, DOI 10.1182/blood.V99.9.3220; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; Louwette S, 2012, FASEB J, V26, P2125, DOI 10.1096/fj.11-198739; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Nagata Y, 2001, BLOOD, V97, P3051, DOI 10.1182/blood.V97.10.3051; Nieswandt B, 2000, BLOOD, V96, P2520; Okada Y, 2003, BLOOD, V101, P4748, DOI 10.1182/blood-2002-02-0380; Parks IK, 2001, J BIOL CHEM, V276, P915, DOI 10.1074/jbc.M005947200; PETERS RF, 1991, THROMB HAEMOSTASIS, V65, P268; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roth BL, 2006, CURR PHARM DESIGN, V12, P1785, DOI 10.2174/138161206776873680; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Serafimidis I, 2011, MOL CELL BIOL, V31, P4442, DOI 10.1128/MCB.05702-11; Shimizu S, 2002, BIOCHEM BIOPH RES CO, V292, P609, DOI 10.1006/bbrc.2002.6693; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Signarvic RS, 2010, BLOOD, V116, P6092, DOI 10.1182/blood-2010-05-283846; Sjogren B, 2011, ADV PHARMACOL, V62, P315, DOI 10.1016/B978-0-12-385952-5.00002-6; Sjogren B, 2010, MOL PHARMACOL, V78, P550, DOI 10.1124/mol.110.065219; Slayton WB, 2002, BLOOD, V100, P3975, DOI 10.1182/blood-2002-02-0490; Tomer A, 2004, BLOOD, V104, P2722, DOI 10.1182/blood-2004-02-0769; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Yowe D, 2001, BIOCHEM J, V359, P109, DOI 10.1042/0264-6021:3590109	40	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113215	10.1371/journal.pone.0113215	http://dx.doi.org/10.1371/journal.pone.0113215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405900	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300091
J	Elkum, N; Alkayal, F; Noronha, F; Ali, MM; Melhem, M; Al-Arouj, M; Bennakhi, A; Behbehani, K; Alsmadi, O; Abubaker, J				Elkum, Naser; Alkayal, Fadi; Noronha, Fiona; Ali, Maisa M.; Melhem, Motasem; Al-Arouj, Monira; Bennakhi, Abdullah; Behbehani, Kazem; Alsmadi, Osama; Abubaker, Jehad			Vitamin D Insufficiency in Arabs and South Asians Positively Associates with Polymorphisms in GC and CYP2R1 Genes	PLOS ONE			English	Article							D-BINDING PROTEIN; GENOME-WIDE ASSOCIATION; 25-HYDROXYVITAMIN D; HYPOVITAMINOSIS D; BONE MARKERS; LIFE-STYLE; D PATHWAY; DISEASE; WOMEN; POPULATION	Background: A number of genetic studies have reported an association between vitamin D related genes such as group-specific component gene (GC), Cytochrome P450, family 2, subfamily R, polypeptide 1 (CYP2R1) and 7-dehydrocholesterol reductase/nicotinamide-adenine dinucleotide synthetase 1 (DHCR7/NADSYN1) and serum levels of the active form of Vitamin D, 25 (OH) D among African Americans, Caucasians, and Chinese. Little is known about how genetic variations associate with, or contribute to, 25(OH) D levels in Arabs populations. Methods: Allele frequencies of 18 SNPs derived from CYP2R1, GC, and DHCR7/NADSYN1 genes in 1549 individuals (Arabs, South Asians, and Southeast Asians living in Kuwait) were determined using real time genotyping assays. Serum levels of 25(OH) D were measured using chemiluminescence immunoassay. Results: GC gene polymorphisms (rs17467825, rs3755967, rs2282679, rs7041 and rs2298850) were found to be associated with 25(OH) D serum levels in Arabs and South Asians. Two of the CYP2R1 SNPs (rs10500804 and rs12794714) and one of GC SNPs (rs1155563) were found to be significantly associated with 25(OH) D serum levels only in people of Arab origin. Across all three ethnicities none of the SNPs of DHCR7/NADSYN1 were associated with serum 25(OH) D levels and none of the 18 SNPs were significantly associated with serum 25(OH) D levels in people from South East Asia. Conclusion: Our data show for the first time significant association between the GC (rs2282679 and rs7041), CYP2R1 (rs10741657) SNPs and 25(OH) D levels. This supports their roles in vitamin D Insufficiency in Arab and South Asian populations respectively. Interestingly, two of the CYP2R1 SNPs (rs10500804 and rs12794714) and one GC SNP (rs1155563) were found to correlate with vitamin D in Arab population exclusively signifying their importance in this population.	[Elkum, Naser; Noronha, Fiona; Behbehani, Kazem] Dasman Diabet Inst, Dept Biostat & Epidemiol, Kuwait, Kuwait; [Alkayal, Fadi; Ali, Maisa M.; Melhem, Motasem; Alsmadi, Osama] Dasman Diabet Inst, Genet & Genom Unit, Kuwait, Kuwait; [Abubaker, Jehad] Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait; [Al-Arouj, Monira; Bennakhi, Abdullah] Dasman Diabet Inst, Clin Serv, Kuwait, Kuwait; [Elkum, Naser] Sidra Med & Res Ctr, Doha, Qatar	Sidra Medical & Research Center	Elkum, N (corresponding author), Dasman Diabet Inst, Dept Biostat & Epidemiol, Kuwait, Kuwait.	nelkum@sidra.org	Elkum, Naser/AAU-5555-2020	Elkum, Naser/0000-0002-0457-0444; Abubaker, Jehad/0000-0003-0681-7305; Kamkar, Maisa/0000-0001-9919-6936	Kuwait Foundation for the Advancement of Sciences	Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS))	This work was funded by Kuwait Foundation for the Advancement of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Allali F, 2009, SEMIN ARTHRITIS RHEU, V38, P444, DOI 10.1016/j.semarthrit.2008.01.009; Ardawi MSM, 2012, OSTEOPOROSIS INT, V23, P675, DOI 10.1007/s00198-011-1606-1; Borkar VV, 2010, PEDIATR DIABETES, V11, P345, DOI 10.1111/j.1399-5448.2009.00589.x; Bosse Y, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-98; Brustad M, 2004, PUBLIC HEALTH NUTR, V7, P327, DOI 10.1079/PHN2003536; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Elkum N, 2014, DIABETIC MED, V31, P531, DOI 10.1111/dme.12386; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Gannage-Yared MH, 2000, J BONE MINER RES, V15, P1856, DOI 10.1359/jbmr.2000.15.9.1856; Heist RS, 2008, J CLIN ONCOL, V26, P5596, DOI 10.1200/JCO.2008.18.0406; Hobbs RD, 2009, ENDOCR PRACT, V15, P35, DOI 10.4158/EP.15.1.35; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Kurylowicz A, 2006, EXP CLIN ENDOCR DIAB, V114, P329, DOI 10.1055/s-2006-924256; Larcombe L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049872; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Saliba W, 2012, OSTEOPOROSIS INT, V23, P687, DOI 10.1007/s00198-011-1597-y; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Signorello LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028623; Simonelli Christine, 2005, Minn Med, V88, P34; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Zhang YL, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13636; Zhang Z, 2013, J BONE MINER RES, V28, P1784, DOI 10.1002/jbmr.1926	32	58	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113102	10.1371/journal.pone.0113102	http://dx.doi.org/10.1371/journal.pone.0113102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405862	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300077
J	Eltom, S; Belvisi, MG; Stevenson, CS; Maher, SA; Dubuis, E; Fitzgerald, KA; Birrell, MA				Eltom, Suffwan; Belvisi, Maria G.; Stevenson, Christopher S.; Maher, Sarah A.; Dubuis, Eric; Fitzgerald, Kate A.; Birrell, Mark A.			Role of the Inflammasome-Caspase1/11-IL-1/18 Axis in Cigarette Smoke Driven Airway Inflammation: An Insight into the Pathogenesis of COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; RECEPTOR; IL-18; INTERLEUKIN-18; ACTIVATION; EMPHYSEMA; POLYMORPHISMS; ASSOCIATION; INHIBITION	Background: Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory airway disease often associated with cigarette smoke (CS) exposure. The disease is increasing in global prevalence and there is no effective therapy. A major step forward would be to understand the disease pathogenesis. The ATP-P2X(7) pathway plays a dominant role in murine models of CS induced airway inflammation, and markers of activation of this axis are upregulated in patients with COPD. This strongly suggests that the axis could be important in the pathogenesis of COPD. The aim of this study was to perform a detailed characterisation of the signalling pathway components involved in the CS-driven, P2X(7) dependent airway inflammation. Methods: We used a murine model system, bioassays and a range of genetically modified mice to better understand this complex signalling pathway. Results: The inflammasome-associated proteins NALP3 and ASC, but not IPAF and AIM2, are required for CS-induced IL-1 beta/IL-18 release, but not IL-1 alpha. This was associated with a partial decrease in lung tissue caspase 1 activity and BALF neutrophilia. Mice missing caspase 1/11 or caspase 11 had markedly attenuated levels of all three cytokines and neutrophilia. Finally the mechanism by which these inflammatory proteins are involved in the CS-induced neutrophilia appeared to be via the induction of proteins involved in neutrophil transmigration e. g. E-Selectin. Conclusion: This data indicates a key role for the P2X(7)-NALP3/ASC-caspase1/11-IL-1 beta/IL-18 axis in CS induced airway inflammation, highlighting this pathway as a possible therapeutic target for the treatment of COPD.	[Eltom, Suffwan; Belvisi, Maria G.; Maher, Sarah A.; Dubuis, Eric; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England; [Stevenson, Christopher S.] Hoffmann La Roche Inc, pRED, DTA Inflammat, Nutley, NJ 07110 USA; [Fitzgerald, Kate A.] Univ Massachusetts, Div Infect Dis & Immunol, Worcester, MA 01605 USA	Imperial College London; Roche Holding; University of Massachusetts System; University of Massachusetts Worcester	Birrell, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England.	m.birrell@imperial.ac.uk	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X; dubuis, eric/0000-0001-7658-4178				Asada M, 2005, CHEST, V128, P1072, DOI 10.1378/chest.128.2.1072; Bezerra FS, 2011, RESP PHYSIOL NEUROBI, V177, P120, DOI 10.1016/j.resp.2011.03.023; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Castro P, 2004, EUR J PHARMACOL, V498, P279, DOI 10.1016/j.ejphar.2004.07.047; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Ekberg-Jansson A, 2001, RESP MED, V95, P363, DOI 10.1053/rmed.2001.1050; Eltom S, 2013, CURR PROTOC PHARM; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Freeman CM, 2010, J IMMUNOL, V184, P6504, DOI 10.4049/jimmunol.1000006; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Herfs M, 2012, AM J RESP CELL MOL, V47, P67, DOI 10.1165/rcmb.2011-0353OC; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Imaoka H, 2008, EUR RESPIR J, V31, P287, DOI 10.1183/09031936.00019207; Joos L, 2001, THORAX, V56, P863, DOI 10.1136/thorax.56.11.863; Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948; Kang MJ, 2012, AM J RESP CRIT CARE, V185, P1205, DOI 10.1164/rccm.201108-1545OC; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kratzer A, 2013, AM J RESP CELL MOL, V48, P725, DOI 10.1165/rcmb.2012-0173OC; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Le Quement C, 2008, BRIT J PHARMACOL, V154, P1206, DOI 10.1038/bjp.2008.180; Lee JM, 2008, RESP MED, V102, P1311, DOI 10.1016/j.rmed.2008.03.026; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; MacNee W, 2005, P AM THORAC SOC, V2, P251; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Muhl H, 2004, EUR J PHARMACOL, V500, P63, DOI 10.1016/j.ejphar.2004.07.012; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Petersen AMW, 2007, LUNG, V185, P161, DOI 10.1007/s00408-007-9000-7; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rathinam VAK, 2012, CELL, V18, P1; Rovina N, 2009, RESP MED, V103, P1056, DOI 10.1016/j.rmed.2009.01.011; Sapey E, 2009, J CLIN IMMUNOL, V29, P508, DOI 10.1007/s10875-009-9286-8; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Singh B, 2010, Monaldi Arch Chest Dis, V73, P86; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; van der Deen M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-49; Wang J, 2013, INT J IMMUNOGENET, V40, P204, DOI 10.1111/iji.12014; Wang JM, 2012, COPD, V9, P375, DOI 10.3109/15412555.2012.670330; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Zeidel A, 2002, ACTA ANAESTH SCAND, V46, P959, DOI 10.1034/j.1399-6576.2002.460806.x	49	58	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112829	10.1371/journal.pone.0112829	http://dx.doi.org/10.1371/journal.pone.0112829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405768	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300055
J	Petersen, H; Patel, M; Ingason, EF; Einarsson, EJ; Haraldsson, A; Fransson, PA				Petersen, Hannes; Patel, Mitesh; Ingason, Einar F.; Einarsson, Einar J.; Haraldsson, Asgeir; Fransson, Per-Anders			Long-Term Effects from Bacterial Meningitis in Childhood and Adolescence on Postural Control	PLOS ONE			English	Article							ADAPTATION; VIBRATION; CHILDREN; VALIDATION; MOVEMENTS; APOPTOSIS; RESPONSES; DISEASE; VERTIGO; VISION	Bacterial meningitis in childhood is associated with cognitive deficiencies, sensorimotor impairments and motor dysfunction later in life. However, the long-term effects on postural control is largely unknown, e. g., whether meningitis subjects as adults fully can utilize visual information and adaptation to enhance stability. Thirty-six subjects (20 women, mean age 19.3 years) treated in childhood or adolescence for bacterial meningitis, and 25 controls (13 women, mean age 25.1 years) performed posturography with eyes open and closed under unperturbed and perturbed standing. The meningitis subjects were screened for subjective vertigo symptoms using a questionnaire, clinically tested with headshake and head thrust test, as well as their hearing was evaluated. Meningitis subjects were significantly more unstable than controls during unperturbed (p <= 0.014) and perturbed standing, though while perturbed only with eyes open in anteroposterior direction (p = 0.034) whereas in lateral direction both with eyes open and closed (p<0.001). Meningitis subjects had poorer adaption ability to balance perturbations especially with eyes open, and they frequently reported symptoms of unsteadiness (88% of the subjects) and dizziness (81%), which was found significantly correlated to objectively decreased stability. Out of the 36 subjects only 3 had unilateral hearing impairment. Hence, survivors of childhood bacterial meningitis may suffer long-term disorders affecting postural control, and would greatly benefit if these common late effects became generally known so treatments can be developed and applied.	[Petersen, Hannes] Landspitali Univ Hosp, Dept Otorhinolaryngol, Reykjavik, Iceland; [Petersen, Hannes; Ingason, Einar F.; Einarsson, Einar J.; Haraldsson, Asgeir] Univ Iceland, Fac Med, Reykjavik, Iceland; [Haraldsson, Asgeir] Landspitali Univ Hosp, Childrens Hosp Iceland, Reykjavik, Iceland; [Patel, Mitesh; Fransson, Per-Anders] Lund Univ, Dept Clin Sci, Lund, Sweden; [Patel, Mitesh] Univ London Imperial Coll Sci Technol & Med, Neurootol Dept, Dept Clin Neurosci, London, England	Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Lund University; Imperial College London	Petersen, H (corresponding author), Landspitali Univ Hosp, Dept Otorhinolaryngol, Reykjavik, Iceland.	hpet@hi.is		Patel, Mitesh/0000-0002-3594-5448; Patel, Mitesh/0000-0001-6926-941X; Haraldsson, Asgeir/0000-0001-5364-7877; Fransson, Per-Anders/0000-0002-9789-1748				Assaiante C, 1998, NEUROSCI BIOBEHAV R, V22, P527, DOI 10.1016/S0149-7634(97)00040-7; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Black F. O., 2001, CURR OPIN OTOLARYNGO, V9, P314, DOI DOI 10.1097/00020840-200110000-00011; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; Caye-Thomasen P, 2012, ACTA OTO-LARYNGOL, V132, P720, DOI 10.3109/00016489.2012.656323; Chandran A, 2011, PEDIATR INFECT DIS J, V30, P3, DOI 10.1097/INF.0b013e3181ef25f7; Cushing SL, 2009, OTOL NEUROTOL, V30, P488, DOI 10.1097/MAO.0b013e31819bd7c8; Eccles JC, 1986, LEARNING MOTOR SYSTE, P3; EKLUND G, 1973, UPSALA J MED SCI, V78, P65; Fellick JM, 2001, ARCH DIS CHILD, V85, P6, DOI 10.1136/adc.85.1.6; Fransson PA, 2003, IEEE T BIO-MED ENG, V50, P1310, DOI 10.1109/TBME.2003.819851; Fransson PA, 2009, ADAPTATION HUMAN POS; Fransson PA, 2007, J VESTIBUL RES-EQUIL, V17, P47; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; Grandgirard D, 2007, ACTA NEUROPATHOL, V114, P609, DOI 10.1007/s00401-007-0304-8; Hofer S, 2011, J NEUROPATH EXP NEUR, V70, P890, DOI 10.1097/NEN.0b013e3182303f31; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; JOHANSSON R, 1991, CRIT REV BIOMED ENG, V18, P413; Johansson R, 2009, J PHYSIOL-PARIS, V103, P159, DOI 10.1016/j.jphysparis.2009.08.013; KESHNER EA, 1987, EXP BRAIN RES, V69, P77; Kingma H, 2011, J VESTIBUL RES-EQUIL, V21, P117, DOI 10.3233/VES-2011-0397; Kristinsdottir EK, 2001, ACTA OTO-LARYNGOL, V121, P700, DOI 10.1080/00016480152583647; Leib SL, 1996, J INFECT DIS, V173, P166, DOI 10.1093/infdis/173.1.166; Mace SE, 2008, EMERG MED CLIN N AM, V26, P281, DOI 10.1016/j.emc.2008.02.002; Mallau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013078; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Modig F, 2012, GAIT POSTURE, V35, P410, DOI 10.1016/j.gaitpost.2011.10.364; Mongelluzzo J, 2008, JAMA-J AM MED ASSOC, V299, P2048, DOI 10.1001/jama.299.17.2048; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; Neuman HB, 2001, CLIN PEDIATR, V40, P595, DOI 10.1177/000992280104001102; Ostergaard C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-1; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Patel M, 2009, CLIN NEUROPHYSIOL, V120, P601, DOI 10.1016/j.clinph.2008.11.026; Pavol MJ, 2002, EXP BRAIN RES, V145, P528, DOI 10.1007/s00221-002-1143-4; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Popov K, 1996, NEUROSCI LETT, V214, P202, DOI 10.1016/0304-3940(96)12909-8; Redfern MS, 2001, GAIT POSTURE, V14, P211, DOI 10.1016/S0966-6362(01)00144-8; RICCIO GE, 1988, HUM MOVEMENT SCI, V7, P265, DOI 10.1016/0167-9457(88)90014-0; Saez-Llorens X, 1990, Infect Dis Clin North Am, V4, P623; Snaebjarnardottir K, 2013, SCAND J INFECT DIS, V45, P819, DOI 10.3109/00365548.2013.817680; Tjernstrom F, 2005, J VESTIBUL RES-EQUIL, V15, P31; Tschan R, 2008, J NEUROL, V255, P1168, DOI 10.1007/s00415-008-0863-1; Wiener-Vacher SR, 2012, J PEDIATR-US, V161, P246, DOI 10.1016/j.jpeds.2012.02.009; Yardley L, 1999, J PSYCHOSOM RES, V46, P63, DOI 10.1016/S0022-3999(98)00056-7	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112016	10.1371/journal.pone.0112016	http://dx.doi.org/10.1371/journal.pone.0112016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405756	gold, Green Published, Green Accepted			2022-12-26	WOS:000347121300020
J	Wali, JA; Gurzov, EN; Fynch, S; Elkerbout, L; Kay, TW; Masters, SL; Thomas, HE				Wali, Jibran A.; Gurzov, Esteban N.; Fynch, Stacey; Elkerbout, Lorraine; Kay, Thomas W.; Masters, Seth L.; Thomas, Helen E.			Activation of the NLRP3 Inflammasome Complex is Not Required for Stress-Induced Death of Pancreatic Islets	PLOS ONE			English	Article							BETA-CELL APOPTOSIS; THIOREDOXIN-INTERACTING PROTEIN; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; HIGH GLUCOSE; GLUTATHIONE-PEROXIDASE; INSULIN-SECRETION; GENE-EXPRESSION; FATTY-ACID; RAT ISLET	Loss of pancreatic beta cells is a feature of type-2 diabetes. High glucose concentrations induce endoplasmic reticulum (ER) and oxidative stress-mediated apoptosis of islet cells in vitro. ER stress, oxidative stress and high glucose concentrations may also activate the NLRP3 inflammasome leading to interleukin (IL)-1 beta production and caspase-1 dependent pyroptosis. However, whether IL-1 beta or intrinsic NLRP3 inflammasome activation contributes to beta cell death is controversial. This possibility was examined in mouse islets. Exposure of islets lacking functional NLRP3 or caspase-1 to H2O2, rotenone or thapsigargin induced similar cell death as in wild-type islets. This suggests that oxidative or ER stress do not cause inflammasome-mediated cell death. Similarly, deficiency of NLRP3 inflammasome components did not provide any protection from glucose, ribose or gluco-lipotoxicity. Finally, genetic activation of NLRP3 specifically in beta cells did not increase IL-1 beta production or cell death, even in response to glucolipotoxicity. Overall, our results show that glucose-, ER stress-or oxidative stress-induced cell death in islet cells is not dependent on intrinsic activation of the NLRP3 inflammasome.	[Wali, Jibran A.; Gurzov, Esteban N.; Fynch, Stacey; Elkerbout, Lorraine; Kay, Thomas W.; Thomas, Helen E.] St Vincents Inst, Fitzroy, Vic, Australia; [Wali, Jibran A.; Gurzov, Esteban N.; Kay, Thomas W.; Thomas, Helen E.] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Masters, Seth L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Thomas, HE (corresponding author), St Vincents Inst, Fitzroy, Vic, Australia.	hthomas@svi.edu.au	Wali, Jibran/K-9843-2019; Masters, Seth L/N-2886-2013	Wali, Jibran/0000-0002-8524-5773; Masters, Seth L/0000-0003-4763-576X; Gurzov, Esteban/0000-0003-4642-0273	National Health and Medical Research Council of Australia (NHMRC); Juvenile Diabetes Research Foundation (JDRF) [APP466658]; NHMRC [APP1032610]; NHMRC; University of Melbourne Viola Edith Reid Bequest Scholarship; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne Viola Edith Reid Bequest Scholarship; Victorian Government's Operational Infrastructure Support Program	This study was supported by a National Health and Medical Research Council of Australia (NHMRC; http://www.nhmrc.gov.au/) and Juvenile Diabetes Research Foundation (JDRF; http://www.jdrf.org/) joint special program grant in type 1 diabetes (APP466658), an NHMRC project grant (APP1032610), fellowships from the NHMRC (HET and SLM) and a University of Melbourne Viola Edith Reid Bequest Scholarship (JAW). This study was supported in part by the Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au/grants-and-assistance/programs/medical-research-operational-infrastructure-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMANN L, 1992, FEBS LETT, V299, P103, DOI 10.1016/0014-5793(92)80110-3; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Hou ZQ, 2008, MOL CELL ENDOCRINOL, V291, P71, DOI 10.1016/j.mce.2008.03.004; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McKenzie MD, 2006, INT IMMUNOL, V18, P837, DOI 10.1093/intimm/dxl020; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Mellado-Gil JM, 2004, J ENDOCRINOL, V183, P155, DOI 10.1677/joe.1.05542; Merry TL, 2014, ANTIOXID REDOX SIGN, V20, P2114, DOI 10.1089/ars.2013.5428; Moore PC, 2004, DIABETES, V53, P2610, DOI 10.2337/diabetes.53.10.2610; Nackiewicz D, 2014, DIABETOLOGIA, V57, P1645, DOI 10.1007/s00125-014-3249-1; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ribaux P, 2007, ENDOCRINOLOGY, V148, P5582, DOI 10.1210/en.2007-0325; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Thomas HE, 2006, IMMUNOL CELL BIOL, V84, P20, DOI 10.1111/j.1440-1711.2005.01397.x; Wali JA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.88; Welsh N, 2005, DIABETES, V54, P3238, DOI 10.2337/diabetes.54.11.3238; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	42	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113128	10.1371/journal.pone.0113128	http://dx.doi.org/10.1371/journal.pone.0113128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405767	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300083
J	Wu, DM; Li, GW; Zhang, JX; Chang, SX; Hu, JN; Dai, YM				Wu, Dongmei; Li, Guanwu; Zhang, Junxiang; Chang, Shixing; Hu, Jiani; Dai, Yongming			Characterization of Breast Tumors Using Diffusion Kurtosis Imaging (DKI)	PLOS ONE			English	Article							NON-GAUSSIAN DIFFUSION; MAGNETIC-RESONANCE; WEIGHTED MRI; WATER DIFFUSION; LESION CHARACTERIZATION; DIFFERENTIAL-DIAGNOSIS; B-VALUES; COEFFICIENT; CANCER; CARCINOMA	Aim: The aim of this study was to investigate and evaluate the role of magnetic resonance (MR) diffusion kurtosis imaging (DKI) in characterizing breast lesions. Materials and Methods: One hundred and twenty-four lesions in 103 patients (mean age: 57 +/- 14 years) were evaluated by MR DKI performed with 7 b-values of 0, 250, 500, 750, 1,000, 1,500, 2,000 s/mm(2) and dynamic contrast-enhanced (DCE) MR imaging. Breast lesions were histologically characterized and DKI related parameters-mean diffusivity (MD) and mean kurtosis (MK)-were measured. The MD and MK in normal fibroglandular breast tissue, benign and malignant lesions were compared by One-way analysis of variance (ANOVA) with Tukey's multiple comparison test. Receiver operating characteristic (ROC) analysis was performed to assess the sensitivity and specificity of MD and MK in the diagnosis of breast lesions. Results: The benign lesions (n = 42) and malignant lesions (n = 82) had mean diameters of 11.4 +/- 3.4 mm and 35.8 +/- 20.1 mm, respectively. The MK for malignant lesions (0.88 +/- 0.17) was significantly higher than that for benign lesions (0.47 +/- 0.14) (P < 0.001), and, in contrast, MD for benign lesions (1.97 +/- 0.35 (10(-3) mm(2)/s)) was higher than that for malignant lesions (1.20 +/- 0.31 (10(-3) mm(2)/s)) (P < 0.001). At a cutoff MD/MK 1.58 (10(-3) mm(2)s)/0.69, sensitivity and specificity of MD/MK for the diagnosis of malignant were 79.3%/84.2% and 92.9%/92.9%, respectively. The area under the curve (AUC) is 0.86/0.92 for MD/MK. Conclusions: DKI could provide valuable information on the diffusion properties related to tumor microenvironment and increase diagnostic confidence of breast tumors.	[Wu, Dongmei] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Wu, Dongmei; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Li, Guanwu; Chang, Shixing] Shanghai Univ Tradit Chinese Med, Dept Radiol, Yue Yang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China; [Zhang, Junxiang] Bengbu Med Coll, Affiliated Hosp 1, Dept Radiol, Bengbu, Anhui, Peoples R China; [Dai, Yongming] Philips Healthcare, Shanghai, Peoples R China	East China Normal University; Wayne State University; Shanghai University of Traditional Chinese Medicine; Bengbu Medical College; Philips; Philips Healthcare	Chang, SX (corresponding author), Shanghai Univ Tradit Chinese Med, Dept Radiol, Yue Yang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China.	shixing.chang@sohu.com		Li, Guanwu/0000-0003-0840-9022				Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Anderson SW, 2014, J MAGN RESON IMAGING, V39, P827, DOI 10.1002/jmri.24234; Pereira FPA, 2009, AM J ROENTGENOL, V193, P1030, DOI 10.2214/AJR.09.2522; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Baron P, 2010, NMR BIOMED, V23, P399, DOI 10.1002/nbm.1475; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bogner W, 2009, RADIOLOGY, V253, P341, DOI 10.1148/radiol.2532081718; Bone B, 1998, ACTA RADIOL, V39, P494; Brinck U, 1997, AM J ROENTGENOL, V168, P1331, DOI 10.2214/ajr.168.5.9129437; Costantini M, 2010, CLIN RADIOL, V65, P1005, DOI 10.1016/j.crad.2010.07.008; De Santis S, 2011, MAGN RESON IMAGING, V29, P1410, DOI 10.1016/j.mri.2011.04.006; DUCATMAN BS, 1993, MODERN PATHOL, V6, P539; El Khouli RH, 2010, RADIOLOGY, V256, P64, DOI 10.1148/radiol.10091367; Englander SA, 1997, NMR BIOMED, V10, P348, DOI 10.1002/(SICI)1099-1492(199710)10:7<348::AID-NBM487>3.0.CO;2-R; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24743, 10.1002/mrm.24389]; Hochman MG, 1997, RADIOLOGY, V204, P123, DOI 10.1148/radiology.204.1.9205233; Jansen JFA, 2010, AM J NEURORADIOL, V31, P741, DOI 10.3174/ajnr.A1919; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kacl GM, 1998, EUR RADIOL, V8, P194, DOI 10.1007/s003300050362; Kinoshita T, 2002, J COMPUT ASSIST TOMO, V26, P1042, DOI 10.1097/00004728-200211000-00033; Kneeshaw PJ, 2003, BRIT J CANCER, V88, P4, DOI 10.1038/sj.bjc.6600713; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Lo GG, 2009, J COMPUT ASSIST TOMO, V33, P63, DOI 10.1097/RCT.0b013e318165dc6b; Marini C, 2007, EUR RADIOL, V17, P2646, DOI 10.1007/s00330-007-0621-2; Paran Y, 2004, NMR BIOMED, V17, P170, DOI 10.1002/nbm.882; Partridge SC, 2011, MAGN RESON MED, V65, P1759, DOI 10.1002/mrm.22762; Partridge SC, 2011, MAGN RESON IMAGING, V29, P1215, DOI 10.1016/j.mri.2011.07.024; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P562, DOI 10.1002/jmri.22078; Partridge SC, 2009, AM J ROENTGENOL, V193, P1716, DOI 10.2214/AJR.08.2139; Partridge SC, 2001, J MAGN RESON IMAGING, V14, P433, DOI 10.1002/jmri.1204; Peters NHGM, 2008, RADIOLOGY, V246, P116, DOI 10.1148/radiol.2461061298; Peters NHGM, 2010, J MAGN RESON IMAGING, V31, P1100, DOI 10.1002/jmri.22152; Petralia G, 2011, CANCER IMAGING, V11, P76, DOI 10.1102/1470-7330.2011.0014; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Rankin SC, 2000, BRIT J RADIOL, V73, P806, DOI 10.1259/bjr.73.872.11026854; Rosenkrantz AB, 2013, AM J ROENTGENOL, V201, P840, DOI 10.2214/AJR.12.10397; Rosenkrantz AB, 2012, MAGN RESON IMAGING, V30, P1534, DOI 10.1016/j.mri.2012.04.020; Rubesova E, 2006, J MAGN RESON IMAGING, V24, P319, DOI 10.1002/jmri.20643; Sigmund EE, 2011, MAGN RESON MED, V65, P1437, DOI 10.1002/mrm.22740; Sinha S, 2002, ANN NY ACAD SCI, V980, P95, DOI 10.1111/j.1749-6632.2002.tb04891.x; Sinha S, 2002, J MAGN RESON IMAGING, V15, P693, DOI 10.1002/jmri.10116; Sinha S, 2009, NMR BIOMED, V22, P3, DOI 10.1002/nbm.1270; Stomper PC, 1997, BREAST CANCER RES TR, V45, P39, DOI 10.1023/A:1005897227030; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Wenkel E, 2007, ACAD RADIOL, V14, P1077, DOI 10.1016/j.acra.2007.06.006; WESBEY GE, 1984, INVEST RADIOL, V19, P491, DOI 10.1097/00004424-198411000-00005; Woodhams R, 2005, J COMPUT ASSIST TOMO, V29, P644, DOI 10.1097/01.rct.0000171913.74086.1b; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Yabuuchi H, 2010, EUR J RADIOL, V75, pE126, DOI 10.1016/j.ejrad.2009.09.013; Yabuuchi H, 2008, J MAGN RESON IMAGING, V28, P1157, DOI 10.1002/jmri.21570; Yamada I, 1999, RADIOLOGY, V210, P617, DOI 10.1148/radiology.210.3.r99fe17617; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	60	52	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113240	10.1371/journal.pone.0113240	http://dx.doi.org/10.1371/journal.pone.0113240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406010	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300092
J	Cheng, ML; Weng, SF; Kuo, CH; Ho, HY				Cheng, Mei-Ling; Weng, Shiue-Fen; Kuo, Chih-Hao; Ho, Hung-Yao			Enterovirus 71 Induces Mitochondrial Reactive Oxygen Species Generation That is Required for Efficient Replication	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; VIRUS PB1-F2 PROTEIN; OXIDATIVE STRESS; OUTER-MEMBRANE; HEPATOMA-CELLS; MOUTH-DISEASE; CYTOCHROME-C; INFECTION; APOPTOSIS; OUTBREAK	Redox homeostasis is an important host factor determining the outcome of infectious disease. Enterovirus 71 (EV71) infection has become an important endemic disease in Southeast Asia and China. We have previously shown that oxidative stress promotes viral replication, and progeny virus induces oxidative stress in host cells. The detailed mechanism for reactive oxygen species (ROS) generation in infected cells remains elusive. In the current study, we demonstrate that mitochondria were a major ROS source in EV71-infected cells. Mitochondria in productively infected cells underwent morphologic changes and exhibited functional anomalies, such as a decrease in mitochondrial electrochemical potential Delta Psi(m) and an increase in oligomycin-insensitive oxygen consumption. Respiratory control ratio of mitochondria from infected cells was significantly lower than that of normal cells. The total adenine nucleotide pool and ATP content of EV71-infected cells significantly diminished. However, there appeared to be a compensatory increase in mitochondrial mass. Treatment with mito-TEMPO reduced eIF2 alpha phosphorylation and viral replication, suggesting that mitochondrial ROS act to promote viral replication. It is plausible that EV71 infection induces mitochondrial ROS generation, which is essential to viral replication, at the sacrifice of efficient energy production, and that infected cells up-regulate biogenesis of mitochondria to compensate for their functional defect.	[Cheng, Mei-Ling] Chang Gung Univ, Coll Med, Dept Biomed Sci, Taoyuan, Taiwan; [Cheng, Mei-Ling; Ho, Hung-Yao] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Cheng, Mei-Ling] Chang Gung Univ, Metabol Core Lab, Taoyuan, Taiwan; [Weng, Shiue-Fen; Kuo, Chih-Hao; Ho, Hung-Yao] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Ho, Hung-Yao] Chang Gung Mem Hosp, Off Res & Dev, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Ho, HY (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan.	hoh01@mail.cgu.edu.tw		zheng, mei ling/0000-0003-2006-133X	Chang Gung University [CMRPD190443, CMRPD1A0562, CMRPD1C0751, CMRPD1A0563, CMRPD1A0521, CMRPD1A0522, CMRPD391683, CMRPD1C0441, CMRPD1C0761]; National Science Council of Taiwan [NSC99-2320-B-182-021-MY3, NSC101-2320-B-182-024-MY3]; Ministry of Education of Taiwan [EMRPD1C0271, EMRPD1D0241]	Chang Gung University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education of Taiwan(Ministry of Education, Taiwan)	This project is supported by grants from Chang Gung University (CMRPD190443, CMRPD1A0562, CMRPD1C0751, CMRPD1A0563, CMRPD1A0521, CMRPD1A0522, CMRPD391683, CMRPD1C0441, and CMRPD1C0761), National Science Council of Taiwan (NSC99-2320-B-182-021-MY3 and NSC101-2320-B-182-024-MY3), and the Ministry of Education of Taiwan (EMRPD1C0271 and EMRPD1D0241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopova O V, 2012, Fiziol Zh, V58, P3; Anand SK, 2013, ADV VIROL, V2013, DOI 10.1155/2013/738794; Aquaro S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-76; Beck MA, 2005, FREE RADICAL BIO MED, V38, P112, DOI 10.1016/j.freeradbiomed.2004.10.007; Beck MA, 2003, J NUTR, V133, p1463S, DOI 10.1093/jn/133.5.1463S; Beck MA, 2000, ANN NY ACAD SCI, V917, P906; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Chang SC, 2004, J NEUROVIROL, V10, P338, DOI 10.1080/13550280490521032; Cheng ML, 2013, FREE RADICAL RES, V47, P699, DOI 10.3109/10715762.2013.816420; Cheng ML, 2011, BIOCHEM PHARMACOL, V82, P1549, DOI 10.1016/j.bcp.2011.07.104; Claus C, 2013, J VIROL, V87, P8481, DOI 10.1128/JVI.00533-13; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; da Costa LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033871; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; El-Bacha T, 2004, MOL CELL BIOCHEM, V266, P191, DOI 10.1023/B:MCBI.0000049154.17866.00; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Hanson PJ, 2013, VIRAL REPLICATION, P103; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Ho HY, 2008, INT J ONCOL, V33, P969, DOI 10.3892/ijo_00000084; Ho HY, 2008, J GEN VIROL, V89, P2080, DOI 10.1099/vir.0.2008/001404-0; Ho HY, 2009, J AGR FOOD CHEM, V57, P6140, DOI 10.1021/jf901128u; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hollander JM, 2014, AM J PHYSL HEART CIR; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jackson AC, 2011, ADV VIRUS RES, V79, P127, DOI 10.1016/B978-0-12-387040-7.00008-1; Jheng JR, 2010, CELL MICROBIOL, V12, P796, DOI 10.1111/j.1462-5822.2010.01434.x; Joshi M, 2013, BIOCHIMIE, V95, P1980, DOI 10.1016/j.biochi.2013.07.030; Kaarbo M, 2011, MITOCHONDRION, V11, P935, DOI 10.1016/j.mito.2011.08.008; Kaul P, 2000, J INFECT DIS, V181, P1885, DOI 10.1086/315504; Kim S, 2007, J VIROL, V81, P1714, DOI 10.1128/JVI.01863-06; Koike K, 2007, J GASTROEN HEPATOL, V22, pS108, DOI 10.1111/j.1440-1746.2006.04669.x; KORNBLITH PL, 1978, J NEUROSURG, V48, P580, DOI 10.3171/jns.1978.48.4.0580; Korytowski W, 2011, J BIOL CHEM, V286, P26334, DOI 10.1074/jbc.M110.188516; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lachgar A, 1999, J VIROL, V73, P1447, DOI 10.1128/JVI.73.2.1447-1452.1999; Lecoeur H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.21; Li QH, 2005, J CLIN VIROL, V34, P133, DOI 10.1016/j.jcv.2004.12.019; Lin CJ, 2010, FREE RADICAL BIO MED, V49, P361, DOI 10.1016/j.freeradbiomed.2010.04.019; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Liu ZW, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-158; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mochizuki H, 2009, INFLAMMATION, V32, P252, DOI 10.1007/s10753-009-9128-0; Moran M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001; Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Ohta A, 2011, MITOCHONDRION, V11, P1, DOI 10.1016/j.mito.2010.08.006; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251; Parekh AB, 2003, NEWS PHYSIOL SCI, V18, P252, DOI 10.1152/nips.01458.2003; Piccoli C, 2009, BBA-BIOENERGETICS, V1787, P539, DOI 10.1016/j.bbabio.2008.11.008; Piccoli C, 2007, HEPATOLOGY, V46, P58, DOI 10.1002/hep.21679; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Quarato G, 2013, INT J BIOCHEM CELL B, V45, P156, DOI 10.1016/j.biocel.2012.06.008; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; Rojo G, 1998, J VIROL, V72, P7583, DOI 10.1128/JVI.72.9.7583-7588.1998; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; Sasaki O, 2013, BBA-MOL CELL RES, V1833, P1017, DOI 10.1016/j.bbamcr.2013.01.010; Schachtele SJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-35; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Schrand AM, 2010, NAT PROTOC, V5, P744, DOI 10.1038/nprot.2010.2; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Tal MC, 2011, IMMUNOL REV, V243, P215, DOI 10.1111/j.1600-065X.2011.01038.x; Tung WH, 2011, J CELL PHYSIOL, V226, P3316, DOI 10.1002/jcp.22677; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Wang T, 2006, J GASTROEN HEPATOL, V21, pS34, DOI 10.1111/j.1440-1746.2006.04591.x; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang SM, 2005, ARCH VIROL, V150, P1579, DOI 10.1007/s00705-005-0521-1	83	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113234	10.1371/journal.pone.0113234	http://dx.doi.org/10.1371/journal.pone.0113234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401329	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700123
J	Kamiya, K; Shimizu, K; Iijima, A; Kobashi, H				Kamiya, Kazutaka; Shimizu, Kimiya; Iijima, Ayaka; Kobashi, Hidenaga			Factors Influencing Contrast Sensitivity Function in Myopic Eyes	PLOS ONE			English	Article							LIGHT-SCATTERING; SCHEIMPFLUG SYSTEM; ABERRATIONS; PUPIL; QUALITY; VISTECH; CHARTS; AGE	Purpose: To evaluate the factors affecting the area under the log contrast sensitivity function (AULCSF) in healthy myopic eyes. Methods: We retrospectively examined 201 eyes of 201 consecutive subjects (age, 31.8 +/- 7.4 years (mean +/- standard deviation)) with myopic refractive errors of -1.25 to -8.25 diopters (D). From the contrast sensitivity data, the area under the log contrast sensitivity function (AULCSF) was calculated. Stepwise multiple regression analysis was used to assess the factors affecting the AULCSF. Results: The mean AULSCF was 1.09 +/- 0.09 (0.89 to 1.55). Explanatory variables relevant to the AULCSF were, in order of influence, the objective scattering index (OSI) (p = 0.018, partial regression coefficient B = -0.032) and logMAR CDVA (p = 0.022, B = -0.209) (adjusted R-2 = 0.231). No significant correlation was seen with other clinical factors such as gender, manifest refraction, pupil size, lens density, corneal HOAs, or ocular HOAs. Conclusions: Although the great majority of the variance remains unexplained, eyes with lower OSI and better CDVA are more predisposed to show higher contrast sensitivity function. These results indicate that not only CDVA but also intraocular forward scattering may play some role in predicting the contrast sensitivity function in myopic subjects.	[Kamiya, Kazutaka; Shimizu, Kimiya; Iijima, Ayaka; Kobashi, Hidenaga] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa 228, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa 228, Japan.	kamiyak-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24592642]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24592642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSONS I, 1992, ARCH OPHTHALMOL-CHIC, V110, P1081, DOI 10.1001/archopht.1992.01080200061025; Applegate RA, 1998, J REFRACT SURG, V14, P397, DOI 10.3928/1081-597X-19980701-05; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Feizi S, 2009, JPN J OPHTHALMOL, V53, P414, DOI 10.1007/s10384-009-0677-4; Fujikado T, 2004, J CATARACT REFR SURG, V30, P1198, DOI 10.1016/j.jcrs.2003.12.023; Hennelly ML, 1998, OPHTHAL PHYSL OPT, V18, P197, DOI 10.1016/S0275-5408(97)00077-X; Hernandez C, 1996, OPHTHAL PHYSL OPT, V16, P336, DOI 10.1016/0275-5408(95)00116-6; JINDRA LF, 1989, J CATARACT REFR SURG, V15, P141, DOI 10.1016/S0886-3350(89)80002-1; Kim JS, 2009, J CATARACT REFR SURG, V35, P1204, DOI 10.1016/j.jcrs.2009.02.032; Lee H, 2014, OPTOMETRY VISION SCI, V91, P437, DOI 10.1097/OPX.0000000000000190; Liang JZ, 1997, J OPT SOC AM A, V14, P2873, DOI 10.1364/JOSAA.14.002873; Oshika T, 2006, INVEST OPHTH VIS SCI, V47, P1334, DOI 10.1167/iovs.05-1154; Oshika T, 2006, OPHTHALMOLOGY, V113, P1807, DOI 10.1016/j.ophtha.2006.03.061; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Pei X, 2008, BRIT J OPHTHALMOL, V92, P1471, DOI 10.1136/bjo.2007.136978; Perez GM, 2009, J VISION, V9, DOI 10.1167/9.3.19; Pesudovs K, 2004, BRIT J OPHTHALMOL, V88, P11, DOI 10.1136/bjo.88.1.11; REEVES BC, 1991, OPTOMETRY VISION SCI, V68, P728, DOI 10.1097/00006324-199109000-00010; SNYDER AW, 1979, BIOL CYBERN, V32, P9, DOI 10.1007/BF00337446; Strang NC, 1999, OPHTHAL PHYSL OPT, V19, P415, DOI 10.1016/S0275-5408(99)00014-9; THAUNG J, 1995, INVEST OPHTH VIS SCI, V36, P2313; VANDENBERG TJTP, 1986, DOC OPHTHALMOL, V61, P327, DOI 10.1007/BF00142360; VIRSU V, 1979, EXP BRAIN RES, V37, P475	23	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113562	10.1371/journal.pone.0113562	http://dx.doi.org/10.1371/journal.pone.0113562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401751	Green Submitted, gold, Green Published			2022-12-26	WOS:000345158700140
J	Lee, JY; Lee, HS; Lee, DC; Chu, SH; Jeon, JY; Kim, NK; Lee, JW				Lee, Jee-Yon; Lee, Hye-Sun; Lee, Duk-Chul; Chu, Sang-Hui; Jeon, Justin Y.; Kim, Nam-Kyu; Lee, Ji-Won			Visceral Fat Accumulation Is Associated with Colorectal Cancer in Postmenopausal Women	PLOS ONE			English	Article							BODY-MASS INDEX; COLON-CANCER; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPONECTIN LEVELS; RECTAL-CANCER; OBESITY; RISK; METAANALYSIS; MORTALITY	Background: Obesity is a known risk factor for colorectal cancer (CRC), and emerging data suggest that this association is mediated by visceral fat rather than total body fat. However, there is a lack of studies evaluating the association between visceral fat area and the prevalence of CRC. Methods: To investigate the relationship between visceral adiposity and prevalence of CRC, data of 497 women diagnosed with CRC and 318 apparently healthy women were analysed and data of well-balanced 191 pairs of women with CRC and healthy women matched based on propensity scores were additionally analysed. Diagnosis of CRC was confirmed by colonoscopy and histology. Metabolic parameters were assessed, along with body composition, using computed tomography. Results: The median visceral fat area was significantly higher in the CRC group compared with the control group before and after matching. The prevalence of CRC increased significantly with increasing visceral fat tertiles after matching (p for trend <0.01). A multivariate analysis showed that mean visceral fat area of individuals in the 67th percentile or greater group was associated with an increased prevalence of CRC (adjusted odds ratio: 1.80; 95% confidence interval: 1.12-2.91 before matching and adjusted odds ratio: 2.96; 95% confidence interval: 1.38-6.33) compared with that of individuals in the 33th percentile or lower group. Conclusion: Thus, we conclude that visceral fat area is positively associated with the prevalence of CRC. Although we could not determine the causality, visceral adiposity may be associated with the risk of CRC. Further prospective studies are required to determine the benefits of controlling visceral obesity for reducing CRC risk.	[Lee, Jee-Yon; Lee, Duk-Chul; Lee, Ji-Won] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Lee, Hye-Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Chu, Sang-Hui] Yonsei Univ, Coll Nursing, Nursing Policy Res Inst, Biobehav Res Ctr,Dept Clin Nursing Sci, Seoul 120749, South Korea; [Jeon, Justin Y.] Yonsei Univ, Sports Med Lab, Dept Sport & Leisure Studies, Seoul 120749, South Korea; [Kim, Nam-Kyu] Yonsei Univ, Coll Med, Dept Gen Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System	Kim, NK (corresponding author), Yonsei Univ, Coll Med, Dept Gen Surg, Seoul, South Korea.	namkyuk@yuhs.ac; indi5645@yuhs.ac	; Lee, Hye Sun/J-2154-2015	LEE, JI WON/0000-0002-2666-4249; Lee, Duk Chul/0000-0001-9166-1813; Lee, Hye Sun/0000-0001-6328-6948; Jeon, Justin/0000-0001-7978-4271; CHU, Sang Hui/0000-0001-6877-5599; Kim, Nam-Kyu/0000-0003-0639-5632	Yonsei University College of Medicine [6-2013-0021]; Bio & Medical Technology Development Program, through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2013M3A9B6046413]	Yonsei University College of Medicine(General Electric); Bio & Medical Technology Development Program, through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning	This study was supported by a 2013 Faculty Research Grant from Yonsei University College of Medicine (6-2013-0021) and the Bio & Medical Technology Development Program, through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9B6046413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2012, EUR J CANCER PREV, V21, P126, DOI 10.1097/CEJ.0b013e32834c9b55; Blum WF, 2004, INSULIN LIKE GROWTH; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Colangelo LA, 2002, CANCER EPIDEM BIOMAR, V11, P385; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Donohoe CL, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-12; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Erarslan E, 2009, DIGEST DIS SCI, V54, P862, DOI 10.1007/s10620-008-0440-6; FEINLEIB M, 1985, ANN INTERN MED, V103, P1019, DOI 10.7326/0003-4819-103-6-1019; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x; Hou LF, 2006, EUR J CANCER, V42, P84, DOI 10.1016/j.ejca.2005.09.014; Huffman DM, 2013, CANCER; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lee JW, 2007, CLIN ENDOCRINOL, V66, P572, DOI 10.1111/j.1365-2265.2007.02780.x; MANN GV, 1974, NEW ENGL J MED, V291, P178, DOI 10.1056/NEJM197407252910405; Marmot M, 2007, FOOD NUTR PHYS ACT P; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Oh TH, 2008, J GASTROEN HEPATOL, V23, P411, DOI 10.1111/j.1440-1746.2007.05125.x; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Schoen RE, 1999, JNCI-J NATL CANCER I, V91, P1147, DOI 10.1093/jnci/91.13.1147; Shimizu N, 2003, BRIT J CANCER, V88, P1038, DOI 10.1038/sj.bjc.6600845; Sugiyama M, 2009, INT J ONCOL, V34, P339, DOI 10.3892/ijo_00000156; Terry PD, 2002, GUT, V51, P191, DOI 10.1136/gut.51.2.191; Tsujinaka S, 2008, DIS COLON RECTUM, V51, P1757, DOI 10.1007/s10350-008-9395-0; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Yamamoto S, 2010, DIABETES CARE, V33, P184, DOI 10.2337/dc09-1197; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011	36	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110587	10.1371/journal.pone.0110587	http://dx.doi.org/10.1371/journal.pone.0110587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402501	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700006
J	Urra, JA; Villaroel-Espindola, F; Covarrubias, AA; Rodriguez-Gil, JE; Ramirez-Reveco, A; Concha, II				Urra, Javier A.; Villaroel-Espindola, Franz; Covarrubias, Alejandra A.; Enric Rodriguez-Gil, Joan; Ramirez-Reveco, Alfredo; Concha, Ilona I.			Presence and Function of Dopamine Transporter (DAT) in Stallion Sperm: Dopamine Modulates Sperm Motility and Acrosomal Integrity	PLOS ONE			English	Article							INFERIOR MESENTERIC PLEXUS; IN-VITRO; ISOFLURANE ANESTHESIA; MAMMALIAN SPERMATOZOA; HAMSTER SPERMATOZOA; HUMAN TESTIS; CATECHOLAMINES; RECEPTORS; CAPACITATION; STIMULATION	Dopamine is a catecholamine with multiple physiological functions, playing a key role in nervous system; however its participation in reproductive processes and sperm physiology is controversial. High dopamine concentrations have been reported in different portions of the feminine and masculine reproductive tract, although the role fulfilled by this catecholamine in reproductive physiology is as yet unknown. We have previously shown that dopamine type 2 receptor is functional in boar sperm, suggesting that dopamine acts as a physiological modulator of sperm viability, capacitation and motility. In the present study, using immunodetection methods, we revealed the presence of several proteins important for the dopamine uptake and signalling in mammalian sperm, specifically monoamine transporters as dopamine (DAT), serotonin (SERT) and norepinephrine (NET) transporters in equine sperm. We also demonstrated for the first time in equine sperm a functional dopamine transporter using 4-[4-(Dimethylamino) styryl]-N-methylpyridinium iodide (ASP+), as substrate. In addition, we also showed that dopamine (1 mM) treatment in vitro, does not affect sperm viability but decreases total and progressive sperm motility. This effect is reversed by blocking the dopamine transporter with the selective inhibitor vanoxerine (GBR12909) and non-selective inhibitors of dopamine reuptake such as nomifensine and bupropion. The effect of dopamine in sperm physiology was evaluated and we demonstrated that acrosome integrity and thyrosine phosphorylation in equine sperm is significantly reduced at high concentrations of this catecholamine. In summary, our results revealed the presence of monoamine transporter DAT, NET and SERT in equine sperm, and that the dopamine uptake by DAT can regulate sperm function, specifically acrosomal integrity and sperm motility.	[Urra, Javier A.] Univ Austral Chile, Fac Ciencias Vet, Escuela Grad, Valdivia, Chile; [Urra, Javier A.; Villaroel-Espindola, Franz; Covarrubias, Alejandra A.; Concha, Ilona I.] Univ Austral Chile, Fac Ciencias, Inst Bioquim & Microbiol, Valdivia, Chile; [Urra, Javier A.; Ramirez-Reveco, Alfredo] Univ Austral Chile, Fac Ciencias Vet, Inst Ciencia Anim, Valdivia, Chile; [Enric Rodriguez-Gil, Joan] Univ Autonoma Barcelona, Fac Vet, Unitat Reprod Anim, E-08193 Barcelona, Spain	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Austral de Chile; Autonomous University of Barcelona	Ramirez-Reveco, A (corresponding author), Univ Austral Chile, Fac Ciencias Vet, Inst Ciencia Anim, Valdivia, Chile.	alfredoramirez@uach.cl; conchagrabinger@uach.cl	Ramírez, Alfredo/ABE-2699-2021; Villarroel-Espindola, Franz/GLU-4201-2022; Rodriguez-Gil, Joan E./F-8748-2016; Ramirez, Alfredo/AAF-8536-2020	Ramírez, Alfredo/0000-0003-4782-4261; Rodriguez-Gil, Joan E./0000-0002-1112-9884; 	FONDEF (Fondo de Fomento al Desarrollo Cientifico y Tecnologico) [D08I11076]; FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico) [1110508, 33130449]; DID-UACh Grant (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile) [D-2010-01]; Direccion de Estudios Postgrados, Universidad Austral de Chile; Escuela de Graduados, Facultad de Ciencias Veterinarias, Universidad Austral de Chile; CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica)	FONDEF (Fondo de Fomento al Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DID-UACh Grant (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile); Direccion de Estudios Postgrados, Universidad Austral de Chile; Escuela de Graduados, Facultad de Ciencias Veterinarias, Universidad Austral de Chile; CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funding: Supported by FONDEF (Fondo de Fomento al Desarrollo Cientifico y Tecnologico: Grant D08I11076 (to A.R.R.), FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico) Grant 1110508 (to I.C.), Grant 33130449 (to FVE), and DID-UACh Grant D-2010-01 (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile), Direccion de Estudios Postgrados, Universidad Austral de Chile and Escuela de Graduados, Facultad de Ciencias Veterinarias, Universidad Austral de Chile and CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) Scholarship for doctoral studies (to J.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoya-Osiguwa SA, 2007, HUM REPROD, V22, P756, DOI 10.1093/humrep/del454; Adeoya-Osiguwa SA, 2006, HUM REPROD, V21, P1555, DOI 10.1093/humrep/del016; Ayala I, 2012, RES VET SCI, V93, P103, DOI 10.1016/j.rvsc.2011.05.013; Bae SE, 2001, REPRODUCTION, V122, P275, DOI 10.1530/reprod/122.2.275; BAVISTER BD, 1979, J REPROD FERTIL, V56, P507, DOI 10.1530/jrf.0.0560507; BILLUPS KL, 1990, J UROLOGY, V143, P625, DOI 10.1016/S0022-5347(17)40043-7; BILLUPS KL, 1990, FERTIL STERIL, V53, P1076; BONISCH H, 1980, PHARMACOLOGY, V21, P93, DOI 10.1159/000137422; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAUD M, 1983, PHARMACOL RES COMMUN, V15, P923, DOI 10.1016/S0031-6989(83)80022-8; CORNETT LE, 1979, BIOL REPROD, V20, P925, DOI 10.1095/biolreprod20.4.925; CORNETT LE, 1978, P NATL ACAD SCI USA, V75, P4954, DOI 10.1073/pnas.75.10.4954; Cortes-Gutierrez EI, 2008, THERIOGENOLOGY, V69, P1022, DOI 10.1016/j.theriogenology.2008.02.002; Davidoff MS, 2005, HISTOCHEM CELL BIOL, V124, P313, DOI 10.1007/s00418-005-0024-x; Fait G, 2001, ANDROLOGIA, V33, P347, DOI 10.1046/j.1439-0272.2001.00461.x; Frungieri MB, 2000, NEUROENDOCRINOLOGY, V71, P43, DOI 10.1159/000054519; Gil AG, 2005, VET REC, V157, P589; Gil AG, 2007, LAB ANIM-UK, V41, P411, DOI 10.1258/002367707782314274; HELM G, 1982, BIOL REPROD, V26, P553, DOI 10.1095/biolreprod26.4.553; KHATCHADOURIAN C, 1987, HUM REPROD, V2, P1; Kotwica G, 2003, THERIOGENOLOGY, V60, P953, DOI 10.1016/S0093-691X(03)00086-4; LINDAHL PE, 1981, EXPERIENTIA, V37, P860, DOI 10.1007/BF01985681; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; Mayerhofer A, 1999, J ANDROL, V20, P341; Mayerhofer A, 1996, BIOL REPROD, V55, P509, DOI 10.1095/biolreprod55.3.509; MEIZEL S, 1980, BIOL REPROD, V22, P211, DOI 10.1095/biolreprod22.2.211; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; OZ M, 2010, ASP J NEUROCHEM, V114, P1019; Ramirez AR, 2009, BIOL REPROD, V80, P753, DOI 10.1095/biolreprod.108.070961; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Villarroel-Espindola F, 2013, J CELL BIOCHEM, V114, P1653, DOI 10.1002/jcb.24507; Way AL, 2002, J ANDROL, V23, P352; Wu XH, 1999, GENE, V233, P163, DOI 10.1016/S0378-1119(99)00143-2	33	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112834	10.1371/journal.pone.0112834	http://dx.doi.org/10.1371/journal.pone.0112834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG2MR	25402186	Green Published, Green Submitted, gold			2022-12-26	WOS:000353109300001
J	Jiang, L; Wang, H; Shi, CL; Liu, K; Liu, MD; Wang, NA; Wang, KK; Zhang, HL; Wang, GL; Xiao, XZ				Jiang, Lei; Wang, Hao; Shi, Chunli; Liu, Ke; Liu, Meidong; Wang, Nian; Wang, Kangkai; Zhang, Huali; Wang, Guiliang; Xiao, Xianzhong			ZNF667/Mipu1 Is a Novel Anti-Apoptotic Factor That Directly Regulates the Expression of the Rat Bax Gene in H9c2 Cells	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; PEROXIDE-INDUCED APOPTOSIS; BCL-2 FAMILY PROTEINS; OXIDATIVE STRESS; UP-REGULATION; MITOCHONDRIAL DYSFUNCTION; FUNCTIONAL-ANALYSIS; DEATH; MIPU1; TRANSCRIPTION	ZNF667/Mipu1, a C2H2-type zinc finger transcription factor, was suggested to play an important role in oxidative stress. However, none of the target genes or potential roles of ZNF667 in cardiomyocytes have been elucidated. Here, we investigated the functional role of ZNF667 in H9c2 cell lines focusing on its molecular mechanism by which it protects the cells from apoptosis. We found that ZNF667 inhibited the expression and the promoter activity of the rat proapoptotic gene Bax gene, and at the same time prevented apoptosis of H9c2 cells, induced by H2O2 and Dox. Western immunoblotting analysis revealed that ZNF667 also inhibited Bax protein expression, accompanied by attenuation of the mitochondrial translocation of Bax protein, induced by H2O2. EMSA and target detection assay showed that the purified ZNF667 fusion proteins could interact with the Bax promoter sequence in vitro, and this interaction was dependent upon the ZNF667 DNA binding sequences or its core sequence in the promoter. Furthermore, ChIP assay demonstrated that a stimulus H2O2 could enhance the ability of ZNF667 protein binding to the promoter. Finally, a reporter gene assay showed that ZNF667 could repress the activity of the Bax gene promoter, and the repression was dependent upon its binding to the specific DNA sequence in the promoter. Our work demonstrates that ZNF667 that confers cytoprotection is a novel regulator of the rat Bax gene, mediating the inhibition of the Bax mRNA and protein expression in H9c2 cardiomyocytes in response to H2O2 treatment.	[Jiang, Lei; Wang, Hao; Shi, Chunli; Liu, Ke; Liu, Meidong; Wang, Nian; Wang, Kangkai; Zhang, Huali; Wang, Guiliang; Xiao, Xianzhong] Cent S Univ, Xiangya Sch Med, Dept Pathophysiol, Changsha 410078, Hunan, Peoples R China	Central South University	Xiao, XZ (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Pathophysiol, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	xianzhongxiao@xysm.net	xiao, xiang/GWU-6035-2022		Major National Basic Research Program of China [2007CB512007]; National Natural Science Foundation of China [30971205]	Major National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major National Basic Research Program of China (2007CB512007 for X. X.) and the National Natural Science Foundation of China (30971205 for L.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdach J, 2012, TRENDS BIOCHEM SCI, V37, P199, DOI 10.1016/j.tibs.2012.02.001; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Fortuno MA, 1999, HYPERTENSION, V33, P1348, DOI 10.1161/01.HYP.33.6.1348; Gonzalez-Girones DM, 2013, APOPTOSIS, V18, P1008, DOI 10.1007/s10495-013-0850-6; Gou DM, 2004, BBA-GENE STRUCT EXPR, V1676, P203, DOI 10.1016/j.bbaexp.2003.11.011; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Jiang L, 2007, BIOCHEM BIOPH RES CO, V356, P829, DOI 10.1016/j.bbrc.2007.02.138; Jiang L, 2009, MOL CELL BIOCHEM, V328, P137, DOI 10.1007/s11010-009-0083-8; Jin HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051720; Jin KL, 2001, J NEUROCHEM, V77, P1508, DOI 10.1046/j.1471-4159.2001.00361.x; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu K, 2013, LIVER INT, V33, P1566, DOI 10.1111/liv.12238; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Nelson DP, 2002, ANN THORAC SURG, V73, P156, DOI 10.1016/S0003-4975(01)03303-3; Nishikawa S, 2006, J MOL CELL CARDIOL, V40, P510, DOI 10.1016/j.yjmcc.2006.01.020; Nunez N, 2011, J BIOL CHEM, V286, P38190, DOI 10.1074/jbc.M111.301234; Plumier JCL, 1996, J MOL CELL CARDIOL, V28, P1251, DOI 10.1006/jmcc.1996.0115; Qu SL, 2010, FREE RADICAL BIO MED, V49, P580, DOI 10.1016/j.freeradbiomed.2010.05.004; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P217, DOI 10.1134/S0006297912030017; Sardao VA, 2009, CANCER CHEMOTH PHARM, V64, P811, DOI 10.1007/s00280-009-0932-x; Shigematsu S, 2011, EXP CELL RES, V317, P1851, DOI 10.1016/j.yexcr.2011.05.012; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wang G, 2010, BRAZ J MED BIOL RES, V43, P43, DOI 10.1590/S0100-879X2009005000010; Wang GL, 2009, INT J MOL SCI, V10, P492, DOI 10.3390/ijms10020492; Wang GL, 2009, MOL CELL BIOCHEM, V322, P93, DOI 10.1007/s11010-008-9944-9; Wang KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082827; Wang Z, 2013, CHIN J NEUROSURG DIS, V12, P37; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xiang SY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004405; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan C, 2004, PROG BIOCHEM BIOPHYS, V31, P231; Yuan C, 2004, J CLIN RES, V21, P837; Zhang B, 2010, CELL STRESS CHAPERON, V15, P249, DOI 10.1007/s12192-009-0138-5; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	41	8	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111653	10.1371/journal.pone.0111653	http://dx.doi.org/10.1371/journal.pone.0111653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397408	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558500021
J	Lee, T; Kim, J; Kim, S; Kim, K; Park, Y; Kim, Y; Lee, YS; Kwon, HS; Kim, SH; Chang, YS; Cho, YS; Jang, AS; Park, JW; Nahm, DH; Yoon, HJ; Cho, SH; Cho, YJ; Choi, BW; Moon, HB; Kim, TB				Lee, Taehoon; Kim, Jinhee; Kim, Sujeong; Kim, Kyoungjoo; Park, Yunjin; Kim, Yuri; Lee, Yoon Su; Kwon, Hyouk-Soo; Kim, Sae-Hoon; Chang, Yoon-Seok; Cho, You Sook; Jang, An-Soo; Park, Jung-Won; Nahm, Dong-Ho; Yoon, Ho-Joo; Cho, Sang-Heon; Cho, Young-Joo; Choi, Byoung Whui; Moon, Hee-Bom; Kim, Tae-Bum		COREA Study Grp	Risk Factors for Asthma-Related Healthcare Use: Longitudinal Analysis Using the NHI Claims Database in a Korean Asthma Cohort	PLOS ONE			English	Article							INHALED CORTICOSTEROIDS; RESOURCE UTILIZATION; AIRWAY-OBSTRUCTION; ADULT ASTHMA; HOSPITALIZATION; POPULATION; PREVALENCE; MEDICAID; CHILDREN; DEATH	Background: Though insurance claims data are useful for researching asthma, they have important limitations, such as a diagnostic inaccuracy and a lack of clinical information. To overcome these drawbacks, we used the novel method by merging the clinical data from our asthma cohort with the National Health Insurance (NHI) claims data. Methods and Results: Longitudinal analysis of asthma-related healthcare use from the NHI claims database, merged with data of 736 patients registered in a Korean asthma cohort, was conducted for three consecutive years from registration of the cohort. Asthma-related asthma healthcare referred to outpatient and emergency department visits, hospitalizations, and the use of systemic corticosteroids. Univariate and multivariate logistic regression analysis was used to evaluate risk factors for asthma-related healthcare. Over three years after enrollment, many patients changed from tertiary to primary/secondary hospitals with a lack of maintenance of inhaled corticosteroid-based controllers. An independent risk factor for emergency visits was a previous history of asthma exacerbation. In hospitalizations, old age and Asthma Control Test (ACT) score variability were independent risk factors. An independent risk factor for per person cumulative duration of systemic corticosteroids was the FEV1 (Forced expiratory volume in one second)%. The use of systemic corticosteroids was independently associated with being female, the FEV1%, and ACT score variability. Conclusion: We found that old age, being female, long-standing asthma, a low FEV1%, asthma brittleness, asthma drug compliance, and a history of asthma exacerbation were independent risk factors for increased asthma-related healthcare use in Korea.	[Lee, Taehoon; Kim, Sujeong; Lee, Yoon Su; Kwon, Hyouk-Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Allergy & Clin Immunol, Seoul, South Korea; [Lee, Taehoon] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan 680749, South Korea; [Kim, Jinhee; Kim, Kyoungjoo; Kim, Yuri] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea; [Kim, Jinhee] Chosun Univ, Coll Med, Dept Nursing, Kwangju, South Korea; [Kim, Sujeong] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Park, Yunjin] Dongguk Univ, Dept Stat, Seoul, South Korea; [Kim, Sae-Hoon; Chang, Yoon-Seok; Cho, Sang-Heon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Jang, An-Soo] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon, South Korea; [Park, Jung-Won] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Nahm, Dong-Ho] Ajou Univ, Coll Med, Dept Internal Med, Suwon 441749, South Korea; [Yoon, Ho-Joo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Cho, Young-Joo] Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Choi, Byoung Whui] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Ulsan University Hospital; National Evidence-based Healthcare Collaborating Agency (NECA); Chosun University; Kyungpook National University; Dongguk University; Seoul National University (SNU); Soonchunhyang University; Yonsei University; Yonsei University Health System; Ajou University; Hanyang University; Ewha Womans University; Chung Ang University; Chung Ang University Hospital	Moon, HB (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Allergy & Clin Immunol, Seoul, South Korea.	hbmoon@amc.seoul.kr; allergy@medimail.co.kr	Chang, Yoon-Seok/J-5628-2012; Lee, Taehoon/AHA-1437-2022	Chang, Yoon-Seok/0000-0003-3157-0447; Lee, Taehoon/0000-0002-9224-0866	Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea [A102065, HI13C0776]	Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea (grant no. A102065 & HI13C0776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2000, THORAX, V55, P566, DOI 10.1136/thorax.55.7.566; [Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; Ayres JG, 1998, THORAX, V53, P315, DOI 10.1136/thx.53.4.315; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; Bateman ED, 2010, GLOBAL STRATEGY ASTH, P1; Blais R, 2001, CHEST, V119, P1316, DOI 10.1378/chest.119.5.1316; BRAMAN SS, 1991, AM REV RESPIR DIS, V143, P336, DOI 10.1164/ajrccm/143.2.336; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P350; Chan J, 2007, J MANAG CARE PHARM, V13, P21, DOI 10.18553/jmcp.2007.13.1.21; Clark T, 2002, GLOBAL INITIATIVE AS, P1; Diette GB, 2002, ARCH INTERN MED, V162, P1123, DOI 10.1001/archinte.162.10.1123; Guilbert TW, 2011, J ASTHMA, V48, P126, DOI 10.3109/02770903.2010.535879; Hasford J, 2010, ALLERGY, V65, P347, DOI 10.1111/j.1398-9995.2009.02161.x; Kang HY, 2008, YONSEI MED J, V49, P521, DOI 10.3349/ymj.2008.49.4.521; Kim S, 2013, ALLERGY, V68, P1435, DOI 10.1111/all.12256; Kim TB, 2013, EUR RESPIR J, V41, P1308, DOI 10.1183/09031936.00100811; Kim TB, 2009, ANN ALLERG ASTHMA IM, V103, P311, DOI 10.1016/S1081-1206(10)60530-3; Lanes SF, 1998, AM J RESP CRIT CARE, V158, P857, DOI 10.1164/ajrccm.158.3.9803047; Lee T, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-1; LOZANO P, 1995, JAMA-J AM MED ASSOC, V274, P469, DOI 10.1001/jama.274.6.469; MANFREDA J, 1993, CHEST, V103, P151, DOI 10.1378/chest.103.1.151; Park Choon Seon, 2006, J Prev Med Public Health, V39, P397; Ray NF, 1998, CHEST, V113, P1277, DOI 10.1378/chest.113.5.1277; Salamzadeh J, 2003, J ASTHMA, V40, P645, DOI 10.1081/JAS-120019035; Sawicki GS, 2010, ANN ALLERG ASTHMA IM, V104, P30, DOI 10.1016/j.anai.2009.11.004; Schatz M, 2003, J ALLERGY CLIN IMMUN, V111, P503, DOI 10.1067/mai.2003.178; Schokker S, 2010, PRIM CARE RESP J, V19, P28, DOI 10.4104/pcrj.2009.00039; Shaya FT, 2009, CHEST, V136, P405, DOI 10.1378/chest.08-2304; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Stanford RH, 2010, CLIN THER, V32, P1782, DOI 10.1016/j.clinthera.2010.09.012; Stock S, 2005, EUR RESPIR J, V25, P47, DOI 10.1183/09031936.04.00116203; Suissa S, 1996, AM J RESP CRIT CARE, V154, P1598, DOI 10.1164/ajrccm.154.6.8970341; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; TUUPONEN T, 1993, AGE AGEING, V22, P97, DOI 10.1093/ageing/22.2.97; van Manen JG, 2001, J CLIN EPIDEMIOL, V54, P287, DOI 10.1016/S0895-4356(01)00346-8; Vollmer WM, 2002, AM J RESP CRIT CARE, V165, P195, DOI 10.1164/ajrccm.165.2.2102127; Wenzel SE, 2007, J ALLERGY CLIN IMMUN, V119, P14, DOI 10.1016/j.jaci.2006.10.025	37	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112844	10.1371/journal.pone.0112844	http://dx.doi.org/10.1371/journal.pone.0112844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397972	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558500099
J	Noordzij, W; van Beek, AP; Tio, RA; van der Horst-Schrivers, AN; de Vries, EG; van Ginkel, B; Walenkamp, AM; Glaudemans, AW; Slart, RH; Dierckx, RA				Noordzij, Walter; van Beek, Andre P.; Tio, Rene A.; van der Horst-Schrivers, Anouk N.; de Vries, Elisabeth G.; van Ginkel, Bram; Walenkamp, Annemiek M.; Glaudemans, Andor W.; Slart, Riemer H.; Dierckx, Rudi A.			Myocardial Metastases on 6-[F-18] fluoro-L-DOPA PET/CT: A Retrospective Analysis of 116 Serotonin Producing Neuroendocrine Tumour Patients	PLOS ONE			English	Article							CARCINOID HEART-DISEASE; F-18-DIHYDROXY-PHENYL-ALANINE; ECHOCARDIOGRAPHY; GUIDELINES; MANAGEMENT	Purpose: This study evaluates the prevalence of cardiac metastases in patients with serotonin producing neuroendocrine tumours (NET), examined with F-18-FDOPA PET/CT, and the relationship of these metastases to the presence of carcinoid heart disease (CHD) based on echocardiography. Background: CHD occurs in patients with serotonin producing NET. The diagnostic method of choice remains echocardiography. The precise prevalence of cardiac metastases is unknown given the limitations of standard technologies. Nuclear medicine modalities have the potential to visualize metastases of NET. Methods: All patients who underwent F-18-FDOPA PET/CT because of serotonin producing NET between November 2009 and May 2012 were retrospectively analyzed. The presence of cardiac metastasis was defined as myocardial tracer accumulation higher than the surrounding physiological myocardial uptake. Laboratory tests and transthoracic echocardiography (TTE) results were digitally collected. Results: 116 patients (62 male) underwent F-18-FDOPA PET/CT, mean age was 61 +/- 13 years. TTE was performed in 79 patients. Cardiac metastases were present in 15 patients, of which 10 patients also underwent TTE. One patient had both cardiac metastasis (only on F-18-FDOPA PET/CT) and echocardiographic signs of CHD. There were no differences in echocardiographic parameters for CHD between patients with and without cardiac metastases. TTE in none of the 79 patients showed cardiac metastases. Conclusion: The prevalence of cardiac metastases detected with F-18-FDOPA PET/CT in this study is 13%. F-18-FDOPA PET/CT can visualize cardiac metastases in serotonin producing NET patients. There appears to be no relationship between the presence of cardiac metastases and TTE parameters of CHD.	[Noordzij, Walter; Glaudemans, Andor W.; Slart, Riemer H.; Dierckx, Rudi A.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [van Beek, Andre P.; van der Horst-Schrivers, Anouk N.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Tio, Rene A.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [de Vries, Elisabeth G.; Walenkamp, Annemiek M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [van Ginkel, Bram] Univ Groningen, Univ Med Ctr Groningen, Fac Med, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Noordzij, W (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands.	w.noordzij@umcg.nl	Tio, Rene/ABG-2820-2020; van Beek, Andre/O-3753-2014	de Vries, Elisabeth/0000-0002-8949-7425; van Beek, Andre/0000-0002-0335-8177; Glaudemans, Andor/0000-0001-8081-0641				American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Anderson AS, 1997, AM HEART J, V134, P693, DOI 10.1016/S0002-8703(97)70053-X; Bernheim AM, 2007, PROG CARDIOVASC DIS, V49, P439, DOI 10.1016/j.pcad.2006.12.002; Bhattacharyya S, 2010, CIRC-CARDIOVASC IMAG, V3, P103, DOI 10.1161/CIRCIMAGING.109.886846; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Calissendorff J, 2014, ENDOCRINE, V47, P169, DOI 10.1007/s12020-013-0108-7; Carreras Cecilia, 2013, Recent Results Cancer Res, V194, P379, DOI 10.1007/978-3-642-27994-2_20; Castillo JG, 2013, SEMIN CARDIOTHORAC V, V17, P212, DOI 10.1177/1089253212465475; Denney WD, 1998, J AM COLL CARDIOL, V32, P1017, DOI 10.1016/S0735-1097(98)00354-4; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fiebrich HB, 2008, CIRCULATION, V118, P1602, DOI 10.1161/CIRCULATIONAHA.108.767111; Jann H, 2010, HORM METAB RES, V42, P967, DOI 10.1055/s-0030-1267204; Koestenberger M, 2009, J AM SOC ECHOCARDIOG, V22, P715, DOI 10.1016/j.echo.2009.03.026; Koopmans KP, 2008, J CLIN ONCOL, V26, P1489, DOI 10.1200/JCO.2007.15.1126; Moller JE, 2005, CIRCULATION, V112, P3320, DOI 10.1161/CIRCULATIONAHA.105.553750; Palaniswamy C, 2012, CARDIOL REV, V20, P167, DOI 10.1097/CRD.0b013e31824c866e; Pandya UH, 2002, J AM COLL CARDIOL, V40, P1328, DOI 10.1016/S0735-1097(02)02109-5; Pape UF, 2012, NEUROENDOCRINOLOGY, V95, P135, DOI 10.1159/000335629; PELLIKKA PA, 1993, CIRCULATION, V87, P1188, DOI 10.1161/01.CIR.87.4.1188; ROBERTS WC, 1964, AM J MED, V36, P5, DOI 10.1016/0002-9343(64)90145-7; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	23	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112278	10.1371/journal.pone.0112278	http://dx.doi.org/10.1371/journal.pone.0112278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397775	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500043
J	Sax, PE; Sypek, A; Berkowitz, BK; Morris, BL; Losina, E; Paltiel, AD; Kelly, KA; Seage, GR; Walensky, RP; Weinstein, MC; Eron, J; Freedberg, KA				Sax, Paul E.; Sypek, Alexis; Berkowitz, Bethany K.; Morris, Bethany L.; Losina, Elena; Paltiel, A. David; Kelly, Kathleen A.; Seage, George R., III; Walensky, Rochelle P.; Weinstein, Milton C.; Eron, Joseph; Freedberg, Kenneth A.			HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?	PLOS ONE			English	Article							QUALITY-OF-LIFE; COST-EFFECTIVENESS; UNITED-STATES; HEPATITIS-C; INFECTION; VACCINE; TRANSPLANTATION; POPULATION; VORINOSTAT; LYMPHOMA	Background: We examined efficacy, toxicity, relapse, cost, and quality-of-life thresholds of hypothetical HIV cure interventions that would make them cost-effective compared to life-long antiretroviral therapy (ART). Methods: We used a computer simulation model to assess three HIV cure strategies: Gene Therapy, Chemotherapy, and Stem Cell Transplantation (SCT), each compared to ART. Efficacy and cost parameters were varied widely in sensitivity analysis. Outcomes included quality-adjusted life expectancy, lifetime cost, and cost-effectiveness in dollars/quality-adjusted life year ($/QALY) gained. Strategies were deemed cost-effective with incremental cost-effectiveness ratios <$100,000/QALY. Results: For patients on ART, discounted quality-adjusted life expectancy was 16.4 years and lifetime costs were $591,400. Gene Therapy was cost-effective with efficacy of 10%, relapse rate 0.5%/month, and cost $54,000. Chemotherapy was cost-effective with efficacy of 88%, relapse rate 0.5%/month, and cost $12,400/month for 24 months. At $150,000/procedure, SCT was cost-effective with efficacy of 79% and relapse rate 0.5%/month. Moderate efficacy increases and cost reductions made Gene Therapy cost-saving, but substantial efficacy/cost changes were needed to make Chemotherapy or SCT cost-saving. Conclusions: Depending on efficacy, relapse rate, and cost, cure strategies could be cost-effective compared to current ART and potentially cost-saving. These results may help provide performance targets for developing cure strategies for HIV.	[Sax, Paul E.; Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Sax, Paul E.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; [Seage, George R., III; Weinstein, Milton C.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sypek, Alexis; Berkowitz, Bethany K.; Morris, Bethany L.; Losina, Elena; Kelly, Kathleen A.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Sypek, Alexis; Berkowitz, Bethany K.; Morris, Bethany L.; Losina, Elena; Kelly, Kathleen A.; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Eron, Joseph] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Boston University; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sax, PE (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	psax@partners.org	Morris, Bethany L./GNH-4419-2022	Losina, ELENA/0000-0002-3424-0892; Walensky, Rochelle P./0000-0002-8795-379X; Paltiel, A. David/0000-0002-4861-3290	National Institute of Allergy and Infectious Diseases [R37 AI042006, AI051966, R01 AI093269, U01 AI 069472, U01 AI068636, UM1 AI 069423]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093269, UM1AI069423, R37AI042006, U01AI069472, R56AI114617, K24AI051966, P30AI050410, U01AI068636] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx): R37 AI042006 (PS, AS, BB, BM, EL, ADP, KK, RW, MW, KF), AI051966 (GS), R01 AI093269 (RW, KF, ADP, MW), U01 AI 069472 (PS, EL, KF, RQ, ADP, AS, BB, BM, KK) (Partners/Harvard AIDS Clinical Trials Unit), U01 AI068636 (PS, EL, KF, RQ, ADP, AS, BB, BM, KK) (Central AIDS Clinical Trials Group), and UM1 AI 069423 (JE) (UNC Global Clinical Trials Unit). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; Andrinopoulos K, 2011, AIDS EDUC PREV, V23, P367, DOI 10.1521/aeap.2011.23.4.367; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Centers for Medicare and Medicaid Services, 2012, MED PHYS FEE SCHED 2; Centers for Medicare and Medicaid Services American Medical Association, 2012, CLIN DIAGN LAB FEE S; Crespo C, 2012, CLIN THER, V34, P1774, DOI 10.1016/j.clinthera.2012.06.029; Dignan FL, 2013, CLIN TRANSPLANT, V27, pE56, DOI 10.1111/ctr.12065; Dotinga R, 2010, GENE THERAPY HIV INC; Elting LS, 2003, CANCER, V97, P1541, DOI 10.1002/cncr.11195; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gebo Kelly A, 2003, Hopkins HIV Rep, V15, P5; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Havrilesky LJ, 2012, CANCER-AM CANCER SOC, V118, P386, DOI 10.1002/cncr.26199; Kasiske BL, 2000, JAMA-J AM MED ASSOC, V283, P2445, DOI 10.1001/jama.283.18.2445; Kavanaugh SA, 2010, AM J HEALTH-SYST PH, V67, P793, DOI 10.2146/ajhp090247; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Leelahavarong P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-534; Lewin SR, 2014, ANN INTERN MED, V161, P368, DOI 10.7326/M14-1573; Margolis DM, 2013, CURR OPIN HIV AIDS, V8, P230, DOI 10.1097/COH.0b013e32835ef089; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; Mellors J, 2014, NCT01933594; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Merck Sharp & Dohme Corp, 2006, ZOL VOR PACK INS; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Moore RD, 2011, CLIN INFECT DIS, V53, P600, DOI 10.1093/cid/cir467; National Bone Marrow Transplant Link, 2010, BON MARR STEM CELL T; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUID PREV TREATM OPP; Pepper PV, 2002, MED DECIS MAKING, V22, pS45, DOI 10.1177/027298902237705; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; RED BOOK Online, 2013, PROD INF ANT DRUG PR; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shenoy S, 2011, HEMATOL-AM SOC HEMAT, P273, DOI 10.1182/asheducation-2011.1.273; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Stamatovic D, 2011, VOJNOSANIT PREGL, V68, P1026, DOI 10.2298/VSP1112026S; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; United Nations. Department of Economic and Social Affairs. Population Division, 2009, ESAPWP210 UN DEP EC; University HealthSystems Consortium, 2008, CDP ONL REP; US Department of Health and Human Services. Office of Inspector General, 2005, MED DRUG PRIC COMP A; Vertex Pharmaceuticals Incorporated, 2012, KAL IV PACK INS; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Walensky RP, 2004, VACCINE, V22, P4044, DOI 10.1016/j.vaccine.2004.03.059	50	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113031	10.1371/journal.pone.0113031	http://dx.doi.org/10.1371/journal.pone.0113031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397616	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500125
J	Jiang, W; Huang, H; Ding, L; Zhu, P; Saiyin, H; Ji, G; Zuo, J; Han, D; Pan, Y; Ding, D; Ma, X; Zhang, Y; Wu, J; Yi, Q; Liu, JO; Huang, H; Dang, Y; Yu, L				Jiang, W.; Huang, H.; Ding, L.; Zhu, P.; Saiyin, H.; Ji, G.; Zuo, J.; Han, D.; Pan, Y.; Ding, D.; Ma, X.; Zhang, Y.; Wu, J.; Yi, Q.; Liu, J. O.; Huang, H.; Dang, Y.; Yu, L.			Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability	ONCOGENE			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; MITOTIC CONTROL; NUCLEAR EXPORT; BINDING; PROTEIN; PHOSPHORYLATION; STABILIZATION; OVEREXPRESSION; IDENTIFICATION	Activation of cyclin E1, a key regulator of the G1/S cell-cycle transition, has been implicated in many cancers including hepatocellular carcinoma (HCC). Although much is known about the regulation of cyclin E1 expression and stability, its post-transcriptional regulation mechanism remains incompletely understood. Here, we report that nuclear factor 90 (NF90), a double-stranded RNA (dsRNA) binding protein, regulates cyclin E1 in HCC. We demonstrate that NF90 is upregulated in HCC specimens and that suppression of NF90 decreases HCC cell growth and delays G1/S transition. We identified cyclin E1 as a new target of NF90 and found a significant correlation between NF90 and cyclin E1 expression in HCC. The mRNA and protein levels of cyclin E1 were downregulated upon NF90 knockdown. Suppression of NF90 caused a decrease in the half-life of cyclin E1 mRNA, which was rescued by ectopic expression of NF90. Furthermore, NF90 bound to the 3' untranslated regions (3' UTRs) of cyclin E1 mRNA in vitro and in vivo. Knockdown of NF90 also inhibited tumor growth of HCC cell lines in mouse xenograft model. Moreover, we showed that inhibition of NF90 sensitized HCC cells to the cyclin-dependent kinase 2 (CDK2) inhibitor, roscovitine. Taken together, downregulation of NF90 in HCC cell lines can delay cell-cycle progression, inhibit cell proliferation, and reduce tumorigenic capacity in vivo. These results suggest that NF90 has an important role in HCC pathogenesis and that it can serve as a novel therapeutic target for HCC.	[Jiang, W.; Huang, H.; Ding, L.; Zhu, P.; Saiyin, H.; Ji, G.; Zuo, J.; Han, D.; Pan, Y.; Ding, D.; Ma, X.; Zhang, Y.; Wu, J.; Huang, H.; Dang, Y.; Yu, L.] Fudan Univ, State Key Lab Genet Engn,Inst Genet,Sch Life Sci, Key Lab Metab & Mol Med,Minist Educ, Dept Biochem & Mol Biol,Sch Basic Med Sci, Shanghai 200032, Peoples R China; [Ding, L.; Pan, Y.] Mayo Clin, Coll Med, Ctr Canc, Dept Biochem & Mol Biol,Dept Urol, Rochester, NY USA; [Yi, Q.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Liu, J. O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Fudan University; Mayo Clinic; Cleveland Clinic Foundation; Johns Hopkins University	Dang, Y (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med, 130 Dongan Rd, Shanghai 200032, Peoples R China.	yongjundang@fudan.edu.cn; longyu@fudan.edu.cn	dang, yongjun/M-6531-2016; Han, Dingding/HGD-2042-2022	dang, yongjun/0000-0001-7237-1132; Han, Dingding/0000-0003-0963-6286; Saiyin, Hexige/0000-0003-2993-6817	National Key Sci-Tech Special Project of China [2013ZX10002010]; National Natural Science Foundation of China [31270830]; NATIONAL CANCER INSTITUTE [P30CA015083, P30CA006973] Funding Source: NIH RePORTER	National Key Sci-Tech Special Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Key Sci-Tech Special Project of China (2013ZX10002010), and the National Natural Science Foundation of China (31270830). We thank Dr Tilman Schneider-Poetsch, Sarah Head and Yang Xianmei for generously editing the manuscript.	AKAMA Y, 1995, JPN J CANCER RES, V86, P617, DOI 10.1111/j.1349-7006.1995.tb02442.x; Benson C, 2007, BRIT J CANCER, V96, P29, DOI 10.1038/sj.bjc.6603509; Bose SK, 2006, BIOCHEM J, V396, P99, DOI 10.1042/BJ20051548; Cam WR, 2001, DIGEST DIS SCI, V46, P2187, DOI 10.1023/A:1011962915280; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; Fung LF, 2000, LIFE SCI, V67, P923, DOI 10.1016/S0024-3205(00)00684-6; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Guo X, 2006, CANCER RES, V66, P7948, DOI 10.1158/0008-5472.CAN-05-4362; Guzi Timothy, 2004, Curr Opin Investig Drugs, V5, P1311; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Nanda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003442; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Peng SY, 1998, J HEPATOL, V29, P281, DOI 10.1016/S0168-8278(98)80014-7; Shamanna RA, 2013, ONCOGENE, V32, P5176, DOI 10.1038/onc.2012.533; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sui L, 2001, GYNECOL ONCOL, V83, P56, DOI 10.1006/gyno.2001.6308; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Whittaker SR, 2007, CELL CYCLE, V6, P3114, DOI 10.4161/cc.6.24.5142; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Xu YH, 1999, MOL GENET METAB, V68, P441, DOI 10.1006/mgme.1999.2934; Zhu P, 2010, J IMMUNOL, V185, P5140, DOI 10.4049/jimmunol.1000849	32	40	40	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2015	34	34					4460	4470		10.1038/onc.2014.373	http://dx.doi.org/10.1038/onc.2014.373			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BR	25399696	Green Accepted			2022-12-26	WOS:000360189200005
J	Li, Z; Lee, ASE; Bracher, S; Jung, H; Paz, A; Kumar, JP; Abramson, J; Quick, M; Shi, L				Li, Zheng; Lee, Ashley S. E.; Bracher, Susanne; Jung, Heinrich; Paz, Aviv; Kumar, Jay P.; Abramson, Jeff; Quick, Matthias; Shi, Lei			Identification of a Second Substrate-binding Site in Solute-Sodium Symporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Computational Biology; Galactose; Membrane Transport; Molecular Dynamics; Transporter; Equilibrium Binding; Scintillation Proximity Assay; Solute-Sodium Symporter; Structural Alignment	NA+/PROLINE TRANSPORTER PUTP; TRANSMEMBRANE DOMAIN-IX; AMINO-ACID ANTIPORTER; ESCHERICHIA-COLI; MEMBRANE-TRANSPORT; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; NEUROTRANSMITTER TRANSPORTERS; NA+/GLUCOSE COTRANSPORTER; GALACTOSE TRANSPORTER	Background: Although the solute-sodium symporter (SSS) vSGLT and the neurotransmitter-sodium symporter (NSS) LeuT have similar structural folds, their crystallographically identified substrate sites diverge in location and composition. Results: We identified second substrate sites in two SSSs that align with the crystallographically identified site in LeuT. Conclusion: Substrate transport by SSSs involves two substrate sites. Significance: NSS and SSS share common mechanistic features. The structure of the sodium/galactose transporter (vSGLT), a solute-sodium symporter (SSS) from Vibrio parahaemolyticus, shares a common structural fold with LeuT of the neurotransmitter-sodium symporter family. Structural alignments between LeuT and vSGLT reveal that the crystallographically identified galactose-binding site in vSGLT is located in a more extracellular location relative to the central substrate-binding site (S1) in LeuT. Our computational analyses suggest the existence of an additional galactose-binding site in vSGLT that aligns to the S1 site of LeuT. Radiolabeled galactose saturation binding experiments indicate that, like LeuT, vSGLT can simultaneously bind two substrate molecules under equilibrium conditions. Mutating key residues in the individual substrate-binding sites reduced the molar substrate-to-protein binding stoichiometry to approximate to 1. In addition, the related and more experimentally tractable SSS member PutP (the Na+/proline transporter) also exhibits a binding stoichiometry of 2. Targeting residues in the proposed sites with mutations results in the reduction of the binding stoichiometry and is accompanied by severely impaired translocation of proline. Our data suggest that substrate transport by SSS members requires both substrate-binding sites, thereby implying that SSSs and neurotransmitter-sodium symporters share common mechanistic elements in substrate transport.	[Li, Zheng; Shi, Lei] Cornell Univ, Dept Physiol & Biophys, Weill Cornell Med Coll, New York, NY 10065 USA; [Lee, Ashley S. E.; Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Lee, Ashley S. E.; Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Bracher, Susanne; Jung, Heinrich] Univ Munich, Bioctr, D-82152 Martinsried, Germany; [Paz, Aviv; Abramson, Jeff] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Kumar, Jay P.; Abramson, Jeff] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Shi, Lei] Cornell Univ, Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA	Cornell University; Columbia University; Columbia University; University of Munich; University of California System; University of California Los Angeles; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; New York State Psychiatry Institute; Cornell University	Quick, M (corresponding author), New York State Psychiat Inst & Hosp, 1051 Riverside Dr,Unit 25, New York, NY 10032 USA.	mq2102@columbia.edu; les2007@med.cornell.edu	Paz, Aviv/AAN-3966-2021; Jung, Heinrich/K-3790-2014; Shi, Lei/AAV-1321-2020	Jung, Heinrich/0000-0002-5450-3063; Shi, Lei/0000-0002-4137-096X; Paz, Aviv/0000-0003-0792-492X; Kumar, Jay Prakash/0000-0003-4488-0292	National Science Foundation [TG-MCB090022]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000606] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Computations were performed on Ranger at the Texas Advanced Computing Center (National Science Foundation Grant TG-MCB090022) and the David A. Cofrin computational infrastructure of the Institute for Computational Biomedicine at Weill Cornell Medical College. We thank Drs. Jonathan Javitch and Harel Weinstein for helpful discussions, MiEstrella Miller-Cruz and Trang Nguyen for technical assistance, and Dr. Ernest Wright for critical reading of the manuscript.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bowers K. J., 2006, P ACM IEEE SC 2006 C, P43; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P237, DOI 10.1113/jphysiol.1967.sp008298; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; Hirayama BA, 2007, BIOCHEMISTRY-US, V46, P13391, DOI 10.1021/bi701562k; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kalayil S, 2013, P NATL ACAD SCI USA, V110, P17296, DOI 10.1073/pnas.1309071110; Khelashvili G, 2013, J AM CHEM SOC, V135, P14266, DOI 10.1021/ja405984v; Korkmaz F, 2013, BBA-BIOMEMBRANES, V1828, P1181, DOI 10.1016/j.bbamem.2013.01.004; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li J, 2012, BBA-BIOMEMBRANES, V1818, P263, DOI 10.1016/j.bbamem.2011.09.011; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mazier S, 2011, J BIOL CHEM, V286, P29347, DOI 10.1074/jbc.M111.263327; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; MOGI T, 1984, J BIOL CHEM, V259, P7797; Nasr ML, 2014, BIOCHEMISTRY-US, V53, P4, DOI 10.1021/bi401412e; OHSAWA M, 1988, J BACTERIOL, V170, P5185, DOI 10.1128/jb.170.11.5185-5191.1988; Olkhova E, 2011, J MOL BIOL, V406, P59, DOI 10.1016/j.jmb.2010.11.045; Penheiter AR, 2012, CURR GENE THER, V12, P33; Perez C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5231; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Pohlenz J, 1999, BIOCHIMIE, V81, P469, DOI 10.1016/S0300-9084(99)80097-2; Quick M, 1998, BIOCHEMISTRY-US, V37, P13800, DOI 10.1021/bi980562j; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Raba M, 2008, J MOL BIOL, V382, P884, DOI 10.1016/j.jmb.2008.07.070; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schulze JM, 2010, EPIGENETICS-US, V5, P573, DOI 10.4161/epi.5.7.12856; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Simmons KJ, 2014, EMBO J, V33, P1831, DOI 10.15252/embj.201387557; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Xie ZY, 2000, J BIOL CHEM, V275, P25959, DOI 10.1074/jbc.M002687200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAMATO I, 1988, J BIOL CHEM, V263, P16055; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2010, MOL BIOSYST, V6, P1040, DOI 10.1039/b927492h	73	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					127	141		10.1074/jbc.M114.584383	http://dx.doi.org/10.1074/jbc.M114.584383			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398883	Green Published, hybrid			2022-12-26	WOS:000347231200012
J	Zhi, XY; Han, YC; Mao, SC; Wang, GP; Feng, L; Yang, BF; Fan, ZY; Du, WL; Lu, JH; Li, YB				Zhi, Xiaoyu; Han, Yingchun; Mao, Shuchun; Wang, Guoping; Feng, Lu; Yang, Beifang; Fan, Zhengyi; Du, Wenli; Lu, Jianhua; Li, Yabing			Light Spatial Distribution in the Canopy and Crop Development in Cotton	PLOS ONE			English	Article							PHOTOSYNTHETICALLY ACTIVE RADIATION; LEAF-AREA INDEX; USE EFFICIENCY; BIOMASS ACCUMULATION; PLANT-DENSITY; INTERCEPTION; YIELD; MODELS; TRANSPIRATION; ARCHITECTURE	The partitioning of light is very difficult to assess, especially in discontinuous or irregular canopies. The aim of the present study was to analyze the spatial distribution of photosynthetically active radiation (PAR) in a heterogeneous cotton canopy based on a geo-statistical sampling method. Field experiments were conducted in 2011 and 2012 in Anyang, Henan, China. Field plots were arranged in a randomized block design with the main plot factor representing the plant density. There were 3 replications and 6 densities used in every replicate. The six plant density treatments were 15,000, 33,000, 51,000, 69,000, 87,000 and 105,000 plants ha(-1). The following results were observed: 1) transmission within the canopy decreased with increasing density and significantly decreased from the top to the bottom of the canopy, but the greatest decreases were observed in the middle layers of the canopy on the vertical axis and closing to the rows along the horizontal axis; 2) the transmitted PAR (TPAR) of 6 different cotton populations decreased slowly and then increased slightly as the leaves matured, the TPAR values were approximately 52.6-84.9% (2011) and 42.7-78.8% (2012) during the early cotton developmental stage, and were 33.9-60.0% (2011) and 34.5-61.8% (2012) during the flowering stage; 3) the Leaf area index (LAI) was highly significant exponentially correlated (R-2 = 0.90 in 2011, R-2 = 0.91 in 2012) with the intercepted PAR (IPAR) within the canopy; 4) and a highly significant linear correlation (R-2 = 0.92 in 2011, R-2 = 0.96 in 2012) was observed between the accumulated IPAR and the biomass. Our findings will aid researchers to improve radiation-use efficiency by optimizing the ideotype for cotton canopy architecture based on light spatial distribution characteristics.	[Zhi, Xiaoyu; Han, Yingchun; Mao, Shuchun; Wang, Guoping; Feng, Lu; Yang, Beifang; Fan, Zhengyi; Du, Wenli; Lu, Jianhua; Li, Yabing] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, YB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	criliyabing@163.com	Yabing, Li/GLU-9964-2022		National Natural Science Foundation of China [31371561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China(31371561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alados I, 1996, AGR FOREST METEOROL, V78, P121, DOI 10.1016/0168-1923(95)02245-7; Alados I, 2000, AGR FOREST METEOROL, V102, P39, DOI 10.1016/S0168-1923(00)00091-5; Castillo-Santiago MA, 2013, ENERGY SUSTAIN DEV, V17, P177, DOI 10.1016/j.esd.2012.10.007; Arbia G, 2014, SPAT STAT-NETH, V7, P21, DOI 10.1016/j.spasta.2013.10.001; Baldissera TC, 2014, ANN BOT-LONDON, V113, P145, DOI 10.1093/aob/mct251; BALDOCCHI DD, 1985, J APPL ECOL, V22, P539, DOI 10.2307/2403184; Boote KJ, 1998, SYST APPR S, V7, P99; Campbell G, 1989, PLANT CANOPIES THEIR, P1, DOI DOI 10.1017/CBO9780511752308.002; CAMPBELL GS, 1986, AGR FOREST METEOROL, V36, P317, DOI 10.1016/0168-1923(86)90010-9; Campbell GS, 1991, AGR FOREST METEOROL, V36, P107; Campillo C, 2008, HORTSCIENCE, V43, P1780, DOI 10.21273/HORTSCI.43.6.1780; CAMPILLO C, 2012, SOLAR RAD; Ceotto E, 2013, FIELD CROP RES, V149, P159, DOI 10.1016/j.fcr.2013.05.002; Chen JM, 1996, IEEE T GEOSCI REMOTE, V34, P1353, DOI 10.1109/36.544559; CHRISTENSEN S, 1993, REMOTE SENS ENVIRON, V43, P87, DOI 10.1016/0034-4257(93)90066-7; COHEN S, 1987, AGR FOREST METEOROL, V40, P123, DOI 10.1016/0168-1923(87)90002-5; Cooper J. P., 1970, Herbage Abstracts, V40, P1; Delagrange S, 2011, ENVIRON EXP BOT, V70, P1, DOI 10.1016/j.envexpbot.2010.05.008; Fila G, 2011, AGR FOREST METEOROL, V151, P575, DOI 10.1016/j.agrformet.2011.01.004; Fortin MJ, 2012, SPAT STAT-NETH, V1, P100, DOI 10.1016/j.spasta.2012.02.004; Francescangeli N, 2006, SCI HORTIC-AMSTERDAM, V110, P135, DOI 10.1016/j.scienta.2006.06.025; FROUIN R, 1995, REMOTE SENS ENVIRON, V51, P98, DOI 10.1016/0034-4257(94)00068-X; Gonias ED, 2011, ENVIRON EXP BOT, V72, P217, DOI 10.1016/j.envexpbot.2011.03.008; Gonsamo A, 2008, FOREST ECOL MANAG, V256, P749, DOI 10.1016/j.foreco.2008.05.032; Griffith DA, 2012, SPAT STAT-NETH, V1, P3, DOI 10.1016/j.spasta.2012.03.005; HALL FG, 1990, REMOTE SENS ENVIRON, V32, P47, DOI 10.1016/0034-4257(90)90097-6; HATFIELD JL, 1978, AGRON J, V70, P592, DOI 10.2134/agronj1978.00021962007000040018x; Higashide T, 2009, AGR FOREST METEOROL, V149, P756, DOI 10.1016/j.agrformet.2008.10.017; HIPPS LE, 1983, AGR METEOROL, V28, P253, DOI 10.1016/0002-1571(83)90030-4; Jamieson PD, 1998, FIELD CROP RES, V55, P23, DOI 10.1016/S0378-4290(97)00060-9; Jones CA, 1986, CERES MAIZE SIMULATI, V04; Kilicman A, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/603463; Kiniry J, 2011, AGRON J, V103, P119, DOI 10.2134/agronj2010.0280; KINIRY JR, 1989, FIELD CROP RES, V20, P51, DOI 10.1016/0378-4290(89)90023-3; Leblanc SG, 2005, AGR FOREST METEOROL, V129, P187, DOI 10.1016/j.agrformet.2004.09.006; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Maddonni G, 2001, FIELD CROP RES, V70, P1, DOI 10.1016/S0378-4290(00)00144-1; Maddonni GA, 1996, FIELD CROP RES, V48, P81, DOI 10.1016/0378-4290(96)00035-4; Mao LL, 2014, FIELD CROP RES, V155, P67, DOI 10.1016/j.fcr.2013.09.021; McCree K. J., 1981, Encyclopedia of Plant Physiology. New Series. Volume 12A. Physiological plant ecology I. Responses to the physical environment. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P41; McCREE K. J., 1966, AGR METEOROL, V3, P353, DOI 10.1016/0002-1571(66)90017-3; Melo JD, 2014, ELECTR POW SYST RES, V111, P177, DOI 10.1016/j.epsr.2014.02.019; Monsi TM, 1953, JAP J BOT, V14, P22; MORRIS JT, 1989, AGR FOREST METEOROL, V46, P349, DOI 10.1016/0168-1923(89)90036-1; MUCHOW RC, 1994, AUST J AGR RES, V45, P37, DOI 10.1071/AR9940037; Naraghi M, 2010, ACTA HORTIC, V871, P385; O'Neal ME, 2002, J ECON ENTOMOL, V95, P1190, DOI 10.1603/0022-0493-95.6.1190; Purcell LC, 2002, CROP SCI, V42, P172, DOI 10.2135/cropsci2002.0172; Ratjen AM, 2013, FIELD CROP RES, V149, P338, DOI 10.1016/j.fcr.2013.05.015; Reta-Sanchez DG, 2002, AGRON J, V94, P1317, DOI 10.2134/agronj2002.1317; Ritchie J.R., 1985, US DEPART AGR, V38, P159, DOI DOI 10.1007/978-1-4899-3665-3_27; Robinson KM, 2004, BIOMASS BIOENERG, V26, P417, DOI 10.1016/j.biombioe.2003.08.012; ROSENTHAL WD, 1977, AGRON J, V69, P461, DOI 10.2134/agronj1977.00021962006900030032x; Ross J., 1981, The radiation regime and architecture of plant stands.; Russell G., 1989, Plant canopies: their growth, form and function., P21, DOI 10.1017/CBO9780511752308.003; SAKAMOTO CM, 1967, AGRON J, V59, P73, DOI 10.2134/agronj1967.00021962005900010022x; Sarlikioti V, 2011, ANN BOT-LONDON, V108, P1065, DOI 10.1093/aob/mcr221; SASSENRATHCOLE GF, 1995, AGR FOREST METEOROL, V77, P55, DOI 10.1016/0168-1923(95)02238-S; Singer JW, 2011, FIELD CROP RES, V121, P147, DOI 10.1016/j.fcr.2010.12.007; Song QF, 2013, FUNCT PLANT BIOL, V40, P109, DOI 10.1071/FP12056; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; STOCKLE CO, 1992, ECOL MODEL, V60, P31, DOI 10.1016/0304-3800(92)90011-3; Stockle CO, 2003, EUR J AGRON, V18, P289, DOI 10.1016/S1161-0301(02)00109-0; Tharakan PJ, 2008, BIOENERG RES, V1, P229, DOI 10.1007/s12155-008-9023-9; TOURNEBIZE R, 1995, AGR FOREST METEOROL, V72, P277, DOI 10.1016/0168-1923(94)02162-D; Van der Zande D, 2011, INT J APPL EARTH OBS, V13, P792, DOI 10.1016/j.jag.2011.05.005; Vargas LA, 2002, BIOMASS BIOENERG, V22, P1, DOI 10.1016/S0961-9534(01)00058-7; Westgate ME, 1997, FIELD CROP RES, V49, P249, DOI 10.1016/S0378-4290(96)01055-6; Yang YM, 2006, PROC SPIE, V6298, DOI 10.1117/12.678677; Yaseen M, 2013, IND CROP PROD, V43, P61, DOI 10.1016/j.indcrop.2012.06.032; Zhu K, 2013, CLEAN TECHNOL ENVIR, V15, P687, DOI 10.1007/s10098-012-0563-5; Zhu XiangCheng, 2012, Scientia Agricultura Sinica, V45, P34	72	16	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113409	10.1371/journal.pone.0113409	http://dx.doi.org/10.1371/journal.pone.0113409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409026	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200113
J	Hansen, MJ; Chan, SPJ; Langenbach, SY; Dousha, LF; Jones, JE; Yatmaz, S; Seow, HJ; Vlahos, R; Anderson, GP; Bozinovski, S				Hansen, Michelle J.; Chan, Sheau Pyng J.; Langenbach, Shenna Y.; Dousha, Lovisa F.; Jones, Jessica E.; Yatmaz, Selcuk; Seow, Huei Jiunn; Vlahos, Ross; Anderson, Gary P.; Bozinovski, Steven			IL-17A and Serum Amyloid A Are Elevated in a Cigarette Smoke Cessation Model Associated with the Persistence of Pigmented Macrophages, Neutrophils and Activated NK Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY INFLAMMATION; MOUSE MODEL; LUNG INFLAMMATION; EPITHELIAL-CELLS; TOBACCO-SMOKE; COPD; MICE; EXPOSURE; EXPRESSION	While global success in cessation advocacy has seen smoking rates fall in many developed countries, persistent lung inflammation in ex-smokers is an increasingly important clinical problem whose mechanistic basis remains poorly understood. In this study, candidate effector mechanisms were assessed in mice exposed to cigarette smoke (CS) for 4 months following cessation from long term CS exposure. BALF neutrophils, CD4(+) and CD8(+) T cells and lung innate NK cells remained significantly elevated following smoking cessation. Analysis of neutrophil mobilization markers showed a transition from acute mediators (MIP-2 alpha, KC and G-CSF) to sustained drivers of neutrophil and macrophage recruitment and activation (IL-17A and Serum Amyoid A (SAA)). Follicle-like lymphoid aggregates formed with CS exposure and persisted with cessation, where they were in close anatomical proximity to pigmented macrophages, whose number actually increased 3-fold following CS cessation. This was associated with the elastolytic protease, MMP-12 (macrophage metalloelastase) which remained significantly elevated post-cessation. Both GM-CSF and CSF-1 were significantly increased in the CS cessation group relative to the control group. In conclusion, we show that smoking cessation mediates a transition to accumulation of pigmented macrophages, which may contribute to the expanded macrophage population observed in COPD. These macrophages together with IL-17A, SAA and innate NK cells are identified here as candidate persistence determinants and, we suggest, may represent specific targets for therapies directed towards the amelioration of chronic airway inflammation.	[Hansen, Michelle J.; Chan, Sheau Pyng J.; Langenbach, Shenna Y.; Dousha, Lovisa F.; Jones, Jessica E.; Yatmaz, Selcuk; Seow, Huei Jiunn; Vlahos, Ross; Anderson, Gary P.; Bozinovski, Steven] Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Melbourne, Vic 3010, Australia	University of Melbourne	Hansen, MJ (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Melbourne, Vic 3010, Australia.	mjhansen@unimelb.edu.au	Vlahos, Ross/AAM-3837-2020	Vlahos, Ross/0000-0001-8443-7071; Anderson, Gary/0000-0001-6580-3398; Bozinovski, Steven/0000-0001-6533-8641; Hansen, Michelle/0000-0002-2607-461X; Seow, Huei/0000-0002-4790-4811	NHMRC (National Health and Medical Research Council) Australia [628492]	NHMRC (National Health and Medical Research Council) Australia	This work was supported by NHMRC (National Health and Medical Research Council) Australia (www.NHMRC.gov.au), project grant number 628492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony D, 2013, AM J RESP CRIT CARE, V188, P179, DOI 10.1164/rccm.201211-2139OC; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Beckett EL, 2013, J ALLERGY CLIN IMMUN, V131, P752, DOI 10.1016/j.jaci.2012.11.053; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Bozinovski S, 2011, AM J RESP CELL MOL, V45, P229, DOI 10.1165/rcmb.2010-0272OC; Braber S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-99; Bracke KR, 2013, AM J RESP CRIT CARE, V188, P343, DOI 10.1164/rccm.201211-2055OC; Chang Y, 2014, AM J PHYSIOL-LUNG C, V306, pL132, DOI 10.1152/ajplung.00111.2013; Chen H, 2005, NEUROPSYCHOPHARMACOL, V30, P713, DOI 10.1038/sj.npp.1300597; Chen H, 2007, PEPTIDES, V28, P384, DOI 10.1016/j.peptides.2006.07.034; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; D'hulst AI, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-147; DAMIANO VV, 1986, J CLIN INVEST, V78, P482, DOI 10.1172/JCI112600; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Duan M-C, 2013, CLIN DEV IMMUNOL, V2013, P11; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Halappanavar S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-56; Hansen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080471; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Levy BD, 2012, CLIN CHEST MED, V33, P559, DOI 10.1016/j.ccm.2012.06.006; Morissette MC, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-49; Motz GT, 2010, J IMMUNOL, V184, P4460, DOI 10.4049/jimmunol.0903654; Motz GT, 2008, J IMMUNOL, V181, P8036, DOI 10.4049/jimmunol.181.11.8036; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Rutgers SR, 2000, CHEST, V117, p262S, DOI 10.1378/chest.117.5_suppl_1.262S; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shao MXG, 2005, J IMMUNOL, V175, P4009, DOI 10.4049/jimmunol.175.6.4009; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Shen N, 2011, INHAL TOXICOL, V23, P212, DOI 10.3109/08958378.2011.559603; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Stevenson CS, 2005, AM J PHYSIOL-LUNG C, V288, pL514, DOI 10.1152/ajplung.00317.2004; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Urbanowicz RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-76; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Vlahos R, 2014, CLIN SCI, V126, P253, DOI 10.1042/CS20130182; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Willemse BWM, 2005, EUR RESPIR J, V26, P835, DOI 10.1183/09031936.05.00108904; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC	44	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113180	10.1371/journal.pone.0113180	http://dx.doi.org/10.1371/journal.pone.0113180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405776	Green Published, gold			2022-12-26	WOS:000347121300090
J	Tanigawa, N; Fujita, T; Fujii, H				Tanigawa, Naoki; Fujita, Toshitsugu; Fujii, Hodaka			Oligoribonucleotide (ORN) Interference-PCR (ORNi-PCR): A Simple Method for Suppressing PCR Amplification of Specific DNA Sequences Using ORNs	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PYROCOCCUS-FURIOSUS; DEGENERATE PRIMERS; OLIGONUCLEOTIDES; IDENTIFICATION; SYSTEM	Polymerase chain reaction (PCR) amplification of multiple templates using common primers is used in a wide variety of molecular biological techniques. However, abundant templates sometimes obscure the amplification of minor species containing the same primer sequences. To overcome this challenge, we used oligoribonucleotides (ORNs) to inhibit amplification of undesired template sequences without affecting amplification of control sequences lacking complementarity to the ORNs. ORNs were effective at very low concentrations, with IC50 values for ORN-mediated suppression on the order of 10 nM. DNA polymerases that retain 3'-5' exonuclease activity, such as KOD and Pfu polymerases, but not those that retain 5'-3' exonuclease activity, such as Taq polymerase, could be used for ORN-mediated suppression. ORN interference-PCR (ORNi-PCR) technology should be a useful tool for both molecular biology research and clinical diagnosis.	[Tanigawa, Naoki; Fujita, Toshitsugu; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Chromatin Biochem Res Grp, Suita, Osaka 565, Japan	Osaka University	Fujii, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Chromatin Biochem Res Grp, Suita, Osaka 565, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/A-2420-2008; Tanigawa, Naoki/HCI-8558-2022; Fujii, Hodaka/N-9792-2019; Fujita, Toshitsugu/AAB-4964-2022; FUJITA, Toshitsugu/ABH-5101-2020	Fujii, Hodaka/0000-0003-1296-4256; Fujii, Hodaka/0000-0003-1296-4256; FUJITA, Toshitsugu/0000-0002-9536-9999	Research Institute for Microbial Diseases, Osaka University	Research Institute for Microbial Diseases, Osaka University	This study was supported by Research Institute for Microbial Diseases, Osaka University (TF, HF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; Carlson CM, 2003, GENETICS, V165, P243; Dominguez PL, 2005, ONCOGENE, V24, P6830, DOI 10.1038/sj.onc.1208832; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; Kornberg A., 1992, DNA REPLICATION; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; MACK DH, 1988, P NATL ACAD SCI USA, V85, P6977, DOI 10.1073/pnas.85.18.6977; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PYTELA R, 1994, METHOD ENZYMOL, V245, P420; SEYAMA T, 1992, NUCLEIC ACIDS RES, V20, P2493, DOI 10.1093/nar/20.10.2493; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; UEMORI T, 1993, NUCLEIC ACIDS RES, V21, P259, DOI 10.1093/nar/21.2.259; Vestheim H, 2011, METHODS MOL BIOL, V687, P265, DOI 10.1007/978-1-60761-944-4_19; Yu D, 1997, BIOTECHNIQUES, V23, P714, DOI 10.2144/97234st06; Yuen PST, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e31	16	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113345	10.1371/journal.pone.0113345	http://dx.doi.org/10.1371/journal.pone.0113345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405983	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300106
J	Thurman, SM; Lu, HJ				Thurman, Steven M.; Lu, Hongjing			Perception of Social Interactions for Spatially Scrambled Biological Motion	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ANIMACY; MODEL	It is vitally important for humans to detect living creatures in the environment and to analyze their behavior to facilitate action understanding and high-level social inference. The current study employed naturalistic point-light animations to examine the ability of human observers to spontaneously identify and discriminate socially interactive behaviors between two human agents. Specifically, we investigated the importance of global body form, intrinsic joint movements, extrinsic whole-body movements, and critically, the congruency between intrinsic and extrinsic motions. Motion congruency is hypothesized to be particularly important because of the constraint it imposes on naturalistic action due to the inherent causal relationship between limb movements and whole body motion. Using a free response paradigm in Experiment 1, we discovered that many naive observers (55%) spontaneously attributed animate and/or social traits to spatially-scrambled displays of interpersonal interaction. Total stimulus motion energy was strongly correlated with the likelihood that an observer would attribute animate/social traits, as opposed to physical/mechanical traits, to the scrambled dot stimuli. In Experiment 2, we found that participants could identify interactions between spatially-scrambled displays of human dance as long as congruency was maintained between intrinsic/extrinsic movements. Violating the motion congruency constraint resulted in chance discrimination performance for the spatially-scrambled displays. Finally, Experiment 3 showed that scrambled point-light dancing animations violating this constraint were also rated as significantly less interactive than animations with congruent intrinsic/extrinsic motion. These results demonstrate the importance of intrinsic/extrinsic motion congruency for biological motion analysis, and support a theoretical framework in which early visual filters help to detect animate agents in the environment based on several fundamental constraints. Only after satisfying these basic constraints could stimuli be evaluated for high-level social content. In this way, we posit that perceptual animacy may serve as a gateway to higher-level processes that support action understanding and social inference.	[Thurman, Steven M.; Lu, Hongjing] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Lu, Hongjing] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Thurman, SM (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	sthurman@ucla.edu		Thurman, Steven/0000-0003-3962-8447	National Science Foundation [EIA-0196217]; National Science Foundation (NSF) [BCS-1353391]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation (NSF)(National Science Foundation (NSF))	The motion capture data used in this project was obtained from mocap.cs.cmu.edu. The database was created with funding from National Science Foundation EIA-0196217. This research project was supported by a grant from the National Science Foundation (NSF BCS-1353391) awarded to HL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Bardi L, 2011, DEVELOPMENTAL SCI, V14, P353, DOI 10.1111/j.1467-7687.2010.00985.x; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Bidet-Ildei C, 2013, DEV PSYCHOL; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chang DHF, 2009, J VIS, V9; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Chang DHF, 2009, J VISION, V9, DOI [10.1167/9.1.19, 10.1167/9.5.8]; de la Rosa S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00752; Gao T, 2010, PSYCHOL SCI, V21, P1845, DOI 10.1177/0956797610388814; Gao T, 2009, COGNITIVE PSYCHOL, V59, P154, DOI 10.1016/j.cogpsych.2009.03.001; Hirai M, 2011, PSYCHOL SCI, V22, P1543, DOI 10.1177/0956797611417257; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jung EL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00795; Lu HJ, 2010, J VISION, V10, DOI 10.1167/10.12.13; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; McAleer P, 2008, BEHAV RES METHODS, V40, P830, DOI 10.3758/BRM.40.3.830; McAleer P, 2011, J AUTISM DEV DISORD, V41, P1053, DOI 10.1007/s10803-010-1130-8; Miller LE, 2013, COGNITION, V128, P140, DOI 10.1016/j.cognition.2013.03.013; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Neri P, 2009, P ROY SOC B-BIOL SCI, V276, P861, DOI 10.1098/rspb.2008.1363; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrini K, 2014, HUM BRAIN MAPP; Reid VM, 2007, EUR J DEV PSYCHOL, V4, P100, DOI 10.1080/17405620601005648; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schultz J, 2013, J VISION, V13, DOI 10.1167/13.4.15; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Simion F, 2011, PROG BRAIN RES, V189, P173, DOI 10.1016/B978-0-444-53884-0.00024-5; Tadin D, 2002, NAT NEUROSCI, V5, P1010, DOI 10.1038/nn914; Thurman SM, 2013, PSYCHOL SCI, V24, P1133, DOI 10.1177/0956797612467212; Thurman SM, 2010, J VISION, V10, DOI 10.1167/10.12.15; Thurman SM, 2008, J VISION, V8, DOI 10.1167/8.3.28; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; Vallortigara G, 2006, CURR BIOL, V16, pR279, DOI 10.1016/j.cub.2006.03.052; van Boxtel JJA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00209; Van Boxtel JJA, 2013, J VIS, V13	40	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112539	10.1371/journal.pone.0112539	http://dx.doi.org/10.1371/journal.pone.0112539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25406075	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300037
J	Huang, F; Qureshi, JA; Meagher, RL; Reisig, DD; Head, GP; Andow, DA; Ni, XZ; Kerns, D; Buntin, GD; Niu, Y; Yang, F; Dangal, V				Huang, Fangneng; Qureshi, Jawwad A.; Meagher, Robert L., Jr.; Reisig, Dominic D.; Head, Graham P.; Andow, David A.; Ni, Xinzi; Kerns, David; Buntin, G. David; Niu, Ying; Yang, Fei; Dangal, Vikash			Cry1F Resistance in Fall Armyworm Spodoptera frugiperda: Single Gene versus Pyramided Bt Maize	PLOS ONE			English	Article							BORER LEPIDOPTERA CRAMBIDAE; FIELD-EVOLVED RESISTANCE; FLORIDA POPULATIONS; PUERTO-RICO; F-2 SCREEN; NOCTUIDAE; SUSCEPTIBILITY; CORN; PROTEINS; LOUISIANA	Evolution of insect resistance to transgenic crops containing Bacillus thuringiensis (Bt) genes is a serious threat to the sustainability of this technology. However, field resistance related to the reduced efficacy of Bt maize has not been documented in any lepidopteran pest in the mainland U. S. after 18 years of intensive Bt maize planting. Here we report compelling evidence of field resistance in the fall armyworm, Spodoptera frugiperda (J.E. Smith), to Cry1F maize (TC 3507) in the southeastern region of the U. S. An F-2 screen showed a surprisingly high (0.293) Cry1F resistance allele frequency in a population collected in 2011 from non-Bt maize in south Florida. Field populations from non-Bt maize in 2012-2013 exhibited 18.8-fold to >85.4-fold resistance to purified Cry1F protein and those collected from unexpectedly damaged Bt maize plants at several locations in Florida and North Carolina had >85.4-fold resistance. In addition, reduced efficacy and control failure of Cry1F maize against natural populations of S. frugiperda were documented in field trials using Cry1F-based and pyramided Bt maize products in south Florida. The Cry1F-resistant S. frugiperda also showed a low level of cross-resistance to Cry1A.105 and related maize products, but not to Cry2Ab2 or Vip3A. The occurrence of Cry1F resistance in the U.S. mainland populations of S. frugiperda likely represents migration of insects from Puerto Rico, indicating the great challenges faced in achieving effective resistance management for long-distance migratory pests like S. frugiperda.	[Huang, Fangneng; Kerns, David; Niu, Ying; Yang, Fei; Dangal, Vikash] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Qureshi, Jawwad A.] Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL USA; [Meagher, Robert L., Jr.] ARS, Insect Behav & Biocontrol Unit, USDA, CMAVE, Gainesville, FL USA; [Reisig, Dominic D.] N Carolina State Univ, Vernon G James Res & Extens Ctr, Dept Entomol, Plymouth, NC USA; [Head, Graham P.] Monsanto Co, St Louis, MO USA; [Andow, David A.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Ni, Xinzi] ARS, USDA, Crop Genet & Breeding Res Unit, Tifton, GA USA; [Buntin, G. David] Univ Georgia, Dept Entomol, Griffin, GA USA	Louisiana State University System; Louisiana State University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Monsanto; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Huang, F (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	fhuang@agcenter.lsu.edu	Yang, Fei/Q-6498-2016	Yang, Fei/0000-0001-5162-4575; Head, Graham/0000-0003-0521-0616; Reisig, Dominic/0000-0002-9979-5813	Louisiana Soybean; Feed Grain Promotion Board; Monsanto Company; Hatch funds from the USDA National Institute of Food and Agriculture; Monsanto	Louisiana Soybean; Feed Grain Promotion Board; Monsanto Company; Hatch funds from the USDA National Institute of Food and Agriculture; Monsanto	This project represents work supported by the Louisiana Soybean and Feed Grain Promotion Board, Monsanto Company, and Hatch funds from the USDA National Institute of Food and Agriculture. The funder Monsanto provided support in the form of salaries for the coauthor (G. P. H.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section. The authors also confirm that this does not alter their adherence to PLOS ONE policies on sharing data and materials. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by Louisiana State University Agricultural Center, University of Florida or the U.S. Department of Agriculture.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Andow D, 1999, J ECON ENTOMOL, V92, P755, DOI 10.1093/jee/92.4.755; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; Biosafety Cleaning-House, 2014, GEN DNA SEQ CRY1A 10; Brevault T, 2009, J ECON ENTOMOL, V102, P2301, DOI 10.1603/029.102.0636; Buntin D, 2012, BT CORN PRODUCTS SE; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Capinera JL, 1999, U FLA PUBLI; Davis FM, 1992, MISS AGR FORESTRY EX, V186; DIFONZO C., 2012, HANDY BT TRAIT TABLE; FINNEY D J, 1971, P333; Frizzas MR, 2014, CIENC RURAL, V44, P203, DOI 10.1590/S0103-84782014000200002; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Hardke JT, 2011, CROP PROT, V30, P168, DOI 10.1016/j.cropro.2010.10.005; Huang Fangneng, 2006, Insect Science, V13, P73, DOI 10.1111/j.1744-7917.2006.00070.x; Huang FN, 2012, INSECT SCI, V19, P570, DOI 10.1111/j.1744-7917.2012.01507.x; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Jakka SRK, 2014, J ECON ENTOMOL, V107, P342, DOI 10.1603/EC13326; Matten, 2012, REGULATION AGR BIOTE, P1752267; Matten Sharlene R., 2008, V5, P27, DOI 10.1007/978-1-4020-8373-0_2; MITCHELL ER, 1991, J ENTOMOL SCI, V26, P39, DOI 10.18474/0749-8004-26.1.39; Nagoshi RN, 2010, J ECON ENTOMOL, V103, P360, DOI 10.1603/EC09253; NASS (National Agricultural Statistics Service), 2013, ACR; Niu Y, 2014, CROP PROT, V59, P22, DOI 10.1016/j.cropro.2014.01.005; Niu Y, 2013, FLA ENTOMOL, V96, P701, DOI 10.1653/024.096.0302; PASHLEY DP, 1988, FLA ENTOMOL, V71, P227, DOI 10.2307/3495425; Ritchie S.W., 1993, 48 IOW STAT U SCI TE; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; SAS Institute Inc, 2010, SAS STAT 9 3 US; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; Sivasupramaniam S, 2008, J ECON ENTOMOL, V101, P546, DOI 10.1603/0022-0493(2008)101[546:TACOCE]2.0.CO;2; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Stodola TJ, 2004, J ECON ENTOMOL, V97, P1756, DOI 10.1603/0022-0493-97.5.1756; Storer Nicholas P, 2012, GM Crops Food, V3, P154, DOI 10.4161/gmcr.20945; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Sumerford DV, 2013, J ECON ENTOMOL, V106, P1525, DOI 10.1603/EC13103; Sumerford DV, 2014, CROP PROT IN PRESS; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; US EPA (U.S. Environmental Protection Agency), 2001, BIOP REG ACT DOC BAC; US-EPA (U.S. Environmental Protection Agency), 2007, TC1507 MAIZ FALL ARM; Velez AM, 2013, B ENTOMOL RES, V103, P700, DOI 10.1017/S0007485313000448; Wu XY, 2009, J INVERTEBR PATHOL, V100, P29, DOI 10.1016/j.jip.2008.10.003; Yang F, 2013, FLA ENTOMOL, V96, P714, DOI 10.1653/024.096.0303; Yang F, 2013, CROP PROT, V50, P37, DOI 10.1016/j.cropro.2013.04.002; Zhang LP, 2013, J INVERTEBR PATHOL, V112, P267, DOI 10.1016/j.jip.2012.12.007	47	195	212	5	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112958	10.1371/journal.pone.0112958	http://dx.doi.org/10.1371/journal.pone.0112958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401494	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700085
J	Hung, CS; Lee, JK; Yang, CY; Hsieh, HR; Ma, WY; Lin, MS; Liu, PH; Shih, SR; Liou, JM; Chuang, LM; Chen, MF; Lin, JW; Wei, JN; Li, HY				Hung, Chi-Sheng; Lee, Jen-Kuang; Yang, Chung-Yi; Hsieh, Hung-Ren; Ma, Wen-Ya; Lin, Mao-Shin; Liu, Pi-Hua; Shih, Shyang-Rong; Liou, Jyh-Ming; Chuang, Lee-Ming; Chen, Ming-Fong; Lin, Jou-Wei; Wei, Jung-Nan; Li, Hung-Yuan			Measurement of Visceral Fat: Should We Include Retroperitoneal Fat?	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; PORTAL THEORY; OBESE MEN; ADIPOSITY; RISK; ASSOCIATION; DEFINITION; STATEMENT; PROGRAM	Objective: Whether retroperitoneal fat should be included in the measurement of visceral fat remains controversial. We compared the relationships of fat areas in peritoneal, retroperitoneal, and subcutaneous compartments to metabolic syndrome, adipokines, and incident hypertension and diabetes. Methods: We enrolled 432 adult participants (153 men and 279 women) in a community-based cohort study. Computed tomography at the umbilicus level was used to measure the fat areas. Results: Retroperitoneal fat correlated significantly with metabolic syndrome (adjusted odds ratio (OR), 5.651, p < 0.05) and the number of metabolic abnormalities (p < 0.05). Retroperitoneal fat area was significantly associated with blood pressure, plasma glycemic indices, lipid profile, C-reactive protein, adiponectin (r = -0.244, p < 0.05), and leptin (r = 0.323, p < 0.05), but not plasma renin or aldosterone concentrations. During the 2.94 +/- 0.84 years of follow-up, 32 participants developed incident hypertension. Retroperitoneal fat area (hazard ration (HR) 1.62, p = 0.003) and peritoneal fat area (HR 1.62, p = 0.009), but not subcutaneous fat area (p = 0.14) were associated with incident hypertension. Neither retroperitoneal fat area, peritoneal fat area, nor subcutaneous fat areas was associated with incident diabetes after adjustment. Conclusions: Retroperitoneal fat is similar to peritoneal fat, but differs from subcutaneous fat, in terms of its relationship with metabolic syndrome and incident hypertension. Retroperitoneal fat area should be included in the measurement of visceral fat for cardio-metabolic studies in human.	[Hung, Chi-Sheng; Lin, Mao-Shin; Shih, Shyang-Rong; Liou, Jyh-Ming; Chuang, Lee-Ming; Chen, Ming-Fong; Li, Hung-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Jen-Kuang] Far Eastern Mem Hosp, Dept Clin Pathol, New Taipei City, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsieh, Hung-Ren] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Radiol, Yunlin, Taiwan; [Ma, Wen-Ya] Cardinal Tien Hosp, Dept Internal Med, Div Endocrinol, Xindian, Taiwan; [Liu, Pi-Hua] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Gueishan, Taiwan; [Lin, Jou-Wei] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Wei, Jung-Nan] Chia Nan Univ Pharm & Sci, Tainan, Taiwan	National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; Chia Nan University of Pharmacy & Science	Li, HY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	larsli@ntuh.gov.tw	Chuang, Lee-Ming/AAF-3324-2019; Chen, Ming/GVU-8412-2022	LIOU, JYH-MING/0000-0002-7945-5408; SHIH, SHYANG-RONG/0000-0001-7424-1358; Liu, Pi-Hua/0000-0002-7165-6248; CHUANG, LEE-MING/0000-0003-0978-2662; Li, Hung-Yuan/0000-0001-9644-2855	National Science Council, Taiwan [NSC 98-2314-B-002-024-MY3]; Diabetes Association of the Republic of China, Taiwan [DAROC2012YPI-0001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Diabetes Association of the Republic of China, Taiwan	This work was supported in part by a grant (NSC 98-2314-B-002-024-MY3) from the National Science Council, Taiwan, and a grant (DAROC2012YPI-0001) from the Diabetes Association of the Republic of China, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Betz MJ, 2013, J CLIN ENDOCR METAB, V98, P4097, DOI 10.1210/jc.2012-3535; Borel AL, 2013, DIABETES CARE, V36, P3254, DOI 10.2337/dc12-2353; Chapados N, 2008, BRIT J NUTR, V100, P518, DOI 10.1017/S0007114508921735; Cohen CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066477; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Dekker JM, 2005, CIRCULATION, V112, P666, DOI 10.1161/CIRCULATIONAHA.104.516948; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ersoz F, 2011, WORLD J SURG, V35, P986, DOI 10.1007/s00268-011-1012-z; Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hung CS, 2011, CLIN ENDOCRINOL, V75, P780, DOI 10.1111/j.1365-2265.2011.04129.x; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Li HY, 2011, ENDOCR J, V58, P441, DOI 10.1507/endocrj.K11E-005; Little RR, 2001, CLIN CHEM, V47, P1985; Ma WY, 2013, DIABETES CARE, V36, P1660, DOI 10.2337/dc12-1452; Ross R, 2002, AM J PHYSIOL-ENDOC M, V282, pE657, DOI 10.1152/ajpendo.00469.2001; Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Yoshii H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1089, DOI 10.1152/ajpendo.00306.2005; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	24	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112355	10.1371/journal.pone.0112355	http://dx.doi.org/10.1371/journal.pone.0112355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401949	gold, Green Submitted, Green Published			2022-12-26	WOS:000345158700040
J	Ren, KQ; Yuan, J; Yang, MJ; Gao, X; Ding, XF; Zhou, JL; Hu, XW; Cao, JG; Deng, XY; Xiang, SL; Zhang, J				Ren, Kaiqun; Yuan, Jing; Yang, Manjun; Gao, Xiang; Ding, Xiaofeng; Zhou, Jianlin; Hu, Xingwang; Cao, Jianguo; Deng, Xiyun; Xiang, Shuanglin; Zhang, Jian			KCTD10 Is Involved in the Cardiovascular System and Notch Signaling during Early Embryonic Development	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; INHIBITS TUMOR-GROWTH; DNA-POLYMERASE-DELTA; UBIQUITIN LIGASES; VASCULAR DEVELOPMENT; PROTEIN; MICE; ANGIOGENESIS; GENES; EXPRESSION	As a member of the polymerase delta-interacting protein 1 (PDIP1) gene family, potassium channel tetramerisation domain-containing 10 (KCTD10) interacts with proliferating cell nuclear antigen (PCNA) and polymerase delta, participates in DNA repair, DNA replication and cell-cycle control. In order to further investigate the physiological functions of KCTD10, we generated the KCTD10 knockout mice. The heterozygous KCTD10(+/-) mice were viable and fertile, while the homozygous KCTD10(-/-) mice showed delayed growth from E9.0, and died at approximately E10.5, which displayed severe defects in angiogenesis and heart development. Further study showed that VEGF induced the expression of KCTD10 in a time-and dose-dependent manner. Quantitative real-time PCR and western blotting results revealed that several key members in Notch signaling were up-regulated either in KCTD10-deficient embryos or in KCTD10-silenced HUVECs. Meanwhile, the endogenous immunoprecipitation (IP) analysis showed that KCTD10 interacted with Cullin3 and Notch1 simultaneously, by which mediating Notch1 proteolytic degradation. Our studies suggest that KCTD10 plays crucial roles in embryonic angiogenesis and heart development in mammalians by negatively regulating the Notch signaling pathway.	[Ren, Kaiqun; Yuan, Jing; Yang, Manjun; Ding, Xiaofeng; Zhou, Jianlin; Hu, Xingwang; Xiang, Shuanglin; Zhang, Jian] Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, State Educ Minist China, Changsha, Hunan, Peoples R China; [Ren, Kaiqun; Gao, Xiang] Nanjing Univ, Sch Med, MOE Key Lab Model Anim Dis Res, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China; [Ren, Kaiqun; Cao, Jianguo; Deng, Xiyun] Hunan Normal Univ, Coll Med, Changsha, Hunan, Peoples R China	Hunan Normal University; Nanjing University; Hunan Normal University	Xiang, SL (corresponding author), Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, State Educ Minist China, Changsha, Hunan, Peoples R China.	xshlin@hunnu.edu.cn; Zhangjian@hunnu.edu.cn	Zhou, Jianlin/R-1304-2019; Hu, Xingwang/ABG-6400-2021	Zhou, Jianlin/0000-0001-8640-5364; Hu, Xingwang/0000-0002-2320-3279	Ministry of Science and Technique of China [2010CB529900]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]; program for excellent talents in Hunan Normal University [ET13107]; Construct Program of the Key Discipline of Basic Medicine in Hunan Province	Ministry of Science and Technique of China(Ministry of Science and Technology, China); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province; program for excellent talents in Hunan Normal University; Construct Program of the Key Discipline of Basic Medicine in Hunan Province	This work was supported by the 973 project of Ministry of Science and Technique of China (No. 2010CB529900), the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (No. 20134486), the program for excellent talents in Hunan Normal University (No. ET13107), and the Construct Program of the Key Discipline of Basic Medicine in Hunan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Boucher J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00081; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Delibas Sennur, 2009, Acta Neurol Taiwan, V18, P262; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; He H, 2001, P NATL ACAD SCI USA, V98, P11979, DOI 10.1073/pnas.221452098; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hu X, 2014, ACTA BIOCH BIOPHYS S; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jain R, 2010, ANN NY ACAD SCI, V1188, P184, DOI 10.1111/j.1749-6632.2009.05099.x; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Krebs LT, 2000, GENE DEV, V14, P1343; Kubota D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073896; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu R, 2009, FEBS J, V276, P1114, DOI 10.1111/j.1742-4658.2008.06855.x; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Marshall J, 2011, ADV EXP MED BIOL, V717, P115, DOI 10.1007/978-1-4419-9557-5_10; McCright B, 2001, DEVELOPMENT, V128, P491; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rho SB, 2010, CANCER LETT, V294, P49, DOI 10.1016/j.canlet.2010.01.021; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Sun Ji-Kang, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P1011; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Thurston G, 2004, INT J HEMATOL, V80, P7, DOI 10.1532/ijh97.04065; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tong XJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4153; Wang YB, 2009, J CELL BIOCHEM, V106, P409, DOI 10.1002/jcb.22026; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhou JL, 2005, BBA-GENE STRUCT EXPR, V1729, P200, DOI 10.1016/j.bbaexp.2005.05.005; Zhou JL, 2005, FEBS LETT, V579, P1715, DOI 10.1016/j.febslet.2005.02.027; Zhou JL, 2005, J EXP ZOOL PART A, V303A, P227, DOI 10.1002/jez.a.150; Zhou W, 2013, BIOCH BIOPHYS ACTA; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	52	20	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112275	10.1371/journal.pone.0112275	http://dx.doi.org/10.1371/journal.pone.0112275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401743	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700037
J	Tijore, A; Wen, F; Lam, CRI; Tay, CY; Tan, LP				Tijore, Ajay; Wen, Feng; Lam, Chee Ren Ivan; Tay, Chor Yong; Tan, Lay Poh			Modulating Human Mesenchymal Stem Cell Plasticity Using Micropatterning Technique	PLOS ONE			English	Article							MYOGENIC DIFFERENTIATION; PRECURSOR CELLS; ADIPOSE-TISSUE; BONE-MARROW; INDUCTION; PLATFORM; SHAPE	In our previous work, we have reported that enforced elongation of human mesenchymal stem cells (hMSCs) through micropatterning promoted their myocardial lineage commitment. However, whether this approach is robust enough to retain the commitment when subsequently subjected to different conditions remains unsolved. This de-differentiation, if any, would have significant implication on the application of these myocardial-like hMSCs either as tissue engineered product or in stem cell therapy. Herein, we investigated the robustness of micropatterning induced differentiation by evaluating the retention of myocardial differentiation in patterned hMSCs when challenged with non-myocardial differentiation cues. Altogether, we designed four groups of experiments; 1) Patterned hMSCs cultured in normal growth medium serving as a positive control; 2) Patterned hMSCs cultured in normal growth medium for 14 days followed by osteogenic and adipogenic media for next 7 days (to study the robustness of the effect of micropatterning); 3) Patterned hMSCs (initially grown in normal growth medium for 14 days) trypsinized and recultured in different induction media for next 7 days (to study the robustness of the effect of micropatterning without any shape constrain) and 4) Patterned hMSCs cultured in osteogenic and adipogenic media for 14 days (to study the effects of biochemical cues versus biophysical cues). It was found that hMSCs that were primed to commit to myocardial lineage (Groups 2 and 3) were able to maintain myocardial lineage commitment despite subsequent culturing in osteogenic and adipogenic media. However, for hMSCs that were not primed (Group 4), the biochemical cues seem to dominate over the biophysical cue in modulating hMSCs differentiation. It demonstrates that cell shape modulation is not only capable of inducing stem cell differentiation but also ensuring the permanent lineage commitment.	[Tijore, Ajay; Wen, Feng; Lam, Chee Ren Ivan; Tan, Lay Poh] Nanyang Technol Univ, Sch Mat Sci & Engn, Mat Technol Div, Singapore 639798, Singapore; [Tay, Chor Yong] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Tan, LP (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Mat Technol Div, Singapore 639798, Singapore.	lptan@ntu.edu.sg	Tay, Chor Yong/C-1999-2016; Tan, LP/A-2229-2011	Tan, LP/0000-0002-0172-1569; Tay, Chor Yong/0000-0001-6721-7106	Nanyang Technological University, Singapore	Nanyang Technological University, Singapore(Nanyang Technological University)	This work was supported by Nanyang Technological University, Singapore (LPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; D'Andrea F, 2008, TISSUE ENG PART C-ME, V14, P233, DOI 10.1089/ten.tec.2008.0108; d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07; Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; La Noce M, 2014, J DENT, V42, P761, DOI 10.1016/j.jdent.2014.02.018; Leong DT, 2006, DIFFERENTIATION, V74, P519, DOI 10.1111/j.1432-0436.2006.00092.x; Leong DT, 2012, J CELL BIOCHEM, V113, P2744, DOI 10.1002/jcb.24150; Leong DT, 2006, CELLS TISSUES ORGANS, V182, P1, DOI 10.1159/000091713; Li HQ, 2012, ACTA BIOMATER, V8, P531, DOI 10.1016/j.actbio.2011.09.029; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 2001, CURR BIOL, V11, pR7, DOI 10.1016/S0960-9822(00)00033-6; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; Tay CY, 2011, SMALL, V7, P1416, DOI 10.1002/smll.201002298; Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010; Teo BKK, 2010, METHOD CELL BIOL, V98, P241, DOI 10.1016/S0091-679X(10)98011-4; Tijore A, 2014, ACS APPL MATER INTER, V6, P15686, DOI 10.1021/am504407n; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]; Yeong WY, 2010, TISSUE ENG PART C-ME, V16, P1011, DOI [10.1089/ten.tec.2009.0604, 10.1089/ten.TEC.2009.0604]; Yu HY, 2013, ADV HEALTHC MATER, V2, P442, DOI 10.1002/adhm.201200142; Yu HY, 2013, STEM CELLS DEV, V22, P136, DOI 10.1089/scd.2012.0160	31	7	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113043	10.1371/journal.pone.0113043	http://dx.doi.org/10.1371/journal.pone.0113043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401734	Green Published, gold			2022-12-26	WOS:000345158700100
J	Torre, I; Gonzalez-Tendero, A; Garcia-Canadilla, P; Crispi, F; Garcia-Garcia, F; Bijnens, B; Iruretagoyena, I; Dopazo, J; Amat-Roldan, I; Gratacos, E				Torre, Iratxe; Gonzalez-Tendero, Anna; Garcia-Canadilla, Patricia; Crispi, Fatima; Garcia-Garcia, Francisco; Bijnens, Bart; Iruretagoyena, Igor; Dopazo, Joaquin; Amat-Roldan, Ivan; Gratacos, Eduard			Permanent Cardiac Sarcomere Changes in a Rabbit Model of Intrauterine Growth Restriction	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; TARGETED DELETION; M-BAND; TITIN; EXPRESSION; GENERATION; LENGTH; LEADS; TRANSCRIPTOMICS; CONTRACTION	Background: Intrauterine growth restriction (IUGR) induces fetal cardiac remodelling and dysfunction, which persists postnatally and may explain the link between low birth weight and increased cardiovascular mortality in adulthood. However, the cellular and molecular bases for these changes are still not well understood. We tested the hypothesis that IUGR is associated with structural and functional gene expression changes in the fetal sarcomere cytoarchitecture, which remain present in adulthood. Methods and Results: IUGR was induced in New Zealand pregnant rabbits by selective ligation of the utero-placental vessels. Fetal echocardiography demonstrated more globular hearts and signs of cardiac dysfunction in IUGR. Second harmonic generation microscopy (SHGM) showed shorter sarcomere length and shorter A-band and thick-thin filament interaction lengths, that were already present in utero and persisted at 70 postnatal days (adulthood). Sarcomeric M-band (GO: 0031430) functional term was over-represented in IUGR fetal hearts. Conclusion: The results suggest that IUGR induces cardiac dysfunction and permanent changes on the sarcomere.	[Torre, Iratxe; Gonzalez-Tendero, Anna; Garcia-Canadilla, Patricia; Crispi, Fatima; Iruretagoyena, Igor; Amat-Roldan, Ivan; Gratacos, Eduard] Univ Barcelona, IDIBAPS, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Torre, Iratxe; Gonzalez-Tendero, Anna; Garcia-Canadilla, Patricia; Crispi, Fatima; Iruretagoyena, Igor; Amat-Roldan, Ivan; Gratacos, Eduard] Univ Barcelona, IDIBAPS, Hosp St Joan de Deu, Barcelona, Spain; [Torre, Iratxe; Gonzalez-Tendero, Anna; Garcia-Canadilla, Patricia; Crispi, Fatima; Iruretagoyena, Igor; Amat-Roldan, Ivan; Gratacos, Eduard] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain; [Garcia-Canadilla, Patricia] Univ Pompeu Fabra, DTIC, Physense, Barcelona, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] CIPF, Bioinformat Dept, Valencia, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] CIPF, INB, Funct Genom Node, Valencia, Spain; [Dopazo, Joaquin] CIPF, CIBERER, Valencia, Spain; [Bijnens, Bart] Univ Pompeu Fabra, ICREA, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Pompeu Fabra University; Prince Felipe Research Center; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center; ICREA; Pompeu Fabra University	Gratacos, E (corresponding author), Univ Barcelona, IDIBAPS, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain.	gratacos@clinic.ub.es	García-García, Francisco/N-2263-2019; Dopazo, Joaquin/A-9270-2014; Bijnens, Bart/AAE-7186-2021; Garcia-Canadilla, Patricia/D-8085-2014; Bijnens, Bart H/C-2955-2008; García-García, Francisco/B-1929-2014; Gratacos, Eduard/AAR-4939-2020	García-García, Francisco/0000-0001-8354-5636; Dopazo, Joaquin/0000-0003-3318-120X; Bijnens, Bart/0000-0003-3130-6937; Garcia-Canadilla, Patricia/0000-0002-0223-1617; Bijnens, Bart H/0000-0003-3130-6937; García-García, Francisco/0000-0001-8354-5636; Gratacos, Eduard/0000-0002-7405-7224; Crispi, Fatima/0000-0002-7422-5240	Ministerio de Economia y Competitividad PN de I+D+I [SAF2009_08815, SAF2012-37196, BIO2011-27069]; Instituto de Salud Carlos III [PI11/00051, PI11/01709, PI12/00801]; Fondo Europeo de Desarrollo Regional de la Union Europea "Una manera de hacer Europa''; Centro para el Desarrollo Tecnico Industrial [cvREMOD 2009-2012]; Ministerio de Economia y Competitividad y Fondo de inversion local para el empleo, Spain; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Obra Social "La Caixa'' (Spain); Fundacio Mutua Madrilena (Spain); Fundacio Agrupacio Mutua (Spain); AGAUR SGR [1099]; Red Tematica de Investigacion Cooperativa en cancer [RD06/0020/1019]; Carlos III Institute of Health, Spain [CD08/00176]; Programa de Ayudas Predoctorales de Formacion en Investigacion en Salud del Instituto Carlos III, Spain [FI12/00362]; IDIBAPS (Institut d'Investigacions Biomediques August Pi i Sunyer); ICREA Funding Source: Custom	Ministerio de Economia y Competitividad PN de I+D+I; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional de la Union Europea "Una manera de hacer Europa''; Centro para el Desarrollo Tecnico Industrial; Ministerio de Economia y Competitividad y Fondo de inversion local para el empleo, Spain; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Obra Social "La Caixa'' (Spain)(La Caixa Foundation); Fundacio Mutua Madrilena (Spain); Fundacio Agrupacio Mutua (Spain); AGAUR SGR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Red Tematica de Investigacion Cooperativa en cancer; Carlos III Institute of Health, Spain(Instituto de Salud Carlos III); Programa de Ayudas Predoctorales de Formacion en Investigacion en Salud del Instituto Carlos III, Spain; IDIBAPS (Institut d'Investigacions Biomediques August Pi i Sunyer); ICREA(ICREA)	This study was supported by grants from Ministerio de Economia y Competitividad PN de I+D+I 2008-2011 (ref. SAF2009_08815, SAF2012-37196, and BIO2011-27069); Instituto de Salud Carlos III (ref. PI11/00051, PI11/01709, PI12/00801) cofinanciado por el Fondo Europeo de Desarrollo Regional de la Union Europea "Una manera de hacer Europa''; Centro para el Desarrollo Tecnico Industrial (ref. cvREMOD 2009-2012) apoyado por el Ministerio de Economia y Competitividad y Fondo de inversion local para el empleo, Spain; The Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Obra Social "La Caixa'' (Spain); Fundacio Mutua Madrilena (Spain); Fundacio Agrupacio Mutua (Spain); AGAUR 2009 SGR grant no 1099; and Red Tematica de Investigacion Cooperativa en cancer (ref. RD06/0020/1019). I. T. was supported by a post-doctoral fellowship from Carlos III Institute of Health, Spain (CD08/00176) during the time these studies were performed. P. G. C. acknowledges grant support to the Programa de Ayudas Predoctorales de Formacion en Investigacion en Salud del Instituto Carlos III, Spain (FI12/00362). A. G. T. was supported by an IDIBAPS (Institut d'Investigacions Biomediques August Pi i Sunyer) pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2005, TRENDS CELL BIOL, V15, P477, DOI 10.1016/j.tcb.2005.07.001; Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Alberry M, 2007, ARCH DIS CHILD-FETAL, V92, pF62, DOI 10.1136/adc.2005.082297; ANDERSON PG, 1987, AM J PATHOL, V129, P152; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulesteix T, 2004, OPT LETT, V29, P2031, DOI 10.1364/OL.29.002031; Chaturvedi RR, 2010, CIRCULATION, V121, P979, DOI 10.1161/CIRCULATIONAHA.109.850677; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Comas M, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.044; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Falcao-Pires I, 2011, BASIC RES CARDIOL, V106, P801, DOI 10.1007/s00395-011-0184-x; Fouron JC, 1999, AM J OBSTET GYNECOL, V181, P1102, DOI 10.1016/S0002-9378(99)70089-X; Fukuda N, 2001, CIRCULATION, V104, P1639, DOI 10.1161/hc3901.095898; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Garcia-Canadilla P, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.056010; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gonzalez-Tendero A, 2013, AM J PHYSIOL-HEART C, V305, pH1752, DOI 10.1152/ajpheart.00514.2013; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HADDAD F, 1995, J APPL PHYSIOL, V78, P1489, DOI 10.1152/jappl.1995.78.4.1489; HECHER K, 1995, CIRCULATION, V91, P129, DOI 10.1161/01.CIR.91.1.129; Iruretagoyena JI, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.023; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Labeit S, 1997, CIRC RES, V80, P290, DOI 10.1161/01.RES.80.2.290; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; NASSAR R, 1987, CIRC RES, V61, P465, DOI 10.1161/01.RES.61.3.465; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; Prado-Lopez S, 2010, STEM CELLS, V28, P407, DOI 10.1002/stem.295; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Rodriguez AG, 2011, BIOPHYS J, V101, P2455, DOI 10.1016/j.bpj.2011.09.057; Schoenauer R, 2011, BASIC RES CARDIOL, V106, P233, DOI 10.1007/s00395-010-0131-2; Schwarzer M, 2013, AM J PHYSIOL-HEART C, V304, pH529, DOI 10.1152/ajpheart.00699.2012; Sela G, 2010, ANN NY ACAD SCI, V1188, P222, DOI 10.1111/j.1749-6632.2009.05104.x; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOOTHILL PW, 1987, BRIT MED J, V294, P1051, DOI 10.1136/bmj.294.6579.1051; Tchirikov M, 2006, ULTRASOUND OBST GYN, V27, P452, DOI 10.1002/uog.2747; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Verburg BO, 2008, CIRCULATION, V117, P649, DOI 10.1161/CIRCULATIONAHA.107.709717; Wannenburg T, 2000, AM J PHYSIOL-HEART C, V279, pH779, DOI 10.1152/ajpheart.2000.279.2.H779; Warren CM, 2003, CARDIOVASC RES, V59, P86, DOI 10.1016/S0008-6363(03)00328-6; Wu Y, 2009, J MAGN RESON IMAGING, V30, P47, DOI 10.1002/jmri.21814	49	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113067	10.1371/journal.pone.0113067	http://dx.doi.org/10.1371/journal.pone.0113067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402351	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700105
J	Donega, V; Nijboer, CH; Braccioli, L; Slaper-Cortenbach, I; Kavelaars, A; van Bel, F; Heijnen, CJ				Donega, Vanessa; Nijboer, Cora H.; Braccioli, Luca; Slaper-Cortenbach, Ineke; Kavelaars, Annemieke; van Bel, Frank; Heijnen, Cobi J.			Intranasal Administration of Human MSC for Ischemic Brain Injury in the Mouse: In Vitro and In Vivo Neuroregenerative Functions	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; THERAPY POSITION STATEMENT; STROMAL CELLS; NEONATAL ENCEPHALOPATHY; INTERNATIONAL-SOCIETY; HYPOXIA-ISCHEMIA; TRANSPLANTATION; NEUROGENESIS; CYTOKINES; FATE	Intranasal treatment with C57BL/6 MSCs reduces lesion volume and improves motor and cognitive behavior in the neonatal hypoxic-ischemic (HI) mouse model. In this study, we investigated the potential of human MSCs (hMSCs) to treat HI brain injury in the neonatal mouse. Assessing the regenerative capacity of hMSCs is crucial for translation of our knowledge to the clinic. We determined the neuroregenerative potential of hMSCs in vitro and in vivo by intranasal administration 10 d post-HI in neonatal mice. HI was induced in P9 mouse pups. 1 x 10(6) or 2 x 10(6) hMSCs were administered intranasally 10 d post-HI. Motor behavior and lesion volume were measured 28 d post-HI. The in vitro capacity of hMSCs to induce differentiation of mouse neural stem cell (mNSC) was determined using a transwell co-culture differentiation assay. To determine which chemotactic factors may play a role in mediating migration of MSCs to the lesion, we performed a PCR array on 84 chemotactic factors 10 days following sham-operation, and at 10 and 17 days post-HI. Our results show that 2610 6 hMSCs decrease lesion volume, improve motor behavior, and reduce scar formation and microglia activity. Moreover, we demonstrate that the differentiation assay reflects the neuroregenerative potential of hMSCs in vivo, as hMSCs induce mNSCs to differentiate into neurons in vitro. We also provide evidence that the chemotactic factor CXCL10 may play an important role in hMSC migration to the lesion site. This is suggested by our finding that CXCL10 is significantly upregulated at 10 days following HI, but not at 17 days after HI, a time when MSCs no longer reach the lesion when given intranasally. The results described in this work also tempt us to contemplate hMSCs not only as a potential treatment option for neonatal encephalopathy, but also for a plethora of degenerative and traumatic injuries of the nervous system.	[Donega, Vanessa; Nijboer, Cora H.; Braccioli, Luca; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Slaper-Cortenbach, Ineke] Univ Med Ctr Utrecht, Cell Therapy Facil, Dept Clin Pharm, Utrecht, Netherlands; [Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA; [van Bel, Frank] Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Utrecht University; Utrecht University Medical Center	Heijnen, CJ (corresponding author), Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands.	CJHeijnen@mdanderson.org	Donega, Vanessa/M-8058-2014; Braccioli, Luca/P-8142-2019	Donega, Vanessa/0000-0002-3152-2675	Zon-MW Project [116002003]	Zon-MW Project	This study was supported by Zon-MW Project (no 116002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borlongan CV, 2011, PEDIATR RES, V70, P3, DOI 10.1203/PDR.0b013e31821d0d00; Croft AP, 2009, EXP NEUROL, V216, P329, DOI 10.1016/j.expneurol.2008.12.010; Dammann O, 2011, PEDIATR RES, V70, P1, DOI 10.1203/01.pdr.0000403893.61640.b6; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donega V, 2014, EXP NEUROL, V261, P53, DOI 10.1016/j.expneurol.2014.06.009; Donega V, 2013, J CEREBR BLOOD F MET, V33, P625, DOI 10.1038/jcbfm.2013.3; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gonzalo-Daganzo R, 2009, CYTOTHERAPY, V11, P278, DOI 10.1080/14653240902807018; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Lee JA, 2010, PEDIATR RES, V67, P42, DOI 10.1203/PDR.0b013e3181bf594b; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Prins HJ, 2009, TISSUE ENG PT A, V15, P3741, DOI [10.1089/ten.tea.2008.0666, 10.1089/ten.TEA.2008.0666]; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Velthoven CTJ, 2014, MOL THER, V22, P645, DOI 10.1038/mt.2013.260; van Velthoven CTJ, 2012, ANN NEUROL, V71, P785, DOI 10.1002/ana.23543; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; Velthoven C, 2011, BRAIN BEHAV IMMUN, V25, P1342; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Wang CC, 2008, CARDIOVASC RES, V77, P515, DOI 10.1093/cvr/cvm046; Yang B, 2012, STEM CELLS DEV, V21, P3332, DOI 10.1089/scd.2012.0037; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	40	62	64	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112339	10.1371/journal.pone.0112339	http://dx.doi.org/10.1371/journal.pone.0112339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396420	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500047
J	Hyun, TK; van der Graaff, E; Albacete, A; Eom, SH; Grosskinsky, DK; Bohm, H; Janschek, U; Rim, Y; Ali, WW; Kim, SY; Roitsch, T				Hyun, Tae Kyung; van der Graaff, Eric; Albacete, Alfonso; Eom, Seung Hee; Grosskinsky, Dominik K.; Boehm, Hannah; Janschek, Ursula; Rim, Yeonggil; Ali, Walid Wahid; Kim, Soo Young; Roitsch, Thomas			The Arabidopsis PLAT Domain Protein1 Is Critically Involved in Abiotic Stress Tolerance	PLOS ONE			English	Article							ABSCISIC-ACID; ENDOPLASMIC-RETICULUM; SALICYLIC-ACID; TRANSCRIPTION FACTORS; GENE-EXPRESSION; PSEUDOMONAS-SYRINGAE; SIGNAL-TRANSDUCTION; PLANTS RESPONSE; COLD STRESS; SALT STRESS	Despite the completion of the Arabidopsis genome sequence, for only a relatively low percentage of the encoded proteins experimental evidence concerning their function is available. Plant proteins that harbour a single PLAT (Polycystin, Lipoxygenase, Alpha-toxin and Triacylglycerol lipase) domain and belong to the PLAT-plant-stress protein family are ubiquitously present in monocot and dicots. However, the function of PLAT-plant-stress proteins is still poorly understood. Therefore, we have assessed the function of the uncharacterised Arabidopsis PLAT-plant-stress family members through a combination of functional genetic and physiological approaches. PLAT1 overexpression conferred increased abiotic stress tolerance, including cold, drought and salt stress, while loss-of-function resulted in opposite effects on abiotic stress tolerance. Strikingly, PLAT1 promoted growth under non-stressed conditions. Abiotic stress treatments induced PLAT1 expression and caused expansion of its expression domain. The ABF/ABRE transcription factors, which are positive mediators of abscisic acid signalling, activate PLAT1 promoter activity in transactivation assays and directly bind to the ABRE elements located in this promoter in electrophoretic mobility shift assays. This suggests that PLAT1 represents a novel downstream target of the abscisic acid signalling pathway. Thus, we showed that PLAT1 critically functions as positive regulator of abiotic stress tolerance, but also is involved in regulating plant growth, and thereby assigned a function to this previously uncharacterised PLAT domain protein. The functional data obtained for PLAT1 support that PLAT-plant-stress proteins in general could be promising targets for improving abiotic stress tolerance without yield penalty.	[Hyun, Tae Kyung; van der Graaff, Eric; Albacete, Alfonso; Eom, Seung Hee; Grosskinsky, Dominik K.; Boehm, Hannah; Janschek, Ursula; Roitsch, Thomas] Graz Univ, Inst Plant Sci, Graz, Austria; [Hyun, Tae Kyung; Eom, Seung Hee; Rim, Yeonggil] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju, South Korea; [van der Graaff, Eric; Grosskinsky, Dominik K.; Roitsch, Thomas] Univ Copenhagen, Copenhagen Plant Sci Ctr, Dept Plant & Environm Sci, Taastrup, Denmark; [Albacete, Alfonso] CEBAS CSIC, Dept Nutr Vegetal, Murcia, Spain; [Ali, Walid Wahid] Univ Wurzburg, Dept Pharmaceut Biol, D-97070 Wurzburg, Germany; [Kim, Soo Young] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Mol Biotechnol, Kwangju, South Korea; [Kim, Soo Young] Chonnam Natl Univ, Coll Agr & Life Sci, Kumho Life Sci Lab, Kwangju, South Korea; [Roitsch, Thomas] CzechGlobe AS CR, Vvi, Global Change Res Ctr, Drasov, Czech Republic	University of Graz; Gyeongsang National University; University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Wurzburg; Chonnam National University; Chonnam National University; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Roitsch, T (corresponding author), Graz Univ, Inst Plant Sci, Graz, Austria.	roitsch@plen.ku.dk	van der Graaff, Eric/F-8198-2014; Großkinsky, Dominik/F-9011-2014; Albacete, Alfonso/K-6093-2014; Roitsch, Thomas G/H-4347-2014; Albacete, Alfonso/AGE-8957-2022; Albacete, Alfonso/AAO-3481-2020	van der Graaff, Eric/0000-0002-5265-4239; Großkinsky, Dominik/0000-0001-8976-1057; Albacete, Alfonso/0000-0003-1332-8593; Roitsch, Thomas G/0000-0001-7109-3134; Albacete, Alfonso/0000-0003-1332-8593; Albacete, Alfonso/0000-0003-1332-8593	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea [NRF-2014R1A1A2004432]; Fundacion Seneca, Comunidad Autonoma de la Region de Murcia	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea; Fundacion Seneca, Comunidad Autonoma de la Region de Murcia(Fundacion Seneca)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2004432), Republic of Korea (T.K.H.), and by the Fundacion Seneca, Comunidad Autonoma de la Region de Murcia (A.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard JB, 2005, CURR PROTEIN PEPT SC, V6, P125, DOI 10.2174/1389203053545417; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Audenaert K, 2002, MOL PLANT MICROBE IN, V15, P1147, DOI 10.1094/MPMI.2002.15.11.1147; Barrero JM, 2010, PLANT J, V61, P611, DOI 10.1111/j.1365-313X.2009.04088.x; Bateman A, 1999, CURR BIOL, V9, pR588, DOI 10.1016/S0960-9822(99)80380-7; Bhardwaj PK, 2011, GENE, V483, P49, DOI 10.1016/j.gene.2011.05.014; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Choudhary SP, 2012, TRENDS PLANT SCI, V17, P594, DOI 10.1016/j.tplants.2012.05.012; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; Duan LN, 2013, PLANT CELL, V25, P324, DOI 10.1105/tpc.112.107227; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Grokinsky DK, 2014, MOL PLANT, V7, P1053, DOI 10.1093/mp/ssu015; Grosskinsky DK, 2014, PHYTOPATHOLOGY, V104, P1283, DOI 10.1094/PHYTO-03-14-0076-R; Grosskinsky DK, 2012, PHYTOPATHOLOGY, V102, P662, DOI 10.1094/PHYTO-02-12-0022-R; Grosskinsky DK, 2011, PLANT PHYSIOL, V157, P815, DOI 10.1104/pp.111.182931; Hara-Nishimura I, 2003, CURR OPIN PLANT BIOL, V6, P583, DOI 10.1016/j.pbi.2003.09.015; Hong YW, 2000, P NATL ACAD SCI USA, V97, P8717, DOI 10.1073/pnas.140213697; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Hsu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028888; Hu JH, 2005, MOL BIOL CELL, V16, P458, DOI 10.1091/mbc.E04-09-0851; Hussain SS, 2011, BIOTECHNOL PROGR, V27, P297, DOI 10.1002/btpr.514; Hyun TK, 2009, FUNCT PLANT BIOL, V36, P1088, DOI 10.1071/FP09136; Inamdar M. I., 2010, Karnataka Journal of Agricultural Sciences, V23, P350; Islam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080035; Joshi N, 2013, BIOCHEMISTRY-US, V52, P8026, DOI 10.1021/bi4010649; Joshi-Saha A, 2011, MOL PLANT, V4, P562, DOI 10.1093/mp/ssr055; Kim JB, 2004, PLANT BIOTECHNOL J, V2, P459, DOI 10.1111/j.1467-7652.2004.00090.x; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Leal GA, 2007, MOL PLANT PATHOL, V8, P279, DOI 10.1111/J.1364-3703.2007.00393.X; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Lee SC, 2006, PLANT MOL BIOL, V62, P151, DOI 10.1007/s11103-006-9010-5; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li ST, 2012, PLANT MOL BIOL REP, V30, P1283, DOI 10.1007/s11105-012-0439-1; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Liu LJ, 2011, CELL RES, V21, P957, DOI 10.1038/cr.2010.181; Matsushima R, 2003, PLANT CELL PHYSIOL, V44, P661, DOI 10.1093/pcp/pcg089; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Mosher S, 2010, PLANT PHYSIOL, V152, P1901, DOI 10.1104/pp.109.152603; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Scott MS, 2005, PLOS COMPUT BIOL, V1, P518, DOI 10.1371/journal.pcbi.0010066; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sharma N, 2007, PLANT MOL BIOL, V63, P171, DOI 10.1007/s11103-006-9080-4; Shin R, 2004, PLANT PHYSIOL, V135, P561, DOI 10.1104/pp.103.035436; Shin Y, 2003, PLANT CELL PHYSIOL, V44, P549, DOI 10.1093/pcp/pcg069; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Tomchick DR, 2001, BIOCHEMISTRY-US, V40, P7509, DOI 10.1021/bi002893d; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yamada K, 2011, PLANT CELL PHYSIOL, V52, P2039, DOI 10.1093/pcp/pcr156; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yuasa T, 2004, GENOMICS, V84, P126, DOI 10.1016/j.ygeno.2004.02.008; Zhang HM, 2010, PLANT J, V64, P764, DOI 10.1111/j.1365-313X.2010.04367.x; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263	66	32	34	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112946	10.1371/journal.pone.0112946	http://dx.doi.org/10.1371/journal.pone.0112946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396746	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500117
J	Lombardo, G; Serrao, S; Rosati, M; Lombardo, M				Lombardo, Giuseppe; Serrao, Sebastiano; Rosati, Marianna; Lombardo, Marco			Analysis of the Viscoelastic Properties of the Human Cornea Using Scheimpflug Imaging in Inflation Experiment of Eye Globes	PLOS ONE			English	Article							COLLAGEN FIBRILS; BIOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; ANTERIOR STROMA; CROSS-LINKING; BOVINE; ORGANIZATION; ELASTICITY; RABBIT; STRAIN	Purpose: To demonstrate a Scheimpflug-based imaging procedure for investigating the depth-and time-dependent strain response of the human cornea to inflation testing of whole eye globes. Methods: Six specimens, three of which with intact corneal epithelium, were mounted in a customized apparatus within a humidity and temperature-monitored wet chamber. Each specimen was subjected to two mechanical tests in order to measure corneal strain resulting from application of cyclic (cyclic regimen) and constant (creep regimen) stress by changing the intra-ocular pressure (IOP) within physiological ranges (18-42 mmHg). Corneal shape changes were analyzed as a function of IOP and both corneal stress-strain curves and creep curves were generated. Results: The procedure was highly accurate and repeatable. Upon cyclic stress application, a biomechanical corneal elasticity gradient was found in the front-back direction. The average Young's modulus of the anterior cornea ranged between 2.28 +/- 0.87 MPa and 3.30 +/- 0.90 MPa in specimens with and without intact epithelium (P = 0.05) respectively. The Young's modulus of the posterior cornea was on average 0.21 +/- 0.09 MPa and 0.17 +/- 0.06 MPa (P>0.05) respectively. The time-dependent strain response of the cornea to creep testing was quantified by fitting data to a modified Zener model for extracting both the relaxation time and compliance function. Conclusion: Cyclic and creep mechanical tests are valuable for investigating the strain response of the intact human cornea within physiological IOP ranges, providing meaningful results that can be translated to clinic. The presence of epithelium influences the results of anterior corneal shape changes when monitoring deformation via Scheimpflug imaging in inflation experiments of whole eye globes.	[Lombardo, Giuseppe] CNR IPCF, Unit Support Cosenza, I-87036 Cosenza, Italy; [Lombardo, Giuseppe] Vis Engn Italy Srl, I-00198 Rome, Italy; [Serrao, Sebastiano; Rosati, Marianna; Lombardo, Marco] Fdn GB Bietti, IRCCS, I-00198 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Lombardo, G (corresponding author), CNR IPCF, Unit Support Cosenza, I-87036 Cosenza, Italy.	mlombardo@visioeng.it; giuseppe.lombardo@cnr.it	; Lombardo, Giuseppe/B-2656-2012	Lombardo, Marco/0000-0001-8842-7102; Lombardo, Giuseppe/0000-0002-9416-967X	National Framework Program for Research and Innovation PON [01_00110]	National Framework Program for Research and Innovation PON	This work was supported by a grant from the National Framework Program for Research and Innovation PON (research program n. 01_00110). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Boschetti F, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006089; Boyce BL, 2007, J BIOMECH, V40, P2367, DOI 10.1016/j.jbiomech.2006.12.001; Boyce BL, 2008, BIOMATERIALS, V29, P3896, DOI 10.1016/j.biomaterials.2008.06.011; Browning AC, 2004, BRIT J OPHTHALMOL, V88, P1395, DOI 10.1136/bjo.2003.037887; Bueno JM, 2011, CORNEA, V30, P692, DOI 10.1097/ICO.0b013e3182000f94; BUREK H, 1993, OPHTHAL PHYSL OPT, V13, P68, DOI 10.1111/j.1475-1313.1993.tb00428.x; CASTORO JA, 1988, INVEST OPHTH VIS SCI, V29, P963; Dias JM, 2013, EXP EYE RES, V115, P41, DOI 10.1016/j.exer.2013.06.004; Dupps WJ, 2007, J REFRACT SURG, V23, P66; Dupps WJ, 2005, J REFRACT SURG, V21, P186; Elsheikh A, 2005, J R SOC INTERFACE, V2, P177, DOI 10.1098/rsif.2005.0034; Elsheikh A, 2008, EXP EYE RES, V86, P445, DOI 10.1016/j.exer.2007.12.002; Elsheikh A, 2008, CURR EYE RES, V33, P205, DOI 10.1080/02713680701882519; Elsheikh A, 2007, J REFRACT SURG, V23, P808, DOI 10.3928/1081-597X-20071001-11; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; FUNG YC, 1993, BIOMECHANICS MECH PR, pCH7; Gatinel D, 2011, CORNEA, V30, P508, DOI 10.1097/ICO.0b013e3181fb4fa7; Glass DH, 2008, INVEST OPHTH VIS SCI, V49, P3919, DOI 10.1167/iovs.07-1321; Hamaoui M, 2001, CORNEA, V20, P317, DOI 10.1097/00003226-200104000-00015; Hatami-Marbini H, 2014, EXP EYE RES, V120, P103, DOI 10.1016/j.exer.2013.11.017; Hatami-Marbini H, 2013, EXP EYE RES, V116, P47, DOI 10.1016/j.exer.2013.07.016; Hennighausen H, 1998, INVEST OPHTH VIS SCI, V39, P253; Hjortdal JO, 1996, J BIOMECH, V29, P931, DOI 10.1016/0021-9290(95)00152-2; HJORTDAL JO, 1995, ACTA OPHTHALMOL SCAN, V73, P5; HOELTZEL DA, 1992, J BIOMECH ENG-T ASME, V114, P202, DOI 10.1115/1.2891373; JUE B, 1986, J BIOMECH, V19, P847, DOI 10.1016/0021-9290(86)90135-1; Kling S, 2013, J REFRACT SURG, V29, P490, DOI 10.3928/1081597X-20130617-08; Kling S, 2010, INVEST OPHTH VIS SCI, V51, P3961, DOI 10.1167/iovs.09-4536; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Lombardo M, 2014, J CATARACT REFR SURG, V40, P1706, DOI 10.1016/j.jcrs.2014.04.024; Lombardo M, 2012, INVEST OPHTH VIS SCI, V53, P1050, DOI 10.1167/iovs.11-8720; Lombardo M, 2011, INVEST OPHTH VIS SCI, V52, P6994, DOI 10.1167/iovs.10-7052; Lombardo M, 2009, CORNEA, V28, P408, DOI 10.1097/ICO.0b013e31818d33c7; MEEK KM, 1987, CURR EYE RES, V6, P841, DOI 10.3109/02713688709034853; MILLODOT M, 1979, VISION RES, V19, P685, DOI 10.1016/0042-6989(79)90244-X; Miranda MA, 2009, CORNEA, V28, P657, DOI 10.1097/ICO.0b013e31819b01b5; Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Muller LJ, 2004, EXP EYE RES, V78, P493, DOI 10.1016/S0014-4835(03)00206-9; NASH IS, 1982, EXP EYE RES, V35, P413, DOI 10.1016/0014-4835(82)90040-9; Navarro R, 2006, J OPT SOC AM A, V23, P219, DOI 10.1364/JOSAA.23.000219; Nguyen TD, 2011, BIOMECH MODEL MECHAN, V10, P323, DOI 10.1007/s10237-010-0237-3; Nguyen TD, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2947399; Pandolfi A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2982251; Perez-Escudero A, 2009, INVEST OPHTH VIS SCI, V50, P4146, DOI 10.1167/iovs.09-3411; Pinsky PM, 2005, J CATARACT REFR SURG, V31, P136, DOI 10.1016/j.jcrs.2004.10.048; Preussner PR, 2003, J CATARACT REFR SURG, V29, P471, DOI 10.1016/S0886-3350(02)01512-2; Reinhardt HW, 2009, CREEP SHRINKAGE DURA, P65; Scarcelli G, 2013, INVEST OPHTH VIS SCI, V53, P185; Serrao S, 2014, J CATARACT REFR SURG, V40, P531, DOI 10.1016/j.jcrs.2013.11.027; Serrao S, 2013, J REFRACT SURG, V29, P418, DOI 10.3928/1081597X-20130430-01; Shin TJ, 1997, J BIOMECH, V30, P497, DOI 10.1016/S0021-9290(97)84433-8; Studer H, 2010, J BIOMECH, V43, P836, DOI 10.1016/j.jbiomech.2009.11.021; TERRY MA, 1994, ARCH OPHTHALMOL-CHIC, V112, P538, DOI 10.1001/archopht.1994.01090160118031; Wainwright SA, 1976, MECHANICAL DESIGN OR, P6; WILSON G, 1984, INVEST OPHTH VIS SCI, V25, P1105	58	22	22	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112169	10.1371/journal.pone.0112169	http://dx.doi.org/10.1371/journal.pone.0112169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397674	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500036
J	Xavier, CH; Ianzer, D; Lima, AM; Marins, FR; Pedrino, GR; Vaz, G; Menezes, GB; Nalivaiko, E; Antonio, M; Fontes, P				Xavier, Carlos Henrique; Ianzer, Danielle; Lima, Augusto Martins; Marins, Fernanda Ribeiro; Pedrino, Gustavo Rodrigues; Vaz, Gisele; Menezes, Gustavo Batista; Nalivaiko, Eugene; Antonio, Marco; Fontes, Peliky			Excitatory Amino Acid Receptors Mediate Asymmetry and Lateralization in the Descending Cardiovascular Pathways from the Dorsomedial Hypothalamus	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; SYMPATHETIC PREGANGLIONIC NEURONS; PERIAQUEDUCTAL GRAY; HEART-RATE; CARDIAC-ARRHYTHMIAS; EMOTIONAL-STRESS; CONSCIOUS RATS; GABA-A; NUCLEUS; ORGANIZATION	The dorsomedial hypothalamus (DMH) and lateral/dorsolateral periaqueductal gray (PAG) are anatomically and functionally connected. Both the DMH and PAG depend on glutamatergic inputs for activation. We recently reported that removal of GABA-ergic tone in the unilateral DMH produces: asymmetry, that is, a right- (R-) sided predominance in cardiac chronotropism, and lateralization, that is, a greater increase in ipsilateral renal sympathetic activity (RSNA). In the current study, we investigated whether excitatory amino acid (EAA) receptors in the DMH-PAG pathway contribute to the functional interhemispheric difference. In urethane (1.2 to 1.4 g/kg, i.p.) anesthetized rats, we observed that: (i) nanoinjections of N-methyl D-aspartate (NMDA 100 pmol/100 nl) into the unilateral DMH produced the same right- sided predominance in the control of cardiac chronotropy, (ii) nanoinjections of NMDA into the ipsilateral DMH or PAG evoked lateralized RSNA responses, and (iii) blockade of EAA receptors in the unilateral DMH attenuated the cardiovascular responses evoked by injection of NMDA into either the R- or left- (L-) PAG. In awake rats, nanoinjection of kynurenic acid (1 nmol/100 nL) into the L-DMH or R- or L- PAG attenuated the tachycardia evoked by air stress. However, the magnitude of stress-evoked tachycardia was smallest when the EAA receptors of the R-DMH were blocked. We conclude that EAA receptors contribute to the right-sided predominance in cardiac chronotropism. This interhemispheric difference that involves EAA receptors was observed in the DMH but not in the PAG.	[Xavier, Carlos Henrique; Pedrino, Gustavo Rodrigues] Univ Fed Goias, Inst Ciencias Biol, Dept Ciencias Fisiol, Lab Fisiol & Terapeut Cardiovasc, Goiania, Go, Brazil; [Xavier, Carlos Henrique; Ianzer, Danielle; Lima, Augusto Martins; Marins, Fernanda Ribeiro; Vaz, Gisele; Fontes, Peliky] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Nalivaiko, Eugene] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Menezes, Gustavo Batista] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal de Goias; Universidade Federal de Minas Gerais; University of Newcastle; Universidade Federal de Minas Gerais	Xavier, CH (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Dept Ciencias Fisiol, Lab Fisiol & Terapeut Cardiovasc, Goiania, Go, Brazil.	carlosxavier@ufg.br	Xavier, Carlos Henrique/AAE-8390-2022; Pedrino, Gustavo R/I-5614-2015; Lima, Augusto Martins/D-7730-2015; Menezes, Gustavo B/B-3350-2013; Custodio, Carlos Henrique Xavier/F-8450-2010; Fontes, Marco Antônio Peliky/AAT-7570-2021; Xavier, Carlos H/C-8561-2013	Xavier, Carlos Henrique/0000-0003-4006-8213; Pedrino, Gustavo R/0000-0003-0488-5400; Fontes, Marco Antônio Peliky/0000-0003-4525-3565; Xavier, Carlos H/0000-0003-4006-8213; Nalivaiko, Eugene/0000-0002-6449-8181; Martins Lima, Augusto/0000-0002-0461-1226	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [143005/2008-1, 301519/2009-9]; INCT NanoBiofar; FAPEMIG	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT NanoBiofar; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq processos (143005/2008-1; 301519/2009-9), INCT NanoBiofar, and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1990, NEUROSCI LETT, V118, P112, DOI 10.1016/0304-3940(90)90261-7; Apps R, 2007, NAT PROTOC, V2, P1862, DOI 10.1038/nprot.2007.263; Bandler R, 1996, PROG BRAIN RES, V107, P285; BANDLER R, 1988, BRAIN RES, V439, P95, DOI 10.1016/0006-8993(88)91465-5; BEART PM, 1990, NEUROSCIENCE, V34, P163, DOI 10.1016/0306-4522(90)90310-Z; Bernard JF, 1998, J COMP NEUROL, V401, P429; Campos RR, 1999, AM J PHYSIOL-REG I, V276, pR1102, DOI 10.1152/ajpregu.1999.276.4.R1102; Cao WH, 2004, NEUROSCIENCE, V126, P229, DOI 10.1016/j.neuroscience.2004.03.013; CARRIVE P, 1993, BEHAV BRAIN RES, V58, P27, DOI 10.1016/0166-4328(93)90088-8; Carrive P, 2009, ENCY NEUROSCIENCE, P923; Carrive P, 2008, EUR J NEUROSCI, V28, P428, DOI 10.1111/j.1460-9568.2008.06351.x; Critchley HD, 2005, BRAIN, V128, P75, DOI 10.1093/brain/awh324; Da Silva LG, 2006, NEUROSCIENCE, V139, P1129, DOI 10.1016/j.neuroscience.2005.12.041; da Silva LG, 2003, BRAIN RES, V984, P206, DOI 10.1016/S0006-8993(03)03157-3; de Menezes RCA, 2008, AM J PHYSIOL-REG I, V295, pR881, DOI 10.1152/ajpregu.00181.2008; de Menezes RCA, 2009, J PHYSIOL-LONDON, V587, P1201, DOI 10.1113/jphysiol.2008.161463; de Oliveira RW, 2000, BRAIN RES BULL, V51, P457, DOI 10.1016/S0361-9230(99)00248-8; Dimicco JA, 1992, CENTRAL NEURAL MECH, VII; FANG HS, 1962, AM J PHYSIOL, V203, P147, DOI 10.1152/ajplegacy.1962.203.1.147; Farkas E, 1998, BRAIN RES, V792, P179, DOI 10.1016/S0006-8993(98)00029-8; Fontes MAP, 2011, NEUROSCIENCE, V184, P64, DOI 10.1016/j.neuroscience.2011.03.018; Fontes MAP, 2001, AM J PHYSIOL-HEART C, V280, pH2891, DOI 10.1152/ajpheart.2001.280.6.H2891; FURNIVAL CM, 1968, J PHYSIOL-LONDON, V197, pP74; Harris JA, 1996, NEUROSCI BIOBEHAV R, V20, P637, DOI 10.1016/0149-7634(95)00077-1; Horiuchi J, 2009, J PHYSIOL-LONDON, V587, P5149, DOI 10.1113/jphysiol.2009.179739; Huang JH, 2002, AUTON NEUROSCI-BASIC, V95, P57, DOI 10.1016/S1566-0702(01)00356-3; KAMOSINSKA B, 1989, J AUTONOM NERV SYST, V26, P241, DOI 10.1016/0165-1838(89)90173-2; Kerman IA, 2008, EXP BRAIN RES, V187, P1, DOI 10.1007/s00221-008-1337-5; Lane RD, 2014, HDB CARDIOV IN PRESS; Menezes RCA, 2007, NEUROSCIENCE, V144, P336, DOI 10.1016/j.neuroscience.2006.08.062; Moon EA, 2002, BRAIN RES, V929, P181, DOI 10.1016/S0006-8993(01)03388-1; Myers B, 2014, BRAIN STRUCT FUNCT, V219, P1287, DOI 10.1007/s00429-013-0566-y; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; Fontes MAP, 2014, BRAIN RES, V1554, P49, DOI 10.1016/j.brainres.2014.01.043; RANDALL WC, 1972, FED PROC, V31, P1199; Shafton AD, 1998, BRAIN RES, V801, P239, DOI 10.1016/S0006-8993(98)00587-3; Soltis RP, 1998, AM J PHYSIOL-REG I, V275, pR624, DOI 10.1152/ajpregu.1998.275.2.R624; SOLTIS RP, 1991, AM J PHYSIOL, V260, pR13, DOI 10.1152/ajpregu.1991.260.1.R13; SOLTIS RP, 1991, AM J PHYSIOL, V261, pR427, DOI 10.1152/ajpregu.1991.261.2.R427; StottPotter EH, 1996, J NEUROSCI, V16, P1173; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAYLOR RB, 1992, AM J PHYSIOL, V263, pH1026, DOI 10.1152/ajpheart.1992.263.4.H1026; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Vianna DML, 2003, BRAZ J MED BIOL RES, V36, P557, DOI 10.1590/S0100-879X2003000500002; Winter J, 2012, AUTON NEUROSCI-BASIC, V166, P4, DOI 10.1016/j.autneu.2011.08.004; Wittling W, 1997, ACTA PHYSIOL SCAND, V161, P55; Xavier CH, 2009, NEUROSCIENCE, V164, P1360, DOI 10.1016/j.neuroscience.2009.09.018; Xavier CH, 2013, AM J PHYSIOL-REG I, V304, pR664, DOI 10.1152/ajpregu.00401.2012; Xavier CH, 2011, AUTON NEUROSCI-BASIC, V163, P57; YANOWITZ F, 1966, CIRC RES, V18, P416, DOI 10.1161/01.RES.18.4.416; Zaretskaia MV, 2008, BRAIN RES, V1200, P39, DOI 10.1016/j.brainres.2008.01.018	53	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112412	10.1371/journal.pone.0112412	http://dx.doi.org/10.1371/journal.pone.0112412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397884	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500051
J	Xiao, XS; Chen, B; Liu, XP; Liu, P; Zheng, GP; Ye, F; Tang, HL; Xie, XM				Xiao, Xiangsheng; Chen, Bo; Liu, Xiaoping; Liu, Peng; Zheng, Guopei; Ye, Feng; Tang, Hailin; Xie, Xiaoming			Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating miR-34a	PLOS ONE			English	Article							HUMAN GASTRIC-CANCER; CELL-LINE MCF-7; INDUCED APOPTOSIS; MICRORNAS; ACTIVATION; PATHWAY; EXPRESSION; ARREST; KINASE; P53	Diallyl disulfide (DADS) is one of the major volatile components of garlic oil. DADS has various biological properties, including anticancer, antiangiogenic, and antioxidant effects. However, the anticancer mechanisms of DADS in human breast cancer have not been elucidated, particularly in vivo. In this study, we demonstrated that the expression of miR-34a was up-regulated in DADS-treated MDA-MB-231 cells. miR-34a not only inhibited breast cancer growth but also enhanced the antitumor effect of DADS, both in vitro and in vivo. Furthermore, Src was identified as a target of miR-34a, with miR-34a inhibiting SRC expression and consequently triggering the suppression of the SRC/Ras/ERK pathway. These results suggest that DADS could be a promising anticancer agent for breast cancer. miR-34a may also demonstrate a potential gene therapy agent that could enhance the antitumor effects of DADS.	[Xiao, Xiangsheng; Chen, Bo; Liu, Xiaoping; Liu, Peng; Ye, Feng; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xiao, Xiangsheng; Chen, Bo; Liu, Xiaoping; Liu, Peng; Ye, Feng; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Guopei] Guangzhou Med Univ, Affiliated Canc Hosp, Guangzhou 510095, Guangdong, Peoples R China; [Zheng, Guopei] Guangzhou Med Univ, Canc Res Inst, Guangzhou 510095, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University; Guangzhou Medical University	Tang, HL (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China.	tanghl@sysucc.org.cn; xiexm@sysucc.org.cn	xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81472575, 81472469, 31100935, 81272514, 81302318, 81372133, 81301798]; Key Programme of the National Natural Science Foundation of China [31030061]; China Postdoctoral Science Foundation [2012M520075, 2014M550447]; Science and Technology Planning Project of Guangzhou [2014J4100169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Programme of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Planning Project of Guangzhou	This work was supported by funds from the National Natural Science Foundation of China (81472575, 81472469, 31100935, 81272514, 81302318, 81372133, and 81301798), the Key Programme of the National Natural Science Foundation of China (31030061), the China Postdoctoral Science Foundation (2012M520075 and 2014M550447), and the Science and Technology Planning Project of Guangzhou (2014J4100169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, HYPERTENS RES, V31, P987, DOI 10.1291/hypres.31.987; Altonsy MO, 2012, NUTR CANCER, V64, P1251, DOI 10.1080/01635581.2012.721156; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Catuogno Silvia, 2011, Cancers (Basel), V3, P1877, DOI 10.3390/cancers3021877; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Elsberger B, 2014, CRIT REV ONCOL HEMAT, V89, P343, DOI 10.1016/j.critrevonc.2013.12.009; Fan MY, 2013, J BIOL CHEM, V288, P27480, DOI 10.1074/jbc.M113.491803; Filomeni G, 2005, CANCER RES, V65, P11735, DOI 10.1158/0008-5472.CAN-05-3067; Filomeni G, 2003, CANCER RES, V63, P5940; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang YS, 2011, MOL MED REP, V4, P553, DOI 10.3892/mmr.2011.453; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Lei XY, 2008, ACTA PHARMACOL SIN, V29, P1233, DOI 10.1111/j.1745-7254.2008.00851.x; Nakagawa H, 2001, CARCINOGENESIS, V22, P891, DOI 10.1093/carcin/22.6.891; Nguyen DHD, 2000, J BIOL CHEM, V275, P19382, DOI 10.1074/jbc.M909575199; Peiro G, 2014, BR J CANC; Peurala H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026122; Pratheeshkumar P, 2010, J ENVIRON PATHOL TOX, V29, P113, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i2.50; Profumo Valentina, 2013, Critical Reviews in Oncogenesis, V18, P341; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Serpico D, 2014, CANCER TREAT REV, V40, P595, DOI 10.1016/j.ctrv.2013.11.002; Sundaram SG, 1996, BBA-MOL BASIS DIS, V1315, P15, DOI 10.1016/0925-4439(95)00088-7; Tang HL, 2013, CANCER LETT, V340, P72, DOI 10.1016/j.canlet.2013.06.027; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tsubura A, 2011, ANTI-CANCER AGENT ME, V11, P249, DOI 10.2174/187152011795347441; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wang YH, 2014, MOL CELL BIOCHEM, V393, P77, DOI 10.1007/s11010-014-2048-9; Xiao DH, 2005, MOL CANCER THER, V4, P1388, DOI 10.1158/1535-7163.MCT-05-0152; Xu Y, 2014, INT J BIOL SCI, V10, P396, DOI 10.7150/ijbs.8193; Yuan JP, 2004, WORLD J GASTROENTERO, V10, P2731, DOI 10.3748/wjg.v10.i18.2731; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	36	53	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112720	10.1371/journal.pone.0112720	http://dx.doi.org/10.1371/journal.pone.0112720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396727	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500082
J	Zang, MD; Zhang, BG; Zhang, YQ; Li, JF; Su, LP; Zhu, ZG; Gu, QL; Liu, BY; Yan, M				Zang, Mingde; Zhang, Baogui; Zhang, Yunqiang; Li, Jianfang; Su, Liping; Zhu, Zhenggang; Gu, Qinlong; Liu, Bingya; Yan, Min			CEACAM6 Promotes Gastric Cancer Invasion and Metastasis by Inducing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling Pathway	PLOS ONE			English	Article							DOWN-REGULATION; PROLIFERATION; DETERMINANT; EXPRESSION; THERAPY; EMT	Overexpressed CEACAM6 in tumor tissues plays important roles in invasion, metastasis and anoikis resistance in a variety of human cancers. We recently reported that CEACAM6 expression is upregulated in Gastric cancer (GC) tissues and promoted GC metastasis. Here, we report that CEACAM6 promotes peritoneal metastases in vivo and is negatively correlated with E-cadherin expression in GC tissues. Overexpressed CEACAM6 induced epithelial-mesenchymal transition (EMT) in GC, as measured by increases in the EMT markers N-cadherin, Vimentin and Slug while E-cadherin expression was decreased in CEACAM6-overexpressing GC cells; opposing results were observed in CEACAM6-silenced cells. Furthermore, E-cadherin expression was negatively correlated with depth of tumor invasion, lymph node metastasis and TNM stage in GC tissues. Additionally, CEACAM6 elevated matrix metalloproteinase-9 (MMP-9) activity in GC, and anti-MMP-9 antibody could reverse the increasing invasion and migration induced by CEACAM6. CEACAM6 also increased the levels of phosphorylated AKT, which is involved in the progression of a variety of human tumors. We further observed that LY294002, a PI3K inhibitor, could reverse CEACAM6-induced EMT via mesenchymal-epithelial transition. These findings suggest that CEACAM6 enhances invasion and metastasis in GC by promoting EMT via the PI3K/AKT signaling pathway.	[Zang, Mingde; Zhang, Baogui; Zhang, Yunqiang; Li, Jianfang; Su, Liping; Zhu, Zhenggang; Gu, Qinlong; Liu, Bingya; Yan, Min] Shanghai Jiao Tong Univ, Sch Med, Dept Surg,Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Shanghai Inst Di, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Surg,Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Shanghai Inst Di, Shanghai 200030, Peoples R China.	byliu@sjtu.edu.cn; ym10299@163.com	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81172324, 91229106, 81272749, 81372231]; Key Project of Shanghai Education Committee [12ZZ105, 12ZZ102]; Science and Technology Commission of Shanghai Municipality [13ZR1425600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Shanghai Education Committee; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Foundation of China (No. 81172324, No. 91229106, No. 81272749, and No. 81372231), and Key Project of Shanghai Education Committee (No. 12ZZ105 and No. 12ZZ102) and Science and Technology Commission of Shanghai Municipality (No. 13ZR1425600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Camacho-Leal P, 2007, J CELL PHYSIOL, V211, P791, DOI 10.1002/jcp.20989; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Chen JM, 2013, INT J ONCOL, V43, P877, DOI 10.3892/ijo.2013.2015; Correa P, 2013, GASTROENTEROL CLIN N, V42, P211, DOI 10.1016/j.gtc.2013.01.002; Duxbury MS, 2004, ANN SURG, V240, P667, DOI 10.1097/01.sla.0000140755.97224.9a; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Fujitani K, 2013, DIGEST SURG, V30, P119, DOI 10.1159/000350877; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Han SU, 2008, ONCOGENE, V27, P675, DOI 10.1038/sj.onc.1210686; Hu L, 2014, ONCOTARGET, V5, P1885, DOI 10.18632/oncotarget.1871; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim KS, 2013, CLIN CHIM ACTA, V415, P12, DOI 10.1016/j.cca.2012.09.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Macha MA, 2013, CANCER LETT, V341, P166, DOI 10.1016/j.canlet.2013.07.037; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Scholzel S, 2000, AM J PATHOL, V156, P595, DOI 10.1016/S0002-9440(10)64764-5; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.122; Zhang YQ, 2014, ACTA BIOCH BIOPH SIN, V46, P283, DOI 10.1093/abbs/gmu001	30	40	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112908	10.1371/journal.pone.0112908	http://dx.doi.org/10.1371/journal.pone.0112908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398131	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500108
J	Fujita, M; Zhu, K; Fujita, CK; Zhao, M; Lam, KS; Kurth, MJ; Takada, YK; Takada, Y				Fujita, Masaaki; Zhu, Kan; Fujita, Chitose K.; Zhao, Min; Lam, Kit S.; Kurth, Mark J.; Takada, Yoko K.; Takada, Yoshikazu			Proinflammatory Secreted Phospholipase A2 Type IIA (sPLA-IIA) Induces Integrin Activation through Direct Binding to a Newly Identified Binding Site (Site 2) in Integrins alpha v beta 3, alpha 4 beta 1, and alpha 5 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Allosteric Regulation; Inflammation; Integrin; Peptides; Docking Simulation; Fractalkine; Integrin Activation; Secreted Phospholipase A2 Type IIA	TERNARY COMPLEX-FORMATION; CRYSTAL-STRUCTURE; RECEPTOR IGF1R; EXTRACELLULAR SEGMENT; MEMBRANE-RECEPTOR; DEFECTIVE MUTANT; FIBRINOGEN GAMMA; TERMINAL DOMAINS; ONCOGENIC ACTION; STRUCTURAL BASIS	Background: Besides inside-out signaling, integrins are activated by the binding of fractalkine to a newly identified binding site (site 2). Results: sPLA2-IIA induced integrin activation through site 2. A peptide from site 2 or a small compound that binds to sPLA2-IIA suppressed the activation. Conclusion: sPLA2-IIA activates integrins through direct binding to site 2. Significance: Integrin activation through site 2 may be a potential therapeutic target in inflammation. Integrins are activated by signaling from inside the cell (inside-out signaling) through global conformational changes of integrins. We recently discovered that fractalkine activates integrins in the absence of CX3CR1 through the direct binding of fractalkine to a ligand-binding site in the integrin headpiece (site 2) that is distinct from the classical RGD-binding site (site 1). We propose that fractalkine binding to the newly identified site 2 induces activation of site 1 though conformational changes (in an allosteric mechanism). We reasoned that site 2-mediated activation of integrins is not limited to fractalkine. Human secreted phospholipase A2 type IIA (sPLA2-IIA), a proinflammatory protein, binds to integrins v3 and 41 (site 1), and this interaction initiates a signaling pathway that leads to cell proliferation and inflammation. Human sPLA2-IIA does not bind to M-type receptor very well. Here we describe that sPLA2-IIA directly activated purified soluble integrin v3 and transmembrane v3 on the cell surface. This activation did not require catalytic activity or M-type receptor. Docking simulation predicted that sPLA2-IIA binds to site 2 in the closed-headpiece of v3. A peptide from site 2 of integrin 1 specifically bound to sPLA2-IIA and suppressed sPLA2-IIA-induced integrin activation. This suggests that sPLA2-IIA activates v3 through binding to site 2. sPLA2-IIA also activated integrins 41 and 51 in a site 2-mediated manner. We recently identified small compounds that bind to sPLA2-IIA and suppress integrin-sPLA2-IIA interaction (e.g. compound 21 (Cmpd21)). Cmpd21 effectively suppressed sPLA2-IIA-induced integrin activation. These results define a novel mechanism of proinflammatory action of sPLA2-IIA through integrin activation.	[Fujita, Masaaki; Zhu, Kan; Zhao, Min; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Fujita, Masaaki; Lam, Kit S.; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Kurth, Mark J.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Fujita, Chitose K.] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Clin Immunol & Rheumatol, Osaka 5308480, Japan	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Kitano Hospital	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu	Zhu, Kan/AAJ-7450-2021	Zhu, Kan/0000-0002-1146-8130; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA13015]; TRDRP (Tobacco-related Disease Research Program) Grant [18XT-0169]; Department of Defense [W81XWH-10-1-0312]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TRDRP (Tobacco-related Disease Research Program) Grant; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA13015. This work was also supported by TRDRP (Tobacco-related Disease Research Program) Grant 18XT-0169 and Department of Defense Grant W81XWH-10-1-0312 (to Y. T.).	Aho HJ, 1996, INVEST OPHTH VIS SCI, V37, P1826; Birts CN, 2010, TRENDS BIOCHEM SCI, V35, P28, DOI 10.1016/j.tibs.2009.08.003; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Bowton DL, 2005, J ASTHMA, V42, P65, DOI 10.1081/JAS-200044748; Bradley JD, 2005, J RHEUMATOL, V32, P417; Cierniewski CS, 1999, J BIOL CHEM, V274, P16923, DOI 10.1074/jbc.274.24.16923; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; Dong QH, 2006, CANCER LETT, V240, P9, DOI 10.1016/j.canlet.2005.08.012; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Fujita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096372; Fujita M, 2013, J BIOL CHEM, V288, P19593, DOI 10.1074/jbc.M113.470872; Fujita M, 2013, J BIOL CHEM, V288, P3059, DOI 10.1074/jbc.M112.412536; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Hu DD, 1999, J BIOL CHEM, V274, P4633, DOI 10.1074/jbc.274.8.4633; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Jaross W, 2002, EUR J CLIN INVEST, V32, P383, DOI 10.1046/j.1365-2362.2002.01000.x; Jiang JZ, 2002, AM J PATHOL, V160, P667, DOI 10.1016/S0002-9440(10)64886-9; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Legler DF, 2001, J CELL SCI, V114, P1545; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mori S., 2013, MED SCI, V1, P20; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mori S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057927; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; NEVALAINEN TJ, 1994, INVEST OPHTH VIS SCI, V35, P417; NICOLAS JP, 1995, J BIOL CHEM, V270, P28869, DOI 10.1074/jbc.270.48.28869; Niessen HWM, 2003, CARDIOVASC RES, V60, P68, DOI 10.1016/S0008-6363(03)00324-9; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Saari KM, 2001, INVEST OPHTH VIS SCI, V42, P318; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Sved P, 2004, CANCER RES, V64, P6934, DOI 10.1158/0008-5472.CAN-03-3018; Tada K, 1998, J IMMUNOL, V161, P5008; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Triggiani M, 2003, J IMMUNOL, V170, P3279, DOI 10.4049/jimmunol.170.6.3279; VADAS P, 1985, LIFE SCI, V36, P579, DOI 10.1016/0024-3205(85)90640-X; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273; Ye L, 2013, BIOORG MED CHEM LETT, V23, P340, DOI 10.1016/j.bmcl.2012.10.080; Yokoyama K, 2000, J BIOL CHEM, V275, P16891, DOI 10.1074/jbc.M000610200; Yokoyama K, 1999, BIOCHEMISTRY-US, V38, P5872, DOI 10.1021/bi9827619; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	50	28	37	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					259	271		10.1074/jbc.M114.579946	http://dx.doi.org/10.1074/jbc.M114.579946			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398877	Green Published, hybrid			2022-12-26	WOS:000347231200024
J	Guilherme, FR				Guilherme, Flavio Ricardo		PLOS One Staff	Hypertriglyceridemic Waist and Metabolic Abnormalities in Brazilian Schoolchildren (vol 9, e111724, 2014)	PLOS ONE			English	Correction									Univ Estadual Maringa, Dept Educ Phys, Maringa, Parana, Brazil		Guilherme, FR (corresponding author), Univ Estadual Maringa, Dept Educ Phys, Maringa, Parana, Brazil.		Rinaldi, Wilson WR/T-4560-2017	Alexandre Molena Fernandes, Carlos/0000-0002-4019-8379; Ricardo Guilherme, Flavio/0000-0003-4808-6192				Guilherme FR, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0111724, 10.1371/journal.pone.0116445]	1	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e116445	10.1371/journal.pone.0116445	http://dx.doi.org/10.1371/journal.pone.0116445			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25397885	Green Published, gold			2022-12-26	WOS:000348563300106
J	Swift, SM; Hudgens, JW; Heselpoth, RD; Bales, PM; Nelson, DC				Swift, Steven M.; Hudgens, Jeffrey W.; Heselpoth, Ryan D.; Bales, Patrick M.; Nelson, Daniel C.			Characterization of AlgMsp, an Alginate Lyase from Microbulbifer sp 6532A	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; PSEUDOMONAS-AERUGINOSA; OLIGOALGINATE LYASE; CIRCULAR-DICHROISM; CYSTIC-FIBROSIS; IN-VITRO; PURIFICATION; DEPOLYMERIZATION; STRAIN; DELIVERY	Alginate is a polysaccharide produced by certain seaweeds and bacteria that consists of mannuronic acid and guluronic acid residues. Seaweed alginate is used in food and industrial chemical processes, while the biosynthesis of bacterial alginate is associated with pathogenic Pseudomonas aeruginosa. Alginate lyases cleave this polysaccharide into short oligo-uronates and thus have the potential to be utilized for both industrial and medicinal applications. An alginate lyase gene, algMsp, from Microbulbifer sp. 6532A, was synthesized as an E. coli codon-optimized clone. The resulting 37 kDa recombinant protein, AlgMsp, was expressed, purified and characterized. The alginate lyase displayed highest activity at pH 8 and 0.2 M NaCl. Activity of the alginate lyase was greatest at 50 degrees C; however the enzyme was not stable over time when incubated at 50 degrees C. The alginate lyase was still highly active at 25 degrees C and displayed little or no loss of activity after 24 hours at 25 degrees C. The activity of AlgMsp was not dependent on the presence of divalent cations. Comparing activity of the lyase against polymannuronic acid and polyguluronic acid substrates showed a higher turnover rate for polymannuronic acid. However, AlgMSP exhibited greater catalytic efficiency with the polyguluronic acid substrate. Prolonged AlgMsp-mediated degradation of alginate produced dimer, trimer, tetramer, and pentamer oligo-uronates.	[Swift, Steven M.; Hudgens, Jeffrey W.; Heselpoth, Ryan D.; Bales, Patrick M.; Nelson, Daniel C.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Hudgens, Jeffrey W.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Nelson, Daniel C.] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Nelson, DC (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	nelsond@umd.edu	Nelson, Daniel C./I-2198-2012	Nelson, Daniel C./0000-0003-3248-4831; Hudgens, Jeffrey/0000-0003-2805-1048; Swift, Steven/0000-0002-3840-4401	United States Department of Defense [DM102823]	United States Department of Defense(United States Department of Defense)	This work was supported by grants from the United States Department of Defense (DM102823) to DCN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DOGGETT RG, 1966, J PEDIATR-US, V68, P215, DOI 10.1016/S0022-3476(66)80152-X; Duan GF, 2009, CAN J MICROBIOL, V55, P1113, DOI [10.1139/W09-051, 10.1139/w09-051]; Easterby JS, 2003, HYPER32 HYPER EXE VE; Farrell EK, 2012, BIOCHEMISTRY-US, V51, P10259, DOI 10.1021/bi301425r; GACESA P, 1992, INT J BIOCHEM, V24, P545, DOI 10.1016/0020-711X(92)90325-U; GALAMBOS JT, 1967, ANAL BIOCHEM, V19, P119, DOI 10.1016/0003-2697(67)90141-8; Gaspar MC, 2013, EUR J CLIN MICROBIOL, V32, P1231, DOI 10.1007/s10096-013-1876-y; George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017; GILCHRIST T, 1983, BIOMATERIALS, V4, P317, DOI 10.1016/0142-9612(83)90036-4; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; HAUG A, 1962, ACTA CHEM SCAND, V16, P1908, DOI 10.3891/acta.chem.scand.16-1908; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Hutcheson SW, 2011, MAR DRUGS, V9, P645, DOI 10.3390/md9040645; Iwamoto Y, 2001, BIOSCI BIOTECH BIOCH, V65, P133, DOI 10.1271/bbb.65.133; Kim HT, 2012, APPL MICROBIOL BIOT, V93, P2233, DOI 10.1007/s00253-012-3882-x; Kobayashi T, 2009, EXTREMOPHILES, V13, P121, DOI 10.1007/s00792-008-0201-7; Li JW, 2011, MAR DRUGS, V9, P109, DOI 10.3390/md9010109; LINKER A, 1956, J BIOL CHEM, V219, P13; LINKER A, 1966, J BIOL CHEM, V241, P3845; MABEAU S, 1987, J EXP BOT, V38, P1573, DOI 10.1093/jxb/38.9.1573; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Matsubara Y, 1998, BIOSCI BIOTECH BIOCH, V62, P1055, DOI 10.1271/bbb.62.1055; McHugh DJ, 1987, PRODUCTION UTILIZATI; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miyake O, 2003, PROTEIN EXPRES PURIF, V29, P33, DOI 10.1016/S1046-5928(03)00018-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Remminghorst U, 2006, APPL ENVIRON MICROB, V72, P298, DOI 10.1128/AEM.72.1.298-305.2006; Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287; Sim SJ, 2012, J IND MICROBIOL BIOT, V39, P585, DOI 10.1007/s10295-011-1054-0; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Wakabayashi M, 2012, BIODEGRADATION, V23, P93, DOI 10.1007/s10532-011-9489-6; Wang Y, 2013, BIOTECHNOL LETT, V35, P703, DOI 10.1007/s10529-012-1134-x; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Xu X, 2003, BIOSCI BIOTECH BIOCH, V67, P2022, DOI 10.1271/bbb.67.2022; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075	43	55	59	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112939	10.1371/journal.pone.0112939	http://dx.doi.org/10.1371/journal.pone.0112939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409178	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200049
J	Avtzis, DN; Doudoumis, V; Bourtzis, K				Avtzis, Dimitrios N.; Doudoumis, Vangelis; Bourtzis, Kostas			Wolbachia Infections and Mitochondrial Diversity of Two Chestnut Feeding Cydia Species	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HORIZONTAL TRANSFER; HYBRID INTROGRESSION; NATURAL-POPULATIONS; SELECTIVE SWEEPS; TSETSE-FLIES; HOST MTDNA; DNA; EVOLUTION; FAGIGLANDANA	Cydia splendana and C. fagiglandana are two closely related chestnut feeding lepidopteran moth species. In this study, we surveyed the bacterial endosymbiont Wolbachia in these two species. Infection rates were 31% in C. splendana and 77% in C. fagiglandana. MLST analysis showed that these two species are infected with two quite diverse Wolbachia strains. C. splendana with Sequence Type (ST) 409 from the A-supergroup and C. fagiglandana with ST 150 from the B-supergroup. One individual of C. splendana was infected with ST 150, indicating horizontal transfer between these sister species. The mitochondrial DNA of the two Cydia species showed a significantly different mtDNA diversity, which was inversely proportional to their infection rates.	[Avtzis, Dimitrios N.] Hellen Agr Org Demeter, Lab Forest Entomol, Forest Res Inst, Vassilika Thessaloniki, Greece; [Doudoumis, Vangelis; Bourtzis, Kostas] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece; [Bourtzis, Kostas] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria	University of Patras; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Avtzis, DN (corresponding author), Hellen Agr Org Demeter, Lab Forest Entomol, Forest Res Inst, Vassilika Thessaloniki, Greece.	dimitrios.avtzis@fri.gr	Avtzis, Dimitrios/F-8635-2018	Avtzis, Dimitrios/0000-0002-7772-6892				Aguin-Pombo D, 2008, ACTA HORTIC, P175, DOI 10.17660/ActaHortic.2008.784.27; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avtzis DN, 2013, J PEST SCI, V86, P185, DOI 10.1007/s10340-012-0451-0; Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Ballard JWO, 2000, MOL BIOL EVOL, V17, P1126, DOI 10.1093/oxfordjournals.molbev.a026394; Ballard JWO, 2002, EVOLUTION, V56, P527; Bogenschutz H., 1991, World Crop Pests, V5, P673; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bradley JD, 1979, BRIT TORTRICOID MOTH; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; DenOtter CJ, 1996, J APPL ENTOMOL, V120, P413, DOI 10.1111/j.1439-0418.1996.tb01629.x; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; DRUMMOND AJ, 2008, GENEIOUS V4 0; Dyer KA, 2011, MOL ECOL, V20, P2805, DOI 10.1111/j.1365-294X.2011.05128.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FU YX, 1993, GENETICS, V133, P693; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Graham RI, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-204; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Ilinsky Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054373; Jackel R, 2013, MOL ECOL, V22, P4241, DOI 10.1111/mec.12389; Jiggins FM, 2003, GENETICS, V164, P5; Jimenez-Pino A, 2011, SPAN J AGRIC RES, V9, P570; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Karagoz M, 2009, BIOCONTROL SCI TECHN, V19, P755, DOI 10.1080/09583150903100831; Le Clec'h W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060232; LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Morrow JL, 2014, ENVIRON MICROBIOL, V16, P3622, DOI 10.1111/1462-2920.12382; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Nei M., 1987, MOL EVOLUTIONARY GEN; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Ritter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078107; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; Sambrook J, 1989, MOL CLONING; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Seger J, 2010, GENETICS, V184, P529, DOI 10.1534/genetics.109.103556; Shoemaker DD, 2004, GENETICS, V168, P2049, DOI 10.1534/genetics.104.030890; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stahlhut JK, 2010, MOL ECOL, V19, P1940, DOI 10.1111/j.1365-294X.2010.04572.x; Sun XJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-86; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Symula RE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-31; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xiao JH, 2012, EVOLUTION, V66, P1907, DOI 10.1111/j.1558-5646.2011.01561.x; Yun YL, 2011, CURR MICROBIOL, V62, P139, DOI 10.1007/s00284-010-9686-2; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	69	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112795	10.1371/journal.pone.0112795	http://dx.doi.org/10.1371/journal.pone.0112795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405506	gold, Green Submitted, Green Published			2022-12-26	WOS:000347121300053
J	Goldschalt, C; Doll, S; Ihle, B; Kirsch, J; Mutzbauer, TS				Goldschalt, Christin; Doll, Sara; Ihle, Brit; Kirsch, Joachim; Mutzbauer, Till Sebastian			Intraosseous Vascular Access through the Anterior Mandible - A Cadaver Model Pilot Study	PLOS ONE			English	Article							ANESTHETIC EFFICACY; INFUSION DEVICES; METHYLENE-BLUE; BONE-MARROW; VARIABILITY; PLACEMENT; ADULTS; MOLARS; TRIAL; FLUSH	Background: Several insertion sites have been described for intraosseous puncture in cases of emergencies when a conventional vascular access cannot be established. This pilot study has been designed to evaluate the feasibility of the mandibular bone for the use of an intraosseous vascular access in a cadaver model. Methodology/Principal Findings: 17 dentistry and 16 medical students participating in a voluntary course received a short introduction into the method and subsequently used the battery powered EZ-IO system with a 15 mm cannula for a puncture of the anterior mandible in 33 cadavers. The time needed to perform each procedure was evaluated. India ink was injected into the accesses and during the anatomy course cadavers were dissected to retrace the success or failure of the puncture. Dental students needed 25.5 +/- 18.9(mean +/- standard deviation)s and medical students 33 +/- 20.4 s for the procedure (p = 0.18). Floor of mouth extravasation occurred in both groups in 3 cases. Success rates were 82 and 75% (p = 0.93). Conclusions/Significance: Despite floor of mouth extravasation of injected fluid into a mandibular intraosseous access might severely complicate this procedure, the anterior mandible may be helpful as an alternative to other intraosseous and intravenous insertion sites when these are not available in medical emergencies.	[Goldschalt, Christin; Doll, Sara; Ihle, Brit; Kirsch, Joachim; Mutzbauer, Till Sebastian] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany; [Mutzbauer, Till Sebastian] Mutzbauer&Partner, Maxillofacial Surg & Anesthesiol, Zurich, Switzerland	Ruprecht Karls University Heidelberg	Mutzbauer, TS (corresponding author), Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany.	mutzbauer@gmail.com						Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Byars DV, 2011, PREHOSP DISASTER MED, V26, P127, DOI 10.1017/S1049023X11000057; Calkins MD, 2000, J TRAUMA, V48, P1068, DOI 10.1097/00005373-200006000-00012; Erdmann L, 2013, OR SURG OR MED OR PA, V116, P686, DOI 10.1016/j.oooo.2013.07.027; Favier JC, 2007, ANN FR ANESTH, V26, P884, DOI 10.1016/j.annfar.2007.06.005; Frascone R, 2003, J BURN CARE REHABIL, V24, P306, DOI 10.1097/01.BCR.0000085875.68085.6B; Gallatin Juliane, 2003, Anesth Prog, V50, P111; Graetz C, 2013, MED ORAL PATOL ORAL, V18, pE130, DOI 10.4317/medoral.18386; Hafner JW, 2013, WEST J EMERG MED, V14, P629, DOI 10.5811/westjem.2013.4.13361; Hallas P, 2013, WEST J EMERG MED, V14, P440, DOI 10.5811/westjem.2013.1.12000; Halm B, 1998, AM J EMERG MED, V16, P420, DOI 10.1016/S0735-6757(98)90146-2; Harcke HT, 2011, J SPEC OPER MED, V11, P23; Herman MI, 1999, ANN EMERG MED, V33, P111, DOI 10.1016/S0196-0644(99)70427-0; Hori T, 2008, HEPATOB PANCREAT DIS, V7, P362; Kalpidis Christos D, 2005, Implant Dent, V14, P117; Kang SS, 2011, J ULTRAS MED, V30, P1711, DOI 10.7863/jum.2011.30.12.1711; Kovar Jay, 2010, JEMS, V35, P52, DOI 10.1016/S0197-2510(10)70207-2; Lairet J, 2013, PREHOSP EMERG CARE, V17, P280, DOI 10.3109/10903127.2012.755582; Levitan RM, 2009, ANN EMERG MED, V54, P692, DOI 10.1016/j.annemergmed.2009.06.012; McCarthy G, 2003, RESUSCITATION, V56, P183, DOI 10.1016/S0300-9572(02)00348-9; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; ONEILL JF, 1945, ANN SURG, V122, P266, DOI 10.1097/00000658-194508000-00011; Ozer S, 2012, OR SURG OR MED OR PA, V114, pS132, DOI 10.1016/j.oooo.2011.09.021; Pereira LAP, 2013, OR SURG OR MED OR PA, V116, pE85, DOI 10.1016/j.oooo.2011.10.045; Rubal BJ, 2012, LAB ANIMAL, V41, P224, DOI 10.1038/laban0812-224; Santos D, 2013, RESUSCITATION, V84, P440, DOI 10.1016/j.resuscitation.2012.11.006; Schalk R, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-65; Shavit I, 2009, RESUSCITATION, V80, P1029, DOI 10.1016/j.resuscitation.2009.05.026; Sontgerath JS, 2014, AM J EMERG MED, V32, P665, DOI 10.1016/j.ajem.2014.03.001; Tocantins LM, 1941, ANN SURG, V114, P1085, DOI 10.1097/00000658-194112000-00015; Waisman M, 1997, J TRAUMA, V42, P288, DOI 10.1097/00005373-199702000-00019; Zarei M, 2012, INT ENDOD J, V45, P921, DOI 10.1111/j.1365-2591.2012.02050.x	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112686	10.1371/journal.pone.0112686	http://dx.doi.org/10.1371/journal.pone.0112686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405476	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300046
J	Ishii, S; Tanaka, T; Akishita, M; Ouchi, Y; Tuji, T; Iijima, K				Ishii, Shinya; Tanaka, Tomoki; Akishita, Masahiro; Ouchi, Yasuyoshi; Tuji, Tetsuo; Iijima, Katsuya		Kashiwa Study Investigators	Metabolic Syndrome, Sarcopenia and Role of Sex and Age: Cross-Sectional Analysis of Kashiwa Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; MUSCLE STRENGTH; PHYSICAL PERFORMANCE; VISCERAL OBESITY; AEROBIC FITNESS; BLOOD-PRESSURE; ELDERLY-MEN; OLDER MEN; ASSOCIATION	Recent epidemiological evidence suggests that effects of cardiovascular risk factors may vary depending on sex and age. In this study, we assessed the associations of metabolic syndrome (MetS) with sarcopenia and its components in older adults, and examined whether the associations vary by sex and age. We also tested if any one of the MetS components could explain the associations. We conducted a cross-sectional analysis of the baseline data from the cohort study conducted in Kashiwa city, Chiba, Japan in 2012 which included 1971 functionally-independent, community-dwelling Japanese adults aged 65 years or older (977 men, 994 women). Sarcopenia was defined based on appendicular skeletal muscle mass, grip strength and usual gait speed. MetS was defined based on the National Cholesterol Education Program's Adult Treatment Panel-III criteria. The prevalence of sarcopenia was 14.2% in men and 22.1% in women, while the prevalence of MetS was 43.6% in men and 28.9% in women. After adjustment for potential confounders, MetS was positively associated with sarcopenia in men aged 65 to 74 years (odds ratio 5.5; 95% confidence interval 1.9-15.9) but not in older men or women. Among the sarcopenia components, MetS was associated with lower muscle mass and grip strength, particularly in men aged 65 to 74 years. The associations of MetS with sarcopenia and its components were mainly driven by abdominal obesity regardless of sex or age. In conclusion, MetS is positively associated with sarcopenia in older men. The association is modified by sex and age, but abdominal obesity is the main contributor to the association across sex and age.	[Ishii, Shinya; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; [Tanaka, Tomoki; Tuji, Tetsuo; Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Bunkyo Ku, Tokyo 1138656, Japan; [Ouchi, Yasuyoshi] Toranomon Gen Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Minato Ku, Tokyo 1058470, Japan	University of Tokyo; University of Tokyo; Toranomon Hospital	Iijima, K (corresponding author), Univ Tokyo, Inst Gerontol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	iijima@iog.u-tokyo.ac.jp			Health and Labor Sciences Research Grant from Ministry of Health, Labor, and Welfare of Japan [H24-Choju-Ippan-002]	Health and Labor Sciences Research Grant from Ministry of Health, Labor, and Welfare of Japan	This work was supported by a Health and Labor Sciences Research Grant (H24-Choju-Ippan-002 to KI) from the Ministry of Health, Labor, and Welfare of Japan (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], CIRCULATION, V120, P1640; Auyeung TW, 2011, EUR J ENDOCRINOL, V164, P811, DOI 10.1530/EJE-10-0952; Beavers KM, 2013, J GERONTOL A-BIOL, V68, P617, DOI 10.1093/gerona/gls213; Beenakker KGM, 2010, AGEING RES REV, V9, P431, DOI 10.1016/j.arr.2010.05.005; Bucci L, 2013, BIOGERONTOLOGY, V14, P261, DOI 10.1007/s10522-013-9428-5; Carriere I, 2014, J GERONTOL A-BIOL, V69, P79, DOI 10.1093/gerona/glt101; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Everson-Rose SA, 2011, J AM GERIATR SOC, V59, P1376, DOI 10.1111/j.1532-5415.2011.03518.x; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Kawano Y, 2011, AM J HYPERTENS, V24, P1250, DOI 10.1038/ajh.2011.138; Kim TN, 2013, J CLIN ENDOCR METAB, V98, P811, DOI 10.1210/jc.2012-3292; Koh KK, 2005, J AM COLL CARDIOL, V46, P1978, DOI 10.1016/j.jacc.2005.06.082; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Landi F, 2000, ARCH INTERN MED, V160, P2641, DOI 10.1001/archinte.160.17.2641; Laudisio A, 2013, CLIN NUTR; Lee CG, 2011, J AM GERIATR SOC, V59, P1217, DOI 10.1111/j.1532-5415.2011.03472.x; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Liu PY, 2007, J CLIN ENDOCR METAB, V92, P3599, DOI 10.1210/jc.2007-0862; Lu CW, 2013, OBES RES CLIN PRACT, V7, pE301, DOI 10.1016/j.orcp.2012.02.003; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922; Moon SS, 2014, ENDOCR J, V61, P61, DOI 10.1507/endoc; Nagasaki H, 1996, PERCEPT MOTOR SKILL, V82, P435, DOI 10.2466/pms.1996.82.2.435; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Park S, 2013, CLIN NUTR, DOI 10.1016; Park SW, 2009, DIABETES CARE, V32, P1993, DOI 10.2337/dc09-0264; Penninx BWJH, 2009, J GERONTOL A-BIOL, V64, P96, DOI 10.1093/gerona/gln005; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stenholm S, 2010, J GERONTOL A-BIOL, V65, P84, DOI 10.1093/gerona/glp150; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Weiss A, 2009, DIABETIC MED, V26, P253, DOI 10.1111/j.1464-5491.2009.02672.x; Wijndaele K, 2007, MED SCI SPORT EXER, V39, P233, DOI 10.1249/01.mss.0000247003.32589.a6; Yang EF, 2012, METABOLISM, V61, P317, DOI 10.1016/j.metabol.2011.07.005; Zoico E, 2004, J GERONTOL A-BIOL, V59, P935, DOI 10.1093/gerona/59.9.M935	43	55	55	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112718	10.1371/journal.pone.0112718	http://dx.doi.org/10.1371/journal.pone.0112718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405866	gold, Green Submitted, Green Published			2022-12-26	WOS:000347121300049
J	Hu, WT; Anand, G; Sivaraman, J; Leung, KY; Mok, YK				Hu, Wentao; Anand, Ganesh; Sivaraman, J.; Leung, Ka Yin; Mok, Yu-Keung			A Disordered Region in the EvpP Protein from the Type VI Secretion System of Edwardsiella tarda EvpC Binding	PLOS ONE			English	Article							BACTERIAL TYPE-VI; PSEUDOMONAS-AERUGINOSA; IMMUNITY PROTEIN; STRUCTURAL INSIGHTS; EFFECTOR; CHAPERONE; COMPLEX; COMPETITION; INHIBITION; PROTEOMICS	The type VI secretion system (T6SS) of pathogenic bacteria plays important roles in both virulence and inter-bacterial competitions. The effectors of T6SS are presumed to be transported either by attaching to the tip protein or by interacting with HcpI (haemolysin corregulated protein 1). In Edwardsiella tarda PPD130/91, the T6SS secreted protein EvpP (E. tarda virulent protein P) is found to be essential for virulence and directly interacts with EvpC (Hcp-like), suggesting that it could be a potential effector. Using limited protease digestion, nuclear magnetic resonance heteronuclear Nuclear Overhauser Effects, and hydrogen-deuterium exchange mass spectrometry, we confirmed that the dimeric EvpP (40 kDa) contains a substantial proportion (40%) of disordered regions but still maintains an ordered and folded core domain. We show that an N-terminal, 10-kDa, protease-resistant fragment in EvpP connects to a shorter, 4-kDa protease-resistant fragment through a highly flexible region, which is followed by another disordered region at the C-terminus. Within this C-terminal disordered region, residues Pro143 to Ile168 are essential for its interaction with EvpC. Unlike the highly unfolded T3SS effector, which has a lower molecular weight and is maintained in an unfolded conformation with a dedicated chaperone, the T6SS effector seems to be relatively larger, folded but partially disordered and uses HcpI as a chaperone.	[Hu, Wentao; Anand, Ganesh; Sivaraman, J.; Mok, Yu-Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Leung, Ka Yin] Trinity Western Univ, Fac Nat & Appl Sci, Dept Biol, Langley, BC V2Y 1Y1, Canada; [Leung, Ka Yin] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	National University of Singapore; Trinity Western University; East China University of Science & Technology	Mok, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsmokh@nus.edu.sg	Anand, Ganesh/H-8473-2012	J, Sivaraman/0000-0001-9781-5326	Academic Research Fund, National University of Singapore [R-154-000-498-112]; National Science and Engineering Research Council (NSERC), Canada [372373-2010]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering of China	Academic Research Fund, National University of Singapore(National University of Singapore); National Science and Engineering Research Council (NSERC), Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Open Funding Project of the State Key Laboratory of Bioreactor Engineering of China	This project was supported by Academic Research Fund, National University of Singapore grant R-154-000-498-112 to Y.K.M. K.Y.L. was supported by a grant from the National Science and Engineering Research Council (NSERC) Discovery Grant (372373-2010), Canada, and the Open Funding Project of the State Key Laboratory of Bioreactor Engineering of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzalimov RR, 2009, J AM SOC MASS SPECTR, V20, P1514, DOI 10.1016/j.jasms.2009.04.006; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong C, 2013, BIOCHEM J, V454, P59, DOI 10.1042/BJ20130193; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Goddard TD, KNELLER DG SPARKY; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kaltashov IA, 2009, ANAL CHEM, V81, P7892, DOI 10.1021/ac901366n; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leung KY, 2012, MICROBES INFECT, V14, P26, DOI 10.1016/j.micinf.2011.08.005; Leung KY, 2011, CURR OPIN MICROBIOL, V14, P9, DOI 10.1016/j.mib.2010.09.017; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lu DF, 2014, MOL MICROBIOL, V92, P1092, DOI 10.1111/mmi.12616; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Robb CS, 2013, ACTA CRYSTALLOGR F, V69, P607, DOI 10.1107/S1744309113012220; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; van Soest JJ, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-58; Vogelaar NJ, 2010, BIOCHEMISTRY-US, V49, P5870, DOI 10.1021/bi100432e; Wang TY, 2013, ACTA CRYSTALLOGR D, V69, P1889, DOI 10.1107/S090744491301576X; Wang X, 2009, FISH SHELLFISH IMMUN, V27, P469, DOI 10.1016/j.fsi.2009.06.013; Xu YQ, 2006, NAT METHODS, V3, P931, DOI 10.1038/NMETH938; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081074; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng ZD, 2012, BIOCHEM BIOPH RES CO, V417, P129, DOI 10.1016/j.bbrc.2011.11.070; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110810	10.1371/journal.pone.0110810	http://dx.doi.org/10.1371/journal.pone.0110810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401506	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700008
J	Uetake, J; Tanaka, S; Hara, K; Tanabe, Y; Samyn, D; Motoyama, H; Imura, S; Kohshima, S				Uetake, Jun; Tanaka, Sota; Hara, Kosuke; Tanabe, Yukiko; Samyn, Denis; Motoyama, Hideaki; Imura, Satoshi; Kohshima, Shiro			Novel Biogenic Aggregation of Moss Gemmae on a Disappearing African Glacier	PLOS ONE			English	Article							GULKANA GLACIER; PHYLOGENETIC ANALYSIS; MICROBIAL ACTIVITY; UNIVERSAL PRIMERS; CRYOCONITE HOLES; AMPLIFICATION; BRYOPHYTES; MORPHOLOGY; FALLJOKULL; BERGGRENII	Tropical regions are not well represented in glacier biology, yet many tropical glaciers are under threat of disappearance due to climate change. Here we report a novel biogenic aggregation at the terminus of a glacier in the Rwenzori Mountains, Uganda. The material was formed by uniseriate protonemal moss gemmae and protonema. Molecular analysis of five genetic markers determined the taxon as Ceratodon purpureus, a cosmopolitan species that is widespread in tropical to polar region. Given optimal growing temperatures of isolate is 20-30 degrees C, the cold glacier surface might seem unsuitable for this species. However, the cluster of protonema growth reached approximately 10 degrees C in daytime, suggesting that diurnal increase in temperature may contribute to the moss's ability to inhabit the glacier surface. The aggregation is also a habitat for microorganisms, and the disappearance of this glacier will lead to the loss of this unique ecosystem.	[Uetake, Jun] Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo, Japan; [Uetake, Jun] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Tanaka, Sota; Motoyama, Hideaki; Imura, Satoshi] Chiba Univ, Fac Sci, Chiba, Japan; [Hara, Kosuke] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Tanabe, Yukiko] Waseda Univ, Inst Adv Study, Shinjuku Ku, Tokyo, Japan; [Samyn, Denis] Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 94021, Japan; [Kohshima, Shiro] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan	Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Chiba University; Kyoto University; Waseda University; Nagaoka University of Technology; Kyoto University	Uetake, J (corresponding author), Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo, Japan.	juetake@nipr.ac.jp	Uetake, Jun/V-4853-2018		Ministry of Education, Culture, Sports, Science and Technology [22241005]; Proposal for Seeds of Transdisciplinary Research from the Transdisciplinary Research Integration Center; NIPR; Grants-in-Aid for Scientific Research [25740012] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Proposal for Seeds of Transdisciplinary Research from the Transdisciplinary Research Integration Center; NIPR(National Institute of Polar Research (NIPR) - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research (A) No. 22241005 and by Proposal for Seeds of Transdisciplinary Research from the Transdisciplinary Research Integration Center, and by an NIPR publication subsidy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R.A., 2005, ALGAL CULTURING TECH, P437; Anesio AM, 2009, GLOBAL CHANGE BIOL, V15, P955, DOI 10.1111/j.1365-2486.2008.01758.x; Benninghoff W.S., 1955, J GLACIOL, V2, P514; Cameron KA, 2012, FEMS MICROBIOL ECOL, V82, P254, DOI 10.1111/j.1574-6941.2011.01277.x; Chiang TY, 1998, BOT BULL ACAD SINICA, V39, P245; Coulson SJ, 2012, POLAR BIOL, V35, P1651, DOI 10.1007/s00300-012-1205-4; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards A, 2011, ISME J, V5, P150, DOI 10.1038/ismej.2010.100; Eythorsson J, 1951, J GLACIOL, V1, P503, DOI 10.1017/S0022143000026538; Hamilton TL, 2013, ISME J, V7, P1402, DOI 10.1038/ismej.2013.31; Hauman L., 1942, BULL JARD BOT ETAT BRUXELLES, V16, P311, DOI 10.2307/3666740; HEUSSER CJ, 1972, B TORREY BOT CLUB, V99, P34, DOI 10.2307/2484240; HICKLENTON PR, 1976, CAN J BOT, V54, P1104, DOI 10.1139/b76-118; Higuchi S, 2003, J PLANT RES, V116, P461, DOI 10.1007/s10265-003-0125-3; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Hope GS, 1976, EQUATORIAL GLACIERS, P81; Imura S., 1986, MEMOIRS NATL I POLAR, V44, P241; Kanda H, 1979, MEM NATL I POLAR RES, V11, P58; Kaser G, 2002, TROPICAL GLACIERS, P63; La Farge C, 2013, P NATL ACAD SCI USA, V110, P9839, DOI 10.1073/pnas.1304199110; Lentini G, 2011, GEOGR FIS DIN QUAT, V34, P183, DOI 10.4461/GFDQ.2011.34.17; Longton R.E., 1988, BIOL POLAR BRYOPHYTE, P141; McDaniel SF, 2005, MOL ECOL, V14, P1121, DOI 10.1111/j.1365-294X.2005.02484.x; McMinn A, 2004, J MAR BIOL ASSOC UK, V84, P865, DOI 10.1017/S0025315404010112h; Moelg T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026384; NADOT S, 1995, MOL PHYLOGENET EVOL, V4, P257, DOI 10.1006/mpev.1995.1024; Oechel WC, 1978, VEGETATION PRODUCTIO, P269; Porter PR, 2008, ANN GLACIOL-SER, V48, P25, DOI 10.3189/172756408784700734; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rabatel A, 2013, CRYOSPHERE, V7, P81, DOI 10.5194/tc-7-81-2013; Remias D, 2012, FEMS MICROBIOL ECOL, V79, P638, DOI 10.1111/j.1574-6941.2011.01245.x; SATAKE K, 1990, J BRYOL, V16, P109, DOI 10.1179/jbr.1990.16.1.109; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segawa T, 2010, MICROBES ENVIRON, V25, P171, DOI 10.1264/jsme2.ME10119; Shaw AJ, 2003, AM J BOT, V90, P1777, DOI 10.3732/ajb.90.12.1777; SHAW J, 1991, BRYOLOGIST, V94, P270, DOI 10.2307/3243964; Smith LRI, 1999, J VEG SCI, V10, P231; Sonoike K, 1998, J PLANT RES, V111, P121, DOI 10.1007/BF02507158; SouzaChies TT, 1997, PLANT SYST EVOL, V204, P109, DOI 10.1007/BF00982535; Stibal M, 2008, BIOGEOCHEMISTRY, V90, P1, DOI 10.1007/s10533-008-9226-3; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takeuchi N, 2001, HYDROL PROCESS, V15, P3447, DOI 10.1002/hyp.1040; Takeuchi N., 2005, B GLACIOLOG RES, V22, P1; Takeuchi N, 2006, ANN GLACIOL-SER, V43, P378, DOI 10.3189/172756406781812113; Takeuchi N, 2010, ANN GLACIOL, V51, P9, DOI 10.3189/172756411795932010; Tanabe Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014690; Taylor RG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025962; Telling J, 2011, J GEOPHYS RES, V116, P2; Thompson LG, 2013, SCIENCE, V340, P945, DOI 10.1126/science.1234210; Thompson LG, 2009, P NATL ACAD SCI USA, V106, P19770, DOI 10.1073/pnas.0906029106; Uetake J, 2012, FEMS MICROBIOL ECOL, V82, P279, DOI 10.1111/j.1574-6941.2012.01323.x; WHARTON RA, 1985, BIOSCIENCE, V35, P499, DOI 10.2307/1309818	52	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112510	10.1371/journal.pone.0112510	http://dx.doi.org/10.1371/journal.pone.0112510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401789	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700051
J	da Costa, AC; Costa, AD; de Oliveira, FM; Nogueira, SV; Rosa, JD; Resende, DP; Kipnis, A; Junqueira-Kipnis, AP				da Costa, Adeliane Castro; Costa-Junior, Abadio de Oliveira; de Oliveira, Fabio Muniz; Nogueira, Sarah Veloso; Rosa, Joseane Damaceno; Resende, Danilo Pires; Kipnis, Andre; Junqueira-Kipnis, Ana Paula			A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; BACILLUS-CALMETTE-GUERIN; T-CELLS; FUSION PROTEIN; NITRIC-OXIDE; INFECTION; CYTOKINE; RESPONSES; MOREAU; HSPX	Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that is a major public health problem. The vaccine used for TB prevention is Mycobacterium bovis bacillus Calmette-Guerin (BCG), which provides variable efficacy in protecting against pulmonary TB among adults. Consequently, several groups have pursued the development of a new vaccine with a superior protective capacity to that of BCG. Here we constructed a new recombinant BCG (rBCG) vaccine expressing a fusion protein (CMX) composed of immune dominant epitopes from Ag85C, MPT51, and HspX and evaluated its immunogenicity and protection in a murine model of infection. The stability of the vaccine in vivo was maintained for up to 20 days post-vaccination. rBCG-CMX was efficiently phagocytized by peritoneal macrophages and induced nitric oxide (NO) production. Following mouse immunization, this vaccine induced a specific immune response in cells from lungs and spleen to the fusion protein and to each of the component recombinant proteins by themselves. Vaccinated mice presented higher amounts of Th1, Th17, and polyfunctional specific T cells. rBCG-CMX vaccination reduced the extension of lung lesions caused by challenge with Mtb as well as the lung bacterial load. In addition, when this vaccine was used in a prime-boost strategy together with rCMX, the lung bacterial load was lower than the result observed by BCG vaccination. This study describes the creation of a new promising vaccine for TB that we hope will be used in further studies to address its safety before proceeding to clinical trials.	[da Costa, Adeliane Castro; Costa-Junior, Abadio de Oliveira; Nogueira, Sarah Veloso; Rosa, Joseane Damaceno; Resende, Danilo Pires; Junqueira-Kipnis, Ana Paula] Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Imunopatol Doencas Infecciosas, Goiania, Go, Brazil; [de Oliveira, Fabio Muniz; Kipnis, Andre] Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Bacteriol Mol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Junqueira-Kipnis, AP (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Imunopatol Doencas Infecciosas, Goiania, Go, Brazil.	apkipnis@gmail.com	de Oliveira, Fábio Muniz/AAG-4987-2019; Junqueira-Kipnis, Ana Paula/I-5534-2012; Castro da Costa, Adeliane/G-3848-2015; Kipnis, Andre/ABG-5707-2020; Kipnis, Andre/M-7485-2017; Castro da Costa, Adeliane/CAF-9210-2022	de Oliveira, Fábio Muniz/0000-0002-4470-8444; Castro da Costa, Adeliane/0000-0002-5440-8613; Kipnis, Andre/0000-0001-5950-106X; Kipnis, Andre/0000-0001-5950-106X; Resende, Danilo/0000-0002-3329-7352	National Council for Scientific and Technological Development (CNPq) [301976/2011-2, 472906/2011-9, 301198/2009-8, 472909/2011-8]; Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG-PRONEX); CNPq; PIBIC-CNPq	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG-PRONEX); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PIBIC-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financed by the National Council for Scientific and Technological Development (CNPq, Project #301976/2011-2, 472906/2011-9, 301198/2009-8, 472909/2011-8) and by Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG-PRONEX). ACC received a PhD fellowship from CNPq. AOCJ, DPR, and FMO each received a MSc fellowship from CNPq. SVN received a Post Doc fellowship from CNPq. JDR received an undergraduate fellowship from PIBIC-CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x; Achkar JM, 2010, CLIN VACCINE IMMUNOL, V17, P384, DOI 10.1128/CVI.00503-09; Andrade PM, 2010, UROL ONCOL-SEMIN ORI, V28, P520, DOI 10.1016/j.urolonc.2008.12.017; Bastos RG, 2009, VACCINE, V27, P6495, DOI 10.1016/j.vaccine.2009.08.044; Behr MA, 1997, NATURE, V389, P133, DOI 10.1038/38151; Berredo-Pinho M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-80; Brosch R, 2000, INT J MED MICROBIOL, V290, P143; Calmette A, 1929, ANN I PASTEUR, V41, P201; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Clark SO, 2010, VACCINE, V28, P7109, DOI 10.1016/j.vaccine.2010.07.087; Cooper AM, 2002, TRENDS MICROBIOL, V10, P221, DOI 10.1016/S0966-842X(02)02344-2; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; da Costa AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00152; de Araujo JA, 2008, TUBERCULOSIS, V88, P474, DOI 10.1016/j.tube.2008.06.002; de Sousa EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047781; Silva BDD, 2009, VACCINE, V27, P4402, DOI 10.1016/j.vaccine.2009.05.049; Deng YH, 2014, J MICROBIOL IMMUNOL, V47, P48, DOI 10.1016/j.jmii.2012.11.005; Desel C, 2011, J INFECT DIS, V204, P1573, DOI 10.1093/infdis/jir592; Farinacci M, 2012, VACCINE, V30, P7608, DOI 10.1016/j.vaccine.2012.10.031; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Vasconcellos HLF, 2012, VACCINE, V30, P5999, DOI 10.1016/j.vaccine.2012.05.083; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Gomes LHF, 2011, J BACTERIOL, V193, P5600, DOI 10.1128/JB.05827-11; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Junqueira-Kipnis AP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00188; Junqueira-Kipnis AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078639; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kashyap RS, 2013, CLIN NEUROL NEUROSUR, V115, P678, DOI 10.1016/j.clineuro.2012.07.031; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lienhardt C, 2005, LANCET, V366, P1414, DOI 10.1016/S0140-6736(05)67535-6; Lin CW, 2012, APMIS, V120, P72, DOI 10.1111/j.1600-0463.2011.02815.x; Maroof A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003875; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Nascimento IP, 2000, INFECT IMMUN, V68, P4877, DOI 10.1128/IAI.68.9.4877-4883.2000; Nascimento IP, 2009, VACCINE, V27, P7346, DOI 10.1016/j.vaccine.2009.09.043; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Partnership WST, 2010, GLOB PLAN STOP TB 20; Pearl JE, 2012, EUR J IMMUNOL, V42, P3267, DOI 10.1002/eji.201142158; Rabahi MF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-148; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Shi CW, 2010, VACCINE, V28, P5237, DOI 10.1016/j.vaccine.2010.05.063; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Spratt Joanne M, 2010, Bioeng Bugs, V1, P61, DOI 10.4161/bbug.1.1.10027; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tang C, 2008, J INFECT DIS, V197, P1263, DOI 10.1086/586902; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Varaldo PB, 2004, INFECT IMMUN, V72, P3336, DOI 10.1128/IAI.72.6.3336-3343.2004; Wang C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/563838; Wareham AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088149; *WHO, 1998, GLOB TUB CONTR; Wilson RA, 2004, J MOL BIOL, V335, P519, DOI 10.1016/j.jmb.2003.11.001; World Health Organization, 2013, GLOB TUB CONTR EP ST; Xu WM, 2005, CELL RES, V15, P63, DOI 10.1038/sj.cr.7290267; Yuk JM, 2014, CLIN EXP VACCINE RES, V3, P155, DOI 10.7774/cevr.2014.3.2.155; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071243	61	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112848	10.1371/journal.pone.0112848	http://dx.doi.org/10.1371/journal.pone.0112848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398087	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500100
J	Duszyk, A; Bierzynska, M; Radzikowska, Z; Milanowski, P; Kus, R; Suffczynski, P; Michalska, M; Labecki, M; Zwolinski, P; Durka, P				Duszyk, Anna; Bierzynska, Maria; Radzikowska, Zofia; Milanowski, Piotr; Kus, Rafal; Suffczynski, Piotr; Michalska, Magdalena; Labecki, Maciej; Zwolinski, Piotr; Durka, Piotr			Towards an Optimization of Stimulus Parameters for Brain-Computer Interfaces Based on Steady State Visual Evoked Potentials	PLOS ONE			English	Article							GANGLION-CELLS; RECEPTIVE-FIELDS; PRIMATE RETINA; EEG; DYNAMICS; MONKEY	Efforts to construct an effective brain-computer interface (BCI) system based on Steady State Visual Evoked Potentials (SSVEP) commonly focus on sophisticated mathematical methods for data analysis. The role of different stimulus features in evoking strong SSVEP is less often considered and the knowledge on the optimal stimulus properties is still fragmentary. The goal of this study was to provide insight into the influence of stimulus characteristics on the magnitude of SSVEP response. Five stimuli parameters were tested: size, distance, colour, shape, and presence of a fixation point in the middle of each flickering field. The stimuli were presented on four squares on LCD screen, with each square highlighted by LEDs flickering with different frequencies. Brighter colours and larger dimensions of flickering fields resulted in a significantly stronger SSVEP response. The distance between stimulation fields and the presence or absence of the fixation point had no significant effect on the response. Contrary to a popular belief, these results suggest that absence of the fixation point does not reduce the magnitude of SSVEP response. However, some parameters of the stimuli such as colour and the size of the flickering field play an important role in evoking SSVEP response, which indicates that stimuli rendering is an important factor in building effective SSVEP based BCI systems.	[Duszyk, Anna; Radzikowska, Zofia] Univ Social Sci & Humanities, Warsaw, Poland; [Milanowski, Piotr; Kus, Rafal; Suffczynski, Piotr; Michalska, Magdalena; Labecki, Maciej; Durka, Piotr] Univ Warsaw, Fac Phys, Warsaw, Poland; [Bierzynska, Maria] Nencki Inst Expt Biol PAS, Warsaw, Poland; [Zwolinski, Piotr] Warsaw Mem Child Hosp, Dept Neurosurg, Warsaw, Poland	SWPS University of Social Sciences & Humanities; University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Duszyk, A (corresponding author), Univ Social Sci & Humanities, Warsaw, Poland.	aduszyk@st.swps.edu.pl	Suffczynski, Piotr/ABG-5183-2020	Durka, Piotr/0000-0001-5816-8082; Duszyk, Anna/0000-0002-5984-2339; Suffczynski, Piotr/0000-0002-2300-1415	Polish funds for science; project "Optimisation of stimuli for SSVEP-based Brain Computer Interfaces based on psychophysiology of phenomenon" realized within the Ventures Programme of Foundation for Polish Science	Polish funds for science; project "Optimisation of stimuli for SSVEP-based Brain Computer Interfaces based on psychophysiology of phenomenon" realized within the Ventures Programme of Foundation for Polish Science	This research was financed from Polish funds for science and the project "Optimisation of stimuli for SSVEP-based Brain Computer Interfaces based on psychophysiology of phenomenon" realized within the Ventures Programme of Foundation for Polish Science, operated within the Innovative Economy Operational Programme (IE OP) 2007-2013 within European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Cheong SK, 2013, J NEUROSCI, V33, P6864, DOI 10.1523/JNEUROSCI.5208-12.2013; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; Durka PJ, 2012, B POL ACAD SCI-TECH, V60, P427, DOI 10.2478/v10175-012-0054-1; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Fukunaga K., 2013, INTRO STAT PATTERN R; Gerloff M, 2012, BIOMED ENG-BIOMED TE, V57, P95, DOI 10.1515/bmt-2012-4119; Hevre A, 2007, BONFERONI SIDAK CORR, P103; Hoffmann U, 2009, I IEEE EMBS C NEUR E, P459; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Kalloniatis Michael, 2007, WEBVISION ORG RETINA; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Kaplan E, 2003, VISUAL NEUROSCIENCES, P481; Kelly SP, 2005, IEEE T BIO-MED ENG, V52, P1588, DOI 10.1109/TBME.2005.851510; Kus R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077536; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Lotto RB, 2000, P NATL ACAD SCI USA, V97, P12834, DOI 10.1073/pnas.210369597; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Pastor MA, 2003, J NEUROSCI, V23, P11621; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; REGAN D, 1975, NATURE, V253, P401, DOI 10.1038/253401a0; Regan D, 1977, ELECTROENCEPHALOGR C, V25, P231; Regan David, 2000, HUMAN PERCEPTION OBJ; Summers RJ, 2009, VISION RES, V49, P1894, DOI 10.1016/j.visres.2009.04.027; Vialatte F, 2008, P 15 INT C ADV NEUR; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang NY, 2010, 2ND IEEE INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER CONTROL (ICACC 2010), VOL. 4, P355, DOI 10.1109/ICACC.2010.5486907; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zhu Danhua, 2010, Comput Intell Neurosci, P702357, DOI 10.1155/2010/702357	37	42	43	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112099	10.1371/journal.pone.0112099	http://dx.doi.org/10.1371/journal.pone.0112099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398134	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500032
J	Nagasaki, H; Katsumata, T; Oishi, H; Tai, PH; Sekiguchi, Y; Koshida, R; Jung, Y; Kudo, T; Takahashi, S				Nagasaki, Haruka; Katsumata, Tokio; Oishi, Hisashi; Tai, Pei-Han; Sekiguchi, Yukari; Koshida, Ryusuke; Jung, Yunshin; Kudo, Takashi; Takahashi, Satoru			Generation of Insulin-Producing Cells from the Mouse Liver Using beta Cell-Related Gene Transfer Including Mafa and Mafb	PLOS ONE			English	Article							IN-VIVO; DNA-BINDING; PHOSPHORYLATION; EXPRESSION; GLUCOSE; MICE; PANCREAS; PLASTICITY; TARGET	Recent studies on the large Maf transcription factors have shown that Mafb and Mafa have respective and distinctive roles in beta-cell development and maturation. However, whether this difference in roles is due to the timing of the gene expression (roughly, expression of Mafb before birth and of Mafa after birth) or to the specific function of each gene is unclear. Our aim was to examine the functional differences between these genes that are closely related to beta cells by using an in vivo model of beta-like cell generation. We monitored insulin gene transcription by measuring bioluminescence emitted from the liver of insulin promoter-luciferase transgenic (MIP-Luc-VU) mice. Adenoviral gene transfers of Pdx1/Neurod/Mafa (PDA) and Pdx1/Neurod/Mafb (PDB) combinations generated intense luminescence from the liver that lasted for more than 1 week and peaked at 3 days after transduction. The peak signal intensities of PDA and PDB were comparable. However, PDA but not PDB transfer resulted in significant bioluminescence on day 10, suggesting that Mafa has a more sustainable role in insulin gene activation than does Mafb. Both PDA and PDB transfers ameliorated the glucose levels in a streptozotocin (STZ)-induced diabetic model for up to 21 days and 7 days, respectively. Furthermore, PDA transfer induced several gene expressions necessary for glucose sensing and insulin secretion in the liver on day 9. However, a glucose tolerance test and liver perfusion experiment did not show glucose-stimulated insulin secretion from intrahepatic beta-like cells. These results demonstrate that bioluminescence imaging in MIP-Luc-VU mice provides a noninvasive means of detecting beta-like cells in the liver. They also show that Mafa has a markedly intense and sustained role in beta-like cell production in comparison with Mafb.	[Nagasaki, Haruka; Katsumata, Tokio; Oishi, Hisashi; Tai, Pei-Han; Sekiguchi, Yukari; Koshida, Ryusuke; Jung, Yunshin; Kudo, Takashi; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Oishi, Hisashi; Takahashi, Satoru] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Oishi, H (corresponding author), Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan.	hoishi@md.tsukuba.ac.jp; satoruta@md.tsukuba.ac.jp		Jung, Yunshin/0000-0001-8093-5620; Kudo, Takashi/0000-0001-5477-7235; Koshida, Ryusuke/0000-0003-4726-7282	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21220009]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (21220009) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Artner I, 2008, J ENDOCRINOL, V198, P271, DOI 10.1677/JOE-08-0063; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Guo SL, 2010, J BIOL CHEM, V285, P12655, DOI 10.1074/jbc.M110.105759; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Ham DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079076; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Kajihara M, 2003, BIOCHEM BIOPH RES CO, V312, P831, DOI 10.1016/j.bbrc.2003.10.196; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Katsumata T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060411; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lu YX, 2004, MOL THER, V9, P428, DOI 10.1016/j.ymthe.2004.01.008; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P7711, DOI 10.1073/pnas.86.20.7711; Palumbo MO, 2006, DIABETES, V55, P2595, DOI 10.2337/db05-1651; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Sadikot Ruxana T., 2008, V477, P383, DOI 10.1007/978-1-60327-517-0_29; Sekiguchi Y, 2012, EXP ANIM TOKYO, V61, P445, DOI 10.1538/expanim.61.445; Shao CL, 2009, J BIOL CHEM, V284, P3117, DOI 10.1074/jbc.M806286200; Szabat M, 2012, DIABETES, V61, P1365, DOI 10.2337/db11-1361; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Walde SSI, 2002, LIFE SCI, V71, P1681, DOI 10.1016/S0024-3205(02)01918-5; Yamazaki H, 2012, MOL CELL BIOL, V32, P808, DOI 10.1128/MCB.06543-11; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Zinn KR, 2008, ILAR J, V49, P103, DOI 10.1093/ilar.49.1.103	36	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113022	10.1371/journal.pone.0113022	http://dx.doi.org/10.1371/journal.pone.0113022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397325	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558500124
J	Rodriguez, J; Pitts, JP; von Dohlen, CD; Wilson, JS				Rodriguez, Juanita; Pitts, James P.; von Dohlen, Carol D.; Wilson, Joseph S.			Mullerian Mimicry as a Result of Codivergence between Velvet Ants and Spider Wasps	PLOS ONE			English	Article							EVOLUTION; HYMENOPTERA; DIET; MUTILLIDAE; PIGEONS; FROGS	Recent studies have delineated a large Nearctic Mullerian mimicry complex in Dasymutilla velvet ants. Psorthaspis spider wasps live in areas where this mimicry complex is found and are phenotypically similar to Dasymutilla. We tested the idea that Psorthaspis spider wasps are participating in the Dasymutilla mimicry complex and that they codiverged with Dasymutilla. We performed morphometric analyses and human perception tests, and tabulated distributional records to determine the fit of Psorthaspis to the Dasymutilla mimicry complex. We inferred a dated phylogeny using nuclear molecular markers (28S, elongation factor 1-alpha, long-wavelength rhodopsin and wingless) for Psorthaspis species and compared it to a dated phylogeny of Dasymutilla. We tested for codivergence between the two groups using two statistical analyses. Our results show that Psorthaspis spider wasps are morphologically similar to the Dasymutilla mimicry rings. In addition, our tests indicate that Psorthaspis and Dasymutilla codiverged to produce similar color patterns. This study expands the breadth of the Dasymutilla Mullerian mimicry complex and provides insights about how codivergence influenced the evolution of mimicry in these groups.	[Rodriguez, Juanita; Pitts, James P.; von Dohlen, Carol D.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Wilson, Joseph S.] Utah State Univ Tooele, Dept Biol, Tooele, UT USA	Utah System of Higher Education; Utah State University	Rodriguez, J (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	juanitarodrigueza@gmail.com	Rodriguez, Juanita/M-6973-2016	Rodriguez, Juanita/0000-0001-9922-1978; von Dohlen, Carol/0000-0002-3961-251X	National Science Foundation [DEB-0743763]; Utah Agricultural Experiment Station, Utah State UAES [8743]	National Science Foundation(National Science Foundation (NSF)); Utah Agricultural Experiment Station, Utah State UAES	This work was supported by National Science Foundation (www.nsf.gov) award DEB-0743763 to JPP and CDvD, and Utah Agricultural Experiment Station (http://uaes.usu.edu/), Utah State UAES #8743, to JPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACORN J H, 1988, Coleopterists Bulletin, V42, P28; Anderson MJ, 2005, PERMANOVA; Bain RS, 2007, P R SOC B, V274, P1949, DOI 10.1098/rspb.2007.0458; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; BEST TL, 1987, SOUTHWEST NAT, V32, P415, DOI 10.2307/3671473; Chouteau M, 2011, BIOL LETTERS, V7, P796, DOI 10.1098/rsbl.2011.0039; Cicek Kerim, 2007, Turkish Journal of Zoology, V31, P83; Cuthill JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036464; DITTRICH W, 1993, P ROY SOC B-BIOL SCI, V251, P195, DOI 10.1098/rspb.1993.0029; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards G.B., 1984, Peckhamia, V2, P46; EVANS H E, 1968, Psyche (Cambridge), V75, P1, DOI 10.1155/1968/76089; Flanagan NS, 2004, P NATL ACAD SCI USA, V101, P9704, DOI 10.1073/pnas.0306243101; Futuyma D.J., 1983, P1; Gilbert L.E., 1983, P263; Green PR, 1999, BEHAV PROCESS, V46, P97, DOI 10.1016/S0376-6357(99)00022-4; Hines HM, 2011, P NATL ACAD SCI USA, V108, P19666, DOI 10.1073/pnas.1110096108; Hommola K, 2009, MOL BIOL EVOL, V26, P1457, DOI 10.1093/molbev/msp062; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jenks G. E., 1938, National Geographic Magazine Washington, V74, P807; Jones RT, 2013, EVOLUTION, V67, P2323, DOI 10.1111/evo.12114; Lanteri AA, 2005, COLEOPTS BULL, V59, P47, DOI 10.1649/683; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Manley DG, 2001, SOUTHWEST NAT, V46, P221, DOI 10.2307/3672534; MAWDSLEY JR, 1994, COLEOPTS BULL, V48, P115; Merrill RM, 2009, CURR BIOL, V19, pR687, DOI 10.1016/j.cub.2009.07.008; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; NENTWIG W, 1985, STUD NEOTROP FAUNA E, V20, P113, DOI 10.1080/01650528509360679; NIJHOUT HF, 1994, BIOSCIENCE, V44, P148, DOI 10.2307/1312251; Nylander J.A.A, 2004, MRMODELTEST V2; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; Parker ML, 2004, J HERPETOL, V38, P127, DOI 10.1670/19-03N; Penney HD, 2012, NATURE, V483, P461, DOI 10.1038/nature10961; Punzo F, 2003, TEX J SCI, V55, P75; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2013, TRACER V1 5; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Rodriguez J, 2014, J BIOGEOGR IN PRESS; Schmidt JO, 2004, J KANSAS ENTOMOL SOC, V77, P402, DOI 10.2317/E-39.1; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812; Toledo Luis Felipe, 2009, International Journal of Zoology, V2009, P1, DOI 10.1155/2009/910892; Tschopp A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-74; Williams KA, 2012, THESIS UTAH STATE U; Wilson JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061610; Wilson JS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2275	49	14	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112942	10.1371/journal.pone.0112942	http://dx.doi.org/10.1371/journal.pone.0112942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396424	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558500116
J	Guan, WJ; Gao, YH; Xu, G; Lin, ZY; Tang, Y; Li, HM; Lin, ZM; Zheng, JP; Chen, RC; Zhong, NS				Guan, Wei-jie; Gao, Yong-hua; Xu, Gang; Lin, Zhi-ya; Tang, Yan; Li, Hui-min; Lin, Zhi-min; Zheng, Jin-ping; Chen, Rong-chang; Zhong, Nan-shan			Capsaicin Cough Sensitivity and the Association with Clinical Parameters in Bronchiectasis	PLOS ONE			English	Article							CYSTIC FIBROSIS BRONCHIECTASIS; VALIDATION; MORTALITY; TRPV1	Background: Cough hypersensitivity has been common among respiratory diseases. Objective: To determine associations of capsaicin cough sensitivity and clinical parameters in adults with clinically stable bronchiectasis. Methods: We recruited 135 consecutive adult bronchiectasis patients and 22 healthy subjects. History inquiry, sputum culture, spirometry, chest high-resolution computed tomography (HRCT), Leicester Cough Questionnaire scoring, Bronchiectasis Severity Index (BSI) assessment and capsaicin inhalation challenge were performed. Cough sensitivity was measured as the capsaicin concentration eliciting at least 2 (C-2) and 5 coughs (C-5). Results: Despite significant overlap between healthy subjects and bronchiectasis patients, both C-2 and C-5 were significantly lower in the latter group (all P<0.01). Lower levels of C-5 were associated with a longer duration of bronchiectasis symptoms, worse HRCT score, higher 24-hour sputum volume, BSI and sputum purulence score, and sputum culture positive for P. aeruginosa. Determinants associated with increased capsaicin cough sensitivity, defined as C-5 being 62.5 mu mol/L or less, encompassed female gender (OR: 3.25, 95%CI: 1.35-7.83, P<0.01), HRCT total score between 7-12 (OR: 2.57, 95%CI: 1.07-6.173, P = 0.04), BSI between 5-8 (OR: 4.05, 95%CI: 1.48-11.06, P<0.01) and 9 or greater (OR: 4.38, 95%CI: 1.48-12.93, P<0.01). Conclusion: Capsaicin cough sensitivity is heightened in a subgroup of bronchiectasis patients and associated with the disease severity. Gender and disease severity, but not sputum purulence, are independent determinants of heightened capsaicin cough sensitivity. Current testing for cough sensitivity diagnosis may be limited because of overlap with healthy subjects but might provide an objective index for assessment of cough in future clinical trials.	[Guan, Wei-jie; Lin, Zhi-ya; Tang, Yan; Li, Hui-min; Lin, Zhi-min; Zheng, Jin-ping; Chen, Rong-chang; Zhong, Nan-shan] Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Gao, Yong-hua] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Zhengzhou 450052, Henan, Peoples R China; [Xu, Gang] Guangzhou First Peoples Hosp, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Zhengzhou University; South China University of Technology	Zhong, NS (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	chenrc@vip.163.com; nanshan@vip.163.com	Guan, Wei-jie/K-8257-2019		Changjiang Scholars and Innovative Research Team in University [ITR0961]; National Key Technology R&D Program of the 12th National Five-year Development Plan [2012BAI05B01]; National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer [2013BAI09B09]	Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology R&D Program of the 12th National Five-year Development Plan(National Key Technology R&D Program); National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer	This research was supported by the Changjiang Scholars and Innovative Research Team in University ITR0961, The National Key Technology R&D Program of the 12th National Five-year Development Plan 2012BAI05B01 and National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer No. 2013BAI09B09 (to Profs. Zhong and Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar GA, 2013, RESP MED, V107, P1001, DOI 10.1016/j.rmed.2013.04.013; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; Chalmers JD, 2013, MOL IMMUNOL, V55, P27, DOI 10.1016/j.molimm.2012.09.011; Chan KKY, 2010, EUR RESPIR J, V35, P368, DOI 10.1183/09031936.00110409; Chung KF, 2011, PULM PHARMACOL THER, V24, P267, DOI 10.1016/j.pupt.2011.01.012; Couto M, 2013, J INVEST ALLERG CLIN, V23, P289; Goeminne PC, 2014, RESP MED, V108, P287, DOI 10.1016/j.rmed.2013.12.015; Goeminne PC, 2014, RESPIROLOGY, V19, P203, DOI 10.1111/resp.12219; Hilton ECY, 2013, J ALLERGY CLIN IMMUN, V132, P847, DOI 10.1016/j.jaci.2013.04.042; Ho JC, 2001, AM J RESP CRIT CARE, V163, P983, DOI 10.1164/ajrccm.163.4.9909121; KLINK ME, 1994, CHEST, V105, P151, DOI 10.1378/chest.105.1.151; Lee LY, 2011, PULM PHARMACOL THER, V24, P280, DOI 10.1016/j.pupt.2010.12.003; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Ma W, 2009, COUGH, V25, P5; Mandal P, 2014, LANCET RESP MED, V2, P455, DOI 10.1016/S2213-2600(14)70050-5; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Milross Maree A, 2002, Sleep Med, V3, P205, DOI 10.1016/S1389-9457(01)00157-5; Morice Alyn H, 2013, Cough, V9, P14, DOI 10.1186/1745-9974-9-14; Murray MP, 2009, EUR RESPIR J, V34, P125, DOI 10.1183/09031936.00160508; Olveira C, 2013, QUAL LIFE RES, V22, P597, DOI 10.1007/s11136-012-0188-5; Park HK, 2006, THORAX, V61, P1070, DOI 10.1136/thx.2005.054429; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Song WJ, 2014, ASIA PAC ALLERGY, V4, P3, DOI [10.5415/apallergy.2014.4.1.3, 10.5415/apallergy.2014.4.2.75]; Torrego A, 2006, THORAX, V61, P706, DOI 10.1136/thx.2005.049767; Tsang K W, 2000, Respirology, V5, P91, DOI 10.1046/j.1440-1843.2000.00233.x; Tsang KW, 2009, RESPIROLOGY, V14, P637, DOI 10.1111/j.1440-1843.2009.01569.x; Tsang KW, 2000, CHEST, V117, P420, DOI 10.1378/chest.117.2.420; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Varechova S, 2008, J PHYSIOL PHARMACOL, V59, P719; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50	33	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113057	10.1371/journal.pone.0113057	http://dx.doi.org/10.1371/journal.pone.0113057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409316	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200060
J	Tu, CC; Spencer, JV				Tu, Carolyn C.; Spencer, Juliet V.			The DRY Box and C-Terminal Domain of the Human Cytomegalovirus US27 Gene Product Play a Role in Promoting Cell Growth and Survival	PLOS ONE			English	Article							IDENTIFICATION; TRANSCRIPTION; INFECTION	Human cytomegalovirus (HCMV) is a widespread pathogen that can lay dormant in healthy individuals and establish lifelong latent infection. This successful co-existence is facilitated by a number of viral gene products that manipulate host cellular functions and immune responses. Among these immunomodulatory genes are four G-protein coupled receptors (GPCRs) encoded by HCMV, designated US27, US28, UL33, and UL78. Studies have shown the US28 gene product to be a functional chemokine receptor that signals both constitutively and in a ligand-dependent manner, resulting in a wide range of cellular effects. In previous work, we have found that US27 expression results in at least two biological effects: enhanced CXCR4 signaling and increased in cellular proliferation in HEK293 cells. Here, we examined the involvement of two protein domains, the DRY box and the C-terminal intracellular domain (CTD) of US27, in mediating both cell proliferation and survival. While both domains were required for a proliferative effect, loss of either domain only moderately impacted cell survival, suggesting that US27 may interact with cell survival pathways through protein regions other than the DRY box and CTD. Quantitative RT-PCR arrays were used to profile changes in cellular gene expression in the HEK293-US27 cell line, and down-regulation of cell cycle regulators CDKN1A/p21/CIP1 (cyclin dependent kinase inhibitor 1A) and SESN (Sestrin2 or Hi95) was observed. These results indicate that increased cell proliferation due to US27 may be linked to suppression of negative growth regulators, and that these interactions require the DRY box and CTD.	[Tu, Carolyn C.; Spencer, Juliet V.] Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA	University of San Francisco	Spencer, JV (corresponding author), Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA.	jspencer@usfca.edu			National Institutes of Health [AI074029, CA158767]; Lily Drake Cancer Fund; USF Faculty Development Funds; NATIONAL CANCER INSTITUTE [R15CA158767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI074029, R15AI111232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lily Drake Cancer Fund; USF Faculty Development Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (www.nih.gov) grants AI074029 and CA158767, the Lily Drake Cancer Fund, and USF Faculty Development Funds (www.usfca.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnolds KL, 2013, VIROLOGY, V439, P122, DOI 10.1016/j.virol.2013.02.006; Ben-Sahra I, 2013, CELL DEATH DIFFER, V20, P611, DOI 10.1038/cdd.2012.157; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Brennan DC, 2001, J AM SOC NEPHROL, V12, P848, DOI 10.1681/ASN.V124848; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; de la Hoz RE, 2002, J CLIN VIROL, V25, pS1, DOI 10.1016/S1386-6532(02)00091-4; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Fraile-Ramos A, 2002, TRAFFIC, V3, P218, DOI 10.1034/j.1600-0854.2002.030307.x; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Han Y, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1743; HARPER JW, 1993, CELL, V75, P805; Kesson AM, 2007, PAEDIATR RESPIR REV, V8, P231, DOI 10.1016/j.prrv.2007.07.005; Lares AP, 2013, VIRUS RES, V176, P312, DOI 10.1016/j.virusres.2013.07.002; Margulies BJ, 2007, VIRUS RES, V123, P57, DOI 10.1016/j.virusres.2006.08.003; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Mocarski ES, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P465; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10; Pleskoff O, 2005, FEBS J, V272, P4163, DOI 10.1111/j.1742-4658.2005.04829.x; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; Revello MG, 2008, J MED VIROL, V80, P1415, DOI 10.1002/jmv.21243; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Stapleton LK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-42; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Waldhoer M, 2002, J VIROL, V76, P8161, DOI 10.1128/JVI.76.16.8161-8168.2002	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113427	10.1371/journal.pone.0113427	http://dx.doi.org/10.1371/journal.pone.0113427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409008	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200118
J	Nunez, M; Sanchez-Jimenez, C; Alcalde, J; Izquierdo, JM				Nunez, Mario; Sanchez-Jimenez, Carmen; Alcalde, Jose; Izquierdo, Jose M.			Long-Term Reduction of T-Cell Intracellular Antigens Reveals a Transcriptome Associated with Extracellular Matrix and Cell Adhesion Components	PLOS ONE			English	Article							MESSENGER-RNA; PROTEIN TIA-1; BINDING; IDENTIFICATION; EXPRESSION; GENE; NORMALIZATION; REGULATOR; GENECODIS; DYNAMICS	Knockdown of T-cell intracellular antigens TIA1 and TIAR contributes to a cellular phenotype characterised by uncontrolled proliferation and tumorigenesis. Massive-scale poly(A+) RNA sequencing of TIA1 or TIAR-knocked down HeLa cells reveals transcriptome signatures comprising genes and functional categories potentially able to modulate several aspects of membrane dynamics associated with extracellular matrix and focal/cell adhesion events. The transcriptomic heterogeneity is the result of differentially expressed genes and RNA isoforms generated by alternative splicing and/or promoter usage. These results suggest a role for TIA proteins in the regulation and/or modulation of cellular homeostasis related to focal/cell adhesion, extracellular matrix and membrane and cytoskeleton dynamics.	[Nunez, Mario; Sanchez-Jimenez, Carmen; Alcalde, Jose; Izquierdo, Jose M.] Univ Autonoma Madrid CSIC UAM, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Izquierdo, JM (corresponding author), Univ Autonoma Madrid CSIC UAM, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain.	jmizquierdo@cbm.uam.es		Izquierdo, Jose M/0000-0002-7942-4046	Ministerio de Economia y Competitividad-FEDER [BFU2008-00354, BFU2011-29653]; Fundacion Ramon Areces, Spain	Ministerio de Economia y Competitividad-FEDER; Fundacion Ramon Areces, Spain	This work was supported by grants from Ministerio de Economia y Competitividad-FEDER (BFU2008-00354 and BFU2011-29653). The CBMSO receives an institutional grant from Fundacion Ramon Areces, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznarez I, 2008, GENOME RES, V18, P1247, DOI 10.1101/gr.073155.107; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Carrascoso I, 2014, BIOCHEM J, V461, P43, DOI 10.1042/BJ20140227; Carrascoso I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-90; Chen Y, 2011, BIO-PROTOCOL, V1, pe98; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Duperret EK, 2013, CELL CYCLE, V12, P3272, DOI 10.4161/cc.26385; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Gottschald OR, 2010, J MOL CELL BIOL, V2, P345, DOI 10.1093/jmcb/mjq032; Heck MV, 2014, NEUROGENETICS, V15, P135, DOI 10.1007/s10048-014-0397-x; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2011, BIOCHEM J, V435, P337, DOI 10.1042/BJ20101030; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Karalok HM, 2014, J CLIN ENDOCRINOL ME, V20; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kharraz Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011352; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li X, 2014, MOL CELL, V55, P305, DOI 10.1016/j.molcel.2014.05.027; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; McAlinden A, 2007, J BIOL CHEM, V282, P24444, DOI 10.1074/jbc.M702717200; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Miyazaki H, 2012, FEMS IMMUNOL MED MIC, V65, P481, DOI 10.1111/j.1574-695X.2012.00979.x; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Oliveros JC., 2007, FIESTA BIOINFOGP INT; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Reyes R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r87; Sanchez-Jimenez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075127; Sanchez-Jimenez C, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-4; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Suswam EA, 2005, NUCLEIC ACIDS RES, V33, P4507, DOI 10.1093/nar/gki763; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Zadeh MAH, 2015, MOL ONCOL, V9, P167, DOI 10.1016/j.molonc.2014.07.017; Zweig AS, 2008, GENOMICS, V92, P75, DOI 10.1016/j.ygeno.2008.02.003	52	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113141	10.1371/journal.pone.0113141	http://dx.doi.org/10.1371/journal.pone.0113141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405991	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300085
J	Oliveira, V; Akamine, EH; Carvalho, MHC; Michelini, LC; Fortes, ZB; Cunha, TS; Franco, MD				Oliveira, Vanessa; Akamine, Eliana Hiromi; Carvalho, Maria Helena C.; Michelini, Lisete Compagno; Fortes, Zuleica Bruno; Cunha, Tatiana Sousa; Franco, Maria do Carmo			Influence of Aerobic Training on the Reduced Vasoconstriction to Angiotensin II in Rats Exposed to Intrauterine Growth Restriction: Possible Role of Oxidative Stress and AT(2) Receptor of Angiotensin II	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; FRUCTOSE-RICH DIET; ENDOTHELIAL DYSFUNCTION; BLOOD-PRESSURE; NITRIC-OXIDE; UNDERNOURISHED RATS; HEART-FAILURE; CARDIOVASCULAR-DISEASE; NADPH OXIDASE; ADULT LIFE	Intrauterine growth restriction (IUGR) is associated with impaired vascular function, which contributes to the increased incidence of chronic disease. The aim of this study was to investigate whether aerobic training improves AngII-induced vasoconstriction in IUGR rats. Moreover, we assess the role of superoxide dismutase (SOD) isoforms and NADPH oxidase-derived superoxide anions in this improvement. Female Wistar rats were randomly divided into two groups on day 1 of pregnancy. A control group was fed standard chow ad libitum, and a restricted group was fed 50% of the ad libitum intake throughout gestation. At 8 weeks of age, male offspring from both groups were randomly assigned to 4 experimental groups: sedentary control (SC), trained control (TC), sedentary restricted (SRT), and trained restricted (TRT). The training protocol was performed on a treadmill and consisted of a continuous 60-min session 5 days/week for 10 weeks. Following aerobic training, concentration-response curves to AngII were obtained in endothelium-intact aortic rings. Protein expression of SOD isoforms, AngII receptors and the NADPH oxidase component p47(phox) was assessed by Western blot analysis. The dihydroethidium was used to evaluate the in situ superoxide levels under basal conditions or in the presence of apocynin, losartan or PD 123,319. Our results indicate that aerobic training can prevent IUGR-associated increases in AngII-dependent vasoconstriction and can restore basal superoxide levels in the aortic rings of TRT rats. Moreover, we observed that aerobic training normalized the increased p47(phox) protein expression and increased MnSOD and AT(2) receptor protein expression in thoracic aortas of SRT rats. In summary, aerobic training can result in an upregulation of antioxidant defense by improved of MnSOD expression and attenuation of NADPH oxidase component p47(phox). These effects are accompanied by increased expression of AT(2) receptor, which provide positive effects against Ang II-induced superoxide generation, resulting in attenuation of AngII-induced vasoconstriction.	[Oliveira, Vanessa; Franco, Maria do Carmo] Univ Fed Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil; [Akamine, Eliana Hiromi; Carvalho, Maria Helena C.; Fortes, Zuleica Bruno] Univ Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Michelini, Lisete Compagno] Univ Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Cunha, Tatiana Sousa] Univ Fed Sao Paulo, Sci & Technol Inst, Sao Paulo, Brazil; [Franco, Maria do Carmo] Univ Fed Sao Paulo, Sch Med, Dept Physiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Franco, MD (corresponding author), Univ Fed Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	maria.franco@unifesp.br	Franco, Maria CP/F-9421-2012; do Carmo P Franco, Maria/F-7771-2015; Sousa Cunha, Tatiana/GLN-2685-2022; Carvalho, Maria Helena C/C-8539-2013; Cunha, Tatiana S/G-4662-2012; Oliveira, Vanessa/AAA-4748-2021; Akamine, Eliana Hiromi/C-5231-2012	Franco, Maria CP/0000-0003-0604-7689; Sousa Cunha, Tatiana/0000-0001-9070-1414; Cunha, Tatiana S/0000-0001-9070-1414; Akamine, Eliana Hiromi/0000-0003-2715-7158	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/58044-2, 2010/51904-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by project grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2007/58044-2 and 2010/51904-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSIO HM, 1988, J APPL PHYSIOL, V64, P1333, DOI 10.1152/jappl.1988.64.4.1333; Andresen JJ, 2004, AM J PHYSIOL-HEART C, V287, pH1141, DOI 10.1152/ajpheart.01215.2003; Bacon SL, 2004, SPORTS MED, V34, P307, DOI 10.2165/00007256-200434050-00003; BARKER DJP, 1993, BRIT MED J, V306, P422, DOI 10.1136/bmj.306.6875.422; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Cambri LT, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-164; Cambri LT, 2010, APPL PHYSIOL NUTR ME, V35, P490, DOI 10.1139/H10-034; Ceravolo GS, 2007, LIFE SCI, V80, P782, DOI 10.1016/j.lfs.2006.11.006; Chakraphan D, 2005, CLIN HEMORHEOL MICRO, V32, P217; Chrissobolis S, 2010, HYPERTENSION, V55, P905, DOI 10.1161/HYPERTENSIONAHA.109.147041; Ciampone S, 2011, J RENIN-ANGIO-ALDO S, V12, P394, DOI 10.1177/1470320311408750; da Rocha RF, 2010, CELL BIOCHEM FUNCT, V28, P190, DOI 10.1002/cbf.1640; Delbin MA, 2011, INFLAMMATION, V34, P319, DOI 10.1007/s10753-010-9237-9; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Franco MD, 2002, J CARDIOVASC PHARM, V40, P501, DOI 10.1097/00005344-200210000-00002; Franco MDP, 2003, CARDIOVASC RES, V59, P767, DOI 10.1016/S0008-6363(03)00461-9; Franco MDP, 2003, J CARDIOVASC PHARM, V42, P211, DOI 10.1097/00005344-200308000-00009; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Gaspari TA, 2012, HYPERTENSION, V60, P17, DOI 10.1161/HYPERTENSIONAHA.112.193375; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Kemi OJ, 2013, SCAND CARDIOVASC J, V47, P160, DOI 10.3109/14017431.2012.754935; Kimura H, 2010, CLIN EXP HYPERTENS, V32, P407, DOI 10.3109/10641961003667930; Langley-Evans SC, 1999, BIOCHEM SOC T, V27, P88, DOI 10.1042/bst0270088; Lawler JM, 2009, AM J PHYSIOL-REG I, V296, pR1496, DOI 10.1152/ajpregu.90314.2008; Li JM, 2003, J BIOL CHEM, V278, P12094, DOI 10.1074/jbc.M209793200; Li Y, 2012, CARDIOVASC DIAGN THE, V2, P56, DOI 10.3978/j.issn.2223-3652.2012.02.02; Maiorana AJ, 2011, HYPERTENSION, V57, P56, DOI 10.1161/HYPERTENSIONAHA.110.163022; McAllister RM, 2008, APPL PHYSIOL NUTR ME, V33, P173, DOI 10.1139/H07-146; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Pal S, 2013, J AM SOC HYPERTENS, V7, P494, DOI 10.1016/j.jash.2013.07.004; Roque FR, 2013, BRIT J PHARMACOL, V168, P686, DOI 10.1111/j.1476-5381.2012.02224.x; Rosety-Rodriguez M, 2012, MED SCI MONITOR, V18, pBR346, DOI 10.12659/MSM.883343; Sabuhi R, 2011, AM J PHYSIOL-RENAL, V300, pF700, DOI 10.1152/ajprenal.00616.2010; Selemidis S, 2008, PHARMACOL THERAPEUT, V120, P254, DOI 10.1016/j.pharmthera.2008.08.005; Sohn HY, 2000, BRIT J PHARMACOL, V131, P667, DOI 10.1038/sj.bjp.0703566; Tinken TM, 2010, HYPERTENSION, V55, P312, DOI 10.1161/HYPERTENSIONAHA.109.146282; Toda N, 2007, PHARMACOL REV, V59, P54, DOI 10.1124/pr.59.1.2; Torrens C, 2009, BRIT J NUTR, V101, P27, DOI 10.1017/S0007114508988760; Trott DW, 2009, J APPL PHYSIOL, V106, P1925, DOI 10.1152/japplphysiol.91232.2008; Wagenaar LJ, 2002, CAN J CARDIOL, V18, P1331; Warnholtz A, 1999, CIRCULATION, V99, P2027, DOI 10.1161/01.CIR.99.15.2027; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Wollert KC, 1999, CARDIOVASC RES, V43, P838, DOI 10.1016/S0008-6363(99)00145-5	49	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113035	10.1371/journal.pone.0113035	http://dx.doi.org/10.1371/journal.pone.0113035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406086	gold, Green Submitted, Green Published			2022-12-26	WOS:000347121300072
J	Paerl, HW; Xu, H; Hall, NS; Zhu, GW; Qin, BQ; Wu, YL; Rossignol, KL; Dong, LH; McCarthy, MJ; Joyner, AR				Paerl, Hans W.; Xu, Hai; Hall, Nathan S.; Zhu, Guangwei; Qin, Boqiang; Wu, Yali; Rossignol, Karen L.; Dong, Linghan; McCarthy, Mark J.; Joyner, Alan R.			Controlling Cyanobacterial Blooms in Hypertrophic Lake Taihu, China: Will Nitrogen Reductions Cause Replacement of Non-N-2 Fixing by N-2 Fixing Taxa?	PLOS ONE			English	Article							CONTROLLING EUTROPHICATION; PHYTOPLANKTON GROWTH; SHALLOW LAKES; PHOSPHORUS; INPUTS; DOMINANCE; RATIOS; LIMITATION; COMMUNITY; DYNAMICS	Excessive anthropogenic nitrogen (N) and phosphorus (P) inputs have caused an alarming increase in harmful cyanobacterial blooms, threatening sustainability of lakes and reservoirs worldwide. Hypertrophic Lake Taihu, China's third largest freshwater lake, typifies this predicament, with toxic blooms of the non-N-2 fixing cyanobacteria Microcystis spp. dominating from spring through fall. Previous studies indicate N and P reductions are needed to reduce bloom magnitude and duration. However, N reductions may encourage replacement of non-N-2 fixing with N-2 fixing cyanobacteria. This potentially counterproductive scenario was evaluated using replicate, large (1000 L), in-lake mesocosms during summer bloom periods. N+P additions led to maximum phytoplankton production. Phosphorus enrichment, which promoted N limitation, resulted in increases in N-2 fixing taxa (Anabaena spp.), but it did not lead to significant replacement of non-N-2 fixing with N-2 fixing cyanobacteria, and N-2 fixation rates remained ecologically insignificant. Furthermore, P enrichment failed to increase phytoplankton production relative to controls, indicating that N was the most limiting nutrient throughout this period. We propose that Microcystis spp. and other non-N-2 fixing genera can maintain dominance in this shallow, highly turbid, nutrient-enriched lake by outcompeting N-2 fixing taxa for existing sources of N and P stored and cycled in the lake. To bring Taihu and other hypertrophic systems below the bloom threshold, both N and P reductions will be needed until the legacy of high N and P loading and sediment nutrient storage in these systems is depleted. At that point, a more exclusive focus on P reductions may be feasible.	[Paerl, Hans W.; Hall, Nathan S.; Rossignol, Karen L.; Dong, Linghan; Joyner, Alan R.] Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; [Xu, Hai; Zhu, Guangwei; Qin, Boqiang; Wu, Yali] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [McCarthy, Mark J.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA	University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Texas System; University of Texas Austin	Paerl, HW (corresponding author), Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA.	hpaerl@email.unc.edu	McCarthy, Mark/E-3071-2015; Qin, Boqiang/E-5900-2013	McCarthy, Mark/0000-0002-2246-5947; 	US National Science Foundation [0826819, 1230543, 1240851]; National Science Foundation of China [41003043, 41230744]; Natural Science Foundation of Jiangsu Province [BK2012895]; External Cooperation Program of Chinese Academy of Sciences; Direct For Biological Sciences [1240851] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); External Cooperation Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the US National Science Foundation (0826819, 1230543, and 1240851), the National Science Foundation of China (41003043, 41230744), Natural Science Foundation of Jiangsu Province (BK2012895), and the External Cooperation Program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2007, LIMNOL OCEANOGR-METH, V5, P111, DOI 10.4319/lom.2007.5.111; [Anonymous], 1980, FRESHWATER ALGAE CHI; APHA, 1995, STANDARD METHODS EXA, Vnineteenth; Attridge EM, 1997, NEW PHYTOL, V135, P517, DOI 10.1046/j.1469-8137.1997.00666.x; BLOMQVIST P, 1994, ARCH HYDROBIOL, V132, P141; Bryhn AC, 2009, P NATL ACAD SCI USA, V106, pE3, DOI 10.1073/pnas.0810905106; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; DODDS W K, 1989, Lake and Reservoir Management, V5, P21; EBINA J, 1983, WATER RES, V17, P1721, DOI 10.1016/0043-1354(83)90192-6; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; FOGG GE, 1974, ALGAL PHYSL BIOCH, P560; Havens KE, 2003, ENVIRON POLLUT, V122, P379, DOI 10.1016/S0269-7491(02)00304-4; Howarth R, 2012, FRONT ECOL ENVIRON, V10, P37, DOI 10.1890/100178; Jeppesen E, 2007, HYDROBIOLOGIA, V584, P239, DOI 10.1007/s10750-007-0596-7; KAPPERS FI, 1980, HYPERTROPHIC ECOSYST, P37; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; Likens GE, 1972, AM SOC LIMN OC SPEC; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; McCarthy MJ, 2007, HYDROBIOLOGIA, V581, P195, DOI 10.1007/s10750-006-0496-2; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Paerl HW, 2006, ECOL STU AN, V189, P95, DOI 10.1007/978-3-540-32210-8_8; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Paerl Hans W., 1996, Phycologia, V35, P160, DOI 10.2216/i0031-8884-35-6S-160.1; Paerl HW, 2009, ESTUAR COAST, V32, P593, DOI 10.1007/s12237-009-9158-8; Paerl Hans W., 1998, P3; PAERL HW, 1990, ADV MICROB ECOL, V11, P305; Papista E, 2002, HYDROBIOLOGIA, V485, P191, DOI 10.1023/A:1021329602685; Paterson MJ, 2011, LIMNOL OCEANOGR, V56, P1545, DOI 10.4319/lo.2011.56.4.1545; Pinckney JL, 2001, ORG GEOCHEM, V32, P585, DOI 10.1016/S0146-6380(00)00196-0; Qin BQ, 2007, HYDROBIOLOGIA, V581, P1, DOI 10.1007/s10750-006-0522-4; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; Scheffer M, 1997, ECOLOGY, V78, P272; Schindler D. W., 1975, INT VEREINIGUNG F R, V19, P3221; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Schluter L, 2006, FRESHWATER BIOL, V51, P1474, DOI 10.1111/j.1365-2427.2006.01582.x; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Shi K, 2014, REMOTE SENS ENVIRON, V140, P365, DOI 10.1016/j.rse.2013.09.013; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Smolders AJP, 2010, BIOGEOCHEMISTRY, V98, P1, DOI 10.1007/s10533-009-9387-8; Spivak AC, 2011, FRESHWATER BIOL, V56, P279, DOI 10.1111/j.1365-2427.2010.02495.x; Trolle D, 2009, HYDROBIOLOGIA, V627, P31, DOI 10.1007/s10750-009-9713-0; VANHEUKELEM L, 1994, MAR ECOL PROG SER, V114, P303, DOI 10.3354/meps114303; Visser PM., 2005, HARMFUL CYANOBACTERI, V3; Xu H, 2013, HYDROBIOLOGIA, V700, P187, DOI 10.1007/s10750-012-1229-3; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Zhang YL, 2006, SCI CHINA SER D, V49, P114, DOI 10.1007/s11430-006-8111-y	57	76	83	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113123	10.1371/journal.pone.0113123	http://dx.doi.org/10.1371/journal.pone.0113123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405474	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300081
J	Golnabi, AH; Harris, RS; Venegas, JG; Winkler, T				Golnabi, Amir H.; Harris, R. Scott; Venegas, Jose G.; Winkler, Tilo			Deep Inspiration and the Emergence of Ventilation Defects during Bronchoconstriction: A Computational Study	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; HEALTHY-SUBJECTS; NONASTHMATIC SUBJECTS; METHACHOLINE; ASTHMA; LUNG; INFLATION; VOLUME; RESPONSIVENESS; HETEROGENEITY	Deep inspirations (DIs) have a dilatory effect on airway smooth muscle (ASM) that helps to prevent or reduce more severe bronchoconstriction in healthy individuals. However, this bronchodilation appears to fail in some asthmatic patients or under certain conditions, and the reason is unclear. Additionally, quantitative effects of the frequency and magnitude of DIs on bronchodilation are not well understood. In the present study, we used a computational model of bronchoconstriction to study the effects of DI volumes, time intervals between intermittent DIs, relative speed of ASM constriction, and ASM activation on bronchoconstriction and the emergence of ventilation defects (VDefs). Our results showed a synergistic effect between the volume of DIs and the time intervals between them on bronchoconstriction and VDefs. There was a domain of conditions with sufficiently large volumes of DIs and short time intervals between them to prevent VDefs. Among conditions without VDefs, larger volumes of DIs resulted in greater airway dilation. Similarly, the time interval between DIs, during which the activated ASM re-constricts, affected the amplitude of periodic changes in airway radii. Both the relative speed of ASM constriction and ASM activation affected what volume of DIs and what time interval between them could prevent the emergence of VDefs. In conclusion, quantitative characteristics of DIs, such as their volume and time interval between them, affect bronchoconstriction and may contribute to difficulties in asthma. Better understanding of the quantitative aspects of DIs may result in novel or improved therapeutic approaches.	[Golnabi, Amir H.; Venegas, Jose G.; Winkler, Tilo] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Golnabi, Amir H.; Harris, R. Scott; Venegas, Jose G.; Winkler, Tilo] Harvard Univ, Sch Med, Boston, MA USA; [Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Winkler, T (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	twinkler@mgh.harvard.edu	Winkler, Tilo/B-5337-2009	Winkler, Tilo/0000-0002-7276-5550; Golnabi, Amir H./0000-0002-5976-1985	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL087281]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087281] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by National Heart, Lung, and Blood Institute of the National Institutes of Health under award number R01HL087281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altes TA, 2004, ACAD RADIOL, V11, P729, DOI 10.1016/j.acra.2004.04.001; Anafi RC, 2001, J APPL PHYSIOL, V91, P1185, DOI 10.1152/jappl.2001.91.3.1185; Bayat S, 2006, J APPL PHYSIOL, V100, P1964, DOI 10.1152/japplphysiol.00594.2005; BENDIXEN HH, 1964, J APPL PHYSIOL, V19, P195, DOI 10.1152/jappl.1964.19.2.195; Black LD, 2004, J APPL PHYSIOL, V96, P1808, DOI 10.1152/japplphysiol.01170.2003; Boulet Louis-Philippe, 2005, Can Respir J, V12, P371; Brown RH, 2003, EUR RESPIR J, V22, P57, DOI 10.1183/09031936.03.00090403; BROWN RH, 1994, CHEST, V106, P920, DOI 10.1378/chest.106.3.920; Brown RH, 2001, AM J RESP CRIT CARE, V163, P994, DOI 10.1164/ajrccm.163.4.2007119; Brown RH, 2001, J APPL PHYSIOL, V91, P2574, DOI 10.1152/jappl.2001.91.6.2574; Brown RH, 2006, J APPL PHYSIOL, V101, P30, DOI 10.1152/japplphysiol.01190.2005; Brusasco V, 1999, J APPL PHYSIOL, V87, P567, DOI 10.1152/jappl.1999.87.2.567; Costella S, 2012, RESPIROLOGY, V17, P1237, DOI 10.1111/j.1440-1843.2012.02250.x; Crimi E, 2002, J APPL PHYSIOL, V93, P1384, DOI 10.1152/japplphysiol.00209.2002; DUGGAN CJ, 1990, THORAX, V45, P930, DOI 10.1136/thx.45.12.930; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959, DOI 10.1164/ajrccm.159.3.9804060; GUNST SJ, 1983, J APPL PHYSIOL, V54, P906, DOI 10.1152/jappl.1983.54.4.906; GUNST SJ, 1988, J APPL PHYSIOL, V65, P2490, DOI 10.1152/jappl.1988.65.6.2490; Hulme KM, 2013, RESP PHYSIOL NEUROBI, V189, P506, DOI 10.1016/j.resp.2013.08.015; Jackson AC, 2004, J APPL PHYSIOL, V96, P137, DOI 10.1152/japplphysiol.00504.2003; Kapsali T, 2000, J APPL PHYSIOL, V89, P711, DOI 10.1152/jappl.2000.89.2.711; King GG, 2001, AM J RESP CRIT CARE, V164, P216, DOI 10.1164/ajrccm.164.2.2006101; Lavoie TL, 2012, AM J RESP CRIT CARE, V186, P225, DOI 10.1164/rccm.201202-0368OC; Moore BJ, 1997, AM J RESP CRIT CARE, V156, P1278, DOI 10.1164/ajrccm.156.4.96-11082; MORENO RH, 1986, AM REV RESPIR DIS, V133, P1171; NADEL JA, 1961, J APPL PHYSIOL, V16, P717, DOI 10.1152/jappl.1961.16.4.717; Pyrgos G, 2010, J APPL PHYSIOL, V110, P472, DOI [10.1152/japplphysiol.00603.2010, DOI 10.1152/JAPPLPHYSI0L.00603.2010]; Salerno FG, 2005, J APPL PHYSIOL, V98, P817, DOI 10.1152/japplphysiol.00763.2004; Salome CM, 2003, EUR RESPIR J, V22, P62, DOI 10.1183/09031936.03.00117502; Schweitzer C, 2002, EUR RESPIR J, V19, P1020, DOI 10.1183/09031936.02.00992001; Shen X, 1997, J APPL PHYSIOL, V83, P1202, DOI 10.1152/jappl.1997.83.4.1202; Tzeng YS, 2009, J APPL PHYSIOL, V106, P813, DOI 10.1152/japplphysiol.01133.2007; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Winkler T, 2007, J APPL PHYSIOL, V103, P655, DOI 10.1152/japplphysiol.00041.2007; Winkler Tilo, 2011, Critical Reviews in Biomedical Engineering, V39, P263, DOI 10.1615/CritRevBiomedEng.v39.i4.20	36	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112443	10.1371/journal.pone.0112443	http://dx.doi.org/10.1371/journal.pone.0112443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402457	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700044
J	Hull, JJ; Chaney, K; Geib, SM; Fabrick, JA; Brent, CS; Walsh, D; Lavine, LC				Hull, J. Joe; Chaney, Kendrick; Geib, Scott M.; Fabrick, Jeffrey A.; Brent, Colin S.; Walsh, Douglas; Lavine, Laura Corley			Transcriptome-Based Identification of ABC Transporters in the Western Tarnished Plant Bug Lygus hesperus	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTERS; MULTIDRUG-RESISTANCE PROTEINS; GENOME-WIDE ANALYSIS; RNASE-L INHIBITOR; RED-EYE MUTANT; DROSOPHILA-MELANOGASTER; GENE FAMILY; P-GLYCOPROTEIN; MALPIGHIAN TUBULES; FUNCTIONAL-ANALYSIS	ATP-binding cassette (ABC) transporters are a large superfamily of proteins that mediate diverse physiological functions by coupling ATP hydrolysis with substrate transport across lipid membranes. In insects, these proteins play roles in metabolism, development, eye pigmentation, and xenobiotic clearance. While ABC transporters have been extensively studied in vertebrates, less is known concerning this superfamily in insects, particularly hemipteran pests. We used RNA-Seq transcriptome sequencing to identify 65 putative ABC transporter sequences (including 36 full-length sequences) from the eight ABC subfamilies in the western tarnished plant bug (Lygus hesperus), a polyphagous agricultural pest. Phylogenetic analyses revealed clear orthologous relationships with ABC transporters linked to insecticide/xenobiotic clearance and indicated lineage specific expansion of the L. hesperus ABCG and ABCH subfamilies. The transcriptional profile of 13 LhABCs representative of the ABCA, ABCB, ABCC, ABCG, and ABCH subfamilies was examined across L. hesperus development and within sex-specific adult tissues. All of the transcripts were amplified from both reproductively immature and mature adults and all but LhABCA8 were expressed to some degree in eggs. Expression of LhABCA8 was spatially localized to the testis and temporally timed with male reproductive development, suggesting a potential role in sexual maturation and/or spermatozoa protection. Elevated expression of LhABCC5 in Malpighian tubules suggests a possible role in xenobiotic clearance. Our results provide the first transcriptome-wide analysis of ABC transporters in an agriculturally important hemipteran pest and, because ABC transporters are known to be important mediators of insecticidal resistance, will provide the basis for future biochemical and toxicological studies on the role of this protein family in insecticide resistance in Lygus species.	[Hull, J. Joe; Chaney, Kendrick; Fabrick, Jeffrey A.; Brent, Colin S.] USDA ARS, Arid Land Agr Res Ctr, Maricopa, AZ 85138 USA; [Geib, Scott M.] USDA ARS, Daniel K Inouye Pacific Basin Agr Res Ctr, Hilo, HI USA; [Walsh, Douglas; Lavine, Laura Corley] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Washington State University	Hull, JJ (corresponding author), USDA ARS, Arid Land Agr Res Ctr, Maricopa, AZ 85138 USA.	joe.hull@ars.usda.gov		Fabrick, Jeffrey/0000-0002-3893-9545; Geib, Scott/0000-0002-9511-5139; Brent, Colin/0000-0003-2078-1417; Lavine, Laura/0000-0002-0262-359X	CSB - Cotton Incorporated [12-373]; KC - Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-38422-30955]; SMG - National Science Foundation [OCI-1053575XSEDE, TG-MCB140032]	CSB - Cotton Incorporated; KC - Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; SMG - National Science Foundation	This work was supported by CSB - Cotton Incorporated (project no. 12-373), by KC - Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (no. 2011-38422-30955), and by SMG - National Science Foundation (no. OCI-1053575XSEDE under allocation TG-MCB140032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2011, ESSAYS BIOCHEM, V50, P249, DOI [10.1042/BSE0500249, 10.1042/bse0500249]; Abrabam EG, 2000, MOL GEN GENET, V264, P11, DOI 10.1007/s004380000283; Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Akasaka T, 2006, P NATL ACAD SCI USA, V103, P11999, DOI 10.1073/pnas.0603098103; Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; Allen M. L., 2013, Open Journal of Animal Sciences, V3, P1; Anaka M, 2008, J NEUROGENET, V22, P243, DOI 10.1080/01677060802309629; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Azad P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005371; Bain LJ, 1996, TOXICOL APPL PHARM, V141, P288, DOI 10.1016/S0041-008X(96)80035-4; Bao YY, 2010, J INSECT PHYSIOL, V56, P1087, DOI 10.1016/j.jinsphys.2010.03.004; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Barthelme D, 2011, P NATL ACAD SCI USA, V108, P3228, DOI 10.1073/pnas.1015953108; Baum JA, 2012, J ECON ENTOMOL, V105, P616, DOI 10.1603/EC11207; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Beckstead RB, 2007, INSECT BIOCHEM MOLEC, V37, P570, DOI 10.1016/j.ibmb.2007.03.001; Beers MF, 2011, J LIPID RES, V52, P1471, DOI 10.1194/jlr.M013284; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; Brent CS, 2014, J INSECT PHYSIOL, V60, P104, DOI 10.1016/j.jinsphys.2013.12.001; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Bryon A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-815; Buchmann J, 2007, ENDOCRINOLOGY, V148, P1561, DOI 10.1210/en.2006-1244; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Leite JCD, 2014, MOL REPROD DEV, V81, P66, DOI 10.1002/mrd.22283; de Boussac H, 2012, BIOCHEM BIOPH RES CO, V426, P172, DOI 10.1016/j.bbrc.2012.08.046; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DEBOLT JW, 1982, ANN ENTOMOL SOC AM, V75, P119, DOI 10.1093/aesa/75.2.119; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dermauw W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-317; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EWART GD, 1994, J BIOL CHEM, V269, P10370; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; George AM, 2012, PROG BIOPHYS MOL BIO, V109, P95, DOI 10.1016/j.pbiomolbio.2012.06.003; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grailles M, 2003, GENE, V307, P41, DOI 10.1016/S0378-1119(03)00455-4; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Hock T, 2000, P NATL ACAD SCI USA, V97, P9519, DOI 10.1073/pnas.160271797; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang H, 2007, PHYSIOL GENOMICS, V29, P260, DOI 10.1152/physiolgenomics.00166.2006; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Itoh TQ, 2011, GENES CELLS, V16, P1159, DOI 10.1111/j.1365-2443.2011.01559.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones SR, 2011, TOXICOL SCI, V119, P369, DOI 10.1093/toxsci/kfq318; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; KARTNER N, 1983, SCIENCE, V221, P1285, DOI 10.1126/science.6137059; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kim Y, 2013, GENOMICS, V101, P354, DOI 10.1016/j.ygeno.2013.04.003; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruh GD, 2006, PFLUGERS ARCH, V453, P675; Kulkarni SR, 2014, ANTIOXID REDOX SIGN, V20, P15, DOI 10.1089/ars.2012.5082; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Labbe R, 2011, J EXP BIOL, V214, P937, DOI 10.1242/jeb.051060; Lage H, 2003, INT J ANTIMICROB AG, V22, P188, DOI 10.1016/S0924-8579(03)00203-6; Lei YY, 2014, GENE, V533, P180, DOI 10.1016/j.gene.2013.09.091; Leprohon P, 2011, ESSAYS BIOCHEM, V50, P121, DOI [10.1042/BSE0500121, 10.1042/bse0500121]; Li YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066251; Liu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063895; Liu SH, 2014, INSECT SCI, V21, P469, DOI 10.1111/1744-7917.12049; Liu SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-491; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Luckenbach T, 2008, AM J PHYSIOL-REG I, V294, pR1919, DOI 10.1152/ajpregu.00563.2007; Luo L, 2013, INSECT BIOCHEM MOLEC, V43, P627, DOI 10.1016/j.ibmb.2013.04.006; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Martins GF, 2012, ISJ-INVERT SURVIV J, V9, P139; Merzendorfer H, 2012, INSECT BIOCHEM MOLEC, V42, P264, DOI 10.1016/j.ibmb.2011.12.008; Meyer F, 2013, PEST MANAG SCI, V69, P1136, DOI 10.1002/ps.3476; Monnier V, 2002, GENESIS, V34, P76, DOI 10.1002/gene.10130; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Morozova TV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r231; Morozova TV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r95; Mosallanejad H, 2010, J INSECT PHYSIOL, V56, P1973, DOI 10.1016/j.jinsphys.2010.08.022; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Paytubi S, 2009, J BIOL CHEM, V284, P24061, DOI 10.1074/jbc.M109.031625; Peelman F, 2003, J MOL BIOL, V325, P259, DOI 10.1016/S0022-2836(02)01105-1; Popovic M, 2010, MAR ENVIRON RES, V69, pS11, DOI 10.1016/j.marenvres.2009.10.016; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Roth CW, 2003, MOL CELLS, V15, P150; Scott D.R., 1977, Bulletin Ent Soc Amer, V23, P19; Seo BY, 2011, J ASIA-PAC ENTOMOL, V14, P469, DOI 10.1016/j.aspen.2011.06.005; Shah S, 2012, PEST MANAG SCI, V68, P38, DOI 10.1002/ps.2218; Shan N, 1996, J BIOL CHEM, V271, P8725, DOI 10.1074/jbc.271.15.8725; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Snodgrass GL, 2009, J ECON ENTOMOL, V102, P699, DOI 10.1603/029.102.0231; Snodgrass GL, 1996, J ECON ENTOMOL, V89, P783, DOI 10.1093/jee/89.4.783; Snodgrass GL, 2002, ANN ENTOMOL SOC AM, V95, P366, DOI 10.1603/0013-8746(2002)095[0366:COAREM]2.0.CO;2; Snodgrass GL, 2002, SOUTHWEST ENTOMOL, V27, P191; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Strauss AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098637; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; SULLIVAN DT, 1980, BIOCHEM GENET, V18, P1109, DOI 10.1007/BF00484342; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; Tapadia MG, 2005, CELL STRESS CHAPERON, V10, P7, DOI 10.1379/CSC-67R.1; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; Telonis-Scott M, 2009, J INSECT PHYSIOL, V55, P549, DOI 10.1016/j.jinsphys.2009.01.010; Tian LX, 2013, INT J MOL SCI, V14, P22891, DOI 10.3390/ijms141122891; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Vache C, 2007, ENVIRON TOXICOL CHEM, V26, P1418, DOI 10.1897/06-552R.1; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; WU CT, 1991, MOL CELL BIOL, V11, P3940, DOI 10.1128/MCB.11.8.3940; Xia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068185; Xie XD, 2012, MOL BIOL REP, V39, P7281, DOI 10.1007/s11033-012-1558-3; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yang N, 2013, INSECT MOL BIOL, V22, P485, DOI 10.1111/imb.12038; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Ye XD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-370; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; YOUNG OP, 1986, ANN ENTOMOL SOC AM, V79, P747, DOI 10.1093/aesa/79.4.747; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456	162	43	45	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113046	10.1371/journal.pone.0113046	http://dx.doi.org/10.1371/journal.pone.0113046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401762	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700101
J	Li, WL; Duan, HK; Chen, FY; Wang, Z; Huang, XQ; Deng, X; Liu, YX				Li, Wenlong; Duan, Huikun; Chen, Fengying; Wang, Zhi; Huang, Xueqing; Deng, Xin; Liu, Yongxiu			Identification of Quantitative Trait Loci Controlling High Calcium Response in Arabidopsis thaliana	PLOS ONE			English	Article							INBRED LINE POPULATION; PLANT DEVELOPMENT; NATURAL VARIATION; SEED DORMANCY; ADAPTATION; STRESS; GENES; QTL; EXPRESSION; RESISTANCE	Natural variation for primary root growth response to high Ca stress in Arabidopsis thaliana was studied by screening a series of accessions (ecotypes) under high Calcium (40 mM CaCl2) conditions. The genetic basis of this variation was further investigated by QTL analysis using recombinant inbred lines from Landsberg erecta (Ler)xCape Verde Islands (Cvi) cross. Four QTLs were identified in chromosome 1, 2 and 5, and named response to high Calcium (RHCA) 1-4. The three QTLs (RHCA1, RHCA2 and RHCA4) were further confirmed by analysis of near isogenic lines harboring Cvi introgression fragments in Ler background. Real-time PCR analysis showed that several genes associated with high Ca response including SMT1 and XHT25 have changed expression pattern between Ler and near isogenic lines. These results were useful for detecting molecular mechanisms of plants for high Ca adaption.	[Li, Wenlong; Duan, Huikun; Deng, Xin] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing 100093, Peoples R China; [Li, Wenlong; Chen, Fengying; Wang, Zhi; Liu, Yongxiu] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China; [Huang, Xueqing] Fudan Univ, Sch Life Sci, Inst Plant Biol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Li, Wenlong] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Fudan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, YX (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China.	yongxiu@ibcas.ac.cn	Wang, Zhi/AGG-0325-2022; Xin, deng/AAH-4009-2020	Wang, Zhi/0000-0002-8207-776X; 	National Natural Science Foundation of China [30970431]; National Basic Research Program of China (973 Program) [2006CB403200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Natural Science Foundation of China (No. 30970431, http://www.nsfc.gov.cn/) and the National Basic Research Program of China (973 Program) (No. 2006CB403200, http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Hernandez HS, 2011, J PLANT PHYSIOL, V168, P2102, DOI 10.1016/j.jplph.2011.06.006; Alonso-Blanco C, 2003, GENETICS, V164, P711; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Blanco F, 2005, PLANT MOL BIOL, V59, P927, DOI 10.1007/s11103-005-2227-x; [曹建华 Cao Jian hua], 2003, [地球科学进展, Advance in Earth Sciences], V18, P37; Chan CWM, 2008, FEBS LETT, V582, P967, DOI 10.1016/j.febslet.2008.02.043; Chan CWM, 2003, PLANT PHYSIOL, V132, P728, DOI 10.1104/pp.102.019216; Chen FS, 2011, FOOD CHEM, V126, P450, DOI 10.1016/j.foodchem.2010.11.009; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Day M, 2011, KARST MANAGEMENT, P439, DOI 10.1007/978-94-007-1207-2_20; Dayod M, 2010, PROTOPLASMA, V247, P215, DOI 10.1007/s00709-010-0182-0; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; FALKENGRENGRERUP U, 1995, ENVIRON EXP BOT, V35, P9, DOI 10.1016/0098-8472(94)00039-8; Gilliham M, 2011, J EXP BOT, V62, P2233, DOI 10.1093/jxb/err111; Gunter CC, 2008, AM J POTATO RES, V85, P324, DOI 10.1007/s12230-008-9025-3; Hirschi KD, 2009, ANNU REV NUTR, V29, P401, DOI 10.1146/annurev-nutr-080508-141143; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ookawa T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1132; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; SCAIFE MA, 1978, PLANT SOIL, V50, P723, DOI 10.1007/BF02107226; SIMMONS KE, 1987, AM POTATO J, V64, P119, DOI 10.1007/BF02854208; Song WY, 2011, P NATL ACAD SCI USA, V108, P19808, DOI 10.1073/pnas.1104905108; Vaughn LM, 2011, G3-GENES GENOM GENET, V1, P105, DOI 10.1534/g3.111.000331; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Yuan DX, 2001, ACTA GEOL SIN-ENGL, V75, P336; Yuan DX, 1988, SCI KARST ENV	37	2	3	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112511	10.1371/journal.pone.0112511	http://dx.doi.org/10.1371/journal.pone.0112511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401959	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700052
J	Mills, P; Zara, J				Mills, Patrick; Zara, Jason			3D Simulation of an Audible Ultrasonic Electrolarynx Using Difference Waves	PLOS ONE			English	Article							FUNDAMENTAL-FREQUENCY; TOTAL LARYNGECTOMY; SPEECH; ABSORPTION; EQUATIONS; QUALITY; MEDIA	A total laryngectomy removes the vocal folds which are fundamental in forming voiced sounds that make speech possible. Although implanted prosthetics are commonly used in developed countries, simple handheld vibrating electrolarynxes are still common worldwide. These devices are easy to use but suffer from many drawbacks including dedication of a hand, mechanical sounding voice, and sound leakage. To address some of these drawbacks, we introduce a novel electrolarynx that uses vibro-acoustic interference of dual ultrasonic waves to generate an audible fundamental frequency. A 3D simulation of the principles of the device is presented in this paper.	[Mills, Patrick; Zara, Jason] George Washington Univ, Sch Engn & Appl Sci, Washington, DC 20052 USA	George Washington University	Mills, P (corresponding author), George Washington Univ, Sch Engn & Appl Sci, Washington, DC 20052 USA.	patmills@gwmail.gwu.edu						Ackermann H., 2010, HDB PHONETIC SCI, P202; Ahmadi F, 2012, PROG BIOPHYS MOL BIO, V108, P119, DOI 10.1016/j.pbiomolbio.2012.01.004; Amirat Y, 2011, INT REV ELECTR ENG-I, V6, P1249; [Anonymous], 1992, S141983 ANSI; Azhari H., 2010, BASICS BIOMEDICAL UL; Bachorowski JA, 1999, CURR DIR PSYCHOL SCI, V8, P53, DOI 10.1111/1467-8721.00013; COLEMAN RF, 1977, J SPEECH HEAR RES, V20, P197, DOI 10.1044/jshr.2002.197; Crocker M.J., 1998, HDB ACOUSTICS; Duck F.A., 1990, MED PHYS, V18; Espy-Wilson CY, 1998, J SPEECH LANG HEAR R, V41, P1253, DOI 10.1044/jslhr.4106.1253; FORMBY C, 1982, J ACOUST SOC AM, V71, P196, DOI 10.1121/1.387347; Hasgall P. A., 2012, ITIS DATABASE THERMA; Hendee W. R., 2003, MED IMAGING PHYS; Hill AJ, 2011, J AUDIO ENG SOC, V59, P321; Hollins M., 2011, ACOUSTICS NOISE CONT; Howard Carl, 2005, J OCCUPATIONAL HLTH, V21, P253; Luo LF, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-35; Maddox PT, 2012, OTOLARYNG HEAD NECK, V147, P85, DOI 10.1177/0194599812438170; Mallis A, 2011, EUR REV MED PHARMACO, V15, P937; Mariani J., 2009, LANGUAGE SPEECH PROC; Markel J., 1976, LINEAR PREDICTION SP; Massey JW, 2011, THESIS U TEXAS AUSTI; Meltzner GS, 2003, THESIS MIT CAMBRIDGE; MUR G, 1981, IEEE T ELECTROMAGN C, V23, P377, DOI 10.1109/TEMC.1981.303970; Ooe K, 1999, C P IEEE ASME INT C; Pandey P, 2002, C P 14 INT C DIG SIG; Pierce A. D., 1989, ACOUSTICS INTRO ITS; QI YY, 1991, J SPEECH HEAR RES, V34, P1250, DOI 10.1044/jshr.3406.1250; ROSENBERG AE, 1971, J ACOUST SOC AM, V49, P583, DOI 10.1121/1.1912389; Schindler A, 2005, Acta Otorhinolaryngol Ital, V25, P240; Schneider John B., 2010, UNDERSTANDING FINITE, V28; SEHGAL CM, 1982, J ACOUST SOC AM, V72, P1711, DOI 10.1121/1.388664; Stemple JC, 2014, CLIN VOICE PATHOLOGY; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Titze IR, 1997, J ACOUST SOC AM, V101, P2234, DOI 10.1121/1.418246; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; van der Molen L, 2013, CURR OPIN OTOLARYNGO, V21, P230, DOI 10.1097/MOO.0b013e3283610060; Vikholt OB, 2012, THESIS NORGES TEKNIS; Walker J., 2007, PROGR NONLINEAR SPEE; Watson PJ, 2008, AM J SPEECH-LANG PAT, V17, P348, DOI 10.1044/1058-0360(2008/07-0048); WEISS MS, 1979, J ACOUST SOC AM, V65, P1298, DOI 10.1121/1.382697; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Zuur JK, 2007, MED BIOL ENG COMPUT, V45, P737, DOI 10.1007/s11517-007-0217-7	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113339	10.1371/journal.pone.0113339	http://dx.doi.org/10.1371/journal.pone.0113339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401965	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700129
J	Niu, S; Gil-Salas, FM; Tewary, SK; Samales, AK; Johnson, J; Swaminathan, K; Wong, SM				Niu, Shengniao; Gil-Salas, Francisco M.; Tewary, Sunil Kumar; Samales, Ashwin Kuppusamy; Johnson, John; Swaminathan, Kunchithapadam; Wong, Sek-Man			Hibiscus Chlorotic Ringspot Virus Coat Protein Is Essential for Cell-to-Cell and Long-Distance Movement but Not for Viral RNA Replication	PLOS ONE			English	Article							TURNIP-CRINKLE-VIRUS; BROME-MOSAIC-VIRUS; AUG INITIATOR CODON; OPEN READING FRAMES; CAPSID PROTEIN; MOTTLE-VIRUS; SYSTEMIC MOVEMENT; POINT MUTATIONS; BETA-ANNULUS; PROTEOLYTIC DISSECTION	Hibiscus chlorotic ringspot virus (HCRSV) is a member of the genus Carmovirus in the family Tombusviridae. In order to study its coat protein (CP) functions on virus replication and movement in kenaf (Hibiscus cannabinus L.), two HCRSV mutants, designated as p2590 (A to G) in which the first start codon ATG was replaced with GTG and p2776 (C to G) in which proline 63 was replaced with alanine, were constructed. In vitro transcripts of p2590 (A to G) were able to replicate to a similar level as wild type without CP expression in kenaf protoplasts. However, its cell-to-cell movement was not detected in the inoculated kenaf cotyledons. Structurally the proline 63 in subunit C acts as a kink for beta-annulus formation during virion assembly. Progeny of transcripts derived from p2776 (C to G) was able to move from cell-to-cell in inoculated cotyledons but its long-distance movement was not detected. Virions were not observed in partially purified mutant virus samples isolated from 2776 (C to G) inoculated cotyledons. Removal of the N-terminal 77 amino acids of HCRSV CP by trypsin digestion of purified wild type HCRSV virions resulted in only T = 1 empty virus-like particles. Taken together, HCRSV CP is dispensable for viral RNA replication but essential for cell-to-cell movement, and virion is required for the virus systemic movement. The proline 63 is crucial for HCRSV virion assembly in kenaf plants and the N-terminal 77 amino acids including the b-annulus domain is required in T = 3 assembly in vitro.	[Niu, Shengniao; Gil-Salas, Francisco M.; Tewary, Sunil Kumar; Samales, Ashwin Kuppusamy; Swaminathan, Kunchithapadam; Wong, Sek-Man] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Niu, Shengniao] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Hainan, Peoples R China; [Gil-Salas, Francisco M.] Inst Andaluz Invest & Formac Agr Pesquera Aliment, Almeria, Spain; [Johnson, John] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wong, Sek-Man] Temasek Life Sci Lab, Singapore, Singapore; [Wong, Sek-Man] Natl Univ Singapore, Suzhou Res Inst, Suzhou, Jiangsu, Peoples R China	National University of Singapore; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Scripps Research Institute; National University of Singapore	Wong, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswsm@nus.edu.sg			National University of Singapore [R-154-000-552-112, R154-000-559-112]	National University of Singapore(National University of Singapore)	This work was supported by National University of Singapore research grants R-154-000-552-112 to Sek-Man Wong and R154-000-559-112 to Kunchithapadam Swaminathan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjikuttira P, 2005, J GEN VIROL, V86, P1543, DOI 10.1099/vir.0.80772-0; BRUGIDOU C, 1995, VIROLOGY, V206, P108, DOI 10.1016/S0042-6822(95)80025-5; BRUNT A, 1996, VIRUSES PLANT DESCRI; Brunt AA, 2000, PLANT PATHOL, V49, P798, DOI 10.1046/j.1365-3059.2000.00501.x; Cao MX, 2010, J VIROL, V84, P7793, DOI 10.1128/JVI.02643-09; Cheng A, 2009, ACTA CRYSTALLOGR F, V65, P589, DOI 10.1107/S1744309109015760; Cohen Y, 2000, VIROLOGY, V273, P258, DOI 10.1006/viro.2000.0441; CUILLEL M, 1981, VIROLOGY, V110, P63, DOI 10.1016/0042-6822(81)90008-8; DEGRAAFF M, 1995, VIROLOGY, V208, P583, DOI 10.1006/viro.1995.1189; Diez Juana, 1998, V81, P211; Ding XS, 1996, P NATL ACAD SCI USA, V93, P11155, DOI 10.1073/pnas.93.20.11155; Doan DNP, 2003, J STRUCT BIOL, V144, P253, DOI 10.1016/j.jsb.2003.10.001; FUENTES AL, 1993, J GEN VIROL, V74, P1903, DOI 10.1099/0022-1317-74-9-1903; Garmann RF, 2014, J MOL BIOL, V426, P1050, DOI 10.1016/j.jmb.2013.10.017; GOLDEN JS, 1982, BIOCHEMISTRY-US, V21, P3862, DOI 10.1021/bi00259a022; GORDON K, 1992, PLANT J, V2, P809, DOI 10.1046/j.1365-313X.1992.t01-17-00999.x; HACKER DL, 1992, VIROLOGY, V186, P1, DOI 10.1016/0042-6822(92)90055-T; Harrison Stephen C., 1996, P59; HEATON LA, 1991, VIROLOGY, V183, P143, DOI 10.1016/0042-6822(91)90127-W; Hill HR, 1997, J MOL BIOL, V266, P1, DOI 10.1006/jmbi.1996.0786; HOGLE JM, 1986, J MOL BIOL, V191, P625, DOI 10.1016/0022-2836(86)90450-X; Huang M, 2000, J VIROL, V74, P3149, DOI 10.1128/JVI.74.7.3149-3155.2000; Hui E, 2006, J VIROL, V80, P5968, DOI 10.1128/JVI.02485-05; Ishikawa M, 2004, P JPN ACAD B-PHYS, V80, P215, DOI 10.2183/pjab.80.215; Ivanov KI, 2012, CURR OPIN VIROL, V2, P712, DOI 10.1016/j.coviro.2012.10.001; Jones D. R., 1980, Australasian Plant Pathology, V9, P4, DOI 10.1071/APP9800004; Kakani K, 2008, J VIROL, V82, P1547, DOI 10.1128/JVI.01976-07; Ke J, 2004, VIROLOGY, V321, P349, DOI 10.1016/j.virol.2004.01.018; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lee KC, 2003, ACTA CRYSTALLOGR D, V59, P1481, DOI 10.1107/S0907444903011648; Li VZ, 1998, VIROLOGY, V244, P405, DOI 10.1006/viro.1998.9125; Li WM, 2006, J VIROL, V80, P3395, DOI 10.1128/JVI.80.7.3395-3405.2006; Liang XZ, 2002, PLANT CELL REP, V20, P982, DOI 10.1007/s00299-002-0435-2; Lokesh GL, 2002, VIROLOGY, V292, P211, DOI 10.1006/viro.2001.1242; Lommel SA, 2000, VIRUS TAXONOMY, P791; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; MACKENZIE DJ, 1986, J GEN VIROL, V67, P727, DOI 10.1099/0022-1317-67-4-727; Meng CY, 2008, J GEN VIROL, V89, P2349, DOI 10.1099/vir.0.2008/002170-0; MORGUNOVA EY, 1994, FEBS LETT, V338, P267, DOI 10.1016/0014-5793(94)80281-5; Nagano H, 1997, J VIROL, V71, P2270, DOI 10.1128/JVI.71.3.2270-2276.1997; Nagano H, 2001, J VIROL, V75, P8045, DOI 10.1128/JVI.75.17.8045-8053.2001; Nagano H, 1999, VIROLOGY, V265, P226, DOI 10.1006/viro.1999.0065; Pantaleo V, 2006, ARCH VIROL, V151, P1973, DOI 10.1007/s00705-006-0767-2; Pappachan A, 2008, VIROLOGY, V375, P190, DOI 10.1016/j.virol.2008.01.023; PETTY ITD, 1990, VIROLOGY, V179, P712, DOI 10.1016/0042-6822(90)90138-H; Powell JD, 2012, VIROLOGY, V422, P165, DOI 10.1016/j.virol.2011.10.019; Ryabov EV, 1999, P NATL ACAD SCI USA, V96, P1212, DOI 10.1073/pnas.96.4.1212; SAITO T, 1990, VIROLOGY, V176, P329, DOI 10.1016/0042-6822(90)90002-9; Sangita V, 2005, ACTA CRYSTALLOGR D, V61, P1402, DOI [10.1107/S0907444905024029, 10.1107/S090744905024029]; Sangita V, 2004, J MOL BIOL, V342, P987, DOI 10.1016/j.jmb.2004.07.003; Satheshkumar PS, 2005, J MOL BIOL, V353, P447, DOI 10.1016/j.jmb.2005.08.021; SCHOLTHOF HB, 1993, MOL PLANT MICROBE IN, V6, P309, DOI 10.1094/MPMI-6-309; Shi Y, 2009, PLANT SIGNAL BEHAV, V4, P15, DOI 10.4161/psb.4.1.7573; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Spitsin S, 1999, P NATL ACAD SCI USA, V96, P2549, DOI 10.1073/pnas.96.5.2549; Stonehouse NJ, 1996, J MOL BIOL, V256, P330, DOI 10.1006/jmbi.1996.0089; STRONG RK, 1990, J VIROL, V64, P3992, DOI 10.1128/JVI.64.8.3992-3994.1990; SUZUKI M, 1991, VIROLOGY, V183, P106, DOI 10.1016/0042-6822(91)90123-S; Takeda A, 2004, J GEN VIROL, V85, P1751, DOI 10.1099/vir.0.79976-0; Tatineni S, 2014, J VIROL, V88, P1366, DOI 10.1128/JVI.02737-13; VAEWHONGS AA, 1995, VIROLOGY, V212, P607, DOI 10.1006/viro.1995.1518; Wada Y, 2008, ACTA CRYSTALLOGR F, V64, P8, DOI 10.1107/S1744309107066481; WATERWORTH HE, 1976, PHYTOPATHOLOGY, V66, P570, DOI 10.1094/Phyto-66-570; Waterworth HE, 1980, HIBISCUS CHLOROTIC R; XIONG Z, 1993, VIROLOGY, V192, P27, DOI 10.1006/viro.1993.1004; Yuan XF, 2006, J GEN VIROL, V87, P3077, DOI 10.1099/vir.0.81928-0; Zhang XF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-200; Zhang X, 2009, J GEN VIROL, V90, P3042, DOI 10.1099/vir.0.012112-0; Zhou T, 2006, MOL PLANT MICROBE IN, V19, P1291	70	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113347	10.1371/journal.pone.0113347	http://dx.doi.org/10.1371/journal.pone.0113347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402344	Green Submitted, gold, Green Published			2022-12-26	WOS:000345158700131
J	Trujillo-de Santiago, G; Rojas-de Gante, C; Garcia-Lara, S; Ballesca-Estrada, A; Alvarez, MM				Trujillo-de Santiago, Grissel; Rojas-de Gante, Cecilia; Garcia-Lara, Silverio; Ballesca-Estrada, Adriana; Moises Alvarez, Mario			Studying Mixing in Non-Newtonian Blue Maize Flour Suspensions Using Color Analysis	PLOS ONE			English	Article							TRANSITIONAL FLOW; PH; RHEOLOGY; FLUIDS; FERMENTATION; CONSUMPTION; SIMULATION; TURBULENT; GELATION; RANGE	Background: Non-Newtonian fluids occur in many relevant flow and mixing scenarios at the lab and industrial scale. The addition of acid or basic solutions to a non-Newtonian fluid is not an infrequent operation, particularly in Biotechnology applications where the pH of Non-Newtonian culture broths is usually regulated using this strategy. Methodology and Findings: We conducted mixing experiments in agitated vessels using Non-Newtonian blue maize flour suspensions. Acid or basic pulses were injected to reveal mixing patterns and flow structures and to follow their time evolution. No foreign pH indicator was used as blue maize flours naturally contain anthocyanins that act as a native, wide spectrum, pH indicator. We describe a novel method to quantitate mixedness and mixing evolution through Dynamic Color Analysis (DCA) in this system. Color readings corresponding to different times and locations within the mixing vessel were taken with a digital camera (or a colorimeter) and translated to the CIELab scale of colors. We use distances in the Lab space, a 3D color space, between a particular mixing state and the final mixing point to characterize segregation/mixing in the system. Conclusion and Relevance: Blue maize suspensions represent an adequate and flexible model to study mixing (and fluid mechanics in general) in Non-Newtonian suspensions using acid/base tracer injections. Simple strategies based on the evaluation of color distances in the CIELab space (or other scales such as HSB) can be adapted to characterize mixedness and mixing evolution in experiments using blue maize suspensions.	[Trujillo-de Santiago, Grissel; Garcia-Lara, Silverio; Ballesca-Estrada, Adriana; Moises Alvarez, Mario] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico; [Trujillo-de Santiago, Grissel] Tecnol Monterrey, Ctr Invest & Desarrollo Prot CIDPRO, Monterrey, Nuevo Leon, Mexico; [Rojas-de Gante, Cecilia] Tecnol Monterrey, Dept Ingn Biotecnol, Tlalpan, DF, Mexico	Tecnologico de Monterrey; Tecnologico de Monterrey; Tecnologico de Monterrey	Alvarez, MM (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico.	mario.alvarez@itesm.mx	García-Lara, Silverio/B-5746-2009; García-Lara, Silverio/D-9687-2012	García-Lara, Silverio/0000-0002-3463-957X; García-Lara, Silverio/0000-0002-3463-957X; Alvarez, Mario Moises/0000-0002-9131-5344; Trujillo de Santiago, Grissel/0000-0001-9230-4607	Tecnologico de Monterrey [CAT-122]; CONACYT	Tecnologico de Monterrey; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors gratefully acknowledge the financial support of Tecnologico de Monterrey (through the seed fund CAT-122), and CONACYT (through the doctoral scholarship provided to GTdeS). The authors deeply appreciate the donation of the blue maize used in the experiments by EDOMEX Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari-Jouybari H, 2011, J FOOD ENG, V106, P170, DOI 10.1016/j.jfoodeng.2011.02.034; Aguirre-Ezkauriatza EJ, 2008, J DAIRY SCI, V91, P4454, DOI 10.3168/jds.2008-1140; Alberini F, 2014, AICHE J, V60, P332, DOI 10.1002/aic.14237; Alvarez M, 2000, THESIS RUTGERS STATE; Alvarez MM, 2002, CAN J CHEM ENG, V80, P546; Arratia PE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.084501; Bhattacharya S, 2004, CHEM ENG RES DES, V82, P1153, DOI 10.1205/cerd.82.9.1153.44173; Bouvier L, 2011, J FOOD SCI, V76, pE384, DOI 10.1111/j.1750-3841.2011.02183.x; Bryant CM, 1997, CEREAL CHEM, V74, P171, DOI 10.1094/CCHEM.1997.74.2.171; Bulnes-Abundis D, 2013, AICHE J, V59, P3092, DOI 10.1002/aic.14064; Bulnes-Abundis D, 2013, BIOTECHNOL BIOENG, V110, P1106, DOI 10.1002/bit.24780; Castaneda-Ovando A, 2010, FOOD ANAL METHOD, V3, P12, DOI 10.1007/s12161-008-9068-6; Celli JP, 2007, BIOMACROMOLECULES, V8, P1580, DOI 10.1021/bm0609691; Chang GF, 2014, BIORESOURCE TECHNOL, V152, P234, DOI 10.1016/j.biortech.2013.11.002; Chen SJ, 2012, CHEM SCI, V3, P1804, DOI 10.1039/c2sc01108e; Chen Y, 2013, BIORESOURCE TECHNOL, V134, P173, DOI 10.1016/j.biortech.2013.02.023; Craig KJ, 2013, WATER RES, V47, P4485, DOI 10.1016/j.watres.2013.05.011; Curran SJ, 2002, J FOOD SCI, V67, P176, DOI 10.1111/j.1365-2621.2002.tb11379.x; de la Rosa-Millan J, 2010, STARCH-STARKE, V62, P549, DOI 10.1002/star.201000023; Dhillon GS, 2013, FOOD BIOPROCESS TECH, V6, P1240, DOI 10.1007/s11947-011-0771-8; Domingues N, 2012, J POLYM ENG, V32, P81, DOI 10.1515/polyeng-2012-0501; Fayolle F, 2013, J FOOD ENG, V116, P390, DOI 10.1016/j.jfoodeng.2012.12.009; Fubin Y, 2013, J RENEWABLE SUSTAINA, V5; Gabelle JC, 2012, CHEM ENG SCI, V75, P408, DOI 10.1016/j.ces.2012.03.053; Guida A, 2011, AICHE J, V57, P2302, DOI 10.1002/aic.12456; Hanwu Lei, 2008, International Journal of Agricultural and Biological Engineering, V1, P55, DOI 10.3965/j.issn.1934-6344.2008.02.055-063; Harrington JC, 2012, J APPL POLYM SCI, V126, P770, DOI 10.1002/app.36946; Karsheva M., 2013, J CHEM TECHNOLOGY ME, V48, P483; Kelly W, 2003, CHEM ENG SCI, V58, P2141, DOI 10.1016/S0009-2509(03)00060-5; KING DW, 1989, MAR CHEM, V26, P5, DOI 10.1016/0304-4203(89)90061-3; Liu Q, 2014, J FOOD ENG, V121, P58, DOI 10.1016/j.jfoodeng.2013.08.016; Machado MB, 2013, CHEM ENG SCI, V98, P218, DOI 10.1016/j.ces.2013.04.039; Maingonnat JF, 2008, J FOOD ENG, V87, P82, DOI 10.1016/j.jfoodeng.2007.11.015; Mendez-Montealvo G, 2008, J CEREAL SCI, V48, P420, DOI 10.1016/j.jcs.2007.10.007; Migliori M, 2013, INT J FOOD SCI TECH, V48, P121, DOI 10.1111/j.1365-2621.2012.03167.x; Moreira HR, 2014, CARBOHYD POLYM, V103, P339, DOI 10.1016/j.carbpol.2013.12.057; Mouquet C, 2001, INT J FOOD SCI NUTR, V52, P389, DOI 10.1080/09637480120078276; Nguyen TH, 2014, SENSOR ACTUAT B-CHEM, V191, P498, DOI 10.1016/j.snb.2013.09.072; Nunez-Santiago MC, 2003, J FOOD ENG, V60, P55, DOI 10.1016/S0260-8774(03)00018-9; Olmos E, 2013, BIOPROC BIOSYST ENG, V36, P259, DOI 10.1007/s00449-012-0794-1; Patel D, 2014, AICHE J, V60, P315, DOI 10.1002/aic.14235; Rao M. A., 2014, RHEOLOGY FLUID SEMIS, P161, DOI 10.1007/978-1-4614-9230-6_4; Ryu SH, 2013, ECON BOT, V67, P98, DOI 10.1007/s12231-013-9232-9; Cervantes MIS, 2006, CHEM ENG SCI, V61, P8075, DOI 10.1016/j.ces.2006.09.035; Perez JAS, 2006, CHEM ENG J, V124, P1, DOI 10.1016/j.cej.2006.07.002; Shi HF, 2014, J COLLOID INTERF SCI, V418, P95, DOI 10.1016/j.jcis.2013.11.078; Soos M, 2008, J COLLOID INTERF SCI, V319, P577, DOI 10.1016/j.jcis.2007.12.005; Suzuki K, 2002, ANAL CHEM, V74, P5766, DOI 10.1021/ac0259414; Tamburini A, 2013, CHEM ENG SCI, V87, P341, DOI 10.1016/j.ces.2012.11.005; Urias-Peraldi M, 2013, FIELD CROP RES, V141, P69, DOI 10.1016/j.fcr.2012.11.008; WOLFBEIS OS, 1987, FRESEN Z ANAL CHEM, V327, P347, DOI 10.1007/BF00491840; Wong ACY, 2009, ADV POLYM TECH, V28, P1, DOI 10.1002/adv.20142; Zhang HL, 2012, ENERGY, V48, P380, DOI 10.1016/j.energy.2012.05.015; Zhang ZX, 2014, POLYM INT IN PRESS	54	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112954	10.1371/journal.pone.0112954	http://dx.doi.org/10.1371/journal.pone.0112954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401332	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700084
J	Tynkevich, E; Flamant, M; Haymann, JP; Metzger, M; Thervet, E; Boffa, JJ; Vrtovsnik, F; Houillier, P; Froissart, M; Stengel, B				Tynkevich, Elena; Flamant, Martin; Haymann, Jean-Philippe; Metzger, Marie; Thervet, Eric; Boffa, Jean-Jacques; Vrtovsnik, Francois; Houillier, Pascal; Froissart, Marc; Stengel, Benedicte		NephroTest Study Grp	Decrease in Urinary Creatinine Excretion in Early Stage Chronic Kidney Disease	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; MAINTENANCE HEMODIALYSIS-PATIENTS; INFLAMMATION COMPLEX SYNDROME; GLOMERULAR-FILTRATION-RATE; BODY-MASS INDEX; MUSCLE MASS; NUTRITIONAL-STATUS; DIALYSIS PATIENTS; SKELETAL-MUSCLE; SERUM-ALBUMIN	Background: Little is known about muscle mass loss in early stage chronic kidney disease (CKD). We used 24-hour urinary creatinine excretion rate to assess determinants of muscle mass and its evolution with kidney function decline. We also described the range of urinary creatinine concentration in this population. Methods: We included 1072 men and 537 women with non-dialysis CKD stages 1 to 5, all of them with repeated measurements of glomerular filtration rate (mGFR) by Cr-51-EDTA renal clearance and several nutritional markers. In those with stage 1 to 4 at baseline, we used a mixed model to study factors associated with urinary creatinine excretion rate and its change over time. Results: Baseline mean urinary creatinine excretion decreased from 15.3 +/- 3.1 to 12.1 +/- 3.3 mmol/24 h (0.20 +/- 0.03 to 0.15 +/- 0.04 mmol/kg/24 h) in men, with mGFR falling from >60 to <15 mL/min/1.73 m(2), and from 9.6 +/- 1.9 to 7.6 +/- 2.5 (0.16 +/- 0.03 to 0.12 +/- 0.03) in women. In addition to mGFR, an older age, diabetes, and lower levels of body mass index, proteinuria, and protein intake assessed by urinary urea were associated with lower mean urinary creatinine excretion at baseline. Mean annual decline in mGFR was 1.53 +/- 0.12 mL/min/1.73 m(2) per year and that of urinary creatinine excretion rate, 0.28 +/- 0.02 mmol/24 h per year. Patients with fast annual decline in mGFR of 5 mL/min/1.73 m(2) had a decrease in urinary creatinine excretion more than twice as big as in those with stable mGFR, independent of changes in urinary urea as well as of other determinants of low muscle mass. Conclusions: Decrease in 24-hour urinary creatinine excretion rate may appear early in CKD patients, and is greater the more mGFR declines independent of lowering protein intake assessed by 24-hour urinary urea. Normalizing urine analytes for creatininuria may overestimate their concentration in patients with reduced kidney function and low muscle mass.	[Tynkevich, Elena; Metzger, Marie; Froissart, Marc; Stengel, Benedicte] INSERM, Ctr Epidemiol & Populat Hlth, CESP, Unit 1018, Villejuif, France; [Tynkevich, Elena; Metzger, Marie; Stengel, Benedicte] Univ Paris 11, UMRS 1018, Villejuif, France; [Flamant, Martin] Hop Bichat Claude Bernard, AP HP, Dept Physiol, F-75877 Paris, France; [Haymann, Jean-Philippe] Hop Tenon, AP HP, Dept Physiol, F-75970 Paris, France; [Haymann, Jean-Philippe; Boffa, Jean-Jacques] INSERM, UNIT 702, Paris, France; [Haymann, Jean-Philippe; Boffa, Jean-Jacques] Univ Paris 06, UMRS 702, Paris, France; [Thervet, Eric] Hop Europeen Georges Pompidou, AP HP, Dept Nephrol, Paris, France; [Thervet, Eric] Hop Europeen Georges Pompidou, AP HP, DHU Common & Rare Arterial Dis, Paris, France; [Boffa, Jean-Jacques] Hop Tenon, AP HP, Dept Nephrol, Paris, France; [Vrtovsnik, Francois] Hop Bichat Claude Bernard, AP HP, Dept Nephrol, F-75877 Paris, France; [Houillier, Pascal] Univ Paris 05, UMRS 775, Paris, France; [Houillier, Pascal] Hop Europe Georges Pompidou, AP HP, Dept Physiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Tynkevich, E (corresponding author), INSERM, Ctr Epidemiol & Populat Hlth, CESP, Unit 1018, Villejuif, France.	elena.tynkevich@inserm.fr	Combe, Christian/N-3726-2015; Stengel, Benedicte/G-5730-2015; Froissart, Marc/L-7493-2014; Houillier, Pascal/AAD-4903-2019; Metzger, Marie/K-9772-2018	Combe, Christian/0000-0002-0360-573X; Stengel, Benedicte/0000-0001-9469-0804; Froissart, Marc/0000-0002-4010-3173; Houillier, Pascal/0000-0003-4953-6917; Vrtovsnik, Francois/0000-0003-1554-314X; Metzger, Marie/0000-0003-3597-5409; Eladari, Dominique/0000-0003-1067-0844; DAUGAS, Eric/0000-0001-7256-7979; Vidal-Petiot, Emmanuelle/0000-0001-9356-7302	INSERM GIS-IReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; INSERM [AO 8022LS]; Agence de la Biomedecine [R0 8156LL]; AURA; Roche [2009-152-447G]	INSERM GIS-IReSP; French Ministry of Health; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding)	The NephroTest CKD cohort study is supported by the following grants: INSERM GIS-IReSP AO 8113LS TGIR (B. S.), French Ministry of Health AOM 09114 (M.Fr.), INSERM AO 8022LS (B. S.), Agence de la Biomedecine R0 8156LL (B. S.), AURA (M.Fr.), and Roche 2009-152-447G (M.Fr.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2011, J RENAL NUTR, V21, P429, DOI 10.1053/j.jrn.2010.09.007; Aparicio M, 1999, NEPHROL DIAL TRANSPL, V14, P1679, DOI 10.1093/ndt/14.7.1679; Avesani CM, 2006, KIDNEY INT, V70, pS8, DOI 10.1038/sj.ki.5001969; Bailey JL, 1996, J CLIN INVEST, V97, P1447, DOI 10.1172/JCI118566; Bansal N, 2011, AM J CARDIOL, V108, P179, DOI 10.1016/j.amjcard.2011.03.020; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Baumgartner RN, 1996, AM J CLIN NUTR, V64, P552, DOI 10.1093/ajcn/64.4.552; BHATLA B, 1995, ASAIO J, V41, pM442, DOI 10.1097/00002480-199507000-00048; BLUMENKRANTZ MJ, 1980, AM J CLIN NUTR, V33, P1567, DOI 10.1093/ajcn/33.7.1567; Cano NJM, 2002, KIDNEY INT, V62, P593, DOI 10.1046/j.1523-1755.2002.00457.x; Carrero JJ, 2008, CLIN NUTR, V27, P557, DOI 10.1016/j.clnu.2008.04.007; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, pS49, DOI 10.2215/CJN.02720409; Chertow GM, 2000, KIDNEY INT, V58, P2512, DOI 10.1046/j.1523-1755.2000.00435.x; De Keyzer W, 2012, BRIT J NUTR, V108, P1118, DOI 10.1017/S0007114511006295; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Fouque D, 2011, KIDNEY INT, V80, P348, DOI 10.1038/ki.2011.118; Gama-Axelsson T, 2012, CLIN J AM SOC NEPHRO, V7, P1446, DOI 10.2215/CJN.10251011; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Honda H, 2007, AM J CLIN NUTR, V86, P633, DOI 10.1093/ajcn/86.3.633; Ix JH, 2011, CLIN J AM SOC NEPHRO, V6, P184, DOI 10.2215/CJN.05030610; Ix JH, 2010, CIRCULATION, V121, P1295, DOI 10.1161/CIRCULATIONAHA.109.924266; JONES JD, 1974, CLIN CHEM, V20, P1204; Kalantar-Zadeh K, 2004, SEMIN DIALYSIS, V17, P455, DOI 10.1111/j.0894-0959.2004.17606.x; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1343, DOI 10.1053/ajkd.2001.29250; Kaysen GA, 2005, AM J CLIN NUTR, V82, P988, DOI 10.1093/ajcn/82.5.988; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Kovesdy CP, 2010, SEMIN DIALYSIS, V23, P353, DOI 10.1111/j.1525-139X.2010.00745.x; Kovesdy CP, 2009, AM J CLIN NUTR, V90, P407, DOI 10.3945/ajcn.2008.27390; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P119, DOI 10.1007/s13539-011-0026-6; Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P9, DOI 10.1007/s13539-011-0019-5; Micco LD, 2013, CLIN J AM SOC NEPHRO, DOI [10.2215/CJN.01350213, DOI 10.2215/CJN.01350213]; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Molnar MZ, 2011, AM J TRANSPLANT, V11, P725, DOI 10.1111/j.1600-6143.2011.03468.x; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P2258, DOI 10.2215/CJN.02080310; Ortega O, 2002, NEPHROL DIAL TRANSPL, V17, P1105, DOI 10.1093/ndt/17.6.1105; Oterdoom LH, 2008, TRANSPLANTATION, V86, P391, DOI 10.1097/TP.0b013e3181788aea; Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; Pupim LB, 2005, KIDNEY INT, V68, P2368, DOI 10.1111/j.1523-1755.2005.00699.x; Qureshi AR, 2002, J AM SOC NEPHROL, V13, pS28; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Rule AD, 2009, KIDNEY INT, V75, P1071, DOI 10.1038/ki.2008.698; Siew ED, 2007, KIDNEY INT, V71, P146, DOI 10.1038/sj.ki.5001984; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	53	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111949	10.1371/journal.pone.0111949	http://dx.doi.org/10.1371/journal.pone.0111949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401694	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700022
J	Finsen, AV; Ueland, T; Sjaastad, I; Ranheim, T; Ahmed, MS; Dahl, CP; Askevold, ET; Aakhus, S; Husberg, C; Fiane, AE; Lipp, M; Gullestad, L; Christensen, G; Aukrust, P; Yndestad, A				Finsen, Alexandra Vanessa; Ueland, Thor; Sjaastad, Ivar; Ranheim, Trine; Ahmed, Mohammed S.; Dahl, Christen P.; Askevold, Erik T.; Aakhus, Svend; Husberg, Cathrine; Fiane, Arnt E.; Lipp, Martin; Gullestad, Lars; Christensen, Geir; Aukrust, Pal; Yndestad, Arne			The Homeostatic Chemokine CCL21 Predicts Mortality in Aortic Stenosis Patients and Modulates Left Ventricular Remodeling	PLOS ONE			English	Article							RECEPTOR CCR7; EXPRESSION; ECHOCARDIOGRAPHY; CARDIOLOGY; DISEASE	Background: CCL21 acting through CCR7, is termed a homeostatic chemokine. Based on its role in concerting immunological responses and its proposed involvement in tissue remodeling, we hypothesized that this chemokine could play a role in myocardial remodeling during left ventricular (LV) pressure overload. Methods and Results: Our main findings were: (i) Serum levels of CCL21 were markedly raised in patients with symptomatic aortic stenosis (AS, n = 136) as compared with healthy controls (n = 20). (ii) A CCL21 level in the highest tertile was independently associated with all-cause mortality in these patients. (iii) Immunostaining suggested the presence of CCR7 on macrophages, endothelial cells and fibroblasts within calcified human aortic valves. (iv). Mice exposed to LV pressure overload showed enhanced myocardial expression of CCL21 and CCR7 mRNA, and increased CCL21 protein levels. (v) CCR7(-/-) mice subjected to three weeks of LV pressure overload had similar heart weights compared to wild type mice, but increased LV dilatation and reduced wall thickness. Conclusions: Our studies, combining experiments in clinical and experimental LV pressure overload, suggest that CCL21/CCR7 interactions might be involved in the response to pressure overload secondary to AS.	[Finsen, Alexandra Vanessa; Ueland, Thor; Ranheim, Trine; Dahl, Christen P.; Askevold, Erik T.; Aukrust, Pal; Yndestad, Arne] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Finsen, Alexandra Vanessa; Dahl, Christen P.; Askevold, Erik T.; Aakhus, Svend; Gullestad, Lars] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Ueland, Thor] Oslo Univ Hosp, Rikshosp, Endocrinol Sect, Oslo, Norway; [Fiane, Arnt E.] Oslo Univ Hosp, Rikshosp, Dept Cardiothorac Surg, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Ahmed, Mohammed S.] Oslo Univ Hosp, Rikshosp, Inst Surg Res, Oslo, Norway; [Sjaastad, Ivar; Husberg, Cathrine; Christensen, Geir] Univ Oslo, Ulleval Hosp, Expt Med Res Inst, Oslo, Norway; [Sjaastad, Ivar] Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway; [Finsen, Alexandra Vanessa; Sjaastad, Ivar; Ahmed, Mohammed S.; Dahl, Christen P.; Askevold, Erik T.; Aakhus, Svend; Husberg, Cathrine; Gullestad, Lars; Christensen, Geir; Yndestad, Arne] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Aukrust, Pal; Yndestad, Arne] Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Ueland, Thor; Sjaastad, Ivar; Gullestad, Lars; Christensen, Geir] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Sjaastad, Ivar; Ranheim, Trine; Fiane, Arnt E.; Gullestad, Lars; Christensen, Geir; Aukrust, Pal; Yndestad, Arne] Univ Oslo, Fac Med, Oslo, Norway; [Lipp, Martin] Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, Berlin, Germany; [Askevold, Erik T.] Lovisenberg Diakonale Hosp, Dept Med, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Finsen, AV (corresponding author), Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway.	a.v.finsen@medisin.uio.no		Lipp, Martin/0000-0002-0087-2672	Center for Heart Failure Research, University of Oslo; Regional Health Authorities of South-Eastern Norway; Norwegian Research Council	Center for Heart Failure Research, University of Oslo; Regional Health Authorities of South-Eastern Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was funded by Center for Heart Failure Research, University of Oslo, the Regional Health Authorities of South-Eastern Norway and the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akat K, 2009, HEART, V95, P616, DOI 10.1136/hrt.2007.134783; Banas B, 2004, KIDNEY INT, V66, P2256, DOI 10.1111/j.1523-1755.2004.66037.x; Bruhl H, 2008, RHEUMATOLOGY, V47, P1771, DOI 10.1093/rheumatology/ken383; Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c; Finsen AV, 2005, J APPL PHYSIOL, V98, P680, DOI 10.1152/japplphysiol.00924.2004; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Kaur D, 2006, AM J RESP CRIT CARE, V174, P1179, DOI 10.1164/rccm.200603-394OC; Kawashima D, 2005, J CLIN PATHOL, V58, P1057, DOI 10.1136/jcp.2004.024828; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LAURENT GJ, 1981, ANAL BIOCHEM, V113, P301, DOI 10.1016/0003-2697(81)90081-6; Liu HJ, 1998, J CHROMATOGR A, V828, P383, DOI 10.1016/S0021-9673(98)00836-X; Muller G, 2002, J LEUKOCYTE BIOL, V72, P1; Ngo DTM, 2004, J AM SOC ECHOCARDIOG, V17, P1123, DOI 10.1016/j.echo.2004.06.012; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Pickens SR, 2012, ARTHRITIS RHEUM-US, V64, P2471, DOI 10.1002/art.34452; Pierce EM, 2007, EUR RESPIR J, V29, P1082, DOI 10.1183/09031936.00122806; Rajamannan NM, 2007, NAT CLIN PRACT CARD, V4, P254, DOI 10.1038/ncpcardio0827; Ross J Jr, 1968, Circulation, V38, P61; SKJAERPE T, 1985, CIRCULATION, V72, P810, DOI 10.1161/01.CIR.72.4.810; Waehre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018668; Yndestad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033038	22	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112172	10.1371/journal.pone.0112172	http://dx.doi.org/10.1371/journal.pone.0112172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398010	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000345558500038
J	Kumar, KA; Lalitha, A; Reddy, U; Chandak, GR; Sengupta, S; Raghunath, M				Kumar, Kalle Anand; Lalitha, Anumula; Reddy, Umakar; Chandak, Giriraj Ratan; Sengupta, Shantanu; Raghunath, Manchala			Chronic Maternal Vitamin B12 Restriction Induced Changes in Body Composition & Glucose Metabolism in the Wistar Rat Offspring Are Partly Correctable by Rehabilitation	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; SKELETAL-MUSCLE; BIRTH-WEIGHT; PREGNANCY; FOLATE; FAT; SUPPLEMENTATION; HOMOCYSTEINE; METHYLATION	Maternal under-nutrition increases the risk of developing metabolic diseases. We studied the effects of chronic maternal dietary vitamin B12 restriction on lean body mass (LBM), fat free mass (FFM), muscle function, glucose tolerance and metabolism in Wistar rat offspring. Prevention/reversibility of changes by rehabilitating restricted mothers from conception or parturition and their offspring from weaning was assessed. Female weaning Wistar rats (n = 30) were fed ad libitum for 12 weeks, a control diet (n = 6) or the same with 40% restriction of vitamin B12 (B12R) (n = 24); after confirming deficiency, were mated with control males. Six each of pregnant B12R dams were rehabilitated from conception and parturition and their offspring weaned to control diet. While offspring of six B12R dams were weaned to control diet, those of the remaining six B12R dams continued on B12R diet. Biochemical parameters and body composition were determined in dams before mating and in male offspring at 3, 6, 9 and 12 months of their age. Dietary vitamin B12 restriction increased body weight but decreased LBM% and FFM% but not the percent of tissue associated fat (TAF%) in dams. Maternal B12R decreased LBM% and FFM% in the male offspring, but their TAF%, basal and insulin stimulated glucose uptake by diaphragm were unaltered. At 12 months age, B12R offspring had higher (than controls) fasting plasma glucose, insulin, HOMA-IR and impaired glucose tolerance. Their hepatic gluconeogenic enzyme activities were increased. B12R offspring had increased oxidative stress and decreased antioxidant status. Changes in body composition, glucose metabolism and stress were reversed by rehabilitating B12R dams from conception, whereas rehabilitation from parturition and weaning corrected them partially, highlighting the importance of vitamin B12 during pregnancy and lactation on growth, muscle development, glucose tolerance and metabolism in the offspring.	[Kumar, Kalle Anand; Lalitha, Anumula; Raghunath, Manchala] Indian Council Med Res, Natl Inst Nutr, Div Endocrinol & Metab, Hyderabad, Telangana, India; [Reddy, Umakar; Chandak, Giriraj Ratan] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Telangana, India; [Sengupta, Shantanu] CSIR, Inst Genom & Integrat Biol, New Delhi 110001, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Raghunath, M (corresponding author), Indian Council Med Res, Natl Inst Nutr, Div Endocrinol & Metab, Hyderabad, Telangana, India.	mraghunath55@yahoo.com		Chandak, Giriraj Ratan/0000-0002-3095-9453	Department of Biotechnology, Government of India, New Delhi, India [BT/PR-7506/PID/20/294/2006]; Indian Council of Medical Research (ICMR), India	Department of Biotechnology, Government of India, New Delhi, India(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR))	This work was supported by a research grant (#BT/PR-7506/PID/20/294/2006) to Manchala Raghunath, Giriraj Ratan Chandak and Shantanu Sengupta, from the Department of Biotechnology, Government of India, New Delhi, India (URL: http://dbtindia.nic.in/index.asp). The authors acknowledge the support and encouragement received from the Directors of National Institute of Nutrition and the Centre for Cellular and Molecular Biology, Hyderabad in the conduct of these studies. Kalle Anand Kumar is grateful to the Indian Council of Medical Research (ICMR), India, for awarding a senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, J PROTEOMICS, V91, P297, DOI 10.1016/j.jprot.2013.07.027; Alwan NA, 2011, HUM REPROD, V26, P911, DOI 10.1093/humrep/der005; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Bourre JM, 2006, J NUTR HEALTH AGING, V10, P377; BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S; Choi SW, 2004, J NUTR, V134, P750, DOI 10.1093/jn/134.4.750; Devrim E, 2006, J SOC GYNECOL INVEST, V13, P502, DOI 10.1016/j.jsgi.2006.07.004; Donahue RP, 1997, DIABETES CARE, V20, P1670, DOI 10.2337/diacare.20.11.1670; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; EMERSON GA, 1949, FED PROC, V8, P381; Frith AL, 2009, AM J CLIN NUTR, V90, P141, DOI 10.3945/ajcn.2008.26817; Ganeshan M, 2011, EXP DIABETES RES, DOI 10.1155/2011/486316; GAUTHIER GF, 1966, J CELL BIOL, V28, P333, DOI 10.1083/jcb.28.2.333; GIEROW P, 1982, METHOD ENZYMOL, V89, P44; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Iannotti LL, 2008, AM J CLIN NUTR, V88, P154, DOI 10.1093/ajcn/88.1.154; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; Karen LY, 1999, THESIS U TORONTO; KIPNIS DM, 1957, J BIOL CHEM, V224, P681; Krishnaveni GV, 2009, DIABETOLOGIA, V52, P2350, DOI 10.1007/s00125-009-1499-0; Krishnaveni GV, 2011, AM J CLIN NUTR, V93, P628, DOI 10.3945/ajcn.110.003921; Kulkarni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017706; Kumar KA, 2013, J NUTR BIOCHEM, V24, P25, DOI 10.1016/j.jnutbio.2012.01.004; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; Leeda M, 1998, AM J OBSTET GYNECOL, V179, P135, DOI 10.1016/S0002-9378(98)70263-7; Lin YF, 2005, J NUTR, V135, P2457, DOI 10.1093/jn/135.10.2457; LING CT, 1952, J BIOL CHEM, V198, P439; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; MARCUS F, 1982, METHOD ENZYMOL, V90, P352; Mitrou P, 2010, ENDOCR REV, V31, P663, DOI 10.1210/er.2009-0046; MORBACH CA, 1992, J PEDIATR GASTR NUTR, V14, P283, DOI 10.1097/00005176-199204000-00009; Muthayya S, 2006, EUR J CLIN NUTR, V60, P791, DOI 10.1038/sj.ejcn.1602383; Nelen WLDM, 2000, OBSTET GYNECOL, V95, P519, DOI 10.1016/S0029-7844(99)00610-9; NUUTILA P, 1995, DIABETES, V44, P31, DOI 10.2337/diabetes.44.1.31; Padmavathi IJN, 2010, DIABETES, V59, P98, DOI 10.2337/db09-0779; Padmavathi IJN, 2009, EXP PHYSIOL, V94, P761, DOI 10.1113/expphysiol.2008.045856; Pilkis S J, 1975, Methods Enzymol, V42, P31; Raghunath M, 2009, INDIAN J MED RES, V130, P655; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Rao S, 2001, J NUTR, V131, P1217, DOI 10.1093/jn/131.4.1217; Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395; Selhub J, 2002, J Nutr Health Aging, V6, P39; Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; Setola E, 2004, EUR J ENDOCRINOL, V151, P483, DOI 10.1530/eje.0.1510483; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith U, 2002, INT J OBESITY, V26, P897, DOI 10.1038/sj.ijo.0802028; Sucharita S, 2014, MATERN CHILD NUTR, V10, P226, DOI 10.1111/j.1740-8709.2012.00418.x; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; US Department of Health Education and Welfare: Guide for the Care and Use of Laboratory Animals, 1985, US DHEW NIH PUBL, P85; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Venu L, 2004, DIABETOLOGIA, V47, P1493, DOI 10.1007/s00125-004-1506-4; Venu L, 2004, EUR J ENDOCRINOL, V151, P287, DOI 10.1530/eje.0.1510287; Venu L, 2008, OBESITY, V16, P1270, DOI 10.1038/oby.2008.72; WARDZALA LJ, 1983, BIOCHIM BIOPHYS ACTA, V730, P49, DOI 10.1016/0005-2736(83)90315-2; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053; Zhu MJ, 2006, J PHYSIOL-LONDON, V575, P241, DOI 10.1113/jphysiol.2006.112110	66	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112991	10.1371/journal.pone.0112991	http://dx.doi.org/10.1371/journal.pone.0112991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398136	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500122
J	Wang, WJ; Li, YH; Wang, HM; Zu, YG				Wang, Wenjie; Li, Yanhong; Wang, Huimei; Zu, Yuangang			Differences in the Activities of Eight Enzymes from Ten Soil Fungi and Their Possible Influences on the Surface Structure, Functional Groups, and Element Composition of Soil Colloids	PLOS ONE			English	Article							ACID-PHOSPHATASE; ENZYMATIC-ACTIVITY; CHITINASE ACTIVITY; MYCORRHIZAL FUNGI; FOREST SOILS; ECTOMYCORRHIZAL; PLANT; BIODIVERSITY; VARIABILITY; PHOSPHORUS	How soil fungi function in soil carbon and nutrient cycling is not well understood by using fungal enzymatic differences and their interactions with soil colloids. Eight extracellular enzymes, EEAs (chitinase, carboxymethyl cellulase, beta-glucosidase, protease, acid phosphatase, polyphenol oxidase, laccase, and guaiacol oxidase) secreted by ten fungi were compared, and then the fungi that showed low and high enzymatic activity were co-cultured with soil colloids for the purpose of finding fungi-soil interactions. Some fungi (Gomphidius rutilus, Russula integra, Pholiota adiposa, and Geastrum mammosum) secreted 3-4 enzymes with weak activities, while others (Cyathus striatus, Suillus granulate, Phallus impudicus, Collybia dryophila, Agaricus sylvicola, and Lactarius deliciosus) could secret over 5 enzymes with high activities. The differences in these fungi contributed to the alterations of functional groups (stretching bands of O-H, N-H, C-H, C = O, COO-decreased by 11-60%, while P = O, C-O stretching, O-H bending and Si-O-Si stretching increased 9-22%), surface appearance (disappearance of adhesive organic materials), and elemental compositions (11-49% decreases in C1s) in soil colloids. Moreover, more evident changes were generally in high enzymatic fungi (C. striatus) compared with low enzymatic fungi (G. rutilus). Our findings indicate that inter-fungi differences in EEA types and activities might be responsible for physical and chemical changes in soil colloids (the most active component of soil matrix), highlighting the important roles of soil fungi in soil nutrient cycling and functional maintenance.	[Wang, Wenjie; Li, Yanhong; Wang, Huimei; Zu, Yuangang] Minist Educ, Key Lab Forest Plant Ecol, Harbin, Heilongjiang Pr, Peoples R China		Wang, HM (corresponding author), Minist Educ, Key Lab Forest Plant Ecol, Harbin, Heilongjiang Pr, Peoples R China.	whm0709@hotmail.com	wang, wenjie/G-9041-2014; li, yan/GTI-4638-2022	wang, wenjie/0000-0003-0465-686X; 	China's Ministry of Science and Technology [2011CB403205]; Fundamental Research Funds for the Central Universities [2572014EA01]; China's National Foundation of Natural Sciences [31170575, 41373075]	China's Ministry of Science and Technology(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China's National Foundation of Natural Sciences	This study was supported financially by the China's Ministry of Science and Technology (2011CB403205), Fundamental Research Funds for the Central Universities (2572014EA01), China's National Foundation of Natural Sciences (31170575, 41373075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksieva P, 2003, Z NATURFORSCH C, V58, P239; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Barton CD, 2003, WATER AIR SOIL POLL, V143, P3, DOI 10.1023/A:1022886225564; BOLAN NS, 1991, PLANT SOIL, V134, P189, DOI 10.1007/BF00012037; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burke RM, 2002, MYCORRHIZA, V12, P105, DOI 10.1007/s00572-002-0162-0; Cairney JWG, 1998, PLANT SOIL, V205, P181, DOI 10.1023/A:1004376731209; Caldwell BA, 2005, PEDOBIOLOGIA, V49, P637, DOI 10.1016/j.pedobi.2005.06.003; Carter DO, 2007, PEDOBIOLOGIA, V51, P295, DOI 10.1016/j.pedobi.2007.05.002; CHEN KS, 1994, ELECTROPHORESIS, V15, P662, DOI 10.1002/elps.1150150193; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cosgrove DJ, 1977, MICROBIAL TRANSFORMA, P95; Cullings K, 2008, OECOLOGIA, V158, P77, DOI 10.1007/s00442-008-1119-6; DeNovio NM, 2004, VADOSE ZONE J, V3, P338, DOI 10.2113/3.2.338; Desai S, 2014, MYCORRHIZA, V24, P369, DOI 10.1007/s00572-013-0548-1; Dirks-Hofmeister ME, 2012, PLANT MOL BIOL, V80, P203, DOI 10.1007/s11103-012-9943-9; Ekenler M, 2003, SOIL BIOL BIOCHEM, V35, P871, DOI 10.1016/S0038-0717(03)00094-4; Fansler SJ, 2005, BIOL FERT SOILS, V42, P17, DOI 10.1007/s00374-005-0867-2; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; GELLERSTEDT G, 1989, WOOD SCI TECHNOL, V23, P75, DOI 10.1007/BF00350609; GIANFREDA L, 1993, SOIL BIOL BIOCHEM, V25, P671, DOI 10.1016/0038-0717(93)90106-L; HAZEN GG, 1965, ANN NY ACAD SCI, V130, P761, DOI 10.1111/j.1749-6632.1965.tb12620.x; Hilszczanska D, 2008, POL J ENVIRON STUD, V17, P881; Huang QY, 2005, COLLOID SURFACE B, V45, P209, DOI 10.1016/j.colsurfb.2005.08.011; Jarosz-Wilkolazka A, 2002, ENZYME MICROB TECH, V30, P566, DOI 10.1016/S0141-0229(02)00022-4; Johnson CT, 1996, METHODS SOIL ANAL 3; Kelleher BP, 2003, LANGMUIR, V19, P9411, DOI 10.1021/la034971e; Klose S, 2003, WATER AIR SOIL POLL, V142, P3, DOI 10.1023/A:1022075130048; Leduc SD, 2013, OECOLOGIA, V172, P257, DOI 10.1007/s00442-012-2471-0; Li Yan-Hong, 2013, Bulletin of Botanical Research, V33, P404, DOI 10.7525/j.issn.1673-5102.2013.04.004; Li YH, 2013, SCI WORLD J, DOI 10.1155/2013/698752; Marcote I, 2001, BIORESOURCE TECHNOL, V79, P147, DOI 10.1016/S0960-8524(01)00048-7; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mucha J, 2006, ARCH MICROBIOL, V185, P69, DOI 10.1007/s00203-005-0068-2; NICHOLSORIANS C, 1991, J CHEM ECOL, V17, P1811, DOI 10.1007/BF00993730; Ohnuma T, 2011, FEBS J, V278, P3991, DOI 10.1111/j.1742-4658.2011.08301.x; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Pointing SB, 2001, APPL MICROBIOL BIOT, V57, P20; Rao MA, 2000, SOIL BIOL BIOCHEM, V32, P1007, DOI 10.1016/S0038-0717(00)00010-9; Redlak K, 2001, BIOL FERT SOILS, V33, P83, DOI 10.1007/s003740000295; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schreiner RP, 1997, PLANT SOIL, V188, P199, DOI 10.1023/A:1004271525014; Shaik NM, 2013, MOL BIOL REP, V40, P1351, DOI 10.1007/s11033-012-2179-6; Shao L.P., 1997, FOREST MUSHROOM CHIN; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Srinivasulu M, 2013, INT J ENVIRON SCI TE, V10, P341, DOI 10.1007/s13762-012-0133-8; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wang WJ, 2011, PLANT SOIL, V339, P177, DOI 10.1007/s11104-010-0565-1; WOLF DC, 1989, J ENVIRON QUAL, V18, P39, DOI 10.2134/jeq1989.00472425001800010007x; [谢丽源 Xie Liyuan], 2010, [食品工业科技, Science & Technology of Food Industry], V31, P183; Xu Y, 2009, ADV ATMOS SCI, V26, P783, DOI 10.1007/s00376-009-9034-2; [于富强 Yu Fuqiang], 2002, [生态学报, Acta Ecologica Sinica], V22, P2217; Zhou DM, 2011, J SOIL SEDIMENT, V11, P491, DOI 10.1007/s11368-010-0331-2; Zifcakova L, 2011, FUNGAL ECOL, V4, P427, DOI 10.1016/j.funeco.2011.04.002	59	14	14	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111740	10.1371/journal.pone.0111740	http://dx.doi.org/10.1371/journal.pone.0111740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398013	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500024
J	Zheng, C; Ge, LS; Zhao, JL; Zhang, WW; Chen, XS; Chen, XX; Li, YC				Zheng Cheng; Ge Li-Sha; Zhao Jing-Lin; Zhang Wen-Wu; Chen Xue-Si; Chen Xing-Xing; Li Yue-Chun			Protective Role of the Cholinergic Anti-Inflammatory Pathway in a Mouse Model of Viral Myocarditis	PLOS ONE			English	Article							NF-KAPPA-B; NICOTINIC ACETYLCHOLINE-RECEPTOR; VAGUS NERVE; ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY REFLEX; IMPROVES SURVIVAL; ACTIVATION; STIMULATION; AUTOIMMUNITY; AGONIST	Background: Activation of the cholinergic anti-inflammatory pathway, which relies on the alpha 7nAchR (alpha 7 nicotinic acetylcholine receptor), has been shown to decrease proinflammatory cytokines. This relieves inflammatory responses and improves the prognosis of patients with experimental sepsis, endotoxemia, ischemia/reperfusion injury, hemorrhagic shock, pancreatitis, arthritis and other inflammatory syndromes. However, whether the cholinergic anti-inflammatory pathway has an effect on acute viral myocarditis has not been investigated. Here, we studied the effects of the cholinergic anti-inflammatory pathway on acute viral myocarditis. Methodology/Principal Findings: In a coxsackievirus B3 murine myocarditis model (Balb/c), nicotine and methyllycaconitine were used to stimulate and block the cholinergic anti-inflammatory pathway, respectively. Relevant signal pathways were studied to compare their effects on myocarditis, survival rate, histopathological changes, ultrastructural changes, and cytokine levels. Nicotine treatments significantly improved survival rate, attenuated myocardial lesions, and downregulated the expression of TNF-alpha and IL-6. Methyllycaconitine decreased survival rate, aggravated myocardial lesions, and upregulated the expression of TNF-alpha and IL-6. In addition, levels of the signaling protein phosphorylated STAT3 were higher in the nicotine group and lower in the methyllycaconitine group compared with the untreated myocarditis group. Conclusions/Significance: These results show that nicotine protects mice from CVB3-induced viral myocarditis and that methyllycaconitine aggravates viral myocarditis in mice. Because nicotine is a alpha 7nAchR agonist and methyllycaconitine is a alpha 7nAchR antagonist, we conclude that alpha 7nAchR activation increases the phosphorylation of STAT3, reduces the expression of TNF-alpha and IL-6, and, ultimately, alleviates viral myocarditis. We also conclude that blocking alpha 7nAchR reduces the phosphorylation of STAT3, increases the expression of TNF-alpha and IL-6, aggravating viral myocarditis.	[Zheng Cheng; Zhao Jing-Lin; Zhang Wen-Wu; Chen Xue-Si; Chen Xing-Xing; Li Yue-Chun] Wenzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, Wenzhou 325000, Peoples R China; [Ge Li-Sha] Wenzhou Med Univ, Affiliated Hosp 2, Dept Pediat, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Li, YC (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, Wenzhou 325000, Peoples R China.	liyuechun1980@sina.com	Chen, Xuesi/ABB-5039-2020		National Natural Science Foundation of China [81200165]; Zhejiang Provincial Natural Science Foundation of China [LY14H310011]; Wenzhou Municipal Science and Technology Commission, China [Y20130038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Commission, China	This study was supported by the National Natural Science Foundation of China (Grant No. 81200165), the Zhejiang Provincial Natural Science Foundation of China (Grant No. LY14H310011) and the Wenzhou Municipal Science and Technology Commission, China (Grant No. Y20130038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Caforio ALP, 1996, INT J CARDIOL, V54, P157, DOI 10.1016/0167-5273(96)02593-4; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Cui WY, 2013, MOL PHARMACOL, V83, P61, DOI 10.1124/mol.112.081497; Cui WY, 2010, J NEUROIMMUNE PHARM, V5, P479, DOI 10.1007/s11481-010-9210-2; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Han Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086166; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Lakhan SE, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-129; Lee SE, 2013, NEUROSCI LETT, V548, P291, DOI 10.1016/j.neulet.2013.05.073; Leib C, 2011, CIRC RES, V109, P130, DOI 10.1161/CIRCRESAHA.111.245563; Li H, 2009, MED HYPOTHESES, V73, P725, DOI 10.1016/j.mehy.2009.04.036; Mabley J, 2011, INFLAMMATION, V34, P231, DOI 10.1007/s10753-010-9228-x; Nicolussi EM, 2009, NEUROBIOL DIS, V35, P24, DOI 10.1016/j.nbd.2009.03.010; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Oke SL, 2009, ANN NY ACAD SCI, V1172, P172, DOI 10.1196/annals.1393.013; Park J, 2013, EUR J PHARMACOL, V707, P61, DOI 10.1016/j.ejphar.2013.03.026; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rose NR, 2000, NAT MED, V6, P631, DOI 10.1038/76199; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Safieh-Garabedian B, 2013, NEUROSCIENCE, V250, P455, DOI 10.1016/j.neuroscience.2013.07.031; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Sun P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069424; The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; USTINOVA EE, 1994, CIRC RES, V74, P904, DOI 10.1161/01.RES.74.5.904; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Zhao M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0345-1; Zhou YO, 2012, RHEUMATOL INT, V32, P97, DOI 10.1007/s00296-010-1549-4	39	14	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112719	10.1371/journal.pone.0112719	http://dx.doi.org/10.1371/journal.pone.0112719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396421	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500081
J	Pandey, A; Pain, J; Ghosh, AK; Dancis, A; Pain, D				Pandey, Alok; Pain, Jayashree; Ghosh, Arnab K.; Dancis, Andrew; Pain, Debkumar			Fe-S Cluster Biogenesis in Isolated Mammalian Mitochondria COORDINATED USE OF PERSULFIDE SULFUR AND IRON AND REQUIREMENTS FOR GTP, NADH, AND ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Friedreich Ataxia; Iron; Iron Metabolism; Iron-Sulfur Protein; Metal Homeostasis; Mitochondria; Mitochondrial Aconitase; Mitochondrial Metabolism; Sulfur; Yeast	SUCCINYL-COA SYNTHETASES; SACCHAROMYCES-CEREVISIAE; SCAFFOLD PROTEIN; CYSTEINE DESULFURASE; INTACT MITOCHONDRIA; INTERACTING PROTEIN; YEAST FRATAXIN; HUMAN-DISEASE; IDENTIFICATION; CELLS	Background: Fe-S cluster assembly in mitochondria involves generation of an activated form of sulfur called persulfide. Results: A novel experimental system tracks new Fe-S cluster synthesis in isolated mammalian mitochondria. Conclusion: The use of persulfide sulfur and iron for Fe-S cluster biogenesis is tightly coordinated by processes requiring GTP, NADH, and ATP. Significance: These cofactor targets can now be defined. Iron-sulfur (Fe-S) clusters are essential cofactors, and mitochondria contain several Fe-S proteins, including the [4Fe-4S] protein aconitase and the [2Fe-2S] protein ferredoxin. Fe-S cluster assembly of these proteins occurs within mitochondria. Although considerable data exist for yeast mitochondria, this biosynthetic process has never been directly demonstrated in mammalian mitochondria. Using [S-35]cysteine as the source of sulfur, here we show that mitochondria isolated from Cath.A-derived cells, a murine neuronal cell line, can synthesize and insert new Fe-S-35 clusters into aconitase and ferredoxins. The process requires GTP, NADH, ATP, and iron, and hydrolysis of both GTP and ATP is necessary. Importantly, we have identified the S-35-labeled persulfide on the NFS1 cysteine desulfurase as a genuine intermediate en route to Fe-S cluster synthesis. In physiological settings, the persulfide sulfur is released from NFS1 and transferred to a scaffold protein, where it combines with iron to form an Fe-S cluster intermediate. We found that the release of persulfide sulfur from NFS1 requires iron, showing that the use of iron and sulfur for the synthesis of Fe-S cluster intermediates is a highly coordinated process. The release of persulfide sulfur also requires GTP and NADH, probably mediated by a GTPase and a reductase, respectively. ATP, a cofactor for a multifunctional Hsp70 chaperone, is not required at this step. The experimental system described here may help to define the biochemical basis of diseases that are associated with impaired Fe-S cluster biogenesis in mitochondria, such as Friedreich ataxia.	[Pandey, Alok; Pain, Jayashree; Ghosh, Arnab K.; Pain, Debkumar] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07101 USA; [Dancis, Andrew] Univ Penn, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania	Pain, D (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave,MSB 1-669, Newark, NJ 07101 USA.	painde@njms.rutgers.edu		Ghosh, Arnab/0000-0002-6962-1935	National Institutes of Health [R01GM107542, R37DK053953]; Friedreich's Ataxia Research Alliance grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich's Ataxia Research Alliance grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM107542 (to D. P.) and R37DK053953 (to A. D.). The work was also supported by a Friedreich's Ataxia Research Alliance grant.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Amutha B, 2009, METHOD ENZYMOL, V456, P247, DOI 10.1016/S0076-6879(08)04414-5; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Holmes-Hampton GP, 2010, BIOCHEMISTRY-US, V49, P4227, DOI 10.1021/bi1001823; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580; Johnson JD, 1998, J BIOL CHEM, V273, P27573, DOI 10.1074/jbc.273.42.27573; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Lacour T, 1998, J BIOL CHEM, V273, P23984, DOI 10.1074/jbc.273.37.23984; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Monne M, 2013, J BIOENERG BIOMEMBR, V45, P1, DOI 10.1007/s10863-012-9475-7; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pain D., 2014, IRON SULFUR CLUSTERS, P367; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Pandey A, 2012, MITOCHONDRION, V12, P539, DOI 10.1016/j.mito.2012.07.103; Pandey BN, 2006, ANTIOXID REDOX SIGN, V8, P1253, DOI 10.1089/ars.2006.8.1253; Pasuit JB, 2004, J NEUROCHEM, V89, P1508, DOI 10.1111/j.1471-4159.2004.02450.x; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Walden WE, 2002, P NATL ACAD SCI USA, V99, P4138, DOI 10.1073/pnas.082108799; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Yoon H, 2014, BIOCHEM J, V459, P71, DOI 10.1042/BJ20131273; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; Zhang R, 2013, BIOL OPEN, V2, P432, DOI 10.1242/bio.20134259; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	65	24	25	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					640	657		10.1074/jbc.M114.610402	http://dx.doi.org/10.1074/jbc.M114.610402			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398879	hybrid, Green Published			2022-12-26	WOS:000347231200055
J	Vivet-Boudou, V; Isel, C; El Safadi, Y; Smyth, RP; Laumond, G; Moog, C; Paillart, JC; Marquet, R				Vivet-Boudou, Valerie; Isel, Catherine; El Safadi, Yazan; Smyth, Redmond P.; Laumond, Geraldine; Moog, Christiane; Paillart, Jean-Christophe; Marquet, Roland			Evaluation of Anti-HIV-1 Mutagenic Nucleoside Analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agent; Human Immunodeficiency Virus (HIV); Mutagenesis; Nucleoside; Nucleotide Analogue; Reverse Transcription; Lethal	IMMUNODEFICIENCY-VIRUS TYPE-1; HEPATITIS-C VIRUS; HIV-1 REVERSE-TRANSCRIPTASE; MOUTH-DISEASE VIRUS; DEFICIENCY SYNDROME AIDS; LETHAL MUTAGENESIS; ERROR CATASTROPHE; RNA VIRUS; RIBONUCLEOSIDE ANALOGS; REPLICATION FIDELITY	Background: Lethal mutagenesis is an antiviral strategy. Results: Nucleoside analogue mutagenicity is correlated to base pair stability and the ability to function as a template during reverse transcription. Conclusion: Two simple biophysical/biochemical assays predict mutagenicity of nucleoside analogues. Significance: Mutagenicity of anti-HIV-1 compounds can be reliably predicted in vitro without labor-intensive and costly in cellula tests. Because of their high mutation rates, RNA viruses and retroviruses replicate close to the threshold of viability. Their existence as quasi-species has pioneered the concept of lethal mutagenesis that prompted us to synthesize pyrimidine nucleoside analogues with antiviral activity in cell culture consistent with an accumulation of deleterious mutations in the HIV-1 genome. However, testing all potentially mutagenic compounds in cell-based assays is tedious and costly. Here, we describe two simple in vitro biophysical/biochemical assays that allow prediction of the mutagenic potential of deoxyribonucleoside analogues. The first assay compares the thermal stabilities of matched and mismatched base pairs in DNA duplexes containing or not the nucleoside analogues as follows. A promising candidate should display a small destabilization of the matched base pair compared with the natural nucleoside and the smallest gap possible between the stabilities of the matched and mismatched base pairs. From this assay, we predicted that two of our compounds, 5-hydroxymethyl-2-deoxyuridine and 5-hydroxymethyl-2-deoxycytidine, should be mutagenic. The second in vitro reverse transcription assay assesses DNA synthesis opposite nucleoside analogues inserted into a template strand and subsequent extension of the newly synthesized base pairs. Once again, only 5-hydroxymethyl-2-deoxyuridine and 5-hydroxymethyl-2-deoxycytidine are predicted to be efficient mutagens. The predictive potential of our fast and easy first line screens was confirmed by detailed analysis of the mutation spectrum induced by the compounds in cell culture because only compounds 5-hydroxymethyl-2-deoxyuridine and 5-hydroxymethyl-2-deoxycytidine were found to increase the mutation frequency by 3.1- and 3.4-fold, respectively.	[Vivet-Boudou, Valerie; Isel, Catherine; El Safadi, Yazan; Smyth, Redmond P.; Paillart, Jean-Christophe; Marquet, Roland] Univ Strasbourg, Architecture & React ARN, CNRS, IBMC, F-67084 Strasbourg, France; [Laumond, Geraldine; Moog, Christiane; Marquet, Roland] Univ Strasbourg, Inst Virol, INSERM, U748, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vivet-Boudou, V (corresponding author), Univ Strasbourg, Architecture & React ARN, CNRS, IBMC, F-67084 Strasbourg, France.	v.vivet@ibmc-cnrs.unistra.fr; c.isel@ibmc-cnrs.unistra.fr; r.marquet@ibmc-cnrs.unistra.fr	Paillart, Jean-Christophe/A-4171-2010; C, Moog/E-3962-2016; Smyth, Redmond/AAP-1637-2020; Isel, Catherine/B-9406-2015; Isel, Catherine/AAH-2174-2020	Paillart, Jean-Christophe/0000-0003-1647-8917; C, Moog/0000-0002-0916-156X; Isel, Catherine/0000-0001-7258-869X; Isel, Catherine/0000-0002-8014-7525; Smyth, Redmond/0000-0002-1580-0671; LAUMOND, Geraldine/0000-0003-1867-0734; Marquet, Roland/0000-0002-4209-3976	CNRS; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales; SIDACTION; Strasbourg University; Centre National de la Recherche Scientifique	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de Recherche sur le SIDA et les Hepatites Virales(ANRSFrench National Research Agency (ANR)); SIDACTION; Strasbourg University; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by CNRS, the Agence Nationale de Recherche sur le SIDA et les Hepatites Virales, SIDACTION, and the Strasbourg University. Funding for open access charges: Centre National de la Recherche Scientifique.	ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Agudo R, 2008, J MOL BIOL, V382, P652, DOI 10.1016/j.jmb.2008.07.033; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Armitage AE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002550; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Chelico L, 2009, NAT STRUCT MOL BIOL, V16, P454, DOI 10.1038/nsmb0509-454; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Chung DH, 2007, J VIROL, V81, P11722, DOI 10.1128/JVI.00874-07; Contreras AM, 2002, J VIROL, V76, P8505, DOI 10.1128/JVI.76.17.8505-8517.2002; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dahl C, 2011, CLIN CHIM ACTA, V412, P831, DOI 10.1016/j.cca.2011.02.013; Daifuku R, 2003, BIODRUGS, V17, P169, DOI 10.2165/00063030-200317030-00003; Dapp MJ, 2014, J VIROL, V88, P354, DOI 10.1128/JVI.02444-13; Dapp MJ, 2009, J VIROL, V83, P11950, DOI 10.1128/JVI.01406-09; Davis GL, 1998, NEW ENGL J MED, V339, P1493, DOI 10.1056/NEJM199811193392102; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; Eigen M, 2002, P NATL ACAD SCI USA, V99, P13374, DOI 10.1073/pnas.212514799; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; El Safadi Y, 2007, APPL MICROBIOL BIOT, V75, P723, DOI 10.1007/s00253-007-0919-7; El Safadi Y, 2010, J MED CHEM, V53, P1534, DOI 10.1021/jm901758f; Ferrer-Orta C, 2010, J VIROL, V84, P6188, DOI 10.1128/JVI.02420-09; GAFFNEY BL, 1989, BIOCHEMISTRY-US, V28, P5881, DOI 10.1021/bi00440a026; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Harris KS, 2005, ANTIVIR RES, V67, P1, DOI 10.1016/j.antiviral.2005.03.004; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kriukiene E, 2012, CHEM SOC REV, V41, P6916, DOI 10.1039/c2cs35104h; Li DY, 2014, P NATL ACAD SCI USA, V111, pE3252, DOI 10.1073/pnas.1405635111; Lindberg J, 2002, EUR J BIOCHEM, V269, P1670, DOI 10.1046/j.1432-1327.2002.02811.x; Loeb LA, 2000, AIDS RES HUM RETROV, V16, P1, DOI 10.1089/088922200309539; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Menendez-Arias L, 2002, PROG NUCLEIC ACID RE, V71, P91, DOI 10.1016/S0079-6603(02)71042-8; Menendez-Arias L., 2013, HUMAN IMMUNODEFICIEN, P225; Menendez-Arias L, 2009, VIRUSES-BASEL, V1, P1137, DOI 10.3390/v1031137; Mercenne G, 2010, NUCLEIC ACIDS RES, V38, P633, DOI 10.1093/nar/gkp1009; Mikkelsen JG, 2000, J BIOMED SCI, V7, P77, DOI 10.1159/000025434; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; MIZRAHI V, 1994, J BIOL CHEM, V269, P19245; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mullins JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015135; O'Neil PK, 2002, J BIOL CHEM, V277, P38053, DOI 10.1074/jbc.M204774200; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; PATHAK VK, 1992, J VIROL, V66, P3093, DOI 10.1128/JVI.66.5.3093-3100.1992; Perales C, 2012, TRENDS MICROBIOL, V20, P595, DOI 10.1016/j.tim.2012.08.010; Perales C, 2011, CURR OPIN VIROL, V1, P419, DOI 10.1016/j.coviro.2011.09.001; Perales C, 2011, J MOL BIOL, V407, P60, DOI 10.1016/j.jmb.2011.01.026; Perales C, 2010, FUTURE VIROL, V5, P679, DOI 10.2217/FVL.10.61; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, J VIROL, V79, P2346, DOI 10.1128/JVI.79.4.2346-2355.2005; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Sadeghipour S, 2013, J VIROL, V87, P1759, DOI 10.1128/JVI.02139-12; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; Smyth RP, 2014, J VIROL, V88, P2891, DOI 10.1128/JVI.03014-13; Smyth RP, 2012, VIRUS RES, V169, P415, DOI 10.1016/j.virusres.2012.06.015; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tapia N, 2005, VIROLOGY, V338, P1, DOI 10.1016/j.virol.2005.05.008; Vivet-Boudou V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027456; Waters L, 2007, INT J CLIN PRACT, V61, P105, DOI 10.1111/j.1742-1241.2006.01146.x; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WERNTGES H, 1986, NUCLEIC ACIDS RES, V14, P3773, DOI 10.1093/nar/14.9.3773; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	84	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					371	383		10.1074/jbc.M114.616383	http://dx.doi.org/10.1074/jbc.M114.616383			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398876	Green Published, hybrid			2022-12-26	WOS:000347231200033
J	Chouhan, BS; Kapyla, J; Denessiouk, K; Denesyuk, A; Heino, J; Johnson, MS				Chouhan, Bhanupratap Singh; Kapyla, Jarmo; Denessiouk, Konstantin; Denesyuk, Alexander; Heino, Jyrki; Johnson, Mark S.			Early Chordate Origin of the Vertebrate Integrin alpha I Domains	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; A-DOMAIN; CIONA-INTESTINALIS; STRUCTURAL BASIS; RKKH PEPTIDES; EVOLUTION; GENOME; RECOGNITION; INSIGHTS; BINDING	Half of the 18 human integrins alpha subunits have an inserted alpha I domain yet none have been observed in species that have diverged prior to the appearance of the urochordates (ascidians). The urochordate integrin alpha I domains are not human orthologues but paralogues, but orthologues of human alpha I domains extend throughout later-diverging vertebrates and are observed in the bony fish with duplicate isoforms. Here, we report evidence for orthologues of human integrins with alpha I domains in the agnathostomes (jawless vertebrates) and later diverging species. Sequence comparisons, phylogenetic analyses and molecular modeling show that one nearly full-length sequence from lamprey and two additional fragments include the entire integrin alpha I domain region, have the hallmarks of collagen-binding integrin alpha I domains, and we show that the corresponding recombinant proteins recognize the collagen GFOGER motifs in a metal dependent manner, unlike the alpha 1I domain of the ascidian C. intestinalis. The presence of a functional collagen receptor integrin alpha I domain supports the origin of orthologues of the human integrins with aI domains prior to the earliest diverging extant vertebrates, a domain that has been conserved and diversified throughout the vertebrate lineage.	[Chouhan, Bhanupratap Singh; Denessiouk, Konstantin; Denesyuk, Alexander; Johnson, Mark S.] Abo Akad Univ, Dept Biosci, Struct Bioinformat Lab, Turku, Finland; [Kapyla, Jarmo; Heino, Jyrki] Univ Turku, Dept Biochem, SF-20500 Turku, Finland	Abo Akademi University; Finland National Institute for Health & Welfare; University of Turku	Johnson, MS (corresponding author), Abo Akad Univ, Dept Biosci, Struct Bioinformat Lab, Turku, Finland.	johnson4@abo.fi		Kapyla, Jarmo/0000-0003-3036-713X	National Doctoral Network in Informational and Structural Biology (BSC); Academy of Finland; Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Abo Akademi Center of Excellence in Cell Stress and Aging	National Doctoral Network in Informational and Structural Biology (BSC); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Abo Akademi Center of Excellence in Cell Stress and Aging	These studies received financial support from the National Doctoral Network in Informational and Structural Biology (BSC), the Academy of Finland, Sigrid Juselius Foundation, Joe, Pentti and Tor Borg Memorial Fund, and the Abo Akademi Center of Excellence in Cell Stress and Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARNAOUT MA, 1990, BLOOD, V75, P1037; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burke RD, 1999, INT REV CYTOL, V191, P257, DOI 10.1016/S0074-7696(08)60161-8; Chin YKY, 2013, J BIOL CHEM, V288, P36796, DOI 10.1074/jbc.M113.480251; Chouhan B, 2012, WASET, V65, P546; Chouhan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025069; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DESIMONE DW, 1988, J BIOL CHEM, V263, P5333; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eble JA, 1997, INTEGRIB LIGAND INTE; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Ewan R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-31; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FLEMING JC, 1993, J IMMUNOL, V150, P480; Guyon R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-222; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1992, MOL BIOL EVOL, V9, P216; Hughes AL, 2001, J MOL EVOL, V52, P63, DOI 10.1007/s002390010134; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 1999, J BIOL CHEM, V274, P3513, DOI 10.1074/jbc.274.6.3513; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; Johnson MS, 2003, MOL B INT U, P1; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; Johnson MS, 2013, EVOLUTION EXTRACELLU, P243; Johnson MS, 2014, ADV EXPT MED BIOL; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kang S.-G., UNPUB; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Lahti M, 2013, INT J BIOCHEM CELL B, V45, P1204, DOI 10.1016/j.biocel.2013.03.016; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Miyazawa S, 2001, J IMMUNOL, V166, P1710, DOI 10.4049/jimmunol.166.3.1710; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Pentikainen O, 1999, J BIOL CHEM, V274, P31493, DOI 10.1074/jbc.274.44.31493; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Suzuki T, 2004, DEV COMP IMMUNOL, V28, P993, DOI 10.1016/j.dci.2004.04.005; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Tulla M, 2007, FEBS LETT, V581, P2434, DOI 10.1016/j.febslet.2007.04.054; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022	79	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112064	10.1371/journal.pone.0112064	http://dx.doi.org/10.1371/journal.pone.0112064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409021	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200013
J	Katz, B; Reis, ST; Viana, NI; Morais, DR; Moura, CM; Dip, N; Silva, IA; Iscaife, A; Srougi, M; Leite, KRM				Katz, Betina; Reis, Sabrina T.; Viana, Nayara I.; Morais, Denis R.; Moura, Caio M.; Dip, Nelson; Silva, Iran A.; Iscaife, Alexandre; Srougi, Miguel; Leite, Katia R. M.			Comprehensive Study of Gene and microRNA Expression Related to Epithelial-Mesenchymal Transition in Prostate Cancer	PLOS ONE			English	Article							NEGATIVE FEEDBACK LOOP; E-CADHERIN; MIR-200 FAMILY; RADICAL PROSTATECTOMY; TUMOR-METASTASIS; INTRAEPITHELIAL NEOPLASIA; ANDROGEN RECEPTOR; PROGNOSTIC MARKER; REPRESSORS ZEB1; CELL MIGRATION	Prostate cancer is the most common cancer in men, and most patients have localized disease at the time of diagnosis. However, 4% already present with metastatic disease. Epithelial-mesenchymal transition is a fundamental process in carcinogenesis that has been shown to be involved in prostate cancer progression. The main event in epithelial-mesenchymal transition is the repression of E-cadherin by transcription factors, but the process is also regulated by microRNAs. The aim of this study was to analyze gene and microRNA expression involved in epithelial-mesenchymal transition in localized prostate cancer and metastatic prostate cancer cell lines and correlate with clinicopathological findings. We studied 51 fresh frozen tissue samples from patients with localized prostate cancer (PCa) treated by radical prostatectomy and three metastatic prostate cancer cell lines (LNCaP, DU145, PC3). The expression of 10 genes and 18 miRNAs were assessed by real-time PCR. The patients were divided into groups according to Gleason score, pathological stage, preoperative PSA, biochemical recurrence, and risk group for correlation with clinicopathological findings. The majority of localized PCa cases showed an epithelial phenotype, with overexpression of E-cadherin and underexpression of the mesenchymal markers. MiRNA-200 family members and miRNAs 203, 205, 183, 373, and 21 were overexpressed, while miRNAs 9, 495, 29b, and 1 were underexpressed. Low-expression levels of miRNAs 200b, 30a, and 1 were significantly associated with pathological stage. Lower expression of miR-200b was also associated with a Gleason score >= 8 and shorter biochemical recurrence-free survival. Furthermore, low-expression levels of miR-30a and high-expression levels of Vimentin and Twist1 were observed in the high-risk group. Compared with the primary tumor, the metastatic cell lines showed significantly higher expression levels of miR-183 and Twist1. In summary, miRNAs 200b, 30a, 1, and 183 and the genes Twist1 and Vimentin might play important roles in the progression of prostate cancer and may eventually become important prognostic markers.	[Katz, Betina] Univ Sao Paulo, Sch Med, Div Urol, Sao Paulo, Brazil; Univ Sao Paulo, Sch Med, Lab Med Invest LIM55, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Katz, B (corresponding author), Univ Sao Paulo, Sch Med, Div Urol, Sao Paulo, Brazil.	bkatz@usp.br	LEITE, KATIA RM/C-2055-2008; da Silva, Iran Amorim/B-2917-2013; Iscaife, Alexandre/A-5630-2015; Iscaife, Alexandre/I-8536-2012; Viana, Nayara I/P-6868-2015; Srougi, Miguel Srougi/AEV-2674-2022; Srougi, Miguel/AAT-8625-2021	LEITE, KATIA RM/0000-0002-2615-7730; da Silva, Iran Amorim/0000-0001-5441-790X; Iscaife, Alexandre/0000-0001-6388-8228; Iscaife, Alexandre/0000-0001-6388-8228; Reis, Sabrina Thalita dos/0000-0002-3564-3597; Viana, Nayara/0000-0003-4505-8508	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/50094-9]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) under protocol number 2012/50094-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Behnsawy HM, 2013, BJU INT, V111, P30, DOI 10.1111/j.1464-410X.2012.11551.x; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carlsson J, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-14; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Eide T, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-4; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hudson RS, 2012, NUCLEIC ACIDS RES, V40, P3689, DOI 10.1093/nar/gkr1222; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; Kao CJ, 2013, ONCOGENE; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Li XL, 2014, MOL CELL BIOL, V34, P533, DOI 10.1128/MCB.01043-13; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Liu Y, 2012, MED SCI MONITOR, V18, pBR299, DOI 10.12659/MSM.883262; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mackinnon AC, 2009, ARCH PATHOL LAB MED, V133, P1033, DOI 10.1043/1543-2165-133.7.1033; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Putzke AP, 2011, AM J PATHOL, V179, P400, DOI 10.1016/j.ajpath.2011.03.028; Qu Y, 2013, INT J CANCER, V133, P544, DOI 10.1002/ijc.28056; Quinn DI, 2001, J CLIN ONCOL, V19, P3692, DOI 10.1200/JCO.2001.19.16.3692; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomita K, 2000, CANCER RES, V60, P3650; Ueno K, 2013, BRIT J CANCER, V108, P1659, DOI 10.1038/bjc.2013.125; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; Wang W, 2013, EUR J SURG ONCOL; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yuen HF, 2007, HISTOPATHOLOGY, V50, P648, DOI 10.1111/j.1365-2559.2007.02665.x; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994	63	35	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113700	10.1371/journal.pone.0113700	http://dx.doi.org/10.1371/journal.pone.0113700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409297	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200145
J	Kim, S				Kim, Sooyun			Action Potential Modulation in CA1 Pyramidal Neuron Axons Facilitates OLM Interneuron Activation in Recurrent Inhibitory Microcircuits of Rat Hippocampus	PLOS ONE			English	Article							GATED K+ CHANNELS; CELLS IN-VIVO; GABAERGIC INTERNEURON; THETA OSCILLATIONS; STRATUM-ORIENS; INITIATION; CURRENTS; ASSOCIATION; DENDRITES; RELEASE	Oriens-lacunosum moleculare (O-LM) interneurons in the CA 1 region of the hippocampus play a key role in feedback inhibition and in the control of network activity. However, how these cells are efficiently activated in the network remains unclear. To address this question, I performed recordings from CA 1 pyramidal neuron axons, the presynaptic fibers that provide feedback innervation of these interneurons. Two forms of axonal action potential (AP) modulation were identified. First, repetitive stimulation resulted in activity-dependent AP broadening. Broadening showed fast onset, with marked changes in AP shape following a single AP. Second, tonic depolarization in CA 1 pyramidal neuron somata induced AP broadening in the axon, and depolarization-induced broadening summated with activity-dependent broadening. Outside-out patch recordings from CA 1 pyramidal neuron axons revealed a high density of alpha-dendrotoxin (alpha-DTX)-sensitive, inactivating K+ channels, suggesting that K+ channel inactivation mechanistically contributes to AP broadening. To examine the functional consequences of axonal AP modulation for synaptic transmission, I performed paired recordings between synaptically connected CA 1 pyramidal neurons and O-LM interneurons. CA 1 pyramidal neuron-O-LM interneuron excitatory postsynaptic currents (EPSCs) showed facilitation during both repetitive stimulation and tonic depolarization of the presynaptic neuron. Both effects were mimicked and occluded by alpha-DTX, suggesting that they were mediated by K+ channel inactivation. Therefore, axonal AP modulation can greatly facilitate the activation of O-LM interneurons. In conclusion, modulation of AP shape in CA 1 pyramidal neuron axons substantially enhances the efficacy of principal neuroninterneuron synapses, promoting the activation of O-LM interneurons in recurrent inhibitory microcircuits.	IST Austria, Klosterneuburg, Austria	Institute of Science & Technology - Austria	Kim, S (corresponding author), IST Austria, Klosterneuburg, Austria.	sooyun.kim@ist.ac.at	Kim, Sooyun/J-9071-2014; Kim, Sooyun/AAH-6262-2020	Kim, Sooyun/0000-0002-2035-3247; Kim, Sooyun/0000-0002-2035-3247	European Union (ERC advanced grant) [268548]	European Union (ERC advanced grant)	This work was supported by the European Union (ERC advanced grant 268548) to P. Jonas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Debanne D, 2013, NAT REV NEUROSCI, V14, P63, DOI 10.1038/nrn3361; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Guzman SJ, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00016; Hu H, 2014, NAT NEUROSCI, V17, P686, DOI 10.1038/nn.3678; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Katona L, 2014, NEURON, V82, P872, DOI 10.1016/j.neuron.2014.04.007; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kim S, 2012, NAT NEUROSCI, V15, P600, DOI [10.1038/nn.3060, 10.1038/nn.3173]; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; Lien CC, 2002, J PHYSIOL-LONDON, V538, P405, DOI 10.1113/jphysiol.2001.013066; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Martina M, 1998, J NEUROSCI, V18, P8111; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; McIntosh P, 1997, PFLUG ARCH EUR J PHY, V435, P43, DOI 10.1007/s004240050482; NICHOLLS J, 1978, J PHYSIOL-LONDON, V281, P157, DOI 10.1113/jphysiol.1978.sp012414; Pernia-Andrade AJ, 2014, NEURON, V81, P140, DOI 10.1016/j.neuron.2013.09.046; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Sasaki T, 2012, J NEUROSCI, V32, P2868, DOI 10.1523/JNEUROSCI.5365-11.2012; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SHIMAHARA T, 1975, J PHYSIOL-LONDON, V247, P299, DOI 10.1113/jphysiol.1975.sp010933; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P647, DOI 10.1113/jphysiol.1995.sp020997; Zhu J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001032; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	40	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113124	10.1371/journal.pone.0113124	http://dx.doi.org/10.1371/journal.pone.0113124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409299	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200070
J	Wang, Q; Taylor, JE				Wang, Qi; Taylor, John E.			Quantifying Human Mobility Perturbation and Resilience in Hurricane Sandy	PLOS ONE			English	Article							IMPACT	Human mobility is influenced by environmental change and natural disasters. Researchers have used trip distance distribution, radius of gyration of movements, and individuals' visited locations to understand and capture human mobility patterns and trajectories. However, our knowledge of human movements during natural disasters is limited owing to both a lack of empirical data and the low precision of available data. Here, we studied human mobility using high-resolution movement data from individuals in New York City during and for several days after Hurricane Sandy in 2012. We found the human movements followed truncated power-law distributions during and after Hurricane Sandy, although the beta value was noticeably larger during the first 24 hours after the storm struck. Also, we examined two parameters: the center of mass and the radius of gyration of each individual's movements. We found that their values during perturbation states and steady states are highly correlated, suggesting human mobility data obtained in steady states can possibly predict the perturbation state. Our results demonstrate that human movement trajectories experienced significant perturbations during hurricanes, but also exhibited high resilience. We expect the study will stimulate future research on the perturbation and inherent resilience of human mobility under the influence of hurricanes. For example, mobility patterns in coastal urban areas could be examined as hurricanes approach, gain or dissipate in strength, and as the path of the storm changes. Understanding nuances of human mobility under the influence of such disasters will enable more effective evacuation, emergency response planning and development of strategies and policies to reduce fatality, injury, and economic loss.	[Wang, Qi; Taylor, John E.] Virginia Tech, Charles E Via Jr Dept Civil & Environm Engn, Civil Engn Network Dynam Lab, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Taylor, JE (corresponding author), Virginia Tech, Charles E Via Jr Dept Civil & Environm Engn, Civil Engn Network Dynam Lab, Blacksburg, VA 24061 USA.	jet@vt.edu			National Science Foundation [1142379]; Virginia Tech's Open Access Subvention Fund; Directorate For Engineering [1142379] Funding Source: National Science Foundation; Div Of Civil, Mechanical, & Manufact Inn [1733695] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Virginia Tech's Open Access Subvention Fund; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study is supported by the National Science Foundation under Grant No. 1142379. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Open access publication of this article was supported by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Chaintreau A, 2007, IEEE T MOBILE COMPUT, V6, P606, DOI 10.1109/TMC.2007.1060; CWS (Church World Service - Asia/Pacific), 2013, 19 CWS; Feeley M, 2004, LECT NOTES COMPUT SC, V3158, P324; Ferris E., 2013, YEAR RECURRING DISAS; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Horanont T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081153; Kaufman S., 2012, TRANSPORTATION HURRI; Kleinberg J, 2007, NATURE, V449, P287, DOI 10.1038/449287a; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; McGeeham P, 2012, NY TIMES, pA20; MORROWJONES HA, 1991, DISASTERS, V15, P126, DOI 10.1111/j.1467-7717.1991.tb00441.x; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; OCHA, 2012, 2 OCHA; Pan XS, 2007, AI SOC, V22, P113, DOI 10.1007/s00146-007-0126-1; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; UNISDR, 2013, DIS IMP 2000 2012; Vespignani A, 2010, NATURE, V464, P984, DOI 10.1038/464984a; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	25	53	53	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112608	10.1371/journal.pone.0112608	http://dx.doi.org/10.1371/journal.pone.0112608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409009	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200028
J	Xu, XY; Shen, YB; Fu, JJ; Lu, LQ; Li, JL				Xu, Xiaoyan; Shen, Yubang; Fu, Jianjun; Lu, Liqun; Li, Jiale			De novo Assembly of the Grass Carp Ctenopharyngodon idella Transcriptome to Identify miRNA Targets Associated with Motile Aeromonad Septicemia	PLOS ONE			English	Article							RNA-SEQ DATA; IMMUNE-RESPONSE; HEAD KIDNEY; GENES; MICRORNAS; IDENTIFICATION; EXPRESSION; ACTIVATION; INNATE; QUANTIFICATION	Background: De novo transcriptome sequencing is a robust method of predicting miRNA target genes, especially for organisms without reference genomes. Differentially expressed miRNAs had been identified previously in kidney samples collected from susceptible and resistant grass carp (Ctenopharyngodon idella) affected by Aeromonas hydrophila. Target identification for these differentially expressed miRNAs poses a major challenge in this non-model organism. Results: Two cDNA libraries constructed from mRNAs of susceptible and resistant C. idella were sequenced by Illumina Hiseq 2000 technology. A total of more than 100 million reads were generated and de novo assembled into 199,593 transcripts which were further extensively annotated by comparing their sequences to different protein databases. Biochemical pathways were predicted from these transcript sequences. A BLASTx analysis against a non-redundant protein database revealed that 61,373 unigenes coded for 28,311 annotated proteins. Two cDNA libraries from susceptible and resistant samples showed that 721 unigenes were expressed at significantly different levels; 475 were significantly up-regulated and 246 were significantly down-regulated in the SG samples compared to the RG samples. The computational prediction of miRNA targets from these differentially expressed genes identified 188 unigenes as the targets of 5 conserved and 4 putative novel miRNA families. Conclusion: This study demonstrates the feasibility of identifying miRNA targets by transcriptome analysis. The transcriptome assembly data represent a substantial increase in the genomic resources available for C. idella and will provide insights into the gene expression profile analysis and the miRNA function annotations in further studies.	[Xu, Xiaoyan; Shen, Yubang; Fu, Jianjun; Li, Jiale] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China; [Li, Jiale] Shanghai Ocean Univ, E Inst Shanghai Univ, Shanghai 201306, Peoples R China; [Lu, Liqun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Coll Fisheries & Life Sci, Shanghai 201306, Peoples R China	Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University	Li, JL (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China.	jlli2009@126.com	li, jia/GVT-7587-2022; Yubang, Shen/AAC-4325-2019		National Key Technology R&D Program of China [2012BAD26B02]; China's Agricultural Research System [CARS-46-04]; Agricultural Seed Development Program of Shanghai City [2012NY10]; Shanghai Ocean University Doctoral Research Foundation; Shanghai Universities First-class Disciplines Project of Fisheries; Innovation Plan of Shanghai Graduate Education	National Key Technology R&D Program of China(National Key Technology R&D Program); China's Agricultural Research System; Agricultural Seed Development Program of Shanghai City; Shanghai Ocean University Doctoral Research Foundation; Shanghai Universities First-class Disciplines Project of Fisheries; Innovation Plan of Shanghai Graduate Education	This work was supported by grants from National Key Technology R&D Program of China (2012BAD26B02), the China's Agricultural Research System (CARS-46-04), the Agricultural Seed Development Program of Shanghai City (2012NY10), Shanghai Ocean University Doctoral Research Foundation, Shanghai Universities First-class Disciplines Project of Fisheries and the Innovation Plan of Shanghai Graduate Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barozai MYK, 2012, MOL BIOL REP, V39, P8867, DOI 10.1007/s11033-012-1753-2; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bhardwaj J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-647; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-108; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Enright AJ, 2004, GENOME BIOL, V5; FAO (Food and Agriculture Organization), 2014, FAO YB FISH AQ STAT; Figueras MJ, 2005, REV MED MICROBIOL, V16, P145; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2008, NATURE, V453, P1197, DOI 10.1038/4531197b; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heng JF, 2011, FISH SHELLFISH IMMUN, V30, P45, DOI 10.1016/j.fsi.2010.09.004; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang QY, 1983, ICHTHYOPATHOLOGY; Igbinosa IH, 2012, SCI WORLD J, DOI 10.1100/2012/625023; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kursar M, 2005, J EXP MED, V201, P1447, DOI 10.1084/jem.20041204; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu F, 2011, FISH SHELLFISH IMMUN, V31, P765, DOI 10.1016/j.fsi.2011.07.014; Liu F, 2010, COMP BIOCHEM PHYS D, V5, P116, DOI 10.1016/j.cbd.2010.02.003; Liu PT, 2012, NAT MED, V18, P267, DOI 10.1038/nm.2584; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Mennigen JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038604; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu XJ, 2011, FISH SHELLFISH IMMUN, V31, P1162, DOI 10.1016/j.fsi.2011.10.011; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Oltmanns U, 2003, BRIT J PHARMACOL, V139, P1228, DOI 10.1038/sj.bjp.0705345; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Plata-Salaman CR, 1998, INT J MOL MED, V1, P387; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rahman M, 2002, APPL ENVIRON MICROB, V68, P650, DOI 10.1128/AEM.68.2.650-655.2002; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Renkui C, 1991, DEV HIST FRESHWATER; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Su JG, 2011, FISH SHELLFISH IMMUN, V30, P830, DOI 10.1016/j.fsi.2011.01.006; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Xu XY, 2014, FISH SHELLFISH IMMUN, V36, P374, DOI 10.1016/j.fsi.2013.12.007; Xu XY, 2013, FISH SHELLFISH IMMUN, V35, P801, DOI 10.1016/j.fsi.2013.06.009; Xu XY, 2012, FISH SHELLFISH IMMUN, V33, P251, DOI 10.1016/j.fsi.2012.05.015; Yan B, 2012, AQUACULTURE, V364, P240, DOI 10.1016/j.aquaculture.2012.08.018; Zhang PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073506; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20; Zhu YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-413	69	24	25	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112722	10.1371/journal.pone.0112722	http://dx.doi.org/10.1371/journal.pone.0112722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409340	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200035
J	Chiarelli-Neto, O; Ferreira, AS; Martins, WK; Pavani, C; Severino, D; Faiao-Flores, F; Maria-Engler, SS; Aliprandini, E; Martinez, GR; Di Mascio, P; Medeiros, MHG; Baptista, MS				Chiarelli-Neto, Orlando; Ferreira, Alan Silva; Martins, Waleska Kerllen; Pavani, Christiane; Severino, Divinomar; Faiao-Flores, Fernanda; Maria-Engler, Silvya Stuchi; Aliprandini, Eduardo; Martinez, Glaucia R.; Di Mascio, Paolo; Medeiros, Marisa H. G.; Baptista, Mauricio S.			Melanin Photosensitization and the Effect of Visible Light on Epithelial Cells	PLOS ONE			English	Article							HUMAN SKIN; SINGLET OXYGEN; DNA-DAMAGE; UVA-RADIATION; MALIGNANT-MELANOMA; COMET ASSAY; ULTRAVIOLET-RADIATION; FINGERPRINT MUTATIONS; OXIDATIVE DAMAGE; GENERATION	Protecting human skin from sun exposure is a complex issue that involves unclear aspects of the interaction between light and tissue. A persistent misconception is that visible light is safe for the skin, although several lines of evidence suggest otherwise. Here, we show that visible light can damage melanocytes through melanin photosensitization and singlet oxygen (O-1(2)) generation, thus decreasing cell viability, increasing membrane permeability, and causing both DNA photo-oxidation and necro-apoptotic cell death. UVA (355 nm) and visible (532 nm) light photosensitize O-1(2) with similar yields, and pheomelanin is more efficient than eumelanin at generating O-1(2) and resisting photobleaching. Although melanin can protect against the cellular damage induced by UVB, exposure to visible light leads to pre-mutagenic DNA lesions (i.e., Fpg- and Endo III-sensitive modifications); these DNA lesions may be mutagenic and may cause photoaging, as well as other health problems, such as skin cancer.	[Chiarelli-Neto, Orlando; Ferreira, Alan Silva; Martins, Waleska Kerllen; Pavani, Christiane; Severino, Divinomar; Di Mascio, Paolo; Medeiros, Marisa H. G.; Baptista, Mauricio S.] Univ Sao Paulo, Dept Quim, Inst Quim, Sao Paulo, Brazil; [Faiao-Flores, Fernanda; Maria-Engler, Silvya Stuchi] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Analises Clin, BR-09500900 Sao Paulo, Brazil; [Aliprandini, Eduardo; Martinez, Glaucia R.] Univ Fed Parana, Setor Ciencias Biol, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Parana	Baptista, MS (corresponding author), Univ Sao Paulo, Dept Quim, Inst Quim, Sao Paulo, Brazil.	baptista@iq.usp.br	Martinez, Glaucia Regina/I-3110-2016; Martins, Waleska Kerllen/L-5187-2018; Baptista, Mauricio S/AAO-5749-2021; Engler, Silvya Stuchi Maria/K-5936-2016; Baptista, Mauricio S/A-5140-2008; Maria-Engler, Silvya/ABC-2016-2020; de Medeiros, Marisa Helena Gennari/AAA-8015-2019; Faião-Flores, Fernanda/F-7111-2012; Di Mascio, Paolo/D-1264-2014; Medeiros, Marisa H. G./A-5212-2008; PAVANI, Christiane/G-5869-2012; Severino, Divinomar/F-9029-2012	Martinez, Glaucia Regina/0000-0002-2628-4406; Martins, Waleska Kerllen/0000-0003-1502-4606; Baptista, Mauricio S/0000-0001-7079-7666; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Baptista, Mauricio S/0000-0001-7079-7666; Maria-Engler, Silvya/0000-0003-4771-6041; de Medeiros, Marisa Helena Gennari/0000-0002-5438-1174; Faião-Flores, Fernanda/0000-0003-3449-9930; Di Mascio, Paolo/0000-0003-4125-8350; Medeiros, Marisa H. G./0000-0002-5438-1174; PAVANI, Christiane/0000-0001-8275-7370; Severino, Divinomar/0000-0001-9483-6287; Chiarelli-Neto, Orlando/0000-0002-8685-1185	FAPESP [12/50680-5, 13/07937-8, 2010/08796-0]; CNPq; INCT Redoxoma (FAPESP/CNPq/CAPES) [573530/2008-4]; FARMA	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT Redoxoma (FAPESP/CNPq/CAPES); FARMA	FAPESP (12/50680-5; 13/07937-8), CNPq, INCT Redoxoma (FAPESP/CNPq/CAPES; Proc. 573530/2008-4) and FARMA Service Bioextract are acknowledged for providing funds for this research. OCN acknowledges FAPESP for his PhD fellowship (2010/08796-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Beltran-Garcia MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091616; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brohem CA, 2012, PIGM CELL MELANOMA R, V25, P354, DOI 10.1111/j.1755-148X.2012.00992.x; Cadet J, 2011, J INVEST DERMATOL, V131, P1005, DOI 10.1038/jid.2011.51; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chiarelli-Neto O, 2011, FREE RADICAL BIO MED, V51, P1195, DOI 10.1016/j.freeradbiomed.2011.06.013; Collier AC, 2003, BIOCHEM PHARMACOL, V66, P281, DOI 10.1016/S0006-2952(03)00240-5; Dahle J, 2003, CANCER RES, V63, P1464; FIDLER IJ, 1975, CANCER RES, V35, P218; Fisher DE, 2010, NEW ENGL J MED, V363, P901, DOI 10.1056/NEJMp1005999; Grether-Beck S, 2014, PHOTODERMATOL PHOTO, V30, P167, DOI 10.1111/phpp.12111; Halliday GM, 2005, PHOTOCHEM PHOTOBIOL, V81, P3, DOI 10.1562/2004-07-27-IR-247.1; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Haywood RM, 2008, PHOTOCHEM PHOTOBIOL, V84, P572, DOI 10.1111/j.1751-1097.2008.00343.x; Hearing VJ, 2000, PIGM CELL RES, V13, P23, DOI 10.1034/j.1600-0749.13.s8.7.x; Heo SJ, 2009, TOXICOL IN VITRO, V23, P1123, DOI 10.1016/j.tiv.2009.05.013; Ito S, 2003, PIGM CELL RES, V16, P523, DOI 10.1034/j.1600-0749.2003.00072.x; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Kolbe L, 2012, J INVEST DERMATOL, V132, P1756, DOI 10.1038/jid.2012.148; Kvam E, 1997, CARCINOGENESIS, V18, P2379, DOI 10.1093/carcin/18.12.2379; Liebel F, 2012, J INVEST DERMATOL, V132, P1901, DOI 10.1038/jid.2011.476; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Mahmoud BH, 2008, PHOTOCHEM PHOTOBIOL, V84, P450, DOI 10.1111/j.1751-1097.2007.00286.x; Mahmoud BH, 2010, J INVEST DERMATOL, V130, P2092, DOI 10.1038/jid.2010.95; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Oplander C, 2011, J PHOTOCH PHOTOBIO B, V103, P118, DOI 10.1016/j.jphotobiol.2011.02.018; Pierlot C, 2000, METHOD ENZYMOL, V319, P3; Pouget JP, 2000, CHEM RES TOXICOL, V13, P541, DOI 10.1021/tx000020e; RALPH P, 1975, NATURE, V257, P393, DOI 10.1038/257393a0; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; Sauvaigo S, 2002, ANAL BIOCHEM, V303, P107, DOI 10.1006/abio.2001.5559; Schieke SM, 2003, PHOTODERMATOL PHOTO, V19, P228, DOI 10.1034/j.1600-0781.2003.00054.x; SETLOW RB, 1993, P NATL ACAD SCI USA, V90, P6666, DOI 10.1073/pnas.90.14.6666; Suzukawa AA, 2012, FREE RADICAL BIO MED, V52, P1945, DOI 10.1016/j.freeradbiomed.2012.02.039; Tadokoro T, 2005, J INVEST DERMATOL, V124, P1326, DOI 10.1111/j.0022-202X.2005.23760.x; Tadokoro T, 2003, FASEB J, V17, P1177, DOI 10.1096/fj.02-0865fje; Uchoa AF, 2008, EUR BIOPHYS J BIOPHY, V37, P843, DOI 10.1007/s00249-008-0287-y; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Wood SR, 2006, P NATL ACAD SCI USA, V103, P4111, DOI 10.1073/pnas.0511248103; Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149	46	61	63	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113266	10.1371/journal.pone.0113266	http://dx.doi.org/10.1371/journal.pone.0113266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405352	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300094
J	Kurauchi, M; Niwano, Y; Shirato, M; Kanno, T; Nakamura, K; Egusa, H; Sasaki, K				Kurauchi, Michiko; Niwano, Yoshimi; Shirato, Midori; Kanno, Taro; Nakamura, Keisuke; Egusa, Hiroshi; Sasaki, Keiichi			Cytoprotective Effect of Short-Term Pretreatment with Proanthocyanidin on Human Gingival Fibroblasts Exposed to Harsh Environmental Conditions	PLOS ONE			English	Article							RAPID COLORIMETRIC ASSAY; SERUM DEPRIVATION; OXIDATIVE DAMAGE; GRAPE SEEDS; CELL-DEATH; POLYPHENOLS; TOXICITY; SURVIVAL; CYTOTOXICITY; NEUTROPHILS	Our previous study showed that exposing mouse fibroblasts to proanthocyanidin (PA) for only 1 min accelerated cell proliferation in a concentration-dependent manner. In this study, exposing human gingival fibroblasts (HGFs) to PA for 1 min similarly accelerated the proliferative response of the cells. Besides the accelerated proliferative response, PA showed a cytoprotective effect on HGFs exposed to harsh environmental conditions; short-term exposure of HGFs in the mitotic phase to pure water or physiological saline resulted in a lower recovery of viable cells. Pretreatment and concomitant treatment with PA improved the low recovery of cells exposed to pure water or physiological saline. In addition, HGFs exposed to PA for 1 min proliferated well even after being cultured in serum-free medium. In 100% confluent HGFs, being cultured in serum-free medium resulted in a high intracellular reactive oxygen species (ROS) level, but pretreatment with PA prevented the cells from increasing intracellular ROS. Thus, the results suggest that a short-term PA treatment exerts cytoprotective effects on HGFs exposed to harsh environmental conditions by improving the intracellular oxidative stress response.	[Kurauchi, Michiko; Niwano, Yoshimi; Shirato, Midori; Kanno, Taro; Nakamura, Keisuke; Egusa, Hiroshi; Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 980, Japan	Tohoku University	Niwano, Y (corresponding author), Tohoku Univ, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 980, Japan.	niwano@m.tohoku.ac.jp	Egusa, Hiroshi/AFT-9694-2022; Niwnao, Yoshimi/Z-3593-2019	Egusa, Hiroshi/0000-0002-0200-8132; 	Ministry of Education, Science, Sports and Culture, Japan [25893019, 2013, 26460116, 2014]; All Japan Coffee Association	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); All Japan Coffee Association(All Japan Coffee Association)	This work was supported by The Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Research Activity start-up, 25893019, 2013, to MS; The Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 26460116, 2014, to YN; and the grant of All Japan Coffee Association, 2014, to YN and KN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASS DA, 1983, J IMMUNOL, V130, P1910; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Campos J, 2014, FOOD CHEM, V151, P175, DOI 10.1016/j.foodchem.2013.11.018; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Fine A M, 2000, Altern Med Rev, V5, P144; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Jayasena T, 2013, AGEING RES REV, V12, P867, DOI 10.1016/j.arr.2013.06.003; Kalaiselvi P, 2013, FOOD CHEM TOXICOL, V56, P110, DOI 10.1016/j.fct.2013.01.042; Kim YS, 2013, BIOL PHARM BULL, V36, P609, DOI 10.1248/bpb.b12-00990; Kim Y, 2013, FOOD CHEM, V137, P136, DOI 10.1016/j.foodchem.2012.10.006; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pandey S, 2003, APOPTOSIS, V8, P497, DOI 10.1023/A:1025542424986; PRIEUR C, 1994, PHYTOCHEMISTRY, V36, P781, DOI 10.1016/S0031-9422(00)89817-9; RAMOS CL, 1992, J BIOL CHEM, V267, P8307; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tsuruya M, 2014, APPL BIOCHEM BIOTECH, V174, P2223, DOI 10.1007/s12010-014-1124-7; Wu PF, 2013, J NUTR BIOCHEM, V24, P1070, DOI 10.1016/j.jnutbio.2012.08.005; ZHANG SZ, 1990, CELL BIOL TOXICOL, V6, P219; Zhuge J, 2006, FREE RADICAL BIO MED, V40, P63, DOI 10.1016/j.freeradbiomed.2005.08.012	22	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113403	10.1371/journal.pone.0113403	http://dx.doi.org/10.1371/journal.pone.0113403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405354	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300115
J	Anand, S; Ebner, J; Warren, CB; Raam, MS; Piliang, M; Billings, SD; Maytin, EV				Anand, Sanjay; Ebner, John; Warren, Christine B.; Raam, Manu S.; Piliang, Melissa; Billings, Steven D.; Maytin, Edward V.			C/EBP Transcription Factors in Human Squamous Cell Carcinoma: Selective Changes in Expression of Isoforms Correlate with the Neoplastic State	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; IN-VIVO; PHOTODYNAMIC THERAPY; INHIBITORY PROTEIN; SKIN TUMORIGENESIS; DOWN-REGULATION	The CCAAT/Enhancer Binding Proteins (C/EBPs) are a family of leucine-zipper transcription factors that regulate physiological processes such as energy metabolism, inflammation, cell cycle, and the development and differentiation of several tissues including skin. Recently, a role for C/EBPs in tumor cell proliferation and differentiation has been proposed, but the incomplete characterization in the literature of multiple translational isoforms of these proteins has made interpretation of these roles difficult. Therefore, we have carefully reexamined C/EBP isoform expression in human non-melanoma skin cancers. C/EBP alpha, C/EBP beta, and C/EBP delta were analyzed histologically in squamous cell carcinomas (SCC). The individual isoforms of C/EBP alpha and C/EBP beta were examined by immunofluorescent digital imaging, western blotting and DNA binding activity (electrophoretic mobility shift analysis). Expression of all C/EBP family proteins was decreased in SCC tumors. Suppression was greatest for C/EBP alpha, less for C/EBP beta, and least for C/EBP delta. Western analyses confirmed that C/EBP alpha p42 and p30 isoforms were decreased. For C/EBP beta, only the abundant full-length isoform (C/EBP beta-1, LAP*, 55 kD) was reduced, whereas the smaller isoforms, C/EBP beta-2 (LAP, 48 kD) and C/EBP beta-3 (LIP, 20 kD), which are predominantly nuclear, were significantly increased in well-and moderately-differentiated SCC (up to 14-fold for C/EBP beta-3). These elevations correlated with increases in PCNA, a marker of proliferation. Although C/EBP beta displayed increased post-translational modifications in SCC, phosphorylation of C/EBP beta-1 (Thr 235) was not altered. C/EBP-specific DNA binding activity in nuclear and whole-cell extracts of cultured cells and tumors was predominantly attributable to C/EBP beta. In summary, two short C/EBP beta isoforms, C/EBP beta-2 and C/EBP beta-3, represent strong candidate markers for epithelial skin malignancy, due to their preferential expression in carcinoma versus normal skin, and their strong correlation with tumor proliferation.	[Anand, Sanjay; Ebner, John; Warren, Christine B.; Piliang, Melissa; Billings, Steven D.; Maytin, Edward V.] Cleveland Clin, Dept Dermatol, Cleveland, OH 44106 USA; [Anand, Sanjay; Raam, Manu S.; Maytin, Edward V.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Piliang, Melissa; Billings, Steven D.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Maytin, Edward V.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Harvard Medical School; Massachusetts General Hospital	Maytin, EV (corresponding author), Cleveland Clin, Dept Dermatol, Cleveland, OH 44106 USA.	maytine@ccf.org			National Cancer Institute, of the National Institute of Health [PO1-CA84203]; NATIONAL CANCER INSTITUTE [P01CA084203] Funding Source: NIH RePORTER	National Cancer Institute, of the National Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Cancer Institute, of the National Institute of Health, grant number PO1-CA84203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2013, MOL CANCER THER, V12, P1638, DOI 10.1158/1535-7163.MCT-13-0047; Anand S, 2009, CLIN CANCER RES, V15, P3333, DOI 10.1158/1078-0432.CCR-08-3054; Atwood AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025205; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; Bull JJ, 2002, J INVEST DERMATOL, V118, P17, DOI 10.1046/j.0022-202x.2001.01629.x; Bundy L, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-43; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Dearth LR, 2001, J CELL BIOCHEM, V82, P357, DOI 10.1002/jcb.1167; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Halmos B, 2002, CANCER RES, V62, P528; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; Korabiowska M, 2002, HISTOL HISTOPATHOL, V17, P805, DOI 10.14670/HH-17.805; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Minner F, 2009, J INVEST DERMATOL, V129, P770, DOI 10.1038/jid.2008.247; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Oya M, 2003, CLIN CANCER RES, V9, P1021; Pabst T, 2009, CLIN CANCER RES, V15, P5303, DOI 10.1158/1078-0432.CCR-08-2941; Pawar SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094967; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Raught B, 1996, CANCER RES, V56, P4382; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Ridky TW, 2007, J AM ACAD DERMATOL, V57, P484, DOI 10.1016/j.jaad.2007.01.033; Sankpal NV, 2006, ONCOGENE, V25, P643, DOI 10.1038/sj.onc.1209081; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Shim M, 2005, CANCER RES, V65, P861; Sinha AK, 2006, BRIT J CANCER, V95, P485, DOI 10.1038/sj.bjc.6603273; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Takai N, 2005, MOL CANCER RES, V3, P261, DOI 10.1158/1541-7786.MCR-04-0110; Taniguchi M, 2005, FEBS LETT, V579, P5785, DOI 10.1016/j.febslet.2005.09.068; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Thompson EA, 2011, J INVEST DERMATOL, V131, P1339, DOI 10.1038/jid.2011.31; Verbeek W, 2001, LEUKEMIA, V15, P103, DOI 10.1038/sj.leu.2401995; Xu L, 2001, CANCER RES, V61, P3176; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033; Zhang WT, 2005, INT J CANCER, V116, P885, DOI 10.1002/ijc.21103; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	59	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112073	10.1371/journal.pone.0112073	http://dx.doi.org/10.1371/journal.pone.0112073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402211	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700027
J	Barageine, JK; Tumwesigye, NM; Byamugisha, JK; Almroth, L; Faxelid, E				Barageine, Justus Kafunjo; Tumwesigye, Nazarius Mbona; Byamugisha, Josaphat K.; Almroth, Lars; Faxelid, Elisabeth			Risk Factors for Obstetric Fistula in Western Uganda: A Case Control Study	PLOS ONE			English	Article							WOMEN	Introduction: Two million women worldwide are living with genital fistula with an annual incidence of 50,000-100,000 women. Risk factors for obstetric fistula are context bound. Studies from other countries show variation in the risk factors for obstetric fistula. This study was conducted to identify risk factors for obstetric fistula in western Ugandan context. Methods: A case control study comparing background factors of women with obstetric fistula (cases) and women without fistula (controls) was conducted in western Uganda. Data was collected using face-to-face interviews. Univariate, bivariate and multivariate analysis was conducted using Stata 12. Results: Altogether, 420 respondents (140 cases and 280 controls) participated in the study. Duration of labour was used to form the product terms when assessing for interaction and confounding since it was one the most significant factors at bivariate level with a narrow confidence interval and was hence considered the main predictor. After adjusting for interaction and confounding, significant risk factors associated with development of obstetric fistula in western Uganda were: Caesarean section (adjusted odds ratio [AOR] = 13.30, 95% CI = 6.74-26.39), respondent height of 150 cm or less (AOR = 2.63, 95% CI = 1.35-5.26), baby weight of 3.5 kg or more (AOR = 1.52, 95% CI = 1.15-1.99), prolonged labour (AOR = 1.06, 95% CI = 1.04-1.08. A quarter of the fistulas had resulted from iatrogenic complication during caesarean section. Compared to no education, post primary level of education was protective against obstetric fistula (AOR = 0.31, 95% CI = 0.13-0.72) and there was no difference between respondents without education and those with primary level education. Conclusions: Surgeons contribute to a big proportion (25%) of fistula cases hence caesarean section being a risk factor in this region. Other risk factors include; prolonged labour, weight of the baby of 3.5 kg or more, respondent height of 150 cm or less (short stature), and low or no education are risk factors for obstetric fistula in western Ugandan.	[Barageine, Justus Kafunjo; Byamugisha, Josaphat K.] Makerere Univ, Mulago Natl Referral Hosp, Coll Hlth Sci, Dept Obstet & Gynecol,Sch Med, Kampala, Uganda; [Barageine, Justus Kafunjo; Almroth, Lars; Faxelid, Elisabeth] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, Sweden; [Tumwesigye, Nazarius Mbona] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda	Makerere University; Mulago National Referral Hospital; Karolinska Institutet; Makerere University	Barageine, JK (corresponding author), Makerere Univ, Mulago Natl Referral Hosp, Coll Hlth Sci, Dept Obstet & Gynecol,Sch Med, Kampala, Uganda.	barageinej@gmail.com	Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Swedish International Development Cooperation Agency (Sida) under the Makerere University - Karolinska Institutet collaboration Phase 3	Swedish International Development Cooperation Agency (Sida) under the Makerere University - Karolinska Institutet collaboration Phase 3	The study was funded by Swedish International Development Cooperation Agency (Sida) under the Makerere University - Karolinska Institutet collaboration Phase 3. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Abrams P, 2012, OBSTET FISTULA DEV W, P17; AMPOFO EK, 1990, TROP DOCT, V20, P138, DOI 10.1177/004947559002000320; [Anonymous], 2012, UG DEM HLTH SURV 201; Browning A, 2014, BJOG-INT J OBSTET GY, V121, P604, DOI 10.1111/1471-0528.12527; Danso K A, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P117, DOI 10.1007/BF01894198; Donnay F, 2006, INT J GYNECOL OBSTET, V94, P254, DOI 10.1016/j.ijgo.2006.04.005; FIGO P, 2011, GLOB COMP BAS FIST S, P119; Goh JWT, 2004, FEMALE GENITAL TRACT; Hadar E, 2011, ARCH GYNECOL OBSTET, V283, P735, DOI 10.1007/s00404-010-1450-0; Hancock B, 2005, 1 STEPS VESICO VAGIN; Hancock B, 2009, TXB PRACTICAL OBSTET; Harrison KA, 1996, J ROY SOC MED, V89, P361, DOI 10.1177/014107689608900701; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kabayambi J, 2014, INT J TROPICAL DIS H, V4, P352, DOI DOI 10.9734/IJTDH/2014/7505; Kelly J, 2007, INT J GYNECOL OBSTET, V99, pS21, DOI 10.1016/j.ijgo.2007.06.017; Kelly J, 1993, INT UROGYNECOL J, V4, P278; Kelsey JL., 1996, METHODS OBSERVATIONA; Larissa M, 2007, AM J OBSTET GYNECOL, V197, p90 e91; Lewis G., 2006, OBSTET FISTULA GUIDI; Melah GS, 2007, J OBSTET GYNAECOL, V27, P819, DOI 10.1080/01443610701709825; Muleta M, 2004, ETHIOPIAN MED J, V42, P9; Murray C, 2002, BJOG-INT J OBSTET GY, V109, P828, DOI 10.1111/j.1471-0528.2002.00124.x; Murray CJL, 1998, HLTH DIAMENSIONS SEX; Ntozi JPM, 1988, MARRIAGE PATTERNS AN; Olusegun AK, 2009, J NATL MED ASSOC, V101, P593, DOI 10.1016/S0027-9684(15)30946-9; Onsrud M, 2011, INT J GYNECOL OBSTET, V114, P10, DOI 10.1016/j.ijgo.2011.01.018; Raassen TJIP, 2008, INT UROGYNECOL J, V19, P73, DOI 10.1007/s00192-007-0389-6; Roka ZG, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-56; Serour GI, 2006, INT J GYNECOL OBSTET, V94, P174, DOI 10.1016/j.ijgo.2006.06.007; STATA Corp, 2011, STATA REL 12 STAT SO; TAHZIB F, 1983, BRIT J OBSTET GYNAEC, V90, P387, DOI 10.1111/j.1471-0528.1983.tb08933.x; Tann Carolyn J, 2007, BMC Pregnancy Childbirth, V7, P23, DOI 10.1186/1471-2393-7-23; Tebeu PM, 2012, INT UROGYNECOL J, V23, P387, DOI 10.1007/s00192-011-1622-x; Tebeu PM, 2009, INT J GYNECOL OBSTET, V107, P12, DOI 10.1016/j.ijgo.2009.05.019; Thomson AM, 2007, MIDWIFERY, V23, P335, DOI 10.1016/j.midw.2007.09.004; UBOS, 2007, UG DEM HLTH SURV 200; UNFPA, 2005, ANN REPORT; UNFPA, 2005, CAMP END FIST; Waaldijk K, 1998, STEP STEP SURG VESIC; Waaldijk K, 2008, OBSTET FISTULA SURG; Wall L L, 2005, Obstet Gynecol Surv, V60, pS3, DOI 10.1097/00006254-200507001-00002; Wall LL, 2004, AM J OBSTET GYNECOL, V190, P1011, DOI 10.1016/j.ajog.2004.02.007; WHO, 2005, MAK EV MOTH CHILD CO; Williams G, 2007, SURG-J R COLL SURG E, V5, P54, DOI 10.1016/S1479-666X(07)80113-2; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	45	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112299	10.1371/journal.pone.0112299	http://dx.doi.org/10.1371/journal.pone.0112299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401756	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700038
J	Neilson, JD; Loefer, J; Prince, ED; Royer, F; Calmettes, B; Gaspar, P; Lopez, R; Andrushchenko, I				Neilson, John D.; Loefer, Josh; Prince, Eric D.; Royer, Francois; Calmettes, Beatriz; Gaspar, Philippe; Lopez, Remy; Andrushchenko, Irene			Seasonal Distributions and Migrations of Northwest Atlantic Swordfish: Inferences from Integration of Pop-Up Satellite Archival Tagging Studies	PLOS ONE			English	Article							HORIZONTAL MOVEMENTS; HABITAT COMPRESSION; XIPHIAS-GLADIUS; TRACKING; TUNA	Data sets from three laboratories conducting studies of movements and migrations of Atlantic swordfish (Xiphias gladius) using pop-up satellite archival tags were pooled, and processed using a common methodology. From 78 available deployments, 38 were selected for detailed examination based on deployment duration. The points of deployment ranged from southern Newfoundland to the Straits of Florida. The aggregate data comprise the most comprehensive information describing migrations of swordfish in the Atlantic. Challenges in using data from different tag manufacturers are discussed. The relative utility of geolocations obtained with light is compared with results derived from temperature information for this deep-diving species. The results show that fish tagged off North America remain in the western Atlantic throughout their deployments. This is inconsistent with the model of stock structure used in assessments conducted by the International Commission for the Conservation of Atlantic Tunas, which assumes that fish mix freely throughout the North Atlantic.	[Neilson, John D.; Andrushchenko, Irene] Fisheries & Oceans Canada, St Andrews, NB E5B 2L9, Canada; [Loefer, Josh] Marine Resources Res Inst, South Carolina Dept Nat Resources, Charleston, SC 29412 USA; [Prince, Eric D.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA; [Royer, Francois] Datasio, F-31000 Toulouse, France; [Calmettes, Beatriz; Gaspar, Philippe; Lopez, Remy] Collecte Localisat Satellites, F-31526 Ramonville St Agne, France	Fisheries & Oceans Canada; National Oceanic Atmospheric Admin (NOAA) - USA	Neilson, JD (corresponding author), Fisheries & Oceans Canada, 531 Brandy Cove Rd, St Andrews, NB E5B 2L9, Canada.	John.Neilson@dfo-mpo.gc.ca			Canadian Department of Fisheries and Oceans; United States National Marine Fisheries Service; South Carolina Department of Natural Resources	Canadian Department of Fisheries and Oceans; United States National Marine Fisheries Service; South Carolina Department of Natural Resources	The work was jointly supported by the Canadian Department of Fisheries and Oceans, the United States National Marine Fisheries Service and the South Carolina Department of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid N, 2006, SWORDFISH; Armannsson H, 2007, ICES J MAR SCI, V64, P1006, DOI 10.1093/icesjms/fsm076; Briers M, 2010, ANN I STAT MATH, V62, P61, DOI 10.1007/s10463-009-0236-2; Chaprales W, 1998, MAR TECHNOL SOC J, V32, P104; Chow S, 2007, MAR BIOL, V152, P87, DOI 10.1007/s00227-007-0662-8; Dewar H, 2011, FISH OCEANOGR, V20, P219, DOI 10.1111/j.1365-2419.2011.00581.x; Dunn J M, 1996, GENERALISED ORTHO NE; Garulli A, 2001, IEEE T ROBOTIC AUTOM, V17, P450, DOI 10.1109/70.954757; Goodyear CP, 2011, COLLECT VOL SCI PAP, V68, P1510; Guy Christophr S., 1996, P353; Hein AM, 2012, ECOL LETT, V15, P104, DOI 10.1111/j.1461-0248.2011.01714.x; MILANESE M, 1991, AUTOMATICA, V27, P997, DOI 10.1016/0005-1098(91)90134-N; Neilson J, 2013, REV FISH SCI, V21, P59, DOI 10.1080/10641262.2012.754842; Neilson JD, 2009, REV-METHODS TECHNOL, V9, P145, DOI 10.1007/978-1-4020-9640-2_9; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Prince ED, 2002, AM FISH S S, V30, P155; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Prince ED, 2010, FISH OCEANOGR, V19, P448, DOI 10.1111/j.1365-2419.2010.00556.x; Royer F, 2009, POSITIONING PELAGIC; Sedberry GR, 2001, MAR BIOL, V139, P355; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; Skud B.E., 1977, INT PAC HALIBUT COMM, V63, P42; Smith B.L., FISH RES; Sperling A. T., 2005, COL VOL SCI PAP ICCA, V58, P1483; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Thygesen UH, 2009, TAGGING TRACKING MAR; Vallado D.A., 2001, SPACE TECHNOLOGY LIB, V2nd ed.	28	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112736	10.1371/journal.pone.0112736	http://dx.doi.org/10.1371/journal.pone.0112736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401964	Green Published, gold			2022-12-26	WOS:000345158700066
J	Sasaki, M; Sumi, M; Eida, S; Katayama, I; Hotokezaka, Y; Nakamura, T				Sasaki, Miho; Sumi, Misa; Eida, Sato; Katayama, Ikuo; Hotokezaka, Yuka; Nakamura, Takashi			Simple and Reliable Determination of Intravoxel Incoherent Motion Parameters for the Differential Diagnosis of Head and Neck Tumors	PLOS ONE			English	Article							DIFFUSION; PERFUSION; MR; CIRRHOSIS; MODEL	Intravoxel incoherent motion (IVIM) imaging can characterize diffusion and perfusion of normal and diseased tissues, and IVIM parameters are authentically determined by using cumbersome least-squares method. We evaluated a simple technique for the determination of IVIM parameters using geometric analysis of the multiexponential signal decay curve as an alternative to the least-squares method for the diagnosis of head and neck tumors. Pure diffusion coefficients (D), microvascular volume fraction (f), perfusion-related incoherent microcirculation (D*), and perfusion parameter that is heavily weighted towards extravascular space (P) were determined geometrically (Geo D, Geo f, and Geo P) or by least-squares method (Fit D, Fit f, and Fit D*) in normal structures and 105 head and neck tumors. The IVIM parameters were compared for their levels and diagnostic abilities between the 2 techniques. The IVIM parameters were not able to determine in 14 tumors with the least-squares method alone and in 4 tumors with the geometric and least-squares methods. The geometric IVIM values were significantly different (p<0.001) from Fit values (+2 +/- 4% and -7 +/- 24% for D and f values, respectively). Geo D and Fit D differentiated between lymphomas and SCCs with similar efficacy (78% and 80% accuracy, respectively). Stepwise approaches using combinations of Geo D and Geo P, Geo D and Geo f, or Fit D and Fit D* differentiated between pleomorphic adenomas, Warthin tumors, and malignant salivary gland tumors with the same efficacy (91% accuracy = 21/23). However, a stepwise differentiation using Fit D and Fit f was less effective (83% accuracy = 19/23). Considering cumbersome procedures with the least squares method compared with the geometric method, we concluded that the geometric determination of IVIM parameters can be an alternative to least-squares method in the diagnosis of head and neck tumors.	[Sasaki, Miho; Sumi, Misa; Eida, Sato; Katayama, Ikuo; Hotokezaka, Yuka; Nakamura, Takashi] Nagasaki Univ, Sch Dent, Dept Radiol & Canc Biol, Nagasaki 852, Japan	Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Sch Dent, Dept Radiol & Canc Biol, Nagasaki 852, Japan.	taku@nagasaki-u.ac.jp			Nagasaki University	Nagasaki University	The authors received the funds of this study from the internal source of Nagasaki University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L., 2005, WHO CLASSIFICATION T; Gao Q, 2011, J MAGN RESON IMAGING, V33, P1177, DOI 10.1002/jmri.22522; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Lai V, 2013, EUR RADIOL, V23, P2793, DOI 10.1007/s00330-013-2889-8; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2008, RADIOLOGY, V249, P748, DOI 10.1148/radiol.2493081301; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lewin M, 2011, EUR RADIOL, V21, P281, DOI 10.1007/s00330-010-1914-4; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Mazaheri Y, 2012, J MAGN RESON IMAGING, V35, P660, DOI 10.1002/jmri.22888; Moteki T, 2006, J MAGN RESON IMAGING, V24, P637, DOI 10.1002/jmri.20682; Nakamura T, 2010, METHODS CANCER DIAGN, V7, P255; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Penner AH, 2013, EUR RADIOL, V23, P2773, DOI 10.1007/s00330-013-2869-z; Sasaki M, 2013, AM J ROENTGENOL, V201, P1101, DOI 10.2214/AJR.12.9729; Sumi M, 2013, AM J NEURORADIOL, V34, P410, DOI 10.3174/ajnr.A3227; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248	17	16	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112866	10.1371/journal.pone.0112866	http://dx.doi.org/10.1371/journal.pone.0112866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402436	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700080
J	Wang, JL; Wang, F; Chu, LM; Wang, H; Zhong, ZP; Liu, ZP; Gao, JY; Duan, HR				Wang, Jiali; Wang, Fang; Chu, Limin; Wang, Hao; Zhong, Zhiping; Liu, Zhipei; Gao, Jianyong; Duan, Hairong			High Genetic Diversity and Novelty in Eukaryotic Plankton Assemblages Inhabiting Saline Lakes in the Qaidam Basin	PLOS ONE			English	Article							BACTERIAL DIVERSITY; MOLECULAR DIVERSITY; MICROBIAL DIVERSITY; RARE BIOSPHERE; 80S RIBOSOME; SALT LAKES; REVEALS; PICOEUKARYOTES; SEA; DNA	Saline lakes are intriguing ecosystems harboring extremely productive microbial communities in spite of their extreme environmental conditions. We performed a comprehensive analysis of the genetic diversity (18S rRNA gene) of the planktonic microbial eukaryotes (nano- and picoeukaryotes) in six different inland saline lakes located in the Qaidam Basin. The novelty level are high, with about 11.23% of the whole dataset showing <90% identity to any previously reported sequence in GenBank. At least 4 operational taxonomic units (OTUs) in mesosaline lakes, while up to eighteen OTUs in hypersaline lakes show very low CCM and CEM scores, indicating that these sequences are highly distantly related to any existing sequence. Most of the 18S rRNA gene sequence reads obtained in investigated mesosaline lakes is closely related to Holozoa group (48.13%), whereas Stramenopiles (26.65%) and Alveolates (10.84%) are the next most common groups. Hypersaline lakes in the Qaidam Basin are also dominated by Holozoa group, accounting for 26.65% of the total number of sequence reads. Notably, Chlorophyta group are only found in high abundance in Lake Gasikule (28.00%), whereas less represented in other hypersaline lakes such as Gahai (0.50%) and Xiaochaidan (1.15%). Further analysis show that the compositions of planktonic eukaryotic assemblages are also most variable between different sampling sites in the same lake. Out of the parameters, four show significant correlation to this CCA: altitude, calcium, sodium and potassium concentrations. Overall, this study shows important gaps in the current knowledge about planktonic microbial eukaryotes inhabiting Qaidam Basin (hyper) saline water bodies. The identified diversity and novelty patterns among eukaryotic plankton assemblages in saline lake are of great importance for understanding and interpreting their ecology and evolution.	[Wang, Jiali; Wang, Fang; Chu, Limin; Wang, Hao] China Inst Water Resources & Hydropower Res, State Key Lab Simulat & Regulat Water Cycle River, Beijing, Peoples R China; [Wang, Jiali] Inst Shandong River Wetlands, Laiwu, Peoples R China; [Chu, Limin] Hohai Univ, Coll Hydrol & Water Resource, Nanjing, Jiangsu, Peoples R China; [Zhong, Zhiping; Liu, Zhipei] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Gao, Jianyong; Duan, Hairong] Genewiz Inc, Beijing, Peoples R China	China Institute of Water Resources & Hydropower Research; Hohai University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, F (corresponding author), A-1 Fuxing Rd, Beijing, Peoples R China.	wangf@iwhr.com	Zhong, ZhiPing/AAH-9652-2019	Zhong, ZhiPing/0000-0002-4275-0403	Independent Study Project of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin [2013ZY06]	Independent Study Project of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin	Independent Study Project of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin (NO. 2013ZY06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; BEAVER JR, 1989, MICROBIAL ECOL, V17, P111, DOI 10.1007/BF02011847; Bryant RG, 1996, INT J REMOTE SENS, V17, P315, DOI 10.1080/01431169608949008; Buchheim MA, 2013, EUR J PHYCOL, V48, P318, DOI 10.1080/09670262.2013.830344; Caron D, 2012, ANNU REV MAR SCI, V4, P61; Casamayor EO, 2013, FEMS MICROBIOL ECOL, V85, P503, DOI 10.1111/1574-6941.12139; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Charvet S, 2014, FEMS MICROBIOL ECOL, V88, P550, DOI 10.1111/1574-6941.12324; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; Countway PD, 2007, ENVIRON MICROBIOL, V9, P1219, DOI 10.1111/j.1462-2920.2007.01243.x; del Campo J, 2011, PROTIST, V162, P435, DOI 10.1016/j.protis.2010.10.003; Demergasso C, 2008, EXTREMOPHILES, V12, P491, DOI 10.1007/s00792-008-0153-y; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Dillon JG, 2009, HYDROBIOLOGIA, V632, P49, DOI 10.1007/s10750-009-9827-4; Ebenezer V, 2012, MAR BIOTECHNOL, V14, P129, DOI 10.1007/s10126-011-9427-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; FRONTIER S, 1985, OCEANOGR MAR BIOL, V23, P253; Gaedke U, 2004, AQUAT MICROB ECOL, V34, P247, DOI 10.3354/ame034247; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hauer G, 2005, CELL ORIG LIFE EXTRE, V9, P519; Heidelberg KB, 2013, FRONTIERS MICROBIOLO, V4, P1, DOI DOI 10.3389/FMIC; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hosoi-Tanabe S, 2005, HARMFUL ALGAE, V4, P319, DOI 10.1016/j.hal.2004.04.002; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Ki JS, 2012, J APPL PHYCOL, V24, P1035, DOI 10.1007/s10811-011-9730-z; Kilias E, 2013, J PHYCOL, V49, P996, DOI 10.1111/jpy.12109; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Lefranc M, 2005, APPL ENVIRON MICROB, V71, P5935, DOI 10.1128/AEM.71.10.5935-5942.2005; Lepere C, 2008, APPL ENVIRON MICROB, V74, P2940, DOI 10.1128/AEM.01156-07; Lepere C, 2013, FEMS MICROBIOL ECOL, V85, P85, DOI 10.1111/1574-6941.12100; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Logares R, 2013, ISME J, V7, P937, DOI 10.1038/ismej.2012.168; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Makhdoumi-Kakhki A, 2012, MICROBES ENVIRON, V27, P87, DOI 10.1264/jsme2.ME11267; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Massana R, 2011, ISME J, V5, P184, DOI 10.1038/ismej.2010.104; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Metfies K, 2008, APPL ENVIRON MICROB, V74, P2814, DOI 10.1128/AEM.02122-07; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Oren A, 2002, J IND MICROBIOL BIOT, V28, P56, DOI 10.1038/sj.jim.7000176; Oren A., 2009, NAT RESOUR ENV ISS, V15, P51; Pagaling E, 2009, APPL ENVIRON MICROB, V75, P5750, DOI 10.1128/AEM.00040-09; Parnell JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012919; Pedros-Alio C, 2000, FEMS MICROBIOL ECOL, V32, P143, DOI 10.1016/S0168-6496(00)00025-8; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ramsar Convention Secretariat, 2010, RAMS HDB WIS US WETL, V17; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Triado-Margarit X, 2013, FEMS MICROBIOL ECOL, V85, P27, DOI 10.1111/1574-6941.12095; Triado-Margarit X, 2012, ENVIRON MICROBIOL, V14, P2445, DOI 10.1111/j.1462-2920.2012.02797.x; Waiser MJ, 2009, ENCY INLAND WATERS; Williams WD, 2002, ENVIRON CONSERV, V29, P154, DOI 10.1017/S0376892902000103; Wolf C, 2014, POLAR BIOL, V37, P375, DOI 10.1007/s00300-013-1438-x; Wu QLL, 2009, MICROB ECOL, V58, P569, DOI 10.1007/s00248-009-9526-8; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017	70	11	12	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112812	10.1371/journal.pone.0112812	http://dx.doi.org/10.1371/journal.pone.0112812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401703	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700074
J	Gambini, A; De Stefano, A; Bevacqua, RJ; Karlanian, F; Salamone, DF				Gambini, Andres; De Stefano, Adrian; Jimena Bevacqua, Romina; Karlanian, Florencia; Felipe Salamone, Daniel			The Aggregation of Four Reconstructed Zygotes is the Limit to Improve the Developmental Competence of Cloned Equine Embryos	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; IN-VITRO CULTURE; BOVINE PREIMPLANTATION EMBRYOS; TREATED DONOR CELLS; WELL WOW SYSTEM; GENE-EXPRESSION; POSTHATCHING DEVELOPMENT; CHIMERIC EMBRYOS; PORCINE EMBRYOS; SIZE REGULATION	Embryo aggregation has been demonstrated to improve cloning efficiency in mammals. However, since no more than three embryos have been used for aggregation, the effect of using a larger number of cloned zygotes is unknown. Therefore, the goal of the present study was to determine whether increased numbers of cloned aggregated zygotes results in improved in vitro and in vivo embryo development in the equine. Zona-free reconstructed embryos (ZFRE's) were cultured in the well of the well system in four different experimental groups: I. 1x, only one ZFRE per microwell; II. 3x, three per microwell; III. 4x, four per microwell; and IV. 5x, five ZFRE's per microwell. Embryo size was measured on day 7, after which blastocysts from each experimental group were either a) maintained in culture from day 8 until day 16 to follow their growth rates, b) fixed to measure DNA fragmentation using the TUNEL assay, or c) transferred to synchronized mares. A higher blastocyst rate was observed on day 7 in the 4x group than in the 5x group. Non-aggregated embryos were smaller on day 8 compared to those aggregated, but from then on the in vitro growth was not different among experimental groups. Apoptotic cells averaged 10% of total cells of day 8 blastocysts, independently of embryo aggregation. Only pregnancies resulting from the aggregation of up to four embryos per microwell went beyond the fifth month of gestation, and two of these pregnancies, derived from experimental groups 3x and 4x, resulted in live cloned foals. In summary, we showed that the in vitro and in vivo development of cloned zona-free embryos improved until the aggregation of four zygotes and declined when five reconstructed zygotes were aggregated.	[Gambini, Andres; De Stefano, Adrian; Jimena Bevacqua, Romina; Karlanian, Florencia; Felipe Salamone, Daniel] Univ Buenos Aires, Fac Agr, Lab Anim Biotechnol, Buenos Aires, DF, Argentina; [Gambini, Andres; Jimena Bevacqua, Romina; Felipe Salamone, Daniel] Natl Inst Sci & Technol Res, Buenos Aires, DF, Argentina	University of Buenos Aires	Salamone, DF (corresponding author), Univ Buenos Aires, Fac Agr, Lab Anim Biotechnol, Buenos Aires, DF, Argentina.	salamone@agro.uba.ar	Gambini, Andres/H-9119-2019; Salamone, Daniel F/G-1096-2019; Bevacqua, Romina/AAU-9227-2021	Gambini, Andres/0000-0002-3652-2068; Salamone, Daniel F/0000-0003-0858-0313; Bevacqua, Romina J/0000-0002-3903-6508	SIDUS Company	SIDUS Company	This work was partially funded by SIDUS Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2011, J REPROD DEVELOP, V57, P500, DOI 10.1262/jrd.10-140A; Alexopoulos NI, 2009, ANIM REPROD SCI, V114, P43, DOI 10.1016/j.anireprosci.2008.09.010; Allen WR, 2001, REPROD FERT DEVELOP, V13, P623, DOI 10.1071/RD01063; Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Balbach ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035322; Bertolini M, 2002, MOL REPROD DEV, V63, P318, DOI 10.1002/mrd.90015; Boediono A, 1999, MOL REPROD DEV, V53, P159, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;159::AID-MRD5&gt;3.0.CO;2-X; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Brandao DO, 2004, BIOL REPROD, V71, P2048, DOI 10.1095/biolreprod.103.025916; Choi YH, 2013, THERIOGENOLOGY, V79, P791, DOI 10.1016/j.theriogenology.2012.12.005; Choi YH, 2009, CLONING STEM CELLS, V11, P301, DOI 10.1089/clo.2008.0077; Eckardt S, 2004, ANIM REPROD SCI, V82-3, P97, DOI 10.1016/j.anireprosci.2004.04.017; FISCHER B, 1991, ANAT EMBRYOL, V183, P17; Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Gambini A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.098855; Gopichandran N, 2006, REPRODUCTION, V131, P269, DOI 10.1530/rep.1.00677; Hao YH, 2003, BIOL REPROD, V69, P501, DOI 10.1095/biolreprod.103.016170; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Hardy K, 2003, BIOL REPROD, V68, P1165, DOI 10.1095/biolreprod.102.010090; He Wenteng, 2013, Genomics Proteomics & Bioinformatics, V11, P327, DOI 10.1016/j.gpb.2013.09.007; HILLMAN N, 1972, J EMBRYOL EXP MORPH, V28, P263; Hinrichs K, 2007, REPRODUCTION, V134, P319, DOI 10.1530/REP-07-0069; Hinrichs K, 2006, REPRODUCTION, V131, P1063, DOI 10.1530/rep.1.01095; Hiriart MI, 2013, THERIOGENOLOGY, V80, P357, DOI 10.1016/j.theriogenology.2013.04.023; Hoelker M, 2009, REPRODUCTION, V137, P415, DOI 10.1530/REP-08-0370; Johnson AK, 2010, JAVMA-J AM VET MED A, V236, P983, DOI 10.2460/javma.236.9.983; Kurosaka S, 2007, CLONING STEM CELLS, V9, P630, DOI 10.1089/clo.2007.0015; Lagutina I, 2005, REPRODUCTION, V130, P559, DOI 10.1530/rep.1.00772; Lagutina I, 2007, THERIOGENOLOGY, V67, P90, DOI 10.1016/j.theriogenology.2006.09.011; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; Levy RR, 2001, MARC MALPIG SYMP SER, V8, P101; LEWIS NE, 1982, J EMBRYOL EXP MORPH, V72, P169; Li J, 2013, ZYGOTE, V15, P1; Machado GM, 2013, MOL REPROD DEV, V80, P936, DOI 10.1002/mrd.22230; Machado GM, 2013, REPROD FERT DEVELOP, V25, P600, DOI 10.1071/RD11282; Maddox-Hyttel P, 2003, REPRODUCTION, P103; Melka MG, 2010, REPROD DOMEST ANIM, V45, P915, DOI 10.1111/j.1439-0531.2009.01463.x; Misica-Turner PA, 2007, BIOL REPROD, V76, P268, DOI 10.1095/biolreprod.106.050922; Moussa M, 2004, THERIOGENOLOGY, V61, P921, DOI 10.1016/S0093-691X(03)00280-2; Nakano K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061900; Oback B, 2008, REPROD DOMEST ANIM, V43, P407, DOI 10.1111/j.1439-0531.2008.01192.x; Ohtsuka M, 2012, CELL TISSUE RES, V350, P251, DOI 10.1007/s00441-012-1470-0; Pedersen HG, 2005, MOL CELL ENDOCRINOL, V234, P137, DOI 10.1016/j.mce.2004.08.016; PETTERS RM, 1984, THERIOGENOLOGY, V22, P167, DOI 10.1016/0093-691X(84)90429-1; Pomar FJR, 2005, THERIOGENOLOGY, V63, P2254, DOI 10.1016/j.theriogenology.2004.10.015; RANDS GF, 1986, J EMBRYOL EXP MORPH, V94, P139; Ribeiro ED, 2009, CLONING STEM CELLS, V11, P377, DOI 10.1089/clo.2009.0022; Sananmuang T, 2013, J REPROD DEVELOP, V59, P180, DOI 10.1262/jrd.2012-116; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Shan ZY, 2012, DEV GROWTH DIFFER, V54, P481, DOI 10.1111/j.1440-169X.2012.01335.x; Siriboon C, 2014, REPROD FERT DEVELOP, V26, P395, DOI 10.1071/RD12243; Taka M, 2005, J REPROD DEVELOP, V51, P533, DOI 10.1262/jrd.17005; Tecirlioglu RT, 2005, REPROD FERT DEVELOP, V17, P573, DOI 10.1071/RD04122; Terashita Y, 2011, REPROD DOMEST ANIM, V46, P189, DOI 10.1111/j.1439-0531.2010.01614.x; Tremoleda JL, 2003, BIOL REPROD, V69, P1895, DOI 10.1095/biolreprod.103.018515; Vajta G, 2000, ANIM REPROD SCI, V60, P357, DOI 10.1016/S0378-4320(00)00097-X; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Vejlsted M, 2006, THERIOGENOLOGY, V65, P153, DOI 10.1016/j.theriogenology.2005.09.021; Woods GL, 2003, SCIENCE, V301, P1063, DOI 10.1126/science.1086743; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Zhou WL, 2008, MOL REPROD DEV, V75, P1281, DOI 10.1002/mrd.20875	61	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e110998	10.1371/journal.pone.0110998	http://dx.doi.org/10.1371/journal.pone.0110998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396418	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500012
J	He, C; O'Halloran, DM				He, Chao; O'Halloran, Damien M.			Analysis of the Na+/Ca2+ Exchanger Gene Family within the Phylum Nematoda	PLOS ONE			English	Article							BEST-FIT MODELS; NA+-CA2+ EXCHANGER; PROTEIN EVOLUTION; ADULT-RAT; NCX1; CA2+; K+; MECHANISM; SELECTION; ISOFORMS	Na+/Ca2+ exchangers are low affinity, high capacity transporters that rapidly transport calcium at the plasma membrane, mitochondrion, endoplasmic (and sarcoplasmic) reticulum, and the nucleus. Na+/Ca2+ exchangers are widely expressed in diverse cell types where they contribute homeostatic balance to calcium levels. In animals, Na+/Ca2+ exchangers are divided into three groups based upon stoichiometry: Na+/Ca2+ exchangers (NCX), Na+/Ca2+/K+ exchangers (NCKX), and Ca2+/Cation exchangers (CCX). In mammals there are three NCX genes, five NCKX genes and one CCX (NCLX) gene. The genome of the nematode Caenorhabditis elegans contains ten Na+/Ca2+ exchanger genes: three NCX; five CCX; and two NCKX genes. Here we set out to characterize structural and taxonomic specializations within the family of Na+/Ca2+ exchangers across the phylum Nematoda. In this analysis we identify Na+/Ca2+ exchanger genes from twelve species of nematodes and reconstruct their phylogenetic and evolutionary relationships. The most notable feature of the resulting phylogenies was the heterogeneous evolution observed within exchanger subtypes. Specifically, in the case of the CCX exchangers we did not detect members of this class in three Clade III nematodes. Within the Caenorhabditis and Pristionchus lineages we identify between three and five CCX representatives, whereas in other Clade V and also Clade IV nematode taxa we only observed a single CCX gene in each species, and in the Clade III nematode taxa that we sampled we identify NCX and NCKX encoding genes but no evidence of CCX representatives using our mining approach. We also provided re-annotation for predicted CCX gene structures from Heterorhabditis bacteriophora and Caenorhabditis japonica by RT-PCR and sequencing. Together, these findings reveal a complex picture of Na+/Ca2+ transporters in nematodes that suggest an incongruent evolutionary history of proteins that provide central control of calcium dynamics.	[He, Chao; O'Halloran, Damien M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [He, Chao; O'Halloran, Damien M.] George Washington Univ, Inst Neurosci, Washington, DC 20052 USA	George Washington University; George Washington University	O'Halloran, DM (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	damienoh@gwu.edu			George Washington University (GW) Columbian College of Arts and Sciences; GW Office of the Vice-President for Research; GW Department of Biological Sciences	George Washington University (GW) Columbian College of Arts and Sciences; GW Office of the Vice-President for Research; GW Department of Biological Sciences	Funding was from The George Washington University ( GW) Columbian College of Arts and Sciences, GW Office of the Vice-President for Research, and the GW Department of Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altimimi HF, 2013, ADV EXP MED BIOL, V961, P81, DOI 10.1007/978-1-4614-4756-6_8; BAKER PF, 1969, J PHYSIOL-LONDON, V200, P431, DOI 10.1113/jphysiol.1969.sp008702; BLAUSTEIN MP, 1968, J GEN PHYSIOL, V51, P293, DOI 10.1085/jgp.51.3.293; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; BRENNER S, 1974, GENETICS, V77, P71; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cai XJ, 2004, J BIOL CHEM, V279, P5867, DOI 10.1074/jbc.M310908200; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Gobbi P, 2007, PHARMACOL RES, V56, P556, DOI 10.1016/j.phrs.2007.10.005; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris TW, 2014, NUCLEIC ACIDS RES, V42, pD789, DOI 10.1093/nar/gkt1063; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Kang KJ, 2005, J BIOL CHEM, V280, P6834, DOI 10.1074/jbc.M412933200; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiontke K, 2002, NEMATOLOGY, V4, P933, DOI 10.1163/156854102321122557; Kovacs R, 2005, J NEUROSCI, V25, P4260, DOI 10.1523/JNEUROSCI.4000-04.2005; Lee SH, 2002, J NEUROSCI, V22, P6891; LEVESQUE PC, 1991, ANN NY ACAD SCI, V639, P386, DOI 10.1111/j.1749-6632.1991.tb17327.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LI ZP, 1994, J BIOL CHEM, V269, P17434; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebich I, 2002, NUCLEIC ACIDS RES, V30, P372, DOI 10.1093/nar/30.1.372; Lytton J, 2002, ANN NY ACAD SCI, V976, P382; Marshall CR, 2005, PHYSIOL GENOMICS, V21, P161, DOI 10.1152/physiolgenomics.00286.2004; Martin J, 2012, NUCLEIC ACIDS RES, V40, pD720, DOI 10.1093/nar/gkr1194; Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004; Molinaro P, 2013, ADV EXP MED BIOL, V961, P213, DOI 10.1007/978-1-4614-4756-6_18; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; O'Halloran D, 2014, JOVE-J VIS EXP, DOI 10.3791/50975; O'Halloran DM, 2003, PARASITOLOGY, V127, P375, DOI 10.1017/S0031182003003688; O'Leary SA, 1998, J PARASITOL, V84, P665, DOI 10.2307/3284567; On C, 2009, AM J PHYSIOL-CELL PH, V296, pC173, DOI 10.1152/ajpcell.00455.2008; On C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-127; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Palty R, 2012, J BIOL CHEM, V287, P31650, DOI 10.1074/jbc.R112.355867; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pannaccione A, 2012, J NEUROSCI, V32, P10609, DOI 10.1523/JNEUROSCI.6429-11.2012; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Ren XY, 2013, J MOL CELL CARDIOL, V57, P68, DOI 10.1016/j.yjmcc.2013.01.010; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schulze DH, 2002, ANN NY ACAD SCI, V976, P187; Sharma V, 2014, GENESIS, V52, P93, DOI 10.1002/dvg.22735; Sharma V, 2013, GENETICS, V195, P611, DOI 10.1534/genetics.113.153106; Shu XD, 2007, DEVELOPMENT, V134, P1921, DOI 10.1242/dev.02851; Sisalli MJ, 2014, CELL DEATH DIFFER, V21, P1142, DOI 10.1038/cdd.2014.32; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Wood-Kaczmar A, 2013, ADV EXP MED BIOL, V961, P241, DOI 10.1007/978-1-4614-4756-6_20; WOODRING JL, 1998, SOUTHERN COOPERATIVE; Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045; Yang H, 2010, MOL REPROD DEV, V77, P971, DOI 10.1002/mrd.21245	65	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112841	10.1371/journal.pone.0112841	http://dx.doi.org/10.1371/journal.pone.0112841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397810	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558500098
J	Liu, H; Liang, JP; Li, PB; Peng, W; Peng, YY; Zhang, GM; Xie, CS; Long, CF; Su, WW				Liu, Hong; Liang, Jie-ping; Li, Pei-bo; Peng, Wei; Peng, Yao-yao; Zhang, Gao-min; Xie, Cheng-shi; Long, Chao-feng; Su, Wei-wei			Core Bioactive Components Promoting Blood Circulation in the Traditional Chinese Medicine Compound Xueshuantong Capsule (CXC) Based on the Relevance Analysis between Chemical HPLC Fingerprint and In Vivo Biological Effects	PLOS ONE			English	Article							GREY RELATIONAL ANALYSIS; GINSENOSIDE-RD; CELLS; COAGULATION; RECEPTOR; FLOW	Compound xueshuantong capsule (CXC) is an oral traditional Chinese herbal formula (CHF) comprised of Panax notoginseng (PN), Radix astragali (RA), Salvia miltiorrhizae (SM), and Radix scrophulariaceae (RS). The present investigation was designed to explore the core bioactive components promoting blood circulation in CXC using high-performance liquid chromatography (HPLC) and animal studies. CXC samples were prepared with different proportions of the 4 herbs according to a four-factor, nine-level uniform design. CXC samples were assessed with HPLC, which identified 21 components. For the animal experiments, rats were soaked in ice water during the time interval between two adrenaline hydrochloride injections to reduce blood circulation. We assessed whole-blood viscosity (WBV), erythrocyte aggregation and red corpuscle electrophoresis indices (EAI and RCEI, respectively), plasma viscosity (PV), maximum platelet aggregation rate (MPAR), activated partial thromboplastin time (APTT), and prothrombin time (PT). Based on the hypothesis that CXC sample effects varied with differences in components, we performed grey relational analysis (GRA), principal component analysis (PCA), ridge regression (RR), and radial basis function (RBF) to evaluate the contribution of each identified component. Our results indicate that panaxytriol, ginsenoside Rb1, angoroside C, protocatechualdehyde, ginsenoside Rd, and calycosin-7-O-beta-D-glucoside are the core bioactive components, and that they might play different roles in the alleviation of circulation dysfunction. Panaxytriol and ginsenoside Rb1 had close relevance to red blood cell (RBC) aggregation, angoroside C was related to platelet aggregation, protocatechualdehyde was involved in intrinsic clotting activity, ginsenoside Rd affected RBC deformability and plasma proteins, and calycosin-7-O-beta-D-glucoside influenced extrinsic clotting activity. This study indicates that angoroside C, calycosin-7-O-beta-D-glucoside, panaxytriol, and protocatechualdehyde may have novel therapeutic uses.	[Liu, Hong; Liang, Jie-ping; Li, Pei-bo; Peng, Wei; Peng, Yao-yao; Zhang, Gao-min; Su, Wei-wei] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou Qual R&D Ctr Tradit Chinese Med, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Cheng-shi; Long, Chao-feng] Guangdong Zhongsheng Pharmaceut Co Ltd, Dongguan, Peoples R China	Sun Yat Sen University	Su, WW (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou Qual R&D Ctr Tradit Chinese Med, Guangzhou 510275, Guangdong, Peoples R China.	lsssww@126.com	su, wei/GZM-3986-2022	Liu, Hong/0000-0002-7320-0260	National Science and Technology Major Projects of Significant Drug Discovery of China [2011ZX09201-201-22]; Science and Technology Project for Medical and Health Units of Dongguan city [2012105102004]	National Science and Technology Major Projects of Significant Drug Discovery of China; Science and Technology Project for Medical and Health Units of Dongguan city	This work is financially supported by the National Science and Technology Major Projects of Significant Drug Discovery of China (No 2011ZX09201-201-22), and Science and Technology Project for Medical and Health Units of Dongguan city (No 2012105102004). Guangdong Zhongsheng Pharmaceutical Co., Ltd., provided support in the form of the supply of 4 herbs (PN, RA, SM, and RS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj SP, 1999, SEMIN THROMB HEMOST, V25, P407, DOI 10.1055/s-2007-994943; Bensky D, 2004, CHINESE HERBAL MED M, P265; Chen Q., 2006, TRADITIONAL CHINESE; Chiu CC, 2002, COMPUT METH PROG BIO, V69, P1, DOI 10.1016/S0169-2607(01)00181-X; Diaz AM, 2004, LIFE SCI, V74, P2515, DOI 10.1016/j.lfs.2003.10.008; Fan Y, 2003, EUR J PHARMACOL, V481, P33, DOI 10.1016/j.ejphar.2003.09.007; GACHET C, 1991, NOUV REV FR HEMATOL, V33, P347; Guan YY, 2006, EUR J PHARMACOL, V548, P129, DOI 10.1016/j.ejphar.2006.08.001; He F Y, 2004, WORLD SCI TECHNOL MO, V6, P44; He XQ, 2011, APPL REGRESSION ANAL, P169; Kamal AH, 2007, MAYO CLIN PROC, V82, P864, DOI 10.4065/82.7.864; Kesmarky G, 2006, CLIN HEMORHEOL MICRO, V35, P67; Kim YS, 2007, EUR J PHARMACOL, V569, P171, DOI 10.1016/j.ejphar.2007.05.054; Kong WJ, 2011, FOOD CHEM, V127, P1342, DOI 10.1016/j.foodchem.2011.01.095; Kuo Y, 2008, COMPUT IND ENG, V55, P80, DOI 10.1016/j.cie.2007.12.002; Li J, 2011, EUR J PHARMACOL, V652, P104, DOI 10.1016/j.ejphar.2010.11.017; Li R, 2002, J ED CHINESE MED, V21, P62; Liang JP, 2012, J CHINESE MED MAT, V35, P146; Liang YZ, 2001, CHEMOMETR INTELL LAB, V58, P43, DOI 10.1016/S0169-7439(01)00139-3; Liu L, 2012, J ETHNOPHARMACOL, V139, P381, DOI 10.1016/j.jep.2011.11.016; Lu HM, 2006, CHEM PHARM BULL, V54, P725, DOI 10.1248/cpb.54.725; Mchedlishvili G, 1998, CLIN HEMORHEOL MICRO, V19, P315; Ng F, 2008, TETRAHEDRON LETT, V49, P7178, DOI 10.1016/j.tetlet.2008.09.169; Ngo SH, 2003, CHEMOMETR INTELL LAB, V67, P69, DOI 10.1016/S0169-7439(03)00062-5; Ning LiLi, 2000, Acta Pharmaceutica Sinica, V35, P131; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; QIN R, 1999, HEMORRHEOLOGY, P45; Qu N, 2007, EUR J PHARM SCI, V31, P156, DOI 10.1016/j.ejps.2007.03.006; Shao ML, 2010, PHARM PEOPLES REPUBL, P909; Shibahara N, 1996, J AUTONOM NERV SYST, V61, P109, DOI 10.1016/S0165-1838(96)00065-3; Song QB, 2011, EXPERT SYST APPL, V38, P7302, DOI 10.1016/j.eswa.2010.12.005; Sun K, 2007, LIFE SCI, V81, P509, DOI 10.1016/j.lfs.2007.06.008; Thrall G, 2005, THROMB RES, V115, P171, DOI 10.1016/j.thromres.2004.08.021; Tian Y, 2010, J ETHNOPHARMACOL, V129, P1, DOI 10.1016/j.jep.2010.02.023; Tziakas DN, 2007, ATHEROSCLEROSIS, V193, P196, DOI 10.1016/j.atherosclerosis.2006.06.016; Wang XC, 1989, APPL GREY SYSTEM MOD, P1; Wen ZY, 2000, CLIN HEMORHEOL MICRO, V23, P51; [肖小河 XIAO Xiao-he], 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P505; Xue TH, 2003, SCIENCE, V300, P740, DOI 10.1126/science.300.5620.740; Ye RD, 2011, NEUROPHARMACOLOGY, V61, P815, DOI 10.1016/j.neuropharm.2011.05.029; Ye RD, 2011, NEUROCHEM INT, V58, P391, DOI 10.1016/j.neuint.2010.12.015; Yu DH, 2009, BIOMED ENVIRON SCI, V22, P50, DOI 10.1016/S0895-3988(09)60022-2	42	15	23	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112675	10.1371/journal.pone.0112675	http://dx.doi.org/10.1371/journal.pone.0112675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396725	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558500075
J	Wales, KM; Kavazos, K; Nataatmadja, M; Brooks, PR; Williams, C; Russell, FD				Wales, Kathryn M.; Kavazos, Kristyn; Nataatmadja, Maria; Brooks, Peter R.; Williams, Chloe; Russell, Fraser D.			N-3 PUFAs Protect against Aortic Inflammation and Oxidative Stress in Angiotensin II-Infused Apolipoprotein E-/- Mice	PLOS ONE			English	Article							RESOLVIN D1; ACID SUPPLEMENTATION; RANDOMIZED-TRIAL; RISK-FACTORS; FATTY-ACID; RESOLUTION; ANEURYSMS; CIRCUITS; OMEGA-3-FATTY-ACIDS; ATHEROSCLEROSIS	Abdominal aortic aneurysm is associated with infiltration of inflammatory cells into the aortic wall. The inflammatory response is also evident in animal models, such as apolipoprotein E-deficient (ApoE(-/-)) mice that have been infused with angiotensin II, prior to development of aortic aneurysm. Since omega-3 polyunsaturated fatty acids (n-3 PUFAs) and their metabolites have anti-inflammatory and pro-resolving activity, we hypothesised that dietary supplementation with n-3 PUFAs would protect against inflammatory processes in this mouse model. Twenty C57 and 20 ApoE(-/-) 3-4 week old male mice were supplemented with a low (0.14%, n = 10/group) or high (0.70%, n = 10/group) n-3 PUFA diet for 8 weeks before 2-day infusion with 0.9% saline or angiotensin II (1000 ng/kg/min). Four ApoE(-/-) mice on the low n-3 PUFA diet and none of the ApoE(-/-) mice on the high n-3 PUFA diet showed morphological evidence of abdominal aortic dissection. The plasma concentration of the n-3 PUFA metabolite, resolvin D1 was higher in angiotensin II-infused ApoE(-/-) mice fed the high, compared to the low n-3 PUFA diet. The number of neutrophils and macrophages infiltrating the abdominal aorta was elevated in ApoE(-/-) mice on the low n-3 PUFA diet, and this was significantly attenuated in mice that were fed the high n-3 PUFA diet. Most neutrophils and macrophages were associated with dissected aortas. Immunoreactivity of the catalytic subunit of nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase, Nox2, and superoxide were elevated in ApoE(-/-) mice that were fed the low n-3 PUFA diet, and this was also significantly attenuated in mice that were fed the high n-3 PUFA diet. Together, the findings indicate that supplementation of ApoE(-/-) mice with a diet high in n-3 PUFA content protected the mice against pro-inflammatory and oxidative stress responses following short-term infusion with angiotensin II.	[Wales, Kathryn M.; Kavazos, Kristyn; Brooks, Peter R.; Williams, Chloe; Russell, Fraser D.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld, Australia; [Nataatmadja, Maria] Univ Queensland, Prince Charles Hosp, Dept Med, Cardiovasc Res Grp, Herston, Qld, Australia	University of the Sunshine Coast; Prince Charles Hospital; University of Queensland	Russell, FD (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld, Australia.	FRussell@usc.edu.au	Nataatmadja, Maria/F-6338-2010	Russell, Fraser/0000-0001-8396-4558; Wales, Kathryn/0000-0002-7164-4140; Brooks, Peter/0000-0003-4915-4986	Faculty Seed Grant	Faculty Seed Grant	This study was funded by a Faculty Seed Grant to FR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Cao J, 2006, CLIN CHEM, V52, P2265, DOI 10.1373/clinchem.2006.072322; Chavis C, 1996, J EXP MED, V183, P1633, DOI 10.1084/jem.183.4.1633; Daugherty A, 2008, FUTURE LIPIDOL, V3, P625, DOI 10.2217/17460875.3.6.625; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Eliason JL, 2005, CIRCULATION, V112, P232, DOI 10.1161/CIRCULATIONAHA.104.517391; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Geppert J, 2005, LIPIDS, V40, P807, DOI 10.1007/s11745-005-1442-9; Givens DI, 2008, P NUTR SOC, V67, P273, DOI 10.1017/S0029665108007167; Guzik B, 2013, INT J CARDIOL, V168, P2389, DOI 10.1016/j.ijcard.2013.01.278; Howe P, 2006, NUTRITION, V22, P47, DOI 10.1016/j.nut.2005.05.009; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Nogi A, 2007, J OCCUP HEALTH, V49, P205, DOI 10.1539/joh.49.205; Norling LV, 2012, ARTERIOSCLER THROMB, V32, P1; Nobre MEP, 2013, NUTR RES, V33, P422, DOI 10.1016/j.nutres.2013.02.011; Plourde M, 2007, APPL PHYSIOL NUTR ME, V32, P619, DOI 10.1139/H07-034; Ramos-Mozo P, 2011, ARTERIOSCL THROM VAS, V31, P3011, DOI 10.1161/ATVBAHA.111.237537; Recchiuti A, 2013, PROSTAG OTH LIPID M, V107, P64, DOI 10.1016/j.prostaglandins.2013.02.004; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Root M, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-40; Russell FD, 2012, MAR DRUGS, V10, P2535, DOI 10.3390/md10112535; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Wang YH, 2012, AGING CELL, V11, P410, DOI 10.1111/j.1474-9726.2012.00796.x; Zhou RH, 2012, ARTERIOSCL THROM VAS, V32, P745, DOI 10.1161/ATVBAHA.111.243121	33	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112816	10.1371/journal.pone.0112816	http://dx.doi.org/10.1371/journal.pone.0112816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398022	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500093
J	Chichger, H; Duong, H; Braza, J; Harrington, EO				Chichger, Havovi; Huetran Duong; Braza, Julie; Harrington, Elizabeth O.			p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin	FASEB JOURNAL			English	Article						endosome; adherens junction; endocytosis; lung injury	ACUTE LUNG INJURY; CELL-CELL ADHESION; IN-VIVO; VASCULAR-PERMEABILITY; TYROSINE PHOSPHORYLATION; LEUKOCYTE EXTRAVASATION; DEPENDENT ENDOCYTOSIS; ADHERENS JUNCTIONS; CATENIN COMPLEX; BETA-CATENIN	Vascular permeability is a hallmark of several disease states including acute lung injury (ALI). Endocytosis of VE-cadherin, away from the interendothelial junction (IEJ), causes acute endothelial barrier permeability. A novel protein, p18, anchors to the endosome membrane and plays a role in late endosomal signaling via MAPK and mammalian target of rapamycin. However, the fate of the VE-cadherin-positive endosome has yet to be elucidated. We sought to elucidate a role for p18 in VE-cadherin trafficking and thus endothelial barrier function, in settings of ALI. Endothelial cell (EC) resistance, whole-cell ELISA, and filtration coefficient were studied in mice or lung ECs overexpressing wild-type or nonendosomal-binding mutant p18, using green fluorescent protein as a control. We demonstrate a protective role for the endocytic protein p18 in endothelial barrier function in settings of ALI in vitro and in vivo, through enhanced recycling of VE-cadherin-positive early endosomes to the IEJ. In settings of LPS-induced ALI, we show that Src tethered to the endosome tyrosine phosphorylates p18 concomitantly with VE-cadherin internalization and pulmonary edema formation. We conclude that p18 regulates pulmonary endothelial barrier function in vitro and in vivo, by enhancing recycling of VE-cadherin-positive endosomes to the IEJ.	Providence Vet Affairs Med Ctr, Vasc Res Lab, Providence, RI USA; Brown Univ, Alpert Med Sch, Dept Med, Providence, RI 02912 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Chichger, H (corresponding author), Providence VA Med Ctr, 830 Chalkstone Ave, Providence, RI 02908 USA.	havovi_chichger@brown.edu	Chichger, Havovi/Y-7117-2019; Chichger, Havovi/M-5129-2015	Chichger, Havovi/0000-0002-8549-7583; Chichger, Havovi/0000-0002-8549-7583; Harrington, Elizabeth/0000-0002-3207-5301	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant [R01 HL-67795]; American Heart Association Grant [10GRNT4160055, 13POST16860031]; COBRE NIH National Institute of General Medical Sciences Award [5P20 GM103652]; University Medicine Foundation of Rhode Island Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103652] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant; American Heart Association Grant(American Heart Association); COBRE NIH National Institute of General Medical Sciences Award; University Medicine Foundation of Rhode Island Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is the result of work supported with resources and the use of facilities at the Providence Veterans Affairs Medical Center. The work was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01 HL-67795, American Heart Association Grant 10GRNT4160055, COBRE NIH National Institute of General Medical Sciences Award 5P20 GM103652, and University Medicine Foundation of Rhode Island Hospital (to E.O.H.). H.C. was supported by American Heart Association Grant 13POST16860031. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Buttenschoen K, 2008, LANGENBECK ARCH SURG, V393, P473, DOI 10.1007/s00423-008-0317-3; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Chichger H, 2012, AM J PHYSIOL-LUNG C, V303, pL880, DOI 10.1152/ajplung.00169.2012; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; de Leeuw HPJC, 1998, BRIT J HAEMATOL, V103, P15, DOI 10.1046/j.1365-2141.1998.00965.x; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Durrbach A, 1996, J CELL SCI, V109, P457; Gao XP, 2000, AM J PHYSIOL-LUNG C, V279, pL1218, DOI 10.1152/ajplung.2000.279.6.L1218; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gotsch U, 1997, J CELL SCI, V110, P583; Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009; Grinnell KL, 2012, AM J RESP CELL MOL, V46, P623, DOI 10.1165/rcmb.2011-0271OC; Guillaumot P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010977; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Hoshino D, 2011, J BIOL CHEM, V286, P3139, DOI 10.1074/jbc.M110.159715; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Li HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081903; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Maniatis Nikolaos A, 2012, Pulm Circ, V2, P452, DOI 10.4103/2045-8932.105033; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Oas RG, 2013, MOL BIOL CELL, V24, P704, DOI 10.1091/mbc.E12-06-0471; Oyaizu T, 2012, INTENS CARE MED, V38, P894, DOI 10.1007/s00134-012-2498-z; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Soma-Nagae T, 2013, J CELL SCI, V126, P3575, DOI 10.1242/jcs.121913; Stasyk T, 2010, PROTEOMICS, V10, P4117, DOI 10.1002/pmic.201000258; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takahashi Y, 2012, BIOCHEM BIOPH RES CO, V417, P1151, DOI 10.1016/j.bbrc.2011.12.082; UHLIG S, 1994, J PHARMACOL TOXICOL, V31, P85, DOI 10.1016/1056-8719(94)90047-7; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Wang Y, 2013, MOL BIOL REP, V40, P3093, DOI 10.1007/s11033-012-2383-4; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407	51	24	24	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					868	881		10.1096/fj.14-257212	http://dx.doi.org/10.1096/fj.14-257212			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25404710	Green Published			2022-12-26	WOS:000350633000014
J	Hedinger, D; Braun, J; Zellweger, U; Kaplan, V; Bopp, M				Hedinger, Damian; Braun, Julia; Zellweger, Ueli; Kaplan, Vladimir; Bopp, Matthias		Swiss Natl Cohort Study Grp	Moving to and Dying in a Nursing Home Depends Not Only on Health - An Analysis of Socio-Demographic Determinants of Place of Death in Switzerland	PLOS ONE			English	Article							PEOPLE DIE; LAST YEAR; CARE; LIFE; POPULATION; CHALLENGE; END	Background: In developed countries generally about 7 out of 10 deaths occur in institutions such as acute care hospitals or nursing homes. However, less is known about the influence of non-medical determinants of place of death. This study examines the influence of socio-demographic and regional factors on place of death in Switzerland. Data and Methods: We linked individual data from hospitals and nursing homes with census and mortality records of the Swiss general population. We differentiated between those who died in a hospital after a length of stay <= 2 days or >= 3 days, those who died in nursing homes, and those who died at home. In gender-specific multinomial logistic regression models we analysed N = 85,129 individuals, born before 1942 (i.e., >= 65 years old) and deceased in 2007 or 2008. Results: Almost 70% of all men and 80% of all women died in a hospital or nursing home. Regional density of nursing home beds, being single, divorced or widowed, or living in a single-person household were predictive of death in an institution, especially among women. Conversely, homeownership, high educational level and having children were associated with dying at home. Conclusion: Place of death substantially depends on socio-demographic determinants such as household characteristics and living conditions as well as on regional factors. Individuals with a lower socio-economic position, living alone or having no children are more prone to die in a nursing home. Health policy should empower these vulnerable groups to choose their place of death in accordance to needs and wishes.	[Hedinger, Damian; Braun, Julia; Zellweger, Ueli; Bopp, Matthias] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Kaplan, Vladimir] Dist Hosp Freiamt Muri, Muri, Switzerland	University of Zurich	Bopp, M (corresponding author), Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland.	matthias.bopp@uzh.ch	Puhan, Milo/ABE-6298-2020; Kuenzli, Nino/F-7195-2014	Puhan, Milo/0000-0003-4721-1879; Kuenzli, Nino/0000-0001-8360-080X; Bopp, Matthias/0000-0003-0766-3723; Zwahlen, Marcel/0000-0002-6772-6346	Swiss National Science Foundation (SNSF), project 67 "end-of-life'' [3347CO-108806, 33CS30-134273, 406740-139331]; SNSF	Swiss National Science Foundation (SNSF), project 67 "end-of-life''(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF))	The project is funded by the Swiss National Science Foundation (SNSF, grants 3347CO-108806, 33CS30-134273 and 406740-139331), project 67 "end-of-life''. Persons who received fundings from the SNSF: DH JB. Website with detail information about the financing situation: http://p3.snf.ch/Project-139331. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artazcoz L, 2007, J EPIDEMIOL COMMUN H, V61, P466, DOI 10.1136/jech.2006.058081; BAG, 2012, VERS SPEZ PALL CAR S; BfS, 2011, EINTR ALT PFLEG; BfS, 2012, INV DAT PALL CAR; Bickel H, 1998, Z GERONTOL GERIATR, V31, P193, DOI 10.1007/s003910050034; Bopp M, 2011, DIABETES CARE, V34, P2387, DOI 10.2337/dc11-0157; Bopp M, 2009, INT J EPIDEMIOL, V38, P379, DOI 10.1093/ije/dyn042; BOWLING A, 1983, J MED ETHICS, V9, P158, DOI 10.1136/jme.9.3.158; Broad JB, 2013, INT J PUBLIC HEALTH, V58, P257, DOI 10.1007/s00038-012-0394-5; Brogaard T, 2013, PALLIATIVE MED, V27, P155, DOI 10.1177/0269216312438468; Centeno C, 2007, PALLIATIVE MED, V21, P463, DOI 10.1177/0269216307081942; Clark D, 2002, BRIT MED J, V324, P905, DOI 10.1136/bmj.324.7342.905; Cohen J, 2006, HEALTH POLICY, V78, P319, DOI 10.1016/j.healthpol.2005.11.003; Evans Nici, 2002, Nurs Stand, V16, P33; Faeh D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-567; Fischer S, 2006, SWISS MED WKLY, V136, P370; Fischer S, 2004, Z GERONTOL GERIATR, V37, P467, DOI 10.1007/s00391-004-0216-3; Foreman LM, 2006, PALLIATIVE MED, V20, P447, DOI 10.1191/0269216306pm1149oa; Gomes B, 2014, COCHRANE DATABASE SY; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Houttekier D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-228; Houttekier D, 2009, J PAIN SYMPTOM MANAG, V37, P996, DOI 10.1016/j.jpainsymman.2008.05.014; Jaggi A, 2001, SOZ PRAVENTIV MED, V46, P379, DOI 10.1007/BF01321664; Jayaraman J, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-19; Kelley AS, 2011, ANN INTERN MED, V154, P235, DOI 10.7326/0003-4819-154-4-201102150-00004; Klinkenberg M, 2005, HEALTH SOC CARE COMM, V13, P420, DOI 10.1111/j.1365-2524.2005.00567.x; Medizinische Statistik der Krankenhauser, 2011, MED STAT KRANK 2011; Reich O, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-116; Rice DP, 2004, ANNU REV PUBL HEALTH, V25, P457, DOI 10.1146/annurev.publhealth.25.101802.123054; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Shugarman LR, 2009, J PAIN SYMPTOM MANAG, V38, P15, DOI 10.1016/j.jpainsymman.2009.04.004; Statistik der sozialmedizinischen Institutionen, 2011, STAT SOZ I 2011 STAN; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Thomas C, 2004, SOC SCI MED, V58, P2431, DOI 10.1016/j.socscimed.2003.09.005; TOWNSEND J, 1990, BRIT MED J, V301, P415, DOI 10.1136/bmj.301.6749.415; Weitzen S, 2003, MED CARE, V41, P323, DOI 10.1097/00005650-200302000-00013; Zellweger U, 2010, RECORD LINKAGE MED S; Zellweger U, 2011, 7 U ZUR I SOZ PRAV	38	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113236	10.1371/journal.pone.0113236	http://dx.doi.org/10.1371/journal.pone.0113236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409344	Green Published, gold			2022-12-26	WOS:000345533200080
J	Labonte, L; Coulombe, P; Zago, M; Bourbeau, J; Baglole, CJ				Labonte, Laura; Coulombe, Patrick; Zago, Michela; Bourbeau, Jean; Baglole, Carolyn J.			Alterations in the Expression of the NF-kappa B Family Member RelB as a Novel Marker of Cardiovascular Outcomes during Acute Exacerbations of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							CIGARETTE-SMOKE; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTORS; DEFICIENT MICE; TIME-COURSE; RESPONSES; CYCLOOXYGENASE-2; INTERLEUKIN-8; INFLAMMATION; MECHANISMS	Background: Chronic obstructive pulmonary disease (COPD) exacerbations are acute events of worsened respiratory symptoms and enhanced inflammation partly mediated by NF-kappa B activation. RelB, an NF-kappa B family member, suppresses cigarette smoke-induced inflammation but its expression in COPD is unknown. Moreover, there is no information on its association with clinical features of COPD. The objectives of this study were to assess RelB expression relative to markers of inflammation as well as its association with cardiovascular and pulmonary features of COPD patients at stable-state and exacerbation. Methods: Data from 48 COPD patients were analyzed. Blood samples were collected from stable-state and exacerbating patients. After RNA isolation, quantitative real-time polymerase chain reaction (qRT-PCR) was performed to assess RelB, Cox-2, IL-8 and IL-1 beta mRNA expression and their associations with measured clinical variables. Results: Of the 48 COPD subjects, 18 were in stable-state and 30 were in exacerbation. RelB mRNA expression was lower than that of Cox-2, IL-8, and IL-1 beta in all cases (all p<0.001, except for IL-8 at exacerbation (p = 0.22)). Cox-2, IL-8 and IL-1 beta were significantly associated with clinical features of patients in both stable-state and at exacerbation. There was no association with RelB expression and any clinical features in COPD subjects at stable-state. RelB mRNA levels were significantly associated with cardiovascular events such as systolic blood pressure during exacerbation. Conclusions: RelB mRNA expression is lower than that of the other inflammatory mediators. Expression of Cox-2, IL-8 and IL-1 beta were related to clinical features in both stable-state and at exacerbation. However, RelB expression was associated with clinical features of patients only during exacerbation, suggesting that RelB may represent a novel marker of health outcomes, in particular cardiovascular, during exacerbation in COPD.	[Labonte, Laura; Zago, Michela; Bourbeau, Jean; Baglole, Carolyn J.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Labonte, Laura; Coulombe, Patrick; Bourbeau, Jean] McGill Univ, Ctr Hlth, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Zago, Michela; Baglole, Carolyn J.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Baglole, CJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	Carolyn.baglole@McGill.ca			GlaxoSmithKline Canada Ltd [5427]; Canadian Institute of Health Research Doctoral Award; Canada Foundation for Innovation (CFI)-Leaders Opportunities Fund; Fonds de Recherche du Quebec-Sante (FRQ-S)	GlaxoSmithKline Canada Ltd; Canadian Institute of Health Research Doctoral Award(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)-Leaders Opportunities Fund; Fonds de Recherche du Quebec-Sante (FRQ-S)	This study was funded as an investigator-initiated grant (no. 5427) by GlaxoSmithKline Canada Ltd (http://www.gsk.ca/english/index.html). LL was funded by a Canadian Institute of Health Research Doctoral Award (http://www.cihr-irsc.gc.ca). Infrastructure for this project was supported by the Canada Foundation for Innovation (CFI)-Leaders Opportunities Fund (http://www.mcgill.ca/medresearch/research/funding/cfi) (CJB). CJB was supported by a salary award from the Fonds de Recherche du Quebec-Sante (FRQ-S) (http://www.frqs.gouv.qc.ca/en/index.shtml). GlaxoSmithKline Canada Ltd, had a role in study design but no role in data collection and analysis, decision to publish, or preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2012, THORAX, V67, P238, DOI 10.1136/thoraxjnl-2011-200768; Ammon C, 2000, BIOCHEM BIOPH RES CO, V268, P99, DOI 10.1006/bbrc.1999.2083; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Braam B, 2004, AM J PHYSIOL-HEART C, V287, pH1977, DOI 10.1152/ajpheart.00323.2004; Bruno CM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/915150; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; CARRASCO D, 1993, DEVELOPMENT, V118, P1221; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; Cejas PJ, 2005, MOL CELL BIOL, V25, P7900, DOI 10.1128/MCB.25.17.7900-7916.2005; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Coakley RJ, 2002, J LEUKOCYTE BIOL, V71, P603; Jancic CC, 2012, CYTOKINE, V57, P258, DOI 10.1016/j.cyto.2011.11.013; de Souza A. R., 2014, TOXICOL SCI; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; GOLD, 2011, GLOB STRAT DIAGN MAN; Grossmann M, 1999, INT J BIOCHEM CELL B, V31, P1209, DOI 10.1016/S1357-2725(99)00068-0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hocherl K, 2002, BRIT J PHARMACOL, V136, P1117, DOI 10.1038/sj.bjp.0704821; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Lindner V, 1998, PATHOBIOLOGY, V66, P311, DOI 10.1159/000028039; LO D, 1992, AM J PATHOL, V141, P1237; McAllister DA, 2012, EUR RESPIR J, V39, P1097, DOI 10.1183/09031936.00124811; McMillan DH, 2011, AM J PATHOL, V179, P125, DOI 10.1016/j.ajpath.2011.03.030; Millet P, 2013, J LEUKOCYTE BIOL, V94, P941, DOI 10.1189/jlb.0513305; Nymo SH, 2014, EUR J HEART FAIL, V16, P68, DOI 10.1093/eurjhf/hft125; Oliver KM, 2012, J BIOL CHEM, V287, P14004, DOI 10.1074/jbc.M112.347971; Patel ARC, 2013, AM J RESP CRIT CARE, V188, P1091, DOI 10.1164/rccm.201306-1170OC; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Sarir H, 2008, EUR J PHARMACOL, V585, P346, DOI 10.1016/j.ejphar.2008.03.009; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sethi S, 2005, SEM RESP CRIT CARE M, V26, P192, DOI 10.1055/s-2005-869538; Sincer I, 2012, HEART LUNG, V41, P238, DOI 10.1016/j.hrtlng.2011.07.011; Taketa K, 2008, J BIOL CHEM, V283, P9852, DOI 10.1074/jbc.M703318200; Tam A, 2012, MED CLIN N AM, V96, P681, DOI 10.1016/j.mcna.2012.04.012; Testelmans D, 2013, CYTOKINE, V62, P210, DOI 10.1016/j.cyto.2013.02.021; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Tully JE, 2013, J IMMUNOL, V191, P5811, DOI 10.4049/jimmunol.1301329; Tully JE, 2012, AM J RESP CELL MOL, V47, P497, DOI 10.1165/rcmb.2012-0014OC; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wedzicha Jadwiga A, 2003, Respir Care, V48, P1204; Wedzicha JA, 2014, CLIN CHEST MED, V35, P157, DOI 10.1016/j.ccm.2013.11.001; Weih F, 1997, J IMMUNOL, V158, P5211; Weih F, 1996, J IMMUNOL, V157, P3974; Xiong SL, 2014, MOL CELL BIOCHEM, V389, P197, DOI 10.1007/s11010-013-1941-y; Zago M, 2014, TOXICOL LETT, V226, P107, DOI 10.1016/j.toxlet.2014.01.020	58	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112965	10.1371/journal.pone.0112965	http://dx.doi.org/10.1371/journal.pone.0112965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409035	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200053
J	Kemse, NG; Kale, AA; Joshi, SR				Kemse, Nisha G.; Kale, Anvita A.; Joshi, Sadhana R.			A Combined Supplementation of Omega-3 Fatty Acids and Micronutrients (Folic Acid, Vitamin B-12) Reduces Oxidative Stress Markers in a Rat Model of Pregnancy Induced Hypertension	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; POLYUNSATURATED FATTY-ACIDS; NITRIC-OXIDE SYNTHASE; BLOOD-PRESSURE; PREECLAMPSIA RELATIONSHIP; GESTATIONAL HYPERTENSION; MATERNAL MICRONUTRIENTS; INFLAMMATORY MARKERS; BRAIN NEUROTROPHINS; HOMOCYSTEINE LEVELS	Objectives: Our earlier studies have highlighted that an altered one carbon metabolism (vitamin B-12, folic acid, and docosahexaenoic acid) is associated with preeclampsia. Preeclampsia is also known to be associated with oxidative stress and inflammation. The current study examines whether maternal folic acid, vitamin B-12 and omega-3 fatty acid supplementation given either individually or in combination can ameliorate the oxidative stress markers in a rat model of pregnancy induced hypertension (PIH). Materials and Methods: Pregnant Wistar rats were assigned to control and five treatment groups: PIH; PIH + vitamin B-12; PIH + folic acid; PIH + Omega-3 fatty acids and PIH + combined micronutrient supplementation (vitamin B-12 + folic acid + omega-3 fatty acids). L-Nitroarginine methylester (L-NAME; 50 mg/kg body weight/day) was used to induce hypertension during pregnancy. Blood Pressure (BP) was recorded during pregnancy and dams were dissected at d20 of gestation. Results: Animals from the PIH group demonstrated higher (p<0.01 for both) systolic and diastolic BP; lower (p<0.01) pup weight; higher dam plasma homocysteine (p<0.05) and dam and offspring malondialdehyde (MDA) (p<0.01), lower (p<0.05) placental and offspring liver DHA and higher (p<0.01) tumor necrosis factor-alpha (TNF-alpha) levels as compared to control. Individual micronutrient supplementation did not offer much benefit. In contrast, combined supplementation lowered systolic BP, homocysteine, MDA and placental TNF-alpha levels in dams and liver MDA and protein carbonyl in the offspring as compared to PIH group. Conclusion: Key constituents of one carbon cycle (folic acid, vitamin B-12 and DHA) may play a role in reducing oxidative stress and inflammation in preeclampsia.	[Kemse, Nisha G.; Kale, Anvita A.; Joshi, Sadhana R.] Bharati Vidyapeeth Deemed Univ, Interact Res Sch Hlth Affairs, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University	Joshi, SR (corresponding author), Bharati Vidyapeeth Deemed Univ, Interact Res Sch Hlth Affairs, Pune, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001	Department of Biotechnology (DBT), New Delhi, India [BT/PR6472/FNS/20/656/2012]	Department of Biotechnology (DBT), New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology (DBT), New Delhi, India DBT Sanction Order No. & Date: BT/PR6472/FNS/20/656/2012 (SRJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acilmis YG, 2011, J OBSTET GYNAECOL RE, V37, P45, DOI 10.1111/j.1447-0756.2010.01317.x; Adamcova M, 2013, J PHYSIOL PHARMACOL, V64, P211; Afshari JT, 2005, BMC PREGNANCY CHILDB, P5; ATALLAH AN, 2002, COCHRANE DB SYST REV; Atallah AN, 2010, COCHRANE DB SYST REV, V4; Bayram M, 2012, J MATERN FETAL NEONA; Bergen NE, 2012, BJOG-INT J OBSTET GY, V119, P739, DOI 10.1111/j.1471-0528.2012.03321.x; Bernardi F, 2008, J OBSTET GYNAECOL RE, V34, P948, DOI 10.1111/j.1447-0756.2008.00803.x; Bodnar LM, 2006, AM J EPIDEMIOL, V164, P470, DOI 10.1093/aje/kwj218; Brown Caneta, 2013, J Nat Sci Biol Med, V4, P330, DOI 10.4103/0976-9668.116998; Calder PC, 2002, BRIT J NUTR, V88, pS165, DOI 10.1079/BJN2002682; Catarino C, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/684384; Chaturvedi S, 2013, J HEALTH POPUL NUTR, V31, P86; Chen YC, 2013, INT J MOL SCI, V14, P5380, DOI 10.3390/ijms14035380; D'Souza V, 2013, CURR MED CHEM, V20, P4777, DOI 10.2174/09298673113209990160; De Giuseppe R, 2014, EUR J NUTR; de Moura RS, 2007, HYPERTENS PREGNANCY, V26, P89, DOI 10.1080/10641950601147960; Derks JB, 2010, PEDIATR RES, V68, P374, DOI 10.1203/PDR.0b013e3181ef7780; Dhobale M, 2012, J MATERN-FETAL NEO M, V25, P317, DOI 10.3109/14767058.2011.579209; Dhobale MV, 2011, PROSTAG LEUKOTR ESS, V85, P149, DOI 10.1016/j.plefa.2011.06.003; Ellis J, 2001, ACTA OBSTET GYN SCAN, V80, P602, DOI 10.1034/j.1600-0412.2001.800703.x; Erickson KL, 2000, J INFECT DIS, V182, pS5, DOI 10.1086/315922; Fernandez Celadilla Lina, 2005, Archives of Gynecology and Obstetrics, V271, P243, DOI 10.1007/s00404-004-0633-y; Fowles ER, 2012, ARCH GYNECOL OBSTET, V285, P891, DOI 10.1007/s00404-011-2213-2; Freeman DJ, 2004, HYPERTENSION, V44, P708, DOI 10.1161/01.HYP.0000143849.67254.ca; Gad HI, 2013, SAUDI MED J, V34, P490; Gadgil M, 2014, EUR J CLIN NUTR; Gairard A, 2004, J CARDIOVASC PHARM, V43, P731, DOI 10.1097/00005344-200405000-00017; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Gohil JT, 2011, J OBSTET GYN INDIA, V61, P638, DOI 10.1007/s13224-011-0094-8; Guven MA, 2009, HYPERTENS PREGNANCY, V28, P190, DOI 10.1080/10641950802601179; Henao DE, 2013, CURR HYPERTENS REP, V15, P600, DOI 10.1007/s11906-013-0400-1; Hernandez-Diaz S, 2002, AM J EPIDEMIOL, V156, P806, DOI 10.1093/aje/kwf129; Hopkins MH, 2010, CANCER EPIDEM BIOMAR, V19, P850, DOI 10.1158/1055-9965.EPI-09-1052; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Howlader MZH, 2009, J TROP PEDIATRICS, V55, P363, DOI 10.1093/tropej/fmp025; Isler CM, 2003, J SOC GYNECOL INVEST, V10, P151, DOI 10.1016/S1071-5576(03)00009-1; Jia D, 2014, NEUROSCIENCE, V258, P228, DOI 10.1016/j.neuroscience.2013.11.016; Jido TA, 2013, ANN AFR MED, V12, P75, DOI 10.4103/1596-3519.112395; Jones ML, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103754; Jones ML, 2014, REPRODUCTION; Kale A, 2010, PSYCHIAT RES, V175, P47, DOI 10.1016/j.psychres.2009.01.013; Kilic I, 2003, PEDIATR INT, V45, P375, DOI 10.1046/j.1442-200X.2003.01740.x; Kolling J, 2011, CARDIOVASC TOXICOL, V11, P67, DOI 10.1007/s12012-010-9094-7; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; Kulkarni A, 2011, CLIN NUTR, V30, P60, DOI 10.1016/j.clnu.2010.07.007; Kulkarni AV, 2011, PROSTAG LEUKOTR ESS, V84, P51, DOI 10.1016/j.plefa.2010.09.005; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Laskowska M, 2013, MED SCI MONITOR, V19, P430, DOI 10.12659/MSM.883932; Lau SY, 2013, AM J REPROD IMMUNOL, V70, P412, DOI 10.1111/aji.12138; Li ZW, 2013, HYPERTENSION, V61, P873, DOI 10.1161/HYPERTENSIONAHA.111.00230; Liu HH, 2013, SCI WORLD J, DOI 10.1155/2013/370487; Ma RQ, 2011, CHINESE MED J-PEKING, V124, P3141, DOI 10.3760/cma.j.issn.0366-6999.2011.19.033; Ma RQ, 2010, CHINESE MED J-PEKING, V123, P707, DOI 10.3760/cma.j.issn.0366-6999.2010.06.013; Maes M, 2000, BIOL PSYCHIAT, V47, P910, DOI 10.1016/S0006-3223(99)00268-1; Mahomed K, 2007, PHYSIOL RES, V56, P37, DOI 10.33549/physiolres.930859; Mayr AJ, 2005, HYPERTENS PREGNANCY, V24, P29, DOI 10.1081/PRG-200045770; McMahon JA, 2007, J NUTR, V137, P1183, DOI 10.1093/jn/137.5.1183; Mehendale S, 2008, INT J GYNECOL OBSTET, V100, P234, DOI 10.1016/j.ijgo.2007.08.011; Menon J, 2007, COMP BIOCHEM PHYS C, V145, P625, DOI 10.1016/j.cbpc.2007.02.011; Micle O, 2012, J Med Life, V5, P68; Morris CD, 2001, AM J OBSTET GYNECOL, V184, P643, DOI 10.1067/mob.2001.111101; Mujawar SA, 2011, INDIAN J CLIN BIOCHE, V26, P257, DOI 10.1007/s12291-011-0109-3; Murphy SR, 2013, AM J PHYSIOL-REG I, V304, pR130, DOI 10.1152/ajpregu.00069.2012; Namdev S, 2013, J MATERN FETAL NEONA; Nassar AH, 2012, AM J PERINAT, V29, P429, DOI 10.1055/s-0032-1304823; Neerhof MG, 2011, HYPERTENS PREGNANCY, V30, P28, DOI 10.3109/10641950903322915; Negi R, 2014, CHEM-BIOL INTERACT, V208, P77, DOI 10.1016/j.cbi.2013.11.010; Nilsson A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-99; Ogundipe O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-481; Oken E, 2007, ANN EPIDEMIOL, V17, P663, DOI 10.1016/j.annepidem.2007.03.003; Orhan Hilmi, 2003, Archives of Gynecology and Obstetrics, V267, P189; Ozler A, 2012, EUR REV MED PHARMACO, V16, P1707; Patil SB, 2007, CLIN EXP OBSTET GYN, V34, P239; Pimentel AML, 2013, HYPERTENS RES, V36, P783, DOI 10.1038/hr.2013.34; Poprawski G, 2012, GINEKOL POL, V83, P688; Qureshi SB, 2010, J PAK MED ASSOC, V60, P741; Rajkovic A, 1997, OBSTET GYNECOL, V90, P168, DOI 10.1016/S0029-7844(97)00223-8; Ray JG, 2002, ARCH INTERN MED, V162, P1776, DOI 10.1001/archinte.162.15.1776; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Sable PS, 2012, NEUROSCIENCE, V217, P46, DOI 10.1016/j.neuroscience.2012.05.001; Sable PS, 2013, METABOLISM, V62, P1607, DOI 10.1016/j.metabol.2013.06.002; Salvig JD, 1996, BRIT J OBSTET GYNAEC, V103, P529, DOI 10.1111/j.1471-0528.1996.tb09801.x; Sanchez SE, 2001, AM J EPIDEMIOL, V153, P474, DOI 10.1093/aje/153.5.474; Shiraishi M, 2013, NURS HLTH SCI; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; Sung JL, 2013, KOREAN J PHYSIOL PHA, V17, P339, DOI 10.4196/kjpp.2013.17.4.339; Takei H, 2007, J PHARMACOL SCI, V104, P319, DOI 10.1254/jphs.FP0070224; Tang ZH, 2013, AM J REPROD IMMUNOL, V70, P104, DOI 10.1111/aji.12112; Tanir HM, 2005, EUR J OBSTET GYN R B, V118, P190, DOI 10.1016/j.ejogrb.2004.04.033; Theriault S, 2013, OBSTET GYNECOL, V122, P345, DOI 10.1097/AOG.0b013e31829b2f7c; Thompson LP, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/582748; Thurnham DI, 2004, NUTR RES REV, V17, P211, DOI 10.1079/NRR200486; Tsukimori K, 2008, AM J HYPERTENS, V21, P477, DOI 10.1038/ajh.2007.80; Tsukimori K, 2007, HYPERTENSION, V49, P1436, DOI 10.1161/HYPERTENSIONAHA.106.086751; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Villar J, 2006, AM J OBSTET GYNECOL, V194, P639, DOI 10.1016/j.ajog.2006.01.068; Walker MC, 2011, J OBSTET GYNAECOL CA, V33, P1124, DOI 10.1016/S1701-2163(16)35080-0; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Williams AL, 2006, J AFFECT DISORDERS, V93, P117, DOI 10.1016/j.jad.2006.02.023; Wintergerst ES, 2007, ANN NUTR METAB, V51, P301, DOI 10.1159/000107673; Xie C, 2011, CYTOKINE, V56, P550, DOI 10.1016/j.cyto.2011.09.021; Xun P, 2012, AM J CLIN NUTR, V95, P1023, DOI 10.3945/ajcn.111.027250; Yanez P, 2013, ARCH GYNECOL OBSTET, V288, P1011, DOI 10.1007/s00404-013-2851-7; Yang X, 2011, PLACENTA, V32, P681, DOI 10.1016/j.placenta.2011.06.020; Zhang Z, 2013, HYPERTENS PREGNANCY, V32, P270, DOI 10.3109/10641955.2013.798332; Zhou QJ, 2013, HYPERTENS PREGNANCY, V32, P422, DOI 10.3109/10641955.2013.824978; Zithanova I, 2007, CLIN BIOCHEM, V40, P567, DOI 10.1016/j.clinbiochem.2006.10.013	110	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111902	10.1371/journal.pone.0111902	http://dx.doi.org/10.1371/journal.pone.0111902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405347	gold, Green Submitted, Green Published			2022-12-26	WOS:000347121300017
J	Vinicius, L; Mace, R; Migliano, A				Vinicius, Lucio; Mace, Ruth; Migliano, Andrea			Variation in Male Reproductive Longevity across Traditional Societies	PLOS ONE			English	Article							LIFE-HISTORY; EVOLUTION; MORTALITY; MENOPAUSE; PATTERNS; HUMANS; TRENDS; SPAN; MEN	Most accounts of human life history propose that women have short reproductive spans relative to their adult lifespans, while men not only remain fertile but carry on reproducing until late life. Here we argue that studies have overlooked evidence for variation in male reproductive ageing across human populations. We apply a Bayesian approach to census data from Agta hunter-gatherers and Gambian farmers to show that long post-reproductive lifespans characterise not only women but also males in some traditional human populations. We calculate three indices of reproductive ageing in men (oldest age at reproduction, male late-life reproduction, and post-reproductive representation) and identify a continuum of male reproductive longevity across eight traditional societies ranging from IKung, Hadza and Agta hunter-gatherers exhibiting low levels of polygyny, early age at last reproduction and long post-reproductive lifespans, to male Gambian agriculturalists and Turkana pastoralists showing higher levels of polygyny, late-life reproduction and shorter postreproductive lifespans. We conclude that the uniquely human detachment between rates of somatic senescence and reproductive decline, and the existence of post-reproductive lifespans, are features of both male and female life histories, and therefore not exclusive consequences of menopause.	[Vinicius, Lucio; Mace, Ruth; Migliano, Andrea] UCL, Dept Anthropol, London, England	University of London; University College London	Vinicius, L (corresponding author), UCL, Dept Anthropol, London, England.	l.vinicius@ucl.ac.uk		Mace, Ruth/0000-0002-6137-7739; Migliano, Andrea/0000-0003-4364-2735	Leverhulme Trust [RP2011-R-045]; ERC [AdG 249347]	Leverhulme Trust(Leverhulme Trust); ERC(European Research Council (ERC)European Commission)	AM is funded by the Leverhulme Trust ('Hunter-gatherers' Resilience', RP2011-R-045) and RM is funded by the ERC (The Evolution of Cultural Norms in Real World Settings', AdG 249347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2013, P NATL ACAD SCI USA, V110, P13440, DOI 10.1073/pnas.1311857110; Blurton-Jones NG, 2013, HADZA DEMOGRAPHY SOC; Bribiescas RG, 2006, EVOL ANTHROPOL, V15, P132, DOI 10.1002/evan.20087; Bribiescas RG, 2012, CURR ANTHROPOL, V53, pS424, DOI 10.1086/667538; Colchero F, 2012, METHODS ECOL EVOL, V3, P466, DOI 10.1111/j.2041-210X.2012.00186.x; Colchero F, 2012, J ANIM ECOL, V81, P139, DOI 10.1111/j.1365-2656.2011.01898.x; Demeny Coale AJ., 1966, REGIONAL MODEL LIFE; Early JD, 1998, POPULATION DYNAMICS; Early JD, 2000, XILIXANA YANOMAMI AM; Finch CE, 1990, LONGEVITY SENESCENCE; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Hawkes K, 2009, AM J HUM BIOL, V21, P578, DOI 10.1002/ajhb.20890; Headland TN, 2011, SIL LANGUAGE CULTURE, V2; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Howell N., 1979, DEMOGRAPHY DOBE KUNG; Kaplan H, 2010, ANN NY ACAD SCI, V1204, P30, DOI [10.1111/J.1749-6632.2010.05528.x, 10.1111/j.1749-6632.2010.05528.x]; Levitis DA, 2013, EVOL ANTHROPOL, V22, P66, DOI 10.1002/evan.21332; Little MA, 1999, TURKANA HERDERS DRY; Marlowe FW, 2003, EVOL HUM BEHAV, V24, P217, DOI 10.1016/S1090-5138(03)00014-X; Marlowe FW, 2000, HUM NATURE-INT BIOS, V11, P27, DOI 10.1007/s12110-000-1001-7; MCGREGOR IA, 1991, DIS MORTALITY SUBSAH, P306; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Morton RA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003092; NEEL JV, 1975, AM J PHYS ANTHROPOL, V42, P25, DOI 10.1002/ajpa.1330420105; PARTRIDGE L, 1993, GENETICA, V91, P89, DOI 10.1007/BF01435990; Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570; Rayco-Solon P, 2004, TROP MED INT HEALTH, V9, P1151, DOI 10.1111/j.1365-3156.2004.01325.x; Tuljapurkar SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000785; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Weiss K. M., 1973, MEMOIRS SOC AM ARCHA, V27; WHITE DR, 1988, CURR ANTHROPOL, V29, P529, DOI 10.1086/203674; Winking J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3078	32	17	17	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112236	10.1371/journal.pone.0112236	http://dx.doi.org/10.1371/journal.pone.0112236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405763	Green Published, gold			2022-12-26	WOS:000347121300027
J	Wang, YJ; McAllister, F; Bailey, JM; Scott, SG; Hendley, AM; Leach, SD; Ghosh, B				Wang, Yue J.; McAllister, Florencia; Bailey, Jennifer M.; Scott, Sherri-Gae; Hendley, Audrey M.; Leach, Steven D.; Ghosh, Bidyut			Dicer Is Required for Maintenance of Adult Pancreatic Acinar Cell Identity and Plays a Role in Kras-Driven Pancreatic Neoplasia	PLOS ONE			English	Article							MICRORNA EXPRESSION; DIFFERENTIATION; REGENERATION; METAPLASIA; CONTRIBUTE; INDUCTION; ONCOGENES	The role of miRNA processing in the maintenance of adult pancreatic acinar cell identity and during the initiation and progression of pancreatic neoplasia has not been studied in detail. In this work, we deleted Dicer specifically in adult pancreatic acinar cells, with or without simultaneous activation of oncogenic Kras. We found that Dicer is essential for the maintenance of acinar cell identity. Acinar cells lacking Dicer showed increased plasticity, as evidenced by loss of polarity, initiation of epithelial-to-mesenchymal transition (EMT) and acinar-to-ductal metaplasia (ADM). In the context of oncogenic Kras activation, the initiation of ADM and pancreatic intraepithelial neoplasia (PanIN) were both highly sensitive to Dicer gene dosage. Homozygous Dicer deletion accelerated the formation of ADM but not PanIN. In contrast, heterozygous Dicer deletion accelerated PanIN initiation, revealing complex roles for Dicer in the regulation of both normal and neoplastic pancreatic epithelial identity.	[Wang, Yue J.; Bailey, Jennifer M.; Hendley, Audrey M.; Leach, Steven D.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [McAllister, Florencia] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bailey, Jennifer M.; Leach, Steven D.; Ghosh, Bidyut] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Scott, Sherri-Gae] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Leach, SD (corresponding author), Mem Sloan Kettering Canc Ctr, David M Rubenstein Ctr Pancreat Canc Res, 1275 York Ave, New York, NY 10021 USA.	leachs@mskcc.org	Wang, Julia/M-4516-2016	Wang, Julia/0000-0003-2641-6904; Bailey-Lundberg, Jennifer/0000-0002-4750-106X; Hendley, Audrey/0000-0003-0289-2092	NIH [P01 CA134292]; Paul K. Neumann Professorship in Pancreatic Cancer at Johns Hopkins University; NIGMS [T32GMO66691]; Pancreatic Cancer Action Network-AACR Fellowship in Memory of Samuel Stroum [12-40-25-MCAL]; Conquer Cancer Foundation Young Investigator Award; Pancreatic Cancer Action Network-AACR Pathway; NCI [5F32 CA157044]; NATIONAL CANCER INSTITUTE [P01CA134292, F32CA157044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul K. Neumann Professorship in Pancreatic Cancer at Johns Hopkins University; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pancreatic Cancer Action Network-AACR Fellowship in Memory of Samuel Stroum; Conquer Cancer Foundation Young Investigator Award; Pancreatic Cancer Action Network-AACR Pathway; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SDL was supported by NIH P01 CA134292 and the Paul K. Neumann Professorship in Pancreatic Cancer at Johns Hopkins University. FM was supported by NIGMS T32GMO66691, a 2012 Pancreatic Cancer Action Network-AACR Fellowship in Memory of Samuel Stroum, Grant Number 12-40-25-MCAL and a Conquer Cancer Foundation Young Investigator Award 2012. JMB was supported by the 2011 Pancreatic Cancer Action Network-AACR Pathway to Leadership Award and NCI 5F32 CA157044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bombardelli L, 2010, GASTROENTEROLOGY, V138, P2531, DOI 10.1053/j.gastro.2010.02.043; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Esni F, 2005, METH MOLEC MED, V103, P259; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Morris JPt, 2014, PLOS ONE, V9; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Prevot PP, 2013, GASTROENTEROLOGY, V145, P668, DOI 10.1053/j.gastro.2013.05.016; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Shi G, 2013, ONCOGENE, V32, P1950, DOI 10.1038/onc.2012.210; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Yoshikawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071969; Zhang B, 2013, ONCOGENE; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	38	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113127	10.1371/journal.pone.0113127	http://dx.doi.org/10.1371/journal.pone.0113127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405615	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300082
J	Abiko, Y; Nagano, K; Yoshida, Y; Yoshimura, F				Abiko, Yuki; Nagano, Keiji; Yoshida, Yasuo; Yoshimura, Fuminobu			Characterization of Treponema denticola Mutants Defective in the Major Antigenic Proteins, Msp and TmpC	PLOS ONE			English	Article							GINGIVAL EPITHELIAL-CELLS; OUTER SHEATH PROTEIN; CHYMOTRYPSIN-LIKE PROTEASE; PORPHYROMONAS-GINGIVALIS; ORAL SPIROCHETE; TANNERELLA-FORSYTHIA; MEMBRANE COMPLEXES; BINDING-PROPERTIES; PALLIDUM ANTIGENS; SURFACE PROTEIN	Treponema denticola, a gram-negative and anaerobic spirochete, is associated with advancing severity of chronic periodontitis. In this study, we confirmed that two major antigenic proteinswere Msp and TmpC, and examined their physiological and pathological roles using gene-deletion mutants. Msp formed a large complex that localized to the outer membrane, while TmpC existed as a monomer and largely localized to the inner membrane. However, TmpC was also detected in the outer membrane fraction, but its cell-surface exposure was not detected. Msp defects increased cell-surface hydrophobicity and secretion of TNF-alpha from macrophage-like cells, whereas TmpC defects decreased autoagglutination and chymotrypsin-like protease activities. Both mutants adhered to gingival epithelial cells similarly to the wild-type and showed slightly decreased motility. In addition, in Msp-defective mutants, the TDE1072 protein, which is a major membrane protein, was abolished; therefore, phenotypic changes in the mutant can be, at least in part, attributed to the loss of the TDE1072 protein. Thus, the major antigenic proteins, Msp and TmpC, have significant and diverse impacts on the characteristics of T. denticola, especially cell surface properties.	[Abiko, Yuki; Nagano, Keiji; Yoshida, Yasuo; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Nagoya, Aichi 464, Japan	Aichi Gakuin University	Nagano, K (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Microbiol, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	nagano@dpc.agu.ac.jp	Nagano, Keiji/AAS-4912-2020	Nagano, Keiji/0000-0003-3587-7606	JSPS KAKENHI [24791973, 25462880]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 24791973 (YA) and 25462880 (KN). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2003, CELLULAR MOL IMMUNOL; Abiko Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089051; Anand A, 2013, J BACTERIOL, V195, P2060, DOI 10.1128/JB.00078-13; Bamford CV, 2007, INFECT IMMUN, V75, P4364, DOI 10.1128/IAI.00258-07; BenMohamed L, 2002, LANCET INFECT DIS, V2, P425, DOI 10.1016/S1473-3099(02)00318-3; Bian XL, 2005, INFECT IMMUN, V73, P1252, DOI 10.1128/IAI.73.2.1252-1255.2005; Bodet C, 2006, MICROBES INFECT, V8, P27, DOI 10.1016/j.micinf.2005.05.015; Brissette CA, 2008, ORAL MICROBIOL IMMUN, V23, P474, DOI 10.1111/j.1399-302X.2008.00452.x; Capone R, 2008, ORAL MICROBIOL IMMUN, V23, P165, DOI 10.1111/j.1399-302X.2007.00404.x; COCKAYNE A, 1989, J GEN MICROBIOL, V135, P3209; Cogoni V, 2012, MICROBIOL-SGM, V158, P759, DOI 10.1099/mic.0.055939-0; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Edwards AM, 2005, INFECT IMMUN, V73, P2891, DOI 10.1128/IAI.73.5.2891-2898.2005; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; Fenno JC, 1996, J BACTERIOL, V178, P2489, DOI 10.1128/jb.178.9.2489-2497.1996; Fenno JC, 1998, FEMS MICROBIOL LETT, V163, P209, DOI 10.1111/j.1574-6968.1998.tb13047.x; Fenno JC, 1997, J BACTERIOL, V179, P1082, DOI 10.1128/jb.179.4.1082-1089.1997; Fenno JC, 1998, INFECT IMMUN, V66, P1869, DOI 10.1128/IAI.66.5.1869-1877.1998; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Fenno JC, 2001, INFECT IMMUN, V69, P6193, DOI 10.1128/IAI.69.10.6193-6200.2001; Fenno JC, 2012, J ORAL MICROBIOL, V4; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gaibani P, 2010, J PERIODONTAL RES, V45, P361, DOI 10.1111/j.1600-0765.2009.01246.x; Godovikova V, 2011, INFECT IMMUN, V79, P4868, DOI 10.1128/IAI.05701-11; Godovikova V, 2010, J BACTERIOL, V192, P3337, DOI 10.1128/JB.00274-10; Goetting-Minesky MP, 2010, J MICROBIOL METH, V83, P66, DOI 10.1016/j.mimet.2010.07.020; GRENIER D, 1990, INFECT IMMUN, V58, P347, DOI 10.1128/IAI.58.2.347-351.1990; HAAPASALO M, 1992, INFECT IMMUN, V60, P2058, DOI 10.1128/IAI.60.5.2058-2065.1992; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Ishihara K, 1999, FEMS MICROBIOL LETT, V181, P199; Ishihara K, 1998, J BACTERIOL, V180, P3837, DOI 10.1128/JB.180.15.3837-3844.1998; Izard J, 2001, J BACTERIOL, V183, P1078, DOI 10.1128/JB.183.3.1078-1084.2001; Ji S, 2007, J PERIODONTAL RES, V42, P503, DOI 10.1111/j.1600-0765.2007.00974.x; Kesavalu L, 1997, INFECT IMMUN, V65, P5096, DOI 10.1128/IAI.65.12.5096-5102.1997; Kesavalu L, 1999, INFECT IMMUN, V67, P5736, DOI 10.1128/IAI.67.11.5736-5746.1999; Kurniyati K, 2013, MOL MICROBIOL, V89, P842, DOI 10.1111/mmi.12311; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1989, ANTIMICROB AGENTS CH, V33, P1831, DOI 10.1128/AAC.33.11.1831; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; Rosen G, 1999, INFECT IMMUN, V67, P1180, DOI 10.1128/IAI.67.3.1180-1186.1999; Rosen G, 2008, FEMS MICROBIOL LETT, V289, P59, DOI 10.1111/j.1574-6968.2008.01373.x; ROSENBERG M, 1981, J BACTERIOL, V148, P51, DOI 10.1128/JB.148.1.51-57.1981; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Sakon H, 2008, INT J SYST EVOL MICR, V58, P970, DOI 10.1099/ijs.0.65456-0; SCHOULS LM, 1991, INFECT IMMUN, V59, P3536, DOI 10.1128/IAI.59.10.3536-3546.1991; Schultz CP, 1998, J BIOL CHEM, V273, P15661, DOI 10.1074/jbc.273.25.15661; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Tamai R, 2009, ANAEROBE, V15, P87, DOI 10.1016/j.anaerobe.2008.12.004; UMEMOTO T, 1989, INFECT IMMUN, V57, P2470, DOI 10.1128/IAI.57.8.2470-2474.1989; Umemoto T, 1987, JPN J ORAL BIOL, V29, P488; Veith PD, 2009, BBA-PROTEINS PROTEOM, V1794, P1421, DOI 10.1016/j.bbapap.2009.06.001; WICHER K, 1989, INT ARCH ALLER A IMM, V89, P128, DOI 10.1159/000234935	57	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113565	10.1371/journal.pone.0113565	http://dx.doi.org/10.1371/journal.pone.0113565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401769	gold, Green Submitted, Green Published			2022-12-26	WOS:000345158700141
J	Deeny, S; Chicoine, C; Hargrove, L; Parrish, T; Jayaraman, A				Deeny, Sean; Chicoine, Caitlin; Hargrove, Levi; Parrish, Todd; Jayaraman, Arun			A Simple ERP Method for Quantitative Analysis of Cognitive Workload in Myoelectric Prosthesis Control and Human-Machine Interaction	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; MENTAL WORKLOAD; PERFORMANCE; REINNERVATION; ELECTROENCEPHALOGRAPHY; REHABILITATION; CLASSIFICATION; RECOGNITION; THERAPY; TASKS	Common goals in the development of human-machine interface (HMI) technology are to reduce cognitive workload and increase function. However, objective and quantitative outcome measures assessing cognitive workload have not been standardized for HMI research. The present study examines the efficacy of a simple event-related potential (ERP) measure of cortical effort during myoelectric control of a virtual limb for use as an outcome tool. Participants trained and tested on two methods of control, direct control (DC) and pattern recognition control (PRC), while electroencephalographic (EEG) activity was recorded. Eighteen healthy participants with intact limbs were tested using DC and PRC under three conditions: passive viewing, easy, and hard. Novel auditory probes were presented at random intervals during testing, and significant task-difficulty effects were observed in the P200, P300, and a late positive potential (LPP), supporting the efficacy of ERPs as a cognitive workload measure in HMI tasks. LPP amplitude distinguished DC from PRC in the hard condition with higher amplitude in PRC, consistent with lower cognitive workload in PRC relative to DC for complex movements. Participants completed trials faster in the easy condition using DC relative to PRC, but completed trials more slowly using DC relative to PRC in the hard condition. The results provide promising support for ERPs as an outcome measure for cognitive workload in HMI research such as prosthetics, exoskeletons, and other assistive devices, and can be used to evaluate and guide new technologies for more intuitive HMI control.	[Deeny, Sean; Chicoine, Caitlin; Hargrove, Levi; Jayaraman, Arun] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Deeny, Sean; Parrish, Todd; Jayaraman, Arun] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine	Jayaraman, A (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.	a-jayaraman@northwestern.edu		Parrish, Todd/0000-0002-1184-1572	National Institute on Disability and Rehabilitation Research (NIDRR) [H133F120017]; American Orthotic and Prosthetic Association (AOPA) [EBP-043012]	National Institute on Disability and Rehabilitation Research (NIDRR); American Orthotic and Prosthetic Association (AOPA)	This research was supported by the National Institute on Disability and Rehabilitation Research (NIDRR) (H133F120017), and the American Orthotic and Prosthetic Association (AOPA) (EBP-043012). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe HA, 2013, IEEE ENG MED BIO, P5590, DOI 10.1109/EMBC.2013.6610817; Allison BZ, 2008, BIOL PSYCHOL, V77, P277, DOI 10.1016/j.biopsycho.2007.10.014; BAUER LO, 1987, HUM FACTORS, V29, P213, DOI 10.1177/001872088702900208; Behrend C, 2011, J HAND SURG-AM, V36A, P1711, DOI 10.1016/j.jhsa.2011.07.024; Belter JT, 2013, J REHABIL RES DEV, V50, P599, DOI 10.1682/JRRD.2011.10.0188; Casson AJ, 2010, IEEE ENG MED BIOL, V29, P44, DOI 10.1109/MEMB.2010.936545; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Dawson MR, 2011, EXPERT REV MED DEVIC, V8, P581, DOI [10.1586/erd.11.23, 10.1586/ERD.11.23]; Diaz I, 2014, COMPUT METH PROG BIO, V116, P97, DOI 10.1016/j.cmpb.2013.10.010; Do AH, 2012, IEEE ENG MED BIO, P6414, DOI 10.1109/EMBC.2012.6347462; Do AH, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-49; Fabiani M, 1996, PSYCHOPHYSIOLOGY, V33, P462, DOI 10.1111/j.1469-8986.1996.tb01072.x; Fabiani M., 2000, HDB PSYCHOPHYSIOLOGY; Gentili RJ, 2009, IEEE ENG MED BIO, P5930, DOI 10.1109/IEMBS.2009.5334743; Goldberg JH, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P493, DOI 10.1016/B978-044451020-4/50027-X; Gollee H, 2010, IEEE T BIO-MED ENG, V57, P1847, DOI 10.1109/TBME.2010.2043432; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Handy TC, 2005, EVENT RELATED POTENT; Hill W, 2009, J PROSTHET ORTHOT S, V21, P69, DOI DOI 10.1097/JPO.0B013E3181AE970B; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kilicarslan A, 2013, IEEE ENG MED BIO, P5606, DOI 10.1109/EMBC.2013.6610821; King CE, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-77; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kothe CA, 2011, IEEE ENG MED BIO, P6547, DOI 10.1109/IEMBS.2011.6091615; KRAMER AF, 1987, HUM FACTORS, V29, P145, DOI 10.1177/001872088702900203; KRAMER AF, 1995, BIOL PSYCHOL, V40, P83, DOI 10.1016/0301-0511(95)05108-2; KRAMER AF, 1985, J EXP PSYCHOL HUMAN, V11, P393, DOI 10.1037/0096-1523.11.4.393; Kruse AA, 2007, AVIAT SPACE ENVIR MD, V78, pB191; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Lan Tian, 2007, Comput Intell Neurosci, P74895, DOI 10.1155/2007/74895; Lindner HYN, 2010, PROSTHET ORTHOT INT, V34, P109, DOI 10.3109/03093641003776976; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; Marasco PD, 2009, BRAIN, V132, P1441, DOI 10.1093/brain/awp082; Mathan S, 2010, IEEE ENG MED BIO, P6595, DOI 10.1109/IEMBS.2010.5627126; Mazur LM, 2013, PRACT RADIAT ONCOL, V3, pE171, DOI 10.1016/j.prro.2013.01.001; Metcalf C, 2007, MUSCULOSKELET CARE, V5, P160, DOI 10.1002/msc.108; Miller MW, 2011, INT J PSYCHOPHYSIOL, V80, P75, DOI 10.1016/j.ijpsycho.2011.02.003; PAPANICOLAOU AC, 1984, INT J NEUROSCI, V24, P107, DOI 10.3109/00207458409089800; PARASURAMAN R, 1980, SCIENCE, V210, P80, DOI 10.1126/science.7414324; Parker P, 2006, J ELECTROMYOGR KINES, V16, P541, DOI 10.1016/j.jelekin.2006.08.006; Pascual J, 2012, IEEE ENG MED BIO, P3269, DOI 10.1109/EMBC.2012.6346663; Paulmann S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00345; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pons JL, 2010, IEEE ENG MED BIOL, V29, P57, DOI 10.1109/MEMB.2010.936548; Resnik L, 2012, ARCH PHYS MED REHAB, V93, P710, DOI 10.1016/j.apmr.2011.11.010; Rietschel JC, 2012, BIOL PSYCHOL, V90, P127, DOI 10.1016/j.biopsycho.2012.02.022; Sale P, 2012, EUR J PHYS REHAB MED, V48, P111; Schultz AE, 2009, BRAIN RES, V1251, P121, DOI 10.1016/j.brainres.2008.11.039; Seneviratne U, 2013, EPILEPSY RES, V105, P1, DOI 10.1016/j.eplepsyres.2013.02.004; Simon AM, 2011, J REHABIL RES DEV, V48, P619, DOI 10.1682/JRRD.2010.08.0149; Simorov A, 2012, SURG ENDOSC, V26, P2117, DOI 10.1007/s00464-012-2182-y; SIREVAAG EJ, 1993, ERGONOMICS, V36, P1121, DOI 10.1080/00140139308967983; Sobuh MMD, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-72; Soussou W, 2012, IEEE ENG MED BIO, P1623, DOI 10.1109/EMBC.2012.6346256; Tokuda S, 2011, C P IEEE ENG MED BIO, V45, P23; Ullsperger P, 2001, INT J PSYCHOPHYSIOL, V40, P201, DOI 10.1016/S0167-8760(00)00188-4; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Wilson GF, 2003, HUM FACTORS, V45, P635, DOI 10.1518/hfes.45.4.635.27088; Witteveen HJB, 2012, J REHABIL RES DEV, V49, P1517, DOI 10.1682/JRRD.2011.12.0243; Young AJ, 2013, IEEE T BIO-MED ENG, V60, P1250, DOI 10.1109/TBME.2012.2232293	63	37	37	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112091	10.1371/journal.pone.0112091	http://dx.doi.org/10.1371/journal.pone.0112091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402345	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700028
J	Geronikolou, S; Zimeras, S; Davos, CH; Michalopoulos, I; Tsitomeneas, S				Geronikolou, Styliani; Zimeras, Stelios; Davos, Constantinos H.; Michalopoulos, Ioannis; Tsitomeneas, Stephanos			Diverse Radiofrequency Sensitivity and Radiofrequency Effects of Mobile or Cordless Phone near Fields Exposure in Drosophila melanogaster	PLOS ONE			English	Article							MEASUREMENT ERROR; JUVENILE-HORMONE; RADIATION; STROKE; CELL; REPRODUCTION; ASSOCIATION	Introduction: The impact of electromagnetic fields on health is of increasing scientific interest. The aim of this study was to examine how the Drosophila melanogaster animal model is affected when exposed to portable or mobile phone fields. Methods/Results: Two experiments have been designed and performed in the same laboratory conditions. Insect cultures were exposed to the near field of a 2G mobile phone (the GSM 2G networks support and complement in parallel the 3G wide band or in other words the transmission of information via voice signals is served by the 2G technology in both mobile phones generations) and a 1880 MHz cordless phone both digitally modulated by human voice. Comparison with advanced statistics of the egg laying of the second generation exposed and non-exposed cultures showed limited statistical significance for the cordless phone exposed culture and statistical significance for the 900 MHz exposed insects. We calculated by physics, simulated and illustrated in three dimensional figures the calculated near fields of radiation inside the experimenting vials and their difference. Comparison of the power of the two fields showed that the difference between them becomes null when the experimental cylinder radius and the height of the antenna increase. Conclusions/Significance: Our results suggest a possible radiofrequency sensitivity difference in insects which may be due to the distance from the antenna or to unexplored intimate factors. Comparing the near fields of the two frequencies bands, we see similar not identical geometry in length and height from the antenna and that lower frequencies tend to drive to increased radiofrequency effects.	[Geronikolou, Styliani; Davos, Constantinos H.; Michalopoulos, Ioannis] Biomed Res Fdn, Acad Athens, Athens 11527, Greece; [Tsitomeneas, Stephanos] TEI Piraeus, Dept Elect, Athens 12244, Greece; [Zimeras, Stelios] Univ Aegean, Div Stat & Actuarial Financial Math, Dept Math, Karlovassi 82300, Samos, Greece	Academy of Athens; University of West Attica; University of Aegean	Geronikolou, S (corresponding author), Biomed Res Fdn, Acad Athens, 4 Soranou Efessiou Str, Athens 11527, Greece.	sgeronik@bioacademy.gr	, 0000-0001-8991-8712/S-4398-2016; Davos, Constantinos/AAR-3259-2021; Davos, Constantinos H./AAR-9392-2020	, 0000-0001-8991-8712/0000-0001-8991-8712; Davos, Constantinos/0000-0002-0321-7569; 				Atli E, 2006, INT J RADIAT BIOL, V82, P435, DOI 10.1080/09553000600798849; DAPPLES CC, 1970, Z ZELLFORSCH MIK ANA, V103, P34, DOI 10.1007/BF00335399; Davies L, 2007, PROTEINS, V67, P720, DOI 10.1002/prot.21357; Demarin V, 2011, ACTA CLIN CROAT, V50, P67; Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004; DUTTA SK, 1989, BIOELECTROMAGNETICS, V10, P197, DOI 10.1002/bem.2250100208; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; Geronikolou S, 1996, REGRESSION ANAL SOLA; Geronikolou S, 2005, MORTALITY GREECE REL; Geronikolou S, 1996, 3 SOLT S BEIJ; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; HANDLER AM, 1977, J EXP ZOOL, V202, P389, DOI 10.1002/jez.1402020309; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; HATCH M, 1993, ENVIRON HEALTH PERSP, V101, P49, DOI 10.2307/3431659; Heid IM, 2004, J EXPO ANAL ENV EPID, V14, P365, DOI 10.1038/sj.jea.7500332; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Huang CJ, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00314; Kubli E, 2003, CELL MOL LIFE SCI, V60, P1689, DOI 10.1007/s00018-003-3052; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; LINLIU S, 1982, BIOELECTROMAGNETICS, V3, P309, DOI 10.1002/bem.2250030303; Luechese FA, 2013, REV BRAS CIR CARDIOV, V28, P103, DOI 10.5935/1678-9741.20130015; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Mu QY, 2014, MCN-AM J MATERN-CHIL, V39, P35, DOI 10.1097/NMC.0b013e3182a76b88; Otsuka K, 2001, BIOMED PHARMACOTHER, V55, p63S; Ovbiagele B, 2011, NEUROTHERAPEUTICS, V8, P319, DOI 10.1007/s13311-011-0053-1; Panagopoulos DJ, 2007, ELECTROMAGN BIOL MED, V26, P33, DOI 10.1080/15368370701205644; Panagopoulos DJ, 2000, BIOCHEM BIOPH RES CO, V272, P634, DOI 10.1006/bbrc.2000.2746; Panagopoulos DJ., 2018, MOBILE TELEPHONES, P107; PAY TL, 1978, RADIAT RES, V76, P271, DOI 10.2307/3574778; Potter CJ, 2000, TRENDS GENET, V16, P33, DOI 10.1016/S0168-9525(99)01878-8; RAMIREZ E, 1983, BIOELECTROMAGNETICS, V4, P315, DOI 10.1002/bem.2250040404; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Satterfield G, 2012, J NEUROSCI NURS, V44, P244, DOI 10.1097/JNN.0b013e3182666248; SHIRRAS AD, 1989, P NATL ACAD SCI USA, V86, P4559, DOI 10.1073/pnas.86.12.4559; Stoupel E., 2002, Journal of Basic and Clinical Physiology and Pharmacology, V13, P23; Stoupel E, 1996, J Basic Clin Physiol Pharmacol, V7, P303; Stoupel E., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P37; Stoupel Elijah, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P225; Stoupel Elijah, 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P135; Stoupel E, 2007, MEDICINA-LITHUANIA, V43, P824, DOI 10.3390/medicina43100106; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; Tsitomeneas S, 2010, SAFETY MEASURES PROD, P177; Tsitomeneas S, 1993, RISK ISSUES USERS PO, P62; Velizarov S, 1999, BIOELECTROCH BIOENER, V48, P177, DOI 10.1016/S0302-4598(98)00238-4; Weisbrot D, 2003, J CELL BIOCHEM, V89, P48, DOI 10.1002/jcb.10480; Wilson ME, 2013, PFLUG ARCH EUR J PHY, V465, P595, DOI 10.1007/s00424-013-1260-x; Wilson TG, 2003, INSECT BIOCHEM MOLEC, V33, P1167, DOI 10.1016/j.ibmb.2003.06.007	49	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112139	10.1371/journal.pone.0112139	http://dx.doi.org/10.1371/journal.pone.0112139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402465	Green Published, gold			2022-12-26	WOS:000345158700030
J	Kinoshita, T; Yano, T; Sugiura, M; Nagasaki, Y				Kinoshita, Takafumi; Yano, Takayoshi; Sugiura, Makoto; Nagasaki, Yuji			Effects of Controlled-Release Fertilizer on Leaf Area Index and Fruit Yield in High-Density Soilless Tomato Culture Using Low Node-Order Pinching	PLOS ONE			English	Article							QUANTITATIVE NUTRIENT MANAGEMENT; LIGHT-INTERCEPTION; ROCKWOOL HYDROPONICS; GROWTH; TEMPERATURE; PLANTS; SET	To further development of a simplified fertigation system using controlled-release fertilizers (CRF), we investigated the effects of differing levels of fertilizers and plant density on leaf area index (LAI), fruit yields, and nutrient use in soilless tomato cultures with low node-order pinching and high plant density during spring-summer (SS), summer-fall (SF), and fall-winter (FW) seasons. Plants were treated with 1 of 3 levels of CRF in a closed system, or with liquid fertilizer (LF) with constant electrical conductivity (EC) in a drip-draining system. Two plant densities were examined for each fertilizer treatment. In CRF treatments, LAI at pinching increased linearly with increasing nutrient supply for all cropping seasons. In SS, both light interception by plant canopy at pinching and total marketable fruit yield increased linearly with increasing LAI up to 6 m(2).m(-2); the maximization point was not reached for any of the treatments. In FW, both light interception and yield were maximized at an LAI of approximately 4. These results suggest that maximizing the LAI in SS and FW to the saturation point for light interception is important for increasing yield. In SF, however, the yield maximized at an LAI of approximately 3, although the light interception linearly increased with increasing LAI, up to 4.5. According to our results, the optimal LAI at pinching may be 6 in SS, 3 in SF, and 4 in FW. In comparing LAI values with similar fruit yield, we found that nutrient supply was 32-46% lower with the CRF method than with LF. In conclusion, CRF application in a closed system enables growers to achieve a desirable LAI to maximize fruit yield with a regulated amount of nutrient supply per unit area. Further, the CRF method greatly reduced nutrient use without decreasing fruit yield at similar LAIs, as compared to the LF method.	[Kinoshita, Takafumi] Natl Agr & Food Res Org NARO, NARO Tohoku Agr Res Ctr, Morioka, Iwate, Japan; [Yano, Takayoshi; Sugiura, Makoto; Nagasaki, Yuji] Natl Agr & Food Res Org NARO, NARO Western Reg Agr Res Ctr, Zentsuji, Kagawa, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Kinoshita, T (corresponding author), Natl Agr & Food Res Org NARO, NARO Tohoku Agr Res Ctr, Morioka, Iwate, Japan.	takino@affrc.go.jp						Bertin N, 2005, ANN BOT-LONDON, V95, P439, DOI 10.1093/aob/mci042; BROUGHAM R. W., 1958, Australian Journal of Agricultural Research, V9, P39, DOI 10.1071/AR9580039; COCKSHULL KE, 1992, J HORTIC SCI, V67, P11, DOI 10.1080/00221589.1992.11516215; Constabel AJ, 1996, CAN J FOREST RES, V26, P1008, DOI 10.1139/x26-111; Heuvelink E, 2004, ACTA HORTIC, V691, P43; Heuvelink E, 2005, CROP PRODUCTION SCI, V13, P53; Higashide T, 2009, J AM SOC HORTIC SCI, V134, P460, DOI 10.21273/JASHS.134.4.460; Higashide T, 2009, AGR FOREST METEOROL, V149, P756, DOI 10.1016/j.agrformet.2008.10.017; Hikosaka K, 2001, FUNCT ECOL, V15, P642, DOI 10.1046/j.0269-8463.2001.00557.x; Hosoi N., 2003, Bulletin of the National Institute of Vegetable and Tea Science, P245; Isoda A, 1990, TECH B FAC HORTIC CH, V43, P39; Iwakiri S., 1974, J AGRIC METEOROL, V30, P17, DOI [10.2480/agrmet.30.17, DOI 10.2480/AGRMET.30.17]; Kinoshita T, 2014, ACTA HORTIC, V1034, P517; Kinoshita T, 2012, HORTSCIENCE, V47, P1529, DOI 10.21273/HORTSCI.47.10.1529; Kinoshita T, 2011, HORTSCIENCE, V46, P1170, DOI 10.21273/HORTSCI.46.8.1170; KURATA K, 1988, Journal of Agricultural Meteorology, V44, P15; Matsuda Ryo, 2011, Journal of Agricultural Meteorology, V67, P117, DOI 10.2480/agrmet.67.3.6; Matsuda Ryo, 2010, Journal of Agricultural Meteorology, V66, P217, DOI 10.2480/agrmet.66.4.4; Monteith JL., 1969, PHYSL ASPECTS CROP Y, P89, DOI DOI 10.2135/1969.PHYSIOLOGICALASPECTS.C9; Nakano Y, 2006, J JPN SOC HORTIC SCI, V75, P421, DOI 10.2503/jjshs.75.421; Nakano Y, 2010, J JPN SOC HORTIC SCI, V79, P47, DOI 10.2503/jjshs1.79.47; Pardossi A, 2002, SCI HORTIC-AMSTERDAM, V92, P89, DOI 10.1016/S0304-4238(01)00292-8; Peet MM, 1996, J AM SOC HORTIC SCI, V121, P514, DOI 10.21273/JASHS.121.3.514; Peet MM, 1998, PLANT CELL ENVIRON, V21, P225, DOI 10.1046/j.1365-3040.1998.00281.x; Saeki T, 1960, J PLANT RES, V73, P55; Sasaki H, 2005, JARQ-JPN AGR RES Q, V39, P135, DOI 10.6090/jarq.39.135; Sato S., 2006, HortResearch, P85; Shiraiwa T., 2011, JPN J CROP SCI, V80, P360; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; Terabayashi S, 2004, J JPN SOC HORTIC SCI, V73, P324, DOI 10.2503/jjshs.73.324; Watanabe S, 2003, J JPN SOC HORTIC SCI, V72, P497, DOI 10.2503/jjshs.72.497; Watanabe S., 2006, P VEGE TEA SCI, V3, P91; Yoshikawa H., 2010, MISC PUB NARO W REG, V7, P21	33	9	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113074	10.1371/journal.pone.0113074	http://dx.doi.org/10.1371/journal.pone.0113074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402478	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700107
J	Madec, S; Pichereau, V; Jacq, A; Paillard, M; Boisset, C; Guerard, F; Paillard, C; Nicolas, JL				Madec, Stephanie; Pichereau, Vianney; Jacq, Annick; Paillard, Mathieu; Boisset, Claire; Guerard, Fabienne; Paillard, Christine; Nicolas, Jean-Louis			Characterization of the Secretomes of Two Vibrios Pathogenic to Mollusks	PLOS ONE			English	Article							BROWN RING DISEASE; OYSTER CRASSOSTREA-GIGAS; AUTOPROCESSING RTX TOXIN; RUDITAPES-PHILIPPINARUM; PROTEOMIC ANALYSIS; MANILA CLAM; VIRULENCE; TAPETIS; CHOLERAE; METALLOPROTEASE	Vibrio tapetis causes the brown ring disease in the Japanese clam Ruditapes philippinarum while Vibrio aestuarianus is associated with massive oyster mortalities. As extracellular proteins are often associated with the virulence of pathogenic bacteria, we undertook a proteomic approach to characterize the secretomes of both vibrios. The extracellular proteins (ECPs) of both species were fractionated by SEC-FPLC and in vitro assays were performed to measure the effects of each fraction on hemocyte cellular parameters (phagocytosis and adhesion). Fractions showing a significant effect were subjected to SDS-PAGE, and proteins were identified by nano LC-MS/MS. 45 proteins were identified for V. aestuarianus and 87 for V. tapetis. Most of them belonged to outer membrane or were periplasmic, including porins or adhesins that were already described as virulence factors in other bacterial species. Others were transporter components, flagella proteins, or proteins of unknown function (14 and 15 respectively). Interestingly, for V. aestuarianus, we noted the secretion of 3 extracellular enzymes including the Vam metalloprotease and two other enzymes (one putative lipase and one protease). For V. tapetis, we identified five extracellular enymes, i.e. two different endochitinases, one protease, one lipase and an adhesin. A comparison of both secretomes also showed that only the putative extracellular lipase was common to both secretomes, underscoring the difference in pathogenicity mechanisms between these two species. Overall, these results characterize for the first time the secretomes of these two marine pathogenic vibrios and constitute a useful working basis to further analyze the contribution of specific proteins in the virulence mechanisms of these species.	[Madec, Stephanie] UBO, Lab Univ Biodivers & Ecol Microbienne EA3882, ScInBios SFR48, UEB,ESIAB, F-29280 Plouzane, France; [Pichereau, Vianney; Paillard, Mathieu; Guerard, Fabienne; Paillard, Christine; Nicolas, Jean-Louis] UBO, UMR UBO CNRS IRD Ifremer 6539, Lab Sci Environm Marin, Inst Univ Europeen Mer, F-29280 Plouzane, France; [Jacq, Annick] Univ Paris 11, CNRS, UMR8621, Inst Genet & Microbiol, F-91405 Orsay, France; [Boisset, Claire] CERMAV CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Madec, S (corresponding author), UBO, Lab Univ Biodivers & Ecol Microbienne EA3882, ScInBios SFR48, UEB,ESIAB, Technopole Brest Iroise, F-29280 Plouzane, France.	stephanie.madec@univ-brest.fr	PICHEREAU, Vianney/B-2168-2008; PICHEREAU, Vianney/Q-7236-2019; Jacq, Annick/H-3896-2012	PICHEREAU, Vianney/0000-0003-1078-9407; PICHEREAU, Vianney/0000-0003-1078-9407; Jacq, Annick/0000-0002-8526-5942; Paillard, Christine/0000-0002-3812-0724; MADEC, Stephanie/0000-0002-4684-7931	Bivalife FP7 KBBE program [266157]	Bivalife FP7 KBBE program	The work was funded by the Bivalife FP7 KBBE program (ref 266157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam B, 2006, FISH SHELLFISH IMMUN, V20, P374, DOI 10.1016/j.fsi.2005.05.012; Austin B, 2010, VET MICROBIOL, V140, P310, DOI 10.1016/j.vetmic.2009.03.015; Barbey C, 2009, VET MICROBIOL, V135, P334, DOI 10.1016/j.vetmic.2008.09.086; Barh D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052773; Benachour A, 2009, CAN J MICROBIOL, V55, P967, DOI [10.1139/W09-052, 10.1139/w09-052]; Chaudhuri S, 2013, MBIO, V4, DOI 10.1128/mBio.00617-12; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Choquet G, 2003, DIS AQUAT ORGAN, V57, P109, DOI 10.3354/dao057109; Combie H., 2008, SUMMER MORTALITY PAC; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Garnier M, 2007, MICROB ECOL, V53, P187, DOI 10.1007/s00248-006-9061-9; Gay M, 2004, DIS AQUAT ORGAN, V62, P65, DOI 10.3354/dao062065; Gomez-Leon J, 2005, APPL ENVIRON MICROB, V71, P98, DOI 10.1128/AEM.71.1.98-104.2005; KOTHARY MH, 1995, INFECT IMMUN, V63, P2418, DOI 10.1128/IAI.63.7.2418-2423.1995; Labreuche Y, 2006, DEV COMP IMMUNOL, V30, P367, DOI 10.1016/j.dci.2005.05.003; Labreuche Y, 2010, FISH SHELLFISH IMMUN, V29, P753, DOI 10.1016/j.fsi.2010.07.007; Lakhal F, 2008, APPL ENVIRON MICROB, V74, P5750, DOI 10.1128/AEM.01043-08; Lang C, 2011, EUR J CELL BIOL, V90, P903, DOI 10.1016/j.ejcb.2010.12.003; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Lopez-Cortes L, 1999, FISH SHELLFISH IMMUN, V9, P543, DOI 10.1006/fsim.1999.0211; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Mendez JA, 2012, J PROTEOME RES, V11, P5678, DOI 10.1021/pr300496c; Merino S, 1999, INFECT IMMUN, V67, P4008, DOI 10.1128/IAI.67.8.4008-4013.1999; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; PAILLARD C, 1990, CR ACAD SCI III-VIE, V310, P15; PAILLARD C, 1995, J INVERTEBR PATHOL, V65, P101, DOI 10.1006/jipa.1995.1016; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P467, DOI 10.1051/alr:2004053; Paillard C, 2004, DIS AQUAT ORGAN, V59, P249, DOI 10.3354/dao059249; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P477, DOI 10.1051/alr:2004054; Pocsfalvi G, 2008, PROTEOMICS, V8, P2462, DOI 10.1002/pmic.200700965; Romalde JL, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00413; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Santos ED, 2011, ISME J, V5, P1471, DOI 10.1038/ismej.2011.19; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Thiele H, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-141; Unal CM, 2011, SEMIN IMMUNOPATHOL, V33, P395, DOI 10.1007/s00281-010-0231-y; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Varina M, 2008, J BACTERIOL, V190, P6589, DOI 10.1128/JB.00535-08; Ziolo KJ, 2014, INFECT IMMUN, V82, P2148, DOI 10.1128/IAI.00017-14	42	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113097	10.1371/journal.pone.0113097	http://dx.doi.org/10.1371/journal.pone.0113097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401495	Green Published, gold			2022-12-26	WOS:000345158700111
J	Vladusich, T; McDonnell, MD				Vladusich, Tony; McDonnell, Mark D.			A Unified Account of Perceptual Layering and Surface Appearance in Terms of Gamut Relativity	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; LIGHTNESS PERCEPTION; SURROUND ARTICULATION; BRIGHTNESS CONTRAST; PERCEIVED LIGHTNESS; GANGLION-CELLS; ILLUMINATION; LUMINANCE; RESPONSES	When we look at the world-or a graphical depiction of the world-we perceive surface materials (e. g. a ceramic black and white checkerboard) independently of variations in illumination (e. g. shading or shadow) and atmospheric media (e. g. clouds or smoke). Such percepts are partly based on the way physical surfaces and media reflect and transmit light and partly on the way the human visual system processes the complex patterns of light reaching the eye. One way to understand how these percepts arise is to assume that the visual system parses patterns of light into layered perceptual representations of surfaces, illumination and atmospheric media, one seen through another. Despite a great deal of previous experimental and modelling work on layered representation, however, a unified computational model of key perceptual demonstrations is still lacking. Here we present the first general computational model of perceptual layering and surface appearance-based on a boarder theoretical framework called gamut relativity-that is consistent with these demonstrations. The model (a) qualitatively explains striking effects of perceptual transparency, figure-ground separation and lightness, (b) quantitatively accounts for the role of stimulus-and task-driven constraints on perceptual matching performance, and (c) unifies two prominent theoretical frameworks for understanding surface appearance. The model thereby provides novel insights into the remarkable capacity of the human visual system to represent and identify surface materials, illumination and atmospheric media, which can be exploited in computer graphics applications.	[Vladusich, Tony; McDonnell, Mark D.] Univ S Australia, Inst Telecommun Res, Mawson Lakes 5095, Australia; [Vladusich, Tony] Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA	University of South Australia; Boston University	Vladusich, T (corresponding author), Univ S Australia, Inst Telecommun Res, Mawson Lakes 5095, Australia.	therealrealvlad@gmail.com	McDonnell, Mark/A-8374-2008	McDonnell, Mark/0000-0002-7009-3869	Australian Research Fellowship from the Australian Research Council [DP1093425]	Australian Research Fellowship from the Australian Research Council(Australian Research Council)	Mark D. McDonnell's contribution was supported by an Australian Research Fellowship from the Australian Research Council (http://www.arc.gov.au/), project number DP1093425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson E. H., 1995, Proceedings IEEE Workshop on Representation of Visual Scenes (In Conjunction with ICCV'95) (Cat. No.95TB8126), P3, DOI 10.1109/WVRS.1995.476846; Adelson E. H., 2000, NEW COGNITIVE NEUROS, V339, P339, DOI DOI 10.1068/P230869; ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Adelson EH, 2001, PROC SPIE, V4299, P1, DOI 10.1117/12.429489; Allred SR, 2013, J VISION, V13, DOI 10.1167/13.7.18; Anderson BL, 2008, J VISION, V8, DOI 10.1167/8.7.18; Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; Anderson BL, 2003, PSYCHOL REV, V110, P785, DOI 10.1037/0033-295X.110.4.785; Anderson BL, 1999, NEURON, V24, P919, DOI 10.1016/S0896-6273(00)81039-9; AREND LE, 1993, PERCEPT PSYCHOPHYS, V54, P446, DOI 10.3758/BF03211767; AREND LE, 1987, J OPT SOC AM A, V4, P2281, DOI 10.1364/JOSAA.4.002281; AREND LE, 1993, PERCEPT PSYCHOPHYS, V54, P457, DOI 10.3758/BF03211768; AREND LE, 1990, J OPT SOC AM A, V7, P1929, DOI 10.1364/JOSAA.7.001929; BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; BARLOW RB, 1978, EXP BRAIN RES, V31, P163; BARLOW RB, 1976, VISION RES, V16, P1291, DOI 10.1016/0042-6989(76)90056-0; Barrow H.G., 1978, COMPUTER VISION SYST, P3; Blakeslee B, 2012, VISION RES, V60, P40, DOI 10.1016/j.visres.2012.03.006; Blakeslee B, 2008, J VISION, V8, DOI 10.1167/8.11.3; Bressan P, 2001, PERCEPTION, V30, P1031, DOI 10.1068/p3109; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Chandraker M, 2011, IEEE T PATTERN ANAL, V33, P2122, DOI 10.1109/TPAMI.2011.124; Corney D, 2007, PLOS COMPUT BIOL, V3, P1790, DOI 10.1371/journal.pcbi.0030180; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Donner C, 2005, ACM T GRAPHIC, V24, P1032, DOI 10.1145/1073204.1073308; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Ekroll V, 2002, P NATL ACAD SCI USA, V99, P13352, DOI 10.1073/pnas.192216699; Faul F, 2002, J OPT SOC AM A, V19, P1084, DOI 10.1364/JOSAA.19.001084; Faul F, 2012, J VISION, V12, DOI 10.1167/12.12.7; Faul F, 2011, J VISION, V11, DOI 10.1167/11.7.7; Fleming RW, 2014, VISION RES, V94, P62, DOI 10.1016/j.visres.2013.11.004; Fleming RW, 2012, CURR BIOL, V22, pR865, DOI 10.1016/j.cub.2012.08.030; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Geisler WS, 2007, J NEUROSCI, V27, P5063, DOI 10.1523/JNEUROSCI.0835-07.2007; Ghosh A, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1409060.1409092; Gilchrist A, 1999, PSYCHOL REV, V106, P795, DOI 10.1037/0033-295X.106.4.795; GILCHRIST A, 1983, PERCEPT PSYCHOPHYS, V33, P425, DOI 10.3758/BF03202893; Gilchrist A., 2006, SEEING BLACK WHITE; Gilchrist AL, 2005, CURR BIOL, V15, pR330, DOI 10.1016/j.cub.2005.04.028; GILCHRIST AL, 1983, J EXP PSYCHOL HUMAN, V9, P936, DOI 10.1037/0096-1523.9.6.936; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; Gilchrist AL, 2007, CURR BIOL, V17, pR267, DOI 10.1016/j.cub.2007.01.040; Grady L, 2006, IEEE T PATTERN ANAL, V28, P469, DOI 10.1109/TPAMI.2006.57; Hillis JM, 2007, CURR BIOL, V17, P1714, DOI 10.1016/j.cub.2007.09.012; HUBEL DH, 1960, J PHYSIOL-LONDON, V154, P572, DOI 10.1113/jphysiol.1960.sp006596; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; KAYAMA Y, 1979, J NEUROPHYSIOL, V42, P1495, DOI 10.1152/jn.1979.42.6.1495; Kim J, 2012, NAT NEUROSCI, V15, P1590, DOI 10.1038/nn.3221; Kim J, 2011, J VISION, V11, DOI 10.1167/11.9.4; Kim J, 2010, J VISION, V10, DOI 10.1167/10.9.3; Kingdom FAA, 2008, VISION RES, V48, P2090, DOI 10.1016/j.visres.2008.03.020; Kingdom FAA, 2011, VISION RES, V51, P652, DOI 10.1016/j.visres.2010.09.012; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Knau H, 2000, J OPT SOC AM A, V17, P1382, DOI 10.1364/JOSAA.17.001382; Logvinenko AD, 2006, PERCEPT PSYCHOPHYS, V68, P76, DOI 10.3758/BF03193657; Logvinenko AD, 2004, J VISION, V4, P1102, DOI 10.1167/4.12.9; Logvinenko AD, 1999, PERCEPTION, V28, P803, DOI 10.1068/p2801; Logvinenko AD, 2011, ATTEN PERCEPT PSYCHO, V73, P1886, DOI 10.3758/s13414-011-0154-2; Logvinenko AD, 2008, PERCEPT PSYCHOPHYS, V70, P828, DOI 10.3758/PP.70.5.828; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Mausfeld R., 2003, COLOUR PERCEPTION MI, P381, DOI 10.1093/acprof:oso/9780198505006.001.0001; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; Odermatt B, 2012, NEURON, V73, P758, DOI 10.1016/j.neuron.2011.12.023; PAPAIOANNOU J, 1972, EXP NEUROL, V34, P558, DOI 10.1016/0014-4886(72)90050-7; Peng XM, 2005, J NEUROPHYSIOL, V93, P1620, DOI 10.1152/jn.00793.2004; Poirier FJAM, 2009, ATTEN PERCEPT PSYCHO, V71, P1353, DOI 10.3758/APP.71.6.1353; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Rudd ME, 2013, J VISION, V13, DOI 10.1167/13.14.18; SCHIRILLO J, 1990, PERCEPT PSYCHOPHYS, V48, P82, DOI 10.3758/BF03205014; Schirillo JA, 1999, J OPT SOC AM A, V16, P793, DOI 10.1364/JOSAA.16.000793; Schirillo JA, 1999, J OPT SOC AM A, V16, P804, DOI 10.1364/JOSAA.16.000804; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Singh M, 2002, PSYCHOL REV, V109, P492, DOI 10.1037//0033-295X.109.3.492; Sinha P., 1993, [1993] Proceedings Fourth International Conference on Computer Vision, P156, DOI 10.1109/ICCV.1993.378224; Tappen MF, 2005, IEEE T PATTERN ANAL, V27, P1459, DOI 10.1109/TPAMI.2005.185; Todorovic D, 2006, SPATIAL VISION, V19, P219, DOI 10.1163/156856806776923407; Vladusich T, 2006, J NEUROPHYSIOL, V95, P2638, DOI 10.1152/jn.01016.2005; Vladusich T, 2014, COLOR RES APPL, V39, P463, DOI 10.1002/col.21823; Vladusich T, 2013, J OPT SOC AM A, V30, P1568, DOI 10.1364/JOSAA.30.001568; Vladusich T, 2013, J OPT SOC AM A, V30, P418, DOI 10.1364/JOSAA.30.000418; Vladusich T, 2013, J VISION, V13, DOI 10.1167/13.1.14; Vladusich T, 2012, VISION RES, V69, P49, DOI 10.1016/j.visres.2012.07.022; Vladusich T, 2007, PLOS COMPUT BIOL, V3, P1849, DOI 10.1371/journal.pcbi.0030179; Xing DJ, 2014, P NATL ACAD SCI USA, V111, P1210, DOI 10.1073/pnas.1314690111; Xing DJ, 2010, J NEUROSCI, V30, P13504, DOI 10.1523/JNEUROSCI.2473-10.2010; Yeh CI, 2009, J NEUROSCI, V29, P11753, DOI 10.1523/JNEUROSCI.1991-09.2009; Zurawel G, 2014, J NEUROSCI, V34, P14388, DOI 10.1523/JNEUROSCI.0848-14.2014	90	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113159	10.1371/journal.pone.0113159	http://dx.doi.org/10.1371/journal.pone.0113159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402466	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000345158700121
J	Xie, BB; Zhang, XM; Hashimoto, T; Tien, AH; Chen, A; Ge, J; Yang, XJ				Xie, Bin-Bin; Zhang, Xiang-Mei; Hashimoto, Takao; Tien, Amy H.; Chen, Andrew; Ge, Jian; Yang, Xian-Jie			Differentiation of Retinal Ganglion Cells and Photoreceptor Precursors from Mouse Induced Pluripotent Stem Cells Carrying an Atoh7/Math5 Lineage Reporter	PLOS ONE			English	Article							MAMMALIAN RETINA; PROGENITOR CELLS; COMPETENCE STATE; XENOPUS RETINA; SONIC HEDGEHOG; MULLER GLIA; MATH5; GENERATION; NEUROGENESIS; NEURONS	The neural retina is a critical component of the visual system, which provides the majority of sensory input in humans. Various retinal degenerative diseases can result in the permanent loss of retinal neurons, especially the light-sensing photoreceptors and the centrally projecting retinal ganglion cells (RGCs). The replenishment of lost RGCs and the repair of optic nerve damage are particularly challenging, as both RGC specification and their subsequent axonal growth and projection involve complex and precise regulation. To explore the developmental potential of pluripotent stem cell-derived neural progenitors, we have established mouse iPS cells that allow cell lineage tracing of progenitors that have expressed Atoh7/Math5, a bHLH transcription factor required for RGC production. These Atoh7 lineage reporter iPS cells encode Cre to replace one copy of the endogenous Atoh7 gene and a Cre-dependent YFP reporter in the ROSA locus. In addition, they express pluripotent markers and are capable of generating teratomas in vivo. Under anterior neural induction and neurogenic conditions in vitro, the Atoh7-Cre/ROSA-YFP iPS cells differentiate into neurons that co-express various RGC markers and YFP, indicating that these neurons are derived from Atoh7-expressing progenitors. Consistent with previous in vivo cell lineage studies, the Atoh7-Cre/ROSA-YFP iPS cells also give rise to a subset of Crx-positive photoreceptor precursors. Furthermore, inhibition of Notch signaling in the iPSC cultures results in a significant increase of YFP-positive RGCs and photoreceptor precursors. Together, these results show that Atoh7-Cre/ROSA-YFP iPS cells can be used to monitor the development and survival of RGCs and photoreceptors from pluripotent stem cells.	[Xie, Bin-Bin; Ge, Jian] Sun Yat Sen Univ, Zhong Shan Ophthalm Ctr, Guangzhuo, Peoples R China; [Zhang, Xiang-Mei; Hashimoto, Takao; Tien, Amy H.; Chen, Andrew; Yang, Xian-Jie] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Yang, Xian-Jie] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	Sun Yat Sen University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yang, XJ (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	Yang@jsei.ucla.edu	Chen, Andrew/AAT-6318-2021	Chen, Andrew/0000-0002-6688-7674	National Institute of Health [RO1 EY019052]; Oppenheimer Family Foundation; Ernest G. Herman Endowed Chair in Ophthalmology; Research to Prevent Blindness Foundation; National Eye Institute [EY00331]; NATIONAL EYE INSTITUTE [P30EY000331, R01EY019052] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oppenheimer Family Foundation; Ernest G. Herman Endowed Chair in Ophthalmology; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was in part supported by grants from National Institute of Health RO1 EY019052, the Oppenheimer Family Foundation, and the Ernest G. Herman Endowed Chair in Ophthalmology to X.-J. Y., and Research to Prevent Blindness Foundation unrestricted funds and National Eye Institute Core Grant EY00331 for vision research at UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Chen MF, 2010, INVEST OPHTH VIS SCI, V51, P5970, DOI 10.1167/iovs.09-4504; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Hashimoto T, 2007, GENE THER, V14, P584, DOI 10.1038/sj.gt.3302897; Hashimoto T, 2006, DEVELOPMENT, V133, P2201, DOI 10.1242/dev.02385; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Hyde DR, 2014, EXP EYE RES; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jiang Y, 2013, J BIOL CHEM, V288, P18429, DOI 10.1074/jbc.M113.478503; Karl Mike O, 2012, Methods Mol Biol, V884, P213, DOI 10.1007/978-1-61779-848-1_15; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; La Torre Anna, 2012, Methods Mol Biol, V884, P229, DOI 10.1007/978-1-61779-848-1_16; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lee HY, 2005, DEV BIOL, V284, P464, DOI 10.1016/j.ydbio.2005.06.010; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Omori Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019685; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; Riazifar H, 2014, STEM CELL TRANSL MED, V3, P424, DOI 10.5966/sctm.2013-0147; Riesenberg AN, 2009, J NEUROSCI, V29, P12865, DOI 10.1523/JNEUROSCI.3382-09.2009; Riesenberg AN, 2009, GENESIS, V47, P175, DOI 10.1002/dvg.20479; Sakagami K, 2009, J NEUROSCI, V29, P6932, DOI 10.1523/JNEUROSCI.0289-09.2009; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zhang XM, 2001, DEVELOPMENT, V128, P943	49	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112175	10.1371/journal.pone.0112175	http://dx.doi.org/10.1371/journal.pone.0112175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401462	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700034
J	Kairamkonda, S; Nongthomba, U				Kairamkonda, Subhash; Nongthomba, Upendra			Beadex Function in the Motor Neurons Is Essential for Female Reproduction in Drosophila melanogaster	PLOS ONE			English	Article							SEMINAL FLUID PROTEIN; MEDIATES OVULATION; WING DEVELOPMENT; SENSORY NEURONS; SPERM STORAGE; RECEPTOR OAMB; LIM DOMAIN; GENE; EXPRESSION; OCTOPAMINE	Drosophila melanogaster has served as an excellent model system for understanding the neuronal circuits and molecular mechanisms regulating complex behaviors. The Drosophila female reproductive circuits, in particular, are well studied and can be used as a tool to understand the role of novel genes in neuronal function in general and female reproduction in particular. In the present study, the role of Beadex, a transcription co-activator, in Drosophila female reproduction was assessed by generation of mutant and knock down studies. Null allele of Beadex was generated by transposase induced excision of P-element present within an intron of Beadex gene. The mutant showed highly compromised reproductive abilities as evaluated by reduced fecundity and fertility, abnormal oviposition and more importantly, the failure of sperm release from storage organs. However, no defect was found in the overall ovariole development. Tissue specific, targeted knock down of Beadex indicated that its function in neurons is important for efficient female reproduction, since its neuronal knock down led to compromised female reproductive abilities, similar to Beadex null females. Further, different neuronal class specific knock down studies revealed that Beadex function is required in motor neurons for normal fecundity and fertility of females. Thus, the present study attributes a novel and essential role for Beadex in female reproduction through neurons.	[Kairamkonda, Subhash; Nongthomba, Upendra] Indian Inst Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Nongthomba, U (corresponding author), Indian Inst Sci, Bangalore 560012, Karnataka, India.	upendra@mrdg.iisc.ernet.in	Nongthomba, Upendra/AAY-3009-2021	Nongthomba, Upendra/0000-0002-0616-5995	Department of Biotechnology; Indian Institute of Science	Department of Biotechnology; Indian Institute of Science(Indian Institute of Science (IISC) - Bangalore)	This work was supported by the Department of Biotechnology (http://dbtindia.nic.in/index.asp, to UN), and Indian Institute of Science (www.iisc.ernet.in, to UN and SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmar J, 2008, DEV BIOL, V316, P487, DOI 10.1016/j.ydbio.2008.01.040; Avila FW, 2012, P NATL ACAD SCI USA, V109, P4562, DOI 10.1073/pnas.1117689109; Avila FW, 2010, GENETICS, V186, P595, DOI 10.1534/genetics.110.119735; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Chapman T, 2001, P ROY SOC B-BIOL SCI, V268, P1647, DOI 10.1098/rspb.2001.1684; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Heifetz Y, 2000, CURR BIOL, V10, P99, DOI 10.1016/S0960-9822(00)00288-8; Hodin J, 2000, EVOLUTION, V54, P1638, DOI 10.1111/j.0014-3820.2000.tb00708.x; Joshi K, 2009, NEURON, V61, P839, DOI 10.1016/j.neuron.2009.02.011; Kahsai L, 2011, INT REV NEUROBIOL, V99, P139, DOI 10.1016/B978-0-12-387003-2.00006-9; Lasek AW, 2010, GENES BRAIN BEHAV, V9, P817, DOI 10.1111/j.1601-183X.2010.00620.x; Lasek AW, 2011, ALCOHOL CLIN EXP RES, V35, P1600, DOI 10.1111/j.1530-0277.2011.01506.x; Lasek AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022636; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004716; LIFSCHYTZ E, 1979, MOL GEN GENET, V171, P153, DOI 10.1007/BF00270001; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; McGuire SE, 2003, DROS RES C, V44, P153; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; Prado A, 1999, GENETICS, V151, P163; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Ren J, 2014, CELL RES, V24, P636, DOI 10.1038/cr.2014.24; ROBERTSON HM, 1988, GENETICS, V118, P461; Rodriguez-Valentin R, 2006, J CELL PHYSIOL, V209, P183, DOI 10.1002/jcp.20722; Rubinstein CD, 2013, P NATL ACAD SCI USA, V110, P17420, DOI 10.1073/pnas.1220018110; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Shoresh M, 1998, GENETICS, V150, P283; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Vu D, 2003, MOL BRAIN RES, V115, P93, DOI 10.1016/S0169-328X(03)00119-0; Weihe U, 2001, DEVELOPMENT, V128, P4615; Wolfner M.F., 2007, P183; Wolfram V, 2014, J NEUROSCI, V34, P2538, DOI 10.1523/JNEUROSCI.4511-13.2014; Wolfram V, 2012, NEURON, V75, P663, DOI 10.1016/j.neuron.2012.06.015; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Zeng CY, 1998, P NATL ACAD SCI USA, V95, P10637, DOI 10.1073/pnas.95.18.10637; Zenvirt S, 2008, GENETICS, V179, P1989, DOI 10.1534/genetics.108.090076; ZHU TH, 1995, ONCOGENE, V11, P1283; Zwarts L, 2012, FLY, V6, P35, DOI 10.4161/fly.19249	49	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113003	10.1371/journal.pone.0113003	http://dx.doi.org/10.1371/journal.pone.0113003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396431	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500123
J	Kaneko, T; Ito, H; Sakamoto, H; Onuma, M; Inoue-Murayama, M				Kaneko, Takehito; Ito, Hideyuki; Sakamoto, Hidefusa; Onuma, Manabu; Inoue-Murayama, Miho			Sperm Preservation by Freeze-Drying for the Conservation of Wild Animals	PLOS ONE			English	Article							DRIED MOUSE SPERMATOZOA; LONG-TERM PRESERVATION; INTRACYTOPLASMIC INJECTION; EMBRYOS; OOCYTES; CRYOPROTECTION; ABILITY; MICE	Sperm preservation is a useful technique for the maintenance of biological resources in experimental and domestic animals, and in wild animals. A new preservation method has been developed that enables sperm to be stored for a long time in a refrigerator at 4 degrees C. Sperm are freeze-dried in a solution containing 10 mM Tris and 1 mM EDTA. Using this method, liquid nitrogen is not required for the storage and transportation of sperm. We demonstrate that chimpanzee, giraffe, jaguar, weasel and the long-haired rat sperm remain viable after freeze-drying. In all species, pronuclei were formed after the injection of freeze-dried sperm into the mouse oocytes. Although preliminary, these results may be useful for the future establishment of "freeze-drying zoo'' to conserve wild animals.	[Kaneko, Takehito] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan; [Ito, Hideyuki; Sakamoto, Hidefusa] Kyoto City Zoo, Kyoto, Japan; [Ito, Hideyuki; Sakamoto, Hidefusa; Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Onuma, Manabu; Inoue-Murayama, Miho] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Ibaraki, Japan	Kyoto University; Kyoto University; National Institute for Environmental Studies - Japan	Kaneko, T (corresponding author), Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan.	tkaneko@anim.med.kyoto-u.ac.jp		Ito, Hideyuki/0000-0002-3502-0074	JSPS [30332878, 25290082]; Wildlife Research Center of Kyoto University	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Wildlife Research Center of Kyoto University	This work was supported in part by a Grant-in-Aid for Scientific Research from JSPS (No. 30332878 and 25290082) and the Cooperation Research Program from Wildlife Research Center of Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; Choi YH, 2011, REPRODUCTION, V142, P529, DOI 10.1530/REP-11-0145; Comizzoli P, 2000, REPROD NUTR DEV, V40, P493, DOI 10.1051/rnd:2000113; Dickey RP, 2006, FERTIL STERIL, V86, P732, DOI 10.1016/j.fertnstert.2006.01.035; Kaneko T, 2007, THERIOGENOLOGY, V68, P1017, DOI 10.1016/j.theriogenology.2007.07.017; Kaneko T, 2005, COMPARATIVE MED, V55, P140; Kaneko T, 2003, BIOL REPROD, V68, P136, DOI 10.1095/biolreprod.102.008706; Kaneko T, 2014, LATEST IMPROVEMENTS, P357, DOI [DOI 10.1007/978-1-60327-292-6_21, 10.1007/978-1-60327-292-6_21]; Kaneko T, 2006, CRYOBIOLOGY, V53, P279, DOI 10.1016/j.cryobiol.2006.06.004; Kaneko T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035043; Kaneko T, 2012, CRYOBIOLOGY, V64, P211, DOI 10.1016/j.cryobiol.2012.01.010; Kaneko T, 2009, CRYOBIOLOGY, V58, P293, DOI 10.1016/j.cryobiol.2009.02.004; Keskintepe L, 2002, BIOL REPROD, V67, P409, DOI 10.1095/biolreprod67.2.409; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kishikawa H, 1999, J REPROD FERTIL, V116, P217, DOI 10.1530/jrf.0.1160217; KOSOWER NS, 1992, J ANDROL, V13, P342; Kwon IK, 2004, BIOL REPROD, V71, P1430, DOI 10.1095/biolreprod.104.031260; Lee JD, 1996, HUM REPROD, V11, P1942; Leibo SP, 2002, THERIOGENOLOGY, V57, P303, DOI 10.1016/S0093-691X(01)00673-2; Li MW, 2009, ZYGOTE, V17, P239, DOI 10.1017/S0967199409005292; Liu JL, 2004, BIOL REPROD, V70, P1776, DOI 10.1095/biolreprod.103.025957; Muneto T., 2011, Journal of Mammalian Ova Research, V28, P32, DOI 10.1274/jmor.28.32; Sanchez-Partida LG, 2008, FERTIL STERIL, V89, P742, DOI 10.1016/j.fertnstert.2007.02.066; Ward MA, 2003, BIOL REPROD, V69, P2100, DOI 10.1095/biolreprod.103.020529; Watanabe H, 2010, J ASSIST REPROD GEN, V27, P581, DOI 10.1007/s10815-010-9445-0; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471	27	25	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113381	10.1371/journal.pone.0113381	http://dx.doi.org/10.1371/journal.pone.0113381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409172	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200104
J	Tondervik, A; Sletta, H; Klinkenberg, G; Emanuel, C; Powell, LC; Pritchard, MF; Khan, S; Craine, KM; Onsoyen, E; Rye, PD; Wright, C; Thomas, DW; Hill, KE				Tondervik, Anne; Sletta, Havard; Klinkenberg, Geir; Emanuel, Charlotte; Powell, Lydia C.; Pritchard, Manon F.; Khan, Saira; Craine, Kieron M.; Onsoyen, Edvar; Rye, Phil D.; Wright, Chris; Thomas, David W.; Hill, Katja E.			Alginate Oligosaccharides Inhibit Fungal Cell Growth and Potentiate the Activity of Antifungals against Candida and Aspergillus spp	PLOS ONE			English	Article							AMPHOTERICIN-B; DRUG-RESISTANCE; ESSENTIAL OIL; COMBINATION; ALBICANS; DISEASE; ECHINOCANDINS; TERBINAFINE; SYNERGY; AGENTS	The oligosaccharide OligoG, an alginate derived from seaweed, has been shown to have anti-bacterial and anti-biofilm properties and potentiates the activity of selected antibiotics against multi-drug resistant bacteria. The ability of OligoG to perturb fungal growth and potentiate conventional antifungal agents was evaluated using a range of pathogenic fungal strains. Candida (n = 11) and Aspergillus (n = 3) spp. were tested using germ tube assays, LIVE/DEAD staining, scanning electron microscopy (SEM), atomic force microscopy (AFM) and high-throughput minimum inhibition concentration assays (MICs). In general, the strains tested showed a significant dose-dependent reduction in cell growth at >= 6% OligoG as measured by optical density (OD600;p<0.05). OligoG (>0.5%) also showed a significant inhibitory effect on hyphal growth in germ tube assays, although strain-dependent variations in efficacy were observed (P<0.05). SEM and AFM both showed that OligoG (>= 2%) markedly disrupted fungal biofilm formation, both alone, and in combination with fluconazole. Cell surface roughness was also significantly increased by the combination treatment (P<0.001). High-throughput robotic MIC screening demonstrated the potentiating effects of OligoG (2, 6, 10%) with nystatin, amphotericin B, fluconazole, miconazole, voriconazole or terbinafine with the test strains. Potentiating effects were observed for the Aspergillus strains with all six antifungal agents, with an up to 16-fold (nystatin) reduction in MIC. Similarly, all the Candida spp. showed potentiation with nystatin (up to 16-fold) and fluconazole (up to 8-fold). These findings demonstrate the antifungal properties of OligoG and suggest a potential role in the management of fungal infections and possible reduction of antifungal toxicity.	[Tondervik, Anne; Sletta, Havard; Klinkenberg, Geir] SINTEF Mat & Chem, Dept Bioproc Technol, N-7465 Trondheim, Norway; [Emanuel, Charlotte; Powell, Lydia C.; Pritchard, Manon F.; Khan, Saira; Craine, Kieron M.; Thomas, David W.; Hill, Katja E.] Cardiff Univ, Sch Dent, Adv Therapies Grp, Cardiff CF14 4XY, S Glam, Wales; [Onsoyen, Edvar; Rye, Phil D.] AlgiPharma AS, N-1337 Sandvika, Norway; [Wright, Chris] Swansea Univ, Coll Engn, Ctr NanoHlth, Syst & Proc Engn Ctr, Swansea SA2 8PP, W Glam, Wales	SINTEF; Cardiff University; Swansea University	Sletta, H (corresponding author), SINTEF Mat & Chem, Dept Bioproc Technol, N-7465 Trondheim, Norway.	Havard.Sletta@sintef.no		/0000-0002-8590-0117; Khan, Saira/0000-0002-3284-3198; Rye, Philip/0000-0001-7762-3300; Thomas, David/0000-0001-7319-5820; Pritchard, Manon/0000-0002-5135-4744; Wright, Chris/0000-0003-2375-8159; Powell, Lydia/0000-0002-8641-0160	AlgiPharma AS	AlgiPharma AS	This work was supported by AlgiPharma AS. The funding organization was directly involved in the study design, decision to publish and preparation of the manuscript.	Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x; Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896; Ali I, 2011, J MED MICROBIOL, V60, P1326, DOI 10.1099/jmm.0.031906-0; Alves IA, 2012, MYCOPATHOLOGIA, V174, P215, DOI 10.1007/s11046-012-9538-7; Aperis G, 2006, EXPERT OPIN INV DRUG, V15, P1319, DOI 10.1517/13543784.15.11.1319; Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE246, DOI 10.1111/j.1469-0691.2012.03880.x; Bes DF, 2012, ARCH ARGENT PEDIATR, V110, P46, DOI [10.5546/aap.2012.46, 10.1590/S0325-00752012000100010]; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Emri T, 2013, APPL MICROBIOL BIOT, V97, P3267, DOI 10.1007/s00253-013-4761-9; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Fukuda T, 2008, J ANTIBIOT, V61, P550, DOI 10.1038/ja.2008.73; Giordani R, 2006, PHYTOTHER RES, V20, P58, DOI 10.1002/ptr.1803; Giordani R, 2004, PHYTOTHER RES, V18, P990, DOI 10.1002/ptr.1594; Guinea J, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12539; Harris MR, 2010, INT J ANTIMICROB AG, V35, P347, DOI 10.1016/j.ijantimicag.2009.11.021; Institute CaLS, 2005, M100S15 I CALS; Kalkanci A, 2010, CENT EUR J MED, V5, P194, DOI 10.2478/s11536-010-0010-0; Kamysz W, 2006, POL J MICROBIOL, V55, P303; Khan S, 2012, ANTIMICROB AGENTS CH, V56, P5134, DOI 10.1128/AAC.00525-12; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Lagorce A, 2002, EUR J BIOCHEM, V269, P1697, DOI 10.1046/j.1432-1327.2002.02814.x; Lass-Florl C, 2009, MYCOSES, V52, P197, DOI 10.1111/j.1439-0507.2009.01691.x; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Odds FC, 2009, FEMS YEAST RES, V9, P1091, DOI 10.1111/j.1567-1364.2009.00577.x; Peters BM, 2012, MICROBIOL-SGM, V158, P2975, DOI 10.1099/mic.0.062109-0; Powell LC, 2014, AM J RESP CELL MOL, V50, P483, DOI 10.1165/rcmb.2013-0287OC; Powell LC, 2013, BIOFOULING, V29, P413, DOI 10.1080/08927014.2013.777954; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Ryder NS, 1998, ANTIMICROB AGENTS CH, V42, P1057, DOI 10.1128/AAC.42.5.1057; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Simon J, 2013, MYCOSES, V56, P601, DOI 10.1111/myc.12085; Veiga-Santos P, 2012, INT J ANTIMICROB AG, V40, P61, DOI 10.1016/j.ijantimicag.2012.03.009; Veras HNH, 2011, CURR TOP NUTRACEUT R, V9, P25; Walsh TJ, 2013, HEMATOL-AM SOC HEMAT, P423, DOI 10.1182/asheducation-2013.1.423; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yalcin B, 2010, MIKROBIYOL BUL, V44, P65; Zarember KA, 2009, ANTIMICROB AGENTS CH, V53, P2654, DOI 10.1128/AAC.01547-08; Zeidler U, 2013, J ANTIMICROB CHEMOTH, V68, P1285, DOI 10.1093/jac/dks538	40	53	61	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112518	10.1371/journal.pone.0112518	http://dx.doi.org/10.1371/journal.pone.0112518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409186	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000345533200024
J	Velez-Zuazo, X; Quinones, J; Pacheco, AS; Klinge, L; Paredes, E; Quispe, S; Kelez, S				Velez-Zuazo, Ximena; Quinones, Javier; Pacheco, Aldo S.; Klinge, Luciana; Paredes, Evelyn; Quispe, Sixto; Kelez, Shaleyla			Fast Growing, Healthy and Resident Green Turtles (Chelonia mydas) at Two Neritic Sites in the Central and Northern Coast of Peru: Implications for Conservation	PLOS ONE			English	Article							BAJA-CALIFORNIA; FEEDING ECOLOGY; SOMATIC GROWTH; SEA-TURTLES; SURVIVAL PROBABILITY; BAHIA MAGDALENA; MARINE TURTLES; OCEAN; MIGRATIONS; PATTERNS	In order to enhance protection and conservation strategies for endangered green turtles (Chelonia mydas), the identification of neritic habitats where this species aggregates is mandatory. Herein, we present new information about the population parameters and residence time of two neritic aggregations from 2010 to 2013; one in an upwelling dominated site (Paracas similar to 14 degrees S) and the other in an ecotone zone from upwelling to warm equatorial conditions (El Nuro similar to 4 degrees S) in the Southeast Pacific. We predicted proportionally more adult individuals would occur in the ecotone site; whereas in the site dominated by an upwelling juvenile individuals would predominate. At El Nuro, the population was composed by (15.3%) of juveniles, (74.9%) sub-adults, and (9.8%) adults, with an adult sex ratio of 1.16 males per female. Times of residence in the area ranged between a minimum of 121 and a maximum of 1015 days (mean 331.1 days). At Paracas the population was composed by (72%) of juveniles and (28%) sub-adults, no adults were recorded, thus supporting the development habitat hypothesis stating that throughout the neritic distribution there are sites exclusively occupied by juveniles. Residence time ranged between a minimum of 65 days and a maximum of 680 days (mean 236.1). High growth rates and body condition index values were estimated suggesting healthy individuals at both study sites. The population traits recorded at both sites suggested that conditions found in Peruvian neritic waters may contribute to the recovery of South Pacific green turtles. However, both aggregations are still at jeopardy due to pollution, bycatch and illegal catch and thus require immediate enforcing of conservation measurements.	[Velez-Zuazo, Ximena] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR USA; [Velez-Zuazo, Ximena; Pacheco, Aldo S.; Klinge, Luciana; Kelez, Shaleyla] ecOceanica, Lima, Peru; [Quinones, Javier; Quispe, Sixto] Inst Mar Peru, Lab Costero Pisco, Ica, Peru; [Pacheco, Aldo S.] Univ Antofagasta, CENSOR Lab, Inst Ciencias Nat Alexander von Humboldt, Antofagasta, Chile; [Paredes, Evelyn] Inst Mar Peru, Unidad Invest Depredadores Super, Callao, Peru	University of Puerto Rico; University of Puerto Rico Rio Piedras; Instituto del Mar del Peru; Universidad de Antofagasta; Instituto del Mar del Peru	Quinones, J (corresponding author), Inst Mar Peru, Lab Costero Pisco, Ica, Peru.	javierantonioquinones@gmail.com; shaleyla.kelez@ecoceanica.org	Pacheco, Aldo S/L-9939-2017; Kelez, Shaleyla/AAE-8259-2020; Quinones, Javier/O-7755-2018	Pacheco, Aldo S/0000-0002-2767-6436; Kelez, Shaleyla/0000-0003-3296-8721; Paredes-Coral, Evelyn/0000-0002-9940-3066; Quinones, Javier/0000-0002-6193-8022	PADI Fundation; Idea Wild; Pro Natura Japan; Rufford Small Grants Foundation; Patagonia Footwear through 1% for the Planet; OAK Foundation through Duke Minigrants; Umanotera Foundation through Krilca Gifts; Instituto del Mar del Peru	PADI Fundation; Idea Wild; Pro Natura Japan; Rufford Small Grants Foundation; Patagonia Footwear through 1% for the Planet; OAK Foundation through Duke Minigrants; Umanotera Foundation through Krilca Gifts; Instituto del Mar del Peru	Green turtle research at El Nuro was supported with funds from PADI Fundation, Idea Wild, Pro Natura Japan, Rufford Small Grants Foundation, Patagonia Footwear through 1% for the Planet, OAK Foundation through Duke Minigrants and Umanotera Foundation through Krilca Gifts. The Instituto del Mar del Peru provided funds for sea turtle research at Paracas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro Shigueto Joanna, 2008, Endangered Species Research, V5, P129, DOI 10.3354/esr00142; Alfaro-Shigueto J., 2010, Marine Turtle Newsletter, P19; Alfaro-Shigueto J, 2011, J APPL ECOL, V48, P1432, DOI 10.1111/j.1365-2664.2011.02040.x; Amorocho Diego F., 2007, Endangered Species Research, V3, P43, DOI 10.3354/esr003043; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Aranda A. C., 1989, Boletin de Lima, V11, P77; Arthur Karen E., 2009, Marine Turtle Newsletter, P6; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.2307/2641001; Bjorndal KA, 2003, MAR ECOL PROG SER, V252, P273, DOI 10.3354/meps252273; BJORNDAL KA, 1988, COPEIA, P555, DOI 10.2307/1445373; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bjorndal KA, 1997, BIOL SEA TURTLES, P137; CARR A, 1980, COPEIA, P366, DOI 10.2307/1444022; CARR A, 1987, Conservation Biology, V1, P103, DOI 10.1111/j.1523-1739.1987.tb00020.x; Carrion J, 2010, J MAR BIOL ASS UK, V90, P1005; Castro J, 2012, LAT AM J AQUAT RES, V40, P970, DOI 10.3856/vol40-issue4-fulltext-13; Chaloupka M, 2004, CORAL REEFS, V23, P325, DOI 10.1007/s00338-004-0387-9; Christianen MJA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2890; de Paz N, 2002, 1 JORN CIENT BAS EC, P125; Echevin V, 2008, PROG OCEANOGR, V79, P167, DOI 10.1016/j.pocean.2008.10.026; Eguchi T, 2012, HERPETOLOGICA, V68, P76, DOI 10.1655/HERPETOLOGICA-D-11-00050.1; Eguchi T, 2010, MAR BIOL, V157, P1869, DOI 10.1007/s00227-010-1458-9; Ehrhart Llewellyn M., 1999, P61; Forsberg Kerstin S., 2012, Marine Turtle Newsletter, P9; Gil-Kodaka P., 2002, JORNADA CIENT FICA B, P154; Hamann Mark, 2006, Endangered Species Research, V2, P81, DOI 10.3354/esr002081; Hays-Brown C, 1982, BIOL CONSERVATION SE, P235; Kelez Shaleyla, 2003, Ecol. apl., V2, P141; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Koch V, 2007, MAR BIOL, V153, P35, DOI 10.1007/s00227-007-0782-1; Krueger BH, 2011, MAR ECOL PROG SER, V432, P269, DOI 10.3354/meps09125; Kubis S, 2009, MAR ECOL PROG SER, V389, P257, DOI 10.3354/meps08206; Lopez-Castro Melania C., 2010, Endangered Species Research, V11, P35, DOI 10.3354/esr00264; Lopez-Mendilaharsu M, 2005, AQUAT CONSERV, V15, P259, DOI 10.1002/aqc.676; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Marquez R, 1990, FAO SPECIES CATALOGU, V125, P1; McMichael E, 2008, J NAT HIST, V42, P2793, DOI 10.1080/00222930802357335; Meylan PA, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/357.1; Mianzan Hermes W., 1999, P513; MORTIMER JA, 1981, BIOTROPICA, V13, P49, DOI 10.2307/2387870; Munoz Perez JP, 2009, THESIS U SAN FRANCIS; Musick John A., 1997, P137; NMFS, 1998, REC PLAN E PAC GREEN; Paredes R, 1969, THESIS U NACL FEDERI; Patricio AR, 2011, MAR ECOL PROG SER, V440, P217, DOI 10.3354/meps09337; Patricio R, 2014, ENDANGER SPECIES RES, V23, P51, DOI 10.3354/esr00554; Quinones J, 2008, INFORME INSTITUTO MA, V35, P221; Quinones J, 2010, DEV HYDROBIOL, V212, P69, DOI 10.1007/s10750-010-0225-8; Riascos JM, 2013, J MAR BIOL ASSOC UK, V93, P919, DOI 10.1017/S002531541200094X; Rosales Carlos A., 2010, Rev. peru biol., V17, P293; Santillan LA, 2008, THESIS U NACL AGRARI; Seminoff JA, 2003, J MAR BIOL ASSOC UK, V83, P1355, DOI 10.1017/S0025315403008816; Seminoff JA, 2002, J HERPETOL, V36, P447, DOI 10.2307/1566189; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Senko J, 2010, J EXP MAR BIOL ECOL, V391, P92, DOI 10.1016/j.jembe.2010.06.017; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sterling EJ, 2013, CHELONIAN CONSERV BI, V12, P2, DOI 10.2744/CCB-1014.1; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Taquet C, 2006, MAR ECOL PROG SER, V306, P295, DOI 10.3354/meps306295; Wabnitz CCC, 2010, MAR ECOL PROG SER, V420, P27, DOI 10.3354/meps08846; Wallace BP, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00388.1; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Wester J, 2010, THESIS LEIDEN U NEDE	63	26	27	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113068	10.1371/journal.pone.0113068	http://dx.doi.org/10.1371/journal.pone.0113068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409240	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200064
J	Jin, H; Mimura, N; Kashio, M; Koseki, H; Aoe, T				Jin, Hisayo; Mimura, Naoya; Kashio, Makiko; Koseki, Haruhiko; Aoe, Tomohiko			Late-Onset of Spinal Neurodegeneration in Knock-In Mice Expressing a Mutant BiP	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; KDEL RECEPTOR; ER STRESS; REELIN; MOUSE; DISEASE; GLYCOPROTEIN; DYSFUNCTION	Most human neurodegenerative diseases are sporadic, and appear later in life. While the underlying mechanisms of the progression of those diseases are still unclear, investigations into the familial forms of comparable diseases suggest that endoplasmic reticulum (ER) stress is involved in the pathogenesis. Binding immunoglobulin protein (BiP) is an ER chaperone that is central to ER function. We produced knock-in mice expressing a mutant BiP that lacked the retrieval sequence in order to evaluate the effect of a functional defect in an ER chaperone in multi-cellular organisms. Here we report that heterozygous mutant BiP mice revealed motor disabilities in aging. We found a degeneration of some motoneurons in the spinal cord accompanied by accumulations of ubiquitinated proteins. The defect in retrieval of BiP by the KDEL receptor leads to impaired activities in quality control and autophagy, suggesting that functional defects in the ER chaperones may contribute to the late onset of neurodegenerative diseases.	[Jin, Hisayo; Kashio, Makiko; Aoe, Tomohiko] Chiba Univ, Dept Anesthesiol, Grad Sch Med, Chiba, Japan; [Mimura, Naoya] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Koseki, Haruhiko] RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Aoe, Tomohiko] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Anesthesiol, Chiba, Japan	Chiba University; Chiba University; RIKEN; Tokyo Women's Medical University	Aoe, T (corresponding author), Chiba Univ, Dept Anesthesiol, Grad Sch Med, Chiba, Japan.	taoe@faculty.chiba-u.jp	Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854	Ministry of Education, Culture, Sports, Science and Technology of Japan [20059008]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aids for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T.A. (20059008, http://www.mext.go.jp/english/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; BEH CT, 1995, P NATL ACAD SCI USA, V92, P9820, DOI 10.1073/pnas.92.21.9820; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dobashi T, 2010, J CELL MOL MED, V14, P2816, DOI 10.1111/j.1582-4934.2009.00932.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fatemi SH, 2005, MOL PSYCHIATR, V10, P251, DOI 10.1038/sj.mp.4001613; Gorbatyuk MS., 2013, J GENET SYNDR GENE T, V4; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8007-8017.2004; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Mimura N, 2007, CELL DEATH DIFFER, V14, P1475, DOI 10.1038/sj.cdd.4402151; Mimura N, 2008, MOL CELL BIOL, V28, P293, DOI 10.1128/MCB.00473-07; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Wang P, 2011, NEUROSCIENCE, V190, P43, DOI 10.1016/j.neuroscience.2011.06.008; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	30	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112837	10.1371/journal.pone.0112837	http://dx.doi.org/10.1371/journal.pone.0112837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405877	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300056
J	Laur, J; Hacke, UG				Laur, Joan; Hacke, Uwe G.			The Role of Water Channel Proteins in Facilitating Recovery of Leaf Hydraulic Conductance from Water Stress in Populus trichocarpa	PLOS ONE			English	Article							DROUGHT STRESS; PLASMA-MEMBRANE; AQUAPORIN EXPRESSION; GENE-EXPRESSION; XYLEM EMBOLISM; VULNERABILITY; PLANT; TRANSPORT; RICE; DEHYDRATION	Gas exchange is constrained by the whole-plant hydraulic conductance (K-plant). Leaves account for an important fraction of Kplant and may therefore represent a major determinant of plant productivity. Leaf hydraulic conductance (K-leaf) decreases with increasing water stress, which is due to xylem embolism in leaf veins and/or the properties of the extra-xylary pathway. Water flow through living tissues is facilitated and regulated by water channel proteins called aquaporins (AQPs). Here we assessed changes in the hydraulic conductance of Populus trichocarpa leaves during a dehydration-rewatering episode. While leaves were highly sensitive to drought, K-leaf recovered only 2 hours after plants were rewatered. Recovery of K-leaf was absent when excised leaves were bench-dried and subsequently xylem-perfused with a solution containing AQP inhibitors. We examined the expression patterns of 12 highly expressed AQP genes during a dehydration-rehydration episode to identify isoforms that may be involved in leaf hydraulic adjustments. Among the AQPs tested, several genes encoding tonoplast intrinsic proteins (TIPs) showed large increases in expression in rehydrated leaves, suggesting that TIPs contribute to reversing drought-induced reductions in K-leaf. TIPs were localized in xylem parenchyma, consistent with a role in facilitating water exchange between xylem vessels and adjacent living cells. Dye uptake experiments suggested that reversible embolism formation in minor leaf veins contributed to the observed changes in K-leaf.	[Laur, Joan; Hacke, Uwe G.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Laur, J (corresponding author), Univ Alberta, Dept Renewable Resources, 442 Earth Sci Bldg, Edmonton, AB, Canada.	laur@ualberta.ca	Hacke, Uwe/M-7719-2015; laur, joan/M-5727-2017	Hacke, Uwe/0000-0001-5983-3582; laur, joan/0000-0001-6759-6484	Natural Sciences and Engineering Research Council (NSERC) Discovery grant; Canada Foundation for Innovation; Canada Research Chair program	Natural Sciences and Engineering Research Council (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair program(Canada Research Chairs)	U. G. H. acknowledges funding from a Natural Sciences and Engineering Research Council (NSERC) Discovery grant, the Canada Foundation for Innovation and the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Almeida-Rodriguez AM, 2010, PHYSIOL PLANTARUM, V140, P321, DOI 10.1111/j.1399-3054.2010.01405.x; Almeida-Rodriguez AM, 2012, AM J BOT, V99, P1249, DOI 10.3732/ajb.1200088; Almeida-Rodriguez AM, 2011, PLANT CELL ENVIRON, V34, P1318, DOI 10.1111/j.1365-3040.2011.02331.x; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Barrieu F, 1998, PLANT PHYSIOL, V117, P1153, DOI 10.1104/pp.117.4.1153; Brodribb TJ, 2005, PLANT PHYSIOL, V137, P1139, DOI 10.1104/pp.104.058156; Brodribb TJ, 2004, NEW PHYTOL, V162, P663, DOI 10.1111/j.1469-8137.2004.01060.x; Brodribb TJ, 2003, PLANT CELL ENVIRON, V26, P443, DOI 10.1046/j.1365-3040.2003.00975.x; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Chitarra W, 2014, PLANTA, V239, P887, DOI 10.1007/s00425-013-2017-7; Christman MA, 2012, NEW PHYTOL, V193, P713, DOI 10.1111/j.1469-8137.2011.03984.x; Cohen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055506; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Fouquet R, 2008, PLANT CELL REP, V27, P1541, DOI 10.1007/s00299-008-0566-1; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Gong HQ, 2006, PLANT MOL BIOL REP, V24, P93, DOI 10.1007/BF02914049; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Guyot G, 2012, PLANT CELL ENVIRON, V35, P857, DOI 10.1111/j.1365-3040.2011.02458.x; Hacke UG, 2000, OECOLOGIA, V124, P495, DOI 10.1007/PL00008875; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Jang HY, 2013, J PLANT PHYSIOL, V170, P1028, DOI 10.1016/j.jplph.2013.03.001; Johnson DM, 2011, TREE PHYSIOL, V31, P659, DOI 10.1093/treephys/tpr050; Johnson DM, 2012, PLANT CELL ENVIRON, V35, P760, DOI 10.1111/j.1365-3040.2011.02449.x; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; Kirch HH, 2000, PLANT PHYSIOL, V123, P111, DOI 10.1104/pp.123.1.111; LARSON P R, 1971, Canadian Journal of Forest Research, V1, P1, DOI 10.1139/x71-001; Laur J, 2014, NEW PHYTOL, V203, P388, DOI 10.1111/nph.12806; Laur J, 2013, J EXP BOT, V64, P2283, DOI 10.1093/jxb/ert096; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martorell S, 2014, PLANT CELL ENVIRON, V37, P617, DOI 10.1111/pce.12182; Martre P, 2002, PLANT PHYSIOL, V130, P2101, DOI 10.1104/pp.009019; Mayr S, 2014, PLANT PHYSIOL, V164, P1731, DOI 10.1104/pp.114.236646; Nardini A, 2003, TREES-STRUCT FUNCT, V17, P529, DOI 10.1007/s00468-003-0265-z; Nardini A, 2014, FUNCT ECOL, V28, P810, DOI 10.1111/1365-2435.12246; Nardini A, 2011, PLANT SCI, V180, P604, DOI 10.1016/j.plantsci.2010.12.011; North GB, 2004, PLANT CELL ENVIRON, V27, P219, DOI 10.1111/j.1365-3040.2003.01137.x; Pavy N, 2008, NEW PHYTOL, V180, P766, DOI 10.1111/j.1469-8137.2008.02615.x; PEZESHKI SR, 1982, CAN J FOREST RES, V12, P761, DOI 10.1139/x82-115; Postaire O, 2010, PLANT PHYSIOL, V152, P1418, DOI 10.1104/pp.109.145326; Pou A, 2013, PLANT CELL ENVIRON, V36, P828, DOI 10.1111/pce.12019; Prado K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00255; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; SACK L, 2012, JOVE-J VIS EXP, P1, DOI DOI 10.3791/4179; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Sakurai J, 2008, PLANT CELL PHYSIOL, V49, P30, DOI 10.1093/pcp/pcm162; SCHULTE PJ, 1987, PLANT CELL ENVIRON, V10, P313, DOI 10.1111/j.1365-3040.1987.tb01611.x; Scoffoni C, 2014, PLANT PHYSIOL, V164, P1772, DOI 10.1104/pp.113.221424; Scoffoni C, 2012, J EXP BOT, V63, P643, DOI 10.1093/jxb/err270; Secchi F, 2007, ANN APPL BIOL, V150, P163, DOI 10.1111/j.1744-7348.2007.00118.x; Secchi F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00507; Secchi F, 2010, PLANT CELL ENVIRON, V33, P1285, DOI 10.1111/j.1365-3040.2010.02147.x; Shatil-Cohen A, 2011, PLANT J, V67, P72, DOI 10.1111/j.1365-313X.2011.04576.x; Sparks JP, 1999, TREE PHYSIOL, V19, P453; Sperry JS, 2002, PLANT CELL ENVIRON, V25, P251, DOI 10.1046/j.0016-8025.2001.00799.x; Stiller V, 2003, PLANT PHYSIOL, V132, P1698, DOI 10.1104/pp.102.019851; Stiller V, 2005, AM J BOT, V92, P1970, DOI 10.3732/ajb.92.12.1970; Trifilo P, 2003, J EXP BOT, V54, P2323, DOI 10.1093/jxb/erg259; TYREE MT, 1988, PLANT PHYSIOL, V88, P574, DOI 10.1104/pp.88.3.574; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Yamada S, 2000, PLANT CELL PHYSIOL, V41, P719, DOI 10.1093/pcp/41.6.719	64	33	35	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111751	10.1371/journal.pone.0111751	http://dx.doi.org/10.1371/journal.pone.0111751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406088	gold, Green Submitted, Green Published			2022-12-26	WOS:000347121300016
J	Mohideen, AMSH; Hyde, A; Squires, J; Wang, J; Dicks, E; Younghusband, B; Parfrey, P; Green, R; Savas, S				Mohideen, Asan M. S. Haja; Hyde, Angela; Squires, Jessica; Wang, Jing; Dicks, Elizabeth; Younghusband, Ban; Parfrey, Patrick; Green, Roger; Savas, Sevtap			Examining the Polymorphisms in the Hypoxia Pathway Genes in Relation to Outcome in Colorectal Cancer	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; LYSYL OXIDASE; IMPACT	Introduction: Colorectal cancer is a common malignancy. Identification of genetic prognostic markers may help prognostic estimations in colorectal cancer. Genes that regulate response to hypoxia and other genes that are regulated under the hypoxic conditions have been shown to play roles in cancer progression. In this study, we hypothesized that genetic variations in the hypoxia pathway genes were associated with the risk of outcome in colorectal cancer patients. Methods: This study was performed in two phases. In the first phase, 49 SNPs from six hypoxia pathway genes (HIF1A, HIF1B, HIF2A, LOX, MIF and CXCL12) in 272 colorectal cancer patients were analyzed. In the second phase, 77 SNPs from seven hypoxia pathway genes (HIF1A, HIF1B, HIF2A, HIF2B, HIF3A, LOX and CXCL12) were analyzed in an additional cohort of 535 patients. Kaplan Meier, Cox univariate and multivariable regression analyses were performed to analyze the relationship between the SNPs and overall survival (OS), disease free survival (DFS) or disease specific survival (DSS). Since this was a hypothesis-generating study, no correction for multiple testing was applied. Results: In phase I, one SNP (HIF2A rs11125070) was found to be associated with DFS in multivariable analysis; yet association of a proxy polymorphism (HIF2A rs4953342) was not detected in the phase II patient cohort. In phase II, associations of two SNPs (HIF2A rs4953352 and HIF2B rs12593988) were significant in both OS and DFS multivariable analyses. However, association of HIF2A rs4953352 was not replicated in the phase I cohort using a proxy SNP (HIF2A rs6706003). Conclusion: Overall, our study did not find a convincing evidence of association of the investigated polymorphisms with the disease outcomes in colorectal cancer.	[Mohideen, Asan M. S. Haja; Hyde, Angela; Squires, Jessica; Younghusband, Ban; Green, Roger; Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Wang, Jing] Mem Univ Newfoundland, Fac Med, Div Community Hlth & Humanities, St John, NF, Canada; [Dicks, Elizabeth; Parfrey, Patrick] Mem Univ Newfoundland, Fac Med, Clin Epidemiol Unit, St John, NF, Canada; [Savas, Sevtap] Mem Univ Newfoundland, Fac Med, Discipline Oncol, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Savas, S (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.	savas@mun.ca			Research and Development Corporation of Newfoundland (RDC; Ignite fund) [5404.1201.101]; Research and Development Corporation of Newfoundland (RDC; leverage fund) [5404.1201.102]; Canadian Institute of Health Research (CIHR) operating fund [FRN: 110045]; Medical Research Foundation (MRF)-Cox Award; CIHR fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto and Memorial University; National Cancer Institute of Canada [18223, 18226]; Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; Walter and Jessie Boyd & Charles Scriver MD/PhD Studentship Award (Canadian Institute of Health Research Institute of Genetics and the Canadian Gene Cure Foundation)	Research and Development Corporation of Newfoundland (RDC; Ignite fund); Research and Development Corporation of Newfoundland (RDC; leverage fund); Canadian Institute of Health Research (CIHR) operating fund(Canadian Institutes of Health Research (CIHR)); Medical Research Foundation (MRF)-Cox Award; CIHR fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto and Memorial University; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics; Walter and Jessie Boyd & Charles Scriver MD/PhD Studentship Award (Canadian Institute of Health Research Institute of Genetics and the Canadian Gene Cure Foundation)	This study was supported by the Research and Development Corporation of Newfoundland (RDC; Ignite fund to SS: contract number: 5404.1201.101 and leverage fund to SS, RG, PP: contract number: 5404.1201.102), the Canadian Institute of Health Research (CIHR) operating fund (to SS, RG, PP; FRN: 110045), the Medical Research Foundation (MRF)-Cox Award 2010 (to SS and RG), CIHR fund for the Colorectal Cancer Interdisciplinary Health Research Team at the University of Toronto and Memorial University, the National Cancer Institute of Canada (grants 18223 and 18226) and the Atlantic Innovation Fund for the Interdisciplinary Research Team in Human Genetics. Angela Hyde was supported by the Walter and Jessie Boyd & Charles Scriver MD/PhD Studentship Award (Canadian Institute of Health Research Institute of Genetics and the Canadian Gene Cure Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Beerlage C, 2013, INFECT IMMUN, V81, P2562, DOI 10.1128/IAI.00302-13; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Chang SC, 2009, ANN SURG ONCOL, V16, P2323, DOI 10.1245/s10434-009-0501-x; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gerger A, 2011, CLIN CANCER RES, V17, P5783, DOI 10.1158/1078-0432.CCR-11-1115; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Hidalgo-Pascual M, 2007, ONCOL REP, V18, P1583; Negandhi AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061469; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Santiago B, 2011, CYTOKINE, V53, P184, DOI 10.1016/j.cyto.2010.06.006; Savas S, 2010, HUM MUTAT, V31, P901, DOI 10.1002/humu.21285; Szkandera J, 2010, ANTICANCER RES, V30, P2393; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Woods MO, 2010, GUT, V59, P1369, DOI 10.1136/gut.2010.208462; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135	20	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113513	10.1371/journal.pone.0113513	http://dx.doi.org/10.1371/journal.pone.0113513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405996	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000347121300120
J	Valcz, G; Patai, AV; Kalmar, A; Peterfia, B; Furi, I; Wichmann, B; Muzes, G; Sipos, F; Krenacs, T; Mihaly, E; Spisak, S; Molnar, B; Tulassay, Z				Valcz, Gabor; Patai, Arpad V.; Kalmar, Alexandra; Peterfia, Balint; Furi, Istvan; Wichmann, Barnabas; Muzes, Gyoergyi; Sipos, Ferenc; Krenacs, Tibor; Mihaly, Emese; Spisak, Sandor; Molnar, Bela; Tulassay, Zsolt			Myofibroblast-Derived SFRP1 as Potential Inhibitor of Colorectal Carcinoma Field Effect	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; WNT SIGNALING PATHWAY; BETA-CATENIN; COLON-CANCER; PROMOTER METHYLATION; WNT/BETA-CATENIN; GENES; EXPRESSION; CELLS; BINDS	Epigenetic changes of stromal-epithelial interactions are of key importance in the regulation of colorectal carcinoma (CRC) cells and morphologically normal, but genetically and epigenetically altered epithelium in normal adjacent tumor (NAT) areas. Here we demonstrated retained protein expression of well-known Wnt inhibitor, secreted frizzled-related protein 1 (SFRP1) in stromal myofibroblasts and decreasing epithelial expression from NAT tissues towards the tumor. SFRP1 was unmethylated in laser microdissected myofibroblasts and partially hypermethylated in epithelial cells in these areas. In contrast, we found epigenetically silenced myofibroblast-derived SFRP1 in CRC stroma. Our results suggest that the myofibroblast-derived SFRP1 protein might be a paracrine inhibitor of epithelial proliferation in NAT areas and loss of this signal may support tumor proliferation in CRC.	[Valcz, Gabor; Wichmann, Barnabas; Molnar, Bela; Tulassay, Zsolt] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary; [Patai, Arpad V.; Kalmar, Alexandra; Peterfia, Balint; Furi, Istvan; Muzes, Gyoergyi; Sipos, Ferenc; Mihaly, Emese; Molnar, Bela; Tulassay, Zsolt] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Spisak, Sandor] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Patai, AV (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	arpad.patai@gmail.com	Sipos, Ferenc/GYV-6182-2022		National Office for Research and Technology, Hungary [TECH08-AI/2-2008_0114]	National Office for Research and Technology, Hungary(National Office for Research and Technology)	This study was supported in part by the National Office for Research and Technology, Hungary, Grant number: TECH08-AI/2-2008_0114. Funder's website:www.magzrt.hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no other funding to this study.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bernstein C, 2008, CANCER LETT, V260, P1, DOI 10.1016/j.canlet.2007.11.027; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Di Domenico M, 2011, CANCER BIOL THER, V12, P447, DOI 10.4161/cbt.12.5.15963; Galamb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048547; Ge L, 2010, MED HYPOTHESES, V75, P26, DOI 10.1016/j.mehy.2010.01.019; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Hughes KR, 2011, INFLAMM BOWEL DIS, V17, P213, DOI 10.1002/ibd.21353; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Lee JL, 2004, BREAST CANCER RES TR, V84, P139, DOI 10.1023/B:BREA.0000018412.83348.ff; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Patai AV, 2012, DIGEST DIS, V30, P310, DOI 10.1159/000337004; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Rubin JS, 2006, FRONT BIOSCI, V11, P2093, DOI 10.2741/1952; Saini S, 2009, CANCER RES, V69, P6815, DOI 10.1158/0008-5472.CAN-09-1254; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Shtilbans V, 2013, CANCER MICROENVIRON, V6, P193, DOI 10.1007/s12307-013-0131-5; Spisak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046215; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Tanaka J, 2008, HEPATO-GASTROENTEROL, V55, P1265; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Trujillo KA, 2011, INT J CANCER, V129, P1310, DOI 10.1002/ijc.25788; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	45	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e106143	10.1371/journal.pone.0106143	http://dx.doi.org/10.1371/journal.pone.0106143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405986	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300001
J	Vinit, S; Keomani, E; Deramaudt, TB; Spruance, VM; Bezdudnaya, T; Lane, MA; Bonay, M; Petitjean, M				Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Spruance, Victoria M.; Bezdudnaya, Tatiana; Lane, Michael A.; Bonay, Marcel; Petitjean, Michel			Interdisciplinary Approaches of Transcranial Magnetic Stimulation Applied to a Respiratory Neuronal Circuitry Model	PLOS ONE			English	Article							MOTOR EVOKED-POTENTIALS; COIL ORIENTATION; SPINAL-CORD; CORTICAL REPRESENTATION; PHRENIC MOTONEURONS; BRAIN-STIMULATION; HUMAN DIAPHRAGM; RAT; CORTEX; NERVE	Respiratory related diseases associated with the neuronal control of breathing represent life-threatening issues and to date, no effective therapeutics are available to enhance the impaired function. The aim of this study was to determine whether a preclinical respiratory model could be used for further studies to develop a non-invasive therapeutic tool applied to rat diaphragmatic neuronal circuitry. Transcranial magnetic stimulation (TMS) was performed on adult male Sprague-Dawley rats using a human figure-of-eight coil. The largest diaphragmatic motor evoked potentials (MEPdia) were recorded when the center of the coil was positioned 6 mm caudal from Bregma, involving a stimulation of respiratory supraspinal pathways. Magnetic shielding of the coil with mu metal reduced magnetic field intensities and improved focality with increased motor threshold and lower amplitude recruitment curve. Moreover, transynaptic neuroanatomical tracing with pseudorabies virus (applied to the diaphragm) suggest that connections exist between the motor cortex, the periaqueductal grey cell regions, several brainstem neurons and spinal phrenic motoneurons (distributed in the C3-4 spinal cord). These results reveal the anatomical substrate through which supraspinal stimulation can convey descending action potential volleys to the spinal motoneurons (directly or indirectly). We conclude that MEPdia following a single pulse of TMS can be successfully recorded in the rat and may be used in the assessment of respiratory supraspinal plasticity. Supraspinal non-invasive stimulations aimed to neuromodulate respiratory circuitry will enable new avenues of research into neuroplasticity and the development of therapies for respiratory dysfunction associated with neural injury and disease (e.g. spinal cord injury, amyotrophic lateral sclerosis).	[Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Bonay, Marcel; Petitjean, Michel] Univ Versailles St Quentin En Yvelines, Unite End Icap, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France; [Deramaudt, Therese B.; Bonay, Marcel] CSM, LIA BAHN, Monaco, Monaco; [Spruance, Victoria M.; Bezdudnaya, Tatiana; Lane, Michael A.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Bonay, Marcel; Petitjean, Michel] Hop Ambroise Pare, AP HP, Serv Physiol Explorat Fonct, Grp Hosp Paris Ile de France Ouest, Boulogne, France	UDICE-French Research Universities; Universite Paris Saclay; Drexel University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Petitjean, M (corresponding author), Univ Versailles St Quentin En Yvelines, Unite End Icap, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France.	michel.petitjean134@gmail.com	Lane, Michael/B-3395-2014; Bonay, Marcel/ABG-2039-2020	Lane, Michael/0000-0003-1375-6483; Bonay, Marcel/0000-0003-1446-7456; vinit, stephane/0000-0001-7013-1741	European Union Seventh framework Programme (FP7) (European project RBUCE-UP) [246556]; internal funds	European Union Seventh framework Programme (FP7) (European project RBUCE-UP); internal funds	This work was supported by funding from the European Union Seventh framework Programme (FP7/2007-2013) under grant agreement No. 246556 (European project RBUCE-UP), HandiMedEx allocated by the French Public Investment Board, the Chancellerie des Universites de Paris (Legs Poix), the << Centre d'Assistance Respiratoire a Domicile d'Ile de France (CARDIF) >>, the << Fonds de Dotation de Recherche en Sante Respiratoire >> and LVL Medical. Financial support for neuroanatomical studies was provided through internal funds awarded to Michael Lane at Drexel University - College of Medicine, Department of Neurobiology & Anatomy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov VG, 2007, J PHYSIOL PHARMACOL, V58, P17; Azabou E, 2013, RESP PHYSIOL NEUROBI, V189, P183, DOI 10.1016/j.resp.2013.07.024; Bader SR, 2011, J NEUROSCI METH, V194, P342, DOI 10.1016/j.jneumeth.2010.11.002; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; CROS D, 1990, MUSCLE NERVE, V13, P1076, DOI 10.1002/mus.880131110; Davey NJ, 1996, RESP PHYSIOL, V106, P127, DOI 10.1016/S0034-5687(96)00069-2; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; Dubach P, 2004, CLIN NEUROPHYSIOL, V115, P862, DOI 10.1016/j.clinph.2003.11.033; FISHBACK AS, 1995, NEUROSURGERY, V37, P969, DOI 10.1227/00006123-199511000-00017; GANDEVIA SC, 1987, J PHYSIOL-LONDON, V384, P109, DOI 10.1113/jphysiol.1987.sp016445; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Hunanyan AS, 2012, J NEUROPHYSIOL, V107, P3027, DOI 10.1152/jn.00015.2012; Huxtable AG, 2011, RESP PHYSIOL NEUROBI, V178, P482, DOI 10.1016/j.resp.2011.06.017; Kamida T, 1998, MUSCLE NERVE, V21, P722, DOI 10.1002/(SICI)1097-4598(199806)21:6<722::AID-MUS3>3.0.CO;2-9; Khedr EM, 2001, EUR J APPL PHYSIOL, V85, P560, DOI 10.1007/s004210100504; Kolb B.E., 1990, CEREBRAL CORTEX RAT; Lane MA, 2008, TRENDS NEUROSCI, V31, P538, DOI 10.1016/j.tins.2008.07.002; Lane MA, 2008, J COMP NEUROL, V511, P692, DOI 10.1002/cne.21864; Lane MA, 2009, RESP PHYSIOL NEUROBI, V169, P123, DOI 10.1016/j.resp.2009.08.007; Laviolette L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062258; Linden RD, 1999, J NEUROSURG, V91, P205, DOI 10.3171/spi.1999.91.2.0205; LIPSKI J, 1986, EXP BRAIN RES, V61, P280; LISSENS MA, 1994, J NEUROL SCI, V124, P204, DOI 10.1016/0022-510X(94)90327-1; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Maccabee PJ, 1998, J PHYSIOL-LONDON, V513, P571, DOI 10.1111/j.1469-7793.1998.571bb.x; MACEFIELD G, 1991, J PHYSIOL-LONDON, V439, P545, DOI 10.1113/jphysiol.1991.sp018681; MASKILL D, 1991, J PHYSIOL-LONDON, V443, P105, DOI 10.1113/jphysiol.1991.sp018825; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Muller PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091065; Nakatoh S, 1998, MUSCLE NERVE, V21, P1172, DOI 10.1002/(SICI)1097-4598(199809)21:9<1172::AID-MUS8>3.0.CO;2-4; Ni Z, 2011, J NEUROPHYSIOL, V105, P749, DOI 10.1152/jn.00640.2010; Niehaus L, 2000, CLIN NEUROPHYSIOL, V111, P75, DOI 10.1016/S1388-2457(99)00198-4; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PLANCHE D, 1972, J PHYSIOL-PARIS, V64, P31; Raux M, 2010, J APPL PHYSIOL, V108, P39, DOI 10.1152/japplphysiol.91454.2008; Rotenberg A, 2010, CLIN NEUROPHYSIOL, V121, P104, DOI 10.1016/j.clinph.2009.09.008; Sharshar T, 2003, AM J RESP CRIT CARE, V168, P760, DOI 10.1164/rccm.200203-241OC; Sharshar T, 2003, J APPL PHYSIOL, V95, P26, DOI 10.1152/japplphysiol.00918.2002; Subramanian HH, 2013, J COMP NEUROL, V521, P3083, DOI 10.1002/cne.23334; Vinit S, 2011, RESP PHYSIOL NEUROBI, V176, P130, DOI 10.1016/j.resp.2011.02.008; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Zifko U, 1996, MUSCLE NERVE, V19, P614, DOI 10.1002/(SICI)1097-4598(199605)19:5<614::AID-MUS9>3.0.CO;2-E	43	17	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113251	10.1371/journal.pone.0113251	http://dx.doi.org/10.1371/journal.pone.0113251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406091	Green Published, gold			2022-12-26	WOS:000347121300093
J	Bruch, J; Xu, H; De Andrade, A; Hoglinger, G				Bruch, Julius; Xu, Hong; De Andrade, Anderson; Hoeglinger, Guenter			Mitochondrial Complex 1 Inhibition Increases 4-Repeat Isoform Tau by SRSF2 Upregulation	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; I INHIBITOR; PHOSPHORYLATION; TAUOPATHIES; ANNONACIN; NEURONS; DEGENERATION; DYSFUNCTION; DISEASE; BRAIN	Progressive Supranuclear Palsy (PSP) is a neurodegenerative disorder characterised by intracellular aggregation of the microtubule-associated protein tau. The tau protein exists in 6 predominant isoforms. Depending on alternative splicing of exon 10, three of these isoforms have four microtubule-binding repeat domains (4R), whilst the others only have three (3R). In PSP there is an excess of the 4R tau isoforms, which are thought to contribute significantly to the pathological process. The cause of this 4R increase is so far unknown. Several lines of evidence link mitochondrial complex I inhibition to the pathogenesis of PSP. We demonstrate here for the first time that annonacin and MPP+, two prototypical mitochondrial complex I inhibitors, increase the 4R isoforms of tau in human neurons. We show that the splicing factor SRSF2 is necessary to increase 4R tau with complex I inhibition. We also found SRSF2, as well as another tau splicing factor, TRA2B, to be increased in brains of PSP patients. Thereby, we provide new evidence that mitochondrial complex I inhibition may contribute as an upstream event to the pathogenesis of PSP and suggest that splicing factors may represent an attractive therapeutic target to intervene in the disease process.	[Bruch, Julius; Xu, Hong; De Andrade, Anderson; Hoeglinger, Guenter] German Ctr Neurodegenerat Dis DZNE, Dept Translat Neurodegenerat, Munich, Germany; [Bruch, Julius; Xu, Hong; Hoeglinger, Guenter] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich	Hoglinger, G (corresponding author), German Ctr Neurodegenerat Dis DZNE, Dept Translat Neurodegenerat, Munich, Germany.	hoeglinger@lrz.tum.de	Höglinger, Günter U/F-2388-2015; Xu, Hong/AAP-6568-2020	Höglinger, Günter U/0000-0001-7587-6187; 	Bavarian Research Foundation (Bayerische Forschungsstiftung); DAAD ( German Academic Exchange Service); DFG (Deutsche Forschungsgemeinschaft) [HO2402/6-2]	Bavarian Research Foundation (Bayerische Forschungsstiftung); DAAD ( German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	J.B. was funded by the Bavarian Research Foundation (Bayerische Forschungsstiftung), H. X. by the DAAD ( German Academic Exchange Service), G. U. H. by the DFG (Deutsche Forschungsgemeinschaft, HO2402/6-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers DS, 2001, EXP NEUROL, V168, P196, DOI 10.1006/exnr.2000.7607; Avale ME, 2013, HUM MOL GENET, V22, P2603, DOI 10.1093/hmg/ddt108; Buee L, 1999, BRAIN PATHOL, V9, P681; Chambers CB, 1999, ANN NEUROL, V46, P325, DOI 10.1002/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V; Chen SF, 2010, J ALZHEIMERS DIS, V22, P1313, DOI 10.3233/JAD-2010-101155; Edmond V, 2011, CELL CYCLE, V10, P1968, DOI 10.4161/cc.10.12.15825; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; Glinka Y, 1997, J NEURAL TRANSM-SUPP, P55; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Lannuzel A, 2003, NEUROSCIENCE, V121, P287, DOI 10.1016/S0306-4522(03)00441-X; Lannuzel A, 2007, BRAIN, V130, P816, DOI 10.1093/brain/awl347; Lenaz Giorgio, 2006, Ital J Biochem, V55, P232; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Pilch B, 2001, CANCER RES, V61, P6876; Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; SILVER IA, 1994, J NEUROSCI, V14, P5068; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stamelou M, 2010, BRAIN, V133, P1578, DOI 10.1093/brain/awq115; Stamelou M, 2009, J CEREBR BLOOD F MET, V29, P861, DOI 10.1038/jcbfm.2009.2; Swerdlow RH, 2000, J NEUROCHEM, V75, P1681, DOI 10.1046/j.1471-4159.2000.0751681.x; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Williams DR, 2006, INTERN MED J, V36, P652, DOI 10.1111/j.1445-5994.2006.01153.x; Yamada ES, 2014, EXP NEUROL, V253, P113, DOI 10.1016/j.expneurol.2013.12.017; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou JH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S10	28	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113070	10.1371/journal.pone.0113070	http://dx.doi.org/10.1371/journal.pone.0113070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402454	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700106
J	Favaro, B; Claar, DC; Fox, CH; Freshwater, C; Holden, JJ; Roberts, A				Favaro, Brett; Claar, Danielle C.; Fox, Caroline H.; Freshwater, Cameron; Holden, Jessica J.; Roberts, Allan		Uvic Res Derby	Trends in Extinction Risk for Imperiled Species in Canada	PLOS ONE			English	Article							HABITAT LOSS; RECOVERY; THREATS; FISHES; BIODIVERSITY; ECOSYSTEM; SCIENCE; ACT	Protecting and promoting recovery of species at risk of extinction is a critical component of biodiversity conservation. In Canada, the Committee on the Status of Endangered Wildlife in Canada (COSEWIC) determines whether species are at risk of extinction or extirpation, and has conducted these assessments since 1977. We examined trends in COSEWIC assessments to identify whether at-risk species that have been assessed more than once tended to improve, remain constant, or deteriorate in status, as a way of assessing the effectiveness of biodiversity conservation in Canada. Of 369 species that met our criteria for examination, 115 deteriorated, 202 remained unchanged, and 52 improved in status. Only 20 species (5.4%) improved to the point where they were 'not at risk', and five of those were due to increased sampling efforts rather than an increase in population size. Species outcomes were also dependent on the severity of their initial assessment; for example, 47% of species that were initially listed as special concern deteriorated between assessments. After receiving an at-risk assessment by COSEWIC, a species is considered for listing under the federal Species at Risk Act (SARA), which is the primary national tool that mandates protection for at-risk species. We examined whether SARA-listing was associated with improved COSEWIC assessment outcomes relative to unlisted species. Of 305 species that had multiple assessments and were SARA-listed, 221 were listed at a level that required identification and protection of critical habitat; however, critical habitat was fully identified for only 56 of these species. We suggest that the Canadian government should formally identify and protect critical habitat, as is required by existing legislation. In addition, our finding that at-risk species in Canada rarely recover leads us to recommend that every effort be made to actively prevent species from becoming at-risk in the first place.	[Favaro, Brett; Claar, Danielle C.; Freshwater, Cameron; Holden, Jessica J.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Favaro, Brett] Mem Univ Newfoundland, Fisheries & Marine Inst, Ctr Sustainable Aquat Resources, St John, NF, Canada; [Favaro, Brett] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; [Fox, Caroline H.] Univ Victoria, Dept Geog, Victoria, BC, Canada; [Fox, Caroline H.] Raincoast Conservat Fdn, Sidney, BC, Canada; [Roberts, Allan] Bamfield Marine Sci Ctr, Bamfield East, BC, Canada; [Uvic Res Derby] Univ Victoria, Sch Environm Studies, Victoria, BC, Canada	University of Victoria; Memorial University Newfoundland; Memorial University Newfoundland; University of Victoria; Simon Fraser University; University of Victoria	Favaro, B (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	brett.favaro@mi.mun.ca	Claar, Danielle/AAP-9348-2020	Claar, Danielle/0000-0003-2389-111X	Liber Ero postdoctoral fellowship; Raincoast Conservation Foundation; National Sciences and Engineering Research Council of Canada; University of Victoria Graduate Fellowships	Liber Ero postdoctoral fellowship; Raincoast Conservation Foundation; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Victoria Graduate Fellowships	BF was supported by a Liber Ero postdoctoral fellowship (http://liberero.ca/). CHF was supported by the Raincoast Conservation Foundation (http://www.raincoast.org/) and the National Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). DCC and CF were supported by University of Victoria Graduate Fellowships. Catering for the UVIC Research Derby event was provided by the University of Victoria Environmental Science and Biology departments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, SARA SPECIES RISK AC, V29, P15; Arponen A, 2012, BIODIVERS CONSERV, V21, P875, DOI 10.1007/s10531-012-0242-1; Auditor General of Canada, 2013, AN REP COMM ENV SUST, P1; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Canada Gazette, 2013, SPEC RISK ACT; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Christensen R., 2013, R PACKAGE VERSION 20, P08; Christensen R. H. B., 2013, TUTORIAL FITTING CUM; Convention on Biological Diversity, 2010, GLOBAL BIODIVERSITY; COSEWIC, 2011, COSEWICS ASS PROC CR; COSEWIC, 2013, TERMS REF COMM STAT; COSEWIC, 2013, DAT WILDL SPEC ASS C; COSEWIC, 2005, OR CRIT DEF US STAT; Favaro B, 2013, IDEAS ECOL EVOL, V6, P40, DOI 10.4033/iee.2013.6.9.n; Favaro B, 2012, SCIENCE, V337, P154, DOI 10.1126/science.1225523; Findlay CS, 2009, CONSERV BIOL, V23, P1609, DOI 10.1111/j.1523-1739.2009.01255.x; Government of Canada, 2014, SPEC RISK ACT PUBL R; Hassan RM, 2005, FINDINGS CONDITION T; Homan RN, 2004, ECOL APPL, V14, P1547, DOI 10.1890/03-5125; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hutchings JA, 2013, FISHERIES, V38, P497, DOI 10.1080/03632415.2013.848345; IUCN, 2022, GUID US IUCN RED LIS; KAREIVA P, 1995, NATURE, V373, P299, DOI 10.1038/373299a0; Kirchhoff D, 2014, IMPACT ASSESS PROJ A, V32, P108, DOI 10.1080/14615517.2014.894673; Kowalchuk KA, 2012, ECOL SOC, V17, DOI 10.5751/ES-04893-170304; Lukey JR, 2010, CONSERV BIOL, V24, P1398, DOI 10.1111/j.1523-1739.2010.01555.x; Lukey JR, 2009, CAN J FISH AQUAT SCI, V66, P959, DOI 10.1139/F09-054; McCune JL, 2013, BIOL CONSERV, V166, P254, DOI 10.1016/j.biocon.2013.07.006; Mooers AO, 2007, CONSERV BIOL, V21, P572, DOI 10.1111/j.1523-1739.2007.00689.x; Mooers AO, 2010, BIOSCIENCE, V60, P843, DOI 10.1525/bio.2010.60.10.11; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Powles H, 2011, FISHERIES, V36, P231, DOI 10.1080/03632415.2011.574582; R Core Team, 2021, R LANGUAGE ENV STAT; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Redford KH, 2011, BIOSCIENCE, V61, P39, DOI 10.1525/bio.2011.61.1.9; Schultz JA, 2013, MAR POLICY, V42, P125, DOI 10.1016/j.marpol.2013.01.021; Taylor EB, 2013, ENVIRON REV, V21, P93, DOI 10.1139/er-2013-0002; Taylor MFJ, 2011, BIODIVERS CONSERV, V20, P767, DOI 10.1007/s10531-010-9977-8; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; Tutz G, 1996, COMPUT STAT DATA AN, V22, P537, DOI 10.1016/0167-9473(96)00004-7; VanderZwaag DL, 2005, OCEAN DEV INT LAW, V36, P219, DOI 10.1080/00908320591004333; Venter O, 2006, BIOSCIENCE, V56, P903, DOI 10.1641/0006-3568(2006)56[903:TTESIC]2.0.CO;2; Waples RS, 2013, BIOSCIENCE, V63, P723, DOI 10.1525/bio.2013.63.9.8; Westwood A, 2014, BIOL CONSERV, V172, P155, DOI 10.1016/j.biocon.2014.02.031; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	46	38	39	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113118	10.1371/journal.pone.0113118	http://dx.doi.org/10.1371/journal.pone.0113118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401772	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000345158700115
J	Qin, GM; Luo, LS; Lv, LH; Xiao, YF; Tu, JF; Tao, LS; Wu, JQ; Tang, XX; Pan, WS				Qin, Guangming; Luo, Laisheng; Lv, Lihong; Xiao, Yufei; Tu, Jiangfeng; Tao, Lisha; Wu, Jiaqi; Tang, Xiaoxiao; Pan, Wensheng			Decision Tree Analysis of Traditional Risk Factors of Carotid Atherosclerosis and a Cutpoint-Based Prevention Strategy	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS	Background: Reducing the exposure to risk factors for the prevention of cardio-cerebral vascular disease is a crucial issue. Few reports have described practical interventions for preventing cardiovascular disease in different genders and age groups, particularly detailed and specific cutpoint-based prevention strategies. Methods: We collected the health examination data of 5822 subjects between 20 and 80 years of age. The administration of medical questionnaires and physical examinations and the measurement of blood pressure, fasting plasma glucose (FPG) and blood lipids [total cholesterol (TC), triglycerides (TG), high density lipoprotein-cholesterol (HDL-C), and low density lipoprotein-cholesterol (LDL-C)] were performed by physicians. Carotid ultrasound was performed to examine the carotid intima-media thickness (CIMT), which was defined as carotid atherosclerosis when CIMT >= 0.9 mm. Decision tree analysis was used to screen for the most important risk factors for carotid atherosclerosis and to identify the relevant cutpoints. Results: In the study population, the incidence of carotid atherosclerosis was 12.20% (men: 14.10%, women: 9.20%). The statistical analysis showed significant differences in carotid atherosclerosis incidence between different genders (P, 0.0001) and age groups (P, 0.001). The decision tree analysis showed that in men, the most important traditional risk factors for carotid atherosclerosis were TC (cutpoint [CP]: 6.31 mmol/L) between the ages of 20-40 and FPG (CP: 5.79 mmol/L) between the ages of 41-59. By comparison, LDL-C (CP: 4.27 mmol/L) became the major risk factor when FPG <= 5.79 mmol/L. FPG (CP: 5.52 mmol/L) and TG (CP: 1.51 mmol/L) were the most important traditional risk factors for women between 20-40 and 41-59 years of age, respectively. Conclusion: Traditional risk factors and relevant cutpoints were not identical in different genders and age groups. A specific gender and age group-based cutpoint strategy might contribute to preventing cardiovascular disease.	[Qin, Guangming; Xiao, Yufei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Laisheng; Lv, Lihong; Tu, Jiangfeng; Tao, Lisha; Wu, Jiaqi; Tang, Xiaoxiao; Pan, Wensheng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Wensheng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Pan, WS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	wspan223@163.com			National Health Key Special Fund [200802112]; Health Department Fund [2007A093]; Traditional Chinese Medicine Bureau Fund [2007ZA019]; Natural Science Fund of Zhejiang Province [Y2080001, Y12H160121]; Zhejiang Province Education Department Fund [Y201121724]; Zhejiang Province Health Department Fund [201343550]; Key Project of Zhejiang Province [2009C03012-5, 2013C03044-5]; National Natural Science Foundation of China [81372302]	National Health Key Special Fund; Health Department Fund; Traditional Chinese Medicine Bureau Fund; Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Province Education Department Fund; Zhejiang Province Health Department Fund; Key Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Health Key Special Fund (No. 200802112), the Health Department Fund (No. 2007A093), the Traditional Chinese Medicine Bureau Fund (No. 2007ZA019), the Natural Science Fund of Zhejiang Province (No. Y2080001 and Y12H160121), the Zhejiang Province Education Department Fund (No. Y201121724), the Zhejiang Province Health Department Fund (No. 201343550), the Key Project of Zhejiang Province (No. 2009C03012-5 and No. 2013C03044-5) and the National Natural Science Foundation of China (general project No. 81372302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer MS, 2014, AM J CARDIOVASC DIS, V4, P14; Bauer M, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13705; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P866; Chevalier P, 2013, CIRC-ARRHYTHMIA ELEC, V6, P185, DOI 10.1161/CIRCEP.112.970459; Chinese Society of Cardiology, 2013, CHINESE J CARDIOLOGY, V41, P820; Crooke Michael, 2007, Clin Biochem Rev, V28, P19; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P177, DOI 10.1161/ATVBAHA.108.173609; Gandomi AH, 2013, SCI WORLD J, DOI 10.1155/2013/346285; George JM, 2013, J CLIN DIAGN RES, V7, P1082, DOI 10.7860/JCDR/2013/4767.3029; Hamirani YS, 2010, ATHEROSCLEROSIS, V211, P141, DOI 10.1016/j.atherosclerosis.2010.01.020; Johnsen SH, 2007, STROKE, V38, P2873, DOI 10.1161/STROKEAHA.107.487264; Khalil A, 2013, INT J CARDIOL, V167, P1322, DOI 10.1016/j.ijcard.2012.03.180; Kozakova M, 2013, ARTERIOSCL THROM VAS, V33, P1409, DOI 10.1161/ATVBAHA.112.300948; Kweon SS, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-112; Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Marshall RJ, 2001, J CLIN EPIDEMIOL, V54, P603, DOI 10.1016/S0895-4356(00)00344-9; Pearson TA, 2002, CIRCULATION, V105, P886, DOI 10.1161/hc0702.103727; Rundek T, 2013, STROKE, V44, P2101, DOI 10.1161/STROKEAHA.111.000745; Sirimarco G, 2013, STROKE, V44, P373, DOI 10.1161/STROKEAHA.112.673129; Sun Jia-Yi, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P649; Tabatabaei-Malazy O, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-13; Takahashi R, 2012, INT HEART J, V53, P29, DOI 10.1536/ihj.53.29; Ton VK, 2013, CLIN CARDIOL, V36, pE1, DOI 10.1002/clc.22079; Viikki K, 2001, J Med Syst, V25, P133, DOI 10.1023/A:1005624715089; Wang Wei, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P1118; Wang Wei, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P553; [杨颖 YANG Ying], 2010, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V19, P120	28	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111769	10.1371/journal.pone.0111769	http://dx.doi.org/10.1371/journal.pone.0111769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398126	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500025
J	Strickland, DH; Fear, V; Shenton, S; Wikstrom, ME; Zosky, G; Larcombe, AN; Holt, PG; Berry, C; von Garnier, C; Stumbles, PA				Strickland, Deborah H.; Fear, Vanessa; Shenton, Seth; Wikstrom, Mathew E.; Zosky, Graeme; Larcombe, Alexander N.; Holt, Patrick G.; Berry, Cassandra; von Garnier, Christophe; Stumbles, Philip A.			Persistent and Compartmentalised Disruption of Dendritic Cell Subpopulations in the Lung following Influenza A Virus Infection	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; COLONY-STIMULATING FACTOR; CD8 T-CELLS; MHC CLASS-I; AIRWAY EPITHELIUM; ANTIGEN PRESENTATION; ALLERGIC DISEASE; EARLY-LIFE; AGE 13; INDUCTION	Immunological homeostasis in the respiratory tract is thought to require balanced interactions between networks of dendritic cell (DC) subsets in lung microenvironments in order to regulate tolerance or immunity to inhaled antigens and pathogens. Influenza A virus (IAV) poses a serious threat of long-term disruption to this balance through its potent pro-inflammatory activities. In this study, we have used a BALB/c mouse model of A/PR8/34 H1N1 Influenza Type A Virus infection to examine the effects of IAV on respiratory tissue DC subsets during the recovery phase following clearance of the virus. In adult mice, we found differences in the kinetics and activation states of DC residing in the airway mucosa (AMDC) compared to those in the parenchymal lung (PLDC) compartments. A significant depletion in the percentage of AMDC was observed at day 4 post-infection that was associated with a change in steady-state CD11b(+) and CD11b(-) AMDC subset frequencies and significantly elevated CD40 and CD80 expression and that returned to baseline by day 14 post-infection. In contrast, percentages and total numbers of PLDC were significantly elevated at day 14 and remained so until day 21 post-infection. Accompanying this was a change in CD11b(+) and CD11b(-) PLDC subset frequencies and significant increase in CD40 and CD80 expression at these time points. Furthermore, mice infected with IAV at 4 weeks of age showed a significant increase in total numbers of PLDC, and increased CD40 expression on both AMDC and PLDC, when analysed as adults 35 days later. These data suggest that the rate of recovery of DC populations following IAV infection differs in the mucosal and parenchymal compartments of the lung and that DC populations can remain disrupted and activated for a prolonged period following viral clearance, into adulthood if infection occurred early in life.	[Strickland, Deborah H.; Fear, Vanessa; Shenton, Seth; Wikstrom, Mathew E.; Zosky, Graeme; Larcombe, Alexander N.; Holt, Patrick G.; von Garnier, Christophe; Stumbles, Philip A.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Strickland, Deborah H.; Fear, Vanessa; Shenton, Seth; Wikstrom, Mathew E.; Zosky, Graeme; Larcombe, Alexander N.; Holt, Patrick G.; von Garnier, Christophe; Stumbles, Philip A.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Shenton, Seth; Berry, Cassandra; Stumbles, Philip A.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Zosky, Graeme] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Holt, Patrick G.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [von Garnier, Christophe] Univ Bern, Univ Hosp Bern, Bern, Switzerland; [von Garnier, Christophe] Univ Bern, Dept Clin Res, Bern, Switzerland	Telethon Kids Institute; University of Western Australia; University of Western Australia; Murdoch University; University of Tasmania; University of Queensland; University of Bern; University Hospital of Bern; University of Bern	Stumbles, PA (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	p.stumbles@murdoch.edu.au	Fear, Vanessa/O-5618-2019; Zosky, Graeme/B-2048-2014; Larcombe, Alexander/AAG-8533-2019; Berry, Cassandra/AAX-7145-2020; Holt, Patrick G/H-1548-2011; Strickland, Deborah/AGV-6937-2022; Fear, Vanessa S/AAF-9805-2020; strickland, deborah/K-4597-2019	Larcombe, Alexander/0000-0003-4196-4482; Holt, Patrick G/0000-0003-1193-0935; Strickland, Deborah/0000-0003-0114-4201; Fear, Vanessa S/0000-0001-8363-6685; Berry, Cassandra/0000-0003-0768-0857; von Garnier, Christophe/0000-0003-3585-9176; Zosky, Graeme/0000-0001-9039-0302	National Health and Medical Research Council of Australia [211912, 437200]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (APP ID 211912, 437200; www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Garawi AA, 2009, J IMMUNOL, V182, P3095, DOI 10.4049/jimmunol.0802837; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Beyer M, 2004, J ALLERGY CLIN IMMUN, V113, P127, DOI 10.1016/j.jaci.2003.10.057; BILYK N, 1993, J EXP MED, V177, P1773, DOI 10.1084/jem.177.6.1773; Bozanicha EM, 2008, RESP PHYSIOL NEUROBI, V162, P190, DOI 10.1016/j.resp.2008.06.011; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Cull VS, 2002, IMMUNOLOGY, V106, P428, DOI 10.1046/j.1365-2567.2002.01423.x; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Fear VS, 2011, J IMMUNOL, V187, P4561, DOI 10.4049/jimmunol.1004189; Gern JE, 2008, PEDIATR INFECT DIS J, V27, pS97, DOI 10.1097/INF.0b013e318168b718; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gill MA, 2005, J INFECT DIS, V191, P1105, DOI 10.1086/428589; Hantos Z, 2003, J APPL PHYSIOL, V95, P1695, DOI 10.1152/japplphysiol.00104.2003; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ingulli E, 2009, J IMMUNOL, V182, P29, DOI 10.4049/jimmunol.182.1.29; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; McWilliam AS, 1997, J VIROL, V71, P226, DOI 10.1128/JVI.71.1.226-236.1997; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; STERK PJ, 1993, EUR RESPIR J, V6, P894; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Stumbles PA, 2001, J IMMUNOL, V167, P228, DOI 10.4049/jimmunol.167.1.228; Stumbles PA, 2010, METHODS MOL BIOL, V595, P249, DOI 10.1007/978-1-60761-421-0_17; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Suzuki S, 1998, J ALLERGY CLIN IMMUN, V102, P732, DOI 10.1016/S0091-6749(98)70012-0; Tsitoura DC, 2000, J IMMUNOL, V165, P3484, DOI 10.4049/jimmunol.165.6.3484; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609; von Garnier C, 2007, J IMMUNOL, V179, P5748, DOI 10.4049/jimmunol.179.9.5748; Wikstrom ME, 2007, IMMUNOL CELL BIOL, V85, P182, DOI 10.1038/sj.icb.7100039; Wikstrom ME, 2006, J IMMUNOL, V177, P913, DOI 10.4049/jimmunol.177.2.913; Yoo JK, 2013, J ALLERGY CLIN IMMUN, V132, P1263, DOI 10.1016/j.jaci.2013.06.006; Zosky GR, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-15	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111520	10.1371/journal.pone.0111520	http://dx.doi.org/10.1371/journal.pone.0111520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398128	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500018
J	Chen, Q; Zou, JH; Shen, ZL; Zhang, WP; Yang, J				Chen, Qian; Zou, Junhuang; Shen, Zuolian; Zhang, Weiping; Yang, Jun			Whirlin and PDZ Domain-containing 7 (PDZD7) Proteins Are Both Required to Form the Quaternary Protein Complex Associated with Usher Syndrome Type 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COCHLEAR HAIR-CELLS; ANKLE-LINK COMPLEX; RETINITIS-PIGMENTOSA; CRYSTAL-STRUCTURE; HEARING-LOSS; MYOSIN-XVA; GENE; VLGR1; MUTATION; REVEALS	Usher syndrome (USH) is the leading genetic cause of combined hearing and vision loss. Among the three USH clinical types, type 2 (USH2) occurs most commonly. USH2A, GPR98, and WHRN are three known causative genes of USH2, whereas PDZD7 is a modifier gene found in USH2 patients. The proteins encoded by these four USH genes have been proposed to form a multiprotein complex, the USH2 complex, due to interactions found among some of these proteins in vitro, their colocalization in vivo, and mutual dependence of some of these proteins for their normal in vivo localizations. However, evidence showing the formation of the USH2 complex is missing, and details on how this complex is formed remain elusive. Here, we systematically investigated interactions among the intracellular regions of the four USH proteins using colocalization, yeast two-hybrid, and pull-down assays. We show that multiple domains of the four USH proteins interact among one another. Importantly, both WHRN and PDZD7 are required for the complex formation with USH2A and GPR98. In this USH2 quaternary complex, WHRN prefers to bind to USH2A, whereas PDZD7 prefers to bind to GPR98. Interaction between WHRN and PDZD7 is the bridge between USH2A and GPR98. Additionally, the USH2 quaternary complex has a variable stoichiometry. These findings suggest that a non-obligate, short term, and dynamic USH2 quaternary protein complex may exist in vivo. Our work provides valuable insight into the physiological role of the USH2 complex in vivo and informs possible reconstruction of the USH2 complex for future therapy.	[Chen, Qian; Zou, Junhuang; Shen, Zuolian; Zhang, Weiping; Yang, Jun] Univ Utah, Dept Opthalmol & Visual Sci, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Yang, Jun] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Yang, Jun] Univ Utah, Dept Otolaryngol Head & Neck Surg, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Yang, J (corresponding author), Univ Utah, Dept Opthalmol & Visual Sci, John A Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	jun.yang@hsc.utah.edu			National Institutes of Health [EY020853, EY014800]; Foundation Fighting Blindness; E. Matilda Ziegler Foundation for the Blind, Inc.; Research to Prevent Blindness, Inc.; Knights Templar Eye Foundation; Hearing Health Foundation; National Organization for Hearing Research Foundation; Moran Eye Center, University of Utah; NATIONAL EYE INSTITUTE [P30EY014800, R01EY020853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); E. Matilda Ziegler Foundation for the Blind, Inc.; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Knights Templar Eye Foundation; Hearing Health Foundation; National Organization for Hearing Research Foundation; Moran Eye Center, University of Utah; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY020853 (to J. Y.) and EY014800 (to the Department of Ophthalmology and Visual Sciences, University of Utah). This work was also supported by grants from the Foundation Fighting Blindness (to J. Y.), the E. Matilda Ziegler Foundation for the Blind, Inc. (to J. Y.), Research to Prevent Blindness, Inc. (to J. Y. and the Department of Ophthalmology and Visual Sciences, University of Utah), the Knights Templar Eye Foundation (to Q. C.), the Hearing Health Foundation (to J. Z.), and the National Organization for Hearing Research Foundation (to J. Z.) and a startup package from the Moran Eye Center, University of Utah (to J. Y.).	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Gee SH, 2000, BIOCHEMISTRY-US, V39, P14638, DOI 10.1021/bi001633t; Grati M, 2012, J NEUROSCI, V32, P14288, DOI 10.1523/JNEUROSCI.3071-12.2012; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Johnson KR, 2005, GENOMICS, V85, P582, DOI 10.1016/j.ygeno.2005.02.006; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liebscher I, 2013, BIOL CHEM, V394, P937, DOI 10.1515/hsz-2013-0109; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; McMillan DR, 2004, MOL CELL NEUROSCI, V26, P322, DOI 10.1016/j.mcn.2004.02.005; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Paavola K. J., MOL PHARM, V82, P777; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Rivolta C, 2002, ARCH OPHTHALMOL-CHIC, V120, P1566, DOI 10.1001/archopht.120.11.1566; Schneider E, 2009, HUM MOL GENET, V18, P655, DOI 10.1093/hmg/ddn395; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sugi T, 2007, EMBO J, V26, P2192, DOI 10.1038/sj.emboj.7601651; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Wang L, 2012, HUM MOL GENET, V21, P692, DOI 10.1093/hmg/ddr503; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Wu L, 2012, J BIOL CHEM, V287, P33460, DOI 10.1074/jbc.M112.378505; Yagi H, 2005, J NEUROCHEM, V92, P191, DOI 10.1111/j.1471-4159.2004.02875.x; Yagi H, 2007, GENES CELLS, V12, P235, DOI 10.1111/j.1365-2443.2007.01046.x; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; Zallocchi M, 2012, J NEUROSCI, V32, P13841, DOI 10.1523/JNEUROSCI.1242-12.2012; Zallocchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030573; Zou JH, 2014, HUM MOL GENET, V23, P2374, DOI 10.1093/hmg/ddt629; Zou JH, 2011, INVEST OPHTH VIS SCI, V52, P2343, DOI 10.1167/iovs.10-6141	46	46	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36070	36088		10.1074/jbc.M114.610535	http://dx.doi.org/10.1074/jbc.M114.610535			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25406310	hybrid, Green Published			2022-12-26	WOS:000346897900035
J	Lim, JG; Bang, YJ; Choi, SH				Lim, Jong Gyu; Bang, Ye-Ji; Choi, Sang Ho			Characterization of the Vibrio vulnificus 1-Cys Peroxiredoxin Prx3 and Regulation of Its Expression by the Fe-S Cluster Regulator IscR in Response to Oxidative Stress and Iron Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DISTINCT CHARACTERISTICS; 2-CYS PEROXIREDOXINS; ANTIOXIDANT PROTEIN; REACTIVE OXYGEN; GENE; GLUTAREDOXIN; ENZYME; IDENTIFICATION; PURIFICATION	Peroxiredoxins (Prxs) are ubiquitous antioxidant enzymes that reduce toxic peroxides. A new Vibrio vulnificus Prx, named Prx3, was identified and characterized in this study. Biochemical and mutational analyses revealed that Prx3 reduces H2O2, utilizing glutaredoxin 3 (Grx3) and glutathione (GSH) as reductants, and requires only N-terminal peroxidatic cysteine for its catalysis. These results, combined with the monomeric size of Prx3 observed under non-reducing conditions, suggested that Prx3 is a Grx3/GSH-dependent 1-Cys Prx and oxidized without forming intermolecular disulfide bonds. The prx3 mutation impaired growth in the medium containing peroxides and reduced virulence in mice, indicating that Prx3 is essential for survival under oxidative stress and pathogenesis of V. vulnificus. The Fe-S cluster regulator IscR activates prx3 by direct binding to a specific binding sequence centered at -44 from the transcription start site. The binding sequence was homologous to the Type 2 IscR-binding sequence, most likely recognized by the Fe-S clusterless apo-IscR in Escherichia coli. The iscR(3CA) mutant, chromosomally encoding the apo-locked IscR, exhibited 3-fold higher levels of activation of prx3 than the wild type and accumulated more IscR(3CA) protein in cells. The IscR-dependent activation of prx3 by aerobic growth and iron starvation was also associated with the increase in cellular levels of IscR protein. Taken together, the results suggested that IscR senses iron starvation as well as reactive oxygen species and shifts to the apo-form, which leads to the increase of cellular IscR and in turn prx3 expression, contributing to the survival and virulence of V. vulnificus during pathogenesis.	[Lim, Jong Gyu; Bang, Ye-Ji; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Ctr Food Safety & Toxicol, Natl Res Lab Mol Microbiol & Toxicol, Seoul 151921, South Korea	Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	choish@snu.ac.kr		Choi, Sang Ho/0000-0003-3865-1039; Bang, Ye-Ji/0000-0003-4009-0824	National Research Foundation - Ministry of Science, ICT, and Future Planning [2012R1A2A1A03009679]; R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs; Ministry of Food and Drug Safety, Republic of Korea [14162MFDS972]	National Research Foundation - Ministry of Science, ICT, and Future Planning; R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs; Ministry of Food and Drug Safety, Republic of Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by Mid-career Researcher Program Grant 2012R1A2A1A03009679 through the National Research Foundation funded by the Ministry of Science, ICT, and Future Planning; the R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs; and Ministry of Food and Drug Safety, Republic of Korea, Grant 14162MFDS972 (to S. H. C).	Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Baek WK, 2009, J MICROBIOL, V47, P624, DOI 10.1007/s12275-009-0130-x; Bang YJ, 2012, J BIOL CHEM, V287, P42516, DOI 10.1074/jbc.M112.421214; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Chung KJ, 2010, J INFECT DIS, V201, P97, DOI 10.1086/648612; Clarke DJ, 2010, BIOCHEMISTRY-US, V49, P1319, DOI 10.1021/bi901703m; Cubadda F, 2005, MICROCHEM J, V79, P91, DOI 10.1016/j.microc.2004.10.007; Djuika CF, 2013, BBA-GEN SUBJECTS, V1830, P4073, DOI 10.1016/j.bbagen.2013.04.020; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Dubbs James M., 2007, V44, P143; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Kim SM, 2012, MICROBIOL-SGM, V158, P2017, DOI 10.1099/mic.0.059071-0; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Knoops B, 1999, J BIOL CHEM, V274, P30451, DOI 10.1074/jbc.274.43.30451; Knoops Bernard, 2007, V44, P27; Lim JG, 2014, J MICROBIOL, V52, P413, DOI 10.1007/s12275-014-3592-4; Lim JG, 2014, INFECT IMMUN, V82, P569, DOI 10.1128/IAI.01141-13; Miller HK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004194; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Pauwels F, 2003, J BIOL CHEM, V278, P16658, DOI 10.1074/jbc.M300157200; Poole Leslie B., 2007, V44, P61; Poole Leslie B, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0709s49; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Pedrajas JR, 2010, ANTIOXID REDOX SIGN, V13, P249, DOI 10.1089/ars.2009.2950; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Sarma GN, 2005, J MOL BIOL, V346, P1021, DOI 10.1016/j.jmb.2004.12.022; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Wu Y, 2009, J BACTERIOL, V191, P1248, DOI 10.1128/JB.01086-08; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	53	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36263	36274		10.1074/jbc.M114.611020	http://dx.doi.org/10.1074/jbc.M114.611020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25398878	Green Published, hybrid			2022-12-26	WOS:000346897900050
J	Cai, FF; Chen, P; Chen, L; Biskup, E; Liu, Y; Chen, PC; Chang, JF; Jiang, WJ; Jing, YY; Chen, YW; Jin, H; Chen, S				Cai, Fengfeng; Chen, Ping; Chen, Li; Biskup, Ewelina; Liu, Yan; Chen, Pei-Chao; Chang, Jian-Feng; Jiang, Wenjie; Jing, Yuanya; Chen, Youwei; Jin, Hui; Chen, Su			Human RAD6 Promotes G1-S Transition and Cell Proliferation through Upregulation of Cyclin D1 Expression	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYME; HISTONE H2B; DNA-REPAIR; PROTEIN-DEGRADATION; H3 METHYLATION; YEAST RAD6; SUMO; UBIQUITYLATION; CROSSTALK; END	Protein ubiquitinylation regulates protein stability and activity. RAD6, an E2 ubiquitin-conjugating enzyme, which that has been substantially biochemically characterized, functions in a number of biologically relevant pathways, including cell cycle progression. In this study, we show that RAD6 promotes the G1-S transition and cell proliferation by regulating the expression of cyclin D1 (CCND1) in human cells. Furthermore, our data indicate that RAD6 influences the transcription of CCND1 by increasing monoubiquitinylation of histone H2B and trimethylation of H3K4 in the CCND1 promoter region. Our study presents, for the first time, an evidence for the function of RAD6 in cell cycle progression and cell proliferation in human cells, raising the possibility that RAD6 could be a new target for molecular diagnosis and prognosis in cancer therapeutics.	[Cai, Fengfeng; Chen, Ping; Chen, Li; Chang, Jian-Feng; Jiang, Wenjie; Jing, Yuanya; Chen, Youwei; Chen, Su] Tongji Univ, Sch Life Sci & Technol, Dept Breast Surg, Yangpu Hosp,Res Ctr Translat Med,East Hosp, Shanghai 200092, Peoples R China; [Biskup, Ewelina] Univ Basel Hosp, Dept Oncol, CH-4031 Basel, Switzerland; [Liu, Yan] Hebei United Univ, Coll Life Sci, Tangshan, Hebei Province, Peoples R China; [Liu, Yan] Tangshan Peoples Hosp, Inst Canc, Tangshan, Hebei Province, Peoples R China; [Chen, Pei-Chao] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China; [Jin, Hui] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China	Tongji University; University of Basel; North China University of Science & Technology; Wenzhou University; Shanghai Jiao Tong University	Jin, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China.	joycejinhui@shsmu.edu.cn; chensu@tongji.edu.cn		biskup, ewelina/0000-0002-9871-927X; Chen, Peichao/0000-0001-9587-7080	National Natural Science Foundation of China [31201051, 31301148]; Shanghai Municipal Natural Science Foundation [12ZR1433100, 12ZR1433000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation	This work was supported by National Natural Science Foundation of China (Youth Program, #31201051, #31301148) and Shanghai Municipal Natural Science Foundation (General Program, #12ZR1433100, #12ZR1433000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chen S, 2012, MOL CELL BIOL, V32, P576, DOI 10.1128/MCB.05966-11; Chen S, 2011, J BIOL CHEM, V286, P9020, DOI 10.1074/jbc.M110.190314; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kessler BM, 2013, CURR OPIN CHEM BIOL, V17, P59, DOI 10.1016/j.cbpa.2012.12.024; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lu DD, 2012, CANCER CELL, V21, P92, DOI 10.1016/j.ccr.2011.12.016; Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shekhar MPV, 2002, CANCER RES, V62, P2115; Shimura T, 2013, CELL CYCLE, V12, P2738, DOI 10.4161/cc.25746; Soares LM, 2013, MOL CELL, V49, P1019, DOI 10.1016/j.molcel.2013.03.012; Stein GS, 2006, J CELL PHYSIOL, V209, P706, DOI 10.1002/jcp.20843; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; WATKINS JF, 1993, GENE DEV, V7, P250, DOI 10.1101/gad.7.2.250; Zimmermann C, 2011, P NATL ACAD SCI USA, V108, P18748, DOI 10.1073/pnas.1115885108	25	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113727	10.1371/journal.pone.0113727	http://dx.doi.org/10.1371/journal.pone.0113727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409181	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200149
J	Comstedt, P; Hanner, M; Schuler, W; Meinke, A; Lundberg, U				Comstedt, Par; Hanner, Markus; Schueler, Wolfgang; Meinke, Andreas; Lundberg, Urban			Design and Development of a Novel Vaccine for Protection against Lyme Borreliosis	PLOS ONE			English	Article							OUTER-SURFACE PROTEIN; BURGDORFERI SENSU-LATO; DISEASE ANTIGEN OSPA; MONOCLONAL-ANTIBODIES; MEMBRANE-PROTEIN; DISULFIDE BONDS; A OSPA; IDENTIFICATION; IMMUNITY; SPIROCHETE	There is currently no Lyme borreliosis vaccine available for humans, although it has been shown that the disease can be prevented by immunization with an OspA-based vaccine (LYMErix). Outer surface protein A (OspA) is one of the dominant antigens expressed by the spirochetes when present in a tick. The Borrelia species causing Lyme borreliosis in Europe express different OspA serotypes on their surface, B. burgdorferi (serotype 1), B. afzelii (serotype 2), B. garinii (serotypes, 3, 5 and 6) and B. bavariensis (serotype 4), while only B. burgdorferi is present in the US. In order to target all these pathogenic Borrelia species, we have designed a multivalent OspA-based vaccine. The vaccine includes three proteins, each containing the C-terminal half of two OspA serotypes linked to form a heterodimer. In order to stabilize the C-terminal fragment and thus preserve important structural epitopes at physiological temperature, disulfide bonds were introduced. The immunogenicity was increased by introduction of a lipidation signal which ensures the addition of an N-terminal lipid moiety. Three immunizations with 3.0 mu g adjuvanted vaccine protected mice from a challenge with spirochetes expressing either OspA serotype 1, 2 or 5. Mice were protected against both challenge with infected ticks and in vitro grown spirochetes. Immunological analyses (ELISA, surface binding and growth inhibition) indicated that the vaccine can provide protection against the majority of Borrelia species pathogenic for humans. This article presents the approach which allows for the generation of a hexavalent vaccine that can potentially protect against a broad range of globally distributed Borrelia species causing Lyme borreliosis.	[Comstedt, Par; Hanner, Markus; Schueler, Wolfgang; Meinke, Andreas; Lundberg, Urban] Valneva Austria GmbH, Vienna, Austria		Comstedt, P (corresponding author), Valneva Austria GmbH, Vienna, Austria.	par.comstedt@valneva.com			Austrian Research Promotion Agency, BorreliaVac [821824]	Austrian Research Promotion Agency, BorreliaVac	This study was funded by the Austrian Research Promotion Agency (www.ffg.at/en), BorreliaVac; grant 821824. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1983, INFECT IMMUN, V41, P795, DOI 10.1128/IAI.41.2.795-804.1983; Battisti JM, 2008, INFECT IMMUN, V76, P5228, DOI 10.1128/IAI.00410-08; BERGSTROM S, 1989, MOL MICROBIOL, V3, P479, DOI 10.1111/j.1365-2958.1989.tb00194.x; BOCKENSTEDT LK, 1993, J IMMUNOL, V151, P900; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Centers for Disease Control and Prevention, 2013, MAN PEOPL GET LYM DI; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Ding W, 2000, J MOL BIOL, V302, P1153, DOI 10.1006/jmbi.2000.4119; Diza E, 2004, EMERG INFECT DIS, V10, P1692, DOI 10.3201/eid1009.030439; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; FIKRIG E, 1995, J EXP MED, V181, P215, DOI 10.1084/jem.181.1.215; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Foldvari G, 2005, EMERG INFECT DIS, V11, P1794; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gern L, 1997, VACCINE, V15, P1551, DOI 10.1016/S0264-410X(97)00066-2; Gipson CL, 2005, INFECT IMMUN, V73, P1644, DOI 10.1128/IAI.73.3.1644-1647.2005; Golde WT, 1997, INFECT IMMUN, V65, P882, DOI 10.1128/IAI.65.3.882-889.1997; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; Huang XL, 1998, J MOL BIOL, V281, P61, DOI 10.1006/jmbi.1998.1930; Hubalek Zdenek, 2009, V37, P31, DOI 10.1159/000213069; JOHNSON BJB, 1995, VACCINE, V13, P1086, DOI 10.1016/0264-410X(95)00035-Y; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koide S, 2005, J MOL BIOL, V350, P290, DOI 10.1016/j.jmb.2005.04.066; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; Liang FT, 1999, J IMMUNOL, V163, P5566; Lindgren E, 2006, CITESEER; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; Makabe K, 2008, J MOL BIOL, V378, P459, DOI 10.1016/j.jmb.2008.02.051; Maraspin V, 2006, EMERG INFECT DIS, V12, P1177, DOI 10.3201/eid1207.060077; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Nadelman RB, 1998, LANCET, V352, P557, DOI 10.1016/S0140-6736(98)01146-5; Noppa L, 2001, INFECT IMMUN, V69, P3323, DOI 10.1128/IAI.69.5.3323-3334.2001; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Poljak A, 2012, VACCINE, V30, P4398, DOI 10.1016/j.vaccine.2011.10.073; Rathinavelu S, 2003, INFECT IMMUN, V71, P822, DOI 10.1128/IAI.71.2.822-829.2003; Rizzoli A, 2011, EURO SURVEILL, V16; Ruzic-Sabljic E, 2002, WIEN KLIN WOCHENSCHR, V114, P544; SCHAIBLE UE, 1990, P NATL ACAD SCI USA, V87, P3768, DOI 10.1073/pnas.87.10.3768; SCHUBACH WH, 1991, INFECT IMMUN, V59, P1911, DOI 10.1128/IAI.59.6.1911-1915.1991; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwendinger MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079022; SEARS JE, 1991, J IMMUNOL, V147, P1995; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Steere AC, 2011, CLIN INFECT DIS, V52, pS259, DOI 10.1093/cid/ciq117; Strle F, 1997, CLIN INFECT DIS, V25, P273, DOI 10.1086/514551; Vinayagam A, 2004, NUCLEIC ACIDS RES, V32, pD200, DOI 10.1093/nar/gkh026; Wang GQ, 1999, J CLIN MICROBIOL, V37, P3025, DOI 10.1128/JCM.37.9.3025-3028.1999; Wressnigg N, 2013, LANCET INFECT DIS, V13, P680, DOI 10.1016/S1473-3099(13)70110-5	55	29	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113294	10.1371/journal.pone.0113294	http://dx.doi.org/10.1371/journal.pone.0113294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409015	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200093
J	Liechti, FD; Studle, N; Theurillat, R; Grandgirard, D; Thormann, W; Leib, SL				Liechti, Fabian D.; Stuedle, Nicolas; Theurillat, Regula; Grandgirard, Denis; Thormann, Wolfgang; Leib, Stephen L.			The Mood-Stabilizer Lithium Prevents Hippocampal Apoptosis and Improves Spatial Memory in Experimental Meningitis	PLOS ONE			English	Article							DENTATE GYRUS; BACTERIAL-MENINGITIS; NEUROTROPHIC FACTOR; BRAIN-INJURY; MATRIX METALLOPROTEINASES; PNEUMOCOCCAL MENINGITIS; CEREBROSPINAL-FLUID; MOUSE MODEL; NEUROGENESIS; NEURONS	Pneumococcal meningitis is associated with high morbidity and mortality rates. Brain damage caused by this disease is characterized by apoptosis in the hippocampal dentate gyrus, a morphological correlate of learning deficits in experimental paradigms. The mood stabilizer lithium has previously been found to attenuate brain damage in ischemic and inflammatory diseases of the brain. An infant rat model of pneumococcal meningitis was used to investigate the neuroprotective and neuroregenerative potential of lithium. To assess an effect on the acute disease, LiCl was administered starting five days prior to intracisternal infection with live Streptococcus pneumoniae. Clinical parameters were recorded, cerebrospinal fluid ( CSF) was sampled, and the animals were sacrificed 42 hours after infection to harvest the brain and serum. Cryosections of the brains were stained for Nissl substance to quantify brain injury. Hippocampal gene expression of Bcl-2, Bax, p53, and BDNF was analyzed. Lithium concentrations were measured in serum and CSF. The effect of chronic lithium treatment on spatial memory function and cell survival in the dentate gyrus was evaluated in a Morris water maze and by quantification of BrdU incorporation after LiCl treatment during 3 weeks following infection. In the hippocampus, LiCl significantly reduced apoptosis and gene expression of Bax and p53 while it increased expression of Bcl-2. IL-10, MCP-1, and TNF were significantly increased in animals treated with LiCl compared to NaCl. Chronic LiCl treatment improved spatial memory in infected animals. The mood stabilizer lithium may thus be a therapeutic alternative to attenuate neurofunctional deficits as a result of pneumococcal meningitis.	[Liechti, Fabian D.; Stuedle, Nicolas; Grandgirard, Denis; Leib, Stephen L.] Univ Bern, Inst Infect Dis, Neuroinfect Lab, Bern, Switzerland; [Liechti, Fabian D.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Theurillat, Regula; Thormann, Wolfgang] Univ Bern, Inst Infect Dis, Clin Pharmacol Lab, Bern, Switzerland; [Leib, Stephen L.] Swiss Fed Off Civil Protect, Spiez Lab, Div Biol, Spiez, Switzerland	University of Bern; University of Bern; University of Bern	Leib, SL (corresponding author), Univ Bern, Inst Infect Dis, Neuroinfect Lab, Bern, Switzerland.	stephen.leib@ifik.unibe.ch	Leib, Stephen/M-3786-2019; Grandgirard, Denis/AAB-8786-2020; Leib, Stephen L/A-7866-2011	Leib, Stephen/0000-0002-1106-6123; Grandgirard, Denis/0000-0002-4151-5196; Leib, Stephen L/0000-0002-1106-6123; Liechti, Fabian D./0000-0003-1006-6903	Gottfried und Julia Bangerter-Rhyner Stiftung; Swiss National Science Foundation [138094]	Gottfried und Julia Bangerter-Rhyner Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by financial contributions from the Gottfried und Julia Bangerter-Rhyner Stiftung (www.bangerter-stiftung.ch) and the Swiss National Science Foundation (Grant 138094, www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2011, BIOL PHARM BULL, V34, P272, DOI 10.1248/bpb.34.272; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bifrare YD, 2005, J INFECT DIS, V191, P40, DOI 10.1086/426399; Bifrare YD, 2003, HIPPOCAMPUS, V13, P481, DOI 10.1002/hipo.10142; Blaser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017840; Brandt CT, 2008, J INFECT DIS, V197, P235, DOI 10.1086/524874; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Caldero J, 2010, NEUROSCIENCE, V165, P1353, DOI 10.1016/j.neuroscience.2009.11.034; Castro AA, 2012, BEHAV BRAIN RES, V229, P208, DOI 10.1016/j.bbr.2012.01.016; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chandran A, 2010, PEDIAT INFECT DIS J; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Epp JR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00057; Ferrucci M, 2010, NEUROBIOL DIS, V37, P370, DOI 10.1016/j.nbd.2009.10.017; Forlenza OV, 2014, ACS CHEM NEUROSCI; Fukumoto T, 2001, PSYCHOPHARMACOLOGY, V158, P100, DOI 10.1007/s002130100871; Gehre F, 2008, J INTERN MED; Gerber J, 2003, J NEUROSCI RES, V73, P441, DOI 10.1002/jnr.10682; Gerber J, 2009, NEUROLOGY, V73, P1026, DOI 10.1212/WNL.0b013e3181b9c892; Giambelluca MS, 2014, FASEB J; Gianinazzi C, 2003, ACTA NEUROPATHOL, V105, P499, DOI 10.1007/s00401-003-0672-7; Grandgirard D, 2007, DEV NEUROSCI-BASEL, V29, P134, DOI 10.1159/000096218; Grandgirard D, 2007, ACTA NEUROPATHOL, V114, P609, DOI 10.1007/s00401-007-0304-8; Grandjean EM, 2009, CNS DRUGS, V23, P331, DOI 10.2165/00023210-200923040-00005; Guron G, 2000, J HYPERTENS, V18, P123, DOI 10.1097/00004872-200018020-00001; Hanson ND, 2011, J PHARMACOL EXP THER, V337, P180, DOI 10.1124/jpet.110.175372; Hillert M, 2012, NEUROSCI LETT, V521, P62, DOI 10.1016/j.neulet.2012.05.060; Huo KM, 2012, MOL CELL NEUROSCI, V51, P32, DOI 10.1016/j.mcn.2012.07.002; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Jornada LK, 2010, J PSYCHIATR RES, V44, P506, DOI 10.1016/j.jpsychires.2009.11.002; Kang K, 2014, NEUROL RES, V36, P79, DOI 10.1179/1743132813Y.0000000265; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KERSTEN L, 1982, ARCH INT PHARMACOD T, V260, P4; Kim JS, 2004, J NEUROCHEM, V89, P324, DOI 10.1046/j.1471-4159.2004.02329.x; Kjaersgaard G, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.202; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Leib SL, 2003, PEDIATR RES, V54, P353, DOI 10.1203/01.PDR.0000079185.67878.72; Leib SL, 2000, INFECT IMMUN, V68, P615, DOI 10.1128/IAI.68.2.615-620.2000; Leib SL, 2001, BRAIN, V124, P1734, DOI 10.1093/brain/124.9.1734; Liechti FD, 2014, INFECT IMMUN, V82, P1710, DOI 10.1128/IAI.00073-14; Linder MW, 1998, CLIN CHEM, V44, P1073; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malhi GS, 2012, AUST NZ J PSYCHIAT, V46, P192, DOI 10.1177/0004867412437346; Manji HK, 1999, BIOL PSYCHIAT, V46, P929, DOI 10.1016/S0006-3223(99)00165-1; Mitchell L, 2004, J INFECT DIS, V190, P2039, DOI 10.1086/425520; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Morichi S, 2013, INT J NEUROSCI, V123, P17, DOI 10.3109/00207454.2012.721829; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Nassar A, 2014, ACS CHEM NEUROSCI; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; Nonaka S, 1998, NEUROREPORT, V9, P2081, DOI 10.1097/00001756-199806220-00031; Pascali JP, 2010, ANAL BIOANAL CHEM, V396, P2543, DOI 10.1007/s00216-010-3537-7; Quiroz JA, 2010, NEUROPSYCHOBIOLOGY, V62, P50, DOI 10.1159/000314310; Ratajczak MZ, 2010, LEUKEMIA, V24, P1667, DOI 10.1038/leu.2010.162; Severus WE, 2009, J AFFECT DISORDERS, V115, P466, DOI 10.1016/j.jad.2008.10.009; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Son H, 2003, J NEUROCHEM, V85, P872, DOI 10.1046/j.1471-4159.2003.01725.x; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; vanFurth AM, 1996, INFECT IMMUN, V64, P4883, DOI 10.1128/IAI.64.12.4883-4890.1996; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wada A, 2005, J PHARMACOL SCI, V99, P307, DOI 10.1254/jphs.CRJ05009X; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Wittwer M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-176; WRAAE O, 1978, BRIT J PHARMACOL, V64, P273, DOI 10.1111/j.1476-5381.1978.tb17300.x; Yoneyama M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087953; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008; Zysset-Burri DC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-393	76	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113607	10.1371/journal.pone.0113607	http://dx.doi.org/10.1371/journal.pone.0113607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409333	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200140
J	Phelan, JA; Abrams, WR; Norman, RG; Li, YH; Laverty, M; Corby, PM; Nembhard, J; Neri, D; Barber, CA; Aberg, JA; Fisch, GS; Poles, MA; Malamud, D				Phelan, Joan A.; Abrams, William R.; Norman, Robert G.; Li, Yihong; Laverty, Maura; Corby, Patricia M.; Nembhard, Jason; Neri, Dinah; Barber, Cheryl A.; Aberg, Judith A.; Fisch, Gene S.; Poles, Michael A.; Malamud, Daniel			Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; TYPE-1 INFECTION; EPITHELIAL-CELLS; LYMPHOID-TISSUE; INDIVIDUALS; CARIES; SALIVA; TRACT; HAART	Introduction: The impaired host defense system in HIV infection impacts the oral and gastrointestinal microbiota and associated opportunistic infections. Antiretroviral treatment is predicted to partially restore host defenses and decrease the oral manifestation of HIV/AIDS. Well-designed longitudinal studies are needed to better understand the interactions of soluble host defense proteins with bacteria and virus in HIV/AIDS. "Crosstalk'' was designed as a longitudinal study of host responses along the gastrointestinal (GI) tract and interactions between defense molecules and bacteria in HIV infection and subsequent therapy. Purpose: The clinical core formed the infrastructure for the study of the interactions between the proteome, microbiome and innate immune system. The core recruited and retained study subjects, scheduled visits, obtained demographic and medical data, assessed oral health status, collected samples, and guided analysis of the hypotheses. This manuscript presents a well-designed clinical core that may serve as a model for studies that combine clinical and laboratory data. Methods: Crosstalk was a case-control longitudinal clinical study an initial planned enrollment of 170 subjects. HIV+ antiretroviral naive subjects were followed for 9 visits over 96 weeks and HIV uninfected subjects for 3 visits over 24 weeks. Clinical prevalence of oral mucosal lesions, dental caries and periodontal disease were assessed. Results: During the study, 116 subjects (47 HIV+, 69 HIV-) were enrolled. Cohorts of HIV+ and HIV- were demographically similar except for a larger proportion of women in the HIV-group. The most prevalent oral mucosal lesions were oral candidiasis and hairy leukoplakia in the HIV+ group. Discussion: The clinical core was essential to enable the links between clinical and laboratory data. The study aims to determine specific differences between oral and GI tissues that account for unique patterns of opportunistic infections and to delineate the differences in their susceptibility to infection by HIV and their responses post-HAART.	[Phelan, Joan A.] NYU, Coll Dent, Dept Oral & Maxillofacial Pathol Radiol & Med, New York, NY USA; [Abrams, William R.; Li, Yihong; Barber, Cheryl A.; Malamud, Daniel] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10012 USA; [Norman, Robert G.; Fisch, Gene S.] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY USA; [Laverty, Maura; Aberg, Judith A.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Laverty, Maura; Aberg, Judith A.] Icahn Sch Med Mt Sinai, Dept Immunol & Infect Dis, New York, NY 10029 USA; [Corby, Patricia M.; Nembhard, Jason; Neri, Dinah] NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY USA; [Poles, Michael A.] NYU, Langone Med Ctr, Dept Med, Div Gastroenterol, New York, NY USA; [Malamud, Daniel] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; New York University; NYU Langone Medical Center; New York University	Abrams, WR (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10012 USA.	william.abrams@nyu.edu	Abrams, William R/A-5782-2008	Poles, Michael/0000-0002-7993-6156; Malamud, Daniel/0000-0002-9094-4122; Li, Yihong/0000-0002-5476-1943	National Institute of Dental and Craniofacial Research [U19DE018385]; NYU HHC Clinical and Translational Science Institute [NIH/NCRR1UL1RR029893-01]; NYU Center for AIDS Research (CFAR) National Institute of Allergy and Infectious Diseases [5P30AI027742]; NYU AIDS Clinical Trials Unit [5U01AI069532]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027742, U01AI069532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U19DE018385] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NYU HHC Clinical and Translational Science Institute; NYU Center for AIDS Research (CFAR) National Institute of Allergy and Infectious Diseases; NYU AIDS Clinical Trials Unit; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The National Institute of Dental and Craniofacial Research (U19DE018385); the NYU HHC Clinical and Translational Science Institute (NIH/NCRR1UL1RR029893-01) supported this work; the support of the NYU Center for AIDS Research (CFAR) National Institute of Allergy and Infectious Diseases (5P30AI027742); and the NYU AIDS Clinical Trials Unit (5U01AI069532) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NEW YORK CIT HIV AID; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cameron Jennifer E, 2008, Curr HIV/AIDS Rep, V5, P126, DOI 10.1007/s11904-008-0020-6; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Dietrich EA, 2012, AIDS RES HUM RETROV, V28, P1574, DOI [10.1089/aid.2011.0069, 10.1089/AID.2011.0069]; Feller L, 2011, SADJ, V66, P82; FLEISS JL, 1987, COMMUNITY DENT ORAL, V15, P221, DOI 10.1111/j.1600-0528.1987.tb00525.x; GREENSPAN D, 1988, GASTROENTEROL CLIN N, V17, P535; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hamza Omar J M, 2006, BMC Oral Health, V6, P12; KATZ RV, 1980, J PUBLIC HEALTH DENT, V40, P7, DOI 10.1111/j.1752-7325.1980.tb01844.x; Langman LJ, 2007, ANN NY ACAD SCI, V1098, P145, DOI 10.1196/annals.1384.001; Liu G, 2012, J DENT RES, V91, P834, DOI 10.1177/0022034512454298; Malamud D, 2011, Adv Dent Res, V23, P34, DOI 10.1177/0022034511399282; Malamud D, 2010, AIDS, V24, P5, DOI 10.1097/QAD.0b013e328333525f; Marcus M, 2005, COMMUNITY DENT ORAL, V33, P99, DOI 10.1111/j.1600-0528.2004.00171.x; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Mehandru S, 2007, J VIROL, V81, P599, DOI 10.1128/JVI.01739-06; Mravak-Stipetic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069736; Navazesh M, 2009, ORAL DIS, V15, P52, DOI 10.1111/j.1601-0825.2008.01456.x; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Phelan JA, 2004, J DENT RES, V83, P869, DOI 10.1177/154405910408301109; PHELAN JA, 1987, ORAL SURG ORAL MED O, V64, P50, DOI 10.1016/0030-4220(87)90116-2; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; Ramirez-Amador V, 2011, Adv Dent Res, V23, P165, DOI 10.1177/0022034511400080; Rodriguez-Inigo E, 2005, J MED VIROL, V77, P17, DOI [10.1002/jmv.20409, 10.1002/JMV.20409]; Saxena D, 2012, CURR HIV-AIDS REP, V9, P44, DOI 10.1007/s11904-011-0103-7; SCHIODT M, 1987, ORAL SURG ORAL MED O, V64, P716, DOI 10.1016/0030-4220(87)90174-5; SCHIODT M, 1987, INT J ORAL MAX SURG, V16, P1, DOI 10.1016/S0901-5027(87)80025-5; Shiboski CH, 2009, J ORAL PATHOL MED, V38, P481, DOI 10.1111/j.1600-0714.2009.00749.x; Tami-Maury I, 2011, J PUBLIC HEALTH DENT, V71, P257, DOI 10.1111/j.1752-7325.2011.00256.x; van der Burg SH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-108; Veazey R S, 1998, AIDS, V12 Suppl A, pS35; Veazey RS, 2004, J EXP MED, V200, P697, DOI 10.1084/jem.20041464; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Zakrzewska J M, 2003, Oral Health Prev Dent, V1, P73; Zhang NW, 2013, ANAL CHIM ACTA, V774, P61, DOI 10.1016/j.aca.2013.02.038	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112901	10.1371/journal.pone.0112901	http://dx.doi.org/10.1371/journal.pone.0112901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409430	gold, Green Published			2022-12-26	WOS:000345533200046
J	Seeley, CJ; Beninger, RJ; Smith, CT				Seeley, Corrine J.; Beninger, Richard J.; Smith, Carlyle T.			Post Learning Sleep Improves Cognitive-Emotional Decision-Making: Evidence for a 'Deck B Sleep Effect' in the Iowa Gambling Task	PLOS ONE			English	Article							EXPLICIT KNOWLEDGE; DECLARATIVE MEMORY; PERFORMANCE; SPINDLES; CONSOLIDATION; CONSEQUENCES; DAMAGE; ROLES; LEVEL; THETA	The Iowa Gambling Task (IGT) is widely used to assess real life decision-making impairment in a wide variety of clinical populations. Our study evaluated how IGT learning occurs across two sessions, and whether a period of intervening sleep between sessions can enhance learning. Furthermore, we investigate whether pre-sleep learning is necessary for this improvement. A 200-trial version of the IGT was administered at two sessions separated by wake, sleep or sleep and wake (time-of-day control). Participants were categorized as learners and non-learners based on initial performance in session one. In session one, participants initially preferred the high-frequency reward decks B and D, however, a subset of learners decreased choice from negative expected value 'bad' deck B and increased choices towards with a positive expected value 'good' decks (decks C and D). The learners who had a period of sleep (sleep and sleep/wake control conditions) between sessions showed significantly larger reduction in choices from deck B and increase in choices from good decks compared to learners that had intervening wake. Our results are the first to show that post-learning sleep can improve performance on a complex decision-making task such as the IGT. These results provide new insights into IGT learning and have important implications for understanding the neural mechanisms of "sleeping on'' a decision.	[Seeley, Corrine J.; Beninger, Richard J.] Queens Univ, Ctr Neurosci, Kingston, ON, Canada; [Beninger, Richard J.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Smith, Carlyle T.] Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada	Queens University - Canada; Queens University - Canada; Trent University	Seeley, CJ (corresponding author), Queens Univ, Ctr Neurosci, Kingston, ON, Canada.	corrineseeley@gmail.com	Beninger, Richard/AAR-1584-2021		Natural Sciences and Engineering Research Council of Canada; Canadian Institute of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by grants from the Natural Sciences and Engineering Research Council of Canada to RJB and CTS and Canadian Institute of Health Research to CTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2012, SLEEP BIOL RHYTHMS, V10, P72, DOI 10.1111/j.1479-8425.2011.00509.x; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; Chiu YC, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-13; Crone EA, 2004, PSYCHOPHYSIOLOGY, V41, P531, DOI 10.1111/j.1469-8986.2004.00197.x; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Djonlagic I, 2009, LEARN MEMORY, V16, P751, DOI 10.1101/lm.1634509; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Fernie G, 2006, BRAIN COGNITION, V60, P94, DOI 10.1016/j.bandc.2005.09.011; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Fogel SM, 2010, BRAIN RES, V1319, P112, DOI 10.1016/j.brainres.2010.01.026; Fogel SM, 2009, BRAIN RES BULL, V79, P445, DOI 10.1016/j.brainresbull.2009.03.002; Guillaume S, 2009, NEUROPSYCHOLOGIA, V47, P2120, DOI 10.1016/j.neuropsychologia.2009.04.003; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Killgore WDS, 2012, CHRONOBIOL INT, V29, P43, DOI 10.3109/07420528.2011.635230; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; Lin CH, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-16; Lin CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-72; Linnet J, 2011, ADDICTION, V106, P383, DOI 10.1111/j.1360-0443.2010.03126.x; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Overman WH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00935; Pace-Schott EF, 2012, J SLEEP RES, V21, P30, DOI 10.1111/j.1365-2869.2011.00921.x; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Perogamvros L, 2012, NEUROSCI BIOBEHAV R, V36, P1934, DOI 10.1016/j.neubiorev.2012.05.010; Peters KR, 2007, J COGNITIVE NEUROSCI, V19, P817, DOI 10.1162/jocn.2007.19.5.817; Preston SD, 2007, BEHAV NEUROSCI, V121, P257, DOI 10.1037/0735-7044.121.2.257; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Seeley CJ, 2014, J BEHAV DECIS MAKING, V27, P170, DOI 10.1002/bdm.1795; Singh V, 2009, MIND SOC, V8, P43, DOI [10.1007/s11299-008-0050-1, DOI 10.1007/S11299-008-0050-1]; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; SMITH C, 1991, BEHAV NEUROSCI, V105, P282, DOI 10.1037/0735-7044.105.2.282; Smith Carlyle, 2011, Handb Clin Neurol, V98, P259, DOI 10.1016/B978-0-444-52006-7.00017-4; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; Wasserman JI, 2012, PSYCHOPHARMACOLOGY, V222, P173, DOI 10.1007/s00213-011-2634-4; Wilhelm I, 2012, DEVELOPMENTAL SCI, V15, P506, DOI 10.1111/j.1467-7687.2012.01146.x; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Yordanova J, 2008, LEARN MEMORY, V15, P508, DOI 10.1101/lm.897908	45	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112056	10.1371/journal.pone.0112056	http://dx.doi.org/10.1371/journal.pone.0112056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409323	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200010
J	Tschinkel, WR				Tschinkel, Walter R.			Nest Relocation and Excavation in the Florida Harvester Ant, Pogonomyrmex badius	PLOS ONE			English	Article							EMIGRATION; HYMENOPTERA; COLONY; RECRUITMENT; FORMICIDAE; POLYDOMY; ECOLOGY	The Florida harvester ant (Pogonomyrmex badius) excavates deep nests in the sandy soils of the Gulf and Atlantic coastal plains. Nest relocations of over 400 colonies in a north Florida coastal plains pine forest were tracked and mapped from 2010 to 2013. Individual colonies varied from one move in two years to four times a year, averaging about one per year. Almost all moves occurred between May and November peaking in July when more than 1% of the colonies moved per day. Move directions were random, and averaged 4 m, with few moves exceeding 10 m. Distance moved was not related to colony size. Over multiple moves, paths were random walks around the original nest location. Relocation is probably intrinsic to the life history of this species, and the causes of relocation remain obscure-the architecture of old and new nests was very similar, and neither the forest canopy nor the density or size of neighbors was correlated with relocation. Monitoring entire relocations (n = 20) showed that they were usually completed in 4 to 6 days. Moves were diurnal, peaking in the mornings and afternoons dipping during mid-day, and ceasing before sundown. Workers excavated the new nest continuously during the daytime throughout the move and beyond. A minority of workers carried seeds, charcoal and brood, with seeds being by far the most common burden. The proportion of burdened workers increased throughout the move. Measured from year to year, small colonies gained size and large ones lost it. Colonies moving more than once in two years lost more size than those moving less often, suggesting that moving may bear a fitness cost. Colony relocation is a dramatic and consistent feature of the life history of the Florida harvester ant, inviting inquiry into its proximal and ultimate causes.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Science Foundation Grant [IOS 1021632]	National Science Foundation Grant(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant No. IOS 1021632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AN, 1991, ANT - PLANT INTERACTIONS, P539; Apple JL, 2014, INSECT SOC, V61, P347, DOI 10.1007/s00040-014-0359-1; AUTUORI M., 1941, ARQ INST BIOL [SAO PAULO], V12, P197; Avargues-Weber A, 2009, INSECT SOC, V56, P177, DOI 10.1007/s00040-009-0009-1; Brown MJF, 1999, INSECT SOC, V46, P66, DOI 10.1007/s000400050114; Buczkowski G, 2008, ECOL ENTOMOL, V33, P780, DOI 10.1111/j.1365-2311.2008.01034.x; CARLSON DM, 1973, ECOLOGY, V54, P452, DOI 10.2307/1934357; Dahbi A, 2008, NEST MOVING POLYDOMO; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; Diniz JLM, 1998, NATURWISSENSCHAFTEN, V85, P270, DOI 10.1007/s001140050497; FOWLER HG, 1981, BIOTROPICA, V13, P316, DOI 10.2307/2387811; Gibb H, 2003, INSECT SOC, V50, P323, DOI 10.1007/s00040-003-0689-x; GOLLEY FB, 1964, ECOLOGY, V45, P217, DOI 10.2307/1933834; GORDON DM, 1992, ANN ENTOMOL SOC AM, V85, P44, DOI 10.1093/aesa/85.1.44; Halfen AF, 2010, 19 WORLD C SOIL SCI; HARRISON JS, 1981, ECOLOGY, V62, P1467, DOI 10.2307/1941503; Hart AG, 2001, ANIM BEHAV, V62, P227, DOI 10.1006/anbe.2001.1743; Heller NE, 2006, ECOL ENTOMOL, V31, P499, DOI 10.1111/j.1365-2311.2006.00806.x; HERBERS JM, 1985, INSECT SOC, V32, P224, DOI 10.1007/BF02224913; Johnson RA, 2000, SOCIOBIOLOGY, V36, P89; Kwapich CL, 2013, BEHAV ECOL SOCIOBIOL, V67, P2011, DOI 10.1007/s00265-013-1611-9; Laskis KO, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0201; LONGHURST C, 1979, INSECT SOC, V26, P204, DOI 10.1007/BF02223798; LOPEZ F, 1994, TRENDS ECOL EVOL, V9, P150, DOI 10.1016/0169-5347(94)90185-6; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; McGlynn TP, 2007, ECOL ENTOMOL, V32, P621, DOI 10.1111/j.1365-2311.2007.00909.x; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; McGlynn TP, 2010, J TROP ECOL, V26, P559, DOI 10.1017/S0266467410000313; McGlynn TP, 2006, BIOTROPICA, V38, P419, DOI 10.1111/j.1744-7429.2006.00153.x; McGlynn TP, 2004, OIKOS, V106, P611, DOI 10.1111/j.0030-1299.2004.13135.x; Mikheyev AS, 2004, INSECT SOC, V51, P30, DOI 10.1007/s00040-003-0703-3; Nickele MA, 2012, REV BRAS ENTOMOL, V56, P385, DOI [10.1590/S0085-56262012005000045, 10.1590/S0085-56262012000300020]; PORTER SD, 1980, BIOTROPICA, V12, P232, DOI 10.2307/2387983; Pratt SC, 2005, INSECT SOC, V52, P383, DOI 10.1007/s00040-005-0823-z; Pratt SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1369, DOI 10.1007/s00265-008-0565-9; Rink WJ, 2013, J ARCHAEOL SCI, V40, P2217, DOI 10.1016/j.jas.2012.11.006; ROCKWOOD LL, 1973, J ANIM ECOL, V42, P803, DOI 10.2307/3140; Seeley T.D., 2010, HONEYBEE DEMOCRACY; SMALLWOOD J, 1982, INSECT SOC, V29, P138, DOI 10.1007/BF02228747; Smith CR, 2007, ECOL ENTOMOL, V32, P105, DOI 10.1111/j.1365-2311.2006.00845.x; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2013, ONLINE PLOSONE, V8; TSUJI K, 1988, INSECT SOC, V35, P321, DOI 10.1007/BF02225809; VANPELT A, 1976, ANN ENTOMOL SOC AM, V69, P493, DOI 10.1093/aesa/69.3.493	45	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112981	10.1371/journal.pone.0112981	http://dx.doi.org/10.1371/journal.pone.0112981			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409332	Green Submitted, gold, Green Published			2022-12-26	WOS:000345533200055
J	Agha, Z; Iqbal, Z; Azam, M; Ayub, H; Vissers, LELM; Gilissen, C; Ali, SHB; Riaz, M; Veltman, JA; Pfundt, R; van Bokhoven, H; Qamar, R				Agha, Zehra; Iqbal, Zafar; Azam, Maleeha; Ayub, Humaira; Vissers, Lisenka E. L. M.; Gilissen, Christian; Ali, Syeda Hafiza Benish; Riaz, Moeen; Veltman, Joris A.; Pfundt, Rolph; van Bokhoven, Hans; Qamar, Raheel			Exome Sequencing Identifies Three Novel Candidate Genes Implicated in Intellectual Disability	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; MUTATIONS; DISORDERS; DELETION; REVEALS; CILIA	Intellectual disability (ID) is a major health problem mostly with an unknown etiology. Recently exome sequencing of individuals with ID identified novel genes implicated in the disease. Therefore the purpose of the present study was to identify the genetic cause of ID in one syndromic and two non-syndromic Pakistani families. Whole exome of three ID probands was sequenced. Missense variations in two plausible novel genes implicated in autosomal recessive ID were identified: lysine (K)-specific methyltransferase 2B (KMT2B), zinc finger protein 589 (ZNF589), as well as hedgehog acyltransferase (HHAT) with a de novo mutation with autosomal dominant mode of inheritance. The KMT2B recessive variant is the first report of recessive Kleefstra syndrome-like phenotype. Identification of plausible causative mutations for two recessive and a dominant type of ID, in genes not previously implicated in disease, underscores the large genetic heterogeneity of ID. These results also support the viewpoint that large number of ID genes converge on limited number of common networks i.e. ZNF589 belongs to KRAB-domain zinc-finger proteins previously implicated in ID, HHAT is predicted to affect sonic hedgehog, which is involved in several disorders with ID, KMT2B associated with syndromic ID fits the epigenetic module underlying the Kleefstra syndromic spectrum. The association of these novel genes in three different Pakistani ID families highlights the importance of screening these genes in more families with similar phenotypes from different populations to confirm the involvement of these genes in pathogenesis of ID.	[Agha, Zehra; Azam, Maleeha; Ayub, Humaira; Ali, Syeda Hafiza Benish; Riaz, Moeen; Qamar, Raheel] COMSATS Inst Informat Technol, Fac Sci, Dept Biosci, Islamabad, Pakistan; [Agha, Zehra; Iqbal, Zafar; Vissers, Lisenka E. L. M.; Gilissen, Christian; Veltman, Joris A.; Pfundt, Rolph; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Agha, Zehra] Int Islamic Univ, Dept Bioinformat & Biotechnol, Islamabad, Pakistan; [van Bokhoven, Hans] Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Dept Biochem, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Radboud University Nijmegen; International Islamic University, Pakistan; Radboud University Nijmegen	van Bokhoven, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	h.vanbokhoven@radboudumc.nl; raheelqamar@hotmail.com	Gilissen, Christian/E-5246-2012; Iqbal, Zafar/J-8700-2015; Veltman, Joris A/F-5128-2010; Azam, Maleeha/AAD-9924-2022; Pfundt, Rolph/L-4576-2015; Bokhoven, J.H.L.M. van van/H-8015-2014; Vissers, Lisenka ELM/A-2598-2015; Azam, Maleeha/L-1721-2017	Gilissen, Christian/0000-0003-1693-9699; Iqbal, Zafar/0000-0002-6387-8019; Veltman, Joris A/0000-0002-3218-8250; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Vissers, Lisenka ELM/0000-0001-6470-5497; agha, zehra/0000-0003-3413-0578; Iqbal, Zafar/0000-0002-1334-6372; Azam, Maleeha/0000-0003-0170-3325	COMSATS Institute of Information Technology; European Union [241995, 223143]	COMSATS Institute of Information Technology; European Union(European Commission)	This work was supported by the COMSATS Institute of Information Technology to RQ. This study was also supported by the European Union's Seventh Framework Program [grant agreement number 241995 project GENCODYS and grant agreement number 223143, project TECHGENE]. None of the funding agencies had any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agha Z, 2013, GENE, V519, P177, DOI 10.1016/j.gene.2013.01.047; Barbaro V, 2012, AM J MED GENET A, V158A, P1957, DOI 10.1002/ajmg.a.35414; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Das I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005983; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dennis JF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002927; Ding G, 2009, NUCLEIC ACIDS RES, V37, pD267, DOI 10.1093/nar/gkn782; Fickie MR, 2011, AM J MED GENET A, V155A, P2105, DOI 10.1002/ajmg.a.34156; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Iqbal Z, 2014, HUM HERED, V77, P150, DOI 10.1159/000360539; Kanda H, 2013, MOL CELL BIOL, V33, P1702, DOI 10.1128/MCB.01585-12; Kerimoglu C, 2013, J NEUROSCI, V33, P3452, DOI 10.1523/JNEUROSCI.3356-12.2013; Kim DH, 2009, MOL ENDOCRINOL, V23, P1556, DOI 10.1210/me.2009-0099; Kleefstra T, 1993, KLEEFSTRA SYNDROME; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Liu C, 1999, EXP HEMATOL, V27, P313, DOI 10.1016/S0301-472X(98)00035-6; Lugtenberg D, 2006, AM J HUM GENET, V78, P265, DOI 10.1086/500306; Makrythanasis P, 2013, CLIN GENET, V84, P539, DOI 10.1111/cge.12081; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Shoichet SA, 2003, AM J HUM GENET, V73, P1341, DOI 10.1086/380309; Stein Z, 1987, Ups J Med Sci Suppl, V44, P89; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; van Bokhoven H, 2010, NEUROBIOL DIS, V39, P3, DOI 10.1016/j.nbd.2010.03.010; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Vissers LELM, 2012, METHODS MOL BIOL, V838, P29, DOI 10.1007/978-1-61779-507-7_2	35	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112687	10.1371/journal.pone.0112687	http://dx.doi.org/10.1371/journal.pone.0112687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405613	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300047
J	Huerta, E; Kampichler, C; Ochoa-Gaona, S; De Jong, B; Hernandez-Daumas, S; Geissen, V				Huerta, Esperanza; Kampichler, Christian; Ochoa-Gaona, Susana; De Jong, Ben; Hernandez-Daumas, Salvador; Geissen, Violette			A Multi-Criteria Index for Ecological Evaluation of Tropical Agriculture in Southeastern Mexico	PLOS ONE			English	Article							SUSTAINABILITY INDICATORS; CROPPING SYSTEMS; FARMING SYSTEMS; SOIL PROPERTIES; MANAGEMENT; AGROECOSYSTEMS; BIODIVERSITY; PLANTATIONS; CHALLENGES; IMPACTS	The aim of this study was to generate an easy to use index to evaluate the ecological state of agricultural land from a sustainability perspective. We selected environmental indicators, such as the use of organic soil amendments (green manure) versus chemical fertilizers, plant biodiversity (including crop associations), variables which characterize soil conservation of conventional agricultural systems, pesticide use, method and frequency of tillage. We monitored the ecological state of 52 agricultural plots to test the performance of the index. The variables were hierarchically aggregated with simple mathematical algorithms, if-then rules, and rule-based fuzzy models, yielding the final multi-criteria index with values from 0 (worst) to 1 (best conditions). We validated the model through independent evaluation by experts, and we obtained a linear regression with an r(2) = 0.61 (p = 2.4e-06, d.f. = 49) between index output and the experts' evaluation.	[Huerta, Esperanza; Hernandez-Daumas, Salvador] El Colegio Frontera Sur, Unidad Campeche, Dept Agroecol, Campeche, Mexico; [Kampichler, Christian] Univ Juarez Autonoma Tabasco, Div Ciencias Biol, Villahermosa, Tabasco, Mexico; [Kampichler, Christian] Sovon Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [Ochoa-Gaona, Susana; De Jong, Ben] El Colegio Frontera Sur, Unidad Campeche, Dept Sustainabil Sci, Campeche, Mexico; [Geissen, Violette] Univ Bonn, INRES, Bonn, Germany; [Geissen, Violette] Wageningen Univ & Res Ctr Alterra, Wageningen, Gelderland, Netherlands	El Colegio de la Frontera Sur (ECOSUR); Universidad Juarez Autonoma de Tabasco; El Colegio de la Frontera Sur (ECOSUR); University of Bonn; Wageningen University & Research	Huerta, E (corresponding author), El Colegio Frontera Sur, Unidad Campeche, Dept Agroecol, Campeche, Mexico.	ehuerta@ecosur.mx	de Jong, Ben HJ/GYV-3632-2022		Conacyt-SEMARNAT Project "Uso sustentable de los recursos naturales en la frontera sur de Mexico'' (Sustainable use of natural resources on the southern border of Mexico) [SEMARNAT-2002-C01-1109]	Conacyt-SEMARNAT Project "Uso sustentable de los recursos naturales en la frontera sur de Mexico'' (Sustainable use of natural resources on the southern border of Mexico)	Financial support was obtained from the Conacyt-SEMARNAT Project "Uso sustentable de los recursos naturales en la frontera sur de Mexico'' (Sustainable use of natural resources on the southern border of Mexico) (code SEMARNAT-2002-C01-1109). El Colegio de la Frontera Sur provided infrastructural resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbede TM, 2008, SOIL TILL RES, V99, P49, DOI 10.1016/j.still.2007.12.003; Allen CR, 2011, J ENVIRON MANAGE, V92, P1339, DOI 10.1016/j.jenvman.2010.11.019; Garcia-Perez JA, 2014, APPL SOIL ECOL, V83, P230, DOI 10.1016/j.apsoil.2013.09.006; Aryal DR, 2012, J PLANT NUTR SOIL SC, V175, P553, DOI 10.1002/jpln.201100117; Astier M, 2011, INT J AGR SUSTAIN, V9, P409, DOI 10.1080/14735903.2011.583481; Belalcazar S., 2000, Better Crops International, V14, P12; BELLON MR, 1995, HUM ORGAN, V54, P263, DOI 10.17730/humo.54.3.98460132152k434l; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Bockstaller C, 2003, AGR SYST, V76, P639, DOI 10.1016/S0308-521X(02)00053-7; Bockstaller C, 1997, EUR J AGRON, V7, P261, DOI 10.1016/S1161-0301(97)00041-5; Bockstaller C, 2008, AGRIENVIRONMENTAL IN, P725; Bockstaller C, 2009, AGRON SUSTAIN DEV, V29, P223, DOI 10.1051/agro:2008058; Borjesson P, 1999, BIOMASS BIOENERG, V16, P137, DOI 10.1016/S0961-9534(98)00080-4; Brussaard L, 2010, CURR OPIN ENV SUST, V2, P34, DOI 10.1016/j.cosust.2010.03.007; Cabell JF, 2012, ECOL SOC, V17, DOI 10.5751/ES-04666-170118; Carter H, 1989, CALIF AGR, V43, P1618; Correia FV, 2010, B ENVIRON CONTAM TOX, V85, P264, DOI 10.1007/s00128-010-0089-7; Darnhofer I, 2010, AGRON SUSTAIN DEV, V30, P545, DOI 10.1051/agro/2009053; Dick J, 2008, SOIL USE MANAGE, V24, P292, DOI 10.1111/j.1475-2743.2008.00163.x; Dobbs T. L., 1991, Journal for Farming Systems Research-Extension, V2, P109; EDWARDS CA, 1993, AGR ECOSYST ENVIRON, V46, P99, DOI 10.1016/0167-8809(93)90017-J; EDWARDS CA, 1989, AGR ECOSYST ENVIRON, V27, P25, DOI 10.1016/0167-8809(89)90069-8; Geissen V, 2009, GEODERMA, V151, P87, DOI 10.1016/j.geoderma.2009.03.011; Geissen V, 2006, APPL SOIL ECOL, V841, P1; Grande D., 2010, Research Journal of Biological Sciences, V5, P75; Gurr GM, 2003, BASIC APPL ECOL, V4, P107, DOI 10.1078/1439-1791-00122; HAUPTLI H, 1990, SUSTAINABLE AGRICULTURAL SYSTEMS, P141; HOUGHTON RA, 1994, BIOSCIENCE, V44, P305, DOI 10.2307/1312380; Huerta E, 2009, PESQUI AGROPECU BRAS, V44, P1056, DOI 10.1590/S0100-204X2009000800039; INEGI, 2000, CUAD EST MUN TEN GOB; INEGI, 2008, CUAD EST MUN TEN; Isaac-Marquez R, 2008, ANALISIS CAMBIO USO; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kampichler C, 2004, ECOL INDIC, V4, P99, DOI 10.1016/j.ecolind.2004.01.001; Kampichler C, 2010, ECOL INDIC, V10, P320, DOI 10.1016/j.ecolind.2009.06.010; Knorr Cetina K.D., 1984, ALTERATIONS FOOD PRO, P223; Koocheki A, 2009, AGRON SUSTAIN DEV, V29, P401, DOI 10.1051/agro/2008061; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li BL, 1996, ECOL MODEL, V90, P109, DOI 10.1016/0304-3800(96)90072-1; Lockeretz W., 1988, American Journal of Alternative Agriculture, V3, P174, DOI 10.1017/S0889189300002460; Madden P, 1990, SUSTAINABLE AGR TEMP, P315; Malezieux E, 2009, AGRON SUSTAIN DEV, V29, P43, DOI 10.1051/agro:2007057; Manjarrez-Munoz B, 2008, ORDENAMIENTO TERRITO; Melgar C, 2008, J PLANT NUTR SOIL SC, V171, P597, DOI 10.1002/jpln.200700171; Mendoza G.A., 2003, ECOLOGICAL INDICATOR, V3, P227, DOI DOI 10.1016/J.ECOLIND.2003.08.001; Meul M, 2009, ECOL INDIC, V9, P284, DOI 10.1016/j.ecolind.2008.05.007; MITCHELL G, 1995, INT J SUST DEV WORLD, V2, P104, DOI 10.1080/13504509509469893; Morales H., 2000, Agriculture and Human Values, V17, P49, DOI 10.1023/A:1007680726231; Moreno-Unda AA, 2011, ENV EFFECTS NATL TRE; Nambiar KKM, 2001, AGR ECOSYST ENVIRON, V87, P209, DOI 10.1016/S0167-8809(01)00279-1; Nyende R, 2004, EXP AGR, V40, P77, DOI 10.1017/S0014479703001443; Ortiz SM, 1994, EVALUACION CARTOGRAF; Ouedraogo E, 2001, AGR ECOSYST ENVIRON, V84, P259, DOI 10.1016/S0167-8809(00)00246-2; Pervanchon F, 2002, AGR SYST, V72, P149, DOI 10.1016/S0308-521X(01)00073-7; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Rigby D, 2001, ECOL ECON, V39, P463, DOI 10.1016/S0921-8009(01)00245-2; Riley J, 2001, AGR ECOSYST ENVIRON, V87, P119, DOI 10.1016/S0167-8809(01)00271-7; Rommelse R, 2001, ICRAF NATURAL RESOUR; Salski A, 1996, ECOL MODEL, V85, P1, DOI 10.1016/0304-3800(96)90053-8; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Shaahan MM, 1999, SCI HORTIC-AMSTERDAM, V82, P339, DOI 10.1016/S0304-4238(99)00060-6; STINNER B.R., 1987, AM J ALTERNATIVE AGR, V2, P146, DOI [10.1017/S0889189300009243, DOI 10.1017/S0889189300009243]; Tellarini V, 2000, AGR ECOSYST ENVIRON, V77, P111, DOI 10.1016/S0167-8809(99)00097-3; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; van der Werf HMG, 2002, AGR ECOSYST ENVIRON, V93, P131, DOI 10.1016/S0167-8809(01)00354-1	65	5	6	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112493	10.1371/journal.pone.0112493	http://dx.doi.org/10.1371/journal.pone.0112493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405980	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300036
J	Amarilyo, G; Iikuni, N; Liu, AJ; Matarese, G; La Cava, A				Amarilyo, Gil; Iikuni, Noriko; Liu, Aijing; Matarese, Giuseppe; La Cava, Antonio			Leptin Enhances Availability of Apoptotic Cell-Derived Self-Antigen in Systemic Lupus Erythematosus	PLOS ONE			English	Article							CLEARANCE; AUTOANTIGENS; AUTOIMMUNITY; WOMEN	In systemic lupus erythematosus (SLE), the availability of self-antigen promotes and fuels self-reactive immune responses. Apoptotic cells represent a major source of self-antigens, and an impairment of the removal of apoptotic material containing self-antigen can contribute to the development of autoimmunity. To address whether the adipocytokine leptin - which favors autoimmune responses through little understood mechanisms - could modulate the handling of apoptotic cells in SLE, we evaluated the ability of leptin to modulate the capacity of macrophages to phagocytose apoptotic bodies in (NZBxNZW)F-1 lupus mice. It was found that leptin promoted phagocytosis of apoptotic cells by macrophages by modulating cAMP levels in macrophages. This finding associated with an increased availability of antigen that favored the development of T cell responses to apoptotic-derived antigen. As leptin promotes macrophage phagocytosis of apoptotic bodies in SLE and subsequent availability of apoptotic-derived antigen to T cells, an inhibition of this process via leptin blockade might have a therapeutic potential in SLE.	[Amarilyo, Gil; Iikuni, Noriko; Liu, Aijing; La Cava, Antonio] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Matarese, Giuseppe] Univ Salerno, I-84081 Baronissi, Italy; [Matarese, Giuseppe] IRCCS MultiMed, Milan, Italy	University of California System; University of California Los Angeles; University of Salerno; IRCCS Multimedica	La Cava, A (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	alacava@mednet.ucla.edu	/AAG-9576-2020; Matarese, Giuseppe/AAO-4077-2021	/0000-0002-8839-0933; Matarese, Giuseppe/0000-0001-9429-0616				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Amarilyo G, 2013, CLIN IMMUNOL, V149, P530, DOI 10.1016/j.clim.2013.09.002; Bach JF, 1998, IMMUNOL REV, V164, P139, DOI 10.1111/j.1600-065X.1998.tb01216.x; Ballinger MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013962; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Galgani M, 2010, J IMMUNOL, V185, P7474, DOI 10.4049/jimmunol.1001674; Garcia-Gonzalez A, 2002, RHEUMATOL INT, V22, P138, DOI 10.1007/s00296-002-0216-9; Iikuni Noriko, 2008, Current Immunology Reviews, V4, P70, DOI 10.2174/157339508784325046; Janko C, 2008, AUTOIMMUN REV, V8, P9, DOI 10.1016/j.autrev.2008.07.015; Jiang JX, 2008, HEPATOLOGY, V48, P1497, DOI 10.1002/hep.22515; Katsiari CG, 2010, SEMIN ARTHRITIS RHEU, V39, P491, DOI 10.1016/j.semarthrit.2008.11.002; Kredel LI, 2013, GUT, V62, P852, DOI 10.1136/gutjnl-2011-301424; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; McMahon M, 2011, ANN RHEUM DIS, V70, P1619, DOI 10.1136/ard.2010.142737; Munoz LE, 2008, LUPUS, V17, P371, DOI 10.1177/0961203308089990; OGMUNDSDOTTIR H, 1980, CLIN EXP IMMUNOL, V40, P223; Petri M, 2001, AM J MANAG CARE, V7, pS480; Potter PK, 2003, J IMMUNOL, V170, P3223, DOI 10.4049/jimmunol.170.6.3223; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; Suber T, 2009, ARTHRITIS RHEUM-US, V60, P2216, DOI 10.1002/art.24715; Wong M, 2011, DRUG TODAY, V47, P289, DOI 10.1358/dot.2011.47.4.1583186	22	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112826	10.1371/journal.pone.0112826	http://dx.doi.org/10.1371/journal.pone.0112826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401752	Green Published, gold			2022-12-26	WOS:000345158700076
J	Buscemi, S; Vasto, S; Di Gaudio, F; Grosso, G; Bergante, S; Galvano, F; Massenti, FM; Amodio, E; Rosafio, G; Verga, S				Buscemi, Silvio; Vasto, Sonya; Di Gaudio, Francesca; Grosso, Giuseppe; Bergante, Sonia; Galvano, Fabio; Massenti, Fatima Maria; Amodio, Emanuele; Rosafio, Giuseppe; Verga, Salvatore			Endothelial Function and Serum Concentration of Toxic Metals in Frequent Consumers of Fish	PLOS ONE			English	Article							FLOW-MEDIATED VASODILATION; N-3 FATTY-ACIDS; INSULIN-RESISTANCE; CARDIOVASCULAR EVENTS; MEDITERRANEAN DIET; ARSENIC EXPOSURE; RISK; CONSUMPTION; MERCURY; ASSOCIATION	Background: Endothelial dysfunction is involved in the pathogenesis of atherosclerosis. Consumption of fish is associated with reduced cardiovascular risk, but there is paucity of data concerning its effect on endothelial function. Furthermore, investigation of the effects of fish consumption on health must take into account the ingestion of contaminants, including transition metals and some metalloids, which may have unfavorable effects on health, including those on the cardiovascular system. We investigated the association between fish consumption, endothelial function (flow mediated dilation of the brachial artery), and serum concentration of some toxic metals in apparently healthy people. Methods: Twenty-nine high fish consumers (at least 3 portions a week) were compared with 25 low fish consumers (less than 1 portion a week). All participants were free of diabetes, cardiovascular or other systemic diseases. Serum metal (antimonium, arsenic, mercury, lead, cobalt, copper, zinc, selenium, strontium) concentrations were measured in subgroups of 24 high fish consumers and 19 low fish consumers. Results: Both groups exhibited similar habitual dietary patterns, age and anthropometric characteristics. The high fish consumers had higher flow mediated dilation (9.7 +/- 1.8 vs. 7.3 +/- 1.9%; P<0.001), but also higher serum concentrations of mercury (5.87 +/- 2.69 vs. 1.65 +/- 1.10 mcg/L; P<0.001) and arsenic (6.04 +/- 3.25 vs. 2.30 +/- 1.58 mcg/L; P<0.001). The fasting plasma glucose concentrations were significantly correlated with both mercury (r=0.39; P=0.01) and arsenic concentrations (r=0.55; P<0.001). Conclusions: Habitual consumption of high amounts of fish is associated with better endothelial function despite higher serum concentrations of mercury and arsenic.	[Buscemi, Silvio; Rosafio, Giuseppe; Verga, Salvatore] Univ Palermo, Dipartimento Biomed Med & Interna, Palermo, Italy; [Buscemi, Silvio; Rosafio, Giuseppe; Verga, Salvatore] Univ Palermo, Specialist Lab Nutr Clin, Palermo, Italy; [Vasto, Sonya] Univ Palermo, Dipartimento Sci & Tecnol Biol Chimiche & Farmace, Palermo, Italy; [Di Gaudio, Francesca; Massenti, Fatima Maria; Amodio, Emanuele] Univ Palermo, Dipartimento Sci Promozione Salute Materno Infant, Palermo, Italy; [Grosso, Giuseppe; Galvano, Fabio] Univ Catania, Dipartimento Sci Farmaco, Catania, Italy; [Bergante, Sonia] Policlin San Donato, Hosp & Hlth Care, Sci Inst Res, Milan, Italy	University of Palermo; University of Palermo; University of Palermo; University of Palermo; University of Catania; IRCCS Policlinico San Donato	Buscemi, S (corresponding author), Univ Palermo, Dipartimento Biomed Med & Interna, Palermo, Italy.	silbus@tin.it	Buscemi, Silvio/K-9662-2016; Galvano, Fabio/F-8122-2010; Vasto, Sonya/I-4771-2013; bergante, sonia/AAI-1215-2019; Grosso, Giuseppe/ABA-1587-2020; DI GAUDIO, FRANCESCA/P-4974-2016; Grosso, Giuseppe/K-6730-2016	Buscemi, Silvio/0000-0003-0730-7649; Galvano, Fabio/0000-0003-0644-0755; Vasto, Sonya/0000-0002-6033-4745; Grosso, Giuseppe/0000-0003-3930-5285; DI GAUDIO, FRANCESCA/0000-0002-5910-5750; Grosso, Giuseppe/0000-0003-3930-5285; VERGA, Salvatore/0000-0002-7743-7847	Regione Sicilia, Assessorato Regionale delle Risorse Agricole e Alimentari - Dipartimento Regionale degli Interventi per la Pesca decreto [134, P09/5/120]	Regione Sicilia, Assessorato Regionale delle Risorse Agricole e Alimentari - Dipartimento Regionale degli Interventi per la Pesca decreto	This work was supported by the Regione Sicilia, Assessorato Regionale delle Risorse Agricole e Alimentari - Dipartimento Regionale degli Interventi per la Pesca decreto no 134 del 28.05.2010 (project code: P09/5/120). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barac A, 2007, HYPERTENSION, V49, P748, DOI 10.1161/01.HYP.0000259601.38807.a6; Bergdahl IA, 1998, ENVIRON RES, V77, P20, DOI 10.1006/enrs.1997.3820; Buscemi S, 2013, EUR J CLIN NUTR, V67, P1284, DOI 10.1038/ejcn.2013.172; Buscemi S, 2009, EUR J CLIN INVEST, V39, P339, DOI 10.1111/j.1365-2362.2009.02091.x; Buscemi S, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-2; Buscemi S, 2012, AM J CLIN NUTR, V95, P1089, DOI 10.3945/ajcn.111.031088; Buscemi S, 2011, OBESITY, V19, P1187, DOI 10.1038/oby.2010.313; Choi AL, 2009, ENVIRON HEALTH PERSP, V117, P367, DOI 10.1289/ehp.11608; Copat C, 2012, B ENVIRON CONTAM TOX, V88, P78, DOI 10.1007/s00128-011-0433-6; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Elvevoll EO, 2006, LIPIDS, V41, P1109, DOI 10.1007/s11745-006-5060-3; Ferrantelli V, 2012, FOOD ADDIT CONTAM A, V29, P1046, DOI 10.1080/19440049.2012.675595; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gillum RF, 1996, ARCH INTERN MED, V156, P537, DOI 10.1001/archinte.156.5.537; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hamdy O, 2003, DIABETES CARE, V26, P2119, DOI 10.2337/diacare.26.7.2119; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; He K, 2002, JAMA-J AM MED ASSOC, V288, P3130, DOI 10.1001/jama.288.24.3130; He K, 2013, DIABETES CARE, V36, P1584, DOI 10.2337/dc12-1842; He K, 2009, AM J CARDIOL, V103, P1238, DOI 10.1016/j.amjcard.2009.01.016; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Keogh JB, 2005, ARTERIOSCL THROM VAS, V25, P1274, DOI 10.1161/01.ATV.0000163185.28245.a1; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; Moon SS, 2013, DIABETIC MED, V30, pe143, DOI 10.1111/dme.12103; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Nahab F, 2011, NEUROLOGY, V76, P154, DOI 10.1212/WNL.0b013e3182061afb; Newens KJ, 2011, AM J CLIN NUTR, V94, P742, DOI 10.3945/ajcn.110.009233; Pan WC, 2013, AM J EPIDEMIOL, V178, P1563, DOI 10.1093/aje/kwt195; Pan WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070792; Pastorelli AA, 2012, FOOD ADDIT CONTAM A, V29, P1913, DOI 10.1080/19440049.2012.719644; Petersen MM, 2010, CELL MOL BIOL, V56, P38, DOI 10.1170/T877; Plat J, 2007, J NUTR, V137, P2635, DOI 10.1093/jn/137.12.2635; Raissy M, 2014, ENVIRON MONIT ASSESS, V186, P1235, DOI 10.1007/s10661-013-3452-4; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossi R, 2008, J AM COLL CARDIOL, V51, P997, DOI 10.1016/j.jacc.2007.11.044; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; SALONEN JT, 1995, CIRCULATION, V91, P645, DOI 10.1161/01.CIR.91.3.645; Sanders TAB, 2011, AM J CLIN NUTR, V94, P973, DOI 10.3945/ajcn.111.018036; Shimabukuro M, 2007, AM J CLIN NUTR, V86, P923, DOI 10.1093/ajcn/86.4.923; Storelli MM, 2013, J FOOD SCI, V78, pT362, DOI 10.1111/j.1750-3841.2012.02976.x; van Bussel BCT, 2011, J NUTR, V141, P1719, DOI 10.3945/jn.111.139733; Virtanen JK, 2007, J NUTR BIOCHEM, V18, P75, DOI 10.1016/j.jnutbio.2006.05.001; Vogel RA, 2000, J AM COLL CARDIOL, V36, P1455, DOI 10.1016/S0735-1097(00)00896-2; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Whelton SP, 2004, AM J CARDIOL, V93, P1119, DOI 10.1016/j.amjcard.2004.01.038; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Willett W., 1988, NUTR EPIDEMIOLOGY; Wu GY, 2002, ANNU REV NUTR, V22, P61, DOI 10.1146/annurev.nutr.22.110901.145329; Xin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046028; Xu Y, 2014, EUR HEART J-CARD IMG, V15, P736, DOI 10.1093/ehjci/jet256; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276	61	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112478	10.1371/journal.pone.0112478	http://dx.doi.org/10.1371/journal.pone.0112478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401695	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700048
J	Christopher, MM; Hawkins, MG; Burton, AG				Christopher, Mary M.; Hawkins, Michelle G.; Burton, Andrew G.			Poikilocytosis in Rabbits: Prevalence, Type, and Association with Disease	PLOS ONE			English	Article							LIVER-DISEASE; ECHINOCYTOSIS; ERYTHROCYTES; CHOLESTEROL; ANEMIA; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; ACANTHOCYTOSIS; INFLAMMATION; ASYMMETRY	Rabbits (Oryctolagus cuniculus) are a popular companion animal, food animal, and animal model of human disease. Abnormal red cell shapes (poikilocytes) have been observed in rabbits, but their significance is unknown. The objective of this study was to investigate the prevalence and type of poikilocytosis in pet rabbits and its association with physiologic factors, clinical disease, and laboratory abnormalities. We retrospectively analyzed blood smears from 482 rabbits presented to the University of California-Davis Veterinary Medical Teaching Hospital from 1990 to 2010. Number and type of poikilocytes per 2000 red blood cells (RBCs) were counted and expressed as a percentage. Acanthocytes (>3% of RBCs) were found in 150/482 (31%) rabbits and echinocytes (>3% of RBCs) were found in 127/482 (27%) of rabbits, both healthy and diseased. Thirty-three of 482 (7%) rabbits had >30% acanthocytes and echinocytes combined. Mild to moderate (>0.5% of RBCs) fragmented red cells (schistocytes, microcytes, keratocytes, spherocytes) were found in 25/403 (6%) diseased and 0/79 (0%) healthy rabbits (P = 0.0240). Fragmentation and acanthocytosis were more severe in rabbits with inflammatory disease and malignant neoplasia compared with healthy rabbits (P < 0.01). The % fragmented cells correlated with % polychromasia, RDW, and heterophil, monocyte, globulins, and fibrinogen concentrations (P < 0.05). Echinocytosis was significantly associated with renal failure, azotemia, and acid-base/electrolyte abnormalities (P < 0.05). Serum cholesterol concentration correlated significantly with % acanthocytes (P < 0.0001), % echinocytes (P = 0.0069), and % fragmented cells (P = 0.0109), but correlations were weak (Spearman rho < 0.02). These findings provide important insights into underlying pathophysiologic mechanisms that appear to affect the prevalence and type of naturally-occurring poikilocytosis in rabbits. Our findings support the need to carefully document poikilocytes in research investigations and in clinical diagnosis and to determine their diagnostic and prognostic value.	[Christopher, Mary M.] Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA; [Hawkins, Michelle G.] Univ Calif Davis, Dept Med & Epidemiol, Davis, CA 95616 USA; [Burton, Andrew G.] Univ Calif Davis, William R Pritchard Vet Med Teaching Hosp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Christopher, MM (corresponding author), Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA.	mmchristopher@ucdavis.edu						Agroyannis B, 2001, ARTIF ORGANS, V25, P486, DOI 10.1046/j.1525-1594.2001.025006486.x; Christopher MM, 2008, ISR J VET MED, V63, P4; Christopher Mary M., 1994, Vet Clin Pathol, V23, P7, DOI 10.1111/j.1939-165X.1994.tb01007.x; COOPER RA, 1980, J LIPID RES, V21, P1082; Duranthon V, 2012, TRANSGENIC RES, V21, P699, DOI 10.1007/s11248-012-9599-x; Harvey J.W., 2012, VET HEMATOLOGY DIAGN, P328, DOI 10.1016/C2009-0-39565-3; KANAKARAJ P, 1989, ATHEROSCLEROSIS, V76, P209, DOI 10.1016/0021-9150(89)90105-6; Karbiner MS, 2013, LIFE SCI, V93, P503, DOI 10.1016/j.lfs.2013.08.003; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; KLAINER AS, 1972, INFECT IMMUN, V5, P808, DOI 10.1128/IAI.5.5.808-813.1972; Kuwai T, 2006, J ATHEROSCLER THROMB, V13, P286, DOI 10.5551/jat.13.286; LANGE Y, 1984, J MEMBRANE BIOL, V77, P153; Lichtman M, 2006, WILLIAMS HEMATOLOGY, Vseventh; Lopez-Revuelta A, 2007, FREE RADICAL BIO MED, V42, P1106, DOI 10.1016/j.freeradbiomed.2007.01.010; Marks PW, 2013, SEMIN HEMATOL, V50, P216, DOI 10.1053/j.seminhematol.2013.06.003; Moore DM, 1986, SCHALMS VET HEMATOLO, P1100; MORSE EE, 1990, ANN CLIN LAB SCI, V20, P169; OWEN JS, 1985, J CLIN INVEST, V76, P2275, DOI 10.1172/JCI112237; Palek J, 1994, WILLIAMS HEMATOLOGY, P557; PESSINA GP, 1981, INT J BIOCHEM, V13, P805, DOI 10.1016/0020-711X(81)90099-9; PINTER GG, 1961, AM J PHYSIOL, V200, P292, DOI 10.1152/ajplegacy.1961.200.2.292; REBAR AH, 1981, VET PATHOL, V18, P415, DOI 10.1177/030098588101800401; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Sakthivel R, 2007, CLIN CHIM ACTA, V382, P1, DOI 10.1016/j.cca.2007.02.044; Sanderson JH, 1981, ATLAS LAB ANIMAL HEM; Schermer S., 1967, BLOOD MORPHOLOGY LAB; Straat M, 2012, TRANSFUS MED HEMOTH, V39, P353, DOI 10.1159/000342229; Susheela AK, 1985, STUDIES ENV SCI, V27, P231; Warry E, 2013, VET CLIN PATH, V42, P465, DOI 10.1111/vcp.12097; Weiss D J, 1984, Vet Clin Pathol, V13, P27, DOI 10.1111/j.1939-165X.1984.tb00836.x; WEISS DJ, 1992, AM J VET RES, V53, P1769; Weiss Douglas J., 1993, Vet Clin Pathol, V22, P117, DOI 10.1111/j.1939-165X.1993.tb00663.x; Weiss Douglas J., 1990, Vet Clin Pathol, V19, P114, DOI 10.1111/j.1939-165X.1990.tb00556.x; Yanni AE, 2004, LAB ANIM-UK, V38, P246, DOI 10.1258/002367704323133628; Zini G, 2012, INT J LAB HEMATOL, V34, P107, DOI 10.1111/j.1751-553X.2011.01380.x	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112455	10.1371/journal.pone.0112455	http://dx.doi.org/10.1371/journal.pone.0112455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402479	Green Published, gold			2022-12-26	WOS:000345158700045
J	Huber, R; Parsa, V; Scollie, S				Huber, Rainer; Parsa, Vijay; Scollie, Susan			Predicting the Perceived Sound Quality of Frequency-Compressed Speech	PLOS ONE			English	Article							AUDIO QUALITY; HEARING; MODEL; PERCEPTION; ACCLIMATIZATION; MUSIC	The performance of objective speech and audio quality measures for the prediction of the perceived quality of frequency-compressed speech in hearing aids is investigated in this paper. A number of existing quality measures have been applied to speech signals processed by a hearing aid, which compresses speech spectra along frequency in order to make information contained in higher frequencies audible for listeners with severe high-frequency hearing loss. Quality measures were compared with subjective ratings obtained from normal hearing and hearing impaired children and adults in an earlier study. High correlations were achieved with quality measures computed by quality models that are based on the auditory model of Dau et al., namely, the measure PSM, computed by the quality model PEMO-Q; the measure qc, computed by the quality model proposed by Hansen and Kollmeier; and the linear subcomponent of the HASQI. For the prediction of quality ratings by hearing impaired listeners, extensions of some models incorporating hearing loss were implemented and shown to achieve improved prediction accuracy. Results indicate that these objective quality measures can potentially serve as tools for assisting in initial setting of frequency compression parameters.	[Huber, Rainer] Ctr Competence HorTech gGmbH, Oldenburg, Germany; [Huber, Rainer] Cluster Excellence Hearing4All, Oldenburg, Germany; [Huber, Rainer] Ctr Competence HorTech gGmbH, Hannover, Germany; [Parsa, Vijay; Scollie, Susan] Univ Western Ontario, Natl Ctr Audiol, London, ON, Canada	Western University (University of Western Ontario)	Huber, R (corresponding author), Ctr Competence HorTech gGmbH, Oldenburg, Germany.	Rainer.Huber@HoerTech.de			Deutsche Forschungsgemeinschaft (Research Unit "Individualized Hearing Acoustics") [For-1732]; NSERC	Deutsche Forschungsgemeinschaft (Research Unit "Individualized Hearing Acoustics")(German Research Foundation (DFG)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the following: Deutsche Forschungsgemeinschaft (Research Unit "Individualized Hearing Acoustics"; For-1732) (to Dr. Huber), http://www.dfg.de/en/research_funding/programmes/coordinated_programmes/research_units/index.html; NSERC Discovery grant (to Dr. Vijay Parsa), http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp; and NSERC Collaborative Health Research grant (to Dr. Scollie), http://www.nserc-crsng.gc.ca/Professors-Professeurs/grants-subs/CHRP-PRCS_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, WID EXT REC P 862 AS; [Anonymous], 2001, PERC EV SPEECH QUAL; Beerends JG, 2008, P 124 AES CONV AMST; Beerends JG, 1994, WORKSH SPEECH QUAL A; Chen G, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P2174; Dau T, 1996, J ACOUST SOC AM, V99, P3623, DOI 10.1121/1.414960; Dau T, 1996, J ACOUST SOC AM, V99, P3615, DOI 10.1121/1.414959; Dau T, 1997, J ACOUST SOC AM, V102, P2906, DOI 10.1121/1.420345; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Derleth RP, 2000, J ACOUST SOC AM, V108, P285, DOI 10.1121/1.429464; Derleth RP, 2001, HEARING RES, V159, P132, DOI 10.1016/S0378-5955(01)00322-7; Dillon H., 2012, HEARING AIDS; Fassel R, 1994, THESIS U GOTTINGEN G; Glista D, 2012, J SPEECH LANG HEAR R, V55, P1765, DOI 10.1044/1092-4388(2012/11-0163); Glista D, 2009, INT J AUDIOL, V48, P632, DOI 10.1080/14992020902971349; Goetze S, 2010, P ICASSP; HAGERMAN B, 1985, SCAND AUDIOL, V14, P109, DOI 10.3109/01050398509045931; Hansen J, 1998, P ICSLP 98 SYDN AUST; Hansen M, 2000, J AUDIO ENG SOC, V48, P395; Huber R, 2010, 2 WORKSH SPEECH NOIS; Huber R, 2003, THESIS U OLDENBURG G; Huber R, 2006, IEEE T AUDIO SPEECH, V14, P1902, DOI 10.1109/TASL.2006.883259; ITAKURA F, 1975, IEEE T ACOUST SPEECH, VAS23, P67, DOI 10.1109/TASSP.1975.1162641; Itakura F, 1997, SPEECH ANAL; ITU-R Recommendation BS. 1387, 1998, METH OBJ MEAS PERC A; ITU-T, 2002, E MOD COMP MOD US TR; Kates JM, 2014, J AUDIO ENG SOC, V62, P99, DOI 10.17743/jaes.2014.0006; Kates JM, 2010, J AUDIO ENG SOC, V58, P363; Klatt D, 1998, P IEEE ICASSP, V1982, P1278; Kochkin S., 2002, HEAR REV, V9, P14; Krebber J, 2007, REPORT EXPT PERFORMA; Kuk P, 2006, HEARING REV, V13, P42; McDermott HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022358; Moore BCJ, 2004, EAR HEARING, V25, P98, DOI 10.1097/01.AUD.0000120359.49711.D7; Moore BCJ, 1997, AUDIT NEUROSCI, V3, P289; Moore BCJ, 2004, HEARING RES, V188, P70, DOI 10.1016/S0378-5955(03)00347-2; Moore BCJ, 2004, J AUDIO ENG SOC, V52, P1228; Moore BCJ, 2004, J AUDIO ENG SOC, V52, P900; Moore BCJ, 1997, CONTRIBUTIONS PSYCHO; Munkner S, 1993, CONTRIB PSYCHOL, P121; NIELSEN LB, 1993, OBJECTIVE SCALING SO; Ovegard A, 1997, SCAND AUDIOL, V26, P43, DOI 10.3109/01050399709074974; Parsa V, 2013, TRENDS AMPLIF, V17, P54, DOI 10.1177/1084713813480856; Quackenbush S. R., 1998, OBJECTIVE MEASURES S; Recommendation ITU-R, 2003, METH SUBJ ASS INT QU; Rix AW, 2006, IEEE T AUDIO SPEECH, V14, P1890, DOI 10.1109/TASL.2006.883260; Rohdenburg T, 2005, P INT WORKSH AC ECH; Sander A, 1994, THESIS U OLDENBURG G; Schmalfuss G, 2004, THESIS TU MUNICH GER; Scollie Susan, 2005, Trends Amplif, V9, P159, DOI 10.1177/108471380500900403; Simpson A, 2005, INT J AUDIOL, V44, P281, DOI 10.1080/14992020500060636; Souza PE, 2013, J SPEECH LANG HEAR R, V56, P1349, DOI 10.1044/1092-4388(2013/12-0151); Stelmachowicz PG, 2007, EAR HEARING, V28, P483, DOI 10.1097/AUD.0b013e31806dc265; Tan CT, 2004, J AUDIO ENG SOC, V52, P699; Verhey JL, 1998, PSYCHOACOUSTICS SPEC; Wolfe J, 2010, J AM ACAD AUDIOL, V21, P618, DOI 10.3766/jaaa.21.10.2; Wong Lena L N, 2003, Trends Amplif, V7, P117, DOI 10.1177/108471380300700402	57	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110260	10.1371/journal.pone.0110260	http://dx.doi.org/10.1371/journal.pone.0110260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402456	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700002
J	Wang, YX; Yang, M				Wang, Yixing; Yang, Ming			Loss-of-Function Mutants and Overexpression Lines of the Arabidopsis Cyclin CYCA1;2/TARDY ASYNCHRONOUS MEIOSIS Exhibit Different Defects in Prophase-I Meiocytes but Produce the Same Meiotic Products	PLOS ONE			English	Article							HISTONE-H3 SERINE-10 PHOSPHORYLATION; CELL-DIVISION; PROGRESSION; SYNAPSIS; RECOMBINATION; REGULATOR; ROUGHEX; PROTEIN; DAMAGE; SMG7	In Arabidopsis, loss-of-function mutations in the A-type cyclin CYCA1;2/TARDY ASYNCHRONOUS MEIOSIS (TAM) gene lead to the production of abnormal meiotic products including triads and dyads. Here we report that overexpression of TAM by the ASK1:TAM transgene also led to the production of triads and dyads in meiosis, as well as shriveled seeds, in a dominant fashion. However, the partial loss-of-function mutant tam-1, an ASK1:TAM line, and the wild type differed in dynamic changes in chromosome thread thickness from zygotene to diplotene. We also found that the pericentromeric heterochromatin regions in male meiocytes in tam-1 and tam-2 (a null allele) frequently formed a tight cluster at the pachytene and diplotene stages, in contrast to the infrequent occurrences of such clusters in the wild type and the ASK1:TAM line. Immunolocalization studies of the chromosome axial component ASY1 revealed that ASY1 was highly expressed at the appropriate male meiotic stages but not localized to the chromosomes in tam-2. The level of ASY1, however, was greatly reduced in another ASK1:TAM line with much overexpressed TAM. Our results indicate that the reduction and increase in the activity of TAM differentially affect chromosomal morphology and the action of ASY1 in prophase I. Based on these results, we propose that either the different meiotic defects or a common defect such as missing ASY1 on the chromosomal axes triggers a hitherto uncharacterized cell cycle checkpoint in the male meiocytes in the tam mutants and ASK1:TAM lines, leading to the production of the same abnormal meiotic products.	[Wang, Yixing; Yang, Ming] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yang, M (corresponding author), Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA.	ming.yang@okstate.edu			Environmental Institute, Oklahoma State University; Oklahoma Center for the Advancement of Science and Technology [PS13-006]	Environmental Institute, Oklahoma State University; Oklahoma Center for the Advancement of Science and Technology	This work was partially supported by a grant from the Environmental Institute, Oklahoma State University, and a grant (PS13-006) from the Oklahoma Center for the Advancement of Science and Technology to M.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SJ, 2002, J CELL SCI, V115, P3645, DOI 10.1242/jcs.00048; Avedisov SN, 2000, MOL CELL BIOL, V20, P8220, DOI 10.1128/MCB.20.21.8220-8229.2000; Bolcun-Filas E, 2014, SCIENCE, V343, P533, DOI 10.1126/science.1247671; Bulankova P, 2010, PLANT CELL, V22, P3791, DOI 10.1105/tpc.110.078378; Caryl AP, 2003, J EXP BOT, V54, P25, DOI 10.1093/jxb/erg041; Chaubet-Gigot N, 2000, PLANT MOL BIOL, V43, P659, DOI 10.1023/A:1006303100592; Chuang CN, 2012, NUCLEIC ACIDS RES, V40, P11416, DOI 10.1093/nar/gks920; Cromer L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002865; d'Erfurth I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000989; Foley E, 1999, CURR BIOL, V9, P1392, DOI 10.1016/S0960-9822(00)80084-6; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Garber PM, 2005, TRENDS BIOCHEM SCI, V30, P63, DOI 10.1016/j.tibs.2004.12.004; GONCZY P, 1994, CELL, V77, P1015, DOI 10.1016/0092-8674(94)90441-3; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Iwata E, 2011, PLANT CELL, V23, P4382, DOI 10.1105/tpc.111.092049; Jha AK, 2014, PLANT MOL BIOL, V85, P81, DOI 10.1007/s11103-013-0170-9; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Magnard JL, 2001, PLANT PHYSIOL, V127, P1157, DOI 10.1104/pp.010473; Nickerson HD, 2007, DEV BIOL, V306, P725, DOI 10.1016/j.ydbio.2007.04.009; Riehs N, 2008, J CELL SCI, V121, P2208, DOI 10.1242/jcs.027862; Ross KJ, 1997, CHROMOSOME RES, V5, P551, DOI 10.1023/A:1018497804129; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Subramanian VV, 2014, COLD SPRING HARB PER, V6; Vasileva A, 2013, J CELL SCI, V126, P3927, DOI 10.1242/jcs.126763; Wang YX, 2010, GENESIS, V48, P254, DOI [10.1002/dvg.20610, 10.1002/dvg.20629]; Wang YX, 2004, PLANT PHYSIOL, V136, P4127, DOI 10.1104/pp.104.051201; Wang YX, 2004, SEX PLANT REPROD, V16, P273, DOI 10.1007/s00497-004-0206-z; Wijnker E, 2013, PLANT REPROD, V26, P143, DOI 10.1007/s00497-013-0223-x; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Yang M, 1999, P NATL ACAD SCI USA, V96, P11416, DOI 10.1073/pnas.96.20.11416; Yang M, 2001, PLANT PHYSIOL, V126, P622, DOI 10.1104/pp.126.2.622; Zamariola L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00279	33	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113348	10.1371/journal.pone.0113348	http://dx.doi.org/10.1371/journal.pone.0113348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402453	Green Submitted, gold, Green Published			2022-12-26	WOS:000345158700132
J	Bin Nisar, Y; Dibley, MJ				Bin Nisar, Yasir; Dibley, Michael J.			Earlier Initiation and Use of a Greater Number of Iron-Folic Acid Supplements during Pregnancy Prevents Early Neonatal Deaths in Nepal and Pakistan	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; SYSTEMATIC ANALYSIS; RANDOMIZED-TRIAL; CHILD SURVIVAL; MORTALITY; VACCINATION; ANEMIA; RISK; COMMUNITY; TRENDS	Introduction: Early neonatal deaths account for 75% of neonatal deaths globally. Antenatal iron-folic acid (IFA) supplementation has significantly reduced the risk of early neonatal deaths in China and Indonesia. We investigated the impact of antenatal IFA supplements on the risk of early neonatal deaths in Nepal and Pakistan during the last decade. Methods: Data from the most recent singleton live-births of 8,186 from two Nepal Demographic and Health Surveys (DHS) and 13,034 from two Pakistan DHS were selected for the current study. The primary outcome was early neonatal deaths and the main study variable was antenatal IFA supplementation. Analyses used multivariate Cox proportional regression, adjusted for the cluster sampling design and for 18 potential confounders. Findings: The adjusted risk of early neonatal deaths was significantly reduced by 51% (aHR = 0.49, 95% CI = 0.32-0.75) in Nepal and 23% (aHR = 0.77, 95% CI = 0.59-0.99) in Pakistan with any use of IFA compared to none. When IFA supplementation started at or before the 5 th month of pregnancy, the adjusted risk of early neonatal mortality was significantly reduced by 53% in Nepal, and 28% in Pakistan, compared to no IFA. When >90 IFA supplements were used and started at or before 5 th months, the adjusted risk of early neonatal deaths was significantly reduced by 57% in Nepal, and 45% in Pakistan. In Nepal 4,600 and in Pakistan 75,000 early neonatal deaths could be prevented annually if all pregnant women used >90 IFA supplements and started at or before the 5 th month of pregnancy. Conclusions: Any use of IFA supplements was significantly associated with reduced risk of early neonatal deaths in Nepal and Pakistan. The greatest mortality sparing effect of IFA on early neonatal deaths in both countries was with early initiation and use of a greater number of supplements.	[Bin Nisar, Yasir; Dibley, Michael J.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Bin Nisar, Y (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia.	yasi8204@uni.sydney.edu.au	Nisar, Yasir Bin/AFO-2407-2022		University of Sydney	University of Sydney(University of Sydney)	We would like to thank the Measure Demographic and Health Survey for providing all of Demographic and Health Survey data used in this analysis. This manuscript is a part of YBN's thesis to fulfil the requirement for a PhD in International Public Health at the University of Sydney. We are grateful to the University of Sydney for funding YBN's PhD scholarship (IPRS & APA) in International Public Health.	Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; [Anonymous], 2013, UNICEF NEPAL; [Anonymous], 2012, GUID DAIL IR FOL AC; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; Brabin L, 2013, NUTR REV, V71, P528, DOI 10.1111/nure.12049; Christian P, 2009, AM J EPIDEMIOL, V170, P1127, DOI 10.1093/aje/kwp253; Curtis SL, 1995, ASSESSMENT QUALITY D; Dibley MJ, 2012, AM J CLIN NUTR, V95, P220, DOI 10.3945/ajcn.111.022699; Dibley MJ, 2009, ANN NUTR METABOLISM, V55; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Hall S, 2005, NEONATAL MORTALITY D; Hill K, 2006, DEMOGR RES, V14, P429, DOI 10.4054/DemRes.2006.14.18; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P168, DOI 10.1111/j.1365-3016.2012.01312.x; Khan A, 2012, HEALTH POLICY PLANN, V27, P72, DOI 10.1093/heapol/czs047; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macro International, 1996, 6 MACR INT INC; Mahy M, 2003, DHS COMP REPORTS, V4; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health and Population Nepal, 2007, NEP DEM HLTH SURV 20; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Natarajan S, 2007, STAT MED, V26, P3229, DOI 10.1002/sim.2779; National Institute of Population Studies (NIPS) and Macro International, 2006, PAKISTAN DEMOGRAPHIC; National Institute of Population Studies (NIPS) [Pakistan] Macro International Inc, 2013, PAK DEM HLTH SURV 20; Nisar YB, 2014, AM J CLIN NUTR UNPUB; Pokharel RK, 2011, SUCCESS DELIVERING I; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roth A, 2004, PEDIATR INFECT DIS J, V23, P544, DOI 10.1097/01.inf.0000129693.81082.a0; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rusia U, 1995, Indian J Pathol Microbiol, V38, P273; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Titaley CR, 2010, B WORLD HEALTH ORGAN, V88, P500, DOI 10.2471/BLT.09.065813; UNICEF, 2017, LEVELS TRENDS CHILD; UNICEF Nutrition Wing Planning Commission Government of Pakistan Aga Khan University, 2011, NAT NUTR SURV PAK; Vaugelade J, 2004, BRIT MED J, V329, P1309, DOI 10.1136/bmj.38261.496366.82; World Health Organization United Nations Children's Fund United Nations University, 2001, IRON DEF AN ASS PREV; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608; Zeng LX, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2001	42	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112446	10.1371/journal.pone.0112446	http://dx.doi.org/10.1371/journal.pone.0112446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398011	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500052
J	Otti, GR; Saleh, L; Velicky, P; Fiala, C; Pollheimer, J; Knofler, M				Otti, Gerlinde R.; Saleh, Leila; Velicky, Philipp; Fiala, Christian; Pollheimer, Juergen; Knoefler, Martin			Notch2 Controls Prolactin and Insulin-Like Growth Factor Binding Protein-1 Expression in Decidualizing Human Stromal Cells of Early Pregnancy	PLOS ONE			English	Article							CHORIONIC-GONADOTROPIN; SIGNALING PATHWAY; HUMAN ENDOMETRIUM; CROSS-TALK; PROGESTERONE; MECHANISMS; DIFFERENTIATION; IMPLANTATION; MODULATION; RECEPTORS	Decidualization, the transformation of the human uterine mucosa into the endometrium of pregnancy, is critical for successful implantation and embryonic development. However, key regulatory factors controlling differentiation of uterine stromal cells into hormone-secreting decidual cells have not been fully elucidated. Hence, we herein investigated the role of the Notch signaling pathway in human decidual stromal cells (HDSC) isolated from early pregnancy samples. Immunofluorescence of first trimester decidual tissues revealed expression of Notch2 receptor and its putative, membrane-anchored interaction partners Jagged1, Delta-like (DLL) 1 and DLL4 in stromal cells whereas other Notch receptors and ligands were absent from these cells. During in vitro differentiation with estrogen/progesterone (E2P4) and/or cyclic adenosine monophosphate (cAMP) HDSC constitutively expressed Notch2 and weakly downregulated Jagged1 mRNA and protein, measured by quantitative PCR (qPCR) and Western blotting, respectively. However, increased levels of DLL1 and DLL4 were observed in the decidualizing cultures. Transfection of a Notch luciferase reporter and qPCR of the Notch target gene hairy and enhancer of split 1 (HES1) revealed an induction of canonical Notch activity during in vitro differentiation. In contrast, treatment of HDSC with a chemical Notch/c-secretase inhibitor decreased cAMP/E2P4-stimulated Notch luciferase activity, HES1 transcript levels and mRNA expression of the decidual marker genes prolactin (PRL) and insulin-like growth factor binding protein 1 (IGFBP1). Similarly, siRNA-mediated gene silencing or antibody-mediated blocking of Notch2 diminished HES1, PRL and IGFBP1 mRNA levels as well as secreted PRL protein. In summary, the data suggest that canonical, Notch2-dependent signaling plays a role in human decidualization.	[Otti, Gerlinde R.; Saleh, Leila; Velicky, Philipp; Pollheimer, Juergen; Knoefler, Martin] Med Univ Vienna, Reprod Biol Unit, Dept Obstet & Fetal Maternal Med, Vienna, Austria; [Fiala, Christian] Gynmed Clin, Vienna, Austria	Medical University of Vienna	Knofler, M (corresponding author), Med Univ Vienna, Reprod Biol Unit, Dept Obstet & Fetal Maternal Med, Vienna, Austria.	martin.knoefler@meduniwien.ac.at		Fiala, Christian/0000-0001-6451-7349; Pollheimer, Jurgen/0000-0001-8440-5221; Velicky, Philipp/0000-0002-2340-7431	Austrian Science Funds, Vienna, Austria [P-25187-B13]; Austrian Science Fund (FWF) [P 25187] Funding Source: researchfish	Austrian Science Funds, Vienna, Austria(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Study was supported by grant P-25187-B13 of the Austrian Science Funds, Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Y, 2007, J ASSIST REPROD GEN, V24, P296, DOI 10.1007/s10815-007-9149-2; Afshar Y, 2012, ENDOCRINOLOGY, V153, P2884, DOI 10.1210/en.2011-2122; Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Angulo-Rojo C, 2013, ASN NEURO, V5, DOI 10.1042/AN20130023; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Cobellis L, 2008, J ANAT, V213, P464, DOI 10.1111/j.1469-7580.2008.00963.x; Cuman C, 2014, REPRODUCTION, V147, pR75, DOI 10.1530/REP-13-0474; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Fazleabas AT, 2004, PLACENTA, V25, pS26, DOI 10.1016/j.placenta.2004.01.014; Gasperowicz M, 2008, PLACENTA, V29, P651, DOI 10.1016/j.placenta.2008.06.004; Gasperowicz M, 2013, GENE EXPR PATTERNS, V13, P249, DOI 10.1016/j.gep.2013.04.006; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Haider S, 2014, ENDOCRINOLOGY, V155, P263, DOI 10.1210/en.2013-1455; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Hunkapiller NM, 2011, DEVELOPMENT, V138, P2987, DOI 10.1242/dev.066589; Johansson A, 2011, HUM GENET, V129, P25, DOI 10.1007/s00439-010-0893-5; Kajihara T, 2013, MED MOL MORPHOL, V46, P61, DOI 10.1007/s00795-013-0018-z; Kane NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012970; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Larabee JL, 2013, J BIOL CHEM, V288, P21526, DOI 10.1074/jbc.M113.465120; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Manaster I, 2010, J REPROD IMMUNOL, V84, P1, DOI 10.1016/j.jri.2009.10.009; Mazella J, 2008, ENDOCRINOLOGY, V149, P15, DOI 10.1210/en.2007-0477; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Meinhardt G, 2014, ENDOCRINOLOGY, V155, P1908, DOI 10.1210/en.2013-2042; Mikhailik A, 2009, BIOCHEM BIOPH RES CO, V388, P479, DOI 10.1016/j.bbrc.2009.07.037; Mitsuhashi Y, 2012, HISTOPATHOLOGY, V60, P826, DOI 10.1111/j.1365-2559.2011.04158.x; Saleh L, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-155; Tang MY, 2005, MOL HUM REPROD, V11, P237, DOI 10.1093/molehr/gah149; Tsuzuki T, 2012, HUM REPROD, V27, P523, DOI 10.1093/humrep/der405; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Wu LZ, 2004, GENE, V328, P153, DOI 10.1016/j.gene.2003.12.007; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	41	14	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112723	10.1371/journal.pone.0112723	http://dx.doi.org/10.1371/journal.pone.0112723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397403	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500083
J	Rosello-Lleti, E; Tarazon, E; Barderas, MG; Ortega, A; Otero, M; Molina-Navarro, MM; Lago, F; Gonzalez-Juanatey, JR; Salvador, A; Portoles, M; Rivera, M				Rosello-Lleti, Esther; Tarazon, Estefania; Barderas, Maria G.; Ortega, Ana; Otero, Manuel; Micaela Molina-Navarro, Maria; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Salvador, Antonio; Portoles, Manuel; Rivera, Miguel			Heart Mitochondrial Proteome Study Elucidates Changes in Cardiac Energy Metabolism and Antioxidant PRDX3 in Human Dilated Cardiomyopathy	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN PYRUVATE-DEHYDROGENASE; MYOCARDIAL-INFARCTION; STRUCTURAL BASIS; FAILURE; PROTEINS; BINDING; OVEREXPRESSION; IDENTIFICATION; GUIDELINES	Background: Dilated cardiomyopathy (DCM) is a public health problem with no available curative treatment, and mitochondrial dysfunction plays a critical role in its development. The present study is the first to analyze the mitochondrial proteome in cardiac tissue of patients with DCM to identify potential molecular targets for its therapeutic intervention. Methods and Results: 16 left ventricular (LV) samples obtained from explanted human hearts with DCM (n = 8) and control donors (n = 8) were extracted to perform a proteomic approach to investigate the variations in mitochondrial protein expression. The proteome of the samples was analyzed by quantitative differential electrophoresis and Mass Spectrometry. These changes were validated by classical techniques and by novel and precise selected reaction monitoring analysis and RNA sequencing approach increasing the total heart samples up to 25. We found significant alterations in energy metabolism, especially in molecules involved in substrate utilization (ODPA, ETFD, DLDH), energy production (ATPA), other metabolic pathways (AL4A1) and protein synthesis (EFTU), obtaining considerable and specific relationships between the alterations detected in these processes. Importantly, we observed that the antioxidant PRDX3 overexpression is associated with impaired ventricular function. PRDX3 is significantly related to LV end systolic and diastolic diameter (r = 0.73, p value<0.01; r = 0.71, p value<0.01), fractional shortening, and ejection fraction (r = -0.61, p value < 0.05; and r = -20.62, p value< 0.05, respectively). Conclusion: This work could be a pivotal study to gain more knowledge on the cellular mechanisms related to the pathophysiology of this disease and may lead to the development of etiology-specific heart failure therapies. We suggest new molecular targets for therapeutic interventions, something that up to now has been lacking.	[Rosello-Lleti, Esther; Tarazon, Estefania; Ortega, Ana; Micaela Molina-Navarro, Maria; Rivera, Miguel] Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain; [Barderas, Maria G.] SESCAM, Hosp Nacl Paraplej, Dept Vasc Physiopathol, Toledo, Spain; [Otero, Manuel; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Otero, Manuel; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain; [Salvador, Antonio] Hosp La Fe, Serv Cardiol, E-46009 Valencia, Spain; [Portoles, Manuel] Hosp La Fe, Hlth Res Inst, Cell Biol & Pathol Unit, E-46009 Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Nacional de Paraplejicos; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Rivera, M (corresponding author), Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain.	miguelrivera492@gmail.com	Roselló-Lletí, Esther/B-2695-2017; Roselló Lletí, Esther/ABG-8503-2020; PORTOLES, MANUEL/B-4789-2009; Ortega, Ana/AAG-5941-2020; Tarazón, Estefanía/D-6950-2017; Ortega, Ana AO/D-3027-2017	Roselló-Lletí, Esther/0000-0003-2627-6104; Roselló Lletí, Esther/0000-0003-2627-6104; PORTOLES, MANUEL/0000-0002-4415-7160; Ortega, Ana/0000-0002-9763-0505; Tarazón, Estefanía/0000-0003-3466-2558; Ortega, Ana AO/0000-0002-9763-0505; , Micaela/0000-0002-2103-0351; Barderas, Maria G./0000-0003-4290-4721; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	NIH "Fondo de Investigaciones Sanitarias del Instituto Carlos III" [RD12/0042/0003, PI10/00275, PI13/00100]; Health Research Institute Hospital La Fe [07/2013]	NIH "Fondo de Investigaciones Sanitarias del Instituto Carlos III"; Health Research Institute Hospital La Fe	This work was supported by grants from the NIH "Fondo de Investigaciones Sanitarias del Instituto Carlos III," (RD12/0042/0003; FIS Project PI10/00275; PI13/00100) and Health Research Institute Hospital La Fe (Project 07/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetti G, 2011, CIRC RES, V108, P512, DOI 10.1161/CIRCRESAHA.110.226910; Agnetti G, 2010, CIRC-CARDIOVASC GENE, V3, P78, DOI 10.1161/CIRCGENETICS.109.871236; Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Azorin I, 2004, ALCOHOL ALCOHOLISM, V39, P203, DOI 10.1093/alcalc/agh043; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Bindoff L, 2003, EUR HEART J, V24, P221, DOI 10.1016/S0195-668X(02)00694-2; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Brioschi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035841; Cieniewski-Bernard C, 2008, J PROTEOME RES, V7, P5004, DOI 10.1021/pr800409u; Comunian C, 2011, PROTEOMICS, V11, P2320, DOI 10.1002/pmic.201000479; de Weger RA, 2011, J HEART LUNG TRANSPL, V30, P497, DOI 10.1016/j.healun.2010.11.011; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054; GOODMAN SI, 1994, EUR J BIOCHEM, V219, P277, DOI 10.1111/j.1432-1033.1994.tb19939.x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Heinke MY, 1998, ELECTROPHORESIS, V19, P2021, DOI 10.1002/elps.1150191122; Horstkotte J, 2011, CIRCULATION, V124, P2892, DOI 10.1161/CIRCULATIONAHA.111.059253; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; KAGAN VE, 1992, BIOCHEM PHARMACOL, V44, P1637, DOI 10.1016/0006-2952(92)90482-X; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Keith M, 1998, J AM COLL CARDIOL, V31, P1352, DOI 10.1016/S0735-1097(98)00101-6; KOROTCHKINA LG, 1995, J BIOL CHEM, V270, P14297, DOI 10.1074/jbc.270.24.14297; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lal H, 2012, CIRCULATION, V125, P65, DOI 10.1161/CIRCULATIONAHA.111.050666; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WM, 2012, J CELL MOL MED, V16, P59, DOI 10.1111/j.1582-4934.2011.01336.x; Liesa M, 2011, CIRCULATION, V124, P806, DOI 10.1161/CIRCULATIONAHA.110.003418; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nishtala K, 2011, PROTEOMICS, V11, P4310, DOI 10.1002/pmic.201100229; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PORTOLES M, 1994, J CELL SCI, V107, P3601; REYNOLDS WA, 1963, J EXP ZOOL, V153, P237, DOI 10.1002/jez.1401530306; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Rosca MG, 2009, J MOL CELL CARDIOL, V46, P927, DOI 10.1016/j.yjmcc.2009.02.009; Rosello-Lleti E, 2012, J CELL MOL MED, V16, P2471, DOI 10.1111/j.1582-4934.2012.01565.x; SANBE A, 1995, J MOL CELL CARDIOL, V27, P2209, DOI 10.1016/S0022-2828(95)91551-6; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shiomi T, 2004, CIRCULATION, V109, P544, DOI 10.1161/01.CIR.0000109701.77059.E9; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Tomas M, 2002, J NEUROCHEM, V83, P601, DOI 10.1046/j.1471-4159.2002.01167.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yang JC, 2000, CIRCULATION, V102, P3046; Zhang DX, 2012, J PROTEOMICS, V77, P469, DOI 10.1016/j.jprot.2012.09.024	54	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112971	10.1371/journal.pone.0112971	http://dx.doi.org/10.1371/journal.pone.0112971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397948	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500120
J	Xiao, J; Li, SY; Sui, Y; Wu, Q; Li, XP; Xie, BJ; Zhang, MW; Sun, ZD				Xiao, Juan; Li, Shuyi; Sui, Yong; Wu, Qian; Li, Xiaopeng; Xie, Bijun; Zhang, Mingwei; Sun, Zhida			Lactobacillus casei-01 Facilitates the Ameliorative Effects of Proanthocyanidins Extracted from Lotus Seedpod on Learning and Memory Impairment in Scopolamine-Induced Amnesia Mice	PLOS ONE			English	Article							URINARY-EXCRETION; OXIDATIVE DAMAGE; GUT MICROBIOTA; PROCYANIDINS; LACTOBACILLI; FLAVAN-3-OLS; METABOLISM; ABSORPTION; DEMENTIA; PERICARP	Learning and memory abilities are associated with alterations in gut function. The two-way proanthocyanidins-microbiota interaction in vivo enhances the physiological activities of proanthocyanidins and promotes the regulation of gut function. Proanthocyanidins extracted from lotus seedpod (LSPC) have shown the memory-enhancing ability. However, there has been no literature about whether Lactobacillus casei-01 (LC) enhances the ameliorative effects of LSPC on learning and memory abilities. In this study, learning and memory abilities of scopolamine-induced amnesia mice were evaluated by Y-maze test after 20-day administration of LC (10(9) cfu/kg body weight (BW)), LSPC (low dose was 60 mg/kg BW (L-LSPC) and high dose was 90 mg/kg BW (H-LSPC)), or LSPC and LC combinations (L-LSPC+LC and H-LSPC+LC). Alterations in antioxidant defense ability and oxidative damage of brain, serum and colon, and brain cholinergic system were investigated as the possible mechanisms. As a result, the error times of H-LSPC+LC group were reduced by 41.59% and 68.75% relative to those of H-LSPC and LC groups respectively. LSPC and LC combinations ameliorated scopolamine-induced memory impairment by improving total antioxidant capacity (TAOC) level, glutathione peroxidase (GSH-Px) and total superoxide dismutase (T-SOD) activities of brain, serum and colon, suppressing malondialdehyde (MDA) level of brain, serum and colon, and inhibiting brain acetylcholinesterase (AchE), myeloperoxidase, total nitric oxide synthase and neural nitric oxide synthase (nNOS) activities, and nNOS mRNA level. Moreover, LC facilitated the ameliorative effects of H-LSPC on GSH-Px activity of colon, TAOC level, GSH-Px activity and ratio of T-SOD to MDA of brain and serum, and the inhibitory effects of H-LSPC on serum MDA level, brain nNOS mRNA level and AchE activity. These results indicated that LC promoted the memory-enhancing effect of LSPC in scopolamine-induced amnesia mice.	[Sui, Yong; Wu, Qian; Li, Xiaopeng; Xie, Bijun; Sun, Zhida] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Xiao, Juan; Zhang, Mingwei] Guangdong Acad Agr Sci, Guangdong Key Lab Agr Prod Proc, Minist Agr, Key Lab Funct Foods,Sericultural & Agrifood Res I, Guangzhou 510610, Guangdong, Peoples R China; [Li, Shuyi] Wuhan Polytech Univ, Coll Food Sci & Engn, Wuhan 430023, Hubei, Peoples R China	Huazhong Agricultural University; Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Wuhan Polytechnic University	Sun, ZD (corresponding author), Huazhong Agr Univ, Coll Food Sci & Technol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.	sunzhida@sina.com			National Natural Science Foundation of China (NSFC) [31071633]; Innovation Capacity Construction Special Project of Main Scientific Research Organization of Guangdong Province	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Innovation Capacity Construction Special Project of Main Scientific Research Organization of Guangdong Province	This work was supported by National Natural Science Foundation of China (NSFC, No. 31071633) and the Innovation Capacity Construction Special Project of Main Scientific Research Organization of Guangdong Province (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2002, FREE RADICAL BIO MED, V33, P142, DOI 10.1016/S0891-5849(02)00871-7; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Bhattacharjee S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00153; Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5; Bustos I, 2012, J AGR FOOD CHEM, V60, P9082, DOI 10.1021/jf301133g; Chen J, 2008, PHARMACOL BIOCHEM BE, V90, P441, DOI 10.1016/j.pbb.2008.03.029; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Davari S, 2013, NEUROSCIENCE, V240, P287, DOI 10.1016/j.neuroscience.2013.02.055; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Dolara P, 2005, MUTAT RES-FUND MOL M, V591, P237, DOI 10.1016/j.mrfmmm.2005.04.022; Formigare A, 2007, COMP BIOCHEM PHYS C, V146, P443, DOI 10.1016/j.cbpc.2007.07.010; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Gong YS, 2008, BEHAV BRAIN RES, V194, P100, DOI 10.1016/j.bbr.2008.06.029; Gonthier MP, 2003, FREE RADICAL BIO MED, V35, P837, DOI 10.1016/S0891-5849(03)00394-0; GROENEWOUD G, 1986, XENOBIOTICA, V16, P99, DOI 10.3109/00498258609043512; Jeong EJ, 2008, EUR J PHARMACOL, V588, P78, DOI 10.1016/j.ejphar.2008.04.015; Jung IH, 2012, J APPL MICROBIOL, V113, P1498, DOI 10.1111/j.1365-2672.2012.05437.x; Kohri T, 2001, J AGR FOOD CHEM, V49, P4102, DOI 10.1021/jf001491+; KOPELMAN MD, 1988, BRAIN, V111, P1079, DOI 10.1093/brain/111.5.1079; Kullisaar T, 2002, INT J FOOD MICROBIOL, V72, P215, DOI 10.1016/S0168-1605(01)00674-2; Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001; Laura P, 2007, BRIT J NUTR, V97, P96; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Li SY, 2013, J AGR FOOD CHEM, V61, P2506, DOI 10.1021/jf305213e; Li SY, 2013, FOOD CHEM, V138, P1536, DOI 10.1016/j.foodchem.2012.09.120; Li W, 2009, PHYSIOL BEHAV, V96, P557, DOI 10.1016/j.physbeh.2008.12.004; Ling ZQ, 2005, J AGR FOOD CHEM, V53, P2441, DOI 10.1021/jf040325p; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; McCarthy M, 1997, INT J GERIATR PSYCH, V12, P404; Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e; Moujalli S, 2008, JBI DATABASE SYSTEMA, V6, pS35; Ohland CL, 2013, PSYCHONEUROENDOCRINO, V38, P1738, DOI 10.1016/j.psyneuen.2013.02.008; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3; REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461; Roowi S, 2010, J AGR FOOD CHEM, V58, P1296, DOI 10.1021/jf9032975; Skrha J, 1999, DIABETES RES CLIN PR, V44, P27, DOI 10.1016/S0168-8227(99)00010-8; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Xiao J, 2013, EUR FOOD RES TECHNOL, V236, P671, DOI 10.1007/s00217-013-1922-0; Xu JQ, 2009, PHYTOTHER RES, V23, P1742, DOI 10.1002/ptr.2837; Xu JQ, 2009, EUR NEUROPSYCHOPHARM, V19, P851, DOI 10.1016/j.euroneuro.2009.07.006; Xu SY, 2001, PHARM EXPT METHODOLO, P826; Zhao LP, 2010, J BIOTECHNOL, V149, P183, DOI 10.1016/j.jbiotec.2010.02.008	44	26	30	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112773	10.1371/journal.pone.0112773	http://dx.doi.org/10.1371/journal.pone.0112773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396737	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500089
J	Zhou, QH; Zhao, LJ; Wang, P; Badr, R; Xu, XJ; Bu, FX; Lappe, J; Recker, R; Zhou, Y; Ye, A; Zhou, BT				Zhou, Qiu-Hong; Zhao, Lan-Juan; Wang, Ping; Badr, Rhamee; Xu, Xiao-Jing; Bu, Feng-Xiao; Lappe, Joan; Recker, Robert; Zhou, Yu; Ye, An; Zhou, Bo-Ting			Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian women	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CIGARETTE-SMOKING; POSTMENOPAUSAL WOMEN; ELDERLY-MEN; RECEPTOR; OSTEOPOROSIS; CALMODULIN; DIFFERENTIATION; METAANALYSIS; EXPRESSION	ASummary: Three genes, including EGFR (epidermal growth factor receptor), CALM3 (calmodulin 3, calcium-modulated protein 3) and SMARCD1 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily d member 1), play different roles in bone and/or fat metabolism in Caucasian women. In this population-based investigation of 870 unrelated postmenopausal Caucasian women, CALM3 polymorphisms were significantly associated with femoral neck bone mineral density (FNK BMD), hip BMD and spine BMD. Age and tobacco status also affected BMD levels and were therefore corrected for in our statistical analysis. Introduction: EGFR, CALM3 and SMARCD1 play roles in bone and/or fat metabolism. However, the correlations between the polymorphisms of these three genes and body composition levels, including BMD, remain to be determined. Materials and Methods: A population-based investigation of 870 white women was conducted. Forty-four SNPs (single nucleotide polymorphisms) in EGFR, CALM3 and SMARCD1 were chosen by the software, including those of potential functional importance. The candidate SNPs were genotyped by the KASPar assay for an association analysis with body composition levels. The correlation analysis was assessed by the Pearson's product-moment correlation coefficient and Spearman rank-order correlation tests, and the family-wise error was corrected using the Wald test implemented in PLINK. Results: The SNP rs12461917 in the 3'-flanking region of the CALM3 gene was significantly associated with FNK BMD (P = 0.001), hip BMD (P, 0.001) and spine BMD (P = 0.001); rs11083838 in the 5'-flanking region of CALM3 gene was associated with spine BMD (P = 0.009). After adjusting for multiple comparisons, rs12461917 remained significant (Padjusted = 0.033 for FNK BMD, P-adjusted = 0.006 for hip BMD and P-adjusted = 0.018 for spine BMD). Conclusions: Our data show that polymorphisms of the CALM3 gene in Caucasian women may contribute to variations in the BMD of the hip, spine and femoral neck.	[Zhou, Qiu-Hong] Cent S Univ, Xiangya Hosp, Dept Endocrinol, Changsha 410008, Hunan, Peoples R China; [Zhao, Lan-Juan; Xu, Xiao-Jing; Bu, Feng-Xiao; Lappe, Joan; Recker, Robert; Zhou, Yu; Ye, An; Zhou, Bo-Ting] Creighton Univ, Med Ctr, Osteoporosis Res Ctr, Omaha, NE 68131 USA; [Zhao, Lan-Juan; Zhou, Yu; Ye, An] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA 70112 USA; [Wang, Ping; Zhou, Bo-Ting] Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha 410008, Hunan, Peoples R China; [Badr, Rhamee] Tulane Univ, Sch Med, New Orleans, LA USA	Central South University; Creighton University; Tulane University; Central South University; Tulane University	Zhou, BT (corresponding author), Creighton Univ, Med Ctr, Osteoporosis Res Ctr, 601 N 30th ST,Suite 4820, Omaha, NE 68131 USA.	botingzhou0918@126.com	Bu, Fengxiao/F-1463-2016	Bu, Fengxiao/0000-0002-4882-4856	Cancer and Smoking Disease Research Bone Biology Program; Nebraska Tobacco Settlement Biomedical Research Development Award; NIH [3R01CA129488-01A2S2]; NATIONAL CANCER INSTITUTE [R01CA129488] Funding Source: NIH RePORTER	Cancer and Smoking Disease Research Bone Biology Program; Nebraska Tobacco Settlement Biomedical Research Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was partially supported by grants from the Cancer and Smoking Disease Research Bone Biology Program, the Nebraska Tobacco Settlement Biomedical Research Development Award and NIH grants (3R01CA129488-01A2S2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifa S, 2006, BIOCHEM BIOPH RES CO, V347, P381, DOI 10.1016/j.bbrc.2006.05.200; Bergmann S, 1998, RESP PHYSIOL, V114, P269, DOI 10.1016/S0034-5687(98)00098-X; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bijl M, 2001, EUR J CLIN INVEST, V31, P550, DOI 10.1046/j.1365-2362.2001.00842.x; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; COSIO FG, 1982, J LAB CLIN MED, V100, P469; Emaus N, 2014, J BONE MINER RES MAR, V28, P10; Friedrich FW, 2009, EUR HEART J, V30, P1648, DOI 10.1093/eurheartj/ehp153; Gnudi S, 2007, J BONE MINER METAB, V25, P326, DOI 10.1007/s00774-007-0758-8; Gourlay Margaret L, 2014, J Bone Metab, V21, P61, DOI 10.11005/jbm.2014.21.1.61; Iqbal J, 2013, P NATL ACAD SCI USA, V110, P11115, DOI 10.1073/pnas.1220919110; Jorgetti V, 2013, KIDNEY INT; Kiel DP, 1996, OSTEOPOROSIS INT, V6, P240, DOI 10.1007/BF01622741; Koszewski NJ, 2003, J STEROID BIOCHEM, V87, P223, DOI 10.1016/j.jsbmb.2003.09.006; Lappe JM, 2006, J AM COLL NUTR, V25, P395, DOI 10.1080/07315724.2006.10719551; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Lu L, 2012, HUM GENET, V131, P505, DOI 10.1007/s00439-011-1099-1; Manabe N, 2001, J IMMUNOL, V167, P2625, DOI 10.4049/jimmunol.167.5.2625; Meier C, 2005, J BONE MINER RES, V20, P579, DOI 10.1359/JBMR.041207; Oyen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092882; Pabst MJ, 1995, J PERIODONTOL, V66, P1047, DOI 10.1902/jop.1995.66.12.1047; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Ralston SH, 2007, P NUTR SOC, V66, P158, DOI 10.1017/S002966510700540X; REID IR, 1992, J CLIN ENDOCR METAB, V75, P45, DOI 10.1210/jc.75.1.45; Saccone V, 2014, GENE DEV, V28, P841, DOI 10.1101/gad.234468.113; Seales EC, 2006, J CELL BIOCHEM, V97, P45, DOI 10.1002/jcb.20659; STEIGER P, 1992, J BONE MINER RES, V7, P625; Toutenhoofd SL, 1998, CELL CALCIUM, V23, P323, DOI 10.1016/S0143-4160(98)90028-8; Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200; Ward KD, 2001, CALCIFIED TISSUE INT, V68, P259, DOI 10.1007/BF02390832; Weitzmann MN, 2000, J CELL BIOCHEM, V78, P318, DOI 10.1002/(SICI)1097-4644(20000801)78:2<318::AID-JCB13>3.0.CO;2-N; Yamada Y, 2007, INT J MOL MED, V19, P791; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zhou JP, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-62	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112358	10.1371/journal.pone.0112358	http://dx.doi.org/10.1371/journal.pone.0112358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396734	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558500048
J	Cai, PL; Wang, B; Ji, JX; Jiang, YS; Wan, L; Tian, CG; Ma, YH				Cai, Pengli; Wang, Bang; Ji, Jingxiao; Jiang, Yongsheng; Wan, Li; Tian, Chaoguang; Ma, Yanhe			The Putative Cellodextrin Transporter-like Protein CLP1 Is Involved in Cellulase Induction in Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIALLY EXPRESSED GENES; SACCHAROMYCES-CEREVISIAE; SYSTEMS-ANALYSIS; GLUCOSE; DEGRADATION; MECHANISMS; XYLOSE; SIGNAL; ROLES	Neurospora crassa recently has become a novel system to investigate cellulase induction. Here, we discovered a novel membrane protein, cellodextrin transporter-like protein 1 (CLP1; NCU05853), a putative cellodextrin transporter-like protein that is a critical component of the cellulase induction pathway in N. crassa. Although CLP1 protein cannot transport cellodextrin, the suppression of cellulase induction by this protein was discovered on both cellobiose and Avicel. The co-disruption of the cellodextrin transporters cdt2 and clp1 in strain Delta 3 beta G formed strain CPL7. With induction by cellobiose, cellulase production was enhanced 6.9-fold in CPL7 compared with Delta 3 beta G. We also showed that the suppression of cellulase expression by CLP1 occurred by repressing the expression of cellodextrin transporters, particularly cdt1 expression. Transcriptome analysis of the hypercellulase-producing strain CPL7 showed that the cellulase expression machinery was dramatically stimulated, as were the cellulase enzyme genes including the inducer transporters and the major transcriptional regulators.	[Cai, Pengli; Wang, Bang; Ji, Jingxiao; Jiang, Yongsheng; Wan, Li; Tian, Chaoguang; Ma, Yanhe] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Tian, CG (corresponding author), Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.	tian_cg@tib.cas.cn	MA, YAN/HHN-2912-2022; wan, li/GRY-7634-2022	Wang, Bang/0000-0003-4223-3040	Natural Science Foundation of China [31171207]; 973 Program of China [2011CB707400]; 863 Program of China [2012AA022203, SS2014AA021300]; Tianjin Zhuanxiang Grant [13ZCDZSY05000]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022203] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); 863 Program of China(National High Technology Research and Development Program of China); Tianjin Zhuanxiang Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Natural Science Foundation of China Grant 31171207, 973 Program of China Grant 2011CB707400, 863 Program of China Grants 2012AA022203 and SS2014AA021300, and Tianjin Zhuanxiang Grant 13ZCDZSY05000.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Benz JP, 2014, MOL MICROBIOL, V91, P275, DOI 10.1111/mmi.12459; Cai PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089330; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Ivanova C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062631; Li J, 2013, APPL MICROBIOL BIOT, V97, P10479, DOI 10.1007/s00253-013-5301-3; Li JG, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-31; Liang H, 1996, MOL BIOL CELL, V7, P1953, DOI 10.1091/mbc.7.12.1953; Madi L, 1997, GENETICS, V146, P499; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sun JP, 2012, EUKARYOT CELL, V11, P482, DOI 10.1128/EC.05327-11; Suto M, 2001, J BIOSCI BIOENG, V92, P305, DOI 10.1263/jbb.92.305; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xiong Y, 2014, FUNGAL GENET BIOL, V72, P21, DOI 10.1016/j.fgb.2014.05.005; Zhang WX, 2013, J BIOL CHEM, V288, P32861, DOI 10.1074/jbc.M113.505826; Zhou QX, 2012, EUKARYOT CELL, V11, P1371, DOI 10.1128/EC.00170-12; Znameroski EA, 2014, J BIOL CHEM, V289, P2610, DOI 10.1074/jbc.M113.533273; Znameroski EA, 2012, P NATL ACAD SCI USA, V109, P6012, DOI 10.1073/pnas.1118440109	32	23	26	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					788	796		10.1074/jbc.M114.609875	http://dx.doi.org/10.1074/jbc.M114.609875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25398875	Green Published, hybrid			2022-12-26	WOS:000347778200009
J	Black, KH; Travouillon, KJ; Den Boer, W; Kear, BP; Cooke, BN; Archer, M				Black, Karen H.; Travouillon, Kenny J.; Den Boer, Wendy; Kear, Benjamin P.; Cooke, Bernard N.; Archer, Michael			A New Species of the Basal "Kangaroo'' Balbaroo and a Re-Evaluation of Stem Macropodiform Interrelationships	PLOS ONE			English	Article							WORLD HERITAGE AREA; NORTHWESTERN QUEENSLAND; BANDICOOTS MARSUPIALIA; PHYLOGENETIC INFERENCE; OLIGOMIOCENE DEPOSITS; MISSING ENTRIES; LATE OLIGOCENE; MIOCENE; RIVERSLEIGH; PERAMELEMORPHIA	Exceptionally well-preserved skulls and postcranial elements of a new species of the plesiomorphic stem macropodiform Balbaroo have been recovered from middle Miocene freshwater limestone deposits in the Riversleigh World Heritage Area of northwestern Queensland, Australia. This constitutes the richest intraspecific sample for any currently known basal "kangaroo'', and, along with additional material referred to Balbaroo fangaroo, provides new insights into structural variability within the most prolific archaic macropodiform clade - Balbaridae. Qualitative and metric evaluations of taxonomic boundaries demonstrate that the previously distinct species Nambaroo bullockensis is a junior synonym of B. camfieldensis. Furthermore, coupled Maximum Parsimony and Bayesian phylogenetic analyses reveal that our new Balbaroo remains represent the most derived member of the Balbaroo lineage, and are closely related to the middle Miocene B. camfieldensis, which like most named balbarid species is identifiable only from isolated jaws. The postcranial elements of Balbaroo concur with earlier finds of the stratigraphically oldest balbarid skeleton, Nambaroo gillespieae, and suggest that quadrupedal progression was a primary gait mode as opposed to bipedal saltation. All Balbaroo spp. have low-crowned bilophodont molars, which are typical for browsing herbivores inhabiting the densely forested environments envisaged for middle Miocene northeastern Australia.	[Black, Karen H.; Travouillon, Kenny J.; Archer, Michael] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Travouillon, Kenny J.] Univ Queensland, Sch Earth Sci, St Lucia, Qld, Australia; [Den Boer, Wendy; Kear, Benjamin P.] Uppsala Univ, Dept Earth Sci, Palaeobiol Programme, Uppsala, Sweden; [Cooke, Bernard N.] Queensland Museum, South Brisbane, Qld, Australia	University of New South Wales Sydney; University of Queensland; Uppsala University; Queensland Museum	Black, KH (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	k.black@unsw.edu.au	Travouillon, Kenny/ABD-1040-2021	Black, Karen/0000-0003-0645-5172; Archer, Michael/0000-0002-0304-4039; Travouillon, Kenny/0000-0003-1734-4742	Australian Research Council [DE130100467, DP043262, DP1094569, LP0453664, LP0989969, LP100200486]; Xstrata Community Partnership Program North Queensland; Queensland Parks and Wildlife Service, Environment Australia; Queensland and Australian Museums; University of New South Wales; P. Creaser and the CREATE Fund at UNSW; Outback at Isa; Mount Isa City Council; Waanyi people of northwestern Queensland; University of Queensland; Swedish Research Council	Australian Research Council(Australian Research Council); Xstrata Community Partnership Program North Queensland; Queensland Parks and Wildlife Service, Environment Australia; Queensland and Australian Museums; University of New South Wales; P. Creaser and the CREATE Fund at UNSW; Outback at Isa; Mount Isa City Council; Waanyi people of northwestern Queensland; University of Queensland(University of Queensland); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Support for Riversleigh research has been provided by the Australian Research Council grants to MA, Suzanne J. Hand and KHB (DE130100467, DP043262, DP1094569, LP0453664, LP0989969, LP100200486), Xstrata Community Partnership Program North Queensland, Queensland Parks and Wildlife Service, Environment Australia, the Queensland and Australian Museums, University of New South Wales, P. Creaser and the CREATE Fund at UNSW, Outback at Isa, Mount Isa City Council and the Waanyi people of northwestern Queensland. R. Day provided funding to the University of Queensland to create a postdoctoral position for KJT. BPK acknowledges funding from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2001, SYST BIOL, V50, P170; Aplin K.P., 1987, P369; APLIN KP, 1990, THESIS U NEW S WALES; Archer M, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P77; ARCHER M, 1978, Memoirs of the Queensland Museum, V18, P157; Archer M., 1982, P477; ARCHER M, 1989, Australian Zoologist, V25, P29; ARCHER M, 1976, ZOOL J LINN SOC-LOND, V59, P217, DOI 10.1111/j.1096-3642.1976.tb01016.x; Archer M., 2006, ALCHERINGA AUSTRALAS, V30, P1, DOI DOI 10.1080/03115510609506851; Archer Michael, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P131; Arena DA, 2005, GEOLOGICAL HIST DEV; Arena DA, 2014, SEDIMENT GEOL, V304, P28, DOI 10.1016/j.sedgeo.2014.01.005; BARTHOLOMAI A, 1971, Memoirs of the Queensland Museum, V16, P1; Billups K, 2010, SPEC PUBL INT ASS SE, V42, P1; Black K, 2006, ALCHERINGA, V30, P351, DOI 10.1080/03115510608619322; Black Karen, 1997, Memoirs of the Queensland Museum, V41, P181; Black Karen, 1997, Memoirs of the Queensland Museum, V41, P187; Black KH, 2014, GONDWANA RES, V25, P1186, DOI 10.1016/j.gr.2013.12.008; Black KH, 2014, J SYST PALAEONTOL, V12, P237, DOI 10.1080/14772019.2013.768304; Black KH, 2013, ACTA PALAEONTOL POL, V58, P679, DOI 10.4202/app.2012.0001; Black KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048213; Black KH, 2010, J VERTEBR PALEONTOL, V30, P993, DOI 10.1080/02724634.2010.483567; Black KH, 2010, AM MUS NOVIT, P1, DOI 10.1206/666.1; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Cooke B. N., 1997, Memoirs of the Queensland Museum, V41, P295; Cooke B. N., 1997, Memoirs of the Queensland Museum, V41, P269; Cooke Bernard, 2006, P647; COOKE BN, 1992, ALCHERINGA, V16, P201, DOI 10.1080/03115519208619119; Cooke BN, 2000, J PALEONTOL, V74, P317, DOI 10.1666/0022-3360(2000)074<0317:CROANS>2.0.CO;2; Cooke BN, 1999, AUST MAMMAL, V21, P34; Cooke BN, 1999, AUST MAMMAL, V21, P27; Cooke BN, 1997, THESIS U NEW S WALES, P456; Creaser Phil, 1997, Memoirs of the Queensland Museum, V41, P303; Felsenstein J., 2004, INFERRING PHYLOGENIE; FLANNERY T, 1986, J PALEONTOL, V60, P418, DOI 10.1017/S0022336000021958; FLANNERY TF, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P1; Flannery TF, 1983, J AUSTR GEOLOGY GEOP, V7, P287; Flower W. H., 1867, PHILOS T ROY SOC LON, V157, P631, DOI DOI 10.1098/RSTL.1867.0020; FREEDMAN L, 1967, REC AUSTMUS, V27, P197; Gillespie AK, 2014, ALCHERINGA, V38, P513, DOI 10.1080/03115518.2014.908268; Gurovich Y, 2014, J SYST PALAEONTOL, V12, P265, DOI 10.1080/14772019.2013.776646; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; JOHNSON P M, 1982, Australian Zoologist, V21, P27; Jones FW, 1924, MAMMALS S AUSTR 2, P133; Kear BP, 2007, AUST J ZOOL, V55, P331, DOI 10.1071/ZO08002; Kear BP, 2007, J PALEONTOL, V81, P1147, DOI 10.1666/04-218.1; Kear BP, 2011, ZOOL J LINN SOC-LOND, V161, P663, DOI 10.1111/j.1096-3642.2010.00648.x; Kear BP, 2001, ASS AUSTRALASIAN PAL, V25, P83; Kirsch JAW, 1997, AUST J ZOOL, V45, P211, DOI 10.1071/ZO96030; Kolaczkowski B, 2006, MOL BIOL EVOL, V23, P1819, DOI 10.1093/molbev/msl059; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; LUCKETT WP, 1993, MAMMAL PHYLOGENY, P182; Martin GM, 2005, J MAMMAL, V86, P793, DOI 10.1644/1545-1542(2005)086[0793:IVILHM]2.0.CO;2; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Megirian D, 2004, AUST J EARTH SCI, V51, P701, DOI 10.1111/j.1400-0952.2004.01085.x; Megirian Dirk, 1992, Beagle, V9, P219; Megirian D, 2010, PALEOBIOLOGY, V36, P658, DOI 10.1666/09047.1; Meredith RW, 2008, AUST J ZOOL, V56, P395, DOI 10.1071/ZO08044; MUIRHEAD J, 1995, J PALEONTOL, V69, P127, DOI 10.1017/S0022336000026986; Muirhead J, 2000, J PALEONTOL, V74, P512, DOI 10.1666/0022-3360(2000)074<0512:YMPANS>2.0.CO;2; MURRAY P, 1990, Beagle, V7, P53; Murray P., 2000, MEMOIRS QUEEN VICTOR, V105, P1; MURRAY P F, 1986, Beagle, V3, P195; Murray Peter, 1992, Beagle, V9, P195; Murray Peter, 2000, MAGNT Research Report, V6, P1; Nixon KC, 2003, J VERTEBR PALEONTOL, V23, P275; Price GJ, 2008, ZOOL J LINN SOC-LOND, V153, P369, DOI 10.1111/j.1096-3642.2008.00387.x; Prideaux GJ, 2010, ZOOL J LINN SOC-LOND, V159, P954, DOI 10.1111/j.1096-3642.2009.00607.x; Ride W. D. L., 1997, Proceedings of the Linnean Society of New South Wales, V117, P243; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schwartz LRS, 2004, J VERTEBR PALEONTOL, V24, P668, DOI 10.1671/0272-4634(2004)024[0668:ANSONM]2.0.CO;2; Simpson G. G., 1960, QUANTITATIVE ZOOLOGY; Sorensen MD, 2007, TREEROT VERSION 3; Stirton R. A., 1967, Bulletin Bureau of Mineral Resources Geology and Geophysics Australia, V85, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TEDFORD RH, 1987, POSSUMS OPOSSUMS STU, P401; Travouillon KJ, 2014, J VERTEBR PALEONTOL, V34, P375, DOI 10.1080/02724634.2013.799071; Travouillon KJ, 2013, PALAEONTOL ELECTRON, V16; Travouillon KJ, 2013, J VERTEBR PALEONTOL, V33, P153, DOI 10.1080/02724634.2012.713416; Travouillon KJ, 2010, J VERTEBR PALEONTOL, V30, P1528, DOI 10.1080/02724634.2010.501463; Travouillon KJ, 2009, PALAEOGEOGR PALAEOCL, V276, P24, DOI 10.1016/j.palaeo.2009.02.025; Travouillon KJ, 2011, PALEOBIOLOGY, V37, P696, DOI 10.1666/09050.1; Travouillon KJ, 2006, ALCHERINGA SPEC ISSU, V1, DOI [10.1080/03115510609506871, DOI 10.1080/03115510609506871]; Travouillon KJ, 2012, GEOLOGY, V40, pe273, DOI [10.1130/G32600C.1, DOI 10.1130/G32600C.1]; WELLS RT, 1995, B AM MUS NAT HIST, P1; Westerman M, 2012, MOL PHYLOGENET EVOL, V62, P97, DOI 10.1016/j.ympev.2011.09.009; Wilkinson M, 2003, J VERTEBR PALEONTOL, V23, P311, DOI 10.1671/0272-4634(2003)023[0311:MEAMTI]2.0.CO;2; Wilkinson M, 1995, SYST BIOL, V44, P501, DOI 10.1093/sysbio/44.4.501; Woodburne Michael O., 1993, Journal of Vertebrate Paleontology, V13, P483; Wroe S, 1998, J PALEONTOL, V72, P738, DOI 10.1017/S0022336000040439; Xu X, 2014, J SYST PALAEONTOL, V12, P323, DOI 10.1080/14772019.2013.764357; [No title captured], DOI DOI 10.1111/j.1096-0031.2008.00229.x; [No title captured]; [No title captured]	95	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112705	10.1371/journal.pone.0112705	http://dx.doi.org/10.1371/journal.pone.0112705			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409233	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200034
J	Correia, C; Oliveira, G; Vicente, AM				Correia, Catarina; Oliveira, Guiomar; Vicente, Astrid M.			Protein Interaction Networks Reveal Novel Autism Risk Genes within GWAS Statistical Noise	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATION; DE-NOVO MUTATIONS; OXIDATIVE STRESS; REFERENCE DATABASE; LOCI; VARIANTS; PHENOTYPE; LINKAGE; ALLELES	Genome-wide association studies (GWAS) for Autism Spectrum Disorder (ASD) thus far met limited success in the identification of common risk variants, consistent with the notion that variants with small individual effects cannot be detected individually in single SNP analysis. To further capture disease risk gene information from ASD association studies, we applied a network-based strategy to the Autism Genome Project (AGP) and the Autism Genetics Resource Exchange GWAS datasets, combining family-based association data with Human Protein-Protein interaction (PPI) data. Our analysis showed that autism-associated proteins at higher than conventional levels of significance (P < 0.1) directly interact more than random expectation and are involved in a limited number of interconnected biological processes, indicating that they are functionally related. The functionally coherent networks generated by this approach contain ASD-relevant disease biology, as demonstrated by an improved positive predictive value and sensitivity in retrieving known ASD candidate genes relative to the top associated genes from either GWAS, as well as a higher gene overlap between the two ASD datasets. Analysis of the intersection between the networks obtained from the two ASD GWAS and six unrelated disease datasets identified fourteen genes exclusively present in the ASD networks. These are mostly novel genes involved in abnormal nervous system phenotypes in animal models, and in fundamental biological processes previously implicated in ASD, such as axon guidance, cell adhesion or cytoskeleton organization. Overall, our results highlighted novel susceptibility genes previously hidden within GWAS statistical "noise'' that warrant further analysis for causal variants.	[Correia, Catarina; Vicente, Astrid M.] Inst Nacl Saude Doutor Ricardo Jorge, Dept Promocao Saude & Doencas Nao Transmissiveis, P-1649016 Lisbon, Portugal; [Correia, Catarina; Vicente, Astrid M.] Univ Lisbon, Fac Sci, Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Correia, Catarina; Vicente, Astrid M.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Oliveira, Guiomar] Ctr Hosp & Univ Coimbra, Hosp Pediat, Ctr Desenvolvimento, Unidade Neurodesenvolvimento & Autismo, P-3000602 Coimbra, Portugal; [Oliveira, Guiomar] Ctr Invest & Formacao Clin HP CHUC, P-3000602 Coimbra, Portugal; [Oliveira, Guiomar] Univ Coimbra, Fac Med, P-3000548 Coimbra, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Coimbra	Vicente, AM (corresponding author), Inst Nacl Saude Doutor Ricardo Jorge, Dept Promocao Saude & Doencas Nao Transmissiveis, P-1649016 Lisbon, Portugal.	astrid.vicente@insa.min-saude.pt	Oliveira, Guiomar/AAF-3911-2021; Vicente, Astrid/F-8692-2014	Oliveira, Guiomar/0000-0002-7049-1277; Vicente, Astrid/0000-0001-7134-8037; Correia, Catarina/0000-0001-5481-2010	Autism Speaks (USA); Health Research Board (HRB, Ireland) [AUT/2006/1, AUT/2006/2, PD/2006/48]; Medical Research Council (MRC, UK); Genome Canada/Ontario Genomics Institute; Hilibrand Foundation (USA); US National Institutes of Health (NIH) [HD055751, HD055782, HD055784, MH52708, MH55284, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261]; NS049261), the Canadian Institutes for Health Research (CIHR); Assistance Publique - Hopitaux de Paris (France), Autism Speaks UK; Canada Foundation for Innovation/Ontario Innovation Trust; Deutsche Forschungsgemeinschaft (Germany) [Po 255/17-4]; EC Sixth FP AUTISM MOLGEN; Fundacao Calouste Gulbenkian (Portugal); Fondation de France; Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France); Fundacao para a Ciencia e Tecnologia (Portugal); Hospital for Sick Children Foundation and University of Toronto (Canada); INSERM (France); Institut Pasteur (France); Ministry of Health (convention 181 of 19 October 2001); John P. Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK) [075491/Z/04]; National Institute of Mental Health [1U24MH081810]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/64281/2009]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055782, P50HD055751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052708, R01MH055284, U54MH066673, R01MH080647, R01MH081754, U10MH066766, R01MH061009, R10MH055284, U24MH081810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042165, R01NS049261, P01NS026630] Funding Source: NIH RePORTER	Autism Speaks (USA); Health Research Board (HRB, Ireland); Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Genome Canada/Ontario Genomics Institute(Genome Canada); Hilibrand Foundation (USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NS049261), the Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Assistance Publique - Hopitaux de Paris (France), Autism Speaks UK; Canada Foundation for Innovation/Ontario Innovation Trust(Canada Foundation for Innovation); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); EC Sixth FP AUTISM MOLGEN; Fundacao Calouste Gulbenkian (Portugal); Fondation de France(Fondation de France); Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France)(Fondation pour la Recherche Medicale); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Hospital for Sick Children Foundation and University of Toronto (Canada); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur (France); Ministry of Health (convention 181 of 19 October 2001); John P. Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada)(Ministry of Research and Innovation, Ontario); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK)(Wellcome Trust); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The AGP study was funded by Autism Speaks (USA), the Health Research Board (HRB, Ireland; AUT/2006/1, AUT/2006/2, PD/2006/48), The Medical Research Council (MRC, UK), Genome Canada/Ontario Genomics Institute and the Hilibrand Foundation (USA). Additional support for individual groups was provided by the US National Institutes of Health (NIH Grants: HD055751, HD055782, HD055784, MH52708, MH55284, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261), the Canadian Institutes for Health Research (CIHR), Assistance Publique - Hopitaux de Paris (France), Autism Speaks UK, Canada Foundation for Innovation/Ontario Innovation Trust, Deutsche Forschungsgemeinschaft (Grant: Po 255/17-4) (Germany), EC Sixth FP AUTISM MOLGEN, Fundacao Calouste Gulbenkian (Portugal), Fondation de France, Fondation FondaMental (France), Fondation Orange (France), Fondation pour la Recherche Medicale (France), Fundacao para a Ciencia e Tecnologia (Portugal), the Hospital for Sick Children Foundation and University of Toronto (Canada), INSERM (France), Institut Pasteur (France), the Italian Ministry of Health (convention 181 of 19 October 2001), the John P. Hussman Foundation (USA), McLaughlin Centre (Canada), Ontario Ministry of Research and Innovation (Canada), the Seaver Foundation (USA), the Swedish Science Council, The Centre for Applied Genomics (Canada), the Utah Autism Foundation (USA) and the Wellcome Trust core award 075491/Z/04 (UK). The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). Catarina Correia is supported by grant SFRH/BPD/64281/2009 from the Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024220; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Ben-David E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002556; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Buxbaum JD, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-1; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chow ML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-449; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Crespi B, 2011, Autism Res, V4, P302, DOI 10.1002/aur.208; Curran S, 2011, AM J MED GENET B, V156B, P633, DOI 10.1002/ajmg.b.31201; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Devlin B, 2011, BRAIN RES, V1380, P78, DOI 10.1016/j.brainres.2010.11.026; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Frustaci A, 2012, FREE RADICAL BIO MED, V52, P2128, DOI 10.1016/j.freeradbiomed.2012.03.011; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Ghanizadeh A, 2012, CURR MED CHEM, V19, P4000, DOI 10.2174/092986712802002572; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; He WW, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-38; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hollander E, 2009, PSYCHIAT RES, V170, P43, DOI 10.1016/j.psychres.2008.07.014; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hussman JP, 2011, MOL AUTISM, V2, DOI [10.1186/2040-2392-2-1, 10.1186/2040-2392-2-18]; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; O'Roak BJ, 2012, NAT GENET, V44, P471, DOI 10.1038/ng0412-471; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Pan W, 2008, HUM GENET, V124, P225, DOI 10.1007/s00439-008-0545-1; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scheuerle A, 2011, AM J MED GENET B, V156B, P413, DOI 10.1002/ajmg.b.31176; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Weng MP, 2010, BIOINFORMATICS, V26, P2212, DOI 10.1093/bioinformatics/btq359; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yaspan BL, 2011, HUM GENET, V129, P563, DOI 10.1007/s00439-011-0956-2	66	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112399	10.1371/journal.pone.0112399	http://dx.doi.org/10.1371/journal.pone.0112399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409314	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200020
J	Galley, JD; Bailey, M; Dush, CK; Schoppe-Sullivan, S; Christian, LM				Galley, Jeffrey D.; Bailey, Michael; Dush, Claire Kamp; Schoppe-Sullivan, Sarah; Christian, Lisa M.			Maternal Obesity Is Associated with Alterations in the Gut Microbiome in Toddlers	PLOS ONE			English	Article							BODY-MASS INDEX; BACTERIAL; WEIGHT; COMMUNITIES; ACQUISITION; PREVALENCE; GREENGENES; SEQUENCES; CHILDREN; TRENDS	Children born to obese mothers are at increased risk for obesity, but the mechanisms behind this association are not fully delineated. A novel possible pathway linking maternal and child weight is the transmission of obesogenic microbes from mother to child. The current study examined whether maternal obesity was associated with differences in the composition of the gut microbiome in children in early life. Fecal samples from children 18-27 months of age (n = 77) were analyzed by pyro-tag 16S sequencing. Significant effects of maternal obesity on the composition of the gut microbiome of offspring were observed among dyads of higher socioeconomic status (SES). In the higher SES group (n = 47), children of obese (BMI >= 30) versus non-obese mothers clustered on a principle coordinate analysis (PCoA) and exhibited greater homogeneity in the composition of their gut microbiomes as well as greater alpha diversity as indicated by the Shannon Diversity Index, and measures of richness and evenness. Also in the higher SES group, children born to obese versus non-obese mothers had differences in abundances of Faecalibacterium spp., Eubacterium spp., Oscillibacter spp., and Blautia spp. Prior studies have linked some of these bacterial groups to differences in weight and diet. This study provides novel evidence that maternal obesity is associated with differences in the gut microbiome in children in early life, particularly among those of higher SES. Among obese adults, the relative contribution of genetic versus behavioral factors may differ based on SES. Consequently, the extent to which maternal obesity confers measureable changes to the gut microbiome of offspring may differ based on the etiology of maternal obesity. Continued research is needed to examine this question as well as the relevance of the observed differences in gut microbiome composition for weight trajectory over the life course.	[Galley, Jeffrey D.; Bailey, Michael] Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA; [Bailey, Michael; Christian, Lisa M.] Ohio State Univ, Wexner Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA; [Dush, Claire Kamp; Schoppe-Sullivan, Sarah] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Dept Psychiat, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bailey, M (corresponding author), Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA.	Michael.Bailey@osumc.edu	Christian, Lisa/E-2892-2011; Dush, Claire Kamp/B-4572-2012; Schoppe-Sullivan, Sarah/F-7137-2013	Christian, Lisa/0000-0001-5571-050X; Dush, Claire Kamp/0000-0003-4307-6825; Bailey, Michael/0000-0002-2222-3980	Food Innovation Center at The Ohio State University; NINR [R01NR01366]; NICHD [R21HD067670]; NCCAM [R01AT006552]; NIDCR [T32 DE014320]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD067670] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014320] Funding Source: NIH RePORTER	Food Innovation Center at The Ohio State University; NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by an Innovative Initiative Award to MTB and LMC from the Food Innovation Center at The Ohio State University. This study was also supported by awards from NINR (R01NR01366) and NICHD (R21HD067670) to LMC, NCCAM (R01AT006552) to MTB and NIDCR (T32 DE014320). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The sponsors did not participate in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzman SL, 2010, INT J OBESITY, V34, P1116, DOI 10.1038/ijo.2010.43; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; COATES ME, 1968, BRIT J NUTR, V22, P493, DOI 10.1079/BJN19680057; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Development RCT, R LANG ENV STAT COMP; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith M.S., 2006, GENES BEHAV SOCIAL E, P236; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Holland E, 2013, MATERN CHILD HLTH J, V17, P1872, DOI 10.1007/s10995-012-1210-9; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Keski-Nisula L, 2013, ACTA PAEDIATR, V102, P480, DOI 10.1111/apa.12186; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koupil I, 2008, INT J OBESITY, V32, P73, DOI 10.1038/sj.ijo.0803681; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Linabery AM, 2013, PEDIATR OBES, V8, P159, DOI 10.1111/j.2047-6310.2012.00100.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oksanen J., **DATA OBJECT**; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Park DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059470; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; Thompson AL, 2013, NUTR REV, V71, pS55, DOI 10.1111/nure.12054; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	51	109	118	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113026	10.1371/journal.pone.0113026	http://dx.doi.org/10.1371/journal.pone.0113026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409177	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200059
J	Lysoe, E; Harris, LJ; Walkowiak, S; Subramaniam, R; Divon, HH; Riiser, ES; Llorens, C; Gabaldon, T; Kistler, HC; Jonkers, W; Kolseth, AK; Nielsen, KF; Thrane, U; Frandsen, RJN				Lysoe, Erik; Harris, Linda J.; Walkowiak, Sean; Subramaniam, Rajagopal; Divon, Hege H.; Riiser, Even S.; Llorens, Carlos; Gabaldon, Toni; Kistler, H. Corby; Jonkers, Wilfried; Kolseth, Anna-Karin; Nielsen, Kristian F.; Thrane, Ulf; Frandsen, Rasmus J. N.			The Genome of the Generalist Plant Pathogen Fusarium avenaceum Is Enriched with Genes Involved in Redox, Signaling and Secondary Metabolism	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; MATING-TYPE; MYCOTOXIN PRODUCTION; FUNCTIONAL-CHARACTERIZATION; BIOSYNTHETIC-PATHWAY; CYCLIC TETRAPEPTIDE; GIBBERELLA-AVENACEA; DRY ROT; FUNGUS; ZEARALENONE	Fusarium avenaceum is a fungus commonly isolated from soil and associated with a wide range of host plants. We present here three genome sequences of F. avenaceum, one isolated from barley in Finland and two from spring and winter wheat in Canada. The sizes of the three genomes range from 41.6-43.1 MB, with 13217-13445 predicted protein-coding genes. Whole-genome analysis showed that the three genomes are highly syntenic, and share>95% gene orthologs. Comparative analysis to other sequenced Fusaria shows that F. avenaceum has a very large potential for producing secondary metabolites, with between 75 and 80 key enzymes belonging to the polyketide, non-ribosomal peptide, terpene, alkaloid and indole-diterpene synthase classes. In addition to known metabolites from F. avenaceum, fuscofusarin and JM-47 were detected for the first time in this species. Many protein families are expanded in F. avenaceum, such as transcription factors, and proteins involved in redox reactions and signal transduction, suggesting evolutionary adaptation to a diverse and cosmopolitan ecology. We found that 20% of all predicted proteins were considered to be secreted, supporting a life in the extracellular space during interaction with plant hosts.	[Lysoe, Erik; Riiser, Even S.] Bioforsk Norwegian Inst Agr & Environm Res, Dept Plant Hlth & Plant Protect, As, Norway; [Harris, Linda J.; Walkowiak, Sean; Subramaniam, Rajagopal] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Walkowiak, Sean; Subramaniam, Rajagopal] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Divon, Hege H.] Norwegian Vet Inst, Sect Mycol, Oslo, Norway; [Llorens, Carlos] Biotechvana, Valencia, Spain; [Gabaldon, Toni] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona, Spain; [Gabaldon, Toni] Univ Pompeu Fabra, Barcelona, Spain; [Gabaldon, Toni] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Kistler, H. Corby; Jonkers, Wilfried] USDA ARS, Cereal Dis Lab, St Paul, MN USA; [Kolseth, Anna-Karin] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Nielsen, Kristian F.; Thrane, Ulf; Frandsen, Rasmus J. N.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Bioforsk; Agriculture & Agri Food Canada; Carleton University; Norwegian Veterinary Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA; United States Department of Agriculture (USDA); Swedish University of Agricultural Sciences; Technical University of Denmark	Lysoe, E (corresponding author), Bioforsk Norwegian Inst Agr & Environm Res, Dept Plant Hlth & Plant Protect, As, Norway.	erik.lysoe@bioforsk.no	Nielsen, Kristian Fog/C-7233-2011; Thrane, Ulf/G-2978-2016; Kistler, Harold/AAC-1645-2019; Lysøe, Erik/AAJ-8894-2020; Gabaldón, Toni/A-7336-2008	Nielsen, Kristian Fog/0000-0002-5848-0911; Thrane, Ulf/0000-0002-6040-4141; Kistler, Harold/0000-0001-5312-6297; Gabaldón, Toni/0000-0003-0019-1735; Frandsen, Rasmus John Normand/0000-0002-3799-6062; Lysoe, Erik/0000-0001-5204-2577; Harris, Linda/0000-0002-9098-305X	Nordisk komite for jordbruks- og matforskning (NKJ) [NKJ 135]; Agriculture and Agri-Food Canada's Genomics Research & Development Initiative; ICREA Funding Source: Custom	Nordisk komite for jordbruks- og matforskning (NKJ); Agriculture and Agri-Food Canada's Genomics Research & Development Initiative(Agriculture & Agri Food Canada); ICREA(ICREA)	Nordisk komite for jordbruks- og matforskning (NKJ), Project number: "NKJ 135 - Impact of climate change on the interaction of Fusarium species in oats and barley'', and Agriculture and Agri-Food Canada's Genomics Research & Development Initiative funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Reedy RM, 2012, FUNGAL GENET BIOL, V49, P2, DOI 10.1016/j.fgb.2011.11.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Batta Y. A., 2012, Journal of Entomological and Acarological Research, V44, P51, DOI 10.4081/jear.2012.e11; Bomke C, 2008, APPL ENVIRON MICROB, V74, P5325, DOI 10.1128/AEM.00694-08; Bomke C, 2009, PHYTOCHEMISTRY, V70, P1876, DOI 10.1016/j.phytochem.2009.05.020; BOOTH C, 1984, T BRIT MYCOL SOC, V82, P178, DOI 10.1016/S0007-1536(84)80231-4; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; CHELKOWSKI J, 1983, PHYTOPATHOL Z, V106, P354; CHELKOWSKI J, 1983, NAHRUNG, V27, P525, DOI 10.1002/food.19830270602; CHELKOWSKI J, 1984, NAHRUNG, V28, P493, DOI 10.1002/food.19840280505; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Condon BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003233; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK RJ, 1967, PHYTOPATHOLOGY, V57, P732; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Crous Pedro W., 1995, Mycoscience, V36, P105, DOI 10.1007/BF02268579; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Desjardins AE, 2003, ANNU REV PHYTOPATHOL, V41, P177, DOI 10.1146/annurev.phyto.41.011703.115501; Dill-Macky R, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P184; Farman ML, 2002, MOL PLANT MICROBE IN, V15, P6, DOI 10.1094/MPMI.2002.15.1.6; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fourie G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-605; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Futami R., 2011, BIOTECHVANA BIOINFOR; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Hamilton AJ, 1999, MED MYCOL, V37, P375, DOI 10.1046/j.1365-280X.1999.00208.x; Hansen FT, 2012, INT J FOOD MICROBIOL, V155, P128, DOI 10.1016/j.ijfoodmicro.2012.01.018; HARRIS SD, 1994, GENETICS, V136, P517; de Dios CH, 2010, CURR PROTEIN PEPT SC, V11, P693; HERSHENHORN J, 1992, PLANT SCI, V86, P155, DOI 10.1016/0168-9452(92)90161-E; Holtz MD, 2011, CAN J PLANT PATHOL, V33, P61, DOI 10.1080/07060661.2011.536651; HUSSEIN HM, 1991, MYCOPATHOLOGIA, V113, P35, DOI 10.1007/BF00436385; ISHII K, 1974, APPL MICROBIOL, V27, P625, DOI 10.1191/0309133303pp399xx; Jiang Z, 2002, PHYTOCHEMISTRY, V60, P33, DOI 10.1016/S0031-9422(02)00061-4; Jin JM, 2010, MOL MICROBIOL, V76, P456, DOI 10.1111/j.1365-2958.2010.07109.x; Jose B, 2004, BIOORG MED CHEM LETT, V14, P5343, DOI 10.1016/j.bmcl.2004.08.016; Karanyi Z, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat037; Kawaide H, 2006, BIOSCI BIOTECH BIOCH, V70, P583, DOI 10.1271/bbb.70.583; Kerenyi Z, 2004, APPL ENVIRON MICROB, V70, P4419, DOI 10.1128/AEM.70.8.4419-4423.2004; Kildgaard S, 2014, MAR DRUGS, V12, P3681, DOI 10.3390/md12063681; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Klitgaard A, 2014, ANAL BIOANAL CHEM, V406, P1933, DOI 10.1007/s00216-013-7582-x; Kohl J, 2007, PHYTOPATHOLOGY, V97, P971, DOI 10.1094/PHYTO-97-8-0971; Kokkonen M, 2010, INT J FOOD MICROBIOL, V143, P17, DOI 10.1016/j.ijfoodmicro.2010.07.015; Kosti I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-133; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulik T, 2011, INT J MOL SCI, V12, P5626, DOI 10.3390/ijms12095626; Kurtz S, 2004, GENOME BIOL, P5; Laatch H., 2012, ANTIBASE 2012 NATURA; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leach MC, 2013, LEARN PUBL, V26, P180, DOI 10.1087/20130305; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; LEE SL, 1976, ARCH BIOCHEM BIOPHYS, V177, P84, DOI 10.1016/0003-9861(76)90418-5; Lysoe E, 2006, APPL ENVIRON MICROB, V72, P3924, DOI 10.1128/AEM.00963-05; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P995, DOI 10.1094/MPMI-02-11-0038; Ma LJ, 2013, ANNU REV MICROBIOL, V67, P399, DOI 10.1146/annurev-micro-092412-155650; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Makkonen J, 2013, J INVERTEBR PATHOL, V113, P184, DOI 10.1016/j.jip.2013.03.008; Malonek S, 2005, APPL ENVIRON MICROB, V71, P1462, DOI 10.1128/AEM.71.3.1462-1472.2005; Malz S, 2005, FUNGAL GENET BIOL, V42, P420, DOI 10.1016/j.fgb.2005.01.010; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; MARASAS WFO, 1984, TOXIGENIC FUSARIUM S; Marcet-Houben M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-646; Marcet-Houben M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004357; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin SH, 2011, FUNGAL GENET BIOL, V48, P731, DOI 10.1016/j.fgb.2011.03.005; Marx F, 2004, APPL MICROBIOL BIOT, V65, P133, DOI 10.1007/s00253-004-1600-z; MERCIER J, 1991, CAN PLANT DIS SURV, V71, P161; Morrison E, 2002, J AGR FOOD CHEM, V50, P3070, DOI 10.1021/jf011532h; Nalim FA, 2009, PHYTOPATHOLOGY, V99, P462, DOI 10.1094/PHYTO-99-4-0462; Niehaus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103336; Nielsen KF, 2011, J NAT PROD, V74, P2338, DOI 10.1021/np200254t; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; PANACCIONE DG, 1992, P NATL ACAD SCI USA, V89, P6590, DOI 10.1073/pnas.89.14.6590; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Peters RD, 2007, HORTSCIENCE, V42, P737, DOI 10.21273/HORTSCI.42.3.737; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plancot B, 2013, PLANT PHYSIOL, V163, P1584, DOI 10.1104/pp.113.222356; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rim SO, 2013, J MICROBIOL BIOTECHN, V23, P623, DOI 10.4014/jmb.1212.12029; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Sato T, 1998, INT CON PLANT PAT, V2, P48; Satyaprasad K, 1997, POTATO RES, V40, P357, DOI 10.1007/BF02357994; Seshime Y, 2005, BIOCHEM BIOPH RES CO, V331, P253, DOI 10.1016/j.bbrc.2005.03.160; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Song ZS, 2004, CHEMBIOCHEM, V5, P1196, DOI 10.1002/cbic.200400138; Sorensen JL, 2013, TOXINS, V5, P1655, DOI 10.3390/toxins5091655; Sorensen JL, 2009, J AGR FOOD CHEM, V57, P1632, DOI 10.1021/jf802926u; Sorensen LQ, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-15; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; TAKEUCHI M, 1989, J ANTIBIOT, V42, P198, DOI 10.7164/antibiotics.42.198; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; Thrane U, 1988, Mycotoxin Res, V4, P2, DOI 10.1007/BF03192082; Uhlig S, 2007, INT J FOOD MICROBIOL, V119, P17, DOI 10.1016/j.ijfoodmicro.2007.07.021; Urban M, 2013, FUSARIUM: GENOMICS, MOLECULAR AND CELLULAR BIOLOGY, P43; Varvas Triin, 2013, Acta Mycologica, V48, P41, DOI 10.5586/am.2013.006; von Dohren H, 2004, ADV BIOCHEM ENG BIOT, V88, P217, DOI 10.1007/b99262; Watanabe M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-322; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Young CA, 2009, APPL ENVIRON MICROB, V75, P2200, DOI 10.1128/AEM.00953-08; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	110	57	58	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112703	10.1371/journal.pone.0112703	http://dx.doi.org/10.1371/journal.pone.0112703			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409087	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200033
J	Tudorache, C; Burgerhout, E; Brittijn, S; van den Thillart, G				Tudorache, Christian; Burgerhout, Erik; Brittijn, Sebastiaan; van den Thillart, Guido			The Effect of Drag and Attachment Site of External Tags on Swimming Eels: Experimental Quantification and Evaluation Tool	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; ANGUILLA-ANGUILLA; SILVER EELS; PERFORMANCE; MIGRATION; COST; TRANSMITTERS; ENERGETICS; TROUT; HYDRODYNAMICS	Telemetry studies on aquatic animals often use external tags to monitor migration patterns and help to inform conservation effort. However, external tags are known to impair swimming energetics dramatically in a variety of species, including the endangered European eel. Due to their high swimming efficiency, anguilliform swimmers are very susceptibility for added drag. Using an integration of swimming physiology, behaviour and kinematics, we investigated the effect of additional drag and site of externally attached tags on swimming mode and costs. The results show a significant effect of a) attachment site and b) drag on multiple energetic parameters, such as Cost Of Transport (COT), critical swimming speed (U-crit) and optimal swimming speed (U-opt), possibly due to changes in swimming kinematics. Attachment at 0.125 bl from the tip of the snout is a better choice than at the Centre Of Mass (0.35 bl), as it is the case in current telemetry studies. Quantification of added drag effect on COT and Ucrit show a (limited) correlation, suggesting that the Ucrit test can be used for evaluating external tags for telemetry studies until a certain threshold value. Uopt is not affected by added drag, validating previous findings of telemetry studies. The integrative methodology and the evaluation tool presented here can be used for the design of new studies using external telemetry tags, and the (re-) evaluation of relevant studies on anguilliform swimmers.	[Tudorache, Christian; Burgerhout, Erik] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Burgerhout, Erik; Brittijn, Sebastiaan; van den Thillart, Guido] NewCatch BV, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Tudorache, C (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.	c.tudorache@biology.leidenuniv.nl	Burgerhout, Erik/AAI-4527-2020	Tudorache, Christian/0000-0002-6208-9608	Dutch Technology Foundation STW-VENI grant [11731]	Dutch Technology Foundation STW-VENI grant	CT was supported by a Dutch Technology Foundation STW-VENI grant [11731]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Erik Burgerhout, Sebastiaan Brittijn and Guido van den Thillart are employed by NewCatch B. V. NewCatch B.V. provided support in the form of salaries for authors EB, SB and GvdT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section''.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; Beguer-Pon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046830; Behrens JW, 2007, MAR BIOL, V150, P1365, DOI 10.1007/s00227-006-0456-4; Bell W. H, 1970, Rep. Fish. Res. Bd Can., VNo. 195, P1; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Burgerhout E, 2011, NATURWISSENSCHAFTEN, V98, P631, DOI 10.1007/s00114-011-0805-0; CULIK BM, 1993, MAR ECOL PROG SER, V98, P209, DOI 10.3354/meps098209; Durif C, 2005, J FISH BIOL, V66, P1025, DOI 10.1111/j.0022-1112.2005.00662.x; Farrell AP, 2007, PHILOS T R SOC B, V362, P2017, DOI 10.1098/rstb.2007.2111; French AP, 1970, MIT INTRO PHYS SERIE; Grusha DS, 2005, FISH B-NOAA, V103, P63; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Haro A, 2004, CAN J FISH AQUAT SCI, V61, P1590, DOI 10.1139/F04-093; HAYNES JM, 1978, T AM FISH SOC, V107, P275, DOI 10.1577/1548-8659(1978)107<275:SMOWSA>2.0.CO;2; Hazekamp AAH, 2010, EUR J WILDLIFE RES, V56, P131, DOI 10.1007/s10344-009-0293-0; Jacoby D, 2014, IUCN 2014 IUCN RED L; Jellyman D, 2002, MAR ECOL PROG SER, V233, P207, DOI 10.3354/meps233207; Jennings JG, 1980, TRACKING PELAGIC DOL, P753; JONES DR, 1974, J FISH RES BOARD CAN, V31, P1641, DOI 10.1139/f74-206; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Lindsey CC, 1978, FISH PHYSIOL, VVII, DOI DOI 10.1016/S1546-5098(08)60163-6; Maes GE, 2006, MOL ECOL, V15, P2095, DOI 10.1111/j.1365-294X.2006.02925.x; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; McCleave J.D., 1985, Contributions in Marine Science, V27, P316; Methling C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020797; Okland F., 2013, ANIM BIOTELEM, V1, P3, DOI [10.1186/2050-3385-1-3, DOI 10.1186/2050-3385-1-3]; Palstra AP, 2007, J EXP MAR BIOL ECOL, V352, P244, DOI 10.1016/j.jembe.2007.08.003; Palstra A, 2008, COMP BIOCHEM PHYS A, V151, P37, DOI 10.1016/j.cbpa.2008.05.011; Pavlov VV, 2007, DEEP-SEA RES PT II, V54, P404, DOI 10.1016/j.dsr2.2006.11.010; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Read DA, 2003, J FLUID STRUCT, V17, P163, DOI 10.1016/S0889-9746(02)00115-9; Righton D, 2012, J FISH BIOL, V81, P365, DOI 10.1111/j.1095-8649.2012.03373.x; Schabetsberger R, 2013, MAR ECOL PROG SER, V475, P177, DOI 10.3354/meps10254; Schmidt J., 1925, Annual Report Smithsonian Institution, V1924, P279; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Sloman KA, 2000, FISH PHYSIOL BIOCHEM, V23, P49, DOI 10.1023/A:1007855100185; Steinhausen MF, 2006, J FISH BIOL, V69, P951, DOI 10.1111/j.1095-8649.2006.01143.x; Tesch WW, 1977, BIOL MANAGEMENT ANGU; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; Triantafyllou MS, 2002, INTEGR COMP BIOL, V42, P1026, DOI 10.1093/icb/42.5.1026; Tudorache C, 2007, J FISH BIOL, V71, P1630, DOI 10.1111/j.1095-8649.2007.01620.x; Tudorache C, 2009, ENVIRON BIOL FISH, V84, P121, DOI 10.1007/s10641-008-9395-x; Tytell ED, 2004, J EXP BIOL, V207, P1825, DOI 10.1242/jeb.00968; Tytell ED, 2007, EXP FLUIDS, V43, P701, DOI 10.1007/s00348-007-0343-x; van den Thillart G, 2004, J FISH BIOL, V65, P312, DOI 10.1111/j.0022-1112.2004.00447.x; van Ginneken V, 2005, J EXP BIOL, V208, P1329, DOI 10.1242/jeb.01524; van Ginneken VJT, 2000, NATURE, V403, P156, DOI 10.1038/35003110; VANDENTHILLART G, 2009, ESTIMATED REPROD SUC, V30, P3; Vogel S., 2003, COMP BIOMECHANICS LI; Watson KP, 1998, J EXP BIOL, V201, P2497; WEBB PW, 1971, J EXP BIOL, V55, P489; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067	54	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112280	10.1371/journal.pone.0112280	http://dx.doi.org/10.1371/journal.pone.0112280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409179	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200019
J	Kuehl, CJ; Dragoi, AM; Agaisse, H				Kuehl, Carole J.; Dragoi, Ana-Maria; Agaisse, Herve			The Shigella flexneri Type 3 Secretion System Is Required for Tyrosine Kinase-Dependent Protrusion Resolution, and Vacuole Escape during Bacterial Dissemination	PLOS ONE			English	Article							III SECRETION; INTERCELLULAR DISSEMINATION; EPITHELIAL-CELLS; IPA INVASINS; HOST-CELLS; APPARATUS; ACTIN; ENTRY; PROTEIN; GENES	Shigella flexneri is a human pathogen that triggers its own entry into intestinal cells and escapes primary vacuoles to gain access to the cytosolic compartment. As cytosolic and motile bacteria encounter the cell cortex, they spread from cell to cell through formation of membrane protrusions that resolve into secondary vacuoles in adjacent cells. Here, we examined the roles of the Type 3 Secretion System (T3SS) in S. flexneri dissemination in HT-29 intestinal cells infected with the serotype 2a strain 2457T. We generated a 2457T strain defective in the expression of MxiG, a central component of the T3SS needle apparatus. As expected, the Delta mxiG strain was severely affected in its ability to invade HT-29 cells, and expression of mxiG under the control of an arabinose inducible expression system (Delta mxiG/pmxiG) restored full infectivity. In this experimental system, removal of the inducer after the invasion steps (Delta mxiG/pmxiG (Ara withdrawal)) led to normal actin-based motility in the cytosol of HT-29 cells. However, the time spent in protrusions until vacuole formation was significantly increased. Moreover, the number of formed protrusions that failed to resolve into vacuoles was also increased. Accordingly, the DmxiG/pmxiG (Ara withdrawal) strain failed to trigger tyrosine phosphorylation in membrane protrusions, a signaling event that is required for the resolution of protrusions into vacuoles. Finally, the Delta mxiG/pmxiG (Ara withdrawal) strain failed to escape from the formed secondary vacuoles, as previously reported in non-intestinal cells. Thus, the T3SS system displays multiple roles in S. flexneri dissemination in intestinal cells, including the tyrosine kinase signaling-dependent resolution of membrane protrusions into secondary vacuoles, and the escape from the formed secondary vacuoles.	[Kuehl, Carole J.; Dragoi, Ana-Maria; Agaisse, Herve] Yale Univ, Boyer Ctr Mol Med, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Agaisse, H (corresponding author), Yale Univ, Boyer Ctr Mol Med, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	herve.agaisse@yale.edu			NIH [R01AI073904]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH Grant R01AI073904. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAOUI A, 1995, MOL MICROBIOL, V17, P461, DOI 10.1111/j.1365-2958.1995.mmi_17030461.x; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Campbell-Valois FX, 2014, CELL HOST MICROBE, V15, P177, DOI 10.1016/j.chom.2014.01.005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeMali KA, 2006, J BIOL CHEM, V281, P39534, DOI 10.1074/jbc.M605939200; Demers B, 1998, EMBO J, V17, P2894, DOI 10.1093/emboj/17.10.2894; Dragoi AM, 2014, INFECT IMMUN, V82, P4447, DOI 10.1128/IAI.02078-14; Dragoi AM, 2013, INFECT IMMUN, V81, P598, DOI 10.1128/IAI.00853-12; Gouin E, 1999, J CELL SCI, V112, P1697; Hachani A, 2008, MICROBES INFECT, V10, P260, DOI 10.1016/j.micinf.2007.11.011; LABREC EH, 1964, J BACTERIOL, V88, P1503, DOI 10.1128/JB.88.5.1503-1518.1964; Leung Y, 2008, CELL HOST MICROBE, V3, P39, DOI 10.1016/j.chom.2007.10.011; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; Mavris M, 2002, J BACTERIOL, V184, P6751, DOI 10.1128/JB.184.24.6751-6759.2002; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Menard R, 1996, P NATL ACAD SCI USA, V93, P1254, DOI 10.1073/pnas.93.3.1254; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; Page AL, 1999, CELL MICROBIOL, V1, P183, DOI 10.1046/j.1462-5822.1999.00019.x; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Sansonetti PJ, 1998, FOLIA MICROBIOL, V43, P239, DOI 10.1007/BF02818608; Schuch R, 1999, MOL MICROBIOL, V34, P675, DOI 10.1046/j.1365-2958.1999.01627.x; WATARAI M, 1995, EMBO J, V14, P2461, DOI 10.1002/j.1460-2075.1995.tb07243.x; Wing HJ, 2004, J BACTERIOL, V186, P699, DOI 10.1128/JB.186.3.699-705.2004	28	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112738	10.1371/journal.pone.0112738	http://dx.doi.org/10.1371/journal.pone.0112738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405985	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300050
J	Cocchiola, R; Grillo, C; Altieri, F; Chichiarelli, S; Turano, C; Eufemi, M				Cocchiola, Rossana; Grillo, Caterina; Altieri, Fabio; Chichiarelli, Silvia; Turano, Carlo; Eufemi, Margherita			Upregulation of TPX2 by STAT3: Identification of a Novel STAT3 Binding Site	PLOS ONE			English	Article							THERAPEUTIC TARGET; GENE; PROTEIN; GROWTH; CANCER	TPX2, a protein involved in mitosis, is considered a good marker for actively proliferating tissues, highly expressed in a number of cancer cells. We show the presence of high-affinity binding site for STAT3 in the 5'-flanking region of the Tpx2 gene, which is in vivo bound by activated STAT3. A specific STAT3 peptide inhibitor represses the expression of the Tpx2 gene and inhibits the binding of STAT3 to its consensus sequence in human cell lines where STAT3 is activated. These results indicate that activated STAT3 contributes to the over-expression of Tpx2 through the binding to an enhancer site.	[Cocchiola, Rossana; Grillo, Caterina; Altieri, Fabio; Chichiarelli, Silvia; Turano, Carlo; Eufemi, Margherita] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Cocchiola, Rossana; Grillo, Caterina; Altieri, Fabio; Chichiarelli, Silvia; Turano, Carlo; Eufemi, Margherita] Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti	Eufemi, M (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy.	margherita.eufemi@uniroma1.it	Cocchiola, Rossana/AAA-1702-2020; Chichiarelli, Silvia/F-1226-2011; Grillo, Caterina Maria/ABD-3404-2021; Altieri, Fabio/D-2790-2009	Altieri, Fabio/0000-0002-6546-2738; Cocchiola, Rossana/0000-0002-2764-5445; Chichiarelli, Silvia/0000-0002-5682-0353	Istituto Pasteur-Fondazione Cenci Bolognetti-Rome; BCC Cassa Rurale ed Artigiana di Paliano	Istituto Pasteur-Fondazione Cenci Bolognetti-Rome(Istituto Pasteur Italia Fondazione Cenci Bolognetti); BCC Cassa Rurale ed Artigiana di Paliano	Istituto Pasteur-Fondazione Cenci Bolognetti-Rome; BCC Cassa Rurale ed Artigiana di Paliano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adach A, 2009, METHODS MOL BIOL, V512, P265, DOI 10.1007/978-1-60327-530-9_14; Agostinelli E, 2006, BBA-MOL CELL RES, V1763, P1040, DOI 10.1016/j.bbamcr.2006.07.014; Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668; Chichiarelli S, 2002, ANAL BIOCHEM, V302, P224, DOI 10.1006/abio.2001.5543; Eufemi M, 2004, BIOCHEM BIOPH RES CO, V323, P1306, DOI 10.1016/j.bbrc.2004.09.009; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; LEMAIRE MA, 1991, P NATL ACAD SCI USA, V88, P1982, DOI 10.1073/pnas.88.5.1982; Meyer WKH, 1997, J BIOL CHEM, V272, P31821, DOI 10.1074/jbc.272.50.31821; Motti ML, 2005, CARCINOGENESIS, V26, P1021, DOI 10.1093/carcin/bgi050; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Pedranzini L, 2004, J CLIN INVEST, V114, P619, DOI 10.1172/JCI200422800; Perez de Castro Ignacio, 2012, Genes Cancer, V3, P721, DOI 10.1177/1947601912473306; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Rojas M, 1998, NAT BIOTECHNOL, V16, P370, DOI 10.1038/nbt0498-370; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Sellier H., 2013, JAK STAT, V2; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Vainio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039801; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Wei P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-313; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Yu CR, 1999, J IMMUNOL, V162, P2785; Zhang LJ, 2008, TOXICOLOGY, V252, P49, DOI 10.1016/j.tox.2008.07.059	24	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113096	10.1371/journal.pone.0113096	http://dx.doi.org/10.1371/journal.pone.0113096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401333	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700110
J	Easter, SL; Mitchell, EH; Baxley, SE; Desmond, R; Frost, AR; Serra, R				Easter, Stephanie L.; Mitchell, Elizabeth H.; Baxley, Sarah E.; Desmond, Renee; Frost, Andra R.; Serra, Rosa			Wnt5a Suppresses Tumor Formation and Redirects Tumor Phenotype in MMTV-Wnt1 Tumors	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; BREAST-CANCER; STEM-CELLS; SIGNALING PATHWAY; SELF-RENEWAL; P-CADHERIN; TGF-BETA; EXPRESSION; PROTEIN; WNT-5A	Wnt5a is a non-canonical signaling Wnt that has been implicated in tumor suppression. We previously showed that loss of Wnt5a in MMTV-PyVmT tumors resulted in a switch in tumor phenotype resulting in tumors with increased basal phenotype and high Wnt/beta-catenin signaling. The object of this study was to test the hypothesis that Wnt5a can act to inhibit tumors formed by activation of Wnt/beta-catenin signaling. To this end, we characterized tumor and non-tumor mammary tissue from MMTV-Wnt1 and double transgenic MMTV-Wnt1; MMTV-Wnt5a mice. Wnt5a containing mice demonstrated fewer tumors with increased latency when compared to MMTV-Wnt1 controls. Expression of markers for basal-like tumors was down-regulated in the tumors that formed in the presence of Wnt5a indicating a phenotypic switch. Reduced canonical Wnt signaling was detected in double transgenic tumors as a decrease in active beta-catenin protein and a decrease in Axin2 mRNA transcript levels. In non-tumor tissues, over-expression of Wnt5a in MMTV-Wnt1 mammary glands resulted in attenuation of phenotypes normally observed in MMTV-Wnt1 glands including hyperbranching and increased progenitor and basal cell populations. Even though Wnt5a could antagonize Wnt/beta-catenin signaling in primary mammary epithelial cells in culture, reduced Wnt/beta-catenin signaling was not detected in non-tumor MMTV-Wnt1; Wnt5a tissue in vivo. The data demonstrate that Wnt5a suppresses tumor formation and promotes a phenotypic shift in MMTV-Wnt1 tumors.	[Easter, Stephanie L.; Mitchell, Elizabeth H.; Baxley, Sarah E.; Serra, Rosa] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Desmond, Renee] Univ Alabama Birmingham, Ctr Comprehens Canc, Dept Med, Biostat & Bioinformat Unit, Birmingham, AL 35294 USA; [Frost, Andra R.] Univ Alabama Birmingham, Dept Pathol, Div Anat Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Serra, R (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	rserra@uab.edu			National Cancer Institute [R01 CA126942]; UAB Comprehensive Cancer Center [P30 CA13148]; NATIONAL CANCER INSTITUTE [R01CA126942, P30CA013148] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UAB Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RS was supported by the National Cancer Institute, R01 CA126942. Statistical work was supported by the UAB Comprehensive Cancer Center (P30 CA13148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Baxley SE, 2011, BIOL REPROD, V85, P907, DOI 10.1095/biolreprod.111.091645; Benhaj K, 2006, ONCOL REP, V15, P701; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Bu W, 2011, ONCOGENE, V30, P4399, DOI 10.1038/onc.2011.147; Byun JY, 2006, MOL VIS, V12, P949; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ghebeh H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-289; GUELSTEIN VI, 1988, INT J CANCER, V42, P147, DOI 10.1002/ijc.2910420202; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Jansson M, 2001, J CELL SCI, V114, P2043; Jonsson M, 2002, CANCER RES, V62, P409; Katoh M, 2005, ONCOL REP, V14, P1583; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Leris ACA, 2005, ANTICANCER RES, V25, P731; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Many AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101800; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Olson DJ, 1997, CELL GROWTH DIFFER, V8, P417; Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030; PALACIOS J, 1995, AM J PATHOL, V146, P605; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; RASBRIDGE SA, 1993, J PATHOL, V169, P245, DOI 10.1002/path.1711690211; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Trifa F, 2013, TUMOR BIOL, V34, P1625, DOI 10.1007/s13277-013-0694-2; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; WETZELS RHW, 1989, AM J PATHOL, V134, P571	59	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113247	10.1371/journal.pone.0113247	http://dx.doi.org/10.1371/journal.pone.0113247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401739	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700126
J	Ellison, TJ; Kedes, DH				Ellison, Thomas J.; Kedes, Dean H.			Variable Episomal Silencing of a Recombinant Herpesvirus Renders Its Encoded GFP an Unreliable Marker of Infection in Primary Cells	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; LYTIC GENE-EXPRESSION; KAPOSIS-SARCOMA; HISTONE DEACETYLASE; FLUORESCENT PROTEIN; DNA-SEQUENCES; LATENCY; KSHV; PERSISTENCE; DIFFERENTIATION	The availability of reliable recombinant reporter virus systems has been a great boon to the study of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8). Unexpectedly, we found that expression of the ostensibly constitutive green fluorescent protein (GFP) marker was progressively lost during unselected passage in primary rat mesenchymal precursor cells (MM), despite efficient maintenance of latent viral gene expression and episomal partitioning. This repression of EF1-alpha promoter-driven GFP expression appeared to be passage-dependent, however, since functionally immortalized MM cells derived from long serial passage retained stable expression of GFP following rKSHV. 219 infection. Chromatin analysis of cultures that we had infected in parallel demonstrated an increase in repressive H3K27 tri-methylation across the viral episome with the exception of the LANA control region in MM cells infected at early rather than late passage post-isolation. The silencing of GFP expression in the MM cells was reversible in a dose-dependent fashion by the histone deacetylase inhibitor valproic acid, further implicating cellular silencing on incoming viral genomes, and underscoring potential differences in viral gene regulation between primary and functionally immortalized cells. Furthermore, using multispectral imaging flow cytometry, we also determined that the extent of GFP expression per cell among those that were positive did not correlate with the number of LANA dots per nucleus nor the extent of overall LANA expression per cell. This suggests a more complex mode of local gene regulation, rather than one that simply reflects the relative intracellular viral copy number. In sum, we have demonstrated the significant potential for false-negative data when using a constitutive marker gene as a sole means of evaluating herpesviral infection, especially in primary cells.	[Ellison, Thomas J.; Kedes, Dean H.] Univ Virginia, Myles H Thaler Ctr AIDS & Human Retrovirus Res, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22904 USA; [Kedes, Dean H.] Univ Virginia, Dept Internal Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA	University of Virginia; University of Virginia	Kedes, DH (corresponding author), Univ Virginia, Myles H Thaler Ctr AIDS & Human Retrovirus Res, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22904 USA.	kedes@virginia.edu		Ellison, Thomas/0000-0001-9231-918X	National Institute of Dental and Craniofacial Research [R01DE022291]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022291] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research R01DE022291 to DHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adang LA, 2006, J VIROL, V80, P10073, DOI 10.1128/JVI.01156-06; Ashlock BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087324; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Ballestas ME, 2001, J VIROL, V75, P3250, DOI 10.1128/JVI.75.7.3250-3258.2001; Borah S, 2012, RNA, V18, P1573, DOI 10.1261/rna.033126.112; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Chang PC, 2009, CANCER RES, V69, P5681, DOI 10.1158/0008-5472.CAN-08-4570; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Collins CM, 2009, J VIROL, V83, P6484, DOI 10.1128/JVI.00297-09; Dollery SJ, 2014, J VIROL, V88, P1748, DOI 10.1128/JVI.03063-13; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Jeffery HC, 2013, J VIROL METHODS, V193, P251, DOI 10.1016/j.jviromet.2013.06.001; Johnson AS, 2005, J VIROL, V79, P13769, DOI 10.1128/JVI.79.21.13769-13777.2005; Jones T, 2012, J CLIN INVEST, V122, P1076, DOI 10.1172/JCI58530; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Myoung J, 2011, J VIROL, V85, P9767, DOI 10.1128/JVI.05136-11; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Myoung JJ, 2011, VIROLOGY, V413, P1, DOI 10.1016/j.virol.2010.12.036; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Nichols LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014535; Seifi A, 2011, VIROLOGY, V410, P17, DOI 10.1016/j.virol.2010.10.023; Shin HJ, 2014, J VIROL, V88, P1281, DOI 10.1128/JVI.02665-13; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Toth Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003813; Toth Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001013; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wu W, 2006, BLOOD, V108, P141, DOI 10.1182/blood-2005-04-1697	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111502	10.1371/journal.pone.0111502	http://dx.doi.org/10.1371/journal.pone.0111502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402328	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700015
J	Buzzi, M; Guarino, A; Gatto, C; Manara, S; Dainese, L; Polvani, G; Tothova, JD				Buzzi, Marina; Guarino, Anna; Gatto, Claudio; Manara, Sabrina; Dainese, Luca; Polvani, Gianluca; Tothova, Jana D'Amato			Residual Antibiotics in Decontaminated Human Cardiovascular Tissues Intended for Transplantation and Risk of Falsely Negative Microbiological Analyses	PLOS ONE			English	Article							HEART-VALVE ALLOGRAFTS; HOMOGRAFT BANK EHB; ARTERIAL ALLOGRAFTS; BACTERIOLOGY; INFLAMMATION; INFECTION; COCKTAILS; PEPTIDES	We investigated the presence of antibiotics in cryopreserved cardiovascular tissues and cryopreservation media, after tissue decontamination with antibiotic cocktails, and the impact of antibiotic residues on standard tissue bank microbiological analyses. Sixteen cardiovascular tissues were decontaminated with bank-prepared cocktails and cryopreserved by two different tissue banks according to their standard operating procedures. Before and after decontamination, samples underwent microbiological analysis by standard tissue bank methods. Cryopreserved samples were tested again with and without the removal of antibiotic residues using a RESEP tube, after thawing. Presence of antibiotics in tissue homogenates and processing liquids was determined by a modified agar diffusion test. All cryopreserved tissue homogenates and cryopreservation media induced important inhibition zones on both Staphylococcus aureus- and Pseudomonas aeruginosa-seeded plates, immediately after thawing and at the end of the sterility test. The RESEP tube treatment markedly reduced or totally eliminated the antimicrobial activity of tested tissues and media. Based on standard tissue bank analysis, 50% of tissues were found positive for bacteria and/or fungi, before decontamination and 2 out of 16 tested samples (13%) still contained microorganisms after decontamination. After thawing, none of the 16 cryopreserved samples resulted positive with direct inoculum method. When the same samples were tested after removal of antibiotic residues, 8 out of 16 ( 50%) were contaminated. Antibiotic residues present in tissue allografts and processing liquids after decontamination may mask microbial contamination during microbiological analysis performed with standard tissue bank methods, thus resulting in false negatives.	[Buzzi, Marina; Manara, Sabrina] Azienda Osped Univ Policlin S Orsola Malpighi, Cardiovasc Tissue Bank Emilia Romagna, Bologna, Italy; [Guarino, Anna; Dainese, Luca; Polvani, Gianluca] Ctr Cardiol Monzino, Cardiovasc Tissue Bank Lombardia, Milan, Italy; [Gatto, Claudio; Tothova, Jana D'Amato] AL CHI MI A Srl, Dept Res & Dev, Ponte San Nicolo, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Centro Cardiologico Monzino	Tothova, JD (corresponding author), AL CHI MI A Srl, Dept Res & Dev, Ponte San Nicolo, Italy.	jtothova@alchilife.com	Tothova, Jana D'Amato/AAE-5502-2021; Buzzi, Marina/AAC-8681-2022; POLVANI, GIANLUCA/I-4656-2018; guarino, maggio1966/AAA-7256-2021	Buzzi, Marina/0000-0002-3711-5886; POLVANI, GIANLUCA/0000-0003-1055-0965; guarino, maggio1966/0000-0003-0705-6851; luca, dainese/0000-0001-8683-3457	AL.CHI.MI.A. S.r.l.	AL.CHI.MI.A. S.r.l.	AL.CHI.MI.A. S.r.l., provided support in the form of salaries for authors C. Gatto and J. D'Amato Tothova, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexander Karen, 2006, Cell and Tissue Banking, V7, P23, DOI 10.1007/s10561-005-3393-4; [Anonymous], 1999, AM J HEALTH-SYST PH, V56, P1839; [Anonymous], EUROPEAN PHARMACOPOE, P175; Brogden NK, 2012, SKIN PHARMACOL PHYS, V25, P167, DOI 10.1159/000337927; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; de By TMMH, 2012, HEART LUNG VESSEL, V4, P251; EASTLUND T, 1995, CELL TRANSPLANT, V4, P455, DOI 10.1016/0963-6897(95)00035-V; Eastlund Ted, 2006, Cell and Tissue Banking, V7, P147, DOI 10.1007/s10561-006-0003-z; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Gatto C, 2013, CELL TISSUE BANK, V14, P107, DOI 10.1007/s10561-012-9305-5; Huang LC, 2006, INVEST OPHTH VIS SCI, V47, P2369, DOI 10.1167/iovs.05-1649; Jashari R, 2013, CELL TISSUE BANK, V14, P589, DOI 10.1007/s10561-012-9359-4; Jashari R., 2007, Cell and Tissue Banking, V8, P247, DOI 10.1007/s10561-007-9040-5; Jashari R, 2011, TRANSFUS MED HEMOTH, V38, P379, DOI 10.1159/000334706; Kainer MA, 2004, NEW ENGL J MED, V350, P2564, DOI 10.1056/NEJMoa023222; Kim JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047642; Kuehnert MJ, 1998, CLIN INFECT DIS, V27, P688, DOI 10.1086/514944; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Mirelli M, 2005, TRANSPLANT P, V37, P2688, DOI 10.1016/j.transproceed.2005.06.034; Mitteregger D, 2013, J CLIN MICROBIOL, V51, P1534, DOI 10.1128/JCM.00103-13; Morris JA, 2006, J CLIN PATHOL, V59, P1, DOI 10.1136/jcp.2005.028183; Pirnay JP, 2012, CELL TISSUE BANK, V13, P287, DOI 10.1007/s10561-011-9256-2; Pitt TL, 2014, CELL TISSUE BANK, V15, P119, DOI 10.1007/s10561-013-9382-0; Saegeman V, 2008, J HOSP INFECT, V70, P278, DOI 10.1016/j.jhin.2008.07.020; Schroeter J, 2012, TRANSFUS MED HEMOTH, V39, P387, DOI 10.1159/000345812; Soo A, 2011, CELL TISSUE BANK, V12, P185, DOI 10.1007/s10561-010-9180-x; Tabaku M., 2004, Cell and Tissue Banking, V5, P261, DOI 10.1007/s10561-004-1440-1; van Kats JP, 2010, EUR J CARDIO-THORAC, V37, P163, DOI 10.1016/j.ejcts.2009.07.011; Varettas K, 2013, CELL TISSUE BANK, V14, P609, DOI 10.1007/s10561-012-9361-x; Welters MJP, 2002, HUM IMMUNOL, V63, P1019, DOI 10.1016/S0198-8859(02)00441-X; Welters MJP, 2001, CLIN EXP IMMUNOL, V124, P353, DOI 10.1046/j.1365-2249.2001.01557.x	31	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112679	10.1371/journal.pone.0112679	http://dx.doi.org/10.1371/journal.pone.0112679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397402	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558500076
J	McLean, AHC; Godfray, HCJ				McLean, Ailsa H. C.; Godfray, H. Charles J.			An Experimental Test of whether the Defensive Phenotype of an Aphid Facultative Symbiont Can Respond to Selection within a Host Lineage	PLOS ONE			English	Article							PEA APHID; SECONDARY SYMBIONTS; BACTERIAL SYMBIONTS; HORIZONTAL TRANSFER; GENETIC-VARIATION; TRADE-OFFS; RESISTANCE; PARASITOIDS; POPULATION; EVOLUTION	An experiment was conducted to test whether parasitoid resistance within a single clonal line of pea aphid (Acyrthosiphon pisum) might increase after exposure to the parasitoid wasp Aphidius ervi. Any change in resistance was expected to occur through an increase in the density of protective symbiotic bacteria rather than genetic change within the aphid or the bacterial symbiont. Six aphid lineages were exposed to high parasitoid attack rates over nine generations, each line being propagated from individuals that had survived attack; a further six lineages were maintained without parasitoids as a control. At the end of the experiment the strength of resistance of aphids from treatment and control lines were compared. No differences in resistance were found.	[McLean, Ailsa H. C.; Godfray, H. Charles J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	McLean, AHC (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	ailsa.mclean@zoo.ox.ac.uk			UK Natural Environment Research Council [NE/G017638/1]; University of Oxford; Natural Environment Research Council [NE/G017638/1] Funding Source: researchfish; NERC [NE/G017638/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Oxford; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was partially funded by a UK Natural Environment Research Council (http://www.nerc.ac.uk/) grant NE/G017638/1 to HCJG. AHCM was funded by the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bilodeau E, 2013, EVOL ECOL, V27, P165, DOI 10.1007/s10682-012-9577-z; BOOTS M, 1993, FUNCT ECOL, V7, P528, DOI 10.2307/2390128; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Degnan PH, 2008, MOL ECOL, V17, P916, DOI 10.1111/j.1365-294X.2007.03616.x; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Dion E, 2011, J EVOLUTION BIOL, V24, P741, DOI 10.1111/j.1420-9101.2010.02207.x; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Fox J., 2019, R COMPANION APPL REG, V.; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Henry LM, 2008, EVOLUTION, V62, P689, DOI 10.1111/j.1558-5646.2007.00316.x; Henry LM, 2013, CURR BIOL, V23, P1713, DOI 10.1016/j.cub.2013.07.029; HENTER HJ, 1995, EVOLUTION, V49, P439, DOI 10.1111/j.1558-5646.1995.tb02276.x; Hufbauer RA, 2001, ECOLOGY, V82, P717, DOI 10.1890/0012-9658(2001)082[0717:PAPIHP]2.0.CO;2; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Martinez AJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-127; McLean AHC, 2011, P ROY SOC B-BIOL SCI, V278, P760, DOI 10.1098/rspb.2010.1654; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Oliver KM, 2006, P ROY SOC B-BIOL SCI, V273, P1273, DOI 10.1098/rspb.2005.3436; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Parker BJ, 2014, EVOLUTION, V68, P2421, DOI 10.1111/evo.12418; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rouchet R, 2012, J EVOLUTION BIOL, V25, P2369, DOI 10.1111/j.1420-9101.2012.02608.x; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; Sandstrom J, 1996, ECOL ENTOMOL, V21, P56, DOI 10.1111/j.1365-2311.1996.tb00266.x; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Schmid M, 2012, FUNCT ECOL, V26, P207, DOI 10.1111/j.1365-2435.2011.01904.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Siva-Jothy MT, 1998, PHYSIOL ENTOMOL, V23, P274, DOI 10.1046/j.1365-3032.1998.233090.x; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Weldon SR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2103	44	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111601	10.1371/journal.pone.0111601	http://dx.doi.org/10.1371/journal.pone.0111601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396733	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500020
J	Schoepf, V; McCulloch, MT; Warner, ME; Levas, SJ; Matsui, Y; Aschaffenburg, MD; Grottoli, AG				Schoepf, Verena; McCulloch, Malcolm T.; Warner, Mark E.; Levas, Stephen J.; Matsui, Yohei; Aschaffenburg, Matthew D.; Grottoli, Andrea G.			Short-Term Coral Bleaching Is Not Recorded by Skeletal Boron Isotopes	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SEA-SURFACE TEMPERATURE; SCLERACTINIAN CORALS; OCEAN ACIDIFICATION; CLIMATE-CHANGE; PORITES CORALS; STYLOPHORA-PISTILLATA; EXTENSION-RATE; BIOLOGICAL CARBONATES; MONTASTREA-ANNULARIS	Coral skeletal boron isotopes have been established as a proxy for seawater pH, yet it remains unclear if and how this proxy is affected by seawater temperature. Specifically, it has never been directly tested whether coral bleaching caused by high water temperatures influences coral boron isotopes. Here we report the results from a controlled bleaching experiment conducted on the Caribbean corals Porites divaricata, Porites astreoides, and Orbicella faveolata. Stable boron (delta(11) B), carbon (delta C-13), oxygen (delta O-18) isotopes, Sr/Ca, Mg/Ca, U/Ca, and Ba/Ca ratios, as well as chlorophyll a concentrations and calcification rates were measured on coral skeletal material corresponding to the period during and immediately after the elevated temperature treatment and again after 6 weeks of recovery on the reef. We show that under these conditions, coral bleaching did not affect the boron isotopic signature in any coral species tested, despite significant changes in coral physiology. This contradicts published findings from coral cores, where significant decreases in boron isotopes were interpreted as corresponding to times of known mass bleaching events. In contrast, delta C-13 and delta O-18 exhibited major enrichment corresponding to decreases in calcification rates associated with bleaching. Sr/Ca of bleached corals did not consistently record the 1.2 degrees C difference in seawater temperature during the bleaching treatment, or alternatively show a consistent increase due to impaired photosynthesis and calcification. Mg/Ca, U/Ca, and Ba/Ca were affected by coral bleaching in some of the coral species, but the observed patterns could not be satisfactorily explained by temperature dependence or changes in coral physiology. This demonstrates that coral boron isotopes do not record short- term bleaching events, and therefore cannot be used as a proxy for past bleaching events. The robustness of coral boron isotopes to changes in coral physiology, however, suggests that reconstruction of seawater pH using boron isotopes should be uncompromised by short- term bleaching events.	[Schoepf, Verena; McCulloch, Malcolm T.] Univ Western Australia, Sch Earth & Environm, Crawley, WA, Australia; [Schoepf, Verena; McCulloch, Malcolm T.] ARC Ctr Excellence Coral Reef Studies, Crawley, WA, Australia; [Schoepf, Verena; Levas, Stephen J.; Matsui, Yohei; Grottoli, Andrea G.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Warner, Mark E.; Aschaffenburg, Matthew D.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA	University of Western Australia; University of Western Australia; University System of Ohio; Ohio State University; University of Delaware	Schoepf, V (corresponding author), Univ Western Australia, Sch Earth & Environm, Crawley, WA, Australia.	schoepf.4@osu.edu	Warner, Mark E/J-6241-2013; Levas, Stephen/AAA-6774-2020; Schoepf, Verena/H-5786-2014; McCulloch, Malcolm Thomas/C-3651-2009	Schoepf, Verena/0000-0002-9467-1088; Warner, Mark/0000-0003-1015-9413; McCulloch, Malcolm Thomas/0000-0003-1538-1558	U.S. National Science Foundation [0825490, 0825413]; Western Australian Premiers Fellowship; Australian Research Council Laureate Fellowship	U.S. National Science Foundation(National Science Foundation (NSF)); Western Australian Premiers Fellowship; Australian Research Council Laureate Fellowship(Australian Research Council)	This work was funded by the U.S. National Science Foundation (OCE# 0825490 to AGG and OCE# 0825413 to MEW). MTM was supported by a Western Australian Premiers Fellowship and an Australian Research Council Laureate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Alibert C, 1997, PALEOCEANOGRAPHY, V12, P345, DOI 10.1029/97PA00318; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Allison N, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000696; Allison N, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001477; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Aschaffenburg M, 2012, PHYSL RESPONSE SYMBI, P155; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cantin NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088720; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Chen TR, 2011, J ENVIRON SCI, V23, P1452, DOI 10.1016/S1001-0742(10)60606-7; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; Cohen AL, 2002, SCIENCE, V296, P331, DOI 10.1126/science.1069330; Cohen AL, 2001, PALEOCEANOGRAPHY, V16, P20, DOI 10.1029/1999PA000478; Colombo-Pallotta MF, 2010, CORAL REEFS, DOI [10.1007/s00338-00010-00638-x, DOI 10.1007/S00338-00010-00638-X]; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Connolly SR, 2012, CORAL REEFS, V31, P951, DOI 10.1007/s00338-012-0925-9; D'Olivo JP, 2013, CORAL REEFS, V32, P999, DOI 10.1007/s00338-013-1071-8; DEVILLIERS S, 1994, GEOCHIM COSMOCHIM AC, V58, P197, DOI 10.1016/0016-7037(94)90457-X; DEVILLIERS S, 1995, SCIENCE, V269, P1247, DOI 10.1126/science.269.5228.1247; Dissard D, 2012, BIOGEOSCIENCES, V9, P4589, DOI 10.5194/bg-9-4589-2012; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Douville E, 2010, BIOGEOSCIENCES, V7, P2445, DOI 10.5194/bg-7-2445-2010; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Fallon SJ, 1999, EARTH PLANET SC LETT, V172, P221, DOI 10.1016/S0012-821X(99)00200-9; Fallon SJ, 2003, CORAL REEFS, V22, P389, DOI 10.1007/s00338-003-0322-5; Felis T, 2003, CORAL REEFS, V22, P328, DOI 10.1007/s00338-003-0324-3; Ferrier-Pages C, 2002, MAR ECOL PROG SER, V245, P93, DOI 10.3354/meps245093; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Gattuso JP, 1999, AM ZOOL, V39, P160; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GOREAU TF, 1959, BIOL BULL, V117, P239, DOI 10.2307/1538903; Grottoli AG, 2005, CHEM GEOL, V221, P225, DOI 10.1016/j.chemgeo.2005.05.004; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Grottoli AG, 2002, GEOCHIM COSMOCHIM AC, V66, P1955, DOI 10.1016/S0016-7037(01)00901-2; Grottoli AG, 1999, CORAL REEFS, V18, P29, DOI 10.1007/s003380050150; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Guerrot C, 2011, GEOSTAND GEOANAL RES, V35, P275, DOI 10.1111/j.1751-908X.2010.00073.x; Hart SR, 1996, GEOCHIM COSMOCHIM AC, V60, P3075, DOI 10.1016/0016-7037(96)00154-8; Hartmann AC, 2010, CORAL REEFS, V29, P1079, DOI 10.1007/s00338-010-0667-5; Harvey BP, 2013, ECOL EVOL, V3, P1016, DOI 10.1002/ece3.516; Hayashi E, 2013, EARTH PLANET SC LETT, V362, P198, DOI 10.1016/j.epsl.2012.11.046; Heikoop JM, 2000, GEOCHIM COSMOCHIM AC, V64, P975, DOI 10.1016/S0016-7037(99)00363-4; HEMMING NG, 1992, GEOCHIM COSMOCHIM AC, V56, P537, DOI 10.1016/0016-7037(92)90151-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Holcomb M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05207; Holcomb M, 2014, PRINCIPLES PRACTICE, P254; Holcomb M, 2014, PEERJ, V2, DOI 10.7717/peerj.375; Holcomb M, 2010, J EXP MAR BIOL ECOL, V386, P27, DOI 10.1016/j.jembe.2010.02.007; Honisch B, 2004, GEOCHIM COSMOCHIM AC, V68, P3675, DOI 10.1016/j.gca.2004.03.002; Horta-Puga G, 2012, APPL GEOCHEM, V27, P1579, DOI 10.1016/j.apgeochem.2012.05.008; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jokiel P.L., 1978, Monographs on Oceanographic Methodology, P529; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Klochko K, 2009, GEOCHIM COSMOCHIM AC, V73, P1890, DOI 10.1016/j.gca.2009.01.002; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; LAND LS, 1975, MAR BIOL, V33, P221, DOI 10.1007/BF00390926; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; LEA DW, 1989, NATURE, V340, P373, DOI 10.1038/340373a0; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; Levas SJ, 2012, BIOGEOCHEMISTRY PHYS, P238; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARSH JA, 1970, ECOLOGY, V51, P254; Marshall JF, 2002, GEOCHIM COSMOCHIM AC, V66, P3263, DOI 10.1016/S0016-7037(02)00926-2; Marubini F, 2003, P ROY SOC B-BIOL SCI, V270, P179, DOI 10.1098/rspb.2002.2212; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; McConnaughey TA, 1997, GEOCHIM COSMOCHIM AC, V61, P611, DOI 10.1016/S0016-7037(96)00361-4; McCulloch M, 1996, EARTH PLANET SC LETT, V138, P169, DOI 10.1016/0012-821X(95)00230-A; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; McCulloch M, 2012, GEOCHIM COSMOCHIM AC, V87, P21, DOI 10.1016/j.gca.2012.03.027; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P2747, DOI 10.1016/0016-7037(94)90142-2; McGinley M, 2012, IMPACT ENV STRESS SY, P173; Meibom A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016864; MIN GR, 1995, GEOCHIM COSMOCHIM AC, V59, P2025; Mitsuguchi T, 2003, CORAL REEFS, V22, P381, DOI 10.1007/s00338-003-0326-1; Mitsuguchi T, 1996, SCIENCE, V274, P961, DOI 10.1126/science.274.5289.961; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Moya A, 2006, J EXP BIOL, V209, P3413, DOI 10.1242/jeb.02382; Nakamura T, 2003, MAR ECOL PROG SER, V256, P287, DOI 10.3354/meps256287; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Pretet C, 2014, CORAL REEFS, V33, P169, DOI 10.1007/s00338-013-1098-x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reynaud S, 2004, CORAL REEFS, V23, P539, DOI 10.1007/s00338-004-0399-5; Reynaud S, 2007, GEOCHIM COSMOCHIM AC, V71, P354, DOI 10.1016/j.gca.2006.09.009; Ries JB, 2011, GEOCHIM COSMOCHIM AC, V75, P4053, DOI 10.1016/j.gca.2011.04.025; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rodrigues LJ, 2006, GEOCHIM COSMOCHIM AC, V70, P2781, DOI 10.1016/j.gca.2006.02.014; Rollion-Bard C, 2011, GEOCHIM COSMOCHIM AC, V75, P1003, DOI 10.1016/j.gca.2010.11.023; Schoepf V, 2013, PHYSL BIOGEOCHEMISTR, P295; Schoepf V, GEOCHIM COS IN PRESS; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; SHEN GT, 1995, GEOCHIM COSMOCHIM AC, V59, P2009, DOI 10.1016/0016-7037(95)00123-9; Sinclair DJ, 2005, EARTH PLANET SC LETT, V237, P354, DOI 10.1016/j.epsl.2005.06.039; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; Sun Y, 2005, CORAL REEFS, V24, P23, DOI 10.1007/s00338-004-0467-x; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; SWART PK, 1983, EARTH-SCI REV, V19, P51, DOI 10.1016/0012-8252(83)90076-4; Tambutte S, 2011, J EXP MAR BIOL ECOL, DOI [10.1016/j.jembe.2011.1007.1026, DOI 10.1016/J.JEMBE.2011.1007.1026]; Teneva L, 2012, CORAL REEFS, V31, P1, DOI 10.1007/s00338-011-0812-9; Trotter J, 2011, EARTH PLANET SC LETT, V303, P163, DOI 10.1016/j.epsl.2011.01.030; Tudhope AW, 1996, PALAIOS, V11, P347, DOI 10.2307/3515245; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; WEBER JN, 1972, J GEOPHYS RES, V77, P463, DOI 10.1029/JC077i003p00463; Wei GJ, 2009, GEOCHIM COSMOCHIM AC, V73, P2332, DOI 10.1016/j.gca.2009.02.009; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wilkinson C, 2008, STATUS CORAL REEFS W; Winer BJ, 1971, STAT PRINCIPLES EXPT	127	14	14	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112011	10.1371/journal.pone.0112011	http://dx.doi.org/10.1371/journal.pone.0112011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396422	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500026
J	Suzuki, S; Kobuke, S; Haruyama, N; Hoshino, H; Kulkarni, AB; Nishimura, F				Suzuki, Shigeki; Kobuke, Seiji; Haruyama, Naoto; Hoshino, Hiroaki; Kulkarni, Ashok B.; Nishimura, Fusanori			Adhesive and Migratory Effects of Phosphophoryn Are Modulated by Flanking Peptides of the Integrin Binding Motif	PLOS ONE			English	Article							DENTIN SIALOPHOSPHOPROTEIN GENE; CELL ATTACHMENT; EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE; DIVALENT-CATIONS; SIALOPROTEIN; EXPRESSION; BONE; PHOSPHOPROTEIN; PROTEINS	Phosphophoryn (PP) is generated from the proteolytic cleavage of dentin sialophosphoprotein (DSPP). Gene duplications in the ancestor dentin matrix protein-1 (DMP-1) genomic sequence created the DSPP gene in toothed animals. PP and DMP-1 are phosphorylated extracellular matrix proteins that belong to the family of small integrin-binding ligand N-linked glycoproteins (SIBLINGs). Many SIBLING members have been shown to evoke various cell responses through the integrin-binding Arg-Gly-Asp (RGD) domain; however, the RGD-dependent function of PP is not yet fully understood. We demonstrated that recombinant PP did not exhibit any obvious cell adhesion ability, whereas the simultaneously purified recombinant DMP-1 did. A cell adhesion inhibitory analysis was performed by pre-incubating human osteosarcoma MG63 cells with various PP peptides before seeding onto vitronectin. The results obtained revealed that the incorporation of more than one amino acid on both sides of the PP-RGD domain was unable to inhibit the adhesion of MG63 cells onto vitronectin. Furthermore, the inhibitory activity of a peptide containing the PP-RGD domain with an open carboxyl-terminal side (H-(463)SDESDTNSESANESGSRGDA(482)-OH) was more potent than that of a peptide containing the RGD domain with an open amino-terminal side (H-(478)SRGDASYTSDESSDDDNDSDSH(499)-OH). This phenomenon was supported by the potent cell adhesion and migration abilities of the recombinant truncated PP, which terminated with Ala(482). Furthermore, various point mutations in Ala(482) and/or Ser(483) converted recombinant PP into cell-adhesive proteins. Therefore, we concluded that the Ala(482)-Ser(483) flanking sequence, which was detected in primates and mice, was the key peptide bond that allowed the PP-RGD domain to be sequestered. The differential abilities of PP and DMP-1 to act on integrin imply that DSPP was duplicated from DMP-1 to serve as a crucial extracellular protein for tooth development rather than as an integrin-mediated signaling molecule.	[Suzuki, Shigeki; Kobuke, Seiji; Hoshino, Hiroaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent Sci Hlth Promot, Hiroshima, Japan; [Haruyama, Naoto] Kyushu Univ, Fac Dent Sci, Sect Orthodont & Dentofacial Orthoped, Fukuoka 812, Japan; [Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Nishimura, Fusanori] Kyushu Univ, Sect Periodontol, Div Oral Rehabil, Fac Dent Sci, Fukuoka 812, Japan	Hiroshima University; Kyushu University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University	Suzuki, S (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent Sci Hlth Promot, Hiroshima, Japan.	suzukis@hiroshima-u.ac.jp	Haruyama, Naoto/D-1993-2011	Haruyama, Naoto/0000-0001-6225-5816; Suzuki, Shigeki/0000-0003-0888-4050	JSPS KAKENHI [21890158, 22792040, 3792176]; JST ASTEP [AS231Z05041F]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST ASTEP; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/) grant numbers 21890158, 22792040, and 3792176 and by JST ASTEP (http://www.jst.go.jp/tt/EN/univ-ip/a-step.html) grant number AS231Z05041F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; Alvares K, 2013, J BIOL CHEM, V288, P13036, DOI 10.1074/jbc.M112.389627; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BUTLER WT, 1995, INT J DEV BIOL, V39, P169; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Deshpande AS, 2011, BIOMACROMOLECULES, V12, P2933, DOI 10.1021/bm2005214; Eapen A, 2013, J BIOL CHEM, V288, P8585, DOI 10.1074/jbc.M112.413997; Eapen A, 2012, J BIOL CHEM, V287, P5211, DOI 10.1074/jbc.M111.290080; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fisher LW, 2004, CLIN CANCER RES, V10, P8501, DOI 10.1158/1078-0432.CCR-04-1072; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Gibson MP, 2013, J BIOL CHEM, V288, P7204, DOI 10.1074/jbc.M112.445775; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Jain A, 2009, CLIN CANCER RES, V15, P5199, DOI 10.1158/1078-0432.CCR-09-0783; JONSSON M, 1978, J CHROMATOGR, V157, P235, DOI 10.1016/S0021-9673(00)92338-0; Joshi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013974; Karadag A, 2005, CANCER RES, V65, P11545, DOI 10.1158/0008-5472.CAN-05-2861; McKnight DA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-299; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; Qin CL, 2006, J BIOL CHEM, V281, P8034, DOI 10.1074/jbc.M512964200; Qin CL, 2003, CONNECT TISSUE RES, V44, P179, DOI 10.1080/03008200390152296; Ravindran S, 2013, J BIOL CHEM, V288, P16098, DOI 10.1074/jbc.M113.450585; Ritchie HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041110; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Sfeir C, 2011, J BIOL CHEM, V286, P20228, DOI 10.1074/jbc.M110.209528; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Stuiver I, 1996, J CELL PHYSIOL, V168, P521, DOI 10.1002/(SICI)1097-4652(199609)168:3<521::AID-JCP4>3.0.CO;2-R; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Suskiewicz MJ, 2011, PROTEIN SCI, V20, P1285, DOI 10.1002/pro.657; Suzuki S, 2012, ARCH ORAL BIOL, V57, P1165, DOI 10.1016/j.archoralbio.2012.03.005; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; Verdelis K, 2008, BONE, V43, P983, DOI 10.1016/j.bone.2008.08.110; von Marschall Z, 2008, J BIOL CHEM, V283, P32730, DOI 10.1074/jbc.M804283200; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamakoshi Y, 2005, J BIOL CHEM, V280, P1552, DOI 10.1074/jbc.M409606200; Yamakoshi Y, 2008, J BIOL CHEM, V283, P14835, DOI 10.1074/jbc.M800633200; Yamakoshi Y, 2009, J ORAL BIOSCI, V51, P134, DOI 10.2330/joralbiosci.51.134; Yang RT, 2013, J BIOL CHEM, V288, P6024, DOI 10.1074/jbc.M112.382952; Yasuda Y, 2008, J ENDODONT, V34, P575, DOI 10.1016/j.joen.2008.02.018; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	51	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112490	10.1371/journal.pone.0112490	http://dx.doi.org/10.1371/journal.pone.0112490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396425	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500054
J	Adini, I; Adini, A; Bazinet, L; Watnick, RS; Bielenberg, DR; D'Amato, RJ				Adini, Irit; Adini, Avner; Bazinet, Lauren; Watnick, Randolph S.; Bielenberg, Diane R.; D'Amato, Robert J.			Melanocyte pigmentation inversely correlates with MCP-1 production and angiogenesis-inducing potential	FASEB JOURNAL			English	Article						vascular biology; endothelial cells; FMOD; NF-kappa B	MONOCYTE CHEMOATTRACTANT PROTEIN-1; FACTOR-KAPPA-B; GENE-EXPRESSION; L-TYROSINE; MACULAR DEGENERATION; ENDOTHELIAL-CELLS; L-DOPA; CHEMOTACTIC PROTEIN-1; MELANIN PIGMENTATION; VASCULAR-DISEASE	The incidence of certain angiogenesis-dependent diseases is higher in Caucasians than in African Americans. Angiogenesis is amplified in wound healing and cornea models in albino C57 mice compared with black C57 mice. Moreover, mouse and human melanocytes with low pigmentation stimulate endothelial cell (EC) proliferation and migration in vitro more than melanocytes with high pigmentation. This effect is due, in part, to the secretion of an angiogenic protein called fibromodulin (FMOD) from lowly pigmented melanocytes. Herein, we expand upon the mechanism contributing to increased angiogenesis in lighter skin and report that monocyte chemotactic protein-1 (MCP-1) is secreted by nonpigmented mouse melanocytes by 5-to 10-fold more than pigmented melanocytes. MCP-1 protein stimulates EC proliferation and migration in vitro and angiogenesis in vivo. Mechanistic studies determine that FMOD is upstream of MCP-1 and promotes its secretion from both melanocytes and activated ECs via stimulation of NF-kappa B activity. Mice injected with FMOD-neutralizing antibodies show 2.3-fold decreased levels of circulating MCP-1. Human studies confirmed that, on average, Caucasians have 2-fold higher serum levels of MCP-1 than African Americans. Taken together, this study implicates the FMOD/MCP-1 pathway in the regulation of angiogenesis by local melanocytes and suggests that melanogenic activity may protect against aberrant angiogenic diseases.-Adini, I., Adini, A., Bazinet, L., Watnick, R. S., Bielenberg, D. R., and D'Amato, R. J. Melanocyte pigmentation inversely correlates with MCP-1 production and angiogenesis-inducing potential.	[Adini, Irit; Adini, Avner; Bazinet, Lauren; Watnick, Randolph S.; Bielenberg, Diane R.; D'Amato, Robert J.] Harvard Univ, Sch Med, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Adini, I (corresponding author), Harvard Univ, Med Ctr, Boston Childrens Hosp, Vasc Biol Program, 1 Blackfan Circle, Boston, MA 02115 USA.	irit.adini@gmail.com	Adini, Avner/AAD-6141-2022		NIH National Eye Institute [R01EY012726]; NATIONAL EYE INSTITUTE [R01EY012726] Funding Source: NIH RePORTER	NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Alexeev Y. Vitali and the Wellcome Trust Functional Genomics Cell Bank for primary murine melanocyte cells and Pouya Pakneshan for helping with ELISAs. I.A. performed the experiments, analyzed the data, and wrote the manuscript. A.A. and L.B. assisted with the experiments. D.R.B. and R.S.W. edited the manuscript. R.J.D. supervised the analysis and edited the manuscript. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the U.S. National Institutes of Health (NIH). Research reported in this publication was supported, in part, by the NIH National Eye Institute under Award Number R01EY012726 ( to R.J.D.). The authors declare no conflicts of interest.	Adini A, 2009, J IMMUNOL METHODS, V342, P78, DOI 10.1016/j.jim.2008.11.016; Adini I, 2014, J CLIN INVEST, V124, P425, DOI 10.1172/JCI69404; Alexeev V, 2000, PIGM CELL RES, V13, P72, DOI 10.1034/j.1600-0749.2000.130205.x; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Aplin AC, 2014, ANGIOGENESIS, V17, P147, DOI 10.1007/s10456-013-9384-3; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; ELNER SG, 1991, LAB INVEST, V64, P819; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Gottlieb JL, 2002, JAMA-J AM MED ASSOC, V288, P2233, DOI 10.1001/jama.288.18.2233; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Jobin C, 1998, J IMMUNOL, V160, P410; Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3; Lee JI, 1998, J CLIN PHARMACOL, V38, P981, DOI 10.1177/009127009803801101; LEONARD EJ, 1990, IMMUNOL TODAY, V11, P97, DOI 10.1016/0167-5699(90)90035-8; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Noonan DM, 2008, CANCER METAST REV, V27, P31, DOI 10.1007/s10555-007-9108-5; Parry GCN, 1998, ARTERIOSCL THROM VAS, V18, P934, DOI 10.1161/01.ATV.18.6.934; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Rohan RM, 2000, FASEB J, V14, P871, DOI 10.1096/fasebj.14.7.871; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Satchi-Fainaro R, 2005, CANCER CELL, V7, P251, DOI 10.1016/j.ccr.2005.02.007; SHYY YJ, 1994, P NATL ACAD SCI USA, V91, P4678, DOI 10.1073/pnas.91.11.4678; SHYY YJ, 1993, J CLIN INVEST, V92, P1745, DOI 10.1172/JCI116762; SLOMINSKI A, 1990, J THEOR BIOL, V143, P123, DOI 10.1016/S0022-5193(05)80292-9; SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142; SLOMINSKI A, 1989, PIGM CELL RES, V2, P109, DOI 10.1111/j.1600-0749.1989.tb00170.x; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SLOMINSKI A, 1988, J CELL SCI, V89, P287; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Sviderskaya EV, 2010, PIGM CELL MELANOMA R, V23, P147, DOI 10.1111/j.1755-148X.2009.00641.x; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; VanderBeek BL, 2011, AM J OPHTHALMOL, V152, P273, DOI 10.1016/j.ajo.2011.02.004; Wang XC, 1999, INVEST OPHTH VIS SCI, V40, P477; Zhang LQ, 2011, MOL BIOL CELL, V22, P128, DOI 10.1091/mbc.E10-06-0556	43	18	20	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					662	670		10.1096/fj.14-255398	http://dx.doi.org/10.1096/fj.14-255398			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25406462	Green Published			2022-12-26	WOS:000349370400027
J	Palve, V; Mallick, S; Ghaisas, G; Kannan, S; Teni, T				Palve, Vinayak; Mallick, Sanchita; Ghaisas, Gauri; Kannan, Sadhana; Teni, Tanuja			Overexpression of Mcl-1L Splice Variant Is Associated with Poor Prognosis and Chemoresistance in Oral Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; BCL2 FAMILY; EXPRESSION; APOPTOSIS; LINES; SURVIVAL; HEAD; BAK	Background: Altered expression of Mcl-1, an anti-apoptotic member of the Bcl-2 family, has been linked to the progression and outcome of a variety of malignancies. We have previously reported the overexpression of Mcl-1 protein in human oral cancers. The present study aimed to evaluate the clinicopathological significance of the expression of three known Mcl-1 isoforms in oral tumors and the effect of targeting Mcl-1L isoform on chemosensitivity of oral cancer cells. Methods: The expression of Mcl-1 isoforms-Mcl-1L, Mcl-1S & Mcl-1ES was analyzed in 130 paired oral tumors and 9 oral cell lines using quantitative real-time PCR & protein by western blotting. The Mcl-1 mRNA levels were correlated with clinicopathological parameters and outcome of oral cancer patients. The effect of Mcl-1L shRNA or Obatoclax (a small molecule Mcl-1 inhibitor), in combination with Cisplatin on chemosensitivity of oral cancer cells was also assessed. Results: Anti-apoptotic Mcl-1L was predominantly expressed, over low or undetectable pro-apoptotic Mcl-1S and Mcl-1ES isoforms. The Mcl-1L transcripts were significantly overexpressed in all cancer cell lines and in 64% oral tumors versus adjacent normals (P<0.02). In oral cancer patients, high Mcl-1L expression was significantly associated with node positivity (P = 0.021), advanced tumor size (P = 0.013) and poor overall survival (P = 0.002). Multivariate analysis indicated Mcl-1L to be an independent prognostic factor for oral cancers (P = 0.037). Mcl-1L shRNA knockdown or its inhibition by Obatoclax in combination with Cisplatin synergistically reduced viability and growth of oral cancer cells than either treatment alone. Conclusion: Our studies suggest that overexpression of Mcl-1L is associated with poor prognosis and chemoresistance in oral cancers. Mcl-1L is an independent prognostic factor and a potential therapeutic target in oral cancers.	[Palve, Vinayak; Mallick, Sanchita; Ghaisas, Gauri; Teni, Tanuja] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Teni Lab, Kharghar 410210, Navi Mumbai, India; [Kannan, Sadhana] Tata Mem Hosp, Epidemiol & Clin Trial Unit, Adv Ctr Treatment Res & Educ Canc, Kharghar 410210, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Teni, T (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Teni Lab, Kharghar 410210, Navi Mumbai, India.	tteni@actrec.gov.in		Palve, Vinayak/0000-0002-8221-5018				Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Coelho KR, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/701932; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Hamada T, 2014, 2014 ANN M AAOMS; Kempkensteffen C, 2009, TUMOR BIOL, V30, P73, DOI 10.1159/000215826; Kim JH, 2009, FEBS LETT, V583, P2758, DOI 10.1016/j.febslet.2009.08.006; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Liu X, 2014, J ANAL ONCOLOGY, V3, P18; Luo L, 2012, MED ONCOL, V29, P1681, DOI 10.1007/s12032-011-0085-8; Mallick S, 2009, J PATHOL, V217, P398, DOI 10.1002/path.2459; Mallick S, 2010, ORAL ONCOL, V46, P688, DOI 10.1016/j.oraloncology.2010.04.003; Martin CL, 2008, ORAL ONCOL, V44, P369, DOI 10.1016/j.oraloncology.2007.05.003; Nagata M, 2009, J PHARMACOL SCI, V110, P344, DOI 10.1254/jphs.08339FP; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; O'Driscoll L, 2004, ANTICANCER RES, V24, P473; Palve VC, 2012, RADIAT ONCOL, V7, P1; Park HR, 2011, CANCER-AM CANCER SOC, V117, P1864, DOI 10.1002/cncr.25760; Pepper C, 2008, BLOOD, V112, P3807, DOI 10.1182/blood-2008-05-157131; Peter B, 2013, J LEUKOCYTE BIOL; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulze-Bergkamen H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-232; Shigemasa K, 2002, JPN J CANCER RES, V93, P542, DOI 10.1111/j.1349-7006.2002.tb01289.x; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Simonin K, 2009, MOL CANCER THER, V8, P3162, DOI 10.1158/1535-7163.MCT-09-0493; Su LP, 2010, ORAL SURG ORAL MED O, V110, P484, DOI 10.1016/j.tripleo.2010.04.009; TATAKE RJ, 1990, J CANCER RES CLIN, V116, P179, DOI 10.1007/BF01612674; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Wang LK, 2009, J SURG ONCOL, V100, P396, DOI 10.1002/jso.21344; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yang C, 2007, AM J PHYSIOL-RENAL, V292, pF1710, DOI 10.1152/ajprenal.00505.2006; Yazbeck VY, 2014, ORAL ONCOL, V50, P120, DOI 10.1016/j.oraloncology.2013.10.013; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559; Zhang Tian C., 2012, Membrane Technology and Environmental Applications, P1; Zhang T, 2012, MED ONCOL, V29, P1985, DOI 10.1007/s12032-011-0005-y	45	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111927	10.1371/journal.pone.0111927	http://dx.doi.org/10.1371/journal.pone.0111927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409302	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200005
J	Slubowski, CJ; Paulissen, SM; Huang, LS				Slubowski, Christian J.; Paulissen, Scott M.; Huang, Linda S.			The GCKIII Kinase Sps1 and the 14-3-3 Isoforms, Bmh1 and Bmh2, Cooperate to Ensure Proper Sporulation in Saccharomyces cerevisiae	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN-KINASE; PROTEOMIC ANALYSIS; STRUCTURAL BASIS; SKELETAL-MUSCLE; HIGH-THROUGHPUT; DNA-DAMAGE; YEAST; 14-3-3-PROTEINS; IDENTIFICATION	Sporulation in the budding yeast Saccharomyces cerevisiae is a developmental program initiated in response to nutritional deprivation. Sps1, a serine/threonine kinase, is required for sporulation, but relatively little is known about the molecular mechanisms through which it regulates this process. Here we show that SPS1 encodes a bona-fide member of the GCKIII subfamily of STE20 kinases, both through phylogenetic analysis of the kinase domain and examination of its C-terminal regulatory domain. Within the regulatory domain, we find Sps1 contains an invariant ExxxPG region conserved from plant to human GCKIIIs that we call the EPG motif; we show this EPG motif is important for SPS1 function. We also find that Sps1 is phosphorylated near its N-terminus on Threonine 12, and that this phosphorylation is required for the efficient production of spores. In Sps1, Threonine 12 lies within a 14-3-3 consensus binding sequence, and we show that the S. cerevisiae 14-3-3 proteins Bmh1 and Bmh2 bind Sps1 in a Threonine 12-dependent fashion. This interaction is significant, as BMH1 and BMH2 are required during sporulation and genetically interact with SPS1 in sporulating cells. Finally, we observe that Sps1, Bmh1 and Bmh2 are present in both the nucleus and cytoplasm during sporulation. We identify a nuclear localization sequence in Sps1 at amino acids 411-415, and show that this sequence is necessary and sufficient for nuclear localization. Taken together, these data identify regions within Sps1 critical for its function and indicate that SPS1 and 14-3-3s act together to promote proper sporulation in S. cerevisiae.	[Slubowski, Christian J.; Paulissen, Scott M.; Huang, Linda S.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	Huang, LS (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	Linda.Huang@umb.edu	Huang, Linda/C-9903-2014	Huang, Linda/0000-0002-9033-4391; Paulissen, Scott/0000-0002-9258-2380	Goranson Research Award; University of Massachusetts Boston Dissertation Support Grant; National Science Foundation [MCB-0544160]	Goranson Research Award; University of Massachusetts Boston Dissertation Support Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by a Goranson Research Award to CJS, an University of Massachusetts Boston Dissertation Support Grant to CJS and by the National Science Foundation (MCB-0544160) to LSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Alexander JS, 2007, J MOL NEUROSCI, V32, P169, DOI 10.1007/s12031-007-0018-3; Ametzazurra A, 2009, HUM REPROD, V24, P954, DOI 10.1093/humrep/den450; [Anonymous], 1991, Methods Enzymol, V194, P1; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Caydasi AK, 2014, MOL BIOL CELL, V25, P2143, DOI 10.1091/mbc.E14-04-0890; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Chohan G, 2010, J NEUROL NEUROSUR PS, V81, P1243, DOI 10.1136/jnnp.2009.197962; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Demmel L, 2008, MOL BIOL CELL, V19, P1046, DOI 10.1091/mbc.E07-02-0134; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engels K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001367; Enyenihi AH, 2003, GENETICS, V163, P47; Favier FB, 2010, AM J PHYSIOL-REG I, V298, pR1659, DOI 10.1152/ajpregu.00550.2009; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; FRIESEN H, 1994, GENE DEV, V8, P2162, DOI 10.1101/gad.8.18.2162; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; GARRELS JI, 1994, ELECTROPHORESIS, V15, P1466, DOI 10.1002/elps.11501501210; GELPERIN D, 1995, P NATL ACAD SCI USA, V92, P11539, DOI 10.1073/pnas.92.25.11539; Grandin N, 2008, CELL CYCLE, V7, P2749, DOI 10.4161/cc.7.17.6592; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall BG, 2007, PLOS COMPUT BIOL, V3, P473, DOI 10.1371/journal.pcbi.0030051; Huang LS, 2005, P NATL ACAD SCI USA, V102, P12431, DOI 10.1073/pnas.0502324102; Irwin N, 2006, P NATL ACAD SCI USA, V103, P18320, DOI 10.1073/pnas.0605135103; Iwamoto MA, 2005, EUKARYOT CELL, V4, P536, DOI 10.1128/EC.4.3.536-544.2005; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kilani RT, 2007, J RHEUMATOL, V34, P1650; Krishnamoorthy T, 2006, GENE DEV, V20, P2580, DOI 10.1101/gad.1457006; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kyriakakis P, 2008, FLY, V2, P229, DOI 10.4161/fly.6669; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee P, 2011, MOL MICROBIOL, V79, P633, DOI 10.1111/j.1365-2958.2010.07471.x; Lee WS, 2004, FEBS LETT, V572, P41, DOI 10.1016/j.febslet.2004.07.007; Li DJ, 2009, CANCER LETT, V279, P65, DOI 10.1016/j.canlet.2009.01.028; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luo J, 2010, MED ONCOL, V27, P791, DOI 10.1007/s12032-009-9287-8; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Matsuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031152; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Nerstedt A, 2012, DIABETOLOGIA, V55, P1797, DOI 10.1007/s00125-012-2511-7; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Parodi EM, 2012, EUKARYOT CELL, V11, P1191, DOI 10.1128/EC.00076-12; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Puig O, 1998, YEAST, V14, P1139; Roberts RL, 1997, CELL, V89, P1055, DOI 10.1016/S0092-8674(00)80293-7; Rolli E, 2011, MOL BIOL CELL, V22, P1585, DOI 10.1091/mbc.E10-03-0268; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Suda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007184; Suel KE, 2009, J BIOL CHEM, V284, P15416, DOI 10.1074/jbc.M809384200; Sugden PH, 2013, BIOCHEM J, V454, P13, DOI 10.1042/BJ20130219; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Trembley MA, 2014, BIOSCIENCE REP, V34, P119, DOI 10.1042/BSR20130096; Uhart M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00010; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; VANHEUSDEN GPH, 1992, FEBS LETT, V302, P145, DOI 10.1016/0014-5793(92)80426-H; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wang C, 2009, GENETICS, V183, P1373, DOI 10.1534/genetics.109.107797; Wang DY, 2010, INVEST OPHTH VIS SCI, V51, P4084, DOI 10.1167/iovs.09-4864; Watanabe K, 2009, ACTA PHYSIOL HUNG, V96, P277, DOI 10.1556/APhysiol.96.2009.3.3; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Wu HY, 2011, INT J BIOCHEM CELL B, V43, P742, DOI 10.1016/j.biocel.2011.01.015; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zahradka J, 2012, BBA-GEN SUBJECTS, V1820, P849, DOI 10.1016/j.bbagen.2012.03.013; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhou JB, 2009, MOL CELL BIOL, V29, P4167, DOI 10.1128/MCB.01067-08; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513; Zurita M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-217	86	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113528	10.1371/journal.pone.0113528	http://dx.doi.org/10.1371/journal.pone.0113528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409301	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200135
J	Munari, CC; de Oliveira, PF; Leandro, LF; Pimenta, LM; Ferreira, NH; da Costa, JD; Bastos, JK; Tavares, DC				Munari, Carla Carolina; de Oliveira, Pollyanna Francielli; Leandro, Luis Fernando; Pimenta, Leandra Mara; Ferreira, Natalia Helen; da Costa, Juliana de Carvalho; Bastos, Jairo Kenupp; Tavares, Denise Crispim			In Vivo Assessment of Genotoxic, Antigenotoxic and Anticarcinogenic Activities of Solanum lycocarpum Fruits Glycoalkaloidic Extract	PLOS ONE			English	Article							ST-HILL FRUITS; COMET ASSAY; RESPONSES; NIGRUM; ANTIMUTAGENICITY; CONSUMPTION; TOXICITY; CONDUCT; PLANTS; CELLS	The fruits of Solanum lycocarpum, known as wolf-fruit, are used in folk medicine, and because of that we have evaluated both the genotoxic potential of its glycoalkaloidic extract (SL) and its influence on the genotoxicity induced by methyl methanesulfonate. Furthermore, the potential blocking effect of SL intake in the initial stage of colon carcinogenesis in Wistar rats was investigated in a short-term (4-week) bioassay using aberrant crypt foci (ACF) as biomarker. The genotoxic potential was evaluated using the Swiss mice peripheral blood micronucleus test. The animals were treated with different doses of SL (15, 30 and 60 mg/kg b.w.) for 14 days, and the peripheral blood samples were collected at 48 h, 7 days and 14 days after starting the treatment. For antigenotoxicity assessment, MMS was administered on the 14 th day, and after 24 h the harvesting of bone marrow and liver cells was performed, for the micronucleus and comet assays, respectively. In the ACF assay, male Wistar rats were given four subcutaneous injections of the carcinogen 1,2-dimethylhydrazine (DMH, 40 mg/kg b.w.), twice a week, during two weeks to induce ACF. The treatment with SL (15, 30 and 60 mg/kg b.w.) was given for four weeks during and after carcinogen treatment to investigate the potential beneficial effects of SL on DMH-induced ACF. The results demonstrated that SL was not genotoxic in the mouse micronucleus test. In animals treated with SL and MMS, the frequencies of micronucleus and extensions of DNA damage were significantly reduced in comparison with the animals receiving only MMS. Regarding the ACF assay, SL significantly reduced the frequency of ACF induced by DMH.	[Munari, Carla Carolina] Univ Estadual Paulista, Fac Med Botucatu, Dept Patol, Dist Rubiao Jr, SP, Brazil; [de Oliveira, Pollyanna Francielli; Leandro, Luis Fernando; Pimenta, Leandra Mara; Ferreira, Natalia Helen; Tavares, Denise Crispim] Univ Franca, Franca, SP, Brazil; [da Costa, Juliana de Carvalho; Bastos, Jairo Kenupp] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ribeirao Preto, SP, Brazil	Universidade Estadual Paulista; Universidad de Franca; Universidade de Sao Paulo	Munari, CC (corresponding author), Univ Estadual Paulista, Fac Med Botucatu, Dept Patol, Dist Rubiao Jr, SP, Brazil.	camunari@yahoo.com.br	da Costa, Juliana/AAL-4204-2021; Tavares, Denise C/C-3396-2012; Munari, Carla Carolina/I-2481-2012	Tavares, Denise C/0000-0003-4646-5914; Munari, Carla/0000-0001-6922-369X; Ferreira, Natalia/0000-0002-0052-6139; Oliveira, Pollyanna/0000-0002-1646-0277; de Carvalho da Costa, Juliana/0000-0002-2336-7361	Sao Paulo Research Foundation (FAPESP; Brazil) [2011/05732-4]; FAPESP [2009/15871-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Sao Paulo Research Foundation (FAPESP; Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the Sao Paulo Research Foundation (FAPESP; Brazil; grant # 2011/05732-4). C.C. Munari thanks FAPESP for a Doctor's scholarship (grant # 2009/15871-1). The authors are grateful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwikar S, 2012, INT J AYURVEDA RES, V3, P167; Bahgat A, 2008, FUND CLIN PHARMACOL, V22, P693, DOI 10.1111/j.1472-8206.2008.00627.x; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; Chacon Daniele Roswell, 2002, Cytologia (Tokyo), V67, P417, DOI 10.1508/cytologia.67.417; Choudhary G, 1998, CHEMOSPHERE, V37, P801, DOI 10.1016/S0045-6535(98)00088-5; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Ding X, 2012, J ETHNOPHARMACOL, V139, P599, DOI 10.1016/j.jep.2011.11.058; Farina F, 2010, APPL PHYSIOL NUTR ME, V35, P40, DOI 10.1139/H09-131; Ferguson LR, 2005, MUTAT RES-FUND MOL M, V591, P3, DOI 10.1016/j.mrfmmm.2005.05.017; Gupta RK, 2011, ASIAN PAC J TROP MED, V4, P964, DOI 10.1016/S1995-7645(11)60227-7; Hanausek M, 2001, P NATL ACAD SCI USA, V98, P11551, DOI 10.1073/pnas.191363198; Javed T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-26; Tiossi RFJ, 2012, J ANAL METHODS CHEM, V2012, DOI 10.1155/2012/947836; Khazir J, 2013, J ASIAN NAT PROD RES, V15, P764, DOI 10.1080/10286020.2013.798314; Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2; Li X, 2011, LIFE SCI, V88, P314, DOI 10.1016/j.lfs.2010.12.006; MACGREGOR JT, 1980, ENVIRON MUTAGEN, V2, P509, DOI 10.1002/em.2860020408; MACGREGOR JT, 1987, MUTAT RES, V189, P103, DOI 10.1016/0165-1218(87)90016-4; Maruo VM, 2003, NEUROTOXICOL TERATOL, V25, P627, DOI 10.1016/S0892-0362(03)00038-2; Maruo VM, 2003, PHYTOMEDICINE, V10, P48, DOI 10.1078/094471103321648656; Munari CC, 2012, FOOD CHEM TOXICOL, V50, P3696, DOI 10.1016/j.fct.2012.07.028; Munari CC, 2013, J NAT MED, V68, P231; Nirmal SA, 2012, J ETHNOPHARMACOL, V142, P91, DOI 10.1016/j.jep.2012.04.019; Patel PK, 2012, J YOUNG PHARM, V4, P164, DOI 10.4103/0975-1483.100022; Peters VM, 2001, CONTRACEPTION, V63, P53, DOI 10.1016/S0010-7824(00)00188-8; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Sa RDDE, 2000, J ETHNOPHARMACOL, V73, P283, DOI 10.1016/S0378-8741(00)00250-6; Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64; Soares-Mota MR, 2010, EXP TOXICOL PATHOL, V62, P549, DOI 10.1016/j.etp.2009.07.006; SULTANA S, 1995, J ETHNOPHARMACOL, V45, P189, DOI 10.1016/0378-8741(94)01214-K; Tavares DC, 2011, PLANTA MED, V77, P1489, DOI 10.1055/s-0030-1270886; TOMASI A, 1987, TOXICOL PATHOL, V15, P178, DOI 10.1177/019262338701500208; vandeWater B, 1996, ARCH BIOCHEM BIOPHYS, V327, P71, DOI 10.1006/abbi.1996.0094; WATERS MD, 1990, MUTAT RES, V238, P57, DOI 10.1016/0165-1110(90)90039-E; Weissenberg M, 2001, PHYTOCHEMISTRY, V58, P501, DOI 10.1016/S0031-9422(01)00185-6; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yen GC, 2001, FOOD CHEM TOXICOL, V39, P1045, DOI 10.1016/S0278-6915(01)00053-9	38	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111999	10.1371/journal.pone.0111999	http://dx.doi.org/10.1371/journal.pone.0111999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405606	Green Submitted, gold, Green Published			2022-12-26	WOS:000347121300019
J	Trotta, E				Trotta, Edoardo			On the Normalization of the Minimum Free Energy of RNAs by Sequence Length	PLOS ONE			English	Article							FOLDING FREE-ENERGIES; PREDICTION; FEATURES; DATABASE; MIRNAS; GENES	The minimum free energy (MFE) of ribonucleic acids (RNAs) increases at an apparent linear rate with sequence length. Simple indices, obtained by dividing the MFE by the number of nucleotides, have been used for a direct comparison of the folding stability of RNAs of various sizes. Although this normalization procedure has been used in several studies, the relationship between normalized MFE and length has not yet been investigated in detail. Here, we demonstrate that the variation of MFE with sequence length is not linear and is significantly biased by the mathematical formula used for the normalization procedure. For this reason, the normalized MFEs strongly decrease as hyperbolic functions of length and produce unreliable results when applied for the comparison of sequences with different sizes. We also propose a simple modification of the normalization formula that corrects the bias enabling the use of the normalized MFE for RNAs longer than 40 nt. Using the new corrected normalized index, we analyzed the folding free energies of different human RNA families showing that most of them present an average MFE density more negative than expected for a typical genomic sequence. Furthermore, we found that a well-defined and restricted range of MFE density characterizes each RNA family, suggesting the use of our corrected normalized index to improve RNA prediction algorithms. Finally, in coding and functional human RNAs the MFE density appears scarcely correlated with sequence length, consistent with a negligible role of thermodynamic stability demands in determining RNA size.	CNR, Inst Translat Pharmacol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Trotta, E (corresponding author), CNR, Inst Translat Pharmacol, Rome, Italy.	edoardo.trotta@ift.cnr.it	Trotta, Edoardo/AAW-4697-2020	Trotta, Edoardo/0000-0002-1417-9238				Alkan C, 2006, LECT NOTES COMPUT SC, V3909, P130, DOI 10.1007/11732990_12; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Catania F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-129; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Felden B, 2007, CURR OPIN MICROBIOL, V10, P286, DOI 10.1016/j.mib.2007.05.001; FREYHULT E, 2005, BMC BIOINFORMATICS, V6; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Knuth D, 1997, SEMINUMERICAL ALGORI, V3; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Loong SNK, 2007, RNA, V13, P170, DOI 10.1261/rna.223807; LE SY, 1989, J THEOR BIOL, V138, P495, DOI 10.1016/S0022-5193(89)80047-5; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Li XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088339; Lopes IDN, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-124; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Ni M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-329; Pervouchine DD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng049; Puzey JR, 2009, GENE, V448, P46, DOI 10.1016/j.gene.2009.08.005; Seffens W, 1999, NUCLEIC ACIDS RES, V27, P1578, DOI 10.1093/nar/27.7.1578; Spirollari J, 2009, BIOINFORM BIOL INSIG, V3, P51; Thakur V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-108; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; WOLFF T, 1993, GENE DEV, V7, P1377, DOI 10.1101/gad.7.7b.1377; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhao DY, 2010, ARTIF INTELL MED, V49, P127, DOI 10.1016/j.artmed.2010.03.004; Zhu Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-718; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113380	10.1371/journal.pone.0113380	http://dx.doi.org/10.1371/journal.pone.0113380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405875	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300112
J	Zhao, C; Wang, XB; Cong, YL; Deng, Y; Xu, YJ; Chen, AH; Yin, YR				Zhao, Cong; Wang, Xianbao; Cong, Yuling; Deng, Yi; Xu, Yijun; Chen, Aihua; Yin, Yanru			Effects of Bile Acids and the Bile Acid Receptor FXR Agonist on the Respiratory Rhythm in the In Vitro Brainstem Medulla Slice of Neonatal Sprague-Dawley Rats	PLOS ONE			English	Article							SPINAL-CORD PREPARATION; NUCLEAR RECEPTOR; IDENTIFICATION; GENERATION	Intrahepatic cholestasis of pregnancy is always accompanied by adverse fetal outcomes such as malfunctions of respiration. Farnesoid X receptor (FXR) plays a critical role in the homeostasis of bile acids. Thus, we are determined to explore the effects of farnesoid X receptor (FXR) and five bile acids on respiratory rhythm generation and modulation of neonatal rats. Spontaneous periodic respiratory-related rhythmical discharge activity (RRDA) was recorded from hypoglossal nerves during the perfusion of modified Krebs solution. Group 1-6 was each given GW4064 and five bile acids of chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA), cholic acid (CA) as well as ursodeoxycholic acid (UDCA) at different concentrations to identify their specific functions on respiratory rhythm modulations. Group 7 was applied to receive FXR blocker Z-guggulsterone and Z-guggulsterone with the above bile acids separately to explore the role of FXR in the respiratory rhythm modulation. Group 8 was given dimethyl sulfoxide (DMSO) as controls. Apart from UDCA, CDCA, DCA LCA and CA all exerted effects on RRDA recorded from hypoglossal nerves in a concentration-dependent manner. Respiratory cycle (RC), Inspiratory time (TI), Expiratory Time (TE) and Integral Amplitude (IA) were influenced and such effects could be reversed by Z-guggulsterone. FXR may contribute to the effects on the modulation of respiratory rhythm exerted by bile acids.	[Zhao, Cong; Wang, Xianbao; Deng, Yi; Chen, Aihua] Southern Med Univ, Zhujiang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Cong, Yuling] Cent Hosp Shengli Oil Field, Dongying, Peoples R China; [Xu, Yijun; Yin, Yanru] Southern Med Univ, Dept Physiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Chen, AH (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	zj_chenaihua@126.com; yyr1707@163.com	王, 贤保/F-8798-2012		Project of National Science Foundation of China [31071010]	Project of National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Project of National Science Foundation of China (31071010, http://www.nsfc.gov.cn/). The funders played a role in study design, decision to publish, and preparation of the manuscript	Cabrerizo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087697; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Cariou B, 2007, TRENDS PHARMACOL SCI, V28, P236, DOI 10.1016/j.tips.2007.03.002; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Chiang JYL, 2003, AM J PHYSIOL-GASTR L, V284, pG349, DOI 10.1152/ajpgi.00417.2002; Herraez E, 2014, J MOL MED, V92, P359, DOI 10.1007/s00109-013-1106-1; Hilaire G, 1997, NEUROSCI LETT, V224, P13, DOI 10.1016/S0304-3940(97)13458-9; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Johnson SM, 2001, J NEUROPHYSIOL, V86, P59; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Perng DW, 2008, RESPIROLOGY, V13, P983, DOI 10.1111/j.1440-1843.2008.01402.x; RIOSECO AJ, 1994, AM J OBSTET GYNECOL, V170, P890, DOI 10.1016/S0002-9378(94)70304-3; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Wang Fei, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1181; Wu Z H, 1990, Sheng Li Xue Bao, V42, P68; WU Z-H, 1988, Acta Physiologica Sinica, V40, P250; Wu ZH, 1997, ACTA PHYSL SIN, V49, P389; Yu L, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/308274; Zecca E, 2008, PEDIATRICS, V121, pE146, DOI 10.1542/peds.2007-1220; ZHANG FT, 1991, RESP PHYSIOL, V85, P73, DOI 10.1016/0034-5687(91)90007-6	28	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112212	10.1371/journal.pone.0112212	http://dx.doi.org/10.1371/journal.pone.0112212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405617	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300026
J	Kim, WY; Kwak, MK; Ko, BS; Yoon, JC; Sohn, CH; Lim, KS; Andersen, LW; Donnino, MW				Kim, Won Young; Kwak, Myoung Kwan; Ko, Byuk Sung; Yoon, Jae Chol; Sohn, Chang Hwan; Lim, Kyoung Soo; Andersen, Lars W.; Donnino, Michael W.			Factors Associated with the Occurrence of Cardiac Arrest after Emergency Tracheal Intubation in the Emergency Department	PLOS ONE			English	Article							RAPID-SEQUENCE INTUBATION; INTENSIVE-CARE-UNIT; AIRWAY MANAGEMENT; ENDOTRACHEAL INTUBATION; CLINICAL-PRACTICE; MULTIPLE-CENTER; CRITICALLY-ILL; RISK-FACTORS; COMPLICATIONS; HYPOTENSION	Objectives: Emergency tracheal intubation has achieved high success and low complication rates in the emergency department (ED). The objective of this study was to evaluate the incidence of post-intubation CA and determine the clinical factors associated with this complication. Methods: A matched case-control study with a case to control ratio of 1: 3 was conducted at an urban tertiary care center between January 2007 and December 2011. Critically ill adult patients requiring emergency airway management in the ED were included. The primary endpoint was post-intubation CA, defined as CA within 10 minutes after tracheal intubation. Clinical variables were compared between patients with post-intubation CA and patients without CA who were individually matched based on age, sex, and pre-existing comorbidities. Results: Of 2,403 patients who underwent emergency tracheal intubation, 41 patients (1.7%) had a post-intubation CA within 10 minutes of the procedure. The most common initial rhythm was pulseless electrical activity (78.1%). Patients experiencing CA had higher in-hospital mortality than patients without CA (61.0% vs. 30.1%; p<0.001). Systolic hypotension prior to intubation, defined as a systolic blood pressure <= 90 mmHg, was independently associated with post-intubation CA (OR, 3.67 [95% CI, 1.58-8.55], p = 0.01). Conclusion: Early post-intubation CA occurred with an approximate 2% frequency in the ED. Systolic hypotension before intubation is associated with this complication, which has potentially significant implications for clinicians at the time of intubation.	[Kim, Won Young; Ko, Byuk Sung; Sohn, Chang Hwan; Lim, Kyoung Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul, South Korea; [Kim, Won Young; Kwak, Myoung Kwan] Seoul Med Ctr, Dept Emergency Med, Seoul, South Korea; [Yoon, Jae Chol] Chonbuk Natl Univ Hosp, Dept Emergency Med, Jeonju, South Korea; [Andersen, Lars W.; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Andersen, Lars W.] Aarhus Univ Hosp, Dept Anesthesiol, DK-8000 Aarhus, Denmark	University of Ulsan; Asan Medical Center; Seoul Medical Center; Jeonbuk National University; Jeonbuk National University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Aarhus University	Kim, WY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul, South Korea.	wonpia@yahoo.co.kr		Andersen, Lars Wiuff/0000-0001-5752-8082				American College of Emergency Physicians, 1997, ANN EMERG MED, V29, P573; Ballow SL, 2012, J TRAUMA ACUTE CARE, V73, P1401, DOI 10.1097/TA.0b013e318270dcf5; Bowles TM, 2011, BRIT J ANAESTH, V107, P687, DOI 10.1093/bja/aer251; Chopra H, 2000, Indian J Otolaryngol Head Neck Surg, V52, P364, DOI 10.1007/BF02991479; Dewhirst Elisabeth, 2013, J Intensive Care Med, V28, P375, DOI 10.1177/0885066612448732; FRANKLIN C, 1994, AM J EMERG MED, V12, P425, DOI 10.1016/0735-6757(94)90053-1; Griesdale DEG, 2008, INTENS CARE MED, V34, P1835, DOI 10.1007/s00134-008-1205-6; Heffner AC, 2013, RESUSCITATION, V84, P1500, DOI 10.1016/j.resuscitation.2013.07.022; Heffner AC, 2012, J CRIT CARE, V27, P587, DOI 10.1016/j.jcrc.2012.04.022; Heffner AC, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.011; Hulme J, 2006, EMERG MED J, V23, P162; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jaber S, 2010, INTENS CARE MED, V36, P248, DOI 10.1007/s00134-009-1717-8; Kovacs G, 2004, CAN J ANAESTH, V51, P174, DOI 10.1007/BF03018780; Mason MA, 2013, ADV EMERG NURS J, V35, P16, DOI 10.1097/TME.0b013e31827fb706; Mort TC, 2004, J CLIN ANESTH, V16, P508, DOI 10.1016/j.jclinane.2004.01.007; Mort TC, 1998, ANESTH ANALG, V86, P1171, DOI 10.1097/00000539-199806000-00006; Mort Thomas C, 2007, J Intensive Care Med, V22, P157, DOI 10.1177/0885066607299525; Mort Thomas C, 2007, J Intensive Care Med, V22, P208, DOI 10.1177/0885066607301359; Newland MC, 2002, ANESTHESIOLOGY, V97, P108, DOI 10.1097/00000542-200207000-00016; Reich DL, 2005, ANESTH ANALG, V101, P622, DOI 10.1213/01.ANE.0000175214.38450.91; Schwab TM, 1998, AM J EMERG MED, V16, P609, DOI 10.1016/S0735-6757(98)90229-7; SCHWARTZ DE, 1995, ANESTHESIOLOGY, V82, P367, DOI 10.1097/00000542-199502000-00007; Tourtier Jean-Pierre, 2012, J Intensive Care Med, V27, P66, DOI 10.1177/0885066611410375; Walls RM, 2011, J EMERG MED, V41, P347, DOI 10.1016/j.jemermed.2010.02.024; Wang HE, 2008, RESUSCITATION, V79, P234, DOI 10.1016/j.resuscitation.2008.06.025; Wilcox SR, 2012, CRIT CARE MED, V40, P1808, DOI 10.1097/CCM.0b013e31824e0e67	27	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112779	10.1371/journal.pone.0112779	http://dx.doi.org/10.1371/journal.pone.0112779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402500	gold, Green Submitted, Green Published			2022-12-26	WOS:000345158700071
J	Majumder, S; Zappulla, F; Silbart, LK				Majumder, Sanjukta; Zappulla, Frank; Silbart, Lawrence K.			Mycoplasma gallisepticum Lipid Associated Membrane Proteins Up-regulate Inflammatory Genes in Chicken Tracheal Epithelial Cells via TLR-2 Ligation through an NF-kappa B Dependent Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; STRAIN R-LOW; SURFACE LIPOPROTEIN; CYTOKINE SECRETION; PHASE VARIATION; NITRIC-OXIDE; PROINFLAMMATORY CYTOKINES; GENITALIUM INFECTION; TERMINAL ORGANELLE; MOLECULAR-CLONING	Mycoplasma gallisepticum-mediated respiratory inflammation in chickens is associated with accumulation of leukocytes in the tracheal submucosa. However the molecular mechanisms underpinning these changes have not been well described. We hypothesized that the initial inflammatory events are initiated upon ligation of mycoplasma lipid associated membrane proteins (LAMP) to TLRs expressed on chicken tracheal epithelial cells (TEC). To test this hypothesis, live bacteria or LAMPs isolated from a virulent (R-low) or a non-virulent (R-high) strain were incubated with primary TECs or chicken tracheae ex vivo. Microarray analysis identified up-regulation of several inflammatory and chemokine genes in TECs as early as 1.5 hours post-exposure. Kinetic analysis using RT-qPCR identified the peak of expression for most genes to be at either 1.5 or 6 hours. Ex-vivo exposure also showed up-regulation of inflammatory genes in epithelial cells by 1.5 hours. Among the commonly upregulated genes were IL-1 beta, IL-6, IL-8, IL-12p40, CCL-20, and NOS-2, all of which are important immune-modulators and/or chemo-attractants of leukocytes. While these inflammatory genes were up-regulated in all four treatment groups, R-low exposed epithelial cells both in vitro and ex vivo showed the most dramatic up-regulation, inducing over 100 unique genes by 5-fold or more in TECs. Upon addition of a TLR-2 inhibitor, LAMP-mediated gene expression of IL-1 beta and CCL-20 was reduced by almost 5-fold while expression of IL-12p40, IL-6, IL-8 and NOS-2 mRNA was reduced by about 2-3 fold. Conversely, an NF-kappa B inhibitor abrogated the response entirely for all six genes. miRNA-146a, a negative regulator of TLR-2 signaling, was up-regulated in TECs in response to either R-low or R-high exposure. Taken together we conclude that LAMPs isolated from both R-high and R-low induced rapid, TLR-2 dependent but transient up-regulation of inflammatory genes in primary TECs through an NF-kappa B dependent pathway.	[Majumder, Sanjukta; Silbart, Lawrence K.] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Zappulla, Frank; Silbart, Lawrence K.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA; [Majumder, Sanjukta; Silbart, Lawrence K.] Univ Connecticut, Ctr Excellence Vaccine Res, Storrs, CT USA; [Silbart, Lawrence K.] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut	Silbart, LK (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.	Lawrence.Silbart@uconn.edu		Majumder, Sanjukta/0000-0002-4906-7199	United States Department of Agriculture, National Institute of Food and Agriculture [CONS00930]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Support was provided by the United States Department of Agriculture, National Institute of Food and Agriculture to LKS (Hatch project number CONS00930) [http://portal.nifa.usda.gov/web/crisprojectpages/0179772-the-role-of-membrane-associated-lipoproteins-and-hydrogen-peroxide-in-the-pathogenesis-of-mycoplasma-gallisepticum-in-chickens.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, EUR J IMMUNOL, V41, P2482, DOI 10.1002/eji.201141740; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; BEHRENS A, 1994, INFECT IMMUN, V62, P5075, DOI 10.1128/IAI.62.11.5075-5084.1994; Bischof DF, 2008, INFECT IMMUN, V76, P263, DOI 10.1128/IAI.00938-07; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Calcutt MJ, 1999, INFECT IMMUN, V67, P760, DOI 10.1128/IAI.67.2.760-771.1999; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Choi SY, 2012, INFLAMM RES, V61, P493, DOI 10.1007/s00011-012-0437-7; Chopra-Dewasthaly R, 2012, FEMS IMMUNOL MED MIC, V66, P307, DOI 10.1111/j.1574-695X.2012.01010.x; Citti C, 1995, MOL MICROBIOL, V18, P649, DOI 10.1111/j.1365-2958.1995.mmi_18040649.x; Cole B C, 1991, Curr Top Microbiol Immunol, V174, P107; COLE BC, 1977, INFECT IMMUN, V18, P393, DOI 10.1128/IAI.18.2.393-399.1977; DALLO SF, 1990, INFECT IMMUN, V58, P4163, DOI 10.1128/IAI.58.12.4163-4165.1990; Deiters U, 1999, INFECT IMMUN, V67, P3390, DOI 10.1128/IAI.67.7.3390-3398.1999; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Furnkranz U, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-63; Gaunson JE, 2006, VACCINE, V24, P2627, DOI 10.1016/j.vaccine.2005.12.008; Gaunson JE, 2000, MICROBIOL-SGM, V146, P1223, DOI 10.1099/00221287-146-5-1223; Gomez MI, 2008, PEDIATR PULM, V43, P11, DOI 10.1002/ppul.20735; Griesinger G, 2001, J SOC GYNECOL INVEST, V8, P334, DOI 10.1016/S1071-5576(01)00135-6; Grodio JL, 2008, AVIAN PATHOL, V37, P385, DOI 10.1080/03079450802216629; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; He J, 2014, INFLAMMATION, V37, P322, DOI 10.1007/s10753-013-9743-7; He J, 2009, CLIN VACCINE IMMUNOL, V16, P1750, DOI 10.1128/CVI.00281-09; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Indikova I, 2013, INFECT IMMUN; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Javed MA, 2005, INFECT IMMUN, V73, P5410, DOI 10.1128/IAI.73.9.5410-5419.2005; Jenkins C, 2007, MICROBIOL-SGM, V153, P1455, DOI 10.1099/mic.0.2006/004937-0; KAHANE I, 1985, INFECT IMMUN, V50, P944, DOI 10.1128/IAI.50.3.944-946.1985; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Krause DC, 2004, MOL MICROBIOL, V51, P917, DOI 10.1046/j.1365-2958.2003.03899.x; Krause DC, 1996, MOL MICROBIOL, V20, P247, DOI 10.1111/j.1365-2958.1996.tb02613.x; Krause DC, 2001, FEMS MICROBIOL LETT, V198, P1, DOI 10.1111/j.1574-6968.2001.tb10610.x; Krishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062706; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Liu XP, 2010, INFECT IMMUN, V78, P5314, DOI 10.1128/IAI.00681-10; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035304; Logunov D Iu, 2009, Mol Gen Mikrobiol Virusol, P25; Love W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010739; May M, 2006, INFECT IMMUN, V74, P1777, DOI 10.1128/IAI.74.3.1777-1785.2006; McGowin CL, 2012, INFECT IMMUN, V80, P3842, DOI 10.1128/IAI.00819-12; McGowin CL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-139; McGowin CL, 2009, INFECT IMMUN, V77, P1175, DOI 10.1128/IAI.00845-08; Medina JL, 2012, AM J RESP CELL MOL, V46, P815, DOI 10.1165/rcmb.2011-0135OC; Medina S, 2005, REGUL PEPTIDES, V131, P46, DOI 10.1016/j.regpep.2005.06.005; Mohammed J, 2007, VACCINE, V25, P8611, DOI 10.1016/j.vaccine.2007.09.057; Much P, 2002, FEMS IMMUNOL MED MIC, V34, P181, DOI 10.1111/j.1574-695X.2002.tb00622.x; Noormohammadi AH, 2000, MOL MICROBIOL, V35, P911, DOI 10.1046/j.1365-2958.2000.01766.x; Nouvel LX, 2009, J BACTERIOL, V191, P4111, DOI 10.1128/JB.00251-09; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Papazisi L, 2002, INFECT IMMUN, V70, P6839, DOI 10.1128/IAI.70.12.6839-6845.2002; Papazisi L, 2000, INFECT IMMUN, V68, P6643, DOI 10.1128/IAI.68.12.6643-6649.2000; Prince A, 2006, AM J RESP CELL MOL, V34, P548, DOI 10.1165/rcmb.2006-0022SF; Qiu Hong, 2007, Weishengwu Xuebao, V47, P899; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062232; Rawadi G, 2000, MICROBES INFECT, V2, P955, DOI 10.1016/S1286-4579(00)00395-6; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Roussel L, 2011, J CYST FIBROS, V10, P107, DOI 10.1016/j.jcf.2010.11.005; SATO S, 1970, NATL I ANIM HEALTH Q, V10, P58; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Seya T, 2002, INT J BIOCHEM CELL B, V34, P901, DOI 10.1016/S1357-2725(01)00164-9; Shen CI, VET RES, V41, P6; SHERRY B, 1988, J EXP MED, V168, P2251, DOI 10.1084/jem.168.6.2251; Shimizu T, 2005, J IMMUNOL, V175, P4641, DOI 10.4049/jimmunol.175.7.4641; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Shimizu T, 2007, IMMUNOLOGY, V121, P473, DOI 10.1111/j.1365-2567.2007.02594.x; Stipkovits L, 2012, AVIAN PATHOL, V41, P51, DOI 10.1080/03079457.2011.635635; Szczepanek SM, 2010, INFECT IMMUN, V78, P1760, DOI 10.1128/IAI.01172-09; TAJIMA M, 1979, AM J VET RES, V40, P1009; Tulman ER, 2012, MICROBIOL-SGM, V158, P2073, DOI 10.1099/mic.0.058560-0; Vogl G, 2008, INFECT IMMUN, V76, P71, DOI 10.1128/IAI.00871-07; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000; Wu HN, 2012, CURR MICROBIOL, V64, P433, DOI 10.1007/s00284-012-0090-y; Xing Z, 2000, J LEUKOCYTE BIOL, V68, P897; Xu CG, 2014, GENET MOL RES, V13, P1527, DOI 10.4238/2014.March.12.5; Xu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077955; Yang J, 2002, INFECT IMMUN, V70, P3649, DOI 10.1128/IAI.70.7.3649-3655.2002; YOGEV D, 1994, INFECT IMMUN, V62, P4962, DOI 10.1128/IAI.62.11.4962-4968.1994; You Xiao-xing, 2006, J Zhejiang Univ Sci B, V7, P342, DOI 10.1631/jzus.2006.B0342; You XX, 2008, FEMS IMMUNOL MED MIC, V52, P228, DOI 10.1111/j.1574-695X.2007.00366.x; Zaffuto KM, 2008, AVIAN PATHOL, V37, P25, DOI 10.1080/03079450701774850; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781; Zuo LL, 2009, J ZHEJIANG UNIV-SC B, V10, P67, DOI 10.1631/jzus.B0820256	93	34	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112796	10.1371/journal.pone.0112796	http://dx.doi.org/10.1371/journal.pone.0112796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401327	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700072
J	Cerri, M; Del Vecchio, F; Mastrotto, M; Luppi, M; Martelli, D; Perez, E; Tupone, D; Zamboni, G; Amici, R				Cerri, Matteo; Del Vecchio, Flavia; Mastrotto, Marco; Luppi, Marco; Martelli, Davide; Perez, Emanuele; Tupone, Domenico; Zamboni, Giovanni; Amici, Roberto			Enhanced Slow-Wave EEG Activity and Thermoregulatory Impairment following the Inhibition of the Lateral Hypothalamus in the Rat	PLOS ONE			English	Article							OREXIN RECEPTOR ANTAGONISTS; PARADOXICAL REM SLEEP; SHALLOW TORPOR; MCH NEURONS; ACTIVATION; IDENTIFICATION; ARCHITECTURE; ZOLPIDEM; DEFENSE; STATE	Neurons within the lateral hypothalamus (LH) are thought to be able to evoke behavioural responses that are coordinated with an adequate level of autonomic activity. Recently, the acute pharmacological inhibition of LH has been shown to depress wakefulness and promote NREM sleep, while suppressing REM sleep. These effects have been suggested to be the consequence of the inhibition of specific neuronal populations within the LH, i.e. the orexin and the MCH neurons, respectively. However, the interpretation of these results is limited by the lack of quantitative analysis of the electroencephalographic (EEG) activity that is critical for the assessment of NREM sleep quality and the presence of aborted NREM-to-REM sleep transitions. Furthermore, the lack of evaluation of the autonomic and thermoregulatory effects of the treatment does not exclude the possibility that the wake-sleep changes are merely the consequence of the autonomic, in particular thermoregulatory, changes that may follow the inhibition of LH neurons. In the present study, the EEG and autonomic/thermoregulatory effects of a prolonged LH inhibition provoked by the repeated local delivery of the GABA(A) agonist muscimol were studied in rats kept at thermoneutral (24 degrees C) and at a low (10 degrees C) ambient temperature (Ta), a condition which is known to depress sleep occurrence. Here we show that: 1) at both Tas, LH inhibition promoted a peculiar and sustained bout of NREM sleep characterized by an enhancement of slow-wave activity with no NREM-to-REM sleep transitions; 2) LH inhibition caused a marked transitory decrease in brain temperature at Ta 10 degrees C, but not at Ta 24 degrees C, suggesting that sleep changes induced by LH inhibition at thermoneutrality are not caused by a thermoregulatory impairment. These changes are far different from those observed after the short-term selective inhibition of either orexin or MCH neurons, suggesting that other LH neurons are involved in sleep-wake modulation.	[Cerri, Matteo; Del Vecchio, Flavia; Mastrotto, Marco; Luppi, Marco; Martelli, Davide; Perez, Emanuele; Tupone, Domenico; Zamboni, Giovanni; Amici, Roberto] Alma Mater Studiorum Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy	University of Bologna	Cerri, M (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy.	matteo.cerri@unibo.it	Martelli, Davide/Q-7375-2016; Luppi, Marco/AGH-3155-2022; Tupone, Domenico/M-8079-2016; Cerri, Matteo/F-5009-2017	Luppi, Marco/0000-0002-9462-5014; Tupone, Domenico/0000-0002-4238-1011; Cerri, Matteo/0000-0003-3556-305X; Martelli, Davide/0000-0001-6523-9598	Ministero dell'Istruzione, dell'Universita e della Ricerca- Italy [2008FY7K9S]	Ministero dell'Istruzione, dell'Universita e della Ricerca- Italy(Ministry of Education, Universities and Research (MIUR))	This work has been supported by the grant PRIN 2008FY7K9S from the Ministero dell'Istruzione, dell'Universita e della Ricerca (http://www.istruzione.it)- Italy (RA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud HR, 2013, PHYSIOL BEHAV, V104, P29; Betschart C, 2013, J MED CHEM, V56, P7590, DOI 10.1021/jm4007627; Bettica P, 2012, NEUROPSYCHOPHARMACOL, V37, P1224, DOI 10.1038/npp.2011.310; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Capitani P, 2005, NEUROSCI LETT, V383, P182, DOI 10.1016/j.neulet.2005.04.009; Cerri M, 2005, NEUROSCIENCE, V135, P627, DOI 10.1016/j.neuroscience.2005.06.039; Cerri M, 2005, SLEEP, V28, P694, DOI 10.1093/sleep/28.6.694; Cerri M, 2010, NEUROSCIENCE, V165, P984, DOI 10.1016/j.neuroscience.2009.10.068; Cerri M, 2013, J NEUROSCI, V33, P2984, DOI 10.1523/JNEUROSCI.3596-12.2013; Clement O, 2012, J NEUROSCI, V32, P16763, DOI 10.1523/JNEUROSCI.1885-12.2012; de Lecea L, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00016; DEBOER T, 1994, NEUROSCI LETT, V166, P35, DOI 10.1016/0304-3940(94)90834-6; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Fox SV, 2013, NEUROPSYCHOPHARMACOL, V38, P2401, DOI 10.1038/npp.2013.139; HARRIS DV, 1984, PHYSIOL ZOOL, V57, P428, DOI 10.1086/physzool.57.4.30163344; Hassani OK, 2010, EUR J NEUROSCI, V32, P448, DOI 10.1111/j.1460-9568.2010.07295.x; HOLM S, 1979, SCAND J STAT, V6, P65; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; KAPAS L, 1988, BRAIN RES, V438, P155, DOI 10.1016/0006-8993(88)91334-0; KRILOWICZ BL, 1988, AM J PHYSIOL, V255, pR1008, DOI 10.1152/ajpregu.1988.255.6.R1008; KRUEGER J M, 1989, Journal of Rheumatology, V16, P52; Krueger JM, 1997, ANN NY ACAD SCI, V813, P281, DOI 10.1111/j.1749-6632.1997.tb51706.x; Li FW, 2011, BEHAV BRAIN RES, V224, P376, DOI 10.1016/j.bbr.2011.06.021; Luppi PH, 2013, SLEEP, V36, P1775, DOI 10.5665/sleep.3192; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Sapin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011766; Sasaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020360; Takahashi Y, 2013, J PHYSIOL-LONDON, V591, P5623, DOI 10.1113/jphysiol.2013.261271; Tanaka M, 2013, AM J PHYSIOL-REG I, V305, pR1479, DOI 10.1152/ajpregu.00401.2013; Tsunematsu T, 2013, BEHAV BRAIN RES, V255, P64, DOI 10.1016/j.bbr.2013.05.021; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Tupone D, 2013, J NEUROSCI, V33, P14512, DOI 10.1523/JNEUROSCI.1980-13.2013; Tupone D, 2011, J NEUROSCI, V31, P15944, DOI 10.1523/JNEUROSCI.3909-11.2011; Vecchio F Del, 2012, J SLEEP RES S, VS358, P571; WALKER JM, 1979, SCIENCE, V204, P1098, DOI 10.1126/science.221974; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104; Winer B.J., 1991, STAT PRINCIPLES EXPT	38	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112849	10.1371/journal.pone.0112849	http://dx.doi.org/10.1371/journal.pone.0112849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398141	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500101
J	Guilherme, FR; Molena-Fernandes, CA; Hintze, LJ; Favero, MTM; Cuman, RKN; Rinaldi, W				Guilherme, Flavio Ricardo; Molena-Fernandes, Carlos Alexandre; Hintze, Luzia Jaeger; Martins Favero, Maria Teresa; Nakamura Cuman, Roberto Kenji; Rinaldi, Wilson			Hypertriglyceridemic Waist and Metabolic Abnormalities in Brazilian Schoolchildren	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTORS; CHOLESTEROL; PHENOTYPE; HYPERTENSION; ADOLESCENTS; PREVALENCE; AMERICAN; CHILDREN; DISEASE	Objective: To identify the prevalence of hypertriglyceridemic waist (HTW) phenotype and its association with metabolic abnormalities in schoolchildren. Methods: A cross-sectional study, with a sample of 241 students aged 10 to 14 years from public schools (4 schools) and private (2 schools) from Paranavai town, in Parana State, Brazil. Anthropometric variables (weight, height, waist circumference) and levels of triglycerides, total cholesterol, HDL-C, non-HDL and LDL-C were analyzed. In statistical tests of Pearson partial correlation and multivariate logistic regression, considering p, < 0,05. Results: The prevalence of HTW was 20,7% among schoolchildren, 14,1% in males and 6,6% among females with higher proportions aged 10-12 years old. Multivariate analysis indicated that the students who attended private schools were nearly three times more likely (95% CI: 1,2-5,6), to be diagnosed with HTW compared with those who attended public schools (p = 0,006), and LDL-C was the only metabolic variable positively associated with the outcome (p = 0,001), where the students categorized with elevated serum levels had odds 4,2 times (95% CI: 1,6-10,9) having the HTW compared to students in appropriate levels. Conclusion: This study showed higher prevalence of hypertriglyceridemic waist phenotype in students when compared to prospective studies in Brazil and worldwide. It also showed that the only metabolic alteration associated with HTW phenotype was LDL-C (low density lipoprotein).	[Guilherme, Flavio Ricardo; Molena-Fernandes, Carlos Alexandre; Nakamura Cuman, Roberto Kenji] Univ Estadual Maringa, Dept Pharm & Pharmacol, Lab Inflammat, Maringa, Parana, Brazil; [Hintze, Luzia Jaeger] Univ Estadual Maringa, Dept Phys Educ, Multiprofess Nucleous Obes Studies, Maringa, Parana, Brazil; [Martins Favero, Maria Teresa; Rinaldi, Wilson] Univ Estadual Maringa, Dept Phys Educ, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Hintze, LJ (corresponding author), Univ Estadual Maringa, Dept Phys Educ, Multiprofess Nucleous Obes Studies, Maringa, Parana, Brazil.	lujhintze@hotmail.com	Rinaldi, Wilson WR/T-4560-2017	Alexandre Molena Fernandes, Carlos/0000-0002-4019-8379; Ricardo Guilherme, Flavio/0000-0003-4808-6192	Araucaria Foundation	Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	The study received funding from Araucaria Foundation (http://www.fundacaoaraucaria.org.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian SM, 2008, J TROP PEDIATRICS, V54, P169, DOI 10.1093/tropej/fmm105; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Basiratnia M, 2013, IRAN J KIDNEY DIS, V7, P282; Bergmann Mauren Lucia de Araujo, 2011, Arq Bras Cardiol, V97, P17; Blackburn P, 2012, METABOLISM, V61, P56, DOI 10.1016/j.metabol.2011.05.017; Conde Wolney L., 2006, J. Pediatr. (Rio J.), V82, P266, DOI 10.2223/JPED.1502; da Conceicao-Machado MEP, 2013, J PEDIAT-BRAZIL, V89, P56, DOI 10.1016/j.jped.2013.02.009; de Queiroz VM, 2010, ARQ BRAS CARDIOL, V95, P629, DOI 10.1590/S0066-782X2010001500011; Esmaillzadeh A, 2006, AM J CLIN NUTR, V83, P36; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; *GOV BRAS, 2010, IND DAD BAS IND MORT; Hosseini-Esfahani F, 2011, J EPIDEMIOL, V21, P319, DOI 10.2188/jea.JE20100162; IDEC BG, 2005, ARQ BRAS CARDIOL, V85, P4; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Kuschnir MCC, 2007, J PEDIAT, V83, P335, DOI [10.2223/JPED.1647, 10.1590/S0021-75572007000500009]; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Moser DC, 2013, J PEDIAT-BRAZIL, V89, P243, DOI 10.1016/j.jped.2012.11.006; PEREIRA FP, 2008, MEDIDAS LOCALIZACAO, P146; Pereira PB, 2010, ARQ BRAS CARDIOL, V95, P606, DOI 10.1590/S0066-782X2010005000136; Pergher RNQ, 2010, J PEDIAT-BRAZIL, V86, P101, DOI [10.2223/JPED.1983, 10.1590/S0021-75572010000200004]; Rana JS, 2012, CURR ATHEROSCLER REP, V14, P130, DOI 10.1007/s11883-011-0224-x; Rentfro AR, 2011, PREV CHRONIC DIS, V8; Rodrigues AN, 2009, J PEDIAT-BRAZIL, V85, P55, DOI [10.2223/JPED.1867, 10.1590/S0021-75572009000100010]; Srinivasan SR, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e29; *WORD HLTH ORG, 2007, GROWTH REFERENCE DAT; World Health Organization, 2011, WORLD HLTH STAT 2011	26	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111724	10.1371/journal.pone.0111724	http://dx.doi.org/10.1371/journal.pone.0111724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397885	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500023
J	Kiya, T; Morishita, K; Uchino, K; Iwami, M; Sezutsu, H				Kiya, Taketoshi; Morishita, Koudai; Uchino, Keiro; Iwami, Masafumi; Sezutsu, Hideki			Establishment of Tools for Neurogenetic Analysis of Sexual Behavior in the Silkmoth, Bombyx mori	PLOS ONE			English	Article							LOBE PROJECTION NEURONS; ANTENNAL LOBE; SILKWORM MOTH; MACROGLOMERULAR COMPLEX; INSECT BRAINS; PHEROMONE; DROSOPHILA; GENE; INTERNEURONS; MECHANISMS	Background: Silkmoth, Bombyx mori, is an ideal model insect for investigating the neural mechanisms underlying sex pheromone-induced innate behavior. Although transgenic techniques and the GAL4/UAS system are well established in the silkmoth, genetic tools useful for investigating brain function at the neural circuit level have been lacking. Results: In the present study, we established silkmoth strains in which we could visualize neural projections (UAS-mCD8GFP) and cell nucleus positions (UAS-GFP. nls), and manipulate neural excitability by thermal stimulation (UAS-dTrpA1). In these strains, neural projections and nucleus position were reliably labeled with green fluorescent protein in a GAL4-dependent manner. Further, the behavior of silkworm larvae and adults could be controlled by GAL4-dependent misexpression of dTrpA1. Ubiquitous dTrpA1 misexpression led both silkmoth larvae and adults to exhibit seizure-like phenotypes in a heat stimulation-dependent manner. Furthermore, dTrpA1 misexpression in the sex pheromone receptor neurons of male silkmoths allowed us to control male sexual behavior by changing the temperature. Thermally stimulated male silkmoths exhibited full sexual behavior, including wing-flapping, orientation, and attempted copulation, and precisely approached a thermal source in a manner similar to male silkmoths stimulated with the sex pheromone. Conclusion: These findings indicate that a thermogenetic approach using dTrpA1 is feasible in Lepidopteran insects and thermogenetic analysis of innate behavior is applicable in the silkmoth. These tools are essential for elucidating the relationships between neural circuits and function using neurogenetic methods.	[Kiya, Taketoshi; Morishita, Koudai; Iwami, Masafumi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan; [Uchino, Keiro; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki, Japan	Kanazawa University; National Institute of Agrobiological Sciences - Japan	Kiya, T (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan.	kiya@staff.kanazawa-u.ac.jp	Kiya, Taketoshi/J-9032-2015; Kiya, Taketoshi/GVT-7846-2022; Iwami, Masafumi/C-1659-2013; Kiya, Taketoshi/ABE-6519-2020	Kiya, Taketoshi/0000-0002-5709-8016; Kiya, Taketoshi/0000-0002-5709-8016; Iwami, Masafumi/0000-0003-2385-9312; Sezutsu, Hideki/0000-0001-8886-1611; Uchino, Keiro/0000-0003-3650-7359	Sasakawa Scientific Research Grant; Hokuriku Bank; JSPS KAKENHI [24780047, 26850218, 22380034]	Sasakawa Scientific Research Grant; Hokuriku Bank; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Sasakawa Scientific Research Grant (to T.K.), the Hokuriku Bank (to T.K.), and JSPS KAKENHI Grant Number 24780047 and 26850218 (to T.K.) and 22380034 (to M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2004, J EXP BIOL, V207, P633, DOI 10.1242/jeb.00784; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Bidaye SS, 2014, SCIENCE, V344, P97, DOI 10.1126/science.1249964; Blomquist GJ, 2003, INSECT PHEROMONE BIO; Fujii T, 2011, P NATL ACAD SCI USA, V108, P18038, DOI 10.1073/pnas.1107282108; Fujita N, 2013, CURR BIOL, V23, P2063, DOI 10.1016/j.cub.2013.08.051; Fujiwara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089132; Fujiwara T, 2009, NEUROREPORT, V20, P1061, DOI 10.1097/WNR.0b013e32832e7d93; Gomez-Diaz C, 2013, EMBO REP, V14, P874, DOI 10.1038/embor.2013.140; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hill ES, 2003, J EXP BIOL, V206, P345, DOI 10.1242/jeb.00080; Hill ES, 2002, CHEM SENSES, V27, P475, DOI 10.1093/chemse/27.5.475; Imamura M, 2003, GENETICS, V165, P1329; KANZAKI R, 1986, BRAIN RES, V377, P378, DOI 10.1016/0006-8993(86)90885-1; Kanzaki R, 2003, CHEM SENSES, V28, P113, DOI 10.1093/chemse/28.2.113; KANZAKI R, 1992, BRAIN RES, V587, P211, DOI 10.1016/0006-8993(92)90999-P; KASANG G, 1978, NATURWISSENSCHAFTEN, V65, P337, DOI 10.1007/BF00368376; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Matsumoto S, 2010, BIOSCI BIOTECH BIOCH, V74, P223, DOI 10.1271/bbb.90756; Namiki S, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.001.2008; Namiki S, 2008, J COMP PHYSIOL A, V194, P501, DOI 10.1007/s00359-008-0325-3; Namiki S, 2013, J COMP NEUROL, V521, P1073, DOI 10.1002/cne.23219; Namiki S, 2011, J COMP NEUROL, V519, P3367, DOI 10.1002/cne.22754; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sakurai T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00125; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; Sato A, 2014, P NATL ACAD SCI USA, V111, pE1249, DOI 10.1073/pnas.1322134111; Seki Y, 2005, J COMP NEUROL, V481, P340, DOI 10.1002/cne.20392; Seki Y, 2008, J COMP NEUROL, V506, P93, DOI 10.1002/cne.21528; Tabuchi M, 2013, P NATL ACAD SCI USA, V110, P15455, DOI 10.1073/pnas.1313707110; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Uchino Keiro, 2006, Journal of Insect Biotechnology and Sericology, V75, P89; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Wada S, 2005, J COMP NEUROL, V484, P168, DOI 10.1002/cne.20452	42	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113156	10.1371/journal.pone.0113156	http://dx.doi.org/10.1371/journal.pone.0113156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396742	gold, Green Published			2022-12-26	WOS:000345558500138
J	Song, HS; Reifman, J; Wallqvist, A				Song, Hyun-Seob; Reifman, Jaques; Wallqvist, Anders			Prediction of Metabolic Flux Distribution from Gene Expression Data Based on the Flux Minimization Principle	PLOS ONE			English	Article							ESCHERICHIA-COLI; HIGH-THROUGHPUT; NETWORK; MODELS; RECONSTRUCTION; INTEGRATION; BIOMARKERS; CANCER	Prediction of possible flux distributions in a metabolic network provides detailed phenotypic information that links metabolism to cellular physiology. To estimate metabolic steady-state fluxes, the most common approach is to solve a set of macroscopic mass balance equations subjected to stoichiometric constraints while attempting to optimize an assumed optimal objective function. This assumption is justifiable in specific cases but may be invalid when tested across different conditions, cell populations, or other organisms. With an aim to providing a more consistent and reliable prediction of flux distributions over a wide range of conditions, in this article we propose a framework that uses the flux minimization principle to predict active metabolic pathways from mRNA expression data. The proposed algorithm minimizes a weighted sum of flux magnitudes, while biomass production can be bounded to fit an ample range from very low to very high values according to the analyzed context. We have formulated the flux weights as a function of the corresponding enzyme reaction's gene expression value, enabling the creation of context-specific fluxes based on a generic metabolic network. In case studies of wild-type Saccharomyces cerevisiae, and wild-type and mutant Escherichia coli strains, our method achieved high prediction accuracy, as gauged by correlation coefficients and sums of squared error, with respect to the experimentally measured values. In contrast to other approaches, our method was able to provide quantitative predictions for both model organisms under a variety of conditions. Our approach requires no prior knowledge or assumption of a context-specific metabolic functionality and does not require trial-and-error parameter adjustments. Thus, our framework is of general applicability for modeling the transcription-dependent metabolism of bacteria and yeasts.	[Song, Hyun-Seob; Reifman, Jaques; Wallqvist, Anders] US Army Med Res & Mat Command, Dept Def, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA	United States Department of Defense; United States Army	Wallqvist, A (corresponding author), US Army Med Res & Mat Command, Dept Def, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA.	awallqvist@bhsai.org	wallqvist, anders/W-2584-2019	wallqvist, anders/0000-0002-9775-7469	U.S. Army Network Science Initiative	U.S. Army Network Science Initiative	This work was funded as part of the U.S. Army Network Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chiaradonna F, 2012, BIOTECHNOL ADV, V30, P30, DOI 10.1016/j.biotechadv.2011.07.006; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Holzhutter HG, 2004, EUR J BIOCHEM, V271, P2905, DOI 10.1111/j.1432-1033.2004.04213.x; Hyduke DR, 2013, MOL BIOSYST, V9, P167, DOI 10.1039/c2mb25453k; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jensen PA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-147; Jerby L, 2012, CLIN CANCER RES, V18, P5572, DOI 10.1158/1078-0432.CCR-12-1856; Kim HU, 2012, BIOTECHNOL J, V7, P330, DOI 10.1002/biot.201100159; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lomax, 2007, STAT CONCEPTS 2 COUR; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Papini M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-136; RAMKRISHNA D, 1987, BIOTECHNOL PROGR, V3, P121, DOI 10.1002/btpr.5420030302; Ramkrishna D, 2012, AICHE J, V58, P986, DOI 10.1002/aic.13734; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Rossell S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002988; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Schuster S, 2008, J THEOR BIOL, V252, P497, DOI 10.1016/j.jtbi.2007.12.008; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Thiele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045635; Vital-Lopez FG, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-63; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zur H, 2010, BIOINFORMATICS, V26, P3140, DOI 10.1093/bioinformatics/btq602	41	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112524	10.1371/journal.pone.0112524	http://dx.doi.org/10.1371/journal.pone.0112524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397773	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500057
J	Wang, T; Chen, Z; Zhu, YF; Pan, QX; Liu, YJ; Qi, XW; Jin, LF; Jin, J; Ma, X; Hua, D				Wang, Teng; Chen, Zhen; Zhu, Yifei; Pan, Qiongxi; Liu, Yanjun; Qi, Xiaowei; Jin, Linfang; Jin, Jian; Ma, Xin; Hua, Dong			Inhibition of Transient Receptor Potential Channel 5 Reverses 5-Fluorouracil Resistance in Human Colorectal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Beta-Catenin (B-catenin); Chemoresistance; Colorectal Cancer; Transient Receptor Potential Channels (TRP Channels)	MULTIDRUG-RESISTANCE; PROSTATE-CANCER; P-GLYCOPROTEIN; TRP CHANNELS; BETA-CATENIN; TUMOR PROGRESSION; GENE-EXPRESSION; BREAST-CANCER; ION CHANNELS; PROLIFERATION	Background: Resistance to 5-fluorouracil leads to the failure of chemotherapy for colorectal cancer. Results: Suppressing TrpC5 expression decreased nuclear -catenin accumulation, reduced the induction of ABCB1, and reversed 5-fluorouracil resistance. Conclusion: TrpC5 is essential in ABCB1 induction and drug resistance in human colorectal cancer cells. Significance: These findings may help develop a novel target for overcoming resistance to chemotherapy in colorectal cancer. 5-Fluorouracil (5-Fu) is commonly used in the chemotherapy of colorectal cancer (CRC), but resistance to 5-Fu occurs in most cases, allowing cancer progression. Suppressing ABCB1 (ATP-binding cassette, subfamily B, member 1), which is a pump overproduced in cancer cells to export cytotoxic drugs, is an attractive strategy to overcome drug resistance. In the present study, transient receptor potential channel TrpC5 was found to be overproduced at the mRNA and protein levels together with ABCB1 in 5-Fu-resistant human CRC HCT-8 (HCT-8/5-Fu) and LoVo (LoVo/5-Fu) cells. More nuclear-stabilized -catenin accumulation was found in HCT-8/5-Fu and LoVo/5-Fu cells than in HCT-8 and LoVo cells. Suppressing TrpC5 expression with TrpC5-specific siRNA inhibited the canonical Wnt/-catenin signal pathway, reduced the induction of ABCB1, weakened the ABCB1 efflux pump, and caused a remarkable reversal of 5-Fu resistance in HCT-8/5-Fu and LoVo/5-Fu cells. On the contrary, enforcing TrpC5 expression resulted in an activated Wnt/-catenin signal pathway and up-regulation of ABCB1. Taken together, we demonstrated an essential role of TrpC5 in ABCB1 induction and drug resistance in human CRC cells via promoting nuclear -catenin accumulation.	[Wang, Teng; Hua, Dong] Jiangnan Univ, Affiliated Hosp, Dept Med Oncol, Wuxi 214062, Jiangsu, Peoples R China; [Qi, Xiaowei; Jin, Linfang] Jiangnan Univ, Affiliated Hosp, Dept Pathol, Wuxi 214062, Jiangsu, Peoples R China; Fourth Peoples Hosp Wuxi, Wuxi 214062, Jiangsu, Peoples R China; [Chen, Zhen; Zhu, Yifei; Pan, Qiongxi; Liu, Yanjun; Jin, Jian; Ma, Xin] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan University	Ma, X (corresponding author), Jiangnan Univ, Sch Pharmaceut Sci, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China.	maxin@jiangnan.edu.cn; huadong@csco.org.cn	Ma, Xin/G-1297-2013; liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; 刘, 严君/GZL-5764-2022		Natural Science Foundation for Distinguished Young Scholars of Jiangsu Province [BK20140004]; National High Technology Research and Development Program of China [SQ2015AA0201349]; Program for New Century Excellent Talents in University of The Ministry of Education of China [NCET-12-0880]; National Natural Science Foundation of China [81100185, 91439131, 81273437]; Fundamental Research Funds for the Central Universities [JUSRP51311A]; Jiangsu Province National Natural Science Foundation [BK2010161]; Jiangsu Province Clinical Medical Science and Technology Specialized Research Fund Grant [BL2014019]; scientific and technological development funds from Wuxi science and technology bureau [CSE31N1419]; Strategic Priority Research Program from the Chinese Academy of Sciences [XDA01040000]	Natural Science Foundation for Distinguished Young Scholars of Jiangsu Province; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University of The Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Province National Natural Science Foundation; Jiangsu Province Clinical Medical Science and Technology Specialized Research Fund Grant; scientific and technological development funds from Wuxi science and technology bureau; Strategic Priority Research Program from the Chinese Academy of Sciences	This work was supported by the Natural Science Foundation for Distinguished Young Scholars of Jiangsu Province BK20140004 (to X. M.); the National High Technology Research and Development Program of China SQ2015AA0201349 (863 Program; to X. M.); the Program for New Century Excellent Talents in University of The Ministry of Education of China NCET-12-0880 (to X. M.); National Natural Science Foundation of China Grants 81100185, 91439131 (to X. M.) and 81273437 (to J. J.); Fundamental Research Funds for the Central Universities Grant JUSRP51311A (to X. M. and J. J.), Jiangsu Province National Natural Science Foundation Grant BK2010161 (to D. H.), Jiangsu Province Clinical Medical Science and Technology Specialized Research Fund Grant BL2014019 (to D. H.), scientific and technological development funds from Wuxi science and technology bureau CSE31N1419 (to T. W.), and Strategic Priority Research Program Grant XDA01040000 from the Chinese Academy of Sciences (to J. J.).	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Bomben VC, 2008, CELL PROLIFERAT, V41, P98, DOI 10.1111/j.1365-2184.2007.00504.x; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Chikazawa N, 2010, ANTICANCER RES, V30, P2041; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Goda K, 2009, CURR CANCER DRUG TAR, V9, P281, DOI 10.2174/156800909788166493; Gomez-Sintes R, 2010, J CLIN INVEST, V120, P2432, DOI 10.1172/JCI37873; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Han Ying, 2005, Chin J Dig Dis, V6, P82, DOI 10.1111/j.1443-9573.2005.00197.x; Hiani YEL, 2009, CELL PHYSIOL BIOCHEM, V23, P335, DOI 10.1159/000218179; Hiendlmeyer E, 2004, CANCER RES, V64, P1209, DOI 10.1158/0008-5472.CAN-3627-2; Janikova M, 2012, NEOPLASMA, V59, P6, DOI 10.4149/neo_2012_002; Jiang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067637; Komoto C, 2007, KOBE J MED SCI, V53, P355; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lehen'kyi V, 2011, ADV EXP MED BIOL, V704, P929, DOI 10.1007/978-94-007-0265-3_48; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Ma X, 2014, P NATL ACAD SCI USA, V111, P6389, DOI 10.1073/pnas.1400272111; Ma X, 2012, P NATL ACAD SCI USA, V109, P16282, DOI 10.1073/pnas.1202989109; McEwen DG, 2000, CURR BIOL, V10, pR562, DOI 10.1016/S0960-9822(00)00611-4; Molnar J, 2010, CURR TOP MED CHEM, V10, P1757; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Pla AF, 2012, AM J PHYSIOL-CELL PH, V302, pC9, DOI 10.1152/ajpcell.00280.2011; Riganti C, 2009, TOXICOL APPL PHARM, V240, P385, DOI 10.1016/j.taap.2009.07.026; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Shen DY, 2013, CANCER SCI, V104, P1303, DOI 10.1111/cas.12223; Shtil AA, 2005, INT REV CYTOL, V246, P1, DOI 10.1016/S0074-7696(05)46001-5; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Thrasivoulou C, 2013, J BIOL CHEM, V288, P35651, DOI 10.1074/jbc.M112.437913; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Vennekens R, 2012, REV PHYSIOL BIOCH P, V163, P27, DOI 10.1007/112_2012_8; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yamada T, 2000, CANCER RES, V60, P4761; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yu ZW, 2004, WORLD J GASTROENTERO, V10, P1979; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	44	61	66	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					448	456		10.1074/jbc.M114.590364	http://dx.doi.org/10.1074/jbc.M114.590364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404731	hybrid, Green Published			2022-12-26	WOS:000347231200039
J	Aregawi, M; Lynch, M; Bekele, W; Kebede, H; Jima, D; Taffese, HS; Yenehun, MA; Lilay, A; Williams, R; Thomson, M; Nafo-Traore, F; Admasu, K; Gebreyesus, TA; Coosemans, M				Aregawi, Maru; Lynch, Michael; Bekele, Worku; Kebede, Henok; Jima, Daddi; Taffese, Hiwot Solomon; Yenehun, Meseret Aseffa; Lilay, Abraham; Williams, Ryan; Thomson, Madeleine; Nafo-Traore, Fatoumata; Admasu, Kesetebirhan; Gebreyesus, Tedros Adhanom; Coosemans, Marc			Time Series Analysis of Trends in Malaria Cases and Deaths at Hospitals and the Effect of Antimalarial Interventions, 2001-2011, Ethiopia	PLOS ONE			English	Article							SCALE-UP	Background: The Government of Ethiopia and its partners have deployed artemisinin-based combination therapies (ACT) since 2004 and long-lasting insecticidal nets (LLINs) since 2005. Malaria interventions and trends in malaria cases and deaths were assessed at hospitals in malaria transmission areas during 2001-2011. Methods: Regional LLINs distribution records were used to estimate the proportion of the population-at-risk protected by LLINs. Hospital records were reviewed to estimate ACT availability. Time-series analysis was applied to data from 41 hospitals in malaria risk areas to assess trends of malaria cases and deaths during pre-intervention (2001-2005) and post-interventions (2006-2011) periods. Findings: The proportion of the population-at-risk potentially protected by LLINs increased to 51% in 2011. The proportion of facilities with ACTs in stock exceeded 87% during 2006-2011. Among all ages, confirmed malaria cases in 2011 declined by 66% (95% confidence interval [CI], 44-79%) and SPR by 37% (CI, 20%-51%) compared to the level predicted by preintervention trends. In children under 5 years of age, malaria admissions and deaths fell by 81% (CI, 47%-94%) and 73% (CI, 48%-86%) respectively. Optimal breakpoint of the trendlines occurred between January and June 2006, consistent with the timing of malaria interventions. Over the same period, non-malaria cases and deaths either increased or remained unchanged, the number of malaria diagnostic tests performed reflected the decline in malaria cases, and rainfall remained at levels supportive of malaria transmission. Conclusions: Malaria cases and deaths in Ethiopian hospitals decreased substantially during 2006-2011 in conjunction with scale-up of malaria interventions. The decrease could not be accounted for by changes in hospital visits, malaria diagnostic testing or rainfall. However, given the history of variable malaria transmission in Ethiopia, more data would be required to	[Aregawi, Maru; Lynch, Michael; Williams, Ryan] WHO, Global Malaria Program, CH-1211 Geneva, Switzerland; [Bekele, Worku; Kebede, Henok; Nafo-Traore, Fatoumata] WHO, Country Off, Addis Ababa, Ethiopia; [Jima, Daddi; Taffese, Hiwot Solomon; Yenehun, Meseret Aseffa; Lilay, Abraham; Admasu, Kesetebirhan; Gebreyesus, Tedros Adhanom] Fed Minist Hlth, Addis Ababa, Ethiopia; [Thomson, Madeleine] Columbia Univ, Earth Inst, Int Res Inst Climate & Soc IRI, New York, NY USA; [Coosemans, Marc] Inst Trop Med, B-2000 Antwerp, Belgium	World Health Organization; World Health Organization; Federal Ministry of Health - Ethiopia (FMOH); Columbia University; Institute of Tropical Medicine (ITM)	Aregawi, M (corresponding author), WHO, Global Malaria Program, CH-1211 Geneva, Switzerland.	aregawim@who.int			International Research Institute for Climate and Society, Columbia University, New York, USA; analysing spatial and temporal climate data for Ethiopia; National Meteorological Agency of Ethiopia	International Research Institute for Climate and Society, Columbia University, New York, USA; analysing spatial and temporal climate data for Ethiopia; National Meteorological Agency of Ethiopia	We thank Ministry of Health of the Federal Government of Ethiopia and the health staff who were involved in data collection and supervision. We also thank the Global Fund for availing resources for this study. We are grateful to the support provided by the International Research Institute for Climate and Society, Columbia University, New York, USA, in compiling and analysing spatial and temporal climate data for Ethiopia and to the National Meteorological Agency of Ethiopia for availing meteorological data mainly Enhanced National Climate Services (ENACTS) rainfall data aggregated for five major regions of the country. We thank Mehran Hosseini and John Aponte for their critical review and suggestion on the statistical methods. We thank Richard Cibulskis, Robert Newman, Umberto D'Alessandro and Christopher Dye for their critical review.	[Anonymous], 2007, RMRSGTR189 USDA FOR; [Anonymous], 2011, ETHIOPIA DEMOGRAPHIC, P452; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Checchi F, 2006, EMERGING INFECT DIS, V12; Connor S., 2011, WMO B, V60; FONTAINE RE, 1961, AM J TROP MED HYG, V10, P795, DOI 10.4269/ajtmh.1961.10.795; Hodrick RJ, 1997, J MONEY CREDIT BANK, V29, P1, DOI 10.2307/2953682; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Ministry of Health of the Federal Democratic Republic of Ethiopia, 2004, MAL DIAGN TREATM GUI; Negash K, 2006, E AFR MED J, V82, P186; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Teklehaimanot HD, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-39; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; Thomson M, 2003, LANCET, V362, P580, DOI 10.1016/S0140-6736(03)14135-9; UN (Unites Nations), 2013, WORLD POP PROSP; United Nations, 2011, WORLD POP PROSP; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization-Geneva Switzerland, 2012, GLOB MAL DIS SRUV MA; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	24	57	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e106359	10.1371/journal.pone.0106359	http://dx.doi.org/10.1371/journal.pone.0106359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406083	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300002
J	Kendrick, BJ; DiTullio, GR; Cyronak, TJ; Fulton, JM; Van Mooy, BAS; Bidle, KD				Kendrick, B. Jacob; DiTullio, Giacomo R.; Cyronak, Tyler J.; Fulton, James M.; Van Mooy, Benjamin A. S.; Bidle, Kay D.			Temperature-Induced Viral Resistance in Emiliania huxleyi (Prymnesiophyceae)	PLOS ONE			English	Article							C-TYPE LECTINS; DIMETHYL SULFIDE; MARINE VIRUSES; ALGAL VIRUS; CELL-DEATH; DIMETHYLSULFONIOPROPIONATE; DMSP; COCCOLITHOPHORE; INFECTION; PHYTOPLANKTON	Annual Emiliania huxleyi blooms (along with other coccolithophorid species) play important roles in the global carbon and sulfur cycles. E. huxleyi blooms are routinely terminated by large, host-specific dsDNA viruses, (Emiliania huxleyi Viruses; EhVs), making these host-virus interactions a driving force behind their potential impact on global biogeochemical cycles. Given projected increases in sea surface temperature due to climate change, it is imperative to understand the effects of temperature on E. huxleyi's susceptibility to viral infection and its production of climatically active dimethylated sulfur species (DSS). Here we demonstrate that a 3 degrees C increase in temperature induces EhV-resistant phenotypes in three E. huxleyi strains and that successful virus infection impacts DSS pool sizes. We also examined cellular polar lipids, given their documented roles in regulating host-virus interactions in this system, and propose that alterations to membrane-bound surface receptors are responsible for the observed temperature-induced resistance. Our findings have potential implications for global biogeochemical cycles in a warming climate and for deciphering the particular mechanism(s) by which some E. huxleyi strains exhibit viral resistance.	[Kendrick, B. Jacob; DiTullio, Giacomo R.; Cyronak, Tyler J.] Coll Charleston, Grice Marine Lab, Charleston, SC 29401 USA; [Fulton, James M.; Van Mooy, Benjamin A. S.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Bidle, Kay D.] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, New Brunswick, NJ 08903 USA	College of Charleston; Woods Hole Oceanographic Institution; Rutgers State University New Brunswick	Kendrick, BJ (corresponding author), Coll Charleston, Grice Marine Lab, Charleston, SC 29401 USA.	jacobkendrick@gmail.com		Fulton, James/0000-0001-7213-8015; Cyronak, Tyler/0000-0003-3556-7616	National Science Foundation [OCE-1061883, OCE-1061876]; Gordon and Betty Moore Foundation; Division Of Ocean Sciences [1061883] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by funding from the National Science Foundation (OCE-1061883 to KDB, BVM, and OCE-1061876 to GRD) and in part by grants from The Gordon and Betty Moore Foundation (to BVM and KDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYERS GP, 1991, NATURE, V349, P404, DOI 10.1038/349404a0; Bell MV, 1996, PHYTOCHEMISTRY, V41, P465, DOI 10.1016/0031-9422(95)00663-X; BERGE GRIM, 1962, SARSIA, V6, P27; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Bidle KD, 2011, CURR OPIN MICROBIOL, V14, P449, DOI 10.1016/j.mib.2011.07.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bratbak G, 1995, MAR ECOL PROG SER, V128, P133, DOI 10.3354/meps128133; Bratbak G, 1996, J MARINE SYST, V9, P75, DOI 10.1016/0924-7963(96)00018-8; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; DITULLIO GR, 1995, DEEP-SEA RES PT I, V42, P873, DOI 10.1016/0967-0637(95)00051-7; Edenhofer O., 2014, CONTRIBUTION WORKING; Eichenberger W, 1997, PHYTOCHEMISTRY, V45, P1561, DOI 10.1016/S0031-9422(97)00201-X; Evans C, 2008, LIMNOL OCEANOGR, V53, P2035, DOI 10.4319/lo.2008.53.5.2035; Evans C, 2007, LIMNOL OCEANOGR, V52, P1036, DOI 10.4319/lo.2007.52.3.1036; Evans C, 2006, LIMNOL OCEANOGR, V51, P2468, DOI 10.4319/lo.2006.51.5.2468; Evans C, 2006, J PHYCOL, V42, P1040, DOI 10.1111/j.1529-8817.2006.00256.x; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Frada MJ, 2012, ENVIRON MICROBIOL, V14, P1558, DOI 10.1111/j.1462-2920.2012.02745.x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fulton JM, 2014, ENVIRON MICROBIOL, V16, P1137, DOI 10.1111/1462-2920.12358; Goss R, 2009, ADV PHOTOSYNTH RESP, V30, P117; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hill RW, 1998, AQUAT MICROB ECOL, V14, P1, DOI 10.3354/ame014001; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Jacquet S, 2002, AQUAT MICROB ECOL, V27, P111, DOI 10.3354/ame027111; Kegel JU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080684; Keller MD, 1989, ACS SYM SER, P167, DOI 10.1021/bk-1989-0393.ch011; KIENE RP, 1990, NATURE, V345, P702, DOI 10.1038/345702a0; Lehahn Y, 2014, CURR BIOL, V24, P2041, DOI 10.1016/j.cub.2014.07.046; Mackinder LCM, 2009, J GEN VIROL, V90, P2306, DOI 10.1099/vir.0.011635-0; Malin G, 1998, LIMNOL OCEANOGR, V43, P1389, DOI 10.4319/lo.1998.43.6.1389; MANSKY LM, 1991, PHYTOPATHOLOGY, V81, P535, DOI 10.1094/Phyto-81-535; Nagasaki K, 1998, AQUAT MICROB ECOL, V15, P211, DOI 10.3354/ame015211; Neilan JG, 1999, J GEN VIROL, V80, P2693, DOI 10.1099/0022-1317-80-10-2693; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Pagarete A, 2009, ENVIRON MICROBIOL, V11, P2840, DOI 10.1111/j.1462-2920.2009.02006.x; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Popendorf KJ, 2013, LIPIDS, V48, P185, DOI 10.1007/s11745-012-3748-0; Riekhof WR, 2005, ARCH BIOCHEM BIOPHYS, V441, P96, DOI 10.1016/j.abb.2005.07.001; Riseman SF, 2004, CAN J FISH AQUAT SCI, V61, P721, DOI 10.1139/F04-052; Rose SL, 2014, ENVIRON MICROBIOL, V16, P1150, DOI 10.1111/1462-2920.12357; Sanabria Natasha M, 2010, Self Nonself, V1, P40; SATO N, 1992, BOT MAG TOKYO, V105, P185, DOI 10.1007/BF02489414; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; Silva NF, 2002, PLANT MOL BIOL, V50, P667, DOI 10.1023/A:1019951120788; Spiese CE, 2009, LIMNOL OCEANOGR, V54, P560, DOI 10.4319/lo.2009.54.2.0560; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Suzuki T, 2006, BIOL PHARM BULL, V29, P1538, DOI 10.1248/bpb.29.1538; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; SYLLER J, 1991, J PHYTOPATHOL, V133, P216, DOI 10.1111/j.1439-0434.1991.tb00156.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Tyrrell T, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P75; Van Mooy BAS, 2010, GEOCHIM COSMOCHIM AC, V74, P6499, DOI 10.1016/j.gca.2010.08.026; van Rijssel M, 2002, J SEA RES, V48, P17, DOI 10.1016/S1385-1101(02)00134-X; Vardi A, 2012, P NATL ACAD SCI USA, V109, P19327, DOI 10.1073/pnas.1208895109; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Wilson WH, 2002, DEEP-SEA RES PT II, V49, P2951, DOI 10.1016/S0967-0645(02)00065-6; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109	66	20	20	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112134	10.1371/journal.pone.0112134	http://dx.doi.org/10.1371/journal.pone.0112134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405345	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300024
J	Staes, N; Stevens, JMG; Helsen, P; Hillyer, M; Korody, M; Eens, M				Staes, Nicky; Stevens, Jeroen M. G.; Helsen, Philippe; Hillyer, Mia; Korody, Marisa; Eens, Marcel			Oxytocin and Vasopressin Receptor Gene Variation as a Proximate Base for Inter- and Intraspecific Behavioral Differences in Bonobos and Chimpanzees	PLOS ONE			English	Article							PAN-TROGLODYTES; WILD CHIMPANZEES; SOCIAL-BEHAVIOR; RELATIONSHIP QUALITY; DICTATOR GAME; OXTR GENE; ASSOCIATION; MICROSATELLITE; DOMINANCE; PANISCUS	Recent literature has revealed the importance of variation in neuropeptide receptor gene sequences in the regulation of behavioral phenotypic variation. Here we focus on polymorphisms in the oxytocin receptor gene (OXTR) and vasopressin receptor gene 1a (Avpr1a) in chimpanzees and bonobos. In humans, a single nucleotide polymorphism (SNP) in the third intron of OXTR (rs53576 SNP (A/G)) is linked with social behavior, with the risk allele (A) carriers showing reduced levels of empathy and prosociality. Bonobos and chimpanzees differ in these same traits, therefore we hypothesized that these differences might be reflected in variation at the rs53576 position. We sequenced a 320 bp region surrounding rs53576 but found no indications of this SNP in the genus Pan. However, we identified previously unreported SNP variation in the chimpanzee OXTR sequence that differs from both humans and bonobos. Humans and bonobos have previously been shown to have a more similar 59 promoter region of Avpr1a when compared to chimpanzees, who are polymorphic for the deletion of,360 bp in this region (+/- DupB) which includes a microsatellite (RS3). RS3 has been linked with variation in levels of social bonding, potentially explaining part of the interspecies behavioral differences found in bonobos, chimpanzees and humans. To date, results for bonobos have been based on small sample sizes. Our results confirmed that there is no DupB deletion in bonobos with a sample size comprising approximately 90% of the captive founder population, whereas in chimpanzees the deletion of DupB had the highest frequency. Because of the higher frequency of DupB alleles in our bonobo population, we suggest that the presence of this microsatellite may partly reflect documented differences in levels of sociability found in bonobos and chimpanzees.	[Staes, Nicky; Stevens, Jeroen M. G.; Helsen, Philippe; Eens, Marcel] Univ Antwerp, Dept Biol, Ethol Res Grp, B-2610 Antwerp, Belgium; [Staes, Nicky; Stevens, Jeroen M. G.; Helsen, Philippe; Hillyer, Mia] Royal Zool Soc Antwerp, Ctr Res & Conservat, B-2018 Antwerp, Belgium; [Korody, Marisa] San Diego Zoo Inst Conservat Res, Escondido, CA 92027 USA; [Hillyer, Mia] Western Australian Museum, Mol Systemat Unit, Perth, WA 6106, Australia	University of Antwerp; Zoological Society of San Diego; Western Australian Museum	Staes, N (corresponding author), Univ Antwerp, Dept Biol, Ethol Res Grp, B-2610 Antwerp, Belgium.	Nicky.Staes@kmda.org	Helsen, Philippe/K-8660-2018; Eens, Marcel/AAC-8466-2020; Staes, Nicky/AAD-4317-2019	Staes, Nicky/0000-0002-5444-4470	Flemish government	Flemish government(European Commission)	Funds for this study come from the Flemish government, who provides structural support of the CRC of the RSZA, FWO Flanders and the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anestis SF, 2014, INT J PRIMATOL, V35, P305, DOI 10.1007/s10764-013-9747-z; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch Christophe, 2002, BEHAV DIVERSITY CHIM; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Carlsen F., 2012, EUROPEAN STUDBOOK CH; Costa B, 2009, PSYCHONEUROENDOCRINO, V34, P1506, DOI 10.1016/j.psyneuen.2009.05.006; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; Donaldson ZR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003729; Donaldson ZR, 2008, BMC EVOLUTIONARY BIO, V8, P180; Doran M.D., 2002, BEHAV DIVERSITY CHIM; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Fraser ON, 2008, ETHOLOGY, V114, P834, DOI 10.1111/j.1439-0310.2008.01527.x; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Gilby IC, 2010, J HUM EVOL, V59, P44, DOI 10.1016/j.jhevol.2010.02.006; Gomes CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005116; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hammock EAD, 2005, GENES BRAIN BEHAV, V4, P289, DOI 10.1111/j.1601-183X.2005.00119.x; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Hare B, 2010, CURR BIOL, V20, pR230, DOI 10.1016/j.cub.2009.12.038; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Hohmann G, 1999, BEHAVIOUR, V136, P1219, DOI 10.1163/156853999501739; Hong KW, 2009, J NEURAL TRANSM, V116, P535, DOI 10.1007/s00702-009-0219-8; Hopkins WD, 2012, GENES BRAIN BEHAV, V11, P552, DOI 10.1111/j.1601-183X.2012.00799.x; Hopkins WD, 2014, SCI REP-UK, V4, DOI 10.1038/srep03774; Idani G., 1990, African Study Monographs, V11, P153; Insel TR, 2000, CURR OPIN NEUROBIOL, V10, P784, DOI 10.1016/S0959-4388(00)00146-X; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; Kano T., 1992, LAST APE PYGMY CHIMP; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Koski SE, 2012, INT J PRIMATOL, V33, P905, DOI 10.1007/s10764-012-9623-2; KURODA S, 1980, Primates, V21, P181, DOI 10.1007/BF02374032; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Langergraber KE, 2013, BEHAV ECOL SOCIOBIOL, V67, P861, DOI 10.1007/s00265-013-1509-6; Lehmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P525, DOI 10.1007/s00265-004-0891-5; Lehmann J, 2008, INT J PRIMATOL, V29, P65, DOI 10.1007/s10764-007-9230-9; Lehmann J, 2009, ANIM BEHAV, V77, P377, DOI 10.1016/j.anbehav.2008.09.038; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; Machanda ZP, 2013, INT J PRIMATOL, V34, P917, DOI 10.1007/s10764-013-9707-7; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matsumoto-Oda A, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P168, DOI 10.1017/CBO9780511606397.017; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; Newton-Fisher NE, 2006, INT J PRIMATOL, V27, P1589, DOI 10.1007/s10764-006-9087-3; Newton-Fisher NE, 2014, BIOL REV, V89, P356, DOI 10.1111/brv.12058; Newton-Fisher NE, 2010, AM J PHYS ANTHROPOL, V142, P417, DOI 10.1002/ajpa.21241; Ophir AG, 2008, HORM BEHAV, V54, P694, DOI 10.1016/j.yhbeh.2008.07.009; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Paoli T, 2006, AM J PRIMATOL, V68, P333, DOI 10.1002/ajp.20228; Parish AR, 1996, HUM NATURE-INT BIOS, V7, P61, DOI 10.1007/BF02733490; Parish AR, 2000, ANN NY ACAD SCI, V907, P97; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Reinartz GE, 1997, THESIS U WISCONSIN M THESIS U WISCONSIN M; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Robinson GE, 2004, SCIENCE, V304, P397, DOI 10.1126/science.1095766; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rosso L, 2008, BIOL LETTERS, V4, P375, DOI 10.1098/rsbl.2008.0122; Sala M, 2013, J NEUROENDOCRINOL, V25, P107, DOI 10.1111/j.1365-2826.2012.02385.x; Seo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076960; Stanford CB, 1998, CURR ANTHROPOL, V39, P399, DOI 10.1086/204757; Stevens JMG, 2006, PRIMATES, V47, P210, DOI 10.1007/s10329-005-0177-1; Stumpf R, 2007, PRIMATES PERSPECTIVE, P321; SUGIYAMA Y, 1988, INT J PRIMATOL, V9, P393, DOI 10.1007/BF02736216; Surbeck M, 2012, ANIM BEHAV, V83, P659, DOI 10.1016/j.anbehav.2011.12.010; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; Tansey KE, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-3; Thomas MA, 2004, TRENDS ECOL EVOL, V19, P439, DOI 10.1016/j.tree.2004.06.010; Thompson RJ, 2011, PSYCHONEUROENDOCRINO, V36, P144, DOI 10.1016/j.psyneuen.2010.07.003; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Vervaecke H, 2000, INT J PRIMATOL, V21, P47, DOI 10.1023/A:1005471512788; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Walum H, 2012, BIOL PSYCHIAT, V71, P419, DOI 10.1016/j.biopsych.2011.09.002; Wang JP, 2013, NEUROIMAGE, V81, P199, DOI 10.1016/j.neuroimage.2013.05.029; White Frances J., 1996, P29, DOI 10.1017/CBO9780511752414.005; Williams JM, 2002, ANIM BEHAV, V63, P347, DOI 10.1006/anbe.2001.1916; Wingender E, 1997, NUCLEIC ACIDS RES, V25, P265, DOI 10.1093/nar/25.1.265; Wittig RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3096; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young WS, 2003, NEUROENDOCRINOLOGY, V78, P185, DOI 10.1159/000073702	93	35	36	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113364	10.1371/journal.pone.0113364	http://dx.doi.org/10.1371/journal.pone.0113364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405348	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300108
J	te Beest, D; de Bruin, E; Imholz, S; Wallinga, J; Teunis, P; Koopmans, M; van Boven, M				te Beest, Dennis; de Bruin, Erwin; Imholz, Sandra; Wallinga, Jacco; Teunis, Peter; Koopmans, Marion; van Boven, Michiel			Discrimination of Influenza Infection (A/2009 H1N1) from Prior Exposure by Antibody Protein Microarray Analysis	PLOS ONE			English	Article							VIRUS; RESPONSES	Reliable discrimination of recent influenza A infection from previous exposure using hemagglutination inhibition (HI) or virus neutralization tests is currently not feasible. This is due to low sensitivity of the tests and the interference of antibody responses generated by previous infections. Here we investigate the diagnostic characteristics of a newly developed antibody (HA1) protein microarray using data from cross-sectional serological studies carried out before and after the pandemic of 2009. The data are analysed by mixture models, providing a probabilistic classification of sera (susceptible, prior-exposed, recently infected). Estimated sensitivity and specificity for identifying A/2009 infections are low using HI (66% and 51%), and high when using A/2009 microarray data alone or together with A/1918 microarray data (96% and 95%). As a heuristic, a high A/2009 to A/1918 antibody ratio (>1.05) is indicative of recent infection, while a low ratio is indicative of a pre-existing response, even if the A/2009 titer is high. We conclude that highly sensitive and specific classification of individual sera is possible using the protein microarray, thereby enabling precise estimation of age-specific infection attack rates in the population even if sample sizes are small.	[te Beest, Dennis; de Bruin, Erwin; Wallinga, Jacco; Teunis, Peter; Koopmans, Marion; van Boven, Michiel] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Imholz, Sandra] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands; [Teunis, Peter] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Emory University; Rollins School Public Health; Erasmus University Rotterdam; Erasmus MC	van Boven, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	michiel.van.boven@rivm.nl	Wallinga, Jacco/C-4382-2018	Wallinga, Jacco/0000-0003-1725-5627; te Beest, Dennis E./0000-0001-5265-9008	National Institute for Public Health; Environment project [S/210096]	National Institute for Public Health; Environment project	This work was supported by the National Institute for Public Health and the Environment project S/210096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas DC, 2013, J MED VIROL, V85, P899, DOI 10.1002/jmv.23535; Boni M. F., 2013, J INFECT DIS; Gilks WR, 1996, MARKOV CHAIN MONTE C; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x; Huijskens EGW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054890; Kerkhove MD, 2013, INFLUENZA OTHER RESP; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; MCDONALD S, UNPUB; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; Teunis PFM, 2009, VET PARASITOL, V159, P345, DOI 10.1016/j.vetpar.2008.10.071; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	16	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113021	10.1371/journal.pone.0113021	http://dx.doi.org/10.1371/journal.pone.0113021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405997	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300071
J	Ferreira, AS; Costa, P; Rocha, T; Amaro, A; Vieira, ML; Ahmed, A; Thompson, G; Hartskeerl, RA; Inacio, J				Ferreira, Ana Sofia; Costa, Pedro; Rocha, Teresa; Amaro, Ana; Vieira, Maria Luisa; Ahmed, Ahmed; Thompson, Gertrude; Hartskeerl, Rudy A.; Inacio, Joao			Direct Detection and Differentiation of Pathogenic Leptospira Species Using a Multi-Gene Targeted Real Time PCR Approach	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; QUANTITATIVE PCR; KIDNEY TISSUE; TAQMAN ASSAY; SPP.; DIAGNOSIS; PORTUGAL; URINE; IDENTIFICATION; ASSOCIATION	Leptospirosis is a growing public and veterinary health concern caused by pathogenic species of Leptospira. Rapid and reliable laboratory tests for the direct detection of leptospiral infections in animals are in high demand not only to improve diagnosis but also for understanding the epidemiology of the disease. In this work we describe a novel and simple TaqMan-based multi-gene targeted real-time PCR approach able to detect and differentiate Leptospira interrogans, L. kirschneri, L. borgpeteresenii and L. noguchii, which constitute the veterinary most relevant pathogenic species of Leptospira. The method uses sets of species-specific probes, and respective flanking primers, designed from ompL1 and secY gene sequences. To monitor the presence of inhibitors, a duplex amplification assay targeting both the mammal beta-actin and the leptospiral lipL32 genes was implemented. The analytical sensitivity of all primer and probe sets was estimated to be,10 genome equivalents (GE) in the reaction mixture. Application of the amplification reactions on genomic DNA from a variety of pathogenic and non-pathogenic Leptospira strains and other non-related bacteria revealed a 100% analytical specificity. Additionally, pathogenic leptospires were successfully detected in five out of 29 tissue samples from animals (Mus spp., Rattus spp., Dolichotis patagonum and Sus domesticus). Two samples were infected with L. borgpetersenii, two with L. interrogans and one with L. kirschneri. The possibility to detect and identify these pathogenic agents to the species level in domestic and wildlife animals reinforces the diagnostic information and will enhance our understanding of the epidemiology of leptopirosis.	[Ferreira, Ana Sofia; Costa, Pedro; Rocha, Teresa; Amaro, Ana; Inacio, Joao] Inst Nacl Invest Agr & Vet IP, Unidade Estrateg Invest, Lisbon, Portugal; [Ferreira, Ana Sofia; Costa, Pedro; Rocha, Teresa; Amaro, Ana; Inacio, Joao] Inst Nacl Invest Agr & Vet IP, Serv Prod & Saude Anim, Lisbon, Portugal; [Ferreira, Ana Sofia; Thompson, Gertrude] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Costa, Pedro; Vieira, Maria Luisa] Univ Nova Lisboa, Unidade Microbiol Med, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Thompson, Gertrude] Univ Porto, Res Ctr Biodivers & Genet Resources CIBIO ICETA, P-4100 Oporto, Portugal; [Ahmed, Ahmed; Hartskeerl, Rudy A.] KIT Biomed Res, WHO FAO OIE, Amsterdam, Netherlands; [Ahmed, Ahmed; Hartskeerl, Rudy A.] KIT Biomed Res, Natl Collaborating Ctr Reference & Res Leptospiro, Amsterdam, Netherlands; [Inacio, Joao] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England	Universidade do Porto; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade do Porto; Food & Agriculture Organization of the United Nations (FAO); University of Brighton	Ferreira, AS (corresponding author), Inst Nacl Invest Agr & Vet IP, Unidade Estrateg Invest, Lisbon, Portugal.	ana.ferreira@iniav.pt; j.inacio@brighton.ac.uk	Inacio, Joao/D-5762-2011; Vieira, Maria Luísa/B-3310-2008; Ferreira, AnaS/O-6745-2019; Thompson, Gertrude/C-3133-2014	Inacio, Joao/0000-0001-7367-5007; Vieira, Maria Luísa/0000-0002-8586-5534; Ferreira, AnaS/0000-0001-7222-9101; Amaro, Ana/0000-0002-5139-3268; Thompson, Gertrude/0000-0002-3939-5762	FCT [SFRH/BD/64136/2009, SFRH/BD/62317/2009]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Ana Sofia Ferreira and Pedro Costa are recipients of PhD grants from FCT (www.fct.pt) (SFRH/BD/64136/2009 and SFRH/BD/62317/2009, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035; Ahmed A, 2012, ADV MICROBIOL, V2, P162, DOI DOI 10.4236/AIM.2012.22021>; Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Boqvist S, 2003, VET MICROBIOL, V93, P361, DOI 10.1016/S0378-1135(03)00042-7; Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; Costa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081337; Cox TE, 2005, J WILDLIFE DIS, V41, P753, DOI 10.7589/0090-3558-41.4.753; Dupouey J, 2014, COMP IMMUNOL MICROB, V37, P77, DOI 10.1016/j.cimid.2013.12.002; Fearnley C, 2008, RES VET SCI, V85, P8, DOI 10.1016/j.rvsc.2007.09.005; Fornazari F, 2012, J MICROBIOL METH, V90, P321, DOI 10.1016/j.mimet.2012.06.005; Foronda P, 2011, EMERG INFECT DIS, V17, P1781, DOI 10.3201/eid1709.101470; Grooms DL, 2005, VET CLIN N AM-FOOD A, V21, P463, DOI 10.1016/j.cvfa.2005.02.010; Latifah I, 2012, Malays J Pathol, V34, P157; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Levieuge A, 2010, REV MED VET-TOULOUSE, V161, P264; Lilenbaum W, 2009, RES VET SCI, V87, P16, DOI 10.1016/j.rvsc.2008.12.014; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; OIE, 2008, MANUAL DIAGNOSTIC TE; Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Bomfim MRQ, 2008, VET J, V178, P251, DOI 10.1016/j.tvjl.2007.07.029; ROCHA T, 1990, VET REC, V126, P602; Rocha T, 1998, REV SCI TECH OIE, V17, P699, DOI 10.20506/rst.17.3.1128; Rojas P, 2010, EUR J CLIN MICROBIOL, V29, P1305, DOI 10.1007/s10096-010-0991-2; Saito M, 2013, INT J SYST EVOL MICR, V63, P2457, DOI 10.1099/ijs.0.047233-0; Slack A, 2007, DIAGN MICR INFEC DIS, V57, P361, DOI 10.1016/j.diagmicrobio.2006.10.004; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Subharat S, 2011, J VET DIAGN INVEST, V23, P743, DOI 10.1177/1040638711407892; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Vieira ML, 2006, INT J INFECT DIS, V10, P378, DOI 10.1016/j.ijid.2005.07.006; Villumsen S, 2012, J MICROBIOL METH, V91, P184, DOI 10.1016/j.mimet.2012.06.009	37	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112312	10.1371/journal.pone.0112312	http://dx.doi.org/10.1371/journal.pone.0112312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398140	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500046
J	Irish, M; Hornberger, M; El Wahsh, S; Lam, BYK; Lah, S; Miller, L; Hsieh, S; Hodges, JR; Piguet, O				Irish, Muireann; Hornberger, Michael; El Wahsh, Shadi; Lam, Bonnie Y. K.; Lah, Suncica; Miller, Laurie; Hsieh, Sharpley; Hodges, John R.; Piguet, Olivier			Grey and White Matter Correlates of Recent and Remote Autobiographical Memory Retrieval - Insights from the Dementias	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MEDIAL TEMPORAL-LOBE; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; SEMANTIC MEMORY; FUNCTIONAL NEUROANATOMY; HIPPOCAMPAL ACTIVATION; BEHAVIORAL-VARIANT; RETROGRADE-AMNESIA; EPISODIC MEMORY	The capacity to remember self-referential past events relies on the integrity of a distributed neural network. Controversy exists, however, regarding the involvement of specific brain structures for the retrieval of recently experienced versus more distant events. Here, we explored how characteristic patterns of atrophy in neurodegenerative disorders differentially disrupt remote versus recent autobiographical memory. Eleven behavioural-variant frontotemporal dementia, 10 semantic dementia, 15 Alzheimer's disease patients and 14 healthy older Controls completed the Autobiographical Interview. All patient groups displayed significant remote memory impairments relative to Controls. Similarly, recent period retrieval was significantly compromised in behavioural-variant frontotemporal dementia and Alzheimer's disease, yet semantic dementia patients scored in line with Controls. Voxel-based morphometry and diffusion tensor imaging analyses, for all participants combined, were conducted to investigate grey and white matter correlates of remote and recent autobiographical memory retrieval. Neural correlates common to both recent and remote time periods were identified, including the hippocampus, medial prefrontal, and frontopolar cortices, and the forceps minor and left hippocampal portion of the cingulum bundle. Regions exclusively implicated in each time period were also identified. The integrity of the anterior temporal cortices was related to the retrieval of remote memories, whereas the posterior cingulate cortex emerged as a structure significantly associated with recent autobiographical memory retrieval. This study represents the first investigation of the grey and white matter correlates of remote and recent autobiographical memory retrieval in neurodegenerative disorders. Our findings demonstrate the importance of core brain structures, including the medial prefrontal cortex and hippocampus, irrespective of time period, and point towards the contribution of discrete regions in mediating successful retrieval of distant versus recently experienced events.	[Irish, Muireann] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Irish, Muireann; Hornberger, Michael; El Wahsh, Shadi; Lam, Bonnie Y. K.; Hsieh, Sharpley; Hodges, John R.; Piguet, Olivier] Neurosci Res Australia, Sydney, NSW, Australia; [Hornberger, Michael; El Wahsh, Shadi; Lam, Bonnie Y. K.; Hsieh, Sharpley; Hodges, John R.; Piguet, Olivier] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Irish, Muireann; El Wahsh, Shadi; Lah, Suncica; Miller, Laurie; Hsieh, Sharpley; Hodges, John R.; Piguet, Olivier] Australian Res Council, Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Miller, Laurie] Univ Sydney, Royal Prince Alfred Hosp, Neuropsychol Unit, Sydney, NSW 2006, Australia; [Miller, Laurie] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Hornberger, Michael] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; University of Cambridge	Irish, M (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	m.irish@neura.edu.au	Hornberger, Michael/C-9610-2011; Lam, Bonnie Yin Ka/J-7578-2016; Piguet, Olivier/C-9658-2011	Hornberger, Michael/0000-0002-2214-3788; Lam, Bonnie Yin Ka/0000-0002-1656-2433; Irish, Muireann/0000-0002-4950-8169; Lah, Suncica/0000-0003-2282-4812; Piguet, Olivier/0000-0002-6696-1440; Miller, Laurie/0000-0001-6329-2969	National Health and Medical Research Council (NHMRC) of Australia Project Grant [510106]; Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021]; ARC Discovery Project [DP10933279]; ARC Discovery Early Career Research Award [DE130100463]; University of Sydney Thompson Fellowship; NHMRC Career Development Fellowship [1022684]	National Health and Medical Research Council (NHMRC) of Australia Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders(Australian Research Council); ARC Discovery Project(Australian Research Council); ARC Discovery Early Career Research Award(Australian Research Council); University of Sydney Thompson Fellowship; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council (NHMRC) of Australia Project Grant [510106], the Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021], and an ARC Discovery Project [DP10933279]. MI is supported by an ARC Discovery Early Career Research Award [DE130100463]. SL is, in part, supported by the University of Sydney Thompson Fellowship. OP is supported by an NHMRC Career Development Fellowship [1022684]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2004, HIPPOCAMPUS, V14, P752, DOI 10.1002/hipo.10215; Andersson J.L.R., 2007, TR07JA1 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barnabe A, 2012, HIPPOCAMPUS, V22, P1809, DOI 10.1002/hipo.22015; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bonnici HM, 2012, J NEUROSCI, V32, P16982, DOI 10.1523/JNEUROSCI.2475-12.2012; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cermak L, 1984, EPISODIC SEMANTIC DI, P55; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Conway MA, 2004, SOC COGNITION, V22, P491, DOI 10.1521/soco.22.5.491.50768; Conway MA, 2001, PHILOS T R SOC B, V356, P1375, DOI 10.1098/rstb.2001.0940; Gilboa A, 2005, HIPPOCAMPUS, V15, P535, DOI 10.1002/hipo.20090; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Greenberg DL, 2010, J INT NEUROPSYCH SOC, V16, P748, DOI 10.1017/S1355617710000676; Greenberg DL, 2003, CORTEX, V39, P687, DOI 10.1016/S0010-9452(08)70860-8; Greene JDW, 1995, NEUROPSYCHOLOGIA, V33, P1647, DOI 10.1016/0028-3932(95)00046-1; Hodges JR, 2001, PHILOS T R SOC B, V356, P1423, DOI 10.1098/rstb.2001.0943; Irish M, 2011, NEUROPSYCHOLOGIA, V49, P2694, DOI 10.1016/j.neuropsychologia.2011.05.017; Irish M, 2014, HUM BRAIN MAPP, V35, P1422, DOI 10.1002/hbm.22263; Irish M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00027; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Irish M, 2012, NAT REV NEUROL, V8, P152, DOI 10.1038/nrneurol.2012.11; Irish M, 2011, CORTEX, V47, P236, DOI 10.1016/j.cortex.2010.01.002; Irish M, 2010, J INT NEUROPSYCH SOC, V16, P546, DOI 10.1017/S1355617710000172; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Keppel G., 2004, DESIGN ANAL RES HDB; Kipps CM, 2010, CURR OPIN NEUROL, V23, P628, DOI 10.1097/WCO.0b013e3283404309; Lam BYK, 2014, HUM BRAIN MAPP, V35, P3547, DOI 10.1002/hbm.22420; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maguire EA, 2003, J NEUROSCI, V23, P5302; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P123, DOI 10.1016/j.neuropsychologia.2009.08.020; Matuszewski V, 2009, CORTEX, V45, P456, DOI 10.1016/j.cortex.2007.11.006; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McKinnon MC, 2008, J COGNITIVE NEUROSCI, V20, P1839, DOI 10.1162/jocn.2008.20126; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Meulenbroek O, 2010, NEUROIMAGE, V53, P331, DOI 10.1016/j.neuroimage.2010.05.082; Meyers J., 1995, MEYERS SCORING SYSTE; Mion M, 2010, BRAIN, V133, P3256, DOI 10.1093/brain/awq272; Mioshi E, 2010, NEUROLOGY, V74, P1591, DOI 10.1212/WNL.0b013e3181e04070; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moss HE, 2003, COGN NEUROPSYCHOL, V20, P703, DOI 10.1080/02643290242000916; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Oddo S, 2010, CORTEX, V46, P29, DOI 10.1016/j.cortex.2008.07.003; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Philippi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046200; Piefke M, 2003, BRAIN, V126, P650, DOI 10.1093/brain/awg064; Piolino P, 2004, NEUROIMAGE, V22, P1371, DOI 10.1016/j.neuroimage.2004.02.025; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2007, NEUROPSYCHOLOGIA, V45, P2730, DOI 10.1016/j.neuropsychologia.2007.04.013; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Savage S, 2013, DEMENT GERIATR COGN, V35, P208, DOI 10.1159/000346389; Schmidt M., 1996, W PSYCHOL SERVICES; Sheldon S, 2013, NEUROIMAGE, V83, P880, DOI 10.1016/j.neuroimage.2013.06.082; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soderlund H, 2012, HIPPOCAMPUS, V22, P670, DOI 10.1002/hipo.20927; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Steinvorth S, 2006, NEUROIMAGE, V30, P285, DOI 10.1016/j.neuroimage.2005.09.025; Strauss E, 2006, COMPENDIUM NEUROPSYC; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Viard A, 2010, HIPPOCAMPUS, V20, P153, DOI 10.1002/hipo.20601; Visser M, 2010, NEUROPSYCHOLOGIA, V48, P1689, DOI 10.1016/j.neuropsychologia.2010.02.016; Westmacott R, 2001, NEUROCASE, V7, P37, DOI 10.1093/neucas/7.1.37; Winocur G, 2011, J INT NEUROPSYCH SOC, V17, P766, DOI 10.1017/S1355617711000683; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	84	43	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113081	10.1371/journal.pone.0113081	http://dx.doi.org/10.1371/journal.pone.0113081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396740	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000345558500131
J	Santoyo-Ramos, P; Likhatcheva, M; Garcia-Zepeda, EA; Castaneda-Patlan, MC; Robles-Flores, M				Santoyo-Ramos, Paula; Likhatcheva, Maria; Garcia-Zepeda, Eduardo A.; Cristina Castaneda-Patlan, M.; Robles-Flores, Martha			Hypoxia-Inducible Factors Modulate the Stemness and Malignancy of Colon Cancer Cells by Playing Opposite Roles in Canonical Wnt Signaling	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-CATENIN; HIF-1-ALPHA; HIF-2-ALPHA; HIF; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; EXPRESSION; SWITCH; MYC	This study examined the role played by hypoxia-inducible factors (HIFs) in malignant phenotype maintenance and canonical Wnt signaling. Under normoxia, we determined that both HIF-1 alpha and HIF-2 alpha are expressed in human colon cancer cells but not in their non-malignant counterparts. The stable knockdown of HIF-1 alpha or HIF-2 alpha expression induced negative effects on the malignant phenotype of colon cancer cells, with lactate production, the rate of apoptosis, migration, CXCR4-mediated chemotaxis, and tumorigenic activity all being significantly affected by HIF knockdown and with HIF-1 alpha depletion exerting greater effects. Knockdown of these two HIF transcripts induced different and even opposite effects on beta-catenin transcriptional activity in colon cancer cells with different genetic Wnt signaling pathways. In SW480 cells, HIF-2 alpha knockdown did not affect beta-catenin levels, increasing the transcriptional activity of beta-catenin by inducing its nuclear accumulation, whereas HIF-1 alpha silencing negatively affected the stability and transcriptional activity of beta-catenin, inducing its exit from the nuclei and its recruitment to the cell membrane by E-cadherin. In addition, although HIF-1 alpha depletion induced a reversal of the epithelial-to-mesenchymal transition (EMT), HIF-2 alpha silencing altered the expression of the stem cell markers CD44, Oct4, and CD24 and of the differentiation marker CK20 in the opposite direction as HIF-1 alpha silencing. Remarkably, HIF-2 alpha knockdown also enhanced beta-catenin transcriptional activity under hypoxia in cells that displayed normal Wnt signaling, suggesting that the gene negatively modulates canonical Wnt signaling in colon cancer cells. Taken together, our results indicate that HIFs play opposing roles in canonical Wnt signaling and are essential for the stemness and malignancy maintenance of colon cancer cells.	[Robles-Flores, Martha] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Biomed Res Inst, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Robles-Flores, M (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico.	rmartha@unam.mx		Castaneda-Patlan, Maria Cristina/0000-0002-2551-4847	Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [IN226111, IN215514]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB2011-151731]	Universidad Nacional Autonoma de Mexico (DGAPA-UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grants from Universidad Nacional Autonoma de Mexico (DGAPA-UNAM IN226111 and IN215514) and Consejo Nacional de Ciencia y Tecnologia (CONACYT CB2011-151731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Luna-Ulloa LB, 2011, CARCINOGENESIS, V32, P1615, DOI 10.1093/carcin/bgr190; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Imamura T, 2009, INT J CANCER, V124, P763, DOI 10.1002/ijc.24032; Ke J, 2012, NEOPLASMA, V59, P282, DOI 10.4149/neo_2012_036; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; Oh YS, 2012, ONCOL REP, V28, P2239, DOI 10.3892/or.2012.2063; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Schneider M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-96; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Yoo YG, 2011, CANCER RES, V71, P1244, DOI 10.1158/0008-5472.CAN-10-2360; Zhang Q, 2013, CARCINOGENESIS, V34, P962, DOI 10.1093/carcin/bgt027; Zhao JH, 2011, CANCER INVEST, V29, P377, DOI 10.3109/07357907.2010.512595	35	54	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112580	10.1371/journal.pone.0112580	http://dx.doi.org/10.1371/journal.pone.0112580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396735	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500062
J	Han, DY; Di, XJ; Fu, YL; Mu, TW				Han, Dong-Yun; Di, Xiao-Jing; Fu, Yan-Lin; Mu, Ting-Wei			Combining Valosin-containing Protein (VCP) Inhibition and Suberanilohydroxamic Acid (SAHA) Treatment Additively Enhances the Folding, Trafficking, and Function of Epilepsy-associated gamma-Aminobutyric Acid, Type A (GABA(A)) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epilepsy; ER Quality Control; ER-associated Degradation; GABA Receptor; Protein Misfolding; Proteostasis; SAHA; VCP	RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; CYS-LOOP RECEPTORS; MUTATION A322D; AAA-ATPASE; SUBUNIT; ALPHA-1; PROTEOSTASIS; ENDOCYTOSIS; MECHANISMS	Background: The 1 subunit harboring the A322D mutation is subject to excessive ERAD. Results: VCP inhibition using Eeyarestatin I reduces the ERAD of 1(A322D) subunits, and coapplication of SAHA additively enhances their proteostasis. Conclusion: Combining ERAD inhibition and folding enhancement yields significant functional rescue. Significance: This combination represents a new, promising strategy to treat epilepsy resulting from GABA(A) receptor misfolding. GABA(A) receptors are the primary inhibitory ion channels in the mammalian central nervous system. The A322D mutation in the 1 subunit results in its excessive endoplasmic reticulum-associated degradation at the expense of plasma membrane trafficking, leading to autosomal dominant juvenile myoclonic epilepsy. Presumably, valosin-containing protein (VCP)/p97 extracts misfolded subunits from the endoplasmic reticulum membrane to the cytosolic proteasome for degradation. Here we showed that inhibiting VCP using Eeyarestatin I reduces the endoplasmic reticulum-associated degradation of the 1(A322D) subunit without an apparent effect on its dynamin-1 dependent endocytosis and that this treatment enhances its trafficking. Furthermore, coapplication of Eeyarestatin I and suberanilohydroxamic acid, a known small molecule that promotes chaperone-assisted folding, yields an additive restoration of surface expression of 1(A322D) subunits in HEK293 cells and neuronal SH-SY5Y cells. Consequently, this combination significantly increases GABA-induced chloride currents in whole-cell patch clamping experiments than either chemical compound alone in HEK293 cells. Our findings suggest that VCP inhibition without stress induction, together with folding enhancement, represents a new strategy to restore proteostasis of misfolding-prone GABA(A) receptors and, therefore, a potential remedy for idiopathic epilepsy.	[Han, Dong-Yun; Di, Xiao-Jing; Fu, Yan-Lin; Mu, Ting-Wei] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Mu, TW (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	tingwei.mu@case.edu	Mu, Tingwei/AAU-8596-2020	Mu, Tingwei/0000-0002-6419-9296	Epilepsy Foundation of America [225243]	Epilepsy Foundation of America	This work was supported by the Epilepsy Foundation of America (225243).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Arain FM, 2012, EPILEPSIA, V53, pE161, DOI 10.1111/j.1528-1167.2012.03596.x; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bradley CA, 2008, J BIOL CHEM, V283, P22043, DOI 10.1074/jbc.M801708200; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Di XJ, 2013, CHEM BIOL, V20, P1456, DOI 10.1016/j.chembiol.2013.09.020; Ding L, 2010, J BIOL CHEM, V285, P26390, DOI 10.1074/jbc.M110.142299; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Franz A, 2014, BBA-MOL CELL RES, V1843, P205, DOI 10.1016/j.bbamcr.2013.03.031; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Herring D, 2003, J BIOL CHEM, V278, P24046, DOI 10.1074/jbc.M301420200; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Krampfl K, 2005, EUR J NEUROSCI, V22, P10, DOI 10.1111/j.1460-9568.2005.04168.x; Lachance-Touchette P, 2011, EUR J NEUROSCI, V34, P237, DOI 10.1111/j.1460-9568.2011.07767.x; Leitman J, 2013, DNA CELL BIOL, V32, P2, DOI 10.1089/dna.2012.1889; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mowrey DD, 2015, BBA-BIOMEMBRANES, V1848, P307, DOI 10.1016/j.bbamem.2014.03.014; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Steinlein OK, 2012, CHEM REV, V112, P6334, DOI 10.1021/cr300044d; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang YJ, 2013, J PROTEOME RES, V12, P5570, DOI 10.1021/pr400535z; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	48	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					325	337		10.1074/jbc.M114.580324	http://dx.doi.org/10.1074/jbc.M114.580324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406314	Green Published, hybrid			2022-12-26	WOS:000347231200029
J	Ford, BE; Sun, B; Carpino, J; Chapler, ES; Ching, J; Choi, Y; Jhun, K; Kim, JD; Lallos, GG; Morgenstern, R; Singh, S; Theja, S; Dennehy, JJ				Ford, Brian E.; Sun, Bruce; Carpino, James; Chapler, Elizabeth S.; Ching, Jane; Choi, Yoon; Jhun, Kevin; Kim, Jung D.; Lallos, Gregory G.; Morgenstern, Rachelle; Singh, Shalini; Theja, Sai; Dennehy, John J.			Frequency and Fitness Consequences of Bacteriophage Phi 6 Host Range Mutations	PLOS ONE			English	Article							STRANDED-RNA SEGMENT; SOURCE-SINK DYNAMICS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; CELL RECOGNITION; HOT-SPOTS; I-TASSER; VIRUS; EVOLUTION; DEHYDROGENASE	Viruses readily mutate and gain the ability to infect novel hosts, but few data are available regarding the number of possible host range-expanding mutations allowing infection of any given novel host, and the fitness consequences of these mutations on original and novel hosts. To gain insight into the process of host range expansion, we isolated and sequenced 69 independent mutants of the dsRNA bacteriophage 6 able to infect the novel host, Pseudomonas pseudoalcaligenes. In total, we found at least 17 unique suites of mutations among these 69 mutants. We assayed fitness for 13 of 17 mutant genotypes on P. pseudoalcaligenes and the standard laboratory host, P. phaseolicola. Mutants exhibited significantly lower fitnesses on P. pseudoalcaligenes compared to P. phaseolicola. Furthermore, 12 of the 13 assayed mutants showed reduced fitness on P. phaseolicola compared to wildtype 6, confirming the prevalence of antagonistic pleiotropy during host range expansion. Further experiments revealed that the mechanistic basis of these fitness differences was likely variation in host attachment ability. In addition, using computational protein modeling, we show that host-range expanding mutations occurred in hotspots on the surface of the phage's host attachment protein opposite a putative hydrophobic anchoring domain.	[Ford, Brian E.; Sun, Bruce; Carpino, James; Chapler, Elizabeth S.; Ching, Jane; Choi, Yoon; Jhun, Kevin; Kim, Jung D.; Lallos, Gregory G.; Morgenstern, Rachelle; Singh, Shalini; Theja, Sai; Dennehy, John J.] CUNY Queens Coll, Dept Biol, New York, NY USA; [Ford, Brian E.] CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; City University of New York (CUNY) System	Dennehy, JJ (corresponding author), New York Stem Cell Fdn, New York, NY 10023 USA.	john.dennehy@qc.cuny.edu	Ford, Brian E/G-5875-2010; Dennehy, John/A-9704-2008	Ford, Brian E/0000-0003-0543-4978; Dennehy, John/0000-0002-9678-4529	Professional Staff Congress of the City University of New York Award [62886-00-40]; National Science Foundation Division of Environmental Biology Award [0804039]; National Science Foundation Faculty Early Career Award [1148879]	Professional Staff Congress of the City University of New York Award; National Science Foundation Division of Environmental Biology Award(National Science Foundation (NSF)); National Science Foundation Faculty Early Career Award	This work was supported by the National Science Foundation Faculty Early Career Award #1148879 (JJD), Professional Staff Congress of the City University of New York Award #62886-00-40 (JJD), and National Science Foundation Division of Environmental Biology Award #0804039 (JJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HK, 2010, J R SOC INTERFACE, V7, P1455, DOI 10.1098/rsif.2010.0123; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Ayora-Talavera G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007836; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Baranowski E, 2003, ADV VIRUS RES, V62, P19, DOI 10.1016/S0065-3527(03)62002-6; Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613; Bono LM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0616; Chao L, 2002, J VIROL, V76, P3276, DOI 10.1128/JVI.76.7.3276-3281.2002; Chattopadhyay S, 2007, J MOL EVOL, V64, P204, DOI 10.1007/s00239-006-0063-5; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Christensen KLY, 2009, CLIN INFECT DIS, V49, P1025, DOI 10.1086/605562; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Cox J, 2010, J VIROL, V84, P4860, DOI 10.1128/JVI.00047-10; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; CUPPELS DA, 1981, CURR MICROBIOL, V5, P247, DOI 10.1007/BF01571156; DAWKINS B, 1991, AM STAT, V45, P76, DOI 10.2307/2685247; Dennehy JJ, 2006, AM NAT, V167, P429, DOI 10.1086/499381; Dennehy JJ, 2014, ANN REV MICROBIOL; Dennehy John J, 2012, Int J Evol Biol, V2012, P396165, DOI 10.1155/2012/396165; Dennehy JJ, 2009, TRENDS MICROBIOL, V17, P450, DOI 10.1016/j.tim.2009.07.006; Duffy S, 2006, GENETICS, V172, P751, DOI 10.1534/genetics.105.051136; Ellegren H, 2003, CURR OPIN GENET DEV, V13, P562, DOI 10.1016/j.gde.2003.10.008; Ferris MT, 2007, GENETICS, V176, P1013, DOI 10.1534/genetics.106.064634; Fisher RA, 1930, GENETICAL THEORY NAT; Gandon S, 2012, PHILOS T R SOC B, V368; GHOSH M, 1995, STRUCTURE, V3, P177, DOI 10.1016/S0969-2126(01)00148-4; GOTTLIEB P, 1988, VIROLOGY, V163, P183, DOI 10.1016/0042-6822(88)90245-0; Hall AR, 2011, AM NAT, V177, P44, DOI 10.1086/657441; Hoper D, 2012, J VIROL, V86, P1394, DOI 10.1128/JVI.00797-11; Holmes EC, 2007, CURR TOP MICROBIOL, V315, P51; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jonah G, 2003, J VIROL, V77, P6709, DOI 10.1128/JVI.77.12.6709-6719.2003; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keitel T, 2000, J MOL BIOL, V297, P961, DOI 10.1006/jmbi.2000.3603; KENNEY JM, 1992, VIROLOGY, V190, P635, DOI 10.1016/0042-6822(92)90901-Z; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lide D.R., 1991, HDB CHEM PHYS; Luria SE, 1943, GENETICS, V28, P491; MCGRAW T, 1986, J VIROL, V58, P142, DOI 10.1128/JVI.58.1.142-151.1986; MINDICH L, 1988, J VIROL, V62, P1180, DOI 10.1128/JVI.62.4.1180-1185.1988; MINDICH L, 1985, J BACTERIOL, V162, P992, DOI 10.1128/JB.162.3.992-999.1985; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Ng TI, 2001, ANTIMICROB AGENTS CH, V45, P1629, DOI 10.1128/AAC.45.6.1629-1636.2001; Oubrie A, 2002, J BIOL CHEM, V277, P3727, DOI 10.1074/jbc.M109403200; Petsko G., 2004, PROTEIN STRUCTURE FU; ROSE MR, 1982, HEREDITY, V48, P63, DOI 10.1038/hdy.1982.7; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; Sasadeusz JJ, 1997, J VIROL, V71, P3872, DOI 10.1128/JVI.71.5.3872-3878.1997; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; STITT BL, 1983, VIROLOGY, V127, P446, DOI 10.1016/0042-6822(83)90157-5; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapparel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021163; VIDAVER AK, 1973, J VIROL, V11, P799, DOI 10.1128/JVI.11.5.799-805.1973; Williams PD, 2010, TRENDS PARASITOL, V26, P83, DOI 10.1016/j.pt.2009.11.009; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803; Yamada S, 2005, VIRUS GENES, V31, P107, DOI 10.1007/s11262-005-2206-y; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yuang TTT, 2000, J VIROL, V74, P4929, DOI 10.1128/JVI.74.10.4929-4932.2000; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113078	10.1371/journal.pone.0113078	http://dx.doi.org/10.1371/journal.pone.0113078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409341	Green Published, gold			2022-12-26	WOS:000345533200065
J	Moutaoufik, MT; El Fatimy, R; Nassour, H; Gareau, C; Lang, J; Tanguay, RM; Mazroui, R; Khandjian, EW				Moutaoufik, Mohamed Taha; El Fatimy, Rachid; Nassour, Hassan; Gareau, Cristina; Lang, Jerome; Tanguay, Robert M.; Mazroui, Rachid; Khandjian, Edouard W.			UVC-Induced Stress Granules in Mammalian Cells	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; INDUCED DNA-DAMAGE; MESSENGER-RNA; TRANSLATIONAL CONTROL; CYTOPLASMIC GRANULES; HISTONE H2AX; PHOSPHORYLATION; RECRUITMENT; REPAIR; ACTIVATION	Stress granules (SGs) are well characterized cytoplasmic RNA bodies that form under various stress conditions. We have observed that exposure of mammalian cells in culture to low doses of UVC induces the formation of discrete cytoplasmic RNA granules that were detected by immunofluorescence staining using antibodies to RNA-binding proteins. UVC-induced cytoplasmic granules are not Processing Bodies (P-bodies) and are bone fide SGs as they contain TIA-1, TIA-1/R, Caprin1, FMRP, G3BP1, PABP1, well known markers, and mRNA. Concomitant with the accumulation of the granules in the cytoplasm, cells enter a quiescent state, as they are arrested in G1 phase of the cell cycle in order to repair DNA damages induced by UVC irradiation. This blockage persists as long as the granules are present. A tight correlation between their decay and re-entry into S-phase was observed. However the kinetics of their formation, their low number per cell, their absence of fusion into larger granules, their persistence over 48 hours and their slow decay, all differ from classical SGs induced by arsenite or heat treatment. The induction of these SGs does not correlate with major translation inhibition nor with phosphorylation of the a subunit of eukaryotic translation initiation factor 2 (eIF2 alpha). We propose that a restricted subset of mRNAs coding for proteins implicated in cell cycling are removed from the translational apparatus and are sequestered in a repressed form in SGs.	[Moutaoufik, Mohamed Taha; El Fatimy, Rachid; Lang, Jerome; Khandjian, Edouard W.] Univ Laval, Dept Psychiat & Neurosci, Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Nassour, Hassan; Gareau, Cristina; Mazroui, Rachid] Univ Laval, Dept Biol Mol Biochim Med & Pathol, CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Tanguay, Robert M.] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Lab Genet Cellulaire & Dev, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Khandjian, EW (corresponding author), Univ Laval, Dept Psychiat & Neurosci, Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada.	Edward.khandjian@crulrg.ulaval.ca	Fatimy, Rachid El/K-2822-2019	EL FATIMY, Rachid/0000-0002-7652-5562; Moutaoufik, Mohamed Taha/0000-0002-2013-1601	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	This work has been supported by grants from the Canadian Institutes of Health Research (CIHR), and the Natural Sciences and Engineering Research Council of Canada (NSERC) to EWK. MTM holds a studentship from PROTEO, Quebec. RM is a recipient of a CIHR New Investigator Scholarship award and holds an NSERC discovery fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Behrmann J, 2007, DETERMINING ROLE RNA; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Dury AY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003890; El Fatimy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039338; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Gaillard H, 2008, MOL BIOL CELL, V19, P4980, DOI 10.1091/mbc.E08-02-0193; Gareau C, 2013, BIOL OPEN, V2, P68, DOI 10.1242/bio.20123012; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Isabelle M, 2012, J CELL SCI, V125, P4555, DOI 10.1242/jcs.106963; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Kruger T, 2013, MOL BIOL CELL, V24, P2098, DOI 10.1091/mbc.E13-01-0068; Kuo LJ, 2008, IN VIVO, V22, P305; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Matthews JD, 2012, J GEN VIROL, V93, P267, DOI 10.1099/vir.0.036780-0; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Stoecklin G, 2013, ADV EXP MED BIOL, V768, P197, DOI 10.1007/978-1-4614-5107-5_12; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; TSAI RL, 1973, NATURE-NEW BIOL, V243, P168, DOI 10.1038/newbio243168a0; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013	45	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112742	10.1371/journal.pone.0112742	http://dx.doi.org/10.1371/journal.pone.0112742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409157	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200039
J	Pan, J; Park, TJ; Cutz, E; Yeger, H				Pan, Jie; Park, Thomas J.; Cutz, Ernest; Yeger, Herman			Immunohistochemical Characterization of the Chemosensory Pulmonary Neuroepithelial Bodies in the Naked Mole-Rat Reveals a Unique Adaptive Phenotype	PLOS ONE			English	Article							NEUROENDOCRINE CELLS; HYPOXIA TOLERANCE; SMOOTH-MUSCLE; INNERVATION; INSIGHTS; RODENT; LUNGS; MODEL	The pulmonary neuroepithelial bodies (NEBs) constitute polymodal airway chemosensors for monitoring and signaling ambient gas concentrations (pO(2), pCO(2)/H+) via complex innervation to the brain stem controlling breathing. NEBs produce the bioactive amine, serotonin (5-HT), and a variety of peptides with multiple effects on lung physiology and other organ systems. NEBs in mammals appear prominent and numerous during fetal and neonatal periods, and decline in the postnatal period suggesting an important role during perinatal adaptation. The naked mole-rat (NMR), Heterocephalus glaber, has adapted to the extreme environmental conditions of living in subterranean burrows in large colonies (up to 300 colony mates). The crowded, unventilated burrows are environments of severe hypoxia and hypercapnia. However, NMRs adjust readily to above ground conditions. The chemosensory NEBs of this species were characterized and compared to those of the conventional Wistar rat (WR) to identify similarities and differences that could explain the NMR's adaptability to environments. A multilabel immunohistochemical analysis combined with confocal microscopy revealed that the expression patterns of amine, peptide, neuroendocrine, innervation markers and chemosensor component proteins in NEBs of NMR were similar to that of WR. However, we found the following differences: 1) NEBs in both neonatal and adult NMR lungs were significantly larger and more numerous as compared to WR; 2) NEBs in NMR had a more variable compact cell organization and exhibited significant differences in the expression of adhesion proteins; 3) NMR NEBs showed a significantly greater ratio of 5-HT positive cells with an abundance of 5-HT; 4) NEBs in NMR expressed the proliferating cell nuclear antigen (PCNA) and the neurogenic gene (MASH1) indicating active proliferation and a state of persistent differentiation. Taken together our findings suggest that NEBs in lungs of NMR are in a hyperactive, functional and developmental state, reminiscent of a persistent fetal state that extends postnatally.	[Pan, Jie; Cutz, Ernest; Yeger, Herman] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [Pan, Jie; Cutz, Ernest; Yeger, Herman] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Park, Thomas J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Cutz, Ernest; Yeger, Herman] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto	Yeger, H (corresponding author), Hosp Sick Children, Dept Paediat Lab Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hermie@sickkids.ca			Canadian Institutes of Health Research (CIHR) [MOP-15270]; National Science Foundation (NSF) [0744979]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science Foundation (NSF)(National Science Foundation (NSF))	The work presented here was supported by an operating grant from Canadian Institutes of Health Research (CIHR; cihr.ca) to EC and HY (MOP-15270) and National Science Foundation (NSF; www.nsf.gov) Grant number 0744979 to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azpurua Jorge, 2013, Frontiers in Genetics, V3, P319, DOI 10.3389/fgene.2012.00319; Brouns I, 2006, AUTON NEUROSCI-BASIC, V126, P307, DOI 10.1016/j.autneu.2006.02.006; Brouns I, 2009, HISTOCHEM CELL BIOL, V131, P55, DOI 10.1007/s00418-008-0495-7; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Cutz E, 2013, SEMIN CELL DEV BIOL, V24, P40, DOI 10.1016/j.semcdb.2012.09.003; Cutz E, 2009, ADV EXP MED BIOL, V648, P427, DOI 10.1007/978-90-481-2259-2_49; Edrey YH, 2013, NEUROBIOL AGING, V34, P2352, DOI 10.1016/j.neurobiolaging.2013.03.032; Gladyshev VN, 2011, AGING-US, V3, P1124, DOI 10.18632/aging.100417; Gu XL, 2014, AM J RESP CELL MOL, V50, P637, DOI 10.1165/rcmb.2013-0199OC; Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf; LaVinka PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045060; LaVinka PC, 2009, J COMP PHYSIOL A, V195, P419, DOI 10.1007/s00359-009-0420-0; Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911; Maina JN, 2001, J ZOOL, V253, P371, DOI 10.1017/S0952836901000346; McGovern S, 2010, LAB INVEST, V90, P180, DOI 10.1038/labinvest.2009.135; Miki M, 2012, LUNG CANCER, V75, P58, DOI 10.1016/j.lungcan.2011.05.019; Nathaniel TI, 2009, J INTEGR NEUROSCI, V8, P123, DOI 10.1142/S0219635209002149; Pan J, 2006, AM J RESP CELL MOL, V35, P320, DOI 10.1165/rcmb.2005-0468OC; Pan J, 2012, ADV EXP MED BIOL, V758, P149, DOI 10.1007/978-94-007-4584-1_21; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Peterson BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031568; Peterson BL, 2012, NEUROSCI LETT, V506, P342, DOI 10.1016/j.neulet.2011.11.042; Rodriguez KA, 2011, CURR PHARM DESIGN, V17, P2290; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Wong AP, 2009, CYTOTHERAPY, V11, P676, DOI 10.3109/14653240903313974; Yeger H, 2009, AIRWAY CHEMORECEPTOR, V306, P287	32	6	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112623	10.1371/journal.pone.0112623	http://dx.doi.org/10.1371/journal.pone.0112623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409164	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200029
J	Datta, S; Roy, S; Chatterjee, S; Saha, A; Sen, B; Pal, T; Som, T; Basu, S				Datta, Saswati; Roy, Subhasree; Chatterjee, Somdatta; Saha, Anindya; Sen, Barsha; Pal, Titir; Som, Tapas; Basu, Sulagna			A Five-Year Experience of Carbapenem Resistance in Enterobacteriaceae Causing Neonatal Septicaemia: Predominance of NDM-1	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; GRAM-NEGATIVE BACILLI; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; MULTIPLEX PCR; SEPSIS; GENES; SUSCEPTIBILITY; DETERMINANTS	Treatment of neonatal sepsis has become a challenge with the emergence of carbapenemase-producing bacteria. This study documents the trend of carbapenem susceptibility in Enterobacteriaceae that caused septicaemia in neonates over a five year period (2007-2011) and the molecular characterisation of Enterobacteriaceae resistant to carbapenems and cephalosporins. Hundred and five Enterobacteriaceae including Escherichia coli (n = 27), Klebsiella pneumoniae (n = 68) and Enterobacter spp. (n = 10) were isolated from blood of septicaemic neonates followed by antibiotic susceptibility tests, determination of MIC values, phenotypic and genotypic detection of beta-lactamases. Carbapenem was the most active antimicrobial tested after tigecycline. CTX-M type was the most prevalent ESBL throughout the period (82%). New Delhi Metallo-beta-lactamase-1 (NDM-1), which is a recent addition to the carbapenemase list, was the only carbapenemase identified in our setting. Fourteen percent of the isolates possessed bla(NDM)-(1). Carbapenem non-susceptibility was first observed in 2007 and it was due to loss of Omp F/Ompk36 in combination with the presence of ESBLs/AmpCs. NDM-1 first emerged in E. coli during 2008; later in 2010, the resistance was detected in K. pneumoniae and E. cloacae isolates. NDM-1producing isolates were resistant to other broad-spectrum antibiotics and possessed ESBLs, AmpCs, 16S-rRNA methylases, AAC(69)-Ib-cr, bleomycin resistant gene and class 1 integron. Pulsed field gel electrophoresis of the NDM-1-producing isolates indicated that the isolates were clonally diverse. The study also showed that there was a significantly higher incidence of sepsis caused by NDM-1-harbouring isolates in the male sex, in neonates with low birth weight and neonates born at an extramural centre. However, sepsis with NDM-1-harbouring isolates did not result in a higher mortality rate. The study is the first to review the carbapenem resistance patterns in neonatal sepsis over an extended period of time. The study highlights the persistence of ESBLs (CTX-Ms) and the emergence of NDM-1 in Enterobacteriaceae in the unit.	[Datta, Saswati; Roy, Subhasree; Chatterjee, Somdatta; Basu, Sulagna] Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, W Bengal, India; [Saha, Anindya; Sen, Barsha; Som, Tapas] SSKM Hosp, Inst Postgrad Med Educ & Res, Dept Neonatol, Kolkata, W Bengal, India; [Pal, Titir] AbsolutData Res & Analyt, Gurgaon, Haryana, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Basu, S (corresponding author), Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, W Bengal, India.	supabasu@yahoo.co.in	Som, Tapas/GQP-1694-2022; Basu, Sulagna/AAL-5503-2021	Som, Tapas/0000-0002-8356-9125; Basu, Sulagna/0000-0002-7811-7140	Department of Science and Technology (DST), West Bengal; "Indian Council of Medical Research''	Department of Science and Technology (DST), West Bengal(Department of Science & Technology (India)); "Indian Council of Medical Research''(Indian Council of Medical Research (ICMR))	The study was partially supported by a fund from Department of Science and Technology (DST), West Bengal. Saswati Datta is now being supported by a fellowship from "Indian Council of Medical Research'' but earlier she had been supported by a fellowship from Department of Science and Technology (DST), West Bengal. Somdatta Chatterjee has been supported by a fellowship from Department of Biotechnology, India. All other funds required for the study were provided by internal funding (Indian Council of Medical Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co- author Titir Pal is employed by AbsolutData Research and Analytics. AbsolutData Research and Analytics provided support in the form of salary for author TP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions'' section.	BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bercot B, 2011, DIAGN MICR INFEC DIS, V71, P442, DOI 10.1016/j.diagmicrobio.2011.08.016; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Chang YY, 2015, J MICROBIOL IMMUNOL, V48, P219, DOI 10.1016/j.jmii.2014.05.010; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Colom K, 2003, FEMS MICROBIOL LETT, V223, P147, DOI 10.1016/S0378-1097(03)00306-9; Coudron PE, 2005, J CLIN MICROBIOL, V43, P4163, DOI 10.1128/JCM.43.8.4163-4167.2005; Das P, 2011, J MED MICROBIOL, V60, P1651, DOI 10.1099/jmm.0.033803-0; Datta S, 2014, J MED MICROBIOL, V63, P480, DOI 10.1099/jmm.0.067223-0; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Jacoby GA, 2004, ANTIMICROB AGENTS CH, V48, P3203, DOI 10.1128/AAC.48.8.3203-3206.2004; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Parveen RM, 2012, INDIAN J MICROBIOL, V52, P35, DOI 10.1007/s12088-011-0140-3; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Patel J. B., 2009, Clinical Microbiology Newsletter, V31, P55, DOI 10.1016/j.clinmicnews.2009.03.005; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P447, DOI 10.1128/AAC.49.1.447-450.2005; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; POLIN RA, 1989, NEW ETHICALS 2, V25, P109; POLIN RA, 1989, NEW ETHICALS 1, V25, P133; Romero L, 2005, CLIN MICROBIOL INFEC, V11, P625, DOI 10.1111/j.1469-0691.2005.01194.x; Roy S, 2010, EUR J CLIN MICROBIOL, V29, P1495, DOI 10.1007/s10096-010-1030-z; Roy S, 2013, INDIAN J MED RES, V137, P791; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Roy S, 2011, J ANTIMICROB CHEMOTH, V66, P2773, DOI 10.1093/jac/dkr376; Roy S, 2011, J ANTIMICROB CHEMOTH, V66, P1411, DOI 10.1093/jac/dkr068; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Shakil S, 2010, J MED MICROBIOL, V59, P948, DOI 10.1099/jmm.0.020214-0; Shibata N, 2003, J CLIN MICROBIOL, V41, P5407, DOI 10.1128/JCM.41.12.5407-5413.2003; Stuart JC, 2010, INT J ANTIMICROB AG, V36, P205, DOI 10.1016/j.ijantimicag.2010.05.014; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tsai MH, 2014, CLIN MICROBIOL INFEC, V20, pO928, DOI 10.1111/1469-0691.12661; Viswanathan R, 2012, ARCH DIS CHILD-FETAL, V97, pF182, DOI 10.1136/archdischild-2011-300097; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	41	53	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112101	10.1371/journal.pone.0112101	http://dx.doi.org/10.1371/journal.pone.0112101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406074	Green Published, gold			2022-12-26	WOS:000347121300023
J	Huang, XL; Gao, Y; Qin, JJ; Lu, S				Huang, Xinli; Gao, Yun; Qin, Jianjie; Lu, Sen			The Role of miR-34a in the Hepatoprotective Effect of Hydrogen Sulfide on Ischemia/Reperfusion Injury in Young and Old Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SIGNALING MOLECULE; LIVER; MICRORNAS; NRF2; PATHWAY; DEATH	Hydrogen sulfide (H2S) can protect the liver against ischemia-reperfusion (I/R) injury. However, it is unknown whether H2S plays a role in the protection of hepatic I/R injury in both young and old patients. This study compared the protective effects of H2S in a rat model (young and old animals) of I/R injury and the mechanism underlying its effects. Young and old rats were assessed following an injection of NaHS. NaHS alone reduced hepatic I/R injury in the young rats by activating the nuclear erythroid-related factor 2 (Nrf2) signaling pathway, but it had little effect on the old rats. NaHS pretreatment decreased miR-34a expression in the hepatocytes of the young rats with hepatic I/R. Overexpresion of miR-34a decreased Nrf-2 and its downstream target expression, impairing the hepatoprotective effect of H2S on the young rats. More importantly, downregulation of miR-34a expression increased Nrf-2 and the expression of its downstream targets, enhancing the effect of H2S on hepatic I/R injury in the old rats. This study reveals the different effects of H2S on hepatic I/R injury in young and old rats and sheds light on the involvement of H2S in miR-34a modulation of the Nrf-2 pathway.	[Huang, Xinli; Gao, Yun; Qin, Jianjie; Lu, Sen] Nanjing Med Univ, Affiliated Hosp 1, Ctr Liver Transplantat, Key Lab Living Donor Liver Transplantat,Minist Hl, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Lu, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Ctr Liver Transplantat, Key Lab Living Donor Liver Transplantat,Minist Hl, Nanjing, Jiangsu, Peoples R China.	senlusen@163.com			Priority Academic Program of Jiangsu Higher Education Institutions	Priority Academic Program of Jiangsu Higher Education Institutions	This work was supported by grant from the Priority Academic Program of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrevoet F, 2003, ACTA CHIR BELG, V103, P485; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020238; Cheng XH, 2013, FREE RADICAL BIO MED, V64, P4, DOI 10.1016/j.freeradbiomed.2013.07.025; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Guo W, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/878052; Henderson PW, 2010, J GASTROEN HEPATOL, V25, P1642, DOI 10.1111/j.1440-1746.2010.06380.x; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jaeschke H, 2012, TRANSPLANT REV-ORLAN, V26, P103, DOI 10.1016/j.trre.2011.10.006; Ke BB, 2013, J HEPATOL, V59, P1200, DOI 10.1016/j.jhep.2013.07.016; Kimura H, 2013, NEUROCHEM INT, V63, P492, DOI 10.1016/j.neuint.2013.09.003; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; Lu YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093013; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Papadopoulos D, 2013, ARCH TRAUMA RES, V2, P63, DOI 10.5812/atr.12501; Park SY, 2013, TOXICOL APPL PHARM, V268, P68, DOI 10.1016/j.taap.2013.01.017; Peake BF, 2013, AM J PHYSIOL-HEART C, V304, pH1215, DOI 10.1152/ajpheart.00796.2012; Sahin K, 2014, NUTR CANC; Schiesser M, 2009, J SURG RES, V152, P61, DOI 10.1016/j.jss.2008.01.007; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Tanaka Y, 2007, MOL PHARMACOL, V71, P817, DOI 10.1124/mol.106.029033; Tulsawani R, 2013, INDIAN J PHARMACOL, V45, P258, DOI 10.4103/0253-7613.111943; van der Bilt JDW, 2008, ANN SURG ONCOL, V15, P1392, DOI 10.1245/s10434-007-9758-0; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Zeng T, 2013, BBA-GEN SUBJECTS, V1830, P4848, DOI 10.1016/j.bbagen.2013.06.028; Zhang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074422	31	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113305	10.1371/journal.pone.0113305	http://dx.doi.org/10.1371/journal.pone.0113305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405338	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300101
J	Worker, A; Blain, C; Jarosz, J; Chaudhuri, KR; Barker, GJ; Williams, SCR; Brown, RG; Leigh, PN; Dell'Acqua, F; Simmons, A				Worker, Amanda; Blain, Camilla; Jarosz, Jozef; Chaudhuri, K. Ray; Barker, Gareth J.; Williams, Steve C. R.; Brown, Richard G.; Leigh, P. Nigel; Dell'Acqua, Flavio; Simmons, Andrew			Diffusion Tensor Imaging of Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy: A Tract-Based Spatial Statistics Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CORTICOBASAL DEGENERATION; DIAGNOSTIC-CRITERIA; CLINICAL-DIAGNOSIS; BRAIN PATHOLOGY; PATTERNS; VARIANT; DAMAGE; PSP	Although often clinically indistinguishable in the early stages, Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) have distinct neuropathological changes. The aim of the current study was to identify white matter tract neurodegeneration characteristic of each of the three syndromes. Tract-based spatial statistics (TBSS) was used to perform a whole-brain automated analysis of diffusion tensor imaging (DTI) data to compare differences in fractional anisotropy (FA) and mean diffusivity (MD) between the three clinical groups and healthy control subjects. Further analyses were conducted to assess the relationship between these putative indices of white matter microstructure and clinical measures of disease severity and symptoms. In PSP, relative to controls, changes in DTI indices consistent with white matter tract degeneration were identified in the corpus callosum, corona radiata, corticospinal tract, superior longitudinal fasciculus, anterior thalamic radiation, superior cerebellar peduncle, medial lemniscus, retrolenticular and anterior limb of the internal capsule, cerebral peduncle and external capsule bilaterally, as well as the left posterior limb of the internal capsule and the right posterior thalamic radiation. MSA patients also displayed differences in the body of the corpus callosum corticospinal tract, cerebellar peduncle, medial lemniscus, anterior and superior corona radiata, posterior limb of the internal capsule external capsule and cerebral peduncle bilaterally, as well as the left anterior limb of the internal capsule and the left anterior thalamic radiation. No significant white matter abnormalities were observed in the PD group. Across groups, MD correlated positively with disease severity in all major white matter tracts. These results show widespread changes in white matter tracts in both PSP and MSA patients, even at a mid-point in the disease process, which are not found in patients with PD.	[Worker, Amanda; Blain, Camilla; Chaudhuri, K. Ray; Barker, Gareth J.; Williams, Steve C. R.; Brown, Richard G.; Dell'Acqua, Flavio; Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Worker, Amanda; Chaudhuri, K. Ray; Williams, Steve C. R.; Brown, Richard G.; Dell'Acqua, Flavio; Simmons, Andrew] Kings Coll London, South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London WC2R 2LS, England; [Worker, Amanda; Chaudhuri, K. Ray; Williams, Steve C. R.; Brown, Richard G.; Dell'Acqua, Flavio; Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Worker, Amanda; Chaudhuri, K. Ray; Brown, Richard G.; Dell'Acqua, Flavio; Simmons, Andrew] Kings Coll London, South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Unit Dementia, London WC2R 2LS, England; [Blain, Camilla; Jarosz, Jozef; Chaudhuri, K. Ray] Kings Coll Hosp London, London, England; [Leigh, P. Nigel] Univ Sussex, Trafford Ctr Biomed Res, Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Brighton; University of Sussex	Simmons, A (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	andy.simmons@kcl.ac.uk	Dell'Acqua, Flavio/I-1407-2012; Williams, Steve C/D-6979-2011; Simmons, Andrew/B-8848-2008; Leigh, Peter/AAD-5638-2019; Brown, Richard G/A-9599-2010; Barker, Gareth J/C-9616-2009	Williams, Steve C/0000-0003-4299-1941; Simmons, Andrew/0000-0003-2306-5811; Brown, Richard G/0000-0001-9021-0172; Barker, Gareth J/0000-0002-5214-7421; Dell'Acqua, Flavio/0000-0001-5313-5476; Ray Chaudhuri, K/0000-0003-2815-0505; opoku, anita/0000-0001-7243-8157	NIHR Biomedical Research Centre for Mental Health; NIHR Biomedical Research Unit for Dementia at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	NIHR Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit for Dementia at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	Support for this study was provided by the NIHR Biomedical Research Centre for Mental Health and NIHR Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2014, J NEUROL, V261, P913, DOI 10.1007/s00415-014-7301-3; Agosta F, 2012, NEUROBIOL AGING, V33, P2817, DOI 10.1016/j.neurobiolaging.2012.02.002; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Boxer AL, 2006, ARCH NEUROL-CHICAGO, V63, P81, DOI 10.1001/archneur.63.1.81; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brenneis C, 2004, J NEUROL NEUROSUR PS, V75, P246; Caso F, 2014, NEUROLOGY, V82; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Ishizawa K, 2004, J NEUROPATH EXP NEUR, V63, P43, DOI 10.1093/jnen/63.1.43; Ishizawa K, 2001, J NEUROPATH EXP NEUR, V60, P647, DOI 10.1093/jnen/60.6.647; Ito S, 2008, NEURORADIOLOGY, V50, P981, DOI 10.1007/s00234-008-0447-x; Josephs KA, 2013, MOVEMENT DISORD, V28, P1117, DOI 10.1002/mds.25437; Klegeris A, 1997, J NEUROSCI RES, V49, P229, DOI 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W; Knake S, 2010, MOVEMENT DISORD, V25, P1232, DOI 10.1002/mds.23054; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Mattis S, 1988, DEMENTIA RATING SCAL; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Paviour DC, 2007, MOVEMENT DISORD, V22, P68, DOI 10.1002/mds.21204; Payan CAM, 2002, MOVEMENT DISORD, V17, pS256; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Price S, 2004, NEUROIMAGE, V23, P663, DOI 10.1016/j.neuroimage.2004.06.013; Prodoehl J, 2013, MOVEMENT DISORD, V28, P1816, DOI 10.1002/mds.25491; Rizzo G, 2008, BRAIN, V131, P2690, DOI 10.1093/brain/awn195; Schocke MFH, 2002, NEUROLOGY, V58, P575, DOI 10.1212/WNL.58.4.575; Schwab R.S., 1969, 3 S PARK DIS, P152; Seppi K, 2006, MOVEMENT DISORD, V21, P847, DOI 10.1002/mds.20843; Simmons A, 1999, MAGNET RESON MED, V41, P1274, DOI 10.1002/(SICI)1522-2594(199906)41:6<1274::AID-MRM27>3.0.CO;2-1; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Tsuboi Y, 2003, NEUROLOGY, V60, P1766, DOI 10.1212/01.WNL.0000068011.21396.F4; Tsukamoto K, 2012, NEURORADIOLOGY, V54, P947, DOI 10.1007/s00234-012-1009-9; Whitwell JL, 2011, ARCH NEUROL-CHICAGO, V68, P753, DOI 10.1001/archneurol.2011.107	47	55	56	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112638	10.1371/journal.pone.0112638	http://dx.doi.org/10.1371/journal.pone.0112638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405990	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000347121300043
J	Yamada, A; Cox, MA; Gaffney, KA; Moreland, A; Boland, CR; Goel, A				Yamada, Atsushi; Cox, Mary A.; Gaffney, Kristin A.; Moreland, Amber; Boland, C. Richard; Goel, Ajay			Technical Factors Involved in the Measurement of Circulating MicroRNA Biomarkers for the Detection of Colorectal Neoplasia	PLOS ONE			English	Article							DIAGNOSTIC-MARKER; LUNG-CANCER; PLASMA; CHALLENGES; SIGNATURES; EXPRESSION; MIR-21; SERUM	Background: Circulating miRNAs are emerging as promising blood-based biomarkers for colorectal and other human cancers; however, technical factors that confound the development of these assays remain poorly understood and present a clinical challenge. The aim of this study was to systematically evaluate the effects of factors that may interfere with the accurate measurement of circulating miRNAs for clinical purposes. Methods: Blood samples from 53 subjects, including routinely drawn serum samples, matched plasma from 30 subjects, and matched serum samples drawn before and after bowel preparation for colonoscopy from 29 subjects were collected. Additionally, 38 serum specimens stored in the clinical laboratory for seven days were used to test the stability of miRNAs. Hemolysis controls with serial dilutions of hemoglobin were prepared. RNA was extracted from serum, plasma or hemolyzed controls with spiked-in cel-miR-39, and levels of miR-21, miR-29a, miR-125b and miR-16 were examined by real-time RT-PCR. Hemolysis was measured by spectrophotometry. Results: The expression levels of miR-16 and the degree of hemolysis were significantly higher in plasma than in serum (P<0.0001). Measured miR-21, miR-29a, miR-125b and miR-16 expression increased with hemoglobin levels in hemolyzed controls. The degree of hemolysis in serum samples correlated significantly with the levels of miR-21 (P<0.0001), miR-29a (P = 0.0002), miR-125b (P<0.0001) and miR-16 (P<0.0001). All four miRNAs showed significantly lower levels in sera that had been stored at 4 degrees C for seven days (P<0.0001). Levels of miR-21 (P<0.0001), miR-29a (P<0.0001) and miR-16 (P = 0.0003), and the degree of hemolysis (P = 0.0002) were significantly higher in sera drawn after vs. before bowel preparation. Conclusions: The measured levels of miRNAs in serum and plasma from same patients varied in the presence of hemolysis, and since hemolysis and other factors affected miRNA expression, it is important to consider these confounders while developing miRNA-based diagnostic assays.	[Yamada, Atsushi; Cox, Mary A.; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab, Dallas, TX 75246 USA; [Yamada, Atsushi; Cox, Mary A.; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA; [Gaffney, Kristin A.; Moreland, Amber] Baylor Univ, Med Ctr, Dept Internal Med, Dallas, TX USA	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Boland, CR (corresponding author), Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab, Dallas, TX 75246 USA.	rickbo@baylorhealth.edu; ajay.goel@baylorhealth.edu		Goel, Ajay/0000-0003-1396-6341	National Cancer Institute, National Institutes of Health [R01 CA72851, CA 181572]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA072851, R01CA181572] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA 181572 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; CRIPPS CM, 1968, J CLIN PATHOL, V21, P110, DOI 10.1136/jcp.21.1.110; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Fortunato O, 2014, MOLECULES, V19, P3038, DOI 10.3390/molecules19033038; Giraldez MD, 2013, CLIN GASTROENTEROL H, V11, P681, DOI 10.1016/j.cgh.2012.12.009; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Kanaan Z, 2012, ANN SURG, V256, P544, DOI 10.1097/SLA.0b013e318265bd6f; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Koberle V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075184; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561	27	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112481	10.1371/journal.pone.0112481	http://dx.doi.org/10.1371/journal.pone.0112481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405754	Green Submitted, gold, Green Published			2022-12-26	WOS:000347121300034
J	Zhang, F; Wang, XT; Qiu, XC; Wang, JJ; Fang, H; Wang, ZH; Sun, Y; Xia, ZF				Zhang, Fang; Wang, Xingtong; Qiu, Xiaochen; Wang, Junjie; Fang, He; Wang, Zhihong; Sun, Yu; Xia, Zhaofan			The Protective Effect of Esculentoside A on Experimental Acute Liver Injury in Mice	PLOS ONE			English	Article							ACUTE LUNG INJURY; NF-KAPPA-B; CARBON-TETRACHLORIDE; OXIDATIVE STRESS; APOPTOSIS; MODEL; LIPOPOLYSACCHARIDE; HEPATOTOXICITY; INTERLEUKIN-1; ACTIVATION	Inflammatory response and oxidative stress are considered to play an important role in the development of acute liver injury induced by carbon tetrachloride (CCl4) and galactosamine (GalN)/lipopolysaccharides (LPS). Esculentoside A (EsA), isolated from the Chinese herb phytolacca esculenta, has the effect of modulating immune response, cell proliferation and apoptosis as well as anti-inflammatory effects. The present study is to evaluate the protective effect of EsA on CCl4 and GalN/LPS-induced acute liver injury. In vitro, CCK-8 assays showed that EsA had no cytotoxicity, while it significantly reduced levels of TNF-alpha and cell death rate challenged by CCl4. Moreover, EsA treatment up-regulated PPAR-c expression of LO2 cells and reduced levels of reactive oxygen species (ROS) challenged by CCl4. In vivo, EsA prevented mice from CCl4-induced liver histopathological damage. In addition, levels of AST and ALT were significantly decreased by EsA treatment. Furthermore, the mice treated with EsA had a lower level of TNF-alpha, Interleukin (IL)-1 beta and IL-6 in mRNA expression. EsA prevented MDA release and increased GSH-Px activity in liver tissues. Immunohistochemical staining showed that over-expression of F4/80 and CD11b were markedly inhibited by EsA. The western bolt results showed that EsA significantly inhibited CCl4-induced phosphonated IkBalpha (P-I kappa B) and ERK. Furthermore, EsA treatment also alleviated GalN/LPS-induced acute liver injury on liver enzyme and histopathological damage. Unfortunately, our results exhibited that EsA had no effects on CCl4-induced hepatocyte apoptosis which were showed by TUNEL staining and Bax, Caspase-3 and cleaved Caspase-3 expression. Our results proved that EsA treatment attenuated CCl4 and GalN/LPS-induced acute liver injury in mice and its protective effects might be involved in inhibiting inflammatory response and oxidative stress, but not apoptosis with its underlying mechanism associated with PPAR-gamma, NF-kappa B and ERK signal pathways.	[Zhang, Fang; Wang, Xingtong; Wang, Junjie; Fang, He; Wang, Zhihong; Sun, Yu; Xia, Zhaofan] Second Mil Med Univ, Changhai Hosp, Dept Burn Surg, Shanghai, Peoples R China; [Zhang, Fang] 73901 Troop PLA, Shanghai, Peoples R China; [Qiu, Xiaochen] 309th Hosp PLA, Dept Gen Surg, Beijing, Peoples R China	Naval Medical University	Xia, ZF (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Burn Surg, Shanghai, Peoples R China.	xiazhaofan@163.com		Xia, Zhaofan/0000-0002-0806-1508	National Natural Science Foundation of China [81120108015]; National "973'' key project of China [2012CB518100]; 1255 Foundation of Changhai Hospital [CH125510200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "973'' key project of China(National Basic Research Program of China); 1255 Foundation of Changhai Hospital	This work was financially supported by the key project of the National Natural Science Foundation of China (No. 81120108015), the National "973'' key project of China (No. 2012CB518100) and the 1255 Foundation of Changhai Hospital (No. CH125510200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhondave PD, 2014, J ETHNOPHARMACOL, V151, P183, DOI 10.1016/j.jep.2013.10.025; Cui YM, 2014, MOLECULES, V19, P291, DOI 10.3390/molecules19010291; Domitrovic R, 2011, TOXICOLOGY, V280, P33, DOI 10.1016/j.tox.2010.11.005; El-Naggar SA, 2014, PHARM BIOL; Fan Q, 2013, EUR REV MED PHARMACO, V17, P3296; Hagiwara S, 2008, CRIT CARE MED, V36, P2407, DOI 10.1097/CCM.0b013e318180b3ba; He DK, 2014, INHAL TOXICOL, V26, P185, DOI 10.3109/08958378.2013.872213; Hu ZL, 2010, INT IMMUNOPHARMACOL, V10, P65, DOI 10.1016/j.intimp.2009.09.022; Hydes T, 2014, BMJ CASE REP; Ju DW, 1998, PHARMACOLOGY, V56, P187, DOI 10.1159/000028197; Jun F, 1992, Mediators Inflamm, V1, P375, DOI 10.1155/S0962935192000565; Kaneko M, 2013, J TOXICOL SCI, V38, P115, DOI 10.2131/jts.38.115; Li WQ, 2013, INT IMMUNOPHARMACOL, V16, P248, DOI 10.1016/j.intimp.2013.02.022; Liu CM, 2013, J AGR FOOD CHEM, V61, P1146, DOI 10.1021/jf304562b; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Ma HL, 2013, ARCH MED SCI, V9, P354, DOI 10.5114/aoms.2012.31439; Ma JQ, 2014, FOOD CHEM TOXICOL, V64, P41, DOI 10.1016/j.fct.2013.11.017; Man X, 2014, TUMOUR BIOL; Montanari RM, 2012, MOLECULES, V17, P9728, DOI 10.3390/molecules17089728; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Patel RP, 2014, WORLD J HEPATOL, V6, P1, DOI 10.4254/wjh.v6.i1.1; Sato A, 2014, PLOS ONE, V25; Seki A, 2013, HEPATOLOGY, V58, P1133, DOI 10.1002/hep.26470; Sun F, 2001, BBA-MOL BASIS DIS, V1535, P186, DOI 10.1016/S0925-4439(00)00098-3; Sun HY, 2011, J HEPATOL, V54, P471, DOI 10.1016/j.jhep.2010.08.011; Tao LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026055; Wang Y, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/153902; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wu F, 2007, BIOORG MED CHEM LETT, V17, P6430, DOI 10.1016/j.bmcl.2007.10.006; Wu Hai-Jian, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3633; Xiao ZY, 2006, INT J RADIAT ONCOL, V65, P882, DOI 10.1016/j.ijrobp.2006.01.031; Xiao ZW, 2002, ACTA PHARMACOL SIN, V23, P638; Xiao ZY, 2004, ACTA PHARMACOL SIN, V25, P817; Yin GJ, 2011, FISH PHYSIOL BIOCHEM, V37, P209, DOI 10.1007/s10695-010-9436-1; Yu H, 2014, INT IMMUNOPHARMACOL; Zhong WT, 2013, J SURG RES, V185, P364, DOI 10.1016/j.jss.2013.05.018; Zhou RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023079	37	46	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113107	10.1371/journal.pone.0113107	http://dx.doi.org/10.1371/journal.pone.0113107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405982	Green Submitted, gold, Green Published			2022-12-26	WOS:000347121300078
J	Hayden, CJ; Beman, JM				Hayden, Curtis J.; Beman, J. Michael			High Abundances of Potentially Active Ammonia-Oxidizing Bacteria and Archaea in Oligotrophic, High-Altitude Lakes of the Sierra Nevada, California, USA	PLOS ONE			English	Article							PHOSPHORUS LIMITATION; FRESH-WATER; NITRIFYING ARCHAEA; NITROGEN DEPOSITION; DIVERSITY; ECOLOGY; MARINE; NITRIFICATION; CRENARCHAEOTA; POPULATIONS	Nitrification plays a central role in the nitrogen cycle by determining the oxidation state of nitrogen and its subsequent bioavailability and cycling. However, relatively little is known about the underlying ecology of the microbial communities that carry out nitrification in freshwater ecosystems-and particularly within high-altitude oligotrophic lakes, where nitrogen is frequently a limiting nutrient. We quantified ammonia-oxidizing archaea (AOA) and bacteria (AOB) in 9 high-altitude lakes (2289-3160 m) in the Sierra Nevada, California, USA, in relation to spatial and biogeochemical data. Based on their ammonia monooxygenase (amoA) genes, AOB and AOA were frequently detected. AOB were present in 88% of samples and were more abundant than AOA in all samples. Both groups showed.100 fold variation in abundance between different lakes, and were also variable through time within individual lakes. Nutrient concentrations (ammonium, nitrite, nitrate, and phosphate) were generally low but also varied across and within lakes, suggestive of active internal nutrient cycling; AOB abundance was significantly correlated with phosphate (r(2) = 0.32, p < 0.1), whereas AOA abundance was inversely correlated with lake elevation (r(2) = 0.43, p < 0.05). We also measured low rates of ammonia oxidation-indicating that AOB, AOA, or both, may be biogeochemically active in these oligotrophic ecosystems. Our data indicate that dynamic populations of AOB and AOA are found in oligotrophic, high-altitude, freshwater lakes.	[Hayden, Curtis J.; Beman, J. Michael] Univ Calif Merced, Life & Environm Sci & Sierra Nevada Res Inst, Merced, CA 95343 USA	University of California System; University of California Merced	Beman, JM (corresponding author), Univ Calif Merced, Life & Environm Sci & Sierra Nevada Res Inst, Merced, CA 95343 USA.	jmbeman@gmail.com			University of California; UC Merced Sierra Nevada Research Institute	University of California(University of California System); UC Merced Sierra Nevada Research Institute	This work was supported University of California start-up funds (to JMB) and the UC Merced Sierra Nevada Research Institute (to JMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguet JC, 2008, ENVIRON MICROBIOL, V10, P1080, DOI 10.1111/j.1462-2920.2007.01498.x; Auguet JC, 2013, FEMS MICROBIOL ECOL, V84, P154, DOI 10.1111/1574-6941.12047; Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Auguet JC, 2011, APPL ENVIRON MICROB, V77, P1937, DOI 10.1128/AEM.01213-10; Baron JS, 2013, BIOGEOCHEMISTRY, V114, P71, DOI 10.1007/s10533-012-9788-y; Baron JS, 2006, ECOL APPL, V16, P433, DOI 10.1890/1051-0761(2006)016[0433:HNDTDA]2.0.CO;2; Beman JM, 2012, LIMNOL OCEANOGR, V57, P711, DOI 10.4319/lo.2012.57.3.0711; Beman JM, 2010, ENVIRON MICROBIOL, V12, P1282, DOI 10.1111/j.1462-2920.2010.02172.x; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Bytnerowicz A, 2002, ENVIRON POLLUT, V118, P187, DOI 10.1016/S0269-7491(01)00312-8; Callieri C, 2009, APPL ENVIRON MICROB, V75, P7298, DOI 10.1128/AEM.01231-09; Cebron A, 2004, APPL ENVIRON MICROB, V70, P6726, DOI 10.1128/AEM.70.11.6726-6737.2004; Church MJ, 2010, ENVIRON MICROBIOL, V12, P679, DOI 10.1111/j.1462-2920.2009.02108.x; Clarisse L, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013291; Clow DW, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008316; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Eilers JM, 1987, CHARACTERISTICS LAKE, VII; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Finlay JC, 2007, ECOL APPL, V17, P2323, DOI 10.1890/07-0245.1; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; French E, 2012, APPL ENVIRON MICROB, V78, P5773, DOI 10.1128/AEM.00432-12; Goldman C. R., 1983, LIMNOLOGY; HALL GH, 1984, MICROB ECOL, V10, P37, DOI 10.1007/BF02011593; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Hu AY, 2010, FRESHWATER BIOL, V55, P2375, DOI 10.1111/j.1365-2427.2010.02454.x; Hugoni M, 2013, RES MICROBIOL, V164, P360, DOI 10.1016/j.resmic.2013.01.004; Junier P, 2008, APPL ENVIRON MICROB, V74, P5231, DOI 10.1128/AEM.00288-08; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lomas MW, 2006, LIMNOL OCEANOGR, V51, P2453, DOI 10.4319/lo.2006.51.5.2453; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Meixner T, 2004, J HYDROL, V285, P272, DOI 10.1016/j.jhydrol.2003.09.005; Merbt SN, 2012, FEMS MICROBIOL LETT, V327, P41, DOI 10.1111/j.1574-6968.2011.02457.x; Murphy DD, 2000, LAKE TAHOE WATERSHED, V1; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; RUDD JWM, 1988, SCIENCE, V240, P1515, DOI 10.1126/science.240.4858.1515; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Sickman JO, 2001, WATER RESOUR RES, V37, P1445, DOI 10.1029/2000WR900371; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Small GE, 2013, LIMNOL OCEANOGR, V58, P276, DOI 10.4319/lo.2013.58.1.0276; Sommaruga R, 2001, J PHOTOCH PHOTOBIO B, V62, P35, DOI 10.1016/S1011-1344(01)00154-3; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Vrede T, 2009, FRESHWATER BIOL, V54, P331, DOI 10.1111/j.1365-2427.2008.02118.x; Ward BB, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P199, DOI 10.1016/B978-0-12-372522-6.00005-0; Whitby CB, 2001, ANTON LEEUW INT J G, V79, P179, DOI 10.1023/A:1010202211368; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273	55	27	29	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111560	10.1371/journal.pone.0111560	http://dx.doi.org/10.1371/journal.pone.0111560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402442	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700016
J	Malinova, I; Kunz, HH; Alseekh, S; Herbst, K; Fernie, AR; Gierth, M; Fettke, J				Malinova, Irina; Kunz, Hans-Henning; Alseekh, Saleh; Herbst, Karoline; Fernie, Alisdair R.; Gierth, Markus; Fettke, Joerg			Reduction of the Cytosolic Phosphoglucomutase in Arabidopsis Reveals Impact on Plant Growth, Seed and Root Development, and Carbohydrate Partitioning	PLOS ONE			English	Article							YEAST-DERIVED INVERTASE; STARCH DEGRADATION; CELL-WALL; BIOCHEMICAL-CHARACTERIZATION; ANTISENSE REPRESSION; MALTOSE METABOLISM; THALIANA L; WILD-TYPE; LEAVES; POTATO	Phosphoglucomutase (PGM) catalyses the interconversion of glucose 1-phosphate (G1P) and glucose 6-phosphate (G6P) and exists as plastidial (pPGM) and cytosolic (cPGM) isoforms. The plastidial isoform is essential for transitory starch synthesis in chloroplasts of leaves, whereas the cytosolic counterpart is essential for glucose phosphate partitioning and, therefore, for syntheses of sucrose and cell wall components. In Arabidopsis two cytosolic isoforms (PGM2 and PGM3) exist. Both PGM2 and PGM3 are redundant in function as single mutants reveal only small or no alterations compared to wild type with respect to plant primary metabolism. So far, there are no reports of Arabidopsis plants lacking the entire cPGM or total PGM activity, respectively. Therefore, amiRNA transgenic plants were generated and used for analyses of various parameters such as growth, development, and starch metabolism. The lack of the entire cPGM activity resulted in a strongly reduced growth revealed by decreased rosette fresh weight, shorter roots, and reduced seed production compared to wild type. By contrast content of starch, sucrose, maltose and cell wall components were significantly increased. The lack of both cPGM and pPGM activities in Arabidopsis resulted in dwarf growth, prematurely die off, and inability to develop a functional inflorescence. The combined results are discussed in comparison to potato, the only described mutant with lack of total PGM activity.	[Malinova, Irina; Herbst, Karoline; Fettke, Joerg] Univ Potsdam, Potsdam, Germany; [Kunz, Hans-Henning] Washington State Univ, Pullman, WA 99164 USA; [Alseekh, Saleh; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Kunz, Hans-Henning; Gierth, Markus] Univ Cologne, Dept Bot 2, D-50931 Cologne, Germany	University of Potsdam; Washington State University; Max Planck Society; University of Cologne	Fettke, J (corresponding author), Univ Potsdam, Potsdam, Germany.	fettke@uni-potsdam.de		Fettke, Joerg/0000-0003-0137-7611	Deutsche Forschungsgemeinschaft [DFG-Az. FE 1030/1-1, FE 1030/2-1]; Human Frontier Science Program Long-Term fellowship; Alexander von Humboldt Feodor Lynen fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program Long-Term fellowship(Human Frontier Science Program); Alexander von Humboldt Feodor Lynen fellowship	The authors acknowledge financial support by the Deutsche Forschungsgemeinschaft to J.F. (DFG-Az. FE 1030/1-1 and FE 1030/2-1). H.-H. K. was supported by the Human Frontier Science Program Long-Term fellowship and an Alexander von Humboldt Feodor Lynen fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Burkle L, 1998, PLANT PHYSIOL, V118, P59, DOI 10.1104/pp.118.1.59; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; DICKINSON CD, 1991, PLANT PHYSIOL, V95, P420, DOI 10.1104/pp.95.2.420; Egli B, 2010, PLANT PHYSIOL, V154, P1659, DOI 10.1104/pp.110.165027; Fernie AR, 2002, PLANT PHYSIOL BIOCH, V40, P921, DOI 10.1016/S0981-9428(02)01457-2; Fernie AR, 2002, PLANTA, V214, P510, DOI 10.1007/s004250100644; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; Fettke J, 2005, PLANT CELL PHYSIOL, V46, P1987, DOI 10.1093/pcp/pci214; Fettke J, 2005, PLANT J, V43, P568, DOI 10.1111/j.1365-313X.2005.02475.x; Fettke J, 2004, PLANT J, V39, P933, DOI 10.1111/j.1365-313X.2004.02181.x; Fettke J, 2006, THESIS U POTSDAM POT; Fettke J, 2012, ESSENTIAL REV EXPT B, V5, P309; Fettke J, 2008, PLANT PHYSIOL, V148, P1614, DOI 10.1104/pp.108.127969; Fettke J, 2011, J PLANT PHYSIOL, V168, P1415, DOI 10.1016/j.jplph.2010.09.008; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Fettke J, 2009, J EXP BOT, V60, P2907, DOI 10.1093/jxb/erp054; Foster C.F., 2010, J VIS EXP, V37, DOI [10.3791/1837, DOI 10.3791/1837]; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; HANSON KR, 1988, PLANT PHYSIOL, V88, P838, DOI 10.1104/pp.88.3.838; HEINEKE D, 1992, PLANT PHYSIOL, V100, P301, DOI 10.1104/pp.100.1.301; Herbst K, 2011, THESIS U POTSDAM POT; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Lou Y, 2007, PLANT CELL, V19, P163, DOI 10.1105/tpc.106.045658; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Lytovchenko A, 2003, PLANT PHYSIOL BIOCH, V41, P193, DOI 10.1016/S0981-9428(03)00010-X; Lytovchenko A, 2002, PLANTA, V215, P1013, DOI 10.1007/s00425-002-0826-1; Manjunath S, 1998, PLANT PHYSIOL, V117, P997, DOI 10.1104/pp.117.3.997; Mitra S, 2010, GLYCOBIOLOGY, V20, P1233, DOI 10.1093/glycob/cwq081; MUHLBACH H, 1978, PLANTA, V141, P65, DOI 10.1007/BF00387746; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakazawa M, 2003, BIOTECHNIQUES, V34, P28, DOI 10.2144/03341bm02; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; RIESMEIER JW, 1994, EMBO J, V13, P1; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; STITT M, 1989, METHOD ENZYMOL, V174, P518; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb S, 2009, PLANT PHYSIOL, V151, P1769, DOI 10.1104/pp.109.144931; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; VONSCHAEWEN A, 1990, EMBO J, V9, P3033, DOI 10.1002/j.1460-2075.1990.tb07499.x; WAFFENSCHMIDT S, 1987, ANAL BIOCHEM, V165, P337, DOI 10.1016/0003-2697(87)90278-8; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Yu TS, 2000, PLANT PHYSIOL, V123, P319, DOI 10.1104/pp.123.1.319	52	42	49	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112468	10.1371/journal.pone.0112468	http://dx.doi.org/10.1371/journal.pone.0112468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401493	gold, Green Submitted, Green Published			2022-12-26	WOS:000345158700047
J	Melbo-Jorgensen, C; Ness, N; Andersen, S; Valkov, A; Donnem, T; Al-Saad, S; Kiselev, Y; Berg, T; Nordby, Y; Bremnes, RM; Busund, LT; Richardsen, E				Melbo-Jorgensen, Christian; Ness, Nora; Andersen, Sigve; Valkov, Andrej; Donnem, Tom; Al-Saad, Samer; Kiselev, Yury; Berg, Thomas; Nordby, Yngve; Bremnes, Roy M.; Busund, Lill-Tove; Richardsen, Elin			Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6	PLOS ONE			English	Article							MICRORNA EXPRESSION; RESISTANCE; INVASION; TARGET; GENES	Aim: microRNAs (miRNAs) are involved in various neoplastic diseases, including prostate cancer (PCs). The aim of this study was to investigate the miRNA profile in PC tissue, to assess their association with clinicopathologic data, and to evaluate the potential of miRNAs as diagnostic and prognostic markers. Materials and Methods: From a cohort of 535 patients submitted to radical prostatectomy (RP), a sample of 30 patients (14 patients with rapid biochemical failure (BF) and 16 patients without BF) with Gleason score 7 were analyzed. A total of 1435 miRNAs were quantified by microarray hybridization, and selected miRNAs with the highest Standard deviation (n = 50) were validated by real-time quantitative PCR (qRT-PCR). In situ hybridization (ISH) was used to evaluate the expression of miR-21. Results: miR-21 was the only miR that was significantly up-regulated in the BF group (p = 0.045) miR-21 was up-regulated in patients with BF compared with non-BF group (p = 0.05). In univariate analyses, high stromal expression of miR-21 had predictive impact on biochemical failure-free survival (BFFS) and clinical failure-free survival (CFFS) (p = 0.006 and p = 0.04, respectively). In the multivariate analysis, high stromal expression of miR-21 expression was found to be an independent prognostic factor for BFFS in patients with Gleason score 6 (HR 2.41, CI 95% 1.06-5.49, p = 0.037). Conclusion: High stromal expression of miR-21 was associated with poor biochemical recurrence-free survival after RP. For patients with Gleason score 6, miR-21 may help predict the risk of future disease progression and thereby help select patients for potential adjuvant treatment or a more stringent follow-up.	[Melbo-Jorgensen, Christian; Ness, Nora; Al-Saad, Samer; Kiselev, Yury; Busund, Lill-Tove; Richardsen, Elin] UIT, Dept Med Biol, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Nordby, Yngve; Bremnes, Roy M.] UIT, Dept Clin Med, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Bremnes, Roy M.] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Valkov, Andrej; Al-Saad, Samer; Berg, Thomas; Busund, Lill-Tove; Richardsen, Elin] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway; [Kiselev, Yury] UIT, Dept Pharm, Tromso, Norway; [Nordby, Yngve] Univ Hosp North Norway, Dept Urol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Melbo-Jorgensen, C (corresponding author), UIT, Dept Med Biol, Tromso, Norway.	Christian.n.melbo-jorgensen@uit.no		Kiselev, Yury/0000-0002-6753-8572	Helse Nord, The Northern Health Administration; University of Tromso Arctic University of Norway	Helse Nord, The Northern Health Administration; University of Tromso Arctic University of Norway	This study was supported by grants from Helse Nord, The Northern Health Administration (www.helse-nord.no) and University of Tromso Arctic University of Norway (www.uit.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Arora R, 2004, CANCER-AM CANCER SOC, V100, P2362, DOI 10.1002/cncr.20243; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Breidablik Hans Johan, 2013, Tidsskr Nor Laegeforen, V133, P1711, DOI 10.4045/tidsskr.13.0023; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Bronisz A, 2011, Nat Cell Biol, V14, P159, DOI 10.1038/ncb2396; Bullock MD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.213; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cheng L, 2012, HISTOPATHOLOGY, V60, P87, DOI 10.1111/j.1365-2559.2011.04025.x; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Etzioni R, 2012, CLIN CANCER RES, V18, P6742, DOI 10.1158/1078-0432.CCR-12-1537; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kielhorn E, 2003, INT J CANCER, V103, P652, DOI 10.1002/ijc.10893; Li T, 2012, J UROLOGY, V187, P1466, DOI 10.1016/j.juro.2011.11.082; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Shi GH, 2010, ACTA PHARMACOL SIN, V31, P867, DOI 10.1038/aps.2010.48; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yao Q, 2011, INT J CANCER, V128, P1783, DOI 10.1002/ijc.25506	30	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113039	10.1371/journal.pone.0113039	http://dx.doi.org/10.1371/journal.pone.0113039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401698	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700099
J	Sato, K; Choyke, PL; Kobayashi, H				Sato, Kazuhide; Choyke, Peter L.; Kobayashi, Hisataka			Photoimmunotherapy of Gastric Cancer Peritoneal Carcinomatosis in a Mouse Model	PLOS ONE			English	Article							CYTOSINE-ANALOG CS-682; ORTHOTOPIC MODEL; FLUORESCENT; EFFICACY; SURVIVAL; GROWTH; TUMORS	Photoimmunotherapy (PIT) is a new cancer treatment that combines the specificity of antibodies for targeting tumors with the toxicity induced by photosensitizers after exposure to near infrared (NIR) light. We performed PIT in a model of disseminated gastric cancer peritoneal carcinomatosis and monitored efficacy with in vivo GFP fluorescence imaging. In vitro and in vivo experiments were conducted with a HER2-expressing, GFP-expressing, gastric cancer cell line (N87-GFP). A conjugate comprised of a photosensitizer, IR-700, conjugated to trastuzumab (tra-IR700), followed by NIR light was used for PIT. In vitro PIT was evaluated by measuring cytotoxicity with dead staining and a decrease in GFP fluorescence. In vivo PIT was evaluated in a disseminated peritoneal carcinomatosis model and a flank xenograft using tumor volume measurements and GFP fluorescence intensity. In vivo anti-tumor effects of PIT were confirmed by significant reductions in tumor volume (at day 15, p<0.0001 vs. control) and GFP fluorescence intensity (flank model: at day 3, PIT treated vs. control p<0.01 and peritoneal disseminated model: at day 3 PIT treated vs. control, p<0.05). Cytotoxic effects in vitro were shown to be dependent on the light dose and caused necrotic cell rupture leading to GFP release and a decrease in fluorescence intensity in vitro. Thus, loss of GFP fluorescence served as a useful biomarker of cell necrosis after PIT.	[Sato, Kazuhide; Choyke, Peter L.; Kobayashi, Hisataka] NCI, Mol Imaging Program, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kobayashi, H (corresponding author), NCI, Mol Imaging Program, Ctr Canc Res, Bethesda, MD 20892 USA.	Kobayash@mail.nih.gov		Sato, Kazuhide/0000-0003-3025-088X	NIH Intramural program; JSPS; NATIONAL CANCER INSTITUTE [ZIABC011513] Funding Source: NIH RePORTER	NIH Intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH Intramural program and JSPS Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caysa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047927; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Gretschel S, 2006, BRIT J SURG, V93, P1530, DOI 10.1002/bjs.5513; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2002, LANCET ONCOL, V3, P546, DOI 10.1016/S1470-2045(02)00848-3; Katz MH, 2004, CANCER RES, V64, P1828, DOI 10.1158/0008-5472.CAN-03-3350; Katz MH, 2003, CANCER RES, V63, P5521; Kimura H, 2010, J CELL BIOCHEM, V110, P1439, DOI 10.1002/jcb.22693; MEW D, 1983, J IMMUNOL, V130, P1473; Mitsunaga M, 2012, BIOCONJUGATE CHEM, V23, P604, DOI 10.1021/bc200648m; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Nakajima T, 2013, THERANOSTICS, V3, P357, DOI 10.7150/thno.5908; Nakajima T, 2012, CANCER RES, V72, P4622, DOI 10.1158/0008-5472.CAN-12-1298; Sano K, 2013, ACS NANO, V7, P717, DOI 10.1021/nn305011p; Sato K, 2014, MOL ONCOL, V8, P620, DOI 10.1016/j.molonc.2014.01.006; Sato K, 2011, MOL BIOL CELL, V22, P3103, DOI 10.1091/mbc.E11-03-0274; Shirasu N., 2014, INT J CANCER, P1; Spring BQ, 2014, P NATL ACAD SCI USA, V111, pE933, DOI 10.1073/pnas.1319493111; Sugarbaker PH, 2000, ONCOLOGY-BASEL, V58, P96, DOI 10.1159/000012086; Thomassen I, 2014, INT J CANCER, V134, P622, DOI 10.1002/ijc.28373; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Walsh GM, 1998, J IMMUNOL METHODS, V217, P153, DOI 10.1016/S0022-1759(98)00103-3; Yamashita-Kashima Y, 2014, GASTRIC CANCER, V17, P638, DOI 10.1007/s10120-013-0329-8; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206	25	58	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113276	10.1371/journal.pone.0113276	http://dx.doi.org/10.1371/journal.pone.0113276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401794	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700128
J	Asaoka, Y; Tateishi, R; Nakagomi, R; Kondo, M; Fujiwara, N; Minami, T; Sato, M; Uchino, K; Enooku, K; Nakagawa, H; Kondo, Y; Shiina, S; Yoshida, H; Koike, K				Asaoka, Yoshinari; Tateishi, Ryosuke; Nakagomi, Ryo; Kondo, Mayuko; Fujiwara, Naoto; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Nakagawa, Hayato; Kondo, Yuji; Shiina, Shuichiro; Yoshida, Haruhiko; Koike, Kazuhiko			Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; DONOR LIVER-TRANSPLANTATION; PORTAL VENOUS INVASION; REPEAT HEPATECTOMY; TUMOR THROMBUS; PROGNOSIS; CANCER; JAPAN; RECURRENCE; CIRRHOSIS	Background: Vascular invasion in patients with hepatocellular carcinoma (HCC) is representative of advanced disease with an extremely poor prognosis. The detailed course of its development has not been fully elucidated. Methods: We enrolled 1057 consecutive patients with HCC who had been treated with curative intent by radiofrequency ablation (RFA) as an initial therapy from 1999 to 2008 at our department. We analyzed the incidence rate of and predictive factors for vascular invasion. The survival rate after detection of vascular invasion was also analyzed. Results: During a mean follow-up period of 4.5 years, 6075 nodules including primary and recurrent lesions were treated by RFA. Vascular invasion was observed in 97 patients. The rate of vascular invasion associated with site of original RFA procedure was 0.66% on a nodule basis. The incidence rates of vascular invasion on a patient basis at 1, 3, and 5 years were 1.1%, 5.9%, and 10.4%, respectively. Univariate analysis revealed that tumor size, tumor number, alpha-fetoprotein (AFP), des-gamma-carboxy prothrombin (DCP), and Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein were significant risk predictors of vascular invasion. In multivariate analysis, DCP was the most significant predictor for vascular invasion (compared with a DCP of <= 100 mAu/mL, the hazard ratio was 1.95 when DCP was 101-200 mAu/mL and 3.22 when DCP was > 200 mAu/mL). The median survival time after development of vascular invasion was only 6 months. Conclusion: Vascular invasion occurs during the clinical course of patients initially treated with curative intent. High-risk patients may be identified using tumor markers.	[Asaoka, Yoshinari; Tateishi, Ryosuke; Nakagomi, Ryo; Kondo, Mayuko; Fujiwara, Naoto; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Nakagawa, Hayato; Kondo, Yuji; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shiina, Shuichiro] Juntendo Univ, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan	University of Tokyo; Juntendo University	Tateishi, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	tateishi-tky@umin.ac.jp	Nakagawa, Hayato/I-2837-2012; Fujiwara, Naoto/Y-5938-2019; Asaoka, Yoshinari/ABC-5412-2021; Tateishi, Ryosuke/G-7758-2014	Nakagawa, Hayato/0000-0002-6973-5094; Fujiwara, Naoto/0000-0002-4109-3421; Asaoka, Yoshinari/0000-0002-2805-8226; Tateishi, Ryosuke/0000-0003-3021-2517	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis)	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis)	This work was supported by Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S; ALBACETE RA, 1967, ANN INTERN MED, V67, P337, DOI 10.7326/0003-4819-67-2-337; Baldan A, 2006, ALIMENT PHARM THER, V24, P1495, DOI 10.1111/j.1365-2036.2006.03136.x; FUJII T, 1993, JPN J CLIN ONCOL, V23, P105; Giannelli G, 2002, HEPATOL RES, V24, P50, DOI 10.1016/S1386-6346(02)00027-X; Hasegawa K, 2008, J GASTROINTEST SURG, V12, P858, DOI 10.1007/s11605-007-0464-9; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; INAMOTO K, 1981, AM J ROENTGENOL, V136, P349, DOI 10.2214/ajr.136.2.349; Ito T, 2007, LIVER TRANSPLANT, V13, P1637, DOI 10.1002/lt.21281; Jeong SW, 2013, GUT LIVER, V7, P696, DOI 10.5009/gnl.2013.7.6.696; Kobayashi M, 2009, CANCER-AM CANCER SOC, V115, P571, DOI 10.1002/cncr.24031; Koike Y, 2001, CANCER, V91, P561, DOI 10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N; Liang HH, 2008, ANN SURG ONCOL, V15, P3484, DOI 10.1245/s10434-008-0076-y; Lin SM, 2004, GASTROENTEROLOGY, V127, P1714, DOI 10.1053/j.gastro.2004.09.003; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; MATHIEU D, 1984, RADIOLOGY, V152, P127, DOI 10.1148/radiology.152.1.6328574; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P850, DOI 10.1093/jjco/hyp106; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mitani T, 1992, Radiat Med, V10, P232; Murata K, 2009, INT J ONCOL, V35, P1005, DOI 10.3892/ijo_00000415; Nagasue N, 1996, BRIT J SURG, V83, P127, DOI 10.1002/bjs.1800830142; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qin LX, 2003, WORLD J GASTROENTERO, V9, P385, DOI 10.3748/wjg.v9.i3.385; Sato M, 2012, J GASTROENTEROL, V47, P1125, DOI 10.1007/s00535-012-0569-0; Sato T, 2009, HEPATOL INT, V3, P544, DOI 10.1007/s12072-009-9145-y; SAWABE M, 1987, ACTA PATHOL JAPON, V37, P1389; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Shimada M, 2005, TRANSPL P, V37, P1177, DOI 10.1016/j.transproceed.2004.12.030; Shirabe K, 2007, J SURG ONCOL, V95, P235, DOI 10.1002/jso.20655; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403; Takahashi Shunsuke, 2008, Oncology, V75 Suppl 1, P91, DOI 10.1159/000173429; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Tateishi R, 2006, HEPATOLOGY, V44, P1518, DOI 10.1002/hep.21408; Torzilli G, 1999, HEPATOLOGY, V30, P889, DOI 10.1002/hep.510300411; VANGANSBEKE D, 1985, AM J ROENTGENOL, V144, P749, DOI 10.2214/ajr.144.4.749	37	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111662	10.1371/journal.pone.0111662	http://dx.doi.org/10.1371/journal.pone.0111662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397677	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500022
J	Su, HJ; Hogenhout, SA; Al-Sadi, AM; Kuo, CH				Su, Huei-Jiun; Hogenhout, Saskia A.; Al-Sadi, Abdullah M.; Kuo, Chih-Horng			Complete Chloroplast Genome Sequence of Omani Lime (Citrus aurantiifolia) and Comparative Analysis within the Rosids	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; INDEPENDENT TRANSFERS; GENETIC DIVERSITY; ALIGNMENT; IDENTIFICATION; ORGANIZATION; DNA; AURANTIFOLIA; GENERATION; EVOLUTION	The genus Citrus contains many economically important fruits that are grown worldwide for their high nutritional and medicinal value. Due to frequent hybridizations among species and cultivars, the exact number of natural species and the taxonomic relationships within this genus are unclear. To compare the differences between the Citrus chloroplast genomes and to develop useful genetic markers, we used a reference-assisted approach to assemble the complete chloroplast genome of Omani lime (C. aurantiifolia). The complete C. aurantiifolia chloroplast genome is 159,893 bp in length; the organization and gene content are similar to most of the rosids lineages characterized to date. Through comparison with the sweet orange (C. sinensis) chloroplast genome, we identified three intergenic regions and 94 simple sequence repeats (SSRs) that are potentially informative markers with resolution for interspecific relationships. These markers can be utilized to better understand the origin of cultivated Citrus. A comparison among 72 species belonging to 10 families of representative rosids lineages also provides new insights into their chloroplast genome evolution.	[Su, Huei-Jiun] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Hogenhout, Saskia A.] John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England; [Al-Sadi, Abdullah M.] Sultan Qaboos Univ, Dept Crop Sci, Al Khoud, Oman; [Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei, Taiwan; [Kuo, Chih-Horng] Acad Sinica, Taipei 115, Taiwan; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	National Taiwan University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Sultan Qaboos University; Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University	Kuo, CH (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	chk@gate.sinica.edu.tw	Kuo, Chih-Horng/E-2045-2013; Hogenhout, Saskia A/D-9266-2012; Al-Sadi, Abdullah M./D-6766-2012	Kuo, Chih-Horng/0000-0002-2857-0529; Hogenhout, Saskia A/0000-0003-1371-5606; Al-Sadi, Abdullah M./0000-0002-3419-8268; Su, Huei-Jiun/0000-0001-5751-7260	Biotechnology and Biological Sciences Research Council [BB/J004553/1]; Gatsby Charitable Foundation; Sultan Qaboos University [SR/AGR/CROP/13/01]; Institute of Plant and Microbial Biology at Academia Sinica; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0623] Funding Source: researchfish; BBSRC [BBS/E/J/000C0623] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; Sultan Qaboos University; Institute of Plant and Microbial Biology at Academia Sinica; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this work was provided by research grants from Biotechnology and Biological Sciences Research Council (BB/J004553/1) and the Gatsby Charitable Foundation to SAH, Sultan Qaboos University (SR/AGR/CROP/13/01) to AMA, and the Institute of Plant and Microbial Biology at Academia Sinica to CHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2012, GENOME BIOL EVOL, V4, P1316, DOI 10.1093/gbe/evs110; Al-Sadi AM, 2012, EUPHYTICA, V188, P285, DOI 10.1007/s10681-012-0728-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davies FS, 1994, CITRUS, P1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ezeabara C. A., 2014, International Research Journal of Pure and Applied Chemistry, V4, P137, DOI 10.9734/IRJPAC/2014/5831; Faghihi MM, 2011, PLANT DIS, V95, P419, DOI 10.1094/PDIS-06-10-0400; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GANTT JS, 1991, EMBO J, V10, P3073, DOI 10.1002/j.1460-2075.1991.tb07859.x; Goremykin V, 2003, PLANT SYST EVOL, V242, P119, DOI 10.1007/s00606-003-0056-4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Hynniewta M, 2014, META GENE, V2, P237, DOI 10.1016/j.mgene.2014.01.008; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Kane N, 2012, AM J BOT, V99, P320, DOI 10.3732/ajb.1100570; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068518; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Mabberley DJ, 2004, BLUMEA, V49, P481; Magee Alan M, 2010, Genome Res, V20, P1700, DOI 10.1101/gr.111955.110; MAIXNER M, 1995, EUR J PLANT PATHOL, V101, P241, DOI 10.1007/BF01874780; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Ohtani K, 2002, P NATL ACAD SCI USA, V99, P2439, DOI 10.1073/pnas.042448499; Penjor T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062574; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Richardson AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-29; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Sloan DB, 2012, NEW PHYTOL, V196, P1228, DOI 10.1111/j.1469-8137.2012.04340.x; Taheri F, 2011, MOL BIOSYST, V7, P3028, DOI 10.1039/c1mb05268c; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; Ueda M, 2008, MOL BIOL EVOL, V25, P1566, DOI 10.1093/molbev/msn102; Ueda M, 2007, GENE, V402, P51, DOI 10.1016/j.gene.2007.07.019; VAND SH, 2012, INDIAN J SCI TECHNOL, V5, P3670; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Worberg A, 2009, TAXON, V58, P468, DOI 10.1002/tax.582012; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Zafari S, 2012, ACTA PHYSIOL PLANT, V34, P561, DOI 10.1007/s11738-011-0855-0; Zamharir MG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121	61	58	63	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113049	10.1371/journal.pone.0113049	http://dx.doi.org/10.1371/journal.pone.0113049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398081	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558500128
J	Tchitchek, N; Safronetz, D; Rasmussen, AL; Martens, C; Virtaneva, K; Porcella, SF; Feldmann, H; Ebihara, H; Katze, MG				Tchitchek, Nicolas; Safronetz, David; Rasmussen, Angela L.; Martens, Craig; Virtaneva, Kimmo; Porcella, Stephen F.; Feldmann, Heinz; Ebihara, Hideki; Katze, Michael G.			Sequencing, Annotation and Analysis of the Syrian Hamster (Mesocricetus auratus) Transcriptome	PLOS ONE			English	Article							GUINEA-PIG; VIRUS; MODEL; EVOLUTION; DISCOVERY; SEARCH	Background: The Syrian hamster (golden hamster, Mesocricetus auratus) is gaining importance as a new experimental animal model for multiple pathogens, including emerging zoonotic diseases such as Ebola. Nevertheless there are currently no publicly available transcriptome reference sequences or genome for this species. Results: A cDNA library derived from mRNA and snRNA isolated and pooled from the brains, lungs, spleens, kidneys, livers, and hearts of three adult female Syrian hamsters was sequenced. Sequence reads were assembled into 62,482 contigs and 111,796 reads remained unassembled (singletons). This combined contig/singleton dataset, designated as the Syrian hamster transcriptome, represents a total of 60,117,204 nucleotides. Our Mesocricetus auratus Syrian hamster transcriptome mapped to 11,648 mouse transcripts representing 9,562 distinct genes, and mapped to a similar number of transcripts and genes in the rat. We identified 214 quasi-complete transcripts based on mouse annotations. Canonical pathways involved in a broad spectrum of fundamental biological processes were significantly represented in the library. The Syrian hamster transcriptome was aligned to the current release of the Chinese hamster ovary (CHO) cell transcriptome and genome to improve the genomic annotation of this species. Finally, our Syrian hamster transcriptome was aligned against 14 other rodents, primate and laurasiatheria species to gain insights about the genetic relatedness and placement of this species. Conclusions: This Syrian hamster transcriptome dataset significantly improves our knowledge of the Syrian hamster's transcriptome, especially towards its future use in infectious disease research. Moreover, this library is an important resource for the wider scientific community to help improve genome annotation of the Syrian hamster and other closely related species. Furthermore, these data provide the basis for development of expression microarrays that can be used in functional genomics studies.	[Tchitchek, Nicolas; Rasmussen, Angela L.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Safronetz, David; Feldmann, Heinz; Ebihara, Hideki] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA; [Martens, Craig; Virtaneva, Kimmo; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Sect, NIH,Rocky Mt Labs, Hamilton, MT USA; [Katze, Michael G.] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	Ebihara, H (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA.	ebiharah@niaid.nih.gov; honey@uw.edu		Ebihara, Hideki/0000-0002-2576-9735; Tchitchek, Nicolas/0000-0003-3307-0446; Rasmussen, Angela/0000-0001-9462-3169	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NIAID Regional Centers of Excellence [U54 AI081680]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001136, ZIAAI001089, U54AI081680] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Regional Centers of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health and the NIAID Regional Centers of Excellence (U54 AI081680) to MGK. The funders were not involved in the study design, data collection and analysis, or preparation of the manuscript. NIAID was solely involved in the decision to publish.	Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Briand F, 2010, CURR OPIN INVEST DR, V11, P289; Castro-Perez J, 2011, J LIPID RES, V52, P1965, DOI 10.1194/jlr.M016410; Chelini MOM, 2011, PHYSIOL BEHAV, V104, P948, DOI 10.1016/j.physbeh.2011.06.006; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Ebihara H, 2013, J INFECT DIS, V207, P306, DOI 10.1093/infdis/jis626; Eklund A.C., 2012, SQUASH COLOR BASED P; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gomes-Silva A, 2013, PARASITOLOGY, V140, P771, DOI 10.1017/S0031182012002156; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; Hammond S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-67; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jukes TH, 1969, EVOLUTION PROTEIN MO; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Landkocz Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-524; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Liu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077062; Monecke S, 2011, J BIOL RHYTHM, V26, P283, DOI 10.1177/0748730411411569; Morin LP, 2001, STEREOTAXIC ATLAS GO; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Oduru S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-22; R Core Team, 2016, R FDN STAT COMP; Rawji KS, 2013, BRAIN RES, V1521, P31, DOI 10.1016/j.brainres.2013.05.003; Ricci LA, 2009, HORM BEHAV, V55, P348, DOI 10.1016/j.yhbeh.2008.10.011; Roberts A, 2008, VIRUS RES, V133, P20, DOI 10.1016/j.virusres.2007.03.025; Romanenko SA, 2007, CHROMOSOME RES, V15, P283, DOI 10.1007/s10577-007-1124-3; Ryu SH, 2013, MOL BIOL REP, V40, P1917, DOI 10.1007/s11033-012-2248-x; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmucki R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-237; Shinya K, 2011, J VIROL, V85, P4673, DOI 10.1128/JVI.00148-11; Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199; Trifonov VA, 2010, CHROMOSOME RES, V18, P265, DOI 10.1007/s10577-010-9110-6; Van Hoosier GL, 1987, LAB HAMSTERS; Wahl-Jensen V, 2012, VIRUSES-BASEL, V4, P3754, DOI 10.3390/v4123754; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004	45	22	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112617	10.1371/journal.pone.0112617	http://dx.doi.org/10.1371/journal.pone.0112617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398096	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500067
J	Shi, WL; Xu, G; Wang, CD; Sperber, SM; Chen, YL; Zhou, Q; Deng, Y; Zhao, H				Shi, Weili; Xu, Gang; Wang, Chengdong; Sperber, Steven M.; Chen, Yonglong; Zhou, Qin; Deng, Yi; Zhao, Hui			Heat Shock 70-kDa Protein 5 (Hspa5) Is Essential for Pronephros Formation by Mediating Retinoic Acid Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Embryo; Endoplasmic Reticulum Stress (ER Stress); Kidney; Retinoic Acid; Xenopus	ENDOPLASMIC-RETICULUM STRESS; XENOPUS-LAEVIS; KIDNEY DEVELOPMENT; CELL-SURFACE; EMBRYONIC-DEVELOPMENT; ANIMAL CAPS; GENE; DIFFERENTIATION; EXPRESSION; INDUCTION	Background: The function of Hspa5 in early embryonic development is not well understood. Results: Hspa5 is involved in mediating retinoic acid signaling and is required for pronephros. Conclusion: Hspa5 is essential for pronephros formation by mediating retinoic acid signaling. Significance: This is the first report on the cross-talk between physiological ER stress and transduction of retinoic acid signaling. Heat shock 70-kDa protein 5 (Hspa5), also known as binding immunoglobulin protein (Bip) or glucose-regulated protein 78 (Grp78), belongs to the heat shock protein 70 kDa family. As a multifunctional protein, it participates in protein folding and calcium homeostasis and serves as an essential regulator of the endoplasmic reticulum (ER) stress response. It has also been implicated in signal transduction by acting as a receptor or co-receptor residing at the plasma membrane. Its function during embryonic development, however, remains largely elusive. In this study, we used morpholino antisense oligonucleotides (MOs) to knock down Hspa5 activity in Xenopus embryos. In Hspa5 morphants, pronephros formation was strongly inhibited with the reduction of pronephric marker genes Lim homeobox protein 1 (lhx1), pax2, and 1 subunit of Na/K-ATPase (atp1b1). Pronephros tissue was induced in vitro by treating animal caps with all-trans-retinoic acid and activin. Depletion of Hspa5 in animal caps, however, blocked the induction of pronephros as well as reduced the expression of retinoic acid (RA)-responsive genes, suggesting that knockdown of Hspa5 attenuated RA signaling. Knockdown of Hspa5 in animal caps resulted in decreased expression of lhx1, a transcription factor directly regulated by RA signaling and essential for pronephros specification. Co-injection of Hspa5MO with lhx1 mRNA partially rescued the phenotype induced by Hspa5MO. These results suggest that the RA-Lhx1 signaling cascade is involved in Hspa5MO-induced pronephros malformation. This study shows that Hspa5, a key regulator of the unfolded protein response, plays an essential role in pronephros formation, which is mediated in part through RA signaling during early embryonic development.	[Shi, Weili; Wang, Chengdong; Zhao, Hui] Chinese Univ Hong Kong, Sch Biomed Sci, Key Lab Regenerat Med, Minist Educ,Fac Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Gang] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon Tong, Hong Kong, Peoples R China; [Deng, Yi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China; [Wang, Chengdong; Zhao, Hui] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Sperber, Steven M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Biomed, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Zhou, Qin] Chongqing Med Univ, Coll Lab Med, Minist Educ, Div Mol Nephrol,Key Lab Lab Med Diagnost, Chongqing 400016, Peoples R China; [Zhou, Qin] Chongqing Med Univ, Coll Lab Med, Minist Educ, Creat Training Ctr Undergrad,Key Lab Lab Med Diag, Chongqing 400016, Peoples R China	Chinese University of Hong Kong; Hong Kong Baptist University; Southern University of Science & Technology; Chinese University of Hong Kong, Shenzhen; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Chongqing Medical University; Chongqing Medical University	Deng, Y (corresponding author), South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China.	deng.y@sustc.edu.cn; zhaohui@cuhk.edu.hk	Zhao, Hui/B-8429-2016	Zhao, Hui/0000-0001-8160-6415; Deng, Yi/0000-0003-1378-015X; Sperber PhD, MSc, FACMG, Steven M./0000-0002-1868-029X; Wang, Chengdong/0000-0001-9891-8765	Research Grants Council of Hong Kong [N_CUHK413/12]; National Basic Research Program of China [81270438, 81200566]; Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Basic Research Program of China(National Basic Research Program of China); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported in part by Research Grants Council of Hong Kong Grant N_CUHK413/12 (to H. Z.) and National Basic Research Program of China Grants 81270438 (to G. X.) and 81200566 (to Y. D.).; Supported by a graduate studentship from The Chinese University of Hong Kong.	Agius E, 2000, DEVELOPMENT, V127, P1173; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Bracken CM, 2008, DEV DYNAM, V237, P132, DOI 10.1002/dvdy.21387; Brandli AW, 1999, INT J DEV BIOL, V43, P381; Cartry J, 2006, DEV BIOL, V299, P35, DOI 10.1016/j.ydbio.2006.06.047; Chan TC, 2000, DEV BIOL, V228, P256, DOI 10.1006/dbio.2000.9951; Chan T, 2006, NEPHRON EXP NEPHROL, V103, pE81, DOI 10.1159/000092192; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Cho GS, 2011, DEVELOPMENT, V138, P465, DOI 10.1242/dev.061234; Cirio MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018858; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Drews C, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-5; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gerth VE, 2005, DEV DYNAM, V233, P1131, DOI 10.1002/dvdy.20415; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; Gu XM, 2010, LIFE SCI, V87, P724, DOI 10.1016/j.lfs.2010.10.012; Haldin CE, 2008, DEV BIOL, V322, P74, DOI 10.1016/j.ydbio.2008.07.012; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hensey C, 2002, NEPHROL DIAL TRANSPL, V17, P73, DOI 10.1093/ndt/17.suppl_9.73; Hollemann T, 1996, MECH DEVELOP, V55, P19, DOI 10.1016/0925-4773(95)00485-8; Hou S, 2007, DEV CELL, V13, P226, DOI 10.1016/j.devcel.2007.07.001; Jones EA, 2005, J AM SOC NEPHROL, V16, P313, DOI 10.1681/ASN.2004070617; Kam RKT, 2013, J BIOL CHEM, V288, P31477, DOI 10.1074/jbc.M113.514984; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; King L, 2001, PROTEIN EXPRES PURIF, V22, P148, DOI 10.1006/prep.2001.1424; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kolm PJ, 1997, DEV BIOL, V192, P1, DOI 10.1006/dbio.1997.8754; Leclerc C, 2008, DEV BIOL, V321, P357, DOI 10.1016/j.ydbio.2008.06.029; Lee SJ, 2010, MECH DEVELOP, V127, P49, DOI 10.1016/j.mod.2009.11.001; Li JM, 2014, DIABETOLOGIA, V57, P754, DOI 10.1007/s00125-013-3147-y; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; Poulain S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-423; Saw YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-329; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Strnad P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016454; Taelman V, 2006, DEVELOPMENT, V133, P2961, DOI 10.1242/dev.02458; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; Tanegashima K, 2009, DEVELOPMENT, V136, P3543, DOI 10.1242/dev.036715; Tetelin S, 2010, DEV DYNAM, V239, P148, DOI 10.1002/dvdy.22012; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Urban AE, 2006, DEV BIOL, V297, P103, DOI 10.1016/j.ydbio.2006.04.469; Wang CD, 2011, DEV DYNAM, V240, P2028, DOI 10.1002/dvdy.22693; Wei JA, 2011, BRAIN RES, V1382, P77, DOI 10.1016/j.brainres.2011.01.027; Wessely O, 2011, PEDIATR NEPHROL, V26, P1545, DOI 10.1007/s00467-011-1881-2; Yao TT, 2011, MED SCI MONITOR, V17, pHY21, DOI 10.12659/MSM.881886; Yuan L, 2008, MECH DEVELOP, V125, P207, DOI 10.1016/j.mod.2007.11.010; Zhang B, 2013, DEV BIOL, V376, P31, DOI 10.1016/j.ydbio.2013.01.017; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhao H, 2003, DEV BIOL, V257, P278, DOI 10.1016/S0012-1606(03)00069-1; Zhao H, 2001, INT J DEV BIOL, V45, P817; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073	73	23	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					577	589		10.1074/jbc.M114.591628	http://dx.doi.org/10.1074/jbc.M114.591628			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398881	hybrid, Green Published			2022-12-26	WOS:000347231200050
J	Ekvall, MK; Urrutia-Cordero, P; Hansson, LA				Ekvall, Mattias K.; Urrutia-Cordero, Pablo; Hansson, Lars-Anders			Linking Cascading Effects of Fish Predation and Zooplankton Grazing to Reduced Cyanobacterial Biomass and Toxin Levels Following Biomanipulation	PLOS ONE			English	Article							FRESH-WATER; LAKE RESTORATION; FOOD; EUTROPHICATION; MICROCYSTINS; COMMUNITY; DEGRADATION; LIMITATION; REDUCTION; SELECTION	Eutrophication has been one of the largest environmental problems in aquatic ecosystems during the past decades, leading to dense, and often toxic, cyanobacterial blooms. In a way to counteract these problems many lakes have been subject to restoration through biomanipulation. Here we combine 13 years of monitoring data with experimental assessment of grazing efficiency of a naturally occurring zooplankton community and a, from a human perspective, desired community of large Daphnia to assess the effects of an altered trophic cascade associated with biomanipulation. Lake monitoring data show that the relative proportion of Daphnia spp. grazers in June has increased following years of biomanipulation and that this increase coincides with a drop in cyanobacterial biomass and lowered microcystin concentrations compared to before the biomanipulation. In June, the proportion of Daphnia spp. (on a biomass basis) went from around 3% in 2005 (the first year of biomanipulation) up to around 58% in 2012. During months when the proportion of Daphnia spp. remained unchanged (July and August) no effect on lower trophic levels was observed. Our field grazing experiment revealed that Daphnia were more efficient in controlling the standing biomass of cyanobacteria, as grazing by the natural zooplankton community never even compensated for the algal growth during the experiment and sometimes even promoted cyanobacterial growth. Furthermore, although the total cyanobacterial toxin levels remained unaffected by both grazer communities in the experimental study, the Daphnia dominated community promoted the transfer of toxins to the extracellular, dissolved phase, likely through feeding on cyanobacteria. Our results show that biomanipulation by fish removal is a useful tool for lake management, leading to a top-down mediated trophic cascade, through alterations in the grazer community, to reduced cyanobacterial biomass and lowered cyanobacterial toxin levels. This improved water quality enhances both the ecological and societal value of lakes as units for ecosystem services.	[Ekvall, Mattias K.; Urrutia-Cordero, Pablo; Hansson, Lars-Anders] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Urrutia-Cordero, Pablo] Lund Univ, Ctr Environm & Climate Res, SE-22362 Lund, Sweden	Lund University; Lund University	Ekvall, MK (corresponding author), Lund Univ, Dept Biol, Ecol Bldg, SE-22362 Lund, Sweden.	mattias.ekvall@biol.lu.se	Hansson, Lars-Anders/HCI-2735-2022	Urrutia Cordero, Pablo/0000-0001-9560-8374; Hansson, Lars-Anders/0000-0002-3035-1317	European Union Interreg IV A project "Algae be gone!''; ERA-Net BiodivERsA; FORMAS	European Union Interreg IV A project "Algae be gone!''; ERA-Net BiodivERsA; FORMAS(Swedish Research Council Formas)	This work was funded by the European Union Interreg IV A project "Algae be gone!'' and by the ERA-Net BiodivERsA, with the national funders FORMAS, part of the 2012 BiodivERsA call for research proposals (LIMNOTIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNDORF J, 1984, INT REV GES HYDROBIO, V69, P407, DOI 10.1002/iroh.19840690308; Bergman E, 1999, HYDROBIOLOGIA, V404, P77, DOI 10.1023/A:1003776613724; Bergman E, 1999, HYDROBIOLOGIA, V404, P145, DOI 10.1023/A:1003788900521; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Chislock MF, 2013, WATER RES, V47, P1961, DOI 10.1016/j.watres.2012.12.038; Christoffersen K, 2002, AQUAT MICROB ECOL, V27, P125, DOI 10.3354/ame027125; Codd GA, 1995, WATER SCI TECHNOL, V32, P149, DOI 10.1016/0273-1223(95)00692-3; CODD GA, 1989, WATER SCI TECHNOL, V21, P1; DAWIDOWICZ P, 1990, HYDROBIOLOGIA, V200, P43, DOI 10.1007/BF02530327; DEBERNARDI R, 1990, HYDROBIOLOGIA, V200, P29, DOI 10.1007/BF02530326; DEMOTT WR, 1986, OECOLOGIA, V69, P334, DOI 10.1007/BF00377053; DeMott WR, 2001, LIMNOL OCEANOGR, V46, P2054, DOI 10.4319/lo.2001.46.8.2054; Dumont H.J., 1975, Oecologia, V19, P75, DOI 10.1007/BF00377592; Ekvall MK, 2013, FRESHWATER BIOL, V58, P2414, DOI 10.1111/fwb.12220; Faassen EJ, 2012, TOXICON, V60, P378, DOI 10.1016/j.toxicon.2012.04.335; Falconer IR, 2005, ACTA HYDROCH HYDROB, V33, P64, DOI 10.1002/aheh.200300551; Gagala I, 2012, POL J ENVIRON STUD, V21, P1125; GLIWICZ ZM, 1990, HYDROBIOLOGIA, V200, P83, DOI 10.1007/BF02530331; Ha JY, 2013, LIMNOLOGY, V14, P19, DOI 10.1007/s10201-012-0381-9; Hansson LA, 1998, ECOSYSTEMS, V1, P558, DOI 10.1007/s100219900051; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Jang MH, 2007, LIMNOL OCEANOGR, V52, P1454, DOI 10.4319/lo.2007.52.4.1454; Lebret K, 2012, LIMNOL OCEANOGR, V57, P727, DOI 10.4319/lo.2012.57.3.0727; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; MEIJER ML, 1994, HYDROBIOLOGIA, V275, P457, DOI 10.1007/BF00026734; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Reitzel K, 2013, HYDROBIOLOGIA, V703, P189, DOI 10.1007/s10750-012-1358-8; Rohrlack T, 2007, PHYCOLOGIA, V46, P277, DOI 10.2216/06-14.1; Romare P, 1999, HYDROBIOLOGIA, V404, P89, DOI 10.1023/A:1003731128746; Sarnelle O, 2010, J PLANKTON RES, V32, P471, DOI 10.1093/plankt/fbp151; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; SHAPIRO J, 1984, FRESHWATER BIOL, V14, P371; Shapiro J., 1975, WATER QUALITY MANAGE, P85; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SONDERGAARD M, 1990, HYDROBIOLOGIA, V200, P229, DOI 10.1007/BF02530342; THEISS J, 1990, HYDROBIOLOGIA, V200, P59, DOI 10.1007/BF02530329; Uusi-Kamppa Jaana, 2000, Journal of Environmental Quality, V29, P151, DOI 10.2134/jeq2000.00472425002900010019x; WEBSTER KE, 1978, LIMNOL OCEANOGR, V23, P1238, DOI 10.4319/lo.1978.23.6.1238; Wilson AE, 2007, LIMNOL OCEANOGR, V52, P1467, DOI 10.4319/lo.2007.52.4.1467	47	44	44	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112956	10.1371/journal.pone.0112956	http://dx.doi.org/10.1371/journal.pone.0112956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409309	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200050
J	Amorim, D; David-Pereira, A; Marques, P; Puga, S; Rebelo, P; Costa, P; Pertovaara, A; Almeida, A; Pinto-Ribeiro, F				Amorim, Diana; David-Pereira, Ana; Marques, Patricia; Puga, Sonia; Rebelo, Patricia; Costa, Patricio; Pertovaara, Antti; Almeida, Armando; Pinto-Ribeiro, Filipa			A Role of Supraspinal Galanin in Behavioural Hyperalgesia in the Rat	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; ROSTRAL VENTROMEDIAL MEDULLA; LOCUS-CERULEUS NEURONS; SPINAL-CORD; DESCENDING MODULATION; MESSENGER-RNA; ANTINOCICEPTIVE ROLE; PERIAQUEDUCTAL GRAY; THERMAL NOCICEPTION; NEUROPATHIC PAIN	Introduction: In chronic pain disorders, galanin (GAL) is able to either facilitate or inhibit nociception in the spinal cord but the contribution of supraspinal galanin to pain signalling is mostly unknown. The dorsomedial nucleus of the hypothalamus (DMH) is rich in galanin receptors (GALR) and is involved in behavioural hyperalgesia. In this study, we evaluated the contribution of supraspinal GAL to behavioural hyperalgesia in experimental monoarthritis. Methods:In Wistar-Han males with a four week kaolin/carrageenan-induced monoarthritis (ARTH), paw-withdrawal latency (PWL) was assessed before and after DMH administration of exogenous GAL, a non-specific GALR antagonist (M40), a specific GALR1 agonist (M617) and a specific GALR2 antagonist (M871). Additionally, the analysis of c-Fos expression after GAL injection in the DMH was used to investigate the potential involvement of brainstem pain control centres. Finally, electrophysiological recordings were performed to evaluate whether pronociceptive On- or antinociceptive Off-like cells in the rostral ventromedial medulla (RVM) relay the effect of GAL. Results: Exogenous GAL in the DMH decreased PWL in ARTH and SHAM animals, an effect that was mimicked by a GALR1 agonist (M617). In SHAM animals, an unselective GALR antagonist (M40) increased PWL, while a GALR2 antagonist (M871) decreased PWL. M40 or M871 failed to influence PWL in ARTH animals. Exogenous GAL increased c-Fos expression in the RVM and dorsal raphe nucleus (DRN), with effects being more prominent in SHAM than ARTH animals. Exogenous GAL failed to influence activity of RVM On- or Off-like cells of SHAM and ARTH animals. Conclusions: Overall, exogenous GAL in the DMH had a pronociceptive effect that is mediated by GALR1 in healthy and arthritic animals and is associated with alterations of c-Fos expression in RVM and DRN that are serotonergic brainstem nuclei known to be involved in the regulation of pain.	[Amorim, Diana; David-Pereira, Ana; Marques, Patricia; Puga, Sonia; Rebelo, Patricia; Costa, Patricio; Almeida, Armando; Pinto-Ribeiro, Filipa] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci ECS, Braga, Portugal; [Amorim, Diana; David-Pereira, Ana; Marques, Patricia; Puga, Sonia; Rebelo, Patricia; Costa, Patricio; Almeida, Armando; Pinto-Ribeiro, Filipa] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Pertovaara, Antti] Univ Helsinki, Inst Biomed Physiol, Helsinki, Finland	Universidade do Minho; University of Helsinki	Pinto-Ribeiro, F (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci ECS, Braga, Portugal.	filiparibeiro@ecsaude.uminho.pt	Pinto-Ribeiro, Filipa/AAB-4822-2019; Pinto-Ribeiro, Filipa/AAM-6559-2021; Pertovaara, Antti Yrjö/AAM-9213-2021; Pinto-Ribeiro, Filipa/M-2696-2013; Almeida, Armando/H-5122-2011; Costa, Patrício/A-3072-2013	Pinto-Ribeiro, Filipa/0000-0001-7574-6489; Pertovaara, Antti Yrjö/0000-0002-8590-7220; Pinto-Ribeiro, Filipa/0000-0001-7574-6489; Almeida, Armando/0000-0002-6233-4693; Costa, Patrício/0000-0002-1201-9177; Puga, Sonia/0000-0003-2995-5356; Rebelo, Patricia/0000-0001-5209-668X; Amorim, Diana/0000-0001-6402-0834; David-Pereira, Ana/0000-0002-5454-966X	Portuguese Science Foundation (FCT) Project [PTDC/SAU-NEU/108557/2008]; FEDER-COMPETE; Academy of Finland; Sigrid Juselius Foundation, Helsinki, Finland; FCT [SFRH/BD/71219/2010, SFRH/BD/90374/2012]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/108557/2008] Funding Source: FCT	Portuguese Science Foundation (FCT) Project; FEDER-COMPETE(European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation, Helsinki, Finland(Sigrid Juselius Foundation); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This study was supported by grants from the Portuguese Science Foundation (FCT) Project no PTDC/SAU-NEU/108557/2008, FEDER-COMPETE, by the Academy of Finland and the Sigrid Juselius Foundation, Helsinki, Finland. DA was supported by FCT grant SFRH/BD/71219/2010 and ADP was supported by FCT grant SFRH/BD/90374/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A., 2006, DRUG DISCOV TODAY DI, V3, P305, DOI [10.1016/j.ddmec.2006.09.001, DOI 10.1016/J.DDMEC.2006.09.001]; Amorim D, 2014, BEHAV BRAIN RES, V265, P12, DOI 10.1016/j.bbr.2014.02.003; Ansah OB, 2007, ANESTH ANALG, V105, P245, DOI 10.1213/01.ane.0000265850.08385.a6; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Barton NJ, 2007, J NEUROSCI METH, V163, P67, DOI 10.1016/j.jneumeth.2007.02.012; Blackshear A, 2007, PEPTIDES, V28, P1120, DOI 10.1016/j.peptides.2007.01.015; Blakeman KH, 2003, NEUROSCIENCE, V117, P221, DOI 10.1016/S0306-4522(02)00779-0; Brumovsky P, 2006, BRAIN RES, V1085, P111, DOI 10.1016/j.brainres.2006.02.088; CERVERO F, 1991, EXP BRAIN RES, V83, P675; CHNG JLC, 1985, NEUROSCIENCE, V16, P343, DOI 10.1016/0306-4522(85)90007-7; de Luca MCZ, 2003, PHARMACOL BIOCHEM BE, V75, P459, DOI 10.1016/S0091-3057(03)00145-X; FIELDS HL, 1985, PHILOS T ROY SOC B, V308, P361, DOI 10.1098/rstb.1985.0037; FIELDS HL, 1983, J NEUROSCI, V3, P2545; Fu LB, 2011, NEUROSCI LETT, V491, P174, DOI 10.1016/j.neulet.2011.01.030; Galban CJ, 2007, OSTEOARTHR CARTILAGE, V15, P550, DOI 10.1016/j.joca.2006.10.007; Gu XL, 2007, BEHAV BRAIN RES, V179, P331, DOI 10.1016/j.bbr.2007.02.033; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; HEINRICHER MM, 1989, SOMATOSENS MOT RES, V6, P427, DOI 10.3109/08990228909144685; Herrero JF, 1996, NEUROSCI LETT, V209, P21, DOI 10.1016/0304-3940(96)12588-X; Hickey L, 2014, J NEUROSCI, V34, P4148, DOI 10.1523/JNEUROSCI.4835-13.2014; Hua XY, 2004, J PHARMACOL EXP THER, V308, P574, DOI 10.1124/jpet.103.058289; Hulse RP, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-41; Jacobowitz DM, 2004, PEPTIDES, V25, P433, DOI 10.1016/j.peptides.2004.02.015; Jimenez-Andrade JM, 2004, PAIN, V110, P10, DOI 10.1016/j.pain.2004.02.032; Jin WY, 2010, BRAIN RES, V1320, P16, DOI 10.1016/j.brainres.2009.12.060; Johnson PL, 2008, J PSYCHOPHARMACOL, V22, P642, DOI 10.1177/0269881107082900; JONES SL, 1991, PROG BRAIN RES, V88, P381; Kong Q, 2013, NEUROSCI LETT, P4; Kovelowski CJ, 2000, PAIN, V87, P265, DOI 10.1016/S0304-3959(00)00290-6; Kuteeva E, 2008, NEUROPSYCHOPHARMACOL, V33, P2573, DOI 10.1038/sj.npp.1301660; Larm JA, 2003, EUR J NEUROSCI, V17, P481, DOI 10.1046/j.1460-9568.2003.02471.x; Li J, 2012, NEUROSCI LETT, V526, P45, DOI 10.1016/j.neulet.2012.07.041; Liu HX, 2002, TRENDS PHARMACOL SCI, V23, P468, DOI 10.1016/S0165-6147(02)02074-6; Liu HX, 2001, P NATL ACAD SCI USA, V98, P9960, DOI 10.1073/pnas.161293598; Lu XY, 2005, NEUROPEPTIDES, V39, P143, DOI 10.1016/j.npep.2004.12.012; Martenson ME, 2009, PAIN, V142, P236, DOI 10.1016/j.pain.2009.01.011; Mennicken F, 2002, J CHEM NEUROANAT, V24, P257, DOI 10.1016/S0891-0618(02)00068-6; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Mitchell V, 1999, J CHEM NEUROANAT, V16, P265, DOI 10.1016/S0891-0618(99)00011-3; Mitchell V, 1997, NEUROENDOCRINOLOGY, V66, P160, DOI 10.1159/000127234; Morgado C, 2007, DIABETES-METAB RES, V23, P644, DOI 10.1002/dmrr.751; Murphy LB, 2012, ARTHRIT CARE RES, V64, P968, DOI 10.1002/acr.21685; MYERS RD, 1966, PHYSIOL BEHAV, V1, P171, DOI 10.1016/0031-9384(66)90064-3; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pertovaara A, 2006, PROG NEUROBIOL, V80, P53, DOI 10.1016/j.pneurobio.2006.08.001; Pertovaara A, 2006, HAND CLINIC, V81, P179, DOI 10.1016/S0072-9752(06)80017-5; Pinto-Ribeiro F, 2008, BRAIN RES, V1197, P63, DOI 10.1016/j.brainres.2007.12.038; Pinto-Ribeiro F, 2013, BRAIN RES BULL, V99, P100, DOI 10.1016/j.brainresbull.2013.10.001; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; POTREBIC SB, 1994, J NEUROSCI, V14, P1655, DOI 10.1523/JNEUROSCI.14-03-01655.1994; Prado WA, 2000, PAIN, V88, P169, DOI 10.1016/S0304-3959(00)00326-2; QIAO JT, 1988, PAIN, V34, P65, DOI 10.1016/0304-3959(88)90183-2; Radhakrishnan R, 2003, PAIN, V104, P567, DOI 10.1016/S0304-3959(03)00114-3; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Reeve AJ, 2000, NEUROSCI LETT, V295, P25, DOI 10.1016/S0304-3940(00)01576-7; Ren K, 2002, PAIN, V100, P1, DOI 10.1016/S0304-3959(02)00368-8; Ren K, 1996, J NEUROPHYSIOL, V76, P3025, DOI 10.1152/jn.1996.76.5.3025; Rivat C, 2008, PAIN, V137, P125, DOI 10.1016/j.pain.2007.08.021; Sanoja R, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.04.006; SEVCIK J, 1993, EUR J PHARMACOL, V230, P223, DOI 10.1016/0014-2999(93)90806-S; Song Z, 2013, NEUROSCIENCE, V247, P134, DOI 10.1016/j.neuroscience.2013.05.027; Sun YG, 2007, J NEUROSCI RES, V85, P2400, DOI 10.1002/jnr.21396; Sun YG, 2004, J NEUROSCI RES, V77, P718, DOI 10.1002/jnr.20206; Sun YG, 2003, PAIN, V106, P143, DOI 10.1016/S0304-3959(03)00316-6; Terayama R, 2000, NEUROREPORT, V11, P1915, DOI 10.1097/00001756-200006260-00022; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Verdu B, 2008, DRUGS, V68, P2611, DOI 10.2165/0003495-200868180-00007; Voisin DL, 2005, J PHYSIOL-LONDON, V566, P929, DOI 10.1113/jphysiol.2005.086520; Wagner KM, 2013, NEUROSCIENCE, V238, P29, DOI 10.1016/j.neuroscience.2013.02.009; Wang D, 2000, NEUROSCIENCE, V96, P767, DOI 10.1016/S0306-4522(00)00005-1; WANG QP, 1994, BRAIN RES BULL, V34, P575; Wang S, 1998, BIOCHEMISTRY-US, V37, P6711, DOI 10.1021/bi9728405; Wang SX, 2012, PAIN, V153, P2448, DOI 10.1016/j.pain.2012.08.016; Waters SM, 2000, NEUROSCIENCE, V95, P265; Webling Kristin E B, 2012, Front Endocrinol (Lausanne), V3, P146, DOI 10.3389/fendo.2012.00146; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; Xu SL, 2012, NEUROSCI LETT, V520, P43, DOI 10.1016/j.neulet.2012.05.027; Yue HY, 2011, J NEUROPHYSIOL, V105, P2337, DOI 10.1152/jn.00991.2010	81	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113077	10.1371/journal.pone.0113077	http://dx.doi.org/10.1371/journal.pone.0113077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405608	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300075
J	Balliu, B; Wurtz, RP; Horsthemke, B; Wieczorek, D; Bohringer, S				Balliu, Brunilda; Wuertz, Rolf P.; Horsthemke, Bernhard; Wieczorek, Dagmar; Boehringer, Stefan			Classification and Visualization Based on Derived Image Features: Application to Genetic Syndromes	PLOS ONE			English	Article								Data transformations prior to analysis may be beneficial in classification tasks. In this article we investigate a set of such transformations on 2D graph-data derived from facial images and their effect on classification accuracy in a high-dimensional setting. These transformations are low-variance in the sense that each involves only a fixed small number of input features. We show that classification accuracy can be improved when penalized regression techniques are employed, as compared to a principal component analysis (PCA) pre-processing step. In our data example classification accuracy improves from 47% to 62% when switching from PCA to penalized regression. A second goal is to visualize the resulting classifiers. We develop importance plots highlighting the influence of coordinates in the original 2D space. Features used for classification are mapped to coordinates in the original images and combined into an importance measure for each pixel. These plots assist in assessing plausibility of classifiers, interpretation of classifiers, and determination of the relative importance of different features.	[Balliu, Brunilda; Boehringer, Stefan] Leiden Univ, Med Ctr, Leiden, Netherlands; [Wuertz, Rolf P.] Ruhr Univ Bochum, Inst Neuroinformat, Bochum, Germany; [Horsthemke, Bernhard; Wieczorek, Dagmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, Essen, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ruhr University Bochum; University of Duisburg Essen	Bohringer, S (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.	S.Boehringer@lumc.nl	Würtz, Rolf P./A-7644-2012; Wieczorek, Dagmar/AAU-6008-2021	Würtz, Rolf P./0000-0002-7160-4157; Wieczorek, Dagmar/0000-0003-2812-6492	DFG [BO 1955/2-3, WU 314/6-2]; German Ministry of Research and Education [BMBF 01GM0802]	DFG(German Research Foundation (DFG)); German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF))	This work was supported by DFG grants BO 1955/2-3 and WU 314/6-2, and by two grants (CRANIRARE and FACE) from the German Ministry of Research and Education to D.W. (BMBF 01GM0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehringer S, 2006, EUR J HUM GENET, V14, P1082, DOI 10.1038/sj.ejhg.5201673; Boehringer S, 2011, AM J MED GENET A, V155A, P2161, DOI 10.1002/ajmg.a.34157; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Guunther M, 2012, STAT GABOR GRAPH BAS; Hammond P, 2005, AM J HUM GENET, V77, P999, DOI 10.1086/498396; Hammond P, 2012, EUR J HUM GENET, V20, P33, DOI 10.1038/ejhg.2011.135; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hennessy RJ, 2007, BIOL PSYCHIAT, V61, P1187, DOI 10.1016/j.biopsych.2006.08.045; JOLLIFFE I., 2005, PRINCIPAL COMPONENT; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; R Core Development Team, 2013, R LANG ENV STAT COMP; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vollmar T, 2008, EUR J MED GENET, V51, P44, DOI 10.1016/j.ejmg.2007.10.002; Winter RM, 1996, NAT GENET, V12, P124, DOI 10.1038/ng0296-124	16	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e109033	10.1371/journal.pone.0109033	http://dx.doi.org/10.1371/journal.pone.0109033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405460	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300004
J	Barroso, GF; Goncalves, MA; Garcia, FD				Barroso, Gilberto F.; Goncalves, Monica A.; Garcia, Fabio da C.			The Morphometry of Lake Palmas, a Deep Natural Lake in Brazil	PLOS ONE			English	Article							DYNAMICS; WATER	Lake Palmas (A = 10.3 km(2)) is located in the Lower Doce River Valley (LDRV), on the southeastern coast of Brazil. The Lake District of the LDRV includes 90 lakes, whose basic geomorphology is associated with the alluvial valleys of the Barreiras Formation (Cenozoic, Neogene) and with the Holocene coastal plain. This study aimed to investigate the relationship of morphometry and thermal pattern of a LDRV deep lake, Lake Palmas. A bathymetric survey carried out in 2011 and the analysis of hydrographic and wind data with a geographic information system allowed the calculation of several metrics of lake morphometry. The vertical profiling of physical and chemical variables in the water column during the wet/warm and dry/mild cold seasons of 2011 to 2013 has furnished a better understanding of the influence of the lake morphometry on its structure and function. The overdeepened basin has a subrectangular elongated shape and is aligned in a NW-SE direction in an alluvial valley with a maximum depth (Z(max)) of 50.7 m, a volume of 2.2 x 10(8) m(3) (0.22 km(3)) and a mean depth (Z(mv)) of 21.4 m. These metrics suggest Lake Palmas as the deepest natural lake in Brazil. Water column profiling has indicated strong physical and chemical stratification during the wet/warm season, with a hypoxic/anoxic layer occupying one- half of the lake volume. The warm monomictic pattern of Lake Palmas, which is in an accordance to deep tropical lakes, is determined by water column mixing during the dry and mild cold season, especially under the influence of a high effective fetch associated with the incidence of cold fronts. Lake Palmas has a very long theoretical retention time, with a mean of 19.4 years. The changes observed in the hydrological flows of the tributary rivers may disturb the ecological resilience of Lake Palmas.	[Barroso, Gilberto F.; Garcia, Fabio da C.] Univ Fed Espirito Santo, Dept Oceanog & Ecol, Vitoria, ES, Brazil; [Goncalves, Monica A.] Espirito Santo State Water Resources Agcy, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo	Barroso, GF (corresponding author), Univ Fed Espirito Santo, Dept Oceanog & Ecol, Vitoria, ES, Brazil.	gilberto.barroso@ufes.br	Barroso, Gilberto F/E-5253-2019; ANIKUZHIYIL, ANISH/Y-8609-2018	Barroso, Gilberto F/0000-0002-4886-4890; ANIKUZHIYIL, ANISH/0000-0001-9686-1283	Espirito Santo State Agency for Environment and Water Resources (IEMA); Linhares Aquaculture Association (AquaLin); Espirito Santo State and Federal research supporting agency FAPES; Espirito Santo State and Federal research supporting agency CNPq; Fabio da Cunha Garcia's researcher fellowship grant; Espirito Santo State Agency for Agriculture, Aquaculture (SEAG)	Espirito Santo State Agency for Environment and Water Resources (IEMA); Linhares Aquaculture Association (AquaLin); Espirito Santo State and Federal research supporting agency FAPES; Espirito Santo State and Federal research supporting agency CNPq; Fabio da Cunha Garcia's researcher fellowship grant; Espirito Santo State Agency for Agriculture, Aquaculture (SEAG)	The authors acknowledge Espirito Santo State Agencies for Environment and Water Resources (IEMA) and Agriculture, Aquaculture (SEAG) as well as Linhares Aquaculture Association (AquaLin) for field work logistics. They also would like to acknowledge Espirito Santo State and Federal research supporting agencies FAPES and CNPq, respectively, for Dr. Fabio da Cunha Garcia's researcher fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti Walter, 2002, Journal of Limnology, V61, P159; Ambrosetti Walter, 2002, Journal of Limnology, V61, P147; Ambrosetti Walter, 2003, Journal of Limnology, V62, P1; [Anonymous], ACTA LIMNOLOGICA BRA; [Anonymous], PRINCIPLES LAKES SED; Aprile FM, 2005, BIOTUPE PHYS BIODIVE; Barroso GF, 2012, P 1 NAT SEM SUST MAN; Barroso GF, 2013, P 15 BRAZ S APPL PHY, P158; Bezerra-Neto Jose Fernandes, 2010, Acta Scientiarum Biological Sciences, V32, P49, DOI 10.4025/actascibiolsci.v32i1.4990; BEZERRANETO JF, 2008, ACTA LIMNOL BRAS, V20, P161; BLAIS JM, 1995, LIMNOL OCEANOGR, V40, P582, DOI 10.4319/lo.1995.40.3.0582; Bozelli R.L., 1992, ACTA LIMNOL BRAS, V4, P13; Bricalli LL, 2013, REV BRAS GEOMORFOL, V14, P301; Brighenti Ludmila Silva, 2011, Acta Scientiarum Biological Sciences, V33, P281, DOI 10.4025/actascibiolsci.v33i3.5545; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Cole GA, 1994, TXB LIMNOLOGY, P4; Dadon JR, 1995, ECOSISTEMAS AGUAS CO, V1, P47; Barros CFD, 2013, ACTA BOT BRAS, V27, P327, DOI 10.1590/S0102-33062013000200009; DUARTE CM, 1986, LIMNOL OCEANOGR, V31, P1072, DOI 10.4319/lo.1986.31.5.1072; Fee EJA, 1980, LIMNOLOGY OCEANOGRAP, V24, P401; HAKANSON L, 1978, WATER RESOUR RES, V14, P545, DOI 10.1029/WR014i004p00545; Hakanson L, 2004, LAKES FORM FUNCTION; HATUSHIKA R.S., 2007, REV BRAS GEOFIS, V25, P433, DOI DOI 10.1590/S0102-261X2007000400007; Hennemann MC, 2011, ENVIRON MONIT ASSESS, V181, P347, DOI 10.1007/s10661-010-1833-5; HENRY R., 1997, LIMNOLOGICAL STUDIES; Herdendorf CE, 1984, TECHNICAL B OHIO STA; Hollister J, 2010, LAKE RESERV MANAGE, V26, P194, DOI 10.1080/07438141.2010.504321; Hollister JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025764; Hutchinson G. E., 1957, TREATISE LIMNOLOGY; IMBERGER J, 1982, ANNU REV FLUID MECH, V14, P153, DOI 10.1146/annurev.fl.14.010182.001101; Isaaks E.H., 1989, ISA; KEREKES J, 1977, INT REV GES HYDROBIO, V62, P291, DOI 10.1002/iroh.1977.3510620207; Kjerfve B, 1996, ESTUAR COAST SHELF S, V42, P701, DOI 10.1006/ecss.1996.0045; KLING GW, 1988, LIMNOL OCEANOGR, V33, P27, DOI 10.4319/lo.1988.33.1.0027; Kosten S, 2009, ECOL APPL, V19, P1791, DOI 10.1890/08-0906.1; Kvarnas H, 2001, AMBIO, V30, P467, DOI 10.1639/0044-7447(2001)030[0467:MAHOTF]2.0.CO;2; Liu WZ, 2010, HYDROBIOLOGIA, V644, P289, DOI 10.1007/s10750-010-0151-9; Llames M.E., 2010, LAKE ECOSYSTEM ECOLO, P332; Marchioro E, 2012, REV ACTA GEOGR, P49, DOI 10.5654/actageo2012.0002.0003; Martin L., 1996, ACAD BRAS CIENCIAS, V68, P389; Melack J. M., 1990, ACTA LIMNOL BRAS, V3, P1; Niencheski L.F.H., 2004, J COASTAL RES, V39, P1040; Noges T, 2009, HYDROBIOLOGIA, V633, P33, DOI 10.1007/s10750-009-9874-x; Panosso R, 2000, LAKE BATATA IMPACTS; PBMC, 2013, CONTR WORK GROUP 2 1; RASMUSSEN JB, 1989, LIMNOL OCEANOGR, V34, P1336, DOI 10.4319/lo.1989.34.7.1336; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Ryanzhin SV, 1999, LIMNOLOGY REMOTE SEN, P53; SCHWARZBOLD A, 1984, AMAZONIANA, V9, P87; Soares MCS, 2012, LIMNOLOGICA, V42, P197, DOI 10.1016/j.limno.2011.11.002; Souza MBG, 2008, HYDROBIOLOGIA, V607, P211, DOI 10.1007/s10750-008-9392-2; Staehr PA, 2012, AQUAT SCI, V74, P155, DOI 10.1007/s00027-011-0207-6; Straskraba M, 1999, THEORETICAL RESERVOIR ECOLOGY AND ITS APPLICATIONS, P385; Straskraba M, 1998, COAST ESTUAR STUD, V288, P601, DOI [10.1029/CE054p0623, DOI 10.1029/CE054P0623]; Tundisi JG, 2010, BRAZ J BIOL, V70, P815, DOI 10.1590/S1519-69842010000400012; von Sperling E, 1999, MORPHOLOGY LAKES RES; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X	57	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111469	10.1371/journal.pone.0111469	http://dx.doi.org/10.1371/journal.pone.0111469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406062	Green Submitted, gold, Green Published			2022-12-26	WOS:000347121300009
J	Kahilainen, KK; Patterson, WP; Sonninen, E; Harrod, C; Kiljunen, M				Kahilainen, Kimmo Kalevi; Patterson, William Paul; Sonninen, Eloni; Harrod, Chris; Kiljunen, Mikko			Adaptive Radiation along a Thermal Gradient: Preliminary Results of Habitat Use and Respiration Rate Divergence among Whitefish Morphs	PLOS ONE			English	Article							COREGONUS-LAVARETUS L.; SALVELINUS-ALPINUS L.; TROUT SALMO-TRUTTA; FRESH-WATER FISH; EUROPEAN WHITEFISH; SYMPATRIC WHITEFISH; ECOLOGICAL SPECIATION; DELTA-C-13 VALUES; LAKE WHITEFISH; ARCTIC CHARR	Adaptive radiation is considered an important mechanism for the development of new species, but very little is known about the role of thermal adaptation during this process. Such adaptation should be especially important in poikilothermic animals that are often subjected to pronounced seasonal temperature variation that directly affects metabolic function. We conducted a preliminary study of individual lifetime thermal habitat use and respiration rates of four whitefish (Coregonus lavaretus (L.)) morphs (two pelagic, one littoral and one profundal) using stable carbon and oxygen isotope values of otolith carbonate. These morphs, two of which utilized pelagic habitats, one littoral and one profundal recently diverged via adaptive radiation to exploit different major niches in a deep and thermally stratified subarctic lake. We found evidence that the morphs used different thermal niches. The profundal morph had the most distinct thermal niche and consistently occupied the coldest thermal habitat of the lake, whereas differences were less pronounced among the shallow water pelagic and littoral morphs. Our results indicated ontogenetic shifts in thermal niches: juveniles of all whitefish morphs inhabited warmer ambient temperatures than adults. According to sampling of the otolith nucleus, hatching temperatures were higher for benthic compared to pelagic morphs. Estimated respiration rate was the lowest for benthivorous profundal morph, contrasting with the higher values estimated for the other morphs that inhabited shallower and warmer water. These preliminary results suggest that physiological adaptation to different thermal habitats shown by the sympatric morphs may play a significant role in maintaining or strengthening niche segregation and divergence in life-history traits, potentially contributing to reproductive isolation and incipient speciation.	[Kahilainen, Kimmo Kalevi] Univ Helsinki, Kilpisjarvi Biol Stn, Kilpisjarvi, Finland; [Kahilainen, Kimmo Kalevi] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Patterson, William Paul] Univ Saskatchewan, Dept Geol Sci, Isotope Lab, Saskatoon, SK S7N 0W0, Canada; [Sonninen, Eloni] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Harrod, Chris] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Harrod, Chris] Univ Antofagasta, Inst Ciencias Nat Alexander Von Humboldt, Antofagasta, Chile; [Kiljunen, Mikko] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Helsinki; University of Helsinki; University of Saskatchewan; University of Helsinki; University of London; Queen Mary University London; Universidad de Antofagasta; University of Jyvaskyla	Kahilainen, KK (corresponding author), Univ Helsinki, Kilpisjarvi Biol Stn, Kilpisjarvi, Finland.	kimmo.kahilainen@helsinki.fi	, Bill/GSD-6628-2022; Harrod, Chris/A-8830-2008; Patterson, William P/J-6473-2012	Harrod, Chris/0000-0002-5353-1556; Kahilainen, Kimmo/0000-0002-1539-014X; Patterson, William/0000-0003-3387-708X	Ministry of Agriculture and Forestry, Academy of Finland [140903, 1268566, 134139]; Emil Aaltonen Foundation	Ministry of Agriculture and Forestry, Academy of Finland(Academy of Finland); Emil Aaltonen Foundation	Funding of this study was obtained from Ministry of Agriculture and Forestry, Academy of Finland (projects # 140903, # 1268566, and # 134139) and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 2004, ANN ZOOL FENN, V41, P301; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Bolnick DI, 2008, AM NAT, V172, P1, DOI 10.1086/587805; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Caro LM, 2013, J EVOLUTION BIOL, V26, P357, DOI 10.1111/jeb.12055; Couton M., 2012, THESIS U TROMSO TROM; Coyne J.A., 2004, SPECIATION; Culumber ZW, 2012, J EVOLUTION BIOL, V25, P1800, DOI 10.1111/j.1420-9101.2012.02562.x; Cadena CD, 2012, P ROY SOC B-BIOL SCI, V279, P194, DOI 10.1098/rspb.2011.0720; Dufour E, 2007, CAN J FISH AQUAT SCI, V64, P1736, DOI 10.1139/F07-132; Evans ML, 2012, MOL ECOL, V21, P4038, DOI 10.1111/j.1365-294X.2012.05682.x; Forsstrom L, 2007, INT REV HYDROBIOL, V92, P301, DOI 10.1002/iroh.200610928; Gao YW, 2003, FISH RES, V60, P393, DOI 10.1016/S0165-7836(02)00134-0; Godiksen J, 2010, HYDROBIOLOGIA, V650, P67, DOI 10.1007/s10750-009-0056-7; Grant P. R., 2008, WHY SPECIES MULTIPLY; Greenberg R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040933; Hanson P. C., 1997, WISCUT97001 U WISC S; Harrod C, 2010, J ANIM ECOL, V79, P1057, DOI 10.1111/j.1365-2656.2010.01702.x; Hayden B, 2013, ECOL FRESHW FISH, V22, P192, DOI 10.1111/eff.12014; HOKANSON KEF, 1977, J FISH RES BOARD CAN, V34, P1524, DOI 10.1139/f77-217; Hudson AG, 2007, ADV LIMNOL, V60, P111; Jensen H, 2008, CAN J FISH AQUAT SCI, V65, P1831, DOI 10.1139/F08-096; Jonsson CE, 2009, J HYDROL, V376, P143, DOI 10.1016/j.jhydrol.2009.07.021; Joukhadar Z, 2002, ERGEB LIMNOL, V57, P453; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; Kahilainen K, 2005, ECOL FRESHW FISH, V14, P50, DOI 10.1111/j.1600-0633.2004.00075.x; Kahilainen K, 2004, J FISH BIOL, V64, P418, DOI 10.1111/j.0022-1112.2004.00307.x; Kahilainen K, 2002, ERGEB LIMNOL, V57, P277; Kahilainen K, 2003, ECOL FRESHW FISH, V12, P275, DOI 10.1046/j.1600-0633.2003.00029.x; Kahilainen K, 2003, J FISH BIOL, V63, P659, DOI 10.1046/j.1095-8649.2003.00179.x; Kahilainen K, 2002, ECOL FRESHW FISH, V11, P158, DOI 10.1034/j.1600-0633.2002.t01-2-00001.x; Kahilainen KK, 2009, ECOL FRESHW FISH, V18, P481, DOI 10.1111/j.1600-0633.2009.00363.x; Kahilainen KK, 2007, BIOL J LINN SOC, V92, P561, DOI 10.1111/j.1095-8312.2007.00856.x; Kahilainen KK, 2011, MOL ECOL, V20, P3838, DOI 10.1111/j.1365-294X.2011.05209.x; Kahilainen KK, 2011, EVOL ECOL, V25, P573, DOI 10.1007/s10682-010-9411-4; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; LINDSTROM T, 1988, Finnish Fisheries Research, V9, P89; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Muir AP, 2014, MOL ECOL, V23, P561, DOI 10.1111/mec.12624; NAESJE TF, 1986, ENVIRON BIOL FISH, V15, P309; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Ohlberger J, 2008, FUNCT ECOL, V22, P501, DOI 10.1111/j.1365-2435.2008.01391.x; Ohlberger J, 2013, AM NAT, V182, P359, DOI 10.1086/671169; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Ostbye K, 2005, MOL ECOL, V14, P4371, DOI 10.1111/j.1365-294X.2005.02737.x; Patterson W.P., 1993, AM GEOPHYS UNION MON, V78, P191, DOI [10.1029/GM078p0191, DOI 10.1029/GM078P0191]; Patterson WP, 1998, PALAEOGEOGR PALAEOCL, V138, P271, DOI 10.1016/S0031-0182(97)00137-5; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Praebel K, 2013, ECOL EVOL, V3, P4970, DOI 10.1002/ece3.867; Price T, 2008, SPECIATION BIRDS; Ravinet M, 2013, J EVOLUTION BIOL, V26, P186, DOI 10.1111/jeb.12049; Rogers SM, 2007, MOL BIOL EVOL, V24, P1423, DOI 10.1093/molbev/msm066; SALONEN K, 1976, LIMNOL OCEANOGR, V21, P724, DOI 10.4319/lo.1976.21.5.0724; SCHLUTER D, 1993, TRENDS ECOL EVOL, V8, P197, DOI 10.1016/0169-5347(93)90098-A; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sherwood GD, 2003, MAR ECOL PROG SER, V258, P283, DOI 10.3354/meps258283; Siikavuopio SI, 2010, HYDROBIOLOGIA, V650, P255, DOI 10.1007/s10750-010-0192-0; Siwertsson A, 2010, EVOL ECOL RES, V12, P929; Solomon CT, 2006, CAN J FISH AQUAT SCI, V63, P79, DOI 10.1139/F05-200; Storm-Suke A, 2007, RAPID COMMUN MASS SP, V21, P4109, DOI 10.1002/rcm.3320; SVARDSON G, 1979, Institute of Freshwater Research Drottningholm Report, P1; Svensson EI, 2012, ORG DIVERS EVOL, V12, P229, DOI 10.1007/s13127-012-0082-6; Trudel M, 2001, CAN J FISH AQUAT SCI, V58, P394, DOI 10.1139/cjfas-58-2-394; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Wanzenbock J, 2012, ADV LIMNOL, V63, P89; WEBB PW, 1984, SCI AM, V251, P72, DOI 10.1038/scientificamerican0784-72; Weidman CR, 2000, FISH RES, V46, P327, DOI 10.1016/S0165-7836(00)00157-0; Wurster CM, 2005, CAN J FISH AQUAT SCI, V62, P700, DOI 10.1139/F04-241; Wurster CM, 2003, PALEOBIOLOGY, V29, P492, DOI 10.1666/0094-8373(2003)029<0492:MROLHF>2.0.CO;2; Wurster CM, 1999, COMPUT GEOSCI, V25, P1159, DOI 10.1016/S0098-3004(99)00052-7	74	37	36	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112085	10.1371/journal.pone.0112085	http://dx.doi.org/10.1371/journal.pone.0112085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405979	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300022
J	Perignon, M; Fiorentino, M; Kuong, K; Burja, K; Parker, M; Sisokhom, S; Chamnan, C; Berger, J; Wieringa, FT				Perignon, Marlene; Fiorentino, Marion; Kuong, Khov; Burja, Kurt; Parker, Megan; Sisokhom, Sek; Chamnan, Chhoun; Berger, Jacques; Wieringa, Frank T.			Stunting, Poor Iron Status and Parasite Infection Are Significant Risk Factors for Lower Cognitive Performance in Cambodian School-Aged Children	PLOS ONE			English	Article							SERUM TRANSFERRIN RECEPTOR; RETINOL-BINDING-PROTEIN; VITAMIN-A-DEFICIENCY; MICRONUTRIENT DEFICIENCIES; DEVELOPING-COUNTRIES; METAANALYSIS; GROWTH; INDICATORS; IMPACT; ZINC	Background: Nutrition is one of many factors affecting the cognitive development of children. In Cambodia, 55% of children <5 y were anemic and 40% stunted in 2010. Currently, no data exists on the nutritional status of Cambodian school-aged children, or on how malnutrition potentially affects their cognitive development. Objective: To assess the anthropometric and micronutrient status (iron, vitamin A, zinc, iodine) of Cambodian schoolchildren and their associations with cognitive performance. Methods: School children aged 6-16 y (n = 2443) from 20 primary schools in Cambodia were recruited. Anthropometry, hemoglobin, serum ferritin, transferrin receptors, retinol-binding protein and zinc concentrations, inflammation status, urinary iodine concentration and parasite infection were measured. Socio-economic data were collected in a sub-group of children (n = 616). Cognitive performance was assessed using Raven's Colored Progressive Matrices (RCPM) and block design and picture completion, two standardized tests from the Wechsler Intelligence Scale for Children (WISC-III). Results: The prevalence of anemia, iron, zinc, iodine and vitamin A deficiency were 15.7%; 51.2%, 92.8%, 17.3% and 0.7% respectively. The prevalence of stunting was 40.0%, including 10.9% of severe stunting. Stunted children scored significantly lower than non-stunted children on all tests. In RCPM test, boys with iron-deficiency anemia had lower scores than boys with normal iron status (-1.46, p<0.05). In picture completion test, children with normal iron status tended to score higher than iron-deficient children with anemia (-0.81; p = 0.067) or without anemia (-0.49; p = 0.064). Parasite infection was associated with an increase in risk of scoring below the median value in block design test (OR = 1.62; p<0.05), and with lower scores in other tests, for girls only (both p<0.05). Conclusion: Poor cognitive performance of Cambodian school-children was multifactorial and significantly associated with long-term (stunting) and current nutritional status indicators (iron status), as well as parasite infection. A life-cycle approach with programs to improve nutrition in early life and at school-age could contribute to optimal cognitive performance.	[Perignon, Marlene; Fiorentino, Marion; Berger, Jacques; Wieringa, Frank T.] Inst Rech Dev, Montpellier, France; [Kuong, Khov; Chamnan, Chhoun] Minist Agr Forestry & Fisheries, Dept Fisheries Postharvest Technol & Qual Control, Phnom Penh, Cambodia; [Burja, Kurt] United Nations World Food Programme, Phnom Penh, Cambodia; [Parker, Megan] PATH, Seattle, WA USA; [Sisokhom, Sek] Royal Univ Phnom Penh, Dept Psychol, Phnom Penh, Cambodia	Institut de Recherche pour le Developpement (IRD)	Perignon, M (corresponding author), Inst Rech Dev, Montpellier, France.	perignonmarlene@gmail.com	Wieringa, Frank Tammo/K-7565-2017; Khov, Kuong/E-5114-2015	Wieringa, Frank Tammo/0000-0002-6010-355X; Khov, Kuong/0000-0002-0464-9179; PERIGNON, Marlene/0000-0003-2862-9030; fiorentino, marion/0000-0002-1615-4579	United Nations World Food Programme (WFP) - DSM consortium; United States Department of Agriculture/Foreign Agricultural Service (USDA/FAS); Institut de Recherche pour le Developpement (IRD)	United Nations World Food Programme (WFP) - DSM consortium; United States Department of Agriculture/Foreign Agricultural Service (USDA/FAS)(United States Department of Agriculture (USDA)); Institut de Recherche pour le Developpement (IRD)	This work has been funded by the United Nations World Food Programme (WFP) - DSM consortium, the United States Department of Agriculture/Foreign Agricultural Service (USDA/FAS), and the Institut de Recherche pour le Developpement (IRD). The WFP had a role in study design. The IRD had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The USDA/FAS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash LR., 1994, BENCH AIDS DIAGNOSIS; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bryan J, 2004, NUTR REV, V62, P295, DOI 10.1301/nr.2004.aug.295-306; Cogill B, 2003, ANTHROPOMETRIC INDIC; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Crookston BT, 2011, MATERN CHILD NUTR, V7, P397, DOI 10.1111/j.1740-8709.2010.00255.x; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Dijkhuizen MA, 2001, AM J CLIN NUTR, V73, P786; Dunn JT., 1993, METHODS MEASURING IO; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Falkingham M, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-4; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Grantham-McGregor S, 2002, LANCET, V359, P542, DOI 10.1016/S0140-6736(02)07719-X; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hall A, 2007, LANCET INFECT DIS, V7, P297, DOI 10.1016/S1473-3099(07)70084-1; Hermoso M, 2011, ANN NUTR METAB, V59, P154, DOI 10.1159/000334490; Hughes D, 2003, NUTR REV, V61, P413, DOI 10.1301/nr.2003.dec.413-422; Isaacs E, 2008, EUR J NUTR, V47, P4, DOI 10.1007/s00394-008-3002-y; Kaplan R.M., 2009, PSYCHOL TESTING PRIN, V7th edition; Khor GL, 2012, ASIA PAC J CLIN NUTR, V21, P476; Knowles J, 2013, BRIT J NUTR, V110, P2285, DOI 10.1017/S000711451300158X; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; National Institute of Public Health National Institute of Statistics (Cambodia) ORC Macro, 2006, CAMB DEM HLTH SURV 2; National Institute of Statistics, 2011, CAMB DEM HLTH SURV 2; Sandjaja, 2013, BRIT J NUTR, V110, pS57, DOI 10.1017/S0007114513002079; SKIKNE BS, 1990, BLOOD, V75, P1870; Sokolovic N, 2014, EUR J CLIN NUTR, V68, P14, DOI 10.1038/ejcn.2013.208; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Thurlow RA, 2006, EUR J CLIN NUTR, V60, P623, DOI 10.1038/sj.ejcn.1602361; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; UNICEF/MI, 2004, VIT MIN DEF GLOB PRO; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 1995, WHO TECHN REP SER; World Health Organization United Nations Children's Fund and International Council for the Control of Iodine Deficiency Disorders., 2007, ASS IOD DEF DIS MON, P32; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X	42	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112605	10.1371/journal.pone.0112605	http://dx.doi.org/10.1371/journal.pone.0112605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405764	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300041
J	Bohringer, D; Vach, W; Hagenlocher, K; Eberwein, P; Maier, P; Reinhard, T				Boehringer, Daniel; Vach, Werner; Hagenlocher, Kai; Eberwein, Philipp; Maier, Philip; Reinhard, Thomas			Are Entry Criteria for Cataract Surgery Justified?	PLOS ONE			English	Article							COMPLICATION RATES; PHACOEMULSIFICATION	Purpose: The German Ophthalmological Society (GOS) recently proposed surgical entry criteria, i.e. 300 cataract surgeries. We herein correlate the surgical hands-on experience with the risk of posterior capsule ruptures in order to assess whether this number is appropriate. Methods: We identified all cataract operations that had been performed at the University Eye Hospital Freiburg since 1995. For each surgeon, we assigned a running number to his/her procedures in the order they had been performed. Thereafter, we excluded all combined procedures and the second eyes. We then selected the 5475 surgical reports between November 2008 and November 2012 for detailed review. We additionally classified each surgery into low-vs. high-a priori risk for posterior capsule ruptures. We fitted a multifactorial logistic regression model to assess the GOS recommendation of 300 surgeries under supervision. In the low-risk group, we additionally visualized the 'typical' learning curve by plotting the posterior capsule ruptures against the respective rank numbers. Results: The odds ratio for posterior capsule ruptures of 'learning-mode' (one of the respective surgeon's 300 first ;procedures) vs. the non-learning-mode was 3.8 (p<0.0001). By contrast, classification into the low-risk group lowered the risk of posterior capsule ruptures three fold (p<0.0001). According to the low-risk plot, the surgeons started with a complication rate of 4% and continuously improved towards 0.5% after 1500 operations. Thereafter, the rate increased again and stabilized around one percent. Conclusion: The learning curve with respect to posterior capsule ruptures is surprisingly flat. The GOS entry criterion of 300 cataract procedures is therefore most likely justified. Careful selection of low-risk patients for the training surgeons may help in reducing the rate of posterior capsule ruptures during training.	[Boehringer, Daniel; Hagenlocher, Kai; Eberwein, Philipp; Maier, Philip; Reinhard, Thomas] Univ Hosp, Ctr Eye, Freiburg, Germany; [Vach, Werner] Univ Freiburg, Med Ctr, Ctr Med Biometry & Med Informat, Freiburg, Germany	University of Freiburg; University of Freiburg	Bohringer, D (corresponding author), Univ Hosp, Ctr Eye, Freiburg, Germany.	daniel.boehringer@uniklinik-freiburg.de	Vach, Werner/F-2512-2011	Vach, Werner/0000-0003-1865-8399				Baxter JM, 2013, EYE, V27, P742, DOI 10.1038/eye.2013.54; Buchan JC, 2008, EYE, V22, P1425, DOI 10.1038/eye.2008.157; Chiu CS, 2014, CURR OPIN OPHTHALMOL, V25, P26, DOI 10.1097/ICU.0000000000000006; de Silva SR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008812.pub2; Fong CSU, 2012, CLIN EXP OPHTHALMOL, V40, P597, DOI 10.1111/j.1442-9071.2012.02759.x; Lee JS, 2009, EYE, V23, P683, DOI 10.1038/sj.eye.6703103; Randleman JB, 2007, ARCH OPHTHALMOL-CHIC, V125, P1215, DOI 10.1001/archopht.125.9.1215; TARBET KJ, 1995, J CATARACT REFR SURG, V21, P661, DOI 10.1016/S0886-3350(13)80562-7; Woodfield AS, 2011, OPHTHALMOLOGY, V118, P954, DOI 10.1016/j.ophtha.2010.08.047; Zare Mohammad, 2009, J Ophthalmic Vis Res, V4, P208	10	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112819	10.1371/journal.pone.0112819	http://dx.doi.org/10.1371/journal.pone.0112819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401738	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700075
J	Hsu, YW; Wang, HJ; Hsieh, MH; Hsieh, HL; Jauh, GY				Hsu, Ya-Wen; Wang, Huei-Jing; Hsieh, Ming-Hsiun; Hsieh, Hsu-Liang; Jauh, Guang-Yuh			Arabidopsis mTERF15 Is Required for Mitochondrial nad2 Intron 3 Splicing and Functional Complex I Activity	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; HIGHER-PLANT MITOCHONDRIA; RNA-BINDING DOMAIN; GENE-EXPRESSION; MONOCLONAL-ANTIBODIES; MTDNA TRANSCRIPTION; CHLOROPLASTS; THALIANA; TERMINATION; FAMILY	Mitochondria play a pivotal role in most eukaryotic cells, as they are responsible for the generation of energy and diverse metabolic intermediates for many cellular events. During endosymbiosis, approximately 99% of the genes encoded by the mitochondrial genome were transferred into the host nucleus, and mitochondria import more than 1000 nuclear-encoded proteins from the cytosol to maintain structural integrity and fundamental functions, including DNA replication, mRNA transcription and RNA metabolism of dozens of mitochondrial genes. In metazoans, a family of nuclear-encoded proteins called the mitochondrial transcription termination factors (mTERFs) regulates mitochondrial transcription, including transcriptional termination and initiation, via their DNA-binding activities, and the dysfunction of individual mTERF members causes severe developmental defects. Arabidopsis thaliana and Oryza sativa contain 35 and 48 mTERFs, respectively, but the biological functions of only a few of these proteins have been explored. Here, we investigated the biological role and molecular mechanism of Arabidopsis mTERF15 in plant organelle metabolism using molecular genetics, cytological and biochemical approaches. The null homozygous T-DNA mutant of mTERF15, mterf15, was found to result in substantial retardation of both vegetative and reproductive development, which was fully complemented by the wild-type genomic sequence. Surprisingly, mitochondria-localized mTERF15 lacks obvious DNA-binding activity but processes mitochondrial nad2 intron 3 splicing through its RNA-binding ability. Impairment of this splicing event not only disrupted mitochondrial structure but also abolished the activity of mitochondrial respiratory chain complex I. These effects are in agreement with the severe phenotype of the mterf15 homozygous mutant. Our study suggests that Arabidopsis mTERF15 functions as a splicing factor for nad2 intron 3 splicing in mitochondria, which is essential for normal plant growth and development.	[Hsu, Ya-Wen; Hsieh, Hsu-Liang] Natl Taiwan Univ, Inst Plant Biol, Taipei 116, Taiwan; [Hsu, Ya-Wen; Wang, Huei-Jing; Hsieh, Ming-Hsiun; Jauh, Guang-Yuh] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Jauh, Guang-Yuh] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 402, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Chung Hsing University	Jauh, GY (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	jauh@gate.sinica.edu.tw		Hsieh, Hsu-Liang/0000-0003-3201-3677; Jauh, Guang-Yuh/0000-0003-3459-1331	Academia Sinica (Taiwan); National Science and Technology Program for Agricultural Biotechnology (NSTP/AB, Taiwan) [098S0030055-AA]; Ministry of Science and Technology [99-2321-B-001-036-MY3, 102-2321-B-001-040-MY3]	Academia Sinica (Taiwan)(Academia Sinica - Taiwan); National Science and Technology Program for Agricultural Biotechnology (NSTP/AB, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by research grants from Academia Sinica (Taiwan; http://ipmb.sinica.edu.tw/index.html/), the National Science and Technology Program for Agricultural Biotechnology (NSTP/AB, 098S0030055-AA, Taiwan) and the Ministry of Science and Technology (99-2321-B-001-036-MY3 and 102-2321-B-001-040-MY3; http://www.most.gov.tw/) to G.-Y. Jauh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2001, BIOCHEM SOC T, V29, P427, DOI 10.1042/BST0290427; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Asakura Y, 2008, RNA, V14, P2319, DOI 10.1261/rna.1223708; Asakura Y, 2007, PLANT CELL, V19, P3864, DOI 10.1105/tpc.107.055160; Babiychuk E, 2011, P NATL ACAD SCI USA, V108, P6674, DOI 10.1073/pnas.1103442108; Bechtold N, 1998, METH MOL B, V82, P259; Binder S, 2003, PHILOS T R SOC B, V358, P181, DOI 10.1098/rstb.2002.1179; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Chaudhury AM, 2001, SEMIN CELL DEV BIOL, V12, P381, DOI 10.1006/scdb.2001.0267; Cupp JD, 2012, PHYSIOL PLANTARUM, V49, P91; de Longevialle AF, 2008, PLANT J, V56, P157, DOI 10.1111/j.1365-313X.2008.03581.x; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; des Francs-Small CC, 2012, PLANT J, V69, P996, DOI 10.1111/j.1365-313X.2011.04849.x; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Gkikas I, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00155; GRAY MW, 1989, ANNU REV CELL BIOL, V5, P25, DOI 10.1146/annurev.cb.05.110189.000325; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hammani K, 2014, NUCLEIC ACIDS RES, V42, P5033, DOI 10.1093/nar/gku112; Hammani K, 2014, TRENDS PLANT SCI, V19, P380, DOI 10.1016/j.tplants.2013.12.008; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kim M, 2012, PLANT CELL, V24, P3349, DOI 10.1105/tpc.112.101006; Kleine T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00233; Koprivova A, 2010, J BIOL CHEM, V285, P32192, DOI 10.1074/jbc.M110.147603; Kroeger TS, 2009, P NATL ACAD SCI USA, V106, P4537, DOI 10.1073/pnas.0812503106; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Kuhn K, 2011, PLANT J, V67, P1067, DOI 10.1111/j.1365-313X.2011.04658.x; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Liu Y, 2010, PLANT J, V63, P749, DOI 10.1111/j.1365-313X.2010.04280.x; LUETHY MH, 1993, PLANT PHYSIOL, V101, P931, DOI 10.1104/pp.101.3.931; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Meskauskiene R, 2009, PLANT J, V60, P399, DOI 10.1111/j.1365-313X.2009.03965.x; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pellegrini M, 2009, BBA-BIOENERGETICS, V1787, P294, DOI 10.1016/j.bbabio.2009.01.018; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Quesada V, 2011, PLANT J, V68, P738, DOI 10.1111/j.1365-313X.2011.04726.x; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Robles P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042924; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Thangasamy S, 2012, PLANT J, V71, P288, DOI 10.1111/j.1365-313X.2012.04989.x; Udy DB, 2012, PLANT PHYSIOL, V160, P1420, DOI 10.1104/pp.112.204198; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Watkins KP, 2011, PLANT CELL, V23, P1082, DOI 10.1105/tpc.111.084335; Welchen E, 2014, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00551; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yakubovskaya E, 2012, STRUCTURE, V20, P1940, DOI 10.1016/j.str.2012.08.027; Yakubovskaya E, 2010, CELL, V141, P982, DOI 10.1016/j.cell.2010.05.018; Zmudjak M, 2013, NEW PHYTOL, V199, P379, DOI 10.1111/nph.12282	58	71	76	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112360	10.1371/journal.pone.0112360	http://dx.doi.org/10.1371/journal.pone.0112360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402171	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700041
J	Pessoa, R; Watanabe, JT; Calabria, P; Felix, AC; Loureiro, P; Sabino, EC; Busch, MP; Sanabani, SS				Pessoa, Rodrigo; Watanabe, Jaqueline Tomoko; Calabria, Paula; Felix, Alvina Clara; Loureiro, Paula; Sabino, Ester C.; Busch, Michael P.; Sanabani, Sabri S.		Int Component NHLBI Recipient	Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE MUTATIONS; MONONUCLEAR-CELLS; SAO-PAULO; SUBTYPE-C; VACCINE DEVELOPMENT; DUAL INFECTION; PLASMA; INDIVIDUALS; DNA	Background: The findings of frequent circulation of HIV-1 subclade F1 viruses and the scarcity of BF1 recombinant viruses based on pol subgenomic fragment sequencing among blood donors in Pernambuco (PE), Northeast of Brazil, were reported recently. Here, we aimed to determine whether the classification of these strains (n = 26) extends to the whole genome sequences. Methods: Five overlapping amplicons spanning the HIV near full-length genomes (NFLGs) were PCR amplified from peripheral blood mononuclear cells (PBMCs) of 26 blood donors. The amplicons were molecularly bar-coded, pooled, and sequenced by Illumina paired-end protocol. The prevalence of viral variants containing drug resistant mutations (DRMs) was compared between plasma and PBMCs. Results: Of the 26 samples studied, 20 NFLGs and 4 partial fragments were de novo assembled into contiguous sequences and successfully subtyped. Two distinct BF1 recombinant profiles designated CRF70_BF1 and CRF71_BF1, with 4 samples in profile I and 11 in profile II were detected and thus constitute two novel recombinant forms circulating in PE. Evidence of dual infections was detected in four patients co-infected with distinct HIV-1 subtypes. According to our estimate, the new CRF71_BF1 accounts for 10% of the HIV-1 circulating strains among blood donors in PE. Discordant data between the plasma and PBMCs-virus were found in 15 of 24 donors. Six of these strains displayed major DRMs only in PBMCs and four of which had detectable DRMs changes at prevalence between 1-20% of the sequenced population. Conclusions: The high percentage of the new RF71_BF1 and other BF1 recombinants found among blood donors in Pernambuco, coupled with high rates of transmitted DRMs and dual infections confirm the need for effective surveillance to monitor the prevalence and distribution of HIV variants in a variety of settings in Brazil.	[Pessoa, Rodrigo; Watanabe, Jaqueline Tomoko; Calabria, Paula; Felix, Alvina Clara] Univ Sao Paulo, Sao Paulo Inst Trop Med, Dept Virol, Sao Paulo, Brazil; [Loureiro, Paula] Pernambuco State Ctr Hematol & Hemotherapy, Recife, PE, Brazil; [Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Dept Infect Dis, Sao Paulo, Brazil; [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Sanabani, Sabri S.] Univ Sao Paulo, Sch Med, Hosp Clin, Clin Lab,Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Vitalant; Vitalant Research Institute; Universidade de Sao Paulo	Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Clin Lab,Dept Pathol, Sao Paulo, Brazil.	sabyem_63@yahoo.com	Pessôa, Rodrigo/B-7206-2018; Sanabani, Sabri Saeed/F-5600-2012; Sabino, Ester C/F-7750-2010; Calabria, Paula Andréia Lucas/T-6144-2019; Loureiro, Paula/A-2965-2013	Sanabani, Sabri Saeed/0000-0002-8876-8262; Sabino, Ester C/0000-0003-2623-5126; Calabria, Paula Andréia Lucas/0000-0001-7955-4724; Loureiro, Paula/0000-0003-1849-0047	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/11090-5, 2011/12297-2]; Retrovirus Epidemiology Donor Study-II contract from NHLBI [HHSN268200417175C]; Recipient Epidemiology and Donor Outcomes Study-III contract from NHLBI [HHSN268201100007I]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Retrovirus Epidemiology Donor Study-II contract from NHLBI; Recipient Epidemiology and Donor Outcomes Study-III contract from NHLBI	This work was supported by grants 2011/11090-5 and 2011/12297-2 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The study was also supported by the Retrovirus Epidemiology Donor Study-II (HHSN268200417175C) and the Recipient Epidemiology and Donor Outcomes Study-III (HHSN268201100007I) contracts from NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Bansode V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-52; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Bi XQ, 2003, JAIDS-J ACQ IMM DEF, V34, P1, DOI 10.1097/00126334-200309010-00001; Passaes CPB, 2009, AIDS RES HUM RETROV, V25, P1339, DOI 10.1089/aid.2009.0167; Blackard JT, 2004, SEX TRANSM DIS, V31, P201, DOI 10.1097/01.OLQ.0000118082.45312.1F; Bon I, 2007, NEW MICROBIOL, V30, P313; Bon I, 2007, J CLIN VIROL, V38, P313, DOI 10.1016/j.jcv.2006.12.018; Chew CB, 2005, J CLIN VIROL, V33, P206, DOI 10.1016/j.jcv.2004.11.006; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; de Medeiros LB, 2006, MEM I OSWALDO CRUZ, V101, P845, DOI 10.1590/S0074-02762006000800004; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; Geretti AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069266; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KAYE S, 1995, AIDS RES HUM RETROV, V11, P1221, DOI 10.1089/aid.1995.11.1221; Konings FAJ, 2006, JAIDS-J ACQ IMM DEF, V42, P331, DOI 10.1097/01.qai.0000219784.81163.2e; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Parisi SG, 2007, J CLIN MICROBIOL, V45, P1783, DOI 10.1128/JCM.00056-07; Peeters M, 2003, AIDS, V17, P2547, DOI 10.1097/00002030-200312050-00002; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093374; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Riva E, 2001, AIDS RES HUM RETROV, V17, P1599, DOI 10.1089/088922201753342004; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Cavalcanti AMS, 2012, BRAZ J INFECT DIS, V16, P157, DOI [10.1590/S1413-86702012000200009, 10.1016/S1413-8670(12)70298-2]; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Sanabani SS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-78; Santos AF, 2006, AIDS, V20, P2011; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; de Oliveira ACS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-223; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomson MM, 2004, AIDS RES HUM RETROV, V20, P1126, DOI 10.1089/aid.2004.20.1126; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Van Laethem K, 1999, J ACQ IMMUN DEF SYND, V22, P107; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wirden M, 2011, J ANTIMICROB CHEMOTH, V66, P709, DOI 10.1093/jac/dkq544; Xu HT, 2012, J VIROL, V86, P8422, DOI 10.1128/JVI.00271-12; Xu HT, 2010, ANTIMICROB AGENTS CH, V54, P2401, DOI 10.1128/AAC.01795-09	55	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112674	10.1371/journal.pone.0112674	http://dx.doi.org/10.1371/journal.pone.0112674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401747	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700063
J	Cheung, SH; Kwok, WK; To, KF; Lau, JYW				Cheung, Sau Ha; Kwok, Wai Kei; To, Ka Fai; Lau, James Yun Wong			Anti-Atherogenic Effect of Hydrogen Sulfide by Over-Expression of Cystathionine Gamma-Lyase (CSE) Gene	PLOS ONE			English	Article							OXIDATIVE STRESS; PROTEIN; ADIPONECTIN; DONOR; CELLS; H2S; P53	Hydrogen sulfide (H2S) is an important gaseous signaling molecule that functions in physiological and pathological conditions, such as atherosclerosis. H2S dilates vessels and therefore has been suggested as an anti-atherogenic molecule. Since cystathionine gamma-lyase (CSE) enzyme is responsible for producing H2S in the cardiovascular system, we hypothesized that up-regulation of CSE expression in vivo with preservation of H2S bioactivity can slow down plaque formation and, can serve as a therapeutic strategy against atherosclerosis. In this study, C57BL/6 wild type mice (WT), ApoE knockout mice (KO) and transgenic ApoE knockout mice overexpressing CSE (Tg/KO) at four weeks of age were weaned. They were then fed with either normal or atherogenic diet for 12 weeks. At week 16, serial plasma lipid levels, body weight, and blood pressure were measured prior to euthanization of the mice and the size of atherosclerotic plaques at their aortic roots was measured. Tg/KO mice showed an increase in endogenous H2S production in aortic tissue, reduced atherosclerotic plaque sizes and attenuation in plasma lipid profiles. We also showed an up-regulation in plasma glutathionine peroxidase that could indicate reduced oxidative stress. Furthermore, there was an increase in expression of p-p53 and down regulation of inflammatory nuclear factor-kappa B (NF-kappa B) in aorta. To conclude, alteration of endogenous H2S by CSE gene activation was associated with reduced atherosclerosis in ApoE-deficient mice. Up-regulation of CSE/H2S pathway attenuates atherosclerosis and this would be a potential target for therapeutic intervention against its formation.	[Cheung, Sau Ha; Kwok, Wai Kei; Lau, James Yun Wong] Chinese Univ Hong Kong, Dept Surg, Fac Med, Hong Kong, Hong Kong, Peoples R China; [To, Ka Fai] Chinese Univ Hong Kong, Fac Med, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lau, JYW (corresponding author), Chinese Univ Hong Kong, Dept Surg, Fac Med, Hong Kong, Hong Kong, Peoples R China.	laujyw@surgery.cuhk.edu.hk	Lau, James Y. W./O-2612-2016	Lau, James Y. W./0000-0003-0122-4068	Focused Investment Scheme; Chinese University of Hong Kong [1903018]	Focused Investment Scheme; Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was funded by the Focused Investment Scheme, the Chinese University of Hong Kong (Project number 1903018) and it was received by JYWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama I, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/1/017104; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Baskar R, 2008, EUR J PHARMACOL, V594, P1, DOI 10.1016/j.ejphar.2008.07.029; Calenic B, 2013, J PERIODONTAL RES, V48, P322, DOI 10.1111/jre.12011; Calenic B, 2010, J PERIODONTOL, V81, P1317, DOI 10.1902/jop.2010.100080; Findeisen HM, 2011, OBESITY, V19, P2429, DOI 10.1038/oby.2011.298; Foster CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083513; Haraguchi FK, 2011, EUR J NUTR, V50, P331, DOI 10.1007/s00394-010-0141-8; Hu LF, 2011, ANTIOXID REDOX SIGN, V15, P405, DOI 10.1089/ars.2010.3517; Ihling C, 1997, ARTERIOSCL THROM VAS, V17, P2218, DOI 10.1161/01.ATV.17.10.2218; Jain SK, 2012, ATHEROSCLEROSIS, V225, P242, DOI 10.1016/j.atherosclerosis.2012.08.036; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kohn C, 2013, PLOS ONE, V7; Lands LC, 1999, J APPL PHYSIOL, V87, P1381, DOI 10.1152/jappl.1999.87.4.1381; Lautamaki R, 2007, METABOLISM, V56, P881, DOI 10.1016/j.metabol.2007.01; Li HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041614; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087810; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li W, 2011, ATHEROSCLEROSIS, V215, P323, DOI 10.1016/j.atherosclerosis.2010.12.037; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069979; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu Z, 2013, BRIT J PHARMACOL, V169, P1795, DOI 10.1111/bph.12246; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ma KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020525; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Mnjoyan ZH, 2003, CIRCULATION, V108, P464, DOI 10.1161/01.CIR.0000080339.49212.49; Pan LL, 2012, ANTIOXID REDOX SIGN, V17, P106, DOI 10.1089/ars.2011.4349; Pan LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019766; Pan LL, 2011, AMINO ACIDS, V41, P205, DOI 10.1007/s00726-011-0834-1; Selley E, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-69; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Wen YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053147; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Zhang HL, 2012, EUR J PHARMACOL, V697, P106, DOI 10.1016/j.ejphar.2012.10.005; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041147; Zhou CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091468; Zhuang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082509	44	38	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113038	10.1371/journal.pone.0113038	http://dx.doi.org/10.1371/journal.pone.0113038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397776	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500126
J	Crabtree, CE; Norman, JF				Crabtree, Charles E.; Norman, J. Farley			Short-Term Visual Deprivation, Tactile Acuity, and Haptic Solid Shape Discrimination	PLOS ONE			English	Article							NATURAL OBJECT SHAPE; EARLY-BLIND SUBJECTS; SPATIAL-RESOLUTION; LIGHT DEPRIVATION; CORTEX; HUMANS; PERCEPTION; PLASTICITY; ORGANIZATION; ACTIVATION	Previous psychophysical studies have reported conflicting results concerning the effects of short-term visual deprivation upon tactile acuity. Some studies have found that 45 to 90 minutes of total light deprivation produce significant improvements in participants' tactile acuity as measured with a grating orientation discrimination task. In contrast, a single 2011 study found no such improvement while attempting to replicate these earlier findings. A primary goal of the current experiment was to resolve this discrepancy in the literature by evaluating the effects of a 90-minute period of total light deprivation upon tactile grating orientation discrimination. We also evaluated the potential effect of short-term deprivation upon haptic 3-D shape discrimination using a set of naturally-shaped solid objects. According to previous research, shortterm deprivation enhances performance in a tactile 2-D shape discrimination task -perhaps a similar improvement also occurs for haptic 3-D shape discrimination. The results of the current investigation demonstrate that not only does shortterm visual deprivation not enhance tactile acuity, it additionally has no effect upon haptic 3-D shape discrimination. While visual deprivation had no effect in our study, there was a significant effect of experience and learning for the grating orientation task -the participants' tactile acuity improved over time, independent of whether they had, or had not, experienced visual deprivation.	[Crabtree, Charles E.; Norman, J. Farley] Western Kentucky Univ, Ogden Coll Sci & Engn, Dept Psychol Sci, Bowling Green, KY 42101 USA	Western Kentucky University	Norman, JF (corresponding author), Western Kentucky Univ, Ogden Coll Sci & Engn, Dept Psychol Sci, Bowling Green, KY 42101 USA.	Farley.Norman@wku.edu	Norman, Farley/A-7169-2012	Norman, Farley/0000-0001-5877-1914				[Anonymous], DROP; Bleyenheuft Y, 2007, SOMATOSENS MOT RES, V24, P111, DOI 10.1080/08990220701496639; BONEAU CA, 1960, PSYCHOL BULL, V57, P49, DOI 10.1037/h0041412; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Craig JC, 1998, SOMATOSENS MOT RES, V15, P29; Craig JC, 2000, CURR DIR PSYCHOL SCI, V9, P29, DOI 10.1111/1467-8721.00054; Cuevas I, 2009, NEUROPSYCHOLOGIA, V47, P3079, DOI 10.1016/j.neuropsychologia.2009.07.004; DAVIDSON PW, 1974, NEUROPSYCHOLOGIA, V12, P395, DOI 10.1016/0028-3932(74)90056-6; Facchini S, 2003, NEUROLOGY, V60, P1998, DOI 10.1212/01.WNL.0000068026.15208.D0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Goldreich D, 2003, J NEUROSCI, V23, P3439; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Howell DC, 1982, STAT METHODS PSYCHOL; HYVARINEN J, 1981, NEUROSCI LETT, V26, P239, DOI 10.1016/0304-3940(81)90139-7; KAAS JH, 1987, ANNU REV PSYCHOL, V38, P129, DOI 10.1146/annurev.ps.38.020187.001021; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; Leon-Sarmiento FE, 2008, NEUROSCI LETT, V441, P332, DOI 10.1016/j.neulet.2008.06.016; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewald J, 2007, NEUROPSYCHOLOGIA, V45, P1215, DOI 10.1016/j.neuropsychologia.2006.10.006; Lewis LB, 2010, J NEUROPHYSIOL, V104, P2995, DOI 10.1152/jn.00983.2009; Macmillan N. A., 1991, DETECTION THEORY USE; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; Munk H, 1881, UEBER FUNCTIONEN GRO; Norman JF, 2008, PERCEPTION, V37, P185, DOI 10.1068/p5679; Norman JF, 2006, PERCEPTION, V35, P1383, DOI 10.1068/p5504; Norman JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068577; Norman JF, 2012, EXP BRAIN RES, V222, P321, DOI 10.1007/s00221-012-3220-7; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P2323, DOI 10.3758/s13414-011-0160-4; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P908, DOI 10.3758/s13414-010-0053-y; Norman JF, 2004, PERCEPT PSYCHOPHYS, V66, P342, DOI 10.3758/BF03194883; REYNOLDS RI, 1989, B PSYCHONOMIC SOC, V27, P237, DOI 10.3758/BF03334594; Rombaux P, 2010, NEUROREPORT, V21, P1069, DOI 10.1097/WNR.0b013e32833fcb8a; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sathian K, 1997, PERCEPT PSYCHOPHYS, V59, P119, DOI 10.3758/BF03206854; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Stevens JC, 1996, J EXP PSYCHOL-APPL, V2, P91, DOI 10.1037/1076-898X.2.2.91; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Van Boven RW, 2000, NEUROLOGY, V54, P2230; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; VANESSEN DC, 1983, TRENDS NEUROSCI, V6, P370, DOI 10.1016/0166-2236(83)90167-4; Wan CY, 2010, NEUROPSYCHOLOGIA, V48, P344, DOI 10.1016/j.neuropsychologia.2009.08.016; Weisser V, 2005, EXP BRAIN RES, V166, P572, DOI 10.1007/s00221-005-2397-4; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025277; ZUBEK JP, 1964, SCIENCE, V144, P1591, DOI 10.1126/science.144.3626.1591	50	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112828	10.1371/journal.pone.0112828	http://dx.doi.org/10.1371/journal.pone.0112828			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397327	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500096
J	Gannon, J; Fernandez-Rodriguez, J; Alamri, H; Feng, SB; Kalantari, F; Negi, S; Wong, AHY; Mazur, A; Asp, L; Fazel, A; Salman, A; Lazaris, A; Metrakos, P; Bergeron, JJM; Nilsson, T				Gannon, Joan; Fernandez-Rodriguez, Julia; Alamri, Hussam; Feng, Shi Bo; Kalantari, Fariba; Negi, Sarita; Wong, Amy H. Y.; Mazur, Alexander; Asp, Lennart; Fazel, Ali; Salman, Ayat; Lazaris, Anthoula; Metrakos, Peter; Bergeron, John J. M.; Nilsson, Tommy			ARFGAP1 Is Dynamically Associated with Lipid Droplets in Hepatocytes	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; GTPASE-ACTIVATING PROTEIN; GOLGI-COMPLEX; COPI VESICLES; ENDOPLASMIC-RETICULUM; BINDING PROTEINS; COATED VESICLES; PHOSPHOLIPASE-D; BETA-COP; ARF	The ARF GTPase Activating Protein 1 (ARFGAP1) associates mainly with the cytosolic side of Golgi cisternal membranes where it participates in the formation of both COPI and clathrin-coated vesicles. In this study, we show that ARFGAP1 associates transiently with lipid droplets upon addition of oleate in cultured cells. Also, that addition of cyclic AMP shifts ARFGAP1 from lipid droplets to the Golgi apparatus and that overexpression and knockdown of ARFGAP1 affect lipid droplet formation. Examination of human liver tissue reveals that ARFGAP1 is found associated with lipid droplets at steady state in some but not all hepatocytes.	[Gannon, Joan; Alamri, Hussam; Feng, Shi Bo; Kalantari, Fariba; Negi, Sarita; Wong, Amy H. Y.; Mazur, Alexander; Fazel, Ali; Salman, Ayat; Lazaris, Anthoula; Metrakos, Peter; Bergeron, John J. M.; Nilsson, Tommy] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3A 1A1, Canada; [Fernandez-Rodriguez, Julia] Univ Gothenburg, Ctr Cellular Imaging, Gothenburg, Sweden; [Asp, Lennart] Univ Gothenburg, Inst Biomed, Dept Med & Clin Genet, Gothenburg, Sweden	McGill University; Royal Victoria Hospital; University of Gothenburg; University of Gothenburg	Nilsson, T (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Res Inst, 687 Pine Ave West, Montreal, PQ H3A 1A1, Canada.	tommy.nilsson@mcgill.ca	Bergeron, John/AAW-1893-2021; metrakos, peter/D-3726-2013	Fernandez-Rodriguez, Julia/0000-0003-4522-0966	Fonds de Recherche Quebec-Sante; Canadian Institute of Health Research [00287-003, MOP 5605]; Canadian Foundation for Innovation [5200, 11476]; Canada Research Chairs [950-212342]; Research Institute of the McGill University Health Centre; McGill University; McGill University Health Centre	Fonds de Recherche Quebec-Sante; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs(Canada Research ChairsCGIAR); Research Institute of the McGill University Health Centre; McGill University; McGill University Health Centre	This study was supported by Fonds de Recherche Quebec-Sante (www.frqs.gouv.qc.ca); Canadian Institute of Health Research (www.cihr-irsc.gc.ca), #00287-003 and MOP 5605; Canadian Foundation for Innovation (www.innovation.ca), #5200 and #11476; Canada Research Chairs (www.chairs-chaires.gc.ca), #950-212342; Research Institute of the McGill University Health Centre (www.muhc.ca/research); McGill University (www.mcgill.ca); McGill University Health Centre (www.muhc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Bai M, 2011, NAT CELL BIOL, V13, P559, DOI 10.1038/ncb2221; BALCH WE, 1992, J BIOL CHEM, V267, P13053; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chen JL, 2005, METHOD ENZYMOL, V404, P345, DOI 10.1016/S0076-6879(05)04030-9; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; GOCZE PM, 1994, ONCOLOGY, V51, P430; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; JUNGAS RL, 1966, P NATL ACAD SCI USA, V56, P757, DOI 10.1073/pnas.56.2.757; KAHN RA, 1992, J BIOL CHEM, V267, P13039; Kahn RA, 2009, FEBS LETT, V583, P3872, DOI 10.1016/j.febslet.2009.10.066; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Malsam J, 1999, FEBS LETT, V462, P267, DOI 10.1016/S0014-5793(99)01543-4; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Nakamura N, 2004, BIOCHEM BIOPH RES CO, V322, P957, DOI 10.1016/j.bbrc.2004.08.010; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pepperkok R, 2000, J CELL SCI, V113, P135; SIMIONESCU N, 1976, J CELL BIOL, V70, P608, DOI 10.1083/jcb.70.3.608; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Takashima K, 2011, CELL STRUCT FUNCT, V36, P223, DOI 10.1247/csf.11035; Thiam AR, 2013, P NATL ACAD SCI USA, V110, P13244, DOI 10.1073/pnas.1307685110; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; WADA I, 1991, J BIOL CHEM, V266, P19599; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Xiong YL, 2012, J NEUROSCI, V32, P3877, DOI 10.1523/JNEUROSCI.4566-11.2012	47	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111309	10.1371/journal.pone.0111309	http://dx.doi.org/10.1371/journal.pone.0111309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397679	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500015
J	Helander, EE; Vuorinen, AL; Wansink, B; Korhonen, IKJ				Helander, Elina E.; Vuorinen, Anna-Leena; Wansink, Brian; Korhonen, Ilkka K. J.			Are Breaks in Daily Self-Weighing Associated with Weight Gain?	PLOS ONE			English	Article							MAINTENANCE	Regular self-weighing is linked to successful weight loss and maintenance. However, an individual's self-weighing frequency typically varies over time. This study examined temporal associations between time differences of consecutive weight measurements and the corresponding weight changes by analysing longitudinal self-weighing data, including 2,838 weight observations from 40 individuals attending a health-promoting programme. The relationship between temporal weighing frequency and corresponding weight change was studied primarily using a linear mixed effects model. Weight change between consecutive weight measurements was associated with the corresponding time difference (beta = 0.021% per day, p<0.001). Weight loss took place during periods of daily self-weighing, whereas breaks longer than one month posed a risk of weight gain. The findings emphasize that missing data in weight management studies with a weight-monitoring component may be associated with non-adherence to the weight loss programme and an early sign of weight gain.	[Helander, Elina E.; Korhonen, Ilkka K. J.] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Vuorinen, Anna-Leena; Korhonen, Ilkka K. J.] VTT Tech Res Ctr Finland, Tampere, Finland; [Wansink, Brian] Cornell Univ, Charles S Dyson Sch Appl Econ & Management, Ithaca, NY USA	Tampere University; VTT Technical Research Center Finland; Cornell University	Vuorinen, AL (corresponding author), VTT Tech Res Ctr Finland, Tampere, Finland.	anna-leena.vuorinen@vtt.fi	Korhonen, Ilkka KJ/G-4301-2014	Korhonen, Ilkka KJ/0000-0002-5322-8469; Vuorinen (previously Orsama), Anna-Leena/0000-0002-5658-1305; Helander, Elina/0000-0002-0076-0590	Tampere University of Technology; Strategic Centre for Science, Technology and Innovation in Health; Well-being (SalWe) Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation) [1104/10]; VTT Technical Research Centre of Finland	Tampere University of Technology; Strategic Centre for Science, Technology and Innovation in Health; Well-being (SalWe) Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation); VTT Technical Research Centre of Finland	The main source of funding for this research was Tampere University of Technology. The research was partly supported by the Strategic Centre for Science, Technology and Innovation in Health and Well-being (SalWe) Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation grant 1104/10) and VTT Technical Research Centre of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutelle KN, 1999, HEALTH PSYCHOL, V18, P364, DOI 10.1037/0278-6133.18.4.364; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Burke LE, 2009, QUAL HEALTH RES, V19, P815, DOI 10.1177/1049732309335395; Butryn ML, 2007, OBESITY, V15, P3091, DOI 10.1038/oby.2007.368; Dionne MM, 2005, J NUTR EDUC BEHAV, V37, P315, DOI 10.1016/S1499-4046(06)60162-0; FUJIMOTO K, 1992, AM J MED SCI, V303, P145, DOI 10.1097/00000441-199203000-00002; Gokee-LaRose J, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-10; Hopsu L, 2010, BARENTS NEWSLETTER O, V13, P56; Linde JA, 2005, ANN BEHAV MED, V30, P210, DOI 10.1207/s15324796abm3003_5; Mattila E, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2557; Mattila E, 2010, IEEE T INF TECHNOL B, V14, P456, DOI 10.1109/TITB.2009.2037751; National Institutes of Health, 2000, NIH PUBLICATION; Phelan S, 2003, AM J CLIN NUTR, V78, P1079, DOI 10.1093/ajcn/78.6.1079; VanWormer JJ, 2012, INT J BEHAV MED, V19, P351, DOI 10.1007/s12529-011-9178-1; VanWormer JJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-54; VanWormer JJ, 2009, AM J PREV MED, V36, P70, DOI 10.1016/j.amepre.2008.09.022; Welsh EM, 2009, J NUTR EDUC BEHAV, V41, P425, DOI 10.1016/j.jneb.2009.04.006; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Wing RR, 2003, OBES RES, V11, P287, DOI 10.1038/oby.2003.43; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206	21	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113164	10.1371/journal.pone.0113164	http://dx.doi.org/10.1371/journal.pone.0113164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25397613	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500139
J	Yu, YY; Yip, KH; Tam, IYS; Sam, SW; Ng, CW; Zhang, W; Lau, HYA				Yu, Yangyang; Yip, Kwok Ho; Tam, Issan Yee San; Sam, Sze Wing; Ng, Chun Wai; Zhang, Wei; Lau, Hang Yung Alaster			Differential Effects of the Toll-Like Receptor 2 Agonists, PGN and Pam3CSK4 on Anti-IgE Induced Human Mast Cell Activation	PLOS ONE			English	Article							EXPRESSION; TLR2; FC-EPSILON-R1; PATHWAYS	Mast cells are pivotal in the pathogenesis of allergy and inflammation. In addition to the classical IgE-dependent mechanism involving crosslinking of the high-affinity receptor for IgE (Fc epsilon RI), mast cells are also activated by Toll-like receptors (TLRs) which are at the center of innate immunity. In this study, we demonstrated that the response of LAD2 cells (a human mast cell line) to anti-IgE was altered in the presence of the TLR2 agonists peptidoglycan (PGN) and tripalmitoyl-S-glycero-Cys(Lys) 4 (Pam3CSK4). Pretreatment of PGN and Pam3CSK4 inhibited anti-IgE induced calcium mobilization and degranulation without down-regulation of FceRI expression. Pam3CSK4 but not PGN acted in synergy with anti-IgE for IL-8 release when the TLR2 agonist was added simultaneously with anti-IgE. Studies with inhibitors of key enzymes implicated in mast cell signaling revealed that the synergistic release of IL-8 induced by Pam3CSK4 and anti-IgE involved ERK and calcineurin signaling cascades. The differential modulations of anti-IgE induced mast cell activation by PGN and Pam3CSK4 suggest that dimerization of TLR2 with TLR1 or TLR6 produced different modulating actions on Fc epsilon RI mediated human mast cell activation.	[Yu, Yangyang; Zhang, Wei] Hong Kong Univ Sci & Technol, Med Ctr, Shenzhen Key Lab Translat Med Dermatol, Biomed Res Inst,Shenzhen Peking Univ, Shenzhen, Guangdong, Peoples R China; [Yu, Yangyang; Yip, Kwok Ho; Tam, Issan Yee San; Sam, Sze Wing; Ng, Chun Wai; Lau, Hang Yung Alaster] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Chinese University of Hong Kong	Zhang, W (corresponding author), Hong Kong Univ Sci & Technol, Med Ctr, Shenzhen Key Lab Translat Med Dermatol, Biomed Res Inst,Shenzhen Peking Univ, Shenzhen, Guangdong, Peoples R China.	zhangweispace@yeah.net	Lau, HYA/M-9405-2019	Lau, HYA/0000-0002-6065-7034; Ng, Chun Wai/0000-0003-1291-4937; Tam, Issan/0000-0003-2152-8632	Research Grants of Faculty of Medicine, The Chinese University of Hong Kong; National Natural Science Foundation of China [81271755, 81371737]; Shenzhen Science and Technology Project [KQCX20120803145850990, JCYJ20130329110752139]	Research Grants of Faculty of Medicine, The Chinese University of Hong Kong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Project	The study was supported by the Research Grants of Faculty of Medicine, The Chinese University of Hong Kong, National Natural Science Foundation of China (81271755, 81371737), and Shenzhen Science and Technology Project (KQCX20120803145850990, JCYJ20130329110752139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2011, J INNATE IMMUN, V3, P495, DOI 10.1159/000327714; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Askarian F, 2014, J INNATE IMMUN, V6, P485, DOI 10.1159/000357618; Eder W, 2004, J ALLERGY CLIN IMMUN, V113, P482, DOI 10.1016/j.jaci.2003.12.374; Fuchs B, 2010, INT ARCH ALLERGY IMM, V152, P131, DOI 10.1159/000265534; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Ishii KJ, 2005, J CLIN IMMUNOL, V25, P511, DOI 10.1007/s10875-005-7829-1; Kasakura K, 2009, INT ARCH ALLERGY IMM, V150, P359, DOI 10.1159/000226237; Kawahara T, 2010, ANIM SCI J, V81, P714, DOI 10.1111/j.1740-0929.2010.00788.x; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Lin HY, 2010, INT IMMUNOPHARMACOL, V10, P883, DOI 10.1016/j.intimp.2010.04.026; Martin RJ, 2006, CLIN CHEST MED, V27, P87, DOI 10.1016/j.ccm.2005.10.004; McCall-Culbreath KD, 2011, J INNATE IMMUN, V3, P459, DOI 10.1159/000324832; Qiao HH, 2006, BLOOD, V107, P610, DOI 10.1182/blood-2005-06-2271; Saluja R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043547; Sandig H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00185; Saturnino SF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-240; Shin SY, 2011, J CELL SCI, V124, P82, DOI 10.1242/jcs.076034; Sumbayev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034259; Takenaka H, 2010, BIOCHEM BIOPH RES CO, V391, P471, DOI 10.1016/j.bbrc.2009.11.082; Taylor RC, 2006, J ALLERGY CLIN IMMUN, V117, P1148, DOI 10.1016/j.jaci.2006.02.014; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Yoshioka M, 2007, J ALLERGY CLIN IMMUN, V120, P452, DOI 10.1016/j.jaci.2007.03.027; Yu YY, 2013, EUR J INFLAMM, V11, P709, DOI 10.1177/1721727X1301100314; Zhang M, 2007, IMMUNOL RES, V37, P1, DOI 10.1007/BF02686092	27	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112989	10.1371/journal.pone.0112989	http://dx.doi.org/10.1371/journal.pone.0112989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398056	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558500121
J	O'Hara, L; McInnes, K; Simitsidellis, I; Morgan, S; Atanassova, N; Slowikowska-Hilczer, J; Kula, K; Szarras-Czapnik, M; Milne, L; Mitchell, RT; Smith, LB				O'Hara, Laura; McInnes, Kerry; Simitsidellis, Ioannis; Morgan, Stephanie; Atanassova, Nina; Slowikowska-Hilczer, Jolanta; Kula, Krzysztof; Szarras-Czapnik, Maria; Milne, Laura; Mitchell, Rod T.; Smith, Lee B.			Autocrine androgen action is essential for Leydig cell maturation and function, and protects against late-onset Leydig cell apoptosis in both mice and men	FASEB JOURNAL			English	Article						testis; testosterone; estrogen; steroidogenesis; spermatogenesis	ESTROGEN SULFOTRANSFERASE; METABOLIC SYNDROME; SERTOLI-CELLS; GERM-CELL; TESTICULAR FEMINIZATION; RECEPTOR EXPRESSION; INTERSTITIAL-CELLS; NERVOUS-SYSTEM; SMOOTH-MUSCLE; STEM-CELLS	Leydig cell number and function decline as men age, and low testosterone is associated with all "Western" cardio-metabolic disorders. However, whether perturbed androgen action within the adult Leydig cell lineage predisposes individuals to this late-onset degeneration remains unknown. To address this, we generated a novel mouse model in which androgen receptor (AR) is ablated from similar to 75% of adult Leydig stem cell/cell progenitors, from fetal life onward (Leydig cell AR knockout mice), permitting interrogation of the specific roles of autocrine Leydig cell AR signaling through comparison to adjacent AR-retaining Leydig cells, testes from littermate controls, and to human testes, including from patients with complete androgen insensitivity syndrome (CAIS). This revealed that autocrine AR signaling is dispensable for the attainment of final Leydig cell number but is essential for Leydig cell maturation and regulation of steroidogenic enzymes in adulthood. Furthermore, these studies reveal that autocrine AR signaling in Leydig cells protects against late-onset degeneration of the seminiferous epithelium in mice and inhibits Leydig cell apoptosis in both adult mice and patients with CAIS, possibly via opposing aberrant estrogen signaling. We conclude that autocrine androgen action within Leydig cells is essential for the lifelong support of spermatogenesis and the development and lifelong health of Leydig cells.	[O'Hara, Laura; Simitsidellis, Ioannis; Morgan, Stephanie; Milne, Laura; Mitchell, Rod T.; Smith, Lee B.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [McInnes, Kerry] Univ Edinburgh, Queens Med Res Inst, BHF Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Atanassova, Nina] Bulgarian Acad Sci, Inst Expt Morphol & Anthropol Museum, Sofia, Bulgaria; [Slowikowska-Hilczer, Jolanta; Kula, Krzysztof] Med Univ Lodz, Dept Androl & Reprod Endocrinol, Lodz, Poland; [Szarras-Czapnik, Maria] Childrens Mem Hlth Inst, Clin Endocrinol & Diabetol, Warsaw, Poland	University of Edinburgh; University of Edinburgh; Bulgarian Academy of Sciences; Medical University Lodz; Children's Memorial Health Institute	Smith, LB (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	lee.smith@ed.ac.uk	Simitsidellis, Ioannis/J-9600-2019; Atanassova, Nina/AAH-2722-2021	Simitsidellis, Ioannis/0000-0002-9764-3330; Atanassova, Nina/0000-0002-9032-3588; Szarras-Czapnik, Maria/0000-0003-4928-9557; Smith, Lee/0000-0002-4103-3074; O'Hara, Laura/0000-0001-7790-9261; Mitchell, Rod/0000-0003-4650-3765	Medical Research Council [G1100354/1]; Wellcome Trust [098522]; Polish Ministry of Science [N N407 277339]; MRC [G1100354] Funding Source: UKRI; Medical Research Council [G1100354] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Polish Ministry of Science(Ministry of Science and Higher Education, Poland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Lyndsey Cruickshanks, Nathan Jeffery, Mike Dodds, Mike Millar, Nancy Evans, Ruth Hamblin, and Dr. Forbes Howie for technical support, Dr. Karel De Gendt and Professor Guido Verhoeven for provision of the AR<SUP>flox</SUP> mouse line, and Professors Iain J. McEwan and Richard Sharpe for comments on the manuscript. L.O., R.T.M., and L.B.S. conceived and designed the study. L.O., K.M., L.M., I.S., S.M., and N.A. carried out experiments. L.O., R.T.M., and L.B.S. analyzed the results. J. S.-H., K.K., M.S.-C., and R.T.M. provided novel resources. L.O. and L.B.S. wrote the paper. This work was funded by Medical Research Council Program Grant Award G1100354/1 (to L.B.S.); Wellcome Trust Intermediate Clinical Fellowship (Grant 098522) (to R.T.M.); and Polish Ministry of Science Award (Grant N N407 277339) (to J.S.-H.).	Aggarwal A, 2009, MOL REPROD DEV, V76, P1076, DOI 10.1002/mrd.21074; Anand-Ivell RJK, 2006, BIOL REPROD, V74, P945, DOI 10.1095/biolreprod.105.048165; Baker PJ, 2001, REPRODUCTION, V122, P553, DOI 10.1530/reprod/122.4.553; Beattie MC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107052; BLACKBURN WR, 1973, BIOL REPROD, V9, P9, DOI 10.1093/biolreprod/9.1.9; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Chen HL, 2009, MOL CELL ENDOCRINOL, V306, P9, DOI 10.1016/j.mce.2009.01.023; De Bruyn R, 2011, METHODS MOL BIOL, V776, P81, DOI 10.1007/978-1-61779-243-4_6; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; Del Borgo MP, 2006, J BIOL CHEM, V281, P13068, DOI 10.1074/jbc.M600472200; Drake AJ, 2009, ENDOCRINOLOGY, V150, P5055, DOI 10.1210/en.2009-0700; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Eisenberg ML, 2012, J UROLOGY, V187, P594, DOI 10.1016/j.juro.2011.10.041; Faria MJS, 2003, MICROSC MICROANAL, V9, P68, DOI 10.1017/S1431927603030101; Farrell JB, 2008, DIABETES EDUCATOR, V34, P799, DOI 10.1177/0145721708323100; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Ge R. S., 1996, LEYDIG CELL, P159; GOLDSTEIN JL, 1972, J CLIN INVEST, V51, P1647, DOI 10.1172/JCI106966; Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501; Hazra R, 2013, ENDOCRINOLOGY, V154, P3410, DOI 10.1210/en.2012-2273; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Huang ZH, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103382; Hughes IA, 2012, LANCET, V380, P1419, DOI 10.1016/S0140-6736(12)60071-3; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Kilcoyne KR, 2014, P NATL ACAD SCI USA, V111, pE1924, DOI 10.1073/pnas.1320735111; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Lague E, 2008, ENDOCRINOLOGY, V149, P4688, DOI 10.1210/en.2008-0310; Landreh L, 2013, MOL CELL ENDOCRINOL, V372, P96, DOI 10.1016/j.mce.2013.03.019; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Li XD, 2006, ENDOCRINOLOGY, V147, P1271, DOI 10.1210/en.2005-0654; Luo LD, 2006, J ANDROL, V27, P240, DOI 10.2164/jandrol.05075; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; MAJDIC G, 1995, J ENDOCRINOL, V147, P285, DOI 10.1677/joe.0.1470285; Martens K, 2010, FEBS LETT, V584, P1054, DOI 10.1016/j.febslet.2010.01.061; McEwan IJ, 2012, MOL BIOSYST, V8, P82, DOI 10.1039/c1mb05249g; McInnes KJ, 2012, DIABETES, V61, P1072, DOI 10.2337/db11-1136; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; MURPHY L, 1991, INT J ANDROL, V14, P66, DOI 10.1111/j.1365-2605.1991.tb01064.x; MURPHY L, 1991, J ENDOCRINOL, V131, P443, DOI 10.1677/joe.0.1310443; NEAVES WB, 1985, BIOL REPROD, V33, P259, DOI 10.1095/biolreprod33.1.259; NEAVES WB, 1984, J CLIN ENDOCR METAB, V59, P756, DOI 10.1210/jcem-59-4-756; O'Hara L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084541; O'Hara Laura, 2012, BMC Res Notes, V5, P16, DOI 10.1186/1756-0500-5-16; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; O'Shaughnessy PJ, 2000, ENDOCRINOLOGY, V141, P2631, DOI 10.1210/en.141.7.2631; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; Ochsner SA, 2012, PHYSIOL GENOMICS, V44, P853, DOI 10.1152/physiolgenomics.00033.2012; Payne A.H., 2007, LEYDIG CELL HLTH DIS; Pye SR, 2014, J CLIN ENDOCR METAB, V99, P1357, DOI 10.1210/jc.2013-2052; Qian YM, 1999, ENDOCRINOLOGY, V140, P1048, DOI 10.1210/en.140.3.1048; Qian YM, 2001, ENDOCRINOLOGY, V142, P5342, DOI 10.1210/en.142.12.5342; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Saad F, 2009, J STEROID BIOCHEM, V114, P40, DOI 10.1016/j.jsbmb.2008.12.022; SHAN LX, 1995, ENDOCRINOLOGY, V136, P3856, DOI 10.1210/en.136.9.3856; SHARPE RM, 1988, J ENDOCRINOL, V117, P19, DOI 10.1677/joe.0.1170019; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Simanainen U, 2011, AM J PHYSIOL-ENDOC M, V301, pE727, DOI 10.1152/ajpendo.00580.2010; Smith L, 2011, REPRODUCTION, V141, P151, DOI 10.1530/REP-10-0404; Smith LB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002697; SONG WC, 1995, ENDOCRINOLOGY, V136, P2477, DOI 10.1210/en.136.6.2477; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SUZUKI K, 1995, SCAND J UROL NEPHROL, V29, P65, DOI 10.3109/00365599509180541; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tong MH, 2005, NAT MED, V11, P153, DOI 10.1038/nm1184; Tong MH, 2002, ENDOCRINOLOGY, V143, P3144, DOI 10.1210/en.143.8.3144; Tyndall V, 2012, REPRODUCTION, V143, P21, DOI 10.1530/REP-11-0239; Welsh M, 2012, INT J ANDROL, V35, P25, DOI 10.1111/j.1365-2605.2011.01150.x; Welsh M, 2011, ENDOCRINOLOGY, V152, P3541, DOI 10.1210/en.2011-0282; Welsh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013632; Welsh M, 2010, ENDOCRINOLOGY, V151, P3374, DOI 10.1210/en.2009-1339; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Welsh M, 2009, ENDOCRINOLOGY, V150, P2472, DOI 10.1210/en.2008-0529; Wranicz JK, 2005, INT J CARDIOL, V101, P105, DOI 10.1016/j.ijcard.2004.07.010; Xu QQ, 2007, ENDOCRINE, V32, P96, DOI 10.1007/s12020-007-9015-0; Yeap BB, 2010, CURR OPIN ENDOCRINOL, V17, P269, DOI 10.1097/MED.0b013e3283383031; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x; Yu IC, 2008, ENDOCRINOLOGY, V149, P2361, DOI 10.1210/en.2007-0516; Yu WP, 2014, J CLIN INVEST, V124, P2709, DOI 10.1172/JCI59901; Zumoff B, 1988, Acta Med Scand Suppl, V723, P153	86	61	62	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					894	910		10.1096/fj.14-255729	http://dx.doi.org/10.1096/fj.14-255729			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25404712	Green Published, hybrid			2022-12-26	WOS:000350633000016
J	Stewart, MD; Ramani, VC; Sanderson, RD				Stewart, Mark D.; Ramani, Vishnu C.; Sanderson, Ralph D.			Shed Syndecan-1 Translocates to the Nucleus of Cells Delivering Growth Factors and Inhibiting Histone Acetylation A NOVEL MECHANISM OF TUMOR-HOST CROSS-TALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MULTIPLE-MYELOMA; I COLLAGEN; SOLUBLE SYNDECAN-1; BONE-MARROW; EXPRESSION; ACETYLTRANSFERASE; ADHESION; GLYCOSAMINOGLYCANS; TRANSCRIPTION	The heparan sulfate proteoglycan syndecan-1 is proteolytically shed from the surface of multiple myeloma cells and is abundant in the bone marrow microenvironment where it promotes tumor growth, angiogenesis, and metastasis. In this study, we demonstrate for the first time that shed syndecan-1 present in the medium conditioned by tumor cells is taken up by bone marrow-derived stromal cells and transported to the nucleus. Translocation of shed syndecan-1 (sSDC1) to the nucleus was blocked by addition of exogenous heparin or heparan sulfate, pretreatment of conditioned medium with heparinase III, or growth of cells in sodium chlorate, indicating that sulfated heparan sulfate chains are required for nuclear translocation. Interestingly, cargo bound to sSDC1 heparan sulfate chains (i.e. hepatocyte growth factor) was transported to the nucleus along with sSDC1, and removal of heparan sulfate-bound cargo from sSDC1 abolished its translocation to the nucleus. Once in the nucleus, sSDC1 binds to the histone acetyltransferase enzyme p300, and histone acetyltransferase activity and histone acetylation are diminished. These findings reveal a novel function for shed syndecan-1 in mediating tumor-host cross-talk by shuttling growth factors to the nucleus and by altering histone acetylation in host cells. In addition, this work has broad implications beyond myeloma because shed syndecan-1 is present in high levels in many tumor types as well as in other disease states.	[Stewart, Mark D.; Ramani, Vishnu C.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sanderson, Ralph D.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, WTI 602B,1720 2nd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu			UAB Comprehensive Cancer Center Core Support Grant from the National Institutes of Health [CA13148]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA138340, F31CA176955, R01CA135075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	UAB Comprehensive Cancer Center Core Support Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the UAB High Resolution Imaging Shared Facility supported by the UAB Comprehensive Cancer Center Core Support Grant CA13148 from the National Institutes of Health.	AMALRIC F, 1994, BIOCHEM PHARMACOL, V47, P111, DOI 10.1016/0006-2952(94)90443-X; Bailly K, 2000, FASEB J, V14, P333, DOI 10.1096/fasebj.14.2.333; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Borset M, 2000, BLOOD, V96, P2528; Borset M, 1996, BLOOD, V88, P3998, DOI 10.1182/blood.V88.10.3998.bloodjournal88103998; Buczek-Thomas JA, 2008, J CELL BIOCHEM, V105, P108, DOI 10.1002/jcb.21803; BUSCH SJ, 1992, J CELL BIOL, V116, P31, DOI 10.1083/jcb.116.1.31; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Dhodapkar MV, 1997, BRIT J HAEMATOL, V99, P368, DOI 10.1046/j.1365-2141.1997.3893203.x; Dudas J, 2000, BIOCHEM J, V350, P245, DOI 10.1042/0264-6021:3500245; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; FEDARKO NS, 1989, J CELL PHYSIOL, V139, P287, DOI 10.1002/jcp.1041390210; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Li WL, 2000, J CELL SCI, V113, P1525; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; LOIDL P, 1994, CHROMOSOMA, V103, P441; Nakamura T, 2002, BIOL PHARM BULL, V25, P356, DOI 10.1248/bpb.25.356; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Raman K, 2013, MOL PHARMACEUT, V10, P1442, DOI 10.1021/mp300679a; Ramani VC, 2014, MATRIX BIOL, V35, P215, DOI 10.1016/j.matbio.2013.10.005; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Reiland J, 2004, J BIOL CHEM, V279, P8047, DOI 10.1074/jbc.M304872200; Richardson PG, 2013, LEUKEMIA RES, V37, P829, DOI 10.1016/j.leukres.2013.03.006; RIDLEY RC, 1993, BLOOD, V81, P767; SANDERSON RD, 1992, J IMMUNOL, V148, P3902; Seidel C, 2000, BLOOD, V96, P3139, DOI 10.1182/blood.V96.9.3139.h8003139_3139_3146; Stewart MD, 2014, MATRIX BIOL, V35, P56, DOI 10.1016/j.matbio.2013.10.009; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	42	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					941	949		10.1074/jbc.M114.608455	http://dx.doi.org/10.1074/jbc.M114.608455			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25404732	hybrid, Green Published			2022-12-26	WOS:000347778200028
J	Takei, N; Sobu, Y; Kimura, A; Urano, S; Piao, Y; Araki, Y; Taru, H; Yamamoto, T; Hata, S; Nakaya, T; Suzuki, T				Takei, Norio; Sobu, Yuriko; Kimura, Ayano; Urano, Satomi; Piao, Yi; Araki, Yoichi; Taru, Hidenori; Yamamoto, Tohru; Hata, Saori; Nakaya, Tadashi; Suzuki, Toshiharu			Cytoplasmic Fragment of Alcadein alpha Generated by Regulated Intramembrane Proteolysis Enhances Amyloid beta-Protein Precursor (APP) Transport into the Late Secretory Pathway and Facilitates APP Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE65-DEPENDENT GENE TRANSACTIVATION; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; MEMBRANE-PROTEINS; ENDOCYTIC PATHWAY; TRANSGENIC MICE; PDZ DOMAINS; MOUSE-BRAIN; PHOSPHORYLATION; X11-ALPHA	The neural type I membrane protein Alcadein alpha (Alc alpha), is primarily cleaved by amyloid beta-protein precursor (APP) alpha-secretase to generate a membrane-associated carboxyl-terminal fragment (Alc alpha CTF), which is further cleaved by gamma-secretase to secrete p3-Alc alpha peptides and generate an intracellular cytoplasmic domain fragment (Alc alpha ICD) in the late secretory pathway. By association with the neural adaptor protein X11L (X11-like), Alc alpha and APP form a ternary complex that suppresses the cleavage of both Alc alpha and APP by regulating the transport of these membrane proteins into the late secretory pathway where secretases are active. However, it has not been revealed how Alc alpha and APP are directed from the ternary complex formed largely in the Golgi into the late secretory pathway to reach a nerve terminus. Using a novel transgenic mouse line expressing excess amounts of human Alc alpha CTF (hAlc alpha CTF) in neurons, we found that expression of hAlc alpha CTF induced excess production of hAlc alpha ICD, which facilitated APP transport into the nerve terminus and enhanced APP metabolism, including A beta generation. In vitro cell studies also demonstrated that excess expression of Alc alpha ICD released both APP and Alc alpha from the ternary complex. These results indicate that regulated intramembrane proteolysis of Alc alpha by gamma-secretase regulates APP trafficking and the production of A beta in vivo.	[Takei, Norio; Sobu, Yuriko; Kimura, Ayano; Urano, Satomi; Piao, Yi; Araki, Yoichi; Taru, Hidenori; Hata, Saori; Nakaya, Tadashi; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Yamamoto, Tohru] Kagawa Univ, Fac Med, Dept Mol Neurobiol, Miki, Kagawa 7610793, Japan	Hokkaido University; Kagawa University	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Suzuki, Toshiharu/B-5342-2013; Hata, Saori/AAP-9634-2020; Yamamoto, Tohru/A-3801-2012	Yamamoto, Tohru/0000-0002-1652-0233; Hata, Saori/0000-0003-4723-5993; Sobu, Yuriko/0000-0003-1178-005X	Ministry of Education, Culture, Sports, Science, and Technology in Japan [26293010, 24790062]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26293010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 26293010 (to T. S.) and 24790062 (to S. H.) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and by Bilateral Joint Research Projects (to S. H.) and an Asian Core Program (to T. S.) of the Japan Society for the Promotion of Science.	Almenar-Queralt A, 2014, J NEUROSCI, V34, P3320, DOI 10.1523/JNEUROSCI.1503-13.2014; Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Hata S, 2011, ANN NEUROL, V69, P1026, DOI 10.1002/ana.22343; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; HOGAN B, 1986, MANIPULATING MOUSE E; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kondo M, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-35; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Konno T, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-76; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Matsushima T, 2012, J BIOL CHEM, V287, P19715, DOI 10.1074/jbc.M111.334847; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Mitchell JC, 2009, HUM MOL GENET, V18, P4492, DOI 10.1093/hmg/ddp408; Morohashi Y, 2013, BBA-BIOMEMBRANES, V1828, P2855, DOI 10.1016/j.bbamem.2013.06.001; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Piao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062431; Saito Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022108; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Saluja I, 2009, NEUROBIOL DIS, V36, P162, DOI 10.1016/j.nbd.2009.07.006; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Tam JHK, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0054-1; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Xie ZC, 2005, J BIOL CHEM, V280, P15413, DOI 10.1074/jbc.M414353200	41	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					987	995		10.1074/jbc.M114.599852	http://dx.doi.org/10.1074/jbc.M114.599852			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406318	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000347778200032
J	Marx, A; Alian, A				Marx, Ailie; Alian, Akram			The First Crystal Structure of a dTTP-bound Deoxycytidylate Deaminase Validates and Details the Allosteric-Inhibitor Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cytidine Deaminase; Protein Structure; X-ray Crystallography; Zinc; Deoxycytidylate Deaminase; S-TIM5; dCMP Deaminase; dTTP	DCTP DEAMINASE; SUBSTRATE; FAMILY; MUTANT; ANALOG	Background: Deoxycytidylate deaminases are the only allosterically regulated members of the zinc-dependent cytidine deaminase family. Results: dTTP binding is confirmed and described in the previously defined dCTP allosteric binding site. Conclusion: Higher affinity of dTTP than dCTP to the allosteric site may confer its inhibitory effect. Significance: This is the first dTTP-bound crystal structure of deoxycytidylate deaminase. Deoxycytidylate deaminase is unique within the zinc-dependent cytidine deaminase family as being allosterically regulated, activated by dCTP, and inhibited by dTTP. Here we present the first crystal structure of a dTTP-bound deoxycytidylate deaminase from the bacteriophage S-TIM5, confirming that this inhibitor binds to the same site as the dCTP activator. The molecular details of this structure, complemented by structures apo- and dCMP-bound, provide insights into the allosteric mechanism. Although the positioning of the nucleoside moiety of dTTP is almost identical to that previously described for dCTP, protonation of N3 in deoxythymidine and not deoxycytidine would facilitate hydrogen bonding of dTTP but not dCTP and may result in a higher affinity of dTTP to the allosteric site conferring its inhibitory activity. Further the functional group on C4 (O in dTTP and NH2 in dCTP) makes interactions with nonconserved protein residues preceding the allosteric motif, and the relative strength of binding to these residues appears to correspond to the potency of dTTP inhibition. The active sites of these structures are also uniquely occupied by dTMP and dCMP resolving aspects of substrate specificity. The methyl group of dTMP apparently clashes with a highly conserved tyrosine residue, preventing the formation of a correct base stacking shown to be imperative for deamination activity. The relevance of these findings to the wider zinc-dependent cytidine deaminase family is also discussed.	[Marx, Ailie; Alian, Akram] Technion Israel Inst Technol, Fac Biol, IL-320003 Haifa, Israel	Technion Israel Institute of Technology	Alian, A (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-320003 Haifa, Israel.	alian@tx.technion.ac.il	Alian, Akram/D-3033-2018; Alian, Akram/O-9740-2019	Alian, Akram/0000-0003-1901-3832; Alian, Akram/0000-0003-1901-3832	Israel Science Foundation [1354/14]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 1354/14.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almog R, 2004, BIOCHEMISTRY-US, V43, P13715, DOI 10.1021/bi048928h; Bransteitter R, 2009, CELL MOL LIFE SCI, V66, P3137, DOI 10.1007/s00018-009-0070-y; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Demorest ZL, 2011, J BIOL CHEM, V286, P26568, DOI 10.1074/jbc.M111.235721; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hou HF, 2008, J MOL BIOL, V377, P220, DOI 10.1016/j.jmb.2007.12.064; Jansen RS, 2011, FUND CLIN PHARMACOL, V25, P172, DOI 10.1111/j.1472-8206.2010.00823.x; Johansson E, 2005, J BIOL CHEM, V280, P3051, DOI 10.1074/jbc.M409534200; Keefe RG, 2000, J BIOL CHEM, V275, P12598, DOI 10.1074/jbc.275.17.12598; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liou JY, 2003, MOL PHARMACOL, V63, P105, DOI 10.1124/mol.63.1.105; Maley F, 1990, Prog Nucleic Acid Res Mol Biol, V39, P49, DOI 10.1016/S0079-6603(08)60623-6; MALEY F, 1982, J BIOL CHEM, V257, P1876; MALEY GF, 1968, J BIOL CHEM, V243, P4506; MALEY GF, 1982, BIOCHEMISTRY-US, V21, P3780, DOI 10.1021/bi00259a009; MALEY GF, 1993, BIOCHIM BIOPHYS ACTA, V1162, P161, DOI 10.1016/0167-4838(93)90143-F; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGaughey KM, 1996, J BIOL CHEM, V271, P23037, DOI 10.1074/jbc.271.38.23037; MOORE JT, 1993, J BIOL CHEM, V268, P2288; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Sabehi G, 2012, P NATL ACAD SCI USA, V109, P2037, DOI 10.1073/pnas.1115467109; Vincenzetti S, 2000, PROTEIN ENG, V13, P791, DOI 10.1093/protein/13.11.791; Zhang YZ, 2007, J VIROL, V81, P7662, DOI 10.1128/JVI.00186-07	25	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					682	690		10.1074/jbc.M114.617720	http://dx.doi.org/10.1074/jbc.M114.617720			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404739	hybrid, Green Published			2022-12-26	WOS:000347231200058
J	Wang, RJ; Wu, P; Shi, DB; Zheng, HT; Huang, LY; Gu, WL; Xu, Y; Cai, SJ; Cai, GX				Wang, Renjie; Wu, Peng; Shi, Debing; Zheng, Hongtu; Huang, Liyong; Gu, Weilie; Xu, Ye; Cai, Sanjun; Cai, Guoxiang			Risk Factors of Synchronous Inguinal Lymph Nodes Metastasis for Lower Rectal Cancer Involving the Anal Canal	PLOS ONE			English	Article							EPIDERMOID CARCINOMA; ADENOCARCINOMA; MORBIDITY; LYMPHADENECTOMY; ANORECTUM	Purpose: The aim of the study is to identify the risk factors of synchronous ILN metastasis for lower rectal cancer involving the anal canal. Methods: Patients with lower rectal cancer who underwent radical resection at the Fudan University Shanghai Cancer Center were retrospectively analyzed. The synchronous ILN metastasis was defined as the metastasis occurring within 6 months after the diagnosis of rectal cancer. Patients' gender, age, tumor diameter, dentate line invasion, differentiation level, histological type, depth of invasion, perirectal LN metastasis, lymphovascular invasion or perineural invasion were analyzed in the study. The correlation between synchronous ILN involvement and clinicopathological features were analyzed with Chi-square test/fisher's exact test. Variables with p<0.05 in univariate analysis were then analyzed in a multivariate logistic model. Odds ratio (OR) along with 95% confidence intervals (95% CI) were calculated. Results: A total of 325 patients (182 men and 143 women) with lower rectal cancer met the criteria and were enrolled in the study. Among them, 20 patients (6.2%) had synchronous ILN metastasis. Both univariate and multivariate analysis showed the invasion of the dentate line had a strong correlation with synchronous ILN metastasis with the odds ratio (OR) of 23.558 [95% confidence interval (CI) 6.380-86.982] (p<0.001). The presence of lymphovascular invasion also showed a significant correlation synchronous ILN metastasis with odds ratio (OR) of 5.260 [95% confidence interval (CI) 1.818-15.212] (p = 0.002). Conclusions: The invasion of dentate line and lymphovascular invasion are two independent risk factors of inguinal lymph node metastasis for lower rectal cancer involving the anal canal.	[Wang, Renjie; Wu, Peng; Shi, Debing; Zheng, Hongtu; Huang, Liyong; Gu, Weilie; Xu, Ye; Cai, Sanjun; Cai, Guoxiang] Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Wang, Renjie; Wu, Peng; Shi, Debing; Zheng, Hongtu; Huang, Liyong; Gu, Weilie; Xu, Ye; Cai, Sanjun; Cai, Guoxiang] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Cai, GX (corresponding author), Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	gxcai@fudan.edu.cn			National Natural Science Foundation of China [81001055]; Shanghai Pujiang Program [13PJD008]; National High Technology Research and Development Program (863 Program) [2012AA02A506]; Shanghai Shenkang Program [SHDC12014206, SHDC12012120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Shanghai Shenkang Program	This study was supported by grants from the National Natural Science Foundation of China (No. 81001055), Shanghai Pujiang Program (No. 13PJD008), National High Technology Research and Development Program (863 Program, No. 2012AA02A506) and Shanghai Shenkang Program (No. SHDC12014206 and No. SHDC12012120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebenek M, 2009, ANN SURG ONCOL, V16, P887, DOI 10.1245/s10434-009-0324-9; BOMAN BM, 1984, CANCER-AM CANCER SOC, V54, P114, DOI 10.1002/1097-0142(19840701)54:1<114::AID-CNCR2820540124>3.0.CO;2-P; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; FROST DB, 1984, CANCER, V53, P1285, DOI 10.1002/1097-0142(19840315)53:6<1285::AID-CNCR2820530611>3.0.CO;2-N; Fuchshuber PR, 1997, J AM COLL SURGEONS, V185, P494, DOI 10.1016/S1072-7515(01)00967-X; Glimelius B, 2010, ANN ONCOL, V21, pv82, DOI 10.1093/annonc/mdq170; GRAHAM RA, 1990, DIS COLON RECTUM, V33, P212, DOI 10.1007/BF02134182; Grinnell RS, 1942, ANN SURG, V116, P200, DOI 10.1097/00000658-194208000-00005; Hamano T, 2010, COLORECTAL DIS, V12, pE200, DOI 10.1111/j.1463-1318.2009.02134.x; Luna-Perez P, 1999, J SURG ONCOL, V70, P177, DOI 10.1002/(SICI)1096-9098(199903)70:3<177::AID-JSO6>3.0.CO;2-0; Mistrangelo M, 2010, INT J RADIAT ONCOL, V77, P73, DOI 10.1016/j.ijrobp.2009.04.020; Mori Takeo, 2003, Nihon Rinsho, V61 Suppl 7, P255; Paley PJ, 1997, GYNECOL ONCOL, V64, P237, DOI 10.1006/gyno.1996.4557; PAPILLON J, 1987, DIS COLON RECTUM, V30, P324, DOI 10.1007/BF02555448; PINTOR MP, 1989, BRIT J SURG, V76, P806, DOI 10.1002/bjs.1800760814; STEARNS MW, 1970, SURG GYNECOL OBSTETR, V131, P953; Taylor N, 2001, INT J RADIAT ONCOL, V51, P741, DOI 10.1016/S0360-3016(01)01687-X; Tocchi A, 1999, DIS COLON RECTUM, V42, P1464, DOI 10.1007/BF02235048; Tonouchi H, 2004, SURG TODAY, V34, P413, DOI 10.1007/s00595-003-2738-5; URIST MM, 1983, CANCER, V51, P2152, DOI 10.1002/1097-0142(19830601)51:11<2152::AID-CNCR2820511134>3.0.CO;2-7	20	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e111770	10.1371/journal.pone.0111770	http://dx.doi.org/10.1371/journal.pone.0111770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409168	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200004
J	Diederich, A; Schomburg, A; van Vugt, M				Diederich, Adele; Schomburg, Annette; van Vugt, Marieke			Fronto-Central Theta Oscillations Are Related to Oscillations in Saccadic Response Times (SRT): An EEG and Behavioral Data Analysis	PLOS ONE			English	Article							NEURONAL OSCILLATIONS; VISUAL-CORTEX; PHASE RESET; SYNCHRONIZATION; PERFORMANCE; ATTENTION	The phase reset hypothesis states that the phase of an ongoing neural oscillation, reflecting periodic fluctuations in neural activity between states of high and low excitability, can be shifted by the occurrence of a sensory stimulus so that the phase value become highly constant across trials (Schroeder et al., 2008). From EEG/MEG studies it has been hypothesized that coupled oscillatory activity in primary sensory cortices regulates multi sensory processing (Senkowski et al. 2008). We follow up on a study in which evidence of phase reset was found using a purely behavioral paradigm by including also EEG measures. In this paradigm, presentation of an auditory accessory stimulus was followed by a visual target with a stimulus-onset asynchrony (SOA) across a range from 0 to 404 ms in steps of 4 ms. This fine-grained stimulus presentation allowed us to do a spectral analysis on the mean SRT as a function of the SOA, which revealed distinct peak spectral components within a frequency range of 6 to 11 Hz with a modus of 7 Hz. The EEG analysis showed that the auditory stimulus caused a phase reset in 7-Hz brain oscillations in a widespread set of channels. Moreover, there was a significant difference in the average phase at which the visual target stimulus appeared between slow and fast SRT trials. This effect was evident in three different analyses, and occurred primarily in frontal and central electrodes.	[Diederich, Adele; Schomburg, Annette] Jacobs Univ Bremen, Sch Humanities & Social Sci, D-28759 Bremen, Germany; [van Vugt, Marieke] Univ Groningen, Dept Artificial Intelligence & Cognit Engn, Groningen, Netherlands	Jacobs University; University of Groningen	Diederich, A (corresponding author), Jacobs Univ Bremen, Sch Humanities & Social Sci, D-28759 Bremen, Germany.	a.diederich@jacobs-university.de	van Vugt, Marieke/A-8159-2011	van Vugt, Marieke/0000-0003-3200-0059	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [DI506/12-1]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) grant DI506/12-1 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Clochon P, 1996, ELECTROEN CLIN NEURO, V98, P126, DOI 10.1016/0013-4694(95)00192-1; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Diederich A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044910; Drewes J, 2011, J NEUROSCI, V31, P4698, DOI 10.1523/JNEUROSCI.4795-10.2011; Fiebelkorn IC, 2013, CURR BIOL, V23, P2553, DOI 10.1016/j.cub.2013.10.063; Fiebelkorn IC, 2011, J NEUROSCI, V31, P9971, DOI 10.1523/JNEUROSCI.1338-11.2011; Freeman WJ, 2002, J NEUROPHYSIOL, V87, P937, DOI 10.1152/jn.00254.2001; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Fries P, 2002, J NEUROSCI, V22, P3739; Hanslmayr S, 2013, CURR BIOL, V23, P2273, DOI 10.1016/j.cub.2013.09.020; Kaiser J, 2002, CEREB CORTEX, V12, P212, DOI 10.1093/cercor/12.2.212; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Mercier MR, 2013, NEUROIMAGE, V79, P19, DOI 10.1016/j.neuroimage.2013.04.060; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Romei V, 2012, CURR BIOL, V22, P807, DOI 10.1016/j.cub.2012.03.025; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Thorne J, 2014, HEARING RES, P1144; Thorne JD, 2011, J NEUROSCI, V31, P3853, DOI 10.1523/JNEUROSCI.6176-10.2011; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; van Atteveldt N, 2014, NEURON, V81, P1240, DOI 10.1016/j.neuron.2014.02.044; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; VARELA FJ, 1981, NEUROPSYCHOLOGIA, V19, P675	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112974	10.1371/journal.pone.0112974	http://dx.doi.org/10.1371/journal.pone.0112974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405521	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300067
J	Garcia, A; Leonardi, D; Vasconi, MD; Hinrichsen, LI; Lamas, MC				Garcia, Agustina; Leonardi, Dario; Vasconi, Maria D.; Hinrichsen, Lucila I.; Lamas, Maria C.			Characterization of Albendazole-Randomly Methylated-beta-Cyclodextrin Inclusion Complex and In Vivo Evaluation of Its Antihelmitic Activity in a Murine Model of Trichinellosis	PLOS ONE			English	Article							TRICHINELLA-SPIRALIS; KETOPROFEN; NAPROXEN; BINARY	Albendazole is a benzimidazole carbamate extensively used in oral chemotherapy against intestinal parasites, due to its broad spectrum activity, good tolerance and low cost. However, the drug has the disadvantage of poor bioavailability due to its very low solubility in water; as a consequence, a very active area of research focuses on the development of new pharmaceutical formulations to increase its solubility, dissolution rate, and bioavailability. The primary objective of this study was to prepare randomly methylated beta-cyclodextrins inclusion complexes to increase albendazole dissolution rate, in order to enhance its antiparasitic activity. This formulation therapeutic efficacy was contrasted with that of the pure drug by treating Trichinella spiralis infected mice during the intestinal phase of the parasite cycle, on days five and six post-infection. This protocol significantly decreased muscle larval burden measured in the parenteral stage on day 30 post-infection, when compared with the untreated control. Thus, it could be demonstrated that the inclusion complexes improve the in vivo therapeutic activity of albendazole.	[Garcia, Agustina; Leonardi, Dario; Lamas, Maria C.] Univ Nacl Rosario, Dept Farm, RA-2000 Rosario, Santa Fe, Argentina; [Garcia, Agustina; Leonardi, Dario; Lamas, Maria C.] Univ Nacl Rosario, IQUIR CONICET, RA-2000 Rosario, Santa Fe, Argentina; [Vasconi, Maria D.] Univ Nacl Rosario, Area Parasitol, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina; [Vasconi, Maria D.; Hinrichsen, Lucila I.] Univ Nacl Rosario, Inst Genet Expt, RA-2000 Rosario, Santa Fe, Argentina; [Hinrichsen, Lucila I.] Univ Nacl Rosario, CIC UNR, Fac Ciencias Med, RA-2000 Rosario, Santa Fe, Argentina	National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; National University of Rosario; National University of Rosario	Lamas, MC (corresponding author), Univ Nacl Rosario, Dept Farm, RA-2000 Rosario, Santa Fe, Argentina.	mlamas@fbioyf.unr.edu.ar		/0000-0001-6738-1918; Leonardi, Dario/0000-0003-2292-3570	Proyectos de investigacion plurianuales; Consejo Nacional de Investigaciones Cientificas y Tecnicas [112-201001-00194]	Proyectos de investigacion plurianuales; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work was supported by the following: Proyectos de investigacion plurianuales. Funder: Consejo Nacional de Investigaciones Cientificas y Tecnicas, N<SUP>o</SUP> 112-201001-00194, MCL and DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marzouqi AH, 2009, J PHARMACEUT BIOMED, V49, P227, DOI 10.1016/j.jpba.2008.10.032; Bassani VL, 1996, J INCLUS PHENOM MOL, V25, P149, DOI 10.1007/BF01041557; Bettinetti G, 2002, EUR J PHARM SCI, V15, P21, DOI 10.1016/S0928-0987(01)00199-3; Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012; Carrier RL, 2007, J CONTROL RELEASE, V123, P78, DOI 10.1016/j.jconrel.2007.07.018; Castillo JA, 1999, DRUG DEV IND PHARM, V25, P1241, DOI 10.1081/DDC-100102294; Cirri M, 2009, J PHARMACEUT BIOMED, V50, P683, DOI 10.1016/j.jpba.2008.11.003; Duchene D, 1999, ADV DRUG DELIVER REV, V36, P29, DOI 10.1016/S0169-409X(98)00053-2; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; Evrard B, 2004, J CONTROL RELEASE, V96, P403, DOI 10.1016/j.jconrel.2004.02.010; Garcia A, 2013, PARASITOL INT, V62, P568, DOI 10.1016/j.parint.2013.08.009; Gokturk S, 2012, SCI WORLD J, DOI 10.1100/2012/718791; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Jug M, 2010, J PHARMACEUT BIOMED, V52, P9, DOI 10.1016/j.jpba.2009.11.013; KHAN KA, 1976, J PHARM PHARMACOL, V28, P633, DOI 10.1111/j.2042-7158.1976.tb02816.x; Kociecka W, 2000, VET PARASITOL, V93, P365, DOI 10.1016/S0304-4017(00)00352-6; Kurkov SV, 2013, INT J PHARMACEUT, V453, P167, DOI 10.1016/j.ijpharm.2012.06.055; LopezGarcia ML, 1997, INT J PARASITOL, V27, P781, DOI 10.1016/S0020-7519(97)00052-0; Mura P, 1999, INT J PHARM, V179, P117, DOI 10.1016/S0378-5173(98)00390-1; Mura P, 2005, J PHARMACEUT BIOMED, V37, P987, DOI 10.1016/j.jpba.2004.06.016; Neghina R, 2011, PARASITOL INT, V60, P230, DOI 10.1016/j.parint.2011.01.007; Palomares-Alonso F, 2010, ACTA TROP, V113, P56, DOI 10.1016/j.actatropica.2009.09.006; Pathak SM, 2010, EUR J PHARM SCI, V41, P440, DOI 10.1016/j.ejps.2010.07.013; Piccirilli GN, 2013, DRUG DEV IND PHARM, P1; Pinho E, 2014, CARBOHYD POLYM, V101, P121, DOI 10.1016/j.carbpol.2013.08.078; Sajeesh S, 2010, J CONTROL RELEASE, V147, P377, DOI 10.1016/j.jconrel.2010.08.007; Salustio PJ, 2009, EUR J PHARM BIOPHARM, V71, P377, DOI 10.1016/j.ejpb.2008.09.027; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Teunis PFM, 2012, EPIDEMIOL INFECT, V140, P210, DOI 10.1017/S0950268811000380; United States Pharmacopeial Convention, 2012, US PHARM; Yang B, 2009, BIOORGAN MED CHEM, V17, P6311, DOI 10.1016/j.bmc.2009.07.060; Zoppi A, 2013, AAPS PHARMSCITECH, V14, P727, DOI 10.1208/s12249-013-9958-9	32	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113296	10.1371/journal.pone.0113296	http://dx.doi.org/10.1371/journal.pone.0113296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406084	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300100
J	Liu, X; Wang, ZZ; Zhao, P; Fan, ZM; Sun, AQ; Zhan, F; Fan, YB; Deng, XY				Liu, Xiao; Wang, Zhenze; Zhao, Ping; Fan, Zhanming; Sun, Anqiang; Zhan, Fan; Fan, Yubo; Deng, Xiaoyan			Nitric Oxide Transport in Normal Human Thoracic Aorta: Effects of Hemodynamics and Nitric Oxide Scavengers	PLOS ONE			English	Article							SHEAR-STRESS; ENDOTHELIAL DYSFUNCTION; FLOW; ATHEROSCLEROSIS; BLOOD; BIOAVAILABILITY; DIFFUSION; SYNTHASE; MODEL; CALCIUM	Despite the crucial role of nitric oxide (NO) in the homeostasis of the vasculature, little quantitative information exists concerning NO transport and distribution in medium and large-sized arteries where atherosclerosis and aneurysm occur and hemodynamics is complex. We hypothesized that local hemodynamics in arteries may govern NO transport and affect the distribution of NO in the arteries, hence playing an important role in the localization of vascular diseases. To substantiate this hypothesis, we presented a lumen/wall model of the human aorta based on its MRI images to simulate the production, transport and consumption of NO in the arterial lumen and within the aortic wall. The results demonstrated that the distribution of NO in the aorta was quite uneven with remarkably reduced NO bioavailability in regions of disturbed flow, and local hemodynamics could affect NO distribution mainly via flow dependent NO production rate of endothelium. In addition, erythrocytes in the blood could moderately modulate NO concentration in the aorta, especially at the endothelial surface. However, the reaction of NO within the wall could only slightly affect NO concentration on the luminal surface, but strongly reduce NO concentration within the aortic wall. A strong positive correlation was revealed between wall shear stress and NO concentration, which was affected by local hemodynamics and NO reaction rate. In conclusion, the distribution of NO in the aorta may be determined by local hemodynamics and modulated differently by NO scavengers in the lumen and within the wall.	[Liu, Xiao; Wang, Zhenze; Zhao, Ping; Sun, Anqiang; Zhan, Fan; Fan, Yubo; Deng, Xiaoyan] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing 100191, Peoples R China; [Fan, Zhanming] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China	Beihang University; Capital Medical University	Fan, YB (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing 100191, Peoples R China.	yubofan@buaa.edu.cn; dengxy1953@buaa.edu.cn			National Natural Science Research Foundation of China [31200703, 11332003, 61190123, 11202016, 11421202]; Specialized Research Fund for the Doctoral Program of Higher Education [20121102120038]; National Key Technology RD Program [2012BAI18B02]; 111 Project [B13003]; Beijing Natural Science Foundation [7132086]	National Natural Science Research Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Technology RD Program(National Key Technology R&D Program); 111 Project(Ministry of Education, China - 111 Project); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by Grants-in-Aid from the National Natural Science Research Foundation of China (No. 31200703, 11332003, 61190123, 11202016, 11421202, http://www.nsfc.gov.cn), Specialized Research Fund for the Doctoral Program of Higher Education (20121102120038, http://www.cutech.edu.cn), the National Key Technology R&D Program (2012BAI18B02, http://www.most.gov.cn/), the 111 Project (B13003, http://www.moe.edu.cn/) and Beijing Natural Science Foundation (7132086, http://www.bjnsf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aji W, 1997, CIRCULATION, V95, P430; Andrews AM, 2010, NITRIC OXIDE-BIOL CH, V23, P335, DOI 10.1016/j.niox.2010.08.003; Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Chen KJ, 2008, ANTIOXID REDOX SIGN, V10, P1185, DOI 10.1089/ars.2007.1959; Chen KJ, 2006, FREE RADICAL BIO MED, V41, P668, DOI 10.1016/j.freeradbiomed.2006.05.009; Chen XW, 2011, MED BIOL ENG COMPUT, V49, P633, DOI 10.1007/s11517-011-0758-7; Chen XW, 2006, J APPL PHYSIOL, V100, P482, DOI 10.1152/japplphysiol.00633.2005; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; CHO YI, 1991, BIORHEOLOGY, V28, P241; Choi HW, 2007, ANN BIOMED ENG, V35, P505, DOI 10.1007/s10439-006-9247-9; Cicha I, 2008, CLIN HEMORHEOL MICRO, V39, P113, DOI 10.3233/CH-2008-1074; Cooke JP, 2004, P NATL ACAD SCI USA, V101, P18262, DOI 10.1073/pnas.0409068101; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; de Nigris F, 2004, P NATL ACAD SCI USA, V101, P18262, DOI 10.1073/pnas.0409060101; El Aidi H, 2009, NAT CLIN PRACT CARD, V6, P219, DOI 10.1038/ncpcardio1444; Fadel AA, 2009, ANN BIOMED ENG, V37, P943, DOI 10.1007/s10439-009-9658-5; Gallo D, 2012, ANN BIOMED ENG, V40, P729, DOI 10.1007/s10439-011-0431-1; Grisham MB, 1999, AM J PHYSIOL-GASTR L, V276, pG315, DOI 10.1152/ajpgi.1999.276.2.G315; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hsiai TK, 2007, FREE RADICAL BIO MED, V42, P519, DOI 10.1016/j.freeradbiomed.2006.11.017; Jiang S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3225; Jin RC, 2010, J BLOOD MED, V1, P147; Kauser K, 2000, AM J PHYSIOL-HEART C, V278, pH1679, DOI 10.1152/ajpheart.2000.278.5.H1679; KUCHAN MJ, 1994, AM J PHYSIOL, V266, pC628, DOI 10.1152/ajpcell.1994.266.3.C628; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Lantz J, 2011, INT J APPL MECH, V3, P759, DOI 10.1142/S1758825111001226; Lasheras JC, 2007, ANNU REV FLUID MECH, V39, P293, DOI 10.1146/annurev.fluid.39.050905.110128; Liao JC, 1999, P NATL ACAD SCI USA, V96, P8757, DOI 10.1073/pnas.96.15.8757; Liu X, 2012, J R SOC INTERFACE, V9, P2468, DOI 10.1098/rsif.2012.0224; Liu X, 2010, ANN BIOMED ENG, V38, P917, DOI 10.1007/s10439-009-9878-8; Liu X, 2009, AM J PHYSIOL-HEART C, V297, pH163, DOI 10.1152/ajpheart.00266.2009; Liu XP, 2008, BIOPHYS J, V94, P1880, DOI 10.1529/biophysj.107.120626; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morbiducci U, 2011, BIOMECH MODEL MECHAN, V10, P339, DOI 10.1007/s10237-010-0238-2; Napoli C, 2006, NITRIC OXIDE-BIOL CH, V15, P265, DOI 10.1016/j.niox.2006.03.011; Neishi Y, 2005, P NATL ACAD SCI USA, V102, P11456, DOI 10.1073/pnas.0501392102; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Plank MJ, 2006, PROG BIOPHYS MOL BIO, V91, P287, DOI 10.1016/j.pbiomolbio.2005.07.005; Plata AM, 2010, ANN BIOMED ENG, V38, P2805, DOI 10.1007/s10439-010-0039-x; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tsoukias N, 2008, MICROCIRCULATION, V15, P813, DOI 10.1080/10739680802010070; Vandrangi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035260; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163; Wang H, 2013, BRIT J HAEMATOL, V162, P120, DOI 10.1111/bjh.12342	52	17	18	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112395	10.1371/journal.pone.0112395	http://dx.doi.org/10.1371/journal.pone.0112395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405341	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300031
J	Tsuda, N; Kumadaki, S; Higashi, C; Ozawa, M; Shinozaki, M; Kato, Y; Hoshida, K; Kikuchi, S; Nakano, Y; Ogawa, Y; Furusako, S				Tsuda, Naoto; Kumadaki, Shin; Higashi, Chika; Ozawa, Makoto; Shinozaki, Mikihiko; Kato, Yutaka; Hoshida, Koutarou; Kikuchi, Satomi; Nakano, Yoshihisa; Ogawa, Yoshihiro; Furusako, Shoji			Intestine-Targeted DGAT1 Inhibition Improves Obesity and Insulin Resistance without Skin Aberrations in Mice	PLOS ONE			English	Article							ACYLTRANSFERASE 1 INHIBITION; DIACYLGLYCEROL ACYLTRANSFERASE; TRIGLYCERIDE SYNTHESIS; LIPID-METABOLISM; SKELETAL-MUSCLE; INTRAMUSCULAR TRIGLYCERIDE; SENSITIVITY; STEATOSIS; SECRETION; POTENT	Objective: Diacylglycerol O-acyltransferase 1 (DGAT1) catalyzes the final committed step in triglyceride biosynthesis. DGAT1 null mice are known to be resistant to diet-induced obesity, and more insulin sensitive relative to the wild-type; however, the mice exhibit abnormalities in the skin. This work determined whether the intestine-targeted DGAT1 inhibitor could improve obesity and insulin resistance without skin aberrations in mice. Design and Methods: We synthesized 2 DGAT1 inhibitors: Compound A, described in the patent application from the Japan Tobacco, and Compound B (A-922500), reported by Abbott Laboratories. Both compounds were evaluated for inhibitory activities against DGAT1 enzymes and effects on the skin in mice in vivo. Compound B was further investigated for effects on obesity and insulin resistance in diet-induced-obese (DIO) mice. Results: The 2 compounds comparably inhibited the DGAT1 enzyme activity and the cellular triglyceride synthesis in vitro, while they showed different distribution patterns in mice in vivo. Compound A, which distributed systemically, caused skin aberrations, while Compound B, which preferentially distributed to the intestine, improved obesity and insulin resistance without skin aberrations in DIO mice. Conclusions: Our results suggest that the intestine is the key tissue in which DGAT1 plays a role in promoting obesity and insulin resistance.	[Tsuda, Naoto; Kumadaki, Shin; Higashi, Chika; Ozawa, Makoto; Shinozaki, Mikihiko; Kato, Yutaka; Hoshida, Koutarou; Kikuchi, Satomi; Nakano, Yoshihisa; Furusako, Shoji] Mochida Pharmaceut Co Ltd, Discovery Res, Shizuoka, Japan; [Tsuda, Naoto; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo, Japan	Mochida Pharmaceutical Co Ltd; Tokyo Medical & Dental University (TMDU)	Tsuda, N (corresponding author), Mochida Pharmaceut Co Ltd, Discovery Res, Shizuoka, Japan.	naoto.tsuda@mochida.co.jp		Ogawa, Yoshihiro/0000-0002-0834-2836	Mochida Pharmaceutical	Mochida Pharmaceutical	Mochida Pharmaceutical provided all funds for this work. NT, SK, CH, MO, MS, YK, KH, SK, YN, and SF are current employees of Mochida Pharmaceutical and may own stock or hold stock options in Mochida Pharmaceutical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables GP, 2012, J LIPID RES, V53, P2364, DOI 10.1194/jlr.M029041; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Denison H, 2014, DIABETES OBES METAB, V16, P334, DOI 10.1111/dom.12221; Ebeling P, 1998, DIABETOLOGIA, V41, P111, DOI 10.1007/s001250050875; Fox B.M., 2004, Fused bicyclic nitrogen-containing heterocycles, Patent No. [WO2004047755, 2004047755]; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; King AJ, 2009, J PHARMACOL EXP THER, V330, P526, DOI 10.1124/jpet.109.154047; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Manco M, 2000, METABOLISM, V49, P220, DOI 10.1016/S0026-0495(00)91377-5; Muise ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088908; Musso G, 2005, HEPATOLOGY, V42, P1175, DOI 10.1002/hep.20896; Okawa M, 2009, BIOCHEM BIOPH RES CO, V390, P377, DOI 10.1016/j.bbrc.2009.08.167; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Serrano-Wu MH, 2012, ACS MED CHEM LETT, V3, P411, DOI 10.1021/ml3000512; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337; Yamamoto T, 2011, EUR J PHARMACOL, V650, P663, DOI 10.1016/j.ejphar.2010.10.040; Yamamoto T, 2010, EUR J PHARMACOL, V640, P243, DOI 10.1016/j.ejphar.2010.04.050; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	28	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112027	10.1371/journal.pone.0112027	http://dx.doi.org/10.1371/journal.pone.0112027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405858	Green Submitted, gold, Green Published			2022-12-26	WOS:000347121300021
J	Adham, SAI; Al Rawahi, H; Habib, S; Al Moundhri, MS; Viloria-Petit, A; Coomber, BL				Adham, Sirin A. I.; Al Rawahi, Hasina; Habib, Sumaya; Al Moundhri, Mansour S.; Viloria-Petit, Alicia; Coomber, Brenda L.			Modeling of Hypo/Hyperglycemia and Their Impact on Breast Cancer Progression Related Molecules	PLOS ONE			English	Article							OVARIAN-CARCINOMA; CELLS; EXPRESSION; GROWTH; INSULIN; OBESITY; ANGIOGENESIS; RECEPTOR-2; METABOLISM; ENZYMOLOGY	Breast cancer (BC) arises commonly in women with metabolic dysfunction. The underlying mechanism by which glycemic load can exert its action on tumor metastasis is under investigated. In this study we showed that glycemic microenvironment alters the expression of three classes of proteins, VEGF and its receptors, cell to cell, and cell to extracellular matrix (ECM) adhesion proteins in MDA-MB-231 parental cells and its two metastatic variants to the bone and brain (MDA-MB-231BO and MDA-MB-231BR, respectively). Using western blotting, we showed that VEGFR2 levels were higher in these variant cells and persisted in the cells under extreme hypoglycemia. Hypoglycemia did not alter VEGFR2 expression per se but rather suppressed its posttranslational glycosylation. This was reversed rapidly upon the restoration of glucose, and cyclohexamide (CHX) treatment demonstrated that this deglycosylated VEGFR2 was not a product of de-novo protein synthesis. VEGFR2 co-receptor Neuropilin-1 was up-regulated four-fold in all MDA-MB-231 cells (parental and two variants) compared to VEGFR2 expression, and was also susceptible to glycemic changes but resistant to CHX treatment for up to 72 hrs. Hypoglycemia also resulted in a significant decrease in specific catenin, cadherin, and integrin proteins, as well as cellular proliferation and colony forming ability. However, MDA-MB-231BR cells showed a unique sensitivity to hypo/hyperglycemia in terms of morphological changes, colony formation ability, integrin beta 3 expression and secreted VEGF levels. In conclusion, this study can be translated clinically to provide insight into breast cancer cell responses to glycemic levels relevant for our understanding of the interaction between diabetes and cancer.	[Adham, Sirin A. I.; Al Rawahi, Hasina; Habib, Sumaya] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat 123, Oman; [Al Moundhri, Mansour S.] Sultan Qaboos Univ, Dept Med, Coll Med, Muscat 123, Oman; [Viloria-Petit, Alicia; Coomber, Brenda L.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	Sultan Qaboos University; Sultan Qaboos University; University of Guelph	Adham, SAI (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, POB 36, Muscat 123, Oman.	sadham@squ.edu.om	Adham, Sirin A/ABB-8842-2020	Adham, Sirin A/0000-0002-8349-6202; Al-Moundhri, Mansour/0000-0003-3963-1232	Sultan Qaboos university [IG/Biol/Sci/01/12]	Sultan Qaboos university	Sultan Qaboos university funded this work. The grant number is: IG/Biol/Sci/01/12. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham SAI, 2010, LAB INVEST, V90, P709, DOI 10.1038/labinvest.2010.52; Adham SAI, 2009, BIOCHEM BIOPH RES CO, V390, P130, DOI 10.1016/j.bbrc.2009.09.081; Banarer S, 2004, MED CLIN N AM, V88, P1107, DOI 10.1016/j.mcna.2004.04.003; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Cohen DH, 2012, ENDOCR-RELAT CANCER, V19, pF27, DOI 10.1530/ERC-11-0374; Corn PG, 2000, CLIN CANCER RES, V6, P4243; D'Anselmi F, 2011, INT J BIOCHEM CELL B, V43, P1052, DOI 10.1016/j.biocel.2010.05.002; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Ferlay J, 2012, LANCET, V379, P1390, DOI 10.1016/S0140-6736(12)60595-9; Freitas VM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-2; Gliozzo B, 1998, J CELL BIOCHEM, V70, P268, DOI 10.1002/(SICI)1097-4644(19980801)70:2<268::AID-JCB12>3.0.CO;2-J; Goodwin PJ, 2011, BREAST, V20, pS31, DOI 10.1016/S0960-9776(11)70291-0; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirsch DS, 2006, CANCER RES, V66, P3523, DOI 10.1158/0008-5472.CAN-05-1547; Hubold C, 2006, INT J OBESITY, V30, P1356, DOI 10.1038/sj.ijo.0803293; Isowa S, 2010, ANTICANCER RES, V30, P2755; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Lee YJ, 1997, J CELL SCI, V110, P681; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Onozuka H, 2011, CANCER SCI, V102, P975, DOI 10.1111/j.1349-7006.2011.01880.x; Pizon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056836; Redaniel MTM, 2012, CANCER CAUSE CONTROL, V23, P1785, DOI 10.1007/s10552-012-0057-0; Scherbakov AM, 2013, B EXP BIOL MED+, V155, P384, DOI 10.1007/s10517-013-2160-y; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Shikata K, 2013, CANCER SCI, V104, P9, DOI 10.1111/cas.12043; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Vaira S, 2012, J CELL PHYSIOL, V227, P578, DOI 10.1002/jcp.22757; Van Swearingen AED, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3651; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang Ke, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1812; WEBER G, 1977, NEW ENGL J MED, V296, P486, DOI 10.1056/NEJM197703032960905; WEBER G, 1977, NEW ENGL J MED, V296, P541, DOI 10.1056/NEJM197703102961005; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Wu LE, 2014, DIABETES; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5; Zeng L, 2010, ENDOCR-RELAT CANCER, V17, P539, DOI 10.1677/ERC-09-0221	41	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113103	10.1371/journal.pone.0113103	http://dx.doi.org/10.1371/journal.pone.0113103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401697	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700112
J	Alexandrescu, R; Siegert, RJ; Turner-Stokes, L				Alexandrescu, Roxana; Siegert, Richard John; Turner-Stokes, Lynne			Functional Outcomes and Efficiency of Rehabilitation in a National Cohort of Patients with Guillain - Barre Syndrome and Other Inflammatory Polyneuropathies	PLOS ONE			English	Article							CARE NEEDS-ASSESSMENT; QUALITY-OF-LIFE; DISABILITY; DEPENDENCY; FIM; MANAGEMENT; SCALE; SCORE; UK	Objectives: To describe functional outcomes, care needs and cost-efficiency of hospital rehabilitation for a UK cohort of inpatients with complex rehabilitation needs arising from inflammatory polyneuropathies. Subjects and Setting: 186 patients consecutively admitted to specialist neurorehabilitation centres in England with Guillain-Barre 'Syndrome (n = 118 (63.4%)) or other inflammatory polyneuropathies, including chronic inflammatory demyelinating polyneuropathy (n = 15 (8.1%) or critical illness neuropathy (n = 32 (17.2%)). Methods: Cohort analysis of data from the UK Rehabilitation Outcomes Collaborative national clinical dataset. Outcome measures include the UK Functional Assessment Measure, Northwick Park Dependency Score (NPDS) and Care Needs Assessment (NPCNA). Patients were analysed in three groups of dependency based on their admission NPDS score: 'low' (NPDS, 10), 'medium' (NPDS 10-24) and 'high' (NPDS $25). Cost-efficiency was measured as the time taken to offset the cost of rehabilitation by savings in NPCNA-estimated costs of on-going care in the community. Results: The mean rehabilitation length of stay was 72.2 (sd = 66.6) days. Significant differences were seen between the diagnostic groups on admission, but all showed significant improvements between admission and discharge, in both motor and cognitive function (p < 0.0001). Patients who were highly dependent on admission had the longest lengths of stay (mean 97.0 (SD 79.0) days), but also showed the greatest reduction in on-going care costs (1049 pound per week (SD 994)) pound, so that overall they were the most cost-efficient to treat. Conclusions: Patients with polyneuropathies have both physical and cognitive disabilities that are amenable to change with rehabilitation, resulting in significant reduction in on-going care-costs, especially for highly dependent patients.	[Alexandrescu, Roxana; Turner-Stokes, Lynne] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London, England; [Siegert, Richard John] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Siegert, Richard John] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Auckland, New Zealand; [Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, London, England	University of London; King's College London; Auckland University of Technology; Auckland University of Technology; Imperial College London	Alexandrescu, R (corresponding author), Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London, England.	roxana.alexandrescu@kcl.ac.uk	Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462; Siegert, Richard/0000-0002-3074-0929	National Institute for Health Research (NIHR) [RP-PG-0407-10185]; Dunhill Medical Trust; National Institute for Health Research [RP-PG-0407-10185] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (RP-PG-0407-10185). Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottemiller KL, 2006, REHABIL NURS, V31, P22, DOI 10.1002/j.2048-7940.2006.tb00006.x; British Society of Rehabilitation Medicine, 2010, SPEC NEUR REH SERV P; Carroll A, 2003, INT J REHABIL RES, V26, P297, DOI 10.1097/01.mrr.0000102064.48781.30; Demir SO, 2008, DISABIL REHABIL, V30, P593, DOI 10.1080/09638280701352626; Forsberg A, 2005, CLIN REHABIL, V19, P900, DOI 10.1191/0269215505cr918oa; Hall K.M., 1993, J HEAD TRAUMA REHAB, DOI [10.1097/00001199-199308020-00008, DOI 10.1097/00001199-199308020-00008]; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Khan F, 2010, J NEUROL, V257, P2024, DOI 10.1007/s00415-010-5653-x; Khan F, 2009, MULT SCLER J, V15, P869, DOI 10.1177/1352458509105230; Khan F, 2010, COCHRANE DB SYST REV, V10; Khan F, 2011, J REHABIL MED, V43, P638, DOI 10.2340/16501977-0826; Law J, 2009, DISABIL REHABIL, V31, P825, DOI 10.1080/09638280802355049; Meythaler JM, 1997, AM J PHYS MED REHAB, V76, P411, DOI 10.1097/00002060-199709000-00012; MOLENAAR DSM, 1995, J NEUROL NEUROSUR PS, V59, P165, DOI 10.1136/jnnp.59.2.165; Nicholas R, 2000, DISABIL REHABIL, V22, P451, DOI 10.1080/09638280050045929; Novak P, 2011, INT J REHABIL RES, V34, P336, DOI 10.1097/MRR.0b013e32834d32c7; Porter M.E., 2006, REDEFINING HLTH CARE; Prasad R, 2001, INT J REHABIL RES, V24, P59, DOI 10.1097/00004356-200103000-00008; Siegert RJ, 2010, J REHABIL MED, V42, P936, DOI 10.2340/16501977-0602; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 1999, CLIN REHABIL, V13, P253, DOI 10.1191/026921599677787870; Turner-Stokes L, 1998, CLIN REHABIL, V12, P304, DOI 10.1191/026921598669173600; Turner-Stokes L, 2013, DISABIL REHABIL, V35, P1885, DOI 10.3109/09638288.2013.766271; Turner-Stokes L, 2012, CLIN REHABIL, V26, P256, DOI 10.1177/0269215511417469; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Vajsar J, 2003, J PEDIATR-US, V142, P305, DOI 10.1067/mpd.2003.115; Westblad ME, 2009, DISABIL REHABIL, V31, P720, DOI 10.1080/09638280802306497; Williams H, 2007, J ADV NURS, V59, P612, DOI 10.1111/j.1365-2648.2007.04344.x	29	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110532	10.1371/journal.pone.0110532	http://dx.doi.org/10.1371/journal.pone.0110532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25402491	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700005
J	Bettaieb, A; Chahed, S; Tabet, G; Yang, J; Morisseau, C; Griffey, S; Hammock, BD; Haj, FG				Bettaieb, Ahmed; Chahed, Samah; Tabet, George; Yang, Jun; Morisseau, Christophe; Griffey, Stephen; Hammock, Bruce D.; Haj, Fawaz G.			Effects of Soluble Epoxide Hydrolase Deficiency on Acute Pancreatitis in Mice	PLOS ONE			English	Article							KAPPA-B ACTIVATION; CERULEIN-INDUCED PANCREATITIS; HORMONE-INDUCED PANCREATITIS; EPOXYEICOSATRIENOIC ACIDS; INFLAMMATORY RESPONSE; GLUCOSE-HOMEOSTASIS; PROTEIN-KINASE; ACINAR-CELLS; MOUSE MODEL; MAP KINASE	Background: Acute pancreatitis (AP) is a frequent gastrointestinal disorder that causes significant morbidity, and its incidence has been progressively increasing. AP starts as a local inflammation in the pancreas that often leads to systemic inflammatory response and complications. Soluble epoxide hydrolase (sEH) is a cytosolic enzyme whose inhibition in murine models has beneficial effects in inflammatory diseases, but its significance in AP remains unexplored. Methodology/Principal Findings: To investigate whether sEH may have a causal role in AP we utilized Ephx2 knockout (KO) mice to determine the effects of sEH deficiency on cerulein-and arginine-induced AP. sEH expression increased at the protein and messenger RNA levels, as well as enzymatic activity in the early phase of cerulein-and arginine-induced AP in mice. In addition, amylase and lipase levels were lower in cerulein-treated Ephx2 KO mice compared with controls. Moreover, pancreatic mRNA and serum concentrations of the inflammatory cytokines IL-1B and IL-6 were lower in cerulein-treated Ephx2 KO mice compared with controls. Further, Ephx2 KO mice exhibited decreased cerulein-and arginine-induced NF-kappa B inflammatory response, MAPKs activation and decreased cell death. Conclusions-These findings demonstrate a novel role for sEH in the progression of cerulein-and arginine-induced AP.	[Bettaieb, Ahmed; Chahed, Samah; Tabet, George; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Yang, Jun; Morisseau, Christophe; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Yang, Jun; Morisseau, Christophe; Hammock, Bruce D.; Haj, Fawaz G.] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Griffey, Stephen] Univ Calif Davis, Comparat Pathol Lab, Davis, CA 95616 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Div Endocrinol Diabet & Metab, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Haj, FG (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	fghaj@ucdavis.edu	Yang, Jun/B-2262-2010	Yang, Jun/0000-0001-8126-1728	JDRF [1-2009-337]; NIH [R56DK084317, R01DK090492, RO1DK095359, K99DK100736, ES02710]; NIEHS [P42 ES04699]; NHLBI [HL059699];  [U24DK097154]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL059699, R01HL059699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095359, K99DK100736, U24DK092993, R56DK084317, R01DK090492, U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002710, R01ES002710, P42ES004699] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by research grants from the JDRF (1-2009-337) and NIH (R56DK084317, R01DK090492 and RO1DK095359) to F. G. H.; K99DK100736 to A. B. and by NIH ES02710 and Superfund Basic Research Program Grant P42 ES04699 from NIEHS, and HL059699 Grant from NHLBI and U24DK097154 (to B. D. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae GS, 2011, BIOCHEM BIOPH RES CO, V410, P382, DOI 10.1016/j.bbrc.2011.05.136; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Bettaieb A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-13; Bettaieb A, 2013, J BIOL CHEM, V288, P14189, DOI 10.1074/jbc.M113.458414; BIALEK R, 1991, SCAND J GASTROENTERO, V26, P190, DOI 10.3109/00365529109025030; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen LD, 2013, PROSTAG OTH LIPID M, V104, P42, DOI 10.1016/j.prostaglandins.2012.12.001; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Dahmer MK, 2005, J NEUROSCI RES, V80, P576, DOI 10.1002/jnr.20471; Dawra R, 2007, AM J PHYSIOL-GASTR L, V292, pG1009, DOI 10.1152/ajpgi.00167.2006; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; GILL SS, 1980, BIOCHEM PHARMACOL, V29, P389, DOI 10.1016/0006-2952(80)90518-3; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Hofken T, 2000, BIOCHEM BIOPH RES CO, V276, P680, DOI 10.1006/bbrc.2000.3530; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Jha RK, 2009, MED SCI MONITOR, V15, pRA147; Ji B, 2003, PHYSIOL GENOMICS, V14, P59, DOI 10.1152/physiolgenomics.00174.2002; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; LESER HG, 1991, GASTROENTEROLOGY, V101, P782, DOI 10.1016/0016-5085(91)90539-W; Lim JW, 2008, INT J BIOCHEM CELL B, V40, P2065, DOI 10.1016/j.biocel.2008.02.015; Lugea A, 2011, GASTROENTEROLOGY, V140, P987, DOI 10.1053/j.gastro.2010.11.038; Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Minutoli L, 2004, LIFE SCI, V75, P2853, DOI 10.1016/j.lfs.2004.03.040; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Naruse S, 2003, INTERNAL MED, V42, P288, DOI 10.2169/internalmedicine.42.288; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Norman J, 1998, AM J SURG, V175, P76, DOI 10.1016/S0002-9610(97)00240-7; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Sarmiento N, 2008, BBA-MOL BASIS DIS, V1782, P271, DOI 10.1016/j.bbadis.2008.01.005; SATO S, 1989, AM J PHYSIOL, V257, pG202, DOI 10.1152/ajpgi.1989.257.2.G202; Schafer C, 2000, J GASTROENTEROL, V35, P1; Shen HC, 2012, J MED CHEM, V55, P1789, DOI 10.1021/jm201468j; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Sirish P, 2013, P NATL ACAD SCI USA, V110, P5618, DOI 10.1073/pnas.1221972110; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Tapia JA, 1999, J BIOL CHEM, V274, P31261, DOI 10.1074/jbc.274.44.31261; Vaquero E, 2001, AM J PHYSIOL-GASTR L, V280, pG1197, DOI 10.1152/ajpgi.2001.280.6.G1197; Wagner ACC, 1999, DIGESTION, V60, P41, DOI 10.1159/000007587; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; WILLEMER S, 1992, EUR SURG RES, V24, P29, DOI 10.1159/000129237; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yang J, 2014, AM J RESP CELL MOL B; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhang WY, 2013, MOL CARCINOGEN, V52, P726, DOI 10.1002/mc.21918; Zhang XP, 2007, J PANCREAS, V8, P400	54	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113019	10.1371/journal.pone.0113019	http://dx.doi.org/10.1371/journal.pone.0113019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402489	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700096
J	Chen, CC; Syue, KS; Li, KC; Yeh, SC				Chen, Chun-Chuan; Syue, Kai-Syun; Li, Kai-Chiun; Yeh, Shih-Ching			Neuronal Correlates of a Virtual-Reality-Based Passive Sensory P300 Network	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; DYNAMIC CAUSAL-MODELS; EFFECTIVE CONNECTIVITY; SOMATOSENSORY CORTEX; ATTENTIONAL CONTROL; EVOKED POTENTIALS; PREFRONTAL CORTEX; VEGETATIVE STATE; BRAIN; P3A	P300, a positive event-related potential (ERP) evoked at around 300 ms after stimulus, can be elicited using an active or passive oddball paradigm. Active P300 requires a person's intentional response, whereas passive P300 does not require an intentional response. Passive P300 has been used in incommunicative patients for consciousness detection and brain computer interface. Active and passive P300 differ in amplitude, but not in latency or scalp distribution. However, no study has addressed the mechanism underlying the production of passive P300. In particular, it remains unclear whether the passive P300 shares an identical active P300 generating network architecture when no response is required. This study aims to explore the hierarchical network of passive sensory P300 production using dynamic causal modelling (DCM) for ERP and a novel virtual reality (VR)-based passive oddball paradigm. Moreover, we investigated the causal relationship of this passive P300 network and the changes in connection strength to address the possible functional roles. A classical ERP analysis was performed to verify that the proposed VR-based game can reliably elicit passive P300. The DCM results suggested that the passive and active P300 share the same parietal-frontal neural network for attentional control and, underlying the passive network, the feed-forward modulation is stronger than the feed-back one. The functional role of this forward modulation may indicate the delivery of sensory information, automatic detection of differences, and stimulus-driven attentional processes involved in performing this passive task. To our best knowledge, this is the first study to address the passive P300 network. The results of this study may provide a reference for future clinical studies on addressing the network alternations under pathological states of incommunicative patients. However, caution is required when comparing patients' analytic results with this study. For example, the task presented here is not applicable to incommunicative patients.	[Chen, Chun-Chuan; Syue, Kai-Syun; Li, Kai-Chiun] Natl Cent Univ, Grad Inst Biomed Engn, Jhongli, Taoyuan County, Taiwan; [Yeh, Shih-Ching] Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli, Taoyuan County, Taiwan	National Central University; National Central University	Yeh, SC (corresponding author), Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli, Taoyuan County, Taiwan.	shihching.yeh@gmail.com			National Science Council of Taiwan [NSC 101-2221-E-008 -003, NSC 103-2420-H-008 -001, NSC 102-2221-E-008 -077]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Chun-Chuan Chen and Shih-Ching Yeh are funded by National Science Council of Taiwan (NSC 101-2221-E-008 -003; NSC 103-2420-H-008 -001; NSC 102-2221-E-008 -077). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka K, 2007, EXP BRAIN RES, V181, P607, DOI 10.1007/s00221-007-0958-4; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Brazdil M, 2007, NEUROIMAGE, V35, P827, DOI 10.1016/j.neuroimage.2006.12.020; Chen CC, 2012, NEUROIMAGE, V59, P340, DOI 10.1016/j.neuroimage.2011.07.066; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Duncan CC, 2009, INT J PSYCHOPHYSIOL, V73, P118, DOI 10.1016/j.ijpsycho.2009.03.005; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; GOODIN DS, 1992, J CLIN NEUROPHYSIOL, V9, P521, DOI 10.1097/00004691-199210000-00006; Herbert AM, 1998, INT J PSYCHOPHYSIOL, V28, P11, DOI 10.1016/S0167-8760(97)00070-6; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Huang MX, 2005, NEUROIMAGE, V28, P99, DOI 10.1016/j.neuroimage.2005.05.036; Jeon YW, 2001, CLIN NEUROPHYSIOL, V112, P2202, DOI 10.1016/S1388-2457(01)00663-0; John NW, 2002, MED RAD DIA IMG, P279; Katayama J, 1996, EVOKED POTENTIAL, V100, P555, DOI 10.1016/S0168-5597(96)95171-0; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1111/1469-8986.3510023; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Lai CL, 2010, CLIN NEUROPHYSIOL, V121, P194, DOI 10.1016/j.clinph.2009.11.001; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Mak JN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025003; Maldjian JA, 1999, BRAIN RES, V824, P291, DOI 10.1016/S0006-8993(99)01126-9; Mertens R, 1997, EVOKED POTENTIAL, V104, P488, DOI 10.1016/S0168-5597(97)00041-5; Montoya P, 2006, BRAIN RES, V1068, P205, DOI 10.1016/j.brainres.2005.11.019; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Obuchi C, 2012, CLIN EXP OTORHINOLAR, V5, pS6, DOI 10.3342/ceo.2012.5.S1.S6; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1989, ELECTROEN CLIN NEURO, V74, P312, DOI 10.1016/0168-5597(89)90061-0; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P334, DOI 10.1111/j.1469-8986.1996.tb01058.x; POLICH J, 1988, J CLIN NEUROPHYSIOL, V5, P287, DOI 10.1097/00004691-198807000-00004; POLICH J, 1994, INT J PSYCHOPHYSIOL, V17, P25, DOI 10.1016/0167-8760(94)90052-3; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2005, Current Alzheimer Research, V2, P515, DOI 10.2174/156720505774932214; Pullamsetti SS, 2012, ARTERIOSCL THROM VAS, V32, P1354, DOI 10.1161/ATVBAHA.112.248500; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; Reuter EM, 2013, PSYCHOPHYSIOLOGY; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; ROBINSON CJ, 1980, J COMP NEUROL, V192, P43, DOI 10.1002/cne.901920104; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2007, J BIOSCIENCES, V32, P129, DOI 10.1007/s12038-007-0012-5; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Wang L, 2010, J COGNITIVE NEUROSCI, V22, P543, DOI 10.1162/jocn.2009.21210; Wang WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066599; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yeung N, 2010, J EXP PSYCHOL LEARN, V36, P348, DOI 10.1037/a0017894; Zhu Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-21	54	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112228	10.1371/journal.pone.0112228	http://dx.doi.org/10.1371/journal.pone.0112228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401520	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700035
J	Fu, JH; Tang, J; Han, JH; Hong, Z				Fu, Jianhui; Tang, Jie; Han, Jinghao; Hong, Zhen			The Reduction of Regional Cerebral Blood Flow in Normal-Appearing White Matter Is Associated with the Severity of White Matter Lesions in Elderly: A Xeon-CT Study	PLOS ONE			English	Article							SMALL VESSEL DISEASE; LEUKOARAIOSIS; MRI; HYPERINTENSITIES; PROGRESSION; INDIVIDUALS; DIFFUSION; LADIS	White matter lesions (WMLs) in normal elderly are related to chronic ischemia, and progression of WML occurs mostly in moderate to severe disease. However, the mechanism is uncertain. Thus, we enrolled fifty-six normal elderly patients without large artery disease. The severity of WML on MRI was graded as grade 0, I, II and III using the modified Fazekas scale. Cerebral blood flow (CBF) was measured by Xenon-CT. We found that CBF (mL/100 g/min) within periventricular lesions and in the right and left centrum semiovales were 20.33, 21.27 and 21.03, respectively, in group I; 16.33, 15.55 and 15.91, respectively, in group II; and 14.05, 14.46 and 14.23, respectively, in group III. CBF of normal-appearing white matter (NAWM) around periventricular areas and in the right and left centrum semiovales were 20.79, 22.26 and 22.15, respectively, in group 0; 21.12, 22.17 and 22.25, respectively, in group I; 18.02, 19.45 and 19.62, respectively, in group II; and 16.38, 18.18 and 16.74, respectively, in group III. Significant reductions in CBF were observed not only within lesions but also in NAWM surrounding the lesions. In addition, CBF was reduced significantly within lesions compared to NAWM of the same grade. Furthermore, CBF was reduced significantly in NAWM in grades II and III when compared to grades 0 and I. Our finding indicates that ischemia may play a role in the pathogenesis of WML. Additionally, our finding provides an alternative explanation for finding that the progression of WML occurred more commonly in patients with moderate to severe WML.	[Fu, Jianhui; Tang, Jie; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Fu, Jianhui] Fudan Univ, Pudong Med Ctr, Shanghai Pudong Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Han, Jinghao] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Han, Jinghao] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Therapeut, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Fu, JH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	jianhuifu@126.com			Science and Technology Commission of Shanghai Municipality [14ZR1437300]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by grants form the Science and Technology Commission of Shanghai Municipality (Grant NO. 14ZR1437300). The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Auriel E, 2011, ACTA NEUROL SCAND, V123, P41, DOI 10.1111/j.1600-0404.2010.01341.x; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Carrera E., 2014, BRAIN; de Groot M, 2013, STROKE, V44, P1037, DOI 10.1161/STROKEAHA.112.680223; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Firbank MJ, 2012, BRIT J PSYCHIAT, V201, P40, DOI 10.1192/bjp.bp.111.098897; Fu Jian-hui, 2009, Zhonghua Yi Xue Za Zhi, V89, P1175; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Grueter BE, 2012, POSTGRAD MED J, V88, P79, DOI 10.1136/postgradmedj-2011-130307; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hatazawa J, 1997, STROKE, V28, P1944, DOI 10.1161/01.STR.28.10.1944; Kreisel SH, 2013, CEREBROVASC DIS, V35, P544, DOI 10.1159/000350725; Lawrence AJ, 2014, NEUROLOGY; Makedonov I, 2013, EUR J NEUROL, V20, P243, DOI 10.1111/j.1468-1331.2012.03785.x; Miyazawa N, 1997, STROKE, V28, P984, DOI 10.1161/01.STR.28.5.984; Nichtweiss M, 2012, CLIN NEURORADIOL, V22, P193, DOI 10.1007/s00062-012-0134-5; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; O'Sullivan Mike, 2008, Pract Neurol, V8, P26, DOI 10.1136/jnnp.2007.139428; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Papma JM, 2014, HUM BRAIN MAPP, V35, P2836, DOI 10.1002/hbm.22370; Poggesi A, 2013, J NEUROL, V260, P1014, DOI 10.1007/s00415-012-6748-3; Sachdev P, 2007, NEUROLOGY, V68, P214, DOI 10.1212/01.wnl.0000251302.55202.73; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Schmidt R, 2010, STROKE, V41, pE402, DOI 10.1161/STROKEAHA.109.576629; Uh J, 2010, J MAGN RESON IMAGING, V32, P184, DOI 10.1002/jmri.22209; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Zhan W, 2009, NEUROIMAGE, V47, pT58, DOI 10.1016/j.neuroimage.2009.02.004	28	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112832	10.1371/journal.pone.0112832	http://dx.doi.org/10.1371/journal.pone.0112832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401786	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700077
J	Schnabel, RB; Wild, PS; Wilde, S; Ojeda, FM; Schulz, A; Zeller, T; Sinning, CR; Kunde, J; Lackner, KJ; Munzel, T; Blankenberg, S				Schnabel, Renate B.; Wild, Philipp S.; Wilde, Sandra; Ojeda, Francisco M.; Schulz, Andreas; Zeller, Tanja; Sinning, Christoph R.; Kunde, Jan; Lackner, Karl J.; Munzel, Thomas; Blankenberg, Stefan			Multiple Biomarkers and Atrial Fibrillation in the General Population	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; CARDIOVASCULAR EVENTS; NATRIURETIC PEPTIDE; OXIDATIVE STRESS; ADRENOMEDULLIN; PLASMA; ENDOTHELIN-1; EXPRESSION; PERSISTENT; PREDICTION	Background: Different biological pathways have been related to atrial fibrillation (AF). Novel biomarkers capturing inflammation, oxidative stress, and neurohumoral activation have not been investigated comprehensively in AF. Methods and Results: In the population-based Gutenberg Health Study (n = 5000), mean age 56 +/- 11 years, 51% males, we measured ten biomarkers representing inflammation (C-reactive protein, fibrinogen), cardiac and vascular function (midregional pro adrenomedullin [MR-proADM], midregional pro atrial natriuretic peptide [MR-proANP], N-terminal pro-Btype natriuretic peptide [Nt-proBNP], sensitive troponin I ultra [TnI ultra], copeptin, and C-terminal pro endothelin-1), and oxidative stress (glutathioneperoxidase-1, myeloperoxidase) in relation to manifest AF (n = 161 cases). Individuals with AF were older, mean age 64.9 +/- 8.3, and more often males, 71.4%. In Bonferroni-adjusted multivariable regression analyses strongest associations per standard deviation increase in biomarker concentrations were observed for the natriuretic peptides Nt-proBNP (odds ratio [OR] 2.89, 99.5% confidence interval [CI] 2.14-3.90; P<0.0001), MR-proANP (OR 2.45, 99.5% CI 1.91-3.14; P<0.0001), the vascular function marker MR-proADM (OR 1.54, 99.5% CI 1.20-1.99; P<0.0001), TnI ultra (OR 1.50, 99.5% CI 1.19-1.90; P<0.0001) and. fibrinogen (OR 1.44, 99.5% CI 1.19-1.75; P<0.0001). Based on a model comprising known clinical risk factors for AF, all biomarkers combined resulted in a net reclassification improvement of 0.665 (99.3% CI 0.441-0.888) and an integrated discrimination improvement of >13%. Conclusions: In conclusion, in our large, population-based study, we identified novel biomarkers reflecting vascular function, MR-proADM, inflammation, and myocardial damage, TnI ultra, as related to AF; the strong association of natriuretic peptides was confirmed. Prospective studies need to examine whether risk prediction of AF can be enhanced beyond clinical risk factors using these biomarkers.	[Schnabel, Renate B.; Wilde, Sandra; Ojeda, Francisco M.; Zeller, Tanja; Sinning, Christoph R.; Blankenberg, Stefan] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Wild, Philipp S.; Schulz, Andreas; Munzel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, Mainz, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Kunde, Jan] BRAHMS GmbH, Hennigsdorf, Germany; [Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, Mainz, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Thermo Fisher Scientific; Brahms AG; Johannes Gutenberg University of Mainz	Schnabel, RB (corresponding author), Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany.	schnabelr@gmx.de	Schnabel, Renate B/ABE-6668-2021; Munzel, Thomas/A-2912-2014; Wild, Philipp S./M-2106-2019	Schnabel, Renate B/0000-0001-7170-9509; Munzel, Thomas/0000-0001-5503-4150; Zeller, Tanja/0000-0003-3379-2641; Blankenberg, Stefan/0000-0001-6488-2362; Wild, Philipp/0000-0003-4413-9752; Ojeda, Francisco/0000-0003-4037-144X	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation") [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Brandenburg Ministry of Economics, Germany; European Regional Development Fund (EFRE/ERDF); Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program [SCHN 1149/3-1]	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation"); Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Brandenburg Ministry of Economics, Germany; European Regional Development Fund (EFRE/ERDF)(European Commission); Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program(German Research Foundation (DFG))	The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation", contract number AZ 961-386261/733), the research programs "Wissenschafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. This work was further supported by research grants from the Brandenburg Ministry of Economics, Germany, and the European Regional Development Fund (EFRE/ERDF). The test kits for Copeptin, Ct-pro-endothelin-1, MR-proADM, and MR-proANP were provided by B. R. A. H. M. S, Hennigsdorf, and for Nt-proBNP by Roche Diagnostics, Mannheim at no cost. Dr. Schnabel is supported by Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program SCHN 1149/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bahrmann P, 2014, EUR HEART J ACUTE CA; Bisping E, 2007, AM J PHYSIOL-HEART C, V293, pH3001, DOI 10.1152/ajpheart.01276.2006; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Brundel BJJM, 2001, J CARDIOVASC ELECTR, V12, P737, DOI 10.1046/j.1540-8167.2001.00737.x; Bruneau BG, 1997, AM J PHYSIOL-HEART C, V273, pH2678, DOI 10.1152/ajpheart.1997.273.6.H2678; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Goette A, 2009, EUR HEART J, V30, P1411, DOI 10.1093/eurheartj/ehp046; Hastie T., 2009, UNSUPERVISED LEARNIN; Holstenson E, 2011, EUROPACE, V13, P23, DOI 10.1093/europace/euq325; ICHIKI Y, 1994, FEBS LETT, V338, P6, DOI 10.1016/0014-5793(94)80106-1; Kerkela R, 2011, AM J PHYSIOL-REG I, V300, pR140, DOI 10.1152/ajpregu.00853.2009; Khan SQ, 2007, J AM COLL CARDIOL, V49, P1525, DOI 10.1016/j.jacc.2006.12.038; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Korantzopoulos P, 2007, INT J CARDIOL, V115, P135, DOI 10.1016/j.ijcard.2006.04.026; Latini R, 2011, J INTERN MED, V269, P160, DOI 10.1111/j.1365-2796.2010.02287.x; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Matsukida K, 2001, J AM SOC ECHOCARDIOG, V14, P1080, DOI 10.1067/mje.2001.114911; McKie PM, 2014, CLIN CHEM; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Patton KK, 2009, CIRCULATION, V120, P1768, DOI 10.1161/CIRCULATIONAHA.109.873265; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Richardson DB, 2003, AM J EPIDEMIOL, V157, P355, DOI 10.1093/aje/kwf217; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Schnabel RB, 2010, EUR HEART J, V31, P3024, DOI 10.1093/eurheartj/ehq322; Schnabel RB, 2010, ARCH INTERN MED, V170, P1909, DOI 10.1001/archinternmed.2010.434; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Schnabel RB, 2009, AM J CARDIOL, V104, P92, DOI 10.1016/j.amjcard.2009.02.053; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; Tuinenburg AE, 1999, J CARDIOVASC ELECTR, V10, P827, DOI 10.1111/j.1540-8167.1999.tb00263.x; Tuinenburg AE, 1998, AM J CARDIOL, V81, P1207, DOI 10.1016/S0002-9149(98)00092-7; van den Bos EJ, 2011, EUR HEART J, V32, P611, DOI 10.1093/eurheartj/ehq491; Velagaleti RS, 2010, CIRCULATION, V122, P1700, DOI 10.1161/CIRCULATIONAHA.109.929661; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wozakowska-Kaplon B, 2010, CARDIOL J, V17, P471	44	34	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112486	10.1371/journal.pone.0112486	http://dx.doi.org/10.1371/journal.pone.0112486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401728	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700049
J	Balabanova, L; Golotin, V; Kovalchuk, S; Bulgakov, A; Likhatskaya, G; Son, O; Rasskazov, V				Balabanova, Larissa; Golotin, Vasily; Kovalchuk, Svetlana; Bulgakov, Alexander; Likhatskaya, Galina; Son, Oksana; Rasskazov, Valery			A Novel Bifunctional Hybrid with Marine Bacterium Alkaline Phosphatase and Far Eastern Holothurian Mannan-Binding Lectin Activities	PLOS ONE			English	Article							CELOMIC FLUID; T-ANTIGEN; INVERTEBRATE; GLYCOPROTEIN	A fusion between the genes encoding the marine bacterium Cobetia marina alkaline phosphatase (CmAP) and Far Eastern holothurian Apostichopus japonicus mannan-binding C-type lectin (MBL-AJ) was performed. Expression of the fusion gene in E. coli cells resulted in yield of soluble recombinant chimeric protein CmAP/MBL-AJ with the high alkaline phosphatase activity and specificity of the lectin MBL-AJ. The bifunctional hybrid CmAP/MBL-AJ was produced as a dimer with the molecular mass of 200 kDa. The CmAP/MBL-AJ dimer model showed the two-subunit lectin part that is associated with two molecules of alkaline phosphatase functioning independently from each other. The highly active CmAP label genetically linked to MBL-AJ has advantaged the lectin-binding assay in its sensitivity and time. The double substitution A156N/F159K in the lectin domain of CmAP/MBL-AJ has enhanced its lectin activity by 2565%. The bifunctional hybrid holothurian's lectin could be promising tool for developing non-invasive methods for biological markers assessment, particularly for improving the MBL-AJ-based method for early detection of a malignant condition in cervical specimens.	[Balabanova, Larissa; Golotin, Vasily; Kovalchuk, Svetlana; Bulgakov, Alexander; Likhatskaya, Galina; Rasskazov, Valery] Russian Acad Sci, Marine Biochem Lab, GB Elyakov Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia; [Son, Oksana] Far Eastern Fed Univ, Sch Econ & Management, Vladivostok, Russia	Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences; Far Eastern Federal University	Balabanova, L (corresponding author), Russian Acad Sci, Marine Biochem Lab, GB Elyakov Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia.	balaban@piboc.dvo.ru	Likhatskaya, Galina/AGO-5605-2022; Balabanova, Larissa/AAO-2209-2020; Likhatskaya, Galina/M-6340-2013	Likhatskaya, Galina/0000-0003-1937-1680; Likhatskaya, Galina/0000-0003-1937-1680; Kovalchuk, Svetlana/0000-0002-5029-0750; Son, Oksana/0000-0002-7995-7387	Russian Found of Fundamental Researches [12-04-00825-a]; Russian projects "Far Eastern" [13-HTPiI-12, 12-I-Pi6-10]; "Scientific Found" of Far Eastern Federal University [14-08-01-11-u]	Russian Found of Fundamental Researches; Russian projects "Far Eastern"; "Scientific Found" of Far Eastern Federal University	The work was supported by grant n. 12-04-00825-a from Russian Found of Fundamental Researches (http://www.rfbr.ru/rffi/ru), the Russian projects "Far Eastern" n. 13-HT Pi I-12, 12-I-Pi 6-10, and the project "Scientific Found" of Far Eastern Federal University n. 14-08-01-11-u (http://www.dvfu.ru/en/web/fefu/). The funders supported the data collection and analysis, and decision to publish.	Arai S, 2014, ACTA CRYSTALLOGR D, V70, P811, DOI 10.1107/S1399004713033609; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulgakov AA, 2011, PAC MED J, V1, P96; Bulgakov AA, 2007, GLYCOBIOLOGY, V17, P1284, DOI 10.1093/glycob/cwm093; Bulgakov AA, 2013, MAR BIOTECHNOL, V15, P73, DOI 10.1007/s10126-012-9460-5; Chang WC, 2011, BIOCHEM PHARMACOL, V81, P388, DOI 10.1016/j.bcp.2010.10.012; Cuzick J, 2000, BRIT J CANCER, V83, P561, DOI 10.1054/bjoc.2000.1375; de Melo FHM, 2007, J HISTOCHEM CYTOCHEM, V55, P1015, DOI 10.1369/jhc.7A7174.2007; Devi RV, 2010, ITAL J ZOOL, V77, P254, DOI 10.1080/11250003.2010.492794; Drago F, 2009, ISJ-INVERT SURVIV J, V6, P15; Gowda NM, 2008, FISH SHELLFISH IMMUN, V24, P450, DOI 10.1016/j.fsi.2008.01.002; Hatakeyama T, 2011, J BIOL CHEM, V286, P10305, DOI 10.1074/jbc.M110.200576; Helland R, 2009, BBA-PROTEINS PROTEOM, V1794, P297, DOI 10.1016/j.bbapap.2008.09.020; Ivanova JL, 2012, BIOCHIMIE, V94, P1833, DOI 10.1016/j.biochi.2012.04.011; Kim BG, 2013, J GYNECOL ONCOL, V24, P291, DOI 10.3802/jgo.2013.24.4.291; Kuzmanov U, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-31; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Moura RD, 2013, FUND CLIN PHARMACOL, V27, P656, DOI 10.1111/j.1472-8206.2012.01073.x; OVODOV Y S, 1991, Journal of Tumor Marker Oncology, V6, P97; PAVLENKO AF, 1988, TUMOR BIOL, V9, P249, DOI 10.1159/000217569; PAVLENKO AF, 1989, BIOORG KHIM+, V15, P816; Petrova IY, 2009, RUSS J MAR BIOL+, V35, P171, DOI 10.1134/S1063074009020096; Plisova EY, 2005, MAR BIOTECHNOL, V7, P173, DOI 10.1007/s10126-004-3022-4; Reddi AL, 2000, CANCER LETT, V149, P207, DOI 10.1016/S0304-3835(99)00363-8; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sawyers C, 2008, NATURE, V452, P3; Smith AM, 2006, J GYNECOL ONCOL, V24, P291; Sturgeon CM, 2010, USE TUMOR MARKERS LI; Teixeira EH, 2012, CARBOHYDRATES - COMPREHENSIVE STUDIES ON GLYCOBIOLOGY AND GLYCOTECHNOLOGY, P533, DOI 10.5772/50632; Vasilenko AA, 2012, RUSS J MAR BIOL+, V38, P72, DOI 10.1134/S1063074012010130; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089	32	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112729	10.1371/journal.pone.0112729	http://dx.doi.org/10.1371/journal.pone.0112729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397876	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558500085
J	Maldonado, EN; Delgado, I; Furland, NE; Buque, X; Iglesias, A; Aveldano, MI; Zubiaga, A; Fresnedo, O; Ochoa, B				Maldonado, Eduardo N.; Delgado, Igotz; Furland, Natalia E.; Buque, Xabier; Iglesias, Ainhoa; Aveldano, Marta I.; Zubiaga, Ana; Fresnedo, Olatz; Ochoa, Begona			The E2F2 Transcription Factor Sustains Hepatic Glycerophospholipid Homeostasis in Mice	PLOS ONE			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; NORMAL LIVER-REGENERATION; PARTIAL-HEPATECTOMY; MAMMALIAN-CELLS; LIPID MEDIATORS; PHOSPHATIDYLCHOLINE; EXPRESSION; PHOSPHATIDYLETHANOLAMINE; GLYCEROLIPIDS; PROGRESSION	Increasing evidence links metabolic signals to cell proliferation, but the molecular wiring that connects the two core machineries remains largely unknown. E2Fs are master regulators of cellular proliferation. We have recently shown that E2F2 activity facilitates the completion of liver regeneration after partial hepatectomy (PH) by regulating the expression of genes required for S-phase entry. Our study also revealed that E2F2 determines the duration of hepatectomy-induced hepatic steatosis. A transcriptomic analysis of normal adult liver identified "lipid metabolism regulation" as a major E2F2 functional target, suggesting that E2F2 has a role in lipid homeostasis. Here we use wild-type (E2F2(+/+)) and E2F2 deficient (E2F2(-/-)) mice to investigate the in vivo role of E2F2 in the composition of liver lipids and fatty acids in two metabolically different contexts: quiescence and 48-h post-PH, when cellular proliferation and anabolic demands are maximal. We show that liver regeneration is accompanied by large triglyceride and protein increases without changes in total phospholipids both in E2F2(+/+) and E2F2(-/-) mice. Remarkably, we found that the phenotype of quiescent liver tissue from E2F2(-/-) mice resembles the phenotype of proliferating E2F2(+/+) liver tissue, characterized by a decreased phosphatidylcholine to phosphatidylethanolamine ratio and a reprogramming of genes involved in generation of choline and ethanolamine derivatives. The diversity of fatty acids in total lipid, triglycerides and phospholipids was essentially preserved on E2F2 loss both in proliferating and non-proliferating liver tissue, although notable exceptions in inflammation-related fatty acids of defined phospholipid classes were detected. Overall, our results indicate that E2F2 activity sustains the hepatic homeostasis of major membrane glycerolipid components while it is dispensable for storage glycerolipid balance.	[Maldonado, Eduardo N.; Delgado, Igotz; Buque, Xabier; Fresnedo, Olatz; Ochoa, Begona] Univ Basque Country, Fac Med & Dent, Dept Physiol, Leioa, Spain; [Iglesias, Ainhoa; Zubiaga, Ana] Univ Basque Country, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Maldonado, Eduardo N.; Furland, Natalia E.; Aveldano, Marta I.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahi Blanca, Bahia Blanca, Buenos Aires, Argentina; [Maldonado, Eduardo N.; Furland, Natalia E.; Aveldano, Marta I.] Univ Nacl Sur, RA-8000 Bahia Blanca, Buenos Aires, Argentina	University of Basque Country; University of Basque Country; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Ochoa, B (corresponding author), Univ Basque Country, Fac Med & Dent, Dept Physiol, Leioa, Spain.	begona.ochoa@ehu.es	Ochoa, Begona/K-9123-2014; Maldonado, Eduardo/AAN-3907-2020; Fresnedo, Olatz/AAT-2084-2021; Delgado, Igotz/N-1205-2014; zubiaga, ana/S-3457-2019; Iglesias, Ainhoa/H-3021-2015; Iglesias, Ainhoa/AAB-8731-2022	Ochoa, Begona/0000-0002-1580-7160; Delgado, Igotz/0000-0001-8675-2921; zubiaga, ana/0000-0002-2132-9708; Iglesias, Ainhoa/0000-0002-2056-8213; Iglesias, Ainhoa/0000-0002-2056-8213; Buque, Xabier/0000-0002-0911-0033; Maldonado, Eduardo/0000-0002-5285-3027	Department of Education, Universities and Research of the Basque Goverment [IT336/10, IT634/2013]; Department of Industry of the Basque Government [PE13UN139, IE12-331]; University of the Basque Country [UFI11/20]	Department of Education, Universities and Research of the Basque Goverment; Department of Industry of the Basque Government; University of the Basque Country	The study design, data collection and analysis and decision to publish were funded by the Department of Education, Universities and Research of the Basque Goverment (grants IT336/10 to BO and OF and IT634/2013 to AZ) and the Department of Industry of the Basque Government(grants PE13UN139 to BO and IE12-331 to AZ). The preparation of the manuscript and the publication costs were funded by the University of the Basque Country (grant UFI11/20 to AZ, AI, BO, OF and XB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2001, CARCINOGENESIS, V22, P795, DOI 10.1093/carcin/22.5.795; Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Arisqueta L, 2013, BBA-MOL CELL BIOL L, V1831, P1357, DOI 10.1016/j.bbalip.2013.04.015; ARVIDSON GA, 1968, EUR J BIOCHEM, V4, P478, DOI 10.1111/j.1432-1033.1968.tb00237.x; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Banchio C, 2006, J BIOL CHEM, V281, P10010, DOI 10.1074/jbc.M513503200; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; BROWN ER, 1994, LIPIDS, V29, P825, DOI 10.1007/BF02536249; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Christie W.W., 2003, LIPID ANAL; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Delgado I, 2011, AM J PHYSIOL-GASTR L, V301, pG20, DOI 10.1152/ajpgi.00481.2010; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dong Hua-Ming, 2008, Indian J Gastroenterol, V27, P31; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gazit V, 2010, HEPATOLOGY, V52, P2109, DOI 10.1002/hep.23920; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; HOLUB BJ, 1987, METHOD ENZYMOL, V141, P234; Hu W, 2014, HEPATOLOGY, V59, P651, DOI 10.1002/hep.26584; Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Krahmer N, 2009, CELL, V139, P1024, DOI 10.1016/j.cell.2009.11.023; LAI HS, 1992, JPEN-PARENTER ENTER, V16, P152, DOI 10.1177/0148607192016002152; Laresgoiti U, 2013, NUCLEIC ACIDS RES, V41, P10185, DOI 10.1093/nar/gkt821; Li FX, 2003, MOL CELL BIOL, V23, P3607, DOI 10.1128/MCB.23.10.3607-3622.2003; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lukas ER, 1999, MOL CARCINOGEN, V25, P295, DOI 10.1002/(SICI)1098-2744(199908)25:4<295::AID-MC8>3.0.CO;2-9; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Marhenke S, 2014, GUT, V63, P1501, DOI 10.1136/gutjnl-2013-304829; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Nevzorova YA, 2009, GASTROENTEROLOGY, V137, P691, DOI 10.1053/j.gastro.2009.05.003; Ochoa B, 2010, HEPATOLOGY, V51, P1712, DOI 10.1002/hep.23525; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Ruiz JI, 1997, J LIPID RES, V38, P1482; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Thevananther S, 2010, HEPATOLOGY, V52, P1875, DOI 10.1002/hep.24057; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yen CLE, 1999, FASEB J, V13, P135, DOI 10.1096/fasebj.13.1.135	63	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112620	10.1371/journal.pone.0112620	http://dx.doi.org/10.1371/journal.pone.0112620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396754	Green Published, gold			2022-12-26	WOS:000345558500069
J	Parang, B; Rosenblatt, D; Williams, AD; Washington, MK; Revetta, F; Short, SP; Reddy, VK; Hunt, A; Shroyer, NF; Engel, ME; Hiebert, SW; Williams, CS				Parang, Bobak; Rosenblatt, Daniel; Williams, Amanda D.; Washington, Mary K.; Revetta, Frank; Short, Sarah P.; Reddy, Vishruth K.; Hunt, Aubrey; Shroyer, Noah F.; Engel, Michael E.; Hiebert, Scott W.; Williams, Christopher S.			The transcriptional corepressor MTGR1 regulates intestinal secretory lineage allocation	FASEB JOURNAL			English	Article						Notch signaling; Paneth cells; CBFA2T2	EPITHELIAL-CELL LINES; STEM-CELLS; PROGENITOR CELLS; TARGET; FATE; DIFFERENTIATION; ESTABLISHMENT; INHIBITORS; DELETION; PATHWAY	Notch signaling largely determines intestinal epithelial cell fate. High Notch activity drives progenitors toward absorptive enterocytes by repressing secretory differentiation programs, whereas low Notch permits secretory cell assignment. Myeloid translocation gene-related 1 (MTGR1) is a transcriptional corepressor in the myeloid translocation gene/Eight-Twenty-One family. Given that Mtgr12/2 mice have a dramatic reduction of intestinal epithelial secretory cells, we hypothesized that MTGR1 is a key repressor of Notch signaling. In support of this, transcriptome analysis of laser capture microdissected Mtgr1(-/-) intestinal crypts revealed Notch activation, and secretory markers Mucin2, Chromogranin A, and Growth factor-independent 1 (Gfi1) were down-regulated in Mtgr1(-/-) whole intestines and Mtgr1(-/-) enteroids. We demonstrate that MTGR1 is in a complex with Suppressor of Hairless Homolog, a key Notch effector, and represses Notch-induced Hairy/Enhancer of Split 1 activity. Moreover, pharmacologic Notch inhibition using a g-secretase inhibitor (GSI) rescued the hyperproliferative baseline phenotype in the Mtgr1(-/-) intestine and increased production of goblet and enteroendocrine lineages in Mtgr1(-/-) mice. GSI increased Paneth cell production in wild-type mice but failed to do so in Mtgr1(-/-) mice. We determined that MTGR1 can interact with GFI1, a transcriptional corepressor required for Paneth cell differentiation, and repress GFI1 targets. Overall, the data suggest that MTGR1, a transcriptional corepressor well characterized in hematopoiesis, plays a critical role in intestinal lineage allocation.	[Parang, Bobak; Rosenblatt, Daniel; Short, Sarah P.; Reddy, Vishruth K.; Williams, Christopher S.] Vanderbilt Univ, Dept Med, Div Gastroenterol, Nashville, TN 37232 USA; [Parang, Bobak; Rosenblatt, Daniel; Short, Sarah P.; Reddy, Vishruth K.; Williams, Christopher S.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA; [Washington, Mary K.; Revetta, Frank] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Hunt, Aubrey; Hiebert, Scott W.] Vanderbilt Univ, Dept Biochem, Nashville, TN USA; [Williams, Amanda D.] Lipscomb Univ, Dept Biol, Nashville, TN USA; [Shroyer, Noah F.] Baylor Univ, Sch Med, Div Pediat Gastroenterol, Houston, TX 77030 USA; [Engel, Michael E.] Univ Utah, Div Pediat Hematol Oncol, Salt Lake City, UT USA; [Hiebert, Scott W.; Williams, Christopher S.] Tennessee Valley Hlth Care Syst, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Williams, Christopher S.] Tennessee Valley Hlth Care Syst, Vet Affairs, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Baylor University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Williams, CS (corresponding author), Vanderbilt Univ, Sch Med, 1065D MRB-IV,B2215 Garland Ave, Nashville, TN 37232 USA.	christopher.williams@vanderbilt.edu	Williams, Christopher/W-3524-2019	Williams, Christopher/0000-0002-1541-579X; Shroyer, Noah/0000-0002-5934-2852; Reddy, Vishruth/0000-0002-9150-7784; Short, Sarah/0000-0001-9606-7370	U.S. National Institutes of Health (NIH) [K08DK080221, R01DK092306, R01CA1428260, K08DK080190, R01CA178030, P30DK058404, P50CA095103, F30DK096718-01, T32 GM07347]; Office of Medical Research, U.S. Department of Veterans Affairs [1I01BX001426, ACS-RSG116552]; National Cancer Institute Cancer Center Support Grant [P30CA068485]; St. Baldrick's Foundation; CTSA award from the National Center for Advancing Translational Sciences [UL1TR000445]; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA142826, P30CA068485, R01CA178030] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, K08DK080221, K08DK080190, R01DK092306, F30DK096718, R01DK099204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001426] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Medical Research, U.S. Department of Veterans Affairs; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; CTSA award from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors would like to thank the members of the C.S.W. lab for helpful discussions and proofing of the manuscript. The authors would also like to thank Robert Whitehead and the Vanderbilt DDRC Novel Cell Line Development Subcore for their assistance in generating the Mtgr1<SUP>-/-</SUP> MSIE line, and Dr. Tarik Moroy for graciously providing reagents to M.E.E. This work was supported by the U.S. National Institutes of Health (NIH) Grants K08DK080221 (to C.S.W.), R01DK092306 (to N.F.S.), R01CA1428260 (to N.F.S.), K08DK080190 (to M.E.E.) R01CA178030 (to S.W.H), P30DK058404 (Vanderbilt Digestive Disease Research Center), P50CA095103 (to M.K.W.), F30DK096718-01 (to B.P.), and T32 GM07347 (NIH/National Institute of General Medical Sciences) (to B.P.), Merit Review Grants from the Office of Medical Research, U.S. Department of Veterans Affairs 1I01BX001426 (to C.S.W.), and ACS-RSG116552 (to C.S.W.). This publication was also supported in part by the National Cancer Institute Cancer Center Support Grant P30CA068485. This publication was also supported by the St. Baldrick's Foundation (to M.E.E.). This publication was also supported by CTSA award UL1TR000445 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the NIH.	Amann JM, 2005, MOL CELL BIOL, V25, P9576, DOI 10.1128/MCB.25.21.9576-9585.2005; Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Barrett CW, 2011, CANCER RES, V71, P1302, DOI 10.1158/0008-5472.CAN-10-3317; Bernard JK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400846; Bjerknes M, 2010, DEV BIOL, V345, P49, DOI 10.1016/j.ydbio.2010.06.021; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Calabi F, 2001, MOL CELL BIOL, V21, P5658, DOI 10.1128/MCB.21.16.5658-5666.2001; Chyla BJ, 2008, MOL CELL BIOL, V28, P6234, DOI 10.1128/MCB.00404-08; Davis JN, 2003, GENE, V303, P1, DOI 10.1016/S0378-1119(02)01172-1; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Engel ME, 2010, MOL CELL BIOL, V30, P1852, DOI 10.1128/MCB.01342-09; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Hunt A, 2011, MOL CELL BIOL, V31, P2544, DOI 10.1128/MCB.01458-10; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Katoh M, 2007, INT J ONCOL, V30, P247; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Martinez JA, 2006, GASTROENTEROLOGY, V131, P579, DOI 10.1053/j.gastro.2006.06.009; Moore AC, 2008, MOL CELL BIOL, V28, P977, DOI 10.1128/MCB.01242-07; Musch MW, 2004, INFECT IMMUN, V72, P3187, DOI 10.1128/IAI.72.6.3187-3194.2004; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705	37	9	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					786	795		10.1096/fj.14-254284	http://dx.doi.org/10.1096/fj.14-254284			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25398765	Green Published			2022-12-26	WOS:000350633000006
J	Dolino, DM; Cooper, D; Ramaswamy, S; Jaurich, H; Landes, CF; Jayaraman, V				Dolino, Drew M.; Cooper, David; Ramaswamy, Swarna; Jaurich, Henriette; Landes, Christy F.; Jayaraman, Vasanthi			Structural Dynamics of the Glycine-binding Domain of the N-Methyl-D-Aspartate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PARTIAL AGONIST ACTION; GLUR2 AMPA RECEPTOR; SINGLE-MOLECULE; CRYSTAL-STRUCTURES; NMDA RECEPTORS; CONFORMATIONAL-CHANGES; ION-CHANNEL; ACTIVATION; MECHANISM	N-Methyl-D-aspartate receptors mediate the slow component of excitatory neurotransmission in the central nervous system. These receptors are obligate heteromers containing glycine- and glutamate-binding subunits. The ligands bind to a bilobed agonist-binding domain of the receptor. Previous x-ray structures of the glycine-binding domain of NMDA receptors showed no significant changes between the partial and full agonist-bound structures. Here we have used single molecule fluorescence resonance energy transfer (smFRET) to investigate the cleft closure conformational states that the glycine-binding domain of the receptor adopts in the presence of the antagonist 5,7-dichlorokynurenic acid (DCKA), the partial agonists 1-amino-1-cyclobutanecarboxylic acid (ACBC) and L-alanine, and full agonists glycine and D-serine. For these studies, we have incorporated the unnatural amino acid p-acetyl-L-phenylalanine for specific labeling of the protein with hydrazide derivatives of fluorophores. The single molecule fluorescence resonance energy transfer data show that the agonist-binding domain can adopt a wide range of cleft closure states with significant overlap in the states occupied by ligands of varying efficacy. The difference lies in the fraction of the protein in a more closed-cleft form, with full agonists having a larger fraction in the closed-cleft form, suggesting that the ability of ligands to select for these states could dictate the extent of activation.	[Dolino, Drew M.; Ramaswamy, Swarna; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr Houston, Ctr Membrane Biol, Dept Biochem & Mol Biol, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Cooper, David; Jaurich, Henriette; Landes, Christy F.] Rice Univ, Dept Chem, Houston, TX 77251 USA; [Landes, Christy F.] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77251 USA	University of Texas System; University of Texas Health Science Center Houston; Rice University; Rice University	Landes, CF (corresponding author), Rice Univ, Dept Chem, MS 60, Houston, TX 77251 USA.	cflandes@rice.edu; vasanthi.jayaraman@uth.tmc.edu	Landes, Christy/I-5501-2014	Dolino, Drew/0000-0002-2690-7140	National Institutes of Health [GM094246]; Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (NIGMS) [1 T32 GM089657-05]; Welch Foundation [C-1787]; National Science Foundation [CHE-1151647]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM089657, R01GM094246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (NIGMS); Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094246 (to V. J.) and by a training fellowship from the Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (NIGMS Grant 1 T32 GM089657-05) (to D. M. D.). This work was also supported by the Welch Foundation Grant C-1787 and the National Science Foundation Grant CHE-1151647 (to C. F. L.).	Ahmed AH, 2013, J BIOL CHEM, V288, P27658, DOI 10.1074/jbc.M113.495564; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Chen PE, 2008, J PHYSIOL-LONDON, V586, P227, DOI 10.1113/jphysiol.2007.143172; Cooper D, 2013, CHEMBIOCHEM, V14, P1075, DOI 10.1002/cbic.201300030; Darugar Q, 2008, J VIROL, V82, P12164, DOI 10.1128/JVI.01158-08; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Hansen KB, 2013, MOL PHARMACOL, V84, P114, DOI 10.1124/mol.113.085803; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JOHNSON KR, 2009, NATL GEOGR, V215, P8; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Ramaswamy S, 2012, J BIOL CHEM, V287, P43557, DOI 10.1074/jbc.M112.371815; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Taylor JN, 2008, BIOCHEM BIOPH RES CO, V373, P213, DOI 10.1016/j.bbrc.2008.05.191; Taylor JN, 2011, J PHYS CHEM B, V115, P1105, DOI 10.1021/jp1050707; Taylor JN, 2010, BIOPHYS J, V98, P164, DOI 10.1016/j.bpj.2009.09.047; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Yao YN, 2013, STRUCTURE, V21, P1788, DOI 10.1016/j.str.2013.07.011; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	31	31	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					797	804		10.1074/jbc.M114.605436	http://dx.doi.org/10.1074/jbc.M114.605436			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25404733	hybrid, Green Published			2022-12-26	WOS:000347778200010
J	Greenblatt, MB; Kim, JM; Oh, H; Park, KH; Choo, MK; Sano, Y; Tye, CE; Skobe, Z; Davis, RJ; Park, JM; Bei, M; Glimcher, LH; Shim, JH				Greenblatt, Matthew B.; Kim, Jung-Min; Oh, Hwanhee; Park, Kwang Hwan; Choo, Min-Kyung; Sano, Yasuyo; Tye, Coralee E.; Skobe, Ziedonis; Davis, Roger J.; Park, Jin Mo; Bei, Marianna; Glimcher, Laurie H.; Shim, Jae-Hyuck			p38 alpha MAPK Is Required for Tooth Morphogenesis and Enamel Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Microtubule-associated Protein (MAP); p38 MAPK; SMAD Transcription Factor; Tooth Development; Ameloblast; Ectodermal Dysplasia	ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; IN-VIVO; MOUSE; BMP; APOPTOSIS; MICE; KNOT; FOLLISTATIN; DOWNSTREAM	Background: Little is known regarding the contribution of MAPKs to the development of ectodermal appendages. Results: Mice with a deletion of p38 in ectoderm display defective secretion of dental enamel and the absence of dental cusps. Conclusion: p38 mediates critical steps in tooth morphogenesis and enamel secretion. Significance: This is the first in vivo study demonstrating that the p38 MAPK pathway is critical for tooth morphogenesis and enamel secretion. An improved understanding of the molecular pathways that drive tooth morphogenesis and enamel secretion is needed to generate teeth from organ cultures for therapeutic implantation or to determine the pathogenesis of primary disorders of dentition (Abdollah, S., Macias-Silva, M., Tsukazaki, T., Hayashi, H., Attisano, L., and Wrana, J. L. (1997) J. Biol. Chem. 272, 27678-27685). Here we present a novel ectodermal dysplasia phenotype associated with conditional deletion of p38 MAPK in ectodermal appendages using K14-cre mice (p38(K14) mice). These mice display impaired patterning of dental cusps and a profound defect in the production and biomechanical strength of dental enamel because of defects in ameloblast differentiation and activity. In the absence of p38, expression of amelogenin and (4)-integrin in ameloblasts and p21 in the enamel knot was significantly reduced. Mice lacking the MAP2K MKK6, but not mice lacking MAP2K MKK3, also show the enamel defects, implying that MKK6 functions as an upstream kinase of p38 in ectodermal appendages. Lastly, stimulation with BMP2/7 in both explant culture and an ameloblast cell line confirm that p38 functions downstream of BMPs in this context. Thus, BMP-induced activation of the p38 MAPK pathway is critical for the morphogenesis of tooth cusps and the secretion of dental enamel.	[Greenblatt, Matthew B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kim, Jung-Min; Oh, Hwanhee; Park, Kwang Hwan; Shim, Jae-Hyuck] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Park, Kwang Hwan] Yonsei Univ, Coll Med, Dept Microbiol, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Park, Kwang Hwan] Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea; [Choo, Min-Kyung; Sano, Yasuyo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Choo, Min-Kyung; Sano, Yasuyo] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Tye, Coralee E.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Skobe, Ziedonis] Forsyth Inst, Cambridge, MA 02142 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med, Worcester, MA 01605 USA; [Bei, Marianna] Harvard Univ, Sch Med, Shriners Burns Hosp, Dept Surg,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Glimcher, Laurie H.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Harvard University; Brigham & Women's Hospital; Cornell University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Harvard University; Massachusetts General Hospital; Harvard University; University of Vermont; Harvard University; Forsyth Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cornell University	Greenblatt, MB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	mag3003@med.cornell.edu; jas2060@med.cornell.edu	Kim, Jung Min/AAL-8604-2021	Kim, Jung Min/0000-0002-9072-4293; Davis, Roger/0000-0002-0130-1652; Shim, Jae-Hyuck/0000-0002-4947-3293; Park, Kwang Hwan/0000-0002-2110-0559; Tye, Coralee/0000-0002-3349-1833	National Institutes of Health [AI074957]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074957 (to J. M. P.). L. H. G. is a member of the board of directors of and holds equity in Bristol-Myers Squibb.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Bartlett JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012703; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; GRUNEBERG H, 1971, J EMBRYOL EXP MORPH, V25, P1; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Koppinen P, 2001, EXP CELL RES, V269, P180, DOI 10.1006/excr.2001.5331; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Lavelle D, 2003, LEUKEMIA RES, V27, P999, DOI 10.1016/S0145-2126(03)00068-7; Li Y, 2011, CELLS TISSUES ORGANS, V194, P227, DOI 10.1159/000324559; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Nakata A, 2003, BIOCHEM BIOPH RES CO, V308, P834, DOI 10.1016/S0006-291X(03)01467-0; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Obara N, 2007, CELL TISSUE RES, V330, P461, DOI 10.1007/s00441-007-0502-7; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Shim JH, 2013, J CLIN INVEST, V123, P4010, DOI 10.1172/JCI69443; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Tucker AS, 2000, DEVELOPMENT, V127, P4691; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Wang XP, 2004, DEV CELL, V7, P719, DOI 10.1016/j.devcel.2004.09.012; Wang XP, 2004, DEV DYNAM, V231, P98, DOI 10.1002/dvdy.20118; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Wysk M, 1999, P NATL ACAD SCI USA, V96, P3763, DOI 10.1073/pnas.96.7.3763; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; Xue H, 2013, EUR J ORAL SCI, V121, P293, DOI 10.1111/eos.12059; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zou WG, 2011, J CLIN INVEST, V121, P4383, DOI 10.1172/JCI59041	36	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					284	295		10.1074/jbc.M114.599274	http://dx.doi.org/10.1074/jbc.M114.599274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406311	Green Published, hybrid			2022-12-26	WOS:000347231200026
J	Hammel, JU; Nickel, M				Hammel, Joerg U.; Nickel, Michael			A New Flow-Regulating Cell Type in the Demosponge Tethya wilhelma - Functional Cellular Anatomy of a Leuconoid Canal System	PLOS ONE			English	Article							FRESH-WATER SPONGE; FLUVIATILIS L PORIFERA; ELECTRON-MICROSCOPE HISTOLOGY; X-RAY MICROTOMOGRAPHY; MARINE SPONGES; BODY STRUCTURE; PETROSIA-FICIFORMIS; CHOANOCYTE CHAMBERS; AQUIFEROUS SYSTEMS; SPECIES PORIFERA	Demosponges possess a leucon-type canal system which is characterized by a highly complex network of canal segments and choanocyte chambers. As sponges are sessile filter feeders, their aquiferous system plays an essential role in various fundamental physiological processes. Due to the morphological and architectural complexity of the canal system and the strong interdependence between flow conditions and anatomy, our understanding of fluid dynamics throughout leuconoid systems is patchy. This paper provides comprehensive morphometric data on the general architecture of the canal system, flow measurements and detailed cellular anatomical information to help fill in the gaps. We focus on the functional cellular anatomy of the aquiferous system and discuss all relevant cell types in the context of hydrodynamic and evolutionary constraints. Our analysis is based on the canal system of the tropical demosponge Tethya wilhelma, which we studied using scanning electron microscopy. We found a hitherto undescribed cell type, the reticuloapopylocyte, which is involved in flow regulation in the choanocyte chambers. It has a highly fenestrated, grid-like morphology and covers the apopylar opening. The minute opening of the reticuloapopylocyte occurs in an opened, intermediate and closed state. These states permit a gradual regulation of the total apopylar opening area. In this paper the three states are included in a theoretical study into flow conditions which aims to draw a link between functional cellular anatomy, the hydrodynamic situation and the regular body contractions seen in T. wilhelma. This provides a basis for new hypotheses regarding the function of bypass elements and the role of hydrostatic pressure in body contractions. Our study provides insights into the local and global flow conditions in the sponge canal system and thus enhances current understanding of related physiological processes.	[Hammel, Joerg U.; Nickel, Michael] Univ Jena, Phyletischem Museum, Inst Spezielle Zool & Evolut Biol, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Hammel, JU (corresponding author), Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, Max Planck Str 1, D-21502 Geesthacht, Germany.	joerg.hammel@uni-jena.de	Hammel, Jörg/D-6555-2011	Hammel, Jörg/0000-0002-6744-6811	Deutsche Forschungs Gemeinschaft [HA 6405/1-1]	Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG))	Funding for this research came from Deutsche Forschungs Gemeinschaft (www.dfg.de) research grant HA 6405/1-1 to JUH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNDT W, 1933, HDB BIOL ARBEITSMETH, V1, P443; BAVESTRELLO G, 1988, ZOOMORPHOLOGY, V108, P161, DOI 10.1007/BF00363932; Boury-Esnault N, 2006, CAN J ZOOL, V84, P205, DOI 10.1139/Z06-003; BOURYESNAULT N, 1984, J MORPHOL, V180, P3, DOI 10.1002/jmor.1051800103; BURLANDO B, 1990, B ZOOL, V57, P233, DOI 10.1080/11250009009355701; De Vos C, 1990, APOPYLAR CELL SPONGE, P153; Elliott GRD, 2007, J EXP BIOL, V210, P3736, DOI 10.1242/jeb.003392; EMSON RH, 1966, COMP BIOCHEM PHYSIOL, V18, P805, DOI 10.1016/0010-406X(66)90215-5; Fossa SA, 1996, KORALLENRIFF AQUARIU, V5, P35; Hammel JU, 2012, ACTA ZOOL-STOCKHOLM, V93, P160, DOI 10.1111/j.1463-6395.2010.00492.x; Hammel JU, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-19; HARRISON FW, 1972, HYDROBIOLOGIA, V40, P513, DOI 10.1007/BF00019986; Humphries S, 2009, P NATL ACAD SCI USA, V106, P7882, DOI 10.1073/pnas.0809063106; Jensen KH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00151; JONES WC, 1962, BIOL REV, V37, P1, DOI 10.1111/j.1469-185X.1962.tb01602.x; JORGENSEN CB, 1983, MAR ECOL PROG SER, V11, P89, DOI 10.3354/meps011089; Kinne O, 1977, MARINE ECOLOGY, VIII, P627; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; LANGENBRUCH PF, 1985, ZOOMORPHOLOGY, V105, P383, DOI 10.1007/BF00312282; LANGENBRUCH PF, 1988, ZOOMORPHOLOGY, V108, P13, DOI 10.1007/BF00312210; LANGENBRUCH PF, 1990, J MORPHOL, V204, P1, DOI 10.1002/jmor.1052040102; Langenbruch PF, 1990, STRUCTURE CHOANOCYTE, P245; LARSEN PS, 1994, J THEOR BIOL, V168, P53, DOI 10.1006/jtbi.1994.1087; Leys SP, 2006, BIOL BULL-US, V211, P157, DOI 10.2307/4134590; Leys SP, 2012, ADV MAR BIOL, V62, P1, DOI 10.1016/B978-0-12-394283-8.00001-1; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Leys SP, 2006, CAN J ZOOL, V84, P288, DOI 10.1139/Z05-171; Ludeman DA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-3; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Nickel M, 2004, J EXP BIOL, V207, P4515, DOI 10.1242/jeb.01289; Nickel M, 2006, ZOOMORPHOLOGY, V125, P225, DOI 10.1007/s00435-006-0022-0; Nickel M, 2006, ZOOMORPHOLOGY, V125, P209, DOI 10.1007/s00435-006-0021-1; Nickel M, 2011, J EXP BIOL, V214, P1692, DOI 10.1242/jeb.049148; Nickel M, 2010, INVERTEBR BIOL, V129, P1, DOI 10.1111/j.1744-7410.2010.00193.x; Pettitt ME, 2002, EUR J PROTISTOL, V38, P313, DOI 10.1078/0932-4739-00854; Rasband W., 2006, IMAGEJ; REISWIG HM, 1975, J MORPHOL, V145, P493, DOI 10.1002/jmor.1051450407; REISWIG HM, 1977, ZOOMORPHOLOGIE, V88, P81, DOI 10.1007/BF01880648; Riisgard HU, 2010, MAR ECOL PROG SER, V418, P255, DOI 10.3354/meps08755; Riisgard HU, 2001, LIMNOL OCEANOGR, V46, P882, DOI 10.4319/lo.2001.46.4.0882; SALLER U, 1990, ZOOMORPHOLOGY, V109, P295, DOI 10.1007/BF00803569; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schippers KJ, 2012, ADV MAR BIOL, V62, P273, DOI 10.1016/B978-0-12-394283-8.00006-0; SHIMETA J, 1991, OCEANOGR MAR BIOL, V29, P191; Simpson T., 1984, CELL BIOL SPONGES; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; VACELET J, 1989, J MORPHOL, V201, P119, DOI 10.1002/jmor.1052010203; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; Vogel S., 1995, B MATH BIOL, V57, P949, DOI [10.2307/1352661, DOI 10.2307/1352661]; Waters SL, 2011, PROG BIOPHYS MOL BIO, V104, P49, DOI 10.1016/j.pbiomolbio.2010.10.001; WEISSENFELS N, 1982, MICROSC ACTA, V85, P345; WEISSENFELS N, 1980, ZOOMORPHOLOGIE, V95, P27, DOI 10.1007/BF01342232; WEISSENFELS N, 1982, ZOOMORPHOLOGY, V100, P75, DOI 10.1007/BF00310355; WEISSENFELS N, 1981, ZOOMORPHOLOGY, V98, P35, DOI 10.1007/BF00310319	55	14	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113153	10.1371/journal.pone.0113153	http://dx.doi.org/10.1371/journal.pone.0113153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409176	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200074
J	Wang, N; Yang, XH; Jiao, SJ; Zhang, J; Ye, BP; Gao, SX				Wang, Na; Yang, Xiaohong; Jiao, Shaojun; Zhang, Jun; Ye, Boping; Gao, Shixiang			Sulfonamide-Resistant Bacteria and Their Resistance Genes in Soils Fertilized with Manures from Jiangsu Province, Southeastern China	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; SUL3; PREVALENCE; ANIMALS	Antibiotic-resistant bacteria and genes are recognized as new environmental pollutants that warrant special concern. There were few reports on veterinary antibiotic-resistant bacteria and genes in China. This work systematically analyzed the prevalence and distribution of sulfonamide resistance genes in soils from the environments around poultry and livestock farms in Jiangsu Province, Southeastern China. The results showed that the animal manure application made the spread and abundance of antibiotic resistance genes (ARGs) increasingly in the soil. The frequency of sulfonamide resistance genes was sul1 > sul2 > sul3 in pig-manured soil DNA and sul2 > sul1 > sul3 in chicken-manured soil DNA. Further analysis suggested that the frequency distribution of the sul genes in the genomic DNA and plasmids of the SR isolates from manured soil was sul2 > sul1 > sul3 overall (p<0.05). The combination of sul1 and sul2 was the most frequent, and the co-existence of sul1 and sul3 was not found either in the genomic DNA or plasmids. The sample type, animal type and sampling time can influence the prevalence and distribution pattern of sulfonamide resistance genes. The present study also indicated that Bacillus, Pseudomonas and Shigella were the most prevalent sul-positive genera in the soil, suggesting a potential human health risk. The above results could be important in the evaluation of antibiotic-resistant bacteria and genes from manure as sources of agricultural soil pollution; the results also demonstrate the necessity and urgency of the regulation and supervision of veterinary antibiotics in China.	[Wang, Na; Gao, Shixiang] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Na; Jiao, Shaojun] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China; [Yang, Xiaohong; Zhang, Jun; Ye, Boping] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Jiangsu, Peoples R China	Nanjing University; China Pharmaceutical University	Ye, BP (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Jiangsu, Peoples R China.	yebp@cpu.edu.cn; ecsxg@nju.edu.cn	GAO, Shixiang/K-8702-2012	GAO, Shixiang/0000-0001-9066-6970	MEP [201109038, 201309031]	MEP	The funding source of this study are the Commonwealth and Environmental Protection project granted by the MEP "The health risk assessment and management technology of veterinary medicine'' (201109038), "Study of determination method, pollution level and pollution control strategy of antibiotic-resistant gene in China'' (201309031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Diene SM, 2013, EXPERT REV ANTI-INFE, V11, P277, DOI [10.1586/ERI.13.1, 10.1586/eri.13.1]; Ghosh S, 2007, ISME J, V1, P191, DOI 10.1038/ismej.2007.31; Hammerum AM, 2006, INT J FOOD MICROBIOL, V106, P235, DOI 10.1016/j.ijfoodmicro.2005.06.023; Heuer H, 2004, MICROBIOL-SGM, V150, P3591, DOI 10.1099/mic.0.27304-0; Heuer H, 2007, ENVIRON MICROBIOL, V9, P657, DOI 10.1111/j.1462-2920.2006.01185.x; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hoa P. T. P., 2010, INTERDISCIPLINARY ST, V3, P15; Hoa PTP, 2008, SCI TOTAL ENVIRON, V405, P377, DOI 10.1016/j.scitotenv.2008.06.023; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; Jechalke S, 2013, APPL ENVIRON MICROB, V79, P1704, DOI 10.1128/AEM.03172-12; Kim KR, 2011, WATER AIR SOIL POLL, V214, P163, DOI 10.1007/s11270-010-0412-2; Kools SAE, 2008, REGUL TOXICOL PHARM, V50, P59, DOI 10.1016/j.yrtph.2007.06.003; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Perreten V, 2003, ANTIMICROB AGENTS CH, V47, P1169, DOI 10.1128/AAC.47.3.1169-1172.2003; Phan TPH, 2011, SCI TOTAL ENVIRON, V409, P2894, DOI 10.1016/j.scitotenv.2011.04.030; Popowska M, 2012, ANTIMICROB AGENTS CH, V56, P1434, DOI 10.1128/AAC.05766-11; Sengelov G, 2003, ENVIRON INT, V28, P587, DOI 10.1016/S0160-4120(02)00084-3; Skold O, 2000, DRUG RESIST UPDATE, V3, P155, DOI 10.1054/drup.2000.0146; Suzuki S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00102; Ungemach F, 1999, ACTA VET SCAND S, V93, P97; Ungemach F, 1999, ACTA VET SCAND S, V93, P111; Ungemach F, 1999, ACTA VET SCAND S, V93, P89; Valderas MW, 2007, MICROB DRUG RESIST, V13, P11, DOI 10.1089/mdr.2006.9992; Xia SL, 2011, J CLIN MICROBIOL, V49, P232, DOI 10.1128/JCM.01508-10; Yun MK, 2012, SCIENCE, V335, P1110, DOI 10.1126/science.1214641; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	29	68	74	4	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112626	10.1371/journal.pone.0112626	http://dx.doi.org/10.1371/journal.pone.0112626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405870	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300042
J	Cao, HL; Zhou, Q; Lan, RF; Roe, OD; Chen, X; Chen, YJ; Wang, DJ				Cao, Hailong; Zhou, Qing; Lan, Rongfang; Roe, Oluf Dimitri; Chen, Xin; Chen, Yijiang; Wang, Dongjin			A Functional Polymorphism C-509T in TGF beta-1 Promoter Contributes to Susceptibility and Prognosis of Lone Atrial Fibrillation in Chinese Population	PLOS ONE			English	Article							GROWTH-FACTOR BETA-1; TRANSFORMING GROWTH-FACTOR-BETA-1; GENETIC POLYMORPHISMS; EUROPEAN-SOCIETY; MAZE PROCEDURE; TASK-FORCE; FIBROSIS; EXPRESSION; ASSOCIATION; MANAGEMENT	Transforming growth factor-b1 (TGF-beta 1) is an important mediator of atrial fibrosis and atrial fibrillation (AF). But the involved genetic mechanism is unknown. Herein, the TGF-beta 1 C-509T polymorphism (rs1800469) was genotyped in a case-control study of 840 patients and 845 controls in Chinese population to explore the association between the polymorphism and susceptibility and prognosis of lone AF. As a result, the CT and/or TT genotypes had an increased lone AF risk [adjusted odds ratio (OR) = 1.50 for CT, OR = 3.72 for TT, and OR = 2.15 for CT/TT], compared with the TGF-beta 1CC genotype. Moreover, patients carrying CT/TT genotypes showed a higher possibility of AF recurrence after catheter ablation, compared with patients carrying CC genotype. In a genotype-phenotype correlation analysis using 24 normal left atrial appendage samples, increasing gradients of atrial TGF-beta 1 expression levels positively correlated with atrial collagen volume fraction were identified in samples with CC, CT and TT genotypes. The in vitro luciferase assays also showed a higher luciferase activity of the -509T allele than that of the -509C allele. In conclusion, the TGF-beta 1 C-509T polymorphism is involved in the etiology of lone AF and thus may be a marker for genetic susceptibility to lone AF and predicting prognosis after catheter ablation in Chinese populations. Therefore, we provide new information about treatment strategies and our understanding of TGF-beta 1 in AF.	[Cao, Hailong; Zhou, Qing; Wang, Dongjin] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Thorac & Cardiovasc Surg, Nanjing 210008, Jiangsu, Peoples R China; [Lan, Rongfang; Chen, Xin] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China; [Roe, Oluf Dimitri; Chen, Yijiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway	Nanjing University; Nanjing University; Nanjing Medical University; Norwegian University of Science & Technology (NTNU)	Wang, DJ (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Thorac & Cardiovasc Surg, Nanjing 210008, Jiangsu, Peoples R China.	gldjw@163.com		Roe, Oluf Dimitri/0000-0002-4870-5822	National Natural Science Foundation of China [81200133]; Jiangsu Top Expert Program in Six Professions [WSN-032]; Jiangsu health department [Z201411]; Medical Science and technology development Foundation, Nanjing Department of Health [YKK12056]; Fundamental Research Funds for the Central Universities [021414330063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Top Expert Program in Six Professions; Jiangsu health department; Medical Science and technology development Foundation, Nanjing Department of Health; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by the National Natural Science Foundation of China [81200133], Jiangsu Top Expert Program in Six Professions [WSN-032], Medical science project supported by Jiangsu health department [Z201411], Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health [YKK12056], the Fundamental Research Funds for the Central Universities [021414330063]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bunch TJ, 2006, CIRCULATION, V113, P2485, DOI 10.1161/CIRCULATIONAHA.105.570796; Burstein B, 2008, J CARDIOVASC PHARM, V52, P4, DOI 10.1097/FJC.0b013e3181668057; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; den Uijl DW, 2011, HEART, V97, P1847, DOI 10.1136/hrt.2010.215335; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Goudis CA, 2012, EUROPACE, V14, P623, DOI 10.1093/europace/eur398; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Hussein AA, 2011, CIRCULATION, V123, P2077, DOI 10.1161/CIRCULATIONAHA.110.007252; Kikuchi K, 2007, ANN NY ACAD SCI, V1110, P15, DOI 10.1196/annals.1423.003; Li Y, 2013, CARDIOLOGY, V124, P233, DOI 10.1159/000347126; Luedecking EK, 2000, HUM GENET, V106, P565, DOI 10.1007/s004390050026; Mattey DL, 2005, ANN RHEUM DIS, V64, P1190, DOI 10.1136/ard.2004.031674; Nakatani Y, 2013, J AM COLL CARDIOL, V61, P582, DOI 10.1016/j.jacc.2012.11.014; Nguyen TN, 2013, INT J CARDIOL, V167, P2412, DOI 10.1016/j.ijcard.2013.01.184; Park SJ, 2013, INT J CARDIOL, V164, P232, DOI 10.1016/j.ijcard.2013.01.066; Rahmutula D, 2013, CARDIOVASC RES, V99, P769, DOI 10.1093/cvr/cvt074; Tomita H, 1998, HYPERTENSION, V32, P273, DOI 10.1161/01.HYP.32.2.273; Tsai CT, 2011, CARDIOVASC RES, V89, P805, DOI 10.1093/cvr/cvq322; Tzou WS, 2010, CIRC-ARRHYTHMIA ELEC, V3, P237, DOI 10.1161/CIRCEP.109.923771; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wang W, 2012, TEX HEART I J, V39, P17; Wang YZ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-23; Wokhlu A, 2010, J CARDIOVASC ELECTR, V21, P1071, DOI 10.1111/j.1540-8167.2010.01786.x; Xiao H, 2010, CLIN CARDIOL, V33, P149, DOI 10.1002/clc.20713; Zhang YJ, 2009, CANCER LETT, V275, P102, DOI 10.1016/j.canlet.2008.10.017; Zheng WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083033	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112912	10.1371/journal.pone.0112912	http://dx.doi.org/10.1371/journal.pone.0112912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402477	Green Submitted, gold, Green Published			2022-12-26	WOS:000345158700082
J	Christensen, QH; Brecht, RM; Dudekula, D; Greenberg, EP; Nagarajan, R				Christensen, Quin H.; Brecht, Ryan M.; Dudekula, Dastagiri; Greenberg, E. Peter; Nagarajan, Rajesh			Evolution of Acyl-Substrate Recognition by a Family of Acyl-Homoserine Lactone Synthases	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; QUORUM-SENSING SIGNAL; ACID SYNTHESIS; SPECIFICITY; LUXI; AUTOINDUCER; HISTORY; GENES	Members of the LuxI protein family catalyze synthesis of acyl-homoserine lactone (acyl-HSL) quorum sensing signals from S-adenosyl-L-methionine and an acyl thioester. Some LuxI family members prefer acyl-CoA, and others prefer acyl-acyl carrier protein (ACP) as the acyl-thioester substrate. We sought to understand the evolutionary history and mechanisms mediating this substrate preference. Our phylogenetic and motif analysis of the LuxI acyl-HSL synthase family indicates that the acyl-CoA-utilizing enzymes evolved from an acyl-ACP-utilizing ancestor. To further understand how acyl-ACPs and acyl-CoAs are recognized by acyl-HSL synthases we studied BmaI1, an octanoyl-ACP-dependent LuxI family member from Burkholderia mallei, and BjaI, an isovaleryl-CoA-dependent LuxI family member from Bradyrhizobium japonicum. We synthesized thioether analogs of their thioester acyl-substrates to probe recognition of the acyl-phosphopantetheine moiety common to both acyl-ACP and acyl-CoA substrates. The kinetics of catalysis and inhibition of these enzymes indicate that they recognize the acyl-phosphopantetheine moiety and they recognize non-preferred substrates with this moiety. We find that CoA substrate utilization arose through exaptation of acyl-phosphopantetheine recognition in this enzyme family.	[Christensen, Quin H.; Greenberg, E. Peter] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Brecht, Ryan M.; Dudekula, Dastagiri; Nagarajan, Rajesh] Boise State Univ, Dept Chem & Biochem, Boise, ID 83725 USA	University of Washington; University of Washington Seattle; Idaho; Boise State University	Nagarajan, R (corresponding author), Boise State Univ, Dept Chem & Biochem, Boise, ID 83725 USA.	rajnagarajan@boisestate.edu		Greenberg, Everett/0000-0001-9474-8041; DUDEKULA, DASTAGIRI/0000-0002-6137-3260	United States Department of Agriculture National Institute of Food Agricultural and Food Research Initiative [2010-65108-20536]; National Institutes of Health [T32-AI055396]; National Institutes of Health IDeA Network of Biomedical Research Excellence [P20 RR016454, GM103408]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	United States Department of Agriculture National Institute of Food Agricultural and Food Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health IDeA Network of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: United States Department of Agriculture National Institute of Food Agricultural and Food Research Initiative Competitive Grants Program no. 2010-65108-20536 (EPG), National Institutes of Health Postdoctoral Training Grant T32-AI055396 (QHC), and National Institutes of Health IDeA Network of Biomedical Research Excellence P20 RR016454 and GM103408 (RN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2011, P NATL ACAD SCI USA, V108, P7183, DOI 10.1073/pnas.1103821108; Barve A, 2013, NATURE, V500, P203, DOI 10.1038/nature12301; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; BLASCHKOWSKI HP, 1979, FEBS LETT, V98, P81, DOI 10.1016/0014-5793(79)80156-8; Brader G, 2005, J BIOL CHEM, V280, P10403, DOI 10.1074/jbc.M408603200; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Chakrabarti S, 2003, PROTEIN ENG, V16, P271, DOI 10.1093/proeng/gzg031; Christensen QH, 2013, P NATL ACAD SCI USA, V110, P13815, DOI 10.1073/pnas.1313098110; Christensen QH, 2010, BIOCHEMISTRY-US, V49, P10024, DOI 10.1021/bi101215f; Chugani S, 2010, P NATL ACAD SCI USA, V107, P10673, DOI 10.1073/pnas.1005909107; Chung J, 2011, P NATL ACAD SCI USA, V108, P12089, DOI 10.1073/pnas.1103165108; Copeland RA, 2005, METHOD BIOCHEM ANAL, V46, P51; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE; Frey P. A., 2007, ENZYMATIC REACTION M; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; GILSON L, 1995, J BACTERIOL, V177, P6946, DOI 10.1128/jb.177.23.6946-6951.1995; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Gould TA, 2004, MOL MICROBIOL, V53, P1135, DOI 10.1111/j.1365-2958.2004.04211.x; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; Huang RQ, 2012, P NATL ACAD SCI USA, V109, P2966, DOI 10.1073/pnas.1019605109; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kambam PKR, 2008, BIOTECHNOL BIOENG, V101, P263, DOI 10.1002/bit.21901; Kambam PKR, 2009, CHEMBIOCHEM, V10, P553, DOI 10.1002/cbic.200800636; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Lindemann A, 2011, P NATL ACAD SCI USA, V108, P16765, DOI 10.1073/pnas.1114125108; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Nei M., 2000, MOL EVOLUTION PHYLOG; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raychaudhuri A, 2005, BIOCHEMISTRY-US, V44, P2974, DOI 10.1021/bi048005m; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Schaefer AL, 2008, NATURE, V454, P595, DOI 10.1038/nature07088; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomarev SI, 1996, EUR J BIOCHEM, V235, P449, DOI 10.1111/j.1432-1033.1996.00449.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Watson WT, 2002, MOL CELL, V9, P685, DOI 10.1016/S1097-2765(02)00480-X; Williams Paul, 2002, Expert Opin Ther Targets, V6, P257, DOI 10.1517/14728222.6.3.257; Zhang JM, 2010, J MOL EVOL, V71, P241, DOI 10.1007/s00239-010-9384-5	50	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112464	10.1371/journal.pone.0112464	http://dx.doi.org/10.1371/journal.pone.0112464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401334	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700046
J	Jin, PY; Peng, JJ; Zou, HD; Wang, WW; Fu, J; Shen, BJ; Bai, XL; Xu, X; Zhang, X				Jin, Peiyao; Peng, Jinjuan; Zou, Haidong; Wang, Weiwei; Fu, Jiong; Shen, Binjie; Bai, Xuelin; Xu, Xun; Zhang, Xi			The 5-Year Onset and Regression of Diabetic Retinopathy in Chinese Type 2 Diabetes Patients	PLOS ONE			English	Article							INTRAVITREAL BEVACIZUMAB AVASTIN; PANRETINAL PHOTOCOAGULATION; MACULAR EDEMA; PROGRESSION; RISK; PATHOGENESIS; POPULATION; PREVALENCE; GLUCOSE; SYSTEM	Purpose: To determine the rate and risk factors of diabetic retinopathy (DR) onset and regression in Chinese type 2 diabetes mellitus patients. Methods: This is a 5-year community-based prospective study. The demographic information, systemic examination results and ophthalmological test results of each participant were collected. The study outcomes were DR incidence, defined as the onset of DR in at least one eye, and DR regression, defined as full regression from existing DR to no retinopathy without invasive treatments. The associations between each potential risk factor and the outcomes were studied. Results: In total, 778 participants were enrolled. There were 322 patients without DR at baseline, of which 151 participants developed DR during follow-up (DR incidence rate = 46.89%). Baseline hyperglycemia and high blood pressure were two independent risk factors associated with DR incidence. Among the 456 participants with existing DR at entry, 110 fully recovered after 5 years (DR regression rate = 24.12%). Low baseline glucose and low serum triglyceride were two independent factors associated with DR regression. Conclusions: DR incidence occurred more frequently in patients with hyperglycemia and high blood pressure. DR regression occurred mostly in patients with lower glucose and lower serum triglyceride levels among Chinese type 2 diabetes patients.	[Jin, Peiyao; Peng, Jinjuan; Zou, Haidong; Xu, Xun; Zhang, Xi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 20080, Peoples R China; [Zou, Haidong] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai 200040, Peoples R China; [Wang, Weiwei; Fu, Jiong; Shen, Binjie; Bai, Xuelin] Beixinjing Community Hlth Serv Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 20080, Peoples R China.	zouhaidong@hotmail.com	Dagdelen, Selcuk/A-9432-2017	Dagdelen, Selcuk/0000-0002-0513-1750; Zou, Haidong/0000-0002-6831-7560	Chinese National Natural Science Foundation [81371069]; Shanghai Pujiang Program [PJ (2012) 0001652]; Shanghai New Hundred Talents Program from the Shanghai Medical and Family Planning Committee [13B141]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai New Hundred Talents Program from the Shanghai Medical and Family Planning Committee	This work was funded by the Chinese National Natural Science Foundation (Project number 81371069), the Shanghai Pujiang Program (Project number PJ (2012) 0001652), and the Shanghai New Hundred Talents Program from the Shanghai Medical and Family Planning Committee (Project number 13B141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2010, OPHTHALMOLOGY, V117, P946, DOI 10.1016/j.ophtha.2009.10.002; Arevalo JF, 2009, EYE, V23, P117, DOI 10.1038/sj.eye.6702980; Bao Y, 2010, BMJ, V340; Cikamatana L, 2007, EYE, V21, P465, DOI 10.1038/sj.eye.6702771; Consultation W, 1999, DEF DIAGN CLASS DIAB; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; GERRITZEN FM, 1973, DIABETES, V22, P122, DOI 10.2337/diab.22.2.122; Gibbins RL, 1998, DIABETOLOGIA, V41, P59, DOI 10.1007/s001250050867; GORDON B, 1991, AM J OPHTHALMOL, V112, P385, DOI 10.1016/S0002-9394(14)76244-0; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; Han Jae Ryong, 2004, Korean J Ophthalmol, V18, P41; Hellstedt T, 1996, BRIT J OPHTHALMOL, V80, P135, DOI 10.1136/bjo.80.2.135; Higashi S, 1998, DIABETES, V47, P653, DOI 10.2337/diabetes.47.4.653; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kameda Y, 2010, BRIT J OPHTHALMOL, V94, P725, DOI 10.1136/bjo.2009.158501; Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P244, DOI 10.1001/archopht.1989.01070010250031; Leske MC, 2003, OPHTHALMOLOGY, V110, P941, DOI 10.1016/S0161-6420(03)00086-1; Lopez F, 2007, EUROPEAN OPHTHALMIC, P68; Manaviat MR, 2008, EUR J OPHTHALMOL, V18, P572, DOI 10.1177/112067210801800412; Mirshahi A, 2008, EUR J OPHTHALMOL, V18, P263, DOI 10.1177/112067210801800215; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Peng JJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-250; Perol J, 2012, DIABETES METAB, V38, P225, DOI 10.1016/j.diabet.2012.01.001; Raymond NT, 2009, DIABETES CARE, V32, P410, DOI 10.2337/dc08-1422; ROY S, 1990, P NATL ACAD SCI USA, V87, P404, DOI 10.1073/pnas.87.1.404; Ruggenenti P, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/106384; Scanlon PH, 2013, MIDDLE EAST AFR J OP, V20, P293, DOI 10.4103/0974-9233.120007; Schoenlau Frank, 2001, International Ophthalmology, V24, P161, DOI 10.1023/A:1021160924583; Sjolie AK, 2011, DIABETIC MED, V28, P345, DOI 10.1111/j.1464-5491.2010.03210.x; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Steigerwalt R, 2009, J OCUL PHARMACOL TH, V25, P537, DOI 10.1089/jop.2009.0023; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Tam VHK, 2009, J DIABETES COMPLICAT, V23, P185, DOI 10.1016/j.jdiacomp.2008.03.001; Tapp RJ, 2006, DIABETES RES CLIN PR, V73, P298, DOI 10.1016/j.diabres.2006.02.009; THEODOSSIADIS GP, 1990, OPHTHALMOLOGICA, V201, P71, DOI 10.1159/000310130; Varma R, 2010, AM J OPHTHALMOL, V149, P752, DOI 10.1016/j.ajo.2009.11.014; Wang N, 2008, OPHTHALMOLOGICA, V222, P32, DOI 10.1159/000109276; WHITE MC, 1981, BRIT J OPHTHALMOL, V65, P307, DOI 10.1136/bjo.65.5.307; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yang CS, 2013, J OCUL PHARMACOL TH, V29, P550, DOI 10.1089/jop.2012.0202; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Zavrelova H, 2011, DIABETES CARE, V34, P867, DOI 10.2337/dc10-1741; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275; Zheng Z, 2009, DIABETES, V58, P954, DOI 10.2337/db07-1524	48	34	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113359	10.1371/journal.pone.0113359	http://dx.doi.org/10.1371/journal.pone.0113359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402474	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700133
J	Liang, CK; Chu, CL; Chou, MY; Lin, YT; Lu, T; Hsu, CJ; Chen, LK				Liang, Chih-Kuang; Chu, Chin-Liang; Chou, Ming-Yueh; Lin, Yu-Te; Lu, Ti; Hsu, Chien-Jen; Chen, Liang-Kung			Interrelationship of Postoperative Delirium and Cognitive Impairment and Their Impact on the Functional Status in Older Patients Undergoing Orthopaedic Surgery: A Prospective Cohort Study	PLOS ONE			English	Article							ELDERLY-PATIENTS; HIP FRACTURE; RISK-FACTORS; OUTCOMES; VALIDATION; DEMENTIA; SYMPTOMS; RECOVERY; DECLINE	Background: The impact of postoperative delirium on post-discharge functional status of older patients remains unclear, and little is known regarding the interrelationship between cognitive impairment and post-operative delirium. Therefore, the main purpose was to evaluate the post-discharge functional status of patients who experience delirium after undergoing orthopaedic surgery and the interrelationship of postoperative delirium with underlying cognitive impairment. Method: This prospective cohort study, conducted at a tertiary care medical center from April 2011 to March 2012, enrolled all subjects aged over 60 years who were admitted for orthopaedic surgery. The baseline characteristics (age, gender, BMI, and living arrangement), surgery-related factors (ASA class, admission type, type of surgery, and length of hospital stay), results of geriatric assessment (postoperative delirium, cognition, depressive mood, comorbidity, pain, malnutrition, polypharmacy, ADL, and instrumental [I] ADL) and 1-12-month postoperative ADL and IADL functional status were collected for analysis. Results: Overall, 9.1% of 232 patients (mean age: 74.767.8 years) experienced postoperative delirium, which was significantly associated with IADL decline at only 6 and 12 months postoperatively (RR: 6.22, 95% CI: 1.08-35.70 and RR: 12.54, 95% CI: 1.88-83.71, respectively). Delirium superimposed on cognitive impairment was a significant predictor for poor functional status at 6 and 12 months postoperatively (RR: 12.80, 95% CI: 1.65-99.40 for ADL at the 6 th month, and RR: 7.96, 95% CI: 1.35-46.99 at the 12 th month; RR: 13.68, 95% CI: 1.94-96.55 for IADL at the 6 th month, and RR: 30.61, 95% CI: 2.94318.54 at the 12 th month, respectively). Conclusion: Postoperative delirium is predictive of IADL decline in older patients undergoing orthopaedic surgery, and delirium superimposed on cognitive impairment is an independent risk factor for deterioration of ADL and IADL functional status. Early identification of cognitive function and to prevent delirium are needed to improve functional status following orthopaedic surgery.	[Liang, Chih-Kuang; Chu, Chin-Liang; Chou, Ming-Yueh; Lin, Yu-Te] Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaohsiung, Taiwan; [Liang, Chih-Kuang; Lin, Yu-Te] Kaohsiung Vet Gen Hosp, Dept Med, Div Neurol, Kaohsiung, Taiwan; [Liang, Chih-Kuang; Chu, Chin-Liang; Chou, Ming-Yueh; Lin, Yu-Te; Chen, Liang-Kung] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Chu, Chin-Liang; Lu, Ti] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Chou, Ming-Yueh] Kaohsiung Vet Gen Hosp, Dept Family Med, Kaohsiung, Taiwan; [Hsu, Chien-Jen] Kaohsiung Vet Gen Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital	Lin, YT (corresponding author), Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaohsiung, Taiwan.	ytlin@vghks.gov.tw; lkchen2@vghtpe.gov.tw	Liang, Chih-Kuang/AAJ-5235-2020	Liang, Chih-Kuang/0000-0003-1604-1600; Chen, Liang-Kung/0000-0002-2387-8508	Veteran Affairs Commission of Taiwan	Veteran Affairs Commission of Taiwan	This work was supported by grants from the Veteran Affairs Commission of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chu CL, 2011, J CLIN GERONTOL GERI, V2, P100, DOI 10.1016/j.jcgg.2011.11.005; Collin C, 1988, Int Disabil Stud, V10, P61; Edelstein DM, 2004, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000128649.59959.0c; Elie M, 2000, CAN MED ASSOC J, V163, P977; Fick DM, 2013, J HOSP MED, V8, P500, DOI 10.1002/jhm.2077; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; FRANCIS J, 1990, J GEN INTERN MED, V5, P65, DOI 10.1007/BF02602312; Givens JL, 2008, J AM GERIATR SOC, V56, P1075, DOI 10.1111/j.1532-5415.2008.01711.x; Gottesman RF, 2010, ANN NEUROL, V67, P338, DOI 10.1002/ana.21899; GUSTAFSON Y, 1988, J AM GERIATR SOC, V36, P525, DOI 10.1111/j.1532-5415.1988.tb04023.x; Holmes J, 2000, PSYCHOL MED, V30, P921, DOI 10.1017/S0033291799002548; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; KOPONEN H, 1989, ACTA PSYCHIAT SCAND, V79, P579, DOI 10.1111/j.1600-0447.1989.tb10306.x; Koster S, 2009, ANN THORAC SURG, V87, P1469, DOI 10.1016/j.athoracsur.2009.02.080; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LEVKOFF SE, 1992, ARCH INTERN MED, V152, P334, DOI 10.1001/archinte.152.2.334; Liao C. Y., 1995, CHANGHUA MED J, V1, P11; Lundstrom M, 2003, J AM GERIATR SOC, V51, P1002, DOI 10.1046/j.1365-2389.2003.51315.x; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618, DOI 10.1111/j.1532-5415.2000.tb04718.x; Norkiene I, 2007, SCAND CARDIOVASC J, V41, P180, DOI 10.1080/14017430701302490; Nyunt MSZ, 2009, AGING MENT HEALTH, V13, P376, DOI 10.1080/13607860902861027; POMPEI P, 1994, J AM GERIATR SOC, V42, P809, DOI 10.1111/j.1532-5415.1994.tb06551.x; Quinlan N, 2011, J AM GERIATR SOC, V59, pS301, DOI 10.1111/j.1532-5415.2011.03679.x; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Rudolph JL, 2008, ANAESTHESIA, V63, P941, DOI 10.1111/j.1365-2044.2008.05523.x; Rudolph JL, 2007, AM J MED, V120, P807, DOI 10.1016/j.amjmed.2007.02.026; Rudolph JL, 2011, ANESTH ANALG, V112, P1202, DOI 10.1213/ANE.0b013e3182147f6d; Sanders RD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4331; SCHOR JD, 1992, JAMA-J AM MED ASSOC, V267, P827, DOI 10.1001/jama.267.6.827; Steiner JF, 1997, J AM GERIATR SOC, V45, P1510, DOI 10.1111/j.1532-5415.1997.tb03204.x; Vida S, 2006, INT PSYCHOGERIATR, V18, P681, DOI 10.1017/S1041610206003310; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wu CH, 2012, J CLIN GERONTOL GERI, V3, P14, DOI 10.1016/j.jcgg.2011.05.002	42	36	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110339	10.1371/journal.pone.0110339	http://dx.doi.org/10.1371/journal.pone.0110339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25402484	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700004
J	Rubattu, S; Marchitti, S; Bianchi, F; Di Castro, S; Stanzione, R; Cotugno, M; Bozzao, C; Sciarretta, S; Volpe, M				Rubattu, Speranza; Marchitti, Simona; Bianchi, Franca; Di Castro, Sara; Stanzione, Rosita; Cotugno, Maria; Bozzao, Cristina; Sciarretta, Sebastiano; Volpe, Massimo			The C2238/alpha ANP Variant Is a Negative Modulator of Both Viability and Function of Coronary Artery Smooth Muscle Cells	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASES; MICRORNA EXPRESSION; MOLECULAR VARIANT; GENE POLYMORPHISM; ENDOTHELIAL-CELLS; RECEPTOR-C; IN-VITRO; ATHEROSCLEROSIS	Background: Abnormalities of vascular smooth muscle cells (VSMCs) contribute to development of vascular disease. Atrial natriuretic peptide (ANP) exerts important effects on VSMCs. A common ANP molecular variant (T2238C/alpha ANP) has recently emerged as a novel vascular risk factor. Objectives: We aimed at identifying effects of CC2238/alpha ANP on viability, migration and motility in coronary artery SMCs, and the underlying signaling pathways. Methods and Results: Cells were exposed to either TT2238/alpha ANP or CC2238/alpha ANP. At the end of treatment, cell viability, migration and motility were evaluated, along with changes in oxidative stress pathway (ROS levels, NADPH and eNOS expression), on Akt phosphorylation and miR21 expression levels. CC2238/alpha ANP reduced cell vitality, increased apoptosis and necrosis, increased oxidative stress levels, suppressed miR21 expression along with consistent changes of its molecular targets (PDCD4, PTEN, Bcl2) and of phosphorylated Akt levels. As a result of increased oxidative stress, CC2238/alpha ANP markedly stimulated cell migration and increased cell contraction. NPR-C gene silencing with specific siRNAs restored cell viability, miR21 expression, and reduced oxidative stress induced by CC2238/alpha ANP. The cAMP/PKA/CREB pathway, driven by NPR-C activation, significantly contributed to both miR21 and phosphoAkt reduction upon CC2238/alpha ANP. miR21 overexpression by mimic-hsa-miR21 rescued the cellular damage dependent on CC2238/alpha ANP. Conclusions: CC2238/alpha ANP negatively modulates viability through NPR-C/cAMP/PKA/CREB/miR21 signaling pathway, and it augments oxidative stress leading to increased migratory and vasoconstrictor effects in coronary artery SMCs. These novel findings further support a damaging role of this common alpha ANP variant on vessel wall and its potential contribution to acute coronary events.	[Rubattu, Speranza; Marchitti, Simona; Bianchi, Franca; Di Castro, Sara; Stanzione, Rosita; Cotugno, Maria; Sciarretta, Sebastiano; Volpe, Massimo] IRCCS Neuromed, Pozzilli, Isernia, Italy; [Rubattu, Speranza; Bozzao, Cristina; Volpe, Massimo] Univ Roma La Sapienza, Sch Med & Psychol, Dept Clin & Mol Med, I-00185 Rome, Italy	IRCCS Neuromed; Sapienza University Rome	Rubattu, S (corresponding author), IRCCS Neuromed, Pozzilli, Isernia, Italy.	rubattu.speranza@neuromed.it	Rubattu, S./K-4036-2016; Cotugno, Maria/ABH-9517-2020; Bianchi, Franca/AAA-6427-2019; Volpe, Massimo/K-5240-2016; Stanzione, Rosita/AAE-2482-2020; Sciarretta, Sebastiano/K-5161-2016	Volpe, Massimo/0000-0002-9642-8380; Rubattu, Speranza/0000-0002-9808-7970; Bianchi, Franca/0000-0001-7355-4694; RUBATTU, Speranza Donatella/0000-0001-5921-7368; Cotugno, Maria/0000-0003-0061-1154; Marchitti, Simona/0000-0002-9097-8496; Sciarretta, Sebastiano/0000-0002-8633-6896; Stanzione, Rosita/0000-0002-3576-4604	Italian Ministry of Health; 5% grant	Italian Ministry of Health(Ministry of Health, Italy); 5% grant	This work was supported by a grant (Ricerca Corrente) from the Italian Ministry of Health to MV and SR; by the 5% grant to MV and SR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbato E, 2012, J AM COLL CARDIOL, V59, P1763, DOI 10.1016/j.jacc.2012.02.017; Bellis A, 2009, ARTERIOSCL THROM VAS, V29, P1207, DOI 10.1161/ATVBAHA.109.184135; Cannone V, 2013, HYPERTENSION, V62, P860, DOI 10.1161/HYPERTENSIONAHA.113.01344; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Gruchala M, 2003, AM HEART J, V145, P125, DOI 10.1067/mhj.2003.52; Hiroshi I, 1990, J CLIN INVEST, V86, P1690; IP JH, 1990, J AM COLL CARDIOL, V15, P1667, DOI 10.1016/0735-1097(90)92845-S; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kang H, 2012, J BIOL CHEM, V287, P3976, DOI 10.1074/jbc.M111.303156; Keller DM, 2012, MOL ENDOCRINOL, V26, P989, DOI 10.1210/me.2011-1205; Kotlo KU, 2011, AM J PHYSIOL-CELL PH, V301, pC929, DOI 10.1152/ajpcell.00088.2011; LIN XB, 1995, CIRC RES, V77, P750, DOI 10.1161/01.RES.77.4.750; Lovren F, 2009, AM J PHYSIOL-ENDOC M, V296, pE1440, DOI 10.1152/ajpendo.90780.2008; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; Martinez-Hervas S, 2014, CARDIOVASC RES, V103, P324, DOI 10.1093/cvr/cvu115; MORISHITA R, 1994, J CLIN INVEST, V94, P824, DOI 10.1172/JCI117402; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Quintavalle C, 2011, VASC PHARMACOL, V55, P87, DOI 10.1016/j.vph.2011.07.004; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Rubattu S, 2014, J CARDIOVAS IN PRESS; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; Scarpino S, 2009, J HYPERTENS, V27, P1804, DOI 10.1097/HJH.0b013e32832d229f; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; Sciarretta S, 2013, CIRC RES, V112, P1355, DOI 10.1161/CIRCRESAHA.113.301325; Shu MF, 2012, MOL PHARMACOL, V81, P292, DOI 10.1124/mol.111.076166; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Villar IC, 2007, CARDIOVASC RES, V74, P515, DOI 10.1016/j.cardiores.2007.02.032; Volpe M, 2014, EUR HEART J, V35, P419, DOI 10.1093/eurheartj/eht466; Wang XP, 2014, EUR HEART J, V35, P911, DOI 10.1093/eurheartj/eht329; WEBER W, 1991, J ANTIBIOT, V44, P164, DOI 10.7164/antibiotics.44.164; Zhou YJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/374963; Ziaee S, 2014, CORONARY ARTERY DIS, V25, P242, DOI 10.1097/MCA.0000000000000075	35	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113108	10.1371/journal.pone.0113108	http://dx.doi.org/10.1371/journal.pone.0113108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401746	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700114
J	Chaiyasen, A; Young, JPW; Teaumroong, N; Gavinlertvatana, P; Lumyong, S				Chaiyasen, Amornrat; Young, J. Peter W.; Teaumroong, Neung; Gavinlertvatana, Paiboolya; Lumyong, Saisamorn			Characterization of Arbuscular Mycorrhizal Fungus Communities of Aquilaria crassna and Tectona grandis Roots and Soils in Thailand Plantations	PLOS ONE			English	Article							PCR PRIMERS; DIVERSITY; GLOMALIN; FOREST; GLOMEROMYCOTA; STRESS; PHYLUM; PLANTS	Aquilaria crassna Pierre ex Lec. and Tectona grandis Linn. f. are sources of resin-suffused agarwood and teak timber, respectively. This study investigated arbuscular mycorrhizal (AM) fungus community structure in roots and rhizosphere soils of A. crassna and T. grandis from plantations in Thailand to understand whether AM fungal communities present in roots and rhizosphere soils vary with host plant species and study sites. Terminal restriction fragment length polymorphism complemented with clone libraries revealed that AM fungal community composition in A. crassna and T. grandis were similar. A total of 38 distinct terminal restriction fragments (TRFs) were found, 31 of which were shared between A. crassna and T. grandis. AM fungal communities in T. grandis samples from different sites were similar, as were those in A. crassna. The estimated average minimum numbers of AM fungal taxa per sample in roots and soils of T. grandis were at least 1.89 vs. 2.55, respectively, and those of A. crassna were 2.85 vs. 2.33 respectively. The TRFs were attributed to Claroideoglomeraceae, Diversisporaceae, Gigasporaceae and Glomeraceae. The Glomeraceae were found to be common in all study sites. Specific AM taxa in roots and soils of T. grandis and A. crassna were not affected by host plant species and sample source (root vs. soil) but affected by collecting site. Future inoculum production and utilization efforts can be directed toward the identified symbiotic associates of these valuable tree species to enhance reforestation efforts.	[Chaiyasen, Amornrat; Lumyong, Saisamorn] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Young, J. Peter W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Teaumroong, Neung] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Nakhon Ratchasima, Thailand; [Gavinlertvatana, Paiboolya] Thai Orchid Labs Co Ltd, Bangkok, Thailand	Chiang Mai University; University of York - UK; Suranaree University of Technology	Lumyong, S (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand.	saisamorn.l@cmu.ac.th	Young, Peter/C-1446-2012	Young, Peter/0000-0001-5259-4830	Thailand Research Fund [RTA5580007]; Commission of Higher Education for National Research University [A1]; Royal Golden Jubilee PhD Program [PHD/0150/2550]	Thailand Research Fund(Thailand Research Fund (TRF)); Commission of Higher Education for National Research University; Royal Golden Jubilee PhD Program(Thailand Research Fund (TRF))	This research was supported by the Thailand Research Fund for Research-Team Promotion Grant (RTA5580007) and the Commission of Higher Education for National Research University (A1) (http://www.trf.or.th/). AC was funded by the Thailand Research Fund; The Royal Golden Jubilee PhD Program (PHD/0150/2550: http://rgj.trf.or.th/indexth.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AzconAguilar C, 1996, MYCORRHIZA, V6, P457, DOI 10.1007/s005720050147; Barto EK, 2011, BIOL INVASIONS, V13, P2755, DOI 10.1007/s10530-011-9945-6; Bever JD, 1996, J ECOL, V84, P71, DOI 10.2307/2261701; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Brundrett M, 1996, WORKING MYCORRHIZAS; Brundrett MC, 1999, MYCORRHIZA, V8, P305, DOI 10.1007/s005720050251; CITES, 2004, 13 M C PART BANGK TH, P1; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; Dhar P. P., 2012, Journal of Forestry Research, V23, P115, DOI 10.1007/s11676-012-0241-9; Doubkova P, 2013, PLANT SOIL, V370, P149, DOI 10.1007/s11104-013-1610-7; GAZEY C, 1993, MYCOL RES, V97, P785, DOI 10.1016/S0953-7562(09)81150-7; Habte M., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P644; Habte M, 2000, PLANT NUTR MANAGEMEN, P127; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 1999, MOL ECOL, V8, P659, DOI 10.1046/j.1365-294x.1999.00604.x; Houba VJG, 1988, SOIL PLANT ANAL 5; INVAM Newsletter 3, 1993, INVAM NEWSLETTER; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Kanakadurga VV, 1990, MYCORRHIZAL SYMBIOSI, P17; Kobayashi S, 2004, FOREST ECOL MANAG, V201, P13, DOI 10.1016/j.foreco.2004.06.009; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Mummey DL, 2007, J MICROBIOL METH, V70, P200, DOI 10.1016/j.mimet.2007.04.002; Mummey DL, 2006, PLANT SOIL, V288, P81, DOI 10.1007/s11104-006-9091-6; Mummey DL, 2005, PLANT SOIL, V271, P83, DOI 10.1007/s11104-004-2066-6; Oehl F, 2009, AGR ECOSYST ENVIRON, V134, P257, DOI 10.1016/j.agee.2009.07.008; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pietikainen A, 2007, NEW PHYTOL, V176, P691, DOI 10.1111/j.1469-8137.2007.02209.x; Porcel R, 2004, J EXP BOT, V55, P1743, DOI 10.1093/jxb/erh188; Rajan SK, 2000, FOREST ECOL MANAG, V126, P91, DOI 10.1016/S0378-1127(99)00089-4; Ramanwong K, 1998, THESIS KASETSART U C; Renker C, 2006, MYCORRHIZA, V16, P525, DOI 10.1007/s00572-006-0067-4; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2003, PLANT SOIL, V253, P293, DOI 10.1023/A:1024807820579; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A, 2010, GLOMEROMYCOTA SPECIE, P1; Singh SS, 2003, TROP ECOL, V44, P207; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Swaminathan C., 2006, Journal of Sustainable Forestry, V22, P63, DOI 10.1300/J091v22n03_05; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tabin T, 2009, TROP ECOL, V50, P243; Tamuli P., 2002, Indian Forester, V128, P991; Thapar HS, 1988, TRENDS TREE SCI, P161; Turjaman M, 2006, MYCORRHIZA, V16, P459, DOI 10.1007/s00572-006-0059-4; Urgiles N, 2009, NEW FOREST, V38, P229, DOI 10.1007/s11056-009-9143-x; van der Heijden MGA, 2003, NEW PHYTOL, V157, P569, DOI 10.1046/j.1469-8137.2003.00688.x; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Wolfe BE, 2007, MYCORRHIZA, V17, P175, DOI 10.1007/s00572-006-0089-y; Wright SF, 1998, PLANT SOIL, V198, P97, DOI 10.1023/A:1004347701584	52	13	16	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112591	10.1371/journal.pone.0112591	http://dx.doi.org/10.1371/journal.pone.0112591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397675	Green Published, gold			2022-12-26	WOS:000345558500064
J	Fan, F; Geurts, AM; Pabbidi, MR; Smith, SV; Harder, DR; Jacob, H; Roman, RJ				Fan, Fan; Geurts, Aron M.; Pabbidi, Mallikarjuna R.; Smith, Stanley V.; Harder, David R.; Jacob, Howard; Roman, Richard J.			Zinc-Finger Nuclease Knockout of Dual-Specificity Protein Phosphatase-5 Enhances the Myogenic Response and Autoregulation of Cerebral Blood Flow in FHH.1(BN) Rats	PLOS ONE			English	Article							RUPTURED INTRACRANIAL ANEURYSMS; HOODED HYPERTENSIVE-RATS; HEAD-INJURY; INTRAVENTRICULAR PRESSURE; SUBARACHNOID HEMORRHAGE; MODULATES PROTEINURIA; BRAIN-TISSUE; ACUTE-PHASE; I-TASSER; REACTIVITY	We recently reported that the myogenic responses of the renal afferent arteriole (Af-Art) and middle cerebral artery (MCA) and autoregulation of renal and cerebral blood flow (RBF and CBF) were impaired in Fawn Hooded hypertensive (FHH) rats and were restored in a FHH.1(BN) congenic strain in which a small segment of chromosome 1 from the Brown Norway (BN) containing 15 genes including dual-specificity protein phosphatase-5 (Dusp5) were transferred into the FHH genetic background. We identified 4 single nucleotide polymorphisms in the Dusp5 gene in FHH as compared with BN rats, two of which altered CpG sites and another that caused a G155R mutation. To determine whether Dusp5 contributes to the impaired myogenic response in FHH rats, we created a Dusp5 knockout (KO) rat in the FHH.1(BN) genetic background using a zinc-finger nuclease that introduced an 11 bp frame-shift deletion and a premature stop codon at AA121. The expression of Dusp5 was decreased and the levels of its substrates, phosphorylated ERK1/2 (p-ERK1/2), were enhanced in the KO rats. The diameter of the MCA decreased to a greater extent in Dusp5 KO rats than in FHH.1(BN) and FHH rats when the perfusion pressure was increased from 40 to 140 mmHg. CBF increased markedly in FHH rats when MAP was increased from 100 to 160 mmHg, and CBF was better autoregulated in the Dusp5 KO and FHH.1(BN) rats. The expression of Dusp5 was higher at the mRNA level but not at the protein level and the levels of p-ERK1/2 and p-PKC were lower in cerebral microvessels and brain tissue isolated from FHH than in FHH.1(BN) rats. These results indicate that Dusp5 modulates myogenic reactivity in the cerebral circulation and support the view that a mutation in Dusp5 may enhance Dusp5 activity and contribute to the impaired myogenic response in FHH rats.	[Fan, Fan; Pabbidi, Mallikarjuna R.; Smith, Stanley V.; Roman, Richard J.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Geurts, Aron M.; Jacob, Howard] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Harder, David R.] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA	University of Mississippi; University of Mississippi Medical Center; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Roman, RJ (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	rroman@umc.edu			National Institutes of Health [R01 HL36279, DK104184, H105997, HL-101681, OD-8396]; American Heart Association [13SDG14000006]; VA Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036279, RC2HL101681, R01HL105997, R01HL033833, R37HL036279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); VA Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by National Institutes of Health R01 HL36279 and DK104184 (RJR), H105997 (Harder), GO grant HL-101681 (Jacob) and New innovator award OD-8396 (Geurts), VA Research Career Scientist Award (Harder) and Scientist Development Grant 13SDG14000006 (Pabbidi) from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNOLI A, 1968, CIRCULATION, V38, P800, DOI 10.1161/01.CIR.38.4.800; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bellapart J, 2009, ULTRASOUND MED BIOL, V35, P883, DOI 10.1016/j.ultrasmedbio.2009.01.005; Burke M, 2013, AM J PHYSIOL-RENAL, V304, pF565, DOI 10.1152/ajprenal.00404.2012; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chen CCA, 2013, PHYSIOL GENOMICS, V45, P110, DOI 10.1152/physiolgenomics.00119.2012; COLD GE, 1981, ACTA ANAESTH SCAND, V25, P397, DOI 10.1111/j.1399-6576.1981.tb01673.x; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COLD GE, 1981, ACTA ANAESTH SCAND, V25, P332, DOI 10.1111/j.1399-6576.1981.tb01662.x; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; DERNBACH PD, 1988, NEUROSURGERY, V22, P822, DOI 10.1227/00006123-198805000-00003; Dunn KM, 2008, AM J PHYSIOL-HEART C, V295, pH2455, DOI 10.1152/ajpheart.00512.2008; Fan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082482; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; FARACI FM, 1990, J AM SOC NEPHROL, V1, P53; FARACI FM, 1987, AM J PHYSIOL, V252, pH738, DOI 10.1152/ajpheart.1987.252.4.H738; Fu Q, 2006, FASEB J, V20, P2127, DOI 10.1096/fj.06-6179fje; Geurts AM, 2010, CLIN SCI, V119, P303, DOI 10.1042/CS20100201; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gibney EM, 2003, AM J KIDNEY DIS, V42, P1, DOI 10.1016/S0272-6386(03)00403-7; HOEDTRASMUSSEN K, 1967, ARCH NEUROL-CHICAGO, V17, P271, DOI 10.1001/archneur.1967.00470270049007; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; ISHII R, 1979, J NEUROSURG, V50, P587, DOI 10.3171/jns.1979.50.5.0587; JOHANSSON B, 1989, J HYPERTENS, V7, pS5; Kamkin A, 2000, CARDIOVASC RES, V48, P409, DOI 10.1016/S0008-6363(00)00208-X; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Lammie GA, 2002, BRAIN PATHOL, V12, P358; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; MELLANDER S, 1989, J HYPERTENS, V7, pS21; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Murphy TV, 2002, CLIN EXP PHARMACOL P, V29, P612, DOI 10.1046/j.1440-1681.2002.03698.x; OLSEN TS, 1983, STROKE, V14, P332, DOI 10.1161/01.STR.14.3.332; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pabbidi MR, 2014, AM J PHYSIOL-HEART C, V306, pH989, DOI 10.1152/ajpheart.00636.2013; Pabbidi MR, 2013, AM J PHYSIOL-HEART C, V304, pH311, DOI 10.1152/ajpheart.00622.2012; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Purkayastha S, 2011, INDIAN J PHARMACOL, V43, P502, DOI 10.4103/0253-7613.84950; Rangel-Filho A, 2005, J AM SOC NEPHROL, V16, P852, DOI 10.1681/ASN.2005010029; Rangel A, 2013, J AM SOC NEPHROL, V24, P283, DOI 10.1681/ASN.2012090927; Roman RJ, 2006, NEUROL RES, V28, P738, DOI 10.1179/016164106X152016; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; STRANDGAARD S, 1991, Cardiovascular Drugs and Therapy, V4, P1217, DOI 10.1007/BF00114223; Sun CW, 1999, HYPERTENSION, V33, P414, DOI 10.1161/01.HYP.33.1.414; Toth P, 2013, AM J PHYSIOL-HEART C, V305, pH1698, DOI 10.1152/ajpheart.00377.2013; VOLDBY B, 1985, J NEUROSURG, V62, P48, DOI 10.3171/jns.1985.62.1.0048; VOLDBY B, 1985, J NEUROSURG, V62, P59, DOI 10.3171/jns.1985.62.1.0059; Wagner BP, 2011, PEDIATR RES, V69, P436, DOI 10.1203/PDR.0b013e3182110177; Walsh MP, 2013, J CEREBR BLOOD F MET, V33, P1, DOI 10.1038/jcbfm.2012.144; Wickramasekera NT, 2013, J APPL PHYSIOL, V114, P252, DOI 10.1152/japplphysiol.01026.2011; Zassadowski F, 2012, CELL SIGNAL, V24, P2369, DOI 10.1016/j.cellsig.2012.08.003; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao Y, 2005, AM J PHYSIOL-REG I, V289, pR164, DOI 10.1152/ajpregu.00847.2004	60	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112878	10.1371/journal.pone.0112878	http://dx.doi.org/10.1371/journal.pone.0112878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397684	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500105
J	Lawhorn, IEB; Ferreira, JP; Wang, CL				Lawhorn, Ingrid E. B.; Ferreira, Joshua P.; Wang, Clifford L.			Evaluation of sgRNA Target Sites for CRISPR-Mediated Repression of TP53	PLOS ONE			English	Article							TRANSCRIPTIONAL START SITES; SEQUENCE-SPECIFIC CONTROL; GENE-EXPRESSION; HUMAN-CELLS; MAMMALIAN-CELLS; CAS SYSTEM; RNA; ACTIVATION; DNA; ENDONUCLEASE	The CRISPR (clustered regularly interspaced short palindromic repeats) platform has been developed as a general method to direct proteins of interest to gene targets. While the native CRISPR system delivers a nuclease that cleaves and potentially mutates target genes, researchers have recently employed catalytically inactive CRISPR-associated 9 nuclease (dCas9) in order to target and repress genes without DNA cleavage or mutagenesis. With the intent of improving repression efficiency in mammalian cells, researchers have also fused dCas9 with a KRAB repressor domain. Here, we evaluated different genomic sgRNA targeting sites for repression of TP53. The sites spanned a 200-kb distance, which included the promoter, transcript sequence, and regions flanking the endogenous human TP53 gene. We showed that repression up to 86% can be achieved with dCas9 alone (i.e., without use of the KRAB domain) by targeting the complex to sites near the TP53 transcriptional start site. This work demonstrates that efficient transcriptional repression of endogenous human genes can be achieved by the targeted delivery of dCas9. Yet, the efficiency of repression strongly depends on the choice of the sgRNA target site.	[Lawhorn, Ingrid E. B.; Ferreira, Joshua P.; Wang, Clifford L.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University	Wang, CL (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	cliff.wang@stanford.edu			National Science Foundation Graduate Research Fellowship Program; Stanford Graduate Fellowship; National Institute on Aging [NIH-5R21AG040360-02]; National Institutes of Health S10 Shared Instrumentation [S10RR025518-01, S10RR027431-01]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025518, S10RR027431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG040360] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health S10 Shared Instrumentation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	IEBL was funded by the National Science Foundation Graduate Research Fellowship Program http://www.nsfgrfp.org/ and Stanford Graduate Fellowship http://sgf.stanford.edu/. IEBL, JPF, and CLW were funded by the National Institute on Aging (NIH-5R21AG040360-02) http://www.nia.nih.gov/. Data and sorting was performed on instruments in the Stanford Shared FACS Facility obtained using National Institutes of Health S10 Shared Instrumentation Grants S10RR025518-01 and S10RR027431-01 http://dpcpsi.nih.gov/orip/diic/shared_instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; Ferreira Joshua P, 2011, Syst Synth Biol, V5, P131, DOI 10.1007/s11693-011-9089-0; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hagmann M, 1997, J VIROL, V71, P5952, DOI 10.1128/JVI.71.8.5952-5962.1997; Hao DL, 2005, ACTA BIOCH BIOPH SIN, V37, P779, DOI 10.1111/j.1745-7270.2005.00107.x; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Saldana-Meyer R, 2011, EPIGENETICS-US, V6, P1068, DOI 10.4161/epi.6.9.16683; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; STEWART N, 1991, VIROLOGY, V180, P49, DOI 10.1016/0042-6822(91)90008-Y; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wu X, 2014, QUANT BIOL; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu K., 2014, CELL MOL LIFE SCI; Yamashita R, 2012, NUCLEIC ACIDS RES, V40, pD150, DOI 10.1093/nar/gkr1005	47	39	43	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113232	10.1371/journal.pone.0113232	http://dx.doi.org/10.1371/journal.pone.0113232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398078	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500142
J	Espinosa-Hernandez, W; Velez-Uriza, D; Valdes, J; Velez-Del Valle, C; Salas-Benito, J; Martinez-Contreras, R; Garcia-Espitia, M; Salas-Benito, M; Vega-Almeida, T; De Nova-Ocampo, M				Espinosa-Hernandez, Wendy; Velez-Uriza, Dora; Valdes, Jesus; Velez-Del Valle, Cristina; Salas-Benito, Juan; Martinez-Contreras, Rebeca; Garcia-Espitia, Matilde; Salas-Benito, Mariana; Vega-Almeida, Tania; De Nova-Ocampo, Monica			PTB Binds to the 3 ' Untranslated Region of the Human Astrovirus Type 8: A Possible Role in Viral Replication	PLOS ONE			English	Article							TERMINAL NSP1A PROTEIN; DENGUE VIRUS; RNA SEQUENCE; STRAND RNA; TRANSLATION; CELL; RELOCALIZATION; IDENTIFICATION; POLYMERASE; REGULATOR	The 3' untranslated region (3'UTR) of human astroviruses (HAstV) consists of two hairpin structures (helix I and II) joined by a linker harboring a conserved PTB/hnRNP1 binding site. The identification and characterization of cellular proteins that interact with the 3'UTR of HAstV-8 virus will help to uncover cellular requirements for viral functions. To this end, mobility shift assays and UV cross-linking were performed with uninfected and HAstV-8-infected cell extracts and HAstV-8 3'UTR probes. Two RNA-protein complexes (CI and CII) were recruited into the 3'UTR. Complex CII formation was compromised with cold homologous RNA, and seven proteins of 35, 40, 45, 50, 52, 57/60 and 75 kDa were cross-linked to the 3'UTR. Supermobility shift assays indicated that PTB/hnRNP1 is part of this complex, and 3'UTR-crosslinked PTB/hnRNP1 was immunoprecipitated from HAstV-8 infected cell-membrane extracts. Also, immunofluorescence analyses revealed that PTB/ hnRNP1 is distributed in the nucleus and cytoplasm of uninfected cells, but it is mainly localized perinuclearly in the cytoplasm of HAstV-8 infected cells. Furthermore, the minimal 3'UTR sequences recognized by recombinant PTB are those conforming helix I, and an intact PTB/hnRNP1-binding site. Finally, small interfering RNA-mediated PTB/hnRNP1 silencing reduced synthesis viral genome and virus yield in CaCo2 cells, suggesting that PTB/hnRNP1 is required for HAstV replication. In conclusion, PTB/hnRNP1 binds to the 3'UTR HAstV-8 and is required or participates in viral replication.	[Espinosa-Hernandez, Wendy; Velez-Uriza, Dora; Salas-Benito, Juan; Garcia-Espitia, Matilde; Salas-Benito, Mariana; De Nova-Ocampo, Monica] Inst Politecn Nacl, ENMH, Programa Inst Biomed Mol, Secc Estudios Posgrad & Invest, Mexico City, DF, Mexico; [Valdes, Jesus] IPN, Ctr Invest & Estudios Avanzados, Dept Bioquim, Mexico City 07738, DF, Mexico; [Velez-Del Valle, Cristina] IPN, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City 07738, DF, Mexico; [Martinez-Contreras, Rebeca] BUAP, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico; [Vega-Almeida, Tania] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico	Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico	De Nova-Ocampo, M (corresponding author), Inst Politecn Nacl, ENMH, Programa Inst Biomed Mol, Secc Estudios Posgrad & Invest, Mexico City, DF, Mexico.	mdenova@ipn.mx	Martínez-Contreras, Rebeca/S-9605-2019	Velez-delValle, Cristina/0000-0002-2377-942X; De Nova Ocampo, Monica/0000-0002-0750-7977; , Wendy/0000-0003-0254-7782; Salas-Benito, Juan Santiago/0000-0002-4096-0079	Secretaria de Investigacion y Posgrado-Instituto Politecnico Nacional [20080174, 20090206, 20100054, 20110182, 20120179, 20130689]; Consejo Nacional de Ciencia y Tecnologia [99682 (MDO), 49355M, 127557M]; Instituto de Ciencia Tecnologia [71/2012]; Consejo Nacional de Ciencia y Tecnologia; Comision de Operacion y Fomento de Actividades Academicas-Instituto Politecnico Nacional/Estimulo al Desempeno de los Investigadores fellowships	Secretaria de Investigacion y Posgrado-Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Ciencia Tecnologia; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comision de Operacion y Fomento de Actividades Academicas-Instituto Politecnico Nacional/Estimulo al Desempeno de los Investigadores fellowships	This work was partially supported by Secretaria de Investigacion y Posgrado-Instituto Politecnico Nacional grants 20080174, 20090206, 20100054, 20110182, 20120179, and 20130689; Consejo Nacional de Ciencia y Tecnologia grants 99682 (MDO), 49355M, and 127557M; and Instituto de Ciencia Tecnologia grant 71/2012 (JV). WEH and DVU were Programa Institucional de Formacion de Investigadores-Instituto Politecnico Nacional scholars. DVU was supported by a scholarship from Consejo Nacional de Ciencia y Tecnologia. MDO and JSB received Comision de Operacion y Fomento de Actividades Academicas-Instituto Politecnico Nacional/Estimulo al Desempeno de los Investigadores fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; Belliot G, 1997, ARCH VIROL, V142, P1323, DOI 10.1007/s007050050163; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Cancio-Lonches C, 2011, J VIROL, V85, P8056, DOI 10.1128/JVI.01878-10; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Coulson JM, 2000, CANCER RES, V60, P1840; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Banos-Lara MD, 2010, VIROLOGY, V401, P322, DOI 10.1016/j.virol.2010.02.028; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fuentes C, 2012, J VIROL, V86, P10070, DOI 10.1128/JVI.00797-12; Fuentes C, 2011, J VIROL, V85, P4470, DOI 10.1128/JVI.01515-10; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Guix S, 2004, J VIROL, V78, P13627, DOI 10.1128/JVI.78.24.13627-13636.2004; Guix S, 2005, VIROLOGY, V333, P124, DOI 10.1016/j.virol.2004.12.023; Gutierrez-Escolano AL, 2003, BIOCHEM BIOPH RES CO, V311, P759, DOI 10.1016/j.bbrc.2003.10.066; Gutierrez-Escolano AL, 2000, J VIROL, V74, P8558, DOI 10.1128/JVI.74.18.8558-8562.2000; HELLEN CUT, 1994, J VIROL, V68, P941, DOI 10.1128/JVI.68.2.941-950.1994; Herold J, 2001, MOL CELL, V7, P581, DOI 10.1016/S1097-2765(01)00205-2; Isken O, 2004, RNA, V10, P1637, DOI 10.1261/rna.7290904; Jang SY, 2010, ARCH VIROL, V155, P1383, DOI 10.1007/s00705-010-0718-9; JIANG BM, 1993, P NATL ACAD SCI USA, V90, P10539, DOI 10.1073/pnas.90.22.10539; Karakasiliotis I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009562; Lai MMC, 1998, VIROLOGY, V244, P1, DOI 10.1006/viro.1998.9098; Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002; Lou Z, 2014, PLOS ONE, V9; McBride AE, 1996, P NATL ACAD SCI USA, V93, P2296, DOI 10.1073/pnas.93.6.2296; Mendez E, 2003, J VIROL, V77, P11378, DOI 10.1128/JVI.77.21.11378-11384.2003; Mendez E, 2012, ASTROVIRUS RES, P19, DOI DOI 10.1007/978-1-4614-4735-1_2; Mendez E., 2007, FIELDS VIROLOGY, P982; Monceyron C, 1997, ARCH VIROL, V142, P699, DOI 10.1007/s007050050112; MONROE SS, 1993, J VIROL, V67, P3611, DOI 10.1128/JVI.67.6.3611-3614.1993; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Shi ST, 2005, CURR TOP MICROBIOL, V287, P95, DOI 10.1007/3-540-26765-4_4; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; Velazquez-Moctezuma R, 2012, J VIROL METHODS, V179, P295, DOI 10.1016/j.jviromet.2011.11.005; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Waggoner S, 1998, J VIROL, V72, P6699, DOI 10.1128/JVI.72.8.6699-6709.1998; WILLCOCKS MM, 1992, ARCH VIROL, V124, P279, DOI 10.1007/BF01309809; Zoll J, 2009, VIRUS RES, V139, P209, DOI 10.1016/j.virusres.2008.07.014; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113113	10.1371/journal.pone.0113113	http://dx.doi.org/10.1371/journal.pone.0113113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406089	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300079
J	Futami, J; Fujiyama, H; Kinoshita, R; Nonomura, H; Honjo, T; Tada, H; Matsushita, H; Abe, Y; Kakimi, K				Futami, Junichiro; Fujiyama, Haruna; Kinoshita, Rie; Nonomura, Hidenori; Honjo, Tomoko; Tada, Hiroko; Matsushita, Hirokazu; Abe, Yoshito; Kakimi, Kazuhiro			Denatured Mammalian Protein Mixtures Exhibit Unusually High Solubility in Nucleic Acid-Free Pure Water	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; SALT-FREE WATER; FUNCTIONAL PROTEIN; SAMPLE PREPARATION; ENTROPIC BRISTLES; DENDRITIC CELLS; AGGREGATION; DISORDER; REAGENT; RNA	Preventing protein aggregation is a major goal of biotechnology. Since protein aggregates are mainly comprised of unfolded proteins, protecting against denaturation is likely to assist solubility in an aqueous medium. Contrary to this concept, we found denatured total cellular protein mixture from mammalian cell kept high solubility in pure water when the mixture was nucleic acids free. The lysates were prepared from total cellular protein pellet extracted by using guanidinium thiocyanate-phenol-chloroform mixture of TRIzol, denatured and reduced total protein mixtures remained soluble after extensive dialysis against pure water. The total cell protein lysates contained fully disordered proteins that readily formed large aggregates upon contact with nucleic acids or salts. These findings suggested that the highly flexible mixtures of disordered proteins, which have fully ionized side chains, are protected against aggregation. Interestingly, this unusual solubility is characteristic of protein mixtures from higher eukaryotes, whereas most prokaryotic protein mixtures were aggregated under identical conditions. This unusual solubility of unfolded protein mixtures could have implications for the study of intrinsically disordered proteins in a variety of cells.	[Futami, Junichiro; Fujiyama, Haruna; Kinoshita, Rie; Nonomura, Hidenori; Honjo, Tomoko; Tada, Hiroko] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biotechnol, Okayama 7008530, Japan; [Matsushita, Hirokazu; Kakimi, Kazuhiro] Tokyo Univ Hosp, Dept Immunotherapeut, Tokyo 113, Japan; [Abe, Yoshito] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Prot Struct Funct & Design, Fukuoka 812, Japan	Okayama University; University of Tokyo; Kyushu University	Futami, J (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biotechnol, Okayama 7008530, Japan.	futamij@okayama-u.ac.jp	Abe, Yoshito/AAH-6141-2021; Abe, Yoshito/D-8370-2012; Futami, Junichiro/B-2578-2011	Abe, Yoshito/0000-0002-0016-8490; Abe, Yoshito/0000-0002-0016-8490; Futami, Junichiro/0000-0002-0020-2855	Japan Society for the Promotion of Science (JSPS) for Junichiro Futami (JSPS KAKENHI) [23360370, 24656506]	Japan Society for the Promotion of Science (JSPS) for Junichiro Futami (JSPS KAKENHI)	This work was supported by the grants from the Japan Society for the Promotion of Science (JSPS: http://www.jsps.go.jp/english/index.html) for Junichiro Futami (JSPS KAKENHI Grant Numbers 23360370 and 24656506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2013, PROTEIN SCI, V22, P467, DOI 10.1002/pro.2228; ATKINSON A, 1973, BIOCHIM BIOPHYS ACTA, V308, P41, DOI 10.1016/0005-2787(73)90120-2; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Csizmok V, 2006, MOL CELL PROTEOMICS, V5, P265, DOI 10.1074/mcp.M500181-MCP200; De Simone A, 2012, P NATL ACAD SCI USA, V109, P6951, DOI 10.1073/pnas.1118048109; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Fukuchi S, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-29; Futami J, 2000, J BIOCHEM, V127, P435, DOI 10.1093/oxfordjournals.jbchem.a022625; Futami J, 2007, EXPERT OPIN DRUG DIS, V2, P261, DOI 10.1517/17460441.2.2.261; Galea CA, 2006, J PROTEOME RES, V5, P2839, DOI 10.1021/pr060328c; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Grana-Montes R, 2014, BIOMACROMOLECULES, V15, P1194, DOI 10.1021/bm401776z; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Ham BM, 2008, J PROTEOME RES, V7, P2215, DOI 10.1021/pr700575m; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; Hummon AB, 2007, BIOTECHNIQUES, V42, P467, DOI 10.2144/000112401; Kim TD, 2000, BIOCHEMISTRY-US, V39, P14839, DOI 10.1021/bi001441y; Kirkland PA, 2006, ANAL BIOCHEM, V351, P254, DOI 10.1016/j.ab.2006.01.017; Kuwada E, 2011, ANTICANCER RES, V31, P881; Li MF, 2006, BIOPHYS J, V91, P4201, DOI 10.1529/biophysj.106.093187; Li MF, 2006, PROTEIN SCI, V15, P1835, DOI 10.1110/ps.062306906; Liu JX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007805; May M, 2010, CANCER IMMUNOL IMMUN, V59, P687, DOI 10.1007/s00262-009-0784-6; Mishima T, 2010, BIOCHEM BIOPH RES CO, V391, P615, DOI 10.1016/j.bbrc.2009.11.108; Murata H, 2006, BIOCHEMISTRY-US, V45, P6124, DOI 10.1021/bi052642a; Obita T, 2003, CELL MOL LIFE SCI, V60, P176, DOI 10.1007/s000180300012; Pace CN, 2004, PHILOS T ROY SOC B, V359, P1225, DOI 10.1098/rstb.2004.1500; Romero P, 1998, Pac Symp Biocomput, P437; Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m; Song Jianxing, 2013, F1000Res, V2, P94, DOI 10.12688/f1000research.2-94.v1; Song JX, 2009, FEBS LETT, V583, P953, DOI 10.1016/j.febslet.2009.02.022; Szasz C, 2011, BIOCHEMISTRY-US, V50, P5834, DOI [10.1021/bi200365J, 10.1021/bi200365j]; Thumann P, 2003, J IMMUNOL METHODS, V277, P1, DOI 10.1016/S0022-1759(03)00102-9; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wolfraim LA, 2013, INT IMMUNOPHARMACOL, V15, P488, DOI 10.1016/j.intimp.2013.01.009; YAMADA H, 1994, J BIOCHEM-TOKYO, V116, P852, DOI 10.1093/oxfordjournals.jbchem.a124606; Yamaguchi S, 2013, BIOTECHNOL J, V8, P17, DOI 10.1002/biot.201200025; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Zeskind BJ, 2007, NAT METHODS, V4, P567, DOI 10.1038/NMETH1053	41	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113295	10.1371/journal.pone.0113295	http://dx.doi.org/10.1371/journal.pone.0113295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405999	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300099
J	Pan, JF; Liu, NH; Sun, H; Xu, F				Pan, Jian-feng; Liu, Ning-hua; Sun, Hui; Xu, Feng			Preparation and Characterization of Electrospun PLCL/Poloxamer Nanofibers and Dextran/Gelatin Hydrogels for Skin Tissue Engineering	PLOS ONE			English	Article							DRUG-DELIVERY; BLOCK-COPOLYMERS; SCAFFOLDS; FABRICATION; GELATIN; MATS	In this study, two different biomaterials were fabricated and their potential use as a bilayer scaffold for skin tissue engineering applications was assessed. The upper layer biomaterial was a Poly(epsilon-caprolactone-co-lactide)/Poloxamer (PLCL/Poloxamer) nanofiber membrane fabricated using electrospinning technology. The PLCL/Poloxamer nanofibers (PLCL/Poloxamer, 9/1) exhibited strong mechanical properties (stress/strain values of 9.37 +/- 0.38 MPa/187.43 +/- 10.66%) and good biocompatibility to support adipose-derived stem cells proliferation. The lower layer biomaterial was a hydrogel composed of 10% dextran and 20% gelatin without the addition of a chemical crosslinking agent. The 5/5 dextran/gelatin hydrogel displayed high swelling property, good compressive strength, capacity to present more than 3 weeks and was able to support cells proliferation. A bilayer scaffold was fabricated using these two materials by underlaying the nanofibers and casting hydrogel to mimic the structure and biological function of native skin tissue. The upper layer membrane provided mechanical support in the scaffold and the lower layer hydrogel provided adequate space to allow cells to proliferate and generate extracellular matrix. The biocompatibility of bilayer scaffold was preliminarily investigated to assess the potential cytotoxicity. The results show that cell viability had not been affected when cocultured with bilayer scaffold. As a consequence, the bilayer scaffold composed of PLCL/Poloxamer nanofibers and dextran/gelatin hydrogels is biocompatible and possesses its potentially high application prospect in the field of skin tissue engineering.	[Pan, Jian-feng; Liu, Ning-hua; Sun, Hui] Shanghai Jiao Tong Univ, Dept Orthopaed, Peoples Hosp 6, Shanghai 200030, Peoples R China; [Xu, Feng] Kunshan Tradit Chinese Med Hosp, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University	Sun, H (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed, Peoples Hosp 6, Shanghai 200030, Peoples R China.	sunshine20002000@126.com						Adams DC, 2005, DERMATOL SURG, V31, P1055; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Boyce ST, 2002, AM J SURG, V183, P445, DOI 10.1016/S0002-9610(02)00813-9; Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002; Ding FY, 2013, J MATER CHEM B, V1, P1729, DOI 10.1039/c3tb00517h; Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031; Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007; Hajiali H, 2011, INT J NANOMED, V6, P2133, DOI 10.2147/IJN.S24312; Hassanzadeh P, 2013, J MATER CHEM B, V1, P4217, DOI [10.1039/c3tb20782j, 10.1039/C3TB20782J]; Heimbach DM, 2003, J BURN CARE REHABIL, V24, P42, DOI 10.1097/00004630-200301000-00009; Ignatova M, 2009, MACROMOL BIOSCI, V9, P102, DOI 10.1002/mabi.200800189; Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218; Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906; Jeong SI, 2008, J BIOMAT SCI-POLYM E, V19, P339, DOI 10.1163/156856208783721029; Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017; Jung Y, 2008, J BIOMAT SCI-POLYM E, V19, P1073, DOI 10.1163/156856208784909336; Kim SH, 2006, J BIOMAT SCI-POLYM E, V17, P1359, DOI 10.1163/156856206778937244; Kim Y, 2013, J MATER CHEM B, V1, P3185, DOI 10.1039/c3tb20485e; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013; Kuwazuru O, 2008, MED ENG PHYS, V30, P516, DOI 10.1016/j.medengphy.2007.06.001; Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497; Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020; Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167; Lin GY, 2013, J MATER CHEM B, V1, P1249, DOI 10.1039/c2tb00468b; Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mo XM, 2010, J BIOMED MATER RES A, V94A, P326, DOI 10.1002/jbm.a.32788; Mo XM, 2000, J BIOMAT SCI-POLYM E, V11, P341, DOI 10.1163/156856200743742; Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011; Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9; Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318; Rieger KA, 2013, J MATER CHEM B, V1, P4531, DOI 10.1039/c3tb20795a; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Spitzenberger TJ, 2007, J CEREBR BLOOD F MET, V27, P1033, DOI 10.1038/sj.jcbfm.9600414; Sun XM, 2014, J MATER CHEM B, V2, P3636, DOI 10.1039/c3tb21814g; Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023; Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.tea.2010.0568, 10.1089/ten.TEA.2010.0568]; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k	39	100	104	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112885	10.1371/journal.pone.0112885	http://dx.doi.org/10.1371/journal.pone.0112885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405611	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300061
J	Petrella, C; Giuli, C; Agostini, S; Bacquie, V; Zinni, M; Theodorou, V; Broccardo, M; Casolini, P; Improta, G				Petrella, Carla; Giuli, Chiara; Agostini, Simona; Bacquie, Valerie; Zinni, Manuela; Theodorou, Vassilia; Broccardo, Maria; Casolini, Paola; Improta, Giovanna			Maternal Exposure to Low Levels of Corticosterone during Lactation Protects against Experimental Inflammatory Colitis-Induced Damage in Adult Rat Offspring	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; COLONIC BARRIER DYSFUNCTION; STRESS-RELATED ALTERATIONS; ENVIRONMENTAL ENRICHMENT; CHILDHOOD ABUSE; MOTOR FUNCTION; RECEPTOR; GLUCOCORTICOIDS; INTESTINE; DISEASE	Opposing emotional events (negative/trauma or positive/maternal care) during the postnatal period may differentially influence vulnerability to the effects of stress later in life. The development and course of intestinal disorders such as inflammatory bowel disease are negatively affected by persistent stress, but to date the role of positive life events on these pathologies has been entirely unknown. In the present study, the effect of early life beneficial experiences in the development of intestinal dysfunctions, where inflammation and stress stimuli play a primary role, was investigated. As a "positive'' experimental model we used adult male rat progeny nursed by mothers whose drinking water was supplemented with moderate doses of corticosterone (CORT) (0.2 mg/ml) during the lactation period. Such animals have been generally shown to cope better with different environmental situations during life. The susceptibility to inflammatory experimental colitis induced by intracolonic infusion of TNBS (2,4,6-trinitrobenzenesulphonic acid) was investigated in CORT-nursed rats in comparison with control rats. This mild increase in maternal corticosterone during lactation induced, in CORT-nursed rats, a long lasting protective effect on TNBS-colitis, characterized by improvements in some indices of the disease (increased colonic myeloperoxidase activity, loss of body weight and food intake) and by the involvement of endogenous peripheral pathways known to participate in intestinal disorder development (lower plasma corticosterone levels and colonic mast cell degranulation, alterations in the colonic expression of both corticotrophin releasing factor/CRF and its receptor/CRH-1R). All these findings contribute to suggesting that the reduced vulnerability to TNBS-colitis in CORT-nursed rats is due to recovery from the colonic mucosal barrier dysfunction. Such long lasting changes induced by mild hormonal manipulation during lactation, making the adult also better adapted to colonic inflammatory stress, constitute a useful experimental model to investigate the etiopathogenetic mechanisms and therapeutic treatments of some gastrointestinal diseases.	[Petrella, Carla; Giuli, Chiara; Zinni, Manuela; Broccardo, Maria; Casolini, Paola; Improta, Giovanna] Univ Roma La Sapienza, Dept Physiol & Pharmacol V Erspamer, I-00185 Rome, Italy; [Agostini, Simona; Bacquie, Valerie; Theodorou, Vassilia] INRA, EI Purpan, UMR 1331, TOXALIM Neurogastroenterol & Nutr Team, F-31931 Toulouse, France	Sapienza University Rome; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Petrella, C (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol V Erspamer, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	carla.petrella@uniroma1.it	Petrella, Carla/AAX-1265-2020	Petrella, Carla/0000-0003-0651-1816; ZINNI, MANUELA/0000-0001-8896-5090				ANGELUCCI L, 1983, ENDOCRINOL EXP, V17, P191; Barreau F, 2006, BRAIN BEHAV IMMUN, V20, P254, DOI 10.1016/j.bbi.2005.07.003; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; BIFULCO A, 1991, BRIT J PSYCHIAT, V159, P115, DOI 10.1192/bjp.159.1.115; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; BROWN GR, 1991, AM J PSYCHIAT, V148, P55; Casolini P, 1997, NEUROSCIENCE, V79, P1005, DOI 10.1016/S0306-4522(96)00668-9; Casolini P, 2007, J NEUROSCI, V27, P7041, DOI 10.1523/JNEUROSCI.1074-07.2007; Catalani A, 2000, NEUROSCIENCE, V100, P319, DOI 10.1016/S0306-4522(00)00277-3; Catalani A, 2011, NEUROSCI BIOBEHAV R, V35, P1502, DOI 10.1016/j.neubiorev.2010.10.017; Chang J, 2007, PEPTIDES, V28, P1453, DOI 10.1016/j.peptides.2007.05.008; Chen M, 2011, WORLD J GASTROENTERO, V17, P2933, DOI 10.3748/wjg.v17.i24.2933; Costalos C, 2003, EARLY HUM DEV, V74, P83, DOI 10.1016/S0378-3782(03)00087-2; Dermitzaki E, 2007, ENDOCRINOLOGY, V148, P1524, DOI 10.1210/en.2006-0967; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; Ergang P, 2008, DIGEST DIS SCI, V53, P2160, DOI 10.1007/s10620-007-0125-6; FABIA R, 1992, DIGESTION, V53, P35, DOI 10.1159/000200969; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Francis DD, 2002, J NEUROSCI, V22, P7840; Greenwood-van Meerveld B, 2005, NEUROGASTROENT MOTIL, V17, P415, DOI 10.1111/j.1365-2982.2005.00648.x; Hart A, 2002, ALIMENT PHARM THER, V16, P2017, DOI 10.1046/j.1365-2036.2002.01359.x; HENNING SJ, 1975, J BIOL CHEM, V250, P2073; Hutchinson KM, 2012, NEUROBIOL LEARN MEM, V97, P250, DOI 10.1016/j.nlm.2012.01.003; Im E, 2010, GASTROENTEROLOGY, V138, P2457, DOI 10.1053/j.gastro.2010.02.055; Kiank C, 2010, BRAIN BEHAV IMMUN, V24, P41, DOI 10.1016/j.bbi.2009.08.006; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Maillot C, 2000, GASTROENTEROLOGY, V119, P1569, DOI 10.1053/gast.2000.20251; MAKINO S, 1995, ENDOCRINOLOGY, V136, P4517, DOI 10.1210/en.136.10.4517; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meddings JB, 2000, GASTROENTEROLOGY, V119, P1019, DOI 10.1053/gast.2000.18152; Milde AM, 2004, PHYSIOL BEHAV, V81, P71, DOI 10.1016/j.physbeh.2004.01.002; Million M, 2003, BRAIN RES, V985, P32, DOI 10.1016/S0006-8993(03)03027-0; MORTEAU O, 1994, DIGEST DIS SCI, V39, P1239, DOI 10.1007/BF02093789; Moussaoui N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088382; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Pacha J, 2003, PEDIATR RES, V53, P808, DOI 10.1203/01.PDR.0000058923.08017.6F; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Ringel Y, 2001, SURG CLIN N AM, V81, P231, DOI 10.1016/S0039-6109(05)70283-8; Ringel Y, 2001, ANN REV MED; RUTTER M, 1979, CHILD DEV, V50, P283, DOI 10.2307/1129404; Rutter M, 1979, Ann Acad Med Singap, V8, P324; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; SMITH J, 1995, J AM ACAD CHILD PSY, V34, P168, DOI 10.1097/00004583-199502000-00012; Soderholm JD, 2002, AM J PHYSIOL-GASTR L, V283, pG1257, DOI 10.1152/ajpgi.00314.2002; Soderholm JD, 2002, GASTROENTEROLOGY, V123, P1099, DOI 10.1053/gast.2002.36019; Tache Y, 2004, NEUROGASTROENT MOTIL, V16, P137, DOI 10.1111/j.1743-3150.2004.00490.x; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; Teitelbaum AA, 2008, AM J PHYSIOL-GASTR L, V295, pG452, DOI 10.1152/ajpgi.90210.2008; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; vanTol EAF, 1996, GUT, V39, P385, DOI 10.1136/gut.39.3.385; WALLACE JL, 1992, GASTROENTEROLOGY, V102, P18, DOI 10.1016/0016-5085(92)91779-4; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; Yorty JL, 2004, AM J PHYSIOL-REG I, V287, pR1316, DOI 10.1152/ajpregu.00685.2003; Zhang Y, 2013, NEUROPSYCHOPHARMACOL, V38, P111, DOI 10.1038/npp.2012.149; Zheng G, 2013, NEUROGASTROENT MOTIL, V25, pE127, DOI 10.1111/nmo.12066	60	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113389	10.1371/journal.pone.0113389	http://dx.doi.org/10.1371/journal.pone.0113389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405993	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300113
J	Santos, F; Penaflor, MFGV; Pare, PW; Sanches, PA; Kamiya, AC; Tonelli, M; Nardi, C; Bento, JMS				Santos, Franciele; Penaflor, Maria Fernanda G. V.; Pare, Paul W.; Sanches, Patricia A.; Kamiya, Aline C.; Tonelli, Mateus; Nardi, Cristiane; Bento, Jose Mauricio S.			A Novel Interaction between Plant-Beneficial Rhizobacteria and Roots: Colonization Induces Corn Resistance against the Root Herbivore Diabrotica speciosa	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; SYSTEMIC RESISTANCE; CUCUMBER; CHRYSOMELIDAE; COLEOPTERA; INDUCTION; ACID	A number of soil-borne microorganisms, such as mycorrhizal fungi and rhizobacteria, establish mutualistic interactions with plants, which can indirectly affect other organisms. Knowledge of the plant-mediated effects of mutualistic microorganisms is limited to aboveground insects, whereas there is little understanding of what role beneficial soil bacteria may play in plant defense against root herbivory. Here, we establish that colonization by the beneficial rhizobacterium Azospirillum brasilense affects the host selection and performance of the insect Diabrotica speciosa. Root larvae preferentially orient toward the roots of non-inoculated plants versus inoculated roots and gain less weight when feeding on inoculated plants. As inoculation by A. brasilense induces higher emissions of (E)-beta-caryophyllene compared with non-inoculated plants, it is plausible that the non-preference of D. speciosa for inoculated plants is related to this sesquiterpene, which is well known to mediate belowground insect-plant interactions. To the best of our knowledge, this is the first study showing that a beneficial rhizobacterium inoculant indirectly alters belowground plant-insect interactions. The role of A. brasilense as part of an integrative pest management (IPM) program for the protection of corn against the South American corn rootworm, D. speciosa, is considered.	[Santos, Franciele; Penaflor, Maria Fernanda G. V.; Sanches, Patricia A.; Kamiya, Aline C.; Tonelli, Mateus; Bento, Jose Mauricio S.] Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Pare, Paul W.] Texas Tech Univ, Dept Chem, Lubbock, TX 79409 USA; [Pare, Paul W.] Texas Tech Univ, Dept Biol, Lubbock, TX 79409 USA; [Tonelli, Mateus; Nardi, Cristiane] Mid West State Univ, Dept Agron, Guarapuava, PR, Brazil	Universidade de Sao Paulo; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Bento, JMS (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	jmsbento@usp.br	Bento, José Maurício Simões/A-9759-2008; Peñaflor, Maria Fernanda G.V./F-7591-2013; Pare, Paul W/E-3055-2013; Sanches, Patricia/J-3035-2017	Bento, José Maurício Simões/0000-0001-8655-5178; Peñaflor, Maria Fernanda G.V./0000-0001-8240-8840; Pare, Paul W/0000-0003-1644-723X; Tonelli, Mateus/0000-0002-2324-8901; Nardi, Cristiane/0000-0003-4264-5379; Sanches, Patricia/0000-0002-9379-9303; Santos, Franciele/0000-0001-8099-4882	Instituto Nacional de Ciencia e Tecnologia (INCT) Semioquimicos na Agricultura; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57701-2, 2012/12252-1, 2013/11993-0]; Fulbright Scholar Program (U.S. Scholar)	Instituto Nacional de Ciencia e Tecnologia (INCT) Semioquimicos na Agricultura; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fulbright Scholar Program (U.S. Scholar)	This work was supported in part by the Instituto Nacional de Ciencia e Tecnologia (INCT) Semioquimicos na Agricultura, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP 2008/57701-2). MFGVP and PAS are funded by the Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP 2012/12252-1 and 2013/11993-0). PWP was funded by the Fulbright Scholar Program (U.S. Scholar 2013-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda L, 2013, APPL SOIL ECOL, V63, P15, DOI 10.1016/j.apsoil.2012.09.001; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; D'Alessandro M, 2014, PLANT CELL ENVIRON, V37, P813, DOI 10.1111/pce.12220; Dean JM, 2009, PLANT SOIL, V323, P187, DOI 10.1007/s11104-009-9924-1; Fontana A, 2009, J CHEM ECOL, V35, P833, DOI 10.1007/s10886-009-9654-0; Gange AC, 2003, ECOL LETT, V6, P1051, DOI 10.1046/j.1461-0248.2003.00540.x; GarciadeSalomone I, 1996, BIOL FERT SOILS, V21, P193, DOI 10.1007/BF00335934; Heath KD, 2011, ACTA OECOL, V37, P87, DOI 10.1016/j.actao.2010.12.002; Herschkovitz Y, 2005, ENVIRON MICROBIOL, V7, P1847, DOI 10.1111/j.1462-2920.2005.00926.x; HUANG BR, 1993, INT J PLANT SCI, V154, P425, DOI 10.1086/297125; Valenzuela-Soto JH, 2010, PLANTA, V231, P397, DOI 10.1007/s00425-009-1061-9; Hungria M, 2011, INOCULACAO COM AZOSP; Hungria M, 2010, PLANT SOIL, V331, P413, DOI 10.1007/s11104-009-0262-0; Kovats E, 1965, ADV CHROMATOGR, V1, P229; Kupferschmied P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00287; Milanez Jose M., 2000, Anais da Sociedade Entomologica do Brasil, V29, P23, DOI 10.1590/S0301-80592000000100003; Pineda A, 2012, PLANT BIOLOGY, V14, P83, DOI 10.1111/j.1438-8677.2011.00549.x; Pineda A, 2013, PLANT CELL ENVIRON, V36, P393, DOI 10.1111/j.1365-3040.2012.02581.x; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Ramamoorthy V, 2001, CROP PROT, V20, P1, DOI 10.1016/S0261-2194(00)00056-9; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Robert CAM, 2012, FUNCT ECOL, V26, P1429, DOI 10.1111/j.1365-2435.2012.02030.x; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Sabulal B, 2006, PHYTOCHEMISTRY, V67, P2469, DOI 10.1016/j.phytochem.2006.08.003; ULUBELEN A, 1994, PHYTOCHEMISTRY, V36, P971, DOI 10.1016/S0031-9422(00)90474-6; Van Oosten VR, 2008, MOL PLANT MICROBE IN, V21, P919, DOI 10.1094/MPMI-21-7-0919; Ventura Mauricio U., 2001, Neotropical Entomology, V30, P361, DOI 10.1590/S1519-566X2001000300003; Walker V, 2011, NEW PHYTOL, V189, P494, DOI 10.1111/j.1469-8137.2010.03484.x; Walsh GC, 2003, ENVIRON ENTOMOL, V32, P276, DOI 10.1603/0046-225X-32.2.276; Zehnder G, 1997, J ECON ENTOMOL, V90, P391, DOI 10.1093/jee/90.2.391; Zehnder G, 1997, ENTOMOL EXP APPL, V83, P81, DOI 10.1023/A:1002907604294	31	24	24	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113280	10.1371/journal.pone.0113280	http://dx.doi.org/10.1371/journal.pone.0113280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405495	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300095
J	Coloccini, RS; Dilernia, D; Ghiglione, Y; Turk, G; Laufer, N; Rubio, A; Socias, ME; Figueroa, MI; Sued, O; Cahn, P; Salomon, H; Mangano, A; Pando, MA				Soledad Coloccini, Romina; Dilernia, Dario; Ghiglione, Yanina; Turk, Gabriela; Laufer, Natalia; Rubio, Andrea; Eugenia Socias, Maria; Ines Figueroa, Maria; Sued, Omar; Cahn, Pedro; Salomon, Horacio; Mangano, Andrea; Angeles Pando, Maria			Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HLA CLASS-I; ANTIGEN CLASS-I; TYPE-1 INFECTION; NATURAL-HISTORY; RNA LEVELS; CCR5; ALLELES; VIREMIA; AIDS	Background: Variants in HIV-coreceptor C-C chemokine receptor type 5 (CCR5) and Human leukocyte antigen (HLA) genes are the most important host genetic factors associated with HIV infection and disease progression. Our aim was to analyze the association of these genetic factors in the presence of clinical symptoms during Primary HIV Infection (PHI) and disease progression within the first year. Methods: Seventy subjects diagnosed during PHI were studied (55 symptomatic and 15 asymptomatic). Viral load (VL) and CD4 T-cell count were evaluated. HIV progression was defined by presence of B or C events and/or CD4 T-cell counts, 350 cell/mm(3). CCR5 haplotypes were characterized by polymerase chain reaction and SDM-PCR-RFLP. HLA-I characterization was performed by Sequencing. Results: Symptoms during PHI were significantly associated with lower frequency of CCR5-CF1 (1.8% vs. 26.7%, p = 0.006). Rapid progression was significantly associated with higher frequency of CCR5-CF2 (16.7% vs. 0%, p = 0.024) and HLA-A*11 (16.7% vs. 1.2%, p = 0.003) and lower frequency of HLA-C*3 (2.8% vs. 17.5%, p = 0.035). Higher baseline VL was significantly associated with presence of HLA-A*11, HLA-A*24, and absence of HLA-A*31 and HLA-B*57. Higher 6-month VL was significantly associated with presence of CCR5-HHE, HLA-A*24, HLA-B*53, and absence of HLA-A*31 and CCR5-CF1. Lower baseline CD4 T-cell count was significantly associated with presence of HLA-A*24/*33, HLA-B*53, CCR5-CF2 and absence of HLA-A*01/*23 and CCR5-HHA. Lower 6-month CD4 T-cell count was associated with presence of HLA-A*24 and HLA-B*53, and absence of HLA-A*01 and HLA-B*07/*39. Moreover, lower 12-month CD4 T-cell count was significantly associated with presence of HLA-A*33, HLA-B*14, HLA-C*08, CCR5-CF2, and absence of HLA-B*07 and HLA-C*07. Conclusion: Several host factors were significantly associated with disease progression in PHI subjects. Most results agree with previous studies performed in other groups. However, some genetic factor associations are being described for the first time, highlighting the importance of genetic studies at a local level.	[Soledad Coloccini, Romina; Dilernia, Dario; Ghiglione, Yanina; Turk, Gabriela; Laufer, Natalia; Rubio, Andrea; Salomon, Horacio; Angeles Pando, Maria] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina; [Laufer, Natalia; Eugenia Socias, Maria; Ines Figueroa, Maria; Sued, Omar; Cahn, Pedro] Hosp Juan A Fernandez, Buenos Aires, DF, Argentina; [Eugenia Socias, Maria; Ines Figueroa, Maria; Sued, Omar; Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Mangano, Andrea] Hosp Pediat Prof Dr Juan P Garrahan, CONICET, Lab Biol Celular & Retrovirus, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital de Pediatria Doctor Juan Garrahan	Pando, MA (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina.	mpando@fmed.uba.ar	Laufer, Natalia/AAB-7472-2022; Sued, Omar/H-3325-2019	Laufer, Natalia/0000-0002-5690-9454; Sued, Omar/0000-0001-5818-770X	Agencia Nacional de Promocion Cientifica y Tecnologica [2008-0559]; Fundacion Florencio Fiorini; UBACYT; CONICET (PIP)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Florencio Fiorini; UBACYT; CONICET (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was funded by grants from: Agencia Nacional de Promocion Cientifica y Tecnologica (grant number 2008-0559), "Fundacion Florencio Fiorini" (period: 2009-2010), UBACYT (period: 2010-2012) and CONICET (PIP 2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2013, BOLETIN; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buchacz K, 2004, JAIDS-J ACQ IMM DEF, V36, P853, DOI 10.1097/00126334-200407010-00013; Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; de Sorrentino AH, 2000, J INFECT DIS, V182, P1523, DOI 10.1086/315854; Douek Daniel, 2007, Top HIV Med, V15, P114; Dun PPJ, 2001, SEQUENCING BASED TYP, P1; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Hightow-Weidman LB, 2009, AIDS BEHAV, V13, P1075, DOI 10.1007/s10461-008-9519-5; Huang X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-201; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hurley CK, 2007, HUM IMMUNOL, V68, P30, DOI 10.1016/j.humimm.2006.09.004; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li LN, 2005, IMMUNOGENETICS, V57, P315, DOI 10.1007/s00251-005-0801-7; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Magierowska M, 1999, BLOOD, V93, P936, DOI 10.1182/blood.V93.3.936.403k08_936_941; Mangano A, 2000, J ACQ IMMUN DEF SYND, V23, P52; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Marmor M, 2006, J URBAN HEALTH, V83, P5, DOI 10.1007/s11524-005-9003-8; McGovern RA, 2010, JOVE-J VIS EXP, V46, P2531; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mummidi S, 1997, J BIOL CHEM, V272, P30662, DOI 10.1074/jbc.272.49.30662; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Naruto T, 2012, J VIROL, V86, P10870, DOI 10.1128/JVI.00689-12; Nguyen L, 2004, JAIDS-J ACQ IMM DEF, V37, P1318, DOI 10.1097/01.qai.0000127059.98621.55; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Prentice HA, 2014, VIROLOGY, V449, P254, DOI 10.1016/j.virol.2013.11.024; Richey LE, 2013, AM J MED SCI, V345, P136, DOI 10.1097/MAJ.0b013e31825d4b88; Rocco CA, 2003, AIDS RES HUM RETROV, V19, P943, DOI 10.1089/088922203322588288; Salamon R, 2002, J ACQ IMMUN DEF SYND, V29, P149, DOI 10.1097/00042560-200202010-00007; Smith Miranda Z, 2005, Sex Health, V2, P53, DOI 10.1071/SH04057; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Socias ME, 2011, J INT AIDS SOC, P14; Tang J, 1999, GENES IMMUN, V1, P20, DOI 10.1038/sj.gene.6363640; Tang JM, 2002, J VIROL, V76, P662, DOI 10.1128/JVI.76.2.662-672.2002; Telenti A, 2006, NAT REV MICROBIOL, V4, P865, DOI 10.1038/nrmicro1532; Telenti A, 2006, FUTURE VIROL, V1, P55, DOI 10.2217/17460794.1.1.55; Tincati C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/935425	57	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113146	10.1371/journal.pone.0113146	http://dx.doi.org/10.1371/journal.pone.0113146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406087	Green Published, gold			2022-12-26	WOS:000347121300086
J	Xu, EK; Fan, GQ; Niu, SY; Zhao, ZL; Deng, MJ; Dong, YP				Xu, Enkai; Fan, Guoqiang; Niu, Suyan; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng			Transcriptome-Wide Profiling and Expression Analysis of Diploid and Autotetraploid Paulownia tomentosa x Paulownia fortunei under Drought Stress	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; GENE-EXPRESSION; PROTEIN-KINASES; PROLINE BIOSYNTHESIS; SUPEROXIDE-DISMUTASE; SIGNAL-TRANSDUCTION; LIPID-PEROXIDATION; STOMATAL CLOSURE; LEAF SENESCENCE; PLANT-GROWTH	Paulownia is a fast-growing deciduous hardwood species native to China, which has high ecological and economic value. In an earlier study, we reported ploidy-dependent differences in Paulownia drought tolerance by the microscopic observations of the leaves. Autotetraploid Paulownia has a higher resistance to drought stress than their diploid relatives. In order to obtain genetic information on molecular mechanisms responses of Paulownia plants to drought, Illumina/Solexa Genome sequencing platform was used to de novo assemble the transcriptomes of leaves from diploid and autotetraploid Paulownia tomentosa x Paulownia fortunei seedlings (PTF2 and PTF4 respectively) grown under control conditions and under drought stress and obtained 98,671 nonredundant unigenes. A comparative transcriptome analysis revealed that hundreds of unigenes were predicted to be involved mainly in ROS-scavenging system, amino acid and carbohydrate metabolism, plant hormone biosynthesis and signal transduction, while these unigenes exhibited differential transcript alteration of the two accessions. This study provides a comprehensive map of how P. tomentosa x P. fortunei responds to drought stress at physiological and molecular levels, which may help in understanding the mechanisms involve in water-deficit response and will be useful for further study of drought tolerance in woody plants.	[Xu, Enkai; Fan, Guoqiang; Niu, Suyan; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng] Henan Agr Univ, Inst Paulownia, Jinshui Area, Zhengzhou, Henan, Peoples R China; [Xu, Enkai; Fan, Guoqiang; Niu, Suyan; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng] Henan Agr Univ, Coll Forestry, Jinshui Area, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Jinshui Area, Zhengzhou, Henan, Peoples R China.	zlxx64@126.com			National Natural Science Foundation of China [30271082, 30571496, U1204309]; Outstanding Talents Project of Henan Province [122101110700]; Transformation Project of the National Agricultural Scientific and Technological Achievement of China [2012GB2D000271]; Science and Technology Innovation Team Project of Zhengzhou City [121PCXTD515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Talents Project of Henan Province; Transformation Project of the National Agricultural Scientific and Technological Achievement of China; Science and Technology Innovation Team Project of Zhengzhou City	This work was supported by GQF, National Natural Science Foundation of China (Grant no. 30271082, 30571496, U1204309, http://www.nsfc.gov.cn/), GQF, Outstanding Talents Project of Henan Province (Grant no. 122101110700), GQF, Transformation Project of the National Agricultural Scientific and Technological Achievement of China (Grant no. 2012GB2D000271), and GQF, Science and Technology Innovation Team Project of Zhengzhou City (Grant no. 121PCXTD515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; [Anonymous], 1997, ACTA GENET SIN; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baloglu MC, 2012, PLANT MOL BIOL REP, V30, P1246, DOI 10.1007/s11105-012-0445-3; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benjamini Y, 2001, ANN STAT, V29, P1165; Bertauche N, 1996, EUR J BIOCHEM, V241, P193, DOI 10.1111/j.1432-1033.1996.0193t.x; Bohnert HJ, 2001, PLANT PHYSIOL BIOCH, V39, P295, DOI 10.1016/S0981-9428(00)01237-7; Bojovic BM., 2005, ARCH BIOL SCI, V57, P283, DOI [10.2298/ABS0504283B, DOI 10.2298/ABS0504283B]; BOWLER C, 1991, EMBO J, V10, P1723, DOI 10.1002/j.1460-2075.1991.tb07696.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JH, 2013, PLANT MOL BIOL REP, V31, P946, DOI 10.1007/s11105-013-0563-6; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Cho EK, 2006, PLANT CELL REP, V25, P349, DOI 10.1007/s00299-005-0093-2; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CSONKA LN, 1988, GENE, V64, P199, DOI 10.1016/0378-1119(88)90335-6; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; DWIVEDI NK, 1989, CYTOLOGIA, V54, P13, DOI 10.1508/cytologia.54.13; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; Fan GuoQiang, 2010, Journal of Northeast Forestry University, V38, P22; Fock I, 2000, PLANT SCI, V160, P165, DOI 10.1016/S0168-9452(00)00375-7; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GUY C, 1992, PLANTA, V188, P265, DOI 10.1007/BF00216823; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Hall T, 2008, TREES LIFE J, V3, P3; Hamdy A, 2003, IRRIG DRAIN, V52, P3, DOI 10.1002/ird.73; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hu XJ, 2010, BIOL PLANTARUM, V54, P213, DOI 10.1007/s10535-010-0039-6; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Ipekci Z, 2003, PLANT CELL REP, V22, P16, DOI 10.1007/s00299-003-0650-5; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P36, DOI 10.1007/s10142-005-0142-5; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Muoma J, 2011, BIOTECHNOLOGY, V10, P469; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nadarajah Kalaivani, 2010, Asian Journal of Plant Sciences, V9, P1; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Oliver MJ, 2010, METHODS MOL BIOL, V639, P3, DOI 10.1007/978-1-60761-702-0_1; Peng SM, 2012, TREE PHYSIOL, V32, P1541, DOI 10.1093/treephys/tps110; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Riddle NC, 2010, THEOR APPL GENET, V120, P341, DOI 10.1007/s00122-009-1113-3; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2004, TRANSCRIPTOME ANAL A, P271; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SnedecorGW WG C, 1980, STAT METHODS, P507; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; Sugano S, 2003, PLANT J, V36, P830, DOI 10.1046/j.1365-313X.2003.01924.x; SUN Y, 1988, CLIN CHEM, V34, P497; Tang S, 2013, PLANT MOL BIOL, V83, P539, DOI 10.1007/s11103-013-0107-3; Tardieu F, 2010, CURR OPIN PLANT BIOL, V13, P206, DOI 10.1016/j.pbi.2009.12.012; Thompson AJ, 2007, PLANT CELL ENVIRON, V30, P67, DOI 10.1111/j.1365-3040.2006.01606.x; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Vandenbussche F, 2010, DEVELOPMENT, V137, P597, DOI 10.1242/dev.040790; Verma DPS, 1999, BIOTECHNOL INTELL UN, P153; Wan BL, 2007, FEBS LETT, V581, P1179, DOI 10.1016/j.febslet.2007.02.030; Wang W, 2000, BIOTECHNOLOGY PLANT, P285; Wang Y, 2005, PLANT J, V43, P413, DOI 10.1111/j.1365-313X.2005.02463.x; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Watkinson JI, 2003, PLANT PHYSIOL, V133, P1702, DOI 10.1104/pp.103.026914; Wilkins O, 2009, PLANT J, V60, P703, DOI 10.1111/j.1365-313X.2009.03993.x; Wittenmyer L, 2005, J PLANT NUTR SOIL SC, V168, P531, DOI 10.1002/jpln.200520507; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Woo HR, 2004, PLANT CELL PHYSIOL, V45, P923, DOI 10.1093/pcp/pch110; Yan DH, 2012, PLANT SCI, V195, P24, DOI 10.1016/j.plantsci.2012.06.005; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhang JZ, 2003, CURR OPIN PLANT BIOL, V6, P430, DOI 10.1016/S1369-5266(03)00081-5; Zhang X.S., 2013, J HENAN AGR U, V46, P646; Zhang XY, 2010, J PLANT PHYSIOL, V167, P88, DOI 10.1016/j.jplph.2009.07.006; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu Z.-H., 1986, PAULOWNIA CHINA CULT; Zhu ZhiTi, 1997, Journal of Beijing Forestry University, English edition, V6, P1	113	18	24	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113313	10.1371/journal.pone.0113313	http://dx.doi.org/10.1371/journal.pone.0113313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405758	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300104
J	Ahmed, B; Nanji, K; Mujeeb, R; Patel, MJ				Ahmed, Bilal; Nanji, Kashmira; Mujeeb, Rakshinda; Patel, Muhammad Junaid			Effects of Polypharmacy on Adverse Drug Reactions among Geriatric Outpatients at a Tertiary Care Hospital in Karachi: A Prospective Cohort Study	PLOS ONE			English	Article							ELDERLY-PATIENTS; EVENTS	Background: Adverse drug reactions (ADRs) present a challenging and expensive public health problem. Polypharmacy is defined according to the WHO criteria as the, "concurrent use of five or more different prescription medication''. Elderly are more prone to adverse reactions due to comorbid conditions, longer lists of medications and sensitivity to drug effects. The aim of the study is to estimate the incidence and strength of association of ADRs due to polypharmacy among the geriatric cohort attending outpatient clinics at a tertiary care center. Methods: A hospital based prospective cohort study was conducted at ambulatory care clinics of Aga Khan University Hospital April 2012 to March 2013. One thousand geriatrics patients (age >= 65 years) visiting ambulatory clinics were identified. They were divided on the basis of exposure (polypharmacy vs. no polypharmacy). We followed them from the time of their enrollment (day zero) to six weeks, checking up on them once a week. Incidence was calculated and Cox Proportional Hazard Model estimates were used. Results: The final analysis was performed on 1000 elderly patients. The occurrence of polypharmacy was 70% and the incidence of ADRs was 10.5% among the study cohort. The majority (30%) of patients were unable to read or write. The use of herbal medicine was reported by 3.2% of the patients and homeopathic by 3%. Our Cox adjusted model shows that polypharmacy was 2.3 times more associated with ADRs, con-current complementary and alternative medicine (CAM) was 7.4 times and those who cannot read and write were 1.5 times more associated with ADRs. Conclusion: The incidence of ADRs due to poly pharmacy is alarmingly high. The factors associated with ADRs are modifiable. Policies are needed to design and strengthen the prescription pattern.	[Ahmed, Bilal; Mujeeb, Rakshinda; Patel, Muhammad Junaid] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Nanji, Kashmira] Aga Khan Univ, Dept Family Med, Karachi, Pakistan	Aga Khan University; Aga Khan University	Patel, MJ (corresponding author), Aga Khan Univ, Dept Med, Karachi, Pakistan.	junaiddrpatel@gmail.com			University Research Council, Aga Khan University URC [102013MED]	University Research Council, Aga Khan University URC	This work was supported by the University Research Council, Aga Khan University URC ID 102013MED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Chumney Elinor C., 2006, Pharmacy Pract (Granada), V4, P103, DOI 10.4321/s1885-642x2006000300001; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Ernst E, 2000, BMJ-BRIT MED J, V321, P1133, DOI 10.1136/bmj.321.7269.1133; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Haider SI, 2007, INT J CLIN PHARM TH, V45, P643; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Herman Patricia M, 2005, BMC Complement Altern Med, V5, P11, DOI 10.1186/1472-6882-5-11; Hilmer SN, 2008, AUST PRESCR, V31, P2, DOI 10.18773/austprescr.2008.001; Hohl CM, 2001, ANN EMERG MED, V38, P666, DOI 10.1067/mem.2001.119456; Lam DPY, 2010, J AM GERIATR SOC, V58, P203, DOI 10.1111/j.1532-5415.2009.02656.x; Najjar MF, 2010, HEALTHMED, V4; Nguyen Julia K, 2006, Am J Geriatr Pharmacother, V4, P36, DOI 10.1016/j.amjopharm.2006.03.002; Nobili A, 2011, EUR J CLIN PHARMACOL, V67, P507, DOI 10.1007/s00228-010-0977-0; Population Division Department of Economic and Social Affairs United Nations, 2013, WORLD POP AG 2013; Sabzwari SR, 2013, J PAK MED ASSOC, V63, P624; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; Trumic Edisa, 2012, Mater Sociomed, V24, P68, DOI 10.5455/msm.2012.24.68-72; Viktil KK, 2007, BRIT J CLIN PHARMACO, V63, P187, DOI 10.1111/j.1365-2125.2006.02744.x; WORLD HEALTH ORGANIZATION, 2009, DENGUE: GUIDELINES FOR DIAGNOSIS, TREATMENT, PREVENTION AND CONTROL, P3	23	58	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112133	10.1371/journal.pone.0112133	http://dx.doi.org/10.1371/journal.pone.0112133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402452	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700029
J	Suzuki, G; Weil, BR; Leiker, MM; Ribbeck, AE; Young, RF; Cimato, TR; Canty, JM				Suzuki, Gen; Weil, Brian R.; Leiker, Merced M.; Ribbeck, Amanda E.; Young, Rebeccah F.; Cimato, Thomas R.; Canty, John M., Jr.			Global Intracoronary Infusion of Allogeneic Cardiosphere-Derived Cells Improves Ventricular Function and Stimulates Endogenous Myocyte Regeneration throughout the Heart in Swine with Hibernating Myocardium	PLOS ONE			English	Article							CARDIAC STEM-CELLS; MARROW PROGENITOR CELLS; ISCHEMIC CARDIOMYOPATHY; PORCINE MODEL; THERAPY; PIGS; HYPERTROPHY; EFFICACY; VALIDATION; INFARCTION	Background: Cardiosphere-derived cells (CDCs) improve ventricular function and reduce fibrotic volume when administered via an infarct-related artery using the "stop-flow'' technique. Unfortunately, myocyte loss and dysfunction occur globally in many patients with ischemic and non-ischemic cardiomyopathy, necessitating an approach to distribute CDCs throughout the entire heart. We therefore determined whether global intracoronary infusion of CDCs under continuous flow improves contractile function and stimulates new myocyte formation. Methods and Results: Swine with hibernating myocardium from a chronic LAD occlusion were studied 3-months after instrumentation (n = 25). CDCs isolated from myocardial biopsies were infused into each major coronary artery (similar to 33x10(6) icCDCs). Global icCDC infusion was safe and while similar to 3% of injected CDCs were retained, they did not affect ventricular function or myocyte proliferation in normal animals. In contrast, four-weeks after icCDCs were administered to animals with hibernating myocardium, %LADWT increased from 23 +/- 6 to 51 +/- 5% (p<0.01). In diseased hearts, myocyte proliferation (phospho-histone-H3) increased in hibernating and remote regions with a concomitant increase in myocyte nuclear density. These effects were accompanied by reductions in myocyte diameter consistent with new myocyte formation. Only rare myocytes arose from sex-mismatched donor CDCs. Conclusions: Global icCDC infusion under continuous flow is feasible and improves contractile function, regresses myocyte cellular hypertrophy and increases myocyte proliferation in diseased but not normal hearts. New myocytes arising via differentiation of injected cells are rare, implicating stimulation of endogenous myocyte regeneration as the primary mechanism of repair.	[Canty, John M., Jr.] Vet Affairs Western New York Hlth Care Syst, Div Cardiovasc Med, Buffalo, NY 14215 USA; [Suzuki, Gen; Weil, Brian R.; Leiker, Merced M.; Ribbeck, Amanda E.; Young, Rebeccah F.; Cimato, Thomas R.; Canty, John M., Jr.] SUNY Buffalo, Dept Med, Div Cardiovasc Med, Buffalo, NY 14260 USA; [Canty, John M., Jr.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Canty, John M., Jr.] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Suzuki, Gen; Weil, Brian R.; Leiker, Merced M.; Ribbeck, Amanda E.; Young, Rebeccah F.; Cimato, Thomas R.; Canty, John M., Jr.] SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Canty, JM (corresponding author), Vet Affairs Western New York Hlth Care Syst, Div Cardiovasc Med, Buffalo, NY 14215 USA.	canty@buffalo.edu	Canty, John M/C-5349-2009	Cimato, Thomas/0000-0001-9230-4463	NIH [HL55324, HL61610, F32 HL114335]; American Heart Association [SDG3990004]; New York State Department of Health NYSTEM [CO24351]; Albert and Elizabeth Rekate Fund in Cardiovascular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL114335, R01HL055324, R01HL061610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); New York State Department of Health NYSTEM; Albert and Elizabeth Rekate Fund in Cardiovascular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH HL55324, HL61610, F32 HL114335, American Heart Association SDG3990004, New York State Department of Health NYSTEM CO24351, and the Albert and Elizabeth Rekate Fund in Cardiovascular Medicine. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2012, HEART FAIL CLIN, V8, P79, DOI 10.1016/j.hfc.2011.08.010; BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Bruel A, 2005, BASIC RES CARDIOL, V100, P311, DOI 10.1007/s00395-005-0524-9; Canty JM, 2004, CIRC RES, V94, P1142, DOI 10.1161/01.RES.0000125628.57672.CF; Cheng K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001260; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Fallavollita JA, 1997, CIRCULATION, V95, P1900; Fallavollita JA, 2001, J AM COLL CARDIOL, V37, P1989, DOI 10.1016/S0735-1097(01)01250-5; Fallavollita JA, 2014, J AM COLL CARDIOL, V63, P141, DOI 10.1016/j.jacc.2013.07.096; Gago-Lopez N, 2014, STEM CELL REP, V2, P576, DOI 10.1016/j.stemcr.2014.03.003; GLENNY RW, 1993, J APPL PHYSIOL, V74, P2585, DOI 10.1152/jappl.1993.74.5.2585; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Leiker M, 2008, CELL TRANSPLANT, V17, P911, DOI 10.3727/096368908786576444; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Lim HJ, 1999, CIRCULATION, V100, P2380, DOI 10.1161/01.CIR.100.23.2380; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2013, CIRCULATION, V128, P2764, DOI 10.1161/CIRCULATIONAHA.113.002863; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Malm BJ, 2002, CARDIOVASC RES, V56, P422, DOI 10.1016/S0008-6363(02)00599-0; Marban E, 2010, CIRCULATION, V121, P1981, DOI 10.1161/CIRCULATIONAHA.110.952580; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Simpson DL, 2012, CIRCULATION, V126, pS46, DOI 10.1161/CIRCULATIONAHA.111.084699; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; SPINALE FG, 1991, CIRC RES, V69, P1058, DOI 10.1161/01.RES.69.4.1058; Suzuki G, 2005, CIRC RES, V96, P767, DOI 10.1161/01.RES.0000162099.01268.d1; Suzuki G, 2011, CIRC RES, V109, P1044, DOI 10.1161/CIRCRESAHA.111.245969; Suzuki G, 2009, CIRC RES, V104, P255, DOI 10.1161/CIRCRESAHA.108.188730; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Xie YC, 2014, STEM CELLS, V32, P2397, DOI 10.1002/stem.1736; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894	42	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113009	10.1371/journal.pone.0113009	http://dx.doi.org/10.1371/journal.pone.0113009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402428	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700093
J	Wang, HW; Wang, FQ; Wang, W; Yao, XL; Wei, DZ; Cheng, HR; Deng, ZX				Wang, Hengwei; Wang, Fengqing; Wang, Wei; Yao, Xueling; Wei, Dongzhi; Cheng, Hairong; Deng, Zixin			Improving the Expression of Recombinant Proteins in E. coli BL21 (DE3) under Acetate Stress: An Alkaline pH Shift Approach	PLOS ONE			English	Article							INDEPENDENT METHIONINE SYNTHASE; HIGH-CELL-DENSITY; ESCHERICHIA-COLI; ACETIC-ACID; INTRACELLULAR PH; GROWTH; ACCUMULATION; INHIBITION; HOMOSERINE; TOLERANCE	Excess acetate has long been an issue for the production of recombinant proteins in E. coli cells. Recently, improvements in acetate tolerance have been achieved through the use of genetic strategies and medium supplementation with certain amino acids and pyrimidines. The aim of our study was to evaluate an alternative to improve the acetate tolerance of E. coli BL21 (DE3), a popular strain used to express recombinant proteins. In this work we reported the cultivation of BL21 (DE3) in complex media containing acetate at high concentrations. In the presence of 300 mM acetate, compared with pH 6.5, pH 7.5 improved cell growth by approximately 71%, reduced intracellular acetate by approximately 50%, and restored the expression of glutathione S-transferase (GST), green fluorescent protein (GFP) and cytochrome P450 monooxygenase (CYP). Further experiments showed that alkaline pHs up to 8.5 had little inhibition in the expression of GST, GFP and CYP. In addition, the detrimental effect of acetate on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) by the cell membrane, an index of cellular metabolic capacity, was substantially alleviated by a shift to alkaline pH values of 7.5-8.0. Thus, we suggest an approach of cultivating E. coli BL21 (DE3) at pH 8.0 +/- 0.5 to minimize the effects caused by acetate stress. The proposed strategy of an alkaline pH shift is a simple approach to solving similar bioprocessing problems in the production of biofuels and biochemicals from sugars.	[Wang, Hengwei] Zhejiang Ocean Univ, IAI, Zhoushan, Peoples R China; [Wang, Hengwei; Cheng, Hairong; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Wang, Fengqing; Wang, Wei; Yao, Xueling; Wei, Dongzhi] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, New World Inst Biotechnol, Shanghai 200237, Peoples R China	Zhejiang Ocean University; Shanghai Jiao Tong University; East China University of Science & Technology	Cheng, HR (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	chrqrq@sjtu.edu.cn	Wei, Dongzhi/AAJ-3404-2021; Wang, Hengwei/AAZ-5205-2021		National Basic Research Program of China [2013CB733903]; Scientific Research Foundation (SRF), Zhejiang Ocean University	National Basic Research Program of China(National Basic Research Program of China); Scientific Research Foundation (SRF), Zhejiang Ocean University	This project is supported by the National Basic Research Program of China (No. 2013CB733903) and Scientific Research Foundation (SRF), Zhejiang Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2001, BIOTECHNOL BIOENG, V73, P223, DOI 10.1002/bit.1054; AXE DD, 1995, BIOTECHNOL BIOENG, V47, P8, DOI 10.1002/bit.260470103; Born TL, 1999, BIOCHEMISTRY-US, V38, P14416, DOI 10.1021/bi991710o; Chong HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077422; De Mey M, 2007, J IND MICROBIOL BIOT, V34, P689, DOI 10.1007/s10295-007-0244-2; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; HAN K, 1993, BIOTECHNOL BIOENG, V41, P316, DOI 10.1002/bit.260410305; Handke P, 2011, METAB ENG, V13, P28, DOI 10.1016/j.ymben.2010.10.007; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Huffer S, 2012, TRENDS BIOTECHNOL, V30, P538, DOI 10.1016/j.tibtech.2012.07.002; JENSEN EB, 1990, BIOTECHNOL BIOENG, V36, P1, DOI 10.1002/bit.260360102; KO YF, 1995, APPL BIOCHEM BIOTECH, V50, P145, DOI 10.1007/BF02783451; Kruse A, 2003, IND ENG CHEM RES, V42, P267, DOI 10.1021/ie0202773; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lara AR, 2008, BIOTECHNOL BIOENG, V99, P893, DOI 10.1002/bit.21664; Liu TG, 2010, ANNU REV GENET, V44, P53, DOI 10.1146/annurev-genet-102209-163440; Ma XY, 2006, PROTEIN EXPRES PURIF, V47, P36, DOI 10.1016/j.pep.2005.09.012; Mordukhova EA, 2013, APPL ENVIRON MICROB, V79, P7905, DOI 10.1128/AEM.01952-13; Mordukhova EA, 2008, APPL ENVIRON MICROB, V74, P7660, DOI 10.1128/AEM.00654-08; Nakano K, 1997, APPL MICROBIOL BIOT, V48, P597, DOI 10.1007/s002530051101; Roe AJ, 1998, J BACTERIOL, V180, P767, DOI 10.1128/JB.180.4.767-772.1998; Roe AJ, 2002, MICROBIOL-SGM, V148, P2215, DOI 10.1099/00221287-148-7-2215; RUSSELL JB, 1991, APPL ENVIRON MICROB, V57, P3383, DOI 10.1128/AEM.57.11.3383-3384.1991; RUSSELL JB, 1991, APPL ENVIRON MICROB, V57, P255, DOI 10.1128/AEM.57.1.255-259.1991; RUSSELL JB, 1992, J APPL BACTERIOL, V73, P363, DOI 10.1111/j.1365-2672.1992.tb04990.x; Sandoval NR, 2011, METAB ENG, V13, P214, DOI 10.1016/j.ymben.2010.12.001; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; SLONCZEWSKI JL, 1982, J BACTERIOL, V152, P384; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; Wang HW, 2012, ANAL BIOCHEM, V421, P324, DOI 10.1016/j.ab.2011.10.043; Wang HW, 2011, J MICROBIOL METH, V84, P140, DOI 10.1016/j.mimet.2010.11.005; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Wang HW, 2009, APPL MICROBIOL BIOT, V82, P249, DOI 10.1007/s00253-008-1756-z; Warnecke T, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-25; Wong MS, 2008, METAB ENG, V10, P97, DOI 10.1016/j.ymben.2007.10.003; Ziegler K, 2007, BIOCHEMISTRY-US, V46, P2674, DOI 10.1021/bi0620252	42	9	11	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112777	10.1371/journal.pone.0112777	http://dx.doi.org/10.1371/journal.pone.0112777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402470	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700070
J	Hou, YY; Cheng, BF; Zhou, MG; Fang, RP; Jiang, M; Hou, WB; Bai, G				Hou, Yuanyuan; Cheng, Binfeng; Zhou, Mengge; Fang, Runping; Jiang, Min; Hou, Wenbin; Bai, Gang			Searching for Synergistic Bronchodilators and Novel Therapeutic Regimens for Chronic Lung Diseases from a Traditional Chinese Medicine, Qingfei Xiaoyan Wan	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; KAPPA-B INHIBITORS; OBSTRUCTIVE PULMONARY-DISEASE; BIOACTIVE COMPOUNDS; ALKALOIDAL EXTRACT; IDENTIFICATION; ARCTIGENIN; MECHANISMS; AGONISTS; ARCTIIN	Classical Chinese pharmacopeias describe numerous excellent herbal formulations, and each prescription is an outstanding pool of effective compounds for drug discovery. Clarifying the bioactivity of the combined mechanisms of the ingredients in complex traditional Chinese medicine formulas is challenging. A classical formula known as Qingfei Xiaoyan Wan, used clinically as a treatment for prevalent chronic lung disease, was investigated in this work. A mutually enhanced bioactivity-guided ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF-MS) characterization system was proposed, coupled with a dual-luciferase reporter assay for beta(2)AR-agonist cofactor screening. Arctiin, arctigenin, descurainoside and descurainolide B, four lignin compounds that showed synergistic bronchodilation effects with ephedrine, were revealed. The synergistic mechanism of arctigenin with the beta(2)ARagonist involved with the reduction of free Ca2+ was clarified by a dual-luciferase reporter assay for intracellular calcium and the Ca2+ indicator fluo-4/AM to monitor changes in the fluorescence. The relaxant and contractile responses of airway smooth muscle are regulated by crosstalk between the intracellular cAMP and calcium signaling pathways. Our data indicated the non-selective beta AR agonist ephedrine as the principal bronchodilator of the formula, whereas the lignin ingredients served as adjuvant ingredients. A greater understanding of the mechanisms governing the control of these pathways, based on conventional wisdom, could lead to the identification of novel therapeutic targets or new agents for the treatment of asthma and COPD.	[Hou, Yuanyuan; Cheng, Binfeng; Zhou, Mengge; Fang, Runping; Jiang, Min; Bai, Gang] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Hou, Yuanyuan; Cheng, Binfeng; Zhou, Mengge; Fang, Runping; Jiang, Min; Bai, Gang] Nankai Univ, Coll Pharm, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Hou, Wenbin] Tianjin Inst Pharmaceut Res, Tianjin Engn Lab Qual Control Techn TCM, Tianjin, Peoples R China	Nankai University; Nankai University	Bai, G (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	gangbai@nankai.edu.cn	Jiang, Min/HGT-8781-2022; Fang, Runping/AAF-6835-2020		National Natural Science Foundation of China [81173638, 81373506]; Specialized Research Fund for the Doctor Program of Higher Education of China [20120031110042]; Key Program of Natural Science of Foundation of Tianjin, China [13JCZDJC31400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctor Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Program of Natural Science of Foundation of Tianjin, China	This work was supported by a Grant from the National Natural Science Foundation of China (grant no: 81173638 and 81373506), the Specialized Research Fund for the Doctor Program of Higher Education of China (grant no: 20120031110042) and the Key Program of Natural Science of Foundation of Tianjin, China (grant no: 13JCZDJC31400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Azmir J, 2013, J FOOD ENG, V117, P426, DOI 10.1016/j.jfoodeng.2013.01.014; Bai G, 2008, ACTA PHARMACOL SIN, V29, P1187, DOI 10.1111/j.1745-7254.2008.00859.x; Bai G, 2014, CHIN HERB MED, V6, P85, DOI 10.1016/S1674-6384(14)60013-7; Billington CK, 2012, BRIT J PHARMACOL, V166, P401, DOI 10.1111/j.1476-5381.2011.01719.x; Brusotti G, 2014, J PHARMACEUT BIOMED, V87, P218, DOI 10.1016/j.jpba.2013.03.007; Butler L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/739716; Carolan BJ, 2013, J ALLERGY CLIN IMMUN, V131, P627, DOI 10.1016/j.jaci.2013.01.010; Chan Yuk-Shing, 2011, Inflammopharmacology, V19, P245, DOI 10.1007/s10787-010-0062-4; Cheng BF, 2012, ANAL BIOANAL CHEM, V404, P2445, DOI 10.1007/s00216-012-6332-9; Gu Y, 2012, BIOCHEM PHARMACOL, V84, P468, DOI 10.1016/j.bcp.2012.06.002; Hall IP, 2000, EUR RESPIR J, V15, P1120, DOI 10.1034/j.1399-3003.2000.01523.x; He F, 2012, PLANTA MED, V78, P800, DOI 10.1055/s-0031-1298433; Holzinger F, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/382789; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Hou YY, 2012, J CHROMATOGR B, V908, P98, DOI 10.1016/j.jchromb.2012.10.004; Hou YY, 2012, J CHROMATOGR A, V1227, P203, DOI 10.1016/j.chroma.2012.01.008; Huang XD, 2004, J CHROMATOGR B, V812, P71, DOI 10.1016/j.jchromb.2004.06.046; Jiang M, 2013, J ETHNOPHARMACOL, V147, P426, DOI 10.1016/j.jep.2013.03.032; Lee S, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-16; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mohamed NH, 2009, REC NAT PROD, V3, P58; Morphy R, 2009, CURR PHARM DESIGN, V15, P587, DOI 10.2174/138161209787315594; Patwardhan B, 2004, CURR SCI INDIA, V86, P789; Preissner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051020; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Radhakrishnan ML, 2008, J CHEM INF MODEL, V48, P1055, DOI 10.1021/ci700452r; Ritchie MF, 2011, CELL CALCIUM, V49, P314, DOI 10.1016/j.ceca.2010.10.001; Shi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044921; Sun K, 2004, CHEM PHARM BULL, V52, P1483, DOI 10.1248/cpb.52.1483; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705315; Wu RH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/323715; Xu SY, 2001, METHODOLOGY PHARM EX; Yuan R, 2000, PHARMACOL THERAPEUT, V86, P191, DOI 10.1016/S0163-7258(00)00039-5; Zhang HW, 2012, J ADV NURS, V68, P1679, DOI 10.1111/j.1365-2648.2011.05925.x; Zhao ZY, 2013, BIOL TRACE ELEM RES, V156, P181, DOI 10.1007/s12011-013-9839-9	39	13	14	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113104	10.1371/journal.pone.0113104	http://dx.doi.org/10.1371/journal.pone.0113104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397687	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500133
J	Karlsson, SL; Ax, E; Nygren, E; Kallgard, S; Blomquist, M; Ekman, A; Benktander, J; Holmgren, J; Lebens, M				Karlsson, Stefan L.; Ax, Elisabeth; Nygren, Erik; Kallgard, Susanne; Blomquist, Margareta; Ekman, Annelie; Benktander, John; Holmgren, Jan; Lebens, Michael			Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co-Expressing the Inaba and Ogawa Lipopolysaccharide Antigens	PLOS ONE			English	Article							ESCHERICHIA-COLI; MONOCLONAL-ANTIBODIES; COLONIZATION FACTORS; B-SUBUNIT; BACTERIA; CONSTRUCTION; EFFICACY; CHAIN; ETEC; MICE	We describe here the development of stable classical and El Tor V. cholerae O1 strains of the Hikojima serotype that co-express the Inaba and Ogawa antigens of O1 lipopolysaccharide (LPS). Mutation of the wbeT gene reduced LPS perosamine methylation and thereby gave only partial transformation into Ogawa LPS on the cell surface. The strains express approximately equal amounts of Inaba- and Ogawa-LPS antigens which are preserved after formalin-inactivation of the bacteria. Oral immunizations of both inbred and outbred mice with formalin-inactivated whole-cell vaccine preparations of these strains elicited strong intestinal IgA anti-LPS as well as serum vibriocidal antibody responses against both Inaba and Ogawa that were fully comparable to the responses induced by the licensed Dukoral vaccine. Passive protection studies in infant mice showed that immune sera raised against either of the novel Hikojima vaccine strains protected baby mice against infection with virulent strains of both serotypes. This study illustrates the power of using genetic manipulation to improve the properties of bacteria strains for use in killed whole-cell vaccines.	[Karlsson, Stefan L.; Ax, Elisabeth; Nygren, Erik; Kallgard, Susanne; Blomquist, Margareta; Ekman, Annelie; Holmgren, Jan; Lebens, Michael] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Benktander, John] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Lebens, M (corresponding author), Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.	michael.lebens@microbio.gu.se		Ax, Elisabeth/0000-0001-7553-5059; Nygren, Erik/0000-0001-6783-4622; Lebens, Michael/0000-0001-9458-9474; Nordqvist, Stefan/0000-0003-4238-6004; Holmgren, Jan/0000-0003-1784-5918	Bill and Melinda Gates Foundation Grand Challenges Phase II award [OPP1008300]; Swedish Research Council; MSB-Sida	Bill and Melinda Gates Foundation Grand Challenges Phase II award; Swedish Research Council(Swedish Research CouncilEuropean Commission); MSB-Sida	This work was supported by a Bill and Melinda Gates Foundation Grand Challenges Phase II award (OPP1008300) and by grants from the Swedish Research Council and from MSB-Sida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibana O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002576; Attridge SR, 1996, INFECT IMMUN, V64, P3369, DOI 10.1128/IAI.64.8.3369-3373.1996; BHASKARAN K, 1957, J GEN MICROBIOL, V16, P721, DOI 10.1099/00221287-16-3-721; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Clemens J, 2014, CURR TOP MICROBIOL, V379, P231, DOI 10.1007/82_2013_353; Clemens J, 2011, NAT REV GASTRO HEPAT, V8, P701, DOI 10.1038/nrgastro.2011.174; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; GUSTAFSSON B, 1985, INFECT IMMUN, V49, P275, DOI 10.1128/IAI.49.2.275-280.1985; HARKKI A, 1986, MICROB PATHOGENESIS, V1, P283, DOI 10.1016/0882-4010(86)90053-7; Holmgren J, 2013, VACCINE, V31, P2457, DOI 10.1016/j.vaccine.2013.03.027; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Jelinek T, 2008, EXPERT REV VACCINES, V7, P561, DOI 10.1586/14760584.7.5.561; JONSON G, 1989, J GEN MICROBIOL, V135, P111; Karlsson S, 2012, US JAP COOP MED SCI; Kondo S, 1996, MICROBIOL-UK, V142, P2879, DOI 10.1099/13500872-142-10-2879; Lebens M, 2011, VACCINE, V29, P7505, DOI 10.1016/j.vaccine.2011.06.121; Liang WL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-173; LOPEZVIDAL Y, 1988, J CLIN MICROBIOL, V26, P1967, DOI 10.1128/JCM.26.10.1967-1972.1988; Lundgren A, 2013, EXCELLENT SAFETY IMM; Luquero FJ, 2014, NEW ENGL J MED, V370, P2111, DOI 10.1056/NEJMoa1312680; Manning Paul A., 1994, P77; Meeks MD, 2004, INFECT IMMUN, V72, P4090, DOI 10.1128/IAI.72.7.4090-4101.2004; Nygren E, 2009, INFECT IMMUN, V77, P3475, DOI 10.1128/IAI.01197-08; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SANCHEZ J, 1989, P NATL ACAD SCI USA, V86, P481, DOI 10.1073/pnas.86.2.481; Sharifnia A, 2012, LETT APPL MICROBIOL, V54, P267, DOI 10.1111/j.1472-765X.2012.03204.x; STROEHER UH, 1992, P NATL ACAD SCI USA, V89, P2566, DOI 10.1073/pnas.89.7.2566; Tobias J, 2010, VACCINE, V28, P6977, DOI 10.1016/j.vaccine.2010.08.047; UJIIYE A, 1968, Tropical Medicine, V10, P65; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	33	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e108521	10.1371/journal.pone.0108521	http://dx.doi.org/10.1371/journal.pone.0108521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397871	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500002
J	Lucas, AT; Fu, XP; Liu, JJ; Brannon, MK; Yang, JH; Capelluto, DGS; Finkielstein, CV				Lucas, Andrew T.; Fu, Xiangping; Liu, JingJing; Brannon, Mary K.; Yang, Jianhua; Capelluto, Daniel G. S.; Finkielstein, Carla V.			Ligand Binding Reveals a Role for Heme in Translationally-Controlled Tumor Protein Dimerization	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; CYTOCHROME-C PEROXIDASE; SEDIMENTATION-VELOCITY; HORSERADISH-PEROXIDASE; ANTIAPOPTOTIC ACTIVITY; SECONDARY STRUCTURE; EPITHELIAL-CELLS; CALCIUM; TCTP; IDENTIFICATION	The translationally-controlled tumor protein (TCTP) is a highly conserved, ubiquitously expressed, abundant protein that is broadly distributed among eukaryotes. Its biological function spans numerous cellular processes ranging from regulation of the cell cycle and microtubule stabilization to cell growth, transformation, and death processes. In this work, we propose a new function for TCTP as a ''buffer protein'' controlling cellular homeostasis. We demonstrate that binding of hemin to TCTP is mediated by a conserved His-containing motif (His(76) His(77)) followed by dimerization, an event that involves ligandmediated conformational changes and that is necessary to trigger TCTP's cytokine-like activity. Mutation in both His residues to Ala prevents hemin from binding and abrogates oligomerization, suggesting that the ligand site localizes at the interface of the oligomer. Unlike heme, binding of Ca2+ ligand to TCTP does not alter its monomeric state; although, Ca2+ is able to destabilize an existing TCTP dimer created by hemin addition. In agreement with TCTP's proposed buffer function, ligand binding occurs at high concentration, allowing the ''buffer'' condition to be dissociated from TCTP's role as a component of signal transduction mechanisms.	[Lucas, Andrew T.; Fu, Xiangping; Liu, JingJing; Yang, Jianhua; Finkielstein, Carla V.] Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA; [Lucas, Andrew T.; Brannon, Mary K.; Capelluto, Daniel G. S.] Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Prot Signaling Domains Lab, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Finkielstein, CV (corresponding author), Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA.	finkielc@vt.edu		finkielstein, carla/0000-0002-8417-4643; Lucas, Andrew/0000-0001-8678-5985	National Science Foundation CAREER Award [MCB-0844491]; Avon Foundation [02-2009-033]; Fralin Life Science Institute [F441598]; Susan G. Komen Foundation [BCTR0706931]	National Science Foundation CAREER Award(National Science Foundation (NSF)); Avon Foundation; Fralin Life Science Institute; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by the National Science Foundation CAREER Award (MCB-0844491, http://www.nsf.gov/), Avon Foundation (02-2009-033, http://www. avonfoundation. org/), Fralin Life Science Institute (F441598), and Susan G. Komen Foundation (BCTR0706931, http://ww5.komen.org/ResearchGrants/ ResearchGrants.html) to C. V. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcuri F, 2005, BIOL REPROD, V73, P745, DOI 10.1095/biolreprod.105.042077; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Baxter NJ, 2000, J BIOMOL NMR, V16, P83, DOI 10.1023/A:1008355030833; Belkacemi L, 2002, ENDOCRINE, V19, P57, DOI 10.1385/ENDO:19:1:57; BERNARD N, 1980, EUR J BIOCHEM, V103, P271, DOI 10.1111/j.1432-1033.1980.tb04311.x; Bhisutthibhan J, 1998, J BIOL CHEM, V273, P16192, DOI 10.1074/jbc.273.26.16192; Bhisutthibhan J, 2001, ANTIMICROB AGENTS CH, V45, P2397, DOI 10.1128/AAC.45.8.2397-2399.2001; Bommer UA, 2002, RNA, V8, P478, DOI 10.1017/S1355838202022586; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Bonnet C, 2000, YEAST, V16, P23, DOI 10.1002/(SICI)1097-0061(20000115)16:1<23::AID-YEA503>3.0.CO;2-A; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Budde IK, 2002, ANN ALLERG ASTHMA IM, V89, P606, DOI 10.1016/S1081-1206(10)62109-6; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Cao WM, 2005, BIOPHYS J, V89, P1589, DOI 10.1529/biophysj.105.061135; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Coban Cevayir, 2010, Allergology International, V59, P115, DOI 10.2332/allergolint.10-RAI-0194; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; Feng YG, 2007, ARCH BIOCHEM BIOPHYS, V467, P48, DOI 10.1016/j.abb.2007.08.021; FULOP V, 1995, STRUCTURE, V3, P1225, DOI 10.1016/S0969-2126(01)00258-1; Gachet Y, 1999, J CELL SCI, V112, P1257; Garfin DE, 2009, METHOD ENZYMOL, V463, P497, DOI 10.1016/S0076-6879(09)63029-9; GARRETT S, 1991, MOL CELL BIOL, V11, P4045, DOI 10.1128/MCB.11.8.4045; Gilmour R, 1995, EUR J BIOCHEM, V234, P878, DOI 10.1111/j.1432-1033.1995.878_a.x; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Gonzalez-Michaca L, 2004, AM J PHYSIOL-RENAL, V286, pF370, DOI 10.1152/ajprenal.00300.2003; GREER FR, 1994, ACTA PAEDIATR, V83, P20, DOI 10.1111/j.1651-2227.1994.tb13393.x; Howes BD, 2001, J BIOL CHEM, V276, P40704, DOI 10.1074/jbc.M107489200; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Kim M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006464; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Laberge M, 2003, BIOPHYS J, V84, P2542, DOI 10.1016/S0006-3495(03)75059-0; Lee DS, 2005, P NATL ACAD SCI USA, V102, P14232, DOI 10.1073/pnas.0506557102; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; LIU MC, 1986, J IMMUNOL, V136, P2588; Liu R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-207; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Oikawa K, 2002, BIOCHEM BIOPH RES CO, V290, P984, DOI 10.1006/bbrc.2001.6302; Pace C N, 1986, Methods Enzymol, V131, P266; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Pauleta SR, 2001, BIOCHEMISTRY-US, V40, P6570, DOI 10.1021/bi002870z; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; POULOS TL, 1993, J BIOL CHEM, V268, P4429; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Schroeder JT, 1997, J IMMUNOL, V159, P447; Sinha P, 2000, ELECTROPHORESIS, V21, P3048, DOI 10.1002/1522-2683(20000801)21:14<3048::AID-ELPS3048>3.0.CO;2-W; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Trump BF, 1996, BBA-MOL CELL RES, V1313, P173, DOI 10.1016/0167-4889(96)00086-9; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Venugopal T, 2005, COMP BIOCHEM PHYS B, V142, P8, DOI 10.1016/j.cbpc.2005.04.011; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wijayanti N, 2004, CURR MED CHEM, V11, P981, DOI 10.2174/0929867043455521; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yoneda K, 2004, AM J PHYSIOL-LUNG C, V286, pL174, DOI 10.1152/ajplung.00118.2003; Yoon T, 2000, ARCH BIOCHEM BIOPHYS, V384, P379, DOI 10.1006/abbi.2000.2108; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	69	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112823	10.1371/journal.pone.0112823	http://dx.doi.org/10.1371/journal.pone.0112823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396429	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500095
J	Scheer, S; Krempl, C; Kallfass, C; Frey, S; Jakob, T; Mouahid, G; Mone, H; Schmitt-Graff, A; Staeheli, P; Lamers, MC				Scheer, Sebastian; Krempl, Christine; Kallfass, Carsten; Frey, Stefanie; Jakob, Thilo; Mouahid, Gabriel; Mone, Helene; Schmitt-Graeff, Annette; Staeheli, Peter; Lamers, Marinus C.			S-mansoni Bolsters Anti-Viral Immunity in the Murine Respiratory Tract	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; INFLUENZA-A VIRUS; NECROSIS-FACTOR-ALPHA; CD4(+) T-CELLS; HELMINTH INFECTION; PNEUMONIA VIRUS; DENDRITIC CELLS; TNF-ALPHA; IN-VIVO; CYTOKINE RESPONSES	The human intestinal parasite Schistosoma mansoni causes a chronic disease, schistosomiasis or bilharzia. According to the current literature, the parasite induces vigorous immune responses that are controlled by Th2 helper cells at the expense of Th1 helper cells. The latter cell type is, however, indispensable for anti-viral immune responses. Remarkably, there is no reliable literature among 230 million patients worldwide describing defective anti-viral immune responses in the upper respiratory tract, for instance against influenza A virus or against respiratory syncitial virus (RSV). We therefore re-examined the immune response to a human isolate of S. mansoni and challenged mice in the chronic phase of schistosomiasis with influenza A virus, or with pneumonia virus of mice (PVM), a mouse virus to model RSV infections. We found that mice with chronic schistosomiasis had significant, systemic immune responses induced by Th1, Th2, and Th17 helper cells. High serum levels of TNF-alpha, IFN-gamma, IL-5, IL-13, IL-2, IL-17, and GM-CSF were found after mating and oviposition. The lungs of diseased mice showed low-grade inflammation, with goblet cell hyperplasia and excessive mucus secretion, which was alleviated by treatment with an anti-TNF-alpha agent (Etanercept). Mice with chronic schistosomiasis were to a relative, but significant extent protected from a secondary viral respiratory challenge. The protection correlated with the onset of oviposition and TNF-alpha-mediated goblet cell hyperplasia and mucus secretion, suggesting that these mechanisms are involved in enhanced immune protection to respiratory viruses during chronic murine schistosomiasis. Indeed, also in a model of allergic airway inflammation mice were protected from a viral respiratory challenge with PVM.	[Scheer, Sebastian; Lamers, Marinus C.] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Scheer, Sebastian] Int Max Planck Res Sch Mol & Cellular Biol, Freiburg, Germany; [Scheer, Sebastian] Univ Freiburg, D-79106 Freiburg, Germany; [Krempl, Christine] Univ Wurzburg, Inst Immunol & Virol, D-97070 Wurzburg, Germany; [Kallfass, Carsten; Staeheli, Peter] Univ Med Ctr Freiburg, Dept Med Microbiol & Hyg, Inst Virol, Freiburg, Germany; [Frey, Stefanie; Jakob, Thilo] Univ Med Ctr Freiburg, Allergy Res Grp, Dept Dermatol, Freiburg, Germany; [Mouahid, Gabriel] Univ Perpignan, UMR 5244, F-66860 Perpignan, France; [Mone, Helene] CNRS, UMR 5244, F-66860 Perpignan, France; [Schmitt-Graeff, Annette] Univ Freiburg, Inst Pathol, Freiburg, Germany	Max Planck Society; Max Planck Society; University of Freiburg; University of Wurzburg; University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; University of Freiburg	Lamers, MC (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	rinuslamers@t-online.de	Moné, Hélène/F-3367-2010; Mouahid, Gabriel/F-3625-2010; Krempl, Christine D/O-2081-2015	Scheer, Sebastian/0000-0002-9716-5009	Fonds National de la Recherche, Luxembourg [PHD-08-045-RE]	Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund)	SS was supported by the Fonds National de la Recherche, Luxembourg (http://www.fnr.lu) (PHD-08-045-RE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzi A, 2011, ADV PARASIT, V77, P1, DOI 10.1016/B978-0-12-391429-3.00005-8; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; ACTOR JK, 1993, P NATL ACAD SCI USA, V90, P948, DOI 10.1073/pnas.90.3.948; Adewusi OI, 1996, EXP PARASITOL, V84, P115, DOI 10.1006/expr.1996.0097; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Araujo MI, 2001, INFECT IMMUN, V69, P1454, DOI 10.1128/IAI.69.3.1454-1462.2001; Brunet LR, 1997, J IMMUNOL, V159, P777; Buchholz UJ, 2009, J VIROL, V83, P1969, DOI 10.1128/JVI.02041-08; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chapoval SP, 2007, J IMMUNOL, V179, P7030, DOI 10.4049/jimmunol.179.10.7030; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Crosby A, 2010, AM J RESP CRIT CARE, V181, P279, DOI 10.1164/rccm.200903-0355OC; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; Davies SJ, 2004, INT J PARASITOL, V34, P27, DOI 10.1016/j.ijpara.2003.10.010; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; de Miguel-Diez J, 2012, J INFECTION, V65, P95, DOI 10.1016/j.jinf.2012.03.003; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Edwards MJ, 2005, J IMMUNOL, V175, P6275, DOI 10.4049/jimmunol.175.10.6275; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fallon PG, 2007, NAT REV IMMUNOL, V7, P220, DOI 10.1038/nri2039; Fallon PG, 2000, IMMUNOL TODAY, V21, P29, DOI 10.1016/S0167-5699(99)01551-0; Frey S, 2008, J VIROL, V82, P11619, DOI 10.1128/JVI.00375-08; Gallo E, 2012, EUR J IMMUNOL, V42, P2322, DOI 10.1002/eji.201142227; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HENDERSON GS, 1993, AM J PATHOL, V142, P703; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krempl CD, 2004, J VIROL, V78, P13362, DOI 10.1128/JVI.78.23.13362-13365.2004; Krempl CD, 2007, J VIROL, V81, P9490, DOI 10.1128/JVI.00364-07; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Lora JM, 2005, J BIOL CHEM, V280, P36510, DOI 10.1074/jbc.M507977200; Marillier RG, 2010, AM J PHYSIOL-GASTR L, V298, pG943, DOI 10.1152/ajpgi.00321.2009; Marillier RG, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-11; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Morgan JAT, 2005, MOL ECOL, V14, P3889, DOI 10.1111/j.1365-294X.2005.02709.x; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mouahid G, 2012, TROP MED INT HEALTH, V17, P727, DOI 10.1111/j.1365-3156.2012.02988.x; Mwatha JK, 1998, J IMMUNOL, V160, P1992; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Peine M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001633; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Perona-Wright G, 2012, J IMMUNOL, V188, P2350, DOI 10.4049/jimmunol.1101642; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Scheer S, 2014, J IMMUNOL METHODS, V406, P66, DOI 10.1016/j.jim.2014.03.008; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; STANDEN OD, 1953, T ROY SOC TROP MED H, V47, P292, DOI 10.1016/0035-9203(53)90051-0; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wu CA, 2008, AM J PATHOL, V172, P714, DOI 10.2353/ajpath.2008.070462; Xu J, 2012, CELL, V151, P929, DOI 10.1016/j.cell.2012.11.007; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Yu LP, 2012, PARASITOL RES, V110, P1547, DOI 10.1007/s00436-011-2661-4; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	87	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112469	10.1371/journal.pone.0112469	http://dx.doi.org/10.1371/journal.pone.0112469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398130	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500053
J	Toung, JM; Lahens, N; Hogenesch, JB; Grant, G				Toung, Jonathan M.; Lahens, Nicholas; Hogenesch, John B.; Grant, Gregory			Detection Theory in Identification of RNA-DNA Sequence Differences Using RNA-Sequencing	PLOS ONE			English	Article							EDITING SITES; ALLELIC EXPRESSION; PARALLEL DNA; TRANSCRIPTOME; ALIGNMENT; ORIGIN	Advances in sequencing technology have allowed for detailed analyses of the transcriptome at single-nucleotide resolution, facilitating the study of RNA editing or sequence differences between RNA and DNA genome-wide. In humans, two types of post-transcriptional RNA editing processes are known to occur: A-to-I deamination by ADAR and C-to-U deamination by APOBEC1. In addition to these sequence differences, researchers have reported the existence of all 12 types of RNA-DNA sequence differences (RDDs); however, the validity of these claims is debated, as many studies claim that technical artifacts account for the majority of these non-canonical sequence differences. In this study, we used a detection theory approach to evaluate the performance of RNA-Sequencing (RNA-Seq) and associated aligners in accurately identifying RNA-DNA sequence differences. By generating simulated RNA-Seq datasets containing RDDs, we assessed the effect of alignment artifacts and sequencing error on the sensitivity and false discovery rate of RDD detection. Overall, we found that even in the presence of sequencing errors, false negative and false discovery rates of RDD detection can be contained below 10% with relatively lenient thresholds. We also assessed the ability of various filters to target false positive RDDs and found them to be effective in discriminating between true and false positives. Lastly, we used the optimal thresholds we identified from our simulated analyses to identify RDDs in a human lymphoblastoid cell line. We found approximately 6,000 RDDs, the majority of which are A-to-G edits and likely to be mediated by ADAR. Moreover, we found the majority of non A-to-G RDDs to be associated with poorer alignments and conclude from these results that the evidence for widespread non-canonical RDDs in humans is weak. Overall, we found RNA-Seq to be a powerful technique for surveying RDDs genome-wide when coupled with the appropriate thresholds and filters.	[Toung, Jonathan M.; Lahens, Nicholas] Univ Penn, Sch Med, Genom & Computat Biol Grad Program, Philadelphia, PA 19104 USA; [Hogenesch, John B.; Grant, Gregory] Univ Penn, Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA; [Hogenesch, John B.; Grant, Gregory] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Grant, Gregory] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Hogenesch, John B.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Grant, G (corresponding author), Univ Penn, Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA.	greg@grant.org	Grant, Gregory Robert/I-3599-2019	Grant, Gregory Robert/0000-0002-0139-7658	Glue Grant [U54HL117798]; CSTA Grant - National Center for Research Resources; National Center for Advancing Translational Sciences; National Institutes of Health [UL1TR000003]; Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	Glue Grant; CSTA Grant - National Center for Research Resources; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by Glue Grant: U54HL117798; CSTA Grant: The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000003. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH; ITMAT: Supported in part by the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Kleinman CL, 2012, RNA, V18, P1586, DOI 10.1261/rna.033233.112; Lahens NF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r86; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qu W, 2009, GENOME RES, V19, P1309, DOI 10.1101/gr.089151.108; Ramaswami G, 2012, NAT METHODS; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112040	10.1371/journal.pone.0112040	http://dx.doi.org/10.1371/journal.pone.0112040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396741	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500027
J	Yoshida, K; Jiang, HF; Kim, M; Vink, J; Cremers, S; Paik, D; Wapner, R; Mahendroo, M; Myers, K				Yoshida, Kyoko; Jiang, Hongfeng; Kim, MiJung; Vink, Joy; Cremers, Serge; Paik, David; Wapner, Ronald; Mahendroo, Mala; Myers, Kristin			Quantitative Evaluation of Collagen Crosslinks and Corresponding Tensile Mechanical Properties in Mouse Cervical Tissue during Normal Pregnancy	PLOS ONE			English	Article							IN-VIVO; CONSTITUENTS; STROMA	The changes in the mechanical integrity of the cervix during pregnancy have implications for a successful delivery. Cervical collagens are known to remodel extensively in mice with progressing gestation leading to a soft cervix at term. During this process, mature crosslinked collagens are hypothesized to be replaced with immature less crosslinked collagens to facilitate cervical softening and ripening. To determine the mechanical role of collagen crosslinks during normal mouse cervical remodeling, tensile load-to-break tests were conducted for the following time points: nonpregnant (NP), gestation day (d) 6, 12, 15, 18 and 24 hr postpartum (PP) of the 19-day gestation period. Immature crosslinks (HLNL and DHLNL) and mature crosslinks (DPD and PYD) were measured using ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry (UPLC-ESI-MS/MS). There were no significant changes in the total immature crosslink density (HLNL+ DHLNL mol per collagen mol) throughout normal mouse gestation (range: 0.31-0.49). Total mature crosslink density (PYD+ DPD mol per collagen mol) decreased significantly in early softening from d6 to d15 (d6: 0.17, d12: 0.097, d15: 0.026) and did not decrease with further gestation. The maturity ratio (total mature to total immature crosslinks) significantly decreased in early softening from d6 to d15 (d6: 0.2, d15: 0.074). All of the measured crosslinks correlated significantly with a measure of tissue stiffness and strength, with the exception of the immature crosslink HLNL. This data provides quantitative evidence to support the hypothesis that as mature crosslinked collagens decline, they are replaced by immature collagens to facilitate increased tissue compliance in the early softening period from d6 to d15.	[Yoshida, Kyoko; Myers, Kristin] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Jiang, Hongfeng; Cremers, Serge] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Kim, MiJung; Paik, David] Columbia Univ, Dept Opthalmol, Med Ctr, New York, NY 10027 USA; [Vink, Joy; Wapner, Ronald] Columbia Univ, Dept Obstet & Gynecol, Med Ctr, New York, NY 10027 USA; [Mahendroo, Mala] UT Southwestern Med Ctr, Dept Obstet & Gynecol, Dallas, TX USA; [Cremers, Serge] Columbia Univ, Med Ctr, Irving Inst Clin & Translat Res, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University	Myers, K (corresponding author), Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.	kmm2233@columbia.edu	Myers, Kristin M/E-5689-2017; Yoshida, Kyoko/AAK-2259-2021; jiang, hongfeng/I-6188-2013; Yoshida, Kyoko/A-9746-2017	Myers, Kristin M/0000-0002-5989-0242; Yoshida, Kyoko/0000-0002-7251-134X; Yoshida, Kyoko/0000-0002-7251-134X	National Science Foundation Graduate Research Fellowship; National Center for Advancing Translational Sciences; National Institutes of Health [UL1 TR000040]; Burroughs Wellcome Fund Prematurity Research Initiative Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Prematurity Research Initiative Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was supported by the National Science Foundation Graduate Research Fellowship (http://www.nsf.org), the National Center for Advancing Translational Sciences, National Institutes of Health (http://www. nih. gov), through Grant No. UL1 TR000040, and the Burroughs Wellcome Fund Prematurity Research Initiative Award (http://www. bwfund. org) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins ML, 2011, BIOL REPROD, V84, P1053, DOI 10.1095/biolreprod.110.089599; Avery Nicholas C., 2009, V522, P103, DOI 10.1007/978-1-59745-413-1_6; Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001; Eleswarapu SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026178; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Fessel G, 2012, J SHOULDER ELB SURG, V21, P209, DOI 10.1016/j.jse.2011.10.002; Gineyts E, 2010, J CHROMATOGR B, V878, P1449, DOI 10.1016/j.jchromb.2010.03.039; GLASSMAN W, 1995, AM J OBSTET GYNECOL, V173, P1550, DOI 10.1016/0002-9378(95)90648-7; House M, 2009, SEMIN PERINATOL, V33, P300, DOI 10.1053/j.semperi.2009.06.002; Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004; Kindt E, 2003, J PHARMACEUT BIOMED, V33, P1081, DOI 10.1016/S0731-7085(03)00359-5; LEPPERT PC, 1995, CLIN OBSTET GYNECOL, V38, P267, DOI 10.1097/00003081-199506000-00009; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Marturano JE, 2013, P NATL ACAD SCI USA, V110, P6370, DOI 10.1073/pnas.1300135110; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Myers K, 2009, EUR J OBSTET GYN R B, V144, pS82, DOI 10.1016/j.ejogrb.2009.02.008; Oxlund H, 1996, BONE, V19, P479, DOI 10.1016/S8756-3282(96)00283-9; OZASA H, 1981, ENDOCRINOLOGY, V109, P618, DOI 10.1210/endo-109-2-618; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schlembach D, 2009, EUR J OBSTET GYN R B, V144, pS70, DOI 10.1016/j.ejogrb.2009.02.036; Sroga GE, 2011, J CHROMATOGR B, V879, P379, DOI 10.1016/j.jchromb.2010.12.024; Timmons BC, 2014, ENDOCRINOLOGY, V155, P287, DOI 10.1210/en.2013-1304; Vargis E, 2012, ANN BIOMED ENG, V40, P1814, DOI 10.1007/s10439-012-0541-4; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Word R, 2010, SEMINARS REPROD MED, V25, P1; Yoshida K, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026423; YU SY, 1995, P SOC EXP BIOL MED, V209, P360; Zhang YY, 2012, P NATL ACAD SCI USA, V109, P12878, DOI 10.1073/pnas.1121495109; Zork N, 2014, SYSTEMATIC EVALUATIO, DOI [10.1016/j.ajog.2014.09.036.AJOG, DOI 10.1016/J.AJOG.2014.09.036.AJOG]	30	32	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112391	10.1371/journal.pone.0112391	http://dx.doi.org/10.1371/journal.pone.0112391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397407	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500049
J	Banigan, JR; Gayen, A; Cho, MK; Traaseth, NJ				Banigan, James R.; Gayen, Anindita; Cho, Min-Kyu; Traaseth, Nathaniel J.			A Structured Loop Modulates Coupling between the Substrate-binding and Dimerization Domains in the Multidrug Resistance Transporter EmrE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-TETRACYCLINE/H+ ANTIPORTER; INDUCED CONFORMATIONAL-CHANGES; PROTEIN SECONDARY STRUCTURE; NUCLEAR-MAGNETIC-RESONANCE; STATE NMR-SPECTROSCOPY; ANGLE-SPINNING NMR; ESCHERICHIA-COLI; CROSS-POLARIZATION; CHEMICAL-SHIFTS; CYTOPLASMIC LOOP	Secondary active transporters undergo large conformational changes to facilitate the efflux of substrates across the lipid bilayer. Among the smallest known transport proteins are members of the small multidrug resistance (SMR) family that are composed of four transmembrane (TM) domains and assemble into dimers. An unanswered question in the SMR field is how the dimerization domain (TM4) is coupled with the substrate-binding chamber (TM1-3). To provide insight for this essential aspect of ion-coupled transport, we carried out a structure-function study on the SMR protein EmrE using solid-state-NMR spectroscopy in lipid bilayers and resistance assays in Escherichia coli. The chemical shifts for EmrE were consistent with beta-strand secondary structure for the loop connecting TM3 and TM4. Based on these structural results, EmrE mutants were created to ascertain whether a specific loop length and composition were necessary for function. A linker encompassing six extra Gly residues relative to wild-type EmrE failed to give resistance; however, the number of residues in the loop was not the only criterion for a functional efflux pump. Replacement of the central hydrophobic residue with Gly (L83G) also conferred no ethidium resistance phenotype, which supported the conclusion that the structure and length of the loop were both essential for ion-coupled transport. Taken together with a bioinformatics analysis, a structured linker is likely conserved across the SMR family to play an active role in mediating the conformational switch between inward-open and outward-open states necessary for drug efflux. These findings underscore the important role loops can play in mediating efflux.	[Banigan, James R.; Gayen, Anindita; Cho, Min-Kyu; Traaseth, Nathaniel J.] NYU, Dept Chem, New York, NY 10003 USA	New York University	Traaseth, NJ (corresponding author), NYU, Dept Chem, 100 Washington Sq East, New York, NY 10003 USA.	traaseth@nyu.edu	Cho, Min-Kyu/H-1303-2011	Cho, Min-Kyu/0000-0003-0537-2340; Banigan, James/0000-0002-1807-1769; Traaseth, Nathaniel/0000-0002-1185-6088	NYSTAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI083745, R01AI108889] Funding Source: NIH RePORTER	NYSTAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The collection of NMR data at the New York Structural Biology Center was made possible by a grant from NYSTAR. We thank Matthew Devany for assistance in using the NMR spectrometer at Hunter College. We thank Prof. Raymond J. Turner at the University of Calgary for providing wild-type EmrE in the pMS119EH vector.	Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; AMMANN C, 1982, J MAGN RESON, V46, P319, DOI 10.1016/0022-2364(82)90147-0; Baldus M, 1996, J MAGN RESON SER A, V118, P140, DOI 10.1006/jmra.1996.0022; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Banigan JR, 2015, BBA-BIOMEMBRANES, V1848, P334, DOI 10.1016/j.bbamem.2014.05.003; Banigan JR, 2013, J BIOMOL NMR, V55, P391, DOI 10.1007/s10858-013-9724-z; Banigan JR, 2012, J PHYS CHEM B, V116, P7138, DOI 10.1021/jp303269m; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Bay DC, 2012, BBA-BIOMEMBRANES, V1818, P1318, DOI 10.1016/j.bbamem.2012.01.022; Bay DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-140; Berjanskii MV, 2008, J BIOMOL NMR, V40, P31, DOI 10.1007/s10858-007-9208-0; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Cho MK, 2014, J AM CHEM SOC, V136, P8072, DOI 10.1021/ja503145x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuff AL, 2006, BIOINFORMATICS, V22, P1464, DOI 10.1093/bioinformatics/btl120; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ditty JL, 1999, J BACTERIOL, V181, P5068, DOI 10.1128/JB.181.16.5068-5074.1999; Dutta S, 2014, BIOPHYS J, V107, P613, DOI 10.1016/j.bpj.2014.06.030; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; Franks WT, 2007, J BIOMOL NMR, V39, P107, DOI 10.1007/s10858-007-9179-1; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P14284, DOI 10.1021/bi972314d; Gayen A, 2013, ANGEW CHEM INT EDIT, V52, P10321, DOI 10.1002/anie.201303091; Goddard T. D., 2006, SPARKY 3; Gopinath T, 2012, J MAGN RESON, V220, P79, DOI 10.1016/j.jmr.2012.04.006; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Jack DL, 2000, J BACTERIOL, V182, P2311, DOI 10.1128/JB.182.8.2311-2313.2000; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Kolbusz MA, 2012, BIOCHEMISTRY-US, V51, P8867, DOI 10.1021/bi300854c; Lehner I, 2008, J BIOL CHEM, V283, P3281, DOI 10.1074/jbc.M707899200; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lloris-Garcera P, 2013, J MOL BIOL, V425, P4642, DOI 10.1016/j.jmb.2013.07.039; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Morrison EA, 2014, J BIOL CHEM, V289, P6825, DOI 10.1074/jbc.M113.535328; Parry-Smith DJ, 1998, GENE, V221, pGC57, DOI 10.1016/S0378-1119(97)00650-1; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poget SF, 2010, BIOMOL NMR ASSIGN, V4, P139, DOI 10.1007/s12104-010-9228-7; Poulsen BE, 2012, ANTIMICROB AGENTS CH, V56, P3911, DOI 10.1128/AAC.00158-12; Poulsen BE, 2011, J BACTERIOL, V193, P5929, DOI 10.1128/JB.05846-11; Poulsen BE, 2009, J BIOL CHEM, V284, P9870, DOI 10.1074/jbc.M900182200; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Schulte-Herbruggen T, 2000, J MAGN RESON, V144, P123, DOI 10.1006/jmre.2000.2020; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi LC, 2009, J MOL BIOL, V386, P1078, DOI 10.1016/j.jmb.2009.01.011; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stringer JA, 2005, J MAGN RESON, V173, P40, DOI 10.1016/j.jmr.2004.11.015; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Takegoshi K, 2003, J CHEM PHYS, V118, P2325, DOI 10.1063/1.1534105; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Traaseth NJ, 2011, J MAGN RESON, V211, P18, DOI 10.1016/j.jmr.2011.03.013; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Weinglass AB, 2000, P NATL ACAD SCI USA, V97, P8938, DOI 10.1073/pnas.140224497; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; YAMAGUCHI A, 1993, J BIOL CHEM, V268, P6496; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P15525; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P19155; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	71	18	18	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					805	814		10.1074/jbc.M114.601963	http://dx.doi.org/10.1074/jbc.M114.601963			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406320	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000347778200011
J	Liu, TF; Vachharajani, V; Millet, P; Bharadwaj, MS; Molina, AJ; McCall, CE				Liu, Tie Fu; Vachharajani, Vidula; Millet, Patrick; Bharadwaj, Manish S.; Molina, Anthony J.; McCall, Charles E.			Sequential Actions of SIRT1-RELB-SIRT3 Coordinate Nuclear-Mitochondrial Communication during Immunometabolic Adaptation to Acute Inflammation and Sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondrial Respiratory Chain Complex; Monocyte; Reactive Oxygen Species (ROS); Sepsis; Sirtuin 1 (SIRT1); Acute Inflammation; Mitochondrial Bioenergetics; RELB; SIRT3; Nuclear-mitochondrial Communication	METABOLISM; HISTONE; DAMAGE; IMMUNOSUPPRESSION; DYSFUNCTION; BIOGENESIS; GLUCOSE; STRESS; ALPHA	Background: Nuclear SIRT1 and SIRT6 switch monocyte energy sources from glycolysis to fatty acid oxidation during sepsis adaptation. Results: Sequential actions of nuclear SIRT1 and RELB differentially induce SIRT3 expression and increase mitochondrial biogenesis during sepsis adaptation. Conclusion: SIRT1 and RELB link nuclear and mitochondrial alterations in bioenergetics during sepsis. Significance: Communication between nuclear and mitochondrial functions may influence sepsis outcomes. We reported that NAD(+)-dependent SIRT1, RELB, and SIRT6 nuclear proteins in monocytes regulate a switch from the glycolysis-dependent acute inflammatory response to fatty acid oxidation-dependent sepsis adaptation. We also found that disrupting SIRT1 activity during adaptation restores immunometabolic homeostasis and rescues septic mice from death. Here, we show that nuclear SIRT1 guides RELB to differentially induce SIRT3 expression and also increases mitochondrial biogenesis, which alters bioenergetics during sepsis adaptation. We constructed this concept using TLR4-stimulated THP1 human promonocytes, a model that mimics the initiation and adaptation stages of sepsis. Following increased expression, mitochondrial SIRT3 deacetylase activates the rate-limiting tricarboxylic acid cycle (TCA) isocitrate dehydrogenase 2 and superoxide dismutase 2, concomitant with increases in citrate synthase activity. Mitochondrial oxygen consumption rate increases early and decreases during adaptation, parallel with modifications to membrane depolarization, ATP generation, and production of mitochondrial superoxide and whole cell hydrogen peroxide. Evidence of SIRT1-RELB induction of mitochondrial biogenesis included increases in mitochondrial mass, mitochondrial-to-nuclear DNA ratios, and both nuclear and mitochondrial encoded proteins. We confirmed the SIRT-RELB-SIRT3 adaptation link to mitochondrial bioenergetics in both TLR4-stimulated normal and sepsis-adapted human blood monocytes and mouse splenocytes. We also found that SIRT1 inhibition ex vivo reversed the sepsis-induced changes in bioenergetics.	[Liu, Tie Fu; Vachharajani, Vidula; Millet, Patrick; McCall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Bharadwaj, Manish S.; Molina, Anthony J.] Wake Forest Univ, Bowman Gray Sch Med, Sect Gerontol & Geriatr Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Vachharajani, Vidula] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Liu, TF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Sect Mol Med, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	tliu@wakehealth.edu; chmccall@wakehealth.edu	Vachharajani, Vidula/AAX-3640-2021	Millet, Patrick/0000-0002-7917-7428; Vachharajani, Vidula/0000-0002-0892-7084; Molina, Anthony/0000-0002-5786-4622	National Institutes of Health [R01AI079144, R01-AI065791, R01GM102497, R01GM099807]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079144, R01AI065791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102497, R01GM099807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI079144, R01-AI065791, and R01GM102497 (to C. E. M.), and R01GM099807 (to V. V.).	Andersson AK, 2011, LEUKEMIA, V25, P1570, DOI 10.1038/leu.2011.133; Belikoff BG, 2011, J IMMUNOL, V186, P2444, DOI 10.4049/jimmunol.1001567; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Carre JE, 2008, BBA-BIOENERGETICS, V1777, P763, DOI 10.1016/j.bbabio.2008.04.024; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; McCall CE, 2010, J INNATE IMMUN, V2, P395, DOI 10.1159/000314077; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Williams SCP, 2012, NAT MED, V18, P1001, DOI 10.1038/nm0712-1001; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	39	97	104	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					396	408		10.1074/jbc.M114.566349	http://dx.doi.org/10.1074/jbc.M114.566349			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404738	hybrid, Green Published			2022-12-26	WOS:000347231200035
J	Marion, JW; Lee, C; Lee, CS; Wang, QH; Lemeshow, S; Buckley, TJ; Saif, LJ; Lee, J				Marion, Jason W.; Lee, Cheonghoon; Lee, Chang Soo; Wang, Qiuhong; Lemeshow, Stanley; Buckley, Timothy J.; Saif, Linda J.; Lee, Jiyoung			Integrating Bacterial and Viral Water Quality Assessment to Predict Swimming-Associated Illness at a Freshwater Beach: A Cohort Study	PLOS ONE			English	Article							RECREATIONAL MARINE WATERS; POLYMERASE-CHAIN-REACTION; FECAL INDICATOR BACTERIA; REAL-TIME PCR; ESCHERICHIA-COLI; COASTAL WATERS; QUANTITATIVE PCR; NONPOINT SOURCES; ENTERIC VIRUSES; GENETIC-MARKERS	Background & Objective: Recreational waters impacted by fecal contamination have been linked to gastrointestinal illness in swimmer populations. To date, few epidemiologic studies examine the risk for swimming-related illnesses based upon simultaneous exposure to more than one microbial surrogate (e. g. culturable E. coli densities, genetic markers). We addressed this research gap by investigating the association between swimming-related illness frequency and water quality determined from multiple bacterial and viral genetic markers. Methods: Viral and bacterial genetic marker densities were determined from beach water samples collected over 23 weekend days and were quantified using quantitative polymerase chain reaction (qPCR). These genetic marker data were paired with previously determined human exposure data gathered as part of a cohort study carried out among beach users at East Fork Lake in Ohio, USA in 2009. Using previously unavailable genetic marker data in logistic regression models, single-and multi-marker/multi-water quality indicator approaches for predicting swimming-related illness were evaluated for associations with swimming-associated gastrointestinal illness. Results: Data pertaining to genetic marker exposure and 8- or 9-day health outcomes were available for a total of 600 healthy susceptible swimmers, and with this population we observed a significant positive association between human adenovirus (HAdV) exposure and diarrhea (odds ratio = 1.6; 95% confidence interval: 1.1-2.3) as well as gastrointestinal illness (OR = 1.5; 95% CI: 1.0-2.2) upon adjusting for culturable E. coli densities in multivariable models. No significant associations between bacterial genetic markers and swimming-associated illness were observed. Conclusions: This study provides evidence that a combined measure of recreational water quality that simultaneously considers both bacterial and viral densities, particularly HAdV, may improve prediction of disease risk than a measure of a single agent in a beach environment likely influenced by nonpoint source human fecal contamination.	[Marion, Jason W.; Lee, Cheonghoon; Lee, Chang Soo; Buckley, Timothy J.; Lee, Jiyoung] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Wang, Qiuhong; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA; [Lemeshow, Stanley] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Lee, Jiyoung] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lee, J (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA.	lee.3598@osu.edu	Buckley, Timothy/AAS-7516-2021; Saif, Linda/E-4005-2011; Lee, Chang Soo/AAA-9586-2022	Lee, Chang Soo/0000-0001-7327-4852; Marion, Jason/0000-0001-5177-889X	Public Health Preparedness for Infectious Diseases program; Ohio State University Targeted Investment in Excellence program - Offices of Academic Affairs, the President, and Research; Ohio Water Development Authority	Public Health Preparedness for Infectious Diseases program; Ohio State University Targeted Investment in Excellence program - Offices of Academic Affairs, the President, and Research; Ohio Water Development Authority	This study was funded by the Public Health Preparedness for Infectious Diseases program (http://phpid.osu.edu) and The Ohio State University Targeted Investment in Excellence program sponsored by the Offices of Academic Affairs, the President, and Research. The human health and exposure data collection effort was funded by the Ohio Water Development Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelzaher AM, 2013, J ENV PUBLIC HLTH, V2013, DOI DOI 10.1155/2013/138521; Abdelzaher AM, 2011, J WATER HEALTH, V9, P443, DOI 10.2166/wh.2011.146; Albinana-Gimenez N, 2009, WATER RES, V43, P2011, DOI 10.1016/j.watres.2009.01.025; Arnold BF, 2013, EPIDEMIOLOGY, V24, P845, DOI 10.1097/01.ede.0000434431.06765.4a; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P1587, DOI 10.1128/AEM.66.4.1587-1594.2000; Boehm AB, 2009, J WATER HEALTH, V7, P9, DOI 10.2166/wh.2009.122; Chern EC, 2011, LETT APPL MICROBIOL, V52, P298, DOI 10.1111/j.1472-765X.2010.03001.x; Chern EC, 2009, WATER QUAL EXPOS HEA, V1, P203, DOI 10.1007/s12403-009-0019-2; Colford JM, 2012, WATER RES, V46, P2176, DOI 10.1016/j.watres.2012.01.033; Colford JM, 2007, EPIDEMIOLOGY, V18, P27, DOI 10.1097/01.ede.0000249425.32990.b9; Dorevitch S, 2012, ENVIRON HEALTH PERSP, V120, P192, DOI 10.1289/ehp.1103934; Dufour A, 1984, EPA6001842004 OFF RE; FEWTRELL L, 1992, LANCET, V339, P1587, DOI 10.1016/0140-6736(92)91843-W; Fewtrell L., 2001, WATER QUALITY GUIDEL; Fleisher JM, 2010, INT J EPIDEMIOL, V39, P1291, DOI 10.1093/ije/dyq084; Fleisher JM, 1996, AM J PUBLIC HEALTH, V86, P1228, DOI 10.2105/AJPH.86.9.1228; FLEISHER JM, 1993, INT J EPIDEMIOL, V22, P698, DOI 10.1093/ije/22.4.698; Fongaro G, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-166; Ge ZF, 2012, ENVIRON SCI TECHNOL, V46, P2204, DOI 10.1021/es203847n; Gerba CP, 2002, APPL ENVIRON MICROB, V68, P5167, DOI 10.1128/AEM.68.10.5167-5169.2002; Gruber SJ, 2005, STORMWATER, V6, P40; Haramoto E, 2005, APPL ENVIRON MICROB, V71, P2403, DOI 10.1128/AEM.71.5.2403-2411.2005; Haugland RA, 2005, WATER RES, V39, P559, DOI 10.1016/j.watres.2004.11.011; Heaney CD, 2012, EPIDEMIOLOGY, V23, P95, DOI 10.1097/EDE.0b013e31823b504c; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hlavsa Michele C., 2011, Morbidity and Mortality Weekly Report, V60, P1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jiang S, 2001, APPL ENVIRON MICROB, V67, P179, DOI 10.1128/AEM.67.1.179-184.2001; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kundu A, 2013, WATER RES, V47, P6309, DOI 10.1016/j.watres.2013.08.002; Lee CS, 2014, SCI TOTAL ENVIRON, V472, P757, DOI 10.1016/j.scitotenv.2013.11.088; Lee CS, 2010, J MICROBIOL METH, V82, P311, DOI 10.1016/j.mimet.2010.07.012; Lee C, 2012, APPL ENVIRON MICROB, V78, P5511, DOI 10.1128/AEM.08009-11; Lee JY, 2004, LUMINESCENCE, V19, P31, DOI 10.1002/bio.753; Leshem E, 2013, EMERG INFECT DIS, V19, P1231, DOI 10.3201/eid1908.130458; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lodder WJ, 2005, APPL ENVIRON MICROB, V71, P1453, DOI 10.1128/AEM.71.3.1453-1461.2005; Ludwig W, 2000, SYST APPL MICROBIOL, V23, P556, DOI 10.1016/S0723-2020(00)80030-2; Marion JW, 2010, WATER RES, V44, P4796, DOI 10.1016/j.watres.2010.07.065; McQuaig S, 2012, APPL ENVIRON MICROB, V78, P6423, DOI 10.1128/AEM.00024-12; Monpoeho S, 2000, BIOTECHNIQUES, V29, P88, DOI 10.2144/00291st03; Newton RJ, 2011, APPL ENVIRON MICROB, V77, P6972, DOI 10.1128/AEM.05480-11; Noble RT, 2001, HYDROBIOLOGIA, V460, P175, DOI 10.1023/A:1013121416891; Okabe S, 2007, APPL MICROBIOL BIOT, V74, P890, DOI 10.1007/s00253-006-0714-x; PAYMENT P, 1982, WATER RES, V16, P939, DOI 10.1016/0043-1354(82)90026-4; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peed LA, 2011, ENVIRON SCI TECHNOL, V45, P5652, DOI 10.1021/es2003167; Pike E, 1994, 34122 WRC DOE, P9; Sinclair RG, 2009, J APPL MICROBIOL, V107, P1769, DOI 10.1111/j.1365-2672.2009.04367.x; Sinigalliano CD, 2010, WATER RES, V44, P3763, DOI 10.1016/j.watres.2010.04.026; Soller JA, 2010, WATER RES, V44, P4736, DOI 10.1016/j.watres.2010.07.064; Soller JA, 2010, WATER RES, V44, P4674, DOI 10.1016/j.watres.2010.06.049; U.S. Army Corps of Engineers Louisville District, 2013, DAT YEARL LAK REP; U.S. Environmental Protection Agency, 2010, EPA821R10004; United States Environmental Protection Agency (US EPA), 2014, HLTH RISK EXP ASS OZ; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wade TJ, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-66; Wade TJ, 2006, ENVIRON HEALTH PERSP, V114, P24, DOI 10.1289/ehp.8273; Wade TJ, 2003, ENVIRON HEALTH PERSP, V111, P1102, DOI 10.1289/ehp.6241; Wyn-Jones AP, 2011, WATER RES, V45, P1025, DOI 10.1016/j.watres.2010.10.015; Yau VM, 2014, WATER RES, V59, P23, DOI 10.1016/j.watres.2014.03.050	61	10	10	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112029	10.1371/journal.pone.0112029	http://dx.doi.org/10.1371/journal.pone.0112029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409012	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200008
J	Mayer, AE; Parks, GD				Mayer, Anne E.; Parks, Griffith D.			An AGM Model for Changes in Complement during Pregnancy: Neutralization of Influenza Virus by Serum Is Diminished in Late Third Trimester	PLOS ONE			English	Article							MONKEY CERCOPITHECUS-AETHIOPS; ANIMAL-MODELS; VERVET MONKEY; RESPIRATORY ILLNESS; INFECTED-CELLS; IN-VIVO; ACTIVATION; PROTEINS; PATHWAY; HOSPITALIZATIONS	Pregnant women in the third trimester are at increased risk of severe influenza disease relative to the general population, though mechanisms behind this are not completely understood. The immune response to influenza infection employs both complement (C') and antibody (Ab). The relative contributions of these components to the anti-viral response are difficult to dissect because most humans have pre-existing influenza-specific Abs. We developed the African green monkey (AGM) as a tractable nonhuman primate model to study changes in systemic innate immunity to influenza during pregnancy. Because the AGMs were influenza-naive, we were able to examine the role of C' in influenza virus neutralization using serum from non-pregnant animals before and after influenza infection. We determined that serum from naive AGMs neutralized influenza via C', while post-infection neutralization did not require C', suggesting an Ab-mediated mechanism. The latter mimicked neutralization using human serum. Further, we found that ex vivo neutralization of influenza with both naive and influenza-immune AGM serum occurred by virus particle aggregation and lysis, with immune serum lysing virus at a much higher rate than naive serum. We hypothesized that the anti-influenza C' response would diminish late in AGM pregnancy, corresponding with the time when pregnant women suffer increased influenza severity. We found that influenza neutralization capacity is significantly diminished in serum collected late in the third trimester. Strikingly, we found that circulating levels of C3, C3a, and C4 are diminished late in gestation relative to nonpregnant animals, and while neutralization capacity and serum C3a return to normal shortly after parturition, C3 and C4 levels do not. This AGM model system will enable further studies of the role of physiologic and hormonal changes in downregulating C'-mediated anti-viral immunity during pregnancy, and it will permit the identification of therapeutic targets to improve outcomes of influenza virus infection in pregnant women.	[Mayer, Anne E.; Parks, Griffith D.] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27101 USA	Wake Forest University	Mayer, AE (corresponding author), Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27101 USA.	anmayer@wakehealth.edu			National Institutes of Health [AI083253, AI101675]; NCI CCSG [P30CA012197, RR019963/OD010965, T32 OD010957]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083253, R03AI101675] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010965, T32OD010957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health www.nih.gov AI083253 (GDP), AI101675 (GDP), NCI CCSG P30CA012197 (flow cytometry and imaging core), RR019963/OD010965 (animal resources), T32 OD010957 (AEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, THROMB RES, V127, pS72, DOI 10.1016/S0049-3848(11)70020-2; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; [Anonymous], 1966, BIOL LAB MOUSE; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; BAINES MG, 1974, OBSTET GYNECOL, V43, P806; Baskin C, 2013, CURR TOP MICROBIOL, V363, P69, DOI 10.1007/82_2012_248; BENSTER B, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P518; BERENDT RF, 1974, INFECT IMMUN, V9, P101, DOI 10.1128/IAI.9.1.101-105.1974; Billington WD, 2003, J REPROD IMMUNOL, V60, P1, DOI 10.1016/S0165-0378(03)00083-4; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Bolger MS, 2007, AM J PHYSIOL-LUNG C, V292, pL748, DOI 10.1152/ajplung.00127.2006; Bossi F, 2004, J IMMUNOL, V173, P6921, DOI 10.4049/jimmunol.173.11.6921; Bowes WK, 2002, OBSTET NORMAL PROBLE; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Carroll RL, 2007, AM J PRIMATOL, V69, P901, DOI 10.1002/ajp.20396; Cerneca F, 1997, EUR J OBSTET GYN R B, V73, P31, DOI 10.1016/S0301-2115(97)02734-6; Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262; Conroy AL, 2011, TRENDS PARASITOL, V27, P294, DOI 10.1016/j.pt.2011.02.005; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Denny KJ, 2013, J REPROD IMMUNOL, V97, P211, DOI 10.1016/j.jri.2012.11.006; Denny KJ, 2013, AM J REPROD IMMUNOL, V69, P3, DOI 10.1111/aji.12000; Devaux P, 2004, J GEN VIROL, V85, P1665, DOI 10.1099/vir.0.79880-0; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Doyle TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079040; ELEY RM, 1989, AM J PRIMATOL, V17, P1, DOI 10.1002/ajp.1350170102; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; ELSE JG, 1986, AM J PRIMATOL, V11, P333, DOI 10.1002/ajp.1350110404; Francis J, 2006, MOL HUM REPROD, V12, P435, DOI 10.1093/molehr/gal048; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; GALLERY ED, 1981, AUST NZ J MED, V11, P243; Ghannam A, 2014, MOL IMMUNOL, V58, P98, DOI 10.1016/j.molimm.2013.11.010; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Girardi G, 2011, MOL IMMUNOL, V48, P1621, DOI 10.1016/j.molimm.2011.04.011; Gonzalez SF, 2008, VACCINE, V26, pI86, DOI 10.1016/j.vaccine.2008.11.057; HESS DL, 1979, J MED PRIMATOL, V8, P273; HIRSCH RL, 1986, ARCH VIROL, V87, P181, DOI 10.1007/BF01315298; Holmberg V, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-61; HYTTEN F, 1985, CLIN HAEMATOL, V14, P601; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Johnson JB, 2008, VIROLOGY, V376, P112, DOI 10.1016/j.virol.2008.03.022; Jones R., 2013, HUMAN REPROD BIOL, V4th ed; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; KORITNIK DR, 1984, METABOLISM, V33, P840, DOI 10.1016/0026-0495(84)90112-4; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; KOVAR IZ, 1988, J CLIN PATHOL, V41, P650, DOI 10.1136/jcp.41.6.650; Kraus TA, 2012, J CLIN IMMUNOL, V32, P300, DOI 10.1007/s10875-011-9627-2; Kundu MC, 2013, SYST BIOL REPROD MED, V59, P74, DOI 10.3109/19396368.2012.752547; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; LEWISJONES DI, 1985, ACTA PAEDIATR SCAND, V74, P655, DOI 10.1111/j.1651-2227.1985.tb10007.x; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Moncla LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078750; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; NYLAND TG, 1984, J CLIN ULTRASOUND, V12, P387, DOI 10.1002/jcu.1870120703; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Oluyomi-Obi T, 2010, J OBSTET GYNAECOL CA, V32, P443, DOI 10.1016/S1701-2163(16)34497-8; Ostensen M, 2002, TRANSPL IMMUNOL, V9, P155, DOI 10.1016/S0966-3274(02)00017-5; Pacheco LD, 2011, AM J PERINAT, V28, P565, DOI 10.1055/s-0031-1274510; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Parks GD, 2002, J GEN VIROL, V83, P1167, DOI 10.1099/0022-1317-83-5-1167; PATERSON RG, 1995, VIROLOGY, V208, P121, DOI 10.1006/viro.1995.1135; Pazos MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040502; Richani K, 2005, J MATERN-FETAL NEO M, V17, P239, DOI 10.1080/14767050500072722; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Ross TM, 2014, HUM VACCIN IMMUNOTHE, V10; Sappenfield Elisabeth, 2013, Infect Dis Obstet Gynecol, V2013, P752852, DOI 10.1155/2013/752852; Simpson KC, 2001, AHWONNS PERINATAL NU; Stephens SM, 2013, COMPARATIVE MED, V63, P432; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; WELSH RM, 1977, J IMMUNOL, V118, P348; Wilder RL, 1998, ANN NY ACAD SCI, V840, P45, DOI 10.1111/j.1749-6632.1998.tb09547.x; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498	84	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112749	10.1371/journal.pone.0112749	http://dx.doi.org/10.1371/journal.pone.0112749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409303	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200040
J	Vilela, B; Villalobos, F; Rodriguez, MA; Terribile, LC				Vilela, Bruno; Villalobos, Fabricio; Rodriguez, Miguel Angel; Terribile, Levi Carina			Body Size, Extinction Risk and Knowledge Bias in New World Snakes	PLOS ONE			English	Article							GEOGRAPHIC RANGE; BIODIVERSITY; PATTERNS; BIRDS; PHYLOGENY; RICHNESS; SQUAMATA; REPTILES; ECOLOGY; BIG	Extinction risk and body size have been found to be related in various vertebrate groups, with larger species being more at risk than smaller ones. We checked whether this was also the case for snakes by investigating extinction risk-body size relationships in the New World's Colubroidea species. We used the IUCN Red List risk categories to assign each species to one of two broad levels of threat (Threatened and Non-Threatened) or to identify it as either Data Deficient or Not-Evaluated by the IUCN. We also included the year of description of each species in our analysis as this could affect the level of threat assigned to it (earlier described species had more time to gather information about them, which might have facilitated their evaluation). Also, species detectability could be a function of body size, with larger species tending to be described earlier, which could have an impact in extinction risk-body size relationships. We found a negative relationship between body size and description year, with large-bodied species being described earlier. Description year also varied among risk categories, with Non-Threatened species being described earlier than Threatened species and both species groups earlier than Data Deficient species. On average, Data Deficient species also presented smaller body sizes, while no size differences were detected between Threatened and Non-Threatened species. So it seems that smaller body sizes are related with species detectability, thus potentially affecting both when a species is described (smaller species tend to be described more recently) as well as the amount of information gathered about it (Data Deficient species tend to be smaller). Our data also indicated that if Data Deficient species were to be categorized as Threatened in the future, snake body size and extinction risk would be negatively related, contrasting with the opposite pattern commonly observed in other vertebrate groups.	[Vilela, Bruno; Villalobos, Fabricio] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Vilela, Bruno; Rodriguez, Miguel Angel] Univ Alcala, Dept Ciencias Vida, Madrid, Spain; [Terribile, Levi Carina] Univ Fed Goias, Lab Macroecol, Jatai, Go, Brazil	Universidade Federal de Goias; Universidad de Alcala; Universidade Federal de Goias	Vilela, B (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil.	brunovilelasilva@hotmail.com	Rodriguez, Miguel A/A-3409-2011; Terribile, Levi Carina/AAW-1102-2021; Villalobos, Fabricio/J-6246-2012; Vilela, Bruno/L-1594-2015	Rodriguez, Miguel A/0000-0002-4082-2995; Terribile, Levi Carina/0000-0001-8420-9300; Villalobos, Fabricio/0000-0002-5230-2217; Vilela, Bruno/0000-0003-4072-0558	Spanish Ministry of Economy and Competitiveness [CGL2010-22119]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [473788/2009-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Spanish Ministry of Economy and Competitiveness(Spanish Government); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Spanish Ministry of Economy and Competitiveness (grant: CGL2010-22119), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Process n. 473788/2009-8) (http://www.cnpq.br/), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Boback SM, 2003, EVOLUTION, V57, P345; Bonner J.T., 2011, WHY SIZE MATTERS BAC; Brown J. H., 1995, MACROECOLOGY; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2003, ANIM CONSERV, V6, P63, DOI 10.1017/S1367943003003093; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; CROWLEY PH, 1992, ANNU REV ECOL SYST, V23, P405, DOI 10.1146/annurev.es.23.110192.002201; Diniz JAF, 2001, EVOLUTION, V55, P1104, DOI 10.1111/j.0014-3820.2001.tb00630.x; Diniz JAF, 2012, ECOGRAPHY, V35, P239, DOI 10.1111/j.1600-0587.2011.06949.x; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Filippi E, 2000, BIOL CONSERV, V93, P219, DOI 10.1016/S0006-3207(99)00138-X; Fitzgerald LA, 2000, WILDLIFE SOC B, V28, P235; Freitas MA, 2007, HERPETOFAUNA CAATING; Freitas MA, 2005, HERPETOFAUNA MATA AT; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gonzalez-Suarez M, 2012, J ANIM ECOL, V81, P1211, DOI 10.1111/j.1365-2656.2012.01999.x; Harnik PG, 2011, P NATL ACAD SCI USA, V108, P13594, DOI 10.1073/pnas.1100572108; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 2012, IUCN RED LIST THREAT; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Kohler G, 2003, REPTILES CENTROAMERI; Luisellil L, 2005, J ZOOL, V265, P207, DOI 10.1017/S0952836904006211; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Olalla-Tarraga MA, 2006, J BIOGEOGR, V33, P781, DOI 10.1111/j.1365-2699.2006.01435.x; Olden JD, 2007, GLOBAL ECOL BIOGEOGR, V16, P694, DOI 10.1111/j.1466-8238.2007.00337.x; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Payne JL, 2007, P NATL ACAD SCI USA, V104, P10506, DOI 10.1073/pnas.0701257104; Pereira-Filho GA, 2007, VERTEBRATE CONSERVAT, P143; Petchey OL, 2010, BIOL LETT; Pincheira-Donoso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059741; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pough F.H., 1983, P141; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; R Core Team, 2021, R LANGUAGE ENV STAT; Reed RN, 2002, GLOBAL ECOL BIOGEOGR, V11, P41, DOI 10.1046/j.1466-822X.2002.00260.x; Reed RN, 2003, ECOGRAPHY, V26, P107, DOI 10.1034/j.1600-0587.2003.03388.x; Reed RN, 2002, CONSERV BIOL, V16, P451, DOI 10.1046/j.1523-1739.2002.02283.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Terribile LC, 2012, J ZOOL SYST EVOL RES, V50, P202, DOI 10.1111/j.1439-0469.2012.00658.x; Terribile LC, 2009, GLOBAL ECOL BIOGEOGR, V18, P123, DOI 10.1111/j.1466-8238.2008.00440.x; Uetz P., 2012, REPTILE DATABASE; Vilela B, 2014, LETSR TOOLS DATA HAN	54	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113429	10.1371/journal.pone.0113429	http://dx.doi.org/10.1371/journal.pone.0113429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409293	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200120
J	Zhang, CB; Teng, FM; Tu, J; Zhang, D				Zhang, Chunbing; Teng, Fengmeng; Tu, Juan; Zhang, Dong			Ultrasound-Enhanced Protective Effect of Tetramethylpyrazine against Cerebral Ischemia/Reperfusion Injury	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; SUPEROXIDE-DISMUTASE; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; RAT-BLOOD; ISCHEMIA; STROKE; DRUG; REPERFUSION; DAMAGE	In traditional Chinese medicine, Ligusticum wallichii (Chuan Xiong) and its bioactive ingredient, tetramethylpyrazine (TMP), have been used to treat cardiovascular diseases and to relieve various neurological symptoms, such as those associated with ischemic injury. In the present study, we investigated whether ultrasound (US) exposure could enhance the protective effect of TMP against cerebral ischemia/reperfusion (I/R) injury. Glutamate-induced toxicity to pheochromocytoma (PC12) cells was used to model I/R injury. TMP was paired with US to examine whether this combination could alleviate glutamate-induced cytotoxicity. The administration of TMP effectively protected cells against glutamate-induced apoptosis, which could be further enhanced by US-mediated sonoporation. The anti-apoptotic effect of TMP was associated with the inhibition of oxidative stress and a change in the levels of apoptosis-related proteins, Bcl-2 and Bax. Furthermore, TMP reduced the expression of proinflammatory cytokines such as TNF-alpha and IL-8, which likely also contributes to its cytoprotective effects. Taken together, our findings suggest that ultrasound-enhanced TMP treatment might be a promising therapeutic strategy for ischemic stroke. Further study is required to optimize ultrasound treatment parameters.	[Zhang, Chunbing; Teng, Fengmeng] Jiangsu Prov TCM, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Chunbing] Nanjing Univ Chinese Med, Nanjing, Jiangsu, Peoples R China; [Tu, Juan; Zhang, Dong] Nanjing Univ, Key Lab Modern Acoust MOE, Inst Acoust, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University	Tu, J (corresponding author), Nanjing Univ, Key Lab Modern Acoust MOE, Inst Acoust, Nanjing 210008, Jiangsu, Peoples R China.	juantu@nju.edu.cn; dzhang@nju.edu.cn		Zhang, Chunbing/0000-0001-5576-7821	National Basic Research Program 973 from Ministry of Science and Technology, China [2011CB707900]; National Natural Science Foundation of China [81171659, 81127901, 81227004, 11374155, 11174141, 11104140, 11474001, 11161120324, 11474161]; National High-Tech Research and Development Program 863 [2012AA022702]	National Basic Research Program 973 from Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program 863(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program 973 (Grant no. 2011CB707900) from Ministry of Science and Technology, China, National Natural Science Foundation of China (Grant no's. 81171659, 81127901, 81227004, 11374155, 11174141, 11104140, 11474001, 11161120324 and 11474161), and the National High-Tech Research and Development Program 863 (2012AA022702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrouz R, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/839151; Cheng XR, 2007, CELL BIOL INT, V31, P438, DOI 10.1016/j.cellbi.2006.10.001; DAI XZ, 1985, J CARDIOVASC PHARM, V7, P841, DOI 10.1097/00005344-198509000-00005; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Genovese T, 2011, BRAIN RES, V1372, P92, DOI 10.1016/j.brainres.2010.11.088; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; Heo JM, 2007, BIOCHEM PHARMACOL, V74, P1361, DOI 10.1016/j.bcp.2007.07.023; HO WKK, 1989, STROKE, V20, P96, DOI 10.1161/01.STR.20.1.96; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Hynynen K, 2008, ADV DRUG DELIVER REV, V60, P1209, DOI 10.1016/j.addr.2008.03.010; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ilan Z, 1994, NEUROSCI LETT, V170; Ito Y, 2010, CURR NEUROVASC RES, V7, P23, DOI 10.2174/156720210790820190; Kostulas N, 1998, STROKE, V29, P462, DOI 10.1161/01.STR.29.2.462; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Liang CC, 1999, J CHROMATOGR B, V724, P303, DOI 10.1016/S0378-4347(99)00010-9; Liao SL, 2004, NEUROSCI LETT, V372, P40, DOI 10.1016/j.neulet.2004.09.013; Liao SL, 2002, NEUROSCI LETT, V324, P133, DOI 10.1016/S0304-3940(02)00236-7; Lindsberg PJ, 1996, CIRCULATION, V94, P939, DOI 10.1161/01.CIR.94.5.939; Lui C., 1978, CLIN MED RES, V4, P24; Marmottant P, 2003, NATURE, V423, P153, DOI 10.1038/nature01613; May DJ, 2002, IEEE T ULTRASON FERR, V49, P1400, DOI 10.1109/TUFFC.2002.1041081; Mei D, 2008, EUR J PHARM BIOPHARM, V70, P874, DOI 10.1016/j.ejpb.2008.06.031; Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662; Muzykantov VR, 2001, J CONTROL RELEASE, V71, P1, DOI 10.1016/S0168-3659(01)00215-2; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Nita DA, 2001, J CELL MOL MED, V5, P163, DOI 10.1111/j.1582-4934.2001.tb00149.x; Oto J, 2008, J ANESTH, V22, P207, DOI 10.1007/s00540-008-0639-x; Ou Y, 2010, PHARMAZIE, V65, P755, DOI 10.1691/ph.2010.0580; Pias EK, 2002, CELL DEATH DIFFER, V9, P1007, DOI 10.1038/sj.cdd.4401064; Qiu YY, 2010, J CONTROL RELEASE, V145, P40, DOI 10.1016/j.jconrel.2010.04.010; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Shih YH, 2002, NEUROREPORT, V13, P515, DOI 10.1097/00001756-200203250-00032; Tsai TH, 2001, INT J PHARMACEUT, V216, P61, DOI 10.1016/S0378-5173(01)00572-5; Tu XK, 2011, INFLAMMATION, V34, P463, DOI 10.1007/s10753-010-9254-8; TUTTLE RS, 1989, AM J OBSTET GYNECOL, V161, P1319, DOI 10.1016/0002-9378(89)90691-1; van Wamel A, 2006, J CONTROL RELEASE, V112, P149, DOI 10.1016/j.jconrel.2006.02.007; Virmani Renu, 2006, Neurosurgery, V59, pS219; Zarnitsyn V, 2008, BIOPHYS J, V95, P4124, DOI 10.1529/biophysj.108.131664; Zhang H, 2014, NEUROCHEM RES, V39, P276, DOI 10.1007/s11064-013-1219-5; Zhang ZH, 2003, LIFE SCI, V72, P2465, DOI 10.1016/S0024-3205(03)00139-5; Zhao H, 2003, BIORHEOLOGY, V40, P179	44	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113673	10.1371/journal.pone.0113673	http://dx.doi.org/10.1371/journal.pone.0113673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409029	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200143
J	Zhang, Q; Liu, HZ; Soukup, GA; He, DZZ				Zhang, Qian; Liu, Huizhan; Soukup, Garrett A.; He, David Z. Z.			Identifying MicroRNAs Involved in Aging of the Lateral Wall of the Cochlear Duct	PLOS ONE			English	Article							ENDOCOCHLEAR POTENTIAL REDUCTION; LIFE-SPAN; DIFFERENTIAL EXPRESSION; HEARING-LOSS; RECEPTOR; PROTEIN; CELLS; OVEREXPRESSION; APOPTOSIS; GROWTH	Age-related hearing loss is a progressive sensorineural hearing loss that occurs during aging. Degeneration of the organ of Corti and atrophy of the lateral wall of the cochlear duct (or scala media) in the inner ear are the two primary causes. MicroRNAs (miRNAs), a class of short non-coding RNAs that regulate the expression of mRNA/protein targets, are important regulators of cellular senescence and aging. We examined miRNA gene expression profiles in the lateral wall of two mouse strains, along with exploration of the potential targets of those miRNAs that showed dynamic expression during aging. We show that 95 and 60 miRNAs exhibited differential expression in C57 and CBA mice during aging, respectively. A majority of downregulated miRNAs are known to regulate pathways of cell proliferation and differentiation, while all upregulated miRNAs are known regulators in the pro-apoptotic pathways. By using apoptosis-related gene array and bioinformatic approaches to predict miRNA targets, we identify candidate miRNA-regulated genes that regulate apoptosis pathways in the lateral wall of C57 and CBA mice during aging.	[Zhang, Qian; Liu, Huizhan; Soukup, Garrett A.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Creighton University	Soukup, GA (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	GarrettSoukup@creighton.edu; hed@creighton.edu		He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	NIH [R01 DC004696, R01 DC 009025]; Creighton University School of Medicine; NCRR, NIH) [RR17417-01]; University of Nebraska Microarray Facility; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417, P20RR018788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696, R01DC009025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creighton University School of Medicine; NCRR, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Nebraska Microarray Facility; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work has been supported by NIH grant R01 DC004696 to DH. QZ has been supported by a graduate student scholarship from Creighton University School of Medicine. GS is supported by NIH grant R01 DC 009025 from the NIDCD. We acknowledge the use of the Integrated Biological Imaging Facility (supported by the Creighton University School of Medicine and C06 Grant RR17417-01 from the NCRR, NIH) and the University of Nebraska Microarray Facility (supported by P20 Grant RR 018788 from the NCRR, NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2013, PHARMACOL RES, V75, P28, DOI 10.1016/j.phrs.2013.04.003; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bates DJ, 2009, BBA-GEN SUBJECTS, V1790, P970, DOI 10.1016/j.bbagen.2009.03.028; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; CABLE J, 1993, PIGM CELL RES, V6, P215, DOI 10.1111/j.1600-0749.1993.tb00605.x; Cammarata G, 2010, AM J HEMATOL, V85, P331, DOI 10.1002/ajh.21667; Chen L, 2013, CELL MOL NEUROBIOL, V33, P651, DOI 10.1007/s10571-013-9927-6; Chen YX, 2012, PHYSIOL GENOMICS, V44, P1042, DOI 10.1152/physiolgenomics.00052.2012; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Devarajan P, 2002, HEARING RES, V174, P45, DOI 10.1016/S0378-5955(02)00634-2; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dynoodt P, 2013, INT J ONCOL, V42, P1443, DOI 10.3892/ijo.2013.1823; Dynoodt P, 2013, J INVEST DERMATOL, V133, P201, DOI 10.1038/jid.2012.266; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; GILAD O, 1979, J AM AUDITORY SOC, V4, P207; GILAD O, 1979, J AM AUDITORY SOC, V4, P195; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Habtemichael N, 2010, MOL CELL NEUROSCI, V45, P297, DOI 10.1016/j.mcn.2010.07.003; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hu BH, 2009, NEUROSCIENCE, V161, P915, DOI 10.1016/j.neuroscience.2009.03.072; Hu ZG, 2012, MOL CELL BIOL, V32, P5035, DOI 10.1128/MCB.01002-12; Hutcheson R, 2013, ARTERIOSCL THROM VAS, V33, P727, DOI 10.1161/ATVBAHA.112.301116; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Jakob P, 2012, CARDIOVASC RES, V93, P614, DOI 10.1093/cvr/cvr311; Jin CY, 2013, BIOMED PHARMACOTHER, V67, P321, DOI 10.1016/j.biopha.2012.11.005; Judice TN, 2002, BRAIN RES PROTOC, V9, P65, DOI 10.1016/S1385-299X(01)00138-6; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kaur P, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/870150; Khan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068753; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Knauer SK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.25; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055532; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; Mao ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065565; McKenna DJ, 2010, J VIROL, V84, P10644, DOI 10.1128/JVI.00703-10; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Mun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057850; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Nelson PT, 2011, NUCLEIC ACIDS RES, V39, P8163, DOI 10.1093/nar/gkr532; Ni C, 2013, PIGM CELL MELANOMA R, V26, P78, DOI 10.1111/pcmr.12030; Niu YN, 2011, IMMUNOLOGY, V133, P8, DOI 10.1111/j.1365-2567.2010.03374.x; Noguchi S, 2012, J BIOL CHEM, V287, P11769, DOI 10.1074/jbc.M111.325027; Ohlemiller KK, 2006, HEARING RES, V220, P10, DOI 10.1016/j.heares.2006.06.012; Ohlemiller Kevin K, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P439, DOI 10.1097/01.moo.0000134450.99615.22; Ohlemiller KK, 2011, JARO-J ASSOC RES OTO, V12, P45, DOI 10.1007/s10162-010-0238-z; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pichiorri Flavia, 2011, Frontiers in Genetics, V2, P22, DOI 10.3389/fgene.2011.00022; Provost P, 2010, AGING-US, V2, P166, DOI 10.18632/aging.100131; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Santovito D, 2013, EXPERT OPIN THER TAR, V17, P217, DOI 10.1517/14728222.2013.745512; Schacht J, 2005, AUDIOL NEURO-OTOL, V10, P243, DOI 10.1159/000086524; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; Spongr VP, 1997, J ACOUST SOC AM, V101, P3546, DOI 10.1121/1.418315; STEEL KP, 1989, DEVELOPMENT, V107, P453; Sun ZH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-276; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; Trivellin G, 2012, AM J PHYSIOL-ENDOC M, V303, pE708, DOI 10.1152/ajpendo.00546.2011; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wei L, 2010, NEUROSCIENCE, V168, P288, DOI 10.1016/j.neuroscience.2010.03.015; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WILLOTT JF, 1986, J NEUROPHYSIOL, V56, P391, DOI 10.1152/jn.1986.56.2.391; Yang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065256; Yao JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015546; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062786; Zhou DH, 2013, HEPATOB PANCREAT DIS, V12, P94, DOI 10.1016/S1499-3872(13)60012-0	81	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112857	10.1371/journal.pone.0112857	http://dx.doi.org/10.1371/journal.pone.0112857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405349	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300059
J	Dobbs, C; Nitschke, CR; Kendal, D				Dobbs, Cynnamon; Nitschke, Craig R.; Kendal, Dave			Global Drivers and Tradeoffs of Three Urban Vegetation Ecosystem Services	PLOS ONE			English	Article							GREEN SPACE; CARBON STORAGE; POLITICAL-ECONOMY; ECOLOGY; IMPACT; COVER; FORM; URBANIZATION; INEQUALITY; BENEFITS	Our world is increasingly urbanizing which is highlighting that sustainable cities are essential for maintaining human wellbeing. This research is one of the first attempts to globally synthesize the effects of urbanization on ecosystem services and how these relate to governance, social development and climate. Three urban vegetation ecosystem services (carbon storage, recreation potential and habitat potential) were quantified for a selection of a hundred cities. Estimates of ecosystem services were obtained from the analysis of satellite imagery and the use of well-known carbon and structural habitat models. We found relationships between ecosystem services, social development, climate and governance, however these varied according to the service studied. Recreation potential was positively related to democracy and negatively related to population. Carbon storage was weakly related to temperature and democracy, while habitat potential was negatively related to democracy. We found that cities under 1 million inhabitants tended to have higher levels of recreation potential than larger cities and that democratic countries have higher recreation potential, especially if located in a continental climate. Carbon storage was higher in full democracies, especially in a continental climate, while habitat potential tended to be higher in authoritarian and hybrid regimes. Similar to other regional or city studies we found that the combination of environment conditions, socioeconomics, demographics and politics determines the provision of ecosystem services. Results from this study showed the existence of environmental injustice in the developing world.	[Dobbs, Cynnamon] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Dobbs, Cynnamon; Nitschke, Craig R.] Univ Melbourne, Melbourne Sch Land & Environm, Sch Forest Sci & Ecosyst, Melbourne, Vic, Australia; [Kendal, Dave] Univ Melbourne, Sch Bot, Royal Bot Gardens Melbourne, Australian Res Ctr Urban Ecol, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Dobbs, C (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic, Australia.	cdobbsbr@gmail.com		kendal, dave/0000-0003-2816-1722; Nitschke, Craig/0000-0003-2514-9744				Alberti M, 2003, BIOSCIENCE, V53, P1169, DOI 10.1641/0006-3568(2003)053[1169:IHIEOA]2.0.CO;2; Andersson E, 2006, ECOL SOC, V11; Angel S., 2005, DYNAMICS GLOBAL URBA; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Bastian O, 2012, ECOL INDIC, V21, P7, DOI 10.1016/j.ecolind.2011.03.014; Begon M., 2009, ECOLOGY INDIVIDUALS; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Bjerke Tore, 2006, Urban Forestry & Urban Greening, V5, P35, DOI 10.1016/j.ufug.2006.01.006; Bowler DE, 2010, LANDSCAPE URBAN PLAN, V97, P147, DOI 10.1016/j.landurbplan.2010.05.006; Camara de Comercio de Bogota, 2009, CAP 3 GEST ESP PUBL, P37; Cilliers S, 2013, URBAN ECOSYST, V16, P681, DOI 10.1007/s11252-012-0254-3; Congalton R. G., 2009, MATER CHARACT, DOI DOI 10.1016/J.MATCHAR.2009.07.002; Conway Tenley M., 2007, Urban Forestry & Urban Greening, V6, P181, DOI 10.1016/j.ufug.2007.07.003; Daily G, 1997, WHAT ARE ECOSYSTEM S; Davies ZG, 2011, J APPL ECOL, V48, P1125, DOI 10.1111/j.1365-2664.2011.02021.x; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Demsar U, 2013, ANN ASSOC AM GEOGR, V103, P106, DOI 10.1080/00045608.2012.689236; Dobbs C, 2011, LANDSCAPE URBAN PLAN, V99, P196, DOI 10.1016/j.landurbplan.2010.11.004; Economist Intelligence Unit, 2011, DEM IND 2011 DEM STR; Edmondson JL, 2014, SCI TOTAL ENVIRON, V472, P444, DOI 10.1016/j.scitotenv.2013.11.025; Eigenbrod F, 2010, J APPL ECOL, V47, P377, DOI 10.1111/j.1365-2664.2010.01777.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ernstson H, 2008, ECOL SOC, V13; Escobedo F., 2006, URBAN FOR URBAN GREE, V4, P105, DOI DOI 10.1016/J.UFUG.2005.12.002; Escobedo FJ, 2011, ENVIRON POLLUT, V159, P2078, DOI 10.1016/j.envpol.2011.01.010; Farzin YH, 2006, J DEV ECON, V81, P213, DOI 10.1016/j.jdeveco.2005.04.003; Fortin MJ, 2012, SPAT STAT-NETH, V1, P100, DOI 10.1016/j.spasta.2012.02.004; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haase D, 2012, ECOL SOC, V17, DOI 10.5751/ES-04853-170322; Heynen N.C., 2003, PUBLIC WORKS MANAGEM, V8, P33, DOI [10.1177/1087724X03008001004, DOI 10.1177/1087724X03008001004, 10.1177/1087724X03253604]; Heynen N, 2006, URBAN AFF REV, V42, P3, DOI 10.1177/1078087406290729; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Huang JG, 2007, LANDSCAPE URBAN PLAN, V82, P184, DOI 10.1016/j.landurbplan.2007.02.010; Huber A., 1995, URBAN ECOLOGY BASIS; Hutyra LR, 2011, GLOBAL CHANGE BIOL, V17, P783, DOI 10.1111/j.1365-2486.2010.02238.x; Imhoff ML, 2004, REMOTE SENS ENVIRON, V89, P434, DOI 10.1016/j.rse.2003.10.015; Jim CY, 2009, CITIES, V26, P187, DOI 10.1016/j.cities.2009.03.003; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Kinzig AP, 2005, ECOL SOC, V10; Kitchen L, 2013, INT J URBAN REGIONAL, V37, P1968, DOI 10.1111/j.1468-2427.2012.01138.x; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kuchelmeister G., 1998, URBAN FORESTRY ASIA; Luck GW, 2011, CONSERV BIOL, V25, P816, DOI 10.1111/j.1523-1739.2011.01685.x; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; McDonald RI, 2008, FRONT ECOL ENVIRON, V6, P99, DOI 10.1890/070038; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Mikkelson GM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000444; Millenium Ecosystem Assessment, 2003, EC HUM WELL BEING EC, P85; Millenium Ecosystem Assessment, 2003, DRIV CHANG EC THEIR; Millenium Ecosystem Assessment, 2003, INTR CONC FRAM EC HU, P26; Myeong S, 2006, REMOTE SENS ENVIRON, V101, P277, DOI 10.1016/j.rse.2005.12.001; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Nowak David J., 2008, Arboriculture & Urban Forestry, V34, P347; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Pedlowski M.A., 2002, URBAN ECOSYST, V6, P9, DOI [DOI 10.1023/A:1025910528583, 10.1023/A:1025910528583]; Perkins HA, 2004, CITIES, V21, P291, DOI 10.1016/j.cities.2004.04.002; Potere D, 2009, INT J REMOTE SENS, V30, P6531, DOI 10.1080/01431160903121134; Poudyal NC, 2010, FOREST POLICY ECON, V12, P432, DOI 10.1016/j.forpol.2010.05.002; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Saura S, 2011, FOREST ECOL MANAG, V262, P150, DOI 10.1016/j.foreco.2011.03.017; Schneider A, 2008, URBAN STUD, V45, P659, DOI 10.1177/0042098007087340; Schwarz N, 2010, LANDSCAPE URBAN PLAN, V96, P29, DOI 10.1016/j.landurbplan.2010.01.007; Singh VS, 2010, URBAN FOREST OPEN GR; Strohbach MW, 2012, LANDSCAPE URBAN PLAN, V104, P220, DOI 10.1016/j.landurbplan.2011.10.013; Szantoi Z, 2012, GISCI REMOTE SENS, V49, P428, DOI 10.2747/1548-1603.49.3.428; Tannier C, 2012, LANDSCAPE URBAN PLAN, V105, P128, DOI 10.1016/j.landurbplan.2011.12.008; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; UN, 2011, AR WE BUILD COMP LIV; UNDP, 2011, HUM DEV REP 2011 BET; Van de Voorde T, 2008, SENSORS-BASEL, V8, P3880, DOI 10.3390/s8063880; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Wang T, 2006, GLOBAL CHANGE BIOL, V12, P2404, DOI 10.1111/j.1365-2486.2006.01271.x; Wang Xiao-Jun, 2009, Journal of Forestry Research (Harbin), V20, P79, DOI 10.1007/s11676-009-0014-2; Wickham JD, 2010, LANDSCAPE URBAN PLAN, V94, P186, DOI 10.1016/j.landurbplan.2009.10.003; Wilkinson C, 2013, URBANIZATION BIODIVE; Zhang JW, 2014, J ENVIRON PSYCHOL, V38, P55, DOI 10.1016/j.jenvp.2013.12.013; Zhu Z, 2012, REMOTE SENS ENVIRON, V117, P72, DOI 10.1016/j.rse.2011.07.020	84	60	64	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113000	10.1371/journal.pone.0113000	http://dx.doi.org/10.1371/journal.pone.0113000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8BL	25402184	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700091
J	Ricker, M; Ramirez, VMP; von Rosen, D				Ricker, Martin; Pena Ramirez, Victor M.; von Rosen, Dietrich			A New Method to Compare Statistical Tree Growth Curves: The PL-GMANOVA Model and Its Application with Dendrochronological Data	PLOS ONE			English	Article								Growth curves are monotonically increasing functions that measure repeatedly the same subjects over time. The classical growth curve model in the statistical literature is the Generalized Multivariate Analysis of Variance (GMANOVA) model. In order to model the tree trunk radius (r) over time (t) of trees on different sites, GMANOVA is combined here with the adapted PL regression model Q=A.T+E, where for b not equal 0 : Q=Ei[-b.r] - Ei[-b.r] and for b=0 : Q=Ln[r/r(1)], A = initial relative growth to be estimated, T=t-t(1), and E is an error term for each tree and time point. Furthermore, Ei[-b.r] = integral (Exp[b.r]/r)dr, b = -1/TPR, with TPR being the turning point radius in a sigmoid curve, and r(1) at t(1) is an estimated calibrating time-radius point. Advantages of the approach are that growth rates can be compared among growth curves with different turning point radiuses and different starting points, hidden outliers are easily detectable, the method is statistically robust, and heteroscedasticity of the residuals among time points is allowed. The model was implemented with dendrochronological data of 235 Pinus montezumae trees on ten Mexican volcano sites to calculate comparison intervals for the estimated initial relative growth (A) over cap. One site (at the Popocatepetl volcano) stood out, with (A) over cap being 3.9 times the value of the site with the slowest-growing trees. Calculating variance components for the initial relative growth, 34% of the growth variation was found among sites, 31% among trees, and 35% over time. Without the Popocatepetl site, the numbers changed to 7%, 42%, and 51%. Further explanation of differences in growth would need to focus on factors that vary within sites and over time.	[Ricker, Martin] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City, DF, Mexico; [Pena Ramirez, Victor M.] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico; [von Rosen, Dietrich] Swedish Univ Agr Sci, Dept Energy & Technol, Uppsala, Sweden	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Swedish University of Agricultural Sciences	Ricker, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City, DF, Mexico.	mricker@ib.unam.mx						[Anonymous], 2006, SAS MIXED MODELS; Belsley D. A., 1991, CONDITIONING DIAGNOS; Burkhart H. E., 2012, MODELING FOREST TREE; CONOVER W. J, 1980, PRACTICAL NONPARAMET; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Duncan T, 2006, INTRO LATENT VARIABL; Enders W., 2010, APPL ECONOMETRIC TIM, Vthird; Fisher RA., 1921, ANN APPL BIOL, DOI [10.1111/j.1744-7348.1921.tb05524.x, DOI 10.1111/J.1744-7348.1921.TB05524.X]; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; FLIGNER MA, 1981, J AM STAT ASSOC, V76, P162, DOI 10.2307/2287062; GABRIEL KR, 1978, J AM STAT ASSOC, V73, P724, DOI 10.2307/2286265; Golub GH., 2013, MATRIX COMPUTATIONS; HUI SL, 1984, BIOMETRICS, V40, P691, DOI 10.2307/2530912; Hunt R, 1982, PLANT GROWTH ANAL; Jeffrey A., 1995, HDB MATH FORMULAS IN; KHATRI CG, 1966, ANN I STAT MATH, V18, P75, DOI 10.1007/BF02869518; Kiviste A., 2002, FUNCIONES CRECIMIENT; Kollo T., 2005, MATH ITS APPL, V579; Kshirsagar A.M., 1995, GROWTH CURVES; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; LISKI EP, 1985, COMMUN STAT-SIMUL C, V14, P13, DOI 10.1080/03610918508812423; Maddala G. S., 2009, INTRO ECONOMETRICS; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Muller KE, 2006, LINEAR MODEL THEORY; Pan J., 2002, GROWTH CURVE MODELS; Pena Ramirez VM, 2013, THESIS U NACL AUTONO; Pinheiro J, 2001, MIXED EFFECTS MODELS; POTTHOFF RF, 1964, BIOMETRIKA, V51, P313, DOI [10.2307/2334137, 10.1093/biomet/51.3-4.313]; Ricker M, 2004, FOREST SCI, V50, P213; Ricker M, 2007, CAN J FOREST RES, V37, P977, DOI 10.1139/X06-304; Rohlf F.J., 2012, STAT TABLES; Ryan TP, 2009, MODERN REGRESSION AN; Sokal R. R., 2012, BIOMETRY; Speer JH, 2010, FUNDAMENTALS TREE RI; Srivastava M., 2002, METHODS MULTIVARIATE; Srivastava MS, 1999, STAT TEXTB MONOG, V159, P547; Stroup W. W., 2013, GEN LINEAR MIXED MOD; Timm NH, 2002, UNIVARIATE MULTIVARI; Verbeke G, 2000, LINEAR MIXED MODELS; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; VONROSEN D, 1995, ANN I STAT MATH, V47, P129, DOI 10.1007/BF00773417; VONROSEN D, 1991, COMMUN STAT THEORY, V20, P2791, DOI 10.1080/03610929108830668; Weerahandi S., 2004, GEN INFERENCE REPEAT; Weiskittel AR, 2011, FOREST GROWTH AND YIELD MODELING, P1, DOI 10.1002/9781119998518; Wenk G., 1990, WALDERTRAGSLEHRE	47	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112396	10.1371/journal.pone.0112396	http://dx.doi.org/10.1371/journal.pone.0112396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402427	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700043
J	Xie, YY; Xue, W; Shao, XH; Che, XJ; Xu, WJ; Ni, ZH; Mou, S				Xie, Yuanyuan; Xue, Wei; Shao, Xinghua; Che, Xiajing; Xu, Weijia; Ni, Zhaohui; Mou, Shan			Analysis of a Urinary Biomarker Panel for Obstructive Nephropathy and Clinical Outcomes	PLOS ONE			English	Article							KIDNEY INJURY MOLECULE-1; ACID-BINDING PROTEIN; GELATINASE-ASSOCIATED LIPOCALIN; CARDIAC-SURGERY; RENAL-DISEASE; EXCRETION; KIM-1; MARKER; PERFORMANCE; PROGRESSION	Objectives: To follow up renal function changes in patients with obstructive nephropathy and to evaluate the predictive value of biomarker panel in renal prognosis. Methods: A total of 108 patients with obstructive nephropathy were enrolled in the study; 90 patients completed the follow-up. At multiple time points before and after obstruction resolution, urinary samples were prospectively collected in patients with obstructive nephropathy; the levels of urinary kidney injury molecule-1 (uKIM-1), liver-type fatty acid-binding protein (uL-FABP), and neutrophil gelatinase associated lipocalin (uNGAL) were determined by enzyme-linked immunosorbent assay (ELISA). After 1 year of follow-up, the predictive values of biomarker panel for determining the prognosis of obstructive nephropathy were evaluated. Results: uKIM-1 (r = 0.823), uL-FABP (r = 0.670), and uNGAL (r = 0.720) levels were positively correlated with the serum creatinine level (all P<0.01). The levels of uKIM-1, uL-FABP, and uNGAL were higher in the renal function deterioration group than in the renal function stable group. Cox regression analysis revealed that the 72-h postoperative uKIM-1 level and the preoperative and 72-h postoperative uL-FABP levels were all risk factors for renal function deterioration (all P<0.01). The area under the curve of Receiver Operating Characteristic(ROC-AUCs) of 72-h postoperative uKIM-1, preoperative uL-FABP, and 72-h postoperative uL-FABP were 0.786, 0.911, and 0.875, respectively. When the combined preoperative uKIM-1, uL-FABP, and uNGAL levels or combined 72-h postoperative uKIM-1, uL-FABP, and uNGAL levels were considered, the accuracy of prediction for renal prognosis was markedly increased, with an ROC-AUC of 0.967 or 0.964, respectively. Kaplan-Meier survival curve analysis demonstrated that a 72-h postoperative uKIM-1>96.69 pg/mg creatinine (Cr), a preoperative uL-FABP>154.62 ng/mg Cr, and a 72-h postoperative uL-FABP>99.86 ng/mg Cr were all positively correlated with poor prognosis (all P<0.01). Conclusion: Biomarker panel may be used as a marker for early screening of patients with obstructive nephropathy and for determining poor prognosis.	[Xie, Yuanyuan; Shao, Xinghua; Che, Xiajing; Xu, Weijia; Ni, Zhaohui; Mou, Shan] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Nephrol,Mol Cell Lab Kidney Dis, Shanghai 200030, Peoples R China; [Xue, Wei] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Urol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xue, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Urol, Shanghai 200030, Peoples R China.	uroxuewei@163.com; shan_mou@126.com	shao, xinghua/GVU-8320-2022	mou, shan/0000-0003-4160-1681	National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China [2014DFT30090]; National Natural Science Foundation of China [81102700, 81373865, 81370794]; Science and Technology Commission of Shanghai Municipality, China [12401906400, 14140903200]; Shanghai Health Bureau [ZYSNXD012-RC-ZXY017]; Funding scheme for training young teachers in Colleges and universities in Shanghai	National Basic Research Program of China 973 Program(National Basic Research Program of China); Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Health Bureau; Funding scheme for training young teachers in Colleges and universities in Shanghai	This study was supported in part by the National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517602). The study was also sponsored by Hong Kong, Macao and Taiwan Science & Technology Cooperation Program of China (2014DFT30090), the National Natural Science Foundation of China (81102700, 81373865 and 81370794) and by grants 12401906400 and 14140903200 from the Science and Technology Commission of Shanghai Municipality, China, and ZYSNXD012-RC-ZXY017 from the Shanghai Health Bureau. Funding scheme for training young teachers in Colleges and universities in Shanghai was also included in the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavsar NA, 2012, AM J KIDNEY DIS, V60, P233, DOI 10.1053/j.ajkd.2012.02.336; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Butt MJ, 2007, KIDNEY INT, V72, P936, DOI 10.1038/sj.ki.5002457; Chaturvedi S, 2009, INT J BIOL SCI, V5, P128; Chevalier RL, 2010, PEDIATR NEPHROL, V25, P687, DOI 10.1007/s00467-009-1316-5; Dear JW, 2008, KIDNEY INT, V74, P7, DOI 10.1038/ki.2008.126; Fu Peng, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P641, DOI 10.3736/jcim20120607; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Kamijo A, 2005, J LAB CLIN MED, V145, P125, DOI 10.1016/j.lab.2004.12.003; Kamijo A, 2004, AM J PATHOL, V165, P1243, DOI 10.1016/S0002-9440(10)63384-6; KLAHR S, 1991, AM J KIDNEY DIS, V18, P689, DOI 10.1016/S0272-6386(12)80611-1; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Mou S, 2012, CLIN CHIM ACTA, V413, P187, DOI 10.1016/j.cca.2011.09.018; Nakamura T, 2006, AM J KIDNEY DIS, V47, P439, DOI 10.1053/j.ajkd.2005.11.006; Parikh CR, 2013, CLIN J AM SOC NEPHRO, V8, P1079, DOI 10.2215/CJN.10971012; Ponte B, 2008, NEPHROL DIAL TRANSPL, V23, P3859, DOI 10.1093/ndt/gfn398; Portilla D, 2008, KIDNEY INT, V73, P465, DOI 10.1038/sj.ki.5002721; Shao XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084131; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Smith JM, 2007, PEDIATR TRANSPLANT, V11, P366, DOI 10.1111/j.1399-3046.2007.00704.x; Soni SS, 2009, BLOOD PURIFICAT, V28, P165, DOI 10.1159/000227785; Srisawat N, 2011, CLIN J AM SOC NEPHRO, V6, P1815, DOI 10.2215/CJN.11261210; Tang XJ, 2014, CURR OPIN NEPHROL HY, V23, P385, DOI 10.1097/01.mnh.0000447017.28852.52; Trnka P, 2012, CLIN J AM SOC NEPHRO, V7, P1567, DOI 10.2215/CJN.09640911; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Wasilewska A, 2011, PEDIATR NEPHROL, V26, P579, DOI 10.1007/s00467-011-1773-5; Xie YY, 2014, BIOMARK MED, V8, P543, DOI 10.2217/bmm.13.136; Xue W, 2014, NEPHROLOGY, V19, P186, DOI 10.1111/nep.12173	31	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112865	10.1371/journal.pone.0112865	http://dx.doi.org/10.1371/journal.pone.0112865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402279	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700079
J	Arambasic, M; Sandoval, PY; Hoehener, C; Singh, A; Swart, EC; Nowacki, M				Arambasic, Miroslav; Sandoval, Pamela Y.; Hoehener, Cristina; Singh, Aditi; Swart, Estienne C.; Nowacki, Mariusz			Pdsg1 and Pdsg2, Novel Proteins Involved in Developmental Genome Remodelling in Paramecium	PLOS ONE			English	Article							PROGRAMMED DNA ELIMINATION; DICER-LIKE PROTEIN; SMALL RNAS; REARRANGEMENTS; SEQUENCES; METHYLATION; TETRAHYMENA; TETRAURELIA; TRANSCRIPTS; CROSSTALK	The epigenetic influence of maternal cells on the development of their progeny has long been studied in various eukaryotes. Multicellular organisms usually provide their zygotes not only with nutrients but also with functional elements required for proper development, such as coding and non-coding RNAs. These maternally deposited RNAs exhibit a variety of functions, from regulating gene expression to assuring genome integrity. In ciliates, such as Paramecium these RNAs participate in the programming of large-scale genome reorganization during development, distinguishing germline-limited DNA, which is excised, from somatic-destined DNA. Only a handful of proteins playing roles in this process have been identified so far, including typical RNAi-derived factors such as Dicer-like and Piwi proteins. Here we report and characterize two novel proteins, Pdsg1 and Pdsg2 (Paramecium protein involved in Development of the Somatic Genome 1 and 2), involved in Paramecium genome reorganization. We show that these proteins are necessary for the excision of germline-limited DNA during development and the survival of sexual progeny. Knockdown of PDSG1 and PDSG2 genes affects the populations of small RNAs known to be involved in the programming of DNA elimination (scanRNAs and iesRNAs) and chromatin modification patterns during development. Our results suggest an association between RNA-mediated trans-generational epigenetic signal and chromatin modifications in the process of Paramecium genome reorganization.	[Arambasic, Miroslav; Sandoval, Pamela Y.; Hoehener, Cristina; Singh, Aditi; Swart, Estienne C.; Nowacki, Mariusz] Univ Bern, Inst Cell Biol, Bern, Switzerland	University of Bern	Nowacki, M (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	mariusz.nowacki@izb.unibe.ch	Sandoval, Pamela Y./AAL-8719-2020; Nowacki, Mariusz/E-4485-2011; Singh, Aditi/ABZ-0850-2022	Sandoval, Pamela Y./0000-0002-6514-3980; Nowacki, Mariusz/0000-0003-4894-2905; Singh, Aditi/0000-0001-7840-9058	Swiss National Science Foundation [31003A_129957]; European Research Council [GA 260358]; European Cooperation in Science and Technology Action BM1102	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Cooperation in Science and Technology Action BM1102	This work was supported by Swiss National Science Foundation grant 31003A_129957 (http://www.snf.ch/); European Research Council grant "EPIGENOME" GA 260358 (http://erc.europa.eu/); European Cooperation in Science and Technology Action BM1102 (http://www.cost.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Arnaiz O, 2011, NUCLEIC ACIDS RES, V39, pD632, DOI 10.1093/nar/gkq918; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Beisson J, 2010, COLD SPRING HARB PRO, V2010, DOI 10.1101; Betermier M, 2004, RES MICROBIOL, V155, P399, DOI 10.1016/j.resmic.2004.01.017; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Brown T, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0209as21; Coyne RS, 2012, BIOL CELL, V104, P309, DOI 10.1111/boc.201100057; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Galvani A, 2002, TRENDS GENET, V18, P11, DOI 10.1016/S0168-9525(01)02548-3; Galvani A, 2001, NUCLEIC ACIDS RES, V29, P4387, DOI 10.1093/nar/29.21.4387; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; Gratias A, 2008, NUCLEIC ACIDS RES, V36, P3244, DOI 10.1093/nar/gkn154; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; KLOBUTCHER LA, 1995, NUCLEIC ACIDS RES, V23, P2006, DOI 10.1093/nar/23.11.2006; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Matsuda A, 2006, EUKARYOT CELL, V5, P806, DOI 10.1128/EC.5.5.806-815.2006; Matsuda A, 2010, EUKARYOT CELL, V9, P1087, DOI 10.1128/EC.00379-09; Mayer KM, 1998, GENETICS, V148, P139; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nowacki M, 2005, CURR BIOL, V15, P1616, DOI 10.1016/j.cub.2005.07.033; Nowak JK, 2011, EUKARYOT CELL, V10, P363, DOI 10.1128/EC.00258-10; Ruiz F, 1998, MOL BIOL CELL, V9, P931, DOI 10.1091/mbc.9.4.931; Sandoval PY, 2014, DEV CELL, V28, P174, DOI 10.1016/j.devcel.2013.12.010; Schoeberl UE, 2012, GENE DEV, V26, P1729, DOI 10.1101/gad.196493.112; Swart EC, 2014, NUCLEIC ACIDS RES, V42, P8970, DOI 10.1093/nar/gku619; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8	41	6	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112899	10.1371/journal.pone.0112899	http://dx.doi.org/10.1371/journal.pone.0112899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397898	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500106
J	Deng, F; Chen, X; Liao, Z; Yan, ZJ; Wang, ZL; Deng, YL; Zhang, Q; Zhang, ZL; Ye, JX; Qiao, M; Li, RF; Denduluri, S; Wang, J; Wei, Q; Li, M; Geng, NS; Zhao, LG; Zhou, GL; Zhang, PH; Luu, HH; Haydon, RC; Reid, RR; Yang, T; He, TC				Deng, Fang; Chen, Xiang; Liao, Zhan; Yan, Zhengjian; Wang, Zhongliang; Deng, Youlin; Zhang, Qian; Zhang, Zhonglin; Ye, Jixing; Qiao, Min; Li, Ruifang; Denduluri, Sahitya; Wang, Jing; Wei, Qiang; Li, Melissa; Geng, Nisha; Zhao, Lianggong; Zhou, Guolin; Zhang, Penghui; Luu, Hue H.; Haydon, Rex C.; Reid, Russell R.; Yang, Tian; He, Tong-Chuan			A Simplified and Versatile System for the Simultaneous Expression of Multiple siRNAs in Mammalian Cells Using Gibson DNA Assembly	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEINS; BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; HEPATIC PROGENITOR CELLS; RNA INTERFERENCE; HUMAN OSTEOSARCOMA; OSTEOBLAST DIFFERENTIATION; TUMOR-GROWTH; WNT; THERAPEUTICS	RNA interference (RNAi) denotes sequence-specific mRNA degradation induced by short interfering double-stranded RNA (siRNA) and has become a revolutionary tool for functional annotation of mammalian genes, as well as for development of novel therapeutics. The practical applications of RNAi are usually achieved by expressing short hairpin RNAs (shRNAs) or siRNAs in cells. However, a major technical challenge is to simultaneously express multiple siRNAs to silence one or more genes. We previously developed pSOS system, in which siRNA duplexes are made from oligo templates driven by opposing U6 and H1 promoters. While effective, it is not equipped to express multiple siRNAs in a single vector. Gibson DNA Assembly (GDA) is an in vitro recombination system that has the capacity to assemble multiple overlapping DNA molecules in a single isothermal step. Here, we developed a GDA-based pSOK assembly system for constructing single vectors that express multiple siRNA sites. The assembly fragments were generated by PCR amplifications from the U6-H1 template vector pB2B. GDA assembly specificity was conferred by the overlapping unique siRNA sequences of insert fragments. To prove the technical feasibility, we constructed pSOK vectors that contain four siRNA sites and three siRNA sites targeting human and mouse beta-catenin, respectively. The assembly reactions were efficient, and candidate clones were readily identified by PCR screening. Multiple beta-catenin siRNAs effectively silenced endogenous beta-catenin expression, inhibited Wnt3A-induced beta-catenin/Tcf4 reporter activity and expression of Wnt/beta-catenin downstream genes. Silencing beta-catenin in mesenchymal stem cells inhibited Wnt3A-induced early osteogenic differentiation and significantly diminished synergistic osteogenic activity between BMP9 and Wnt3A in vitro and in vivo. These findings demonstrate that the GDA-based pSOK system has been proven simplistic, effective and versatile for simultaneous expression of multiple siRNAs. Thus, the reported pSOK system should be a valuable tool for gene function studies and development of novel therapeutics.	[Deng, Fang; Yang, Tian] Third Mil Med Univ, Dept Cell Biol, Chongqing 400038, Peoples R China; [Deng, Fang; Chen, Xiang; Liao, Zhan; Yan, Zhengjian; Wang, Zhongliang; Deng, Youlin; Zhang, Qian; Zhang, Zhonglin; Ye, Jixing; Qiao, Min; Li, Ruifang; Denduluri, Sahitya; Wang, Jing; Wei, Qiang; Li, Melissa; Geng, Nisha; Zhao, Lianggong; Zhou, Guolin; Zhang, Penghui; Luu, Hue H.; Haydon, Rex C.; Reid, Russell R.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Orthopaed Surg & Rehabil Med, Mol Oncol Lab, Chicago, IL 60637 USA; [Liao, Zhan; Qiao, Min; He, Tong-Chuan] Cent S Univ, Affiliated Xiang Ya Hosp, Dept Orthopaed Surg, Changsha 410008, Hunan, Peoples R China; [Yan, Zhengjian; Wang, Zhongliang; Deng, Youlin; Zhang, Qian; Qiao, Min; Wang, Jing; Wei, Qiang; Zhang, Penghui] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing 400016, Peoples R China; [Yan, Zhengjian; Wang, Zhongliang; Deng, Youlin; Zhang, Qian; Qiao, Min; Wang, Jing; Wei, Qiang; Zhang, Penghui] Chongqing Med Univ, Affiliated Hosp, Chongqing 400016, Peoples R China; [Zhang, Zhonglin; Li, Ruifang] Wuhan Univ, Affiliated Zhongnan Hosp, Dept Surg, Wuhan 430071, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 400044, Peoples R China; [Zhao, Lianggong] Lanzhou Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Lanzhou, Gansu, Peoples R China; [Reid, Russell R.] Univ Chicago, Med Ctr, Dept Surg, Lab Craniofacial Biol, Chicago, IL 60637 USA	Army Medical University; University of Chicago; University of Chicago Medical Center; Central South University; Chongqing Medical University; Chongqing Medical University; Wuhan University; Chongqing University; Lanzhou University; University of Chicago; University of Chicago Medical Center	Yang, T (corresponding author), Third Mil Med Univ, Dept Cell Biol, Chongqing 400038, Peoples R China.	tiany@163.net; tche@uchicago.edu	Geng, Nisha/AAA-4646-2022	Geng, Nisha/0000-0002-9849-5296; Deng, Fang/0000-0002-7927-5394; Chen, Xiang/0000-0001-7628-516X	National Institutes of Health [AT004418, AR50142, AR054381]; National Natural Science Foundation of China (NSFC) [81271770]; China Scholarship Council; University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [UL1 TR000430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR050142, K08AR054381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The reported work was supported in part by research grants from the National Institutes of Health (AT004418, AR50142, AR054381 to TCH, RCH and HHL), and the National Natural Science Foundation of China (NSFC grant #81271770 to TY). DF was a recipient of a doctorate fellowship from the China Scholarship Council. This work was also supported in part by The University of Chicago Core Facility Subsidy grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through grant UL1 TR000430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chen X, 2013, CELL PHYSIOL BIOCHEM, V32, P1083, DOI 10.1159/000354508; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Conte C, 2002, EMBO J, V21, P3908, DOI 10.1093/emboj/cdf367; Czech MP, 2011, NAT REV ENDOCRINOL, V7, P473, DOI 10.1038/nrendo.2011.57; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Feng T, 2002, BIOTECHNIQUES, V32, P992, DOI 10.2144/02325bm03; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kong YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1187, DOI 10.1159/000354518; Lamplot JD, 2014, CELL TRANSPLANT; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Li R., 2014, CURR CANC DRUG TARGE; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Liu X, 2013, J CELL MOL MED; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luo XJ, 2008, CLIN ORTHOP RELAT R, V466, P2060, DOI 10.1007/s11999-008-0361-x; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Sarkies P, 2014, NAT REV MOL CELL BIO, V15, P525, DOI 10.1038/nrm3840; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wang JH, 2014, STEM CELLS DEV, V23, P1405, DOI 10.1089/scd.2013.0580; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097316; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093608; Wang Y, 2013, J ORTHOP RES, V31, P1796, DOI 10.1002/jor.22427; Wen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094397; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu N, 2014, GENE THER, V21, P629, DOI 10.1038/gt.2014.40; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang RF, 2011, J INVEST DERMATOL, V131, P2458, DOI 10.1038/jid.2011.242; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073086; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhang Y, 2014, ONCOL REP; Zhao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092908; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	68	42	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113064	10.1371/journal.pone.0113064	http://dx.doi.org/10.1371/journal.pone.0113064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398142	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500129
J	Laeger, I; Dobel, C; Radenz, B; Kugel, H; Keuper, K; Eden, A; Arolt, V; Zwitserlood, P; Dannlowski, U; Zwanzger, P				Laeger, Inga; Dobel, Christian; Radenz, Britta; Kugel, Harald; Keuper, Kati; Eden, Annuschka; Arolt, Volker; Zwitserlood, Pienie; Dannlowski, Udo; Zwanzger, Peter			Of 'Disgrace' and 'Pain' - Corticolimbic Interaction Patterns for Disorder- Relevant and Emotional Words in Social Phobia	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; GENERALIZED ANXIETY DISORDER; AMYGDALA ACTIVATION; PREFRONTAL CORTEX; BRAIN ACTIVATION; ORBITOFRONTAL CORTEX; MAJOR DEPRESSION; HEALTHY-SUBJECTS; FEARFUL FACES; TRAIT ANXIETY	Limbic hyperactivation and an impaired functional interplay between the amygdala and the prefrontal cortex are discussed to go along with, or even cause, pathological anxiety. Within the multi-faceted group of anxiety disorders, the highly prevalent social phobia (SP) is characterized by excessive fear of being negatively evaluated. Although there is widespread evidence for amygdala hypersensitivity to emotional faces in SP, verbal material has rarely been used in imaging studies, in particular with an eye on disorder-specificity. Using functional magnetic resonance imaging (fMRI) and a block design consisting of (1) overall negative, (2) social-phobia related, (3) positive, and (4) neutral words, we studied 25 female patients with social phobia and 25 healthy female control subjects (HC). Results demonstrated amygdala hyperactivation to disorder-relevant but not to generally negative words in SP patients, with a positive correlation to symptom severity. A functional connectivity analysis revealed a weaker coupling between the amygdala and the left middle frontal gyrus in patients. Symptom severity was negatively related to connectivity strength between the amygdala and the ventromedial prefrontal and orbitofrontal cortex (Brodmann Area 10 and 11). The findings clearly support the view of a hypersensitive threat-detection system, combined with disorder-related alterations in amygdala-prefrontal cortex connectivity in pathological anxiety.	[Laeger, Inga; Radenz, Britta; Arolt, Volker; Dannlowski, Udo; Zwanzger, Peter] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Dobel, Christian; Keuper, Kati; Eden, Annuschka] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Kugel, Harald] Univ Munster, Dept Clin Radiol, D-48149 Munster, Germany; [Laeger, Inga; Zwitserlood, Pienie] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Dannlowski, Udo] Univ Marburg, Dept Psychiat, Marburg, Germany; [Zwanzger, Peter] Kbo Inn Salzach Hosp, Wasserburg Am Inn, Germany	University of Munster; University of Munster; University of Munster; University of Munster; Philipps University Marburg	Zwanzger, P (corresponding author), Univ Munster, Dept Psychiat, D-48149 Munster, Germany.	peter.zwanzger@kbo.de		Kugel, Harald/0000-0002-4349-1984; Dannlowski, Udo/0000-0002-0623-3759; Roesmann (Keuper), Kati/0000-0001-6940-3551	Interdisziplinares Zentrum fur klinische Forschung (IZKF) of the Medical Faculty of Muenster University [Do3/021/10]; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of the University of Munster;  [SFB TRR 58];  [C1]	Interdisziplinares Zentrum fur klinische Forschung (IZKF) of the Medical Faculty of Muenster University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Munster; ; 	This work was supported by grants of Interdisziplinares Zentrum fur klinische Forschung (IZKF) of the Medical Faculty of Muenster University (grant number Do3/021/10 to CD and PZ) and the SFB TRR 58 subproject C1 to PZ. The authors furthermore acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of the University of Munster. The named funding sources were not involved in study design, collection, analysis or interpretation of data.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baayen R. H, 1995, CELEX LEXICAL DATABA; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Baur V, 2011, J PSYCHIATR RES, V45, P1366, DOI 10.1016/j.jpsychires.2011.05.007; Beck A.T., 1987, BECK DEPRESSION INVE; Becker ES, 2001, J ANXIETY DISORD, V15, P147, DOI 10.1016/S0887-6185(01)00055-X; Birbaumer N, 1998, NEUROREPORT, V9, P1223, DOI 10.1097/00001756-199804200-00048; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Blair KS, 2011, PSYCHIAT RES-NEUROIM, V193, P38, DOI 10.1016/j.pscychresns.2010.12.016; Blair KS, 2010, AM J PSYCHIAT, V167, P1526, DOI 10.1176/appi.ajp.2010.09121797; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bruhl AB, 2011, BRAIN RES, V1378, P72, DOI 10.1016/j.brainres.2010.12.084; Cooney RE, 2006, PSYCHIAT RES-NEUROIM, V148, P55, DOI 10.1016/j.pscychresns.2006.05.003; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411; Dannlowski U, 2010, NEUROIMAGE, V53, P893, DOI 10.1016/j.neuroimage.2009.11.073; Diemer J, 2010, EUR ARCH PSY CLIN N, V260, pS127, DOI 10.1007/s00406-010-0143-9; Ding JR, 2011, MAGN RESON IMAGING, V29, P701, DOI 10.1016/j.mri.2011.02.013; Domschke K, 2010, NEUROIMAGE, V53, P822, DOI 10.1016/j.neuroimage.2009.11.042; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fehm L, 2005, EUR NEUROPSYCHOPHARM, V15, P453, DOI 10.1016/j.euroneuro.2005.04.002; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Furmark T, 2004, NEUROSCI LETT, V362, P189, DOI 10.1016/j.neulet.2004.02.070; Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008; Gentili C, 2008, BRAIN RES BULL, V77, P286, DOI 10.1016/j.brainresbull.2008.08.003; Goldin PR, 2009, BIOL PSYCHIAT, V66, P1091, DOI 10.1016/j.biopsych.2009.07.014; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hofer A, 2007, PSYCHOL MED, V37, P109, DOI 10.1017/S0033291706008919; Kessler RC, 2003, ACTA PSYCHIAT SCAND, V108, P19, DOI 10.1034/j.1600-0447.108.s417.2.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Koric L, 2012, HUM BRAIN MAPP, V33, P1973, DOI 10.1002/hbm.21340; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Labuschagne I, 2012, INT J NEUROPSYCHOPH, V15, P883, DOI 10.1017/S1461145711001489; Laeger I, 2012, BEHAV BRAIN RES, V233, P508, DOI 10.1016/j.bbr.2012.05.036; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; Lorberbaum JP, 2004, NEUROREPORT, V15, P2701; Maidenberg E, 1996, J ANXIETY DISORD, V10, P529, DOI 10.1016/S0887-6185(96)00028-X; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Miskovic V, 2012, NEUROSCI BIOBEHAV R, V36, P459, DOI 10.1016/j.neubiorev.2011.08.002; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Ouimet AJ, 2009, CLIN PSYCHOL REV, V29, P459, DOI 10.1016/j.cpr.2009.05.004; Pallanti S, 2008, INT J PSYCHIAT CLIN, V12, P256, DOI 10.1080/13651500802007926; Pallanti S, 2009, INT CLIN PSYCHOPHARM, V24, P163, DOI 10.1097/YIC.0b013e32832c2639; Paquette V, 2003, NEUROIMAGE, V18, P401, DOI 10.1016/S1053-8119(02)00030-7; Phan KL, 2009, BIOL PSYCHIAT, V66, P691, DOI 10.1016/j.biopsych.2009.02.028; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; Quadflieg S, 2008, BIOL PSYCHOL, V78, P129, DOI 10.1016/j.biopsycho.2008.01.014; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Schienle A, 2005, NEUROSCI LETT, V388, P1, DOI 10.1016/j.neulet.2005.06.025; Schmidt S, 2010, BIOL PSYCHOL, V84, P304, DOI 10.1016/j.biopsycho.2010.03.005; Sehlmeyer C, 2011, PSYCHOL MED, V41, P789, DOI 10.1017/S0033291710001248; Shah SG, 2009, J PSYCHIATR NEUROSCI, V34; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Straube T, 2006, BIOL PSYCHIAT, V59, P162, DOI 10.1016/j.biopsych.2005.06.013; Straube T, 2005, NEUROPSYCHOBIOLOGY, V52, P163, DOI 10.1159/000087987; Tillfors M, 2001, AM J PSYCHIAT, V158, P1220, DOI 10.1176/appi.ajp.158.8.1220; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Veit R, 2002, NEUROSCI LETT, V328, P233, DOI 10.1016/S0304-3940(02)00519-0; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; Yoon KL, 2007, PSYCHIAT RES-NEUROIM, V154, P93, DOI 10.1016/j.pscychresns.2006.05.004; Zwanzger P, 2009, J NEURAL TRANSM, V116, P767, DOI 10.1007/s00702-008-0162-0	80	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e109949	10.1371/journal.pone.0109949	http://dx.doi.org/10.1371/journal.pone.0109949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25396729	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500006
J	Nepel, M; Voglmayr, H; Schonenberger, J; Mayer, VE				Nepel, Maximilian; Voglmayr, Hermann; Schoenenberger, Juerg; Mayer, Veronika E.			High Diversity and Low Specificity of Chaetothyrialean Fungi in Carton Galleries in a Neotropical Ant-Plant Association	PLOS ONE			English	Article							DNA; IDENTIFICATION; CONSTRUCTION; TRANSMISSION; EVOLUTION	New associations have recently been discovered between arboreal ants that live on myrmecophytic plants, and different groups of fungi. Most of the - usually undescribed - fungi cultured by the ants belong to the order Chaetothyriales (Ascomycetes). Chaetothyriales occur in the nesting spaces provided by the host plant, and form a major part of the cardboard-like material produced by the ants for constructing nests and runway galleries. Until now, the fungi have been considered specific to each ant species. We focus on the three-way association between the plant Tetrathylacium macrophyllum (Salicaceae), the ant Azteca brevis (Formicidae: Dolichoderinae) and various chaetothyrialean fungi. Azteca brevis builds extensive runway galleries along branches of T. macrophyllum. The carton of the gallery walls consists of masticated plant material densely pervaded by chaetothyrialean hyphae. In order to characterise the specificity of the ant-fungus association, fungi from the runway galleries of 19 ant colonies were grown as pure cultures and analyzed using partial SSU, complete ITS, 5.8S and partial LSU rDNA sequences. This gave 128 different fungal genotypes, 78% of which were clustered into three monophyletic groups. The most common fungus (either genotype or approximate species-level OTU) was found in the runway galleries of 63% of the investigated ant colonies. This indicates that there can be a dominant fungus but, in general, a wider guild of chaetothyrialean fungi share the same ant mutualist in Azteca brevis.	[Nepel, Maximilian; Schoenenberger, Juerg; Mayer, Veronika E.] Univ Vienna, Dept Bot & Biodivers Res, Div Struct & Funct Bot, Vienna, Austria; [Voglmayr, Hermann] Univ Vienna, Dept Bot & Biodivers Res, Div Systemat & Evolutionary Bot, Vienna, Austria; [Voglmayr, Hermann] BOKU Univ Nat Resources & Life Sci, Inst Forest Entomol Forest Pathol & Forest Protec, Vienna, Austria	University of Vienna; University of Vienna; University of Natural Resources & Life Sciences, Vienna	Mayer, VE (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Div Struct & Funct Bot, Vienna, Austria.	veronika.mayer@univie.ac.at	Schönenberger, Jürg/AAE-6479-2020; Voglmayr, Hermann/B-1484-2013; Schönenberger, Jürg/D-3413-2014	Schönenberger, Jürg/0000-0001-6791-2731; Voglmayr, Hermann/0000-0001-7666-993X; Schönenberger, Jürg/0000-0001-6791-2731; Mayer, Veronika E./0000-0001-6662-8237; Nepel, Maximilian/0000-0001-7049-0613	University of Vienna, Austria	University of Vienna, Austria	This work was supported by a University of Vienna, Austria, KWA fellowship to MN; https://international.univie.ac.at/graduate-students/kurzfristige-auslandsstipendien-kwa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-115; Blatrix R, 2012, P ROY SOC B-BIOL SCI, V279, P3940, DOI 10.1098/rspb.2012.1403; Cannon PF, 2007, FUNGAL FAMILIES WORL; Chomnunti P, 2012, FUNGAL DIVERS, V56, P63, DOI 10.1007/s13225-012-0197-2; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; Defossez E, 2009, NEW PHYTOL, V182, P942, DOI 10.1111/j.1469-8137.2009.02793.x; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Elimat T, 2013, J NAT PROD, V76, P382, DOI 10.1021/np300749w; Elliott J.S.B., 1915, T BRIT MYCOL SOC, V5, P138; Fabina NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044970; Fresenius G, 1852, BEITRAGE MYKOLOGIE, V2; Gueidan C, 2008, STUD MYCOL, P111, DOI 10.3114/sim.2008.61.11; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaklitsch WM, 2011, MYCOLOGIA, V103, P209, DOI 10.3852/10-178; Janzen DH, 1983, COSTA RICAN NATURAL; Kaufmann E, 2006, NATURWISSENSCHAFTEN, V93, P216, DOI 10.1007/s00114-005-0081-y; Korb J, 2003, BEHAV ECOL SOCIOBIOL, V53, P65, DOI 10.1007/s00265-002-0559-y; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Lagerheim G., 1900, ENTOMOL TIDSKR, V21, P17; Longino JT, 2007, ZOOTAXA, P1; MASCHWITZ U, 1970, Z VERGL PHYSIOL, V66, P176, DOI 10.1007/BF00297777; Mayer VE, 2009, P ROY SOC B-BIOL SCI, V276, P3265, DOI 10.1098/rspb.2009.0768; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012668; Nobre T, 2011, MOL ECOL, V20, P2619, DOI 10.1111/j.1365-294X.2011.05090.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ruiz-Gonzalez MX, 2011, BIOL LETTERS, V7, P475, DOI 10.1098/rsbl.2010.0920; Schlick-Steiner BC, 2008, P NATL ACAD SCI USA, V105, P940, DOI 10.1073/pnas.0708320105; Schluns H, 2009, MYRMECOL NEWS, V12, P237; Schmidt M, 2001, THESIS U VIENNA AUST; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Selbmann L, 2011, FUNGAL BIOL-UK, V115, P937, DOI 10.1016/j.funbio.2011.02.016; Seyedmousavi S, 2011, FUNGAL BIOL-UK, V115, P1030, DOI 10.1016/j.funbio.2011.06.004; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tennant LE, 1989, S INT ANTS PLANTS JU, P27; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Voglmayr H, 2012, FUNGAL DIVERS, V57, P1, DOI 10.1007/s13225-012-0175-8; Voglmayr H, 2011, FUNGAL BIOL-UK, V115, P1077, DOI 10.1016/j.funbio.2010.11.006; Weissflog A, 2001, THESIS JW GOETHE U F; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yek SH, 2012, P ROY SOC B-BIOL SCI, V279, P4215, DOI 10.1098/rspb.2012.1458; Zhao JJ, 2010, MICROB ECOL, V60, P149, DOI 10.1007/s00248-010-9651-4	49	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112756	10.1371/journal.pone.0112756	http://dx.doi.org/10.1371/journal.pone.0112756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398091	gold, Green Submitted, Green Published			2022-12-26	WOS:000345558500087
J	Van Cauwenberg, J; Van Holle, V; De Bourdeaudhuij, I; Clarys, P; Nasar, J; Salmon, J; Goubert, L; Deforche, B				Van Cauwenberg, Jelle; Van Holle, Veerle; De Bourdeaudhuij, Ilse; Clarys, Peter; Nasar, Jack; Salmon, Jo; Goubert, Liesbet; Deforche, Benedicte			Using Manipulated Photographs to Identify Features of Streetscapes That May Encourage Older Adults to Walk for Transport	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; NEIGHBORHOOD; OBESITY; DESIGN; HEALTH; WALKABILITY; EXERCISE; PEOPLE	Experimental evidence of environmental features important for physical activity is challenging to procure in real world settings. The current study aimed to investigate the causal effects of environmental modifications on a photographed street's appeal for older adults' walking for transport. Secondly, we examined whether these effects differed according to gender, functional limitations, and current level of walking for transport. Thirdly, we examined whether different environmental modifications interacted with each other. Qualitative responses were also reported to gain deeper insight into the observed quantitative relationships. Two sets of 16 panoramic photographs of a streetscape were created, in which six environmental factors were manipulated (sidewalk evenness, traffic level, general upkeep, vegetation, separation from traffic, and benches). Sixty older adults sorted these photographs on appeal for walking for transport on a 7-point scale and reported qualitative information on the reasons for their rankings. Sidewalk evenness appeared to have the strongest influence on a street's appeal for transport-related walking. The effect of sidewalk evenness was even stronger when the street's overall upkeep was good and when traffic was absent. Absence of traffic, presence of vegetation, and separation from traffic also increased a street's appeal for walking for transport. There were no moderating effects by gender or functional limitations. The presence of benches increased the streetscape's appeal among participants who already walked for transport at least an hour/week. The protocols and methods used in the current study carry the potential to further our understanding of environment-PA relationships. Our findings indicated sidewalk evenness as the most important environmental factor influencing a street's appeal for walking for transport among older adults. However, future research in larger samples and in real-life settings is needed to confirm current findings.	[Van Cauwenberg, Jelle; Clarys, Peter; Deforche, Benedicte] Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium; [Van Cauwenberg, Jelle; Van Holle, Veerle; De Bourdeaudhuij, Ilse; Deforche, Benedicte] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Van Holle, Veerle] Fund Sci Res Flanders FWO, Brussels, Belgium; [Nasar, Jack] Ohio State Univ, Columbus, OH 43210 USA; [Salmon, Jo] Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia; [Goubert, Liesbet] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; Ghent University; University System of Ohio; Ohio State University; Deakin University; Ghent University	Van Cauwenberg, J (corresponding author), Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium.	jvcauwen@vub.ac.be	Nasar, Jack L/C-5580-2012; Goubert, Liesbet/J-9607-2012; Salmon, Jo/C-1226-2009; Salmon, Jo/X-2630-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019	Goubert, Liesbet/0000-0002-7657-5148; Salmon, Jo/0000-0002-4734-6354; Salmon, Jo/0000-0002-4734-6354; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Cauwenberg, Jelle/0000-0003-1292-6241	Research Foundation Flanders (FWO); National Health and Medical Research Council of Australia Principal Research Fellowship [APP1026216]	Research Foundation Flanders (FWO)(FWO); National Health and Medical Research Council of Australia Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	JVC and WH were supported by a Ph.D. Fellowship - Research Foundation Flanders (FWO, http://www.fwo.be/en/). JS was supported by a National Health and Medical Research Council of Australia Principal Research Fellowship (APP1026216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonzo MA, 2005, ENVIRON BEHAV, V37, P808, DOI 10.1177/0013916504274016; Aspinall P, 2010, INNOVATIVE APPROACHE, V2; Belgian Federal Government, 2013, ENQ NAAR ARB EAK ALG; Berke EM, 2007, AM J PUBLIC HEALTH, V97, P486, DOI 10.2105/AJPH.2006.085837; Bird S, 2009, J WOMEN AGING, V21, P33, DOI 10.1080/08952840802633669; Browne WJ, 2012, MCMC ESTIMATION MLWI; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Carpiano RM, 2009, HEALTH PLACE, V15, P263, DOI 10.1016/j.healthplace.2008.05.003; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; De Fre Brenda., 2009, PARTICIPATIE VLAANDE; De Vries S., 2010, INNOVATIVE APPROACHE, V2; Ferdinand AO, 2012, AM J PUBLIC HEALTH, V102, pE7, DOI 10.2105/AJPH.2012.300740; Fielding A., 2006, 791 U BIRM; Forsyth A, 2009, TRANSPORT RES D-TR E, V14, P42, DOI 10.1016/j.trd.2008.10.003; Frank L, 2010, J PHYS ACT HEALTH, V7, pS82, DOI 10.1123/jpah.7.s1.s82; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; Gallagher NA, 2010, J AGING PHYS ACTIV, V18, P99, DOI 10.1123/japa.18.1.99; Grant TL, 2010, J AGING PHYS ACTIV, V18, P293, DOI 10.1123/japa.18.3.293; Haywood KL, 2005, QUAL LIFE RES, V14, P1651, DOI 10.1007/s11136-005-1743-0; Hurtig-Wennlof A, 2010, PUBLIC HEALTH NUTR, V13, P1847, DOI 10.1017/S1368980010000157; King AC, 2011, SOC SCI MED, V73, P1525, DOI 10.1016/j.socscimed.2011.08.032; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Lenders S., 2005, DELINEATION FLEMISH; Mahmood A, 2012, SOC SCI MED, V74, P1180, DOI 10.1016/j.socscimed.2011.12.039; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; McCormack G.R., 2011, INT J BEHAV NUTR PHY, V8; Murtagh EM, 2010, CURR OPIN CARDIOL, V25, P490, DOI 10.1097/HCO.0b013e32833ce972; Nasar JL, 2008, AM J PREV MED, V34, P357, DOI 10.1016/j.amepre.2008.01.013; Nasar JL, 2013, J PHYS ACT HEALTH, V10, P1201, DOI 10.1123/jpah.10.8.1201; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rantakokko M, 2010, J AM GERIATR SOC, V58, P707, DOI 10.1111/j.1532-5415.2010.02792.x; Rantakokko M, 2009, J AM GERIATR SOC, V57, P634, DOI 10.1111/j.1532-5415.2009.02180.x; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Salvador EP, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-67; Spittaels H, 2009, INT J BEHAV NUTR PHY, V6; Stamps A.E., 1999, J PLAN LIT, V14, P155, DOI [DOI 10.1177/08854129922092630, 10.1177/08854129922092630]; Strath S, 2007, J AGING PHYS ACTIV, V15, P412, DOI 10.1123/japa.15.4.412; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Tafforeau J., 2008, GEZONDHEIDSENQUETE; Thompson CW, 2013, J ENVIRON PSYCHOL, V34, P79, DOI 10.1016/j.jenvp.2013.01.003; Van Cauwenberg J, 2012, BMC PUBLIC HLTH, V12; Van Cauwenberg J, 2014, J ENVIRON PSYCHOL, V38, P94, DOI 10.1016/j.jenvp.2013.12.012; Van Cauwenberg J, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-37; Van Cauwenberg J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-85; Wahl HW, 2004, ANNU REV GERONTOL GE, V23, P1; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Wells NM, 2007, ENVIRON BEHAV, V39, P6, DOI 10.1177/0013916506295570; Wennberg H, 2009, EUR J AGEING, V6, P277, DOI 10.1007/s10433-009-0123-y; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	50	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112107	10.1371/journal.pone.0112107	http://dx.doi.org/10.1371/journal.pone.0112107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DF	25396732	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500034
J	Oh, J; Kim, JY; Kim, HS; Oh, JC; Cheon, YH; Park, J; Yoon, KH; Lee, MS; Youn, BS				Oh, Jaemin; Kim, Ju-Young; Kim, Han-Soo; Oh, Justin Cheesung; Cheon, Yoon-Hee; Park, Jongtae; Yoon, Kwon-Ha; Lee, Myeung Su; Youn, Byung-Soo			Progranulin and a Five Transmembrane Domain-Containing Receptor-like Gene Are the Key Components in Receptor Activator of Nuclear Factor kappa B (RANK)-dependent Formation of Multinucleated Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; GROWTH-FACTOR; EPITHELIN PRECURSOR; BONE HOMEOSTASIS; TNF RECEPTORS; LIGAND; RANKL; DIFFERENTIATION; OSTEOPROTEGERIN; OSTEOPOROSIS	Homeostatic bone remodeling is vital to maintain healthy bone tissue. Although the receptor activator of nuclear factor kappa B ligand (RANKL)/RANK axis is considered the master regulator of osteoclastogenesis, the underlying mechanisms including cell fusion remain incompletely defined. Here, we introduce a new axis in the formation of multinucleated cells via RANK signaling: the progranulin (PGRN)/PIRO (PGRN-induced receptor-like gene during osteoclastogenesis) axis. When mouse bone marrow-derived macrophages were stimulated with PGRN in the presence of RANKL, explosive OC formation was observed. PGRN knockdown experiments suggested that endogenous PGRN is an essential component of the RANKL/RANK axis. Our efforts for identifying genes that are induced by PGRN unveiled a remarkably induced (20-fold) gene named PIRO. Substantial PGRN and PIRO expression was detected after 2 and 3 days, respectively, suggesting that their sequential induction. PIRO was predicted to be a five transmembrane domain-containing receptor-like molecule. The tissue distribution of PGRN and PIRO mRNA expression suggested that bone marrow cells are the most suitable niche. Mouse and human PIRO are part of a multigene family. Knockdown experiments suggested that PIRO is a direct target for the formation of multinucleated cells by PGRN. PGRN levels were also substantially higher in ovariectomized mice than in sham control mice. These observations suggest that PGRN and PIRO form a new regulatory axis in osteoclastogenesis that is included in RANK signaling in cell fusion and OC resorption of osteoclastogenesis, which may offer a novel therapeutic modality for osteoporosis and other bone-associated diseases.	[Oh, Jaemin; Kim, Ju-Young; Yoon, Kwon-Ha; Lee, Myeung Su] Wonkwang Univ, Imaging Sci Based Lung & Bone Dis Res Ctr, Sch Med, Iksan 570749, Jeonbuk, South Korea; [Oh, Justin Cheesung; Cheon, Yoon-Hee; Youn, Byung-Soo] Wonkwang Univ, Dept Anat, Sch Med, Iksan 570749, Jeonbuk, South Korea; [Yoon, Kwon-Ha] Wonkwang Univ, Dept Radiol, Sch Med, Iksan 570749, Jeonbuk, South Korea; [Oh, Jaemin; Cheon, Yoon-Hee] Wonkwang Univ, Grad Sch, Program BK21plus, Iksan 570749, Jeonbuk, South Korea; [Park, Jongtae] Wonkwang Univ, Dept Neurosurg, Iksan 570749, Jeonbuk, South Korea; [Lee, Myeung Su] Wonkwang Univ, Div Rheumatol, Dept Internal Med, Iksan 570749, Jeonbuk, South Korea; [Kim, Han-Soo] Catholic Kwandong Univ, Inst Biomed Convergence, Inchon 404834, South Korea; [Kim, Han-Soo] Int St Marys Hosp, Innovat Cell & Gene Therapy Ctr, Inchon 404834, South Korea; [Youn, Byung-Soo] OsteoNeuroGen, Bundang 461871, Kyunggi Do, South Korea	Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University; Catholic Kwandong University	Lee, MS (corresponding author), Wonkwang Univ, Div Rheumatol, Dept Internal Med, Iksan 570749, Jeonbuk, South Korea.	ckhlms@wku.ac.kr; byung4jc@gmail.com			OsteoNeuroGen; Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea [HI12C0110]	OsteoNeuroGen; Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea	This work was supported by intramural funding from OsteoNeuroGen and Grant HI12C0110 from the Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea. B.-S.Y. has ownership in OsteoNeuroGen.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Brouwers N, 2007, ARCH NEUROL-CHICAGO, V64, P1436, DOI 10.1001/archneur.64.10.1436; Capozzi A, 2014, GYNECOL ENDOCRINOL, V30, P403, DOI 10.3109/09513590.2014.892067; Chen X, 2013, J NEUROSCI, V33, P9202, DOI 10.1523/JNEUROSCI.5336-12.2013; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Etemadi N, 2013, IMMUNOL CELL BIOL, V91, P661, DOI 10.1038/icb.2013.53; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lems WF, 2014, CURR OPIN RHEUMATOL, V26, P245, DOI 10.1097/BOR.0000000000000057; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Morony S, 2001, CANCER RES, V61, P4432; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nguyen AD, 2013, TRENDS ENDOCRIN MET, V24, P597, DOI 10.1016/j.tem.2013.08.003; Romanello M, 2014, BONE, V58, P81, DOI 10.1016/j.bone.2013.10.003; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sleegers K, 2010, BIOMARK MED, V4, P37, DOI 10.2217/BMM.09.82; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tokuyama Naoto, 2014, Clin Calcium, V24, P85, DOI CliCa14018591; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yao Q, 2014, CELL BIOCHEM BIOPHYS, V69, P229, DOI 10.1007/s12013-013-9787-1; ZHOU J, 1993, J BIOL CHEM, V268, P10863	30	13	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2042	2052		10.1074/jbc.M114.608786	http://dx.doi.org/10.1074/jbc.M114.608786			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25406312	hybrid, Green Published			2022-12-26	WOS:000348588000012
J	Falcon, B; Cavallini, A; Angers, R; Glover, S; Murray, TK; Barnham, L; Jackson, S; O'Neill, MJ; Isaacs, AM; Hutton, ML; Szekeres, PG; Goedert, M; Bose, S				Falcon, Benjamin; Cavallini, Annalisa; Angers, Rachel; Glover, Sarah; Murray, Tracey K.; Barnham, Luanda; Jackson, Samuel; O'Neill, Michael J.; Isaacs, Adrian M.; Hutton, Michael L.; Szekeres, Philip G.; Goedert, Michel; Bose, Suchira			Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PATHOLOGICAL ALPHA-SYNUCLEIN; DEPENDENT PROTEIN-KINASE; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; CORTICOBASAL DEGENERATION; NEUROFIBRILLARY TANGLES; PTDP-43 PATHOLOGY; MAMMALIAN PRIONS; BETA-STRUCTURE	Intracellular Tau inclusions are a pathological hallmark of several neurodegenerative diseases, collectively known as the tauopathies. They include Alzheimer disease, tangle-only dementia, Pick disease, argyrophilic grain disease, chronic traumatic encephalopathy, progressive supranuclear palsy, and cortico-basal degeneration. Tau pathology appears to spread through intercellular propagation, requiring the formation of assembled "prion-like" species. Several cell and animal models have been described that recapitulate aspects of this phenomenon. However, the molecular characteristics of seed-competent Tau remain unclear. Here, we have used a cell model to understand the relationships between Tau structure/phosphorylation and seeding by aggregated Tau species from the brains of mice transgenic for human mutant P301S Tau and full-length aggregated recombinant P301S Tau. Deletion of motifs (275)VQIINK(280) and (306)VQIVYK(311) abolished the seeding activity of recombinant full-length Tau, suggesting that its aggregation was necessary for seeding. We describe conformational differences between native and synthetic Tau aggregates that may account for the higher seeding activity of native assembled Tau. When added to aggregated Tau seeds from the brains of mice transgenic for P301S Tau, soluble recombinant Tau aggregated and acquired the molecular properties of aggregated Tau from transgenic mouse brain. We show that seeding is conferred by aggregated Tau that enters cells through macropinocytosis and seeds the assembly of endogenous Tau into filaments.	[Falcon, Benjamin; Angers, Rachel; Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Cavallini, Annalisa; Angers, Rachel; Glover, Sarah; Murray, Tracey K.; Barnham, Luanda; Jackson, Samuel; O'Neill, Michael J.; Hutton, Michael L.; Szekeres, Philip G.; Bose, Suchira] Eli Lilly & Co, Windlesham GU20 6PH, Surrey, England; [Isaacs, Adrian M.] UCL Inst Neurol, London WC1N 3BG, England	MRC Laboratory Molecular Biology; Eli Lilly; University of London; University College London	Goedert, M (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	mg@mrc-lmb.cam.ac.uk; bose_suchira@lilly.com		Ryskeldi-Falcon, Benjamin/0000-0002-8176-2618	Medical Research Council [1359123] Funding Source: researchfish; MRC [MR/J004022/1, MC_U105184291] Funding Source: UKRI; Medical Research Council [MC_U105184291, MR/J004022/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Allen B, 2002, J NEUROSCI, V22, P9340; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P589, DOI 10.1007/s00401-011-0825-z; Brettschneider J, 2014, ACTA NEUROPATHOL, V127, P423, DOI 10.1007/s00401-013-1238-y; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Cavallini A, 2013, J BIOL CHEM, V288, P23331, DOI 10.1074/jbc.M113.463984; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2013, BRAIN PATHOL, V23, P342, DOI 10.1111/bpa.12044; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Delacourte A, 1996, J NEUROPATH EXP NEUR, V55, P159, DOI 10.1097/00005072-199602000-00004; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; FLAMENT S, 1991, ACTA NEUROPATHOL, V81, P591, DOI 10.1007/BF00296367; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jicha GA, 1999, J NEUROCHEM, V72, P214, DOI 10.1046/j.1471-4159.1999.0720214.x; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morozova OA, 2013, BIOCHEMISTRY-US, V52, P6960, DOI 10.1021/bi400866w; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Noda K, 2006, NEUROPATHOLOGY, V26, P508, DOI 10.1111/j.1440-1789.2006.00722.x; Perez M, 1996, J NEUROCHEM, V67, P1183; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Togo T, 2002, J NEUROPATH EXP NEUR, V61, P547, DOI 10.1093/jnen/61.6.547; Tremblay MA, 2010, J ALZHEIMERS DIS, V19, P721, DOI 10.3233/JAD-2010-1271; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yoshida H, 2006, J NEUROCHEM, V99, P154, DOI 10.1111/j.1471-4159.2006.04052.x; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	75	168	174	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1049	1065		10.1074/jbc.M114.589309	http://dx.doi.org/10.1074/jbc.M114.589309			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406315	Green Published, hybrid			2022-12-26	WOS:000347778200037
J	Denhez, B; Lizotte, F; Guimond, MO; Jones, N; Takano, T; Geraldes, P				Denhez, Benoit; Lizotte, Farah; Guimond, Marie-Odile; Jones, Nina; Takano, Tomoko; Geraldes, Pedro			Increased SHP-1 Protein Expression by High Glucose Levels Reduces Nephrin Phosphorylation in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Nephrology; Phosphotyrosine; Podocyte; Src Homology 2 domain (SH2 domain); Protein-Tyrosine Phosphatase (Tyrosine Phosphatase); Nephrin	DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; GROWTH-FACTOR; NCK; ACTIVATION; KINASE; MICE; MUTATIONS; APOPTOSIS; MAINTAIN	Background: Elevated expression of SHP-1 in diabetic podocytes may potentially interact with nephrin phosphorylation. Results: Rat nephrin Tyr(1127) and Tyr(1152) are essential for SHP-1 induced nephrin dephosphorylation under high-glucose conditions. Conclusion: SHP-1 contributes to nephrin deactivation in podocytes exposed to high glucose levels. Significance: Reduction of SHP-1 may serve as potential therapeutic target to prevent glomerular pathology in diabetes. Nephrin, a critical podocyte membrane component that is reduced in diabetic nephropathy, has been shown to activate phosphotyrosine signaling pathways in human podocytes. Nephrin signaling is important to reduce cell death induced by apoptotic stimuli. We have shown previously that high glucose level exposure and diabetes increased the expression of SHP-1, causing podocyte apoptosis. SHP-1 possesses two Src homology 2 domains that serve as docking elements to dephosphorylate tyrosine residues of target proteins. However, it remains unknown whether SHP-1 interacts with nephrin and whether its elevated expression affects the nephrin phosphorylation state in diabetes. Here we show that human podocytes exposed to high glucose levels exhibited elevated expression of SHP-1, which was associated with nephrin. Coexpression of nephrin-CD16 and SHP-1 reduced nephrin tyrosine phosphorylation in transfected human embryonic kidney 293 cells. A single tyrosine-to-phenylalanine mutation revealed that rat nephrin Tyr(1127) and Tyr(1152) are required to allow SHP-1 interaction with nephrin. Overexpression of dominant negative SHP-1 in human podocytes prevented high glucose-induced reduction of nephrin phosphorylation. In vivo, immunoblot analysis demonstrated that nephrin expression and phosphorylation were decreased in glomeruli of type 1 diabetic Akita mice (Ins2(+/C96Y)) compared with control littermate mice (Ins2(+/+)), and this was associated with elevated SHP-1 and cleaved caspase-3 expression. Furthermore, immunofluorescence analysis indicated increased colocalization of SHP-1 with nephrin in diabetic mice compared with control littermates. In conclusion, our results demonstrate that high glucose exposure increases SHP-1 interaction with nephrin, causing decreased nephrin phosphorylation, which may, in turn, contribute to diabetic nephropathy.	[Denhez, Benoit; Lizotte, Farah; Guimond, Marie-Odile; Geraldes, Pedro] Univ Sherbrooke, Res Ctr, Ctr Hosp, Quebec City, PQ J1H 5N4, Canada; [Denhez, Benoit; Lizotte, Farah; Guimond, Marie-Odile; Geraldes, Pedro] Univ Sherbrooke, Dept Med, Div Endocrinol, Quebec City, PQ J1H 5N4, Canada; [Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Takano, Tomoko] McGill Univ, Ctr Hlth, Montreal, PQ H3H 2R9, Canada	Laval University; University of Sherbrooke; University of Sherbrooke; University of Guelph; McGill University	Geraldes, P (corresponding author), Univ Sherbrooke, Dept Med, Div Endocrinol, Quebec City, PQ J1H 5N4, Canada.	Pedro.Geraldes@USherbrooke.ca			Canadian Institute of Health Research [201209PNI]; Juvenile Diabetes Research Foundation [27-2012-531]; Fonds de Recherche du Quebec-Sante; Canadian Diabetes Association	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canadian Diabetes Association	This work was supported by Canadian Institute of Health Research Grant 201209PNI (to P. G.) and Juvenile Diabetes Research Foundation Grant 27-2012-531 (to P. G.). This work was performed at the Centre Hospitalier Universitaire de Sherbrooke Research Center funded by the Fonds de Recherche du Quebec-Sante.; Holder of the Canadian Research Chair in Vascular Complications of Diabetes and recipient of a scholarship award from the Canadian Diabetes Association. To whom correspondence should be addressed: Div. of Endocrinology, Depts. of Medicine, Universite de Sherbrooke, Quebec, Canada. Tel.: 819-820-6868 ext. 12442; Fax: 819-564-5292; E-mail: Pedro.Geraldes@USherbrooke.ca.	Aoudjit L, 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/376543, DOI 10.1155/2011/376543]; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Collins A. J., 2006, AM J KIDNEY DIS, V49, pS1; Coward RJM, 2005, DIABETES, V54, P3095, DOI 10.2337/diabetes.54.11.3095; Drapeau N, 2013, AM J PHYSIOL-ENDOC M, V304, pE1188, DOI 10.1152/ajpendo.00560.2012; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Foster RR, 2005, AM J PHYSIOL-RENAL, V288, pF48, DOI 10.1152/ajprenal.00146.2004; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JJ, 2007, J AM SOC NEPHROL, V18, P2303, DOI 10.1681/ASN.2006101145; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mima A, 2012, FASEB J, V26, P2963, DOI 10.1096/fj.11-202994; New LA, 2013, J BIOL CHEM, V288, P1500, DOI 10.1074/jbc.M112.439463; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Reiser J, 2000, KIDNEY INT, V57, P2035, DOI 10.1046/j.1523-1755.2000.00070.x; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Roy S, 2010, ENDOCRINOLOGY, V151, P660, DOI 10.1210/en.2009-0826; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	39	34	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					350	358		10.1074/jbc.M114.612721	http://dx.doi.org/10.1074/jbc.M114.612721			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404734	hybrid, Green Published			2022-12-26	WOS:000347231200031
J	Abashidze, A; Gold, V; Anavi, Y; Greenspan, H; Weil, M				Abashidze, Anastasia; Gold, Veronica; Anavi, Yaron; Greenspan, Hayit; Weil, Miguel			Involvement of IKAP in Peripheral Target Innervation and in Specific JNK and NGF Signaling in Developing PNS Neurons	PLOS ONE			English	Article							B KINASE COMPLEX; FAMILIAL DYSAUTONOMIA; TRANSCRIPTIONAL ELONGATION; NEURITE OUTGROWTH; IKBKAP; GENE; EXPRESSION; PROTEIN; DIFFERENTIATION; MUTATION	A splicing mutation in the ikbkap gene causes Familial Dysautonomia (FD), affecting the IKAP protein expression levels and proper development and function of the peripheral nervous system (PNS). Here we attempted to elucidate the role of IKAP in PNS development in the chick embryo and found that IKAP is required for proper axonal outgrowth, branching, and peripheral target innervation. Moreover, we demonstrate that IKAP colocalizes with activated JNK (pJNK), dynein, and beta-tubulin at the axon terminals of dorsal root ganglia (DRG) neurons, and may be involved in transport of specific target derived signals required for transcription of JNK and NGF responsive genes in the nucleus. These results suggest the novel role of IKAP in neuronal transport and specific signaling mediated transcription, and provide, for the first time, the basis for a molecular mechanism behind the FD phenotype.	[Abashidze, Anastasia; Gold, Veronica; Weil, Miguel] Tel Aviv Univ, George S Wise Fac Life Sci, Sagol Sch Neurosci, Dept Cell Res & Immunol,Lab Neurodegenerat Dis &, IL-69978 Tel Aviv, Israel; [Anavi, Yaron] Tel Aviv Univ, Sch Math Sci, Dept Appl Math, IL-69978 Tel Aviv, Israel; [Greenspan, Hayit] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Weil, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Sagol Sch Neurosci, Dept Cell Res & Immunol,Lab Neurodegenerat Dis &, IL-69978 Tel Aviv, Israel.	miguelw@tauex.tau.ac.il			Israel Science Foundation (ISF grant) [1491/09]; FD research consortium (FD Hope); FD research consortium (FD Foundation Inc.); FD research consortium (FD Israel Foundation)	Israel Science Foundation (ISF grant); FD research consortium (FD Hope); FD research consortium (FD Foundation Inc.); FD research consortium (FD Israel Foundation)	This study was supported by the FD research consortium (FD Hope, FD Foundation Inc., FD Israel Foundation) and by the Israel Science Foundation (ISF grant 1491/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Avivi C, 1999, DEV BRAIN RES, V115, P89, DOI 10.1016/S0165-3806(99)00054-1; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Cheishvili D, 2011, HUM MOL GENET, V20, P1585, DOI 10.1093/hmg/ddr036; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Coffey ET, 2014, NAT REV NEUROSCI, V15, P285, DOI 10.1038/nrn3729; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Cohen-Kupiec R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019147; Corcoran J, 2000, J CELL SCI, V113, P2567; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dietrich P, 2012, HUM MOL GENET, V21, P5078, DOI 10.1093/hmg/dds354; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; George L, 2013, P NATL ACAD SCI USA, V110, P18698, DOI 10.1073/pnas.1308596110; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Hunnicutt BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032050; Jackson MZ, 2014, DEVELOPMENT, V141, P2452, DOI 10.1242/dev.107797; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; PEARSON J, 1974, ANN NY ACAD SCI, V228, P288, DOI 10.1111/j.1749-6632.1974.tb20517.x; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; RILEY CM, 1949, PEDIATRICS, V3, P468; Rosenberg SS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004259; Sakai D, 2005, CELLS TISSUES ORGANS, V179, P24, DOI 10.1159/000084506; Sakakibara A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130061; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Valensi-Kurtz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009290; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006	37	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113428	10.1371/journal.pone.0113428	http://dx.doi.org/10.1371/journal.pone.0113428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409162	Green Submitted, gold, Green Published			2022-12-26	WOS:000345533200119
J	Drury-Stewart, DN; Lannert, KW; Chung, DW; Teramura, GT; Zimring, JC; Konkle, BA; Gammill, HS; Johnsen, JM				Drury-Stewart, Danielle N.; Lannert, Kerry W.; Chung, Dominic W.; Teramura, Gayle T.; Zimring, James C.; Konkle, Barbara A.; Gammill, Hilary S.; Johnsen, Jill M.			Complex Changes in von Willebrand Factor-Associated Parameters Are Acquired during Uncomplicated Pregnancy	PLOS ONE			English	Article							FACTOR-VIII COMPLEX; FACTOR PROPEPTIDE; VENOUS THROMBOEMBOLISM; ARTERIAL THROMBOSIS; VWF PROPEPTIDE; HEMOSTATIC CHANGES; PRE-ECLAMPSIA; DISEASE; RISK; PUERPERIUM	Background: The coagulation protein von Willebrand Factor (VWF) is known to be elevated in pregnancy. However, the timing and nature of changes in VWF and associated parameters throughout pregnancy are not well understood. Objectives: To better understand the changes in VWF provoked by pregnancy, we studied VWF-associated parameters in samples collected over the course of healthy pregnancies. Methods: We measured VWF antigen (VWF:Ag), VWF propeptide (VWFpp), Factor VIII (FVIII), and ADAMTS13 activity in samples collected from 46 women during pregnancy and at non-pregnant baseline. We also characterized pregnant vs. nonpregnant VWF multimer structure in 21 pregnancies, and performed isoelectric focusing (IEF) of VWF in two pregnancies which had samples from multiple trimesters. Results: VWF:Ag and FVIII levels were significantly increased during pregnancy. ADAMTS13 activity was unchanged. VWFpp levels increased much later in pregnancy than VWF:Ag, resulting in a progressive decrease in VWFpp:Ag ratios. FVIII:VWF ratios also decreased in pregnancy. Most pregnancies exhibited a clear loss of larger VWF multimers and altered VWF triplet structure. Further evidence of acquired VWF qualitative changes in pregnancy was found in progressive, reversible shifts in VWF IEF patterns over gestation. Conclusions: These data support a new view of pregnancy in which VWF can acquire qualitative changes associated with advancing gestational age. Modeling supports a scenario in which both increased VWF production and doubling of the VWF half-life would account for the data observed. We propose that gestation induces a prolongation in VWF survival, which likely contributes to increased total VWF levels and altered VWF structure.	[Drury-Stewart, Danielle N.; Lannert, Kerry W.; Chung, Dominic W.; Teramura, Gayle T.; Zimring, James C.; Konkle, Barbara A.; Johnsen, Jill M.] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA; [Zimring, James C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Konkle, Barbara A.; Johnsen, Jill M.] Univ Washington, Dept Med, Seattle, WA USA; [Gammill, Hilary S.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Gammill, Hilary S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Johnsen, JM (corresponding author), Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA.	jjohnsen@uw.edu	Teramura, Gayle/ABG-2749-2021; Konkle, Barbara/GPX-3325-2022; Sessum, Rachel/F-7312-2015; Konkle, Barbara A/AAD-7712-2022	Sessum, Rachel/0000-0002-2444-7056; Konkle, Barbara A/0000-0002-3959-8797; Zimring, James/0000-0002-1063-4010; Chung, Dominic/0000-0002-2645-5703	Puget Sound Blood Center Hemophilia Program; NIH [2 R01 HL39693-21]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD067221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039693] Funding Source: NIH RePORTER	Puget Sound Blood Center Hemophilia Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These efforts were supported by funding from the Puget Sound Blood Center Hemophilia Program, an unrestricted gift by Dr. Earl Davie, and NIH 2 R01 HL39693-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Blood Banks, 2008, FREQ ABO US POP; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bank I, 2005, J THROMB HAEMOST, V3, P79, DOI 10.1111/j.1538-7836.2004.01033.x; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Butenas S, 2009, J THROMB HAEMOST, V7, P132, DOI 10.1111/j.1538-7836.2008.03210.x; CAIRES D, 1984, ACTA OBSTET GYN SCAN, V63, P411, DOI 10.3109/00016348409156694; Casonato A, 2011, SEMIN THROMB HEMOST, V37, P456, DOI 10.1055/s-0031-1281029; Casonato A, 2010, TRANSL RES, V155, P200, DOI 10.1016/j.trsl.2009.12.003; Castaman G, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.052; Catto AJ, 1997, THROMB HAEMOSTASIS, V77, P1104; Defaus S, 2014, ANALYST, V139, P2944, DOI 10.1039/c3an02245e; Eikenboom J, 2013, BLOOD, V121, P2336, DOI 10.1182/blood-2012-09-455089; Favaloro EJ, 1997, CLIN APPL THROMB-HEM, V3, P110, DOI 10.1177/107602969700300208; Federici AB, 2006, BLOOD, V108, P3229, DOI 10.1182/blood-2006-09-043117; Fischer K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006745; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; FOURNIE A, 1981, BRIT J OBSTET GYNAEC, V88, P250, DOI 10.1111/j.1471-0528.1981.tb00977.x; Fuchs B, 2013, SEMIN THROMB HEMOST, V39, P306, DOI 10.1055/s-0032-1328971; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3; Haberichter SL, 2006, BLOOD, V108, P3344, DOI 10.1182/blood-2006-04-015065; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Hovinga JAK, 2007, J THROMB HAEMOST, V5, P2284; HYTTEN F, 1985, CLIN HAEMATOL, V14, P601; Jenkins PV, 2012, BRIT J HAEMATOL, V157, P653, DOI 10.1111/j.1365-2141.2012.09134.x; Johnsen J, 2010, WILLIAMS HEMATOLOGY, P2069; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Lenting PJ, 2013, CURR VASC PHARMACOL, V11, P448; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Marik PE, 2008, NEW ENGL J MED, V359, P2025, DOI 10.1056/NEJMra0707993; Nossent AY, 2006, J THROMB HAEMOST, V4, P2556, DOI 10.1111/j.1538-7836.2006.02273.x; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; OGAWA T, 1983, BIOL RES PREG PERIN, V4, P155; Rosenkranz A, 2008, THROMB HAEMOSTASIS, V99, P331, DOI 10.1160/TH07-05-0359; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; Saha P, 2009, BJOG-INT J OBSTET GY, V116, P1602, DOI 10.1111/j.1471-0528.2009.02295.x; Sanchez-Luceros A, 2003, BLOOD COAGUL FIBRIN, V14, P647, DOI 10.1097/00001721-200310000-00005; Sanders YV, 2013, J THROMB HAEMOST, V11, P845, DOI 10.1111/jth.12194; Sie P, 2003, BRIT J HAEMATOL, V121, P897, DOI 10.1046/j.1365-2141.2003.04371.x; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Sonneveld MAH, 2014, BLOOD REV, V28, P167, DOI 10.1016/j.blre.2014.04.003; Stockschlaeder M, 2014, BLOOD COAGUL FIBRIN, V25, P206, DOI 10.1097/MBC.0000000000000065; Sztukowska M, 2008, BRIT J HAEMATOL, V143, P107, DOI 10.1111/j.1365-2141.2008.07311.x; THORNTON CA, 1977, BRIT J OBSTET GYNAEC, V84, P919, DOI 10.1111/j.1471-0528.1977.tb12521.x; TREFFERS PE, 1983, INT J GYNECOL OBSTET, V21, P327, DOI 10.1016/0020-7292(83)90024-3; van Mourik JA, 1999, BLOOD, V94, P179, DOI 10.1182/blood.V94.1.179.413k18_179_185; van Schie MC, 2011, J THROMB HAEMOST, V9, P899, DOI 10.1111/j.1538-7836.2011.04243.x; Whincup RH, 2002, EUR HEART J, V23, P1764, DOI 10.1053/euhj.2001.3237; Wu JJ, 2006, J THROMB HAEMOST, V4, P129, DOI 10.1111/j.1538-7836.2005.01677.x	52	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112935	10.1371/journal.pone.0112935	http://dx.doi.org/10.1371/journal.pone.0112935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409031	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200048
J	Jiang, X; Kanda, T; Wu, S; Nakamoto, S; Wakita, T; Shirasawa, H; Yokosuka, O				Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Nakamoto, Shingo; Wakita, Takaji; Shirasawa, Hiroshi; Yokosuka, Osamu			Hepatitis C Virus Nonstructural Protein 5A Inhibits Thapsigargin-Induced Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ANTI-FAS ANTIBODY; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; ER STRESS; MEDIATED APOPTOSIS; NS5A; GENE; INVOLVEMENT; PATHWAY	Background: We previously reported that the hepatitis C virus (HCV) nonstructural protein 5A (NS5A) down-regulates TLR4 signaling and lipopolysaccharide-induced apoptosis of hepatocytes. There have been several reports regarding the association between HCV infection and endoplasmic reticulum (ER) stress. Here, we examined the regulation of HCV NS5A on the apoptosis of hepatocytes induced by thapsigargin, an inducer of ER stress. Methods: The apoptotic response to thapsigargin and the expression of molecules involved in human hepatocyte apoptotic pathways were examined in the presence or absence of HCV NS5A expression. Results: HCV JFH1 infection induced ER stress in the Huh7 cell line. HCV NS5A protected HepG2 cells against thapsigargin-induced apoptosis, the effect of which was linked to the enhanced expression of the 78-kDa glucose-regulated protein/immunoglobulin heavy-chain binding protein (GRP78). Consistent with a conferred pro-survival advantage, HCV NS5A reduced poly(adenosine diphosphate-ribose) polymerase cleavage and activation of caspases-3, -7 and -9, and Bax expression, while increasing the expressions of the anti-apoptotic molecules XIAP and c-FLIP. HCV NS5A weakly interacts with GRP78 and enhances GRP78 expression in hepatocytes. Conclusion: HCV NS5A enhances GRP78 expression, resulting in the inhibition of apoptotic properties, and inhibits thapsigargin-induced apoptotic pathways in human hepatocytes, suggesting that disruption of ER stress-mediated apoptosis may have a role in the pathogenesis of HCV infection. Thus, HCV NS5A might engender the survival of HCV-infected hepatocytes contributing to the establishment of persistent infection.	[Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Nakamoto, Shingo; Shirasawa, Hiroshi] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Chiba University; Chiba University; National Institute of Infectious Diseases (NIID)	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	kandat-cib@umin.ac.jp		Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590955]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a KAKEN Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (24590955), awarded to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2010, VIRUSES-BASEL, V2, P2108, DOI 10.3390/v2092108; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Berthelet Jean, 2013, Cells, V2, P163, DOI 10.3390/cells2010163; Cecconi F, 1999, CELL DEATH DIFFER, V6, P1087, DOI 10.1038/sj.cdd.4400602; Cerella C, 2014, BIOTECHNOL ADV, V32, P1111, DOI 10.1016/j.biotechadv.2014.03.006; Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998; Christen V, 2007, HEPATOLOGY, V46, P558, DOI 10.1002/hep.21611; Chung YL, 2003, INT J CANCER, V107, P65, DOI 10.1002/ijc.11303; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gerotto M, 1999, J VIRAL HEPATITIS, V6, P367, DOI 10.1046/j.1365-2893.1999.00166.x; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Hofgartner WT, 1997, J MED VIROL, V53, P118, DOI 10.1002/(SICI)1096-9071(199710)53:2<118::AID-JMV3>3.0.CO;2-C; Jiang X, 2014, EXP CELL RES, V323, P326, DOI 10.1016/j.yexcr.2014.02.017; Jiang X, 2013, IMMUNOL LETT, V152, P8, DOI 10.1016/j.imlet.2013.03.006; Kanda T, 2006, J VIROL, V80, P4633, DOI 10.1128/JVI.80.9.4633-4639.2006; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; KANEKO Y, 1994, CANCER LETT, V79, P147, DOI 10.1016/0304-3835(94)90253-4; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Merola M, 2001, J VIROL, V75, P11205, DOI 10.1128/JVI.75.22.11205-11217.2001; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Nakamoto S, 2014, WORLD J GASTROENTERO, V20, P2902, DOI 10.3748/wjg.v20.i11.2902; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Rosebeck S, 2011, VIROLOGY, V417, P293, DOI 10.1016/j.virol.2011.06.010; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Safa A. R., 2012, Experimental Oncology, V34, P176; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Saito K, 2006, J VIROL, V80, P4372, DOI 10.1128/JVI.80.9.4372-4379.2006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Tamura R, 2011, J INFECT DIS, V204, P793, DOI 10.1093/infdis/jir381; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; von dem Bussche A, 2010, J HEPATOL, V53, P797, DOI 10.1016/j.jhep.2010.05.022; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Waris G, 2002, BIOCHEM PHARMACOL, V64, P1425, DOI 10.1016/S0006-2952(02)01300-X; Yoo SA, 2012, J EXP MED, V209, P871, DOI 10.1084/jem.20111783	50	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113499	10.1371/journal.pone.0113499	http://dx.doi.org/10.1371/journal.pone.0113499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409163	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200129
J	Kruse, TN; Carter, RE; Rosedahl, JK; Joyner, MJ				Kruse, Timothy N.; Carter, Rickey E.; Rosedahl, Jordan K.; Joyner, Michael J.			Speed Trends in Male Distance Running	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; PERFORMANCE; PROGRESSION; MARATHON; RUNNERS; KENYAN; RACES; SPORT	The major cycling "Grand Tours'' have shown an attenuation of performance over the last decade. This has been interpreted as circumstantial evidence that newer anti-doping strategies have reduced the use of performance-enhancing drugs. To examine this idea under more controlled conditions, speed trends for world class 5000 m, 10000 m, and marathon performances by men from 1980 to 2013 were analyzed. We obtained comprehensive records from the International Association of Athletics Federations, Association of Road Racing Statisticians, and the Track and Field All-time Performances database webpages. The top 40 performances for each event and year were selected for regression analysis. For the three distances, we noted cumulative performance improvements in the 1990s thru the mid-2000s. After the peak speed years of the mid 2000 s, there has been limited improvement in the 5000 m and 10,000 m and world records set during that time remain in place today, marking the longest period of time between new records since the early 1940s. By contrast marathon speed continues to increase and the world record has been lowered four times since 2007, including in 2013. While the speed trends for 5000 m and 10000 m track results parallel those seen in elite cycling, the marathon trends do not. We discuss a number of explanations other than improved anti-doping strategies that might account for these divergent findings.	[Kruse, Timothy N.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Carter, Rickey E.; Rosedahl, Jordan K.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Joyner, Michael J.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA	University of Washington; University of Washington Seattle; Mayo Clinic; Mayo Clinic	Joyner, MJ (corresponding author), Mayo Clin, Dept Anesthesiol, 200 First St SW, Rochester, MN 55905 USA.	Joyner.Michael@Mayo.edu			National Institutes of Health [R25 GM075148, UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants R25 GM075148 and UL1 TR000135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; Berthelot G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008800; Billat V, 2003, MED SCI SPORT EXER, V35, P297, DOI 10.1249/01.MSS.0000053556.59992.A9; Bourne ND, 2008, THESIS U TEXAS; Conti Andrea A, 2010, Med Secoli, V22, P181; D'Angelo C, 2010, J MED ETHICS, V36, P700, DOI 10.1136/jme.2009.034801; de Hon O, 2014, SPORTS MED; Delanghe JR, 2008, J APPL PHYSIOL, V105, P395, DOI 10.1152/japplphysiol.90746.2008; Denny MW, 2008, J EXP BIOL, V211, P3836, DOI 10.1242/jeb.024968; El Helou N, 2010, J SPORT SCI, V28, P789, DOI 10.1080/02640411003739654; Gaudard A, 2003, SPORTS MED, V33, P187, DOI 10.2165/00007256-200333030-00003; Haugen K. K., 2004, Journal of Sports Economics, V5, P67, DOI 10.1177/1527002503251712; Hill R, 2014, RACE CONVERSION; Hunter SK, 2011, MED SCI SPORT EXER, V43, P656, DOI 10.1249/MSS.0b013e3181fb4e00; International Olympic Committee, 2014, FIGHT DOP PROM ATHL; Jelkmann W, 2011, BLOOD, V118, P2395, DOI 10.1182/blood-2011-02-303271; Joyner MJ, 2011, J APPL PHYSIOL, V110, P275, DOI 10.1152/japplphysiol.00563.2010; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Joyner MJ, 2003, BRIT J SPORT MED, V37, P190, DOI 10.1136/bjsm.37.3.190; Larsson P, 2014, MENS STANDARD EVENTS; Lonnberg M, 2013, ANAL BIOANAL CHEM, V405, P9685, DOI 10.1007/s00216-013-6997-8; Lundby C, 2008, J APPL PHYSIOL, V105, P417, DOI 10.1152/japplphysiol.90529.2008; Martin D.M., 2007, WORLD PSYCHIAT J WOR, V6, P118; Miller T, 2001, GLOBALIZATION SPORTS; Noakes TD, 2004, NEW ENGL J MED, V351, P847, DOI 10.1056/NEJMp048208; Papagelopoulos PJ, 2004, ORTHOPEDICS, V27, P1226; Perneger TV, 2010, INT J SPORTS MED, V31, P261, DOI 10.1055/s-0030-1247593; Strelan P, 2006, J APPL SOC PSYCHOL, V36, P2909, DOI 10.1111/j.0021-9029.2006.00135.x; Thibault V, 2010, J SPORT SCI MED, V9, P214; Tokish JM, 2004, AM J SPORT MED, V32, P1543, DOI 10.1177/0363546504268041; Wilber RL, 2012, INT J SPORT PHYSIOL, V7, P92, DOI 10.1123/ijspp.7.2.92; World Anti-Doping Agency, 2010, BRIEF HIST ANT; Young K, 2014, YEARLY RANKINGS MARA	33	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112978	10.1371/journal.pone.0112978	http://dx.doi.org/10.1371/journal.pone.0112978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409192	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200054
J	Li, S; An, YZ; Ren, JY; Zhu, FX; Chen, H				Li, Shu; An, You-zhong; Ren, Jing-yi; Zhu, Feng-xue; Chen, Hong			Myocardial Injury after Surgery Is a Risk Factor for Weaning Failure from Mechanical Ventilation in Critical Patients Undergoing Major Abdominal Surgery	PLOS ONE			English	Article							NONINVASIVE VENTILATION; PNEUMONIA; DISEASE; IMPACT; CARE	Background: Myocardial injury after noncardiac surgery (MINS) is a newly proposed concept that is common among adults undergoing noncardiac surgery and associated with substantial mortality. We analyzed whether MINS was a risk factor for weaning failure in critical patients who underwent major abdominal surgery. Methods: This retrospective study was conducted in the Department of Critical Care Medicine of Peking University People's Hospital. The subjects were all critically ill patients who underwent major abdominal surgery between January 2011 and December 2013. Clinical and laboratory parameters during the perioperative period were investigated. Backward stepwise regression analysis was performed to evaluate MINS relative to the rate of weaning failure. Age, hypertension, chronic renal disease, left ventricular ejection fraction before surgery, Acute Physiologic and Chronic Health Evaluation II score, pleural effusion, pneumonia, acute kidney injury, duration of mechanical ventilation before weaning and the level of albumin after surgery were treated as independent variables. Results: This study included 381 patients, of whom 274 were successfully weaned. MINS was observed in 42.0% of the patients. The MINS incidence was significantly higher in patients who failed to be weaned compared to patients who were successfully weaned (56.1% versus 36.5%; P < 0.001). Independent predictive factors of weaning failure were MINS, age, lower left ventricular ejection fraction before surgery and lower serum albumin level after surgery. The MINS odds ratio was 4.098 (95% confidence interval, 1.07 to 15.6; P = 0.04). The patients who were successfully weaned had shorter hospital stay lengths and a higher survival rate than those who failed to be weaned. Conclusion: MINS is a risk factor for weaning failure from mechanical ventilation in critical patients who have undergone major abdominal surgery, independent of age, lower left ventricular ejection fraction before surgery and lower serum albumin levels after surgery.	[Li, Shu; An, You-zhong; Zhu, Feng-xue] Peking Univ, Peoples Hosp, Dept Crit Care Med, Beijing 100871, Peoples R China; [Ren, Jing-yi; Chen, Hong] Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China	Peking University; Peking University	Chen, H (corresponding author), Peking Univ, Peoples Hosp, Dept Crit Care Med, Beijing 100871, Peoples R China.	chenhong0418@aliyun.com						Ali ZA, 2008, EUR J VASC ENDOVASC, V35, P413, DOI 10.1016/j.ejvs.2007.10.007; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113; Carroll K, 2003, J PUBLIC HEALTH MED, V25, P29, DOI 10.1093/pubmed/fdg007; Dunning J, 2003, EUR J CARDIO-THORAC, V24, P270, DOI 10.1016/S1010-7940(03)00269-0; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Epstein SK, 2009, RESP CARE, V54, P198; Glossop AJ, 2012, BRIT J ANAESTH, V109, P305, DOI 10.1093/bja/aes270; Gupta Barkha, 2010, J Clin Med Res, V2, P68, DOI 10.4021/jocmr2010.03.261e; Hadda V, 2014, LUNG INDIA, V31, P4, DOI 10.4103/0970-2113.125886; Mehta RH, 2008, CIRCULATION, V117, P876, DOI 10.1161/CIRCULATIONAHA.107.728147; Monnet X, 2007, CURR OPIN CRIT CARE, V13, P6, DOI 10.1097/MCC.0b013e328013c865; Naughton C, 2007, INT J CLIN PRACT, V61, P768, DOI 10.1111/j.1742-1241.2007.01304.x; Nozawa E, 2005, INT HEART J, V46, P819, DOI 10.1536/ihj.46.819; Pinsky MR, 2000, INTENS CARE MED, V26, P1164, DOI 10.1007/s001340000619; Porhomayon J, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/173527; Shi ZD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008367.pub2; Siddiqui MMA, 2012, CARDIOVASC DIAGN THE, V2, P192, DOI 10.3978/j.issn.2223-3652.2012.06.05; Teboul JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8852; Thille AW, 2013, AM J RESP CRIT CARE, V187, P1294, DOI 10.1164/rccm.201208-1523CI; TORRES A, 1995, AM J RESP CRIT CARE, V152, P137, DOI 10.1164/ajrccm.152.1.7599812; Zhu F, 2013, CHINESE MED J-PEKING, V126, P1337, DOI 10.3760/cma.j.issn.0366-6999.20121744	22	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113410	10.1371/journal.pone.0113410	http://dx.doi.org/10.1371/journal.pone.0113410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409182	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200114
J	Puspitasari, HP; Aslani, P; Krass, I				Puspitasari, Hanni P.; Aslani, Parisa; Krass, Ines			Challenges in the Care of Clients with Established Cardiovascular Disease: Lessons Learned from Australian Community Pharmacists	PLOS ONE			English	Article							PATIENT OUTCOMES; SECONDARY PREVENTION; PHARMACEUTICAL CARE; MANAGEMENT SERVICES; PART 1; INTERVENTIONS; METAANALYSIS; SENSITIVITY; FACILITATORS; AWARENESS	Background: As primary healthcare professionals, community pharmacists have both opportunity and potential to contribute to the prevention and progression of chronic diseases. Using cardiovascular disease (CVD) as a case study, we explored factors that influence community pharmacists' everyday practice in this area. We also propose a model to best illustrate relationships between influencing factors and the scope of community pharmacy practice in the care of clients with established CVD. Methods: In-depth, semi-structured interviews were conducted with 21 community pharmacists in New South Wales, Australia. All interviews were audio-recorded, transcribed ad verbatim, and analysed using a "grounded-theory'' approach. Results: Our model shows that community pharmacists work within a complex system and their practice is influenced by interactions between three main domains: the "people'' factors, including their own attitudes and beliefs as well as those of clients and doctors; the "environment'' within and beyond the control of community pharmacy; and outcomes of their professional care. Despite the complexity of factors and interactions, our findings shed some light on the interrelationships between these various influences. The overarching obstacle to maximizing the community pharmacists' contribution is the lack of integration within health systems. However, achieving better integration of community pharmacists in primary care is a challenge since the systems of remuneration for healthcare professional services do not currently support this integration. Conclusion: Tackling chronic diseases such as CVD requires mobilization of all sources of support in the community through innovative policies which facilitate inter-professional collaboration and team care to achieve the best possible healthcare outcomes for society.	[Puspitasari, Hanni P.; Aslani, Parisa; Krass, Ines] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Puspitasari, Hanni P.] Univ Airlangga, Fak Farm, Surabaya, Indonesia	University of Sydney; Airlangga University	Puspitasari, HP (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	hanni.puspitasari@sydney.edu.au	Puspitasari, Hanni/GQP-4205-2022	Krass, Ines/0000-0002-0466-9807				Amariles P, 2012, J MANAGE CARE PHARM, V18, P311, DOI 10.18553/jmcp.2012.18.4.311; Australian Government Department of Health and the Pharmacy Guild of Australia, 2010, 5 COMM PHARM AGR COM; Benson A, 2009, SOC SCI MED, V68, P2223, DOI 10.1016/j.socscimed.2009.03.012; BERBATIS CG, 2007, INT J PHARM PRACT, V15, P185, DOI DOI 10.1211/ijpp.15.3.0005; Bereznicki B, 2011, J CLIN PHARM THER, V36, P348, DOI 10.1111/j.1365-2710.2010.01187.x; Bissell P, 2008, HEALTH SOC CARE COMM, V16, P363, DOI 10.1111/j.1365-2524.2007.00749.x; Blake KB, 2010, ANN PHARMACOTHER, V44, P424, DOI 10.1345/aph.1M386; Browne S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093288; Bryant LJM, 2009, RES SOC ADMIN PHARM, V5, P347, DOI 10.1016/j.sapharm.2009.01.002; Chisholm-Burns MA, 2010, MED CARE, V48, P923, DOI 10.1097/MLR.0b013e3181e57962; Chui MA, 2012, RES SOC ADMIN PHARM, V8, P206, DOI 10.1016/j.sapharm.2011.06.001; Chung VCH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050022; Consumers' Health Forum of Australia, 2001, GUID CONS REPR; Creswell J. W., 2013, QUALITATIVE INQUIRY; D'Amour D, 2008, BMC HEALTH SERV RES, V8, DOI [10.1186/1472-6963-8-40, 10.1186/1472-6963-8-188]; DAMBOISE G, 1988, ACAD MANAGE REV, V13, P226, DOI 10.2307/258574; Doucette WR, 2012, RES SOC ADMIN PHARM, V8, P274, DOI 10.1016/j.sapharm.2011.07.002; Evans CD, 2011, ANN PHARMACOTHER, V45, P615, DOI 10.1345/aph.1P615; Feletto Eleonora, 2013, Int J Pharm Pract, V21, P28, DOI 10.1111/j.2042-7174.2012.00225.x; Gastelurrutia M, 2009, PHARM WORLD SCI, V31, P32, DOI 10.1007/s11096-008-9261-0; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Grindrod KA, 2009, CAN PHARM J, V142, P234, DOI 10.3821/1913-701X-142.5.234; Grover A, 2013, ACAD MED, V88, P1827, DOI 10.1097/ACM.0000000000000028; Hatah E, 2012, INT J CLIN PHARM-NET, V34, P364, DOI 10.1007/s11096-012-9617-3; Health Workforce Australia, 2014, AUSTR HLTH WORKF SER; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Holland RW, 1999, AM J HEALTH-SYST PH, V56, P1758, DOI 10.1093/ajhp/56.17.1758; Jacobs Sally, 2011, J Health Organ Manag, V25, P420; Kerner JF, 2008, J PUBLIC HEALTH MAN, V14, P193, DOI 10.1097/01.PHH.0000311899.11197.db; Labrunee M., 2012, Annals of Physical and Rehabilitation Medicine, V55, P322, DOI 10.1016/j.rehab.2012.04.003; Machado M, 2008, ANN PHARMACOTHER, V42, P1195, DOI 10.1345/aph.1K618; Machado M, 2007, ANN PHARMACOTHER, V41, P1770, DOI 10.1345/aph.1K311; Machado M, 2007, ANN PHARMACOTHER, V41, P1569, DOI 10.1345/aph.1K151; Mak Vivienne S L, 2012, Int J Pharm Pract, V20, P33, DOI 10.1111/j.2042-7174.2011.00160.x; Martin-Calero MJ, 2004, CURR PHARM DESIGN, V10, P3969, DOI 10.2174/1381612043382549; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; Mossialos E, 2013, HEALTH POLICY, V111, P135, DOI 10.1016/j.healthpol.2013.04.003; Pharmaceutical Society of Australia, 2011, GUID PHARM HOM MED R; Pharmaceutical Society of Australia, 2012, GUID PHARM MED US RE; Pharmacy Guild of Australia, 2010, ROADM STRAT DIR COMM; Ponniah A, 2007, J CLIN PHARM THER, V32, P343, DOI 10.1111/j.1365-2710.2007.00827.x; Puspitasari HP, 2013, INT J CLIN PHARM-NET, V35, P1218, DOI 10.1007/s11096-013-9854-0; Roberts Alison S, 2005, Res Social Adm Pharm, V1, P546, DOI 10.1016/j.sapharm.2005.09.003; Robinson Jennifer G, 2009, Prev Cardiol, V12, P136, DOI 10.1111/j.1751-7141.2009.00037.x; Smith M, 2013, HEALTH AFFAIR, V32, P1963, DOI 10.1377/hlthaff.2013.0542; Sonnedecker G., 1976, KREMERS URDANGS HIST; Stergachis Andy, 2002, J Am Pharm Assoc (Wash), V42, P743, DOI 10.1331/108658002764653522; Swanson RC, 2012, HEALTH POLICY PLANN, V27, P54, DOI 10.1093/heapol/czs090; Sweeny K, 2007, 34 VICT U TECHN CTR; West MA, 2007, BLACKWELL ENCY SOCIO; White CM, 2014, ANN PHARMACOTHER, V48, P268, DOI 10.1177/1060028013511786; Wong FYY, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-121; World Health Organization, 2007, PREV CARD DIS POCK G; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zellmer WA, 2012, ANN PHARMACOTHER, V46, pS41, DOI 10.1345/aph.1Q805	55	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113337	10.1371/journal.pone.0113337	http://dx.doi.org/10.1371/journal.pone.0113337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU3SG	25409194	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200099
J	Ma, J; Stiller, J; Zhao, Q; Feng, Q; Cavanagh, C; Wang, PH; Gardiner, D; Choulet, F; Feuillet, C; Zheng, YL; Wei, YM; Yan, GJ; Han, B; Manners, JM; Liu, CJ				Ma, Jian; Stiller, Jiri; Zhao, Qiang; Feng, Qi; Cavanagh, Colin; Wang, Penghao; Gardiner, Donald; Choulet, Frederic; Feuillet, Catherine; Zheng, You-Liang; Wei, Yuming; Yan, Guijun; Han, Bin; Manners, John M.; Liu, Chunji			Transcriptome and Allele Specificity Associated with a 3BL Locus for Fusarium Crown Rot Resistance in Bread Wheat	PLOS ONE			English	Article							HEAD-BLIGHT RESISTANCE; MYCOTOXIN DEOXYNIVALENOL; DRAFT GENOME; GENE; EXPRESSION; DEFENSE; GRAMINEARUM; PROTEIN; QTL; OVEREXPRESSION	Fusarium pathogens cause two major diseases in cereals, Fusarium crown rot (FCR) and head blight (FHB). A large-effect locus conferring resistance to FCR disease was previously located to chromosome arm 3BL (designated as Qcrs-3B) and several independent sets of near isogenic lines (NILs) have been developed for this locus. In this study, five sets of the NILs were used to examine transcriptional changes associated with the Qcrs-3B locus and to identify genes linked to the resistance locus as a step towards the isolation of the causative gene(s). Of the differentially expressed genes (DEGs) detected between the NILs, 12.7% was located on the single chromosome 3B. Of the expressed genes containing SNP (SNP-EGs) detected, 23.5% was mapped to this chromosome. Several of the DEGs and SNP-EGs are known to be involved in host-pathogen interactions, and a large number of the DEGs were among those detected for FHB in previous studies. Of the DEGs detected, 22 were mapped in the Qcrs-3B interval and they included eight which were detected in the resistant isolines only. The enrichment of DEG, and not necessarily those containing SNPs between the resistant and susceptible isolines, around the Qcrs-3B locus is suggestive of local regulation of this region by the resistance allele. Functions for 13 of these DEGs are known. Of the SNP-EGs, 28 were mapped in the Qcrs-3B interval and biological functions for 16 of them are known. These results provide insights into responses regulated by the 3BL locus and identify a tractable number of target genes for fine mapping and functional testing to identify the causative gene(s) at this QTL.	[Ma, Jian; Stiller, Jiri; Gardiner, Donald; Manners, John M.; Liu, Chunji] CSIRO Agr Flagship, St Lucia, Qld, Australia; [Ma, Jian; Zheng, You-Liang; Wei, Yuming] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China; [Zhao, Qiang; Feng, Qi; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Ctr Gene Res, Shanghai, Peoples R China; [Cavanagh, Colin; Wang, Penghao] CSIRO Agr Flagship, Black Mt, ACT, Australia; [Choulet, Frederic; Feuillet, Catherine] INRA, UBP Joint Res Unit 1095, Genet Div & Ecophysiol Cereals, Clermont Ferrand, France; [Yan, Guijun; Liu, Chunji] Univ Western Australia, Fac Sci, Sch Plant Biol, Perth, WA 6009, Australia; [Yan, Guijun; Liu, Chunji] Univ Western Australia, Inst Agr, Perth, WA 6009, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Sichuan Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); INRAE; University of Western Australia; University of Western Australia	Liu, CJ (corresponding author), CSIRO Agr Flagship, St Lucia, Qld, Australia.	chunji.liu@csiro.au	Stiller, Jiri/E-1564-2012; Wang, Penghao/A-7482-2015; Ma, Jian/M-3639-2019; Liu, Chunji/B-5243-2009; Manners, John M/A-4922-2008; Gardiner, Donald/A-1297-2010; Yan, Guijun/A-9809-2011	Ma, Jian/0000-0001-6265-7911; Gardiner, Donald/0000-0002-2162-8716; Cavanagh, Colin/0000-0003-4341-4484; Choulet, Frederic/0000-0003-1788-7288; Wang, Penghao/0000-0002-3751-3921; Yan, Guijun/0000-0001-9628-1211	joint CAS/CSIRO project [R-1910-1]; ARC Linkage project [LP120200830]; Sichuan Agricultural University; China Scholarship Council	joint CAS/CSIRO project; ARC Linkage project(Australian Research Council); Sichuan Agricultural University; China Scholarship Council(China Scholarship Council)	This publication is based upon work supported by a joint CAS/CSIRO project (Project No R-1910-1) and an ARC Linkage project (Project No. LP120200830). JM is grateful to the Sichuan Agricultural University and the China Scholarship Council for funding his visit to CSIRO Agriculture Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsanmi OA, 2004, AUST J AGR RES, V55, P97, DOI 10.1071/AR03090; Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Bovill WD, 2006, PLANT BREEDING, V125, P538, DOI 10.1111/j.1439-0523.2006.01251.x; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chakraborty S, 2006, AUSTRALAS PLANT PATH, V35, P643, DOI 10.1071/AP06068; Cho SH, 2012, J PLANT BIOL, V55, P64, DOI 10.1007/s12374-011-9190-7; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Collard BCY, 2005, PLANT BREEDING, V124, P532, DOI 10.1111/j.1439-0523.2005.01163.x; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; Desmond OJ, 2005, PHYSIOL MOL PLANT P, V67, P171, DOI 10.1016/j.pmpp.2005.12.007; Desmond OJ, 2008, PHYSIOL MOL PLANT P, V73, P40, DOI 10.1016/j.pmpp.2008.12.001; Dubin H.J., 1997, FUSARIUM HEAD SCAB G; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Gottwald S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-369; Hancock JT, 2002, PLANT PHYSIOL BIOCH, V40, P611, DOI 10.1016/S0981-9428(02)01403-1; Jia HY, 2009, MOL PLANT MICROBE IN, V22, P1366, DOI 10.1094/MPMI-22-11-1366; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kugler KG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-728; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Li GL, 2008, CROP SCI, V48, P1888, DOI 10.2135/cropsci2008.02.0097; Li HB, 2010, THEOR APPL GENET, V121, P941, DOI 10.1007/s00122-010-1363-0; Li WL, 2001, THEOR APPL GENET, V102, P353, DOI 10.1007/s001220051653; Li X, 2010, PHYTOPATHOLOGY, V100, P183, DOI 10.1094/PHYTO-100-2-0183; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu SX, 2008, CEREAL RES COMMUN, V36, P195, DOI 10.1556/CRC.36.2008.Suppl.B.15; Liu YL, 2004, PLANT J, V38, P800, DOI 10.1111/j.1365-313X.2004.02085.x; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Lu W, 2001, WHEAT SCAB RES CHINA; Ma J, 2012, EUPHYTICA, V183, P147, DOI 10.1007/s10681-011-0414-1; Ma J, 2010, THEOR APPL GENET, V120, P1119, DOI 10.1007/s00122-009-1239-3; Ma J, 2013, PLANTA, V238, P1081, DOI 10.1007/s00425-013-1953-6; Ma J, 2013, GENETICA, V141, P227, DOI 10.1007/s10709-013-9721-x; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; MAUCH F, 1993, PLANT PHYSIOL, V102, P1193, DOI 10.1104/pp.102.4.1193; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; Muhitch MJ, 2000, PLANT SCI, V157, P201, DOI 10.1016/S0168-9452(00)00282-X; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Wallwork H, 2004, AUSTRALAS PLANT PATH, V33, P1, DOI 10.1071/AP03073; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Yang XM, 2010, EUR J PLANT PATHOL, V128, P495, DOI 10.1007/s10658-010-9680-3; Zheng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096011, 10.1371/journal.pone.0090817]; Zhu XL, 2012, FUNCT INTEGR GENOMIC, V12, P481, DOI 10.1007/s10142-012-0286-z	54	26	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113309	10.1371/journal.pone.0113309	http://dx.doi.org/10.1371/journal.pone.0113309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405461	Green Published, gold			2022-12-26	WOS:000347121300102
J	Shahab, L; Beard, E; Brown, J; West, R				Shahab, Lion; Beard, Emma; Brown, Jamie; West, Robert			Prevalence of NRT Use and Associated Nicotine Intake in Smokers, Recent Ex-Smokers and Longer-Term Ex-Smokers	PLOS ONE			English	Article							REPLACEMENT THERAPY; SMOKING-CESSATION; TOBACCO DEPENDENCE; CIGARETTE; COTININE; DURATION; IMPACT; AID; GUM	Background: Nicotine replacement therapy (NRT) is used by smokers wanting to reduce their smoking and to quit. However, there are very little data on nicotine intake associated with NRT use in representative population samples. This study aimed to provide estimates for NRT use and associated nicotine exposure among smokers, recent and longer-term exsmokers in England, a country with a permissive regulatory regime for nicotine substitution. Methods: In the Smoking Toolkit Study, a monthly series of representative household surveys of adults aged 16+ in England, current and recent ex-smokers who agreed to be re-contacted were followed up 6 months later and standard socio-demographic and smoking characteristics assessed (N = 5,467, response rate 25.1%). A random sub-sample (N = 1,614; 29.5%) also provided saliva, analysed for cotinine. Results: The sample followed up was broadly representative of the original sample. At follow-up, 11.8% (95% CI 10.9-12.8, N = 565) of current smokers, 34.8% (95% CI 28.9-41.3, N = 77) of recent (<= 3 months) ex-smokers, and 7.8% (95% CI 5.6-10.6, N = 36) of longer-term (>3 months) ex-smokers reported using NRT. Smokers who used NRT had similar saliva cotinine concentrations to smokers who did not use NRT (mean +/- sd = 356.0 +/- 198.6 ng/ml vs. 313.1 +/- 178.4 ng/ml). Recent exsmokers who used NRT had levels that were somewhat lower, but not significantly so, than current smokers (216.7 +/- 179.3 ng/ml). Longer-term ex-smokers using NRT had still lower levels (157.3 +/- 227.1 ng/ml), which differed significantly from smokers using NRT (p = 0.024). Conclusions: Concurrent use of nicotine replacement therapy while smoking is relatively uncommon and is not associated with higher levels of nicotine intake. Among ex-smokers, NRT use is common in the short but not longer-term and among longer-term users is associated with lower nicotine intake than in smokers.	[Shahab, Lion; Beard, Emma; Brown, Jamie; West, Robert] UCL, Dept Epidemiol & Publ Hlth, London, England; [Brown, Jamie] UCL, Dept Clin Educ & Hlth Psychol, London, England	University of London; University College London; University of London; University College London	Shahab, L (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	lion.shahab@ucl.ac.uk	Brown, Jamie/F-4413-2011; Shahab, Lion/B-5835-2009; West, Robert/B-5414-2009	Brown, Jamie/0000-0002-2797-5428; Shahab, Lion/0000-0003-4033-442X; West, Robert/0000-0001-6398-0921	Department of Health, Cancer Research UK; Pfizer; GlaxoSmithKline; Johnson and Johnson; Cancer Research UK [14135] Funding Source: researchfish; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, MR/K023195/1B] Funding Source: researchfish	Department of Health, Cancer Research UK(Cancer Research UK); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Department of Health, Cancer Research UK, Pfizer, GlaxoSmithKline and Johnson and Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard E, 2013, TOB CONTROL, V22, P118, DOI 10.1136/tobaccocontrol-2011-050007; Beard E, 2011, PSYCHOPHARMACOLOGY, V218, P609, DOI 10.1007/s00213-011-2359-4; BENOWITZ NL, 1982, J PHARMACOL EXP THER, V221, P368; Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X; Black A, 2012, ADDICTION, V107, P2037, DOI 10.1111/j.1360-0443.2012.03955.x; Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878; Etter JF, 2009, ADDICT BEHAV, V34, P246, DOI 10.1016/j.addbeh.2008.10.018; Fagerstrom Karl Olov, 2002, Nicotine Tob Res, V4 Suppl 2, pS73; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450, DOI 10.1111/j.2042-7158.1990.tb06592.x; Fidler JA, 2011, PSYCHOPHARMACOLOGY, V217, P587, DOI 10.1007/s00213-011-2317-1; Fidler JA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-479; Fidler JA, 2011, ADDICTION, V106, P631, DOI 10.1111/j.1360-0443.2010.03226.x; FOULDS J, 1994, AM J PUBLIC HEALTH, V84, P1182, DOI 10.2105/AJPH.84.7.1182; Fucito LM, 2014, NICOTINE TOB RES, V16, P909, DOI 10.1093/ntr/ntu087; Hajek P, 2007, PREV MED, V44, P230, DOI 10.1016/j.ypmed.2006.10.005; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; Hubbard R, 2005, TOB CONTROL, V14, P416, DOI 10.1136/tc.2005.011387; Joseph AM, 2011, ARCH INTERN MED, V171, P1894, DOI 10.1001/archinternmed.2011.500; Kotz D, 2013, DRUG ALCOHOL DEPEN, V128, P15, DOI 10.1016/j.drugalcdep.2012.07.012; Le Houezec J, 2011, DRUG ALCOHOL REV, V30, P119, DOI 10.1111/j.1465-3362.2010.00264.x; Le Strat Y, 2011, TOB CONTROL, V20, P338, DOI 10.1136/tc.2010.038703; MHRA, 2009, MHRA PUBL ASS REP US; NICE, 2013, TOB HARM RED; Schnoll RA, 2010, ANN INTERN MED, V152, P144, DOI 10.7326/0003-4819-152-3-201002020-00005; Shahab L, 2013, CNS DRUGS, V27, P1007, DOI 10.1007/s40263-013-0116-4; Shahab L, 2009, ADDICTION, V104, P1420, DOI 10.1111/j.1360-0443.2009.02641.x; Shiffman S, 2008, HEALTH POLICY, V86, P17, DOI 10.1016/j.healthpol.2007.08.006; Silla K, 2014, NICOTINE TOB RES, V16, P1050, DOI 10.1093/ntr/ntu019; Sims TH, 2002, CNS DRUGS, V16, P653, DOI 10.2165/00023210-200216100-00001; Stratton S, 2001, CLEARING SMOKE ADDRE; Tonnesen P, 1999, EUR RESPIR J, V13, P238, DOI 10.1034/j.1399-3003.1999.13b04.x; Wang D, 2008, HEALTH TECHNOL ASSES, V12, piii, DOI DOI 10.3310/HTA12020; Wennike P, 2003, ADDICTION, V98, P1395, DOI 10.1046/j.1360-0443.2003.00489.x; West R, 2005, TOB CONTROL, V14, P166, DOI 10.1136/tc.2004.008649	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113045	10.1371/journal.pone.0113045	http://dx.doi.org/10.1371/journal.pone.0113045			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405343	Green Published, gold			2022-12-26	WOS:000347121300073
J	Merkes, CM; McCalla, SG; Jensen, NR; Gaikowski, MP; Amberg, JJ				Merkes, Christopher M.; McCalla, S. Grace; Jensen, Nathan R.; Gaikowski, Mark P.; Amberg, Jon J.			Persistence of DNA in Carcasses, Slime and Avian Feces May Affect Interpretation of Environmental DNA Data	PLOS ONE			English	Article							WATER; CONSERVATION; ERADICATION; PREDATION; BIOLOGY; RARE	The prevention of non-indigenous aquatic invasive species spreading into new areas is a goal of many resource managers. New techniques have been developed to survey for species that are difficult to capture with conventional gears that involve the detection of their DNA in water samples (eDNA). This technique is currently used to track the invasion of bigheaded carps (silver carp and bighead carp; Hypophthalmichthys molitrix and H. nobilis) in the Chicago Area Waterway System and Upper Mississippi River. In both systems DNA has been detected from silver carp without the capture of a live fish, which has led to some uncertainty about the source of the DNA. The potential contribution to eDNA by vectors and fomites has not been explored. Because barges move from areas with a high abundance of bigheaded carps to areas monitored for the potential presence of silver carp, we used juvenile silver carp to simulate the barge transport of dead bigheaded carp carcasses, slime residue, and predator feces to determine the potential of these sources to supply DNA to uninhabited waters where it could be detected and misinterpreted as indicative of the presence of live bigheaded carp. Our results indicate that all three vectors are feasible sources of detectable eDNA for at least one month after their deposition. This suggests that current monitoring programs must consider alternative vectors of DNA in the environment and consider alternative strategies to minimize the detection of DNA not directly released from live bigheaded carps.	[Merkes, Christopher M.] IAP Worldwide Serv Inc, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA; [Merkes, Christopher M.; McCalla, S. Grace; Jensen, Nathan R.; Gaikowski, Mark P.; Amberg, Jon J.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA	United States Department of the Interior; United States Geological Survey	Merkes, CM (corresponding author), IAP Worldwide Serv Inc, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA.	cmerkes@usgs.gov		McCalla, S. Grace/0000-0003-4292-8694; Gaikowski, Mark/0000-0002-6507-9341; Merkes, Christopher/0000-0001-8191-627X	U.S. Environmental Protection Agency - Great Lakes Restoration Initiative; IAP Worldwide Services	U.S. Environmental Protection Agency - Great Lakes Restoration Initiative; IAP Worldwide Services	Funding support for this work came from the U.S. Environmental Protection Agency - Great Lakes Restoration Initiative appropriated funds (http://greatlakesrestoration.us). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Christopher M. Merkes was employed by IAP Worldwide Services at the time of the study. IAP Worldwide Services provided support in the form of salary for author Christopher M. Merkes but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	Banks SC, 2003, MOL ECOL, V12, P1663, DOI 10.1046/j.1365-294X.2003.01823.x; Bienert F, 2012, MOL ECOL, V21, P2017, DOI 10.1111/j.1365-294X.2011.05407.x; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Casper RM, 2007, J EXP MAR BIOL ECOL, V347, P144, DOI 10.1016/j.jembe.2007.04.002; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Dallas John F., 2000, Conservation Genetics, V1, P181, DOI 10.1023/A:1026551510861; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gross S, 2013, ARMY CORPS ENG OTHER; Hedmark E, 2004, CONSERV GENET, V5, P405, DOI 10.1023/B:COGE.0000031224.88778.f5; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Lamer JT, 2010, N AM J FISH MANAGE, V30, P1452, DOI 10.1577/M10-053.1; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Matsui K, 2001, AQUAT MICROB ECOL, V26, P95, DOI 10.3354/ame026095; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Oehm J, 2011, MOL ECOL RESOUR, V11, P620, DOI 10.1111/j.1755-0998.2011.03001.x; Palsboll PJ, 1997, NATURE, V388, P767, DOI 10.1038/42005; Piggott MP, 2003, WILDLIFE RES, V30, P1, DOI 10.1071/WR02077; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; U.S. Army Corps of Engineers, 2013, 2012 AS CARP MON RAP; U.S. Army Corps of Engineers, 2013, ENV DNA CAL STUD INT; U.S. Fish & Wildlife Service, 2013, BIGH SILV CARP EDNA; Williams CK, 2003, TLS-TIMES LIT SUPPL, P31	38	94	98	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113346	10.1371/journal.pone.0113346	http://dx.doi.org/10.1371/journal.pone.0113346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402206	gold, Green Submitted, Green Published			2022-12-26	WOS:000345158700130
J	Schwetz, TA; Reissaus, CA; Piston, DW				Schwetz, Tara A.; Reissaus, Christopher A.; Piston, David W.			Differential Stimulation of Insulin Secretion by GLP-1 and Kisspeptin-10	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELLS; GLUCOSE-METABOLISM; GAMMA-SUBUNIT; RELEASE; ISLETS; MECHANISMS; SYSTEM; KISS-1; CA2+	beta-cells in the pancreatic islet respond to elevated plasma glucose by secreting insulin to maintain glucose homeostasis. In addition to glucose stimulation, insulin secretion is modulated by numerous G-protein coupled receptors (GPCRs). The GPCR ligands Kisspeptin-10 (KP) and glucagon-like peptide-1 (GLP-1) potentiate insulin secretion through G(q) and G(s)-coupled receptors, respectively. Despite many studies, the signaling mechanisms by which KP and GLP-1 potentiate insulin release are not thoroughly understood. We investigated the downstream signaling pathways of these ligands and their affects on cellular redox potential, intracellular calcium activity ([Ca2+](i)), and insulin secretion from beta-cells within intact murine islets. In contrast to previous studies performed on single beta-cells, neither KP nor GLP-1 affect [Ca2+] i upon stimulation with glucose. KP significantly increases the cellular redox potential, while no effect is observed with GLP-1, suggesting that KP and GLP-1 potentiate insulin secretion through different mechanisms. Co-treatment with KP and the G(beta gamma)-subunit inhibitor gallein inhibits insulin secretion similar to that observed with gallein alone, while co-treatment with gallein and GLP-1 does not differ from GLP-1 alone. In contrast, co-treatment with the G(beta gamma) activator mSIRK and either KP or GLP-1 stimulates insulin release similar to mSIRK alone. Neither gallein nor mSIRK alter [Ca2+] i activity in the presence of KP or GLP-1. These data suggest that KP likely alters insulin secretion through a G(beta gamma)-dependent process that stimulates glucose metabolism without altering Ca2+ activity, while GLP-1 does so, at least partly, through a G(alpha)-dependent pathway that is independent of both metabolism and Ca2+.	[Schwetz, Tara A.; Reissaus, Christopher A.; Piston, David W.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Piston, David W.] Vanderbilt Univ, Dept Phys, Nashville, TN 37235 USA; [Piston, David W.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Piston, DW (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	dave.piston@vanderbilt.edu		Reissaus, Christopher/0000-0002-3260-4525	National Institutes of Health (NIH) [P30DK020593, P30DK058404, U24DK059637]; NIH [F32DK091181, R01DK085064]; Vanderbilt University through the Louise B. McGavock Chair; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, R01DK098659, P60DK020593, P30DK058404, U24DK059637, R01DK085064, F32DK091181] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University through the Louise B. McGavock Chair; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Experiments were performed in part through use of the Vanderbilt University Cell Imaging Shared Resource (supported by National Institutes of Health (NIH) grants P30DK020593, P30DK058404, and U24DK059637). This work was funded by NIH through grants F32DK091181 (TAS) and R01DK085064 (CAR, DWP), and by Vanderbilt University through the Louise B. McGavock Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWATER I, 1984, J PHYSIOL-LONDON, V348, P615, DOI 10.1113/jphysiol.1984.sp015129; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Benninger RKP, 2011, J PHYSIOL-LONDON, V589, P5453, DOI 10.1113/jphysiol.2011.218909; Bergsten P, 1998, AM J PHYSIOL-ENDOC M, V274, pE796, DOI 10.1152/ajpendo.1998.274.5.E796; Bowe JE, 2009, DIABETOLOGIA, V52, P855, DOI 10.1007/s00125-009-1283-1; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; Damdindorj B, 2012, FEBS LETT, V586, P2555, DOI 10.1016/j.febslet.2012.06.034; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Hauge-Evans AC, 2006, DIABETOLOGIA, V49, P2131, DOI 10.1007/s00125-006-0343-z; HOENIG M, 1986, ENDOCRINOLOGY, V119, P2502, DOI 10.1210/endo-119-6-2502; Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LU M, 1993, ENDOCRINOLOGY, V132, P94, DOI 10.1210/en.132.1.94; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Peyot ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006221; Piston DW, 1999, TRENDS ENDOCRIN MET, V10, P413, DOI 10.1016/S1043-2760(99)00204-0; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; Schwetz TA, 2012, AM J PHYSL ENDOCRINO; Silvestre RA, 2008, J ENDOCRINOL, V196, P283, DOI 10.1677/JOE-07-0454; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; STEFAN Y, 1987, J CLIN INVEST, V80, P175, DOI 10.1172/JCI113045; Vikman J, 2009, DIABETES OBES METAB, V11, P197, DOI 10.1111/j.1463-1326.2009.01116.x; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; YADA T, 1993, ENDOCRINOLOGY, V133, P1685, DOI 10.1210/en.133.4.1685; Zhang M, 2003, BIOPHYS J, V84, P2852, DOI 10.1016/S0006-3495(03)70014-9	40	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113020	10.1371/journal.pone.0113020	http://dx.doi.org/10.1371/journal.pone.0113020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401335	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700097
J	Brookmeyer, R; Boren, D; Baral, SD; Bekker, LG; Phaswana-Mafuya, N; Beyrer, C; Sullivan, PS				Brookmeyer, Ron; Boren, David; Baral, Stefan D.; Bekker, Linda-Gail; Phaswana-Mafuya, Nancy; Beyrer, Chris; Sullivan, Patrick S.			Combination HIV Prevention among MSM in South Africa: Results from Agent-based Modeling	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MEN; TRANSMISSION; INFECTION; SEX; CHALLENGES; RISK; EPIDEMIOLOGY; METAANALYSIS	HIV prevention trials have demonstrated the effectiveness of a number of behavioral and biomedical interventions. HIV prevention packages are combinations of interventions and offer potential to significantly increase the effectiveness of any single intervention. Estimates of the effectiveness of prevention packages are important for guiding the development of prevention strategies and for characterizing effect sizes before embarking on large scale trials. Unfortunately, most research to date has focused on testing single interventions rather than HIV prevention packages. Here we report the results from agent-based modeling of the effectiveness of HIV prevention packages for men who have sex with men (MSM) in South Africa. We consider packages consisting of four components: antiretroviral therapy for HIV infected persons with CD4 count <350; PrEP for high risk uninfected persons; behavioral interventions to reduce rates of unprotected anal intercourse (UAI); and campaigns to increase HIV testing. We considered 163 HIV prevention packages corresponding to different intensity levels of the four components. We performed 2252 simulation runs of our agent-based model to evaluate those packages. We found that a four component package consisting of a 15% reduction in the rate of UAI, 50% PrEP coverage of high risk uninfected persons, 50% reduction in persons who never test for HIV, and 50% ART coverage over and above persons already receiving ART at baseline, could prevent 33.9% of infections over 5 years (95% confidence interval, 31.5, 36.3). The package components with the largest incremental prevention effects were UAI reduction and PrEP coverage. The impact of increased HIV testing was magnified in the presence of PrEP. We find that HIV prevention packages that include both behavioral and biomedical components can in combination prevent significant numbers of infections with levels of coverage, acceptance and adherence that are potentially achievable among MSM in South Africa.	[Brookmeyer, Ron; Boren, David] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Baral, Stefan D.; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Phaswana-Mafuya, Nancy] Nelson Mandela Metropolitan Univ, Human Sci Res Council, HIV AIDS STI TB Res Programme, Off Deputy Vice Chancellor Res & Engagement, Port Elizabeth, South Africa; [Sullivan, Patrick S.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; Human Sciences Research Council-South Africa; Nelson Mandela University; Emory University; Rollins School Public Health	Brookmeyer, R (corresponding author), Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.	rbrookmeyer@ucla.edu	Bekker, Linda-Gail/AAZ-8929-2020; Baral, Stefan/AAG-4818-2020; Phaswana-Mafuya, Nancy Refilwe/B-8902-2018	Baral, Stefan/0000-0002-5482-2419; Phaswana-Mafuya, Nancy Refilwe/0000-0001-9387-0432; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Sullivan, Patrick Sean/0000-0002-7728-0587	National Institutes of Health [R01AI094575]; Human Sciences Research Council; NIH funded program [1P30AI094189]; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094575, P30AI050409, P30AI094189, P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Sciences Research Council; NIH funded program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (R01AI094575), the Human Sciences Research Council, and was facilitated by the Emory Center for AIDS Research (P30 AI050409), the UCLA Center for AIDS Research (AI028697) and the Johns Hopkins University Center for AIDS Research, an NIH funded program (1P30AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2013, J INFECT DIS, V208, P224, DOI 10.1093/infdis/jit150; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Bekker LG, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007435; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Boren D, 2014, STAT MED, DOI 10002/sim6193; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen J, 2005, SCIENCE, V309, P1002, DOI 10.1126/science.309.5737.1002; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; DEGRUTTOLA V, 1991, J AM STAT ASSOC, V86, P569, DOI 10.2307/2290384; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; El-Sadr WM, 2013, JAIDS-J ACQ IMM DEF, V63, pS115, DOI 10.1097/QAI.0b013e318299c3d9; Epstein J.M., 2006, GENERATIVE SOCIAL SC, P4; Goodreau SM, 2005, J INFECT DIS, V191, pS147, DOI 10.1086/425268; Goodreau SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102960; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055449; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Institute of Medicine, 2008, METH CHALL BIOM HIV; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Lagakos SW, 2008, NEW ENGL J MED, V358, P1543, DOI 10.1056/NEJMp0802028; Lou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090985; Marx BD, 1996, TECHNOMETRICS, V38, P374, DOI 10.2307/1271308; McCullagh P., 1989, MONOGRAPHS STAT APPL; R Development Core Team, R PROJ STAT COMP; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tierney L, 2009, INT J PARALLEL PROG, V37, P78, DOI 10.1007/s10766-008-0077-2; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003	34	34	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112668	10.1371/journal.pone.0112668	http://dx.doi.org/10.1371/journal.pone.0112668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398143	Green Published, gold			2022-12-26	WOS:000345558500073
J	Kang, SJ; Lee, TA; Ra, EA; Lee, E; Choi, HJ; Lee, S; Park, B				Kang, Sujin; Lee, Taeyun A.; Ra, Eun A.; Lee, Eunhye; Choi, Hyun Jin; Lee, Sungwook; Park, Boyoun			Differential Control of Interleukin-6 mRNA Levels by Cellular Distribution of YB-1	PLOS ONE			English	Article							Y-BOX PROTEIN-1; ACID BINDING-PROTEINS; INFLAMMATION; CELLS; EXPRESSION; MICRORNAS; STRESS; SURVIVAL; DISEASE; FAMILY	Cytokine production is essential for innate and adaptive immunity against microbial invaders and must be tightly controlled. Cytokine messenger RNA (mRNA) is in constant flux between the nucleus and the cytoplasm and in transcription, splicing, or decay; such processes must be tightly controlled. Here, we report a novel function of Y-box-binding protein 1 (YB-1) in modulating interleukin-6 (IL-6) mRNA levels in a cell type-specific manner. In lipopolysaccharide (LPS)-stimulated macrophages, YB-1 interacts with IL-6 mRNA and actively transports it to the extracellular space by YB-1-enriched vesicles, resulting in the proper maintenance of intracellular IL-6 mRNA levels. YB-1 secretion occurs in a cell type-specific manner. Whereas macrophages actively secret YB-1, dendritic cells maintain it predominantly in the cytoplasm even in response to LPS. Intracellular YB-1 has the distinct function of regulating IL-6 mRNA stability in dendritic cells. Moreover, because LPS differentially regulates the expression of histone deacetylase 6 (HDAC6) in macrophages and dendritic cells, this stimulus might control YB-1 acetylation differentially in both cell types. Taken together, these results suggest a unique feature of YB-1 in controlling intracellular IL-6 mRNA levels in a cell type-specific manner, thereby leading to functions that are dependent on the extracellular and intracellular distribution of YB-1.	[Kang, Sujin; Lee, Taeyun A.; Ra, Eun A.; Lee, Eunhye; Choi, Hyun Jin; Lee, Sungwook; Park, Boyoun] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Lee, S (corresponding author), Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	swlee1905@yonsei.ac.kr; bypark@yonsei.ac.kr	Lee, Sungwook/K-3697-2013		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0015372, 2010-0009203]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea; Yonsei University Research Fund [2014-12-0135]; BK21 PLUS (Brain Korea 21 Program for Leading University Students); NRF (National Research Foundation of Korea) grant - Korean Government	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Yonsei University Research Fund; BK21 PLUS (Brain Korea 21 Program for Leading University Students); NRF (National Research Foundation of Korea) grant - Korean Government	This study was supported by grants from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0015372, 2010-0009203) and from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea. SL was supported by the Yonsei University Research Fund of 2014 (2014-12-0135). SK, TAL, and EAR were supported by BK21 PLUS (Brain Korea 21 Program for Leading University & Students). HJC was supported by NRF (National Research Foundation of Korea) grant funded by the Korean Government (NRF-2013- Global Ph.D. Fellowship Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidousty C, 2014, J BIOL CHEM; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Cohen SB, 2010, ONCOGENE, V29, P403, DOI 10.1038/onc.2009.321; Diamond P, 2001, J BIOL CHEM, V276, P7943, DOI 10.1074/jbc.M009836200; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Hanssen L, 2013, J IMMUNOL, V191, P2604, DOI 10.4049/jimmunol.1300416; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ivanov P, 2013, IMMUNOL REV, V253, P253, DOI 10.1111/imr.12051; Izumi H, 2001, NUCLEIC ACIDS RES, V29, P1200, DOI 10.1093/nar/29.5.1200; Kim ER, 2013, CELL CYCLE, V12, P3791, DOI 10.4161/cc.26670; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Norling LV, 2010, J INTERN MED, V268, P15, DOI 10.1111/j.1365-2796.2010.02235.x; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Raffetseder U, 2012, EUR J CELL BIOL, V91, P567, DOI 10.1016/j.ejcb.2011.07.001; Raffetseder U, 2009, KIDNEY INT, V75, P185, DOI 10.1038/ki.2008.457; Ruzanov PV, 1999, J CELL SCI, V112, P3487; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Tacke F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-185; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Roeyen CR, CELL COMMUN SIGNAL, V11, P63; WOLFFE AP, 1992, NEW BIOL, V4, P290; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407	30	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112754	10.1371/journal.pone.0112754	http://dx.doi.org/10.1371/journal.pone.0112754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398005	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500086
J	Kim, M; Cheeti, A; Yoo, C; Choo, M; Paick, JS; Oh, SJ				Kim, Myong; Cheeti, Abhilash; Yoo, Changwon; Choo, Minsoo; Paick, Jae-Seung; Oh, Seung-June			Non-Invasive Clinical Parameters for the Prediction of Urodynamic Bladder Outlet Obstruction: Analysis Using Causal Bayesian Networks	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; BENIGN PROSTATIC HYPERPLASIA; ARTIFICIAL NEURAL-NETWORKS; PRESSURE-FLOW; MEN; SCORE; DIAGNOSIS; PROBABILITY; VOLUME; SIZE	Purpose: To identify non-invasive clinical parameters to predict urodynamic bladder outlet obstruction (BOO) in patients with benign prostatic hyperplasia (BPH) using causal Bayesian networks (CBN). Subjects and Methods: From October 2004 to August 2013, 1,381 eligible BPH patients with complete data were selected for analysis. The following clinical variables were considered: age, total prostate volume (TPV), transition zone volume (TZV), prostate specific antigen (PSA), maximum flow rate (Qmax), and post-void residual volume (PVR) on uroflowmetry, and International Prostate Symptom Score (IPSS). Among these variables, the independent predictors of BOO were selected using the CBN model. The predictive performance of the CBN model using the selected variables was verified through a logistic regression (LR) model with the same dataset. Results: Mean age, TPV, and IPSS were 6.2 (+/- 7.3, SD) years, 48.5 (+/- 25.9) ml, and 17.9 (+/- 7.9), respectively. The mean BOO index was 35.1 (+/- 25.2) and 477 patients (34.5%) had urodynamic BOO (BOO index >= 40). By using the CBN model, we identified TPV, Qmax, and PVR as independent predictors of BOO. With these three variables, the BOO prediction accuracy was 73.5%. The LR model showed a similar accuracy (77.0%). However, the area under the receiver operating characteristic curve of the CBN model was statistically smaller than that of the LR model (0.772 vs. 0.798, p = 0.020). Conclusions: Our study demonstrated that TPV, Qmax, and PVR are independent predictors of urodynamic BOO.	[Kim, Myong; Choo, Minsoo; Paick, Jae-Seung; Oh, Seung-June] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Cheeti, Abhilash] Florida Int Univ, Sch Comp & Informat Sci, Dept Comp Sci, Miami, FL 33199 USA; [Yoo, Changwon] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Biostat, Miami, FL 33199 USA	Seoul National University (SNU); Seoul National University Hospital; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Oh, SJ (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	sjo@snu.ac.kr			Seoul National University Hospital Research Fund [04-2010-1080]	Seoul National University Hospital Research Fund	This study was supported by grant No. 04-2010-1080 from the Seoul National University Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS P, 1995, BRIT J UROL, V76, P11; [Anonymous], 1996, KOREAN J UROL; BALL AJ, 1981, BRIT J UROL, V53, P613, DOI 10.1111/j.1464-410X.1981.tb03273.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DERKSEN S, 1992, BRIT J MATH STAT PSY, V45, P265, DOI 10.1111/j.2044-8317.1992.tb00992.x; Djavan B, 2004, UROLOGY, V64, P1144, DOI 10.1016/j.urology.2004.08.049; Eckhardt MD, 2001, NEUROUROL URODYNAM, V20, P579, DOI 10.1002/nau.1010; Griffiths D, 1997, NEUROUROL URODYNAM, V16, P1, DOI 10.1002/(SICI)1520-6777(1997)16:1<1::AID-NAU1>3.0.CO;2-I; Jensen K M, 1988, Scand J Urol Nephrol Suppl, V114, P63; Kranse R, 2003, UROLOGY, V62, P667, DOI 10.1016/S0090-4295(03)00575-2; Laniado ME, 2004, BJU INT, V94, P1283, DOI 10.1111/j.1464-410X.2004.05158.x; Madersbacher S, 1997, BRIT J UROL, V80, P72, DOI 10.1046/j.1464-410X.1997.00220.x; Min DS, 2013, KOREAN J UROL, V54, P840, DOI 10.4111/kju.2013.54.12.840; Nikovski D, 2000, IEEE T KNOWL DATA EN, V12, P509, DOI 10.1109/69.868904; Ockrim JL, 2001, J UROLOGY, V166, P2221, DOI 10.1016/S0022-5347(05)65538-3; Pearl J, 1988, PROBABILISTIC REASON, P29, DOI [10.1016/B978-0-08-051489-5.50008-4, DOI 10.1016/B978-0-08-051489-5.50008-4]; Porru D, 1999, NEUROUROL URODYNAM, V18, P647; Rosier PFWM, 1996, J UROLOGY, V155, P1649, DOI 10.1016/S0022-5347(01)66153-6; ROSIER PFWM, 1995, WORLD J UROL, V13, P9, DOI 10.1007/BF00182658; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Sonke GS, 2000, J UROLOGY, V163, P300, DOI 10.1016/S0022-5347(05)68042-1; Spirtes P, 2000, CAUSATION PREDICTION, P42; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; van Venrooij GEPM, 2004, UROLOGY, V63, P476, DOI 10.1016/j.urology.2003.10.021; VANVENROOIJ GEPM, 1995, J UROLOGY, V153, P1516, DOI 10.1016/S0022-5347(01)67449-4; vanVenrooij GEPM, 1996, J UROLOGY, V155, P2014, DOI 10.1016/S0022-5347(01)66077-4; Wadie BS, 2006, UROLOGY, V68, P1211, DOI 10.1016/j.urology.2006.08.1079; Wadie BS, 2001, J UROLOGY, V165, P35, DOI 10.1097/00005392-200101000-00009	28	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113131	10.1371/journal.pone.0113131	http://dx.doi.org/10.1371/journal.pone.0113131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397903	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500134
J	Romanowski, A; Garavaglia, MJ; Goya, ME; Ghiringhelli, PD; Golombek, DA				Romanowski, Andres; Javier Garavaglia, Matias; Eugenia Goya, Maria; Daniel Ghiringhelli, Pablo; Andres Golombek, Diego			Potential Conservation of Circadian Clock Proteins in the phylum Nematoda as Revealed by Bioinformatic Searches	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; C-ELEGANS; MAMMALIAN TIMELESS; E-BOX; GENE-EXPRESSION; DROSOPHILA; TRANSCRIPTION; FEEDBACK; COMPLEX; HOMOLOGS	Although several circadian rhythms have been described in C. elegans, its molecular clock remains elusive. In this work we employed a novel bioinformatic approach, applying probabilistic methodologies, to search for circadian clock proteins of several of the best studied circadian model organisms of different taxa (Mus musculus, Drosophila melanogaster, Neurospora crassa, Arabidopsis thaliana and Synechoccocus elongatus) in the proteomes of C. elegans and other members of the phylum Nematoda. With this approach we found that the Nematoda contain proteins most related to the core and accessory proteins of the insect and mammalian clocks, which provide new insights into the nematode clock and the evolution of the circadian system.	[Romanowski, Andres; Eugenia Goya, Maria; Andres Golombek, Diego] Univ Nacl Quilmes, Lab Cronobiol, Dept Ciencia & Tecnol, Bernal, Buenos Aires, Argentina; [Javier Garavaglia, Matias; Daniel Ghiringhelli, Pablo] Univ Nacl Quilmes, Lab Ingn Genet & Biol Celular & Mol, Area Virosis Insectos, Inst Microbiol Basica & Aplicada,Dept Ciencia & T, Bernal, Buenos Aires, Argentina		Golombek, DA (corresponding author), Univ Nacl Quilmes, Lab Cronobiol, Dept Ciencia & Tecnol, Bernal, Buenos Aires, Argentina.	dgolombek@gmail.com	Ghiringhelli, Pablo D/N-8073-2017; Romanowski, Andres/P-2153-2017	Ghiringhelli, Pablo D/0000-0002-2003-0106; Romanowski, Andres/0000-0003-0737-2408; Golombek, Diego/0000-0002-6291-5586; Goya, Maria Eugenia/0000-0002-5031-2470	National Science Agency (ANPCyT); National Research Council (CONICET); National University of Quilmes (UNQ)	National Science Agency (ANPCyT)(ANPCyT); National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National University of Quilmes (UNQ)	This work was supported by National Science Agency (ANPCyT), National Research Council (CONICET) and National University of Quilmes (UNQ) grants to DAG and PDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Crews ST, 2003, PAS PROTEINS: REGULATORS AND SENSORS OF DEVELOPMENT AND PHYSIOLOGY, P69; Darlington TK, 2000, J BIOL RHYTHM, V15, P462, DOI 10.1177/074873000129001576; Dong GG, 2010, CURR OPIN GENET DEV, V20, P619, DOI 10.1016/j.gde.2010.09.002; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Engelen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056623; Erdelyi P, 2011, J CELL SCI, V124, P1510, DOI 10.1242/jcs.080192; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Fiedler T, 2006, NUCLEIC ACIDS RES, V34, pW546, DOI 10.1093/nar/gkl250; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fitch DHA, 2005, WORMBOOK; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; Golden A, 2003, DEV CELL, V5, P7, DOI 10.1016/S1534-5807(03)00209-0; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gotter AL, 2006, NEUROREPORT, V17, P1229, DOI 10.1097/01.wnr.0000233092.90160.92; Gu HF, 2014, SCI REP-UK, V4, DOI 10.1038/srep04212; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; Hasegawa K, 2005, CHRONOBIOL INT, V22, P1, DOI 10.1081/CBI-200038149; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Janssen T, 2009, J NEUROCHEM, V111, P228, DOI 10.1111/j.1471-4159.2009.06323.x; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Jia HJ, 2011, CELL, V145, P890, DOI 10.1016/j.cell.2011.05.010; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kelly RJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S13; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Kumaki Y, 2008, P NATL ACAD SCI USA, V105, P14946, DOI 10.1073/pnas.0802636105; Migliori ML, 2011, PHYSIOL BEHAV, V103, P315, DOI 10.1016/j.physbeh.2011.01.026; LeBoeuf B, 2011, NEUROSCIENCE, V175, P1, DOI 10.1016/j.neuroscience.2010.12.002; Leclerc GM, 2005, ENDOCRINOLOGY, V146, P2782, DOI 10.1210/en.2005-0100; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; McWatters HG, 2011, FEBS LETT, V585, P1474, DOI 10.1016/j.febslet.2011.03.051; Meelkop E, 2012, MOL CELL ENDOCRINOL, V361, P232, DOI 10.1016/j.mce.2012.05.001; Mehta N, 2004, GENETICS, V166, P1253, DOI 10.1534/genetics.166.3.1253; Migliori ML, 2012, J PINEAL RES, V53, P38, DOI 10.1111/j.1600-079X.2011.00969.x; Migliori ML, 2011, J PINEAL RES; Miskei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022218; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Munoz E, 2003, CHRONOBIOL INT, V20, P371, DOI 10.1081/CBI-120022525; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Olmedo M, 2012, P NATL ACAD SCI USA, V109, P20479, DOI 10.1073/pnas.1211705109; Ooe N, 2007, GENE, V400, P122, DOI 10.1016/j.gene.2007.06.005; Petrillo Ezequiel, 2011, Commun Integr Biol, V4, P284, DOI 10.4161/cib.4.3.14777; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Qin HT, 2006, DEV BIOL, V298, P606, DOI 10.1016/j.ydbio.2006.07.017; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Romanowski A, 2011, MICROB PATHOGENESIS, V50, P23, DOI 10.1016/j.micpath.2010.09.001; Romney SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002394; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; Shemesh Y, 2007, FASEB J, V21, P2304, DOI 10.1096/fj.06-8032com; SIDOW A, 1994, CURR BIOL, V4, P596, DOI 10.1016/S0960-9822(00)00131-7; Simonetta SH, 2008, J COMP PHYSIOL A, V194, P821, DOI 10.1007/s00359-008-0353-z; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Simonetta SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007571; Sudhaus W, 2001, J NEMATOL, V33, P1; Takahashi JS, 2011, GENETICS CIRCADIAN S; Takumi T, 1999, GENES CELLS, V4, P67, DOI 10.1046/j.1365-2443.1999.00238.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temmerman L, 2011, ANN NY ACAD SCI, V1220, P137, DOI 10.1111/j.1749-6632.2010.05927.x; Tennessen JM, 2006, DEV BIOL, V289, P30, DOI 10.1016/j.ydbio.2005.09.044; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; TRENT C, 1983, GENETICS, V104, P619; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; van der Linden AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000503; Wang XD, 2006, DEV BIOL, V289, P456, DOI 10.1016/j.ydbio.2005.10.029; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Weinshenker D, 1999, J NEUROSCI, V19, P9831; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang XM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.050237; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	106	9	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112871	10.1371/journal.pone.0112871	http://dx.doi.org/10.1371/journal.pone.0112871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396739	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500103
J	Schmetterer, KG; Neunkirchner, A; Wojta-Stremayr, D; Leitner, J; Steinberger, P; Pickl, WF				Schmetterer, Klaus G.; Neunkirchner, Alina; Wojta-Stremayr, Daniela; Leitner, Judith; Steinberger, Peter; Pickl, Winfried F.			STAT3 governs hyporesponsiveness and granzyme B-dependent suppressive capacity in human CD4(+) T cells	FASEB JOURNAL			English	Article						regulatory T cells; Tr1 cells	REGULATORY-CELLS; IN-VIVO; TRANSCRIPTION FACTOR; DENDRITIC CELLS; UP-REGULATION; TR1 CELLS; ERYTHROCYTE RECEPTOR; EFFECTOR FUNCTION; CUTTING EDGE; C-MAF	Signal transducer and activator of transcription 3 (STAT3) integrates key signals of cell surface immune receptors, yet its precise role in cluster of differentiation (CD)4(+)T cells is not well-established. Current research has indicated T-helper cell 17-inducing roles but also tolerogenic roles. To address this issue, human T cells were transduced with the constitutively active STAT3 mutant STAT3C. Following stimulation, STAT3C(+) T cells upregulated IL-10 (4.1 +/- 0.5-fold; P < 0.001) and granzyme B (2.5 +/- 1.2, P < 0.05) secretion, combined with significantly reduced IFN-gamma (35 +/- 5%), IL-2 (57 +/- 4%), TNF-alpha (64 +/- 8%), and IL-13 (89 +/- 3%) secretion (P< 0.001). CD3/CD2- or CD3/CD28-activated STAT3C+ T cells revealed reduced proliferation (53.4 +/- 23.5% and 70.5 +/- 10.4%, respectively), which was independent of IL-10 production and significantly suppressed effector T cell proliferation by 68.7 +/- 10.6% and 65.9 +/- 2.6%, respectively (P < 0.001). Phenotypically, STAT3C-transgenic CD4(+) T cells resembled effector T cells regarding expression of T regulatory cell markers, but up-regulated granzyme B expression levels by 2.4-fold (P < 0.05). Suppression was cell contact dependent and mediated by granzyme B-induced cell death, but was independent of IL-10 and TGF-beta. Notably, peripheral blood CD4(+)CD45RA(-)lymphocyte activation gene-3(+)CD49(+) type 1 regulatory T cells revealed activation-induced hyperphosphorylation of STAT3. In agreement, pharmacological inhibition of STAT3 activation partially reverted hyporesponsiveness of peripheral type 1 regulatory T cells (increasing their division index from 0.46 +/- 0.11 to 0.89 +/- 0.04; P < 0.01). These observations indicate a clear-cut relation between activation of STAT3 and the acquisition of a tolerogenic program, which is also used by peripheral blood type 1 regulatory T cells.	[Schmetterer, Klaus G.; Neunkirchner, Alina; Wojta-Stremayr, Daniela; Leitner, Judith; Steinberger, Peter; Pickl, Winfried F.] Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, A-1090 Vienna, Austria; [Schmetterer, Klaus G.; Neunkirchner, Alina; Wojta-Stremayr, Daniela; Pickl, Winfried F.] Christian Doppler Lab Immunomodulat, Vienna, Austria; [Schmetterer, Klaus G.] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Pickl, WF (corresponding author), Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Lazarettgasse 19, A-1090 Vienna, Austria.	winfried.pickl@meduniwien.ac.at		Pickl, Winfried F./0000-0003-0430-4952; Schmetterer, Klaus/0000-0001-9328-4871; Leitner, Judith/0000-0002-7156-1759; Steinberger, Peter/0000-0001-6848-4097	Austrian Science Fund [SFB-F4609]; Christian Doppler Society; Biomay AG	Austrian Science Fund(Austrian Science Fund (FWF)); Christian Doppler Society; Biomay AG	The authors thank Ms. Doris Trapin (Institute of Immunology, Vienna, Austria) for expert technical assistance and Dr. Richard Mulligan (Children's Hospital, Boston, MA, USA) for sharing the pMD. gagpol expression construct with us. This work was supported by Austrian Science Fund grant SFB-F4609, the Christian Doppler Society, and Biomay AG.	Aarts-Riemens T, 2008, EUR J IMMUNOL, V38, P1381, DOI 10.1002/eji.200737590; Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Andolfi G, 2012, MOL THER, V20, P1778, DOI 10.1038/mt.2012.71; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Asquith B, 2006, P R SOC B, V273, P1165, DOI 10.1098/rspb.2005.3432; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bidere N, 2002, J BIOL CHEM, V277, P32339, DOI 10.1074/jbc.M205153200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Che KF, 2012, MOL MED, V18, P1169, DOI 10.2119/molmed.2012.00103; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Derdak SV, 2006, P NATL ACAD SCI USA, V103, P13144, DOI 10.1073/pnas.0602283103; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gregori S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00030; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1998, J IMMUNOL, V160, P3188; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Herrmann A, 2010, CANCER RES, V70, P7455, DOI 10.1158/0008-5472.CAN-10-0736; HOLTER W, 1986, J EXP MED, V163, P654, DOI 10.1084/jem.163.3.654; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iwasaki Y, 2013, EUR J IMMUNOL, V43, P1063, DOI 10.1002/eji.201242942; Kaebisch R, 2014, J IMMUNOL, V192, P316, DOI 10.4049/jimmunol.1302476; Kam CM, 2000, BBA-PROTEIN STRUCT M, V1477, P307, DOI 10.1016/S0167-4838(99)00282-4; Kwon MJ, 2012, J IMMUNOL, V188, P5887, DOI 10.4049/jimmunol.1102941; Leb VM, 2008, J ALLERGY CLIN IMMUN, V121, P64, DOI 10.1016/j.jaci.2007.10.006; Leb VM, 2009, J ALLERGY CLIN IMMUN, V124, P121, DOI 10.1016/j.jaci.2009.04.008; Leitner J, 2010, J IMMUNOL METHODS, V362, P131, DOI 10.1016/j.jim.2010.09.020; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Magnani CF, 2011, EUR J IMMUNOL, V41, P1652, DOI 10.1002/eji.201041120; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Matta BM, 2012, J IMMUNOL, V188, P5227, DOI 10.4049/jimmunol.1103382; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Neunkirchner A, 2011, J IMMUNOL, V187, P4077, DOI 10.4049/jimmunol.1003220; Nguyen KD, 2008, EUR J IMMUNOL, V38, P2034, DOI 10.1002/eji.200738082; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Ozcan E, 2008, J ALLERGY CLIN IMMUN, V122, P1054, DOI 10.1016/j.jaci.2008.10.023; Pallandre JR, 2007, J IMMUNOL, V179, P7593, DOI 10.4049/jimmunol.179.11.7593; Popow I, 2013, AM J TRANSPLANT, V13, P3103, DOI 10.1111/ajt.12514; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Schmetterer KG, 2011, J ALLERGY CLIN IMMUN, V127, P238, DOI 10.1016/j.jaci.2010.10.023; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sharma V, 2006, J IMMUNOL, V176, P97, DOI 10.4049/jimmunol.176.1.97; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Taylor A, 2009, MOL IMMUNOL, V46, P622, DOI 10.1016/j.molimm.2008.07.031; Veldman C, 2004, J IMMUNOL, V172, P6468, DOI 10.4049/jimmunol.172.10.6468; Wakkach A, 2001, J IMMUNOL, V167, P3107, DOI 10.4049/jimmunol.167.6.3107; Wang H, 2011, IMMUNOL LETT, V136, P21, DOI 10.1016/j.imlet.2010.11.007; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	62	14	14	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					759	771		10.1096/fj.14-257584	http://dx.doi.org/10.1096/fj.14-257584			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25398767	hybrid, Green Published			2022-12-26	WOS:000350633000004
J	Bhaskar, A; Munshi, M; Khan, SZ; Fatima, S; Arya, R; Jameel, S; Singh, A				Bhaskar, Ashima; Munshi, MohamedHusen; Khan, Sohrab Zafar; Fatima, Sadaf; Arya, Rahul; Jameel, Shahid; Singh, Amit			Measuring Glutathione Redox Potential of HIV-1-infected Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; REACTIVE OXYGEN; OXIDATIVE STRESS; T-CELLS; HYDROGEN-PEROXIDE; HIV-INFECTION; IN-VIVO; INTRACELLULAR GLUTATHIONE; OXIDIZED GLUTATHIONE	Redox signaling plays a crucial role in the pathogenesis of human immunodeficiency virus type-1 (HIV-1). The majority of HIV redox research relies on measuring redox stress using invasive technologies, which are unreliable and do not provide information about the contributions of subcellular compartments. A major technological leap emerges from the development of genetically encoded redox-sensitive green fluorescent proteins (roGFPs), which provide sensitive and compartment-specific insights into redox homeostasis. Here, we exploited a roGFP-based specific bioprobe of glutathione redox potential (E-GSH; Grx1-roGFP2) and measured subcellular changes in E-GSH during various phases of HIV-1 infection using U1 monocytic cells (latently infected U937 cells with HIV-1). We show that although U937 and U1 cells demonstrate significantly reduced cytosolic and mitochondrial E-GSH (approximately -310 mV), active viral replication induces substantial oxidative stress (E-GSH more than -240 mV). Furthermore, exposure to a physiologically relevant oxidant, hydrogen peroxide (H2O2), induces significant deviations in subcellular E-GSH between U937 and U1, which distinctly modulates susceptibility to apoptosis. Using Grx1-roGFP2, we demonstrate that a marginal increase of about similar to 25 mV in E-GSH is sufficient to switch HIV-1 from latency to reactivation, raising the possibility of purging HIV-1 by redox modulators without triggering detrimental changes in cellular physiology. Importantly, we show that bioactive lipids synthesized by clinical drug-resistant isolates of Mycobacterium tuberculosis reactivate HIV-1 through modulation of intracellular E-GSH. Finally, the expression analysis of U1 and patient peripheral blood mononuclear cells demonstrated a major recalibration of cellular redox homeostatic pathways during persistence and active replication of HIV.	[Bhaskar, Ashima; Munshi, MohamedHusen; Singh, Amit] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis & Res, Bangalore 560012, Karnataka, India; [Khan, Sohrab Zafar; Arya, Rahul; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, New Delhi 11067, India; [Munshi, MohamedHusen; Fatima, Sadaf] Jamia Millia Islamia, Dept Biotechnol, New Delhi 25, India	Indian Institute of Science (IISC) - Bangalore; Jamia Millia Islamia	Singh, A (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis & Res, Bangalore 560012, Karnataka, India.	asingh@mcbl.iisc.ernet.in	Munshi, MohamedHusen/AFY-6972-2022; Khan, Sohrab/H-4074-2019	Munshi, MohamedHusen/0000-0002-2764-5322; Khan, Sohrab/0000-0002-9564-5092; BHASKAR, ASHIMA/0000-0002-7367-874X; Arya, Rahul/0000-0003-0867-6585; Singh, Amit/0000-0001-6761-1664	National Institutes of Health from Office of AIDS Research [P30AI027767]; Wellcome-Department of Biotechnology India Alliance Grant [500034-Z-09-Z]; Indian Council of Medical Research [ICM/13/037]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	National Institutes of Health from Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome-Department of Biotechnology India Alliance Grant; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant P30AI027767 from Office of AIDS Research (to A. S.). This work was also supported by Wellcome-Department of Biotechnology India Alliance Grant, 500034-Z-09-Z (to A. S.) and Indian Council of Medical Research Grant ICM/13/037.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Amarnath S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-57; Ambruso DR, 2013, METHOD ENZYMOL, V527, P145, DOI 10.1016/B978-0-12-405882-8.00008-8; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; AUKRUST P, 1995, BLOOD, V86, P258, DOI 10.1182/blood.V86.1.258.bloodjournal861258; Awodele O, 2012, J INFECT DEV COUNTR, V6, P79, DOI 10.3855/jidc.1906; Baine Michael J, 2013, Methods Mol Biol, V980, P157, DOI 10.1007/978-1-62703-287-2_8; Balestra E, 2001, J BIOL REG HOMEOS AG, V15, P272; Bhaskar A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003902; Budhiraja S, 2013, J VIROL, V87, P1211, DOI 10.1128/JVI.02413-12; Chaudhry A, 2007, CELL HOST MICROBE, V1, P37, DOI 10.1016/j.chom.2007.01.001; Choi H, 2014, J DERMATOL SCI, V74, P56, DOI 10.1016/j.jdermsci.2013.11.011; Cohen I, 2004, APOPTOSIS, V9, P181, DOI 10.1023/B:APPT.0000018800.87358.ba; Cota-Gomez A, 2011, FREE RADICAL BIO MED, V51, P1697, DOI 10.1016/j.freeradbiomed.2011.07.023; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; De Rosa SC, 2000, EUR J CLIN INVEST, V30, P915, DOI 10.1046/j.1365-2362.2000.00736.x; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; FLORES SC, 1993, P NATL ACAD SCI USA, V90, P7632, DOI 10.1073/pnas.90.16.7632; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Fukuhara A, 2012, BIOCHEM J, V443, P75, DOI 10.1042/BJ20111889; Garaci E, 1997, J LEUKOCYTE BIOL, V62, P54, DOI 10.1002/jlb.62.1.54; Geiben-Lynn R, 2003, J BIOL CHEM, V278, P1569, DOI 10.1074/jbc.M209964200; Guerra C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028378; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; HANSEN SH, 1990, EXP CELL RES, V187, P255, DOI 10.1016/0014-4827(90)90089-S; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Hogarth LA, 1999, METH MOLEC MED, V28, P91, DOI 10.1385/1-59259-687-8:91; Ibeh BO, 2012, IMMUNOPHARM IMMUNOT, V34, P1060, DOI 10.3109/08923973.2012.681327; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Kalantari P, 2008, J BIOL CHEM, V283, P33183, DOI 10.1074/jbc.M807403200; Kim CH, 1996, AIDS RES HUM RETROV, V12, P1361, DOI 10.1089/aid.1996.12.1361; Kim C, 2008, BMB REP, V41, P555, DOI 10.5483/BMBRep.2008.41.8.555; Kishimoto N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-107; Kraft-Terry S, 2010, PROTEOM CLIN APPL, V4, P706, DOI 10.1002/prca.201000010; Krishnan V, 2004, J VIROL, V78, P9458, DOI 10.1128/JVI.78.17.9458-9473.2004; Kristiansen KA, 2009, PHYSIOL PLANTARUM, V136, P369, DOI 10.1111/j.1399-3054.2009.01243.x; Kundu TK, 2012, BIOCHEMISTRY-US, V51, P2930, DOI 10.1021/bi3000879; Lake-Bakaar G, 2001, DIGEST DIS SCI, V46, P1072, DOI 10.1023/A:1010770230422; Lang CA, 2001, EXP BIOL MED, V226, P866, DOI 10.1177/153537020122600910; Larrosa PNF, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-19; Lichtenfels R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041345; Liddell JR, 2006, GLIA, V54, P873, DOI 10.1002/glia.20433; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Melendez LM, 2011, J NEUROIMMUNE PHARM, V6, P89, DOI 10.1007/s11481-010-9253-4; Mesfin YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082235; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Morgan B, 2013, NAT CHEM BIOL, V9, P119, DOI [10.1038/nchembio.1142, 10.1038/NCHEMBIO.1142]; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; MULLER F, 1992, FREE RADICAL BIO MED, V13, P651, DOI 10.1016/0891-5849(92)90039-J; Palanisamy GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026254; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Perl A, 2000, ANTIOXID REDOX SIGN, V2, P551, DOI 10.1089/15230860050192323; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Pinti M, 2003, EXP BIOL MED, V228, P1346, DOI 10.1177/153537020322801113; Pirmohamed M, 1996, AIDS, V10, P501, DOI 10.1097/00002030-199605000-00008; POLI G, 1990, P NATL ACAD SCI USA, V87, P782, DOI 10.1073/pnas.87.2.782; Pyo CW, 2008, BIOCHEM BIOPH RES CO, V376, P180, DOI 10.1016/j.bbrc.2008.08.114; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Ranjbar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006116; Reyskens KMSE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073347; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schmidt WN, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00129; Siddappa NB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-53; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Torre D, 2002, LANCET INFECT DIS, V2, P273, DOI 10.1016/S1473-3099(02)00262-1; Venketaraman V, 2003, INFECT IMMUN, V71, P1864, DOI 10.1128/IAI.71.4.1864-1871.2003; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; WITSCHI A, 1995, AIDS RES HUM RETROV, V11, P141, DOI 10.1089/aid.1995.11.141; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zuo L, 2002, METHOD ENZYMOL, V352, P307	84	37	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1020	1038		10.1074/jbc.M114.588913	http://dx.doi.org/10.1074/jbc.M114.588913			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406321	Green Published, hybrid			2022-12-26	WOS:000347778200035
J	Lee, H; Morales, LD; Slaga, TJ; Kim, DJ				Lee, Hyunseung; Morales, Liza D.; Slaga, Thomas J.; Kim, Dae Joon			Activation of T-cell Protein-tyrosine Phosphatase Suppresses Keratinocyte Survival and Proliferation following UVB Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Keratinocyte; Skin; STAT3; Tyrosine-protein Phosphatase (Tyrosine Phosphatase); UVB	GROWTH-FACTOR RECEPTOR; EPITHELIAL CARCINOGENESIS; SIGNAL TRANSDUCER; SKIN CARCINOGENESIS; KINASE INHIBITORS; PROMOTION STAGES; TRANSCRIPTION 3; STAT PROTEINS; CANCER; DISRUPTION	Background: STAT3 promotes UVB-induced keratinocyte cell proliferation. Results: TC-PTP inhibits STAT3-mediated mouse keratinocyte skin cell proliferation and survival following UVB irradiation. Conclusion: TC-PTP plays an important role in the skin cell response to UVB radiation by regulating cell proliferation and survival. Significance: TC-PTP shows tumor-suppressive capabilities in skin. Chronic exposure to UV radiation can contribute to the development of skin cancer by promoting protein-tyrosine kinase (PTK) signaling. Studies show that exposure to UV radiation increases the ligand-independent activation of PTKs and induces protein-tyrosine phosphatase (PTP) inactivation. In the present work, we report that T-cell PTP (TC-PTP) activity is stimulated during the initial response to UVB irradiation, which leads to suppression of keratinocyte cell survival and proliferation via the down-regulation of STAT3 signaling. Our results show that TC-PTP-deficient keratinocyte cell lines expressed a significantly increased level of phosphorylated STAT3 after exposure to low dose UVB. This increase corresponded with increased cell proliferation in TC-PTP-deficient keratinocytes following UVB irradiation. Loss of TC-PTP also reduced UVB-induced apoptosis. Corroborating with these results, overexpression of TC-PTP in keratinocyte cell lines yielded a decrease in phosphorylated STAT3 levels, which corresponded with a significant decrease in cell proliferation in response to low dose UVB. We demonstrate that TC-PTP activity was increased upon UVB exposure, and overexpression of TC-PTP in keratinocyte cell lines further increased its activity in the presence of UVB. Treatment of TC-PTP-deficient keratinocytes with the STAT3 inhibitor STA21 significantly reduced cell viability following UVB exposure in comparison with untreated TC-PTP-deficient keratinocytes, confirming that the effect of TC-PTP on cell viability is mediated by STAT3 dephosphorylation. Combined, our results indicate that UVB-mediated activation of TC-PTP plays an important role in the STAT3-dependent regulation of keratinocyte cell proliferation and survival. Furthermore, these results suggest that TC-PTP may be a novel potential target for the prevention of UVB-induced skin cancer.	[Lee, Hyunseung; Morales, Liza D.; Kim, Dae Joon] Univ Texas Hlth Sci Ctr San Antonio, Div Med Res, Edinburg Reg Acad Hlth Ctr, Edinburg, TX 78541 USA; [Lee, Hyunseung; Slaga, Thomas J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Kim, DJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Med Res, Edinburg Reg Acad Hlth Ctr, 1214 W Schunior St, San Antonio, TX 78229 USA.	KimDJ@uthscsa.edu		KIM, DAE/0000-0002-7977-9955; Morales, Liza/0000-0003-1056-9121	National Institutes of Health; NIEHS [ES022250]; National Institutes of Health Cancer Center Support Grant [P30 CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, Grant ES022250 and National Institutes of Health Cancer Center Support Grant P30 CA054174.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; COFFER PJ, 1995, ONCOGENE, V11, P561; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Denu JM, 2002, METHOD ENZYMOL, V348, P297, DOI 10.1016/S0076-6879(02)48648-X; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Hendriks WJAJ, 2013, FEBS J, V280, P708, DOI 10.1111/febs.12000; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kamatkar S, 1996, J BIOL CHEM, V271, P26755, DOI 10.1074/jbc.271.43.26755; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kim AL, 2002, PHOTOCHEM PHOTOBIOL, V75, P58, DOI 10.1562/0031-8655(2002)075<0058:SSAOCE>2.0.CO;2; Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Kim DJ, 2009, CANCER RES, V69, P7587, DOI 10.1158/0008-5472.CAN-09-1180; KLANN RC, 1989, CANCER RES, V49, P699; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Rho OK, 2011, MOL CARCINOGEN, V50, P264, DOI 10.1002/mc.20665; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; TILLMANN U, 1994, MOL CELL BIOL, V14, P3030, DOI 10.1128/MCB.14.5.3030; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Xu YR, 2006, J BIOL CHEM, V281, P27389, DOI 10.1074/jbc.M602355200; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X	50	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					13	24		10.1074/jbc.M114.611681	http://dx.doi.org/10.1074/jbc.M114.611681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406309	hybrid, Green Published			2022-12-26	WOS:000347231200002
J	Ou, Y; Wang, SJ; Jiang, L; Zheng, B; Gu, W				Ou, Yang; Wang, Shang-Jui; Jiang, Le; Zheng, Bin; Gu, Wei			p53 Protein-mediated Regulation of Phosphoglycerate Dehydrogenase (PHGDH) Is Crucial for the Apoptotic Response upon Serine Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer Biology; Cell Death; Melanoma; Metabolism; p53; Tumor Suppressor Gene	TUMOR-SUPPRESSOR P53; P53-INDUCIBLE REGULATOR; MALIGNANT-MELANOMA; GLUCOSE-METABOLISM; TARGET GENE; WARBURG; CANCER; GROWTH; CELLS; INHIBITION	Background:PHGDH encodes a key metabolic enzyme in the serine biosynthesis pathway and is frequently amplified in melanomas. Results: p53 transcriptionally represses PHGDH expression. Serine starvation promotes p53-mediated apoptosis in melanomas through PHGDH suppression. Conclusion: p53-mediated repression of PHGDH enhances the apoptotic response upon serine starvation in melanoma cells. Significance: The combination of the drugs activating p53 and serine deprivation could be a better treatment for melanomas. Although p53 is frequently mutated in human cancers, about 80% of human melanomas retain wild-type p53. Here we report that PHGDH, the key metabolic enzyme that catalyzes the rate-limiting step of the serine biosynthesis pathway, is a target of p53 in human melanoma cells. p53 suppresses PHGDH expression and inhibits de novo serine biosynthesis. Notably, upon serine starvation, p53-mediated cell death is enhanced dramatically in response to Nutlin-3 treatment. Moreover, PHGDH has been found recently to be amplified frequently in human melanomas. We found that PHGDH overexpression significantly suppresses the apoptotic response, whereas RNAi-mediated knockdown of endogenous PHGDH promotes apoptosis under the same treatment. These results demonstrate an important role of p53 in regulating the serine biosynthesis pathway through suppressing PHGDH expression and reveal serine deprivation as a novel approach to sensitize p53-mediated apoptotic responses in human melanoma cells.	[Ou, Yang; Wang, Shang-Jui; Jiang, Le; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Ou, Yang; Wang, Shang-Jui; Jiang, Le; Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Zheng, Bin] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Columbia University; Columbia University; Harvard University; Massachusetts General Hospital	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu		Zheng, Bin/0000-0002-0998-7177	NCI, National Institutes of Health [5RO1CA085533, 5RO1CA172023, 5RO1 CA166294, 2P01CA080058, R01 CA166717]; National Institutes of Health Cancer Biology Training Grant [T32-CA09503]; NATIONAL CANCER INSTITUTE [R01CA166717, R01CA172023, R01CA166294, R01CA085533, P01CA080058] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Cancer Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Awards 5RO1CA085533, 5RO1CA172023, 5RO1 CA166294, 5RO1CA085533, and 2P01CA080058 (to W. G.) and R01 CA166717 (to B. Z.).; Supported by National Institutes of Health Cancer Biology Training Grant T32-CA09503.	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Chen JY, 2013, ONCOTARGET, V4, P2502, DOI 10.18632/oncotarget.1540; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; de Lange J, 2012, ONCOGENE, V31, P1105, DOI 10.1038/onc.2011.309; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Ji ZY, 2012, J INVEST DERMATOL, V132, P356, DOI 10.1038/jid.2011.313; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Jochemsen AG, 2014, CURR OPIN ONCOL, V26, P114, DOI 10.1097/CCO.0000000000000033; Kuge O, 2003, J BIOCHEM, V133, P397, DOI 10.1093/jb/mvg052; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liang YJ, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-9; Liu Y, 2014, P NATL ACAD SCI USA, V111, pE2414, DOI 10.1073/pnas.1315605111; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tseng HY, 2010, MOL CANCER THER, V9, P3363, DOI 10.1158/1535-7163.MCT-10-0646; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vu BT, 2011, CURR TOP MICROBIOL, V348, P151, DOI 10.1007/82_2010_110; Wang SJ, 2013, CELL CYCLE, V12, P753, DOI 10.4161/cc.23597; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhang J, 2013, INT J GYNECOL CANCER, V23, P1465, DOI 10.1097/IGC.0b013e3182a0c068	37	76	77	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					457	466		10.1074/jbc.M114.616359	http://dx.doi.org/10.1074/jbc.M114.616359			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404730	hybrid, Green Published			2022-12-26	WOS:000347231200040
J	Deng, ZY; Uehara, T; Maeda, H; Hasegawa, M; Matayoshi, S; Kiyuna, A; Agena, S; Pan, XL; Zhang, CL; Yamashita, Y; Xie, MQ; Suzuki, M				Deng, Zeyi; Uehara, Takayuki; Maeda, Hiroyuki; Hasegawa, Masahiro; Matayoshi, Sen; Kiyuna, Asanori; Agena, Shinya; Pan, Xiaoli; Zhang, Chunlin; Yamashita, Yukashi; Xie, Minqiang; Suzuki, Mikio			Epstein-Barr Virus and Human Papillomavirus Infections and Genotype Distribution in Head and Neck Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; LATENT MEMBRANE-PROTEIN; MESSENGER-RNA EXPRESSION; LYTIC CYCLE REPLICATION; 30-BP DELETION VARIANT; NF-KAPPA-B; NASOPHARYNGEAL CARCINOMA; PHYSICAL STATUS; DNA LOAD; EBV	Objective: To investigate the prevalence, genotypes, and prognostic values of Epstein-Barr virus (EBV) and human papillomavirus (HPV) infections in Japanese patients with different types of head and neck cancer (HNC). Methods and Materials: HPV and EBV DNA, EBV genotypes and LMP-1 variants, and HPV mRNA expression were detected by PCR from fresh-frozen HNC samples. HPV genotypes were determined by direct sequencing, and EBV encoded RNA (EBER) was examined by in situ hybridization. Results: Of the 209 HNC patients, 63 (30.1%) had HPV infection, and HPV-16 was the most common subtype (86.9%). HPV E6/E7 mRNA expression was found in 23 of 60 (38.3%) HPV DNA-positive cases detected. The site of highest prevalence of HPV was the oropharynx (45.9%). Among 146 (69.9%) HNCs in which EBV DNA was identified, 107 (73.3%) and 27 (18.5%) contained types A and B, respectively, and 124 (84.9%) showed the existence of del-LMP-1. However, only 13 (6.2%) HNCs were positive for EBER, 12 (92.3%) of which derived from the nasopharynx. Co-infection of HPV and EBER was found in only 1.0% of HNCs and 10.0% of NPCs. Kaplan-Meier survival analysis showed significantly better disease-specific and overall survival in the HPV DNA+/mRNA+ oropharyngeal squamous cell carcinoma (OPC) patients than in the other OPC patients (P = 0.027 and 0.017, respectively). Multivariate analysis showed that stage T1-3 (P = 0.002) and HPV mRNA-positive status (P = 0.061) independently predicted better disease-specific survival. No significant difference in disease-specific survival was found between the EBER-positive and -negative NPC patients (P = 0.155). Conclusions: Our findings indicate that co-infection with HPV and EBV is rare in HNC. Oropharyngeal SCC with active HPV infection was related to a highly favorable outcome, while EBV status was not prognostic in the NPC cohort.	[Deng, Zeyi; Pan, Xiaoli; Zhang, Chunlin; Xie, Minqiang] Southern Med Univ, Zhujiang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Deng, Zeyi; Uehara, Takayuki; Maeda, Hiroyuki; Hasegawa, Masahiro; Matayoshi, Sen; Kiyuna, Asanori; Agena, Shinya; Pan, Xiaoli; Zhang, Chunlin; Yamashita, Yukashi; Suzuki, Mikio] Univ Ryukyus, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Nishihara, Okinawa 90301, Japan	Southern Medical University - China; University of the Ryukyus	Deng, ZY (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China.	jordandzy@hotmail.com; min_qiang_x@hotmail.com		Deng, Zeyi/0000-0003-1064-1031	KAKENHI (Japan Society for the Promotion of Science) [26462610, 26462611]; Okinawa Medical Science Research Foundation; Science and Technology Development Center, Ministry of Education of the People's Republic of China; Ryukyu Society for the Promotion of Oto-Rhino-Laryngology	KAKENHI (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Okinawa Medical Science Research Foundation; Science and Technology Development Center, Ministry of Education of the People's Republic of China; Ryukyu Society for the Promotion of Oto-Rhino-Laryngology	This study was supported by grant KAKENHI 26462610 (Japan Society for the Promotion of Science) to Dr. Suzuki, grant KAKENHI 26462611 (Japan Society for the Promotion of Science) to Dr. Deng, a grant from the Okinawa Medical Science Research Foundation to Dr. Deng, and a grant from the Science and Technology Development Center, Ministry of Education of the People's Republic of China to Dr. Deng. This study was also supported and conducted in cooperation with the Ryukyu Society for the Promotion of Oto-Rhino-Laryngology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2013, CLIN CANCER RES, V19, P2175, DOI 10.1158/1078-0432.CCR-12-2897; Attner P, 2010, INT J CANCER, V126, P2879, DOI 10.1002/ijc.24994; Blake SMS, 2001, VIROLOGY, V282, P278, DOI 10.1006/viro.2001.0828; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; Bussu F, 2013, BRIT J CANCER, V108, P1157, DOI 10.1038/bjc.2013.55; Chan KCA, 2013, CANCER-AM CANCER SOC, V119, P1838, DOI 10.1002/cncr.28001; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Cheung ST, 1996, INT J CANCER, V66, P711, DOI 10.1002/(SICI)1097-0215(19960529)66:5<711::AID-IJC21>3.0.CO;2-5; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Cmelak AJ, 2007, J CLIN ONCOL, V25, P3971, DOI 10.1200/JCO.2007.10.8951; Cohen JI, 1999, CURR OPIN IMMUNOL, V11, P365, DOI 10.1016/S0952-7915(99)80062-4; Correa RM, 2007, J MED VIROL, V79, P401, DOI 10.1002/jmv.20782; Correa RM, 2004, J MED VIROL, V73, P583, DOI 10.1002/jmv.20129; Dardari R, 2006, INT J CANCER, V118, P1977, DOI 10.1002/ijc.21595; de Boer MA, 2007, CLIN CANCER RES, V13, P132, DOI 10.1158/1078-0432.CCR-06-1568; Deng ZY, 2013, HEAD NECK-J SCI SPEC, V35, P800, DOI 10.1002/hed.23034; de Oliveira DE, 2006, AM J CLIN PATHOL, V126, P284, DOI [10.1039/UU2JADUEHDWATVM9, 10.1309/UU2JADUEHDWATVM9]; Fielding CA, 2001, J VIROL, V75, P9129, DOI 10.1128/JVI.75.19.9129-9141.2001; Goldenberg D, 2001, AM J OTOLARYNG, V22, P197, DOI 10.1053/ajot.2001.23429; Higa M, 2002, J CLIN PATHOL, V55, P414, DOI 10.1136/jcp.55.6.414; Hodge CW, 2007, INT J RADIAT ONCOL, V69, P1032, DOI 10.1016/j.ijrobp.2007.05.017; HORDING U, 1994, LARYNGOSCOPE, V104, P99; Hu LF, 2000, CANCER RES, V60, P5589; Huang CC, 2011, J CLIN PATHOL, V64, P571, DOI 10.1136/jcp.2010.087742; HUEN DS, 1995, ONCOGENE, V10, P549; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; Jalouli J, 2012, ANTICANCER RES, V32, P571; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeon YK, 2004, HEAD NECK-J SCI SPEC, V26, P573, DOI 10.1002/hed.10370; Khanim F, 1996, BLOOD, V88, P3491, DOI 10.1182/blood.V88.9.3491.bloodjournal8893491; Kis A, 2009, EUR J ORAL SCI, V117, P536, DOI 10.1111/j.1600-0722.2009.00660.x; Koskinen WJ, 2003, INT J CANCER, V107, P401, DOI 10.1002/ijc.11381; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Laantri N, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-3; Lee LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040767; Lin ZX, 2014, HEAD NECK-J SCI SPEC, V36, P709, DOI 10.1002/hed.23362; Lo EJ, 2010, LARYNGOSCOPE, V120, P1990, DOI 10.1002/lary.21089; Luo CW, 2007, INT J ORAL MAX SURG, V36, P153, DOI 10.1016/j.ijom.2006.09.005; MANOS MM, 1989, CANCER CEL, V7, P209; Mercader M, 2000, AM J PATHOL, V156, P1961, DOI 10.1016/S0002-9440(10)65069-9; Mirzamani N, 2006, EXP MOL PATHOL, V81, P231, DOI 10.1016/j.yexmp.2006.04.006; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; NICHOLLS JM, 1994, PATHOLOGY, V26, P94, DOI 10.1080/00313029400169281; Pai PC, 2004, HEAD NECK-J SCI SPEC, V26, P619, DOI 10.1002/hed.20057; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Rautava J, 2012, J CLIN VIROL, V53, P116, DOI 10.1016/j.jcv.2011.11.005; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Shimakage M, 1999, HUM PATHOL, V30, P1071, DOI 10.1016/S0046-8177(99)90225-3; SHU CH, 1992, J VIROL METHODS, V38, P123, DOI 10.1016/0166-0934(92)90175-D; Sidagis J, 1997, INT J CANCER, V72, P72, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;72::AID-IJC11&gt;3.0.CO;2-C; Singhi AD, 2012, HEAD NECK-J SCI SPEC, V34, P213, DOI 10.1002/hed.21714; Smith-McCune KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010094; Szkaradkiewicz A, 2002, CLIN EXP MED, V2, P137, DOI 10.1007/s102380200019; Tung Yi-Ching, 1999, Kaohsiung Journal of Medical Sciences, V15, P256; TYAN YS, 1993, J CLIN MICROBIOL, V31, P53, DOI 10.1128/JCM.31.1.53-56.1993; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Wiest T, 2002, ONCOGENE, V21, P1510, DOI 10.1038/sj.onc.1205214; Wong M, 2002, JNCI-J NATL CANCER I, V94, P1832, DOI 10.1093/jnci/94.24.1832; Yang HJ, 2001, HEAD NECK-J SCI SPEC, V23, P629, DOI 10.1002/hed.1089; Zhang XS, 2002, CANCER LETT, V176, P65, DOI 10.1016/S0304-3835(01)00733-9; Zheng Y, 2010, ANTICANCER RES, V30, P1233	66	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113702	10.1371/journal.pone.0113702	http://dx.doi.org/10.1371/journal.pone.0113702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405488	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300123
J	Lan, JM; Deng, Y; Chen, H; Lu, GW; Wang, W; Guo, XJ; Lu, ZZ; Gao, GF; Tan, WJ				Lan, Jiaming; Deng, Yao; Chen, Hong; Lu, Guangwen; Wang, Wen; Guo, Xiaojuan; Lu, Zhuozhuang; Gao, George F.; Tan, Wenjie			Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen	PLOS ONE			English	Article							SPIKE PROTEIN; S PROTEIN; IMMUNIZATION; PNEUMONIA; RESPONSES; TARGET; SAFETY	The development of an effective vaccine is critical for prevention of a Middle East respiratory syndrome coronavirus (MERS-CoV) pandemic. Some studies have indicated the receptor-binding domain (RBD) protein of MERS-CoV spike (S) is a good candidate antigen for a MERS-CoV subunit vaccine. However, highly purified proteins are typically not inherently immunogenic. We hypothesised that humoral and cell-mediated immunity would be improved with a modification of the vaccination regimen. Therefore, the immunogenicity of a novel MERS-CoV RBD-based subunit vaccine was tested in mice using different adjuvant formulations and delivery routes. Different vaccination regimens were compared in BALB/c mice immunized 3 times intramuscularly (i.m.) with a vaccine containing 10 mu g of recombinant MERS-CoV RBD in combination with either aluminium hydroxide (alum) alone, alum and polyriboinosinic acid (poly I:C) or alum and cysteine-phosphate-guanine (CpG) oligodeoxynucleotides (ODN). The immune responses of mice vaccinated with RBD, incomplete Freund's adjuvant (IFA) and CpG ODN by a subcutaneous (s.c.) route were also investigated. We evaluated the induction of RBD-specific humoral immunity (total IgG and neutralizing antibodies) and cellular immunity (ELISpot assay for IFN-gamma spot-forming cells and splenocyte cytokine production). Our findings indicated that the combination of alum and CpG ODN optimized the development of RBD-specific humoral and cellular immunity following subunit vaccination. Interestingly, robust RBD-specific antibody and T-cell responses were induced in mice immunized with the rRBD protein in combination with IFA and CpG ODN, but low level of neutralizing antibodies were elicited. Our data suggest that murine immunity following subunit vaccination can be tailored using adjuvant combinations and delivery routes. The vaccination regimen used in this study is promising and could improve the protection offered by the MERS-CoV subunit vaccine by eliciting effective humoral and cellular immune responses.	[Lan, Jiaming; Deng, Yao; Chen, Hong; Wang, Wen; Guo, Xiaojuan; Lu, Zhuozhuang; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing 102206, Peoples R China; [Lan, Jiaming] Hebei Med Univ, Dept Pathogen Biol, Shijiazhuang 050017, Peoples R China; [Lu, Guangwen; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Hebei Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	gaof@im.ac.cn; tanwj28@163.com	Lu, Guangwen/HCH-9193-2022; Gao, George Fu/ABD-5229-2021		State Megaproject for Infectious Disease Research of China [2014ZX10004001-002, 2013ZX10004601]; National 973 Program of China [2011CB504704]	State Megaproject for Infectious Disease Research of China; National 973 Program of China(National Basic Research Program of China)	This work was supported by grants from the State Megaproject for Infectious Disease Research of China (2014ZX10004001-002, 2013ZX10004601) and National 973 Program of China (2011CB504704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Chuai X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054126, DOI 10.1371/JOURNAL.PONE.0054126PONE-D-12-35157]; Conforti VA, 2008, VACCINE, V26, P907, DOI 10.1016/j.vaccine.2007.12.010; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; de Wit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069127; Du LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081587; Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13; Dychter SS, 2012, J INFUS MURS, V35, P154, DOI 10.1097/NAN.0b013e31824d2271; Gong MQ, 2012, VACCINE, V30, P7498, DOI 10.1016/j.vaccine.2012.10.054; Haining WN, 2004, J IMMUNOL, V173, P2578, DOI 10.4049/jimmunol.173.4.2578; Jiang SB, 2012, EXPERT REV VACCINES, V11, P1405, DOI [10.1586/ERV.12.126, 10.1586/erv.12.126]; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lau SKP, 2013, J VIROL, V87, P8638, DOI 10.1128/JVI.01055-13; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Lu L, 2013, MICROBES INFECT, V15, P625, DOI 10.1016/j.micinf.2013.06.003; Ma CQ, 2014, VACCINE, V32, P2100, DOI 10.1016/j.vaccine.2014.02.004; Mou H, 2013, J VIROL, V87, P9379, DOI 10.1128/JVI.01277-13; Munster VJ, 2013, NEW ENGL J MED, V368, P1560, DOI 10.1056/NEJMc1215691; Oleszycka E, 2014, CURR OPIN IMMUNOL, V28, P1, DOI 10.1016/j.coi.2013.12.007; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Reusken CB, 2014, EURO SURVEILL, V19; Samara EM, 2014, MBIO, V5, DOI 10.1128/mBio.01430-14; Vallecillo MFS, 2014, BIOMATERIALS, V35, P2529, DOI 10.1016/j.biomaterials.2013.12.002; Schijns VEJC, 2011, EXPERT REV VACCINES, V10, P539, DOI [10.1586/erv.11.21, 10.1586/ERV.11.21]; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037019; World Health Organization, 2014, MIDDL E RESP SYNDR C; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao GY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-266; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111; Zhu XJ, 2013, J THORAC DIS, V5, pS142, DOI 10.3978/j.issn.2072-1439.2013.06.06	35	63	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112602	10.1371/journal.pone.0112602	http://dx.doi.org/10.1371/journal.pone.0112602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405618	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300040
J	Libran-Perez, M; Velasco, C; Lopez-Patino, MA; Miguez, JM; Soengas, JL				Libran-Perez, Marta; Velasco, Cristina; Lopez-Patino, Marcos A.; Miguez, Jesus M.; Soengas, Jose L.			Counter-Regulatory Response to a Fall in Circulating Fatty Acid Levels in Rainbow Trout. Possible Involvement of the Hypothalamus-Pituitary-Interrenal Axis	PLOS ONE			English	Article							SALMON SALMO-SALAR; VOLUNTARY FEED-INTAKE; ONCORHYNCHUS-MYKISS; FOOD-INTAKE; CORTISOL RESPONSE; GROWTH-HORMONE; INTERMEDIARY METABOLISM; GLUCOSENSING CAPACITY; LIPOSTATIC REGULATION; ENERGY HOMEOSTASIS	We hypothesize that a decrease in circulating levels of fatty acid (FA) in rainbow trout Oncorhynchus mykiss would result in the inhibition of putative hypothalamic FA sensing systems with concomitant changes in the expression of orexigenic and anorexigenic factors ultimately leading to a stimulation of food intake. To assess this hypothesis, we lowered circulating FA levels treating fish with SDZ WAG 994 (SDZ), a selective A1 adenosine receptor agonist that inhibits lipolysis. In additional groups, we also evaluated if the presence of intralipid was able to counteract changes induced by SDZ treatment, and the possible involvement of the hypothalamus-pituitary-interrenal (HPI) axis by treating fish with SDZ in the presence of metyrapone, which decreases cortisol synthesis in fish. The decrease in circulating levels of FA in rainbow trout induced a clear increase in food intake that was associated with the decrease of the anorexigenic potential in hypothalamus (decreased POMC-A1 and CART mRNA abundance), and with changes in several parameters related to putative FA-sensing mechanisms in hypothalamus. Intralipid treatment counteracted these changes. SDZ treatment also induced increased cortisol levels and the activation of different components of the HPI axis whereas these changes disappeared in the presence of intralipid or metyrapone. These results suggest that the HPI axis is involved in a counter-regulatory response in rainbow trout to restore FA levels in plasma.	[Libran-Perez, Marta; Velasco, Cristina; Lopez-Patino, Marcos A.; Miguez, Jesus M.; Soengas, Jose L.] Univ Vigo, Lab Fisioloxia Anim, Dept Bioloxia Func & Ciencias Saude, Fac Bioloxia, Vigo 36310, Spain	Universidade de Vigo	Soengas, JL (corresponding author), Univ Vigo, Lab Fisioloxia Anim, Dept Bioloxia Func & Ciencias Saude, Fac Bioloxia, Vigo 36310, Spain.	jsoengas@uvigo.es	Miguez, J.M./M-3705-2014; Soengas, José L/M-1898-2014; Velasco, Cristina/AAE-4604-2021	Miguez, J.M./0000-0002-3474-2139; Soengas, José L/0000-0002-6847-3993; Velasco Rubial, Cristina/0000-0001-7440-8998; Lopez-Patino, Marcos A./0000-0002-1038-7419	Ministerio de Ciencia e Innovacion and European Fund for Regional Development (FEDER) [AGL2013-46448-3-1-R]; Xunta de Galicia (Consolidacion e estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia [CN 2012/004]; Ministerio de Ciencia e Innovacion (Predoctoral Fellowship, Program FPI)	Ministerio de Ciencia e Innovacion and European Fund for Regional Development (FEDER); Xunta de Galicia (Consolidacion e estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia(Xunta de Galicia); Ministerio de Ciencia e Innovacion (Predoctoral Fellowship, Program FPI)	Ministerio de Ciencia e Innovacion and European Fund for Regional Development (AGL2013-46448-3-1-R and FEDER) to JLS. Xunta de Galicia (Consolidacion e estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia, CN 2012/004) to JLS. Ministerio de Ciencia e Innovacion (Predoctoral Fellowship, Program FPI) to MLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Alderman SL, 2012, GEN COMP ENDOCR, V176, P79, DOI 10.1016/j.ygcen.2011.12.031; Aluru N, 2006, ENDOCRINOLOGY, V147, P1895, DOI 10.1210/en.2005-1143; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Bernier NJ, 2008, J ENDOCRINOL, V196, P637, DOI 10.1677/JOE-07-0568; Bernier NJ, 2005, AM J PHYSIOL-REG I, V289, pR982, DOI 10.1152/ajpregu.00668.2004; Bernier NJ, 2001, NEUROENDOCRINOLOGY, V73, P248, DOI 10.1159/000054642; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Clement L, 2002, PFLUG ARCH EUR J PHY, V445, P375, DOI 10.1007/s00424-002-0937-3; Conde-Sieira M, 2013, J EXP BIOL, V216, P554, DOI 10.1242/jeb.076505; Conde-Sieira M, 2011, J EXP BIOL, V214, P3887, DOI 10.1242/jeb.061564; Conde-Sieira M, 2010, J EXP BIOL, V213, P3858, DOI 10.1242/jeb.048439; Cox BF, 1997, J CARDIOVASC PHARM, V29, P417, DOI 10.1097/00005344-199703000-00017; De Pedro N, 1998, PEPTIDES, V19, P505, DOI 10.1016/S0196-9781(97)00469-5; Dieguez C, 2011, NEUROENDOCRINOLOGY, V94, P1, DOI 10.1159/000328122; Dindia L, 2013, AM J PHYSIOL-ENDOC M, V304, pE1157, DOI 10.1152/ajpendo.00500.2012; Doyon C, 2006, GEN COMP ENDOCR, V146, P126, DOI 10.1016/j.ygcen.2005.10.003; Ducasse-Cabanot S, 2007, ANIMAL, V1, P1272, DOI 10.1017/S1751731107000596; Fabbri E, 1998, COMP BIOCHEM PHYS C, V120, P177, DOI 10.1016/S0742-8413(98)10017-8; Figueiredo-Silva AC, 2012, BRIT J NUTR, V107, P1714, DOI 10.1017/S0007114511004739; Figueiredo-Silva AC, 2012, PHYSIOL BEHAV, V106, P499, DOI 10.1016/j.physbeh.2012.03.027; Froiland E, 2012, GEN COMP ENDOCR, V178, P330, DOI 10.1016/j.ygcen.2012.06.017; Gelineau A, 2001, REPROD NUTR DEV, V41, P487, DOI 10.1051/rnd:2001103; Geslin M, 2004, GEN COMP ENDOCR, V135, P70, DOI 10.1016/S0016-6480(03)00283-1; Geurden I, 2007, AM J PHYSIOL-REG I, V292, pR2275, DOI 10.1152/ajpregu.00444.2006; HARMON JS, 1993, AM J PHYSIOL, V265, pR255, DOI 10.1152/ajpregu.1993.265.1.R255; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jeffrey JD, 2014, GEN COMP ENDOCR, V196, P8, DOI 10.1016/j.ygcen.2013.11.010; Johansen SJS, 2003, AQUAC RES, V34, P317; Johansen SJS, 2002, AQUAC RES, V33, P515, DOI 10.1046/j.1365-2109.2002.00736.x; KASHIWAGI A, 1995, DIABETES RES CLIN PR, V28, pS195, DOI 10.1016/0168-8227(95)01079-S; Kolditz C, 2008, AM J PHYSIOL-REG I, V294, pR1154, DOI 10.1152/ajpregu.00766.2007; Kreitschmann-Andermahr I, 2010, HORM RES PAEDIAT, V73, P153, DOI 10.1159/000284355; Lansard M, 2009, BRIT J NUTR, V102, P1564, DOI 10.1017/S000711450999095X; LEACH GJ, 1980, GEN COMP ENDOCR, V42, P219, DOI 10.1016/0016-6480(80)90191-4; Libran-Perez M, 2014, PHYSIOL BEHAV, V129, P272, DOI 10.1016/j.physbeh.2014.02.061; Libran-Perez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059507; Libran-Perez M, 2013, COMP BIOCHEM PHYS A, V164, P241, DOI 10.1016/j.cbpa.2012.09.012; Libran-Perez M, 2012, AM J PHYSIOL-REG I, V302, pR1340, DOI 10.1152/ajpregu.00070.2012; Lopez M, 2007, BIOESSAYS, V29, P248, DOI 10.1002/bies.20539; Martinez-Rubio L, 2013, AQUACULTURE, V384, P94, DOI 10.1016/j.aquaculture.2012.12.010; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Milligan CL, 2003, J EXP BIOL, V206, P3167, DOI 10.1242/jeb.00538; OCONNOR PK, 1993, J COMP PHYSIOL B, V163, P427; Oh YT, 2014, ENDOCRINOLOGY, V155, P923, DOI 10.1210/en.2013-1700; Oh YT, 2012, ENDOCRINOLOGY, V153, P3587, DOI 10.1210/en.2012-1330; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polakof S, 2011, LIPIDS, V46, P189, DOI 10.1007/s11745-010-3521-1; Polakof S, 2010, DOMEST ANIM ENDOCRIN, V39, P26, DOI 10.1016/j.domaniend.2010.01.003; Polakof S, 2008, J COMP PHYSIOL A, V194, P829, DOI 10.1007/s00359-008-0354-y; Polakof S, 2008, AM J PHYSIOL-REG I, V295, pR478, DOI 10.1152/ajpregu.00176.2008; Polakof S, 2012, J COMP PHYSIOL B, V182, P1015, DOI 10.1007/s00360-012-0658-7; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; QUABBE HJ, 1983, J CLIN ENDOCR METAB, V57, P410, DOI 10.1210/jcem-57-2-410; Rasmussen RS, 2000, AQUACULT NUTR, V6, P17; Sangiao-Alvarellos S, 2006, COMP BIOCHEM PHYS A, V144, P491, DOI 10.1016/j.cbpa.2006.04.015; Saravanan S, 2013, J NUTR, V143, P781, DOI 10.3945/jn.112.173062; Schrama JW, 2012, BRIT J NUTR, V108, P277, DOI 10.1017/S0007114511005654; Shearer KD, 1997, COMP BIOCHEM PHYS A, V118, P1209, DOI 10.1016/S0300-9629(97)86801-6; Silverstein JT, 1999, AQUACULTURE, V177, P161, DOI 10.1016/S0044-8486(99)00076-9; Soengas JL, 2014, GEN COMP EN IN PRESS; Tang ZG, 2013, MOL CELL ENDOCRINOL, V376, P114, DOI 10.1016/j.mce.2013.06.020; Tripathi G, 2003, COMP BIOCHEM PHYS B, V136, P463, DOI 10.1016/S1096-4959(03)00249-5; Velasco-Santamaria YM, 2011, AQUAT TOXICOL, V105, P107, DOI 10.1016/j.aquatox.2011.05.018; Watt MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE120, DOI 10.1152/ajpendo.00542.2003	67	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113291	10.1371/journal.pone.0113291	http://dx.doi.org/10.1371/journal.pone.0113291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405879	Green Published, gold, Green Submitted			2022-12-26	WOS:000347121300098
J	Mehaffy, C; Guthrie, JL; Alexander, DC; Stuart, R; Rea, E; Jamieson, FB				Mehaffy, Carolina; Guthrie, Jennifer L.; Alexander, David C.; Stuart, Rebecca; Rea, Elizabeth; Jamieson, Frances B.			Marked Microevolution of a Unique Mycobacterium tuberculosis Strain in 17 Years of Ongoing Transmission in a High Risk Population	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; ALTERNATE SIGMA-FACTOR; ACTIVE TUBERCULOSIS; STRINGENT RESPONSE; MUTANT LACKING; UNITED-STATES; HOMELESS; DELETIONS; GENES; IDENTIFICATION	The transmission and persistence of Mycobacterium tuberculosis within high risk populations is a threat to tuberculosis (TB) control. In the current study, we used whole genome sequencing (WGS) to decipher the transmission dynamics and microevolution of M. tuberculosis ON-A, an endemic strain responsible for an ongoing outbreak of TB in an urban homeless/under-housed population. Sixty-one M. tuberculosis isolates representing 57 TB cases from 1997 to 2013 were subjected to WGS. Sequencing data was integrated with available epidemiological information and analyzed to determine how the M. tuberculosis ON-A strain has evolved during almost two decades of active transmission. WGS offers higher discriminatory power than traditional genotyping techniques, dividing the M. tuberculosis ON-A strain into 6 sub-clusters, each defined by unique single nucleotide polymorphism profiles. One sub-cluster, designated ON-A NM (Natural Mutant; 26 isolates from 24 cases) was also defined by a large, 15 kb genomic deletion. WGS analysis reveals the existence of multiple transmission chains within the same population/setting. Our results help validate the utility of WGS as a powerful tool for identifying genomic changes and adaptation of M. tuberculosis.	[Mehaffy, Carolina; Guthrie, Jennifer L.; Jamieson, Frances B.] Publ Hlth Ontario, Toronto, ON, Canada; [Mehaffy, Carolina; Jamieson, Frances B.] Univ Toronto, Toronto, ON, Canada; [Alexander, David C.] Saskatchewan Dis Control Lab, Regina, SK, Canada; [Stuart, Rebecca; Rea, Elizabeth] Toronto Publ Hlth, Toronto, ON, Canada	University of Toronto	Mehaffy, C (corresponding author), Colorado State Univ, Ft Collins, CO 80523 USA.	Carolina.mehaffy@colostate.edu	Guthrie, Jennifer/ABE-2378-2021	Guthrie, Jennifer/0000-0001-8565-203X	Lung Association/Ontario Thoracic Society	Lung Association/Ontario Thoracic Society	This study was supported by a grant-in-aid from The Lung Association/Ontario Thoracic Society (http://www.on.lung.ca) (CM, FBJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, INT J TUBERC LUNG D, V14, P1350; Alexander DC, 2009, J CLIN MICROBIOL, V47, P2651, DOI 10.1128/JCM.01946-08; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Benedetti A, 2010, AM J EPIDEMIOL, V172, P318, DOI 10.1093/aje/kwq124; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P904; Chen P, 2000, INFECT IMMUN, V68, P5575, DOI 10.1128/IAI.68.10.5575-5580.2000; Colangeli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091024; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Boer AS, 2000, J CLIN MICROBIOL, V38, P4478, DOI 10.1128/JCM.38.12.4478-4484.2000; Dobbins Claire, 2012, Morbidity and Mortality Weekly Report, V61, P186; Dress AWM, 2004, IEEE ACM T COMPUT BI, V1, P109, DOI 10.1109/TCBB.2004.27; Fang Z, 1999, J BACTERIOL, V181, P1014, DOI 10.1128/JB.181.3.1014-1020.1999; Feske ML, 2013, AM J PUBLIC HEALTH, V103, P839, DOI 10.2105/AJPH.2012.300973; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Gambette P, 2008, IEEE ACM T COMPUT BI, V5, P472, DOI 10.1109/TCBB.2007.1046; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Geiman DE, 2004, INFECT IMMUN, V72, P1733, DOI 10.1128/IAI.72.3.1733-1745.2004; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Haddad MB, 2005, JAMA-J AM MED ASSOC, V293, P2762, DOI 10.1001/jama.293.22.2762; Hartkoorn RC, 2012, J BACTERIOL, V194, P2001, DOI 10.1128/JB.06692-11; Ho TBL, 2000, YEAST, V17, P272, DOI 10.1002/1097-0061(200012)17:4&lt;272::AID-YEA48&gt;3.0.CO;2-2; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P2157, DOI 10.1128/JCM.00691-14; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Lofy KH, 2006, INT J TUBERC LUNG D, V10, P683; McAdam JM, 2009, EMERG INFECT DIS, V15, P1109, DOI 10.3201/eid1507.080410; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Parida BK, 2005, TUBERCULOSIS, V85, P347, DOI 10.1016/j.tube.2005.08.001; Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Reyes A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-249; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sampson SL, 2004, J CLIN MICROBIOL, V42, P895, DOI 10.1128/JCM.42.2.895-898.2004; Schurch AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028365; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Torok ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Yesilkaya H, 2005, J BACTERIOL, V187, P6726, DOI 10.1128/JB.187.19.6726-6732.2005	52	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e112928	10.1371/journal.pone.0112928	http://dx.doi.org/10.1371/journal.pone.0112928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405861	gold, Green Submitted, Green Published			2022-12-26	WOS:000347121300063
J	Radenbaugh, AJ; Ma, S; Ewing, A; Stuart, JM; Collisson, EA; Zhu, JC; Haussler, D				Radenbaugh, Amie J.; Ma, Singer; Ewing, Adam; Stuart, Joshua M.; Collisson, Eric A.; Zhu, Jingchun; Haussler, David			RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection	PLOS ONE			English	Article							GENOME BROWSER; FREQUENT MUTATIONS; POINT MUTATIONS; TP53 MUTATIONS; WHOLE GENOME; CANCER; ALIGNMENT; PATHWAY; EXOME; EVOLUTION	The detection of somatic single nucleotide variants is a crucial component to the characterization of the cancer genome. Mutation calling algorithms thus far have focused on comparing the normal and tumor genomes from the same individual. In recent years, it has become routine for projects like The Cancer Genome Atlas (TCGA) to also sequence the tumor RNA. Here we present RADIA (RNA and DNA Integrated Analysis), a novel computational method combining the patient-matched normal and tumor DNA with the tumor RNA to detect somatic mutations. The inclusion of the RNA increases the power to detect somatic mutations, especially at low DNA allelic frequencies. By integrating an individual's DNA and RNA, we are able to detect mutations that would otherwise be missed by traditional algorithms that examine only the DNA. We demonstrate high sensitivity (84%) and very high precision (98% and 99%) for RADIA in patient data from endometrial carcinoma and lung adenocarcinoma from TCGA. Mutations with both high DNA and RNA read support have the highest validation rate of over 99%. We also introduce a simulation package that spikes in artificial mutations to patient data, rather than simulating sequencing data from a reference genome. We evaluate sensitivity on the simulation data and demonstrate our ability to rescue back mutations at low DNA allelic frequencies by including the RNA. Finally, we highlight mutations in important cancer genes that were rescued due to the incorporation of the RNA.	[Radenbaugh, Amie J.; Ma, Singer; Ewing, Adam; Stuart, Joshua M.; Zhu, Jingchun; Haussler, David] Univ Calif Santa Cruz, Dept Biomol Engn, Genom Inst, Santa Cruz, CA 95064 USA; [Collisson, Eric A.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Haussler, David] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Radenbaugh, AJ (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Genom Inst, Santa Cruz, CA 95064 USA.	aradenba@soe.ucsc.edu; haussler@soe.ucsc.edu	Ewing, Adam D/M-3164-2014	Ewing, Adam D/0000-0002-4544-994X; Stuart, Joshua/0000-0002-2171-565X	National Cancer Institute [U24CA143858, R01CA180778, R01CA194003, U24CA180951]; National Human Genome Research Institute [U01ES017154]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U24CA143858, U24CA180951, R01CA180778] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Cancer Institute [U24CA143858 to AJR, SM, AE, and JZ; R01CA180778 to JMS; R01CA194003 to EAC; and U24CA180951 to JZ]; the National Human Genome Research Institute [U01ES017154 to AJR]; a gift from Edward Schulak [to AE]; and the Howard Hughes Medical Institute [to DH]. The results published here are in whole or part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/, a project of the National Cancer Institute. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Alsner J, 2000, CLIN CANCER RES, V6, P3923; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andujar P, 2010, LUNG CANCER, V67, P23, DOI 10.1016/j.lungcan.2009.03.018; Baertsch R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-466; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Blons H, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-25; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Fernandez-Cuesta L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3179; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gartel AL, 2003, ONCOL RES, V13, P405; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim TH, 2009, MOL CANCER RES, V7, P1645, DOI 10.1158/1541-7786.MCR-09-0117; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Ku CS, 2012, EXPERT REV MOL DIAGN, V12, P241, DOI [10.1586/ERM.12.10, 10.1586/erm.12.10]; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Musumeci L, 2010, HUM MUTAT, V31, P67, DOI 10.1002/humu.21137; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagy E, 2003, EUR J CANCER, V39, P2298, DOI 10.1016/S0959-8049(03)00552-5; Pfaff E, 2010, J CLIN ONCOL, V28, P5188, DOI 10.1200/JCO.2010.31.1670; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Takahira T, 2004, CANCER SCI, V95, P651, DOI 10.1111/j.1349-7006.2004.tb03324.x; Ueki T, 2004, CLIN CANCER RES, V10, P1717, DOI 10.1158/1078-0432.CCR-1137-3; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	54	56	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111516	10.1371/journal.pone.0111516	http://dx.doi.org/10.1371/journal.pone.0111516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405470	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300011
J	Casagrande, JC; Macorini, LFB; Antunes, KA; dos Santos, UP; Campos, JF; Dias, JM; Sangalli, A; Cardoso, CAL; Vieira, MD; Rabelo, LA; Paredes-Gamero, EJ; dos Santos, EL; Souza, KD				Casagrande, Junior Cesar; Benitez Macorini, Luis Fernando; Antunes, Katia Avila; dos Santos, Uilson Pereira; Campos, Jaqueline Ferreira; Dias-Junior, Nelson Miguel; Sangalli, Andreia; Lima Cardoso, Claudia Andrea; Vieira, Maria do Carmo; Rabelo, Luiza Antas; Paredes-Gamero, Edgar Julian; dos Santos, Edson Lucas; Souza, Kely de Picoli			Antioxidant and Cytotoxic Activity of Hydroethanolic Extract from Jacaranda decurrens Leaves	PLOS ONE			English	Article							OXIDATIVE DAMAGE; CELL-DEATH; LIPID-PEROXIDATION; URSOLIC ACID; FLAVONOIDS; MEMBRANE; PROPOLIS; TUMOR	Background and Purpose: Leaves of Jacaranda decurrens are used in traditional Brazilian medicine to treat metabolic diseases related to increased reactive oxygen species. The present study evaluated the antioxidant and cytotoxic potential of hydroethanolic extract from the leaves of Jacaranda decurrens subsp. symmetrifoliolata. Experimental Approach: Phenolic compounds, flavonoids and saponins were evaluated in an ethanol: water (80: 20, v/v) extract from the leaves of Jacaranda decurrens subsp. symmetrifoliolata (E-Jds). The antioxidant activity of E-Jds was investigated by assessing the following: 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity; protection against 2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH)-induced hemolysis of erythrocytes; in vitro and in vivo malondialdehyde dosage; and the ability to activate antioxidant enzymes. K562 leukemia cells were used for the cytotoxic evaluation of E-Jds and for the assessment of the cell death profile through flow cytometry. Key Results: Phenolic and flavonoid compounds were quantified as 14.38% and 2.15%, respectively, of E-Jds. These phenolic and flavonoid compounds proved to be able to scavenge DPPH free radicals with an IC50 of 9.3 +/- 3.3 mu g/mL, to protect up to 50% of erythrocytes against AAPH-induced hemolysis and to reduce in vitro and in vivo malondialdehyde levels up to 84% and 22%, respectively. E-Jds also increased glutathione peroxidase enzyme activity, with a concomitant decrease in superoxide dismutase and catalase activity, and exhibited dose-dependent cytotoxic activity on K562 erythroleukemia cells with cell death occurring via both late apoptosis and necrosis. Conclusions: E-Jds exhibits in vitro and in vivo antioxidant potential, which may be the mechanism mediating the metabolic activities reported in folk medicine. Furthermore, the cytotoxic activity identified in this study contributes with the knowledge of antiproliferative activities that have been described in the literature for the genus Jacaranda.	[Casagrande, Junior Cesar; Benitez Macorini, Luis Fernando; Antunes, Katia Avila; dos Santos, Uilson Pereira; Campos, Jaqueline Ferreira; Sangalli, Andreia; Vieira, Maria do Carmo; dos Santos, Edson Lucas; Souza, Kely de Picoli] Fed Univ Grande Dourados, Dourados, MS, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Dourados, MS, Brazil; [Dias-Junior, Nelson Miguel; Rabelo, Luiza Antas] Univ Fed Alagoas, Maceio, Alagoas, Brazil; [Paredes-Gamero, Edgar Julian] Univ Fed Sao Paulo, Sao Paulo, Brazil	Universidade Federal da Grande Dourados; Universidade Estadual de Mato Grosso do Sul; Universidade Federal de Alagoas; Universidade Federal de Sao Paulo (UNIFESP)	Souza, KD (corresponding author), Fed Univ Grande Dourados, Dourados, MS, Brazil.	kelypicoli@gmail.com	de Picoli Souza, Kely/I-1248-2015; Paredes-Gamero, Edgar J/C-4791-2012; Rabêlo, Luiza A./S-4050-2019; Santos, Edson/C-6820-2014; de Picoli Souza, Kely/AAU-5978-2020; Cardoso, Claudia Andrea Lima/AAK-5578-2020; dos Santos, Edson Lucas/AAU-5857-2020; Dias-Júnior, Nelson Miguel/AAG-9506-2021; Vieira, Maria do Carmo MCV/D-4860-2016	de Picoli Souza, Kely/0000-0001-5764-2125; Paredes-Gamero, Edgar J/0000-0003-3686-8402; Santos, Edson/0000-0002-6557-7914; de Picoli Souza, Kely/0000-0001-5764-2125; Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; dos Santos, Edson Lucas/0000-0002-6557-7914; Ferreira Campos, Jaqueline/0000-0002-4981-238X	Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)	Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants of the Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Mato Grosso do Sul (FUNDECT), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ELS, CALC and MCV are CNPq research productivity fellows.	Abdollahzad H, 2009, INT J VITAM NUTR RES, V79, P281, DOI 10.1024/0300-9831.79.56.281; Ashokkumar P, 2008, BIOMED PHARMACOTHER, V62, P590, DOI 10.1016/j.biopha.2008.06.031; de Almeida MRA, 2013, PAK J PHARM SCI, V26, P881; Blatt CTT, 1998, PLANT SYST EVOL, V210, P289, DOI 10.1007/BF00985673; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Chaabane F, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-153; Chiste RC, 2014, LIFE SCI, V99, P52, DOI 10.1016/j.lfs.2014.01.059; Bieski IGC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/272749; Croft KD, 1998, ANN NY ACAD SCI, V854, P435, DOI 10.1111/j.1749-6632.1998.tb09922.x; Day BJ, 2009, BIOCHEM PHARMACOL, V77, P285, DOI 10.1016/j.bcp.2008.09.029; de Carvalho CA, 2009, REV BRAS FARMACOGN, V19, P592, DOI 10.1590/S0102-695X2009000400015; De Martino L, 2012, INT J MOL SCI, V13, P5406, DOI 10.3390/ijms13055406; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gasmi J, 2013, PHYTOMEDICINE, V20, P734, DOI 10.1016/j.phymed.2013.01.012; Ginsburg I, 2011, ARCH BIOCHEM BIOPHYS, V506, P12, DOI 10.1016/j.abb.2010.11.009; Gu Y, 2012, BIOCHEM PHARMACOL, V84, P468, DOI 10.1016/j.bcp.2012.06.002; Gupta D, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-13; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Iqbal Jamshed, 2012, ISRN Pharmacol, V2012, P563267, DOI 10.5402/2012/563267; Jo Y, 2005, ARCH PHARM RES, V28, P885, DOI 10.1007/BF02973871; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Katiyar SK, 2001, CARCINOGENESIS, V22, P287, DOI 10.1093/carcin/22.2.287; Kazi A, 2003, INT J MOL MED, V12, P879; Kuliaviene I, 2013, WORLD J GASTROENTERO, V19, P5678, DOI 10.3748/wjg.v19.i34.5678; Lee WL, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/925804; Liberio SA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-108; Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Massaoka MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038698; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Moraes VWR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.190; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; OGURA M, 1977, LLOYDIA, V40, P157; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Martucci MEP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093149; Rana A, 2013, NAT PROD RES, V27, P1167, DOI 10.1080/14786419.2012.717290; Rao CV, 2012, CURR DRUG TARGETS, V13, P1820; Sharif T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032526; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; VARANDA EM, 1992, J NAT PROD, V55, P800, DOI 10.1021/np50084a015; Wang Y, 2013, NUTRIENTS, V5, P2969, DOI 10.3390/nu5082969; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Yamasaki M, 2013, J OLEO SCI, V62, P925, DOI 10.5650/jos.62.925; Yin MC, 2007, J AGR FOOD CHEM, V55, P7177, DOI 10.1021/jf071242m	49	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112748	10.1371/journal.pone.0112748	http://dx.doi.org/10.1371/journal.pone.0112748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402205	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700067
J	Mandic, M; Drinovec, L; Glisic, S; Veljkovic, N; Nohr, J; Vrecl, M				Mandic, Maja; Drinovec, Luka; Glisic, Sanja; Veljkovic, Nevena; Nohr, Jane; Vrecl, Milka			Demonstration of a Direct Interaction between beta(2)-Adrenergic Receptor and Insulin Receptor by BRET and Bioinformatics	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-COUPLED RECEPTORS; BETA-ADRENERGIC-RECEPTORS; TYROSINE KINASE; LIVING CELLS; BETA-2-ADRENERGIC RECEPTOR; HETERO-OLIGOMERIZATION; THERAPEUTIC TARGETS; SCREENING ASSAY; HETERODIMERIZATION	Glucose metabolism is under the cooperative regulation of both insulin receptor (IR) and beta(2)-adrenergic receptor (beta(2)AR), which represent the receptor tyrosine kinases (RTKs) and seven transmembrane receptors (7TMRs), respectively. Studies demonstrating cross-talk between these two receptors and their endogenous coexpression have suggested their possible interactions. To evaluate the effect of IR and prospective heteromerization on beta(2)AR properties, we showed that IR coexpression had no effect on the ligand binding properties of beta(2)AR; however, IR reduced beta(2)AR surface expression and accelerated its internalization. Additionally, both receptors displayed a similar distribution pattern with a high degree of colocalization. To test the possible direct interaction between beta(2)AR and IR, we employed quantitative BRET 2 saturation and competition assays. Saturation assay data suggested constitutive beta(2)AR and IR homo-and heteromerization. Calculated acceptor/donor (AD(50)) values as a measure of the relative affinity for homo-and heteromer formation differed among the heteromers that could not be explained by a simple dimer model. In heterologous competition assays, a transient increase in the BRET2 signal with a subsequent hyperbolical decrease was observed, suggesting higher-order heteromer formation. To complement the BRET2 data, we employed the informational spectrum method (ISM), a virtual spectroscopy method to investigate protein-protein interactions. Computational peptide scanning of beta(2)AR and IR identified intracellular domains encompassing residues at the end of the 7th TM domain and C-terminal tail of beta(2)AR and a cytoplasmic part of the IR beta chain as prospective interaction domains. ISM further suggested a high probability of heteromer formation and homodimers as basic units engaged in heteromerization. In summary, our data suggest direct interaction and higher-order beta(2)AR: IR oligomer formation, likely comprising heteromers of homodimers.	[Mandic, Maja; Vrecl, Milka] Univ Ljubljana, Fac Vet, Inst Anat Histol & Embryol, Ljubljana, Slovenia; [Drinovec, Luka] Aerosol Doo, Dept Dev, Ljubljana, Slovenia; [Glisic, Sanja; Veljkovic, Nevena] Univ Belgrade, Inst Nucl Sci VINCA, Ctr Multidisciplinary Res, Belgrade, Serbia; [Nohr, Jane] Novo Nordisk AS, Dept Incretin & Islet Biol, Malov, Denmark	University of Ljubljana; University of Belgrade; Novo Nordisk	Vrecl, M (corresponding author), Univ Ljubljana, Fac Vet, Inst Anat Histol & Embryol, Ljubljana, Slovenia.	milka.vrecl@vf.uni-lj.si	Vrecl, Milka/A-6127-2008; Glisic, Sanja/AAE-8590-2019	Glisic, Sanja/0000-0001-5691-1055; Veljkovic, Nevena/0000-0001-6562-5800	Basileus S Program; Slovenian Research Agency program [P4-0053]; Ministry of Education, Science and Technological Development of the Republic of Serbia [173001]	Basileus S Program; Slovenian Research Agency program(Slovenian Research Agency - Slovenia); Ministry of Education, Science and Technological Development of the Republic of Serbia	The authors acknowledge funding from the Basileus S Program to M. Mandic, the Slovenian Research Agency program (P4-0053) to M. Vrecl, and the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 173001) to S. Glisic and N Veljkovic. M. Vrecl, S. Glisic and N. Veljkovic participate in the European COST Action CM1207 (GLISTEN). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Baltensperger K, 1996, J BIOL CHEM, V271, P1061, DOI 10.1074/jbc.271.2.1061; Barnes PJ, 2006, J CLIN INVEST, V116, P1210, DOI 10.1172/JCI28535; Borroto-Escuela DO, 2011, IUBMB LIFE, V63, P463, DOI 10.1002/iub.473; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Boute N, 2001, MOL PHARMACOL, V60, P640; Breit A, 2004, J BIOL CHEM, V279, P28756, DOI 10.1074/jbc.M313310200; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Dacres H, 2012, BIOCHEM BIOPH RES CO, V425, P625, DOI 10.1016/j.bbrc.2012.07.133; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Di Certo MG, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-56; Doliana R, 2008, MATRIX BIOL, V27, P96, DOI 10.1016/j.matbio.2007.09.008; Doronin S, 2002, J BIOL CHEM, V277, P10698, DOI 10.1074/jbc.M109432200; Doronin S, 2002, J BIOL CHEM, V277, P15124, DOI 10.1074/jbc.M108771200; Drinovec Luka, 2012, Front Endocrinol (Lausanne), V3, P104, DOI 10.3389/fendo.2012.00104; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P1, DOI 10.1016/j.coph.2009.11.002; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Flajolet M, 2008, NAT NEUROSCI, V11, P1402, DOI 10.1038/nn.2216; Fu Q, 2014, DIABETES, V63, P2676, DOI 10.2337/db13-1763; Gavi S, 2005, ENDOCRINOLOGY, V146, P450, DOI 10.1210/en.2004-0595; Ghosh A, 2014, COMPUT BIOL CHEM, V48, P29, DOI 10.1016/j.compbiolchem.2013.11.002; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Heni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021594; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Issad T, 2002, ANN NY ACAD SCI, V973, P120, DOI 10.1111/j.1749-6632.2002.tb04619.x; Issad T, 2002, BIOCHEM PHARMACOL, V64, P813, DOI 10.1016/S0006-2952(02)01143-7; Issad T, 2007, EXPERT OPIN THER TAR, V11, P541, DOI 10.1517/14728222.11.4.541; Karoor V, 1998, J BIOL CHEM, V273, P33035, DOI 10.1074/jbc.273.49.33035; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Kim JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033322; Kubale V, 2007, CELL TISSUE RES, V330, P231, DOI 10.1007/s00441-007-0462-y; Kulahin N, 2012, J RECEPT SIG TRANSD, V32, P57, DOI 10.3109/10799893.2011.647351; Lange LA, 2005, INT J OBESITY, V29, P449, DOI 10.1038/sj.ijo.0802883; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028; LIGGETT SB, 1988, AM J PHYSIOL, V254, pE795, DOI 10.1152/ajpendo.1988.254.6.E795; Mancini M, 2012, J CELL BIOCHEM, V113, P2765, DOI 10.1002/jcb.24154; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McGraw DW, 2006, J CLIN INVEST, V116, P1400, DOI 10.1172/JCI25840; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mondal S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02909; MOTHE I, 1995, EUR J BIOCHEM, V228, P842, DOI 10.1111/j.1432-1033.1995.0842m.x; Navarro G, 2010, J BIOL CHEM, V285, P27346, DOI 10.1074/jbc.M110.115634; Nouaille S, 2006, BIOCHEM PHARMACOL, V72, P1355, DOI 10.1016/j.bcp.2006.07.018; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Shih ML, 1998, CELL SIGNAL, V10, P575, DOI 10.1016/S0898-6568(97)00195-2; Shumay E, 2004, J CELL SCI, V117, P593, DOI 10.1242/jcs.00890; Siddiqui Sana, 2013, Front Endocrinol (Lausanne), V4, P46, DOI 10.3389/fendo.2013.00046; Soni P, 2000, MOL CELL BIOL, V20, P3896, DOI 10.1128/MCB.20.11.3896-3905.2000; Svendsen AM, 2008, ENDOCRINOLOGY, V149, P1113, DOI 10.1210/en.2007-0412; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Veljkovic N, 2008, CURR PROTEIN PEPT SC, V9, P493, DOI 10.2174/138920308785915245; VELJKOVIC V, 1987, CANCER BIOCHEM BIOPH, V9, P139; VELJKOVIC V, 1985, IEEE T BIO-MED ENG, V32, P337, DOI 10.1109/TBME.1985.325549; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-62; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-21; Vrecl M, 2004, J BIOMOL SCREEN, V9, P322, DOI 10.1177/1087057104263212; Vrecl M, 2006, J RECEPT SIG TRANSD, V26, P505, DOI 10.1080/10799890600932253; Vrecl M, 2009, J BIOMOL SCREEN, V14, P371, DOI 10.1177/1087057109333101; Wang CH, 2005, J NEUROCHEM, V93, P899, DOI 10.1111/j.1471-4159.2005.03055.x; Wang H, 2000, ADV IND CON; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; WHITE MF, 1994, J BIOL CHEM, V269, P1; Wrzal PK, 2012, CELL SIGNAL, V24, P342, DOI 10.1016/j.cellsig.2011.09.020	76	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112664	10.1371/journal.pone.0112664	http://dx.doi.org/10.1371/journal.pone.0112664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401701	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700061
J	Hillson, R; Alejandre, JD; Jacobsen, KH; Ansumana, R; Bockarie, AS; Bangura, U; Lamin, JM; Malanoski, AP; Stenger, DA				Hillson, Roger; Alejandre, Joel D.; Jacobsen, Kathryn H.; Ansumana, Rashid; Bockarie, Alfred S.; Bangura, Umaru; Lamin, Joseph M.; Malanoski, Anthony P.; Stenger, David A.			Methods for Determining the Uncertainty of Population Estimates Derived from Satellite Imagery and Limited Survey Data: A Case Study of Bo City, Sierra Leone	PLOS ONE			English	Article							RESOLUTION; MALARIA	This study demonstrates the use of bootstrap methods to estimate the total population of urban and periurban areas using satellite imagery and limited survey data. We conducted complete household surveys in 20 neighborhoods in the city of Bo, Sierra Leone, which collectively were home to 25,954 persons living in 1,979 residential structures. For five of those twenty sections, we quantized the rooftop areas of structures extracted from satellite images. We used bootstrap statistical methods to estimate the total population of the pooled sections, including the associated uncertainty intervals, as a function of sample size. Evaluations based either on rooftop area per person or on the mean number of occupants per residence both converged on the true population size. We demonstrate with this simulation that demographic surveys of a relatively small proportion of residences can provide a foundation for accurately estimating the total population in conjunction with aerial photographs.	[Hillson, Roger; Alejandre, Joel D.] Naval Res Lab, Div Informat Technol, Washington, DC USA; [Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA; [Ansumana, Rashid; Bockarie, Alfred S.] Njala Univ, Bo, Sierra Leone; [Ansumana, Rashid; Bockarie, Alfred S.; Bangura, Umaru; Lamin, Joseph M.] Mercy Hosp Res Lab, Bo, Sierra Leone; [Malanoski, Anthony P.; Stenger, David A.] Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; George Mason University; Njala University; United States Department of Defense; United States Navy; Naval Research Laboratory	Stenger, DA (corresponding author), Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.	david.stenger@nrl.navy.mil	Jacobsen, Kathryn H./B-5857-2008; Malanoski, Anthony/P-6975-2019; Ansumana, Rashid/AGQ-7401-2022; Malanoski, Anthony P/C-7814-2011	Jacobsen, Kathryn H./0000-0002-4198-6246; Malanoski, Anthony/0000-0001-6192-888X; Malanoski, Anthony P/0000-0001-6192-888X	Defense Threat Reduction Agency, Joint Science and Technology Office	Defense Threat Reduction Agency, Joint Science and Technology Office(United States Department of DefenseDefense Threat Reduction Agency)	This work was funded by the Defense Threat Reduction Agency, Joint Science and Technology Office via contract to the United States Naval Research Laboratory. There is no past, present or future Intellectual Property associated with the work described in the paper, and none of the authors have any financial interests or conflicts in the outcome of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminipouri M, 2009, OBJECT ORIENTED ANAL; Ansumana R, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.34.2291; Ansumana R, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-56; Archer BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049482; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Bhaduri B, 2007, GEOJOURNAL, V69, P103, DOI 10.1007/s10708-007-9105-9; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Checchi F, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-4; Collins R, 1995, AUTOMATIC EXTRACTION, P169; Davison AC, 1997, BOOTSTRAP METHODS TH; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Harvey JT, 2002, INT J REMOTE SENS, V23, P2071, DOI 10.1080/01431160110075901; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Jacobsen KH, 2012, INT HEALTH, V4, P307, DOI 10.1016/j.inhe.2012.09.004; Jacobsen KH, 2012, ACTA OBSTET GYN SCAN, V91, P750, DOI 10.1111/j.1600-0412.2012.01384.x; Katriel G, 2011, J R SOC INTERFACE, V8, P856, DOI 10.1098/rsif.2010.0515; Magalhaes RJS, 2011, ADV PARASIT, V74, P267, DOI 10.1016/B978-0-12-385897-9.00005-7; Ripley B, 2013, BOOT BOOTSTRAP R S P; Sharif B, 2012, EPIDEMIOL RES INT, V2012, P14; STINE R, 1989, SOCIOL METHOD RES, V18, P243, DOI 10.1177/0049124189018002003; Viel JF, 2009, EPIDEMIOLOGY, V20, P214, DOI 10.1097/EDE.0b013e31819670dc; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; Wildman J, 2002, GENERATING CONFIDENC; Wolf DA, 2001, CAN STUD POPUL, V28, P313; Wong T., 2003, P ATC 2003 C; Wu CS, 2007, GEOGR ANAL, V39, P26, DOI 10.1111/j.1538-4632.2006.00694.x; Wu S., 2005, GISCI REMOTE SENS, V42, P80, DOI [10.2747/1548-1603.42.1.80, DOI 10.2747/1548-1603.42.1.80]; Xiao YG, 2004, INT GEOSCI REMOTE SE, P2004	30	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112241	10.1371/journal.pone.0112241	http://dx.doi.org/10.1371/journal.pone.0112241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398101	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500039
J	Tokuda, K; Nishikawa, M; Kawahara, S				Tokuda, Keita; Nishikawa, Michimasa; Kawahara, Shigenori			Hippocampal State-Dependent Behavioral Reflex to an Identical Sensory Input in Rats	PLOS ONE			English	Article							NICTITATING-MEMBRANE RESPONSE; CONDITIONAL DISCRIMINATION; ASSOCIATIVE MEMORY; THETA OSCILLATIONS; BRAIN STATES; EYEBLINK; LESIONS; TRACE; SEQUENCES; CORTEX	We examined the local field potential of the hippocampus to monitor brain states during a conditional discrimination task, in order to elucidate the relationship between ongoing brain states and a conditioned motor reflex. Five 10-week-old Wistar/ ST male rats underwent a serial feature positive conditional discrimination task in eyeblink conditioning using a preceding light stimulus as a conditional cue for reinforced trials. In this task, a 2-s light stimulus signaled that the following 350-ms tone (conditioned stimulus) was reinforced with a co-terminating 100-ms periorbital electrical shock. The interval between the end of conditional cue and the onset of the conditioned stimulus was 4 +/- 1 s. The conditioned stimulus was not reinforced when the light was not presented. Animals successfully utilized the light stimulus as a conditional cue to drive differential responses to the identical conditioned stimulus. We found that presentation of the conditional cue elicited hippocampal theta oscillations, which persisted during the interval of conditional cue and the conditioned stimulus. Moreover, expression of the conditioned response to the tone (conditioned stimulus) was correlated with the appearance of theta oscillations immediately before the conditioned stimulus. These data support hippocampal involvement in the network underlying a conditional discrimination task in eyeblink conditioning. They also suggest that the preceding hippocampal activity can determine information processing of the tone stimulus in the cerebellum and its associated circuits.	[Tokuda, Keita] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Bunkyo Ku, Tokyo 1138656, Japan; [Nishikawa, Michimasa; Kawahara, Shigenori] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan	University of Tokyo; University of Toyama	Kawahara, S (corresponding author), Toyama Univ, Grad Sch Sci & Engn, 3190 Gofuku, Toyama 9308555, Japan.	kawahara@eng.u-toyama.ac.jp		Tokuda, Keita/0000-0002-0275-5541	JSPS KAKENHI [21570161]; Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),"	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Aihara Innovative Mathematical Modelling Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI (21570161) and the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),'' initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agster KL, 2002, J NEUROSCI, V22, P5760; Andersen P., 2007, HIPPOCAMPUS BOOK; Bellebaum C, 2004, BEHAV NEUROSCI, V118, P1157, DOI 10.1037/0735-7044.118.6.1157; BERRY SD, 1979, SCIENCE, V205, P209, DOI 10.1126/science.451592; Berry SD, 1978, PREDICTION LEARNING, P1298; Berry SD, 2011, NEUROBIOL LEARN MEM, V95, P185, DOI 10.1016/j.nlm.2010.11.014; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Blankenship MR, 2005, BRAIN RES, V1035, P120, DOI 10.1016/j.brainres.2004.11.061; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Campolattaro MM, 2006, NEUROBIOL LEARN MEM, V86, P205, DOI 10.1016/j.nlm.2006.03.001; Campolattaro MM, 2006, BEHAV NEUROSCI, V120, P970, DOI 10.1037/0735-7044.120.4.970; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cartford MC, 2004, LEARN MEMORY, V11, P732, DOI 10.1101/lm.83104; Cartford MC, 2002, NEUROBIOL LEARN MEM, V78, P246, DOI 10.1006/nlme.2002.4063; Case GR, 2002, NEUROBIOL LEARN MEM, V78, P234, DOI 10.1006/nlme.2002.4061; Christian KM, 2005, BEHAV NEUROSCI, V119, P526, DOI 10.1037/0735-7044.119.2.526; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; DAUM I, 1991, BEHAV NEUROSCI, V105, P396, DOI 10.1037/0735-7044.105.3.396; Deco G, 2005, PROG NEUROBIOL, V76, P236, DOI 10.1016/j.pneurobio.2005.08.004; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fortier CB, 2003, BEHAV NEUROSCI, V117, P1181, DOI 10.1037/0735-7044.117.6.1181; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Galvez R, 2007, LEARN MEMORY, V14, P94, DOI 10.1101/lm.418407; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GRASTYAN E, 1959, ELECTROEN CLIN NEURO, V11, P409, DOI 10.1016/0013-4694(59)90040-9; Green JT, 2000, PSYCHOL BULL, V126, P138, DOI 10.1037/0033-2909.126.1.138; Griffin AL, 2004, BEHAV NEUROSCI, V118, P403, DOI 10.1037/0735-7044.118.2.403; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hoffmann LC, 2009, P NATL ACAD SCI USA, V106, P21371, DOI 10.1073/pnas.0908403106; Holland PEC, 1999, HIPPOCAMPUS, V9, P143, DOI 10.1002/(SICI)1098-1063(1999)9:2<143::AID-HIPO6>3.0.CO;2-Z; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Koo JW, 2004, J NEUROSCI, V24, P7654, DOI 10.1523/JNEUROSCI.1644-04.2004; Kotani S, 2002, EUR J NEUROSCI, V15, P1267, DOI 10.1046/j.1460-9568.2002.01963.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MAUK MD, 1987, BRAIN RES, V403, P89, DOI 10.1016/0006-8993(87)90126-0; McKenna JT, 2008, J SLEEP RES, V17, P365, DOI 10.1111/j.1365-2869.2008.00686.x; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Moyer JR, 1996, J NEUROSCI, V16, P5536; Munera A, 2000, NEUROSCI LETT, V292, P33, DOI 10.1016/S0304-3940(00)01430-0; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nokia MS, 2008, NEUROBIOL LEARN MEM, V90, P62, DOI 10.1016/j.nlm.2008.01.005; NORMAN RJ, 1977, SCIENCE, V196, P551, DOI 10.1126/science.850800; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Otto T, 2006, J NEUROSCI, V26, P6603, DOI 10.1523/JNEUROSCI.1056-06.2006; Paredes DA, 2009, NEUROBIOL LEARN MEM, V92, P267, DOI 10.1016/j.nlm.2008.08.008; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PENICK S, 1991, BEHAV NEUROSCI, V105, P611, DOI 10.1037/0735-7044.105.5.611; Poulos AM, 2006, BEHAV NEUROSCI, V120, P730, DOI 10.1037/0735-7044.120.3.730; Rogers RF, 1998, NEUROBIOL LEARN MEM, V69, P307, DOI 10.1006/nlme.1998.3826; Ruigrok T. J. H., 2004, RAT NERVOUS SYSTEM, P167, DOI DOI 10.1016/B978-012547638-6/50009-2; Sainsbury RS, 1998, NEUROSCI BIOBEHAV R, V22, P237, DOI 10.1016/S0149-7634(97)00011-0; Schmajuk NA, 1997, BEHAV NEUROSCI, V111, P235; SCHNEIDERMAN N, 1966, J COMP PHYSIOL PSYCH, V62, P397, DOI 10.1037/h0023946; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Steinmetz JE, 2000, BEHAV BRAIN RES, V110, P13, DOI 10.1016/S0166-4328(99)00181-3; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2008, SCIENCE, V322, P960, DOI 10.1126/science.1161299; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Waddell J, 2008, J NEUROSCI, V28, P5290, DOI 10.1523/JNEUROSCI.1129-08.2008; Weiss C, 2011, BEHAV NEUROSCI, V125, P318, DOI 10.1037/a0023520; Wikgren J, 2010, NEUROSCIENCE, V165, P1538, DOI 10.1016/j.neuroscience.2009.11.044; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolf OT, 2012, PSYCHOPHYSIOLOGY, V49, P164, DOI 10.1111/j.1469-8986.2011.01294.x; Yoon T, 2011, NEUROBIOL LEARN MEM, V95, P176, DOI 10.1016/j.nlm.2010.07.001	72	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112927	10.1371/journal.pone.0112927	http://dx.doi.org/10.1371/journal.pone.0112927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397873	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500113
J	Fan, YZ; Wang, Y; Jiang, HB; Yang, WW; Yu, M; Yan, WR; Diwan, VK; Xu, B; Dong, HJ; Palm, L; Nie, SF				Fan, Yunzhou; Wang, Ying; Jiang, Hongbo; Yang, Wenwen; Yu, Miao; Yan, Weirong; Diwan, Vinod K.; Xu, Biao; Dong, Hengjin; Palm, Lars; Nie, Shaofa			Evaluation of Outbreak Detection Performance Using Multi-Stream Syndromic Surveillance for Influenza-Like Illness in Rural Hubei Province, China: A Temporal Simulation Model Based on Healthcare-Seeking Behaviors	PLOS ONE			English	Article							ABERRATION DETECTION METHODS; PANDEMIC INFLUENZA; REPRODUCTION NUMBER; A H1N1; DISEASE; TRANSMISSION; SYSTEM; NOTIFICATION; ALGORITHMS; HISTORY	Background: Syndromic surveillance promotes the early detection of diseases outbreaks. Although syndromic surveillance has increased in developing countries, performance on outbreak detection, particularly in cases of multi-stream surveillance, has scarcely been evaluated in rural areas. Objective: This study introduces a temporal simulation model based on healthcare-seeking behaviors to evaluate the performance of multi-stream syndromic surveillance for influenza-like illness. Methods: Data were obtained in six towns of rural Hubei Province, China, from April 2012 to June 2013. A SusceptibleExposed-Infectious-Recovered model generated 27 scenarios of simulated influenza A (H1N1) outbreaks, which were converted into corresponding simulated syndromic datasets through the healthcare-behaviors model. We then superimposed converted syndromic datasets onto the baselines obtained to create the testing datasets. Outbreak performance of single-stream surveillance of clinic visit, frequency of over the counter drug purchases, school absenteeism, and multi-stream surveillance of their combinations were evaluated using receiver operating characteristic curves and activity monitoring operation curves. Results: In the six towns examined, clinic visit surveillance and school absenteeism surveillance exhibited superior performances of outbreak detection than over the counter drug purchase frequency surveillance; the performance of multistream surveillance was preferable to signal-stream surveillance, particularly at low specificity (Sp < 90%). Conclusions: The temporal simulation model based on healthcare-seeking behaviors offers an accessible method for evaluating the performance of multi-stream surveillance.	[Fan, Yunzhou; Wang, Ying; Jiang, Hongbo; Yang, Wenwen; Yu, Miao; Yan, Weirong; Nie, Shaofa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Yan, Weirong; Diwan, Vinod K.] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Xu, Biao] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Dong, Hengjin] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Palm, Lars] Future Posit X, Gavle, Sweden	Huazhong University of Science & Technology; Karolinska Institutet; Fudan University; Ruprecht Karls University Heidelberg	Nie, SF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	sf_nie@mails.tjmu.edu.cn	Fan, Yunzhou/P-8829-2014	Jiang, Hongbo/0000-0002-0631-4460	European Union [241900]	European Union(European Commission)	This work has received financial support from the European Union Framework Program 7 (grant no. 241900) (http://ec.europa.eu/research/participants/portal/desktop/en/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckeridge DL, 2007, J BIOMED INFORM, V40, P370, DOI 10.1016/j.jbi.2006.09.003; Buckeridge David L, 2005, MMWR Suppl, V54, P109; Buckeridge David L, 2004, MMWR Suppl, V53, P137; Buckeridge DL, 2005, J BIOMED INFORM, V38, P99, DOI 10.1016/j.jbi.2004.11.007; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Chowell G, 2013, BMC MED, V11, P214; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Edge Victoria L, 2006, Can J Infect Dis Med Microbiol, V17, P235; Heffernan Richard, 2004, MMWR Suppl, V53, P23; Hiller KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073832; Hutwagner L, 2005, EMERG INFECT DIS, V11, P314, DOI 10.3201/eid1102.040587; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; Hutwagner LC, 2005, STAT MED, V24, P543, DOI 10.1002/sim.2034; Kara EO, 2012, EPIDEMIOL INFECT, V140, P1328, DOI 10.1017/S0950268811002093; Kleinman Ken P, 2005, MMWR Suppl, V54, P101; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; Magruder Steven F, 2004, MMWR Suppl, V53, P117; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; May L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-242; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Moore KM, 2008, CAN J EMERG MED, V10, P114; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Nsoesie EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045414; O'Neill PD, 2010, STAT MED, V29, P2069, DOI 10.1002/sim.3968; Punpanich W, 2012, INT J INFECT DIS, V16, pE714, DOI 10.1016/j.ijid.2012.05.1025; Rha B, 2013, EMERG INFECT DIS, V19, P1214, DOI 10.3201/eid1908.130483; Sosin DM, 2003, J URBAN HEALTH, V80, pI8; Truscott J, 2012, J R SOC INTERFACE, V9, P304, DOI 10.1098/rsif.2011.0309; Uchida M, 2013, J INFECT CHEMOTHER, V19, P665, DOI 10.1007/s10156-012-0540-2; van den Wijngaard C, 2008, EMERG INFECT DIS, V14, P917, DOI 10.3201/eid1406.071467; van Dijk A, 2009, EMERG INFECT DIS, V15, P799, DOI 10.3201/eid1505.081174; Wang C, 2012, PUBLIC HEALTH, V126, P289, DOI 10.1016/j.puhe.2011.11.008; Watkins RE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-37; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Yan WR, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-4; Yan WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062749; Yang F, 2013, ANN EPIDEMIOL, V23, P301, DOI 10.1016/j.annepidem.2013.04.005; Yang P, 2009, EMERG INFECT DIS, V15, P1603, DOI 10.3201/eid1510.081040	41	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112255	10.1371/journal.pone.0112255	http://dx.doi.org/10.1371/journal.pone.0112255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409025	Green Published, gold, Green Submitted			2022-12-26	WOS:000345533200018
J	Gorczynski, RM; Chen, ZQ; Erin, N; Khatri, I; Podnos, A				Gorczynski, Reginald M.; Chen, Zhiqi; Erin, Nuray; Khatri, Ismat; Podnos, Anna			Comparison of Immunity in Mice Cured of Primary/Metastatic Growth of EMT6 or 4THM Breast Cancer by Chemotherapy or Immunotherapy	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-CELLS; PULMONARY METASTASIS; THERAPEUTIC TARGET; CD200 EXPRESSION; PROMOTES; INFLAMMATION; CD4(+)	Purpose: We have compared cure from local/metastatic tumor growth in BALB/c mice receiving EMT6 or the poorly immunogenic, highly metastatic 4THM, breast cancer cells following manipulation of immunosuppressive CD200:CD200R interactions or conventional chemotherapy. Methods: We reported previously that EMT6 tumors are cured in CD200R1KO mice following surgical resection and immunization with irradiated EMT6 cells and CpG oligodeoxynucleotide (CpG), while wild-type (WT) animals developed pulmonary and liver metastases within 30 days of surgery. We report growth and metastasis of both EMT6 and a highly metastatic 4THM tumor in WT mice receiving iv infusions of Fab anti-CD200R1 along with CpG/tumor cell immunization. Metastasis was followed both macroscopically (lung/liver nodules) and microscopically by cloning tumor cells at limiting dilution in vitro from draining lymph nodes (DLN) harvested at surgery. We compared these results with local/metastatic tumor growth in mice receiving 4 courses of combination treatment with anti-VEGF and paclitaxel. Results: In WT mice receiving Fab anti-CD200R, no tumor cells are detectable following immunotherapy, and CD4+ cells produced increased TNF alpha/IL-2/IFN gamma on stimulation with EMT6 in vitro. No long-term cure was seen following surgery/immunotherapy of 4THM, with both microscopic (tumors in DLN at limiting dilution) and macroscopic metastases present within 14 d of surgery. Chemotherapy attenuated growth/metastases in 4THM tumor-bearers and produced a decline in lung/liver metastases, with no detectable DLN metastases in EMT6 tumor-bearing mice-these latter mice nevertheless showed no significantly increased cytokine production after restimulation with EMT6 in vitro. EMT6 mice receiving immunotherapy were resistant to subsequent re-challenge with EMT6 tumor cells, but not those receiving curative chemotherapy. Anti-CD4 treatment caused tumor recurrence after immunotherapy, but produced no apparent effect in either EMT6 or 4THM tumor bearers after chemotherapy treatment. Conclusion: Immunotherapy, but not chemotherapy, enhances CD4+ immunity and affords long-term control of breast cancer growth and resistance to new tumor foci.	[Gorczynski, Reginald M.; Chen, Zhiqi; Khatri, Ismat; Podnos, Anna] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada; [Gorczynski, Reginald M.] Univ Toronto, Fac Med, Dept Immunol, Toronto, ON, Canada; [Gorczynski, Reginald M.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Erin, Nuray] Akdeniz Univ, Sch Med, Dept Med Pharmacol, TR-07058 Antalya, Turkey	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Akdeniz University	Gorczynski, RM (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada.	rgorczynski@uhnres.utoronto.ca	Erin, Nuray/B-8616-2012; Gorczynski, Reginald/AAA-1435-2019	Erin, Nuray/0000-0002-6116-1970; 	Canadian Cancer Society [RG-11]	Canadian Cancer Society(Canadian Cancer Society (CCS))	Supported by a grant (RG-11) to RMG from the Canadian Cancer Society (www.cancer.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi YM, 2013, J IMMUNOL, V190, P3806, DOI 10.4049/jimmunol.1202439; Anderson KS, 2009, CANCER INVEST, V27, P361, DOI 10.1080/07357900802574421; Assudani DP, 2007, CANCER IMMUNOL IMMUN, V56, P70, DOI 10.1007/s00262-006-0154-6; Baxevanis CN, 2006, CANCER IMMUNOL IMMUN, V55, P85, DOI 10.1007/s00262-005-0692-3; Beyer M, 2009, CANCER RES, V69, P4346, DOI 10.1158/0008-5472.CAN-08-3796; Calogero RA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1745; Campoli Michael, 2004, Breast Dis, V20, P105; Chaudhuri S, 2000, P NATL ACAD SCI USA, V97, P11451, DOI 10.1073/pnas.97.21.11451; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DISIS ML, 1994, CANCER RES, V54, P16; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Einav U, 2005, ONCOGENE, V24, P6367, DOI 10.1038/sj.onc.1208797; Erin N, 2014, ONCOGENE IN PRESS; Erin N, 2006, BREAST CANCER RES TR, V99, P351, DOI 10.1007/s10549-006-9219-7; Gorczynski RM, 2013, BREAST CANCER RES TR, V142, P271, DOI 10.1007/s10549-013-2735-3; Gorczynski RM, 2011, BREAST CANCER RES TR, V130, P49, DOI 10.1007/s10549-010-1259-3; Gorczynski RM, 2010, BREAST CANCER RES TR, V123, P405, DOI 10.1007/s10549-009-0667-8; HAMILTON G, 1988, J CANCER RES CLIN, V114, P191, DOI 10.1007/BF00417836; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; JEROME KR, 1993, J IMMUNOL, V151, P1654; Liang ZX, 2005, CANCER RES, V65, P967; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; McWhirter JR, 2006, P NATL ACAD SCI USA, V103, P1041, DOI 10.1073/pnas.0510081103; Menard S, 1997, CLIN CANCER RES, V3, P817; Moreaux J, 2008, BIOCHEM BIOPH RES CO, V366, P117, DOI 10.1016/j.bbrc.2007.11.103; Olkhanud PB, 2009, CANCER RES, V69, P5996, DOI 10.1158/0008-5472.CAN-08-4619; Pakala SB, 2013, CANCER RES, V73, P3761, DOI 10.1158/0008-5472.CAN-12-3998; Pandit TS, 2009, INT J ONCOL, V35, P297, DOI 10.3892/ijo_00000340; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; Pfeffer U, 2009, CLIN EXP METASTAS, V26, P547, DOI 10.1007/s10585-009-9254-y; Podnos A, 2012, BREAST CANCER RES TR, V136, P117, DOI 10.1007/s10549-012-2258-3; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Qin FXF, 2009, CELL MOL IMMUNOL, V6, P3, DOI 10.1038/cmi.2009.2; Ramsey-Goldman R, 1998, J INVEST MED, V46, P217; Siva A, 2008, CANCER IMMUNOL IMMUN, V57, P987, DOI 10.1007/s00262-007-0429-6; Standish Leanna J, 2008, J Soc Integr Oncol, V6, P158; Takahashi M, 2009, CLIN EXP METASTAS, V26, P817, DOI 10.1007/s10585-009-9281-8; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; TICHATSCHEK E, 1988, CANCER IMMUNOL IMMUN, V27, P278; Tonks A, 2007, LEUKEMIA, V21, P566, DOI 10.1038/sj.leu.2404559; Tsavaris N, 2002, BRIT J CANCER, V87, P21, DOI 10.1038/sj.bjc.6600347; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zhou G, 2006, BLOOD, V107, P628, DOI 10.1182/blood-2005-07-2737	47	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113597	10.1371/journal.pone.0113597	http://dx.doi.org/10.1371/journal.pone.0113597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409195	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200139
J	Han, XM; Smyth, RL; Young, BE; Brooks, TM; de Lozada, AS; Bubb, P; Butchart, SHM; Larsen, FW; Hamilton, H; Hansen, MC; Turner, WR				Han, Xuemei; Smyth, Regan L.; Young, Bruce E.; Brooks, Thomas M.; de Lozada, Alexandra Sanchez; Bubb, Philip; Butchart, Stuart H. M.; Larsen, Frank W.; Hamilton, Healy; Hansen, Matthew C.; Turner, Will R.			A Biodiversity Indicators Dashboard: Addressing Challenges to Monitoring Progress towards the Aichi Biodiversity Targets Using Disaggregated Global Data	PLOS ONE			English	Article							FOREST CARBON STOCKS; RED LIST INDEXES; BIOLOGICAL DIVERSITY; CONSERVATION; SCIENCE; DECLINES; SERVICES; ECOLOGY; TRENDS; AREAS	Recognizing the imperiled status of biodiversity and its benefit to human well-being, the world's governments committed in 2010 to take effective and urgent action to halt biodiversity loss through the Convention on Biological Diversity's "Aichi Targets''. These targets, and many conservation programs, require monitoring to assess progress toward specific goals. However, comprehensive and easily understood information on biodiversity trends at appropriate spatial scales is often not available to the policy makers, managers, and scientists who require it. We surveyed conservation stakeholders in three geographically diverse regions of critical biodiversity concern (the Tropical Andes, the African Great Lakes, and the Greater Mekong) and found high demand for biodiversity indicator information but uneven availability. To begin to address this need, we present a biodiversity "dashboard'' - a visualization of biodiversity indicators designed to enable tracking of biodiversity and conservation performance data in a clear, user-friendly format. This builds on previous, more conceptual, indicator work to create an operationalized online interface communicating multiple indicators at multiple spatial scales. We structured this dashboard around the Pressure-State-Response-Benefit framework, selecting four indicators to measure pressure on biodiversity (deforestation rate), state of species (Red List Index), conservation response (protection of key biodiversity areas), and benefits to human populations (freshwater provision). Disaggregating global data, we present dashboard maps and graphics for the three regions surveyed and their component countries. These visualizations provide charts showing regional and national trends and lay the foundation for a web-enabled, interactive biodiversity indicators dashboard. This new tool can help track progress toward the Aichi Targets, support national monitoring and reporting, and inform outcome-based policy-making for the protection of natural resources.	[Han, Xuemei; Smyth, Regan L.; Young, Bruce E.; Brooks, Thomas M.; de Lozada, Alexandra Sanchez; Hamilton, Healy] NatureServe, Arlington, VA 22203 USA; [Han, Xuemei] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Brooks, Thomas M.] Int Union Conservat Nat, Gland, Switzerland; [Brooks, Thomas M.] Univ Philippines, World Agroforestry Ctr, Int Ctr Res Agroforestry, Los Banos, Laguna, Philippines; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas, Australia; [Bubb, Philip] United Nations Environm Programme World Conservat, Cambridge, England; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Larsen, Frank W.] European Environm Agcy, Copenhagen, Denmark; [Larsen, Frank W.; Turner, Will R.] Conservat Int, Arlington, VA USA; [Hansen, Matthew C.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA	Nature Conservancy; George Mason University; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University; University of Tasmania; BirdLife International; Conservation International; University System of Maryland; University of Maryland College Park	Han, XM (corresponding author), NatureServe, Arlington, VA 22203 USA.	xuemei_han@natureserve.org	Butchart, Stuart HM/Y-2711-2018; Butchart, Stuart/AAJ-1852-2021; Hansen, Matthew C/ABE-7226-2020	Butchart, Stuart/0000-0002-1140-4049; Brooks, Thomas/0000-0001-8159-3116; Han, Xuemei/0000-0001-7612-3216	John D. and Catherine T. MacArthur Foundation [11-98252-000-INP, 12-100096-000-INP];  [12-102962-000-INP]	John D. and Catherine T. MacArthur Foundation; 	This work was supported by awards from the John D. and Catherine T. MacArthur Foundation (URL: http://www.macfound.org/) to NatureServe addressing "Dashboard assessments: proof-of-concept and baselines" (Grant No. 11-98252-000-INP), "Moving graphical presentation of biodiversity conservation monitoring indicators from a static proof-of-concept to a dynamic prototype" (Grant No. 12-100096-000-INP), and the bridge grant between the two (Grant No. 12-102962-000-INP). The funders supported the concept development in study design phase, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2003, HYDROLOG SCI J, V48, P317, DOI 10.1623/hysj.48.3.317.45290; Andrew B., 2008, EC BIODIVERSITY ECOS; [Anonymous], 2005, NATURE, V438, P531, DOI 10.1038/438531a; Asner GP, 2012, BIOGEOSCIENCES, V9, P2683, DOI 10.5194/bg-9-2683-2012; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Bertzky M, 2009, J ENVIRON MANAGE, V90, P8, DOI 10.1016/j.jenvman.2007.11.001; Biala K., 2012, STREAMLINING EUROPEA; BirdLife Important Bird Area (IBA) Programme, 2011, BIRDLIFE IMP BIRD AR; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; Bubb P, 2011, REPORT UNEP WCMC IUC; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Butchart SHM, 2010, SCIENCE, V329, P900, DOI 10.1126/science.329.5994.900-c; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calix M., 2018, EUROPEAN RED LIST SA; Carr ER, 2007, INT J SUST DEV WORLD, V14, P543, DOI 10.1080/13504500709469753; Chalakkal K, 2010, YB INT ENV LAW, V21, P301; Chandra A, 2011, BIODIVERS CONSERV, V20, P3295, DOI 10.1007/s10531-011-0141-x; Chavan VS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S2; CHENERY A, 2013, AICHI TARGETS PASSPO; Clua E, 2005, AQUAT LIVING RESOUR, V18, P199, DOI 10.1051/alr:2005026; Convention on Biological Diversity, 2011, REP AD HOC TECHN EXP; Convention on International Trade in Endangered Species of Wild Fauna and Flora, YB INT ENV LAW; Danielsen F, 2003, ORYX, V37, P412, DOI 10.1017/S0030605303000760; Danielsen F, 2003, ORYX, V37, P407, DOI 10.1017/S0030605303000735; Diversity CoB, 2010, C PART DEC 10 2 STRA; Dudley N., 2003, RUNNING PURE IMPORTA; Eckerson W.W., 2011, PERFORMANCE DASHBOAR, V2nd; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; ESA-UCLouvain, 2010, GLOBCOVER 2009 GLOB; ESRI, 2011, ARCGIS DESKT REL 10; Extinction AfZ, 2010, 2010 AZE UPD; FAO, 2010, GLOB FOR RES ASS; FAO GeoNetwork, 2009, HYDR BAS DER HYDR; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Few S., 2006, INFORM DASHBOARD DES; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hansen MC, 2010, GLOBAL FOREST MONITO; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Holland GJ, 2012, BIOL CONSERV, V145, P95, DOI 10.1016/j.biocon.2011.10.016; Hopkin M, 2006, NATURE, V444, P420, DOI 10.1038/444420a; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Larsen FW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036971; Larsen FW, 2011, CONSERV LETT, V4, P355, DOI 10.1111/j.1755-263X.2011.00183.x; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; MacArthur Foundation, 2011, CONS SUST DEV INT PR; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Maxim L, 2009, ECOL ECON, V69, P12, DOI 10.1016/j.ecolecon.2009.03.017; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NASA USGS, J APPL REMOTE SENSIN; *OAK RIDG NAT LAB, 2006, LANDSC GLOB POP DAT; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Pimm SL, 1991, BALANCE NATURE ECOLO; R Core Team, 2021, R LANGUAGE ENV STAT; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Roberts D, 2011, BMC BIOINFORMATICS, V12; Rodriguez JP, 2003, ORYX, V37, P411, DOI 10.1017/S0030605303000759; Rudd MA, 2011, CONSERV BIOL, V25, P476, DOI 10.1111/j.1523-1739.2010.01625.x; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; Sparks TH, 2011, ORYX, V45, P411, DOI 10.1017/S003060531100024X; Stein B. A., 2000, PRECIOUS HERITAGE ST, P399; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tessier E., 2011, DEFINITION INDICATEU; Tscherning K, 2012, LAND USE POLICY, V29, P102, DOI 10.1016/j.landusepol.2011.05.009; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; U.S.Geological Survey, 2000, HYDRO1K EL DER DAT; UNEP-WCMC, 2009, INT EXP WORKSH 2010; Walpole M, 2009, ORYX, V43, P461; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; Yoccoz NG, 2003, ORYX, V37, P410, DOI 10.1017/S0030605303000747; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	86	23	25	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112046	10.1371/journal.pone.0112046	http://dx.doi.org/10.1371/journal.pone.0112046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409183	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200009
J	Rusz, J; Saft, C; Schlegel, U; Hoffman, R; Skodda, S				Rusz, Jan; Saft, Carsten; Schlegel, Uwe; Hoffman, Rainer; Skodda, Sabine			Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease	PLOS ONE			English	Article							EARLY-STAGE; ONSET; VOICE	Purpose: Although dysphonia has been shown to be a common sign of Huntington disease (HD), the extent of phonatory dysfunction in gene positive premanifest HD individuals remains unknown. The aim of the current study was to explore the possible occurrence of phonatory abnormalities in prodromal HD. Method: Sustained vowel phonations were acquired from 28 premanifest HD individuals and 28 healthy controls of comparable age. Data were analysed acoustically for measures of several phonatory dimensions including airflow insufficiency, aperiodicity, irregular vibration of vocal folds, signal perturbations, increased noise, vocal tremor and articulation deficiency. A predictive model was built to find the best combination of acoustic features and estimate sensitivity/specificity for differentiation between premanifest HD subjects and controls. The extent of voice deficits according to a specific phonatory dimension was determined using statistical decision making theory. The results were correlated to global motor function, cognitive score, disease burden score and estimated years to disease onset. Results: Measures of aperiodicity and increased noise were able to significantly differentiate between premanifest HD individuals and controls (p < 0.01). The combination of these aspects of dysphonia led to a sensitivity of 91.5% and specificity of 79.2% to correctly distinguish speakers with premanifest HD from healthy individuals. Some form of disrupted phonatory function was revealed in 68% of our premanifest HD subjects, where 18% had one affected phonatory dimension and 50% showed impairment of two or more dimensions. A relationship between pitch control and cognitive score was also observed (r = 20.50, p = 0.007). Conclusions: Phonatory abnormalities are detectable even the in premotor stages of HD. Speech investigation may have the potential to provide functional biomarkers of HD and could be included in future clinical trials and therapeutic interventions.	[Rusz, Jan] Czech Tech Univ, Fac Elect Engn, Dept Circuit Theory, CR-16635 Prague, Czech Republic; [Rusz, Jan] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Rusz, Jan] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Saft, Carsten; Hoffman, Rainer] Ruhr Univ Bochum, St Josef Hosp, Huntington Ctr NRW, Dept Neurol, Bochum, Germany; [Schlegel, Uwe; Skodda, Sabine] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Neurol, Bochum, Germany	Czech Technical University Prague; Charles University Prague; Charles University Prague; Ruhr University Bochum; Ruhr University Bochum	Rusz, J (corresponding author), Czech Tech Univ, Fac Elect Engn, Dept Circuit Theory, CR-16635 Prague, Czech Republic.	rusz.mz@gmail.com	Rusz, Jan/S-2054-2018; Rusz, Jan/X-5427-2019	Rusz, Jan/0000-0002-1036-3054; Rusz, Jan/0000-0002-1036-3054; Saft, Carsten/0000-0002-3983-7292	Czech Science Foundation [GACR 102/12/2230]; Charles University in Prague [PRVOUK-P26/LF1/4]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University in Prague	This study was supported by the Czech Science Foundation (GACR 102/12/2230) and Charles University in Prague (PRVOUK-P26/LF1/4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beste C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01797; Boersma Paul, 2002, GLOT INT, V5, P341; COLEMAN R, 1990, AM J MED GENET, V37, P36, DOI 10.1002/ajmg.1320370110; Duffy J. R., 2013, MOTOR SPEECH DISORDE; Feigin A, 2007, BRAIN, V130, P2858, DOI 10.1093/brain/awm217; Gamboa J, 1998, J VOICE, V12, P444, DOI 10.1016/S0892-1997(98)80053-2; Hartelius L, 2003, J MED SPEECH-LANG PA, V11, P1; Kay Elemetrics Corp, 2003, MULT VOIC PROGR MDVP; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kirkwood SC, 2000, J NEUROL NEUROSUR PS, V69, P773, DOI 10.1136/jnnp.69.6.773; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Little MA, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-23; Novotny M, 2014, IEEE-ACM T AUDIO SPE, V22, P1366, DOI 10.1109/TASLP.2014.2329734; Peck KK, 2009, NEUROIMAGE, V44, P175, DOI 10.1016/j.neuroimage.2008.08.034; PENNEY JB, 1990, MOVEMENT DISORD, V5, P93, DOI 10.1002/mds.870050202; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; RAMIG LA, 1986, ANN OTO RHINOL LARYN, V95, P288, DOI 10.1177/000348948609500315; Rusz J, 2014, J NEURAL TRANSM, V121, P1529, DOI 10.1007/s00702-014-1229-8; Rusz J, 2014, J NEURAL TRANSM, V121, P655, DOI 10.1007/s00702-014-1158-6; Rusz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065881; Saft C, 2003, J NEUROL, V250, P1469, DOI 10.1007/s00415-003-0256-4; Saft C, 2006, MOVEMENT DISORD, V21, P1208, DOI 10.1002/mds.20939; Skodda S, 2014, J NEURAL TRANSM, V121, P399, DOI 10.1007/s00702-013-1115-9; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tsanas A, 2012, IEEE T BIO-MED ENG, V59, P1264, DOI 10.1109/TBME.2012.2183367; Garcia MJV, 2011, J VOICE, V25, P208, DOI 10.1016/j.jvoice.2009.08.007; Vogel AP, 2012, NEUROPSYCHOLOGIA, V50, P3273, DOI 10.1016/j.neuropsychologia.2012.09.011; Weir DW, 2011, LANCET NEUROL, V10, P573, DOI 10.1016/S1474-4422(11)70070-9	32	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113412	10.1371/journal.pone.0113412	http://dx.doi.org/10.1371/journal.pone.0113412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409322	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200115
J	Dong, YY; Luo, RS; Feng, HK; Wang, JH; Zhao, JL; Zhu, YN; Yang, GJ				Dong, Yingying; Luo, Ruisen; Feng, Haikuan; Wang, Jihua; Zhao, Jinling; Zhu, Yining; Yang, Guijun			Analysing and Correcting the Differences between Multi-Source and Multi-Scale Spatial Remote Sensing	PLOS ONE			English	Article							LAND-COVER; MODIS; CLASSIFICATION	Differences exist among analysis results of agriculture monitoring and crop production based on remote sensing observations, which are obtained at different spatial scales from multiple remote sensors in same time period, and processed by same algorithms, models or methods. These differences can be mainly quantitatively described from three aspects, i.e. multiple remote sensing observations, crop parameters estimation models, and spatial scale effects of surface parameters. Our research proposed a new method to analyse and correct the differences between multi-source and multi-scale spatial remote sensing surface reflectance datasets, aiming to provide references for further studies in agricultural application with multiple remotely sensed observations from different sources. The new method was constructed on the basis of physical and mathematical properties of multi-source and multi-scale reflectance datasets. Theories of statistics were involved to extract statistical characteristics of multiple surface reflectance datasets, and further quantitatively analyse spatial variations of these characteristics at multiple spatial scales. Then, taking the surface reflectance at small spatial scale as the baseline data, theories of Gaussian distribution were selected for multiple surface reflectance datasets correction based on the above obtained physical characteristics and mathematical distribution properties, and their spatial variations. This proposed method was verified by two sets of multiple satellite images, which were obtained in two experimental fields located in Inner Mongolia and Beijing, China with different degrees of homogeneity of underlying surfaces. Experimental results indicate that differences of surface reflectance datasets at multiple spatial scales could be effectively corrected over non-homogeneous underlying surfaces, which provide database for further multi-source and multi-scale crop growth monitoring and yield prediction, and their corresponding consistency analysis evaluation.	[Dong, Yingying; Feng, Haikuan; Zhao, Jinling; Yang, Guijun] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China; [Dong, Yingying; Wang, Jihua] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Agr Stand & Testing, Beijing, Peoples R China; [Luo, Ruisen; Wang, Jihua] Zhejiang Univ, Inst Agr Remote Sensing & Informat Applicat, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Yining] Peking Univ, Sch Math Sci, LMAM, Beijing 100871, Peoples R China	Beijing Academy of Agriculture & Forestry; Beijing Academy of Agriculture & Forestry; Zhejiang University; Peking University	Yang, GJ (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China.	yanggj@nercita.org.cn		Feng, Haikuan/0000-0003-3312-6200; Yang, Guijun/0000-0002-6425-8321	National Key Basic Research and Development Program of China [2011CB311806]; National Natural Science Foundation of China [40901173, 41071228]; Beijing Natural Science Foundation [4141001]; Natural Science Foundation of China [41271345]; Beijing Municipal Talents Training Funded Project [2012D002020000007]; Beijing Academy of Agriculture and Forestry Sciences [KJCX20140417]; Open Funds of State Key Laboratory of Remote Sensing Science; Institute of Remote Sensing Applications of Chinese Academy of Sciences; Beijing Normal University [OFSLRSS201308]	National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Talents Training Funded Project; Beijing Academy of Agriculture and Forestry Sciences; Open Funds of State Key Laboratory of Remote Sensing Science; Institute of Remote Sensing Applications of Chinese Academy of Sciences(Chinese Academy of Sciences); Beijing Normal University	This research was supported by the National Key Basic Research and Development Program of China (Project No. 2011CB311806), the National Natural Science Foundation of China (Project No. 40901173 and 41071228), the Beijing Natural Science Foundation (Project No. 4141001), the Natural Science Foundation of China (Project No. 41271345), the Beijing Municipal Talents Training Funded Project (Project No. 2012D002020000007), the Special Funds for Technology innovation capacity building sponsored by the Beijing Academy of Agriculture and Forestry Sciences (Project No. KJCX20140417), and the Open Funds of State Key Laboratory of Remote Sensing Science, jointly sponsored by the Institute of Remote Sensing Applications of Chinese Academy of Sciences and Beijing Normal University (Project No. OFSLRSS201308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barany I, 2007, ANN PROBAB, V35, P1593, DOI 10.1214/009117906000000791; Bloschl G, 1999, HYDROL PROCESS, V13, P2149, DOI 10.1002/(SICI)1099-1085(199910)13:14/15<2149::AID-HYP847>3.0.CO;2-8; Braswell BH, 2003, REMOTE SENS ENVIRON, V87, P243, DOI 10.1016/j.rse.2003.06.002; Cooley T, 2002, INT GEOSCI REMOTE SE, P1414, DOI 10.1109/IGARSS.2002.1026134; Dong YY, 2012, ADV MATER RES-SWITZ, V356-360, P2833, DOI 10.4028/www.scientific.net/AMR.356-360.2833; Dong YY, 2013, THESIS ZHEJIANG U; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; He X, 2010, SENSOR LETT, V8, P2, DOI 10.1166/sl.2010.1191; Kallenberg O., 2002, FDN MODERN PROBABILI, DOI [10.1007/978-3-030-61871-1, DOI 10.1007/978-3-030-61871-1]; Li Xiang, 2005, Scientia Agricultura Sinica, V38, P1825; Liang SL, 2007, PROG PHYS GEOG, V31, P501, DOI 10.1177/0309133307084626; Liu JiaoDi, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P220; Liu M.L., 2001, J REMOTE SENSING, V5, P183; PERCIVAL DP, 1995, BIOMETRIKA, V82, P619, DOI 10.2307/2337538; Qi J, 2000, AGR FOREST METEOROL, V105, P55, DOI 10.1016/S0168-1923(00)00195-7; Rice J., 1995, MATH STAT DATA ANAL; Rosenqvist A, 2004, INT GEOSCI REMOTE SE, P4527; Tadono T, 2009, IEEE T GEOSCI REMOTE, V47, P4042, DOI 10.1109/TGRS.2009.2025270; Tarnavsky E, 2008, REMOTE SENS ENVIRON, V112, P535, DOI 10.1016/j.rse.2007.05.008; Vermote E. F., 1999, ATMOSPHERIC CORRECTI; Wang J., 2008, BASIS APPL AGR QUANT; Webster R., 2007, STAT PRACTICE; Wu H, 2010, THESIS I GEOGRAPHIC; Wu J., 2000, ANN GIS, V6, P6, DOI DOI 10.1080/10824000009480529; Yang CC, 2003, AGR SYST, V76, P1101, DOI 10.1016/S0308-521X(02)00051-3; Zhang T.B., 2006, J EARTH SCI ENV, V28, P79	27	0	0	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e111642	10.1371/journal.pone.0111642	http://dx.doi.org/10.1371/journal.pone.0111642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405760	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300013
J	Itoh, A; Uchiyama, A; Taniguchi, S; Sagara, J				Itoh, Akihiro; Uchiyama, Atsushi; Taniguchi, Shunichiro; Sagara, Junji			Phactr3/Scapinin, a Member of Protein Phosphatase 1 and Actin Regulator (Phactr) Family, Interacts with the Plasma Membrane via Basic and Hydrophobic Residues in the N-Terminus	PLOS ONE			English	Article							BINDING-PROTEIN; PP1; CYTOSKELETON; SCAPININ; DYNAMICS; COFILIN; SPECIFICITY; MIGRATION; MOTILITY; CELLS	Proteins that belong to the protein phosphatase 1 and actin regulator (phactr) family are involved in cell motility and morphogenesis. However, the mechanisms that regulate the actin cytoskeleton are poorly understood. We have previously shown that phactr3, also known as scapinin, localizes to the plasma membrane, including lamellipodia and membrane ruffles. In the present study, experiments using deletion and point mutants showed that the basic and hydrophobic residues in the N-terminus play crucial roles in the localization to the plasma membrane. A BH analysis (http://helixweb.nih.gov/bhsearch) is a program developed to identify membrane-binding domains that comprise basic and hydrophobic residues in membrane proteins. We applied this program to phactr3. The results of the BH plot analysis agreed with the experimentally determined region that is responsible for the localization of phactr3 to the plasma membrane. In vitro experiments showed that the N-terminal itself binds to liposomes and acidic phospholipids. In addition, we showed that the interaction with the plasma membrane via the N-terminal membrane-binding sequence is required for phactr3-induced morphological changes in Cos7 cells. The membrane-binding sequence in the N-terminus is highly conserved in all members of the phactr family. Our findings may provide a molecular basis for understanding the mechanisms that allow phactr proteins to regulate cell morphogenesis.	[Itoh, Akihiro; Uchiyama, Atsushi; Sagara, Junji] Shinshu Univ, Dept Biomed Lab Sci, Matsumoto, Nagano 390, Japan; [Taniguchi, Shunichiro] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Matsumoto, Nagano 390, Japan	Shinshu University; Shinshu University	Sagara, J (corresponding author), Shinshu Univ, Dept Biomed Lab Sci, Matsumoto, Nagano 390, Japan.	sagaraj@shinshu-u.ac.jp			Minister of Education, Science and Culture, Japan [16570156]	Minister of Education, Science and Culture, Japan	This work was supported by a Grant-in aid 16570156 to JS from the Minister of Education, Science and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLLEN M, 1992, CRIT REV BIOCHEM MOL, V27, P227, DOI 10.3109/10409239209082564; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Farghaian H, 2011, J BIOL CHEM, V286, P19724, DOI 10.1074/jbc.M110.205781; Favot L, 2005, FEBS LETT, V579, P100, DOI 10.1016/j.febslet.2004.11.054; Fils-Aime N, 2013, J BIOL CHEM, V288, P11807, DOI 10.1074/jbc.M112.430934; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Huet G, 2013, J CELL SCI, V126, P497, DOI 10.1242/jcs.113241; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Mouilleron S, 2012, STRUCTURE, V20, P1960, DOI 10.1016/j.str.2012.08.031; Niggli V, 2001, TRENDS BIOCHEM SCI, V26, P604, DOI 10.1016/S0968-0004(01)01927-2; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Sagara J, 2003, J BIOL CHEM, V278, P45611, DOI 10.1074/jbc.M305227200; Sagara J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004247; Solimini NL, 2013, P NATL ACAD SCI USA, V110, pE407, DOI 10.1073/pnas.1221385110; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wider C, 2009, NEUROSCI LETT, V453, P9, DOI 10.1016/j.neulet.2009.02.009; Wiezlak M, 2012, J CELL SCI, V125, P5860, DOI 10.1242/jcs.112078; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhang Y, 2012, GENE DEV, V26, P69, DOI 10.1101/gad.179283.111	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113289	10.1371/journal.pone.0113289	http://dx.doi.org/10.1371/journal.pone.0113289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405772	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300097
J	Lima, ILB; Rodrigues, AFAC; Bergamaschi, CT; Campos, RR; Hirata, AE; Tufik, S; Xylaras, BDP; Visniauskas, B; Chagas, JR; Gomes, GN				Lima, Ingrid L. B.; Rodrigues, Aline F. A. C.; Bergamaschi, Cassia T.; Campos, Ruy R.; Hirata, Aparecida E.; Tufik, Sergio; Xylaras, Beatriz D. P.; Visniauskas, Bruna; Chagas, Jair R.; Gomes, Guiomar N.			Chronic Sleep Restriction during Pregnancy - Repercussion on Cardiovascular and Renal Functioning of Male Offspring	PLOS ONE			English	Article							SENSITIVE METHOD; ANGIOTENSIN-II; HEART-RATE; HYPERTENSION; RATS; DEPRIVATION; DISORDERS; DURATION; ASSOCIATION; PRINCIPLE	Changes in the maternal environment can induce fetal adaptations that result in the progression of chronic diseases in the offspring. The objective of the present study was to evaluate the effects of maternal chronic sleep restriction on blood pressure, renal function and cardiac baroreflex response on male offspring at adult age. Female 3-month-old Wistar rats were divided in two experimental groups: control (C) and chronic sleep restricted (CSR). Pregnancy was confirmed by vaginal smear. Chronic sleep restricted females were subjected to sleep restriction by the multiple platform technique for 20 h daily, between the 1st and 20th day of pregnancy. After birth, the litters were reduced to 6 rats per mother, and were designated as offspring from control (OC) and offspring from chronic sleep restricted (OCSR). Indirect blood pressure (BPi tail cuff) was measured by plethysmography in male offspring at 3 months old. Following, the renal function and cardiac baroreflex response were analyzed. Values of BPi in OCSR were significantly higher compared to OC [OC: 127 +/- 2.6 (19); OCSR: 144 +/- 2.5 (17) mmHg]. The baroreflex sensitivity to the increase of blood pressure was reduced in OCSR [Slope: OC: -2.6 +/- 0.15 (9); OCRS: -1.6 +/- 0.13 (9)]. Hypothalamic activity of ACE2 was significantly reduced in OCSR compared to OC [OC: 97.4 +/- 15 (18); OSR: 60.2 +/- 3.6 (16) UAF/min/protein mg]. Renal function alteration was noticed by the increase in glomerular filtration rate (GFR) observed in OCSR [OC: 6.4 +/- 0.2 (10); OCSR: 7.4 +/- 0.3 (7)]. Chronic sleep restriction during pregnancy caused in the offspring hypertension, altered cardiac baroreflex response, reduced ACE-2 activity in the hypothalamus and renal alterations. Our data suggest that the reduction of sleeping time along the pregnancy is able to modify maternal homeostasis leading to functional alterations in offspring.	[Lima, Ingrid L. B.; Rodrigues, Aline F. A. C.; Bergamaschi, Cassia T.; Campos, Ruy R.; Hirata, Aparecida E.; Gomes, Guiomar N.] Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil; [Tufik, Sergio; Xylaras, Beatriz D. P.; Visniauskas, Bruna; Chagas, Jair R.] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil; [Chagas, Jair R.] Univ Fed Sao Paulo, Dept Biociencias, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Gomes, GN (corresponding author), Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil.	guiomar.gomes@unifesp.br	Visniauskas, Bruna/F-2962-2018; Bergamaschi, Cassia/AAZ-9441-2020; Chagas, Jair Ribeiro/AFV-6501-2022; Gomes, Guiomar/GLS-9245-2022; Gomes, Guiomar N/E-6345-2013; Campos, Ruy R R/I-3691-2015; Campos, Ruy R/H-8339-2017; Chagas, Jair R/A-1701-2012	Visniauskas, Bruna/0000-0002-4525-2194; Chagas, Jair Ribeiro/0000-0002-0357-8276; Gomes, Guiomar/0000-0002-6687-9885; Campos, Ruy R R/0000-0002-9404-0817; Campos, Ruy R/0000-0002-9404-0817; Chagas, Jair R/0000-0002-0357-8276; Bergamaschi, Cassia/0000-0002-5741-6993	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP-10/51665-4]; Associacao Fundo de Incentivo a Pesquisa (AFIP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Associacao Fundo de Incentivo a Pesquisa (AFIP)	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) ILBL, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-10/51665-4) GNG, Associacao Fundo de Incentivo a Pesquisa (AFIP)JRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calegare BFA, 2010, PSYCHONEUROENDOCRINO, V35, P775, DOI 10.1016/j.psyneuen.2009.11.004; Aldabal Laila, 2011, Open Respir Med J, V5, P31, DOI 10.2174/1874306401105010031; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 1997, ACTA PAEDIATR, V86, P78; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641; Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306; Caruso CC, 2006, IND HEALTH, V44, P531, DOI 10.2486/indhealth.44.531; Celsi G, 1998, PEDIATR RES, V44, P317, DOI 10.1203/00006450-199809000-00009; CHAPLEAU MW, 1995, HYPERTENSION, V26, P341, DOI 10.1161/01.HYP.26.2.341; Dall'Ago P, 2002, BRAZ J MED BIOL RES, V35, P843, DOI 10.1590/S0100-879X2002000700013; Rodrigues AFDC, 2013, AM J PHYSIOL-RENAL, V304, pF189, DOI 10.1152/ajprenal.00241.2012; DENTON KM, 1994, J PHYSIOL-LONDON, V475, P159, DOI 10.1113/jphysiol.1994.sp020057; FINK GD, 1987, HYPERTENSION, V9, P355, DOI 10.1161/01.HYP.9.4.355; Flores Mendoza I, 1979, J BRAS NEFROL, V1, P51; Martins PJF, 2010, AM J PHYSIOL-ENDOC M, V298, pE726, DOI 10.1152/ajpendo.00660.2009; Forty EJ, 2012, EXP PHYSIOL, V97, P785, DOI 10.1113/expphysiol.2011.063172; Franco MD, 2009, LIFE SCI, V85, P327, DOI 10.1016/j.lfs.2009.06.013; Franco M, 2009, CURR OPIN NEPHROL HY, V18, P63, DOI 10.1097/MNH.0b013e32831cf5d3; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; ITO S, 1993, J CLIN INVEST, V91, P2012, DOI 10.1172/JCI116423; JOUVET D, 1964, CR SOC BIOL, V158, P756; Kandasamy Y, 2012, AM J PERINAT, V29, P115, DOI 10.1055/s-0031-1295651; Kotronoulas G, 2009, HORM-INT J ENDOCRINO, V8, P232, DOI 10.14310/horm.2002.1239; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; LISHNER M, 1987, J AUTONOM NERV SYST, V19, P119, DOI 10.1016/0165-1838(87)90005-1; Lopes EA, 2004, ARQ NEURO-PSIQUIAT, V62, P217, DOI 10.1590/S0004-282X2004000200005; Lucas SRR, 2001, AM J KIDNEY DIS, V37, P467, DOI 10.1053/ajkd.2001.22088; Machado RB, 2008, PSYCHONEUROENDOCRINO, V33, P1211, DOI 10.1016/j.psyneuen.2008.06.007; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; National Sleep Foundation, 2007, SLEEP AM POLL; Nautiyal M, 2013, HYPERTENSION, V61, pE20, DOI 10.1161/HYPERTENSIONAHA.111.00571; Ofstad J, 2005, AM J PHYSIOL-RENAL, V288, pF665, DOI 10.1152/ajprenal.00226.2004; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Pedersen KB, 2011, AM J PHYSIOL-REG I, V301, pR1293, DOI 10.1152/ajpregu.00339.2011; Pien GW, 2004, SLEEP, V27, P1405, DOI 10.1093/sleep/27.7.1405; Plagemann A, 1999, DEV NEUROSCI-BASEL, V21, P58, DOI 10.1159/000017367; Rocha SO, 2005, PEDIATR RES, V58, P1274, DOI 10.1203/01.pdr.0000188698.58021.ff; Sahota PK, 2003, CURR OPIN PULM MED, V9, P477, DOI 10.1097/00063198-200311000-00005; Salgado H C, 1973, Clin Sci Mol Med Suppl, V45 Suppl 1, p123s; Schussler P, 2006, AM J PHYSIOL-ENDOC M, V291, pE549, DOI 10.1152/ajpendo.00641.2005; SIMPSON JB, 1981, NEUROENDOCRINOLOGY, V32, P248, DOI 10.1159/000123167; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Sriramula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063847; Stranges S, 2010, J HYPERTENS, V28, P896, DOI 10.1097/HJH.0b013e328335d076; Thomal JT, 2010, SLEEP, V33, P1357, DOI 10.1093/sleep/33.10.1357; Tzschentke B, 2006, WORLD POULTRY SCI J, V62, P626, DOI 10.1079/WPS2006117; Vetrivelan R, 2012, SLEEP, V35, P1511, DOI 10.5665/sleep.2200; Xia HJ, 2009, HYPERTENSION, V53, P210, DOI 10.1161/HYPERTENSIONAHA.108.123844	52	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113075	10.1371/journal.pone.0113075	http://dx.doi.org/10.1371/journal.pone.0113075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405471	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300074
J	Samia, DSM; Blumstein, DT				Samia, Diogo S. M.; Blumstein, Daniel T.			Phi Index: A New Metric to Test the Flush Early and Avoid the Rush Hypothesis	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; QUANTILE REGRESSION; HUMAN DISTURBANCE; PATTERNS; BIRDS; RISK; WILDLIFE; BEHAVIOR; ECOLOGY; RULE	Optimal escape theory states that animals should counterbalance the costs and benefits of flight when escaping from a potential predator. However, in apparent contradiction with this well-established optimality model, birds and mammals generally initiate escape soon after beginning to monitor an approaching threat, a phenomena codified as the ``Flush Early and Avoid the Rush'' (FEAR) hypothesis. Typically, the FEAR hypothesis is tested using correlational statistics and is supported when there is a strong relationship between the distance at which an individual first responds behaviorally to an approaching predator (alert distance, AD), and its flight initiation distance (the distance at which it flees the approaching predator, FID). However, such correlational statistics are both inadequate to analyze relationships constrained by an envelope (such as that in the AD-FID relationship) and are sensitive to outliers with high leverage, which can lead one to erroneous conclusions. To overcome these statistical concerns we develop the phi index (W), a distribution-free metric to evaluate the goodness of fit of a 1: 1 relationship in a constraint envelope (the prediction of the FEAR hypothesis). Using both simulation and empirical data, we conclude that W is superior to traditional correlational analyses because it explicitly tests the FEAR prediction, is robust to outliers, and it controls for the disproportionate influence of observations from large predictor values (caused by the constrained envelope in AD-FID relationship). Importantly, by analyzing the empirical data we corroborate the strong effect that alertness has on flight as stated by the FEAR hypothesis.	[Samia, Diogo S. M.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Universidade Federal de Goias; University of California System; University of California Los Angeles	Samia, DSM (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	diogosamia@gmail.com		Blumstein, Daniel/0000-0001-5793-9244				Agresti A, 2007, INTRO CATEGORICAL DA; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Blumstein DT, 2003, BIOL CONSERV, V110, P97, DOI 10.1016/S0006-3207(02)00180-5; BLUMSTEIN DT, 1992, ECOLOGY, V73, P1757, DOI 10.2307/1940027; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Chamaille-Jammes S, 2012, BEHAV ECOL SOCIOBIOL, V66, P985, DOI 10.1007/s00265-012-1354-z; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooper WE, 2005, CAN J ZOOL, V83, P1045, DOI 10.1139/Z05-104; Cooper WE, 2003, BEHAV ECOL SOCIOBIOL, V54, P179, DOI 10.1007/s00265-003-0619-y; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; Cooper WE, 2014, BEHAV ECOL, V25, P44, DOI 10.1093/beheco/art083; Diaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064634; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Dumont F, 2012, ETHOLOGY, V118, P1051, DOI 10.1111/eth.12006; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fernandez-Juricic E, 2005, BIOL CONSERV, V125, P225, DOI 10.1016/j.biocon.2005.03.020; Fernandez-Juricic E, 2002, CAN J ZOOL, V80, P1212, DOI 10.1139/Z02-104; Fernandez-Juricic E, 2001, ENVIRON CONSERV, V28, P263, DOI 10.1017/S0376892901000273; Frid A, 2002, CONSERV ECOL, V6; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Gulbransen D, 2006, ETHOLOGY, V112, P1056, DOI 10.1111/j.1439-0310.2006.01265.x; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Louis S, 2000, CAN J ZOOL, V78, P556, DOI 10.1139/cjz-78-4-556; Mao X, 2012, P IEEE VEH TECHN C, P1; Meiri S, 2005, J BIOGEOGR, V32, P369, DOI 10.1111/j.1365-2699.2005.01197.x; Moller AP, 2013, BEHAV ECOL, V24, P1211, DOI 10.1093/beheco/art054; Montgomery D.C., 2012, INTRO LINEAR REGRESS, Vfifith; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; RODGERS JA, 1995, CONSERV BIOL, V9, P89, DOI 10.1046/j.1523-1739.1995.09010089.x; Rodgers JA, 2002, CONSERV BIOL, V16, P216, DOI 10.1046/j.1523-1739.2002.00316.x; Samia DSM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0016; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Stephens PA, 2007, TRENDS ECOL EVOL, V22, P192, DOI 10.1016/j.tree.2006.12.003; TOKESHI M, 1993, ADV ECOL RES, V24, P111, DOI 10.1016/S0065-2504(08)60042-2; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Zar ZH, 2010, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	50	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113134	10.1371/journal.pone.0113134	http://dx.doi.org/10.1371/journal.pone.0113134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405872	Green Submitted, gold, Green Published			2022-12-26	WOS:000347121300084
J	Aharonson-Raz, K; Lichter-Peled, A; Tal, S; Gelman, B; Cohen, D; Klement, E; Steinman, A				Aharonson-Raz, Karin; Lichter-Peled, Anat; Tal, Shlomit; Gelman, Boris; Cohen, Daniel; Klement, Eyal; Steinman, Amir			Spatial and Temporal Distribution of West Nile Virus in Horses in Israel (1997-2013) - from Endemic to Epidemics	PLOS ONE			English	Article							SOUTHERN FRANCE; CENTRAL-EUROPE; LINEAGE 2; INFECTION; OUTBREAK; DISEASE; FEVER; TRANSMISSION; ANIMALS; SPREAD	With the rapid global spread of West Nile virus (WNV) and the endemic state it has acquired in new geographical areas, we hereby bring a thorough serological investigation of WNV in horses in a longstanding endemic region, such as Israel. This study evaluates the environmental and demographic risk factors for WNV infection in horses and suggests possible factors associated with the transition from endemic to epidemic state. West Nile virus seroprevalence in horses in Israel was determined throughout a period of more than a decade, before (1997) and after (2002 and 2013) the massive West Nile fever outbreak in humans and horses in 2000. An increase in seroprevalence was observed, from 39% (113/290) in 1997 to 66.1% (547/827) in 2002 and 85.5% (153/179) in 2013, with persistent significantly higher seroprevalence in horses situated along the Great Rift Valley (GRV) area, the major birds' migration route in Israel. Demographic risk factors included age and breed of the horse. Significantly lower spring precipitation was observed during years with increased human incidence rate that occurred between 1997-2007. Hence, we suggest referring to Israel as two WNV distinct epidemiological regions; an endemic region along the birds' migration route (GRV) and the rest of the country which perhaps suffers from cyclic epidemics. In addition, weather conditions, such as periods of spring drought, might be associated with the transition from endemic state to epidemic state of WNV.	[Aharonson-Raz, Karin; Lichter-Peled, Anat; Klement, Eyal; Steinman, Amir] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Tal, Shlomit; Cohen, Daniel] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, IL-39040 Tel Aviv, Israel; [Gelman, Boris] Kimron Vet Inst, IL-50250 Bet Dagan, Israel	Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Kimron Veterinary Institute	Steinman, A (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel.	amirst@savion.huji.ac.il	Klement, Eyal/H-8388-2019	Klement, Eyal/0000-0002-2384-2345; Steinman, Amir/0000-0003-0984-6822; Cohen, Daniel/0000-0003-2664-2303				Ahmadnejad F, 2011, EPIDEMIOL INFECT, V139, P1587, DOI 10.1017/S0950268811000173; AKOV Y, 1966, B WORLD HEALTH ORGAN, V34, P901; Anis E, 2013, J INFECT; Armstrong PM, 2013, NEW ENGL J MED, V368, P1670, DOI 10.1056/NEJMp1213696; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Banet-Noach C, 2003, AVIAN PATHOL, V32, P489, DOI 10.1080/0307945031000154080; Banet-Noach C, 2003, VIRUS GENES, V26, P135, DOI 10.1023/A:1023431328933; Barzon L, 2013, INT J ENV RES PUB HE, V10, P4669, DOI 10.3390/ijerph10104669; Beasley DWC, 2013, ANTIVIR RES, V99, P1, DOI 10.1016/j.antiviral.2013.04.015; Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049; Cabre O, 2006, EMERG INFECT DIS, V12, P1958; Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080; Chowers MY, 2005, EUR J CLIN MICROBIOL, V24, P851, DOI 10.1007/s10096-005-0061-3; Cohen D, 1999, Public Health Rev, V27, P217; Cohen DI, 2006, INFECTION, V34, P208, DOI 10.1007/s15010-006-6604-4; Epp T, 2007, CAN VET J, V48, P1137; Jansen CC, 2013, INT J ENV RES PUB HE, V10, P3735, DOI 10.3390/ijerph10083735; Jourdain E, 2007, VECTOR-BORNE ZOONOT, V7, P15, DOI 10.1089/vbz.2006.0543; Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Leshem Y, 1998, IBIS, V140, P41, DOI 10.1111/j.1474-919X.1998.tb04539.x; Lindsey NP, 2013, AM J TROP MED HYG; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; Monath TP, 2013, VACCINE, V31, P5321, DOI 10.1016/j.vaccine.2013.09.029; Murgue B, 2001, EMERG INFECT DIS, V7, P692; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Murgue B, 2002, CURR TOP MICROBIOL, V267, P195; NIR Y, 1969, AM J TROP MED HYG, V18, P416, DOI 10.4269/ajtmh.1969.18.416; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Paz S, 2006, INT J ENVIRON HEAL R, V16, P1, DOI 10.1080/09603120500392400; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Pradier S, 2012, REV SCI TECH OIE, V31, P829; Reiter P, 2010, EUROSURVEILLANCE, V15, P4; Rios LMV, 2009, MED VET ENTOMOL, V23, P357, DOI 10.1111/j.1365-2915.2009.00821.x; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Sanchini A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002184; Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600; SCHMIDT JR, 1963, ANN TROP MED PARASIT, V57, P415, DOI 10.1080/00034983.1963.11686194; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Shaman J, 2010, INT J ENV RES PUB HE, V7, P494, DOI 10.3390/ijerph7020494; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Stanke Carla, 2013, PLOS CURR-TREE LIFE, V1, P13, DOI 10.1371/currents. dis.7a2cee9e980f91ad7697b570bcc4b004.; Steinman A, 2002, VET REC, V151, P47, DOI 10.1136/vr.151.2.47; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38; Weinberger M, 2001, EMERG INFECT DIS, V7, P686, DOI 10.3201/eid0704.010416; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872; Ziegler U, 2013, VIRUSES-BASEL, V5, P2469, DOI 10.3390/v5102469; Ziegler U, 2013, INT J ENV RES PUB HE, V10, P3112, DOI 10.3390/ijerph10083112	53	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113149	10.1371/journal.pone.0113149	http://dx.doi.org/10.1371/journal.pone.0113149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402217	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700118
J	Al-Dwairi, A; Brown, AR; Pabona, JMP; Van, TH; Hamdan, H; Mercado, CP; Quick, CM; Wight, PA; Simmen, RCM; Simmen, FA				Al-Dwairi, Ahmed; Brown, Adam R.; Pabona, John Mark P.; Van, Trang H.; Hamdan, Hamdan; Mercado, Charles P.; Quick, Charles M.; Wight, Patricia A.; Simmen, Rosalia C. M.; Simmen, Frank A.			Enhanced Gastrointestinal Expression of Cytosolic Malic Enzyme (ME1) Induces Intestinal and Liver Lipogenic Gene Expression and Intestinal Cell Proliferation in Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; FATTY-ACID SYNTHASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ADIPOSE-TISSUE; ILEAL AUTOTRANSPLANTATION; LIPID-METABOLISM; SKELETAL-MUSCLE; X-RECEPTOR; OBESITY	The small intestine participates in lipid digestion, metabolism and transport. Cytosolic malic enzyme 1 (ME1) is an enzyme that generates NADPH used in fatty acid and cholesterol biosynthesis. Previous work has correlated liver and adipose ME1 expression with susceptibility to obesity and diabetes; however, the contributions of intestine-expressed ME1 to these conditions are unknown. We generated transgenic (Tg) mice expressing rat ME1 in the gastrointestinal epithelium under the control of the murine villin1 promoter/enhancer. Levels of intestinal ME1 protein (endogenous plus transgene) were greater in Tg than wildtype (WT) littermates. Effects of elevated intestinal ME1 on body weight, circulating insulin, select adipocytokines, blood glucose, and metabolism-related genes were examined. Male Tg mice fed a high-fat (HF) diet gained significantly more body weight than WT male littermates and had heavier livers. ME1-Tg mice had deeper intestinal and colon crypts, a greater intestinal 5-bromodeoxyuridine labeling index, and increased expression of intestinal lipogenic (Fasn, Srebf1) and cholesterol biosynthetic (Hmgcsr, Hmgcs1), genes. The livers from HF diet-fed Tg mice also exhibited an induction of cholesterol and lipogenic pathway genes and altered measures (Irs1, Irs2, Prkce) of insulin sensitivity. Results indicate that gastrointestinal ME1 via its influence on intestinal epithelial proliferation, and lipogenic and cholesterologenic genes may concomitantly impact signaling in liver to modify this tissue's metabolic state. Our work highlights a new mouse model to address the role of intestine-expressed ME1 in whole body metabolism, hepatomegaly, and crypt cell proliferation. Intestinal ME1 may thus constitute a therapeutic target to reduce obesity-associated pathologies.	[Al-Dwairi, Ahmed; Brown, Adam R.; Pabona, John Mark P.; Van, Trang H.; Hamdan, Hamdan; Mercado, Charles P.; Wight, Patricia A.; Simmen, Rosalia C. M.; Simmen, Frank A.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Quick, Charles M.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Brown, Adam R.; Simmen, Rosalia C. M.; Simmen, Frank A.] Univ Arkansas Med Sci, Interdisciplinary Biomed Sci Program, Little Rock, AR 72205 USA; [Simmen, Rosalia C. M.; Simmen, Frank A.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Simmen, FA (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	simmenfranka@uams.edu		Al-Dwairi, Ahmed/0000-0002-8909-9275; Simmen, Frank/0000-0001-6842-7754; Hamdan, Hamdan/0000-0002-2029-6772	NIH [R01CA136493, F31CA165665]; UAMS Translational Research Institute [NIH UL1TR000039]; Arkansas Biosciences Institute; UAMS College of Medicine Research Council; NATIONAL CANCER INSTITUTE [R01CA136493, F31CA165665] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS Translational Research Institute; Arkansas Biosciences Institute; UAMS College of Medicine Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by NIH grants R01CA136493 (FAS, RCMS) and F31CA165665 (ARB). The UAMS Translational Research Institute (NIH UL1TR000039) also supported this research through the authors' use of the Experimental Pathology, Transgenic Mouse, and DNA Sequencing Cores. This work also received support from the Arkansas Biosciences Institute and the UAMS College of Medicine Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Al-Dwairi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046716; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x; BUTS JP, 1990, EUR J CLIN INVEST, V20, P441, DOI 10.1111/j.1365-2362.1990.tb01882.x; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Dave B, 2005, CARCINOGENESIS, V26, P1793, DOI 10.1093/carcin/bgi131; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; Desmarchelier C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-84; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; Dunel-Erb S, 2001, COMP BIOCHEM PHYS A, V129, P933, DOI 10.1016/S1095-6433(01)00360-9; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Ershow Abby G, 2007, J Diabetes Sci Technol, V1, P95; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; GOODRIDGE AG, 1976, J BIOL CHEM, V251, P3027; Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124; Hayashi H, 2002, AM J PHYSIOL-GASTR L, V282, pG69, DOI 10.1152/ajpgi.2002.282.1.G69; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; HOYUMPA AM, 1975, AM J DIG DIS, V20, P1142, DOI 10.1007/BF01070758; Istvan ES, 2002, AM HEART J, V144, pS27, DOI 10.1067/mhj.2002.130300; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kamei Y, 2008, ENDOCRINOLOGY, V149, P2293, DOI 10.1210/en.2007-1461; Kim HS, 2011, CLIN CANCER RES, V17, P1713, DOI 10.1158/1078-0432.CCR-10-2081; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kondo H, 2006, AM J PHYSIOL-ENDOC M, V291, pE1092, DOI 10.1152/ajpendo.00583.2005; Korenblat KM, 2008, GASTROENTEROLOGY, V134, P1369, DOI 10.1053/j.gastro.2008.01.075; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Olivecrona T, 1997, P NUTR SOC, V56, P723, DOI 10.1079/PNS19970072; Pakarinen M, 1997, HEPATOLOGY, V25, P1315, DOI 10.1002/hep.510250602; Pakarinen MP, 1998, LIPIDS, V33, P267, DOI 10.1007/s11745-998-0205-y; Pakarinen MP, 1997, SURGERY, V122, P950, DOI 10.1016/S0039-6060(97)90337-8; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; POPPER DA, 1985, AM J PHYSIOL, V249, pG161, DOI 10.1152/ajpgi.1985.249.2.G161; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; RAUL F, 1988, GUT, V29, P1557, DOI 10.1136/gut.29.11.1557; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Sugita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020467; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Thulesen J, 1999, GUT, V45, P672, DOI 10.1136/gut.45.5.672; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Voss MD, 2005, DIABETOLOGIA, V48, P2622, DOI 10.1007/s00125-005-0025-2; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wei XC, 2012, CELL HOST MICROBE, V11, P140, DOI 10.1016/j.chom.2011.12.006; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Wouters K, 2010, FEBS LETT, V584, P1001, DOI 10.1016/j.febslet.2010.01.046; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Zhang YJ, 2006, BIOORG MED CHEM LETT, V16, P525, DOI 10.1016/j.bmcl.2005.10.065; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	68	24	25	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113058	10.1371/journal.pone.0113058	http://dx.doi.org/10.1371/journal.pone.0113058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402228	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700104
J	Brimnes, MK; Hansen, BE; Nielsen, LK; Dziegiel, MH; Nielsen, CH				Brimnes, Marie Klinge; Hansen, Bjarke Endel; Nielsen, Leif Kofoed; Dziegiel, Morten Hanefeld; Nielsen, Claus Henrik			Uptake and Presentation of Myelin Basic Protein by Normal Human B Cells	PLOS ONE			English	Article							PROGRESSIVE MULTIPLE-SCLEROSIS; OPSONIZED IMMUNE-COMPLEXES; CENTRAL-NERVOUS-SYSTEM; WHOLE-BLOOD CELLS; ANTIGEN PRESENTATION; T-CELLS; COMPLEMENT RECEPTORS; CEREBROSPINAL-FLUID; NATURAL ANTIBODY; SELF-ANTIGEN	B cells may play both pathogenic and protective roles in T-cell mediated autoimmune diseases such as multiple sclerosis (MS). These functions relate to the ability of B cells to bind and present antigens. Under serum-free conditions we observed that 3-4% of circulating B cells from healthy donors were capable of binding the MS-associated self-antigen myelin basic protein (MBP) and of presenting the immunodominant peptide MBP85-99, as determined by staining with the mAb MK16 recognising the peptide presented by HLA-DR15-positive cells. In the presence of serum, however, the majority of B cells bound MBP in a complement-dependent manner, and almost half of the B cells became engaged in presentation of MBP85-99. Even though complement receptor 1 (CR1, CD35) and CR2 (CD21) both contributed to binding of MBP to B cells, only CR2 was important for the subsequent presentation of MBP85-99. A high proportion of MBP85-99 presenting B cells expressed CD27, and showed increased expression of CD86 compared to non-presenting B cells. MBP-pulsed B cells induced a low frequency of IL-10-producing CD4+ T cells in 3 out of 6 donors, indicating an immunoregulatory role of B cells presenting MBP-derived peptides. The mechanisms described here refute the general assumption that B-cell presentation of self-antigens requires uptake via specific B-cell receptors, and may be important for maintenance of tolerance as well as for driving T-cell responses in autoimmune diseases.	[Brimnes, Marie Klinge; Hansen, Bjarke Endel; Nielsen, Claus Henrik] Rigshosp, Copenhagen Univ Hosp, Inst Inflammat Res, Dept Infect Dis & Rheumatol,Sect 7521, DK-2100 Copenhagen, Denmark; [Hansen, Bjarke Endel] Immudex, Copenhagen, Denmark; [Nielsen, Leif Kofoed] Metropolitan Univ Coll, Fac Hlth & Technol, Dept Technol, Copenhagen, Denmark; [Nielsen, Leif Kofoed; Dziegiel, Morten Hanefeld] Rigshosp, Copenhagen Univ Hosp, Dept Clin Immunol, Blood Bank,KI2034, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nielsen, CH (corresponding author), Rigshosp, Copenhagen Univ Hosp, Inst Inflammat Res, Dept Infect Dis & Rheumatol,Sect 7521, DK-2100 Copenhagen, Denmark.	claus.henrik.nielsen@rh.regionh.dk	; Hansen, Bjarke/D-3663-2018	Nielsen, Claus Henrik/0000-0001-7543-9016; Nielsen, Leif Kofoed/0000-0002-6956-1821; Hansen, Bjarke/0000-0002-8167-8459; Dziegiel, Morten Hanefeld/0000-0001-8034-1523	Danish Multiple Sclerosis Society [959531218]	Danish Multiple Sclerosis Society	MKB received funding from The Danish Multiple Sclerosis Society, grant number 959531218. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; ARVIEUX J, 1988, IMMUNOLOGY, V65, P229; Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Barrault DV, 2004, J IMMUNOL, V172, P3509, DOI 10.4049/jimmunol.172.6.3509; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Boackle SA, 1998, J IMMUNOL, V161, P6537; Boackle SA, 1997, EUR J IMMUNOL, V27, P122, DOI 10.1002/eji.1830270119; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Ciechomska M, 2014, IMMUNOLOGY, V141, P70, DOI 10.1111/imm.12169; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Isaak A, 2008, INT IMMUNOL, V20, P185, DOI 10.1093/intimm/dxm132; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; JACQUIERSARLIN MR, 1995, IMMUNOLOGY, V84, P164; Jensen LB, 2004, J IMMUNOL METHODS, V284, P45, DOI 10.1016/j.jim.2003.10.001; JOHNSON AH, 1975, LANCET, V1, P762; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Langkjaer A, 2012, CLIN IMMUNOL, V145, P1, DOI 10.1016/j.clim.2012.07.004; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lee-Chang C, 2011, CLIN IMMUNOL, V139, P12, DOI 10.1016/j.clim.2010.11.004; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; NAKAMURA M, 1988, J IMMUNOL, V141, P4165; Nielsen CH, 1997, IMMUNOLOGY, V90, P129, DOI 10.1046/j.1365-2567.1997.00138.x; Nielsen CH, 2004, EUR J IMMUNOL, V34, P263, DOI 10.1002/eji.200324413; Nielsen CH, 2002, EUR J IMMUNOL, V32, P1359, DOI 10.1002/1521-4141(200205)32:5<1359::AID-IMMU1359>3.0.CO;2-V; NIELSEN CH, 1994, SCAND J IMMUNOL, V40, P228, DOI 10.1111/j.1365-3083.1994.tb03455.x; Nielsen CH, 2001, EUR J IMMUNOL, V31, P2660, DOI 10.1002/1521-4141(200109)31:9<2660::AID-IMMU2660>3.0.CO;2-E; Nielsen CH, 2007, EXPERT OPIN BIOL TH, V7, P1061, DOI 10.1517/14712598.7.7.1061; O'Connor KC, 2010, J NEUROIMMUNOL, V223, P92, DOI 10.1016/j.jneuroim.2010.02.019; O'Connor KC, 2003, J NEUROIMMUNOL, V136, P140, DOI 10.1016/S0165-5728(03)00002-X; OGARRA A, 1992, ANN NY ACAD SCI, V651, P182; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; THORNTON BP, 1994, J IMMUNOL, V152, P1727; Thornton BP, 1996, CLIN EXP IMMUNOL, V104, P531, DOI 10.1046/j.1365-2249.1996.57761.x; Villiers MB, 1996, IMMUNOLOGY, V89, P348, DOI 10.1046/j.1365-2567.1996.d01-747.x; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673	56	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113388	10.1371/journal.pone.0113388	http://dx.doi.org/10.1371/journal.pone.0113388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401487	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700137
J	Sadler, E; Hales, B; Henry, B; Xiong, W; Myers, J; Wynnychuk, L; Taggar, R; Heyland, D; Fowler, R				Sadler, Erin; Hales, Brigette; Henry, Blair; Xiong, Wei; Myers, Jeff; Wynnychuk, Lesia; Taggar, Ru; Heyland, Daren; Fowler, Robert			Factors Affecting Family Satisfaction with Inpatient End-of-Life Care	PLOS ONE			English	Article							QUALITY; HEALTH	Background: Little data exists addressing satisfaction with end-of-life care among hospitalized patients, as they and their family members are systematically excluded from routine satisfaction surveys. It is imperative that we closely examine patient and institution factors associated with quality end-of-life care and determine high-priority target areas for quality improvement. Methods: Between September 1, 2010 and January 1, 2012 the Canadian Health care Evaluation Project (CANHELP) Bereavement Questionnaire was mailed to the next-of-kin of recently deceased inpatients to seek factors associated with satisfaction with end-of-life care. The primary outcome was the global rating of satisfaction. Secondary outcomes included rates of actual versus preferred location of death, associations between demographic factors and global satisfaction, and identification of targets for quality improvement. Results: Response rate was 33% among 275 valid addresses. Overall, 67.4% of respondents were very or completely satisfied with the overall quality of care their relative received. However, 71.4% of respondents who thought their relative did not die in their preferred location favoured an out-of-hospital location of death. A common location of death was the intensive care unit (45.7%); however, this was not the preferred location of death for 47.6% of such patients. Multivariate Poisson regression analysis showed respondents who believed their relative died in their preferred location were 1.7 times more likely to be satisfied with the end-of-life care that was provided (p = 0.001). Items identified as high-priority targets for improvement included: relationships with, and characteristics of health care professionals; illness management; communication; and end-of-life decision-making. Interpretation: Nearly three-quarters of recently deceased inpatients would have preferred an out-of-hospital death. Intensive care units were a common, but not preferred, location of in-hospital deaths. Family satisfaction with end-of-life care was strongly associated with their relative dying in their preferred location. Improved communication regarding end-of-life care preferences should be a high-priority quality improvement target.	[Sadler, Erin] Univ Toronto, Dept Gen Surg, Toronto, ON, Canada; [Hales, Brigette; Henry, Blair; Myers, Jeff; Wynnychuk, Lesia; Taggar, Ru] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Xiong, Wei] Sunnybrook Hlth Sci Ctr, Trauma Emergency & Crit Care Program, Toronto, ON M4N 3M5, Canada; [Heyland, Daren] Queens Univ, Dept Crit Care Med, Kingston, ON, Canada; [Fowler, Robert] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Fowler, Robert] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Queens University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Fowler, R (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada.	Rob.fowler@sunnybrook.ca		Henry, Blair/0000-0002-1073-9592	Heart and Stroke Foundation of Ontario; University of Toronto Department of Medicine Integrating Challenge Grant; Technology Evaluation in the Elderly Network Center of Excellence	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Toronto Department of Medicine Integrating Challenge Grant; Technology Evaluation in the Elderly Network Center of Excellence	The Heart and Stroke Foundation of Ontario, the University of Toronto Department of Medicine Integrating Challenge Grant, and the Technology Evaluation in the Elderly Network Center of Excellence have supported this body of work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Canadian Institute for Health Information, 2007, HLTH CAR US END LIF; Dodek PM, 2004, CRIT CARE MED, V32, P1922, DOI 10.1097/01.CCM.0000139920.53790.61; Frost DW, 2011, CRIT CARE MED, V39, P1174, DOI 10.1097/CCM.0b013e31820eacf2; Heyland DK, 2013, JAMA INTERN MED, V173, P778, DOI 10.1001/jamainternmed.2013.180; Heyland DK, 2010, PALLIATIVE MED, V24, P682, DOI 10.1177/0269216310373168; Heyland DK, 2000, J PALLIATIVE CARE, V16, pS10, DOI 10.1177/082585970001601S04; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; McPherson CJ, 2003, SOC SCI MED, V56, P95, DOI 10.1016/S0277-9536(02)00011-4; Morss S, 2008, J AM GERIATR SOC, V56, P124, DOI 10.1111/j.1532-5415.2007.01507.x; Singer PA, 2002, BMJ-BRIT MED J, V324, P1291, DOI 10.1136/bmj.324.7349.1291; Skrobik Y., 2010, CMAJ CANADIAN MED AS, V182, P747, DOI [10.1503/cmaj.l00131, DOI 10.1503/CMAJ.L00131]; Soberman L R, 1997, Qual Manag Health Care, V5, P63; Standing Senate Committee on Social Affairs Science and Technology, 2000, QUAL END OF LIF CAR; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	16	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110860	10.1371/journal.pone.0110860	http://dx.doi.org/10.1371/journal.pone.0110860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401710	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700009
J	Fimlaid, KA; Lindow, JC; Tribble, DR; Bunn, JY; Maue, AC; Kirkpatrick, BD				Fimlaid, Kelly A.; Lindow, Janet C.; Tribble, David R.; Bunn, Janice Y.; Maue, Alexander C.; Kirkpatrick, Beth D.			Peripheral CD4(+) T Cell Cytokine Responses Following Human Challenge and Re-Challenge with Campylobacter jejuni	PLOS ONE			English	Article							DENDRITIC CELLS; INFECTION; PROTECTION; RISK; BIOGENESIS; CHEMOKINES; CORRELATE; DISEASE; UPDATE	Campylobacter jejuni is a leading cause of human gastroenteritis worldwide; however, our understanding of the human immune response to C. jejuni infection is limited. A previous human challenge model has shown that C. jejuni elicits IFN gamma production by peripheral blood mononuclear cells, a response associated with protection from clinical disease following reinfection. In this study, we investigate T lymphocyte profiles associated with campylobacteriosis using specimens from a new human challenge model in which C. jejuni-naive subjects were challenged and re-challenged with C. jejuni CG8421. Multiparameter flow cytometry was used to investigate T lymphocytes as a source of cytokines, including IFN gamma, and to identify cytokine patterns associated with either campylobacteriosis or protection from disease. Unexpectedly, all but one subject evaluated re-experienced campylobacteriosis after re-challenge. We show that CD4(+) T cells make IFN gamma and other pro-inflammatory cytokines in response to infection; however, multifunctional cytokine response patterns were not found. Cytokine production from peripheral CD4(+) T cells was not enhanced following re-challenge, which may suggest deletion or tolerance. Evaluation of alternative paradigms or models is needed to better understand the immune components of protection from campylobacteriosis.	[Fimlaid, Kelly A.; Kirkpatrick, Beth D.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Fimlaid, Kelly A.; Lindow, Janet C.; Kirkpatrick, Beth D.] Univ Vermont, Coll Med, Vaccine Testing Ctr, Burlington, VT 05405 USA; [Fimlaid, Kelly A.; Lindow, Janet C.; Kirkpatrick, Beth D.] Univ Vermont, Coll Med, Infect Dis Unit, Burlington, VT 05405 USA; [Tribble, David R.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Bunn, Janice Y.] Univ Vermont, Coll Math, Burlington, VT 05405 USA; [Maue, Alexander C.] Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD USA	University of Vermont; University of Vermont; University of Vermont; Uniformed Services University of the Health Sciences - USA; University of Vermont; Naval Medical Research Center (NMRC)	Fimlaid, KA (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	kfimlaid@uvm.edu		Lindow, Janet/0000-0003-3235-3698	National Institute of Health National Center Research Resources [5M01RR000109]; National Center for Research Resources BK [5P20RR021905-07]; National Institute of General Medical Sciences from the National Institutes of Health BK [8 P20 GM103496-07]; US Navy Medical Research Center BK [6000.RAD1.DA3.A0308]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000109, P20RR021905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Institute of Health National Center Research Resources; National Center for Research Resources BK; National Institute of General Medical Sciences from the National Institutes of Health BK; US Navy Medical Research Center BK; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants: National Institute of Health National Center Research Resources 5M01RR000109 (http://www.nih.gov/about/almanac/organization/NCRR. htm) (support of General Clinical Research Center, UVM), the National Center for Research Resources (5P20RR021905-07) BK, the National Institute of General Medical Sciences (8 P20 GM103496-07) (http://www.nigms.nih.gov) from the National Institutes of Health BK, and the US Navy Medical Research Center work unit 6000.RAD1.DA3.A0308 (http://www.med.navy.mil/sites/nmrc/Pages/index.htm) BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Baqar S, 2010, CLIN VACCINE IMMUNOL, V17, P80, DOI 10.1128/CVI.00252-09; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bouwman LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054759; Buettner S, 2010, EPIDEMIOL INFECT, V138, P1748, DOI 10.1017/S095026881000155X; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Edwards LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015398; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Hu L, 2006, INFECT IMMUN, V74, P2697, DOI 10.1128/IAI.74.5.2697-2705.2006; Hu L, 2012, INFECT IMMUN, V80, P2929, DOI 10.1128/IAI.00129-12; Kirkpatrick BD, 2013, CLIN INFECT DIS, V57, P1106, DOI 10.1093/cid/cit454; Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Konkel ME, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-100; Maue AC, 2012, INFECT IMMUN; Nachamkin I, 2008, CAMPYLOBACTER, 3RD EDITION, P1; Rathinam VAK, 2008, MICROBES INFECT, V10, P1316, DOI 10.1016/j.micinf.2008.07.030; RICHARDSON NJ, 1983, ARCH DIS CHILD, V58, P616, DOI 10.1136/adc.58.8.616; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Schonberg-Norio D, 2006, CLIN MICROBIOL INFEC, V12, P754, DOI 10.1111/j.1469-0691.2006.01501.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Tribble DR, 2010, INFECT IMMUN, V78, P1750, DOI 10.1128/IAI.01021-09; Tribble DR, 2009, CLIN INFECT DIS, V49, P1512, DOI 10.1086/644622; Unicomb LE, 2008, FOODBORNE PATHOG DIS, V5, P79, DOI 10.1089/fpd.2007.0047; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Zilbauer M, 2008, T ROY SOC TROP MED H, V102, P123, DOI 10.1016/j.trstmh.2007.09.019	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112513	10.1371/journal.pone.0112513	http://dx.doi.org/10.1371/journal.pone.0112513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397604	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500056
J	Fristedt, R; Elebro, J; Gaber, A; Jonsson, L; Heby, M; Yudina, Y; Nodin, B; Uhlen, M; Eberhard, J; Jirstrom, K				Fristedt, Richard; Elebro, Jacob; Gaber, Alexander; Jonsson, Liv; Heby, Margareta; Yudina, Yulyana; Nodin, Bjorn; Uhlen, Mathias; Eberhard, Jakob; Jirstrom, Karin			Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SECRETORY COMPONENT; TISSUE MICROARRAYS; END-POINTS; CANCER; DIFFERENTIATION; PROLIFERATION; CHEMOTHERAPY; SURVIVAL; DISEASE	The polymeric immunoglobulin receptor (pIgR) is a key component of the mucosal immune system that mediates epithelial transcytosis of immunoglobulins. High pIgR expression has been reported to correlate with a less aggressive tumour phenotype and an improved prognosis in several human cancer types. Here, we examined the expression and prognostic significance of pIgR in pancreatic and periampullary adenocarcinoma. The study cohort encompasses a consecutive series of 175 patients surgically treated with pancreaticoduodenectomy for pancreatic and periampullary adenocarcinoma in Malmo and Lund University Hospitals, Sweden, between 2001-2011. Tissue microarrays were constructed from primary tumours (n = 175) and paired lymph node metastases (n = 105). A multiplied score was calculated from the fraction and intensity of pIgR staining. Classification and regression tree analysis was used to select the prognostic cut-off. Unadjusted and adjusted hazard ratios (HR) for death and recurrence within 5 years were calculated. pIgR expression could be evaluated in 172/175 (98.3%) primary tumours and in 96/105 (91.4%) lymph node metastases. pIgR expression was significantly down-regulated in lymph node metastases as compared with primary tumours (p = 0.018). Low pIgR expression was significantly associated with poor differentiation grade (p<0.001), perineural growth (p = 0.027), lymphatic invasion (p = 0.016), vascular invasion (p = 0.033) and infiltration of the peripancreatic fat (p = 0.039). In the entire cohort, low pIgR expression was significantly associated with an impaired 5-year survival (HR = 2.99, 95% confidence interval (CI) 1.71-5.25) and early recurrence (HR = 2.89, 95% CI 1.67-4.98). This association remained significant for survival after adjustment for conventional clinicopathological factors, tumour origin and adjuvant treatment (HR = 1.98, 95% CI 1.10-3.57). These results demonstrate, for the first time, that high tumour-specific pIgR expression signifies a more favourable tumour phenotype and that low expression independently predicts a shorter survival in patients with pancreatic and periampullary cancer. The mechanistic basis for the putative tumour suppressing properties of pIgR in these cancers merits further study.	[Fristedt, Richard; Elebro, Jacob; Gaber, Alexander; Jonsson, Liv; Heby, Margareta; Yudina, Yulyana; Nodin, Bjorn; Eberhard, Jakob; Jirstrom, Karin] Lund Univ, Dept Clin Sci Lund, SE-22185 Lund, Sweden; [Uhlen, Mathias] Royal Inst Technol, Sci Life Lab, S-17121 Stockholm, Sweden; [Uhlen, Mathias] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, S-10691 Stockholm, Sweden	Lund University; Royal Institute of Technology; Royal Institute of Technology	Fristedt, R (corresponding author), Lund Univ, Dept Clin Sci Lund, SE-22185 Lund, Sweden.	richard.fristedt@med.lu.se	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056; Elebro, Jacob/0000-0002-9550-8012	Knut and Alice Wallenberg Foundation; Swedish Cancer Society, Lund University Faculty of Medicine; University Hospital Research Grants	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Society, Lund University Faculty of Medicine; University Hospital Research Grants	This study was supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Cancer Society, Lund University Faculty of Medicine and University Hospital Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2012, GUT, V61, P1560, DOI 10.1136/gutjnl-2011-301179; Ai J, 2011, JNCI-J NATL CANCER I, V103, P1696, DOI 10.1093/jnci/djr360; Arsenescu R, 2008, MUCOSAL IMMUNOL, V1, P399, DOI 10.1038/mi.2008.32; Berntsson J, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-26; Breiman L, 1993, CLASSIFICATION REGRE; Bronsert P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-428; Denning GM, 1996, J IMMUNOL, V156, P4807; DeSouza LV, 2009, ANAL CHEM, V81, P3462, DOI 10.1021/ac802726a; Elebro J, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-80; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Fristedt R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-83; Gologan A, 2008, ARCH PATHOL LAB MED, V132, P1295, DOI 10.1043/1543-2165(2008)132[1295:PIRTRA]2.0.CO;2; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1565, DOI 10.3748/wjg.v18.i14.1565; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johansen FE, 2004, TRENDS IMMUNOL, V25, P150, DOI 10.1016/j.it.2004.01.001; Kadaba R, 2013, J PATHOL, V230, P107, DOI 10.1002/path.4172; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Khattar NH, 2005, J BIOMED SCI, V12, P65, DOI 10.1007/s11373-004-8185-5; KONDIPAPHITIS A, 1986, HISTOPATHOLOGY, V10, P1279, DOI 10.1111/j.1365-2559.1986.tb02571.x; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Li M, 2012, CELL MOL IMMUNOL, V9, P54, DOI 10.1038/cmi.2011.40; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Qiu XY, 2003, CANCER RES, V63, P6488; ROSSEL M, 1991, UROL RES, V19, P361, DOI 10.1007/BF00310151; Sultana A, 2008, BRIT J CANCER, V99, P6, DOI 10.1038/sj.bjc.6604436; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; Traicoff JL, 2003, J BIOMED SCI, V10, P792, DOI 10.1159/000073967; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.474; Westgaard A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-5; Zhou HB, 2010, EUR J CANCER, V46, P1056, DOI 10.1016/j.ejca.2010.02.005	32	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112728	10.1371/journal.pone.0112728	http://dx.doi.org/10.1371/journal.pone.0112728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397670	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500084
J	Tigdemir, M				Tigdemir, Mesut			Re-Evaluation of the AASHTO-Flexible Pavement Design Equation with Neural Network Modeling	PLOS ONE			English	Article							SBS MODIFIED BITUMEN	Here we establish that equivalent single-axle loads values can be estimated using artificial neural networks without the complex design equality of American Association of State Highway and Transportation Officials (AASHTO). More importantly, we find that the neural network model gives the coefficients to be able to obtain the actual load values using the AASHTO design values. Thus, those design traffic values that might result in deterioration can be better calculated using the neural networks model than with the AASHTO design equation. The artificial neural network method is used for this purpose. The existing AASHTO flexible pavement design equation does not currently predict the pavement performance of the strategic highway research program (Long Term Pavement Performance studies) test sections very accurately, and typically over-estimates the number of equivalent single axle loads needed to cause a measured loss of the present serviceability index. Here we aimed to demonstrate that the proposed neural network model can more accurately represent the loads values data, compared against the performance of the AASHTO formula. It is concluded that the neural network may be an appropriate tool for the development of databased-nonparametric models of pavement performance.	Suleyman Demirel Univ, Fac Engn, Dept Civil Engn, TR-32200 Isparta, Turkey	Suleyman Demirel University	Tigdemir, M (corresponding author), Suleyman Demirel Univ, Fac Engn, Dept Civil Engn, TR-32200 Isparta, Turkey.	mesuttigdemir@sdu.edu.tr	tigdemir, mesut/M-9252-2017	tigdemir, mesut/0000-0002-5303-2722				Alavi AH, 2011, CONSTR BUILD MATER, V25, P1338, DOI 10.1016/j.conbuildmat.2010.09.010; [Anonymous], 2008, FLEX PAV DES MAN; [Anonymous], 1994, SHRPP394; Banan MR, 1996, J TRANSP ENG-ASCE, V122, P358, DOI 10.1061/(ASCE)0733-947X(1996)122:5(358); Hallin JP, 2007, PAVEMENT DESIGN POST, P1; Hudson WR, 2007, AASHO ROAD TEST EFFE, P17; Kok BV, 2013, FUEL, V106, P265, DOI 10.1016/j.fuel.2012.12.073; Kok BV, 2010, EXPERT SYST APPL, V37, P7775, DOI 10.1016/j.eswa.2010.04.063; Ozgan E, 2011, EXPERT SYST APPL, V38, P6025, DOI 10.1016/j.eswa.2010.11.018; Simon H., 1999, NEURAL NETWORKS COMP; Souza RO, 2006, IMPROVING PAVEMENTS; Wu ZH, 2014, EXPERT SYST APPL, V41, P1021, DOI 10.1016/j.eswa.2013.07.063	12	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113226	10.1371/journal.pone.0113226	http://dx.doi.org/10.1371/journal.pone.0113226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397962	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500141
J	Vay, C; Hosch, SB; Stoecklein, NH; Klein, CA; Vallbohmer, D; Link, BC; Yekebas, EF; Izbicki, JR; Knoefel, WT; Scheunemann, P				Vay, Christian; Hosch, Stefan B.; Stoecklein, Nikolas H.; Klein, Christoph A.; Vallboehmer, Daniel; Link, Bjoern-Christian; Yekebas, Emre F.; Izbicki, Jakob R.; Knoefel, Wolfram T.; Scheunemann, Peter			Integrin Expression in Esophageal Squamous Cell Carcinoma: Loss of the Physiological Integrin Expression Pattern Correlates with Disease Progression	PLOS ONE			English	Article							6 BETA 4; ADHESION MOLECULES; ALPHA-6-BETA-4 INTEGRIN; STEM-CELLS; INVASIVE GROWTH; TUMOR INVASION; E-CADHERIN; CANCER; MIGRATION; HEMIDESMOSOMES	The integrins are a family of heterodimeric transmembrane signaling receptors that mediate the adhesive properties of epithelial cells affecting cell growth and differentiation. In many epithelial malignancies, altered integrin expression is associated with tumor progression and often correlates with unfavorable prognosis. However, only few studies have investigated the role of integrin expression in esophageal squamous cell carcinoma (ESCC). Using a novel quantifying immunofluorescence-staining assay, we investigated the expression of the integrins alpha(2)beta(1), alpha(3)beta(1), alpha(6)beta(1), and alpha(6)beta(4) in primary ESCC of 36 patients who underwent surgical resection. Magnitude and distribution of expression were analyzed in primary tumor samples and autologous esophageal squamous epithelium. The persistence of the physiologically polarized expression of the subunits alpha(6), beta(1), and beta(4) in the tumor tissue was significantly associated with prolonged relapse-free survival (p = 0.028, p = 0.034, p = 0.006). In contrast, patients with reduced focal alpha(6) expression at the tumor invasion front shared a significantly shortened relapse-free survival compared to patients with strong alpha(6) expression at their stromal surfaces, as it was regularly observed in normal esophageal epithelium (p = 0.001). Multivariate regression analysis identified the maintenance of strong alpha(6) immunoreactivity at the invasion front as an independent prognostic factor for increased relapse-free and disease-specific survival (p = 0.003; p = 0.003). Our findings suggest that alterations in both pattern and magnitude of integrin expression may play a major role in the disease progression of ESCC patients. Particularly, the distinct expression of the integrins alpha(6)beta(4) and alpha(6)beta(1) at the invasion front as well as the maintenance of a polarized integrin expression pattern in the tumor tissue may serve as valuable new markers to assess the aggressiveness of ESCC.	[Vay, Christian; Hosch, Stefan B.; Stoecklein, Nikolas H.; Vallboehmer, Daniel; Knoefel, Wolfram T.; Scheunemann, Peter] Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany; [Vay, Christian; Hosch, Stefan B.; Stoecklein, Nikolas H.; Vallboehmer, Daniel; Knoefel, Wolfram T.; Scheunemann, Peter] Univ Hosp Dusseldorf, Dusseldorf, Germany; [Vay, Christian; Hosch, Stefan B.; Stoecklein, Nikolas H.; Link, Bjoern-Christian; Yekebas, Emre F.; Izbicki, Jakob R.; Knoefel, Wolfram T.; Scheunemann, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Hosch, Stefan B.] Ingolstadt Med Ctr, Dept Gen Vasc & Visceral Surg, Ingolstadt, Germany; [Klein, Christoph A.] Univ Regensburg, Div Oncogen, Inst Pathol, D-93053 Regensburg, Germany; [Scheunemann, Peter] Univ Hosp Rostock, Dept Pediat Surg, Rostock, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; University of Rostock	Vay, C (corresponding author), Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany.	christian.vay@med.uni-duesseldorf.de		Klein, Christoph A./0000-0001-7128-1725				Adachi M, 1998, J CLIN ONCOL, V16, P1060, DOI 10.1200/JCO.1998.16.3.1060; ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Baba Y, 2008, BRIT J CANCER, V98, P974, DOI 10.1038/sj.bjc.6604252; Bagutti C, 1998, J PATHOL, V186, P8, DOI 10.1002/(SICI)1096-9896(199809)186:1<8::AID-PATH156>3.0.CO;2-H; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; BOSMAN FT, 1993, HISTOCHEM J, V25, P469, DOI 10.1007/BF00159282; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Croagh D, 2008, STEM CELL REV, V4, P261, DOI 10.1007/s12015-008-9031-3; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DOBSON H, 1994, GUT, V35, P1343, DOI 10.1136/gut.35.10.1343; DOWNER CS, 1993, J PATHOL, V171, P183, DOI 10.1002/path.1711710306; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engbring JA, 2003, J PATHOL, V200, P465, DOI 10.1002/path.1396; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Eriksen JG, 2004, APMIS, V112, P560, DOI 10.1111/j.1600-0463.2004.apm1120902.x; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidler I J, 1982, Prog Clin Biol Res, V85 Pt B, P601; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Garzino-Demo P, 1998, ORAL ONCOL, V34, P204, DOI 10.1016/S1368-8375(97)00059-6; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; HALL PA, 1991, J PATHOL, V165, P33, DOI 10.1002/path.1711650107; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Ishii Y, 2000, GASTROENTEROLOGY, V118, P497, DOI 10.1016/S0016-5085(00)70255-1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JONES J, 1993, J PATHOL, V169, P235, DOI 10.1002/path.1711690210; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Katayama M, 2004, J MOL HISTOL, V35, P277; KORETZ K, 1991, AM J PATHOL, V138, P741; Kwon J, 2013, INT J ONCOL, V43, P1523, DOI 10.3892/ijo.2013.2097; Lohi J, 2001, INT J CANCER, V94, P763, DOI 10.1002/ijc.1539; Lordick F, 2013, LANGENBECK ARCH SURG, V398, P177, DOI 10.1007/s00423-012-1001-1; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mawhinney Mark R, 2012, Cancer Manag Res, V4, P367, DOI 10.2147/CMAR.S27593; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Nair KS, 2005, J CLIN PATHOL, V58, P343, DOI 10.1136/jcp.2004.018036; NIGAM AK, 1993, BRIT J CANCER, V68, P507, DOI 10.1038/bjc.1993.377; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; PIGNATELLI M, 1991, J PATHOL, V165, P25, DOI 10.1002/path.1711650106; PIGNATELLI M, 1990, BRIT J CANCER, V61, P636, DOI 10.1038/bjc.1990.141; PIGNATELLI M, 1992, HUM PATHOL, V23, P1159, DOI 10.1016/0046-8177(92)90034-Z; Rabinovitz I, 1996, BIOCHEM CELL BIOL, V74, P811, DOI 10.1139/o96-087; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Serini G, 1996, J NATL CANCER I, V88, P442, DOI 10.1093/jnci/88.7.442; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; STALLMACH A, 1992, GUT, V33, P342, DOI 10.1136/gut.33.3.342; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Thomas GJ, 1997, ORAL ONCOL, V33, P381, DOI 10.1016/S0964-1955(97)00021-3; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; VANWAES C, 1995, CANCER RES, V55, P5434; Villaflor VM, 2012, WORLD J GASTROENTERO, V18, P6737, DOI 10.3748/wjg.v18.i46.6737; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399	68	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e109026	10.1371/journal.pone.0109026	http://dx.doi.org/10.1371/journal.pone.0109026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398092	Green Published, gold			2022-12-26	WOS:000345558500004
J	Wu, J; Teng, YG; Lu, SJ; Wang, YY; Jiao, XD				Wu, Jin; Teng, Yanguo; Lu, Sijin; Wang, Yeyao; Jiao, Xudong			Evaluation of Soil Contamination Indices in a Mining Area of Jiangxi, China	PLOS ONE			English	Article							HEAVY-METAL POLLUTION; URBAN SOILS; ENRICHMENT FACTORS; BASE-LINE; ELEMENTS; PB; NI; CU	There is currently a wide variety of methods used to evaluate soil contamination. We present a discussion of the advantages and limitations of different soil contamination assessment methods. In this study, we analyzed seven trace elements (As, Cd, Cr, Cu, Hg, Pb, and Zn) that are indicators of soil contamination in Dexing, a city in China that is famous for its vast nonferrous mineral resources in China, using enrichment factor (EF), geoaccumulation index (I-geo), pollution index (PI), and principal component analysis (PCA). The three contamination indices and PCA were then mapped to understand the status and trends of soil contamination in this region. The entire study area is strongly enriched in Cd, Cu, Pb, and Zn, especially in areas near mine sites. As and Hg were also present in high concentrations in urban areas. Results indicated that Cr in this area originated from both anthropogenic and natural sources. PCA combined with Geographic Information System (GIS) was successfully used to discriminate between natural and anthropogenic trace metals.	[Wu, Jin; Teng, Yanguo; Jiao, Xudong] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Lu, Sijin; Wang, Yeyao] China Natl Environm Monitoring Ctr, Beijing, Peoples R China	Beijing Normal University	Teng, YG (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	teng1974@163.com	WU, JIN/AAE-9081-2019		Specific Research on Public Service of Environmental Protection in China [201509031]; National Natural Science Foundation in China [41303069]	Specific Research on Public Service of Environmental Protection in China; National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	This work was supported by the Specific Research on Public Service of Environmental Protection in China (No. 201509031) and National Natural Science Foundation in China (No. 41303069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2001, ECOL APPL, V11, P1573, DOI 10.1890/1051-0761(2001)011[1573:DASQAT]2.0.CO;2; BCMOE (British Columbia Ministry of Environment), 2005, BACKGROUND SOIL QUAL, V17; Blaser P, 2000, SCI TOTAL ENVIRON, V249, P257, DOI 10.1016/S0048-9697(99)00522-7; Carlon C., 2007, DERIVATION METHODS S; CCME, 2007, CAN SOIL QUAL GUID P; CEMS, 1990, BACKGR VAL EL SOILS; CHESTER R, 1973, NATURE, V245, P27, DOI 10.1038/245027b0; CSEPA (China State Environmental Protection Administration), 1995, 156181995 CSEPA GB; Darnley AG, 1995, J GEOCHEM EXPLOR, V55, P5, DOI 10.1016/0375-6742(95)00035-6; Desaules A, 2012, SCI TOTAL ENVIRON, V426, P120, DOI 10.1016/j.scitotenv.2012.03.035; Garrett RG, 1991, EXPL GEOCH WORKSH; Gowd SS, 2010, J HAZARD MATER, V174, P113, DOI 10.1016/j.jhazmat.2009.09.024; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hawkes H.E., 1962, GEOCHEMISTRY MINERAL; He J., 2005, SOIL BACKGROUND VALU; Hernandez L, 2003, SCI TOTAL ENVIRON, V312, P195, DOI 10.1016/S0048-9697(03)00223-7; Ikem A, 2008, ENVIRON MONIT ASSESS, V140, P69, DOI 10.1007/s10661-007-9848-2; ISO: International Organisation for Standardisation, 2005, SOIL QUAL VOC 1; Khalil A, 2013, J GEOCHEM EXPLOR, V125, P117, DOI 10.1016/j.gexplo.2012.11.018; Li XD, 2004, ENVIRON POLLUT, V129, P113, DOI 10.1016/j.envpol.2003.09.030; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Loska K, 1997, WATER AIR SOIL POLL, V93, P347, DOI 10.1023/A:1022121615949; Loska K, 2004, ENVIRON INT, V30, P159, DOI 10.1016/S0160-4120(03)00157-0; Luo XS, 2012, SCI TOTAL ENVIRON, V421, P17, DOI 10.1016/j.scitotenv.2011.04.020; Manta DS, 2002, SCI TOTAL ENVIRON, V300, P229, DOI 10.1016/S0048-9697(02)00273-5; MULLER G, 1979, UMSCHAU, V79, P778; Nathanail CP, 2001, HUMAN HLTH RISK ASSE, P85; Porteous A, 1996, DICT ENV SCI TECHNOL; Reimann C, 2000, ENVIRON SCI TECHNOL, V34, P5084, DOI 10.1021/es001339o; Reimann C, 2005, SCI TOTAL ENVIRON, V346, P1, DOI 10.1016/j.scitotenv.2004.11.023; Reimann C, 1998, CHEM ELEMENTS ENV FA, DOI DOI 10.1017/S0016756800264613; Salminen R, 2000, APPL GEOCHEM, V15, P647, DOI 10.1016/S0883-2927(99)00077-3; Sepulvado JG, 2011, ENVIRON SCI TECHNOL, V45, P8106, DOI 10.1021/es103903d; Shotyk W, 1997, WATER AIR SOIL POLL, V100, P297, DOI 10.1023/A:1018384711802; Sutherland RA, 1999, EARTH SURF PROC LAND, V24, P571, DOI 10.1002/(SICI)1096-9837(199907)24:7<571::AID-ESP975>3.0.CO;2-F; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Teng YG, 2014, ENVIRON INT, V69, P177, DOI 10.1016/j.envint.2014.04.014; Teng YG, 2010, J GEOCHEM EXPLOR, V104, P118, DOI 10.1016/j.gexplo.2010.01.006; Teng YG, 2009, ENVIRON GEOL, V57, P1649, DOI 10.1007/s00254-008-1446-2; USEPA: United States Environmental Protection Agency, 1992, 75B92001 USEPA; Utermann J., 2006, BACKGROUND VALUES EU; Vegter, 1998, RISK ASSESSMENT CONT, V1; Wang XQ, 2010, J SOIL SEDIMENT, V10, P827, DOI 10.1007/s11368-010-0196-4; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; Xie YF, 2011, CHEMOSPHERE, V82, P468, DOI 10.1016/j.chemosphere.2010.09.053; ZOLLER WH, 1974, SCIENCE, V183, P198, DOI 10.1126/science.183.4121.198	46	59	61	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112917	10.1371/journal.pone.0112917	http://dx.doi.org/10.1371/journal.pone.0112917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25397401	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500111
J	Fanslow, DA; Wirt, SE; Barker, JC; Connelly, JP; Porteus, MH; Dann, CT				Fanslow, Danielle A.; Wirt, Stacey E.; Barker, Jenny C.; Connelly, Jon P.; Porteus, Matthew H.; Dann, Christina Tenenhaus			Genome Editing in Mouse Spermatogonial Stem/Progenitor Cells Using Engineered Nucleases	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; GERMLINE STEM-CELLS; HOMOLOGOUS RECOMBINATION; GENE CORRECTION; DIRECT TRANSDIFFERENTIATION; PLURIPOTENT; CULTURE; TESTIS	Editing the genome to create specific sequence modifications is a powerful way to study gene function and promises future applicability to gene therapy. Creation of precise modifications requires homologous recombination, a very rare event in most cell types that can be stimulated by introducing a double strand break near the target sequence. One method to create a double strand break in a particular sequence is with a custom designed nuclease. We used engineered nucleases to stimulate homologous recombination to correct a mutant gene in mouse "GS'' (germline stem) cells, testicular derived cell cultures containing spermatogonial stem cells and progenitor cells. We demonstrated that gene-corrected cells maintained several properties of spermatogonial stem/progenitor cells including the ability to colonize following testicular transplantation. This proof of concept for genome editing in GS cells impacts both cell therapy and basic research given the potential for GS cells to be propagated in vitro, contribute to the germline in vivo following testicular transplantation or become reprogrammed to pluripotency in vitro.	[Fanslow, Danielle A.; Dann, Christina Tenenhaus] Indiana Univ, Dept Chem, Bloomington, IN USA; [Wirt, Stacey E.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Barker, Jenny C.; Connelly, Jon P.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA	Indiana University System; Indiana University Bloomington; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Porteus, MH (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	mporteus@stanford.edu; ctdann@indiana.edu		Barker, Jenny/0000-0002-1517-5124	Eunice Kennedy Shriver National Institute of Child Health and Human Development [1R21HD062853]; University of Texas Southwestern Medical Scientist Training Program; PhRMA Foundation Paul Calabresi Medical Student Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071081] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062853] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Texas Southwestern Medical Scientist Training Program; PhRMA Foundation Paul Calabresi Medical Student Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	D. F. and C. T. D. were supported by a grant from Eunice Kennedy Shriver National Institute of Child Health and Human Development (1R21HD062853), and J. B. was funded by the University of Texas Southwestern Medical Scientist Training Program and the PhRMA Foundation Paul Calabresi Medical Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Brenneman M, 1996, P NATL ACAD SCI USA, V93, P3608, DOI 10.1073/pnas.93.8.3608; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Chikhovskaya JV, 2012, HUM REPROD, V27, P210, DOI 10.1093/humrep/der383; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Connelly JP, 2010, MOL THER, V18, P1103, DOI 10.1038/mt.2010.57; Dann Christina Tenenhaus, 2013, Methods Mol Biol, V927, P503; Dann CT, 2008, STEM CELLS; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Falciatori Ilaria, 2008, V450, P181, DOI 10.1007/978-1-60327-214-8_13; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Heim C, 2011, REPROD TOXICOL, V31, P454, DOI 10.1016/j.reprotox.2010.12.056; Heim CN, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101717; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Iwamori N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038914; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P236, DOI 10.1095/biolreprod.104.035659; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Lim JJ, 2010, CELL PROLIFERAT, V43, P405, DOI 10.1111/j.1365-2184.2010.00691.x; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Oatley JM, 2008, ANN REV CELL DEV BIO; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Quintarelli C, 2007, BLOOD, V110, P2793, DOI 10.1182/blood-2007-02-072843; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Simon L, 2009, STEM CELLS, V27, P1666, DOI 10.1002/stem.93; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang ZZ, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-67; Zheng Y, 2014, HUM REPROD IN PRESS; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	53	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e112652	10.1371/journal.pone.0112652	http://dx.doi.org/10.1371/journal.pone.0112652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409432	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200031
J	Gandica, Y; Schwarz, T; Oliveira, O; Travasso, RDM				Gandica, Yerali; Schwarz, Tobias; Oliveira, Orlando; Travasso, Rui D. M.			Hypoxia in Vascular Networks: A Complex System Approach to Unravel the Diabetic Paradox	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; RETINAL BARRIER BREAKDOWN; ENDOTHELIAL GROWTH-FACTOR; FRACTAL ANALYSIS; BLOOD; ANGIOGENESIS; TRANSPORT; MODEL; ANGIOPOIETIN-2; QUANTIFICATION	In this work we model the extent of hypoxia in the diabetic retina as a function of the area affected by vessel disruption. We find two regimes that differ on the ratio between the area of disrupted vasculature and the area of tissue in hypoxia. In the first regime the hypoxia is localized in the vicinity of the vascular disruption, while in the second regime there is a generalized hypoxia in the affected tissue. The transition between these two regimes occurs when the tissue area affected by individual sites of vessel damage is on the order of the square of the characteristic irrigation length in the tissue (the maximum distance that an irrigated point in the tissue is from an existing vessel). We observe that very high levels of hypoxia are correlated with the rupture of larger vessels in the retina, and with smaller radii of individual sites of vessel damage. Based on this property of vascular networks, we propose a novel mechanism for the transition between the nonproliferative and the proliferative stages in diabetic retinopathy.	[Gandica, Yerali; Schwarz, Tobias; Oliveira, Orlando; Travasso, Rui D. M.] Univ Coimbra, Dept Phys, Ctr Computat Phys, Coimbra, Portugal; [Schwarz, Tobias] Heinz Brandt Schule, Berlin, Germany; [Travasso, Rui D. M.] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci, Ctr Ophthalmol & Vis Sci COCV, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Travasso, RDM (corresponding author), Univ Coimbra, Dept Phys, Ctr Computat Phys, Coimbra, Portugal.	rui@teor.fis.uc.pt	Travasso, Rui/B-8342-2018; GANDICA, YERALI/M-6261-2013; Oliveira, Orlando/M-3792-2013	Travasso, Rui/0000-0001-6078-0721; GANDICA, YERALI/0000-0002-6262-1801; Oliveira, Orlando/0000-0001-8266-3796	Fundos FEDER through Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e Tecnologia [FCOMP-01-0124-FEDER-015708, PEst-OE/FIS/UI0405/2014]; Fundacao para a Ciencia e Tecnologia through the Investigador FCT program	Fundos FEDER through Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia through the Investigador FCT program(Portuguese Foundation for Science and Technology)	Y.G., T.S. and R.D.M.T. acknowledge financial support from Fundos FEDER through Programa Operacional Factores de Competitividade - COMPETE and by Fundacao para a Ciencia e Tecnologia, through project FCOMP-01-0124-FEDER-015708. The authors acknowledge support from Fundacao para a Ciencia e Tecnologia through project PEst-OE/FIS/UI0405/2014. R.D.M.T. acknowledges financial support from Fundacao para a Ciencia e Tecnologia through the Investigador FCT program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2012, J MED SYST, V36, P2011, DOI 10.1007/s10916-011-9663-8; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Avakian A, 2002, CURR EYE RES, V24, P274, DOI 10.1076/ceyr.24.4.274.8411; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bearse MA, 2006, PROG RETIN EYE RES, V25, P425, DOI 10.1016/j.preteyeres.2006.07.001; Bento CF, 2010, EXP PHYSIOL, V95, P955, DOI 10.1113/expphysiol.2010.053561; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Costa C, 2011, VASCULOGENESIS ANGIO, P107; Dall'Asta L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/P04006; DAXER A, 1993, GRAEF ARCH CLIN EXP, V231, P681, DOI 10.1007/BF00919281; Fadini GP, 2006, DIABETES CARE, V29, P714, DOI 10.2337/diacare.29.03.06.dc05-1834; Flores J, 2010, J THEOR BIOL, V265, P599, DOI 10.1016/j.jtbi.2010.06.003; Flores J, 2013, J THEOR BIOL, V317, P257, DOI 10.1016/j.jtbi.2012.10.005; Formaggia Luca, 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P273, DOI 10.1080/10255840600857767; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gastner MT, 2006, EUR PHYS J B, V49, P247, DOI 10.1140/epjb/e2006-00046-8; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Guibert R, 2010, TRANSPORT POROUS MED, V83, P171, DOI 10.1007/s11242-009-9492-0; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hellums JD, 1996, ANN BIOMED ENG, V24, P1, DOI 10.1007/BF02770991; Herman AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022973; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; Milde F, 2013, INTEGR BIOL-UK, V5, P1426, DOI 10.1039/c3ib40085a; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Paul G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056130; Paul G, 2004, EUR PHYS J B, V38, P187, DOI 10.1140/epjb/e2004-00112-3; Pittman R.N., 2011, REGULATION TISSUE OX; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Reiter C, 2005, DIABETES, V54, pA222; Secomb TW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002983; Secomb TW, 2004, ANN BIOMED ENG, V32, P1519, DOI 10.1114/B:ABME.0000049036.08817.44; Shih AY, 2012, NAT NEUROSCI, V16, P55; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sivakumar R, 2005, J BIOMED BIOTECHNOL, P20, DOI 10.1155/JBB.2005.20; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Travasso RDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019989; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; Vespignani A, 2010, NATURE, V464, P984, DOI 10.1038/464984a; VINORES SA, 1990, J HISTOCHEM CYTOCHEM, V38, P1341, DOI 10.1177/38.9.2117624; VINORES SA, 1989, AM J PATHOL, V134, P231; West GB, 2000, SFI S SCI C, P87; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yun WL, 2008, INFORM SCIENCES, V178, P106, DOI 10.1016/j.ins.2007.07.020	57	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113165	10.1371/journal.pone.0113165	http://dx.doi.org/10.1371/journal.pone.0113165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409306	Green Published, Green Submitted, gold			2022-12-26	WOS:000345533200075
J	Gebauer, F; Wicklein, D; Horst, J; Sundermann, P; Maar, H; Streichert, T; Tachezy, M; Izbicki, JR; Bockhorn, M; Schumacher, U				Gebauer, Florian; Wicklein, Daniel; Horst, Jennifer; Sundermann, Philipp; Maar, Hanna; Streichert, Thomas; Tachezy, Michael; Izbicki, Jakob R.; Bockhorn, Maximilian; Schumacher, Udo			Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer	PLOS ONE			English	Article							PERITONEAL CARCINOMATOSIS; ADJUVANT CHEMOTHERAPY; FOLINIC ACID; EXPRESSION; ADENOCARCINOMA; GEMCITABINE; RESECTION; THERAPY; MODEL; GENE	Background: Aim of this study was to assess the biological function in tumor progression and metastatic process carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 in pancreatic adenocarcinoma (PDAC). Experimental Design: CEACAM knock down cells were established and assessed in vitro and in a subcutaneous and intraperitoneal mouse xenograft model. Tissue and serum expression of patients with PDAC were assessed by immunohistochemistry (IHC) and by enzyme linked immunosorbent assays. Results: Presence of lymph node metastasis was correlated with CEACAM 5 and 6 expression (determined by IHC) and tumor recurrence exclusively with CEACAM 6. Patients with CEACAM 5 and 6 expression showed a significantly shortened OS in Kaplan-Meier survival analyses. Elevated CEACAM6 serum values showed a correlation with distant metastasis and. Survival analysis revealed a prolonged OS for patients with low serum CEACAM 1 values. In vitro proliferation and migration capacity was increased in CEACAM knock down PDAC cells, however, mice inoculated with CEACAM knock down cells showed a prolonged overall-survival (OS). The number of spontaneous pulmonary metastasis was increased in the CEACAM knock down group. Conclusion: The effects mediated by CEACAM expression in PDAC are complex, though overexpression is correlated with loco-regional aggressive tumor growth. However, loss of CEACAM can be considered as a part of epithelial-mesenchymal transition and is therefore of rather importance in the process of distant metastasis.	[Gebauer, Florian; Sundermann, Philipp; Tachezy, Michael; Izbicki, Jakob R.; Bockhorn, Maximilian] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Gebauer, Florian; Wicklein, Daniel; Horst, Jennifer; Maar, Hanna; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany; [Gebauer, Florian; Wicklein, Daniel; Horst, Jennifer; Maar, Hanna; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hamburg, Germany; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gebauer, F (corresponding author), Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany.	fgebauer@uke.uni-hamburg.de	Tachezy, Michael/AAD-6759-2022					Alexakis N, 2004, BRIT J SURG, V91, P1410, DOI 10.1002/bjs.4794; Arabzadeh A., 2012, ONCOGENE; Beauchemin N, 1999, EXP CELL RES, V252, P243; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Blumenthal RD, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-2; Chen ZG, 2011, J EXP MED, V208, P2633, DOI 10.1084/jem.20102575; Dancau AM, 2010, METHODS MOL BIOL, V576, P49, DOI 10.1007/978-1-59745-545-9_4; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; Duxbury MS, 2005, ANN SURG, V241, P491, DOI 10.1097/01.sla.0000154455.86404.e9; Duxbury MS, 2004, ANN SURG, V240, P667, DOI 10.1097/01.sla.0000140755.97224.9a; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Duxbury MS, 2004, ONCOGENE, V23, P5834, DOI 10.1038/sj.onc.1207775; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V317, P837, DOI 10.1016/j.bbrc.2004.03.128; Gebauer F, 2013, GUT, V62, P741, DOI 10.1136/gutjnl-2011-300629; Gebauer F, 2011, J SURG ONCOL, V104, P140, DOI 10.1002/jso.21957; Gerstel D, 2011, ONCOGENE, V30, P4275, DOI 10.1038/onc.2011.146; GOLD P, 1965, J EXP MED, V122, P467, DOI 10.1084/jem.122.3.467; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Heine M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028030; HOCKEY MS, 1984, BRIT J CANCER, V49, P129, DOI 10.1038/bjc.1984.24; Horst AK, 2004, HANDB EXP PHARM, V165, P283, DOI 10.1007/978-3-540-68170-0_10; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Huang SY, 1996, CLIN CANCER RES, V2, P1969; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Lange T, 2012, CLIN CANCER RES, V18, P1364, DOI 10.1158/1078-0432.CCR-11-2900; Loos M, 2008, ANN NY ACAD SCI, V1138, P169, DOI 10.1196/annals.1414.024; Nehmann N, 2010, ACTA HISTOCHEM, V112, P489, DOI 10.1016/j.acthis.2009.05.004; Neoptolemos JP, 2009, BRIT J CANCER, V100, P246, DOI 10.1038/sj.bjc.6604838; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; ONA FV, 1973, CANCER, V31, P324, DOI 10.1002/1097-0142(197302)31:2<324::AID-CNCR2820310208>3.0.CO;2-Y; Portilla AG, 1999, WORLD J SURG, V23, P23, DOI 10.1007/s002689900560; Scholzel S, 2000, AM J PATHOL, V156, P595, DOI 10.1016/S0002-9440(10)64764-5; Serra S, 2009, APPL IMMUNOHISTO M M, V17, P286, DOI 10.1097/PAI.0b013e318196e13c; Simeone DM, 2007, PANCREAS, V34, P436, DOI 10.1097/MPA.0b013e3180333ae3; Simon R, 2010, METHODS MOL BIOL, V664, P113, DOI 10.1007/978-1-60761-806-5_12; Skubitz KM, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-78; Sperti C, 1997, WORLD J SURG, V21, P195, DOI 10.1007/s002689900215; STOFFEL A, 1993, J IMMUNOL, V150, P4978; Strickland LA, 2009, J PATHOL, V218, P380, DOI 10.1002/path.2545; Tachezy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039018; Thies A, 2002, J CLIN ONCOL, V20, P2530, DOI 10.1200/JCO.2002.05.033; Thom I, 2009, ANTICANCER RES, V29, P249; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Thompson JA, 1997, INT J CANCER, V72, P197, DOI 10.1002/(SICI)1097-0215(19970703)72:1<197::AID-IJC28>3.0.CO;2-F; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Wicklein Daniel, 2012, Methods Mol Biol, V878, P241, DOI 10.1007/978-1-61779-854-2_16; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wright P F, 1993, Rev Sci Tech, V12, P435; Xie SH, 1997, CANCER RES, V57, P2295; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	55	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113023	10.1371/journal.pone.0113023	http://dx.doi.org/10.1371/journal.pone.0113023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409014	Green Submitted, Green Published, gold			2022-12-26	WOS:000345533200058
J	Henning, Y; Vole, C; Begall, S; Bens, M; Broecker-Preuss, M; Sahm, A; Szafranski, K; Burda, H; Dammann, P				Henning, Yoshiyuki; Vole, Christiane; Begall, Sabine; Bens, Martin; Broecker-Preuss, Martina; Sahm, Arne; Szafranski, Karol; Burda, Hynek; Dammann, Philip			Unusual Ratio between Free Thyroxine and Free Triiodothyronine in a Long-Lived Mole-Rat Species with Bimodal Ageing	PLOS ONE			English	Article							CONE OPSIN EXPRESSION; THYROID-HORMONE; TRANSCRIPTIONAL REGULATION; MATERNAL HYPOTHYROXINEMIA; PHYLOGENETIC ANALYSIS; SUBTERRANEAN RODENTS; DWARF MICE; LONGEVITY; SENSITIVITY; ENERGETICS	Ansell's mole-rats (Fukomys anselli) are subterranean, long-lived rodents, which live in eusocial families, where the maximum lifespan of breeders is twice as long as that of non-breeders. Their metabolic rate is significantly lower than expected based on allometry, and their retinae show a high density of S-cone opsins. Both features may indicate naturally low thyroid hormone levels. In the present study, we sequenced several major components of the thyroid hormone pathways and analyzed free and total thyroxine and triiodothyronine in serum samples of breeding and non-breeding F. anselli to examine whether a) their thyroid hormone system shows any peculiarities on the genetic level, b) these animals have lower hormone levels compared to euthyroid rodents (rats and guinea pigs), and c) reproductive status, lifespan and free hormone levels are correlated. Genetic analyses confirmed that Ansell's mole-rats have a conserved thyroid hormone system as known from other mammalian species. Interspecific comparisons revealed that free thyroxine levels of F. anselli were about ten times lower than of guinea pigs and rats, whereas the free triiodothyronine levels, the main biologically active form, did not differ significantly amongst species. The resulting fT4:fT3 ratio is unusual for a mammal and potentially represents a case of natural hypothyroxinemia. Comparisons with total thyroxine levels suggest that mole-rats seem to possess two distinct mechanisms that work hand in hand to downregulate fT4 levels reliably. We could not find any correlation between free hormone levels and reproductive status, gender or weight. Free thyroxine may slightly increase with age, based on sub-significant evidence. Hence, thyroid hormones do not seem to explain the different ageing rates of breeders and non-breeders. Further research is required to investigate the regulatory mechanisms responsible for the unusual proportion of free thyroxine and free triiodothyronine.	[Henning, Yoshiyuki; Vole, Christiane; Begall, Sabine; Burda, Hynek; Dammann, Philip] Univ Duisburg Essen, Fac Biol, Dept Gen Zool, Essen, Germany; [Bens, Martin; Sahm, Arne; Szafranski, Karol] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Broecker-Preuss, Martina] Univ Duisburg Essen, Univ Hosp, Dept Endocrinol & Metab, Essen, Germany; [Broecker-Preuss, Martina] Univ Duisburg Essen, Univ Hosp, Div Lab Res, Essen, Germany; [Dammann, Philip] Univ Duisburg Essen, Univ Hosp, Cent Anim Lab, Essen, Germany	University of Duisburg Essen; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Henning, Y (corresponding author), Univ Duisburg Essen, Fac Biol, Dept Gen Zool, Essen, Germany.	yoshiyuki.henning@uni-due.de	Sahm, Arne/AAG-3842-2019	Sahm, Arne/0000-0002-7330-1790; Bens, Martin/0000-0001-7940-6668; Henning, Yoshiyuki/0000-0002-0166-2204	German Research Foundation (DFG) [DA 992/3-1]; "Publish Open Access''-Program of the University of Duisburg-Essen; German Research Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); "Publish Open Access''-Program of the University of Duisburg-Essen; German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant of the German Research Foundation to PD (DFG-grant DA 992/3-1) (http://www.dfg.de/). The publication fee was funded by the "Publish Open Access''-Program of the University of Duisburg-Essen and the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avivi A, 2005, FASEB J, V19, P1314, DOI 10.1096/fj.04-3414fje; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BAUCH K, 1986, ENDOCRINOL EXP, V20, P67; Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3; Becker NI, 2013, ECOL RES, V28, P249, DOI 10.1007/s11284-012-1010-0; Bianco AC, 2005, THYROID, V15, P777, DOI 10.1089/thy.2005.15.777; Bowers J, 2013, ENDOCR REV, V34, P556, DOI 10.1210/er.2012-1056; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2001, AM J PHYSIOL-REG I, V280, pR149, DOI 10.1152/ajpregu.2001.280.1.R149; Burda H, 2000, BEHAV ECOL SOCIOBIOL, V47, P293, DOI 10.1007/s002650050669; CamposBarros A, 1997, J NEUROCHEM, V68, P795; Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P4128, DOI 10.1210/en.2012-1467; CRANTZ FR, 1980, J CLIN INVEST, V65, P935, DOI 10.1172/JCI109749; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Dammann P, 2011, J GERONTOL A-BIOL, V67, P573; Dammann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018757; Darras VM, 2009, GEN COMP ENDOCR, V163, P58, DOI 10.1016/j.ygcen.2008.11.014; DAVIES DT, 1993, COMP HAEMATOL INT, V3, P142, DOI 10.1007/BF00186098; Dong H, 2014, CEREBRAL CORTEX; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; Edward DA, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P137; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Gesing A, 2012, THYROID RES, V5, P1; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; Glaschke A, 2010, INVEST OPHTH VIS SCI, V51, P1719, DOI 10.1167/iovs.09-3592; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harvey CB, 2002, THYROID, V12, P441, DOI 10.1089/105072502760143791; Hoff J, 2000, LAB ANIMAL, V29, P47; Hood A, 1999, TOXICOL SCI, V49, P263, DOI 10.1093/toxsci/49.2.263; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P623, DOI 10.1016/B978-0-12-370491-7.00020-9; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Kelly G S, 2000, Altern Med Rev, V5, P306; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kott O, 2014, J ZOOL, V294, P67, DOI 10.1111/jzo.12152; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; LOVEGROVE BG, 1986, OECOLOGIA, V69, P551, DOI 10.1007/BF00410361; Ma C, 2009, NUCL MED COMMUN, V30, P586, DOI 10.1097/MNM.0b013e32832c79e0; MARHOLD S, 1995, J COMP PHYSIOL B, V164, P636, DOI 10.1007/BF00389805; Moeller LC, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S6; Moeller LC, 2005, MOL ENDOCRINOL, V19, P2955, DOI 10.1210/me.2004-0542; Monnier V.M., 1989, Progress in Clinical and Biological Research, V304, P1; Montero AG, 2015, VET ANAESTH ANALG, V42, P187, DOI 10.1111/vaa.12180; Moreno M, 1997, J PHYSIOL-LONDON, V505, P529, DOI 10.1111/j.1469-7793.1997.529bb.x; Muller K, 2009, VET CLIN PATH, V38, P507, DOI 10.1111/j.1939-165X.2009.00159.x; Negro R, 2011, ENDOCR PRACT, V17, P422, DOI 10.4158/EP10309.RA; OOKA H, 1983, MECH AGEING DEV, V22, P113, DOI 10.1016/0047-6374(83)90104-5; OOKA H, 1986, MECH AGEING DEV, V33, P275, DOI 10.1016/0047-6374(86)90052-7; Opazo MC, 2008, ENDOCRINOLOGY, V149, P5097, DOI 10.1210/en.2008-0560; Otto T, 2008, ENDOCRINOLOGY, V149, P2241, DOI 10.1210/en.2007-1238; Peeters RP, 2008, HORM-INT J ENDOCRINO, V7, P28, DOI 10.14310/horm.2002.1111035; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Pohlenz J, 1999, THYROID, V9, P1265, DOI 10.1089/thy.1999.9.1265; Refetoff S, 1996, J CLIN ENDOCR METAB, V81, P3335; Roman GC, 2013, ANN NEUROL, V74, P733, DOI 10.1002/ana.23976; Rozing MP, 2010, J CLIN ENDOCR METAB, V95, P4979, DOI 10.1210/jc.2010-0875; SAVU L, 1992, ACTA MED AUST, V19, P88; Schmidt CM, 2013, AFR ZOOL, V48, P193; Schussler GC, 2000, THYROID, V10, P141, DOI 10.1089/thy.2000.10.141; SHUPNIK MA, 1985, J BIOL CHEM, V260, P2900; Storey NM, 2006, P NATL ACAD SCI USA, V103, P5197, DOI 10.1073/pnas.0600089103; Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244; Visser WE, 2008, TRENDS ENDOCRIN MET, V19, P50, DOI 10.1016/j.tem.2007.11.003; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zelova J, 2007, COMP BIOCHEM PHYS A, V147, P412, DOI 10.1016/j.cbpa.2007.01.002; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439	77	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113698	10.1371/journal.pone.0113698	http://dx.doi.org/10.1371/journal.pone.0113698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409169	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200144
J	Ju, JY; Li, RS; Gu, SC; Leader, JK; Wang, XH; Chen, YH; Zheng, B; Wu, SD; Gur, D; Sciurba, F; Pu, JT				Ju, Jieyang; Li, Ruosha; Gu, Suicheng; Leader, Joseph K.; Wang, Xiaohua; Chen, Yahong; Zheng, Bin; Wu, Shandong; Gur, David; Sciurba, Frank; Pu, Jiantao			Impact of Emphysema Heterogeneity on Pulmonary Function	PLOS ONE			English	Article							REGIONAL-DISTRIBUTION; LUNG; CT; COPD; PHYSIOLOGY	Objectives: To investigate the association between emphysema heterogeneity in spatial distribution, pulmonary function and disease severity. Methods and Materials: We ascertained a dataset of anonymized Computed Tomography (CT) examinations acquired on 565 participants in a COPD study. Subjects with chronic bronchitis (CB) and/or bronchodilator response were excluded resulting in 190 cases without COPD and 160 cases with COPD. Low attenuations areas (LAAs) (<= 950 Hounsfield Unit (HU)) were identified and quantified at the level of individual lobes. Emphysema heterogeneity was defined in a manner that ranged in value from -100% to 100%. The association between emphysema heterogeneity and pulmonary function measures (e. g., FEV1% predicted, RV/TLC, and DLco% predicted) adjusted for age, sex, and smoking history (pack-years) was assessed using multiple linear regression analysis. Results: The majority (128/160) of the subjects with COPD had a heterogeneity greater than zero. After adjusting for age, gender, smoking history, and extent of emphysema, heterogeneity in depicted disease in upper lobe dominant cases was positively associated with pulmonary function measures, such as FEV1 Predicted (p<.001) and FEV1/FVC (p<.001), as well as disease severity (p<0.05). We found a negative association between HI%, RV/TLC (p<0.001), and DLco% (albeit not a statistically significant one, p = 0.06) in this group of patients. Conclusion: Subjects with more homogeneous distribution of emphysema and/or lower lung dominant emphysema tend to have worse pulmonary function.	[Ju, Jieyang; Gu, Suicheng; Leader, Joseph K.; Wu, Shandong; Gur, David; Pu, Jiantao] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Li, Ruosha] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Wang, Xiaohua; Chen, Yahong] Peking Univ, Affiliated Hosp 3, Beijing 100871, Peoples R China; [Zheng, Bin] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA; [Sciurba, Frank] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Pu, Jiantao] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peking University; University of Oklahoma System; University of Oklahoma - Norman; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pu, JT (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	puj@upmc.edu	Sciurba, Frank/AAZ-9339-2021; Zheng, Bin/HGU-5316-2022	sciurba, frank/0000-0001-7468-2225; Zheng, Bin/0000-0002-7682-6648	National Institutes of Health [RO1 HL096613]; Bonnie J. Addario Lung Cancer Foundation; National Health and Family Planning Commission of the R.R. China [201402013]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bonnie J. Addario Lung Cancer Foundation; National Health and Family Planning Commission of the R.R. China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by grants from the National Institutes of Health (RO1 HL096613), the Bonnie J. Addario Lung Cancer Foundation, and the National Health and Family Planning Commission of the R.R. China (No. 201402013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Boschetto P, 2003, EUR RESPIR J, V21, P450, DOI 10.1183/09031936.03.00048703; Castaldi PJ, 2013, AM J RESP CRIT CARE, V188, P1083, DOI 10.1164/rccm.201305-0873OC; DeMeo DL, 2007, AM J RESP CRIT CARE, V176, P42, DOI 10.1164/rccm.200612-1797OC; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Gietema HA, 2010, RESP MED, V104, P76, DOI 10.1016/j.rmed.2009.08.004; GURNEY JW, 1992, RADIOLOGY, V183, P457, DOI 10.1148/radiology.183.2.1561350; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Haraguchi M, 1998, RESPIRATION, V65, P125, DOI 10.1159/000029243; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Holme J, 2007, CHEST, V132, P909, DOI 10.1378/chest.07-0341; Ito I, 2005, AM J RESP CRIT CARE, V172, P1378, DOI 10.1164/rccm.200506-953OC; LEOPOLD J. G., 1957, THORAX, V12, P219, DOI 10.1136/thx.12.3.219; Minai Omar A, 2008, Proc Am Thorac Soc, V5, P468, DOI 10.1513/pats.200802-018ET; Nakano Y, 2001, AM J RESP CRIT CARE, V164, P2195, DOI 10.1164/ajrccm.164.12.2012140; Parr DG, 2004, AM J RESP CRIT CARE, V170, P1172, DOI 10.1164/rccm.200406-761OC; Pauls S, 2010, CLIN IMAG, V34, P172, DOI 10.1016/j.clinimag.2009.05.004; Pu J, 2008, COMPUT MED IMAG GRAP, V32, P452, DOI 10.1016/j.compmedimag.2008.04.005; Pu JT, 2009, IEEE T MED IMAGING, V28, P1986, DOI 10.1109/TMI.2009.2027117; Pu JT, 2009, IEEE T MED IMAGING, V28, P710, DOI 10.1109/TMI.2008.2010441; Stolk J, 2011, AM J RESP CRIT CARE, V183, P1578, DOI 10.1164/rccm.201104-0615ED; Tanabe N, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-31; Wang ZM, 2013, EUR RADIOL, V23, P975, DOI 10.1007/s00330-012-2683-z; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Yuan R, 2009, THORAX, V64, P944, DOI 10.1136/thx.2008.112433; Zulueta JJ, 2012, CHEST, V141, P1216, DOI 10.1378/chest.11-0101	26	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113320	10.1371/journal.pone.0113320	http://dx.doi.org/10.1371/journal.pone.0113320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409328	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000345533200095
J	Zanke, CD; Ling, J; Plieske, J; Kollers, S; Ebmeyer, E; Korzun, V; Argillier, O; Stiewe, G; Hinze, M; Neumann, K; Ganal, MW; Roder, MS				Zanke, Christine D.; Ling, Jie; Plieske, Joerg; Kollers, Sonja; Ebmeyer, Erhard; Korzun, Viktor; Argillier, Odile; Stiewe, Gunther; Hinze, Maike; Neumann, Kerstin; Ganal, Martin W.; Roeder, Marion S.			Whole Genome Association Mapping of Plant Height in Winter Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DWARFING GENE RHT8; GREEN-REVOLUTION; WIDE ASSOCIATION; CHROMOSOME 2D; KERNEL NUMBER; GRAIN-YIELD; GIBBERELLIN; RICE; BARLEY	The genetic architecture of plant height was investigated in a set of 358 recent European winter wheat varieties plus 14 spring wheat varieties based on field data in eight environments. Genotyping of diagnostic markers revealed the Rht-D1b mutant allele in 58% of the investigated varieties, while the Rht-B1b mutant was only present in 7% of the varieties. Rht-D1 was significantly associated with plant height by using a mixed linear model and employing a kinship matrix to correct for population stratification. Further genotyping data included 732 microsatellite markers, resulting in 770 loci, of which 635 markers were placed on the ITMI map plus a set of 7769 mapped SNP markers genotyped with the 90 k iSELECT chip. When Bonferroni correction was applied, a total of 153 significant marker-trait associations (MTAs) were observed for plant height and the SSR markers (-log(10) (P-value) >= 4.82) and 280 (-log(10) (P-value) >= 5.89) for the SNPs. Linear regression between the most effective markers and the BLUEs for plant height indicated additive effects for the MTAs of different chromosomal regions. Analysis of syntenic regions in the rice genome revealed closely linked rice genes related to gibberellin acid (GA) metabolism and perception, i.e. GA20 and GA2 oxidases orthologous to wheat chromosomes 1A, 2A, 3A, 3B, 5B, 5D and 7B, ent-kaurenoic acid oxidase orthologous to wheat chromosome 7A, ent-kaurene synthase on wheat chromosome 2B, as well as GA-receptors like DELLA genes orthologous to wheat chromosomes 4B, 4D and 7A and genes of the GID family orthologous to chromosomes 2B and 5B. The data indicated that besides the widely used GA-insensitive dwarfing genes Rht-B1 and Rht-D1 there is a wide spectrum of loci available that could be used for modulating plant height in variety development.	[Zanke, Christine D.; Ling, Jie; Neumann, Kerstin; Roeder, Marion S.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Plieske, Joerg; Ganal, Martin W.] TraitGenet GmbH, Gatersleben, Germany; [Kollers, Sonja; Ebmeyer, Erhard; Korzun, Viktor] KWS LOCHOW GMBH, Bergen, Germany; [Argillier, Odile] Syngenta France SAS, Orgerus, France; [Stiewe, Gunther; Hinze, Maike] Syngenta Seeds GmbH, Bad Salzuflen, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; KWS Saat AG; Syngenta; Syngenta	Roder, MS (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany.	roder@ipk-gatersleben.de	Korzun, Viktor/U-6352-2019	Korzun, Viktor/0000-0003-0760-8249; Neumann, Kerstin/0000-0001-7451-7086; Roder, Marion/0000-0002-9313-0650; Ling, Jie/0000-0001-7054-5119	German Federal Ministry of Education and Research (BMBF) [0315067, 0315947]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was funded by the Plant Biotechnology program of the German Federal Ministry of Education and Research (BMBF) within the frame of the projects GABI-Wheat and VALID (project numbers 0315067 and 0315947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Barboza L, 2013, P NATL ACAD SCI USA, V110, P15818, DOI 10.1073/pnas.1314979110; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Borner A, 1997, THEOR APPL GENET, V95, P1133, DOI 10.1007/s001220050673; BORNER A, 1993, PLANT BREEDING, V111, P204, DOI 10.1111/j.1439-0523.1993.tb00631.x; Brown PJ, 2008, GENETICS, V180, P629, DOI 10.1534/genetics.108.092239; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chandler PM, 2013, J EXP BOT, V64, P1603, DOI 10.1093/jxb/ert022; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Ellis MH, 2005, THEOR APPL GENET, V111, P423, DOI 10.1007/s00122-005-2008-6; Ellis MH, 2004, FUNCT PLANT BIOL, V31, P583, DOI 10.1071/FP03207; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Griffiths S, 2012, MOL BREEDING, V29, P159, DOI 10.1007/s11032-010-9534-x; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Jain M, 2006, GENOMICS, V88, P360, DOI 10.1016/j.ygeno.2006.04.008; Jia QJ, 2011, THEOR APPL GENET, V122, P1451, DOI 10.1007/s00122-011-1544-5; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Khlestkina EK, 2010, MOL BREEDING, V25, P251, DOI 10.1007/s11032-009-9326-3; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Kollers S, 2014, MOL BREEDING, V34, P363, DOI 10.1007/s11032-014-0039-x; Kollers S, 2013, MOL BREEDING, V32, P411, DOI 10.1007/s11032-013-9880-6; Kollers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057500; Korzun V, 1997, PLANT BREEDING, V116, P227, DOI 10.1111/j.1439-0523.1997.tb00987.x; Korzun V, 1998, THEOR APPL GENET, V96, P1104, DOI 10.1007/s001220050845; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Linkiewicz AM, 2004, GENETICS, V168, P665, DOI 10.1534/genetics.104.034835; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matthies IE, 2009, MOL BREEDING, V23, P139, DOI 10.1007/s11032-008-9221-3; Matthies IE, 2012, MOL BREEDING, V30, P951, DOI 10.1007/s11032-011-9678-3; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Parvathaneni RK, 2013, G3-GENES GENOM GENET, V3, P563, DOI 10.1534/g3.113.005587; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pestsova E, 2002, THEOR APPL GENET, V106, P84, DOI 10.1007/s00122-002-0998-x; PESTSOVA EG, 2008, CEREAL RES COMMUN, V36, P235; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rebetzke GJ, 2000, AUST J AGR RES, V51, P235, DOI 10.1071/AR99043; Rebetzke GJ, 2001, AUST J AGR RES, V52, P1221, DOI 10.1071/AR01042; Roder MS, 1998, GENETICS, V149, P2007; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Spielmeyer W, 2004, THEOR APPL GENET, V109, P1303, DOI 10.1007/s00122-004-1745-2; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tosovic-Maric B., 2008, GENETIKA, V40, P31, DOI [10.2298/GENSR0801031T, DOI 10.2298/GENSR0801031T]; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Wilhelm EP, 2013, THEOR APPL GENET, V126, P2233, DOI 10.1007/s00122-013-2130-9; Wilhelm EP, 2013, THEOR APPL GENET, V126, P1733, DOI 10.1007/s00122-013-2088-7; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; WINKLER RG, 1995, PLANT CELL, V7, P1307, DOI 10.1105/tpc.7.8.1307; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; Zanke C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00217; Zhang B, 2013, MOL BREEDING, V32, P327, DOI 10.1007/s11032-013-9873-5; Zhang JJ, 2013, MOL BREEDING, V32, P771, DOI 10.1007/s11032-013-9905-1; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1	73	108	111	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113287	10.1371/journal.pone.0113287	http://dx.doi.org/10.1371/journal.pone.0113287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405621	Green Published, Green Submitted, gold			2022-12-26	WOS:000347121300096
J	Dwivedi, S; Wahab, R; Khan, F; Mishra, YK; Musarrat, J; Al-Khedhairy, AA				Dwivedi, Sourabh; Wahab, Rizwan; Khan, Farheen; Mishra, Yogendra K.; Musarrat, Javed; Al-Khedhairy, Abdulaziz A.			Reactive Oxygen Species Mediated Bacterial Biofilm Inhibition via Zinc Oxide Nanoparticles and Their Statistical Determination	PLOS ONE			English	Article							ZNO; GROWTH	The formation of bacterial biofilm is a major challenge in clinical applications. The main aim of this study is to describe the synthesis, characterization and biocidal potential of zinc oxide nanoparticles (NPs) against bacterial strain Pseudomonas aeruginosa. These nanoparticles were synthesized via soft chemical solution process in a very short time and their structural properties have been investigated in detail by using X-ray diffraction and transmission electron microscopy measurements. In this work, the potential of synthesized ZnO-NPs (similar to 10-15 nm) has been assessed in-vitro inhibition of bacteria and the formation of their biofilms was observed using the tissue culture plate assays. The crystal violet staining on biofilm formation and its optical density revealed the effect on biofilm inhibition. The NPs at a concentration of 100 mg/mL significantly inhibited the growth of bacteria and biofilm formation. The biofilm inhibition by ZnO-NPs was also confirmed via bio-transmission electron microscopy (Bio-TEM). The Bio-TEM analysis of ZnO-NPs treated bacteria confirmed the deformation and damage of cells. The bacterial growth in presence of NPs concluded the bactericidal ability of NPs in a concentration dependent manner. It has been speculated that the antibacterial activity of NPs as a surface coating material, could be a feasible approach for controlling the pathogens. Additionally, the obtained bacterial solution data is also in agreement with the results from statistical analytical methods.	[Dwivedi, Sourabh; Wahab, Rizwan; Al-Khedhairy, Abdulaziz A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Khan, Farheen] Aligarh Muslim Univ, Dept Chem, Aligarh 202002, Uttar Pradesh, India; [Mishra, Yogendra K.] Univ Kiel, Inst Mat Sci, Kiel, Germany; [Musarrat, Javed] Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh 202002, Uttar Pradesh, India	King Saud University; Aligarh Muslim University; University of Kiel; Aligarh Muslim University	Wahab, R (corresponding author), King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia.	rwahab@ksu.edu.sa	Dwivedi, Sourabh/I-2060-2013; Al-Khedhairy, Abdulaziz A A/F-8327-2011; Wahab, Rizwan/ABF-3961-2020; Khan, Farheen/ABF-4968-2020; Mishra, Yogendra Kumar/G-6241-2010; Musarrat, Javed/N-4094-2019; Musarrat, Javed/I-1942-2013	Al-Khedhairy, Abdulaziz A A/0000-0002-1210-6262; Wahab, Rizwan/0000-0003-0340-3844; Mishra, Yogendra Kumar/0000-0002-8786-9379; dwivedi, sourabh/0000-0002-7591-5358; Wahab, Razak/0000-0002-7167-8201; Musarrat, Javed/0000-0001-5981-3813; Khan, Farheen/0000-0003-0158-0791	Deanship of Scientific Research at King Saud University [RGP-218]	Deanship of Scientific Research at King Saud University(King Saud University)	Rizwan Wahab would like to extend the appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project no. RGP-218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneesh PM, 2007, PROC SPIE, V6639, DOI 10.1117/12.730364; [Anonymous], HARM TRIP GUID VAL A; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Baghbamidi SE, 2012, J ANAL METHODS CHEM, V2012, DOI 10.1155/2012/305872; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Contado C, 2008, ANAL CHEM, V80, P7594, DOI 10.1021/ac8012626; Cullity B.D., 1978, ANSWERS PROBLEMS ELE; Dwivedi S, 2012, SCI TOTAL ENVIRON, V437, P331, DOI 10.1016/j.scitotenv.2012.08.004; Dwivedi S, 2011, J HAZARD MATER, V185, P938, DOI 10.1016/j.jhazmat.2010.09.110; Eshed M, 2012, LANGMUIR, V28, P12288, DOI 10.1021/la301432a; FLETCHER M, 1988, J BACTERIOL, V170, P2027, DOI 10.1128/jb.170.5.2027-2030.1988; Hernandez-Sierra JF, 2008, NANOMED-NANOTECHNOL, V4, P237, DOI 10.1016/j.nano.2008.04.005; FRESTA M, 1995, J PHARM SCI, V84, P895, DOI 10.1002/jps.2600840721; Hamouda T, 1999, J INFECT DIS, V180, P1939, DOI 10.1086/315124; Hernandez-Delgadillo Rene, 2012, Int J Nanomedicine, V7, P2109, DOI 10.2147/IJN.S29854; Khan ST, 2013, ARCH ORAL BIOL, V58, P1804, DOI 10.1016/j.archoralbio.2013.09.011; Kierek-Pearscon K, 2005, ADV APPL MICROBIOL, V57, P79, DOI 10.1016/S0065-2164(05)57003-5; Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Ng SM, 2013, ANAL LETT, V46, P1278, DOI 10.1080/00032719.2012.760100; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Ravikumar S., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P92, DOI 10.1016/S2221-1691(11)60199-8; Segets D, 2009, ACS NANO, V3, P1703, DOI 10.1021/nn900223b; Wahab R, 2007, MATER RES BULL, V42, P1640, DOI 10.1016/j.materresbull.2006.11.035; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2013, COLLOID SURFACE B, V111, P211, DOI 10.1016/j.colsurfb.2013.06.003; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wahab R, 2013, CHEM ENG J, V226, P154, DOI 10.1016/j.cej.2013.02.128; Wahab R, 2010, NANOSCALE RES LETT, V5, P1675, DOI 10.1007/s11671-010-9694-y; Wahab R, 2010, APPL MICROBIOL BIOT, V87, P1917, DOI 10.1007/s00253-010-2692-2; Wahab R, 2009, SYNTHETIC MET, V159, P2443, DOI 10.1016/j.synthmet.2009.08.006; Yanez-Sedeno P, 2010, TRAC-TREND ANAL CHEM, V29, P939, DOI 10.1016/j.trac.2010.06.006	36	211	213	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e111289	10.1371/journal.pone.0111289	http://dx.doi.org/10.1371/journal.pone.0111289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402188	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700014
J	Jung, H; Jung, J; Kim, SK; Woo, SH; Kang, KM; Jeong, BK; Jung, MH; Kim, JH; Hahm, JR				Jung, Jung Hwa; Jung, Jaehoon; Kim, Soo Kyoung; Woo, Seung Hoon; Kang, Ki Mun; Jeong, Bae-Kwon; Jung, Myeong Hee; Kim, Jin Hyun; Hahm, Jong Ryeal			Alpha Lipoic Acid Attenuates Radiation-Induced Thyroid Injury in Rats	PLOS ONE			English	Article							SYMPTOMATIC DIABETIC POLYNEUROPATHY; X-IRRADIATION; VITAMIN-A; TGF-BETA; RADIOTHERAPY; DYSFUNCTION; HYPOTHYROIDISM; ANTIOXIDANTS; EXPRESSION; PROTECTION	Exposure of the thyroid to radiation during radiotherapy of the head and neck is often unavoidable. The present study aimed to investigate the protective effect of alpha-lipoic acid (ALA) on radiation-induced thyroid injury in rats. Rats were randomly assigned to four groups: healthy controls (CTL), irradiated (RT), received ALA before irradiation (ALA + RT), and received ALA only (ALA, 100 mg/kg, i.p.). ALA was treated at 24 h and 30 minutes prior to irradiation. The neck area including the thyroid gland was evenly irradiated with 2 Gy per minute (total dose of 18 Gy) using a photon 6-MV linear accelerator. Greater numbers of abnormal and unusually small follicles in the irradiated thyroid tissues were observed compared to the controls and the ALA group on days 4 and 7 after irradiation. However, all pathologies were decreased by ALA pretreatment. The quantity of small follicles in the irradiated rats was greater on day 7 than day 4 after irradiation. However, in the ALA-treated irradiated rats, the numbers of small and medium follicles were significantly decreased to a similar degree as in the control and ALA-only groups. The PAS-positive density of the colloid in RT group was decreased significantly compared with all other groups and reversed by ALA pretreatment. The high activity index in the irradiated rats was lowered by ALA treatment. TGF-beta 1 immunoreactivity was enhanced in irradiated rats and was more severe on the day 7 after radiation exposure than on day 4. Expression of TGF-beta 1 was reduced in the thyroid that had undergone ALA pretreatment. Levels of serum pro-inflammatory cytokines (TNF-alpha, IL-1 beta and IL-6) did not differ significantly between the all groups. This study provides that pretreatment with ALA decreased the severity of radiation-induced thyroid injury by reducing inflammation and fibrotic infiltration and lowering the activity index. Thus, ALA could be used to ameliorate radiation-induced thyroid injury.	[Jung, Jung Hwa; Jung, Jaehoon; Kim, Soo Kyoung; Hahm, Jong Ryeal] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Jinju, Gyeongnam, South Korea; [Woo, Seung Hoon] Gyeongsang Natl Univ, Sch Med, Dept Otolaryngol, Jinju, Gyeongnam, South Korea; [Kang, Ki Mun; Jeong, Bae-Kwon] Gyeongsang Natl Univ, Sch Med, Dept Radiat Oncol, Jinju, Gyeongnam, South Korea; [Jung, Myeong Hee; Kim, Jin Hyun] Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, Gyeongnam, South Korea; [Jung, Jung Hwa; Jung, Jaehoon; Kim, Soo Kyoung; Woo, Seung Hoon; Kang, Ki Mun; Jeong, Bae-Kwon; Kim, Jin Hyun; Hahm, Jong Ryeal] Gyeongsang Natl Univ Hosp, Sch Med, Inst Hlth Sci, Jinju, Gyeongnam, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University Hospital	Kim, JH (corresponding author), Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, Gyeongnam, South Korea.	ajini7044@hanmail.net; jrhahm@hanmail.net	Song, Jin/HHS-8731-2022; Kang, Kimun/AAA-3684-2022; Kwon, Jeong Bae/Q-3852-2019	Kwon, Jeong Bae/0000-0001-8015-6061	Special Clinical Fund from Gyeongsang National University Hospital [GNUHCRF-2012-008]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education Science and Technology [NRF-2012-0000305, 2012R1A1A2005699]; Biomedical Research Fund from Gyeongsang National University Hospital [GNUHBIF-2014-0010]	Special Clinical Fund from Gyeongsang National University Hospital; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education Science and Technology; Biomedical Research Fund from Gyeongsang National University Hospital	This work was supported by Special Clinical Fund from Gyeongsang National University Hospital [GNUHCRF-2012-008], the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education Science and Technology (NRF-2012-0000305) (2012R1A1A2005699), and Biomedical Research Fund from Gyeongsang National University Hospital [GNUHBIF-2014-0010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANTLE JP, 1985, INT J RADIAT ONCOL, V11, P1999, DOI 10.1016/0360-3016(85)90283-4; Bilska A, 2005, PHARMACOL REP, V57, P570; Braley-Mullen H, 2001, J IMMUNOL, V167, P7111, DOI 10.4049/jimmunol.167.12.7111; Chen KM, 2000, J LEUKOCYTE BIOL, V68, P828; Chen KM, 2002, J IMMUNOL, V169, P6530, DOI 10.4049/jimmunol.169.11.6530; CHRISTOV K, 1975, CANCER RES, V35, P1256; CONSTINE LS, 1984, CANCER-AM CANCER SOC, V53, P878, DOI 10.1002/1097-0142(19840215)53:4<878::AID-CNCR2820530411>3.0.CO;2-J; Demir U, 2005, OPHTHALMOLOGICA, V219, P49, DOI 10.1159/000081783; EINHORN J, 1967, RADIOLOGY, V88, P326, DOI 10.1148/88.2.326; HANCOCK SL, 1991, NEW ENGL J MED, V325, P599, DOI 10.1056/NEJM199108293250902; HANCOCK SL, 1995, INT J RADIAT ONCOL, V31, P1165, DOI 10.1016/0360-3016(95)00019-U; Huh JW, 2007, TUBERC RESPIR DIS, V62, P105, DOI 10.4046/trd.2007.62.2.105; Hurdag C, 2005, INT J TISSUE REACT, V27, P145; Jasani B, 1990, GROWTH FACTORS, V2, P149, DOI 10.3109/08977199009071501; Jereczek-Fossa BA, 2004, CANCER TREAT REV, V30, P369, DOI 10.1016/j.ctrv.2003.12.003; Kimura ET, 1999, THYROID, V9, P119, DOI 10.1089/thy.1999.9.119; Korkina Ludmila G., 1993, Biochemical Society Transactions, V21, p314S; LOGAN A, 1994, J ENDOCRINOL, V141, P45, DOI 10.1677/joe.0.1410045; MAASILTA P, 1992, RADIOTHER ONCOL, V25, P192, DOI 10.1016/0167-8140(92)90267-X; Manda K, 2007, CELL BIOL TOXICOL, V23, P129, DOI 10.1007/s10565-006-0137-6; MARKSON JL, 1965, BRIT MED J, V1, P1228, DOI 10.1136/bmj.1.5444.1228; Massimino M, 2007, INT J RADIAT ONCOL, V69, P404, DOI 10.1016/j.ijrobp.2007.03.028; Nishiyama K, 1996, INT J RADIAT ONCOL, V34, P439, DOI 10.1016/0360-3016(95)02079-9; Odabasoglu F, 2011, BRIT J NUTR, V105, P31, DOI 10.1017/S0007114510003107; Papiez MA, 2008, FOLIA HISTOCHEM CYTO, V46, P205, DOI 10.2478/v10042-008-0031-6; Patrick L, 2000, Altern Med Rev, V5, P290; Prasad KN, 2005, BRIT J RADIOL, V78, P485, DOI 10.1259/bjr/87552880; Prasad KN, 2004, BRIT J RADIOL, V77, P97, DOI 10.1259/bjr/88081058; RAMAKRISHNAN N, 1992, RADIAT RES, V130, P360, DOI 10.2307/3578382; Redlich CA, 1998, J NUTR, V128, P1661, DOI 10.1093/jn/128.10.1661; Ricardi U, 2001, INT J RADIAT ONCOL, V50, P1287, DOI 10.1016/S0360-3016(01)01519-X; Saad AG, 2006, J CLIN ENDOCR METAB, V91, P2672, DOI 10.1210/jc.2006-0417; Sagowski C, 2003, EUR ARCH OTO-RHINO-L, V260, P42, DOI 10.1007/s00405-002-0496-4; SCOTT BC, 1994, FREE RADICAL RES, V20, P119, DOI 10.3109/10715769409147509; Sehirli O, 2008, CLIN EXP PHARMACOL P, V35, P249, DOI 10.1111/j.1440-1681.2007.04810.x; Sminia P, 1996, J CANCER RES CLIN, V122, P343, DOI 10.1007/BF01220801; Thresiamma K. C., 1996, Indian Journal of Experimental Biology, V34, P845; van Santen HM, 2006, THYROID, V16, P387, DOI 10.1089/thy.2006.16.387; van Santen HM, 2005, J ENDOCRINOL INVEST, V28, P261, DOI 10.1007/BF03345383; Ziegler D, 1999, DIABETES CARE, V22, P1296, DOI 10.2337/diacare.22.8.1296; Ziegler D, 2006, DIABETES CARE, V29, P2365, DOI 10.2337/dc06-1216	41	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112253	10.1371/journal.pone.0112253	http://dx.doi.org/10.1371/journal.pone.0112253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401725	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700036
J	Pang, YN; Liang, YW; Feng, TS; Zhao, S; Wu, H; Chai, YS; Lei, F; Ding, Y; Xing, DM; Du, LJ				Pang, Yu-Nong; Liang, Yin-Wen; Feng, Tian-Shi; Zhao, Shuang; Wu, Hao; Chai, Yu-Shuang; Lei, Fan; Ding, Yi; Xing, Dong-Ming; Du, Li-Jun			Transportation of Berberine into HepG2, HeLa and SY5Y Cells: A Correlation to Its Anti-Cancer Effect	PLOS ONE			English	Article							COPTIDIS-RHIZOMA EXTRACT; CANCER-CELLS; CEREBRAL-ISCHEMIA; APOPTOSIS; RESISTANCE; EXPRESSION; ARREST; DEATH	The anti-cancer activities of berberine (BBR) have been reported extensively in various cancer cell lines. However, the minimal inhibitory concentrations of BBR varied greatly among different cell lines and very few studies have been devoted to elucidate this aspect. In this study, we employed three cancer cell lines, HepG2, HeLa and SY5Y, to compare the transportation and distribution of BBR. HPLC results demonstrated that BBR was capable of penetrating all the cell lines whereas the cumulative concentrations were significantly different. HepG2 cells accumulated higher level of BBR for longer duration than the other two cell lines. Molecular docking studies revealed the BBR binding site on P-glycoprotein 1 (P-gp). In addition, we elucidated that BBR regulated P-gp at both mRNA and protein levels. BBR induced the transcription and translation of P-gp in HeLa and SY5Y cells, whereas BBR inhibited P-gp expression in HepG2 cells. Further study showed that BBR regulates P-gp expression depending on different mechanisms (or affected by different factors) in different cell lines. To summarize, our study has revealed several mechanistic aspects of BBR regulation on P-gp in different cancer cell lines and might shed some useful insights into the use of BBR in the anti-cancer drug development.	[Pang, Yu-Nong; Liang, Yin-Wen; Feng, Tian-Shi; Zhao, Shuang; Chai, Yu-Shuang; Lei, Fan; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Pang, Yu-Nong; Liang, Yin-Wen; Feng, Tian-Shi; Zhao, Shuang; Chai, Yu-Shuang; Lei, Fan; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wu, Hao] NGM Biopharmaceut Inc, San Francisco, CA USA; [Ding, Yi] Tsinghua Univ, Sch Life Sci, Drug Discovery Facil, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Du, LJ (corresponding author), Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	lijundu@mail.tsinghua.edu.cn	Liang, Yinwen/U-2734-2019		National Natural Science Foundation of China [81374006, 81073092]; National S&T Major Special Project for New Drug R&D Program of China [2012ZX09103-201-041, 2012ZX09102-201-008, 2011ZX09101-002-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project for New Drug R&D Program of China	This study was supported by the National Natural Science Foundation of China (81374006 and 81073092) and the National S&T Major Special Project for New Drug R&D Program of China (2012ZX09103-201-041, 2012ZX09102-201-008 and 2011ZX09101-002-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Chen YY, 2008, BIOMED CHROMATOGR, V22, P28, DOI 10.1002/bmc.889; [丁阳平 Ding Yangping], 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P1765; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Jiang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054234; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kim HS, 2012, BIOCHEM PHARMACOL, V83, P385, DOI 10.1016/j.bcp.2011.11.008; Kosztyu P, 2013, PHARMACOL RES, V67, P79, DOI 10.1016/j.phrs.2012.10.012; [来丽娜 LAI Lina], 2008, [中草药, Chinese Traditional and Herbal Drugs], V39, P244; Lawlor D, 2014, J PHARM SCI-US, V103, P1913, DOI 10.1002/jps.23952; Lin HL, 1999, BRIT J CANCER, V81, P416, DOI 10.1038/sj.bjc.6690710; Liu Shan-Wen, 2011, Shengli Xuebao, V63, P517; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Lu BA, 2010, TOXICOL IN VITRO, V24, P1482, DOI 10.1016/j.tiv.2010.07.017; Luo JY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/545898; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Moon PD, 2011, PHYTOTHER RES, V25, P844, DOI 10.1002/ptr.3353; Muralimanoharan SB, 2009, PROSTATE, V69, P494, DOI 10.1002/pros.20899; Park JJ, 2012, BIOCHEM BIOPH RES CO, V426, P461, DOI 10.1016/j.bbrc.2012.08.091; Patil JB, 2010, EUR J PHARMACOL, V645, P70, DOI 10.1016/j.ejphar.2010.07.037; Prabhakar PK, 2011, THER ADV ENDOCRINOL, V2, P103, DOI 10.1177/2042018811411356; Shan YQ, 2013, BIOL PHARM BULL, V36, P1562, DOI 10.1248/bpb.b13-00272; Shigeta K, 2002, BIOSCI BIOTECH BIOCH, V66, P2491, DOI 10.1271/bbb.66.2491; Singh IP, 2013, EXPERT OPIN THER PAT, V23, P215, DOI 10.1517/13543776.2013.746314; Tan YL, 2006, MOL BIOSYST, V2, P250, DOI 10.1039/b517116d; UEDA K, 1987, J BIOL CHEM, V262, P17432; Wang N, 2010, J CELL BIOCHEM, V111, P1426, DOI 10.1002/jcb.22869; Wang XL, 2005, NEUROSCI LETT, V379, P132, DOI 10.1016/j.neulet.2004.12.050; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Zha WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054349; Zhao Qian, 2012, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V28, P259	33	17	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112937	10.1371/journal.pone.0112937	http://dx.doi.org/10.1371/journal.pone.0112937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402492	Green Submitted, Green Published, gold			2022-12-26	WOS:000345158700083
J	Saito, Y; Takeda, J; Adachi, K; Nobe, Y; Kobayashi, J; Hirota, K; Oliveira, DV; Taoka, M; Isobe, T				Saito, Yuichiro; Takeda, Jun; Adachi, Kousuke; Nobe, Yuko; Kobayashi, Junya; Hirota, Kouji; Oliveira, Douglas V.; Taoka, Masato; Isobe, Toshiaki			RNase MRP Cleaves Pre-tRNA(Ser-Met) in the tRNA Maturation Pathway	PLOS ONE			English	Article							CARTILAGE-HAIR HYPOPLASIA; BACTERIAL RIBONUCLEASE-P; UNIQUE PROTEIN-COMPONENT; CELL-CYCLE PROGRESSION; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; RIBONUCLEOPROTEIN ENDORIBONUCLEASE; CRYSTAL-STRUCTURE; MESSENGER-RNA	Ribonuclease mitochondrial RNA processing (RNase MRP) is a multifunctional ribonucleoprotein (RNP) complex that is involved in the maturation of various types of RNA including ribosomal RNA. RNase MRP consists of a potential catalytic RNA and several protein components, all of which are required for cell viability. We show here that the temperature-sensitive mutant of rmp1, the gene for a unique protein component of RNase MRP, accumulates the dimeric tRNA precursor, pre-tRNA(Ser-Met). To examine whether RNase MRP mediates tRNA maturation, we purified the RNase MRP holoenzyme from the fission yeast Schizosaccharomyces pombe and found that the enzyme directly and selectively cleaves pre-tRNA(Ser-Met), suggesting that RNase MRP participates in the maturation of specific tRNA in vivo. In addition, mass spectrometry-based ribonucleoproteomic analysis demonstrated that this RNase MRP consists of one RNA molecule and 11 protein components, including a previously unknown component Rpl701. Notably, limited nucleolysis of RNase MRP generated an active catalytic core consisting of partial mrp1 RNA fragments, which constitute "Domain 1'' in the secondary structure of RNase MRP, and 8 proteins. Thus, the present study provides new insight into the structure and function of RNase MRP.	[Saito, Yuichiro; Adachi, Kousuke; Hirota, Kouji; Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Tokyo 158, Japan; [Takeda, Jun; Nobe, Yuko; Taoka, Masato; Isobe, Toshiaki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Kobayashi, Junya; Oliveira, Douglas V.] Kyoto Univ, Ctr Radiat Biol, Div Genome Repair Dynam, Kyoto 606, Japan	Tokyo Metropolitan University; Japan Science & Technology Agency (JST); Kyoto University	Isobe, T (corresponding author), Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Tokyo 158, Japan.	isobe-toshiaki@tmu.ac.jp	Isobe, Toshiaki/Q-9279-2017; Kobayashi, Junjiro/J-8547-2015; Kobayashi, Junya/AAX-6390-2021	Kobayashi, Junya/0000-0003-4645-7500; Nogueira Perez Oliveira, Douglas/0000-0002-3529-4219; Taoka, Masato/0000-0001-5554-4951; Saito, Yuichiro/0000-0001-5001-0934	Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency	Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency	This work was supported by Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulds J, 2012, J BIOL CHEM, V287, P37089, DOI 10.1074/jbc.M112.389023; Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; BRENNWALD P, 1988, MOL CELL BIOL, V8, P1580, DOI 10.1128/MCB.8.4.1580; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cai T, 1999, MOL CELL BIOL, V19, P7857; Cai T, 2002, GENETICS, V161, P1029; Chamberlain JR, 1998, GENE DEV, V12, P1678, DOI 10.1101/gad.12.11.1678; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; Chen JL, 1997, RNA, V3, P557; DRAINAS D, 1989, FEBS LETT, V251, P84, DOI 10.1016/0014-5793(89)81433-4; ELDER RT, 1983, P NATL ACAD SCI-BIOL, V80, P2432, DOI 10.1073/pnas.80.9.2432; Esakova O, 2008, RNA, V14, P1558, DOI 10.1261/rna.1106408; Esakova O, 2013, NUCLEIC ACIDS RES, V41, P7084, DOI 10.1093/nar/gkt432; Esakova O, 2011, RNA, V17, P356, DOI 10.1261/rna.2393711; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Goldfarb KC, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-23; Green CJ, 1996, NUCLEIC ACIDS RES, V24, P1497, DOI 10.1093/nar/24.8.1497; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Gutz H, 1974, SCHIZOSACCHAROMYCES; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; Hermanns P, 2005, HUM MOL GENET, V14, P3723, DOI 10.1093/hmg/ddi403; Hernandez-Cid A, 2012, IUBMB LIFE, V64, P521, DOI 10.1002/iub.1052; Hipp K, 2012, NUCLEIC ACIDS RES, V40, P3275, DOI 10.1093/nar/gkr1217; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Hsieh J, 2009, RNA, V15, P224, DOI 10.1261/rna.1309409; Jaag HM, 2011, J VIROL, V85, P243, DOI 10.1128/JVI.01749-10; Jacobson MR, 1995, J CELL BIOL, V131, P1649, DOI 10.1083/jcb.131.6.1649; Jakovljevic J, 2012, RNA, V18, P1805, DOI 10.1261/rna.032540.112; Khanova E, 2012, RNA, V18, P720, DOI 10.1261/rna.030874.111; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Krasilnikov AS, 2004, SCIENCE, V306, P104, DOI 10.1126/science.1101489; Kuijpers TW, 2003, J MED GENET, V40, P761, DOI 10.1136/jmg.40.10.761; Levinger L, 1998, J BIOL CHEM, V273, P1015, DOI 10.1074/jbc.273.2.1015; LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871; Li X, 2004, NUCLEIC ACIDS RES, V32, P3703, DOI 10.1093/nar/gkh689; Li X, 2002, RNA, V8, P740, DOI 10.1017/S1355838202022082; LINDAHL L, 1992, NUCLEIC ACIDS RES, V20, P295, DOI 10.1093/nar/20.2.295; Lopez MD, 2009, RNA BIOL, V6, P208, DOI 10.4161/rna.6.3.8584; Loria A, 1997, BIOCHEMISTRY-US, V36, P6317, DOI 10.1021/bi970115o; Lu QS, 2010, RNA, V16, P529, DOI 10.1261/rna.1893710; Lygerou Z, 1996, SCIENCE, V272, P268, DOI 10.1126/science.272.5259.268; MAO JI, 1980, CELL, V21, P509, DOI 10.1016/0092-8674(80)90488-2; Martin AN, 2007, CELL RES, V17, P219, DOI 10.1038/sj.cr.7310120; Marvin MC, 2009, RNA BIOL, V6, P40, DOI 10.4161/rna.6.1.7566; Mattijssen S, 2010, WIRES RNA, V1, P102, DOI 10.1002/wrna.9; Mattijssen S, 2011, CELL MOL LIFE SCI, V68, P2469, DOI 10.1007/s00018-010-0568-3; Mobley EM, 1999, NUCLEIC ACIDS RES, V27, P4298, DOI 10.1093/nar/27.21.4298; Mondragon A, 2013, ANNU REV BIOPHYS, V42, P537, DOI 10.1146/annurev-biophys-083012-130406; Nakashima E, 2003, AM J MED GENET A, V123A, P253, DOI 10.1002/ajmg.a.20281; Nakashima E, 2007, AM J MED GENET A, V143A, P2675, DOI 10.1002/ajmg.a.32053; Nakayama H, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp099; Paluh JL, 1996, EMBO J, V15, P4723, DOI 10.1002/j.1460-2075.1996.tb00849.x; Paluh JL, 1996, YEAST, V12, P1393; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Perederina A, 2011, RNA, V17, P1922, DOI 10.1261/rna.2855511; Perederina A, 2010, EMBO J, V29, P761, DOI 10.1038/emboj.2009.396; Piccinelli P, 2005, NUCLEIC ACIDS RES, V33, P4485, DOI 10.1093/nar/gki756; Pluk H, 1999, RNA, V5, P512, DOI 10.1017/S1355838299982079; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Qin H, 2001, BIOCHEMISTRY-US, V40, P11202, DOI 10.1021/bi010076n; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; RIBES V, 1988, EMBO J, V7, P231, DOI 10.1002/j.1460-2075.1988.tb02804.x; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Roifman CM, 2006, J ALLERGY CLIN IMMUN, V117, P897, DOI 10.1016/j.jaci.2006.01.003; Rosenblad MA, 2006, NUCLEIC ACIDS RES, V34, P5145, DOI 10.1093/nar/gkl626; Salinas K, 2005, J BIOL CHEM, V280, P11352, DOI 10.1074/jbc.M409568200; SCHMITT ME, 1994, GENE DEV, V8, P2617, DOI 10.1101/gad.8.21.2617; SCHMITT ME, 1992, GENE DEV, V6, P1975, DOI 10.1101/gad.6.10.1975; SCHMITT ME, 1993, MOL CELL BIOL, V13, P7935, DOI 10.1128/MCB.13.12.7935; STATHOPOULOS C, 1995, EUR J BIOCHEM, V228, P976, DOI 10.1111/j.1432-1033.1995.0976m.x; STOHL LL, 1992, MOL CELL BIOL, V12, P2561, DOI 10.1128/MCB.12.6.2561; Suga M, 2005, YEAST, V22, P799, DOI 10.1002/yea.1247; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Taoka M, 2010, ANAL CHEM, V82, P7795, DOI 10.1021/ac101623j; Taoka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp732; Thiel CT, 2007, AM J HUM GENET, V81, P519, DOI 10.1086/521034; Thiel CT, 2005, AM J HUM GENET, V77, P795, DOI 10.1086/497708; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Tsai HY, 2006, P NATL ACAD SCI USA, V103, P16147, DOI 10.1073/pnas.0608000103; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Welting TJM, 2008, BBA-MOL CELL RES, V1783, P455, DOI 10.1016/j.bbamcr.2007.11.016; Welting TJM, 2007, RNA, V13, P65, DOI 10.1261/rna.237807; Welting TJM, 2006, RNA, V12, P1373, DOI 10.1261/rna.2293906; Welting TJM, 2004, NUCLEIC ACIDS RES, V32, P2138, DOI 10.1093/nar/gkh539; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200	89	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112488	10.1371/journal.pone.0112488	http://dx.doi.org/10.1371/journal.pone.0112488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401760	Green Submitted, gold, Green Published			2022-12-26	WOS:000345158700050
J	Tamayo, T; Schipf, S; Meisinger, C; Schunk, M; Maier, W; Herder, C; Roden, M; Nauck, M; Peters, A; Volzke, H; Rathmann, W				Tamayo, Teresa; Schipf, Sabine; Meisinger, Christine; Schunk, Michaela; Maier, Werner; Herder, Christian; Roden, Michael; Nauck, Matthias; Peters, Annette; Voelzke, Henry; Rathmann, Wolfgang			Regional Differences of Undiagnosed Type 2 Diabetes and Prediabetes Prevalence Are Not Explained by Known Risk Factors	PLOS ONE			English	Article							SOUTHERN GERMANY; KORA SURVEY; LIFE-STYLE; MELLITUS; METAANALYSIS; INDIVIDUALS; POPULATIONS; DISPARITIES; HEALTH; EAST	Background: We have previously found regional differences in the prevalence of known type 2 diabetes between northeastern and southern Germany. We aim to also provide prevalence estimates for prediabetes (isolated impaired fasting glucose (i-IFG), isolated glucose intolerance (i-IGT), combined IFG and IGT) and unknown type 2 diabetes for both regions. Methods: Prevalence (95% CI) of prediabetes (i-IFG: fasting glucose 5.6-6.9 mmol/l; i-IGT: 2 h postchallenge gluose 7.8-11.0 mmol/l, oral glucose tolerance test (OGTT), >= 8 h overnight fasting) and unknown diabetes were analyzed in two regional population-based surveys (age group 35-79 years): SHIP-TREND (Study of Health in Pomerania (northeast), 2008-2012) and KORA F4 (Cooperative Health Research in the region of Augsburg (south), 2006-2008). Both studies used similar methods, questionnaires, and identical protocols for OGTT. Overall, 1,980 participants from SHIP-TREND and 2,617 participants from KORA F4 were included. Results: Age-sex-standardized prevalence estimates (95% CI) of prediabetes and unknown diabetes were considerably higher in the northeast (SHIP-TREND: 43.1%; 40.9-45.3% and 7.1%; 5.9-8.2%) than in the south of Germany (KORA F4: 30.1%; 28.4-31.7% and 3.9%; 3.2-4.6%), respectively. In particular, i-IFG (26.4%; 24.5-28.3% vs. 17.2%; 15.7-18.6%) and IFG+IGT (11.2%; 9.8-12.6% vs. 6.6%; 5.7-7.5%) were more frequent in SHIP-TREND than in KORA. In comparison to normal glucose tolerance, the odds of having unknown diabetes (OR, 95% CI: 2.59; 1.84-3.65) or prediabetes (1.98; 1.70-2.31) was higher in the northeast than in the south after adjustment for known risk factors (obesity, lifestyle). Conclusions: The regional differences of prediabetes and unknown diabetes are in line with the geographical pattern of known diabetes in Germany. The higher prevalences in the northeast were not explained by traditional risk factors.	[Tamayo, Teresa; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Schipf, Sabine; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Meisinger, Christine; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Schunk, Michaela; Maier, Werner] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Roden, Michael] Univ Hosp Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Herder, Christian; Roden, Michael; Peters, Annette] German Ctr Diabet Res DZD eV, Dusseldorf, Germany; [Herder, Christian; Roden, Michael; Peters, Annette] German Ctr Diabet Res DZD eV, Munich, Germany; [Peters, Annette; Voelzke, Henry] German Ctr Cardiovasc Res DZHK eV, Munich, Germany; [Peters, Annette; Voelzke, Henry] German Ctr Cardiovasc Res DZHK eV, Greifswald, Germany; [Tamayo, Teresa; Schipf, Sabine; Meisinger, Christine; Schunk, Michaela; Maier, Werner; Nauck, Matthias; Voelzke, Henry; Rathmann, Wolfgang] Fed Minist Educ & Res, Competence Network Diabet Mellitus, Dusseldorf, Germany; [Tamayo, Teresa; Schipf, Sabine; Meisinger, Christine; Schunk, Michaela; Maier, Werner; Nauck, Matthias; Voelzke, Henry; Rathmann, Wolfgang] Fed Minist Educ & Res, Competence Network Diabet Mellitus, Munich, Germany; [Tamayo, Teresa; Schipf, Sabine; Meisinger, Christine; Schunk, Michaela; Maier, Werner; Nauck, Matthias; Voelzke, Henry; Rathmann, Wolfgang] Fed Minist Educ & Res, Competence Network Diabet Mellitus, Greifswald, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Greifswald Medical School; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research	Tamayo, T (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.	teresa.tamayo@ddz.uni-duesseldorf.de	Peters, Annette/A-6117-2011; Meisinger, Christine/B-5358-2014; Roden, Michael/AAD-3843-2019	Peters, Annette/0000-0001-6645-0985; Maier, Werner/0000-0003-4356-7296; Schunk, Michaela/0000-0002-1200-1903; Meisinger, Christa/0000-0002-9026-6544	Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research [01GI1110D]; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation (DFG); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia	Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia	The project was funded by a grant of the Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research (support code 01GI1110D). The KORA research platform (KORA, Cooperative Health Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The KORA Diabetes Study was partly funded by a German Research Foundation (DFG) grant to WR from the German Diabetes Center. The German Diabetes Center is funded by grants of the German Federal Ministry of Health, and the Ministry of School, Science and Research of the State of North-Rhine-Westphalia. The Study of Health in Pomerania (SHIP-TREND) is part of the Community Medicine Research net (CMR) at the University of Greifswald, Germany. The CMR encompasses several research projects, which share data from the population-based SHIP project (http://ship.community-medicine.de). Oral glucose tolerance tests were funded by grants given to WR (German Diabetes Center, Dusseldorf, Germany). The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Bongaerts BWC, 2012, DIABETES CARE, V35, P1891, DOI 10.2337/dc11-2028; Chambless L, 1987, 3186 GSF; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133; Herder C, 2013, DIABETOLOGIA; Icks A, 2013, DIABETES CARE, V36, pE53, DOI 10.2337/dc12-0997; International Diabetes Federation, 2013, IDF DIABETES ATLAS; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kowall B, 2011, EUR J EPIDEMIOL, V26, P637, DOI 10.1007/s10654-011-9609-y; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Meisinger C, 2010, DIABETIC MED, V27, P360, DOI 10.1111/j.1464-5491.2009.02905.x; Meisinger C, 2012, PLOS ONE, V7, P3; Mensink GBM, 2004, EUR J CLIN NUTR, V58, P1000, DOI 10.1038/sj.ejcn.1601923; Muller G, 2013, AM J EPIDEMIOL, V178, P221, DOI 10.1093/aje/kws466; Qiao Q, 2003, DIABETES CARE, V26, P688; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Robert Koch-Institut, 2012, BEITR GES BUND; Robert Koch-Institut, 2004, GBE SCHW GES KIND JU; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Schipf S, 2012, DIABETIC MED, V29, pE88, DOI 10.1111/j.1464-5491.2012.03578.x; Schipf S, 2014, J EPIDEMIOL COMMUN H, V68, P1088, DOI 10.1136/jech-2014-203998; Schulze MB, 1999, ANN NUTR METAB, V43, P235, DOI 10.1159/000012790; Stang A, 2011, EUR J CARDIOV PREV R, V18, P106, DOI 10.1097/HJR.0b013e32833b3305; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Voigt M, 2013, Z GEBURTSH NEONATOL, V217, P24, DOI [10.1055/s-0033-1361096, 10.1055/s-0032-1333256]; Wiesner G, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P266, DOI 10.1007/s00103-003-0793-0; Wilke T, 2013, DEUT MED WOCHENSCHR, V138, P69, DOI 10.1055/s-0032-1327394	37	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113154	10.1371/journal.pone.0113154	http://dx.doi.org/10.1371/journal.pone.0113154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402347	gold, Green Submitted, Green Published			2022-12-26	WOS:000345158700119
J	Thiele, S; Wolf, C; Schulz, IK; Assmy, P; Metfies, K; Fuchs, BM				Thiele, Stefan; Wolf, Christian; Schulz, Isabelle Katharina; Assmy, Philipp; Metfies, Katja; Fuchs, Bernhard M.			Stable Composition of the Nano- and Picoplankton Community during the Ocean Iron Fertilization Experiment LOHAFEX	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENE; FLOW-CYTOMETRIC IDENTIFICATION; EUKARYOTIC PICOPLANKTON; OLIGONUCLEOTIDE PROBES; NANOPLANKTON; SEQUENCES; MECHANISMS; PACIFIC; BLOOMS	The iron fertilization experiment LOHAFEX was conducted in a cold-core eddy in the Southern Atlantic Ocean during austral summer. Within a few days after fertilization, a phytoplankton bloom developed dominated by nano-and picoplankton groups. Unlike previously reported for other iron fertilization experiments, a diatom bloom was prevented by iron and silicate co-limitation. We used 18S rRNA gene tag pyrosequencing to investigate the diversity of these morphologically similar cell types within the nano-and picoplankton and microscopically enumerated dominant clades after catalyzed reported deposition fluorescence in situ hybridization (CARD-FISH) with specific oligonucleotide probes. In addition to Phaeocystis, members of Syndiniales group II, clade 10-11, and the Micromonas clades ABC and E made up a major fraction of the tag sequences of the nano-and picoplankton community within the fertilized patch. However, the same clades were also dominant before the bloom and outside the fertilized patch. Furthermore, only little changes in diversity could be observed over the course of the experiment. These results were corroborated by CARD-FISH analysis which confirmed the presence of a stable nano-and picoplankton community dominated by Phaeocystis and Micromonas during the entire course of the experiment. Interestingly, although Syndiniales dominated the tag sequences, they could hardly be detected by CARD-FISH, possibly due to the intracellular parasitic life style of this clade. The remarkable stability of the nano-and picoplankton community points to a tight coupling of the different trophic levels within the microbial food web during LOHAFEX.	[Thiele, Stefan; Fuchs, Bernhard M.] Max Planck Inst Marine Microbiol, Dept Mol Ecol, Bremen, Germany; [Wolf, Christian; Schulz, Isabelle Katharina; Metfies, Katja] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Dept Polar Biol Oceanog, Div Biosci, Bremerhaven, Germany; [Schulz, Isabelle Katharina] Univ Bremen, MARUM Ctr Marine Environm Sci, Bremen Int Grad Sch Marine Sci GLOMAR, D-28359 Bremen, Germany; [Assmy, Philipp] Norwegian Polar Res Inst, Fram Ctr, Ctr Ice Climate & Ecosyst ICE, Tromso, Norway	Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; Norwegian Polar Institute	Fuchs, BM (corresponding author), Max Planck Inst Marine Microbiol, Dept Mol Ecol, Bremen, Germany.	bfuchs@mpi-bremen.de	Thiele, Stefan/C-4958-2017	Thiele, Stefan/0000-0002-4322-3795; Fuchs, Bernhard/0000-0001-9828-1290	Max Planck Society; Helmholtz Association [VH-NG-500]	Max Planck Society(Max Planck Society); Helmholtz Association(Helmholtz Association)	This work was funded by the Max Planck Society and the Helmholtz Association (Young Investigator Group PLANKTOSENS, VH-NG-500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Assmy P, 2007, DEEP-SEA RES PT I, V54, P340, DOI 10.1016/j.dsr.2006.12.005; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Balzano S, 2012, ISME J, V6, P1480, DOI 10.1038/ismej.2011.213; Beardsley C, 2005, AQUAT MICROB ECOL, V41, P163, DOI 10.3354/ame041163; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; BLOEM J, 1986, APPL ENVIRON MICROB, V52, P1266, DOI 10.1128/AEM.52.6.1266-1272.1986; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Chambouvet A, 2008, SCIENCE, V322, P1254, DOI 10.1126/science.1164387; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Ducklow Hugh W., 2001, Oceanography, V14, P50; Ebersbach F, 2014, DEEP-SEA RES PT I, V89, P94, DOI 10.1016/j.dsr.2014.04.007; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Gall MP, 2001, DEEP-SEA RES PT II, V48, P2551, DOI 10.1016/S0967-0645(01)00008-X; Gasol JM, 1999, AQUAT MICROB ECOL, V16, P251, DOI 10.3354/ame016251; Gomez-Pereira PR, 2013, FEMS MICROBIOL ECOL, V83, P664, DOI 10.1111/1574-6941.12023; Hall JA, 2001, DEEP-SEA RES PT II, V48, P2591, DOI 10.1016/S0967-0645(01)00010-8; Kilias E, 2013, J PHYCOL, V49, P996, DOI 10.1111/jpy.12109; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martin P, 2013, GLOBAL BIOGEOCHEM CY, V27, P871, DOI 10.1002/gbc.20077; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; Not F, 2002, AQUAT MICROB ECOL, V28, P157, DOI 10.3354/ame028157; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Peloquin J, 2011, DEEP-SEA RES PT II, V58, P808, DOI 10.1016/j.dsr2.2010.10.021; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Schulz IK, 2013, THESIS U BREMEN GERM; SHERR EB, 1993, HDB METHODS AQUATIC, P213; Siano R, 2011, BIOGEOSCIENCES, V8, P267, DOI 10.5194/bg-8-267-2011; Simon N, 2000, J EUKARYOT MICROBIOL, V47, P76, DOI 10.1111/j.1550-7408.2000.tb00014.x; Smetacek V, 2012, NATURE, V487, P313, DOI 10.1038/nature11229; Thiele S, 2011, TREATISE ON WATER SCIENCE, VOL 3: AQUATIC CHEMISTRY AND BIOLOGY, P171; Thiele S, 2012, APPL ENVIRON MICROB, V78, P8803, DOI 10.1128/AEM.01814-12; Tsuda A, 2005, PROG OCEANOGR, V64, P189, DOI 10.1016/j.pocean.2005.02.008; Unrein F, 2014, ISME J, V8, P164, DOI 10.1038/ismej.2013.132; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; VORS N, 1995, DEEP-SEA RES PT II, V42, P585, DOI 10.1016/0967-0645(95)00018-L; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wolf C, 2013, ANTARCT SCI, V25, P741, DOI 10.1017/S0954102013000229; Zeder M, 2010, CYTOM PART A, V77A, P76, DOI 10.1002/cyto.a.20810; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zingone A, 1999, J PHYCOL, V35, P1322, DOI 10.1046/j.1529-8817.1999.3561322.x	48	13	13	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113244	10.1371/journal.pone.0113244	http://dx.doi.org/10.1371/journal.pone.0113244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401706	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700125
J	Vaksman, Z; Fonville, NC; Tae, H; Garner, HR				Vaksman, Zalman; Fonville, Natalie C.; Tae, Hongseok; Garner, Harold R.			Exome-Wide Somatic Microsatellite Variation Is Altered in Cells with DNA Repair Deficiencies	PLOS ONE			English	Article							TANDEM REPEATS; FANCONI-ANEMIA; MUTATIONS; CANCER; INSTABILITY; RECOMBINATION; EVOLUTION; LINES; SEQUENCES; EVENTS	Microsatellites (MST), tandem repeats of 1-6 nucleotide motifs, are mutational hot-spots with a bias for insertions and deletions (INDELs) rather than single nucleotide polymorphisms (SNPs). The majority of MST instability studies are limited to a small number of loci, the Bethesda markers, which are only informative for a subset of colorectal cancers. In this paper we evaluate non-haplotype alleles present within next-gen sequencing data to evaluate somatic MST variation (SMV) within DNA repair proficient and DNA repair defective cell lines. We confirm that alleles present within next-gen data that do not contribute to the haplotype can be reliably quantified and utilized to evaluate the SMV without requiring comparisons of matched samples. We observed that SMV patterns found in DNA repair proficient cell lines without DNA repair defects, MCF10A, HEK293 and PD20 RV:D2, had consistent patterns among samples. Further, we were able to confirm that changes in SMV patterns in cell lines lacking functional BRCA2, FANCD2 and mismatch repair were consistent with the different pathways perturbed. Using this new exome sequencing analysis approach we show that DNA instability can be identified in a sample and that patterns of instability vary depending on the impaired DNA repair mechanism, and that genes harboring minor alleles are strongly associated with cancer pathways. The MST Minor Allele Caller used for this study is available at https://github.com/zalmanv/MST_minor_allele_caller.	[Vaksman, Zalman; Fonville, Natalie C.; Tae, Hongseok; Garner, Harold R.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Garner, Harold R.] Genomeon LLC, Floyd, VA 24091 USA	Virginia Polytechnic Institute & State University	Garner, HR (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	garner@vbi.vt.edu			Virginia Bioinformatics Institute Medical Informatics Systems Division; Virginia Bioinformatics Institute Genomics Research Lab Small Grant [CLF-1172]; National Science Foundation [OCI-1124123]; NSF S-STEM grant [DUE-0850198]; Virginia Tech; National Science Foundation (NSF)	Virginia Bioinformatics Institute Medical Informatics Systems Division; Virginia Bioinformatics Institute Genomics Research Lab Small Grant; National Science Foundation(National Science Foundation (NSF)); NSF S-STEM grant; Virginia Tech; National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by the Virginia Bioinformatics Institute Medical Informatics Systems Division director's funds, Virginia Bioinformatics Institute Genomics Research Lab Small Grant (CLF-1172), high performance computing was supported by a grant from the National Science Foundation (OCI-1124123) and NSF S-STEM grant (DUE-0850198). This work was supported by these 4 funds. The first two funds were internal university funds (Virginia Tech), and the latter two were from the National Science Foundation (NSF). None had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. These funds supported portions of author salaries and benefits, computer costs, laboratory supplies, sequencing services, publication costs, and overhead (indirect expenses to the university).	Ananda G, 2013, GENOME BIOL EVOL, V5, P606, DOI 10.1093/gbe/evs116; Bagshaw AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-49; Baptiste BA, 2013, G3-GENES GENOM GENET, V3, P451, DOI 10.1534/g3.112.005173; Barber LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021639; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Brodin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070388; Budworth H, 2013, DNA REPAIR, V12, P672, DOI 10.1016/j.dnarep.2013.04.019; Butz J, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-11; CHEN TR, 1983, CANCER GENET CYTOGEN, V10, P351, DOI 10.1016/0165-4608(83)90092-4; Delagoutte E, 2008, J BIOL CHEM, V283, P13341, DOI 10.1074/jbc.M800153200; Eckert KA, 2002, BIOCHEMISTRY-US, V41, P10490, DOI 10.1021/bi025918c; Fonville NC, 2011, J MOL MICROB BIOTECH, V21, P36, DOI 10.1159/000332748; Fonville NC, GENOME BIOL UNPUB; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Grigorova M, 2004, CYTOGENET GENOME RES, V104, P333, DOI 10.1159/000077512; Gundry M, 2012, MUTAT RES-FUND MOL M, V729, P1, DOI [10.1016/j.mrfmmm.2011.10.001, 10.1016/mrfmmm.2011.10.001]; Harris RS, 1999, MUTAT RES-REV MUTAT, V436, P157, DOI 10.1016/S1383-5742(99)00003-4; Hile SE, 2008, NUCLEIC ACIDS RES, V36, P688, DOI 10.1093/nar/gkm1089; Holt JT, 2008, CANCER GENET CYTOGEN, V186, P85, DOI 10.1016/j.cancergencyto.2008.06.013; Hong SP, 2012, EUR J CANCER, V48, P1235, DOI 10.1016/j.ejca.2011.10.005; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Kunz C, 2009, CELL MOL LIFE SCI, V66, P1021, DOI 10.1007/s00018-009-8739-9; Lacroix-Triki M, 2011, INT J CLIN EXP PATHO, V4, P22; Leclercq S, 2010, GENOME BIOL EVOL, V2, P325, DOI 10.1093/gbe/evq023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McIver LJ, 2013, GENE, V516, P328, DOI 10.1016/j.gene.2012.12.068; McIver LJ, BREAST CANC RES TREA; Mestrovic N, 2006, MOL BIOL EVOL, V23, P2316, DOI 10.1093/molbev/msl119; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Ohashi A, 2005, J BIOL CHEM, V280, P14877, DOI 10.1074/jbc.M414669200; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Schor S L, 1995, EXS, V74, P273; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Sirivatanauksorn V, 2001, INT J CANCER, V91, P350, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1049>3.3.CO;2-3; Tae H, 2013, BIOINFORMATICS; Tae H, 2013, BIOINFORMATICS, V29, P1734, DOI 10.1093/bioinformatics/btt277; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Xiao H, 2013, AM J CLIN PATHOL, V140, P341, DOI 10.1309/AJCP8P2DYNKGRBVI; Yoon K, 2013, GENOME RES, V23, P1109, DOI 10.1101/gr.145706.112	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110263	10.1371/journal.pone.0110263	http://dx.doi.org/10.1371/journal.pone.0110263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402475	Green Published, Green Submitted, gold			2022-12-26	WOS:000345158700003
J	Jung, HJ; Pak, PJ; Park, SH; Ju, JE; Kim, JS; Lee, HS; Chung, N				Jung, Hye Jin; Pak, Pyo June; Park, Sung Hyo; Ju, Jae Eun; Kim, Joong-Su; Lee, Hoi-Seon; Chung, Namhyun			Silver Wire Amplifies the Signaling Mechanism for IL-1beta Production More Than Silver Submicroparticles in Human Monocytic THP-1 Cells	PLOS ONE			English	Article							NALP3 INFLAMMASOME; IL-1-BETA PRODUCTION; DRUG-DELIVERY; NANOPARTICLES; ACTIVATION; RAT; CYTOTOXICITY; PERMEABILITY; EXPRESSION; PARTICLES	Silver materials have been widely used in diverse fields. However, their toxicity and their mechanism, especially in different forms, have not been studied sufficiently. Thus, cytotoxicity, apoptosis, and interleukin-1beta(IL-1 beta) production were investigated using macrophage-like THP-1 cells in the presence of Ag microparticles (AgMPs, 2.7 mu m), Ag submicroparticles (AgSMPs, 150 nm), and Ag wires (AgWs, 274 nm x 5.3 mu m). The levels of cytotoxicity, apoptosis, and IL-1b production by AgWs were higher than those by the other two AgSMPs and AgMPs. This trend was also observed with each step of the signaling mechanism for IL-1b production, which is a single pathway affiliated with ROS generation or lysosomal rupture or both, cathepsin B, caspase-1 (NALP3 inflammasome), and finally IL-1 beta production in THP-1 cells. All these results suggest that, for development of safe and effective silver materials, the shape or form of silver materials should be considered, especially for macrophage cell lines because epithelial cell lines are not overly sensitive to silver materials.	[Jung, Hye Jin; Pak, Pyo June; Park, Sung Hyo; Ju, Jae Eun; Chung, Namhyun] Korea Univ, Coll Life Sci & Biotechnol, Dept Biosyst & Biotechnol, Seoul, South Korea; [Kim, Joong-Su] Korea Res Inst Biosci & Biotechnol, Jeonbuk Branch Inst, Bioind Proc Ctr, Jeoneup, South Korea; [Lee, Hoi-Seon] Chonbuk Natl Univ, Coll Agr & Life Sci, Jeonju, South Korea	Korea University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Jeonbuk National University	Lee, HS (corresponding author), Chonbuk Natl Univ, Coll Agr & Life Sci, Jeonju, South Korea.	hoiseon@jbnu.ac.kr; nchung@korea.ac.kr	Lee, Hoi Seon/A-6589-2013	Lee, Hoi Seon/0000-0003-1776-3373	National Research Foundation of Korea [NRF-2011-0017012]	National Research Foundation of Korea(National Research Foundation of Korea)	Funding provided by the National Research Foundation of Korea; NRF-2011-0017012, www.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adili A, 2008, NANOTOXICOLOGY, V2, P1, DOI 10.1080/17435390701843769; Ainslie KM, 2007, NANOTOXICOLOGY, V1, P279, DOI 10.1080/17435390701781142; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ghasempour S, 2014, PHYSIOL PHARMACOL, V17, P423; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Hussain S, 2010, PART FIBRE TOXICOL, P7; Larese FF, 2009, TOXICOLOGY, V255, P33, DOI 10.1016/j.tox.2008.09.025; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Miura N, 2009, BIOCHEM BIOPH RES CO, V390, P733, DOI 10.1016/j.bbrc.2009.10.039; Morishige T, 2010, BIOMATERIALS, V31, P6833, DOI 10.1016/j.biomaterials.2010.05.036; Morishige T, 2010, BIOCHEM BIOPH RES CO, V392, P160, DOI 10.1016/j.bbrc.2009.12.178; Netea MG, 2010, PLOS PATHOG, P6; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Okimoto Y, 2000, FEBS LETT, V474, P137, DOI 10.1016/S0014-5793(00)01587-8; Park EJ, 2011, ARCH PHARM RES, V34, P299, DOI 10.1007/s12272-011-0216-y; Portney NG, 2006, ANAL BIOANAL CHEM, V384, P620, DOI 10.1007/s00216-005-0247-7; Rauch J, 2013, CHEM REV, V113, P3391, DOI 10.1021/cr3002627; Samberg ME, 2010, ENVIRON HEALTH PERSP, V118, P407, DOI 10.1289/ehp.0901398; Scanlan LD, 2013, ACS NANO, V7, P10681, DOI 10.1021/nn4034103; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5055, DOI 10.1166/jnn.2009.GR09; Stoehr LC, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-36; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Timko BP, 2010, IEEE T NANOTECHNOL, V9, P269, DOI 10.1109/TNANO.2009.2031807; Trickler WJ, 2010, TOXICOL SCI, V118, P160, DOI 10.1093/toxsci/kfq244; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Uskokovic V, 2012, ACS NANO, V6, P7832, DOI 10.1021/nn3019865; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Zhang HY, 1997, J IMMUNOL, V158, P1392; Zhang Y, 2008, BIOMED MICRODEVICES, V10, P321, DOI 10.1007/s10544-007-9139-2	36	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112256	10.1371/journal.pone.0112256	http://dx.doi.org/10.1371/journal.pone.0112256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396430	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558500040
J	Kanaya, M; Tsuda, MC; Sagoshi, S; Nagata, K; Morimoto, C; Thu, CKT; Toda, K; Kato, S; Ogawa, S; Tsukahara, S				Kanaya, Moeko; Tsuda, Mumeko C.; Sagoshi, Shoko; Nagata, Kazuyo; Morimoto, Chihiro; Thu, Chaw Kyi Tha; Toda, Katsumi; Kato, Shigeaki; Ogawa, Sonoko; Tsukahara, Shinji			Regional Difference in Sex Steroid Action on Formation of Morphological Sex Differences in the Anteroventral Periventricular Nucleus and Principal Nucleus of the Bed Nucleus of the Stria Terminalis	PLOS ONE			English	Article							MEDIAL POSTERIOR REGION; ESTROGEN-RECEPTOR GENE; ANDROGEN RECEPTOR; MALE-RATS; COPULATORY-BEHAVIOR; PREOPTIC NUCLEUS; GUINEA-PIG; MOUSE; MICE; DIFFERENTIATION	Sex steroid action is critical to form sexually dimorphic nuclei, although it is not fully understood. We previously reported that masculinization of the principal nucleus of the bed nucleus of the stria terminalis (BNSTp), which is larger and has more neurons in males than in females, involves aromatized testosterone that acts via estrogen receptor-alpha (ER alpha), but not estrogen receptor-beta (ER beta). Here, we examined sex steroid action on the formation of the anteroventral periventricular nucleus (AVPV) that is larger and has more neurons in females. Morphometrical analysis of transgenic mice lacking aromatase, ER alpha, or ER beta genes revealed that the volume and neuron number of the male AVPV were significantly increased by deletion of aromatase and ER alpha genes, but not the ERb gene. We further examined the AVPV and BNSTp of androgen receptor knockout (ARKO) mice. The volume and neuron number of the male BNSTp were smaller in ARKO mice than those in wild-type mice, while no significant effect of ARKO was found on the AVPV and female BNSTp. We also examined aromatase, ER alpha, and AR mRNA levels in the AVPV and BNSTp of wild-type and ARKO mice on embryonic day (ED) 18 and postnatal day (PD) 4. AR mRNA in the BNSTp and AVPV of wild-type mice was not expressed on ED18 and emerged on PD4. In the AVPV, the aromatase mRNA level was higher on ED18, although the ER alpha mRNA level was higher on PD4 without any effect of AR gene deletion. Aromatase and ER alpha mRNA levels in the male BNSTp were significantly increased on PD4 by AR gene deletion. These results suggest that estradiol signaling via ERa during the perinatal period and testosterone signaling via AR during the postnatal period are required for masculinization of the BNSTp, whereas the former is sufficient to defeminize the AVPV.	[Kanaya, Moeko; Thu, Chaw Kyi Tha; Tsukahara, Shinji] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan; [Tsuda, Mumeko C.; Sagoshi, Shoko; Nagata, Kazuyo; Morimoto, Chihiro; Ogawa, Sonoko] Univ Tsukuba, Lab Behav Neuroendocrinol, Tsukuba, Ibaraki, Japan; [Toda, Katsumi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi, Japan; [Kato, Shigeaki] Soma Cent Hosp, Fukushima, Japan	Saitama University; University of Tsukuba; Kochi University	Tsukahara, S (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan.	stsuka@mail.saitama-u.ac.jp	Kanaya, Moeko/K-8994-2017	Kanaya, Moeko/0000-0002-1856-8492	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23310043, 25670114, 23240057]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 23310043 and No. 25670114 to ST, and No. 23240057 to SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2014, EXP NEUROL, V259, P2, DOI 10.1016/j.expneurol.2014.01.021; Aung KH, 2013, NEUROTOXICOLOGY, V34, P226, DOI 10.1016/j.neuro.2012.09.008; BLEIER R, 1982, J COMP NEUROL, V212, P118, DOI 10.1002/cne.902120203; Bodo C, 2006, ENDOCRINOLOGY, V147, P415, DOI 10.1210/en.2005-0834; Brock O, 2013, ENDOCRINOLOGY, V154, P2739, DOI 10.1210/en.2013-1120; BYNE W, 1987, J NEUROSCI, V7, P2688; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; CLARO F, 1995, BRAIN RES BULL, V36, P1, DOI 10.1016/0361-9230(94)00118-K; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; DELABRIL A, 1987, DEV BRAIN RES, V32, P295, DOI 10.1016/0165-3806(87)90110-6; Durazzo A, 2007, NEUROSCI LETT, V419, P168, DOI 10.1016/j.neulet.2007.04.033; EMERY DE, 1976, PHYSIOL BEHAV, V17, P803, DOI 10.1016/0031-9384(76)90044-5; GUILLAMON A, 1988, DEV BRAIN RES, V44, P281, DOI 10.1016/0165-3806(88)90226-X; HINES M, 1992, BRAIN RES, V579, P321, DOI 10.1016/0006-8993(92)90068-K; Hisasue S, 2010, J SEX MED, V7, P1401, DOI 10.1111/j.1743-6109.2009.01669.x; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Juraska JM, 2013, HORM BEHAV, V64, P203, DOI 10.1016/j.yhbeh.2013.05.010; Kauffman AS, 2007, ENDOCRINOLOGY, V148, P1774, DOI 10.1210/en.2006-1540; Kawano H, 2003, P NATL ACAD SCI USA, V100, P9416, DOI 10.1073/pnas.1533500100; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Liu YC, 1997, J NEUROSCI, V17, P5245; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Maeda KI, 2007, REV ENDOCR METAB DIS, V8, P21, DOI 10.1007/s11154-007-9032-6; MARDON G, 1989, CELL, V56, P765, DOI 10.1016/0092-8674(89)90680-6; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; Patchev AV, 2004, FASEB J, V18, P1568, DOI 10.1096/fj.04-1959fje; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Schulz KM, 2009, ENDOCRINOLOGY, V150, P3690, DOI 10.1210/en.2008-1708; Schulz KM, 2004, HORM BEHAV, V45, P242, DOI 10.1016/j.yhbeh.2003.12.007; SIMERLY RB, 1989, MOL BRAIN RES, V6, P297, DOI 10.1016/0169-328X(89)90075-2; SIMERLY RB, 1985, NEUROENDOCRINOLOGY, V40, P501, DOI 10.1159/000124122; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; SIMERLY RB, 1985, BRAIN RES, V330, P55, DOI 10.1016/0006-8993(85)90007-1; SUMIDA H, 1993, NEUROSCI LETT, V151, P41, DOI 10.1016/0304-3940(93)90040-R; TERASAWA E, 1980, AM J PHYSIOL, V238, pE533, DOI 10.1152/ajpendo.1980.238.6.E533; Toda K, 2001, J ENDOCRINOL, V170, P99, DOI 10.1677/joe.0.1700099; Tsukahara S, 2011, NEUROENDOCRINOLOGY, V94, P137, DOI 10.1159/000327541; Tsukahara S, 2009, TOXICOL LETT, V185, P79, DOI 10.1016/j.toxlet.2008.12.001; VANLEEUWEN FW, 1985, BRAIN RES, V325, P391, DOI 10.1016/0006-8993(85)90348-8; Wittmann W, 2013, HORM BEHAV, V64, P605, DOI 10.1016/j.yhbeh.2013.08.017	42	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112616	10.1371/journal.pone.0112616	http://dx.doi.org/10.1371/journal.pone.0112616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398007	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500066
J	Rossi, S; Fortunati, I; Carnevali, L; Baruffi, S; Mastorci, F; Trombini, M; Sgoifo, A; Corradi, D; Callegari, S; Miragoli, M; Macchi, E				Rossi, Stefano; Fortunati, Ilaria; Carnevali, Luca; Baruffi, Silvana; Mastorci, Francesca; Trombini, Mimosa; Sgoifo, Andrea; Corradi, Domenico; Callegari, Sergio; Miragoli, Michele; Macchi, Emilio			The Effect of Aging on the Specialized Conducting System: A Telemetry ECG Study in Rats over a 6 Month Period	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AGE-ASSOCIATED CHANGES; VENTRICULAR ACTIVATION; ATRIAL-FIBRILLATION; IMPULSE CONDUCTION; CARDIAC TISSUE; QT INTERVAL; ARRHYTHMIAS; MYOCYTES; MODEL	Advanced age alone appears to be a risk factor for increased susceptibility to cardiac arrhythmias. We previously observed in the aged rat heart that sinus rhythm ventricular activation is delayed and characterized by abnormal epicardial patterns although conduction velocity is normal. While these findings relate to an advanced stage of aging, it is not yet known when and how ventricular electrical impairment originates and which is the underlying substrate. To address these points, we performed continuous telemetry ECG recordings in freely moving rats over a six-month period to monitor ECG waveform changes, heart rate variability and the incidence of cardiac arrhythmias. At the end of the study, we performed in-vivo multiple lead epicardial recordings and histopathology of cardiac tissue. We found that the duration of ECG waves and intervals gradually increased and heart rate variability gradually decreased with age. Moreover, the incidence of cardiac arrhythmias gradually increased, with atrial arrhythmias exceeding ventricular arrhythmias. Epicardial multiple lead recordings confirmed abnormalities in ventricular activation patterns, likely attributable to distal conducting system dysfunctions. Microscopic analysis of aged heart specimens revealed multifocal connective tissue deposition and perinuclear myocytolysis in the atria. Our results demonstrate that aging gradually modifies the terminal part of the specialized cardiac conducting system, creating a substrate for increased arrhythmogenesis. These findings may open new therapeutic options in the management of cardiac arrhythmias in the elderly population.	[Rossi, Stefano; Fortunati, Ilaria; Baruffi, Silvana; Mastorci, Francesca; Trombini, Mimosa; Macchi, Emilio] Univ Parma, Dept Life Sci, I-43100 Parma, Italy; [Carnevali, Luca; Sgoifo, Andrea] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Rossi, Stefano; Miragoli, Michele; Macchi, Emilio] Univ Parma, Ctr Excellence Toxicol Res, CERT, INAIL,Ex ISPESL, I-43100 Parma, Italy; [Corradi, Domenico] Univ Parma, Unit Pathol, Dept Biomed Biotechnol & Translat Sci S Bi Bi T, I-43100 Parma, Italy; [Callegari, Sergio] Fidenza Hosp, Div Cardiol, Fidenza, Italy; [Miragoli, Michele] Humanitas Clin & Res Ctr, Milan, Italy	University of Parma; University of Parma; University of Parma; University of Parma	Rossi, S (corresponding author), Univ Parma, Dept Life Sci, I-43100 Parma, Italy.	stefano.rossi@unipr.it; michele.miragoli@humanitasresearch.it; emilio.macchi@unipr.it	Carnevali, Luca/E-5322-2017; Sgoifo, Andrea/AAC-6278-2022; Carnevali, Luca/P-9508-2019; Corradi, Domenico/O-1666-2015; Rossi, Stefano/L-2556-2016; Miragoli, Michele/K-6418-2016	Carnevali, Luca/0000-0001-9053-7976; Sgoifo, Andrea/0000-0002-9428-6198; Carnevali, Luca/0000-0001-9053-7976; Corradi, Domenico/0000-0002-8836-4778; Rossi, Stefano/0000-0003-0346-8410; Miragoli, Michele/0000-0002-4058-4368	Fondazione CARIPARMA Grant [2006.0082]; Fondazione CARIPARMA Bilancio; Young Researcher Grant, Italian Ministry of Health [GR2009-1530528]	Fondazione CARIPARMA Grant; Fondazione CARIPARMA Bilancio(Fondazione Cariparma); Young Researcher Grant, Italian Ministry of Health	This research was supported by Fondazione CARIPARMA Grant 2006.0082, Fondazione CARIPARMA Bilancio 2010 to E.M. and Grant GR2009-1530528 Young Researcher Grant, Italian Ministry of Health to M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVERSA P, 1990, CIRC RES, V67, P871, DOI 10.1161/01.RES.67.4.871; Bao L, 2013, AGING CELL, V12, P167, DOI 10.1111/acel.12033; Berg BN, 1955, J GERONTOL, V10, P420, DOI 10.1093/geronj/10.4.420; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Boyett MR, 2006, ADV CARDIOL, V42, P175, DOI 10.1159/000092569; Chui RW, 2012, J PHARMACOL TOX MET, V66, P84, DOI 10.1016/j.vascn.2012.05.002; Colli-Franzone P, 2000, ANN BIOMED ENG, V28, P1326, DOI 10.1114/1.1327595; Corradi D, 2008, NAT CLIN PRACT CARD, V5, P782, DOI 10.1038/ncpcardio1370; Craft Noah, 1995, American Journal of Physiology, V268, pH1441; da Silva VJD, 2002, BRAZ J MED BIOL RES, V35, P1025, DOI 10.1590/S0100-879X2002000900003; Dhein S, 2001, N-S ARCH PHARMACOL, V364, P397; Dupont M, 2012, J AM COLL CARDIOL, V60, P592, DOI 10.1016/j.jacc.2012.03.059; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Ershler P. R., 1984, Computers in Cardiology (Cat. No. 84CH2078-4), P417; FLEG JL, 1990, J GERONTOL, V45, pM95, DOI 10.1093/geronj/45.3.M95; FRATICELLI A, 1989, AM J PHYSIOL, V257, pH259, DOI 10.1152/ajpheart.1989.257.1.H259; GOLDBERG RJ, 1991, AM J CARDIOL, V67, P55, DOI 10.1016/0002-9149(91)90099-7; Gupta Anoop K, 2002, Card Electrophysiol Rev, V6, P120, DOI 10.1023/A:1017963928016; Hayashi H, 2002, J CARDIOVASC ELECTR, V13, P801, DOI 10.1046/j.1540-8167.2002.00801.x; Huelsing DJ, 1998, AM J PHYSIOL-HEART C, V274, pH1163, DOI 10.1152/ajpheart.1998.274.4.H1163; Kaye DM, 2008, NEUROMOL MED, V10, P179, DOI 10.1007/s12017-008-8034-1; KUSUMOTO FM, 1995, J CARDIOVASC PHARM, V26, P348, DOI 10.1097/00005344-199509000-00002; Macchi E, 1998, AM J PHYSIOL-HEART C, V275, pH1886, DOI 10.1152/ajpheart.1998.275.5.H1886; MICHELUCCI A, 1984, INT J CARDIOL, V5, P75, DOI 10.1016/0167-5273(84)90060-3; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Miragoli M, 2011, HEPATOLOGY, V54, P1282, DOI 10.1002/hep.24492; ORCHARD CH, 1985, J GEN PHYSIOL, V86, P637, DOI 10.1085/jgp.86.5.637; PRESSLER ML, 1995, CARDIAC ELECTROPHYSI, P144; Rohr S, 1997, SCIENCE, V275, P841, DOI 10.1126/science.275.5301.841; Rossi S, 2007, P ANN INT IEEE EMBS, P410, DOI 10.1109/IEMBS.2007.4352311; Rossi S, 2008, AM J PHYSIOL-HEART C, V295, pH2336, DOI 10.1152/ajpheart.00517.2008; Saffitz JE, 1999, CARDIOVASC RES, V42, P309, DOI 10.1016/S0008-6363(99)00023-1; SCHAMROTH L, 1963, BRIT HEART J, V25, P219; Schwartz P. J., 1998, European Heart Journal, V19, pF72; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1403, DOI 10.1016/S0031-9384(96)00229-6; Spach MS, 2000, CIRC RES, V86, P302, DOI 10.1161/01.RES.86.3.302; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Stein M, 2008, HEART RHYTHM, V5, P438, DOI 10.1016/j.hrthm.2007.10.033; Surawicz B, 2008, CHOUS ELECTROCARDIOG, Vxiii, P327; Tamaddon HS, 2000, CIRC RES, V87, P929, DOI 10.1161/01.RES.87.10.929; Taneja T, 2001, PACE, V24, P16, DOI 10.1046/j.1460-9592.2001.00016.x; Villareal Rollo P, 2002, Curr Atheroscler Rep, V4, P120, DOI 10.1007/s11883-002-0035-1; WALKER KE, 1993, CARDIOVASC RES, V27, P1968, DOI 10.1093/cvr/27.11.1968; YIN FCP, 1980, CIRC RES, V46, P292, DOI 10.1161/01.RES.46.2.292; [No title captured]	46	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112697	10.1371/journal.pone.0112697	http://dx.doi.org/10.1371/journal.pone.0112697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398004	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500079
J	Golebiewska, EM; Harper, MT; Williams, CM; Savage, JS; Goggs, R; von Mollard, GF; Poole, AW				Golebiewska, Ewelina M.; Harper, Matthew T.; Williams, Christopher M.; Savage, Joshua S.; Goggs, Robert; von Mollard, Gabriele Fischer; Poole, Alastair W.			Syntaxin 8 Regulates Platelet Dense Granule Secretion, Aggregation, and Thrombus Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; SNARE; PROTEIN; EXOCYTOSIS; SNAP-23; RELEASE; TRAFFICKING; LOCALIZATION; FUSION; CELLS	Platelet secretion not only drives thrombosis and hemostasis, but also mediates a variety of other physiological and pathological processes. The ubiquitous SNARE machinery and a number of accessory proteins have been implicated in regulating secretion in platelet. Although several platelet SNAREs have been identified, further members of the SNARE family may be needed to fine-tune platelet secretion. In this study we identified expression of the t-SNARE syntaxin 8 (STX8) (Qc SNARE) in mouse and human platelets. In mouse studies, whereas STX8 was not essential for alpha-granule or lysosome secretion, Stx8(-/-) platelets showed a significant defect in dense granule secretion in response to thrombin and CRP. This was most pronounced at intermediate concentrations of agonists. They also showed an aggregation defect that could be rescued with exogenous ADP and increased embolization in Stx8(-/-) mice in vivo consistent with an important autocrine and paracrine role for ADP in aggregation and thrombus stabilization. STX8 therefore specifically contributes to dense granule secretion and represents another member of a growing family of genes that play distinct roles in regulating granule release from platelets and thus platelet function in thrombosis and hemostasis.	[Golebiewska, Ewelina M.; Harper, Matthew T.; Williams, Christopher M.; Poole, Alastair W.] Univ Walk, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Savage, Joshua S.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Goggs, Robert] Cornell Univ, Dept Clin Sci, Coll Vet Med, Ithaca, NY 14853 USA; [von Mollard, Gabriele Fischer] Univ Bielefeld, Fak Chem, D-33501 Bielefeld, Germany	University of Bristol; University of Birmingham; Cornell University; University of Bielefeld	Poole, AW (corresponding author), Univ Walk, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	a.poole@bris.ac.uk	von Mollard, Gabriele Fischer/A-3935-2012; von Mollard, Gabriele Fischer/O-9778-2019; Savage, Joshua/A-8738-2008; Harper, Matthew T/G-5630-2013	von Mollard, Gabriele Fischer/0000-0003-3236-1401; von Mollard, Gabriele Fischer/0000-0003-3236-1401; Savage, Joshua/0000-0003-0599-0245; Harper, Matthew T/0000-0002-4740-637X; Goggs, Robert/0000-0001-7446-6987; Poole, Alastair/0000-0002-0868-297X	British Heart Foundation [RG/10/006/28299, PG/12/25/29488, FS/09/009/26444]	British Heart Foundation(British Heart Foundation)	This work was supported by grants from the British Heart Foundation to A. W. P. (RG/10/006/28299, PG/12/25/29488, FS/09/009/26444).	Al Hawas R, 2012, BLOOD, V120, P2493, DOI 10.1182/blood-2012-05-430629; Ambrosio AL, 2012, BLOOD, V120, P4072, DOI 10.1182/blood-2012-04-420745; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Atlashkin V, 2003, MOL CELL BIOL, V23, P5198, DOI 10.1128/MCB.23.15.5198-5207.2003; Bilan F, 2004, J CELL SCI, V117, P1923, DOI 10.1242/jcs.01070; Bilan F, 2008, EXP CELL RES, V314, P2199, DOI 10.1016/j.yexcr.2008.04.012; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chen B, 2014, J BIOL CHEM, V289, P19556, DOI 10.1074/jbc.M114.567925; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; Cosemans JMEM, 2013, CARDIOVASC RES, V99, P342, DOI 10.1093/cvr/cvt110; Flaumenhaft R, 1999, J BIOL CHEM, V274, P2492, DOI 10.1074/jbc.274.4.2492; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Goggs R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054663; Golebiewska EM, 2014, BRIT J HAEMATOL, V165, P204, DOI 10.1111/bjh.12682; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Kasai K, 2001, J CELL SCI, V114, P3115; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; King SM, 2009, CIRCULATION, V120, P785, DOI 10.1161/CIRCULATIONAHA.108.845461; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lemons PP, 1997, BLOOD, V90, P1490, DOI 10.1182/blood.V90.4.1490.1490_1490_1500; Lemons PP, 2000, BIOCHEM BIOPH RES CO, V267, P875, DOI 10.1006/bbrc.1999.2039; Lewandrowski U, 2009, BLOOD, V114, pE10, DOI 10.1182/blood-2009-02-203828; Mollinedo F, 2006, J IMMUNOL, V177, P2831, DOI 10.4049/jimmunol.177.5.2831; Neumuller O, 2009, BLOOD, V114, P1396, DOI 10.1182/blood-2008-05-155234; Offenhauser C, 2011, TRAFFIC, V12, P762, DOI 10.1111/j.1600-0854.2011.01189.x; Pattu V, 2012, EUR J IMMUNOL, V42, P470, DOI 10.1002/eji.201141915; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Tang BL, 1998, BIOCHEM BIOPH RES CO, V245, P627, DOI 10.1006/bbrc.1998.8490; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; van den Bosch MTJ, 2014, J THROMB HAEMOST, V12, P726, DOI 10.1111/jth.12542; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Ye SJ, 2012, BLOOD, V120, P2484, DOI 10.1182/blood-2012-05-430603; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	50	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1536	1545		10.1074/jbc.M114.602615	http://dx.doi.org/10.1074/jbc.M114.602615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25404741	hybrid, Green Published			2022-12-26	WOS:000348056400023
J	Shen, S; Berry, GE; Rivera, RMC; Cheung, RY; Troupes, AN; Brown, SM; Kafri, T; Asokan, A				Shen, Shen; Berry, Garrett E.; Rivera, Ruth M. Castellanos; Cheung, Roland Y.; Troupes, Andrew N.; Brown, Sarah M.; Kafri, Tal; Asokan, Aravind			Functional Analysis of the Putative Integrin Recognition Motif on Adeno-associated Virus 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GENE-TRANSFER; TYPE-2 INFECTION; RNAI PHENOTYPES; BINDING DOMAIN; TRANSDUCTION; CORECEPTOR; IDENTIFICATION; DATABASE; SEROTYPE	Adeno-associated viruses (AAVs) display a highly conserved NGR motif on the capsid surface. Earlier studies have established this tripeptide motif as being essential for integrin-mediated uptake of recombinant AAV serotype 2 (AAV2) in cultured cells. However, functional attributes of this putative integrin recognition motif in other recombinant AAV serotypes displaying systemic transduction in vivo remain unknown. In this study, we dissect the biology of an integrin domain capsid mutant derived from the human isolate AAV9 in mice. The AAV9/NGA mutant shows decreased systemic transduction in mice. This defective phenotype was accompanied by rapid clearance of mutant virions from the blood circulation and nonspecific sequestration by the spleen. Transient vascular hyperpermeability, induced by histamine coinjection, exacerbated AAV9/NGA uptake by the spleen but not the liver. However, such treatment did not affect AAV9 virions, suggesting a potential entry/post-entry defect for the mutant in different tissues. Further characterization revealed modestly decreased cell surface binding but a more pronounced defect in the cellular entry of mutant virions. These findings were corroborated by the observation that blocking multiple integrins adversely affected recombinant AAV9 transduction in different cell types, albeit with variable efficiencies. From a structural perspective, we observed that the integrin recognition motif is located in close proximity to the galactose binding footprint on AAV9 capsids and postulate that this feature could influence cell surface attachment, cellular uptake at the tissue level, and systemic clearance by the reticuloendothelial system.	[Shen, Shen; Berry, Garrett E.; Rivera, Ruth M. Castellanos; Cheung, Roland Y.; Troupes, Andrew N.; Brown, Sarah M.; Kafri, Tal; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Berry, Garrett E.; Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Asokan, A (corresponding author), Univ N Carolina, Gene Therapy Ctr, CB 7352,5123 Thurston Bldg, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu	, BRIC Small Animal Imaging Facility/AEV-1023-2022	, BRIC Small Animal Imaging Facility/0000-0002-0535-3214	National Institutes of Health [R01HL089221, P01HL112761, R01-DK058702-10]; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221, P01HL112761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01HL089221 and P01HL112761 (to A. A.) and R01-DK058702-10 (to T. K.).	Adachi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4075; Asokan A, 2006, J VIROL, V80, P8961, DOI 10.1128/JVI.00843-06; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bell CL, 2012, J VIROL, V86, P7326, DOI 10.1128/JVI.00448-12; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Bowles D.E., 2006, PARVOVIRUSES, P15; Burns K, 2007, FIELDS VIROLOGY, P2437; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; DiMattia MA, 2012, J VIROL, V86, P6947, DOI 10.1128/JVI.07232-11; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gilsdorf M, 2010, NUCLEIC ACIDS RES, V38, pD448, DOI 10.1093/nar/gkp1038; Greelish JP, 1999, NAT MED, V5, P439, DOI 10.1038/7439; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; Horn T, 2007, NUCLEIC ACIDS RES, V35, pD492, DOI 10.1093/nar/gkl906; Kaminsky PM, 2012, MOL THER, V20, P972, DOI 10.1038/mt.2011.295; Kashiwakura Y, 2005, J VIROL, V79, P609, DOI 10.1128/JVI.79.1.609-614.2005; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Levy HC, 2009, J STRUCT BIOL, V165, P146, DOI 10.1016/j.jsb.2008.12.002; Ling C, 2010, HUM GENE THER, V21, P1741, DOI 10.1089/hum.2010.075; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; O'Donnell J, 2009, VIROLOGY, V385, P434, DOI 10.1016/j.virol.2008.11.037; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Petrov M, 2011, METHODS MOL BIOL, V709, P277, DOI 10.1007/978-1-61737-982-6_18; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170; Shen S, 2013, J BIOL CHEM, V288, P28814, DOI 10.1074/jbc.M113.482380; Shen S, 2012, J VIROL, V86, P10408, DOI 10.1128/JVI.01155-12; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; Wang JH, 2007, P NATL ACAD SCI USA, V104, P13104, DOI 10.1073/pnas.0702778104; Weller ML, 2010, NAT MED, V16, P662, DOI 10.1038/nm.2145; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Yang B, 2014, MOL THER, V22, P1299, DOI 10.1038/mt.2014.68	36	16	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1496	1504		10.1074/jbc.M114.608281	http://dx.doi.org/10.1074/jbc.M114.608281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25404742	Green Published, hybrid			2022-12-26	WOS:000348056400020
J	Rossi, G; Watson, K; Demonch, M; Temple, B; Brennwald, P				Rossi, Guendalina; Watson, Kelly; Demonch, Mallory; Temple, Brenda; Brennwald, Patrick			In Vitro Reconstitution of Rab GTPase-dependent Vesicle Clustering by the Yeast Lethal Giant Larvae/Tomosyn Homolog, Sro7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exocytosis; Membrane Reconstitution; Rab; Trafficking; Vesicles	GDP DISSOCIATION INHIBITOR; POST-GOLGI VESICLES; SECRETORY PATHWAY; PLASMA-MEMBRANE; BINDING-PROTEIN; SEC15 PROTEIN; EXOCYTOSIS; FAMILY; SNARE; COMPONENT	Background: The mechanism by which Rab GTPases and their effectors act in tethering is not well understood. Results: An in vitro assay was developed to study vesicle clustering by the Lgl family member Sro7. Conclusion: Clustering in vitro and in vivo depends on the conformation of the Rab GTPase and Sro7. Significance: This assay provides a new tool to dissect the role of Rab and Lgl family function. Intracellular traffic in yeast between the Golgi and the cell surface is mediated by vesicular carriers that tether and fuse in a fashion that depends on the function of the Rab GTPase, Sec4. Overexpression of either of two Sec4 effectors, Sro7 or Sec15, results in the formation of a cluster of post-Golgi vesicles within the cell. Here, we describe a novel assay that recapitulates post-Golgi vesicle clustering in vitro utilizing purified Sro7 and vesicles isolated from late secretory mutants. We show clustering in vitro closely replicates the in vivo clustering process as it is highly dependent on both Sro7 and GTP-Sec4. We also make use of this assay to characterize a novel mutant form of Sro7 that results in a protein that is specifically defective in vesicle clustering both in vivo and in vitro. We show that this mutation acts by effecting a conformational change in Sro7 from the closed to a more open structure. Our analysis demonstrates that the N-terminal propeller needs to be able to engage the C-terminal tail for vesicle clustering to occur. Consistent with this, we show that occupancy of the N terminus of Sro7 by the t-SNARE Sec9, which results in the open conformation of Sro7, also acts to inhibit vesicle cluster formation by Sro7. This suggests a model by which a conformational switch in Sro7 acts to coordinate Rab-mediated vesicle tethering with SNARE assembly by requiring a single conformational state for both of these processes to occur.	[Rossi, Guendalina; Watson, Kelly; Demonch, Mallory; Brennwald, Patrick] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Temple, Brenda] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Brennwald, P (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, 522 Taylor Hall, Chapel Hill, NC 27599 USA.	pjbrennw@med.unc.edu			National Institutes of Health [GM-054712]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-054712.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; BOWSER R, 1991, J CELL BIOL, V112, P1117, DOI 10.1083/jcb.112.6.1117; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Forsmark A, 2011, TRAFFIC, V12, P740, DOI 10.1111/j.1600-0854.2011.01186.x; Gangar A, 2005, CURR BIOL, V15, P1136, DOI 10.1016/j.cub.2005.05.046; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Jantti J, 2002, J CELL SCI, V115, P409; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lipatova Z, 2008, MOL BIOL CELL, V19, P4177, DOI 10.1091/mbc.E08-02-0220; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Mulholland J, 1997, MOL BIOL CELL, V8, P1481, DOI 10.1091/mbc.8.8.1481; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Rossi G, 2011, MOL BIOL CELL, V22, P842, DOI 10.1091/mbc.E10-07-0570; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; WALWORTH NC, 1987, J CELL BIOL, V105, P163, DOI 10.1083/jcb.105.1.163; Zhang XY, 2005, J CELL BIOL, V170, P273, DOI 10.1083/jcb.200502055	24	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					612	624		10.1074/jbc.M114.595892	http://dx.doi.org/10.1074/jbc.M114.595892			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404740	Green Published, hybrid			2022-12-26	WOS:000347231200053
J	Smrt, ST; Draney, AW; Lorieau, JL				Smrt, Sean T.; Draney, Adrian W.; Lorieau, Justin L.			The Influenza Hemagglutinin Fusion Domain Is an Amphipathic Helical Hairpin That Functions by Inducing Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Influenza; Membrane Fusion; Membrane Protein; Nuclear Magnetic Resonance (NMR); Structural Biology; Fusion Peptide	MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; VIRUS HEMAGGLUTININ; PHASE-TRANSITIONS; DIPOLAR COUPLINGS; NEGATIVE-CURVATURE; BACKBONE DYNAMICS; PEPTIDE ANALOGS; SIALIC-ACID; BILAYER	Background: The influenza hemagglutinin fusion peptide is responsible for fusion of viral and endosomal membranes upon infection. Results: Negatively induced curvature and fusion activity were significantly reduced by changing the shape of the fusion peptide. Conclusion: The hemagglutinin fusion peptide structure promotes negative membrane curvature. Significance: This work enables elucidates how a crucial component of influenza infection functions and can be targeted. The highly conserved N-terminal 23 residues of the hemagglutinin glycoprotein, known as the fusion peptide domain (HAfp23), is vital to the membrane fusion and infection mechanism of the influenza virus. HAfp23 has a helical hairpin structure consisting of two tightly packed amphiphilic helices that rest on the membrane surface. We demonstrate that HAfp23 is a new class of amphipathic helix that functions by leveraging the negative curvature induced by two tightly packed helices on membranes. The helical hairpin structure has an inverted wedge shape characteristic of negative curvature lipids, with a bulky hydrophobic region and a relatively small hydrophilic head region. The F3G mutation reduces this inverted wedge shape by reducing the volume of its hydrophobic base. We show that despite maintaining identical backbone structures and dynamics as the wild type HAfp23, the F3G mutant has an attenuated fusion activity that is correlated to its reduced ability to induce negative membrane curvature. The inverted wedge shape of HAfp23 is likely to play a crucial role in the initial stages of membrane fusion by stabilizing negative curvature in the fusion stalk.	[Smrt, Sean T.; Draney, Adrian W.; Lorieau, Justin L.] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lorieau, JL (corresponding author), Univ Illinois, Dept Chem, 845 W Taylor St,4500SES, Chicago, IL 60607 USA.	Justin@lorieau.com		Draney, Adrian/0000-0002-2247-4667	Department of Chemistry at the University of Illinois at Chicago (UIC); UIC Campus Research Board grant	Department of Chemistry at the University of Illinois at Chicago (UIC); UIC Campus Research Board grant	This work was supported by the Department of Chemistry at the University of Illinois at Chicago (UIC) and a UIC Campus Research Board grant. Portions of this work were carried out in the Center for Structural Biology via the Research Resources Center at UIC.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P249; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Best RB, 2006, STRUCTURE, V14, P97, DOI 10.1016/j.str.2005.09.012; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; CHERNOMORDIK L, 1995, BIOPHYS J, V69, P922, DOI 10.1016/S0006-3495(95)79966-0; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; CHERNOMORDIK LV, 1985, BIOCHIM BIOPHYS ACTA, V812, P643, DOI 10.1016/0005-2736(85)90257-3; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Clancy S, 2008, NAT ED, V1, P1, DOI DOI https://doi.org/10.1038/nrm2351.pdf; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; Cross KJ, 2001, EMBO J, V20, P4432, DOI 10.1093/emboj/20.16.4432; Davies SMA, 1998, BIOCHEMISTRY-US, V37, P5720, DOI 10.1021/bi980227v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Donald JE, 2011, P NATL ACAD SCI USA, V108, P3958, DOI 10.1073/pnas.1019668108; Draney AW, 2014, LANGMUIR, V30, P11723, DOI 10.1021/la5030668; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Dubovskii PV, 2000, PROTEIN SCI, V9, P786; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; EPAND RF, 1994, BIOCHEM BIOPH RES CO, V205, P1938, DOI 10.1006/bbrc.1994.2897; EPAND RM, 1990, CHEM PHYS LIPIDS, V52, P227, DOI 10.1016/0009-3084(90)90118-B; EPAND RM, 1991, CHEM PHYS LIPIDS, V57, P75, DOI 10.1016/0009-3084(91)90051-C; EPAND RM, 1995, BIOPOLYMERS, V37, P319, DOI 10.1002/bip.360370504; EPAND RM, 1985, BIOCHEMISTRY-US, V24, P7092, DOI 10.1021/bi00346a011; EPAND RM, 1994, BIOCHEM BIOPH RES CO, V202, P1420, DOI 10.1006/bbrc.1994.2089; Epand RM, 2001, BIOCHEMISTRY-US, V40, P8800, DOI 10.1021/bi0107187; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fitzkee NC, 2011, PROTEIN SCI, V20, P500, DOI 10.1002/pro.582; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fuhrmans M, 2012, J AM CHEM SOC, V134, P1543, DOI 10.1021/ja207290b; GARTEN W, 1983, J GEN VIROL, V64, P2127, DOI 10.1099/0022-1317-64-10-2127; Goddard TD, 2008, SPARKY VERSION 3; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Haque ME, 2004, BIOCHEMISTRY-US, V43, P3507, DOI 10.1021/bi035794j; HAY AJ, 1974, VIROLOGY, V60, P398, DOI 10.1016/0042-6822(74)90335-3; Jordanova A, 2003, EUR BIOPHYS J BIOPHY, V31, P626, DOI 10.1007/s00249-002-0263-x; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387; KOYNOVA R, 1994, CHEM PHYS LIPIDS, V69, P1, DOI 10.1016/0009-3084(94)90024-8; KOZLOV MM, 1989, EUR BIOPHYS J BIOPHY, V17, P121; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lai AL, 2007, J BIOL CHEM, V282, P23946, DOI 10.1074/jbc.M704008200; Larsson P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002950; LEAR JD, 1987, J BIOL CHEM, V262, P6500; Leikin S, 1996, BIOPHYS J, V71, P2623, DOI 10.1016/S0006-3495(96)79454-7; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lorieau JL, 2013, BIOPOLYMERS, V99, P189, DOI 10.1002/bip.22102; Lorieau JL, 2012, P NATL ACAD SCI USA, V109, P19994, DOI 10.1073/pnas.1213801109; Lorieau JL, 2011, J AM CHEM SOC, V133, P14184, DOI 10.1021/ja2045309; Lorieau JL, 2011, J AM CHEM SOC, V133, P2824, DOI 10.1021/ja1099775; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Markin VS, 2002, BIOPHYS J, V82, P693, DOI 10.1016/S0006-3495(02)75432-5; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ottiger M, 1999, J BIOMOL NMR, V13, P187, DOI 10.1023/A:1008395916985; Pomorski TG, 2014, ADV COLLOID INTERFAC, V205, P207, DOI 10.1016/j.cis.2013.10.028; Qiang W, 2009, P NATL ACAD SCI USA, V106, P15314, DOI 10.1073/pnas.0907360106; Risselada HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038302; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Schmick SD, 2010, BIOCHEMISTRY-US, V49, P10623, DOI 10.1021/bi101389r; Siegel DP, 2000, BBA-BIOMEMBRANES, V1468, P87, DOI 10.1016/S0005-2736(00)00246-7; SIEGEL DP, 1993, BIOPHYS J, V65, P2124, DOI 10.1016/S0006-3495(93)81256-6; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; SKEHEL JJ, 1978, J GEN VIROL, V39, P1, DOI 10.1099/0022-1317-39-1-1; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; STEGMANN T, 1986, J BIOL CHEM, V261, P966; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tenchov BG, 2008, BBA-BIOMEMBRANES, V1778, P2405, DOI 10.1016/j.bbamem.2008.07.022; Tenchov BG, 2013, BIOPHYS J, V104, P1029, DOI 10.1016/j.bpj.2012.12.034; TYTLER EM, 1993, J BIOL CHEM, V268, P22112; WHARTON SA, 1988, J GEN VIROL, V69, P1847, DOI 10.1099/0022-1317-69-8-1847; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Yao HW, 2014, J AM CHEM SOC, V136, P2611, DOI 10.1021/ja4121956; Zhang Y.Z., 1995, THESIS U PENNSYLVANI; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	87	28	28	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					228	238		10.1074/jbc.M114.611657	http://dx.doi.org/10.1074/jbc.M114.611657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398882	Green Published, hybrid			2022-12-26	WOS:000347231200019
J	Al-Hajoj, S; Memish, Z; Abuljadayel, N; AlHakeem, R; AlRabiah, F; Varghese, B				Al-Hajoj, Sahal; Memish, Ziad; Abuljadayel, Naila; AlHakeem, Raafat; AlRabiah, Fahad; Varghese, Bright			Molecular Confirmation of Bacillus Calmette Guerin Vaccine Related Adverse Events among Saudi Arabian Children	PLOS ONE			English	Article							BCG VACCINE; MYCOBACTERIUM-TUBERCULOSIS; LYMPHADENITIS; INFECTION; STRAIN; CONSANGUINITY; METAANALYSIS; MENINGITIS; DISORDERS; DISEASE	Background: Bacillus Calmette Guerin (BCG) is the only available vaccine for tuberculosis (TB). Low grade complications in healthy recipients and disseminated vaccine associated complications among immuno-suppressed individuals were noticed globally after administration. Recently a series of clinically suspected BCG associated suppurative and non-suppurative lymphadenitis cases were reported from different regions of Saudi Arabia. However a molecular confirmative analysis was lacking to prove these claims. Methodology: During 2009-2010, 42 Mycobacterium bovis BCG suspected clinical isolates from children diagnosed with suppurative lymphadenitis from different provinces of the country were collected and subjected to 24 loci based MIRU-VNTR typing, spoligotyping and first line anti-TB drugs susceptibility testing. Principal Findings: Of the total 42 cases, 41 (97.6%) were Saudi nationals and particularly male (64.3%). Majority of the cases were aged below 6 months (83.3%) with a median of age 4 months. All the enrolled subjects showed left axillary mass which suppurated in a median of 4 months after vaccination. Among the study subjects, 1 (2.4%) case was reactive to HIV antigen and 2 (4.8%) case had severe combined immunodeficiency. Genotyping results showed that, 41 (97.6%) isolates were identical to the vaccine strain Danish 1331 and one to Tokyo 172-1. Phylogenetic analysis revealed all the Danish 1331 isolates in a single cluster. Conclusion: Elevated proportion of suppurative lymphadenitis caused by M. bovis BCG reported in the country recently is majorly related to the vaccine strain Danish 1331. However lack of nationwide data on real magnitude of BCG related adverse events warrants population centric, long term future studies.	[Al-Hajoj, Sahal; Varghese, Bright] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Memish, Ziad; Abuljadayel, Naila; AlHakeem, Raafat] Minist Hlth, Prevent Med Directorate, Riyadh, Saudi Arabia; [AlRabiah, Fahad] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Ministry of Health - Saudi Arabia; King Faisal Specialist Hospital & Research Center	Al-Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	hajoj@kfshrc.edu.sa	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia [AT-26/110]	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia	SA received a grant from King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia (www.kacst.edu.sa, grant code AT-26/110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bhlal LA, 2001, DIAGN CYTOPATHOL, V24, P333, DOI 10.1002/dc.1071; Al-Salem AH, 2012, SAUDI MED J, V33, P172; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Alrabiaah AA, 2012, ANN SAUDI MED, V32, P4, DOI 10.5144/0256-4947.2012.4; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Benamar F, 2001, THERAPIE, V56, P739; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brewer TF, 2000, CLIN INFECT DIS, V31, pS64, DOI 10.1086/314072; Bukhari E, 2012, INDIAN J PATHOL MICR, V55, P202, DOI 10.4103/0377-4929.97869; Calmette A, 1931, Proc R Soc Med, V24, P1481; CASANOVA JL, 1995, LANCET, V346, P581, DOI 10.1016/S0140-6736(95)91421-8; Casanova JL, 1996, PEDIATRICS, V98, P774; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; DeSimone JA, 2000, ANN INTERN MED, V133, P447, DOI 10.7326/0003-4819-133-6-200009190-00013; El Mouzan MI, 2008, ANN SAUDI MED, V28, P169, DOI 10.5144/0256-4947.2008.169; ELHAZMI MAF, 1995, J MED GENET, V32, P623, DOI 10.1136/jmg.32.8.623; GONZALEZ B, 1989, PEDIATR INFECT DIS J, V8, P201; Goraya JS, 2002, POSTGRAD MED J, V78, P327, DOI 10.1136/pmj.78.920.327; HENGSTER P, 1992, ARCH DIS CHILD, V67, P952, DOI 10.1136/adc.67.7.952; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lee PPW, 2008, PEDIATR INFECT DIS J, V27, P224, DOI 10.1097/INF.0b013e31815b494c; Lotte A, 1988, Bull Int Union Tuberc Lung Dis, V63, P47; Lotte A, 1984, Adv Tuberc Res, V21, P194; Lotte A, 1984, Adv Tuberc Res, V21, P107; Mansouri D, 2005, EUR J PEDIATR, V164, P753, DOI 10.1007/s00431-005-1689-9; Markey K, 2010, VACCINE, V28, P6964, DOI [10.1016/j.vaccine.2010.08.045, 10.1016/j.vaccine.2010.07.086]; Mazroa Mohammed A A I, 2012, PLoS One, V7, pe45919, DOI 10.1371/journal.pone.0045919; MILSTIEN JB, 1990, B WORLD HEALTH ORGAN, V68, P93; Mori T, 1996, TUBERCLE LUNG DIS, V77, P269, DOI 10.1016/S0962-8479(96)90012-X; Poyntz HC, 2014, TUBERCULOSIS, V94, P226, DOI 10.1016/j.tube.2013.12.006; Prando C, 2013, MEDICINE, V92, P109, DOI 10.1097/MD.0b013e31828a01f9; Ritz N, 2008, FEMS MICROBIOL REV, V32, P821, DOI 10.1111/j.1574-6976.2008.00118.x; Ritz N, 2009, ANTIMICROB AGENTS CH, V53, P316, DOI 10.1128/AAC.01302-08; RODRIGUES LC, 1990, T ROY SOC TROP MED H, V84, P739, DOI 10.1016/0035-9203(90)90172-B; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Sadeghi-Shabestari M, 2009, INT J INFECT DIS, V13, pE420, DOI 10.1016/j.ijid.2009.02.008; Singla A, 2002, PEDIATR INFECT DIS J, V21, P446, DOI 10.1097/00006454-200205000-00026; Suliaman F, 2006, ALLERGY IMMUNOL, V19, P14; Suliaman Fawzi, 2009, Pediatric Asthma Allergy & Immunology, V22, P21, DOI 10.1089/pai.2008.0513; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; TARDIEU M, 1988, LANCET, V1, P440; Turnbull FM, 2002, CLIN INFECT DIS, V34, P447, DOI 10.1086/338462; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	44	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113472	10.1371/journal.pone.0113472	http://dx.doi.org/10.1371/journal.pone.0113472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409184	gold, Green Published, Green Submitted			2022-12-26	WOS:000345533200124
J	Ngamphiw, C; Tongsima, S; Mutirangura, A				Ngamphiw, Chumpol; Tongsima, Sissades; Mutirangura, Apiwat			Roles of Intragenic and Intergenic L1s in Mouse and Human	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; LINE-1 ELEMENTS; HUMAN GENOME; RETROTRANSPOSON SUBFAMILY; REPEAT HYPOTHESIS; EVOLUTION; MAMMALS; EMBRYO; IMPACT; GENES	Long INterspersed Element-1 (LINE-1 or L1) is a retrotransposable element that has shaped the evolution of mammalian genomes. There is increasing evidence that transcriptionally active L1 could have been co-opted through evolution to play various roles including X-inactivation, homologous recombination and gene regulation. Here, we compare putatively active L1 distributions in the mouse with human. L1 density is higher in the mouse except for the Y-chromosome. L1 density is the highest in X-chromosome, implying an X-inactivation role. L1 is more common outside genes (intergenic) except for the Y-chromosome in both species. The structure of mouse L1 is distinguished from human L1 by the presence of a 200 bp repeat in the 5' UTR of the former. We found that mouse intragenic L1 has significantly higher repeat copy numbers than intergenic L1, suggesting that this is important for control of L1 expression. Furthermore, a significant association between the presence of intragenic L1s and down-regulated genes in early embryogenesis was found in both species. In conclusion, the distribution of L1 in the mouse genome points to biological roles of L1 in mouse similar to human.	[Ngamphiw, Chumpol] Chulalongkorn Univ, Fac Grad Sch, Interdept Program Biomed Sci, Bangkok 10330, Thailand; [Ngamphiw, Chumpol; Tongsima, Sissades] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Genome Technol Res Unit, Pathum Thani, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Dept Anat, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok 10330, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University	Mutirangura, A (corresponding author), Chulalongkorn Univ, Fac Med, Dept Anat, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok 10330, Thailand.	apiwat.mutirangura@gmail.com	Ngamphiw, Chumpol/ABB-6488-2021; Tongsima, Sissades/F-4891-2011	Ngamphiw, Chumpol/0000-0002-8581-397X; Tongsima, Sissades/0000-0002-1491-1839	National Science and Technology Development Agency (NSTDA), Thailand; National Center for Genetic Engineering and Biotechnology (BIOTEC); Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University; BIOTEC; Chulalongkorn University	National Science and Technology Development Agency (NSTDA), Thailand; National Center for Genetic Engineering and Biotechnology (BIOTEC); Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University(Chulalongkorn University); BIOTEC; Chulalongkorn University(Chulalongkorn University)	This work is funded by the 2011 Research Chair Grant from the National Science and Technology Development Agency (NSTDA), Thailand. CN is partly supported by the National Center for Genetic Engineering and Biotechnology (BIOTEC) and the Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University. ST and AM are partially supported by BIOTEC and Chulalongkorn University, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aporntewan C, 2011, ASIAN BIOMED, V5, P257, DOI 10.5372/1905-7415.0502.034; Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Cantrell MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006252; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; dos Santos Silva I, 1999, CANC EPIDEMIOLOGY PR, P305; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hormozdiari F, 2013, P NATL ACAD SCI USA, V110, P13457, DOI 10.1073/pnas.1310914110; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Khowutthitham S, 2012, GENES GENOM, V34, P517, DOI 10.1007/s13258-012-0058-0; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030649; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Ovchinnikov I, 2002, P NATL ACAD SCI USA, V99, P10522, DOI 10.1073/pnas.152346799; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Scott LA, 2006, CYTOGENET GENOME RES, V112, P261, DOI 10.1159/000089880; SEVERYNSE DM, 1992, MAMM GENOME, V2, P41, DOI 10.1007/BF00570439; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Wanichnopparat W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-205; Waters PD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000158; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Zemojtel T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-392; Zimmerman DW, 1997, J EDUC BEHAV STAT, V22, P349, DOI 10.3102/10769986022003349	41	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113434	10.1371/journal.pone.0113434	http://dx.doi.org/10.1371/journal.pone.0113434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	25409429	gold, Green Submitted, Green Published			2022-12-26	WOS:000345533200121
J	Kennefick, M; Maslovat, D; Carlsen, AN				Kennefick, Michael; Maslovat, Dana; Carlsen, Anthony N.			The Time Course of Corticospinal Excitability during a Simple Reaction Time Task	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VOLUNTARY MOVEMENT; MOTOR; INHIBITION; HUMANS; SYSTEM	The production of movement in a simple reaction time task can be separated into two time periods: the foreperiod, which is thought to include preparatory processes, and the reaction time interval, which includes initiation processes. To better understand these processes, transcranial magnetic stimulation has been used to probe corticospinal excitability at various time points during response preparation and initiation. Previous research has shown that excitability decreases prior to the "go" stimulus and increases following the "go"; however these two time frames have been examined independently. The purpose of this study was to measure changes in CE during both the foreperiod and reaction time interval in a single experiment, relative to a resting baseline level. Participants performed a button press movement in a simple reaction time task and excitability was measured during rest, the foreperiod, and the reaction time interval. Results indicated that during the foreperiod, excitability levels quickly increased from baseline with the presentation of the warning signal, followed by a period of stable excitability leading up to the "go" signal, and finally a rapid increase in excitability during the reaction time interval. This excitability time course is consistent with neural activation models that describe movement preparation and response initiation.	[Kennefick, Michael; Carlsen, Anthony N.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Maslovat, Dana] Langara Coll, Dept Kinesiol, Vancouver, BC, Canada; [Maslovat, Dana] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada	University of Ottawa; University of British Columbia	Carlsen, AN (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	tony.carlsen@uottawa.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [RGPIN 418361-2012]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN 418361-2012; www.nserc-crsng.gc.ca/index_eng.asp) awarded to ANC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Carlsen AN, 2010, BRAIN RES, V1322, P38, DOI 10.1016/j.brainres.2010.01.076; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Deecke L, 1996, COGNITIVE BRAIN RES, V3, P59, DOI 10.1016/0926-6410(95)00046-1; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Hallett M., 2003, BEREITSCHAFTSPOTENTI; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hasbroucq T, 1997, COGNITIVE BRAIN RES, V5, P185, DOI 10.1016/S0926-6410(96)00069-9; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; MacKinnon CD, 2000, J PHYSIOL-LONDON, V528, P633, DOI 10.1111/j.1469-7793.2000.00633.x; NAZIR TA, 1991, PSYCHOL RES-PSYCH FO, V53, P281, DOI 10.1007/BF00920481; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; Requin J., 1991, HDB COGNITIVE PSYCHO, P357; Rossini P M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P171; ROSSINI PM, 1988, BRAIN RES, V458, P20, DOI 10.1016/0006-8993(88)90491-X; STARR A, 1988, ELECTROEN CLIN NEURO, V70, P26, DOI 10.1016/0013-4694(88)90191-5; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Thickbroom GW, 2000, BRAIN RES, V874, P233, DOI 10.1016/S0006-8993(00)02588-9; Touge T, 1998, ELECTROMYOGR MOTOR C, V109, P489, DOI 10.1016/S0924-980X(98)00050-2; WICKENS J, 1994, J MOTOR BEHAV, V26, P66, DOI 10.1080/00222895.1994.9941663	26	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113563	10.1371/journal.pone.0113563	http://dx.doi.org/10.1371/journal.pone.0113563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25406079	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300121
J	Kumar, T; Sharma, GS; Singh, LR				Kumar, Tarun; Sharma, Gurumayum Suraj; Singh, Laishram Rajendrakumar			Existence of Molten Globule State in Homocysteine-Induced Protein Covalent Modifications	PLOS ONE			English	Article							TRANSFER RNA-SYNTHETASE; EGG-WHITE LYSOZYME; CYTOCHROME-C; N-HOMOCYSTEINYLATION; PATHOLOGICAL CONSEQUENCES; GUANIDINE-HYDROCHLORIDE; CARDIOVASCULAR-DISEASE; POSSIBLE MECHANISM; SULFHYDRYL-GROUPS; THIOLACTONE	Homocysteine thiolactone is a toxic metabolite produced from homocysteine by amino-acyl t-RNA synthetase in error editing reaction. The basic cause of toxicity of homocysteine thiolactone is believed to be due to the adduct formation with lysine residues (known as protein N-homocysteinylation) leading to protein aggregation and loss of enzyme function. There was no data available until now that showed the effect of homocysteine thiolactone on the native state structural changes that led to aggregate formation. In the present study we have investigated the time dependent structural changes due to homocysteine thiolactone induced modifications on three different proteins having different physico-chemical properties (cytochrome-c, lysozyme and alpha lactalbumin). We discovered that N-homocysteinylation leads to the formation of molten globule state-an important protein folding intermediate in the protein folding pathway. We also found that the formation of the molten globule state might be responsible for the appearance of aggregate formation. The study indicates the importance of protein folding intermediate state in eliciting the homocysteine thiolactone toxicity.	[Kumar, Tarun; Sharma, Gurumayum Suraj; Singh, Laishram Rajendrakumar] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi	Singh, LR (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	lairksingh@gmail.com		Sharma, Gurumayum Suraj/0000-0002-7924-2031	University of Delhi (DRCH/RD); Council of Scientific and Industrial Research [09/045(1131)/2011-EMR-1]; Department of Science and Technology [SR/SO/BB-0003/2011]	University of Delhi (DRCH/RD); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	This work is supported by the grant provided by University of Delhi (DRCH/R&D). LRS, TK and GSS acknowledge Council of Scientific and Industrial Research (File No.: 09/045(1131)/2011-EMR-1) and Department of Science and Technology (Ref No.: SR/SO/BB-0003/2011) for the financial assistance provided in the form of research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2010, PROTEIN PEPTIDE LETT, V17, P11, DOI 10.2174/092986610789909502; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; BUTTERWORTH PH, 1967, ARCH BIOCHEM BIOPHYS, V118, P716, DOI 10.1016/0003-9861(67)90409-2; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fedunova D, 2006, BIOTECHNOL BIOENG, V93, P485, DOI 10.1002/bit.20733; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; Hameed M, 2007, J BIOCHEM, V141, P573, DOI 10.1093/jb/mvm057; Iram A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072075; Jacobsen DW, 1998, CLIN CHEM, V44, P1833; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; Jakubowski H, 2000, J BIOL CHEM, V275, P3957, DOI 10.1074/jbc.275.6.3957; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 2002, ANAL BIOCHEM, V308, P112, DOI 10.1016/S0003-2697(02)00224-5; JAKUBOWSKI H, 1991, EMBO J, V10, P593, DOI 10.1002/j.1460-2075.1991.tb07986.x; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jalili S, 2011, PROTEIN J, V30, P299, DOI 10.1007/s10930-011-9333-1; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Khazaei S, 2012, PROTEIN J, V31, P717, DOI 10.1007/s10930-012-9451-4; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Kuwajima K., 2002, PINSA-A (Proceedings of the Indian National Science Academy) Part A (Physical Sciences), V68, P333; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Naeem A, 2004, INT J BIOCHEM CELL B, V36, P2281, DOI 10.1016/j.biocel.2004.04.023; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Perla-Kajan J, 2007, BIOCHEMISTRY-US, V46, P6225, DOI 10.1021/bi602463m; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rabbani G, 2014, APPL MICROBIOL BIOT, V98, P2533, DOI 10.1007/s00253-013-5123-3; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Raman B, 1996, J BIOL CHEM, V271, P17067, DOI 10.1074/jbc.271.29.17067; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Stroylova YY, 2012, ARCH BIOCHEM BIOPHYS, V526, P29, DOI 10.1016/j.abb.2012.06.008; Stroylova YY, 2011, BBA-PROTEINS PROTEOM, V1814, P1234, DOI 10.1016/j.bbapap.2011.05.017; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x; Yousefi R, 2012, INT J BIOL MACROMOL, V51, P291, DOI 10.1016/j.ijbiomac.2012.05.021; Zang TZ, 2009, ANAL CHEM, V81, P9065, DOI 10.1021/ac9017132	45	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113566	10.1371/journal.pone.0113566	http://dx.doi.org/10.1371/journal.pone.0113566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UZ	25405350	Green Submitted, Green Published, gold			2022-12-26	WOS:000347121300122
J	Triscoli, C; Ackerley, R; Sailer, U				Triscoli, Chantal; Ackerley, Rochelle; Sailer, Uta			Touch Satiety: Differential Effects of Stroking Velocity on Liking and Wanting Touch Over Repetitions	PLOS ONE			English	Article							SENSORY-SPECIFIC SATIETY; UNMYELINATED C FIBERS; HAIRY SKIN; CUTANEOUS MECHANORECEPTORS; TACTILE AFFERENTS; INSULAR CORTEX; FOOD REWARD; BRAIN; HUMANS; RESPONSES	A slow, gentle caress of the skin is a salient hedonic stimulus. Low threshold, unmyelinated C-tactile afferents fire preferentially to this type of touch, where slow (< 1 cm/s) and fast (> 10 cm/s) stroking velocities produce lower firing frequencies and are rated as less pleasant. The current aim was to investigate how the experience of tactile pleasantness changes with repeated exposure (satiety to touch). A further aim was to determine whether tactile satiety varied with different stroking velocities. The experimental paradigm used a controlled brush stroke to the forearm that was delivered repeatedly for similar to 50 minutes. In Experiment 1, brush strokes were administered at three different velocities (0.3 cm/s, 3 cm/s and 30 cm/s), which were presented in a pseudo-randomised order. In Experiment 2, brush strokes were applied using only one velocity (either 3 or 30 cm/s). After each stroke, the participants rated both subjective pleasantness (liking) and wanting (the wish to be further exposed to the same stimulus) for each tactile sensation. In Experiment 1, both pleasantness and wanting showed a small, but significant, decrease over repetitions during stroking at 3 cm/s only, where the mean values for pleasantness and wanting were similar. Conversely, slower (0.3 cm/s) and faster (30 cm/s) stroking showed no decrease in ratings over time, however pleasantness was rated higher than wanting. In Experiment 2, both pleasantness and wanting showed a significant decrease over repetitions for both applied velocities, with a larger decrease in ratings for stroking at 3 cm/s. In conclusion, satiety to touch occurred with a slow onset and progression, where pleasantness and wanting ratings to stroking at 3 cm/s were affected more than at the slower or faster velocities. Tactile satiety appears to differ compared to appetitive and olfactory satiety, because the hedonic and rewarding aspects of touch persist for some time.	[Triscoli, Chantal; Sailer, Uta] Univ Gothenburg, Dept Psychol, S-40020 Gothenburg, Sweden; [Triscoli, Chantal; Ackerley, Rochelle; Sailer, Uta] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Ackerley, Rochelle; Sailer, Uta] Univ Gothenburg, Dept Psychol, Inst Neurosci & Physiol, S-40020 Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg	Sailer, U (corresponding author), Univ Gothenburg, Dept Psychol, Box 14158, S-40020 Gothenburg, Sweden.	uta.sailer@psy.gu.se	Ackerley, Rochelle/Q-5719-2017	Ackerley, Rochelle/0000-0003-4621-7929	Swedish Research Council [2011-1529]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Swedish Research Council (grant 2011-1529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; Ackerley R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00054; BARKER DJ, 1982, NEUROSCI LETT, V30, P117, DOI 10.1016/0304-3940(82)90282-8; Bellisle F, 2012, J NUTR, V142, p1149S, DOI 10.3945/jn.111.149583; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; CAIN WS, 1978, PERCEPTION, V7, P459, DOI 10.1068/p070459; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; CORNELL CE, 1989, PHYSIOL BEHAV, V45, P695, DOI 10.1016/0031-9384(89)90281-3; Croy I, 2013, INT J PSYCHOPHYSIOL, V88, P104, DOI 10.1016/j.ijpsycho.2013.02.005; Dawson SJ, 2013, J SEX MED, V10, P990, DOI 10.1111/jsm.12032; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; GRICE GR, 1964, PSYCHOL REV, V71, P247, DOI 10.1037/h0047547; Guinard JX, 1998, APPETITE, V31, P141, DOI 10.1006/appe.1998.0159; Havermans RC, 2011, APPETITE, V57, P286, DOI 10.1016/j.appet.2011.05.310; Havermans RC, 2009, APPETITE, V52, P222, DOI 10.1016/j.appet.2008.09.020; Hetherington MM, 2006, PHYSIOL BEHAV, V87, P263, DOI 10.1016/j.physbeh.2005.10.012; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; IGGO A, 1977, J PHYSIOL-LONDON, V271, P549, DOI 10.1113/jphysiol.1977.sp012014; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Litman JA, 2005, COGNITION EMOTION, V19, P793, DOI 10.1080/02699930541000101; Loken LS, 2011, BRAIN RES, V1417, P9, DOI 10.1016/j.brainres.2011.08.011; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; McSweeney FK, 1998, PSYCHON B REV, V5, P428, DOI 10.3758/BF03208818; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Nasser J, 2001, Obes Rev, V2, P213, DOI 10.1046/j.1467-789X.2001.00039.x; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Peck J, 2003, J CONSUM RES, V30, P430, DOI 10.1086/378619; Raynor Hollie A, 2006, Eat Behav, V7, P1, DOI 10.1016/j.eatbeh.2005.05.005; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rolls BJ, 1998, AM J CLIN NUTR, V67, P1170, DOI 10.1093/ajcn/67.6.1170; ROLLS BJ, 1990, APPETITE, V15, P115, DOI 10.1016/0195-6663(90)90044-9; Rolls ET, 2007, EUR J NEUROSCI, V26, P1067, DOI 10.1111/j.1460-9568.2007.05724.x; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Rolls ET, 1997, PHYSIOL BEHAV, V61, P461, DOI 10.1016/S0031-9384(96)00464-7; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; Triscoli C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00526; Triscoli C, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00208; VALLBO A, 1993, BRAIN RES, V628, P301, DOI 10.1016/0006-8993(93)90968-S; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3	54	39	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2014	9	11							e113425	10.1371/journal.pone.0113425	http://dx.doi.org/10.1371/journal.pone.0113425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UZ	25405620	gold, Green Published, Green Submitted			2022-12-26	WOS:000347121300117
J	Asano, K; Asano, Y; Ono, HK; Nakane, A				Asano, Krisana; Asano, Yoshiya; Ono, Hisaya K.; Nakane, Akio			Suppression of Starvation-Induced Autophagy by Recombinant Toxic Shock Syndrome Toxin-1 in Epithelial Cells	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; INDUCTION; PATHWAY; PROTEIN	Toxic shock syndrome toxin-1 (TSST-1), a superantigen produced from Staphylococcus aureus, has been reported to bind directly to unknown receptor(s) and penetrate into non-immune cells but its function is unclear. In this study, we demonstrated that recombinant TSST-1 suppresses autophagosomal accumulation in the autophagic-induced HeLa 229 cells. This suppression is shared by a superantigenic-deficient mutant of TSST-1 but not by staphylococcal enterotoxins, suggesting that autophagic suppression of TSST-1 is superantigenic-independent. Furthermore, we showed that TSST-1-producing S. aureus suppresses autophagy in the response of infected cells. Our data provides a novel function of TSST-1 in autophagic suppression which may contribute in staphylococcal persistence in host cells.	[Asano, Krisana; Ono, Hisaya K.; Nakane, Akio] Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori, Japan; [Asano, Yoshiya] Hirosaki Univ, Grad Sch Med, Dept Neuroanat Cell Biol & Histol, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Nakane, A (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori, Japan.	a27k03n0@cc.hirosaki-u.ac.jp	Ono, Hisaya/P-3595-2019	Asano, Yoshiya/0000-0002-8941-7659; , Akio/0000-0002-9583-8919	JSPS KAKENHI [23390100, 23790467]; Grant for Hirosaki University Institutional Research; Grants-in-Aid for Scientific Research [23390100] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant for Hirosaki University Institutional Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant number 23390100, 23790467 and Grant for Hirosaki University Institutional Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RA, 1996, J DAIRY SCI, V79, P1021, DOI 10.3168/jds.S0022-0302(96)76454-8; Andrey DO, 2010, J BACTERIOL, V192, P6077, DOI 10.1128/JB.00146-10; Mestre MB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002664; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Haggar A, 2003, INFECT IMMUN, V71, P2310, DOI 10.1128/IAI.71.5.2310-2317.2003; Hu DL, 2003, J INFECT DIS, V188, P743, DOI 10.1086/377308; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; JUPIN C, 1988, J EXP MED, V167, P752, DOI 10.1084/jem.167.3.752; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kong XF, 2012, J NUTR BIOCHEM, V23, P1178, DOI 10.1016/j.jnutbio.2011.06.012; KUSHNARYOV VM, 1989, REV INFECT DIS, V11, pS282; KUSHNARYOV VM, 1984, INFECT IMMUN, V45, P566, DOI 10.1128/IAI.45.3.566-571.1984; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MARRACK P, 1990, SCIENCE, V248, P1066; Mauthe Mario, 2012, Int J Cell Biol, V2012, P179207, DOI 10.1155/2012/179207; Muthukrishnan G, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-221; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Narita K, 2008, FEMS IMMUNOL MED MIC, V52, P389, DOI 10.1111/j.1574-695X.2008.00384.x; Nuzzo I, 2000, FEMS IMMUNOL MED MIC, V27, P235, DOI 10.1111/j.1574-695X.2000.tb01435.x; Parsonnet J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-249; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Shupp JW, 2002, INFECT IMMUN, V70, P2178, DOI 10.1128/IAI.70.4.2178-2186.2002; Tang YL, 2015, AMINO ACIDS, V47, P2199, DOI 10.1007/s00726-014-1781-4; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Wang BN, 2006, CELL MICROBIOL, V8, P257, DOI 10.1111/j.1462-5822.2005.00618.x; Yang HS, 2012, CYTOKINE, V60, P646, DOI 10.1016/j.cyto.2012.07.033; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113018	10.1371/journal.pone.0113018	http://dx.doi.org/10.1371/journal.pone.0113018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402468	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700095
J	Gao, L; Edwards, EJ; Zeng, YB; Huang, YS				Gao, Li; Edwards, Erika J.; Zeng, Yongbo; Huang, Yongsong			Major Evolutionary Trends in Hydrogen Isotope Fractionation of Vascular Plant Leaf Waxes	PLOS ONE			English	Article							DELTA-D VALUES; N-ALKANES; COMPARATIVE BIOLOGY; WATER; CLIMATE; REGENERATION; VARIABILITY; HYDROLOGY; RECORD; FIELD	Hydrogen isotopic ratios of terrestrial plant leaf waxes (delta D) have been widely used for paleoclimate reconstructions. However, underlying controls for the observed large variations in leaf wax delta D values in different terrestrial vascular plants are still poorly understood, hampering quantitative paleoclimate interpretation. Here we report plant leaf wax and source water delta D values from 102 plant species grown in a common environment (New York Botanic Garden), chosen to represent all the major lineages of terrestrial vascular plants and multiple origins of common plant growth forms. We found that leaf wax hydrogen isotope fractionation relative to plant source water is best explained by membership in particular lineages, rather than by growth forms as previously suggested. Monocots, and in particular one clade of grasses, display consistently greater hydrogen isotopic fractionation than all other vascular plants, whereas lycopods, representing the earlier-diverging vascular plant lineage, display the smallest fractionation. Data from greenhouse experiments and field samples suggest that the changing leaf wax hydrogen isotopic fractionation in different terrestrial vascular plants may be related to different strategies in allocating photosynthetic substrates for metabolic and biosynthetic functions, and potential leaf water isotopic differences.	[Gao, Li; Huang, Yongsong] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Edwards, Erika J.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Zeng, Yongbo] Univ Rhode Isl, Dept Elect Comp & Biomed Engn, Kingston, RI 02881 USA	Brown University; Brown University; University of Rhode Island	Huang, YS (corresponding author), Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA.	yongsong_huang@brown.edu	Gao, Li/H-3747-2014	Gao, Li/0000-0003-0684-3570	NSF [0816739, 0902805, 1024144]; Brown University	NSF(National Science Foundation (NSF)); Brown University	This project is supported by NSF 0816739, 0902805 and 1024144 to Y. Huang and a Brown University Seed Grant to Y. Huang and EJ Edwards. Website for National Science Fundation: http://www.nsf.gov/. Website for Brown University Seed Grant: http://www.brown.edu/research/internal-funding-opportunities-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cernusak LA, 2002, PLANT CELL ENVIRON, V25, P893, DOI 10.1046/j.1365-3040.2002.00875.x; Dupont LM, 2013, EARTH PLANET SC LETT, V375, P408, DOI 10.1016/j.epsl.2013.06.005; Edwards EJ, 2007, TRENDS ECOL EVOL, V22, P243, DOI 10.1016/j.tree.2007.02.002; Eriksson L., 1999, INTRO MULTI MEGAVARI; Feakins SJ, 2010, ORG GEOCHEM, V41, P1269, DOI 10.1016/j.orggeochem.2010.09.007; Gao L, 2014, GEOCHEM GEOPHY GEOSY, V15, P361, DOI 10.1002/2013GC005015; Gao L, 2013, OECOLOGIA, V172, P347, DOI 10.1007/s00442-012-2506-6; Gao L, 2012, RAPID COMMUN MASS SP, V26, P2241, DOI 10.1002/rcm.6348; Gao L, 2012, RAPID COMMUN MASS SP, V26, P115, DOI 10.1002/rcm.5313; Gao L, 2011, GEOCHIM COSMOCHIM AC, V75, P3781, DOI 10.1016/j.gca.2011.04.008; HELLBERG S, 1991, INT J PEPT PROT RES, V37, P414; Hou JZ, 2008, GEOCHIM COSMOCHIM AC, V72, P3503, DOI 10.1016/j.gca.2008.04.030; Hou JZ, 2007, ORG GEOCHEM, V38, P977, DOI 10.1016/j.orggeochem.2006.12.009; Huang YS, 2007, GEOLOGY, V35, P531, DOI 10.1130/G23666A.1; Kahmen A, 2013, GEOCHIM COSMOCHIM AC, V111, P50, DOI 10.1016/j.gca.2012.09.004; Kahmen A, 2013, GEOCHIM COSMOCHIM AC, V111, P39, DOI 10.1016/j.gca.2012.09.003; Kahmen A, 2011, PLANT CELL ENVIRON, V34, P1639, DOI 10.1111/j.1365-3040.2011.02360.x; KAPLAN DR, 1973, Q REV BIOL, V48, P437, DOI 10.1086/407703; Keun HC, 2003, ANAL CHIM ACTA, V490, P265, DOI 10.1016/S0003-2670(03)00094-1; Kuechler RR, 2013, QUATERNARY SCI REV, V82, P56, DOI 10.1016/j.quascirev.2013.10.013; Liu WG, 2008, GLOBAL CHANGE BIOL, V14, P2166, DOI 10.1111/j.1365-2486.2008.01608.x; McInerney FA, 2011, GEOCHIM COSMOCHIM AC, V75, P541, DOI 10.1016/j.gca.2010.10.022; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Polissar PJ, 2009, EARTH PLANET SC LETT, V287, P64, DOI 10.1016/j.epsl.2009.07.037; Rach O, 2014, NAT GEOSCI, V7, P109, DOI [10.1038/ngeo2053, 10.1038/NGEO2053]; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sachse D, 2012, ANNU REV EARTH PL SC, V40, P221, DOI 10.1146/annurev-earth-042711-105535; Schefuss E, 2011, NATURE, V480, P509, DOI 10.1038/nature10685; Shchepinov MS, 2007, BIOESSAYS, V29, P1247, DOI 10.1002/bies.20681; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Smith FA, 2006, GEOCHIM COSMOCHIM AC, V70, P1172, DOI 10.1016/j.gca.2005.11.006; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Tipple BJ, 2013, P NATL ACAD SCI USA, V110, P2659, DOI 10.1073/pnas.1213875110; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Zhuang GS, 2014, EARTH PLANET SC LETT, V390, P186, DOI 10.1016/j.epsl.2014.01.003	39	56	58	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112610	10.1371/journal.pone.0112610	http://dx.doi.org/10.1371/journal.pone.0112610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402476	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700057
J	Gong, WF; He, SP; Tian, JH; Sun, JL; Pan, ZE; Jia, YH; Sun, GF; Du, XM				Gong, Wenfang; He, Shoupu; Tian, Jiahuan; Sun, Junling; Pan, Zhaoe; Jia, Yinhua; Sun, Gaofei; Du, Xiongming			Comparison of the Transcriptome between Two Cotton Lines of Different Fiber Color and Quality	PLOS ONE			English	Article							RNA-SEQ; GOSSYPIUM-HIRSUTUM; GENE-EXPRESSION; CELL ELONGATION; ANTHOCYANIN; L.; 5-O-GLUCOSYLTRANSFERASE; ANNOTATION; PROFILES; ETHYLENE	To understand the mechanism of fiber development and pigmentation formation, the mRNAs of two cotton lines were sequenced: line Z128 (light brown fiber) was a selected mutant from line Z263 (dark brown fiber). The primary walls of the fiber cell in both Z263 and Z128 contain pigments; more pigments were laid in the lumen of the fiber cell in Z263 compared with that in Z128. However, Z263 contained less cellulose than Z128. A total of 71,895 unigenes were generated: 13,278 (20.26%) unigenes were defined as differentially expressed genes (DEGs) by comparing the library of Z128 with that of Z263; 5,345 (8.16%) unigenes were up-regulated and 7,933 (12.10%) unigenes were down-regulated. qRT-PCR and comparative transcriptional analysis demonstrated that the pigmentation formation in brown cotton fiber was possibly the consequence of an interaction between oxidized tannins and glycosylated anthocyanins. Furthermore, our results showed the pigmentation related genes not only regulated the fiber color but also influenced the fiber quality at the fiber elongation stage (10 DPA). The highly expressed flavonoid gene in the fiber elongation stage could be related to the fiber quality. DEGs analyses also revealed that transcript levels of some fiber development genes (Ca2+/CaM, reactive oxygen, ethylene and sucrose phosphate synthase) varied dramatically between these two cotton lines.	[Gong, Wenfang; He, Shoupu; Tian, Jiahuan; Sun, Junling; Pan, Zhaoe; Jia, Yinhua; Sun, Gaofei; Du, Xiongming] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Sun, Gaofei] Anyang Inst Technol, Dept Comp Sci & Informat Engn, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Anyang Institute of Technology	Du, XM (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	dujeffrey8848@hotmail.com	Shoupu, He/AAR-5173-2021; Du, Xiongming/AAI-9999-2020	Shoupu, He/0000-0001-8434-5484; 	"Twelfth Five-Year Plan" of the National Science and Technology Support Project [2011BAD35B05, 2013BAD01B03]; Basic Scientific Research funds in National Nonprofit Institutes [SJA0608]	"Twelfth Five-Year Plan" of the National Science and Technology Support Project; Basic Scientific Research funds in National Nonprofit Institutes	This study was supported by the "Twelfth Five-Year Plan" of the National Science and Technology Support Project (2011BAD35B05 and 2013BAD01B03) and Basic Scientific Research funds in National Nonprofit Institutes (SJA0608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Chaudhary B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-378; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Grauwe L, 2005, PLANT CELL PHYSIOL, V46, P827, DOI 10.1093/pcp/pci111; Dickerson D. K., 1999, NATURALLY COLORED CO; DOONER HK, 1991, ANNU REV GENET, V25, P173, DOI 10.1146/annurev.ge.25.120191.001133; Feng HJ, 2011, PLANT BREEDING, V130, P450, DOI 10.1111/j.1439-0523.2010.01842.x; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Haigler CH, 2007, PLANT MOL BIOL, V63, P815, DOI 10.1007/s11103-006-9127-6; HALLOIN JM, 1982, NEW PHYTOL, V90, P651, DOI 10.1111/j.1469-8137.1982.tb03274.x; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; KOHEL RJ, 1985, CROP SCI, V25, P793, DOI 10.2135/cropsci1985.0011183X0025000500017x; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murthy M.S.S., 2001, RESONANCE, V6, P29, DOI [10.1007/BF02913764, DOI 10.1007/BF02913764]; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nishizaki Y, 2011, MOL GENET GENOMICS, V286, P383, DOI 10.1007/s00438-011-0655-7; Owens DK, 2008, PLANT PHYSIOL BIOCH, V46, P833, DOI 10.1016/j.plaphy.2008.06.004; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Rapp RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-139; Ru ZongLing, 2013, Cotton Science, V25, P184; Seifert GJ, 2004, PLANT CELL, V16, P723, DOI 10.1105/tpc.019661; [詹少华 Shaohua Zhan], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P99; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Tan JF, 2013, PLANT PHYSIOL, V162, P86, DOI 10.1104/pp.112.212142; Tang WX, 2014, NEW PHYTOL, V202, P509, DOI 10.1111/nph.12676; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Vreeland JM, 1999, SCI AM, V280, P112, DOI 10.1038/scientificamerican0499-112; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xia Z, 2011, PLANT MOL BIOL, V77, P1; Xiao YH, 2007, BIOCHEM BIOPH RES CO, V35, P873; Yamazaki M, 1999, J BIOL CHEM, V274, P7405, DOI 10.1074/jbc.274.11.7405; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; [詹少华 ZHAN Shaohua], 2007, [棉花学报, Cotton Science], V19, P183	45	17	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112966	10.1371/journal.pone.0112966	http://dx.doi.org/10.1371/journal.pone.0112966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401744	Green Published, gold, Green Submitted			2022-12-26	WOS:000345158700087
J	Kang, JH; Jeong, JW; Kim, HT; Kim, SH; Kim, SP				Kang, Jae-Hwan; Jeong, Ji Woon; Kim, Hyun Taek; Kim, Sang Hee; Kim, Sung-Phil			Representation of Cognitive Reappraisal Goals in Frontal Gamma Oscillations	PLOS ONE			English	Article							EMOTION REGULATION; PREFRONTAL CORTEX; PHASE SYNCHRONY; BAND ACTIVITY; ELECTROCORTICAL RESPONSE; NEGATIVE AFFECT; EEG; AMYGDALA; POTENTIALS; MODULATION	Recently, numerous efforts have been made to understand the neural mechanisms underlying cognitive regulation of emotion, such as cognitive reappraisal. Many studies have reported that cognitive control of emotion induces increases in neural activity of the control system, including the prefrontal cortex and the dorsal anterior cingulate cortex, and increases or decreases (depending upon the regulation goal) in neural activity of the appraisal system, including the amygdala and the insula. It has been hypothesized that information about regulation goals needs to be processed through interactions between the control and appraisal systems in order to support cognitive reappraisal. However, how this information is represented in the dynamics of cortical activity remains largely unknown. To address this, we investigated temporal changes in gamma band activity (35-55 Hz) in human electroencephalograms during a cognitive reappraisal task that was comprised of three reappraisal goals: to decease, maintain, or increase emotional responses modulated by affect-laden pictures. We examined how the characteristics of gamma oscillations, such as spectral power and large-scale phase synchronization, represented cognitive reappraisal goals. We found that left frontal gamma power decreased, was sustained, or increased when the participants suppressed, maintained, or amplified their emotions, respectively. This change in left frontal gamma power appeared during an interval of 1926 to 2453 ms after stimulus onset. We also found that the number of phase-synchronized pairs of gamma oscillations over the entire brain increased when participants regulated their emotions compared to when they maintained their emotions. These results suggest that left frontal gamma power may reflect cortical representation of emotional states modulated by cognitive reappraisal goals and gamma phase synchronization across whole brain regions may reflect emotional regulatory efforts to achieve these goals. Our study may provide the basis for an electroencephalogram-based neurofeedback system for the cognitive regulation of emotion.	[Kang, Jae-Hwan; Kim, Sang Hee] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Jeong, Ji Woon; Kim, Hyun Taek] Korea Univ, Dept Psychol, Seoul, South Korea; [Kim, Sung-Phil] Ulsan Natl Inst Sci & Technol, Dept Human & Syst Engn, Ulsan, South Korea	Korea University; Korea University; Ulsan National Institute of Science & Technology (UNIST)	Kim, SH (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.	sangheekim.ku@gmail.com; spkim@unist.ac.kr	Kim, Sanghee/AAE-3574-2021	Kang, Jae-Hwan/0000-0002-9425-847X	National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2012R1A2A2A04047239, NRF-2006-2005112]	National Research Foundation of Korea - Ministry of Science, ICT & Future Planning	This research was supported by both the Mid-career Researcher Program (NRF-2012R1A2A2A04047239) and the Brain Research Program (NRF-2006-2005112) through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HM, 2013, J NEUROPSYCHOL; Balconi M, 2008, INT J PSYCHOPHYSIOL, V67, P41, DOI 10.1016/j.ijpsycho.2007.10.002; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Berkovich-Ohana A, 2012, CLIN NEUROPHYSIOL, V123, P700, DOI 10.1016/j.clinph.2011.07.048; Bhattacharya J, 2001, NEUROSCI LETT, V311, P29, DOI 10.1016/S0304-3940(01)02133-4; Bonanno GA, 2004, PSYCHOL SCI, V15, P482, DOI 10.1111/j.0956-7976.2004.00705.x; BURGESS PW, 2005, MEASURING MIND SPEED; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Chiesa A, 2013, CLIN PSYCHOL REV, V33, P82, DOI 10.1016/j.cpr.2012.10.006; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Foucher JR, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-22; Gandal MJ, 2012, NEUROPHARMACOLOGY, V62, P1504, DOI 10.1016/j.neuropharm.2011.02.007; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Gruber T, 2001, NEUROSCI LETT, V316, P29, DOI 10.1016/S0304-3940(01)02361-8; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Herrington JD, 2005, EMOTION, V5, P200, DOI 10.1037/1528-3542.5.2.200; Jausovec N, 2010, SPRINGER SER HUM EXC, P109, DOI 10.1007/978-1-4419-1210-7_7; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Joormann J, 2010, COGNITION EMOTION RE, P174; Kaiser J, 2003, NEUROSCIENTIST, V9, P475, DOI 10.1177/1073858403259137; Kang JH, 2012, NEUROREPORT, V23, P995, DOI 10.1097/WNR.0b013e32835a6475; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Keil A, 2001, NEUROSCI BIOBEHAV R, V25, P527, DOI 10.1016/S0149-7634(01)00031-8; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Liu YL, 2012, J NEUROSCI, V32, P14563, DOI 10.1523/JNEUROSCI.3109-12.2012; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; Martini N, 2012, NEUROIMAGE, V60, P922, DOI 10.1016/j.neuroimage.2012.01.060; Miller GA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00002; Moser JS, 2010, COGN AFFECT BEHAV NE, V10, P195, DOI 10.3758/CABN.10.2.195; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P17, DOI 10.1111/j.1469-8986.2008.00721.x; Muller MM, 2000, INT J PSYCHOPHYSIOL, V38, P283, DOI 10.1016/s0167-8760(00)00171-9; Muller MM, 1999, CLIN NEUROPHYSIOL, V110, P1913, DOI 10.1016/S1388-2457(99)00151-0; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Onton J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.061.2009; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Popov T, 2012, PSYCHOPHYSIOLOGY, V49, P1545, DOI 10.1111/j.1469-8986.2012.01484.x; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Thiruchselvam R, 2011, BIOL PSYCHOL, V87, P84, DOI 10.1016/j.biopsycho.2011.02.009; Tolegenova AA, 2014, PERS INDIV DIFFER, V65, P75, DOI 10.1016/j.paid.2014.01.028; Trujillo LT, 2005, CLIN NEUROPHYSIOL, V116, P172, DOI 10.1016/j.clinph.2004.07.025; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	69	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e113375	10.1371/journal.pone.0113375	http://dx.doi.org/10.1371/journal.pone.0113375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401328	gold, Green Submitted, Green Published			2022-12-26	WOS:000345158700136
J	Oelze, M; Kroller-Schon, S; Welschof, P; Jansen, T; Hausding, M; Mikhed, Y; Stamm, P; Mader, M; Zinssius, E; Agdauletova, S; Gottschlich, A; Steven, S; Schulz, E; Bottari, SP; Mayoux, E; Munzel, T; Daiber, A				Oelze, Matthias; Kroeller-Schoen, Swenja; Welschof, Philipp; Jansen, Thomas; Hausding, Michael; Mikhed, Yuliya; Stamm, Paul; Mader, Michael; Zinssius, Elena; Agdauletova, Saule; Gottschlich, Anna; Steven, Sebastian; Schulz, Eberhard; Bottari, Serge P.; Mayoux, Eric; Muenzel, Thomas; Daiber, Andreas			The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; ENDOTHELIAL DYSFUNCTION; SGLT-2 INHIBITOR; ORGANIC NITRATES; GLYCEMIC CONTROL; OXIDANT STRESS; BURST ACTIVITY; NADPH OXIDASE; NITRIC-OXIDE	Objective: In diabetes, vascular dysfunction is characterized by impaired endothelial function due to increased oxidative stress. Empagliflozin, as a selective sodium-glucose co-transporter 2 inhibitor (SGLT2i), offers a novel approach for the treatment of type 2 diabetes by enhancing urinary glucose excretion. The aim of the present study was to test whether treatment with empagliflozin improves endothelial dysfunction in type I diabetic rats via reduction of glucotoxicity and associated vascular oxidative stress. Methods: Type I diabetes in Wistar rats was induced by an intravenous injection of streptozotocin (60 mg/kg). One week after injection empagliflozin (10 and 30 mg/kg/d) was administered via drinking water for 7 weeks. Vascular function was assessed by isometric tension recording, oxidative stress parameters by chemiluminescence and fluorescence techniques, protein expression by Western blot, mRNA expression by RT-PCR, and islet function by insulin ELISA in serum and immunohistochemical staining of pancreatic tissue. Advanced glycation end products (AGE) signaling was assessed by dot blot analysis and mRNA expression of the AGE-receptor (RAGE). Results: Treatment with empagliflozin reduced blood glucose levels, normalized endothelial function (aortic rings) and reduced oxidative stress in aortic vessels (dihydroethidium staining) and in blood (phorbol ester/zymosan A-stimulated chemiluminescence) of diabetic rats. Additionally, the pro-inflammatory phenotype and glucotoxicity (AGE/RAGE signaling) in diabetic animals was reversed by SGLT2i therapy. Conclusions: Empagliflozin improves hyperglycemia and prevents the development of endothelial dysfunction, reduces oxidative stress and improves the metabolic situation in type 1 diabetic rats. These preclinical observations illustrate the therapeutic potential of this new class of antidiabetic drugs.	[Oelze, Matthias; Kroeller-Schoen, Swenja; Welschof, Philipp; Jansen, Thomas; Hausding, Michael; Mikhed, Yuliya; Stamm, Paul; Mader, Michael; Zinssius, Elena; Agdauletova, Saule; Gottschlich, Anna; Steven, Sebastian; Schulz, Eberhard; Muenzel, Thomas; Daiber, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Cardiol, Med Clin 2, D-55122 Mainz, Germany; [Bottari, Serge P.] Grenoble Alpes Univ, CHU Grenoble, Lab Fundamental & Appl, INSERM U1055, Grenoble, France; [Bottari, Serge P.] CHU Grenoble, Pole Biol, F-38043 Grenoble, France; [Mayoux, Eric] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany	Johannes Gutenberg University of Mainz; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Boehringer Ingelheim	Daiber, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Cardiol, Med Clin 2, D-55122 Mainz, Germany.	andreas.daiber@bioredox.com	Bottari, Serge/ABF-3990-2021; Steven, Sebastian/Z-1583-2019; Munzel, Thomas/A-2912-2014	Munzel, Thomas/0000-0001-5503-4150; Bottari, Serge P./0000-0002-4172-2400; Daiber, Andreas/0000-0002-2769-0094	vascular biology research grant from Boehringer Ingelheim Pharma GmbH Co. KG; Centre of Translational Vascular Biology (CTVB); Institute of Molecular Biology gGmbH, (Mainz, Germany) - Boehringer Ingelheim Foundation	vascular biology research grant from Boehringer Ingelheim Pharma GmbH Co. KG; Centre of Translational Vascular Biology (CTVB); Institute of Molecular Biology gGmbH, (Mainz, Germany) - Boehringer Ingelheim Foundation	The present work was supported by a vascular biology research grant from Boehringer Ingelheim Pharma GmbH & Co. KG (A. D. and T. M.) and by the Centre of Translational Vascular Biology (CTVB). Yuliya Miked holds a stipend from the International PhD Programme on the "Dynamics of Gene Regulation, Epigenetics and DNA Damage Response" from the Institute of Molecular Biology gGmbH, (Mainz, Germany) funded by the Boehringer Ingelheim Foundation. This paper contains results that are part of the doctoral thesis of Philipp Welschof. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. E. M. (Boehringer Ingelheim Pharma GmbH & Co. KG) was involved in the study design.	Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; CHANG FY, 1995, DIABETES RES CLIN PR, V29, P121, DOI 10.1016/0168-8227(95)01123-4; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; Cherney DZI, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-28; Coughlan MT, 2009, J AM SOC NEPHROL, V20, P742, DOI 10.1681/ASN.2008050514; Daiber A, 2004, MOL PHARMACOL, V66, P1372, DOI 10.1124/mol.104.002600; Evans JL, 2013, DIABETES, V62, P346, DOI 10.2337/db12-1239; Ferrannini E, 2013, DIABETES OBES METAB, V15, P721, DOI 10.1111/dom.12081; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Forbes JM, 2002, DIABETES, V51, P3274, DOI 10.2337/diabetes.51.11.3274; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Hansen HH, 2014, J PHARMACOL EXP THER, V350, P657, DOI 10.1124/jpet.114.213454; Hausding M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0386-5; Hink U, 2001, CIRC RES, V88, pE14; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Kroller-Schon S, 2014, ANTIOXID REDOX SIGN, V20, P247, DOI 10.1089/ars.2012.4953; Kroller-Schon S, 2012, CARDIOVASC RES, V96, P140, DOI 10.1093/cvr/cvs246; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067009; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Loot AE, 2009, J EXP MED, V206, P2889, DOI 10.1084/jem.20090449; Luippold G, 2012, DIABETES OBES METAB, V14, P601, DOI 10.1111/j.1463-1326.2012.01569.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OELZE M, 2013, HYPERTENSION; Oelze M, 2006, HYPERTENSION, V48, P677, DOI 10.1161/01.HYP.0000239207.82326.29; Oelze M, 2011, J VASC RES, V48, P275, DOI 10.1159/000320627; Oelze M, 2011, J BIOL CHEM, V286, P8893, DOI 10.1074/jbc.M110.190017; Osar Z, 2004, EXP DIABESITY RES, V5, P155, DOI 10.1080/15438600490424244; Perkins BA, 2014, DIABETES CARE, V37, P1480, DOI 10.2337/dc13-2338; Pricci F, 2003, FREE RADICAL BIO MED, V35, P683, DOI 10.1016/S0891-5849(03)00401-5; Rieg T, 2014, AM J PHYSIOL-RENAL, V306, pF188, DOI 10.1152/ajprenal.00518.2013; Sarashina A, 2013, DRUG METAB PHARMACOK, V28, P213, DOI 10.2133/dmpk.DMPK-12-RG-082; Schuhmacher S, 2011, DIABETES, V60, P2608, DOI 10.2337/db10-1395; Schulz E, 2014, ANTIOXID REDOX SIGN, V20, P308, DOI 10.1089/ars.2012.4609; Shiryaeva YK, 2012, B EXP BIOL MED+, V153, P114, DOI 10.1007/s10517-012-1656-1; Sun M, 1998, INT J EXP PATHOL, V79, P207; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Vickers SP, 2014, DIABETES METAB SYNDR, V7, P265, DOI 10.2147/DMSO.S58786; Wang JL, 2011, MOL MED, V17, P172, DOI 10.2119/molmed.2010.00114; WAUTIER JL, 1994, P NATL ACAD SCI USA, V91, P7742, DOI 10.1073/pnas.91.16.7742; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Wenzel P, 2007, BRIT J PHARMACOL, V150, P526, DOI 10.1038/sj.bjp.0707116; Wenzel P, 2008, FREE RADICAL BIO MED, V45, P619, DOI 10.1016/j.freeradbiomed.2008.05.009; Wenzel P, 2008, ATHEROSCLEROSIS, V198, P65, DOI 10.1016/j.atherosclerosis.2007.10.003; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Yamamoto Y, 2000, ANN NY ACAD SCI, V902, P163; Yu YX, 2005, AM J MED SCI, V330, P227, DOI 10.1097/00000441-200511000-00005	50	185	192	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e112394	10.1371/journal.pone.0112394	http://dx.doi.org/10.1371/journal.pone.0112394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25402275	gold, Green Published, Green Submitted			2022-12-26	WOS:000345158700042
J	Wang, ZC; Hou, XW; Shao, J; Ji, YJ; Li, LL; Zhou, Q; Yu, SM; Mao, YL; Zhang, HJ; Zhang, PC; Lu, H				Wang, Zhan-Chao; Hou, Xu-Wei; Shao, Jiang; Ji, Yong-Jing; Li, Lulu; Zhou, Qiang; Yu, Si-Ming; Mao, Yu-Lun; Zhang, Hao-Jie; Zhang, Ping-Chao; Lu, Hua			HIF-1 alpha Polymorphism in the Susceptibility of Cervical Spondylotic Myelopathy and Its Outcome after Anterior Cervical Corpectomy and Fusion Treatment	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; NUCLEUS PULPOSUS CELLS; OPN GENE POLYMORPHISM; PROSTATE-CANCER; FEMORAL-HEAD; FACTOR-I; ASSOCIATION; LEADS	Background: To investigate the association between the single nucleotide polymorphism (SNP) of hypoxia-inducible factor1 alpha (HIF-1 alpha) and the susceptibility to cervical spondylotic myelopathy (CSM) and its outcome after surgical treatment. Method: A total of 230 CSM patients and 284 healthy controls were recruited. All patients received anterior cervical corpectomy and fusion (ACF) and were followed for 12 months. The genotypes for two HIF-1 alpha variants (1772C>T and 1790G>A) were determined. Results: In the present study, we found that the HIF-1 alpha polymorphism at 1790G>A significantly affects the susceptibility to CSM and its clinical features, including severity and onset age. In addition, the 1790A>G polymorphism also determines the prognosis of CSM patients after ACF treatment. The GG genotype of 1790G>A polymorphism is associated with a higher risk to develop CSM, higher severity and earlier onset age. More importantly, we found that the 1790G>A polymorphism determines the clinical outcome in CSM patients who underwent ACF treatment. Conclusion: Our findings suggest that the HIF-1 alpha 1790G>A polymorphism is associated with the susceptibility to CSM and can be used as predictor for the clinical outcome in CSM patients receiving ACF treatment.	[Wang, Zhan-Chao; Zhou, Qiang; Yu, Si-Ming; Mao, Yu-Lun; Zhang, Hao-Jie; Zhang, Ping-Chao] Shanghai Jiao Tong Univ, Xinhua Hosp Chongming, Dept Orthoped, Shanghai, Peoples R China; [Hou, Xu-Wei] Nanjing Med Univ, Hangzhou Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China; [Hou, Xu-Wei] Hangzhou First Municipal Hosp, Hangzhou, Zhejiang, Peoples R China; [Shao, Jiang; Lu, Hua] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Orthoped, Shanghai, Peoples R China; [Ji, Yong-Jing] Jinan 2nd Peoples Hosp, Dept Internal Med, Jinan, Peoples R China; [Li, Lulu] Harbin Med Univ, Coll Publ Hlth, Dept Biostat, Harbin 150081, Heilongjiang, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University; Shanghai Jiao Tong University; Harbin Medical University	Lu, H (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Orthoped, Shanghai, Peoples R China.	drhualu@163.com						Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Emery S E, 2001, J Am Acad Orthop Surg, V9, P376; Feng G, 2013, OSTEOARTHR CARTILAGE, V21, P582, DOI 10.1016/j.joca.2013.01.001; Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Green C, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/908324; Hong JM, 2007, OSTEOARTHR CARTILAGE, V15, P688, DOI 10.1016/j.joca.2006.12.007; Hou X, 2014, J CELL MOL MED; Hou XW, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-78; Hou XW, 2014, J MOL MED, V92, P487, DOI 10.1007/s00109-013-1099-9; Jing M, 2013, CELL PHYSIOL BIOCHEM, V32, P1798, DOI 10.1159/000356613; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; Koc RK, 2004, NEUROSURG REV, V27, P252, DOI 10.1007/s10143-004-0342-9; Komatsu DE, 2004, BONE, V34, P680, DOI 10.1016/j.bone.2003.12.024; Li H, 2013, YONSEI MED J, V54, P807, DOI 10.3349/ymj.2013.54.4.807; Li LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071041; Lin Wei-Ting, 2013, PLoS ONE, V8, P1; Long HQ, 2012, MED HYPOTHESES, V79, P82, DOI 10.1016/j.mehy.2012.04.006; Lu YJ, 2010, GENE CHROMOSOME CANC, V49, P412, DOI 10.1002/gcc.20752; Mori S, 2006, J ORTHOP RES, V24, P653, DOI 10.1002/jor.20076; Noponen-Hietala N, 2003, ANN RHEUM DIS, V62, P1208, DOI 10.1136/ard.2003.008334; Oga M, 1996, SPINE, V21, P1085, DOI 10.1097/00007632-199605010-00019; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Sakai Y, 2007, SPINE, V32, P1279, DOI 10.1097/BRS.0b013e318059af8a; Schipani E, 2001, GENE DEV, V15, P2865; Setzer M, 2009, J NEUROSURG-SPINE, V11, P659, DOI 10.3171/2009.7.SPINE08667; Tamburrelli F, 2008, EUR REV MED PHARMACO, V12, P161; Tracy JA, 2010, NEUROLOGIST, V16, P176, DOI 10.1097/NRL.0b013e3181da3a29; Vainrib M, 2012, CANCER BIOL THER, V13, P720, DOI 10.4161/cbt.20554; Wang DW, 2013, CELL PHYSIOL BIOCHEM, V32, P210, DOI 10.1159/000350137; Xu HY, 2010, MOL CELL BIOCHEM, V335, P13, DOI 10.1007/s11010-009-0235-x; Yi L., 2014, NEUROMOL MED; Zhang C, 2011, BONE, V48, P507, DOI 10.1016/j.bone.2010.10.006	33	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2014	9	11							e110862	10.1371/journal.pone.0110862	http://dx.doi.org/10.1371/journal.pone.0110862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8BL	25401740	gold, Green Submitted, Green Published			2022-12-26	WOS:000345158700010
J	Kim, K; Bang, SY; Lee, HS; Bae, SC				Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol			Construction and Application of a Korean Reference Panel for Imputing Classical Alleles and Amino Acids of Human Leukocyte Antigen Genes	PLOS ONE			English	Article							HLA ALLELES; MAP; ASSOCIATION; EXPLAIN	Genetic variations of human leukocyte antigen (HLA) genes within the major histocompatibility complex (MHC) locus are strongly associated with disease susceptibility and prognosis for many diseases, including many autoimmune diseases. In this study, we developed a Korean HLA reference panel for imputing classical alleles and amino acid residues of several HLA genes. An HLA reference panel has potential for use in identifying and fine-mapping disease associations with the MHC locus in East Asian populations, including Koreans. A total of 413 unrelated Korean subjects were analyzed for single nucleotide polymorphisms (SNPs) at the MHC locus and six HLA genes, including HLA-A, -B, -C, -DRB1, -DPB1, and -DQB1. The HLA reference panel was constructed by phasing the 5,858 MHC SNPs, 233 classical HLA alleles, and 1,387 amino acid residue markers from 1,025 amino acid positions as binary variables. The imputation accuracy of the HLA reference panel was assessed by measuring concordance rates between imputed and genotyped alleles of the HLA genes from a subset of the study subjects and East Asian HapMap individuals. Average concordance rates were 95.6% and 91.1% at 2-digit and 4-digit allele resolutions, respectively. The imputation accuracy was minimally affected by SNP density of a test dataset for imputation. In conclusion, the Korean HLA reference panel we developed was highly suitable for imputing HLA alleles and amino acids from MHC SNPs in East Asians, including Koreans.	[Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul 133791, South Korea; [Kim, Kwangwoo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Kim, Kwangwoo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Kim, Kwangwoo] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	Hanyang University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bae, SC (corresponding author), Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul 133791, South Korea.	scbae@hanyang.ac.kr	Bae, Sang-Cheol/P-2051-2015	Bae, Sang-Cheol/0000-0003-4658-1093; Kim, Kwangwoo/0000-0001-8926-6216	Korea Healthcare Technology R&D project of the Ministry for Health Welfare [HI13C2124]	Korea Healthcare Technology R&D project of the Ministry for Health Welfare	This work was supported by grants from the Korea Healthcare Technology R&D project of the Ministry for Health & Welfare (HI13C2124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Stephen, 2011, Immune Netw, V11, P324, DOI 10.4110/in.2011.11.6.324; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Bang SY, 2013, J RHEUMATOL, V40, P1054, DOI 10.3899/jrheum.121280; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Foo JN, 2013, AM J HUM GENET, V93, P167, DOI 10.1016/j.ajhg.2013.05.020; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kim K, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204749; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Yamamura T, 2012, TISSUE ANTIGENS, V80, P119, DOI 10.1111/j.1399-0039.2012.01883.x	17	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112546	10.1371/journal.pone.0112546	http://dx.doi.org/10.1371/journal.pone.0112546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398076	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500059
J	Pichrtova, M; Kulichova, J; Holzinger, A				Pichrtova, Martina; Kulichova, Jana; Holzinger, Andreas			Nitrogen Limitation and Slow Drying Induce Desiccation Tolerance in Conjugating Green Algae (Zygnematophyceae, Streptophyta) from Polar Habitats	PLOS ONE			English	Article							ZYGOGONIUM-ERICETORUM ZYGNEMATOPHYCEAE; BIOLOGICAL SOIL CRUST; LAND PLANTS; ZYGNEMA ZYGNEMATOPHYCEAE; CHLOROPHYLL FLUORESCENCE; PHENOLIC-COMPOUNDS; TERRESTRIAL ALGAE; ANTARCTIC STRAINS; OSMOTIC-STRESS; FRESH-WATER	Background: Filamentous Zygnematophyceae are typical components of algal mats in the polar hydro-terrestrial environment. Under field conditions, they form senescent vegetative cells, designated as pre-akinetes, which are tolerant to desiccation and osmotic stress. Key Findings: Pre-akinete formation and desiccation tolerance was investigated experimentally under monitored laboratory conditions in four strains of Arctic and Antarctic isolates with vegetative Zygnema sp. morphology. Phylogenetic analyses of rbcL sequences revealed one Arctic strain as genus Zygnemopsis, phylogenetically distant from the closely related Zygnema strains. Algae were cultivated in liquid or on solidified medium (9 weeks), supplemented with or lacking nitrogen. Nitrogen-free cultures (liquid as well as solidified) consisted of well-developed pre-akinetes after this period. Desiccation experiments were performed at three different drying rates (rapid: 10% relative humidity, slow: 86% rh and very slow); viability, effective quantum yield of PS II, visual and ultrastructural changes were monitored. Recovery and viability of pre-akinetes were clearly dependent on the drying rate: slower desiccation led to higher levels of survival. Pre-akinetes survived rapid drying after acclimation by very slow desiccation. Conclusions: The formation of pre-akinetes in polar Zygnema spp. and Zygnemopsis sp. is induced by nitrogen limitation. Pre-akinetes, modified vegetative cells, rather than specialized stages of the life cycle, can be hardened by mild desiccation stress to survive rapid drying. Naturally hardened pre-akinetes play a key role in stress tolerance and dispersal under the extreme conditions of polar regions, where sexual reproduction and production of dormant stages is largely suppressed.	[Pichrtova, Martina; Kulichova, Jana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Pichrtova, Martina] Acad Sci Czech Republ, Inst Bot, Trebon, Czech Republic; [Holzinger, Andreas] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Innsbruck	Holzinger, A (corresponding author), Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria.	Andreas.Holzinger@uibk.ac.at	Pichrtová, Martina/N-1298-2014; Kulichova, Jana/A-2486-2013; Holzinger, Andreas/E-9530-2010; Holzinger, Andreas/A-6396-2008; Holzinger, Andreas/Z-2659-2019	Pichrtová, Martina/0000-0002-6003-9666; Kulichova, Jana/0000-0001-8035-4770; Holzinger, Andreas/0000-0002-6786-5194; Holzinger, Andreas/0000-0002-7745-3978; Holzinger, Andreas/0000-0002-7745-3978	Charles University Grant Agency [GAUK 794413]; Czech Ministry of Education; long-term research development project [RVO 67985939]; Ministry of Education, Youth and Sports of the Czech Republic [LM2010009]; AKTION "Austria-Czech Republic'' [65 p5]; Austrian Science Fund [P24242-B16]; Austrian Science Fund (FWF) [P 24242] Funding Source: researchfish	Charles University Grant Agency; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); long-term research development project; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); AKTION "Austria-Czech Republic''; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The present study was supported by the Charles University Grant Agency (http://www.cuni.cz) project GAUK 794413 to M. P.; by the institutional resources of the Czech Ministry of Education; by a long-term research development project, RVO 67985939; by the Ministry of Education, Youth and Sports of the Czech Republic (www.msmt.cz) project "CzechPolar stations: Construction and logistic expenses, LM2010009 2010-2015''. M. P. and A. H. acknowledge funding from the AKTION "Austria-Czech Republic'' (http://www.oead.at), Project 65 p5. The study was supported by the Austrian Science Fund (FWF, http://www.fwf.ac.at), Project P24242-B16 to A. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner S, 2013, J PHYCOL, V49, P648, DOI 10.1111/jpy.12075; [Anonymous], ALGOL STUDIES; Bartels D, 2011, ECOL STUD-ANAL SYNTH, V215, P3, DOI 10.1007/978-3-642-19106-0_1; Bischoff H. W., 1963, U TEXAS PUBL; Budel B, 2011, ECOL STUD-ANAL SYNTH, V215, P45, DOI 10.1007/978-3-642-19106-0_4; Cardon ZG, 2008, BIOSCIENCE, V58, P114, DOI 10.1641/B580206; Coleman A.W., 1983, P1; DARLING RB, 1987, J PHYCOL, V23, P598; de Carvalho RC, 2014, PLANT CELL ENVIRON, V37, P1499, DOI 10.1111/pce.12266; Ellis E.A., 2006, MICROSC TODAY, V14, P32, DOI [10.1017/S1551929500050252, DOI 10.1017/S1551929500050252]; Fritsch FE, 1916, ANN BOT-LONDON, V30, P135, DOI 10.1093/oxfordjournals.aob.a089580; Fuller C, 2013, THESIS CALIFORNIA ST; Gasulla F, 2009, PLANTA, V231, P195, DOI 10.1007/s00425-009-1019-y; Gasulla F, 2013, PLANT CELL ENVIRON, V36, P1363, DOI 10.1111/pce.12065; GENKEL' P A, 1979, Biology Bulletin of the Academy of Sciences of the USSR, V6, P504; Gray DW, 2007, PLANT CELL ENVIRON, V30, P1240, DOI 10.1111/j.1365-3040.2007.01704.x; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Hall JD, 2008, J PHYCOL, V44, P467, DOI 10.1111/j.1529-8817.2008.00485.x; HAWES I, 1990, PHYCOLOGIA, V29, P326, DOI 10.2216/i0031-8884-29-3-326.1; Herburger K, 2015, PROTOPLASMA, V252, P571, DOI 10.1007/s00709-014-0703-3; Holzinger A, 2010, PROTOPLASMA, V243, P15, DOI 10.1007/s00709-009-0048-5; Holzinger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110630; Holzinger A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00327; Holzinger A, 2011, J PHYCOL, V47, P591, DOI 10.1111/j.1529-8817.2011.00980.x; Holzinger A, 2009, MICRON, V40, P831, DOI 10.1016/j.micron.2009.06.008; Hoppert M, 2004, GEOMICROBIOL J, V21, P183, DOI 10.1080/01490450490275433; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kadlubowska JZ, 1984, SUSSWASSERFLORA MITT, V16, P1; Kaplan F, 2013, MICRON, V44, P317, DOI 10.1016/j.micron.2012.08.004; Karsten U, 2014, J PHYCOL, V50, P804, DOI 10.1111/jpy.12210; Karsten U, 2014, BIODIVERS CONSERV, V23, P1845, DOI 10.1007/s10531-014-0653-2; Karsten U, 2012, MICROB ECOL, V63, P51, DOI 10.1007/s00248-011-9924-6; Kim GH, 2011, ARCTIC, V64, P25, DOI 10.14430/arctic4077; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Lewis LA, 2005, SYST BIOL, V54, P936, DOI 10.1080/10635150500354852; Marshall WA, 1997, ECOGRAPHY, V20, P585, DOI 10.1111/j.1600-0587.1997.tb00427.x; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McCourt RM, 2000, J PHYCOL, V36, P747, DOI 10.1046/j.1529-8817.2000.99106.x; McLean R.J., 1971, CONTRIBUTIONS PHYCOL, P145; MORISON MO, 1985, PHYCOLOGIA, V24, P129, DOI 10.2216/i0031-8884-24-2-129.1; Nylander JAA, 2004, MRMODELTEST 2 3; Pichrtova M, 2014, FEMS MICROBIOL ECOL, V89, P270, DOI 10.1111/1574-6941.12288; Pichrtova M, 2013, MICROB ECOL, V65, P68, DOI 10.1007/s00248-012-0096-9; POST A, 1993, AQUAT BOT, V45, P231, DOI 10.1016/0304-3770(93)90023-P; Rambaut A, 2009, FIGTREE TREE FIGURE; Remias D, 2012, POLAR BIOL, V35, P899, DOI 10.1007/s00300-011-1135-6; Remias D, 2009, PHYCOLOGIA, V48, P302, DOI 10.2216/08-13.1; Rindi F, 2010, ENVIRON SCI ENG TECH, P105; Rohacek K, 1999, PHOTOSYNTHETICA, V37, P339, DOI 10.1023/A:1007172424619; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Shiratake T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079630; Stancheva R, 2014, J PHYCOL, V50, P790, DOI 10.1111/jpy.12229; Stancheva R, 2012, J PHYCOL, V48, P409, DOI 10.1111/j.1529-8817.2012.01127.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Timme RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029696; Vilumbrales D.M., 2013, CZECH POLAR REPORTS, V3, P163, DOI [DOI 10.5817/CPR2013-2-17, 10.5817/CPR2013-2-17]; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Zhong BJ, 2014, MOL BIOL EVOL, V31, P177, DOI 10.1093/molbev/mst200; Zhong BJ, 2013, TRENDS PLANT SCI, V18, P492, DOI 10.1016/j.tplants.2013.04.009; Zwickl DJ., 2006, THESIS	62	47	47	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113137	10.1371/journal.pone.0113137	http://dx.doi.org/10.1371/journal.pone.0113137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25398135	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500136
J	Rhodes, JR; Lunney, D; Callaghan, J; McAlpine, CA				Rhodes, Jonathan R.; Lunney, Daniel; Callaghan, John; McAlpine, Clive A.			A Few Large Roads or Many Small Ones? How to Accommodate Growth in Vehicle Numbers to Minimise Impacts on Wildlife	PLOS ONE			English	Article							NEW-SOUTH-WALES; OF-FIT TESTS; PHASCOLARCTOS-CINEREUS; PORT STEPHENS; HOME-RANGE; MORTALITY; CONSERVATION; POPULATION; KOALAS; MODELS	Roads and vehicular traffic are among the most pervasive of threats to biodiversity because they fragmenting habitat, increasing mortality and opening up new areas for the exploitation of natural resources. However, the number of vehicles on roads is increasing rapidly and this is likely to continue into the future, putting increased pressure on wildlife populations. Consequently, a major challenge is the planning of road networks to accommodate increased numbers of vehicles, while minimising impacts on wildlife. Nonetheless, we currently have few principles for guiding decisions on road network planning to reduce impacts on wildlife in real landscapes. We addressed this issue by developing an approach for quantifying the impact on wildlife mortality of two alternative mechanisms for accommodating growth in vehicle numbers: (1) increasing the number of roads, and (2) increasing traffic volumes on existing roads. We applied this approach to a koala (Phascolarctos cinereus) population in eastern Australia and quantified the relative impact of each strategy on mortality. We show that, in most cases, accommodating growth in traffic through increases in volumes on existing roads has a lower impact than building new roads. An exception is where the existing road network has very low road density, but very high traffic volumes on each road. These findings have important implications for how we design road networks to reduce their impacts on biodiversity.	[Rhodes, Jonathan R.; McAlpine, Clive A.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Rhodes, Jonathan R.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Rhodes, Jonathan R.; McAlpine, Clive A.] Univ Queensland, NERP Environm Decis Hub, Brisbane, Qld, Australia; [Lunney, Daniel] Off Environm & Heritage New South Wales, Hurstville, NSW, Australia; [Lunney, Daniel] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Callaghan, John] Australian Koala Fdn, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Office of Environment & Heritage - New South Wales; University of Sydney	Rhodes, JR (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	j.rhodes@uq.edu.au	Rhodes, Jonathan/C-4841-2008	Rhodes, Jonathan/0000-0001-6746-7412; Beale, Mathew/0000-0002-4740-3187; Fisher, Matthew/0000-0002-1862-6402; Rhodes, Johanna/0000-0002-1338-7860; McAlpine, Clive/0000-0003-0457-8144; Lunney, Dan/0000-0002-5771-0746	Australian Research Council [C00107594]	Australian Research Council(Australian Research Council)	This work was supported by funding from: An Australian Research Council Linkage Project with contributions from the Australian Koala Foundation and New South Wales Government (project number: C00107594, www.arc.gov.au). The Australian Research Council Centre of Excellence for Environmental Decisions (www.arc.gov.au). The National Environmental Research Program Environmental Decisions Hub (http://www.environment.gov.au/topics/science-and-research/national-environmental-research-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Callaghan J, 2011, WILDLIFE RES, V38, P89, DOI 10.1071/WR07177; Caswell, 2000, MATRIX POPULATION MO; Clarke GP, 1998, BIOL CONSERV, V86, P117, DOI 10.1016/S0006-3207(98)00018-4; Cork SJ, 2000, CONSERV BIOL, V14, P660, DOI 10.1046/j.1523-1739.2000.99389.x; DECC, 2008, NSW 2008 KOAL REC PL; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Dovers SR, 1996, BIODIVERS CONSERV, V5, P1143, DOI 10.1007/BF00051569; Dudaniec RY, 2013, MOL ECOL, V22, P3752, DOI 10.1111/mec.12359; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; FAHRIG L, 1995, BIOL CONSERV, V73, P177, DOI 10.1016/0006-3207(94)00102-V; FAHRIG L, 2009, ECOL SOC, V14; Fields G, 2009, INT J SUSTAIN TRANSP, V3, P360, DOI 10.1080/15568310802260013; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Goosem Miriam, 1997, P241; Grosman PD, 2011, ECOL MODEL, V222, P1423, DOI 10.1016/j.ecolmodel.2011.01.022; Hels T, 2001, BIOL CONSERV, V99, P331, DOI 10.1016/S0006-3207(00)00215-9; HINDELL MA, 1985, AUST WILDLIFE RES, V12, P137; HINDELL MA, 1987, AUST WILDLIFE RES, V14, P349, DOI 10.1071/WR9870349; Hosmer DW, 1997, STAT MED, V16, P965; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; International Road Federation, 2011, WORLD ROAD STAT 2011; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Jaeger Jochen A.G., 2006, P151; Jones ME, 2000, WILDLIFE RES, V27, P289, DOI 10.1071/WR98069; Knott Tiffany, 1998, Pacific Conservation Biology, V4, P354; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Lunney D, 2000, CONSERV BIOL, V14, P669, DOI 10.1046/j.1523-1739.2000.99386.x; Lunney D, 2010, NATURAL HIST SYDNEY; Lunney D, PAC CONSERV IN PRESS; Lunney Daniel, 1998, Pacific Conservation Biology, V4, P186; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Melzer A, 1995, ASPECTS ECOLOGY KOAL; Mitchell P., 1990, P171; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Natural Resource Management Ministerial Council, 2009, NAT KOAL CONS MAN ST; OSIUS G, 1992, J AM STAT ASSOC, V87, P1145, DOI 10.2307/2290653; Phillips S, 2000, WILDLIFE RES, V27, P1, DOI 10.1071/WR98054; Pittman J, 1993, PROBABILITY; Polak T, J APPL ECOL IN PRESS; Port Stephens Council, 2001, PORT STEPH COUNC C 1; Ramp D, 2005, BIOL CONSERV, V126, P474, DOI 10.1016/j.biocon.2005.07.001; Ramp D, 2006, J WILDLIFE MANAGE, V70, P1615, DOI 10.2193/0022-541X(2006)70[1615:TEORFO]2.0.CO;2; Reed P.C., 1990, P55; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Rhodes JR, 2005, ECOLOGY, V86, P1199, DOI 10.1890/04-0912; Roger E, 2011, POPUL ECOL, V53, P215, DOI 10.1007/s10144-010-0209-6; Rondinini C, 2002, FUNCT ECOL, V16, P504, DOI 10.1046/j.1365-2435.2002.00651.x; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Slooten E, 2000, CONSERV BIOL, V14, P1264, DOI 10.1046/j.1523-1739.2000.00099-411.x; Spellerberg IF, 2002, ECOLOGICAL EFFECTS R, DOI DOI 10.1201/9781482279931; Stewart-Oaten Allan, 1996, P17, DOI 10.1016/B978-012627255-0/50004-5; Sushinsky JR, 2013, GLOBAL CHANGE BIOL, V19, P401, DOI 10.1111/gcb.12055; Taylor BD, 2003, WILDLIFE RES, V30, P529, DOI 10.1071/WR01062; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; van Langevelde F, 2004, LANDSCAPE ECOL, V19, P895, DOI 10.1007/s10980-004-0464-z; van Langevelde F, 1997, HABITAT FRAGMENTATIO, P171; van Langevelde F, 2009, ECOL SOC, V14; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Wade PR, 2002, POPULATION VIABILITY ANALYSIS, P213; White NA, 1999, WILDLIFE RES, V26, P731, DOI 10.1071/WR98002; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zar J. H., 1996, BIOSTATISTICAL ANAL; [No title captured], DOI DOI 10.1016/j.jenvman.2010.11.027	74	56	58	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91093	10.1371/journal.pone.0091093	http://dx.doi.org/10.1371/journal.pone.0091093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646891	Green Published, gold			2022-12-26	WOS:000333348500024
